data_2kmx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.359 0.874 . . . . 3.46 113.359 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.89 149.32 3.94 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.969 3.113 . . . . 1.69 112.923 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 3.9 m -131.52 130.24 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.728 2.011 . . . . 3.81 111.903 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.2 p -74.8 126.44 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.396 -0.815 . . . . 2.2 110.745 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.02 -38.29 3.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.733 1.753 . . . . 3.08 115.733 -165.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -149.09 145.18 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.281 1.401 . . . . 3.13 111.961 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 30.1 m -125.41 143.16 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.088 0.955 . . . . 1.55 112.786 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 71.9 tttt -136.88 142.19 42.78 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.526 1.53 . . . . 2.8 111.385 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 58.0 t -94.38 148.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.131 1.373 . . . . 1.31 111.45 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.91 -39.09 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.35 1.46 . . . . 2.31 113.682 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.4 t -81.12 29.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.82 1.191 . . . . 3.41 113.424 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.34 132.42 39.26 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.859 -1.776 . . . . 4.37 111.634 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 20.8 m 61.65 -8.62 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.763 2.505 . . . . 2.53 117.763 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.84 -30.86 12.91 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.397 1.628 . . . . 3.48 115.397 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -150.04 -66.28 0.21 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.658 1.117 . . . . 6.45 112.579 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 4.4 mt -128.15 140.08 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.577 1.951 . . . . 2.57 110.905 -171.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.5 m -103.15 160.27 14.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.637 1.175 . . . . 2.41 112.746 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.8 p80 -47.13 -41.41 17.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.944 1.698 . . . . 3.23 115.466 -169.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -70.55 -42.22 71.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.071 1.348 . . . . 4.51 111.913 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.53 -33.23 72.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.067 -1.02 . . . . 3.84 112.138 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -58.41 -52.65 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.884 1.22 . . . . 2.03 110.768 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.79 -29.96 68.43 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.402 -0.811 . . . . 2.0 112.181 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.62 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.095 0.558 . . . . 1.31 112.279 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 15.1 pt -70.31 -35.53 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.809 1.186 . . . . 2.05 112.867 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 92.4 t -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.452 1.023 . . . . 1.5 111.006 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.8 -34.74 88.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.451 -0.78 . . . . 0.72 113.51 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.9 p -75.9 -32.61 59.72 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.746 1.273 . . . . 1.42 112.815 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.05 67.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.877 0.762 . . . . 0.97 112.137 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.41 -21.13 62.87 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.313 -0.867 . . . . 1.92 112.439 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.0 t -65.23 -18.51 65.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.93 -1.106 . . . . 1.97 112.566 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -117.69 -9.23 10.77 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.169 1.388 . . . . 2.55 113.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.9 t -85.62 -174.89 5.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.409 1.484 . . . . 1.61 112.32 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -135.82 32.13 3.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.547 1.939 . . . . 4.26 112.703 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -93.51 162.3 28.09 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 114.199 1.185 . . . . 2.64 114.199 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.68 -21.55 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.052 3.168 . . . . 1.03 114.657 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.4 -52.48 2.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.054 1.341 . . . . 1.61 113.383 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.91 -23.59 65.83 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 114.154 0.422 . . . . 1.06 114.154 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 12.9 p -61.44 -18.45 58.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.929 -1.336 . . . . 2.56 113.988 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.68 81.42 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.885 -1.134 . . . . 1.6 111.719 168.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.64 -32.85 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.299 1.039 . . . . 2.48 111.291 172.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 28.0 m -52.27 -50.81 61.39 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.798 1.181 . . . . 2.5 111.253 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -61.32 -48.04 83.18 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.852 0.751 . . . . 3.6 112.647 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -55.73 -41.63 74.16 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.961 0.904 . . . . 2.76 111.735 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.1 t -67.91 -52.74 32.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.132 1.373 . . . . 2.48 112.371 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -42.31 88.86 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.413 -1.429 . . . . 3.73 112.455 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -67.47 -31.51 71.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.81 1.644 . . . . 3.79 111.901 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -70.25 -50.34 40.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.501 1.046 . . . . 2.66 112.224 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 27.4 mt -72.18 -22.72 61.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.484 1.29 . . . . 1.47 114.484 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.6 t0 56.36 43.9 25.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.87 1.668 . . . . 2.76 113.333 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.7 t -138.88 -30.8 0.74 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.175 2.287 . . . . 3.31 117.175 -169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 61.1 tt0 64.47 -26.41 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.744 2.498 . . . . 4.43 117.744 -171.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 46.9 p -84.57 45.2 1.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.446 1.898 . . . . 3.93 114.828 -169.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.95 151.75 23.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.159 1.383 . . . . 1.33 113.523 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 92.79 122.76 3.23 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.049 0.841 . . . . 1.34 114.611 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 74.4 m -129.3 -172.58 2.77 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.254 2.622 . . . . 2.6 107.653 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.42 143.37 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.151 1.908 . . . . 2.06 116.151 -168.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 16.5 tt -135.11 140.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 131.523 3.929 . . . . 3.03 106.368 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.2 t0 -124.53 93.48 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.46 1.104 . . . . 3.21 108.845 172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.341 0.0 OUTLIER -97.43 166.55 11.48 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 117.412 2.375 . . . . 4.41 117.412 -169.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -142.81 105.45 4.49 Favored 'General case' 0 CA--C 1.562 1.414 1 C-N-CA 132.332 4.253 . . . . 2.14 107.625 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 6.3 m -109.62 151.04 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.303 -1.498 . . . . 3.99 114.515 -170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 13.9 t -137.71 138.87 25.16 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.9 1.28 . . . . 1.63 110.599 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.33 132.95 28.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.647 2.231 . . . . 2.34 111.758 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.1 -34.5 0.41 Allowed Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.267 1.889 . . . . 2.16 115.893 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -90.21 2.91 54.88 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.212 1.56 . . . . 2.99 115.212 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 90.98 -176.29 40.67 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.308 0.956 . . . . 1.11 114.598 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.5 pt -136.53 160.01 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.111 0.964 . . . . 3.92 112.59 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 21.7 t -130.27 147.03 51.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.415 1.486 . . . . 1.06 111.565 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.4 p -154.63 173.77 15.9 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.013 -1.055 . . . . 1.26 113.003 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -115.88 111.18 20.07 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 106.409 -1.7 . . . . 1.58 106.409 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 2.6 m -103.05 127.93 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.596 1.158 . . . . 3.42 113.432 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.3 t -109.23 159.1 17.21 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.074 0.95 . . . . 1.67 112.306 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.3 t-20 . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 128.728 2.811 . . . . 2.55 107.786 161.281 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 114.635 1.346 . . . . 2.98 114.635 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 119.25 10.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.898 0.879 . . . . 4.68 112.365 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.29 117.29 18.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.23 . . . . 2.07 110.686 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -135.29 144.07 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 0.94 112.198 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.26 154.59 42.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.895 1.278 . . . . 0.9 112.603 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.0 tt -152.5 145.79 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.279 1.032 . . . . 1.89 110.587 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 121.83 166.58 12.89 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 116.042 1.177 . . . . 1.44 116.042 168.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 48.11 -141.36 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.604 1.962 . . . . 2.46 113.93 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.43 -32.58 0.45 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.499 1.52 . . . . 7.29 114.184 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.59 -37.49 79.86 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.433 1.469 . . . . 3.77 114.275 -174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.3 t90 -68.22 -31.18 70.51 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.657 -1.277 . . . . 4.28 111.819 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 10.4 tpp -60.23 -34.53 73.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.137 0.975 . . . . 2.57 111.752 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.66 -67.01 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.467 1.507 . . . . 2.46 109.043 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -52.96 -24.97 10.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.967 2.107 . . . . 6.34 115.987 -172.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.76 20.23 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.006 1.275 . . . . 1.09 113.811 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.26 13.41 81.4 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.193 -1.567 . . . . 0.93 115.376 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.6 mt -83.96 175.3 9.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.605 1.162 . . . . 0.92 111.388 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 57.8 t -119.41 131.05 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.087 1.355 . . . . 2.43 108.744 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.5 tt -102.71 135.73 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.396 0.679 . . . . 2.07 110.954 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.7 p30 -96.82 159.51 14.88 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.736 1.214 . . . . 4.12 113.099 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.1 p30 -71.99 -15.04 62.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.447 1.277 . . . . 4.38 114.447 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -84.24 -45.22 13.11 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.62 -1.3 . . . . 2.46 113.019 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.2 p -64.45 -34.46 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 118.823 -0.608 . . . . 1.3 110.92 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.67 -42.96 81.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.761 1.164 . . . . 2.58 112.604 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.61 -34.69 77.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.274 1.03 . . . . 1.97 112.405 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 39.9 t80 -71.95 -35.41 69.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.818 1.247 . . . . 3.56 112.718 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.3 tpp -71.21 -58.95 3.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.502 1.921 . . . . 1.69 112.435 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -62.53 -28.2 69.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 1.9 112.297 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -58.31 -47.42 83.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.757 2.023 . . . . 2.71 113.403 171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -64.78 -36.11 83.25 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.213 -0.929 . . . . 3.12 111.842 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.41 -31.96 72.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.514 -0.741 . . . . 3.07 112.36 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 48.9 ttp85 -70.6 -39.9 73.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.558 2.343 . . . . 10.41 111.431 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 13.8 mttp -69.2 -1.38 7.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.728 2.011 . . . . 3.06 112.624 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 75.34 16.58 80.53 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.824 1.202 . . . . 1.35 115.022 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -95.45 178.93 5.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.259 1.424 . . . . 4.43 111.205 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.2 m -93.29 121.08 34.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.16 1.784 . . . . 2.0 109.635 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.41 113.95 15.56 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.754 0.822 . . . . 1.27 111.873 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 26.7 m -140.55 163.13 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.569 1.148 . . . . 1.07 114.06 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.1 160.95 23.97 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.352 1.461 . . . . 1.07 112.982 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 5.0 t -127.49 125.75 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.22 1.808 . . . . 2.75 111.677 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -118.66 154.36 32.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.122 1.369 . . . . 0.95 112.19 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.9 m -146.61 122.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.027 1.731 . . . . 2.11 110.462 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 31.2 t70 44.39 46.79 7.98 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 122.705 1.241 . . . . 3.34 113.368 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.265 4.9 m-20 62.42 28.1 16.66 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.549 1.94 . . . . 1.76 115.838 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.46 149.07 42.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.726 2.811 . . . . 3.27 110.273 168.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.61 114.61 26.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.47 -1.394 . . . . 1.62 110.812 170.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.4 p -89.21 -38.06 14.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.738 1.154 . . . . 1.33 113.32 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . 176.48 -168.69 40.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 119.259 0.936 . . . . 0.64 114.883 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.23 156.08 44.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.349 1.46 . . . . 1.0 113.772 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.37 133.05 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 2.82 111.525 -170.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -105.15 136.59 44.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.978 1.711 . . . . 1.77 110.356 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 67.3 mt -140.97 148.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.759 1.624 . . . . 2.21 109.869 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 124.413 1.085 . . . . 1.57 112.585 179.634 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 116.134 1.902 . . . . 2.74 116.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.79 132.48 40.16 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.105 2.537 . . . . 2.81 111.955 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.52 129.52 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.662 1.585 . . . . 3.08 110.946 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 128.23 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.781 0.833 . . . . 2.56 111.531 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.35 -35.3 4.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.128 1.158 . . . . 2.76 114.128 -168.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -164.88 152.66 11.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 2.7 111.69 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.4 m -125.07 135.13 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.514 1.126 . . . . 1.02 109.216 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 51.8 tttt -140.96 148.26 40.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.04 0.936 . . . . 2.91 113.026 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.1 t -90.38 151.13 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 1.67 112.532 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.01 -35.5 4.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.395 1.878 . . . . 1.61 111.42 168.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 92.5 m -119.93 97.85 5.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.225 1.012 . . . . 3.02 111.798 -170.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -91.59 140.89 29.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.449 1.5 . . . . 3.88 111.071 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 52.93 29.13 7.36 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.772 2.138 . . . . 3.31 116.772 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -145.55 -14.7 0.49 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.093 1.886 . . . . 3.49 116.093 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -149.65 -97.53 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.271 1.428 . . . . 5.15 109.99 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 54.9 mt -139.68 146.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.106 1.762 . . . . 2.86 109.857 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 3.3 t -123.18 172.73 8.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.852 1.661 . . . . 5.33 114.975 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.0 p80 -38.79 -53.49 1.67 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 117.194 2.294 . . . . 4.07 117.194 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.34 -36.53 84.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.488 1.495 . . . . 3.73 111.897 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.5 -26.03 21.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 117.476 -1.25 . . . . 3.5 113.04 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.75 -52.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.198 1.363 . . . . 2.52 109.37 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.13 -31.93 73.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.91 -0.494 . . . . 1.89 111.348 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.12 -61.13 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.599 -0.715 . . . . 1.31 112.39 171.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.53 -31.38 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.711 1.141 . . . . 1.04 114.022 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 85.0 t -67.18 -42.25 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.224 0.92 . . . . 1.97 110.224 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.46 91.73 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.633 -0.537 . . . . 0.91 113.276 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.2 p -72.46 -28.46 62.95 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.669 1.235 . . . . 1.76 113.144 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -69.36 -60.81 2.09 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.034 0.834 . . . . 2.6 111.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -65.23 -18.32 65.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.883 1.273 . . . . 2.64 112.462 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 39.7 t -51.53 -31.37 23.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.022 1.329 . . . . 1.78 113.032 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -79.49 3.3 19.05 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.804 -1.185 . . . . 3.48 114.185 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 48.0 m -120.74 -178.48 3.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.181 1.792 . . . . 1.98 112.785 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -139.71 29.95 2.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.234 1.414 . . . . 4.48 113.186 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.05 150.23 64.49 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 114.264 1.209 . . . . 2.39 114.264 -170.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.59 -25.05 75.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.151 3.234 . . . . 1.42 115.066 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.74 -41.57 3.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.469 1.508 . . . . 2.31 111.81 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.66 70.05 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 123.634 0.635 . . . . 1.2 113.918 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 4.8 p -58.96 -24.0 62.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.92 1.288 . . . . 2.9 114.455 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -71.18 -36.53 71.99 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.608 -1.308 . . . . 1.56 111.816 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.2 mt -72.03 -41.14 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.139 1.375 . . . . 1.42 110.425 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 76.9 p -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 117.354 -1.307 . . . . 3.64 111.862 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -59.37 -49.87 76.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.784 1.174 . . . . 3.3 112.498 169.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.91 -41.74 74.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.425 0.69 . . . . 3.88 111.424 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 38.1 t -71.26 -56.19 6.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.51 1.124 . . . . 2.36 113.116 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -42.8 -52.0 5.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.912 2.085 . . . . 4.52 112.005 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.741 0.816 . . . . 5.16 112.428 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.59 -40.28 95.24 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.395 -1.44 . . . . 2.26 112.74 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.5 -10.48 59.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.332 1.053 . . . . 2.07 113.048 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 45.0 t0 54.38 34.06 19.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.797 1.639 . . . . 2.41 113.108 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 15.1 t -115.63 162.76 16.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.055 1.342 . . . . 2.68 111.541 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.96 -16.99 25.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.474 1.51 . . . . 3.63 111.453 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.8 t -146.59 135.28 22.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.306 1.443 . . . . 3.98 111.821 -170.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.68 150.32 32.99 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.876 0.871 . . . . 1.84 111.414 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 81.22 167.33 37.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.594 0.998 . . . . 1.11 115.594 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 52.5 m -152.51 -37.43 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.058 2.143 . . . . 1.92 113.144 -173.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1108 ' ' CYS . . . . . 0.423 ' HB3' ' H ' ' A' 1124 ' ' THR . 51.7 t -134.33 142.96 47.41 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 2.97 114.872 -166.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 4.6 tp -150.6 151.31 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.934 1.293 . . . . 3.31 113.131 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.57 -17.26 12.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.492 1.517 . . . . 3.62 114.082 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 57.3 t80 45.26 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.49 2.716 . . . . 3.96 118.068 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.78 112.61 20.64 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.764 2.026 . . . . 2.46 109.132 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.8 t -99.75 136.67 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 2.94 111.377 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.1 t -131.42 108.37 14.71 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 108.645 -0.872 . . . . 1.26 108.645 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.02 141.5 64.43 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.898 2.399 . . . . 2.0 110.265 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 69.1 13.93 67.68 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 118.997 -0.89 . . . . 2.02 114.819 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 m -137.48 -87.77 0.28 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.803 1.241 . . . . 2.55 112.696 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . -175.16 -151.15 8.32 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.851 0.7 . . . . 1.2 114.851 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 146.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.263 1.425 . . . . 3.09 112.08 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.9 t -133.31 150.69 51.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.393 1.877 . . . . 1.32 111.43 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.6 p -163.06 166.43 23.62 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.967 1.469 . . . . 1.33 114.967 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -109.71 140.72 43.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.553 1.941 . . . . 1.53 107.759 166.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 14.7 p -149.4 140.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.806 1.41 . . . . 3.07 114.806 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1124 ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' 1108 ' ' CYS . 4.4 t -124.32 157.04 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.751 1.621 . . . . 2.67 110.87 166.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 127.187 2.195 . . . . 2.71 109.852 160.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.238 0.449 0 CA-C-O 120.841 0.353 . . . . 3.17 111.226 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -129.23 138.68 51.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.073 1.749 . . . . 4.31 110.417 -171.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -105.83 113.75 27.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.717 1.207 . . . . 2.12 108.718 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.9 m -131.39 139.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.376 0.989 . . . . 1.07 113.319 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.77 154.84 44.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.702 1.201 . . . . 1.2 112.93 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.9 tt -155.91 142.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.753 1.621 . . . . 1.81 110.555 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 125.33 147.36 6.99 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.391 1.317 . . . . 2.18 116.391 168.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.64 -159.46 0.1 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.743 1.617 . . . . 2.14 111.801 -169.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -125.68 -40.53 2.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.258 1.577 . . . . 6.09 115.258 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.25 -41.08 67.19 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.085 -1.635 . . . . 4.05 111.639 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 11.8 t90 -57.71 -23.23 50.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.562 0.949 . . . . 4.05 113.562 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 75.5 mmm -75.42 -53.19 9.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.888 1.275 . . . . 3.25 112.148 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 96.9 mt -47.89 -62.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.139 1.775 . . . . 3.72 110.654 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -47.7 -13.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 128.504 2.722 . . . . 7.3 116.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.61 24.88 0.45 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 119.689 1.131 . . . . 1.03 111.859 169.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.17 27.63 73.65 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.385 -1.447 . . . . 0.82 114.772 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 17.3 mt -95.41 159.08 15.17 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.977 1.389 . . . . 0.94 114.253 -169.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 44.2 t -105.32 125.61 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.276 1.43 . . . . 2.54 110.544 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.9 tt -119.11 148.59 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.795 1.638 . . . . 2.08 110.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -127.43 165.41 19.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.383 1.073 . . . . 2.94 113.041 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.71 -30.84 69.58 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.408 -1.433 . . . . 4.03 114.12 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.36 -42.94 98.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.19 1.396 . . . . 5.08 111.565 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.5 p -77.78 -40.51 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.505 1.522 . . . . 1.43 112.113 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -57.69 -41.6 81.98 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.447 1.022 . . . . 3.72 112.125 171.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.6 -34.71 78.86 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.632 0.975 . . . . 2.92 113.632 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -74.93 -39.32 61.45 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 3.72 112.968 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 37.4 tpp -57.84 -58.7 7.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.033 1.333 . . . . 2.11 110.204 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.3 t -63.23 -31.17 72.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.819 0.674 . . . . 2.7 112.819 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -58.38 -50.19 74.54 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.841 -1.162 . . . . 3.01 112.108 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -72.73 -33.22 66.25 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.355 1.242 . . . . 2.71 114.355 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -65.3 -43.66 90.4 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.423 -0.798 . . . . 4.7 111.686 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -69.49 -25.59 64.14 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.599 -1.313 . . . . 5.93 112.661 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.4 mttp -67.07 -12.56 60.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.225 1.41 . . . . 2.98 112.959 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.0 25.35 66.91 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.531 1.062 . . . . 1.88 113.384 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.83 172.4 7.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.642 1.577 . . . . 7.65 110.076 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 87.5 m -83.76 127.66 33.96 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.541 -0.725 . . . . 1.98 111.192 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -134.65 109.54 8.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.438 1.495 . . . . 1.97 110.045 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.2 m -140.51 154.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.595 1.158 . . . . 1.14 112.498 -172.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.44 170.28 8.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.37 0.878 . . . . 1.25 113.37 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 10.3 t -130.66 130.26 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.426 1.89 . . . . 2.76 111.035 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.08 150.03 47.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.421 1.089 . . . . 1.0 112.227 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.5 m -142.94 117.54 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.912 2.085 . . . . 2.45 111.255 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 45.29 53.9 7.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.701 2.0 . . . . 2.85 112.805 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.65 33.47 23.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.387 1.875 . . . . 1.52 114.091 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.33 144.86 36.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 2.79 109.911 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 146.17 41.08 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.923 -1.736 . . . . 1.86 112.296 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 24.9 p -121.84 -44.24 2.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.107 0.963 . . . . 1.3 113.123 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.23 -169.93 34.75 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.325 0.966 . . . . 0.63 114.853 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.58 161.12 39.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.709 1.603 . . . . 1.26 114.296 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 18.1 mm -129.38 135.01 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.008 1.723 . . . . 1.97 110.651 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -110.77 126.5 54.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.273 1.829 . . . . 1.56 110.198 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.09 153.97 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.421 1.488 . . . . 2.94 110.032 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.16 1.384 . . . . 1.74 111.425 175.167 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 113.705 1.002 . . . . 3.47 113.705 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.58 141.55 46.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.026 3.151 . . . . 1.79 112.19 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.11 128.11 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.727 2.011 . . . . 3.08 110.302 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.293 10.3 p -76.04 117.51 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.61 -1.306 . . . . 2.42 113.464 -169.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -100.72 -47.05 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.9 1.28 . . . . 3.06 112.928 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -154.97 153.81 31.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 4.23 112.203 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -131.87 143.53 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.936 1.294 . . . . 1.14 109.868 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.3 tttt -141.38 146.92 37.23 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.081 0.771 . . . . 2.71 113.081 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 61.2 t -89.93 134.51 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 1.95 111.717 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.9 tp -113.25 -22.82 10.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.136 1.774 . . . . 2.79 113.274 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 121.56 25.2 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.015 1.726 . . . . 2.1 109.111 169.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -135.43 137.72 42.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.742 1.016 . . . . 3.53 113.742 -171.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 5.0 m 61.32 -50.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.98 2.912 . . . . 3.43 115.227 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -75.35 133.47 41.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.999 -1.111 . . . . 3.58 107.999 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 64.34 -53.85 0.27 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.363 2.265 . . . . 6.1 115.393 -168.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.74 154.57 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.299 1.44 . . . . 3.82 111.79 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.6 m -121.86 153.42 38.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.013 1.325 . . . . 2.68 113.954 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 31.9 p80 -50.05 -50.53 47.51 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.678 2.103 . . . . 4.37 116.678 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -74.32 -28.78 61.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.483 1.038 . . . . 3.79 111.978 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.98 -37.51 67.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.8 -1.095 . . . . 4.04 112.007 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.13 -56.19 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 119.416 1.007 . . . . 1.97 110.565 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.98 -28.63 69.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.448 -0.783 . . . . 1.82 112.617 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.27 -46.75 63.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.937 0.717 . . . . 1.84 112.937 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 27.6 pt -70.25 -28.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.968 1.258 . . . . 2.03 113.372 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 63.1 t -70.55 -52.02 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.568 0.622 . . . . 1.53 110.944 170.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.39 -30.37 73.34 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.369 -0.832 . . . . 0.74 114.271 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 12.6 p -70.2 -44.1 69.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.761 1.281 . . . . 1.64 112.85 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.66 -49.56 76.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.679 0.792 . . . . 1.1 111.549 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -65.91 -22.68 66.52 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.568 -0.708 . . . . 2.41 112.905 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 68.4 m -67.0 -38.52 86.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.735 1.214 . . . . 3.5 114.116 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.3 t30 -95.42 -15.18 23.19 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.237 1.415 . . . . 2.73 111.934 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 37.8 t -66.21 176.0 1.92 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.544 1.538 . . . . 1.66 109.928 165.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.2 46.87 1.72 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.263 -1.523 . . . . 3.69 113.407 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -93.39 165.1 19.0 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.219 1.408 . . . . 2.45 113.884 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.98 -26.07 0.96 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.593 2.862 . . . . 1.27 114.74 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.9 tt -110.62 -48.83 3.1 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.212 1.405 . . . . 2.16 112.643 -168.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -56.9 -24.16 48.58 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 113.999 0.36 . . . . 0.98 113.999 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 36.7 p -60.67 -17.38 47.31 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.724 1.379 . . . . 2.23 114.724 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.09 86.1 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.418 1.008 . . . . 1.71 111.396 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.6 mt -70.26 -39.52 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.553 1.141 . . . . 1.45 110.192 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 79.8 m -52.58 -48.09 66.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.338 0.655 . . . . 1.75 111.695 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 43.9 tttt -64.16 -49.7 71.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.313 0.645 . . . . 3.16 112.279 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 11.2 t80 -53.89 -42.84 69.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 2.84 111.542 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.5 t -70.39 -53.74 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.213 1.405 . . . . 2.17 112.031 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -58.17 -42.58 86.31 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.772 -1.205 . . . . 4.41 111.816 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.31 -32.3 70.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.618 0.767 . . . . 3.82 112.953 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.31 -48.41 65.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.319 1.048 . . . . 1.89 111.781 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.47 -31.36 67.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.673 0.99 . . . . 2.28 113.673 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 26.4 t0 53.39 29.5 8.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.335 1.854 . . . . 2.65 113.622 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.1 t -98.82 -21.53 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.36 1.615 . . . . 4.03 115.36 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 6.4 tt0 52.62 20.15 1.43 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.824 2.157 . . . . 2.88 116.824 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 56.7 p -137.46 0.15 2.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.15 -1.594 . . . . 4.48 114.844 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 157.69 36.74 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.112 -0.993 . . . . 1.95 113.413 -169.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 84.4 130.76 2.06 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.528 0.971 . . . . 1.19 115.528 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1107 ' ' THR . . . . . 0.417 HG23 ' H ' ' A' 1108 ' ' CYS . 0.5 OUTLIER -144.18 -170.02 3.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.209 2.604 . . . . 2.69 108.603 -175.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1108 ' ' CYS . . . . . 0.417 ' H ' HG23 ' A' 1107 ' ' THR . 48.8 t -60.68 132.41 53.8 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.063 1.875 . . . . 2.09 116.063 -168.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.03 148.74 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.168 2.187 . . . . 4.27 116.057 169.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.5 143.8 26.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.465 -2.05 . . . . 2.96 105.465 161.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.85 132.3 54.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.645 1.578 . . . . 3.94 112.451 -169.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.48 99.12 4.41 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.935 2.094 . . . . 3.16 109.352 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 33.2 m -102.1 148.61 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.245 0.832 . . . . 3.65 113.245 -169.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 24.5 t -133.16 111.08 12.94 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.959 1.303 . . . . 1.64 107.773 168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.66 134.74 62.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.892 2.394 . . . . 2.16 113.519 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 59.93 26.22 62.82 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.465 1.507 . . . . 2.4 115.924 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.0 t -146.52 -47.9 0.19 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.002 1.401 . . . . 2.41 114.257 -172.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.13 169.26 21.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.888 0.756 . . . . 0.88 113.445 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.84 162.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.673 -0.898 . . . . 3.89 112.621 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 34.6 t -122.49 145.37 48.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.716 2.006 . . . . 1.25 109.757 167.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.1 p -150.03 160.91 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.613 0.765 . . . . 1.3 112.42 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -119.99 105.32 10.93 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.551 -0.718 . . . . 2.05 109.135 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.9 p -104.45 138.28 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.052 1.341 . . . . 2.97 112.191 -168.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 171.37 8.14 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.824 1.416 . . . . 2.08 114.824 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.282 18.2 t-20 . . . . . 0 N--CA 1.477 0.893 1 C-N-CA 134.088 4.955 . . . . 2.85 108.547 166.561 . . . . . . . . 2 1 . 1 . 003 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 115.113 1.523 . . . . 2.54 115.113 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 123.94 30.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.848 1.659 . . . . 4.84 111.067 -170.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.28 123.16 26.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.946 0.794 . . . . 2.68 110.615 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -134.67 133.67 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.359 1.064 . . . . 0.97 111.104 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.18 147.51 41.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.605 1.162 . . . . 0.92 113.01 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.7 tt -149.58 141.35 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.895 1.278 . . . . 1.71 110.77 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.82 -155.25 26.05 Favored Glycine 0 CA--C 1.532 1.133 0 N-CA-C 115.411 0.924 . . . . 1.41 115.411 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -71.41 160.42 32.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.621 1.568 . . . . 3.48 111.59 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -59.13 -16.84 21.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.762 1.225 . . . . 7.37 114.066 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -57.74 -36.0 71.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.683 0.793 . . . . 4.78 112.256 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 5.3 m95 -74.35 -47.57 33.46 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.13 0.972 . . . . 5.03 112.156 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -29.06 68.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.478 0.711 . . . . 2.44 112.164 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.33 -66.89 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.156 2.182 . . . . 3.57 108.127 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -23.38 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.536 1.935 . . . . 9.2 115.953 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.66 14.62 31.43 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 120.349 1.431 . . . . 1.05 114.163 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.81 17.88 67.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.249 1.404 . . . . 1.19 116.517 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.16 155.48 28.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.405 1.103 . . . . 1.25 111.533 -170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 92.3 t -91.94 127.95 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.485 0.714 . . . . 2.89 110.189 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 13.8 tt -112.97 152.44 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.003 1.321 . . . . 2.35 111.954 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.46 156.64 20.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.571 1.693 . . . . 2.91 115.571 -168.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.4 t30 -68.66 -37.26 79.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.533 1.133 . . . . 3.51 113.914 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.29 -33.61 69.89 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.93 -1.106 . . . . 2.91 112.305 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -76.27 -37.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.227 -0.921 . . . . 2.6 112.196 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.59 -35.37 77.67 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.125 0.875 . . . . 3.22 112.075 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.03 -40.29 84.6 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.947 1.092 . . . . 2.72 113.947 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.57 -44.99 48.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.073 0.949 . . . . 4.22 112.319 171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 47.8 tpp -59.85 -56.27 23.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.39 1.076 . . . . 1.86 111.681 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.8 t -66.54 -30.65 71.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.522 -0.736 . . . . 2.24 112.52 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -62.4 -45.79 91.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.401 1.08 . . . . 3.52 111.391 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -67.53 -39.09 85.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.081 1.353 . . . . 5.0 112.071 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.11 -45.26 92.83 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.626 -0.671 . . . . 3.87 112.158 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.52 -21.14 62.77 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.936 -1.102 . . . . 5.76 113.309 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.266 14.2 ptpt -85.23 7.62 21.37 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.934 1.457 . . . . 4.4 114.934 167.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 72.2 21.21 79.34 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.785 1.074 . . . . 2.37 115.785 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -110.42 144.08 39.74 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.121 1.461 . . . . 5.57 110.39 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 52.5 m -61.35 124.31 20.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 2.01 112.44 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.06 125.43 37.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.756 1.222 . . . . 1.32 110.174 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.6 m -141.99 159.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.709 1.204 . . . . 2.0 113.536 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.2 mt -111.61 158.3 19.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.634 1.974 . . . . 1.79 111.559 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.7 p -139.47 128.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.076 0.951 . . . . 3.26 112.665 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.6 153.06 48.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.381 2.272 . . . . 0.98 111.008 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 10.5 m -144.09 136.13 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.252 -0.905 . . . . 1.8 112.098 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 33.3 t70 41.74 50.88 4.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.004 1.721 . . . . 2.99 112.207 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.26 6.0 m-20 66.19 21.59 11.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.385 1.994 . . . . 1.54 116.385 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -126.71 151.04 48.68 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.015 2.126 . . . . 2.48 110.147 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.18 143.08 41.32 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.769 -1.832 . . . . 1.88 111.795 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 17.5 p -118.72 -38.84 3.05 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.422 1.267 . . . . 1.39 114.422 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.73 -172.94 37.53 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 119.389 0.995 . . . . 0.65 114.588 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.7 151.59 41.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.716 1.606 . . . . 1.07 112.838 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.34 137.0 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.944 1.697 . . . . 2.21 109.962 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -123.7 135.06 53.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.653 1.581 . . . . 1.71 110.951 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 32.5 mt -140.41 153.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.463 1.905 . . . . 2.82 110.403 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 125.026 1.33 . . . . 2.5 109.918 168.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 115.235 1.569 . . . . 4.43 115.235 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -84.04 94.51 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.532 2.821 . . . . 2.51 112.008 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 82.2 t -89.96 108.86 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.883 -1.135 . . . . 3.9 109.767 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.1 p -72.38 129.44 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.745 -1.222 . . . . 2.96 111.968 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.14 -50.7 2.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.177 1.547 . . . . 4.03 115.177 -167.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -149.64 149.74 31.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.142 0.883 . . . . 2.77 112.609 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -129.67 145.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.876 1.27 . . . . 1.42 110.904 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.9 tttt -141.66 138.86 32.79 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.155 0.982 . . . . 2.66 113.433 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 94.3 t -82.93 134.5 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.951 0.9 . . . . 1.33 110.71 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 20.0 tp -107.22 -32.31 7.85 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.096 1.358 . . . . 2.55 112.966 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 51.9 m -118.03 99.11 6.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.729 1.212 . . . . 2.76 108.234 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 141.47 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.284 1.034 . . . . 3.49 110.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.7 m 52.52 29.24 6.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.958 1.836 . . . . 2.83 115.958 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -137.91 -17.51 1.24 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.106 1.151 . . . . 3.27 114.106 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.5 -49.3 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.166 1.348 . . . . 5.48 114.41 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.96 142.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.52 1.528 . . . . 2.53 111.25 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 14.5 m -87.53 147.93 25.12 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.335 1.054 . . . . 2.75 112.287 170.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.1 p80 -53.5 -38.89 64.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.45 1.648 . . . . 3.49 115.45 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 23.8 t60 -66.79 -37.19 84.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.609 1.095 . . . . 4.1 111.869 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -65.68 -36.29 83.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 118.228 -0.891 . . . . 4.24 111.259 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.11 -54.35 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 118.947 0.794 . . . . 1.77 111.189 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.51 -33.88 76.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.877 0.762 . . . . 1.66 111.881 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.39 57.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.63 -0.7 . . . . 1.87 112.143 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 6.0 pt -69.48 -27.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 119.642 1.11 . . . . 1.89 113.748 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 77.5 t -70.68 -43.39 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.237 0.926 . . . . 1.42 110.415 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.34 -37.42 93.87 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.127 -0.818 . . . . 0.68 113.282 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.6 p -73.88 -37.62 64.67 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.353 1.576 . . . . 2.19 112.636 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.68 88.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.961 0.801 . . . . 0.91 112.896 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . 0.254 3.4 tp10 -75.75 -20.92 57.95 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.196 0.813 . . . . 3.38 113.196 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 26.3 t -57.7 -47.46 82.32 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.075 -1.64 . . . . 1.86 112.743 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -77.33 -2.94 37.46 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 121.222 -0.924 . . . . 2.14 112.689 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 20.0 m -111.12 -178.6 3.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.584 2.354 . . . . 3.13 111.494 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.03 51.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.135 -0.978 . . . . 4.17 113.55 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.68 147.41 86.77 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.042 . . . . 2.28 113.688 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.83 -36.51 90.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.172 3.248 . . . . 1.55 114.028 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.03 -47.49 4.98 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.787 2.035 . . . . 1.58 110.874 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -33.01 78.98 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 114.583 0.593 . . . . 1.21 114.583 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 3.9 t -66.0 -16.02 63.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.126 1.463 . . . . 4.01 114.458 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -73.63 -27.16 61.13 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.089 -1.007 . . . . 2.65 112.922 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.5 -41.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.878 0.871 . . . . 2.29 109.199 171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.7 m -51.62 -43.97 62.75 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.757 0.708 . . . . 2.4 111.289 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.1 tttt -63.82 -51.78 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.913 0.778 . . . . 3.24 112.936 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.41 -47.2 66.43 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 3.9 111.105 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 98.3 m -69.07 -52.48 28.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.023 1.329 . . . . 2.94 112.369 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -49.49 -48.34 47.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.06 1.344 . . . . 4.74 111.642 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -71.62 -35.91 70.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.844 0.857 . . . . 3.12 112.905 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -70.33 -35.75 73.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.5 -1.375 . . . . 2.18 113.448 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.86 -6.38 37.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.285 1.034 . . . . 1.51 113.751 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.8 t0 54.91 40.07 31.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.239 1.416 . . . . 3.39 112.472 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.6 t -131.38 174.12 10.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.518 1.527 . . . . 2.58 111.508 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -114.87 -3.67 12.71 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.337 1.455 . . . . 2.95 112.4 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 8.1 t -148.76 142.6 25.69 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.337 1.455 . . . . 3.94 111.69 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.69 145.87 20.38 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.974 0.91 . . . . 2.19 112.322 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 83.18 135.75 2.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.074 1.321 . . . . 1.21 114.458 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 54.9 m -105.72 -64.77 1.11 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.041 1.336 . . . . 2.47 111.118 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -137.85 131.67 31.42 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.308 0.575 . . . . 1.7 110.595 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 30.3 mm -143.54 142.29 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.801 4.441 . . . . 4.56 102.797 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.12 106.25 5.47 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 120.895 -1.128 . . . . 4.48 111.442 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -100.62 145.67 28.09 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 118.038 2.607 . . . . 3.59 118.038 -166.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.16 104.65 7.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 130.843 3.657 . . . . 2.78 106.68 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 91.5 t -99.03 139.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.309 1.044 . . . . 3.15 110.932 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 43.4 t -126.48 101.3 27.77 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.021 1.328 . . . . 1.48 109.257 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.01 130.8 32.84 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.039 3.159 . . . . 2.02 114.978 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 75.75 -37.68 1.25 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.031 2.253 . . . . 1.91 114.412 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 60.4 m -82.19 -48.28 11.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.052 1.426 . . . . 2.56 113.938 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 159.43 -178.0 35.73 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.835 0.743 . . . . 0.8 113.387 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.12 157.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.661 0.615 . . . . 3.76 112.661 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -131.68 151.6 51.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.997 1.719 . . . . 0.97 110.871 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -153.8 166.26 33.43 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.842 -1.161 . . . . 1.28 114.003 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -110.71 136.72 49.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.253 -1.017 . . . . 1.6 108.253 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 80.1 t -128.95 139.44 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.458 1.103 . . . . 3.65 111.877 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.8 t -146.6 152.82 39.54 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.789 2.144 . . . . 2.47 116.789 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.305 24.7 t-20 . . . . . 0 CA--C 1.539 0.549 1 C-N-CA 132.582 4.353 . . . . 3.92 106.207 158.061 . . . . . . . . 2 1 . 1 . 004 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.298 0.571 . . . . 2.43 112.37 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.75 143.63 32.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.488 1.515 . . . . 3.88 111.398 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -110.87 115.74 30.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.698 1.599 . . . . 2.92 108.656 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.8 m -133.76 142.35 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 119.979 1.263 . . . . 1.13 112.829 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 150.89 39.7 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.648 0.981 . . . . 0.93 113.648 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.2 tt -141.29 135.24 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.428 1.891 . . . . 1.81 109.799 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.08 -167.9 40.93 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.582 1.393 . . . . 1.49 116.582 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -76.08 166.1 23.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.046 1.738 . . . . 3.02 114.523 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -50.78 -45.32 59.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.904 2.187 . . . . 6.14 116.904 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.27 -31.89 58.51 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.152 1.796 . . . . 3.47 112.003 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -64.0 -35.87 82.13 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.958 -1.089 . . . . 3.92 112.239 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.44 83.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.075 1.139 . . . . 2.94 114.075 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.0 mt -54.94 -60.06 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.506 1.122 . . . . 2.91 109.047 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -49.57 -19.35 0.57 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.59 2.07 . . . . 6.32 116.59 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.82 11.57 4.8 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 121.632 2.014 . . . . 1.05 112.593 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.71 35.59 85.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 119.868 -1.77 . . . . 0.78 113.966 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.18 153.45 19.59 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.535 1.167 . . . . 0.81 111.435 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -84.53 132.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.804 -0.56 . . . . 1.89 109.554 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.67 140.05 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.676 1.19 . . . . 2.08 110.862 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -116.06 167.85 10.61 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.987 1.477 . . . . 2.99 114.987 -167.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.05 -45.98 69.01 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.15 1.537 . . . . 3.49 115.15 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.34 -26.91 64.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.068 -1.02 . . . . 2.39 112.021 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -78.56 -38.62 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 117.748 -1.12 . . . . 1.31 112.481 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.69 -41.56 91.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.902 1.683 . . . . 2.04 110.884 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.18 -40.96 91.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.417 1.487 . . . . 2.39 113.305 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 52.1 t80 -72.11 -40.93 67.79 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.187 0.995 . . . . 3.61 112.523 174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 46.2 tpp -59.96 -57.53 12.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.01 1.724 . . . . 2.22 110.104 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.2 t -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.903 0.881 . . . . 1.79 111.971 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.11 -54.75 42.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.233 1.013 . . . . 2.5 111.776 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.29 -34.19 70.42 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.498 0.925 . . . . 3.64 113.498 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -59.35 -49.92 75.95 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.223 -0.923 . . . . 3.28 110.764 170.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -72.76 -14.86 61.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.936 -1.103 . . . . 5.47 113.957 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 16.7 mttp -75.79 -6.23 49.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.099 1.76 . . . . 3.5 112.367 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 86.2 24.59 39.94 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.231 1.396 . . . . 1.36 114.071 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.74 163.06 13.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.372 1.469 . . . . 5.34 110.302 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 14.0 m -76.2 133.19 40.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 2.28 110.195 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -137.12 116.63 12.84 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.105 1.362 . . . . 1.79 111.138 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 25.9 m -140.22 156.83 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.191 1.396 . . . . 1.99 112.784 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.92 162.88 14.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.901 1.681 . . . . 1.52 112.293 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.6 p -135.65 126.98 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.655 1.582 . . . . 3.57 112.456 172.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.86 157.0 38.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.436 1.894 . . . . 0.85 111.75 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 133.21 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.413 1.485 . . . . 2.23 112.292 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 40.16 45.42 1.71 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.385 2.274 . . . . 2.76 113.428 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 12.3 m-20 64.79 39.79 5.97 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.713 2.405 . . . . 1.56 116.115 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -146.69 146.4 30.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.148 2.179 . . . . 2.29 110.176 169.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.23 147.81 42.13 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 119.498 -2.001 . . . . 2.22 112.964 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.0 p -124.83 -38.52 2.35 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.02 1.489 . . . . 1.13 115.02 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -163.34 179.92 38.18 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 120.7 1.591 . . . . 0.59 115.875 -173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.58 155.62 43.73 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.86 1.664 . . . . 1.06 113.502 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.9 mm -130.93 141.92 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.585 1.954 . . . . 1.96 110.247 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -122.87 131.2 53.64 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.349 1.46 . . . . 1.71 111.59 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 8.4 mt -135.83 145.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.967 1.707 . . . . 2.8 109.789 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.921 0 C-N-CA 125.505 1.522 . . . . 2.0 112.884 -174.242 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 115.274 1.583 . . . . 3.45 115.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.31 166.69 7.13 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.739 2.293 . . . . 1.89 110.486 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 11.7 p -135.47 130.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.969 -1.082 . . . . 2.99 111.28 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -66.59 135.01 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.14 -0.975 . . . . 2.58 111.507 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.88 -33.67 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.227 0.825 . . . . 2.88 113.227 -172.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -159.2 143.87 15.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.296 0.953 . . . . 3.15 112.113 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -114.66 134.27 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.686 0.795 . . . . 1.27 109.15 167.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.5 tttt -140.71 145.1 36.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.291 0.849 . . . . 4.06 113.291 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.3 t -101.5 129.82 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.386 1.474 . . . . 2.36 111.169 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.05 -25.0 11.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.017 1.727 . . . . 2.52 112.45 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 34.4 m -137.0 130.72 31.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.454 1.501 . . . . 2.44 110.492 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.25 144.52 40.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.009 1.324 . . . . 6.2 110.918 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 61.9 m 54.55 13.13 0.62 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.254 2.221 . . . . 3.7 115.839 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -137.53 13.63 2.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.717 2.407 . . . . 3.1 112.433 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -163.46 -58.42 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.298 1.439 . . . . 5.81 110.679 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.48 159.76 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 129.768 3.227 . . . . 2.87 108.006 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 39.7 m -106.6 155.6 19.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.842 1.257 . . . . 2.29 113.68 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.83 -41.36 57.53 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.706 2.484 . . . . 3.94 117.706 -167.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.97 -28.05 54.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.971 1.26 . . . . 3.36 111.406 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1072 ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' 1072 ' ' LYS . 9.7 mmpt? -70.36 -34.63 72.85 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 116.917 -1.516 . . . . 6.3 111.933 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 63.3 mt -56.81 -53.68 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.662 1.574 . . . . 1.87 110.547 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.53 -30.76 71.15 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.4 -0.812 . . . . 1.94 112.323 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.03 60.84 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 1.17 112.231 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.7 pt -69.98 -35.09 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.508 -1.37 . . . . 0.98 112.682 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.0 t -71.01 -43.52 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.096 0.862 . . . . 1.87 111.71 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.96 -35.7 79.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.849 -1.157 . . . . 0.57 113.492 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 73.8 p -73.96 -25.31 59.87 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.51 -0.994 . . . . 1.66 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.27 -55.49 15.87 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.538 0.735 . . . . 0.89 110.98 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.07 -20.85 63.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.133 0.79 . . . . 2.13 113.133 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 24.8 t -55.39 -33.18 63.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.72 -1.238 . . . . 1.86 112.87 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.73 -8.57 58.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.051 0.941 . . . . 2.25 113.361 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 5.0 t -99.35 -179.64 4.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.797 1.639 . . . . 1.59 113.754 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -137.5 8.86 2.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.353 2.261 . . . . 3.91 113.962 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -87.33 150.01 48.23 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.779 1.232 . . . . 2.24 113.906 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.17 -28.65 40.42 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.466 3.444 . . . . 1.1 115.47 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.11 -46.94 4.12 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.182 0.993 . . . . 1.64 112.576 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.84 -30.11 76.76 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 113.938 0.335 . . . . 0.89 113.938 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 21.3 p -63.69 -17.74 63.27 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.947 -1.325 . . . . 2.38 114.248 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.13 85.8 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.136 -0.978 . . . . 1.75 111.71 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 15.1 mt -73.29 -36.4 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.824 1.65 . . . . 1.51 110.573 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 21.5 m -51.44 -47.34 63.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.904 0.775 . . . . 1.92 111.546 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.68 -49.81 75.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.035 0.934 . . . . 3.06 112.574 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.62 -40.0 74.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.563 0.745 . . . . 2.76 111.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 28.3 t -71.66 -52.53 17.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.38 1.472 . . . . 2.15 112.591 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -51.87 -44.16 63.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.751 1.62 . . . . 4.0 112.588 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -69.84 -34.05 73.12 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.602 0.761 . . . . 4.12 112.591 175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.91 -47.77 67.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.413 1.006 . . . . 2.96 112.977 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.91 -32.54 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.78 0.832 . . . . 2.18 112.48 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 1.7 t70 54.94 54.39 9.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.747 2.019 . . . . 2.76 112.009 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.3 t -148.37 142.99 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.125 -0.984 . . . . 2.76 113.193 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -98.0 21.88 10.11 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.042 1.337 . . . . 3.0 112.707 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 43.1 p -131.23 4.23 4.37 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.024 1.861 . . . . 3.83 116.024 -168.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 139.4 57.75 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.689 1.366 . . . . 1.72 114.689 -167.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 70.38 171.77 10.34 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.42 1.009 . . . . 1.12 115.363 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 4.6 m -157.24 -40.49 0.07 Allowed 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.398 -1.06 . . . . 1.82 112.809 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.11 143.54 48.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.517 1.127 . . . . 1.84 113.125 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.2 129.01 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 127.408 2.283 . . . . 3.51 109.097 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -25.71 32.14 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.983 1.105 . . . . 3.6 113.983 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 34.0 t80 60.7 130.49 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 128.613 2.765 . . . . 5.2 114.864 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -149.69 106.89 3.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.613 1.965 . . . . 2.12 108.318 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 9.8 p -106.43 144.44 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.801 0.728 . . . . 3.9 112.744 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 59.2 t -129.25 102.8 18.46 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.196 -1.409 . . . . 1.6 107.196 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.89 136.54 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.276 2.651 . . . . 2.34 113.512 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.79 20.58 77.62 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.42 1.01 . . . . 2.14 114.17 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 21.5 t -145.02 -50.85 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.777 1.231 . . . . 3.72 112.826 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 137.33 -153.3 21.87 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 119.524 1.056 . . . . 1.35 114.643 174.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.3 mm -120.65 147.79 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.738 1.615 . . . . 3.59 112.175 -172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.5 t -133.63 148.26 51.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.502 1.921 . . . . 1.26 109.303 165.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.0 p -167.34 177.5 6.04 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.428 -1.42 . . . . 1.5 114.072 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 137.64 53.78 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 105.965 -1.865 . . . . 5.2 105.965 165.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 29.6 m -132.48 154.51 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.835 0.854 . . . . 3.46 113.053 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.0 t -161.55 165.39 28.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.264 1.579 . . . . 1.9 115.264 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.548 0.878 1 C-N-CA 132.888 4.475 . . . . 2.42 108.144 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 114.478 1.288 . . . . 3.67 114.478 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -135.92 126.82 27.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.833 1.653 . . . . 4.56 109.514 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.1 tttt -84.84 120.39 26.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.327 -0.99 . . . . 1.99 108.327 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.8 m -135.26 141.15 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.56 1.073 . . . . 0.98 112.469 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.58 152.88 41.17 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 1.01 112.92 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.1 tt -153.01 136.77 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 1.74 110.991 -171.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 150.4 -141.89 9.15 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.252 1.261 . . . . 1.32 116.252 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.63 152.14 0.23 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.312 2.645 . . . . 2.41 113.509 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -57.49 -28.72 63.66 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.244 -0.91 . . . . 5.55 112.529 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.35 -31.83 70.69 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.815 1.188 . . . . 4.49 113.941 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.1 m95 -63.86 -27.04 68.89 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.281 1.401 . . . . 5.1 112.716 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -71.54 -38.85 70.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.092 0.557 . . . . 2.7 111.161 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.57 -70.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.12 1.368 . . . . 3.45 109.016 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -40.26 -46.91 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.454 2.301 . . . . 6.23 114.495 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.0 t30 -81.71 9.11 8.37 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.965 1.098 . . . . 1.06 113.965 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.74 20.83 79.35 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 120.759 -1.213 . . . . 0.99 114.791 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.1 mt -89.08 166.62 13.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.247 1.019 . . . . 1.28 109.868 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.2 t -124.9 112.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.859 1.264 . . . . 3.74 109.581 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.2 tt -87.57 147.98 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.569 1.548 . . . . 2.69 111.365 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -116.32 177.6 4.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.63 1.172 . . . . 3.58 113.181 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -72.09 -33.42 67.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.282 1.956 . . . . 3.24 116.282 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.08 -31.05 25.53 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.127 1.331 . . . . 3.24 113.445 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.2 p -67.08 -41.14 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 117.991 -1.004 . . . . 1.83 110.428 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.95 -34.5 76.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.384 1.447 . . . . 2.65 112.157 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.6 -42.13 99.39 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.015 0.926 . . . . 2.25 113.3 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -66.73 -40.94 88.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.162 1.385 . . . . 3.46 112.105 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 20.3 ttm -63.61 -56.26 17.24 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.369 1.068 . . . . 2.49 109.983 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.2 t -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.629 0.772 . . . . 2.04 112.673 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.45 -51.73 67.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.836 -1.165 . . . . 3.56 112.297 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -70.97 -31.09 67.54 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.396 0.887 . . . . 4.71 113.396 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -65.07 -34.08 77.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.755 -1.216 . . . . 3.69 111.853 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -70.92 -29.9 66.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.912 1.285 . . . . 4.28 113.268 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 2.2 mttp -71.54 3.17 4.14 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.996 1.318 . . . . 3.98 113.439 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.77 20.52 55.81 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.732 1.158 . . . . 2.07 114.897 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.55 158.29 17.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.337 1.455 . . . . 3.93 111.482 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.0 m -81.41 137.27 35.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.844 2.058 . . . . 1.95 110.285 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -138.69 124.77 20.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.886 0.874 . . . . 1.14 112.686 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 31.1 m -140.99 158.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 125.936 1.694 . . . . 2.06 112.887 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.54 164.26 12.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.86 1.264 . . . . 2.04 113.311 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 14.4 t -136.55 118.1 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.428 1.891 . . . . 2.92 111.124 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -119.14 155.08 32.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.195 1.398 . . . . 1.92 112.018 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.81 132.45 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.309 1.844 . . . . 1.58 112.218 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 71.1 m-20 40.22 47.94 2.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.882 2.073 . . . . 3.47 112.845 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.263 27.9 m-20 60.05 34.74 21.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.484 2.313 . . . . 1.56 116.383 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -145.13 149.17 34.53 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.578 -1.326 . . . . 2.79 112.651 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.43 142.48 58.16 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.319 -1.488 . . . . 1.79 113.512 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.9 p -125.74 -34.03 2.67 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.897 1.444 . . . . 1.19 114.897 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.69 -176.15 38.11 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-N 120.964 1.711 . . . . 0.6 115.876 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.64 153.61 42.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.839 1.656 . . . . 0.93 113.292 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 22.0 mm -123.6 134.39 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.567 1.547 . . . . 2.04 110.058 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -117.23 133.01 56.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.328 1.851 . . . . 1.69 109.549 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -139.31 147.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.006 1.723 . . . . 2.58 111.974 -167.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 124.621 1.168 . . . . 1.78 112.204 171.665 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.932 1.086 . . . . 3.39 113.932 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -85.87 153.8 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.09 3.193 . . . . 2.62 113.637 -173.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 4.7 m -139.17 126.52 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 126.113 1.765 . . . . 4.25 110.475 171.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -72.09 142.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.756 -1.215 . . . . 2.56 110.008 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.9 -42.57 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.339 0.866 . . . . 3.36 113.339 -168.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -153.59 147.19 25.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.749 0.704 . . . . 3.41 112.073 172.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 2.5 m -130.69 136.13 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.263 1.025 . . . . 1.2 111.043 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 60.9 tttt -138.23 147.83 44.14 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.776 0.831 . . . . 2.39 112.357 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.2 t -91.18 137.64 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.561 1.145 . . . . 1.84 111.374 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.7 tp -107.04 -22.98 12.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.253 1.821 . . . . 1.38 112.753 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 5.0 t -100.03 27.76 5.32 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.512 1.525 . . . . 3.06 113.782 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.82 125.02 21.78 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.695 -1.253 . . . . 4.18 111.538 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 58.6 m 43.65 41.0 3.25 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.808 2.043 . . . . 4.21 113.931 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -133.04 -29.25 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.028 1.331 . . . . 4.57 113.594 172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -146.0 -55.7 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.661 1.726 . . . . 6.51 115.661 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 19.7 mt -135.53 144.04 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.991 1.316 . . . . 2.47 110.89 -169.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 50.9 m -98.42 158.62 15.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.641 1.576 . . . . 2.95 113.357 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -55.5 -38.0 68.6 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.11 1.522 . . . . 4.3 115.11 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 29.2 t60 -75.03 -37.38 61.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.506 1.048 . . . . 3.27 112.165 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.5 mttt -65.99 -40.78 91.46 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.137 0.881 . . . . 3.6 111.637 169.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.2 mt -57.75 -52.43 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.826 0.739 . . . . 1.61 110.932 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.13 -29.76 69.57 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.198 -0.938 . . . . 1.63 112.373 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.01 19.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.092 0.557 . . . . 1.18 111.959 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.64 -35.25 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 120.235 1.38 . . . . 1.02 113.055 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 46.0 t -70.81 -46.06 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.342 -0.849 . . . . 1.45 111.356 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -71.93 -28.58 68.45 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.97 -1.081 . . . . 0.65 114.335 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 62.8 p -76.42 -32.71 58.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.369 1.067 . . . . 1.42 112.398 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.37 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.053 0.842 . . . . 0.81 112.323 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -66.36 -17.07 64.55 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.56 0.948 . . . . 2.23 113.56 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 16.1 p -67.25 -15.62 63.8 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.126 -1.608 . . . . 2.02 114.463 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -94.76 -18.51 21.18 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.377 1.071 . . . . 1.98 112.565 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 4.4 t -77.48 164.43 25.44 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.526 1.306 . . . . 1.99 114.526 -169.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.12 23.5 4.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.881 2.073 . . . . 3.41 112.259 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -85.68 160.8 52.51 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.738 1.215 . . . . 2.72 113.136 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -81.51 1.52 9.2 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.58 3.52 . . . . 2.61 115.425 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -141.12 -48.09 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.938 1.295 . . . . 1.96 112.055 -167.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.15 -23.2 65.9 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.894 1.117 . . . . 0.97 115.894 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 23.7 p -58.0 -25.68 61.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.16 -1.2 . . . . 2.65 113.324 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.9 85.84 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.316 0.858 . . . . 1.67 113.316 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.53 -41.66 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.243 1.417 . . . . 2.33 110.898 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 8.9 t -64.0 -39.13 93.43 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 118.278 -0.867 . . . . 3.79 112.204 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 23.5 tttp -60.14 -50.55 73.23 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.529 1.059 . . . . 4.04 112.785 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.47 -44.73 55.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.574 1.149 . . . . 3.45 112.184 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 35.6 t -69.68 -52.38 26.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.592 1.157 . . . . 2.17 112.416 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 14.9 tptm -49.96 -39.39 40.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.183 1.793 . . . . 3.35 112.545 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.87 -40.37 65.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.718 1.207 . . . . 3.79 113.99 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -70.53 -34.62 72.5 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.061 -1.649 . . . . 2.07 113.298 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.01 -7.92 54.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.225 1.41 . . . . 1.27 114.421 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 40.3 m-20 53.53 29.99 9.96 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.152 1.381 . . . . 4.61 114.094 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -123.4 176.33 6.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.141 1.776 . . . . 2.72 112.557 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -115.44 -2.97 12.45 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.263 1.425 . . . . 2.67 113.716 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.0 t -143.97 125.08 14.47 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.777 -1.202 . . . . 3.83 112.443 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.24 144.89 29.21 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.38 1.472 . . . . 1.39 110.722 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 68.66 179.38 19.35 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 120.687 -1.258 . . . . 1.08 114.201 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.7 m -158.2 -62.54 0.08 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.15 1.38 . . . . 2.18 112.911 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.2 t -136.06 142.23 44.35 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.835 1.198 . . . . 1.89 112.382 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 6.0 mm -143.17 150.17 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 1 C-N-CA 133.085 4.554 . . . . 3.14 107.533 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -7.81 12.34 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.043 1.868 . . . . 3.05 116.043 -173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 65.9 m-85 43.94 109.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 129.396 3.079 . . . . 4.67 118.773 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.37 94.27 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.879 2.072 . . . . 2.33 106.213 166.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 19.2 m -103.21 146.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.276 1.03 . . . . 3.79 113.302 -168.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.3 t -138.61 124.61 12.53 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.414 1.486 . . . . 1.25 109.231 171.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.35 146.31 39.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.976 3.117 . . . . 2.56 112.994 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 53.27 32.57 44.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.39 0.995 . . . . 1.61 113.396 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 53.9 t -150.01 -81.74 0.11 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.548 1.539 . . . . 2.33 111.655 -168.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 178.12 171.01 41.03 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 121.341 -0.849 . . . . 1.18 112.838 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.36 157.16 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 117.373 0.586 . . . . 3.86 112.124 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 20.1 t -130.89 157.31 43.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.025 1.73 . . . . 1.1 111.077 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 27.6 p -162.8 167.44 22.87 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.424 0.898 . . . . 1.34 113.424 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -112.24 119.85 39.74 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.227 1.011 . . . . 1.55 108.853 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.2 p -111.67 139.08 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.944 0.72 . . . . 3.11 112.944 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -128.47 151.44 49.4 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 122.363 1.078 . . . . 2.1 111.75 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 130.171 3.388 . . . . 2.78 104.807 159.609 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 2.46 114.256 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.89 149.87 23.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.635 1.974 . . . . 5.58 110.57 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -104.74 119.04 38.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.779 0.831 . . . . 3.05 111.572 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 11.1 m -133.84 141.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.995 0.739 . . . . 0.94 112.995 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.03 153.54 42.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 2.04 113.457 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 3.4 tt -150.09 143.46 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.101 1.36 . . . . 1.88 108.919 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 161.13 -160.85 32.47 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 117.789 1.876 . . . . 1.52 117.789 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.05 155.97 0.58 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.105 3.362 . . . . 2.56 113.889 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -55.22 -49.93 70.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.308 1.043 . . . . 5.57 113.558 169.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -63.23 -35.38 80.13 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 3.14 112.214 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -67.42 -25.37 65.89 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.581 1.553 . . . . 5.7 113.552 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 23.1 mmt -77.06 -37.63 54.25 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.118 1.155 . . . . 2.19 114.118 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 73.8 mt -53.11 -63.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.382 1.073 . . . . 2.61 108.516 168.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -40.89 -34.43 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.45 2.7 . . . . 7.18 116.348 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.16 9.14 2.7 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 121.458 1.935 . . . . 1.08 112.933 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.72 27.41 73.87 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 119.804 -1.81 . . . . 1.0 113.891 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.4 mt -93.65 160.97 14.54 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.363 1.465 . . . . 0.88 110.894 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 22.0 t -92.67 119.56 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.438 0.695 . . . . 1.78 109.825 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.2 tt -105.81 148.75 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.707 1.603 . . . . 2.46 110.396 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -138.58 163.97 30.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.61 0.966 . . . . 3.64 113.61 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.01 -27.37 69.37 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.97 1.1 . . . . 3.31 113.97 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.62 -30.28 56.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.783 1.174 . . . . 2.84 113.901 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.3 p -76.89 -39.56 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 118.243 -0.884 . . . . 2.64 110.466 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -62.54 -41.0 98.6 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.626 1.103 . . . . 2.49 112.256 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.57 -43.59 80.26 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.039 0.755 . . . . 2.53 113.039 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 18.4 t80 -56.44 -38.98 72.36 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 4.76 111.181 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 17.6 tpp -66.04 -50.55 63.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.933 0.893 . . . . 2.01 111.404 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.6 t -64.98 -38.35 90.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.301 0.955 . . . . 2.16 112.063 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.98 -53.57 55.26 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.218 -0.926 . . . . 4.61 112.334 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -72.33 -32.77 66.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.919 1.081 . . . . 3.89 113.919 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.48 -41.67 85.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.304 0.956 . . . . 3.12 111.121 169.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -74.44 -19.93 60.21 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.088 1.755 . . . . 6.69 114.999 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -69.88 -13.1 62.09 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.39 1.076 . . . . 5.25 112.921 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.53 11.47 59.38 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.327 1.918 . . . . 2.79 113.763 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -91.22 156.53 17.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.621 1.568 . . . . 6.07 109.345 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.6 m -82.92 130.42 35.14 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.639 1.175 . . . . 2.24 108.299 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -117.93 130.23 56.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.19 0.996 . . . . 1.19 110.645 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.7 m -143.0 164.53 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.089 1.356 . . . . 1.08 113.341 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.15 159.77 18.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.508 1.523 . . . . 1.67 111.571 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 7.3 p -138.41 135.08 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.321 1.048 . . . . 3.21 112.597 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -136.74 152.71 50.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.722 1.609 . . . . 0.95 111.685 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.0 m -148.7 136.24 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.123 0.969 . . . . 2.34 112.082 -171.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 38.3 m-20 41.06 45.31 2.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.71 2.004 . . . . 3.67 113.163 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 52.8 m-20 64.89 32.23 10.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.317 2.647 . . . . 1.62 117.414 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -137.57 145.15 42.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.168 -1.582 . . . . 2.39 111.491 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.86 122.84 24.71 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.042 -1.036 . . . . 1.61 111.206 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.7 p -106.3 -32.2 8.28 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 2.11 113.856 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.04 179.44 39.63 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 120.264 1.393 . . . . 0.46 116.489 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.05 144.35 34.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.272 1.829 . . . . 2.29 111.253 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.72 145.53 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.32 1.448 . . . . 2.41 112.028 -166.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -119.79 133.69 55.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.838 1.655 . . . . 1.86 110.878 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.41 150.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.418 1.887 . . . . 2.74 109.896 -171.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.758 0 C-N-CA 124.894 1.277 . . . . 2.18 111.143 171.493 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.438 0.533 . . . . 3.2 112.438 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.34 155.22 4.54 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.803 3.669 . . . . 1.66 112.529 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 5.9 m -134.75 123.94 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.149 1.779 . . . . 4.02 111.057 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.252 2.7 p -74.52 137.19 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.855 -1.153 . . . . 2.3 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.04 -33.1 3.59 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.197 1.554 . . . . 3.22 115.197 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -153.12 148.45 26.99 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.466 1.106 . . . . 3.5 111.06 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 7.5 m -128.73 130.21 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.762 0.825 . . . . 2.34 111.614 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.1 tttt -135.21 144.15 46.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.392 1.077 . . . . 2.58 113.277 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 27.3 t -90.67 135.59 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.417 1.087 . . . . 1.57 110.674 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.18 -41.78 8.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 1.28 110.772 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 1.5 t -81.97 37.9 0.5 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.675 1.59 . . . . 3.5 113.358 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -57.98 119.23 6.38 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.485 -1.384 . . . . 4.86 111.185 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 34.0 m 55.17 25.72 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.138 2.175 . . . . 3.49 116.081 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -123.95 -21.35 5.12 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 116.454 2.02 . . . . 4.19 116.454 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -152.69 -62.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.355 1.434 . . . . 6.54 113.497 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 63.2 mt -129.12 150.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.817 1.647 . . . . 2.11 109.16 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 7.7 t -108.25 161.91 14.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.739 1.385 . . . . 3.39 114.739 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -43.92 -50.7 8.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.925 2.49 . . . . 4.56 116.652 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -76.36 -32.45 58.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.391 0.996 . . . . 3.86 112.149 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 45.9 mttp -67.12 -41.55 86.0 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.057 . . . . 3.47 112.09 170.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.15 -48.3 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.617 0.644 . . . . 1.95 111.05 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.9 -32.94 73.77 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.288 -0.883 . . . . 1.5 112.452 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.16 81.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 1.24 112.742 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.9 pt -70.23 -38.35 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.362 0.983 . . . . 1.78 112.752 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 99.8 t -65.82 -45.58 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.635 1.107 . . . . 1.82 110.71 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.71 -37.58 92.52 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.636 -0.665 . . . . 0.61 113.823 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 23.2 p -72.97 -40.42 65.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.462 1.131 . . . . 1.77 112.182 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.98 -51.71 63.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.977 0.808 . . . . 0.82 112.626 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.12 -23.91 67.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.316 -0.865 . . . . 2.7 112.485 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 11.9 p -63.85 -18.58 64.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.513 1.301 . . . . 2.43 114.513 171.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.85 5.87 31.08 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.744 1.618 . . . . 2.92 111.87 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.7 t -105.31 -177.54 3.39 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.246 1.818 . . . . 1.63 112.697 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -128.82 17.5 6.26 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.585 1.954 . . . . 3.83 113.703 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -88.16 146.68 38.73 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.127 1.528 . . . . 3.1 115.127 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.95 -44.74 4.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.725 2.283 . . . . 1.43 112.363 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -44.21 74.85 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.64 -0.663 . . . . 2.17 111.533 172.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.37 -44.34 95.23 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.222 0.915 . . . . 1.57 113.949 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 20.8 p -64.56 -33.59 76.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.41 -1.053 . . . . 2.73 112.184 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.84 83.22 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.813 -1.179 . . . . 1.95 112.811 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.06 -40.51 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.076 0.55 . . . . 2.02 110.493 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 95.2 m -54.07 -46.53 72.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.374 1.07 . . . . 2.21 111.057 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.9 tttt -59.89 -48.67 80.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.882 0.765 . . . . 3.15 112.343 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -61.55 -43.17 99.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 2.76 112.719 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 77.8 m -68.74 -45.08 72.4 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.704 1.202 . . . . 3.24 111.827 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.75 -31.16 72.24 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.856 -1.152 . . . . 3.83 111.794 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -66.26 -44.18 84.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.07 0.85 . . . . 3.53 110.819 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -61.55 -47.96 83.17 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.199 0.909 . . . . 2.42 112.753 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.11 -23.53 63.05 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.212 1.19 . . . . 1.46 114.212 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.51 54.77 10.42 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.764 1.269 . . . . 2.24 112.78 -174.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.1 t -127.38 -15.35 5.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.679 1.591 . . . . 3.25 114.449 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 58.29 -50.67 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 129.076 2.95 . . . . 2.88 115.649 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.4 t -111.97 135.01 53.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.27 2.228 . . . . 4.04 110.883 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.43 174.28 15.47 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.251 1.02 . . . . 1.64 112.847 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.31 155.88 4.39 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 123.067 1.371 . . . . 1.0 115.495 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1107 ' ' THR . . . . . 0.434 ' CG2' ' H ' ' A' 1108 ' ' CYS . 97.6 m -150.76 -166.5 2.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.373 2.269 . . . . 2.51 107.312 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1108 ' ' CYS . . . . . 0.434 ' H ' ' CG2' ' A' 1107 ' ' THR . 79.5 m -57.84 142.05 47.09 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.655 1.982 . . . . 3.07 114.829 -169.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 177.94 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 129.273 3.029 . . . . 2.97 110.667 -166.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 1.9 t0 -135.64 171.6 14.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.432 1.493 . . . . 2.79 109.484 167.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.385 1.448 . . . . 4.45 113.818 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.78 99.34 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.344 2.657 . . . . 3.31 105.776 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 42.5 t -99.18 138.61 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.244 1.418 . . . . 3.08 110.389 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 11.4 t -133.6 102.8 12.47 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.971 -1.122 . . . . 1.6 107.971 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.69 130.25 30.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.52 2.147 . . . . 2.16 113.001 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.3 20.36 76.68 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.321 0.962 . . . . 1.59 114.816 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 50.8 t -143.52 -43.72 0.28 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.28 1.54 . . . . 2.25 113.804 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.43 34.96 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.666 1.026 . . . . 0.89 115.666 171.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.5 tt -140.61 154.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.529 1.532 . . . . 2.76 111.747 168.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -132.08 147.05 52.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.717 1.607 . . . . 0.98 113.136 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.1 p -151.8 167.37 28.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.532 1.308 . . . . 1.32 114.532 -175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -114.44 97.14 6.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.029 1.732 . . . . 1.62 109.282 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.9 p -107.53 130.13 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.727 1.149 . . . . 3.12 113.499 -169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -115.04 168.54 9.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.514 1.126 . . . . 1.64 113.752 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 129.422 3.089 . . . . 2.23 107.87 162.767 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 tm0? . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 112.982 0.734 . . . . 2.62 112.982 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.07 119.88 25.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.364 1.066 . . . . 3.31 113.347 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -81.35 115.08 20.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.056 1.342 . . . . 3.19 109.477 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.0 m -136.59 142.83 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.757 0.708 . . . . 1.05 112.871 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.61 153.16 47.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.728 1.211 . . . . 0.99 112.976 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -140.3 137.04 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.764 1.626 . . . . 1.69 108.642 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . -172.42 168.12 41.14 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.281 -0.887 . . . . 1.69 113.26 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.301 12.9 p30 -69.43 -49.33 56.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.021 1.489 . . . . 4.19 115.021 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -173.81 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 115.064 1.505 . . . . 5.58 115.064 169.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.16 -32.13 71.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.282 1.401 . . . . 3.32 113.286 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -67.27 -22.49 65.66 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.699 -1.251 . . . . 3.93 113.022 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -29.24 68.36 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.242 -1.536 . . . . 2.74 111.247 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 55.3 mt -69.39 -66.35 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.847 1.659 . . . . 2.46 108.63 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -48.01 -32.97 7.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.81 1.644 . . . . 5.75 114.9 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.68 5.52 27.84 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.919 1.236 . . . . 1.2 113.991 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 73.25 35.49 56.81 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.823 -1.173 . . . . 0.95 114.572 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.82 158.7 15.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.801 1.241 . . . . 0.73 110.343 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 86.7 t -97.26 123.56 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.362 -0.977 . . . . 1.8 108.362 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.1 tt -110.44 139.89 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.97 0.89 . . . . 2.32 112.675 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -96.55 150.83 20.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.699 1.2 . . . . 2.78 114.182 -168.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -69.2 -26.87 65.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.661 1.184 . . . . 3.82 114.057 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -84.26 -42.77 15.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.525 1.13 . . . . 2.85 112.989 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 13.1 p -65.09 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.117 0.871 . . . . 2.22 111.609 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -62.69 -45.71 91.51 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.639 1.109 . . . . 2.54 111.528 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.87 -33.88 73.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.172 0.989 . . . . 2.61 112.652 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.47 -44.35 64.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.605 1.093 . . . . 3.74 112.518 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.3 tpp -58.89 -48.01 82.93 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.711 1.604 . . . . 1.82 111.799 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 9.7 t -75.5 -38.45 59.46 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.99 -0.528 . . . . 2.63 112.364 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -53.95 -44.76 70.98 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.185 1.357 . . . . 3.48 112.744 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -62.49 -44.77 95.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.59 1.556 . . . . 4.78 112.224 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -71.57 -30.71 66.17 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.817 1.247 . . . . 4.26 112.655 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -70.46 -16.78 62.96 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.936 1.694 . . . . 5.81 113.74 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.369 0.0 OUTLIER -104.01 24.01 12.04 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.84 1.656 . . . . 4.84 114.247 170.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.75 76.02 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 117.755 1.862 . . . . 1.5 117.755 167.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -105.6 148.56 27.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.706 1.753 . . . . 5.48 111.598 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 56.5 m -76.41 128.38 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.094 1.358 . . . . 1.8 112.108 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.46 126.69 44.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.542 1.137 . . . . 1.26 112.108 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 32.7 m -141.17 156.73 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.141 1.376 . . . . 2.08 113.818 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.51 157.22 25.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.037 2.535 . . . . 1.86 112.131 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -131.34 119.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.519 1.527 . . . . 2.86 111.103 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -121.5 147.52 45.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.023 1.329 . . . . 0.82 111.601 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 35.1 m -144.44 121.67 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.32 1.048 . . . . 1.36 112.324 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.255 33.3 t0 41.11 50.97 3.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.582 2.353 . . . . 3.44 113.694 -176.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.289 7.6 m-20 68.51 25.77 6.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.855 2.862 . . . . 2.2 116.714 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.31 143.85 49.29 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.736 1.214 . . . . 2.41 111.141 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.14 136.59 48.24 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.535 -1.353 . . . . 1.63 112.355 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.7 p -113.81 -44.1 3.21 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.898 1.073 . . . . 1.13 113.898 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.3 -172.23 34.24 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 120.055 1.298 . . . . 0.59 115.47 -173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.16 154.0 43.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.914 1.686 . . . . 0.99 112.413 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.0 mm -126.9 137.23 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.28 1.432 . . . . 1.99 109.287 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -114.9 131.52 56.84 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.321 1.849 . . . . 2.22 109.801 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.46 155.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.92 1.688 . . . . 2.63 111.266 -168.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.492 1.517 . . . . 1.59 111.881 173.346 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 119.637 -0.22 . . . . 3.82 111.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.25 150.01 52.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.269 2.646 . . . . 1.63 112.765 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 6.1 p -134.86 133.56 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.52 1.528 . . . . 4.22 109.459 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 1.9 p -71.93 121.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.539 1.063 . . . . 2.93 108.941 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 17.4 t30 -106.21 -44.75 4.48 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.796 1.036 . . . . 4.0 113.796 -166.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -142.98 148.67 37.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.542 1.537 . . . . 3.02 110.812 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.0 m -129.16 148.45 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.124 0.97 . . . . 1.53 111.432 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -141.38 147.69 38.43 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.151 -0.968 . . . . 4.49 112.841 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 62.9 t -105.23 136.76 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.412 1.085 . . . . 1.48 111.742 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 22.6 tp -108.77 -23.96 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.872 2.469 . . . . 2.1 113.105 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 46.2 m -132.91 110.4 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.01 1.324 . . . . 2.27 110.051 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -118.54 155.69 30.44 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.688 1.195 . . . . 3.36 112.946 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 58.25 3.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.95 2.574 . . . . 2.85 117.95 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -127.49 -11.92 5.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.512 1.525 . . . . 3.29 114.028 -172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -158.27 -48.88 0.06 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.308 1.843 . . . . 4.94 110.312 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 165.41 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 128.471 2.708 . . . . 2.63 108.569 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.0 m -142.31 162.41 35.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.144 1.777 . . . . 2.56 111.49 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.6 t60 -45.83 -51.87 12.21 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.929 1.826 . . . . 6.05 115.929 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -75.21 -28.96 60.16 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.125 -0.985 . . . . 3.73 112.224 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -70.22 -41.98 72.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.016 -1.053 . . . . 3.82 111.706 170.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.01 -52.91 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 1.8 110.647 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.94 -32.62 74.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.073 0.851 . . . . 1.81 112.462 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.22 -51.17 60.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.97 0.508 . . . . 1.24 112.17 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.2 pt -70.43 -30.99 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.009 -1.057 . . . . 1.02 113.099 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 65.1 t -71.01 -48.86 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.167 0.894 . . . . 1.5 111.796 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.78 -34.64 83.48 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.248 -0.907 . . . . 1.19 113.316 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 58.9 p -74.51 -35.41 63.19 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.527 -0.749 . . . . 2.24 112.86 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.66 66.22 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.125 1.157 . . . . 1.19 114.125 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -78.86 -10.51 59.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.439 1.644 . . . . 2.07 115.439 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.2 t -61.29 -52.07 66.25 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.394 -1.442 . . . . 1.82 113.629 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.7 1.24 31.0 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.969 -1.082 . . . . 2.42 113.638 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.3 t -79.53 177.34 8.94 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.447 1.099 . . . . 1.64 113.914 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.99 2.5 9.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.113 2.165 . . . . 5.23 113.267 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -81.04 158.29 70.2 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 114.397 1.258 . . . . 2.45 114.397 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.21 -32.37 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.088 2.525 . . . . 1.0 113.913 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.6 -55.46 2.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.376 0.67 . . . . 1.5 112.318 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.55 -28.63 71.64 Favored Glycine 0 CA--C 1.543 1.805 0 N-CA-C 114.292 0.477 . . . . 0.94 114.292 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.3 p -61.23 -22.78 65.12 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.011 -1.288 . . . . 2.47 113.725 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.49 72.65 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.579 -1.326 . . . . 1.52 112.334 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.81 -34.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.015 1.326 . . . . 1.26 110.76 173.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 75.4 m -53.14 -46.7 68.94 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 118.432 -0.794 . . . . 1.82 111.508 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.46 -47.32 86.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.463 1.029 . . . . 2.7 112.821 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -55.11 -46.28 75.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.217 1.007 . . . . 3.11 112.145 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.2 t -66.49 -52.94 40.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.669 0.788 . . . . 2.4 112.207 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.2 -35.26 73.28 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 3.74 112.607 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 -48.68 65.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.386 1.075 . . . . 3.64 111.865 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -61.37 -37.86 84.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.096 0.958 . . . . 2.01 113.297 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.59 -16.98 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.333 1.605 . . . . 1.26 115.333 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.2 t0 56.47 30.38 17.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.279 1.432 . . . . 2.72 114.558 -170.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 14.2 t -107.72 159.88 16.14 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.273 -1.517 . . . . 3.04 111.48 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.55 -9.57 26.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.447 1.099 . . . . 2.88 111.569 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.0 t -141.92 130.95 23.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.753 2.021 . . . . 4.41 111.14 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -163.24 162.08 25.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.571 1.548 . . . . 1.86 111.091 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 57.82 76.42 0.21 Allowed Glycine 0 N--CA 1.471 1.013 0 CA-C-N 119.175 0.898 . . . . 2.95 113.748 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 23.6 m -68.14 -50.08 56.9 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.637 0.606 . . . . 3.03 112.637 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.1 t -136.85 142.34 42.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.145 0.978 . . . . 1.75 111.424 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.69 147.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 128.202 2.601 . . . . 4.18 107.615 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.92 81.05 1.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.173 1.389 . . . . 2.68 109.543 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -91.13 137.08 32.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.918 1.822 . . . . 3.62 115.918 -168.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -119.05 101.92 8.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.967 3.707 . . . . 2.36 106.267 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 21.7 m -99.65 142.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.432 0.901 . . . . 4.0 113.432 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 25.7 t -133.65 92.86 22.37 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.764 1.226 . . . . 2.19 109.06 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.9 149.37 61.52 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.938 3.092 . . . . 2.97 113.496 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.07 15.38 65.06 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.069 -0.851 . . . . 1.7 114.688 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 t -147.51 -70.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.966 1.383 . . . . 2.43 112.159 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 177.52 179.48 47.76 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.662 1.125 . . . . 1.02 112.72 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.51 160.76 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.372 -1.075 . . . . 3.82 111.432 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 148.93 50.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.378 1.471 . . . . 1.21 111.227 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.8 p -155.81 173.32 16.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.405 1.261 . . . . 1.3 114.405 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -119.14 123.68 44.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.531 1.132 . . . . 1.77 108.745 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.4 t -106.11 148.31 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.797 1.239 . . . . 3.59 110.037 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.8 t -148.71 158.59 44.25 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.153 1.908 . . . . 2.16 116.153 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.259 24.8 t-20 . . . . . 0 CA--C 1.542 0.64 1 C-N-CA 132.409 4.283 . . . . 2.99 106.949 156.5 . . . . . . . . 2 1 . 1 . 008 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 117.376 2.361 . . . . 2.63 117.376 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.23 110.83 16.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.683 1.593 . . . . 4.32 111.554 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.26 117.81 20.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.115 1.366 . . . . 2.01 109.374 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.2 m -136.61 139.81 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 113.044 0.757 . . . . 2.41 113.044 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.1 150.0 43.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.986 1.315 . . . . 2.04 112.772 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -147.79 141.39 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.277 1.431 . . . . 2.01 109.92 -173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 147.83 -147.32 17.9 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.178 0.831 . . . . 1.46 115.178 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -68.98 157.9 35.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.384 1.874 . . . . 2.61 113.896 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -53.49 -28.11 29.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.268 2.227 . . . . 9.76 114.756 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.65 -39.18 87.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.571 1.148 . . . . 4.05 113.415 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.69 -21.16 26.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.678 -0.639 . . . . 4.63 112.547 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 15.9 mmt -61.83 -34.61 76.25 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.245 -0.909 . . . . 2.34 110.592 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 36.2 mt -68.31 -68.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.812 1.245 . . . . 2.65 109.278 168.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -24.5 23.42 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.194 1.924 . . . . 9.67 116.194 -172.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -76.08 11.92 1.31 Allowed 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 120.841 1.655 . . . . 1.17 112.306 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 77.15 15.44 81.59 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 119.966 -1.709 . . . . 1.15 114.731 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.65 -178.1 6.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.836 1.318 . . . . 1.16 111.248 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 59.9 t -123.37 134.09 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.361 1.465 . . . . 1.92 109.744 170.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -105.6 139.08 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.162 0.985 . . . . 2.2 111.631 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -97.61 160.19 14.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.332 1.453 . . . . 4.11 112.705 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.5 -21.22 56.06 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 3.74 113.222 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -73.94 -35.29 64.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.377 -0.827 . . . . 3.05 112.315 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -74.36 -33.84 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 119.109 -0.472 . . . . 1.43 110.736 168.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -60.27 -37.27 79.94 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.902 0.774 . . . . 2.58 111.654 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -64.77 -46.57 81.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.987 1.315 . . . . 2.13 112.281 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -41.02 81.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.096 1.358 . . . . 4.26 110.646 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 14.1 tpp -64.09 -57.2 10.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.083 1.353 . . . . 1.69 111.996 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.6 t -67.27 -30.84 70.82 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.691 0.626 . . . . 2.25 112.691 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -58.78 -45.49 89.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.296 -0.877 . . . . 2.77 111.113 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -70.55 -35.78 73.3 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.442 0.904 . . . . 2.93 113.442 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.24 -36.87 83.33 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.47 1.032 . . . . 2.66 112.388 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -70.94 -30.49 66.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.867 2.067 . . . . 4.03 113.189 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 26.8 mttp -72.3 -4.61 30.7 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.168 1.787 . . . . 3.02 112.578 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.38 3.11 87.12 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.894 1.711 . . . . 1.57 115.736 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -98.19 164.59 12.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.781 1.291 . . . . 4.73 111.482 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 50.5 m -72.8 130.65 40.94 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.313 -0.867 . . . . 1.96 110.845 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.1 41.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.838 1.655 . . . . 1.28 109.642 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -140.33 153.9 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 113.748 1.018 . . . . 2.04 113.748 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.68 162.65 12.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.173 1.389 . . . . 1.24 111.642 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 12.0 t -131.73 129.37 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.562 1.545 . . . . 3.08 110.272 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -127.7 148.33 50.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.554 1.141 . . . . 1.02 111.039 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.7 m -148.14 130.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.683 0.793 . . . . 1.65 111.093 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.56 51.92 2.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.802 1.641 . . . . 3.0 112.879 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 12.6 m-20 60.56 33.27 20.48 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.795 2.038 . . . . 1.79 115.551 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -133.95 137.31 44.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.864 1.665 . . . . 2.49 111.518 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.02 115.87 15.13 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.059 -1.026 . . . . 1.97 110.702 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.3 p -103.99 -30.16 10.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.727 -1.13 . . . . 1.66 113.676 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -177.57 -169.6 38.82 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.753 1.615 . . . . 0.73 115.88 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.69 153.71 43.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.687 1.595 . . . . 0.97 112.54 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.09 133.73 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 1.9 109.896 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.24 133.96 51.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.173 1.389 . . . . 1.78 110.733 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 41.3 mm -102.54 171.73 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 125.433 1.493 . . . . 2.96 110.469 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 2.45 111.912 167.718 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 113.272 0.841 . . . . 3.15 113.272 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.77 143.82 79.07 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.187 2.592 . . . . 3.5 113.091 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 26.9 m -122.04 129.92 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.401 1.081 . . . . 3.71 111.527 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -73.91 128.39 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.212 -0.93 . . . . 2.17 110.968 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -105.88 -45.15 4.44 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.08 1.352 . . . . 3.46 112.443 -169.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -155.31 160.83 41.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.627 1.571 . . . . 3.03 112.485 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.4 m -127.63 142.33 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.008 1.323 . . . . 1.29 111.525 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 28.9 tttt -140.37 146.9 39.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.185 0.994 . . . . 3.0 112.861 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 39.6 t -84.83 154.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.374 1.469 . . . . 1.53 111.106 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.0 tp -120.85 -33.06 3.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.917 1.687 . . . . 1.4 111.968 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1063 ' ' THR . . . . . 0.453 HG21 ' H ' ' A' 1068 ' ' ILE . 5.0 t -87.24 32.9 0.68 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.197 1.399 . . . . 2.95 113.846 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -59.12 122.0 12.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.795 1.238 . . . . 3.93 110.853 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 66.7 m 50.92 32.51 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.816 1.413 . . . . 3.69 114.816 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -132.6 -21.65 2.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.205 1.402 . . . . 4.45 114.514 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -157.49 -56.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.625 1.557 . . . . 5.24 114.973 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1068 ' ' ILE . . . . . 0.453 ' H ' HG21 ' A' 1063 ' ' THR . 31.8 mt -137.61 155.6 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.453 1.901 . . . . 2.27 110.707 -167.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 75.0 m -117.31 166.69 12.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.786 1.634 . . . . 2.42 114.078 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.7 p80 -57.95 -43.21 86.23 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.834 2.161 . . . . 3.57 116.834 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -72.87 -28.3 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.477 1.035 . . . . 3.63 111.626 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -71.1 -48.61 51.41 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.444 -0.785 . . . . 4.19 110.934 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.19 -46.67 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.842 0.857 . . . . 1.84 111.621 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.4 -34.38 77.82 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.04 0.836 . . . . 1.78 112.048 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.13 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.639 -0.696 . . . . 1.53 112.416 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.78 -26.86 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.493 1.042 . . . . 1.14 113.315 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 94.6 t -71.32 -44.18 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.094 0.861 . . . . 1.58 110.521 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.48 96.53 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.555 -0.716 . . . . 0.7 113.778 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 72.7 p -74.06 -37.84 64.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.701 1.25 . . . . 1.79 112.904 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.46 -51.14 69.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.741 0.816 . . . . 0.97 111.949 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.78 -21.88 62.45 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.648 -0.657 . . . . 2.09 112.703 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 67.5 m -62.76 -21.45 65.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.501 -1.374 . . . . 3.24 112.806 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 2.53 50.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.513 1.525 . . . . 2.98 112.969 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 6.4 t -107.37 -179.59 3.97 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 1.71 113.758 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -136.45 32.9 2.78 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.529 2.732 . . . . 4.47 111.714 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -97.01 154.69 38.11 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.051 1.34 . . . . 2.5 113.61 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.21 -27.54 1.83 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.206 2.604 . . . . 1.14 114.939 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.0 tt -100.17 -48.09 4.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.563 0.745 . . . . 1.76 111.709 -167.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -68.53 -30.24 73.05 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 114.55 0.58 . . . . 0.98 114.55 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 61.1 p -67.14 -11.01 56.1 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.649 -1.501 . . . . 2.52 113.956 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.38 78.64 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.97 0.908 . . . . 1.42 111.012 167.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.08 -32.67 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.42 1.088 . . . . 2.59 110.866 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 52.0 m -53.16 -49.41 66.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 119.562 1.074 . . . . 2.45 112.285 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -65.96 -46.29 78.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.086 0.857 . . . . 3.33 112.543 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.14 -44.19 71.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.439 1.096 . . . . 3.0 111.457 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.9 t -70.44 -55.41 9.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.793 1.237 . . . . 2.53 111.832 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -53.65 -47.12 70.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.299 0.954 . . . . 3.8 112.251 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -72.48 -28.76 63.1 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.78 0.659 . . . . 5.41 112.78 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -70.2 -46.1 65.26 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.184 0.902 . . . . 2.6 112.773 172.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -25.67 62.5 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.804 1.039 . . . . 1.99 113.804 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.47 17.98 0.41 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.667 2.387 . . . . 2.44 114.624 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 4.5 t -82.59 -7.79 59.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.417 2.287 . . . . 4.13 113.979 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 17.5 tt0 63.05 -27.11 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 129.27 3.028 . . . . 4.29 116.819 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.7 t -144.51 130.45 19.35 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.914 1.234 . . . . 3.39 112.368 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.88 154.25 41.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.202 1.401 . . . . 2.13 113.091 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.6 171.46 36.57 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.405 1.479 . . . . 1.43 115.214 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 17.9 m -150.23 -70.5 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.873 -1.369 . . . . 2.12 113.978 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 37.6 t -138.3 139.42 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.959 1.254 . . . . 1.93 112.478 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.7 mp -140.89 140.8 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 131.668 3.987 . . . . 3.8 106.086 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.283 0.0 OUTLIER -100.76 -13.11 18.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.943 1.831 . . . . 3.1 115.943 -174.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 5.5 t80 54.54 86.01 0.05 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 129.346 3.059 . . . . 3.81 118.929 166.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.91 102.65 11.82 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.289 1.835 . . . . 2.46 109.067 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 84.8 t -99.83 138.88 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.313 1.045 . . . . 2.9 111.589 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.9 t -131.82 124.45 19.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.651 1.18 . . . . 1.36 110.989 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.3 140.97 34.68 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.884 2.39 . . . . 2.56 112.507 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 63.16 21.19 63.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.323 0.963 . . . . 1.94 114.992 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 99.7 m -139.25 -62.69 0.53 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.969 1.708 . . . . 3.08 111.897 -169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.67 -173.35 34.4 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.397 1.475 . . . . 0.81 112.01 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.64 158.74 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 122.005 -0.703 . . . . 3.65 111.551 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 27.5 t -132.65 151.63 51.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.422 1.489 . . . . 0.97 110.634 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -160.57 172.9 16.35 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.081 -1.012 . . . . 1.26 113.317 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -113.65 124.1 51.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.59 1.156 . . . . 2.28 108.248 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.8 m -122.39 131.74 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 113.602 0.964 . . . . 3.49 113.602 -170.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -118.68 153.37 34.47 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.757 1.021 . . . . 1.72 113.757 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 131.355 3.862 . . . . 2.4 108.343 161.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 114.646 1.35 . . . . 2.17 114.646 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.52 128.68 33.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.644 1.177 . . . . 3.76 108.807 168.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.1 tttt -81.78 126.03 31.36 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 107.48 -1.304 . . . . 2.96 107.48 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -133.31 138.08 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.786 0.835 . . . . 2.27 111.3 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 153.15 46.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.308 1.043 . . . . 2.12 112.7 172.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.9 tt -147.96 139.89 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.32 1.448 . . . . 1.75 109.135 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.45 -172.34 44.85 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.735 1.054 . . . . 1.48 115.735 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 24.8 p30 -81.08 158.97 24.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.441 1.096 . . . . 3.19 113.16 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -45.53 -51.77 11.35 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.006 1.484 . . . . 6.38 115.006 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -74.29 -34.45 63.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.042 1.292 . . . . 4.52 112.671 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 36.7 t90 -68.69 -40.9 79.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.031 -1.043 . . . . 4.18 111.468 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 91.1 mmm -63.82 -32.9 74.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.698 0.799 . . . . 3.52 112.735 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.67 -63.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.504 1.522 . . . . 3.14 109.047 167.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -47.4 -8.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.887 2.075 . . . . 7.59 116.565 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -83.63 13.17 4.85 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 121.459 1.936 . . . . 1.18 112.517 168.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 70.02 37.23 73.51 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 119.755 -1.841 . . . . 0.95 114.675 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.95 167.49 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.88 112.766 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.2 t -105.47 114.49 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.835 1.254 . . . . 2.68 109.71 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.18 146.04 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.841 1.257 . . . . 2.1 110.511 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -117.84 171.3 8.15 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.284 1.034 . . . . 3.12 112.732 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -71.07 -40.26 71.7 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.968 1.47 . . . . 3.6 114.968 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.15 -28.36 54.14 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.912 -1.118 . . . . 2.62 113.563 -170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 7.5 p -72.04 -43.74 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.608 1.163 . . . . 1.36 111.878 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.4 t30 -66.89 -38.92 87.18 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.53 0.567 . . . . 2.32 112.53 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.5 -44.14 84.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.57 0.582 . . . . 2.02 112.57 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 17.1 t80 -68.16 -45.08 74.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.148 0.979 . . . . 3.74 111.684 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.5 ttm -60.81 -46.91 88.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.974 0.91 . . . . 2.32 112.502 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.4 t -74.76 -33.9 62.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.051 0.541 . . . . 1.89 112.446 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.64 -44.85 85.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.22 1.008 . . . . 2.98 111.823 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -69.59 -45.77 67.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.794 1.637 . . . . 4.48 112.326 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.63 -32.77 74.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.955 -1.09 . . . . 3.98 112.017 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -71.26 -22.96 61.9 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.332 1.234 . . . . 4.92 114.332 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 15.6 mttp -76.04 -0.61 22.35 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.387 1.075 . . . . 3.8 112.56 167.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.43 16.54 68.6 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.882 1.706 . . . . 1.4 113.951 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -117.8 132.32 56.46 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.376 1.47 . . . . 5.13 109.619 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 96.4 m -65.42 137.37 57.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.679 0.992 . . . . 2.19 113.679 -167.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -133.16 119.08 19.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.506 1.123 . . . . 1.51 111.475 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.3 m -132.97 157.98 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.339 1.456 . . . . 1.86 113.03 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.16 156.68 21.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.833 1.653 . . . . 1.75 111.53 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.6 p -132.12 133.95 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.401 1.48 . . . . 3.33 111.236 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -135.08 153.34 52.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.962 1.705 . . . . 0.82 111.405 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.56 135.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 1.58 112.541 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 48.8 m-20 42.3 48.82 4.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.754 1.621 . . . . 2.72 112.832 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 57.3 m-20 55.6 33.94 22.18 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.951 2.1 . . . . 2.5 115.497 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.69 141.48 49.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.081 2.552 . . . . 2.08 110.145 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.43 130.9 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 119.85 -1.781 . . . . 1.74 112.444 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 22.3 p -108.22 -35.3 6.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.599 -1.191 . . . . 2.21 114.081 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -173.23 -167.07 32.57 Favored Glycine 0 N--CA 1.475 1.277 0 CA-C-N 120.7 1.591 . . . . 0.63 116.447 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.84 154.7 44.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.475 1.91 . . . . 1.08 112.481 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.4 137.33 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.932 1.693 . . . . 2.03 109.708 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.53 137.49 46.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.873 1.669 . . . . 1.94 110.351 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.18 151.7 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.877 1.671 . . . . 2.6 110.843 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 125.268 1.427 . . . . 1.49 112.666 169.699 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.499 0.926 . . . . 3.78 113.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.22 148.6 77.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.324 2.016 . . . . 3.25 113.676 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.5 p -120.33 124.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.039 1.735 . . . . 3.37 110.396 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.251 13.1 p -72.12 130.63 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.309 -0.869 . . . . 2.28 110.296 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.54 -40.81 4.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.446 1.276 . . . . 3.13 114.446 -166.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -157.64 146.3 19.41 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.183 0.593 . . . . 2.94 112.08 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 28.1 m -126.86 144.24 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.549 1.14 . . . . 1.45 112.11 169.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 72.7 tttt -134.77 141.76 46.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.119 1.368 . . . . 2.81 110.962 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 49.7 t -92.03 134.36 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.484 1.114 . . . . 1.38 110.778 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 9.7 tp -99.21 -65.27 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.906 2.082 . . . . 1.33 111.022 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 38.1 m -78.63 75.02 5.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.481 -1.303 . . . . 2.86 107.481 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.63 123.97 29.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.274 1.03 . . . . 3.94 109.016 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 70.7 m 60.71 174.76 0.1 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.0 1.482 . . . . 3.66 115.0 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 64.63 -0.03 1.03 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.612 2.449 . . . . 4.26 117.612 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -147.57 -44.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.803 1.241 . . . . 5.7 112.634 167.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mm -130.09 163.9 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.943 1.697 . . . . 2.69 109.614 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 20.4 m -119.35 145.59 46.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.818 1.647 . . . . 2.98 111.109 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -49.79 -51.35 40.13 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.797 1.777 . . . . 4.72 115.797 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 72.8 m80 -74.25 -14.32 60.9 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.969 1.259 . . . . 6.22 112.804 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.94 -37.97 33.36 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.944 -1.027 . . . . 4.15 111.493 168.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.91 -54.34 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.32 0.964 . . . . 1.71 110.13 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.19 -32.27 72.39 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.643 -0.66 . . . . 1.79 112.332 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.98 83.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.65 0.659 . . . . 2.17 112.576 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.36 -29.42 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.916 -1.115 . . . . 1.07 113.427 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.3 t -69.2 -52.35 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.289 0.949 . . . . 1.33 111.107 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.01 -35.87 91.23 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.791 -0.568 . . . . 0.69 113.17 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 36.2 p -71.66 -36.0 70.52 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.523 1.161 . . . . 1.57 112.693 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.31 -49.36 67.3 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.901 0.773 . . . . 0.88 112.846 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -72.08 -15.17 62.01 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 121.366 -0.834 . . . . 2.63 112.715 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.3 t -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.42 -2.05 . . . . 1.78 112.493 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.98 2.04 55.59 Favored 'General case' 0 CA--C 1.557 1.227 0 O-C-N 121.073 -1.017 . . . . 2.13 113.007 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 57.8 m -103.59 167.24 9.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.621 1.569 . . . . 1.93 114.224 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.26 12.34 7.62 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.084 1.754 . . . . 3.47 112.585 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -71.63 148.25 92.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.602 -1.311 . . . . 2.91 113.141 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.95 -31.35 31.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.226 2.617 . . . . 1.13 114.631 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.4 -51.45 3.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.168 1.387 . . . . 1.54 111.793 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -57.12 -34.68 67.05 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.454 0.55 . . . . 1.1 113.514 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.1 p -61.25 -14.5 26.58 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.869 -1.371 . . . . 2.33 114.477 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.09 82.94 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.758 -1.214 . . . . 1.47 111.713 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.12 -39.27 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.397 1.479 . . . . 1.35 109.774 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 24.3 m -57.44 -44.39 84.68 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 117.934 -1.032 . . . . 1.92 112.552 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.27 -47.38 79.77 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.066 1.303 . . . . 3.27 112.091 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.69 -43.12 76.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.903 0.481 . . . . 2.68 111.433 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 94.7 m -69.16 -49.91 52.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.934 1.293 . . . . 4.11 112.389 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -49.9 -48.7 51.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.375 1.47 . . . . 4.74 111.534 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.93 -38.91 72.93 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.591 0.756 . . . . 3.4 112.388 175.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.3 -36.2 81.04 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.485 1.039 . . . . 2.35 112.756 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 5.4 mt -72.42 -9.21 58.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.83 1.252 . . . . 1.42 114.0 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.04 50.82 18.33 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.029 1.332 . . . . 3.58 111.887 -170.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.9 t -138.45 168.73 19.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.385 1.074 . . . . 2.83 112.502 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -102.62 -17.61 15.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.875 1.67 . . . . 3.83 111.26 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.6 t -136.89 130.64 31.99 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.865 -1.147 . . . . 3.88 113.574 -168.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.86 159.14 32.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.591 1.556 . . . . 1.48 110.169 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 76.44 127.82 0.28 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.931 0.777 . . . . 1.4 114.13 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 53.2 m -123.73 -71.17 0.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 1.69 112.709 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 4.4 t -135.44 143.19 45.78 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.096 1.316 . . . . 2.14 112.509 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 5.1 tp -132.35 163.48 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 1 C-N-CA 132.413 4.285 . . . . 3.37 109.416 -166.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.06 86.4 1.92 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.214 1.806 . . . . 2.69 106.176 166.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -93.63 147.9 22.59 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.699 2.111 . . . . 5.19 116.699 -164.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -137.92 118.47 13.91 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.332 2.253 . . . . 2.13 109.133 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 17.0 t -112.73 140.63 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.391 1.076 . . . . 2.72 113.867 -168.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 92.7 t -139.71 117.0 8.42 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 127.025 2.13 . . . . 1.38 107.472 167.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.22 144.24 50.98 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.66 2.24 . . . . 2.53 112.361 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.06 1.41 12.69 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.099 1.2 . . . . 1.68 116.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 1.3 m -136.8 -30.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.686 1.736 . . . . 2.79 115.686 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.66 168.33 19.2 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 121.337 1.88 . . . . 0.93 116.888 168.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 137.35 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.808 1.243 . . . . 2.77 109.911 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 39.3 t -126.67 144.87 50.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.614 1.565 . . . . 1.03 109.785 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.1 174.55 14.57 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.765 1.024 . . . . 1.22 113.765 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -116.77 123.5 47.29 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.215 -2.143 . . . . 1.87 105.215 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.56 144.73 24.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 118.771 0.714 . . . . 3.05 110.807 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -134.3 155.5 50.11 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.134 1.531 . . . . 1.87 115.134 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.28 15.2 t-20 . . . . . 0 CA--C 1.546 0.793 1 C-N-CA 132.991 4.516 . . . . 2.75 104.918 158.843 . . . . . . . . 2 1 . 1 . 010 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 122.141 0.972 . . . . 2.21 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.46 127.34 53.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.675 1.19 . . . . 3.98 108.577 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -86.64 123.36 31.74 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.751 -0.833 . . . . 2.35 108.751 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -132.77 139.54 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.289 0.495 . . . . 1.2 111.934 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.16 147.51 36.75 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.564 1.146 . . . . 1.08 112.471 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.9 tt -141.59 138.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.302 1.441 . . . . 1.85 108.717 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 171.82 -166.85 39.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 117.142 1.617 . . . . 1.45 117.142 -174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.31 162.76 17.21 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.362 3.065 . . . . 2.49 111.895 -169.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -44.21 -65.09 0.55 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.344 1.609 . . . . 9.07 115.344 -167.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.42 -34.3 70.21 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.863 1.21 . . . . 3.25 113.765 -171.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -68.99 -27.88 66.1 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.005 -1.059 . . . . 4.06 112.443 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 55.2 tpp -70.69 -42.88 70.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.103 0.561 . . . . 2.72 112.292 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 97.4 mt -49.3 -61.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.065 1.346 . . . . 2.9 109.504 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -51.31 -11.57 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.071 2.249 . . . . 6.94 117.071 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.28 15.49 0.44 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 121.988 2.176 . . . . 1.07 111.254 166.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.13 11.71 81.69 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 119.354 -2.091 . . . . 0.76 114.589 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.82 159.68 25.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.902 1.351 . . . . 0.8 111.306 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 74.1 t -94.23 122.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.352 . . . . 2.18 109.612 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.4 tt -96.48 132.25 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.245 1.018 . . . . 2.45 110.277 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -93.21 153.9 18.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.521 1.128 . . . . 4.02 112.879 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.88 -32.9 73.3 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.156 -0.965 . . . . 3.26 112.997 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.91 -44.65 80.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.922 0.889 . . . . 2.68 112.139 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.9 p -73.4 -31.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.347 -0.846 . . . . 1.34 111.72 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -64.15 -38.68 91.93 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.898 1.227 . . . . 2.24 111.624 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.75 -33.69 75.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.955 0.902 . . . . 2.51 112.151 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.75 -44.3 81.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.025 1.73 . . . . 3.96 112.096 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 27.0 tpp -62.59 -50.37 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.26 1.424 . . . . 1.6 110.73 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.0 t -72.23 -30.9 65.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.819 0.674 . . . . 1.76 112.819 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.63 -51.77 67.43 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.042 1.292 . . . . 2.56 112.234 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.52 -30.9 68.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.868 0.692 . . . . 3.32 112.868 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.1 -41.27 90.85 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 121.357 -0.839 . . . . 2.57 111.884 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.37 -22.73 61.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.343 1.857 . . . . 5.08 114.232 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 22.3 mttp -73.13 -5.35 38.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.077 2.151 . . . . 3.37 114.406 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 96.68 9.88 55.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.128 1.347 . . . . 2.12 115.246 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -113.73 -176.94 3.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.332 1.453 . . . . 4.03 111.53 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.6 m -102.53 138.35 39.57 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.091 1.756 . . . . 1.99 111.023 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.56 127.77 35.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.985 1.314 . . . . 1.11 111.431 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.4 m -140.14 159.6 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.358 1.063 . . . . 0.98 112.965 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.44 155.04 21.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.895 1.678 . . . . 1.49 110.942 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.1 p -132.86 130.32 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.48 1.112 . . . . 3.29 112.61 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.46 154.59 46.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.559 1.544 . . . . 0.98 111.944 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.7 m -148.72 130.05 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.462 0.705 . . . . 2.1 112.416 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 9.5 m-20 41.35 43.61 2.15 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 3.2 112.853 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.312 14.8 m-20 68.86 30.63 4.63 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 117.095 2.258 . . . . 2.28 117.095 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.71 141.16 50.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.225 1.81 . . . . 2.56 109.871 165.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.74 109.75 13.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.73 -1.231 . . . . 1.78 111.077 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -94.42 -27.59 15.95 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.027 -1.046 . . . . 1.28 112.771 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.27 -176.29 40.96 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 116.336 1.294 . . . . 0.48 116.336 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.39 154.31 45.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.461 1.904 . . . . 2.11 111.905 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 4.0 mt -136.78 135.61 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.917 1.287 . . . . 2.97 110.62 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.39 137.83 45.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.058 1.343 . . . . 1.95 110.678 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.25 145.65 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.163 1.785 . . . . 2.72 108.925 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.519 0 C-N-CA 124.218 1.007 . . . . 1.82 111.618 176.645 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 115.332 1.604 . . . . 3.35 115.332 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -81.48 158.4 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.773 1 C-N-CA 125.552 4.168 . . . . 2.49 112.73 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 2.4 m -139.76 130.11 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.84 1.656 . . . . 4.06 111.734 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.254 8.7 p -77.07 129.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.048 -1.033 . . . . 2.62 112.342 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.82 -39.84 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.042 0.937 . . . . 3.09 113.42 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -149.09 151.58 34.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.095 1.358 . . . . 3.93 111.314 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 8.6 m -135.41 146.6 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.397 1.079 . . . . 1.31 111.356 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 68.1 tttt -141.53 138.9 33.06 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.47 1.108 . . . . 2.32 112.854 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.9 t -88.82 142.39 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.284 1.033 . . . . 1.97 111.286 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.2 tp -106.21 -39.85 5.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.525 1.53 . . . . 2.16 111.977 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 53.1 m -124.81 97.17 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.682 0.674 . . . . 2.5 112.502 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.82 111.61 5.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.469 1.507 . . . . 5.99 108.26 168.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 8.6 t -178.37 -52.8 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.563 1.945 . . . . 5.04 110.777 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 6.7 m120 -150.24 41.76 0.82 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.748 1.619 . . . . 7.4 112.932 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -146.82 -58.57 0.28 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.507 -1.37 . . . . 5.64 112.876 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.16 155.23 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.524 1.53 . . . . 3.37 110.247 -173.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 15.3 m -110.01 143.12 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.306 1.042 . . . . 3.24 110.767 172.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.03 -42.23 68.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.286 2.328 . . . . 4.67 117.286 -168.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 46.9 m80 -68.59 -29.06 67.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.984 1.265 . . . . 6.18 111.81 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.27 -40.19 77.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 117.93 -1.033 . . . . 4.76 111.315 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 82.3 mt -55.15 -54.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 118.968 0.804 . . . . 2.12 110.536 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.51 -33.16 74.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.683 -0.635 . . . . 1.7 112.152 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.11 81.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.542 0.571 . . . . 1.1 112.542 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.0 pt -69.84 -31.25 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.546 1.066 . . . . 1.0 112.921 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 48.0 t -71.12 -49.88 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.007 0.822 . . . . 1.27 111.635 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.68 -33.86 87.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.376 -0.828 . . . . 0.68 113.903 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 34.9 p -74.27 -37.88 63.59 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.822 0.849 . . . . 1.31 112.581 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.39 82.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.069 0.849 . . . . 0.79 112.772 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -66.62 -18.97 65.65 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.858 -1.151 . . . . 2.24 113.362 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 1.6 t -64.91 -15.52 62.14 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.062 -1.024 . . . . 2.29 112.722 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -128.66 -20.22 3.61 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.075 1.35 . . . . 3.19 114.205 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.9 t -70.44 -44.61 67.49 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.908 -1.12 . . . . 3.97 112.313 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . 0.301 33.1 mt-10 70.74 32.29 2.54 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.423 1.889 . . . . 5.23 115.386 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.98 146.32 63.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.263 1.425 . . . . 2.34 113.468 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.42 -54.15 3.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.985 3.79 . . . . 1.28 114.352 -169.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -68.05 -33.69 75.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.818 1.247 . . . . 1.68 111.459 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.34 -22.31 63.16 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.207 1.384 . . . . 0.91 114.813 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 51.7 p -61.92 -35.9 79.75 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.934 1.367 . . . . 3.37 112.611 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.95 79.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.125 0.97 . . . . 2.38 112.168 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.2 mt -72.64 -43.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.352 0.661 . . . . 1.94 111.278 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 5.3 t -66.27 -40.59 90.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.867 -0.587 . . . . 3.14 112.082 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -62.18 -48.82 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.875 0.761 . . . . 4.0 111.964 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -56.4 -42.95 78.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.033 0.833 . . . . 3.1 112.003 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.8 t -61.31 -54.34 45.24 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.771 -0.581 . . . . 3.35 111.277 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.78 -32.67 67.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.588 1.155 . . . . 3.73 113.096 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -71.59 -48.91 45.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.098 1.759 . . . . 4.47 112.856 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.92 -38.19 76.17 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.389 -1.444 . . . . 2.45 112.583 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 -21.3 60.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.072 0.949 . . . . 1.44 113.323 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.92 28.4 2.83 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.512 1.925 . . . . 3.86 114.057 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -128.81 139.37 52.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.919 -1.113 . . . . 2.72 113.86 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -77.25 -11.29 59.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.765 1.226 . . . . 3.83 112.542 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 65.4 p -80.32 47.93 0.97 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.011 2.125 . . . . 5.69 114.21 -171.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.15 148.08 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.821 1.045 . . . . 2.08 113.821 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 75.83 128.41 0.26 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.79 1.662 . . . . 1.61 114.351 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.27 -154.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.797 2.039 . . . . 3.27 108.273 172.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 142.17 50.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.766 1.765 . . . . 2.07 115.766 -167.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.11 153.33 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 1 C-N-CA 132.472 4.309 . . . . 3.22 107.552 -169.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -140.57 117.88 11.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.256 -1.757 . . . . 2.72 106.256 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 166.77 10.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.496 2.036 . . . . 4.81 116.496 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -132.91 131.51 40.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.295 2.238 . . . . 4.15 108.518 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.26 137.32 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.878 0.871 . . . . 3.55 112.044 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 28.6 t -137.3 114.84 9.82 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.421 1.488 . . . . 2.06 107.532 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.76 147.7 45.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.083 2.522 . . . . 3.6 112.607 -172.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 61.23 17.29 52.06 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.657 1.122 . . . . 1.67 114.026 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 38.9 t -139.94 -63.51 0.5 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.746 1.218 . . . . 2.62 113.015 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.17 -152.47 23.64 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 120.583 1.538 . . . . 1.21 115.946 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.33 150.23 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.735 1.614 . . . . 3.5 113.179 -168.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.2 t -130.16 142.38 50.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.12 1.368 . . . . 1.49 109.41 165.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.45 172.87 17.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.46 1.652 . . . . 1.21 115.46 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -118.83 98.33 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 1.64 109.326 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.2 p -112.17 128.38 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.679 0.792 . . . . 3.19 112.829 -168.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 5.6 t -110.38 -163.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.721 1.209 . . . . 2.54 112.998 -171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.327 3.5 m120 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 128.557 2.743 . . . . 5.51 116.842 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.238 0.457 0 CA-C-O 120.967 0.413 . . . . 2.85 110.624 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 125.02 31.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 4.66 110.152 -173.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.9 tttt -79.6 116.93 20.09 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.533 -0.914 . . . . 2.34 108.533 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.7 m -133.67 145.11 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.847 0.859 . . . . 0.92 112.124 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -146.02 151.66 38.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.704 1.001 . . . . 1.06 113.704 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.86 142.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.163 1.385 . . . . 1.69 110.209 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 132.34 143.85 5.19 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 115.492 0.957 . . . . 1.44 115.492 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 7.7 t-20 43.38 -143.99 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.299 1.84 . . . . 2.43 112.281 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.919 1.688 . . . . 8.55 113.064 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -65.3 -36.43 84.04 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.328 -0.858 . . . . 4.56 112.018 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1187 ' ' TRP . . . . . 0.423 ' CE3' ' HD3' ' A' 1190 ' ' ARG . 4.9 m95 -57.03 -30.0 63.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.144 1.164 . . . . 5.14 114.144 172.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.7 mmt -72.05 -37.72 69.62 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.499 0.666 . . . . 2.39 111.626 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.15 -67.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 126.304 1.842 . . . . 2.71 108.259 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1190 ' ' ARG . . . . . 0.423 ' HD3' ' CE3' ' A' 1187 ' ' TRP . 34.5 ttt85 -36.49 -43.51 0.4 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.292 2.637 . . . . 7.59 114.899 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 13.74 5.73 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.28 1.215 . . . . 1.07 114.28 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 69.88 23.76 76.77 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.095 -1.628 . . . . 0.69 115.542 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.16 171.41 12.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.642 1.177 . . . . 0.81 112.059 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -99.66 133.34 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.006 1.322 . . . . 2.13 109.699 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.7 tt -138.78 147.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.761 1.224 . . . . 2.52 111.11 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.69 151.32 32.0 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.101 1.36 . . . . 2.67 113.258 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.07 -26.36 67.45 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.18 -0.95 . . . . 4.6 112.84 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.54 -36.39 76.32 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.002 -1.061 . . . . 3.39 113.213 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -77.16 -36.93 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.724 0.693 . . . . 1.4 111.438 170.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.1 t30 -62.85 -37.72 87.95 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.746 0.703 . . . . 2.52 111.979 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.84 -39.05 93.17 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.475 1.11 . . . . 2.94 112.971 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.56 -37.64 80.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.996 -1.065 . . . . 3.83 111.75 171.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -66.25 -52.16 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.596 1.158 . . . . 1.84 112.01 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.8 t -68.76 -34.62 75.88 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.376 -0.828 . . . . 2.38 112.263 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.37 -49.05 68.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.048 0.84 . . . . 3.26 111.055 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -66.66 -39.57 88.24 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.388 1.075 . . . . 4.99 112.383 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -63.75 -42.31 97.86 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.305 -0.872 . . . . 2.74 112.804 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -70.59 -28.73 65.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.181 1.792 . . . . 4.91 112.785 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.6 mttp -66.81 -12.61 59.57 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.085 1.754 . . . . 3.96 113.565 169.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.89 15.08 71.04 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.188 1.375 . . . . 1.43 114.73 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -106.98 156.57 18.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.818 1.309 . . . . 4.6 110.561 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 27.3 m -77.35 128.35 34.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.571 1.549 . . . . 2.18 112.945 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.42 118.1 16.03 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.674 0.789 . . . . 2.21 113.122 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 23.6 m -141.15 157.09 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 114.75 1.389 . . . . 1.0 114.75 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.91 165.88 10.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.465 . . . . 1.15 113.539 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.7 t -136.96 134.9 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.597 1.959 . . . . 2.98 110.816 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -137.24 157.98 45.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.28 1.432 . . . . 1.0 111.082 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 17.9 m -144.93 138.03 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.546 -1.346 . . . . 1.79 111.394 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 32.8 t70 41.7 48.71 3.7 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.984 2.113 . . . . 2.77 112.377 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.28 3.4 m-20 65.6 32.7 9.06 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.996 2.118 . . . . 1.73 115.995 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.67 145.51 36.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.596 1.558 . . . . 2.25 111.189 169.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 145.68 53.52 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.405 -1.434 . . . . 1.86 111.182 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -121.33 -43.3 2.42 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.496 0.924 . . . . 1.94 113.496 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.28 -173.3 38.84 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.17 0.895 . . . . 0.47 115.062 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.26 152.94 42.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.365 1.466 . . . . 0.86 113.399 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.07 135.34 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.463 1.505 . . . . 2.04 111.101 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.38 124.82 45.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.56 2.344 . . . . 1.7 109.601 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.13 159.84 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.269 1.828 . . . . 2.69 111.579 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.627 1.171 . . . . 1.6 112.402 169.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.732 -0.652 . . . . 3.53 110.82 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 148.44 52.52 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.377 2.718 . . . . 1.92 112.19 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.1 p -138.07 125.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.863 1.265 . . . . 3.2 111.754 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.8 p -72.13 133.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.1 -1.0 . . . . 2.0 111.518 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -126.18 -34.92 2.48 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.524 1.675 . . . . 3.08 115.524 -166.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -155.03 151.17 28.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.294 1.438 . . . . 2.99 111.03 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.2 m -130.03 142.35 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.32 1.048 . . . . 1.12 111.284 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 40.1 tttt -139.61 147.14 40.68 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.096 0.958 . . . . 2.86 112.173 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 43.5 t -96.78 136.99 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.123 1.369 . . . . 1.45 111.294 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 34.6 tp -100.32 -25.7 14.15 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.873 1.669 . . . . 1.39 112.931 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.5 t -104.75 24.3 12.03 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.562 1.319 . . . . 3.67 114.562 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -56.07 128.19 34.21 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.714 -1.241 . . . . 3.77 110.49 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 60.48 -1.15 0.23 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.949 1.833 . . . . 3.47 115.949 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.74 -32.35 8.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.071 1.305 . . . . 4.81 113.191 -171.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -155.61 -46.53 0.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.259 1.577 . . . . 5.08 115.259 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.16 146.48 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.092 1.357 . . . . 2.85 111.172 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -98.65 157.42 16.27 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.323 1.449 . . . . 2.38 112.841 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -61.14 -38.5 86.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.976 2.213 . . . . 4.53 116.976 -166.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -71.24 -34.69 71.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.288 1.404 . . . . 4.73 111.099 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 94.7 mttt -61.15 -44.3 97.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.162 0.585 . . . . 5.02 110.804 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.28 -53.51 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.052 0.941 . . . . 1.73 111.198 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.91 -32.06 73.07 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.402 -0.811 . . . . 1.74 112.189 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.42 68.55 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.531 0.732 . . . . 1.29 112.013 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.1 pt -70.25 -32.66 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.005 1.275 . . . . 2.04 113.095 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.9 t -70.4 -48.01 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.804 1.184 . . . . 1.97 111.387 172.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.85 92.42 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.258 -0.901 . . . . 0.56 113.321 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 71.7 p -77.58 -27.0 51.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.821 1.045 . . . . 1.32 113.821 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.63 91.92 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.006 0.821 . . . . 0.8 112.5 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.48 -12.38 60.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.807 1.04 . . . . 1.94 113.807 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 35.4 t -54.51 -43.11 71.58 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.186 1.394 . . . . 1.99 114.543 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -92.14 2.61 56.48 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.051 0.76 . . . . 2.48 113.051 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.9 t -89.19 168.17 12.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.058 1.343 . . . . 1.73 112.761 -173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -133.64 80.09 1.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.211 1.405 . . . . 4.67 109.823 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -141.39 152.0 62.68 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.964 1.705 . . . . 2.82 110.917 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.77 -35.81 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.304 2.669 . . . . 1.81 115.19 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.24 -41.35 9.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.721 1.208 . . . . 2.08 113.456 -166.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -76.99 -34.82 40.91 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 114.541 0.576 . . . . 1.04 114.541 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 59.4 p -64.28 -17.28 63.48 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.87 -1.37 . . . . 2.93 113.142 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.15 82.93 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.866 -1.146 . . . . 2.25 111.965 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 4.8 mp -72.23 -32.72 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.43 0.692 . . . . 2.4 110.728 171.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 94.9 m -56.1 -47.61 77.72 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 117.424 -1.274 . . . . 2.08 111.395 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 46.9 tttt -62.39 -46.17 89.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.301 1.41 . . . . 3.58 112.789 175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 4.0 t80 -55.94 -42.33 76.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.348 1.059 . . . . 3.23 111.476 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.1 t -70.66 -52.55 20.46 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.611 1.564 . . . . 2.72 112.355 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -47.76 -47.63 30.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.874 1.67 . . . . 3.91 111.927 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.82 -30.41 65.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.077 0.951 . . . . 4.31 113.243 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.18 -42.22 72.7 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.636 1.107 . . . . 3.71 112.662 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.01 -33.63 61.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.006 1.323 . . . . 1.77 114.48 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.28 42.64 25.98 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.487 1.915 . . . . 3.18 114.334 -172.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -119.78 -21.7 7.13 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.409 1.633 . . . . 4.12 115.409 -172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.8 tt0 58.8 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.154 2.582 . . . . 3.01 117.403 -171.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 75.2 p -95.54 22.23 7.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.275 2.23 . . . . 3.54 113.917 -170.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.59 147.13 53.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.753 1.221 . . . . 1.4 113.847 -169.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 66.44 -173.35 25.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.272 0.929 . . . . 1.57 114.639 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -160.45 -51.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.066 1.347 . . . . 1.9 111.629 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 31.6 t -138.24 142.53 39.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.405 1.082 . . . . 1.81 113.58 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.12 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 1 C-N-CA 131.728 4.011 . . . . 4.07 109.229 168.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -20.31 12.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.944 1.461 . . . . 3.24 114.944 -169.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 51.3 m-85 60.8 105.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.507 2.723 . . . . 5.75 117.35 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -120.91 107.09 12.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.448 2.299 . . . . 2.59 107.493 168.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.7 m -98.4 145.17 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.41 0.684 . . . . 3.26 111.96 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 18.7 t -136.99 85.15 23.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 106.552 -1.647 . . . . 1.59 106.552 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -53.1 134.27 55.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.825 3.683 . . . . 2.35 114.708 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 65.22 10.05 45.46 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.855 -0.969 . . . . 1.94 114.457 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 22.8 m -127.51 -49.11 1.4 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.09 1.445 . . . . 4.26 111.933 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 173.14 -170.89 44.04 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.499 0.571 . . . . 1.15 114.096 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 4.3 tt -141.71 158.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.4 1.08 . . . . 2.84 111.665 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 18.7 t -139.0 152.92 48.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.618 1.167 . . . . 2.24 111.903 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 9.2 p -164.2 167.96 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.495 1.118 . . . . 2.97 112.648 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -110.08 123.1 49.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.307 1.043 . . . . 1.64 109.258 172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.7 t -105.01 145.21 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 123.92 0.888 . . . . 3.39 111.37 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.88 160.54 41.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.305 1.05 . . . . 2.0 113.542 164.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 CA--C 1.55 0.946 0 C-N-CA 130.674 3.59 . . . . 2.2 108.24 163.914 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.633 0.73 . . . . 2.33 112.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -122.42 128.17 50.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.578 1.551 . . . . 4.51 110.973 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.4 tttt -88.14 126.56 35.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.987 0.915 . . . . 2.12 109.073 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.6 m -134.49 151.89 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 113.748 1.018 . . . . 1.31 113.748 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.49 152.35 30.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.159 1.384 . . . . 1.8 113.005 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 10.7 tt -149.36 139.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.144 1.378 . . . . 1.89 110.31 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.9 -142.38 9.09 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.908 1.123 . . . . 1.45 115.908 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.41 161.48 2.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.64 2.376 . . . . 2.19 114.456 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -24.99 63.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.091 1.356 . . . . 7.14 113.68 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -76.61 -32.14 57.87 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.868 1.213 . . . . 3.05 113.652 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.2 t90 -64.05 -21.17 66.41 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 119.994 -1.692 . . . . 4.0 112.484 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -63.92 -33.9 76.74 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.846 -1.158 . . . . 2.59 111.256 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 24.3 mt -66.83 -64.84 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.844 1.658 . . . . 3.52 109.169 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -52.58 -30.86 33.28 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.277 1.431 . . . . 5.8 114.344 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.1 6.07 23.69 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.302 1.441 . . . . 1.07 113.954 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.99 29.8 72.35 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.95 1.738 . . . . 0.7 115.081 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 4.6 mt -96.24 160.7 14.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.84 1.256 . . . . 0.83 109.647 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 58.5 t -110.74 124.5 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.499 0.719 . . . . 1.87 110.559 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -95.63 149.44 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.018 0.927 . . . . 2.28 111.004 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -124.06 154.38 40.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.828 1.251 . . . . 3.09 111.495 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -56.92 -32.09 65.6 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.813 1.412 . . . . 2.69 114.813 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.54 -53.56 46.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.54 1.136 . . . . 3.99 111.391 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.8 p -73.48 -34.3 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.171 1.388 . . . . 1.46 111.638 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.74 -42.74 97.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.742 0.817 . . . . 2.33 111.593 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.27 -44.4 91.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.622 0.646 . . . . 2.29 112.321 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.87 -36.17 82.68 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.346 1.058 . . . . 3.54 112.22 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 18.1 tpp -62.62 -55.12 30.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.369 1.068 . . . . 1.84 111.687 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.3 t -68.56 -33.68 74.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.644 -0.66 . . . . 1.93 111.938 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.191 1.397 . . . . 4.25 112.271 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.19 -39.66 71.69 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.883 1.068 . . . . 2.71 113.883 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.54 -39.72 84.9 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.602 -0.686 . . . . 3.06 111.662 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -70.74 -18.62 62.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.523 2.329 . . . . 4.9 113.786 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -71.89 -22.01 61.56 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.008 1.276 . . . . 3.89 111.865 166.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.45 18.32 42.39 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.332 1.92 . . . . 1.98 114.303 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -106.03 -160.78 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.019 1.327 . . . . 5.4 110.123 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 69.9 m -108.09 131.51 54.54 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.885 1.22 . . . . 1.83 112.388 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.08 118.28 19.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.836 1.654 . . . . 1.22 111.125 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -138.04 155.33 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.777 1.231 . . . . 1.13 113.122 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.0 mp -113.42 159.95 18.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.971 1.309 . . . . 1.04 112.587 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.7 t -127.74 123.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.919 1.687 . . . . 2.87 110.397 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.62 147.29 48.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.784 1.234 . . . . 0.9 110.634 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.58 134.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.928 0.891 . . . . 1.84 112.061 -172.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 41.09 49.73 3.15 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.047 1.739 . . . . 3.16 112.043 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.272 24.0 m-20 54.2 36.15 24.3 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.907 2.883 . . . . 1.5 116.435 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.93 138.43 48.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.999 1.72 . . . . 2.48 110.68 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.25 133.77 48.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.642 -1.286 . . . . 1.73 110.762 169.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.2 p -115.76 -37.89 3.83 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.661 0.985 . . . . 1.34 113.661 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -174.57 -171.46 38.8 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 119.806 1.185 . . . . 0.54 115.349 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.81 154.09 44.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.739 1.616 . . . . 0.88 113.025 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.12 133.04 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.723 1.609 . . . . 2.16 110.016 -173.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -107.53 132.31 53.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 1.82 110.77 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 24.9 mt -135.02 152.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.438 1.895 . . . . 2.18 110.604 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 126.967 2.107 . . . . 2.05 111.408 171.386 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 118.552 -0.737 . . . . 3.89 110.39 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.38 135.07 16.22 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.823 2.349 . . . . 2.62 111.465 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.7 p -135.25 132.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.478 -0.764 . . . . 3.65 110.215 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 6.3 p -68.52 123.16 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.643 -0.66 . . . . 2.33 110.177 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 30.4 t30 -103.64 -39.44 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.85 1.26 . . . . 4.77 112.136 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.22 146.85 20.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.227 1.011 . . . . 3.3 112.295 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 16.7 m -132.49 131.7 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.788 0.835 . . . . 2.08 112.201 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 53.0 tttt -135.08 144.61 47.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.883 1.273 . . . . 2.33 113.224 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 87.7 t -79.17 147.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.054 1.341 . . . . 2.35 110.659 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.9 tp -122.22 -24.1 5.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.59 1.556 . . . . 1.28 112.707 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 36.0 m -127.46 107.42 9.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.153 1.381 . . . . 2.97 109.431 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.34 130.51 49.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.535 1.134 . . . . 3.64 111.788 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 59.8 m 51.61 31.21 7.45 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.132 1.773 . . . . 2.7 115.528 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -137.98 5.5 2.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.965 1.306 . . . . 2.92 113.514 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -154.37 -79.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 6.87 110.423 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.83 146.85 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 128.203 2.601 . . . . 2.82 109.032 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -97.93 155.64 16.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.245 1.418 . . . . 2.8 113.682 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -44.76 -49.42 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.669 2.47 . . . . 4.12 117.669 -167.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.9 t60 -75.33 -28.18 59.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.433 1.47 . . . . 3.45 111.348 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -65.17 -38.71 91.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.857 -1.152 . . . . 4.71 111.062 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.36 -51.85 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.088 0.955 . . . . 1.68 110.603 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -31.81 73.0 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.124 0.874 . . . . 1.92 112.262 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.78 54.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 1.75 112.152 173.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 14.4 pt -69.14 -34.95 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.193 . . . . 1.09 113.157 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 58.1 t -70.75 -45.07 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.133 0.878 . . . . 2.16 111.361 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.0 -36.18 91.66 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.487 -0.758 . . . . 0.91 113.304 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.0 p -72.76 -34.89 67.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.45 0.907 . . . . 2.14 113.45 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -58.05 -51.79 68.23 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.275 0.943 . . . . 1.24 112.64 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.52 -13.66 61.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.875 1.065 . . . . 2.56 113.875 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 9.1 p -65.16 -20.85 66.64 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.058 -1.651 . . . . 2.45 112.667 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -122.99 16.84 10.06 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.973 1.709 . . . . 2.49 112.636 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.5 t -127.83 -176.93 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.524 1.93 . . . . 1.7 110.197 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -142.94 46.77 1.55 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.294 1.438 . . . . 3.81 112.607 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.16 164.76 22.01 Favored Pre-proline 0 CA--C 1.554 1.123 0 O-C-N 121.274 -0.891 . . . . 2.5 112.441 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.73 -22.61 5.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.193 2.596 . . . . 1.41 115.314 -169.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 10.3 tt -112.8 -48.59 2.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.437 1.095 . . . . 2.45 112.848 -169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -66.04 -21.22 69.61 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.18 0.832 . . . . 1.11 115.18 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 67.4 p -62.98 -16.8 60.89 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.942 1.371 . . . . 2.42 113.979 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.33 78.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.013 -1.054 . . . . 2.0 111.737 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.69 -38.95 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.205 1.402 . . . . 2.04 110.232 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 90.9 m -53.08 -47.86 68.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.527 -0.749 . . . . 1.88 111.704 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -60.45 -51.0 71.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.649 0.78 . . . . 3.59 112.252 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.02 -41.28 78.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.214 0.605 . . . . 4.96 111.95 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.1 t -67.65 -56.9 7.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.478 1.511 . . . . 2.02 112.246 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -50.55 -45.49 56.94 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.014 1.279 . . . . 4.74 110.88 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -70.98 -32.44 69.29 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.222 1.009 . . . . 4.36 113.361 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -72.06 -41.4 67.44 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.73 1.15 . . . . 2.19 113.789 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.33 -16.21 61.88 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.715 1.206 . . . . 1.28 112.388 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.12 46.17 9.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.847 2.459 . . . . 2.74 112.064 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.83 143.34 26.24 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.525 -0.734 . . . . 2.76 111.937 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -99.4 -0.42 40.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.173 0.989 . . . . 3.5 112.518 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 63.3 p -101.21 9.02 42.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.305 1.842 . . . . 4.49 114.701 -168.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -67.55 149.37 50.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.979 1.312 . . . . 2.09 112.78 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.44 168.26 19.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.399 1.476 . . . . 1.32 115.758 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 9.8 m -160.76 -49.97 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.123 -1.222 . . . . 1.87 113.516 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 53.6 t -136.29 142.68 43.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.503 1.521 . . . . 1.84 114.745 -168.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.2 mm -138.71 148.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 130.346 3.458 . . . . 3.34 109.317 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 19.2 t0 -131.93 98.38 4.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.964 1.706 . . . . 2.56 106.798 166.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.57 124.42 25.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.478 1.911 . . . . 5.49 114.544 -167.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.26 123.47 25.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.443 1.897 . . . . 2.32 108.213 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 7.4 p -129.47 149.06 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.023 1.86 . . . . 4.3 116.023 -166.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 52.8 t -128.41 102.79 20.41 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.098 1.359 . . . . 2.01 107.419 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -57.67 133.79 58.77 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.174 2.582 . . . . 1.94 113.821 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.11 11.38 70.43 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.813 1.197 . . . . 1.58 115.499 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 33.2 t -138.89 -41.73 0.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.655 1.227 . . . . 2.38 114.044 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 174.58 -177.86 46.57 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 115.661 1.024 . . . . 1.03 115.661 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.71 149.05 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 2.73 111.218 170.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.5 t -131.41 142.93 50.12 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.188 2.195 . . . . 1.07 109.137 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.1 p -153.84 165.68 35.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.929 1.085 . . . . 1.32 113.929 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -114.66 122.45 46.5 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.032 -1.099 . . . . 1.71 108.032 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 33.1 m -124.34 136.63 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.224 0.609 . . . . 3.33 112.294 -170.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.6 t -122.95 145.4 48.51 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.884 0.373 . . . . 2.07 111.037 166.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.545 0.778 0 C-N-CA 126.71 2.004 . . . . 3.36 107.184 158.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 113.78 1.03 . . . . 2.27 113.78 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -89.92 137.64 32.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.03 1.332 . . . . 4.71 109.457 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.87 119.75 31.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.015 0.926 . . . . 2.4 109.058 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.9 m -133.91 138.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 118.878 0.763 . . . . 0.92 112.342 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -144.92 154.66 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.113 0.965 . . . . 0.92 113.542 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.4 tt -149.49 139.29 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.837 1.655 . . . . 1.85 110.048 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 178.35 173.88 44.12 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.312 0.885 . . . . 1.8 115.312 -172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -57.65 -70.34 0.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.431 1.492 . . . . 3.81 114.68 -169.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 -72.77 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.725 1.379 . . . . 6.3 114.725 -177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.18 -31.48 70.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.527 1.512 . . . . 4.83 113.413 -168.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 15.3 t90 -68.25 -23.39 64.78 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.396 -1.44 . . . . 4.01 113.117 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 80.2 mmm -72.04 -40.65 68.23 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.789 0.836 . . . . 2.92 110.979 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.38 -64.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.252 1.421 . . . . 3.35 109.482 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -51.69 -9.64 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.908 2.483 . . . . 7.61 116.6 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.31 13.56 0.72 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 120.903 1.683 . . . . 1.02 111.106 167.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 71.31 33.66 64.43 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 119.475 -2.016 . . . . 1.07 114.001 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.25 172.91 6.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.947 1.299 . . . . 0.81 110.836 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.3 t -117.27 138.55 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.808 1.243 . . . . 1.56 110.28 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 17.7 tt -114.1 141.81 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.332 1.053 . . . . 1.99 112.148 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 11.0 p30 -103.2 158.7 16.14 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.242 1.417 . . . . 4.24 113.093 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -74.0 -21.96 59.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.248 1.203 . . . . 3.42 114.248 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.18 -39.92 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.714 -1.241 . . . . 2.91 112.161 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.6 p -70.32 -36.7 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.575 -0.703 . . . . 2.09 111.111 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.7 t30 -64.44 -38.37 90.79 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.884 0.765 . . . . 2.3 112.556 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -44.98 86.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.795 0.838 . . . . 2.12 112.864 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 29.5 t80 -71.34 -43.03 67.79 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.54 0.736 . . . . 3.8 112.393 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.3 tpp -56.84 -48.03 78.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.417 1.087 . . . . 1.66 111.58 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -74.15 -34.74 63.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.94 -0.552 . . . . 1.94 112.055 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.65 -45.33 85.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.115 1.325 . . . . 3.33 111.818 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -65.3 -47.2 77.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.143 0.977 . . . . 4.89 111.684 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.12 -34.61 76.68 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.332 -0.855 . . . . 4.15 111.967 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -69.84 -15.26 63.07 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.586 1.554 . . . . 4.42 113.78 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 63.1 mttt -73.58 -14.49 61.2 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 120.431 1.469 . . . . 4.87 112.059 165.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.98 10.36 58.75 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 126.59 2.043 . . . . 1.93 113.556 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -115.69 132.34 56.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.886 1.274 . . . . 5.55 111.343 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 99.6 m -59.61 128.25 36.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.619 1.341 . . . . 2.0 114.619 -168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.87 130.05 49.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.841 1.256 . . . . 1.36 111.777 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.8 m -140.9 154.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.345 1.458 . . . . 1.21 113.247 -174.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.58 159.32 15.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.174 0.989 . . . . 1.41 110.551 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.8 p -130.57 124.84 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.456 1.102 . . . . 3.19 112.54 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.27 152.31 37.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.921 1.688 . . . . 0.84 111.226 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.7 m -146.69 119.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.545 1.938 . . . . 1.41 112.008 -167.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 46.46 47.48 14.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.984 2.114 . . . . 3.37 113.215 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.321 34.0 m-20 63.38 26.77 15.1 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.228 2.611 . . . . 2.09 116.382 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -125.66 153.67 43.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.216 2.206 . . . . 3.19 110.824 167.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.6 mt -75.17 148.77 39.31 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.218 -1.551 . . . . 1.92 112.418 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.7 p -124.55 -36.94 2.56 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.08 0.771 . . . . 1.14 113.08 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.47 -166.07 29.68 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 119.268 0.94 . . . . 0.59 115.418 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.39 153.04 46.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.884 1.674 . . . . 1.01 111.743 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.4 mm -132.19 140.58 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.796 1.638 . . . . 2.44 108.864 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -130.84 132.06 44.97 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.974 0.91 . . . . 2.11 111.025 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.19 155.87 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.975 2.11 . . . . 2.57 110.099 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.856 0 C-N-CA 126.447 1.899 . . . . 2.43 112.945 170.612 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 113.079 0.77 . . . . 4.25 113.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.51 87.22 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.856 2.371 . . . . 2.45 110.035 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 47.0 t -65.9 109.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.38 1.072 . . . . 4.16 111.107 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.7 p -71.17 131.42 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.605 -0.685 . . . . 2.73 111.552 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -34.43 2.76 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.281 1.586 . . . . 2.96 115.281 -167.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -155.12 145.93 22.42 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.753 1.161 . . . . 2.92 111.666 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.9 m -127.74 133.78 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.072 0.949 . . . . 1.48 111.175 170.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 43.4 tttt -135.88 145.52 46.43 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.935 1.294 . . . . 2.47 112.539 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 96.4 t -89.52 134.15 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.226 1.81 . . . . 1.45 111.077 173.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.3 tp -95.4 -38.53 10.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.898 1.679 . . . . 1.32 110.984 170.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 52.1 m -121.89 111.96 17.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.272 1.429 . . . . 2.2 110.213 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -109.74 136.26 49.36 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.776 1.23 . . . . 3.63 112.854 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 57.93 -57.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 130.072 3.349 . . . . 4.22 118.82 169.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m120 -70.35 -6.28 34.21 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.603 2.075 . . . . 5.75 116.603 -166.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.05 -26.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.401 1.48 . . . . 9.91 114.304 168.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mt -144.96 142.38 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.589 1.156 . . . . 3.64 107.969 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.3 m -91.76 144.08 25.87 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.425 0.69 . . . . 3.17 111.489 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 27.9 p80 -57.31 -41.36 79.76 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.77 1.396 . . . . 4.41 114.77 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 27.1 t60 -74.18 -29.3 61.7 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.075 -1.016 . . . . 3.48 111.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.79 -37.5 84.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 117.493 -1.241 . . . . 6.47 111.7 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.77 -56.63 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.728 1.149 . . . . 2.07 110.309 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.46 -30.1 69.73 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.606 -0.684 . . . . 1.8 112.184 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.7 76.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.759 -0.639 . . . . 1.28 112.596 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 17.3 pt -68.81 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.676 1.58 . . . . 1.26 112.956 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 61.3 t -70.12 -50.77 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.512 1.051 . . . . 1.38 111.349 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.7 84.8 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.526 -0.733 . . . . 0.96 113.349 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 76.6 p -73.58 -35.62 65.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.692 -0.887 . . . . 1.89 112.041 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -71.21 -39.72 71.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.932 1.086 . . . . 1.53 113.932 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.34 -6.94 53.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.952 1.464 . . . . 3.49 114.952 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 84.7 p -58.68 -27.29 64.68 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.221 1.934 . . . . 3.23 116.221 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -95.58 -6.84 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.212 0.914 . . . . 2.44 113.201 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.1 t -79.77 162.03 25.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.562 1.145 . . . . 1.77 113.728 -174.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -112.64 -3.53 14.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.355 2.262 . . . . 4.35 114.097 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -59.66 144.14 85.57 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.087 -1.008 . . . . 2.11 112.282 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.29 -40.54 24.93 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.048 2.498 . . . . 1.88 112.286 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.85 -44.47 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.32 -0.862 . . . . 2.49 111.922 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.61 98.26 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.539 0.59 . . . . 2.05 113.162 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.2 p -64.32 -38.31 90.58 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.586 -0.95 . . . . 2.68 112.201 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.54 94.78 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.898 0.879 . . . . 2.37 112.843 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 54.4 mt -68.29 -42.32 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.087 0.555 . . . . 1.42 110.214 173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 96.7 m -54.43 -44.71 72.69 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.664 0.666 . . . . 1.99 111.514 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.4 tttt -60.13 -51.43 69.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.68 0.673 . . . . 3.21 111.955 174.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.37 -42.52 82.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.714 0.806 . . . . 4.1 111.77 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 69.1 m -70.82 -45.65 64.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.147 . . . . 2.99 112.696 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.98 -34.86 78.43 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.346 1.884 . . . . 3.47 111.371 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -65.08 -39.15 92.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.349 1.06 . . . . 4.84 112.941 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.79 -44.57 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.861 -1.15 . . . . 2.82 113.074 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.17 -3.1 18.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.848 1.425 . . . . 1.85 114.848 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 31.4 t70 58.64 26.22 14.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.627 1.171 . . . . 5.02 113.586 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.3 t -122.54 168.44 12.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.31 1.844 . . . . 2.58 112.047 -170.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.27 -15.0 15.6 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.994 1.717 . . . . 4.03 112.134 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.5 t -132.81 133.42 43.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.061 1.744 . . . . 3.32 111.194 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.98 147.61 25.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.246 0.618 . . . . 1.5 112.042 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 63.11 177.41 3.83 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.74 1.162 . . . . 1.59 115.08 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 70.7 m -138.47 -69.44 0.44 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.542 0.737 . . . . 1.97 111.414 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 48.9 t -136.11 141.4 44.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.197 0.599 . . . . 2.87 111.898 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.98 148.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.255 2.622 . . . . 3.96 111.714 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -110.72 124.34 51.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.909 -2.626 . . . . 3.3 103.909 163.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.1 OUTLIER -121.43 138.12 54.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.383 1.447 . . . . 4.49 112.889 -174.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.95 98.03 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.385 2.274 . . . . 3.54 108.329 -169.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.5 t -96.22 126.62 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.555 -0.715 . . . . 2.99 110.692 -168.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 33.1 t -143.32 113.88 5.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.751 1.62 . . . . 1.91 109.448 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.14 140.36 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.251 2.634 . . . . 2.09 113.925 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 55.4 35.68 61.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.6 1.095 . . . . 2.77 114.362 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 93.0 m -143.5 -32.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.784 1.234 . . . . 3.5 113.791 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 122.18 -164.26 15.31 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.075 1.321 . . . . 0.94 112.629 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.33 151.14 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.542 -1.563 . . . . 2.86 111.249 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 14.5 t -129.87 140.5 50.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.732 1.613 . . . . 2.05 109.859 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 13.5 p -143.97 156.93 44.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.469 1.032 . . . . 3.06 113.682 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -116.23 97.75 6.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.509 1.124 . . . . 2.36 108.735 -174.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.1 p -93.96 146.66 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.634 0.73 . . . . 3.27 111.426 -174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.6 t -142.95 162.02 36.57 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.135 1.532 . . . . 2.69 115.135 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 10.9 t-20 . . . . . 0 CA--C 1.546 0.811 1 C-N-CA 132.183 4.193 . . . . 3.13 109.914 162.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 117.837 2.532 . . . . 2.21 117.837 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -71.2 115.92 10.91 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.898 -1.126 . . . . 4.22 110.545 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -88.14 125.24 34.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.333 -1.358 . . . . 2.96 107.333 168.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.6 m -126.69 141.17 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.295 0.638 . . . . 1.36 110.369 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.5 150.76 47.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.988 0.915 . . . . 0.92 112.392 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.33 158.47 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.801 1.24 . . . . 1.71 109.938 -169.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 104.85 159.18 23.58 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.75 0.691 . . . . 1.74 114.783 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 49.53 -159.6 0.06 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.219 1.408 . . . . 2.49 113.617 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -58.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.777 1.399 . . . . 8.6 114.777 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -80.96 -37.76 28.84 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.152 0.887 . . . . 5.43 113.002 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 83.6 t90 -54.73 -36.44 64.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.927 1.291 . . . . 4.05 113.087 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.52 -36.36 80.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.665 1.186 . . . . 3.6 113.244 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.8 mt -62.37 -61.44 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.723 1.609 . . . . 4.26 109.134 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.4 -13.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.544 2.338 . . . . 7.63 116.268 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 6.0 t30 -74.28 22.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 121.694 2.043 . . . . 1.24 113.153 168.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.95 26.44 73.23 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.894 -1.753 . . . . 0.85 114.409 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 8.2 mt -96.44 147.7 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.052 1.426 . . . . 0.95 110.066 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 89.7 t -97.37 126.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.328 1.051 . . . . 2.36 110.385 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.0 148.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.977 0.911 . . . . 2.26 112.629 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.55 152.12 38.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.845 1.258 . . . . 2.77 113.583 -168.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -70.93 -28.02 64.2 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.462 1.282 . . . . 3.24 114.462 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.21 -36.64 69.24 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.761 -1.212 . . . . 2.57 112.494 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -78.0 -36.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.905 0.882 . . . . 1.31 113.286 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -54.0 -42.79 69.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.581 1.152 . . . . 3.12 112.517 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.42 -40.01 96.03 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.045 0.938 . . . . 1.91 113.086 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -39.03 75.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.687 1.195 . . . . 3.44 110.879 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.4 tpp -62.99 -53.29 56.31 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.509 1.124 . . . . 1.61 112.313 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 11.0 t -67.48 -32.07 72.64 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.665 -0.647 . . . . 1.88 112.485 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -57.43 -50.86 71.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.518 1.053 . . . . 3.18 112.023 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -71.72 -33.94 69.17 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.314 0.857 . . . . 2.96 113.314 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -68.21 -35.95 78.77 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.391 -0.818 . . . . 3.94 112.564 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.82 -22.04 61.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.845 1.658 . . . . 4.99 113.524 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 21.5 mttp -76.51 -7.66 55.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.883 1.273 . . . . 3.89 112.135 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.56 88.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.964 1.745 . . . . 2.35 115.094 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . 0.259 16.0 mtt-85 -84.19 -152.36 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 4.12 109.956 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 86.0 m -120.61 120.88 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 121.451 1.932 . . . . 1.82 112.112 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -117.06 127.59 54.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.902 2.081 . . . . 1.77 109.595 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 35.8 m -142.29 154.68 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 119.543 1.065 . . . . 0.95 113.483 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.32 164.0 12.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.185 1.394 . . . . 1.31 111.731 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.9 t -135.83 129.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.695 1.598 . . . . 3.12 111.168 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -134.43 153.01 52.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.166 1.386 . . . . 0.99 111.99 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 23.8 m -149.25 130.45 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.879 . . . . 1.77 112.899 -169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 35.7 m-20 41.89 40.67 1.62 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.262 1.825 . . . . 3.39 111.577 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 62.48 30.62 17.22 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 128.125 2.57 . . . . 2.11 116.787 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.14 135.16 54.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.735 2.014 . . . . 2.56 110.199 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.79 133.78 49.82 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.254 -1.529 . . . . 1.68 111.523 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -116.83 -42.24 2.98 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.725 1.009 . . . . 1.3 113.725 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.13 -176.47 39.74 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 119.215 0.916 . . . . 0.75 114.725 -172.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.03 155.05 44.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.865 1.666 . . . . 0.98 112.852 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.63 134.48 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.535 1.534 . . . . 2.0 110.266 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -112.93 131.86 55.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.246 1.418 . . . . 1.75 110.904 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -128.86 147.61 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.734 2.014 . . . . 2.63 108.789 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 114.128 1.158 . . . . 4.08 114.128 178.481 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 112.426 0.528 . . . . 3.75 112.426 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -95.04 156.75 1.74 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.198 3.265 . . . . 1.91 111.969 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 30.8 t -134.93 113.08 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.609 1.164 . . . . 3.44 109.588 173.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 5.8 p -73.06 132.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.777 1.171 . . . . 2.32 110.697 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -125.57 -36.17 2.47 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 117.415 2.376 . . . . 3.02 117.415 -164.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -156.42 150.84 25.55 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.737 1.608 . . . . 2.91 111.529 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -129.67 136.69 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.117 0.967 . . . . 1.49 111.375 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -140.8 147.83 39.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.107 0.963 . . . . 4.28 113.153 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 99.1 t -102.45 129.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.318 1.447 . . . . 1.52 112.233 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.65 -35.81 9.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.024 1.73 . . . . 1.54 112.673 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -111.01 88.66 2.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.634 1.574 . . . . 3.0 108.06 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.64 133.12 41.56 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.948 0.899 . . . . 3.59 111.701 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 13.8 m 59.18 25.68 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.226 2.211 . . . . 2.4 115.097 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.61 -6.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.047 1.499 . . . . 2.97 115.047 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -140.87 -77.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.891 1.277 . . . . 5.3 110.799 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 20.9 mt -137.47 147.57 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.111 2.165 . . . . 2.68 110.075 -174.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.5 m -91.68 152.48 20.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.595 1.558 . . . . 2.3 113.704 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 12.2 p80 -53.81 -42.12 68.05 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.781 2.141 . . . . 3.46 116.781 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -73.99 -23.1 59.41 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.073 -1.017 . . . . 4.03 111.73 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.2 tttt -75.77 -39.17 57.5 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.095 0.958 . . . . 4.97 111.474 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 66.3 mt -56.38 -52.2 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 119.459 1.027 . . . . 1.82 110.656 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.23 -33.34 75.53 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.588 -0.695 . . . . 1.56 112.072 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.02 75.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.722 0.638 . . . . 1.28 112.722 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.67 -34.56 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.763 -1.211 . . . . 1.93 113.381 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 73.5 t -70.64 -46.07 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.89 0.768 . . . . 2.14 110.972 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -63.98 -37.41 94.58 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.662 -0.649 . . . . 0.6 113.372 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 32.6 p -73.07 -37.26 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.917 0.887 . . . . 1.82 113.116 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.99 74.5 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.237 0.926 . . . . 0.81 112.247 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.57 -17.36 64.61 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.131 -0.981 . . . . 2.24 112.771 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 4.2 t -60.51 -35.35 75.75 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.927 -1.108 . . . . 1.92 112.077 170.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.88 -22.17 23.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.649 1.18 . . . . 2.05 113.319 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.6 t -74.33 -179.56 4.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.284 1.034 . . . . 1.64 111.8 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -137.3 19.61 2.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.645 1.578 . . . . 4.29 112.691 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -75.95 161.21 76.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.854 1.262 . . . . 2.36 112.617 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.02 -33.67 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.05 2.5 . . . . 1.18 114.108 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.81 -49.35 5.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.572 1.549 . . . . 1.73 112.722 -167.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.91 -31.62 81.42 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.003 0.335 . . . . 0.98 113.772 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.5 p -66.31 -16.34 63.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.746 -1.444 . . . . 2.77 113.915 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.39 80.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.73 -1.231 . . . . 1.48 110.737 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.91 -37.11 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.261 1.424 . . . . 1.52 110.417 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 97.7 m -53.82 -48.26 70.08 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.074 0.852 . . . . 1.9 111.863 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -64.0 -45.97 86.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.342 0.974 . . . . 4.67 112.553 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.7 t80 -55.92 -43.92 77.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.919 0.888 . . . . 2.75 111.457 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.7 t -65.85 -52.09 53.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.416 1.487 . . . . 3.47 111.864 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -51.51 -45.34 62.84 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.107 1.363 . . . . 4.14 112.204 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.54 -43.19 77.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.501 0.72 . . . . 3.59 111.559 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -62.19 -42.83 99.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.653 0.982 . . . . 2.69 113.653 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.4 mt -71.39 -13.24 61.79 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.825 0.85 . . . . 1.45 112.66 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 15.7 t70 50.61 54.91 10.35 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.293 1.837 . . . . 2.55 112.161 -169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.7 t -128.91 175.07 8.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.85 1.66 . . . . 3.09 111.841 -174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -115.69 -7.17 12.14 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.404 1.882 . . . . 2.79 112.402 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 10.0 t -140.04 127.26 21.14 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.402 -1.436 . . . . 3.39 113.819 -168.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -161.52 154.13 20.33 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.649 1.58 . . . . 1.42 113.609 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.74 132.03 0.6 Allowed Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.383 1.313 . . . . 1.32 116.383 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 87.9 m -120.07 -72.45 0.69 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.448 1.277 . . . . 1.66 114.448 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 52.6 t -138.99 142.5 38.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.786 1.234 . . . . 1.78 111.208 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.16 169.97 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 130.584 3.554 . . . . 3.05 108.577 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.27 150.05 40.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.739 1.616 . . . . 2.66 108.44 166.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -112.72 147.76 36.15 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.367 1.894 . . . . 5.82 115.468 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.21 95.24 2.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 129.55 3.14 . . . . 2.3 108.02 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 24.4 t -101.12 144.54 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.472 1.509 . . . . 2.83 111.657 -171.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 48.8 t -132.7 118.14 15.5 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.881 1.273 . . . . 1.66 109.381 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.36 133.26 48.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.252 2.635 . . . . 1.81 115.514 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 62.33 19.06 59.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.675 1.607 . . . . 1.97 114.372 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.8 t -136.93 -42.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.083 1.142 . . . . 3.42 114.083 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 154.79 -176.91 32.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.902 0.763 . . . . 0.91 113.756 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.22 146.67 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.001 0.92 . . . . 2.98 111.536 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 30.0 t -125.41 138.7 54.03 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.853 2.061 . . . . 1.05 110.909 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -145.49 165.97 27.05 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 115.176 1.547 . . . . 1.29 115.176 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -111.66 94.43 4.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.758 1.223 . . . . 2.41 108.367 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.8 p -101.96 130.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.215 1.007 . . . . 3.0 113.238 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.5 t -123.21 161.05 25.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.359 1.463 . . . . 1.88 113.607 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 129.103 2.961 . . . . 2.15 109.931 160.541 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 112.223 0.453 . . . . 3.03 112.223 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.78 121.85 44.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.125 0.97 . . . . 3.44 108.961 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.37 103.15 13.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.29 -1.004 . . . . 2.09 108.29 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -121.61 138.59 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.959 0.8 . . . . 2.0 112.006 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.31 152.52 41.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.851 0.86 . . . . 1.1 113.132 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -146.12 140.54 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.437 1.495 . . . . 1.98 109.501 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 169.7 -166.0 39.3 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.255 0.862 . . . . 1.56 115.255 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.268 10.4 p30 -84.7 173.19 10.91 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.86 1.264 . . . . 3.37 112.546 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -59.19 -10.12 2.61 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 117.276 2.324 . . . . 5.76 117.276 -165.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -71.48 -34.15 69.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.017 1.28 . . . . 5.11 111.921 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 50.2 m95 -65.42 -26.22 67.87 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.826 -1.171 . . . . 5.54 113.658 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -34.16 67.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.446 0.699 . . . . 3.17 111.359 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.87 -67.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.137 1.375 . . . . 3.69 107.805 169.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -38.54 -42.96 0.81 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.968 2.507 . . . . 6.45 115.451 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.15 1.75 56.07 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.759 1.763 . . . . 3.93 115.759 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 75.86 32.43 53.51 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.749 -1.22 . . . . 0.78 114.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.69 177.45 6.1 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.073 1.349 . . . . 0.83 110.987 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.8 t -121.54 132.67 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.09 1.356 . . . . 2.54 110.726 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.8 tt -108.29 134.38 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 2.48 110.599 171.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -106.22 162.74 13.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.234 1.014 . . . . 2.99 113.461 -168.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.03 -40.32 93.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 3.06 113.757 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.72 -34.15 66.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.542 0.737 . . . . 2.54 112.508 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 11.3 p -76.9 -32.97 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.338 0.655 . . . . 1.28 111.667 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.89 -46.1 88.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.588 0.755 . . . . 2.0 111.492 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.94 -33.54 74.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.881 1.272 . . . . 2.54 113.867 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.63 -42.16 52.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.799 1.639 . . . . 3.89 112.392 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.1 tpp -64.46 -50.65 66.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.232 1.413 . . . . 1.78 111.867 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 13.9 t -63.62 -33.12 74.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.427 0.691 . . . . 2.02 112.141 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -62.5 -48.99 77.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.98 0.912 . . . . 3.2 112.352 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.66 -0.65 . . . . 2.92 112.686 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.97 -40.14 87.4 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.904 -1.122 . . . . 2.97 112.323 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -71.22 -27.13 63.26 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.43 -1.419 . . . . 5.59 113.804 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 20.8 mttp -70.38 -2.7 14.47 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.648 1.579 . . . . 3.32 113.219 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.66 23.53 69.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.957 1.265 . . . . 1.31 113.593 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -101.17 -166.86 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.032 1.333 . . . . 3.68 111.043 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.8 m -115.22 121.75 43.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.553 1.541 . . . . 2.25 109.928 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -127.51 118.77 24.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.05 0.94 . . . . 1.86 110.413 -170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 29.1 m -139.29 153.44 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.114 0.965 . . . . 1.12 112.688 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.35 159.15 18.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.206 1.402 . . . . 2.07 111.509 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -128.73 125.93 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.151 1.38 . . . . 3.1 110.741 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.19 154.24 40.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.769 1.228 . . . . 1.86 111.636 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.8 m -148.09 123.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.732 2.013 . . . . 2.27 110.236 -168.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.263 6.7 m-20 40.23 54.91 2.79 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.547 1.939 . . . . 2.92 113.168 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.271 34.2 m-20 57.76 30.9 19.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.125 2.17 . . . . 1.65 115.954 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -134.88 151.67 51.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.914 1.286 . . . . 2.93 110.586 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.02 151.87 45.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.802 -1.811 . . . . 1.82 111.748 170.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -122.09 -44.81 2.27 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.594 -0.692 . . . . 1.22 111.208 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.64 -162.65 24.26 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.224 0.92 . . . . 0.82 115.0 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -140.74 154.25 46.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.591 1.556 . . . . 2.11 112.592 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 13.3 mm -123.94 127.52 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 1.9 109.096 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -97.22 133.0 42.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.684 1.194 . . . . 1.89 109.758 169.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 44.1 mt -140.11 159.85 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.798 2.039 . . . . 2.21 107.397 -170.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.531 0 O-C-N 120.164 -1.585 . . . . 2.02 111.943 174.043 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 119.345 -0.359 . . . . 3.46 111.126 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.59 154.75 18.24 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.734 2.956 . . . . 2.8 111.422 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 59.4 t -142.21 105.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.053 -1.092 . . . . 3.96 108.053 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -71.9 128.99 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.96 0.886 . . . . 2.02 111.396 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.66 -47.99 4.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.17 1.788 . . . . 3.05 112.936 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -153.79 146.9 24.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.589 0.756 . . . . 3.44 112.571 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.2 m -120.15 128.87 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.28 1.032 . . . . 2.32 110.179 167.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 48.2 tttt -134.12 144.37 48.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.662 0.785 . . . . 3.58 113.098 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 97.4 t -90.31 144.31 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.245 1.418 . . . . 1.29 112.407 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.9 -29.4 5.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.832 1.653 . . . . 1.98 112.551 169.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -127.59 123.8 36.57 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.006 1.323 . . . . 2.28 110.423 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.52 143.35 51.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.574 1.55 . . . . 3.88 110.151 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 42.2 m 63.49 -30.83 0.1 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.635 2.374 . . . . 3.4 116.803 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.56 -10.79 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.492 1.496 . . . . 3.85 114.76 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -160.5 -38.91 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.237 1.415 . . . . 6.57 112.299 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.96 167.85 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 126.984 2.114 . . . . 2.71 108.569 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.8 m -143.76 161.77 37.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.902 1.681 . . . . 2.44 111.32 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -42.32 -50.78 4.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.859 2.463 . . . . 5.2 115.225 -169.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -62.35 -38.32 89.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.672 0.669 . . . . 6.12 112.778 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 64.4 mttm -74.29 -39.74 62.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.526 0.73 . . . . 3.62 111.008 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.68 -52.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.987 0.915 . . . . 1.57 110.945 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.72 -31.21 70.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.513 -0.742 . . . . 2.14 112.249 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.67 -50.38 63.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.024 0.379 . . . . 1.71 112.024 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.2 pt -69.09 -35.95 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.915 -1.116 . . . . 0.99 113.086 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 64.7 t -71.24 -43.76 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.223 0.92 . . . . 1.79 111.512 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.53 -34.34 78.81 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.185 -0.947 . . . . 0.69 113.807 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 17.2 p -68.24 -43.23 78.35 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.63 -0.924 . . . . 1.35 111.691 171.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.26 76.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.083 0.856 . . . . 1.04 112.445 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -71.08 -17.26 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.99 -1.069 . . . . 2.32 113.605 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.1 p -72.38 -28.54 63.07 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.204 -1.56 . . . . 2.4 112.715 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 22.9 m120 -91.14 -22.71 20.54 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.44 1.496 . . . . 3.48 112.262 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.5 t -76.42 173.64 11.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.396 1.478 . . . . 1.64 113.72 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.38 15.11 5.56 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.85 2.06 . . . . 4.08 112.714 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -69.35 165.94 34.8 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.212 1.805 . . . . 3.07 113.991 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.51 -23.94 0.72 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.07 2.513 . . . . 1.6 114.395 -173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.6 tt -111.76 -48.77 3.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.934 2.094 . . . . 1.68 112.554 -167.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.5 -21.35 48.88 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.489 0.956 . . . . 1.03 115.489 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 63.4 p -66.73 -14.11 62.16 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.518 -1.578 . . . . 2.23 114.343 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.18 82.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.947 0.899 . . . . 1.9 111.285 167.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 12.9 mt -71.99 -36.31 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.243 1.417 . . . . 1.24 110.278 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 11.2 m -54.84 -48.29 73.04 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.907 0.776 . . . . 2.4 111.519 170.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -59.0 -49.22 78.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.819 0.736 . . . . 3.85 111.735 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.74 -44.8 82.03 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.485 1.114 . . . . 3.91 112.166 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.5 t -70.05 -50.6 39.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.988 0.915 . . . . 2.04 111.763 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -56.22 -38.82 71.57 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.782 -1.199 . . . . 3.9 112.378 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -70.05 -35.87 74.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.815 0.846 . . . . 3.34 112.633 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -70.17 -46.38 64.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 2.03 112.693 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.79 -30.0 62.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 1.27 113.473 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.52 45.5 26.86 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.569 1.547 . . . . 2.68 112.062 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.2 t -147.69 146.27 29.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.686 1.365 . . . . 2.61 114.686 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.95 19.81 19.94 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.081 1.352 . . . . 3.39 114.317 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 80.6 p -110.6 -6.2 14.91 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.946 -1.721 . . . . 5.07 114.138 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.3 148.77 48.1 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.02 1.328 . . . . 2.18 113.407 -172.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 72.97 137.23 0.27 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.131 1.824 . . . . 0.98 114.838 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 97.2 m -136.57 -41.16 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.955 1.302 . . . . 1.65 112.474 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 7.5 t -138.97 142.88 38.36 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.239 1.415 . . . . 3.11 114.139 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.9 mm -140.27 134.1 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 129.576 3.15 . . . . 3.25 108.206 168.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.323 0.0 OUTLIER -92.18 -14.7 28.66 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.996 1.48 . . . . 3.4 114.996 176.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 8.1 m-85 54.33 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 129.04 2.936 . . . . 4.33 117.631 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.98 93.08 2.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.456 1.902 . . . . 2.75 106.272 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 4.4 m -98.94 150.14 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.269 0.628 . . . . 4.08 110.965 -170.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 31.0 t -140.36 106.41 6.59 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.102 1.361 . . . . 1.35 109.6 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 149.9 75.8 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.188 2.592 . . . . 2.49 112.406 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.73 -18.31 1.4 Allowed Glycine 0 CA--C 1.538 1.472 0 O-C-N 121.057 -1.027 . . . . 1.53 114.75 -171.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.7 t -115.05 -72.93 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.064 1.345 . . . . 2.74 112.976 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 163.9 -153.15 23.4 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.312 0.96 . . . . 1.3 113.482 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.0 tt -144.06 148.48 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.075 0.95 . . . . 3.32 112.645 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.4 t -117.79 145.17 44.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.135 1.774 . . . . 1.19 109.381 164.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 25.9 p -164.57 164.93 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.535 0.939 . . . . 1.47 113.535 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -109.63 146.45 34.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 1.87 108.629 166.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 32.8 m -123.16 153.8 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.386 1.074 . . . . 3.36 110.808 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -146.08 157.93 43.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.086 0.954 . . . . 1.76 111.903 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 128.953 2.901 . . . . 2.57 107.97 158.392 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 117.888 2.551 . . . . 2.13 117.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.59 124.55 27.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.585 1.554 . . . . 4.05 110.92 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -88.75 122.74 32.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.555 1.142 . . . . 2.89 110.733 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -135.22 141.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.254 1.021 . . . . 1.97 112.265 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.27 145.44 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.402 1.081 . . . . 1.86 112.465 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.7 tt -144.43 145.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.859 1.264 . . . . 1.95 109.811 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 124.48 162.04 11.27 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.546 0.978 . . . . 1.66 115.546 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.47 -151.63 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.057 1.743 . . . . 2.42 113.368 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.94 -30.23 2.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 127.922 2.489 . . . . 7.11 112.059 168.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -66.07 -37.93 87.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.908 1.231 . . . . 4.19 112.798 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.1 -19.89 65.71 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.433 -1.417 . . . . 3.96 112.759 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 1.7 tpp -70.07 -30.13 67.3 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.384 -0.823 . . . . 3.16 111.351 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.15 -67.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.681 1.993 . . . . 2.96 108.093 166.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -48.47 -21.5 0.57 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 129.348 3.059 . . . . 6.67 115.786 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -93.22 12.9 22.84 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.63 1.344 . . . . 1.1 114.63 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.35 36.18 83.83 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 120.543 -1.348 . . . . 0.81 114.776 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.9 mt -100.61 172.07 7.32 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.589 1.155 . . . . 0.9 111.503 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 16.2 t -121.41 148.11 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.554 1.941 . . . . 3.02 110.625 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.02 155.1 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.393 1.077 . . . . 3.11 113.807 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -117.63 164.98 14.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.993 2.117 . . . . 2.95 113.567 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 58.6 t30 -66.78 -47.04 73.39 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.926 1.454 . . . . 5.41 114.926 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.35 -43.91 98.07 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.201 0.909 . . . . 3.64 111.34 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.9 p -72.18 -35.47 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.172 0.989 . . . . 2.1 112.647 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -68.25 -43.19 78.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.519 1.509 . . . . 2.44 111.723 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.94 -45.04 91.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.701 0.8 . . . . 1.94 111.325 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 35.8 t80 -64.62 -37.56 87.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.267 1.427 . . . . 3.29 112.777 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 28.8 tpp -66.32 -51.07 61.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.809 1.244 . . . . 1.62 111.303 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 14.9 t -66.52 -34.3 77.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.044 -0.503 . . . . 1.95 111.499 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.65 -47.22 86.47 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.529 1.059 . . . . 4.38 113.126 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -70.86 -35.22 72.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.591 0.96 . . . . 2.9 113.591 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.26 -42.32 96.54 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.367 0.985 . . . . 2.96 112.439 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -70.14 -25.99 63.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.667 1.587 . . . . 5.84 113.583 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -81.22 8.22 9.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.929 1.085 . . . . 3.98 113.929 167.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 91.07 -5.43 81.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.175 2.321 . . . . 1.72 116.153 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.63 162.41 14.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 4.43 111.603 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 18.7 m -76.03 119.24 19.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.792 0.837 . . . . 1.81 110.234 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -119.37 115.86 24.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 1.19 109.638 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.89 157.51 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.323 1.049 . . . . 1.21 113.224 -170.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -112.77 162.77 15.38 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.418 1.087 . . . . 1.99 113.214 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 2.8 p -132.37 122.89 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.367 1.467 . . . . 3.45 112.042 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -113.95 152.61 30.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.54 1.936 . . . . 0.99 110.941 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 21.2 m -149.05 120.24 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.646 1.179 . . . . 2.41 111.118 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 20.4 t70 41.75 52.13 4.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.469 1.508 . . . . 3.3 112.683 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.258 6.6 m-20 65.38 22.87 12.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.88 2.178 . . . . 1.44 116.88 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -129.13 151.5 49.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.455 1.502 . . . . 2.78 110.774 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 145.42 48.4 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.757 -1.215 . . . . 2.02 111.965 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -122.61 -35.4 3.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.829 1.048 . . . . 1.27 113.829 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.82 36.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.114 0.87 . . . . 0.51 115.012 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.71 155.28 44.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.679 1.592 . . . . 1.92 112.943 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.83 136.22 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.388 1.475 . . . . 1.95 109.593 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -106.02 130.5 53.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.922 1.289 . . . . 1.98 109.554 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.85 130.72 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 2.34 108.162 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 114.337 1.236 . . . . 3.08 114.337 -175.385 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.008 -0.52 . . . . 3.23 109.952 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.39 146.02 73.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.631 2.221 . . . . 1.82 112.02 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.0 p -133.16 126.61 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.471 1.508 . . . . 3.88 108.276 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.4 p -71.0 123.98 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.667 -1.27 . . . . 2.64 109.239 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -96.49 -41.63 8.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.985 1.314 . . . . 4.52 112.547 -167.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -159.28 156.82 29.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.16 1.384 . . . . 2.92 110.99 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 6.5 m -131.23 143.89 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 1.38 110.587 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 50.6 tttt -129.33 140.74 51.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.91 1.284 . . . . 2.83 110.753 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 47.4 t -77.86 142.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.653 -0.869 . . . . 1.58 108.653 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.45 -38.96 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.862 1.265 . . . . 1.74 111.376 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 74.2 m -100.45 92.37 5.12 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 106.447 -1.686 . . . . 2.97 106.447 168.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.26 123.12 33.78 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.636 -0.665 . . . . 4.44 111.901 -170.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 40.6 m 51.54 39.23 24.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.422 1.638 . . . . 2.91 115.422 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -141.53 -8.15 0.98 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.685 1.735 . . . . 3.48 115.685 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -144.97 -65.45 0.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.573 1.533 . . . . 5.26 112.613 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.3 142.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.922 2.089 . . . . 2.48 110.063 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 47.4 m -98.95 152.88 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 2.21 113.283 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -38.49 51.76 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.515 2.043 . . . . 5.07 116.515 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.1 t60 -68.95 -34.07 74.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.52 1.054 . . . . 3.39 111.729 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.75 -36.51 65.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.17 -0.919 . . . . 3.09 112.004 173.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.08 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.27 0.941 . . . . 1.92 110.729 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -69.68 -32.54 71.23 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.3 -0.875 . . . . 1.88 112.209 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -62.29 -50.7 70.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.259 0.624 . . . . 1.18 112.114 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.85 -36.45 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.514 1.052 . . . . 0.99 113.189 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 70.7 t -70.42 -44.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 118.893 0.77 . . . . 1.63 111.057 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.86 95.85 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.29 -0.881 . . . . 0.72 113.431 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.3 p -75.14 -30.01 60.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.0 0.92 . . . . 2.02 113.382 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.53 66.18 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.91 0.777 . . . . 0.85 111.715 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.87 -18.74 65.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.463 0.912 . . . . 2.13 113.463 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 13.6 t -58.12 -22.31 50.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.945 1.298 . . . . 2.23 114.263 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -103.74 -2.3 26.66 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.882 1.273 . . . . 1.9 113.978 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 16.0 t -86.23 171.76 11.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 1.95 113.804 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -3.65 14.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.161 1.784 . . . . 5.95 113.746 170.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 153.09 93.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.694 1.197 . . . . 3.24 113.878 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -39.83 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.197 2.598 . . . . 1.13 113.455 -173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.51 -51.35 5.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.303 0.853 . . . . 1.73 113.303 -166.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -65.93 -28.34 73.57 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 114.555 0.582 . . . . 0.97 114.555 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 27.3 p -66.27 -13.06 59.84 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.856 -1.379 . . . . 2.71 113.933 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.21 67.91 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.93 -1.106 . . . . 1.97 111.032 167.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 16.6 mt -69.85 -35.17 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.622 1.169 . . . . 1.49 109.973 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 88.3 m -54.71 -50.32 68.6 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.705 -0.622 . . . . 1.9 111.677 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 69.8 tttt -61.14 -46.31 91.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.68 -0.676 . . . . 2.61 111.875 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 30.9 t80 -55.33 -45.66 76.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.876 0.87 . . . . 2.96 112.547 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 53.7 t -63.35 -54.63 33.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.465 1.106 . . . . 2.55 111.76 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -40.64 67.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.798 1.239 . . . . 4.41 112.437 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -73.18 -34.9 66.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.717 1.607 . . . . 4.12 113.888 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.97 -43.44 87.84 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.647 -1.283 . . . . 2.36 111.32 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.3 0.23 10.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.013 1.325 . . . . 2.23 113.765 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 29.0 t70 46.89 43.41 13.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.473 1.909 . . . . 2.7 113.17 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.9 t -132.83 -175.21 3.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.086 0.954 . . . . 3.67 113.148 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -123.58 -4.58 8.22 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.721 2.008 . . . . 3.5 112.182 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.1 t -151.47 144.95 24.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.358 1.863 . . . . 3.97 112.373 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.25 167.62 23.68 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.849 2.46 . . . . 2.16 110.761 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 67.25 168.89 3.81 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.839 1.496 . . . . 1.12 116.839 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.2 m -149.09 -54.58 0.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.228 1.411 . . . . 1.97 113.495 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 16.6 t -134.65 143.35 47.22 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.494 1.517 . . . . 2.73 112.15 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 11.2 tp -139.56 149.04 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.261 3.425 . . . . 3.23 107.658 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -141.62 66.29 1.36 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.428 1.091 . . . . 4.3 109.279 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.62 149.4 26.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.132 1.901 . . . . 3.61 116.132 -168.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -114.34 113.35 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.85 2.06 . . . . 2.49 107.717 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 90.1 t -98.19 124.03 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.024 1.33 . . . . 3.16 110.777 -169.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 56.4 t -139.51 98.08 8.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.816 1.647 . . . . 2.77 106.899 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -59.28 130.55 36.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.728 2.286 . . . . 2.66 113.519 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 74.61 26.99 66.16 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.308 -0.718 . . . . 1.84 114.801 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.8 t -135.44 -43.47 0.69 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.811 1.306 . . . . 2.21 113.745 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 151.36 -161.47 29.17 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.893 -1.13 . . . . 1.02 113.919 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 mm -140.14 145.77 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.811 1.644 . . . . 3.61 110.226 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 47.3 t -133.43 136.35 45.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.266 1.026 . . . . 1.16 109.368 165.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.8 p -154.15 168.89 25.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.742 1.016 . . . . 1.38 113.742 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -109.88 141.44 42.59 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.386 -1.709 . . . . 1.66 106.386 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 4.7 p -143.11 138.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.335 0.97 . . . . 3.07 112.827 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.4 157.73 45.65 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.698 0.761 . . . . 2.6 112.542 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 128.678 2.791 . . . . 3.27 108.895 162.694 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 113.473 0.916 . . . . 2.97 113.473 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.57 123.79 12.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.743 1.217 . . . . 4.08 110.55 -168.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.9 116.25 28.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.106 0.962 . . . . 3.19 108.624 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.8 m -135.4 141.6 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.127 0.876 . . . . 0.98 112.823 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.35 152.35 40.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.823 1.045 . . . . 0.95 113.823 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -152.13 135.91 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.967 1.707 . . . . 1.84 110.077 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 162.79 -151.68 21.57 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.962 1.545 . . . . 1.34 116.962 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.42 150.63 3.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.333 2.653 . . . . 2.67 112.912 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -61.6 -33.37 73.78 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.504 0.927 . . . . 5.68 113.504 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.98 -31.44 69.91 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.776 1.171 . . . . 4.23 113.082 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -69.3 -19.79 63.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.382 -1.449 . . . . 4.32 112.935 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.4 mmt -67.66 -30.73 70.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.092 -1.005 . . . . 2.57 111.42 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.7 mt -71.43 -65.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.108 1.763 . . . . 3.17 109.28 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.17 -32.86 4.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.798 2.039 . . . . 5.87 115.702 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.99 12.53 6.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.509 1.05 . . . . 1.16 113.828 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.62 31.6 58.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.377 -1.452 . . . . 1.18 115.289 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.33 -161.73 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.914 1.286 . . . . 1.64 110.891 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 21.8 t -136.8 136.39 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.192 1.797 . . . . 2.63 110.202 170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.1 tt -125.93 138.63 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.764 1.226 . . . . 2.27 111.485 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.39 168.52 12.91 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.825 1.787 . . . . 3.69 115.825 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.27 -25.33 61.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.841 1.656 . . . . 2.98 115.372 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.51 -40.89 41.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.089 1.313 . . . . 2.7 113.302 -176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -73.61 -33.71 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.481 0.582 . . . . 1.41 111.41 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -56.94 -43.35 81.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.001 0.92 . . . . 2.31 112.081 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.48 -49.93 75.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.169 0.987 . . . . 2.6 113.506 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 33.2 t80 -70.25 -36.61 74.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 3.31 112.258 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -61.19 -60.79 3.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.141 1.776 . . . . 1.59 110.792 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.1 t -66.27 -31.47 72.29 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.896 -0.503 . . . . 2.13 112.244 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -59.99 -49.93 75.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.191 0.997 . . . . 2.74 112.052 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -68.73 -30.88 69.61 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.764 -0.585 . . . . 3.32 112.136 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -65.29 -42.29 93.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.308 1.043 . . . . 2.84 112.769 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -66.81 -30.17 70.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 120.855 -1.153 . . . . 3.88 113.567 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 19.2 mttp -70.52 -2.93 15.58 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.556 1.942 . . . . 3.37 113.566 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 90.63 20.73 39.53 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.0 1.285 . . . . 2.25 115.162 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.08 148.58 33.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.749 1.62 . . . . 4.79 110.616 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 94.1 m -78.34 137.64 38.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.049 1.34 . . . . 1.88 111.063 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -139.22 124.79 19.4 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.096 0.776 . . . . 1.34 113.096 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.69 159.11 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.536 1.534 . . . . 1.15 113.18 -171.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.64 160.14 16.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.687 1.195 . . . . 2.0 112.574 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.5 t -130.86 122.95 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.078 1.751 . . . . 2.92 111.608 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.93 151.78 39.29 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.446 1.499 . . . . 1.0 110.621 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.5 m -143.33 118.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.162 1.385 . . . . 1.91 112.254 -170.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 30.7 t0 42.07 50.08 4.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.848 2.459 . . . . 3.21 112.942 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.301 2.2 m-20 62.7 38.44 11.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.637 2.375 . . . . 2.33 116.182 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -143.33 147.86 35.39 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.285 1.434 . . . . 3.83 109.861 167.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.76 151.52 43.47 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.276 -1.515 . . . . 2.26 113.267 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 31.3 p -130.51 -47.82 1.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.412 1.264 . . . . 1.36 114.412 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.97 -175.56 36.5 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 120.662 1.574 . . . . 0.55 115.884 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.47 155.15 44.28 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.36 1.464 . . . . 1.05 113.231 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.91 135.09 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.905 1.682 . . . . 2.2 109.955 -172.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -115.05 133.29 56.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.515 1.526 . . . . 1.78 109.859 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.05 143.17 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.814 2.045 . . . . 2.46 110.285 -169.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 126.128 1.771 . . . . 2.05 111.343 177.476 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 112.197 0.443 . . . . 4.9 112.197 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.47 138.78 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.968 2.445 . . . . 2.05 112.062 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 14.5 p -144.25 123.06 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.002 0.921 . . . . 3.19 111.945 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.6 p -72.53 139.58 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.512 -1.368 . . . . 1.95 111.138 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.36 -41.16 1.91 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.333 1.975 . . . . 3.25 116.333 -165.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -150.64 154.85 38.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.392 1.477 . . . . 3.32 110.967 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.7 m -134.91 136.05 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.185 0.994 . . . . 1.13 111.153 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.9 tttt -141.02 140.12 34.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.331 1.234 . . . . 2.6 114.331 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 41.2 t -85.6 143.66 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.251 1.42 . . . . 1.96 110.224 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 31.1 tp -114.76 -25.07 8.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.04 1.736 . . . . 2.29 113.275 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 93.0 m -126.03 67.22 1.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.474 1.509 . . . . 2.56 111.23 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.19 130.33 38.07 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.733 -1.229 . . . . 3.85 112.438 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 23.2 m 64.03 -18.62 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.608 2.077 . . . . 2.56 116.608 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 30.7 m120 -87.05 -15.99 36.97 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.787 1.176 . . . . 3.69 113.646 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 -95.66 0.14 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.388 1.075 . . . . 6.03 110.48 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.38 133.16 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.474 1.51 . . . . 2.78 111.141 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 66.7 m -98.17 164.24 12.41 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.642 1.577 . . . . 2.49 113.291 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -43.04 -56.01 3.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.513 1.925 . . . . 5.21 116.103 -169.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 47.7 m170 -64.74 -30.82 71.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.969 0.804 . . . . 5.14 112.702 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 44.6 mttp -77.56 -38.14 49.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 118.123 -0.942 . . . . 3.36 111.97 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.05 -52.48 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.488 1.04 . . . . 1.83 110.844 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.76 -28.15 66.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.673 -0.642 . . . . 1.69 112.427 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.2 -47.89 59.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.828 -0.605 . . . . 1.88 112.598 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.6 pt -69.62 -32.62 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.53 1.514 . . . . 1.04 112.901 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.2 t -70.88 -45.58 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.813 0.733 . . . . 2.19 111.376 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -69.17 -36.26 79.41 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.975 -1.078 . . . . 0.71 114.009 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 35.8 p -69.15 -34.38 74.89 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.413 -1.051 . . . . 1.7 111.794 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.2 91.21 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.765 0.711 . . . . 0.89 112.56 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.16 -21.97 62.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.956 1.095 . . . . 3.75 113.956 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.0 t -55.88 -42.13 75.45 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.863 -1.148 . . . . 2.24 112.258 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.54 -23.1 40.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.567 0.951 . . . . 2.19 113.567 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 27.0 m -89.47 160.61 16.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.057 1.132 . . . . 3.54 114.057 -167.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -122.73 18.71 10.29 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.668 1.587 . . . . 5.39 113.225 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 143.29 91.56 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.753 1.221 . . . . 2.05 112.132 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.55 -45.52 1.14 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.316 2.677 . . . . 1.44 114.356 -169.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.37 -34.23 72.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.297 -0.877 . . . . 2.06 111.069 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -61.16 -20.33 58.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.135 1.35 . . . . 1.81 115.545 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 66.7 p -59.49 -37.98 79.68 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.019 1.409 . . . . 3.96 112.184 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.55 -36.39 80.87 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.49 -0.756 . . . . 1.96 112.407 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.8 mt -70.78 -36.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.054 -1.029 . . . . 2.04 111.023 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.3 m -55.14 -51.79 65.34 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.168 0.987 . . . . 2.76 110.438 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.5 tttt -54.44 -55.23 30.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.181 0.992 . . . . 4.46 111.574 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -57.72 -45.85 85.22 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.321 0.648 . . . . 2.92 112.636 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 37.3 t -66.82 -54.15 25.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.243 0.617 . . . . 2.07 111.4 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -43.07 75.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.238 1.015 . . . . 4.23 110.756 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.34 -44.54 87.42 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.972 0.73 . . . . 3.86 112.972 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -67.11 -38.7 86.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.535 1.062 . . . . 2.79 113.303 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.35 -19.87 60.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.621 1.168 . . . . 1.41 113.107 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 8.8 t70 64.47 15.66 9.71 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.593 2.357 . . . . 3.31 114.221 -170.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 2.6 t -130.52 147.1 52.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.816 1.646 . . . . 3.12 115.249 -169.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.11 -12.67 43.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.559 1.144 . . . . 3.51 111.858 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 35.6 p -73.43 26.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.397 1.999 . . . . 5.53 116.397 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.74 29.07 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.532 1.533 . . . . 1.85 114.659 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 78.24 145.07 2.55 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.656 1.598 . . . . 1.11 116.989 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -141.42 -63.34 0.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.964 1.705 . . . . 2.06 113.392 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 41.4 t -136.54 141.51 43.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.181 1.355 . . . . 1.58 112.443 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.1 mm -141.93 140.19 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 132.18 4.192 . . . . 2.98 109.389 -170.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.8 t0 -111.72 104.17 12.5 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.905 -1.887 . . . . 2.57 105.905 165.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 32.9 t80 -88.54 133.15 34.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.931 1.292 . . . . 4.79 114.436 -165.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.34 120.7 14.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.304 1.842 . . . . 2.11 110.993 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 44.3 t -104.34 140.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.97 1.308 . . . . 3.07 111.68 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 51.7 t -126.33 111.94 23.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.029 0.932 . . . . 1.89 109.188 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.19 143.08 93.93 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.313 2.675 . . . . 2.33 113.634 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.38 15.15 65.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.947 1.26 . . . . 2.22 113.696 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 73.4 m -134.34 -87.32 0.39 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.86 1.664 . . . . 2.38 111.39 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 172.99 -151.37 13.78 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.937 0.779 . . . . 1.3 112.455 -172.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.26 146.32 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.265 1.026 . . . . 3.02 111.893 -173.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.8 t -134.24 144.18 48.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.857 1.663 . . . . 1.04 111.259 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.8 p -158.04 172.38 18.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.549 1.685 . . . . 1.22 115.549 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -114.64 120.81 41.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.252 1.421 . . . . 2.23 107.453 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 12.0 p -128.76 134.52 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 115.033 1.494 . . . . 2.89 115.033 -167.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -133.81 161.34 35.01 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 123.242 1.496 . . . . 2.09 114.276 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 130.233 3.413 . . . . 2.6 108.289 160.354 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.459 0.647 . . . . 3.51 109.788 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.54 133.38 53.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.937 1.695 . . . . 3.68 110.781 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.13 116.19 27.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.798 0.726 . . . . 2.4 111.767 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.7 m -137.47 144.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.083 0.953 . . . . 1.05 113.067 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.08 152.54 46.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.844 1.258 . . . . 1.1 113.492 171.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.3 tt -149.18 139.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.432 1.493 . . . . 1.88 110.352 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 131.18 150.16 6.66 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.156 0.884 . . . . 1.64 115.09 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 49.29 -155.98 0.09 Allowed 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 126.103 1.761 . . . . 2.34 113.931 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -140.08 -37.46 0.47 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.47 2.396 . . . . 7.29 117.47 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.33 -30.67 69.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.568 1.531 . . . . 3.99 110.703 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -55.45 -34.32 64.38 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.192 -0.942 . . . . 3.91 113.465 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -35.03 77.78 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.745 1.017 . . . . 2.86 113.745 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.68 -60.39 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.986 -1.116 . . . . 2.97 107.986 168.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.19 -27.04 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.835 2.054 . . . . 7.29 115.687 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.85 16.07 1.25 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.892 1.678 . . . . 1.37 112.498 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.73 16.05 67.42 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 119.797 -1.814 . . . . 1.22 116.07 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.59 174.23 10.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.393 1.597 . . . . 0.94 111.911 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.2 t -115.8 130.98 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.664 1.186 . . . . 1.82 109.309 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.69 127.77 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.867 1.267 . . . . 2.38 110.011 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . 0.253 8.9 p30 -89.41 158.3 17.8 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.99 1.107 . . . . 3.84 113.99 -176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 64.6 t30 -62.6 -23.71 67.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.954 1.302 . . . . 3.42 114.344 -170.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.21 -43.37 42.65 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.708 -1.245 . . . . 3.8 112.907 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 3.3 p -75.6 -31.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 125.303 1.441 . . . . 1.3 110.985 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -52.87 -50.59 63.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.987 1.267 . . . . 3.82 111.213 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.32 -44.93 80.43 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.206 0.447 . . . . 2.17 112.206 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.7 t80 -71.57 -36.01 70.78 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.62 0.97 . . . . 3.56 113.62 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.7 tpp -63.22 -50.92 68.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.201 1.401 . . . . 1.88 111.077 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.2 t -69.93 -33.25 71.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.012 -0.43 . . . . 1.77 111.718 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.66 -46.8 87.96 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.731 -1.231 . . . . 4.12 112.889 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -71.16 -37.03 72.22 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.249 1.203 . . . . 2.77 114.249 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -62.28 -37.46 85.59 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.108 -0.995 . . . . 3.69 112.21 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -72.73 -24.33 60.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.31 1.844 . . . . 4.41 114.961 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 77.6 mttt -66.39 -6.85 15.83 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.627 1.171 . . . . 4.32 114.128 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.64 19.98 35.93 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.854 1.692 . . . . 1.35 113.092 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -118.67 178.36 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.531 1.532 . . . . 3.99 111.994 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 3.4 m -100.4 120.97 40.78 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.771 1.629 . . . . 2.32 110.246 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -116.84 119.65 36.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.014 1.325 . . . . 1.33 110.098 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.2 m -136.34 153.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.431 0.9 . . . . 1.02 113.431 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.17 166.01 10.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.133 0.973 . . . . 1.07 112.794 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 11.6 t -131.71 125.86 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.003 2.121 . . . . 2.82 110.026 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -130.13 156.64 44.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.612 1.165 . . . . 0.86 111.81 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.3 m -144.74 120.11 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.839 1.655 . . . . 2.67 111.689 -169.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 23.3 t70 44.65 47.28 8.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.109 1.364 . . . . 4.15 113.316 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 60.79 42.15 13.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.039 -1.663 . . . . 1.99 115.023 -174.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.93 141.52 30.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.686 1.595 . . . . 2.19 110.561 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.71 137.44 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.108 -1.62 . . . . 1.78 112.852 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.0 p -115.01 -40.96 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.097 0.959 . . . . 2.12 112.719 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -168.13 -174.02 36.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.656 1.116 . . . . 0.61 115.384 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.37 155.71 43.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.402 1.881 . . . . 1.03 112.702 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.9 mm -129.76 140.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.382 1.473 . . . . 1.96 110.526 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -113.07 130.12 56.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.094 1.758 . . . . 1.67 110.36 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.14 157.7 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.846 2.059 . . . . 2.4 109.598 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 126.268 1.827 . . . . 1.74 111.956 177.034 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 112.631 0.604 . . . . 3.77 112.631 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.92 130.02 24.82 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.691 2.928 . . . . 1.82 112.961 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 96.7 t -105.5 124.22 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.187 1.795 . . . . 3.68 109.648 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.4 121.68 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.046 0.839 . . . . 2.27 110.915 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.26 -47.69 3.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.502 0.721 . . . . 4.49 112.82 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -151.49 149.25 29.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.79 1.636 . . . . 4.0 111.713 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 12.3 m -125.52 139.78 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.178 0.991 . . . . 1.21 110.402 168.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.1 tttt -141.99 148.48 38.62 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.048 0.759 . . . . 3.48 113.048 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 73.9 t -106.61 145.01 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.191 1.397 . . . . 1.8 111.31 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.95 -25.04 10.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.559 1.544 . . . . 1.4 113.44 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 9.9 t -93.94 162.09 14.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.824 2.05 . . . . 3.93 112.813 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -146.46 116.02 7.15 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.619 -1.301 . . . . 5.36 110.32 167.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 63.4 m 51.67 33.75 11.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.525 2.046 . . . . 4.11 116.525 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 28.2 m120 -126.97 -30.89 2.67 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.463 1.283 . . . . 4.68 114.463 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 113.52 2.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.713 1.605 . . . . 6.98 108.649 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.3 mm 66.17 133.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 127.55 2.34 . . . . 3.3 114.725 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 67.0 m -81.5 151.11 27.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.985 1.314 . . . . 3.29 113.099 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 61.9 m80 -53.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.598 1.703 . . . . 8.25 115.598 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 43.3 t60 -74.96 -29.45 60.92 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.726 -1.234 . . . . 3.24 111.695 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.47 -36.69 81.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.84 -1.163 . . . . 3.47 111.804 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 98.0 mt -56.62 -53.86 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.117 . . . . 2.09 109.668 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.7 76.53 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.238 0.926 . . . . 1.66 112.367 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.58 -46.17 76.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.105 0.779 . . . . 1.41 113.105 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.71 -35.39 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.232 1.378 . . . . 1.01 112.815 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 59.8 t -70.52 -46.61 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.754 0.706 . . . . 1.5 111.381 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.53 91.45 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.43 -0.794 . . . . 0.75 113.642 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.3 p -73.95 -34.31 64.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.181 0.808 . . . . 1.62 113.181 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.35 90.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.434 0.901 . . . . 0.92 113.434 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.31 -11.73 60.83 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.673 0.99 . . . . 2.07 113.673 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.5 t -62.47 -19.21 63.32 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.587 -1.321 . . . . 1.84 113.6 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -107.43 0.25 22.76 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.203 1.401 . . . . 1.96 113.379 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 69.4 m -101.28 167.46 10.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.271 1.211 . . . . 2.19 114.271 -169.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.83 54.72 1.21 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.312 1.845 . . . . 3.66 111.572 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.03 69.09 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.52 1.528 . . . . 3.18 112.66 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.33 -17.22 9.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.961 3.107 . . . . 1.0 116.285 -167.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.82 -50.91 2.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.575 0.954 . . . . 1.59 113.575 -166.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.61 67.4 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-O 121.531 0.517 . . . . 1.05 113.557 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 32.0 p -63.68 -22.76 67.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.114 1.366 . . . . 2.76 113.337 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.22 69.1 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.701 -1.25 . . . . 1.48 111.702 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.68 -35.75 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.973 0.909 . . . . 1.89 110.077 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 34.3 m -57.1 -48.08 79.47 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.247 0.93 . . . . 1.95 110.93 168.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -54.81 -51.32 66.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.303 1.041 . . . . 5.13 112.036 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.01 -44.39 91.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.331 1.052 . . . . 2.81 111.496 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 48.9 t -65.93 -49.7 67.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.266 1.026 . . . . 2.47 111.93 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.88 -33.04 74.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 3.76 111.446 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.8 -41.12 72.04 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.784 1.234 . . . . 4.13 113.524 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -69.61 -40.49 76.57 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.944 1.247 . . . . 2.0 113.359 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.07 -20.22 61.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.673 1.189 . . . . 1.39 113.351 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.2 t0 54.14 42.36 31.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.687 1.195 . . . . 2.34 112.498 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.1 t -125.85 165.97 17.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.261 1.824 . . . . 2.63 111.086 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -100.01 -11.13 20.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.942 1.297 . . . . 3.12 113.885 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 9.9 t -148.15 135.12 20.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.843 1.257 . . . . 3.75 111.551 -172.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -158.22 149.48 21.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.764 1.226 . . . . 1.54 112.476 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 69.88 142.94 0.18 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.032 1.301 . . . . 1.03 115.244 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 19.0 m -112.01 -80.03 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.653 1.581 . . . . 2.39 112.125 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 44.5 t -135.39 136.75 41.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.92 1.288 . . . . 2.35 111.279 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.4 mp -141.09 149.78 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.275 3.83 . . . . 4.04 107.056 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 31.5 t70 -137.03 109.01 7.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.896 1.278 . . . . 3.34 109.348 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -97.35 135.07 39.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.198 1.925 . . . . 4.43 116.198 -171.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.1 26.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.637 2.775 . . . . 3.05 107.12 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.4 m -112.49 142.57 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 115.092 1.515 . . . . 3.5 115.092 -167.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.77 131.23 14.63 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.321 1.449 . . . . 2.66 109.39 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.4 130.88 21.96 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.784 2.322 . . . . 2.59 111.862 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.74 -41.53 0.69 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.722 2.106 . . . . 2.2 115.148 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -78.75 10.97 2.85 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.636 2.087 . . . . 2.76 116.636 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 85.98 171.79 48.23 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 119.093 0.86 . . . . 1.28 113.249 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.4 pt -136.12 165.51 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.665 1.186 . . . . 4.18 111.868 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.2 t -127.14 152.37 47.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.333 1.053 . . . . 1.9 112.112 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 23.1 p -144.35 169.68 17.46 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.028 -1.045 . . . . 2.78 113.258 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -118.51 119.94 36.05 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.578 -1.267 . . . . 2.09 107.578 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.1 p -127.09 136.78 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.846 1.054 . . . . 3.01 113.846 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 5.3 t -119.76 150.11 40.93 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.445 0.906 . . . . 1.78 113.445 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 . . . . . 0 CA--C 1.551 1.011 0 C-N-CA 128.459 2.704 . . . . 2.68 108.463 158.601 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 111.909 0.337 . . . . 2.11 111.909 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -131.03 129.96 42.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.808 1.643 . . . . 4.33 112.12 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -88.42 123.51 33.04 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.595 -0.891 . . . . 2.32 108.595 167.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.6 m -131.67 154.95 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.232 1.013 . . . . 1.24 111.514 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.45 152.06 32.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.076 0.951 . . . . 1.02 112.807 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.9 tt -153.85 153.07 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.048 1.339 . . . . 2.19 110.673 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 103.03 154.55 24.64 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.98 0.767 . . . . 1.92 114.281 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.9 t-20 54.08 -161.52 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.178 1.791 . . . . 2.4 113.248 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -27.95 3.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.594 1.558 . . . . 6.98 113.516 168.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.7 -48.13 73.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.534 1.061 . . . . 4.56 113.033 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 9.7 t90 -75.92 -37.37 58.8 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.425 . . . . 4.24 112.008 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 76.3 mmm -54.68 -37.51 65.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.472 0.709 . . . . 3.52 111.966 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.36 -66.75 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.197 1.399 . . . . 3.52 108.954 166.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -9.97 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.623 2.369 . . . . 8.04 116.627 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.88 21.01 0.22 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 120.298 1.408 . . . . 1.22 112.131 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 63.88 17.65 61.03 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.27 -1.518 . . . . 1.13 115.249 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.07 164.05 26.07 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.278 1.539 . . . . 0.92 111.338 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 55.9 t -91.51 127.66 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.449 -0.782 . . . . 2.32 109.007 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.68 140.02 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.822 0.849 . . . . 1.85 111.087 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -116.8 155.77 28.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.522 1.129 . . . . 2.7 112.437 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.62 -37.0 85.66 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.717 1.006 . . . . 2.69 113.717 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -73.53 -37.31 65.67 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.026 0.83 . . . . 2.69 112.672 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 -35.28 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.911 -0.566 . . . . 1.3 111.407 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -63.33 -43.6 97.29 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.766 1.166 . . . . 1.91 112.16 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.67 -33.23 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.404 -0.81 . . . . 2.17 113.036 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -74.06 -36.81 64.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.046 . . . . 3.78 113.529 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.2 tpp -64.38 -52.61 57.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.165 1.386 . . . . 1.68 111.139 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 7.0 t -65.23 -28.98 69.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.267 1.027 . . . . 1.92 112.687 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -57.52 -54.45 46.68 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.044 0.937 . . . . 2.66 112.987 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -71.09 -29.92 65.9 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.921 0.341 . . . . 3.5 111.921 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.21 -39.98 93.52 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.339 1.056 . . . . 3.61 112.083 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -68.66 -25.61 64.9 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.705 2.402 . . . . 4.41 113.593 172.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 17.7 mttp -78.56 4.87 12.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.506 1.522 . . . . 3.94 113.09 168.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 71.81 18.4 77.44 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.441 1.496 . . . . 1.9 112.877 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -101.89 -174.76 2.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.411 1.484 . . . . 4.36 110.907 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.5 m -108.2 125.15 51.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.439 1.096 . . . . 2.0 111.741 -169.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.28 127.4 29.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.348 1.059 . . . . 1.32 110.303 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.4 m -140.96 158.11 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.907 1.283 . . . . 1.08 113.23 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.0 163.83 11.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.84 1.256 . . . . 1.23 111.791 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.2 p -139.29 134.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.857 1.263 . . . . 3.42 112.56 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -131.04 153.48 49.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.269 1.828 . . . . 0.81 112.53 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.4 m -146.29 131.09 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.999 2.12 . . . . 1.94 110.316 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.395 0.0 OUTLIER 41.29 46.17 2.72 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.335 1.854 . . . . 3.88 114.596 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 61.03 31.31 19.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.308 2.243 . . . . 1.47 115.874 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.03 158.89 39.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.65 1.98 . . . . 2.59 111.82 168.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 146.5 33.27 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.667 -1.271 . . . . 1.92 112.619 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 7.6 p -118.7 -41.82 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.282 0.633 . . . . 1.25 111.085 167.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.17 -163.24 24.85 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.798 1.181 . . . . 0.44 115.869 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.64 153.22 43.24 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.795 2.038 . . . . 1.02 112.57 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 25.6 mm -124.35 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.383 1.473 . . . . 1.78 109.579 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.24 132.27 54.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.21 1.404 . . . . 1.86 110.898 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 19.1 mt -136.02 158.05 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.71 2.004 . . . . 2.55 110.646 -168.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 C-N-CA 125.907 1.683 . . . . 2.05 111.573 174.464 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.487 0.18 . . . . 3.12 111.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.01 146.95 66.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.756 2.304 . . . . 1.72 111.441 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 10.9 p -130.59 134.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.347 1.059 . . . . 3.75 110.698 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -72.44 113.63 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.87 0.843 . . . . 2.31 109.642 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -91.52 -40.44 11.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.466 1.106 . . . . 3.96 111.725 -168.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -154.4 152.32 30.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.131 0.972 . . . . 3.19 112.099 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.9 m -125.65 142.62 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.943 1.297 . . . . 1.95 111.422 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -143.45 149.35 37.47 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.925 1.083 . . . . 3.43 113.925 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 46.3 t -96.3 143.65 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.638 1.575 . . . . 1.81 111.614 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.3 tp -107.41 -46.15 3.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.605 1.962 . . . . 1.53 111.5 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.8 m -118.98 126.39 51.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.393 1.477 . . . . 2.57 109.115 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -150.52 138.81 20.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.857 0.463 . . . . 4.49 111.568 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.1 m 63.67 -14.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.956 2.103 . . . . 2.99 116.59 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -95.52 -3.25 46.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.665 1.186 . . . . 2.95 114.145 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -157.88 -44.51 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.146 0.979 . . . . 4.93 112.987 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mm -134.12 157.65 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.61 1.964 . . . . 2.38 110.346 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 71.6 m -113.5 149.84 33.74 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.019 1.727 . . . . 2.13 112.589 172.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 21.1 p80 -55.98 -47.01 78.47 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.634 2.087 . . . . 4.02 116.634 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -70.32 -18.01 63.09 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.531 1.06 . . . . 4.12 111.378 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.29 -30.09 18.71 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.558 1.543 . . . . 4.76 111.784 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 92.7 mt -58.6 -52.22 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.191 0.905 . . . . 1.86 109.528 168.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.21 -34.13 77.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.801 -0.562 . . . . 1.69 111.645 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -59.6 -52.96 63.31 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.535 -0.745 . . . . 1.37 112.548 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 28.3 pt -68.37 -31.01 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.94 1.246 . . . . 1.92 113.836 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.0 t -70.37 -45.27 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.609 1.095 . . . . 1.94 110.416 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -61.37 -41.19 99.46 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.28 -0.733 . . . . 0.76 113.241 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 66.3 p -72.82 -37.42 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.159 0.98 . . . . 1.32 113.541 176.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.13 83.27 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.023 0.829 . . . . 0.96 112.379 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.1 -16.91 63.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.275 -0.89 . . . . 2.26 112.763 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 -23.83 67.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.159 1.17 . . . . 1.8 114.159 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -94.22 -13.12 26.93 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.25 -0.906 . . . . 1.9 112.757 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.7 t -73.84 160.18 31.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.298 1.592 . . . . 1.81 115.298 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.24 12.42 26.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.576 2.35 . . . . 5.31 113.445 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.59 160.1 59.69 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.912 1.078 . . . . 2.06 113.912 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.85 -34.66 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.897 3.065 . . . . 1.17 114.61 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.79 -51.67 4.79 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.853 0.861 . . . . 1.93 113.308 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.4 -30.43 77.55 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.844 -0.217 . . . . 1.12 113.345 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 29.2 p -65.19 -18.91 65.7 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.62 -1.518 . . . . 2.8 113.557 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.66 -32.05 73.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.802 -1.186 . . . . 1.6 111.545 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.19 -41.18 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.488 1.515 . . . . 2.09 110.474 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 99.4 m -52.58 -47.99 66.51 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.892 1.223 . . . . 2.08 111.404 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.2 tttt -59.11 -50.29 74.6 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.243 0.929 . . . . 3.48 112.284 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 76.9 t80 -58.28 -40.51 82.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.683 1.193 . . . . 3.15 112.534 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 83.7 m -72.84 -43.19 62.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.732 1.613 . . . . 4.28 113.032 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.93 -36.81 80.29 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.329 1.422 . . . . 3.71 110.836 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.22 -47.39 79.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.216 1.006 . . . . 4.0 111.127 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -62.67 -44.52 96.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.884 1.22 . . . . 1.95 113.844 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.64 -18.71 62.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.322 0.86 . . . . 1.48 113.322 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 18.3 t70 48.99 32.06 3.65 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.69 1.596 . . . . 2.32 113.59 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -99.85 -12.35 19.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.145 1.778 . . . . 3.44 115.344 -167.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 16.8 tt0 66.84 -19.93 0.11 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.656 2.382 . . . . 4.29 116.677 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.8 t -154.35 138.12 16.17 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.101 1.319 . . . . 3.34 113.507 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -156.62 153.78 29.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.012 1.325 . . . . 1.39 114.449 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 98.4 136.95 9.49 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 125.477 1.513 . . . . 1.04 114.622 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 25.1 m -125.94 -68.07 0.84 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.894 0.878 . . . . 2.06 112.661 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 12.8 t -138.77 142.48 38.8 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.395 1.258 . . . . 1.6 114.395 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.4 mm -143.82 139.44 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 130.997 3.719 . . . . 3.17 109.211 -174.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 17.0 t0 -94.72 -28.06 15.5 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.524 1.53 . . . . 2.74 114.027 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.82 97.1 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.946 2.098 . . . . 3.89 116.222 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.59 114.48 22.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.967 1.707 . . . . 2.55 109.136 169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 92.8 t -113.71 131.33 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.445 1.498 . . . . 2.94 111.453 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 50.7 t -133.9 118.79 14.45 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.201 1.4 . . . . 1.92 107.602 169.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -53.42 136.62 63.82 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.214 2.609 . . . . 1.95 113.677 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.31 -45.22 0.96 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.422 1.963 . . . . 2.17 114.767 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 79.2 m -71.48 -5.34 32.26 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 117.369 2.359 . . . . 3.17 117.369 -167.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 110.46 -167.41 12.63 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.983 1.265 . . . . 0.8 113.819 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 143.39 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.127 1.371 . . . . 2.71 110.204 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.6 t -129.19 151.8 49.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.559 1.144 . . . . 1.09 111.466 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 29.3 p -162.94 172.52 14.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.197 0.999 . . . . 1.55 113.413 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.16 135.91 53.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.447 1.499 . . . . 1.58 107.191 169.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 35.0 m -128.6 148.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.609 0.763 . . . . 3.78 112.35 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.0 t -134.09 145.78 49.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.054 0.942 . . . . 2.19 109.68 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 126.233 1.813 . . . . 2.95 108.371 159.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 122.144 0.973 . . . . 2.17 112.937 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -126.33 134.58 51.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.955 2.502 . . . . 3.7 109.179 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -95.04 105.9 17.85 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.855 1.262 . . . . 2.72 110.786 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -124.11 142.33 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.382 0.673 . . . . 1.31 112.652 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.5 151.87 38.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.536 1.135 . . . . 0.97 112.836 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.47 155.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.767 1.627 . . . . 1.74 109.891 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 107.55 163.66 21.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.111 0.839 . . . . 1.7 114.127 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 4.8 t-20 49.98 -155.23 0.11 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.212 1.805 . . . . 2.62 114.013 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -130.11 -34.69 1.65 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.171 2.589 . . . . 5.77 111.556 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.88 -32.47 51.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.159 1.17 . . . . 3.3 114.159 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.2 t90 -72.39 -28.98 63.34 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.354 -1.466 . . . . 4.04 111.892 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 6.1 tpp -57.38 -34.23 68.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.922 0.889 . . . . 2.69 111.617 171.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.96 -66.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.554 1.942 . . . . 2.58 109.985 168.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -55.8 -18.89 9.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 116.01 1.856 . . . . 6.43 116.01 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.71 9.86 2.55 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 120.15 1.341 . . . . 1.17 112.79 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 72.77 18.63 78.92 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.387 1.47 . . . . 0.99 115.571 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.59 171.23 13.53 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.445 1.098 . . . . 2.03 111.325 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 94.7 t -108.79 120.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.568 1.147 . . . . 1.65 109.989 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.87 125.27 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.158 0.983 . . . . 2.27 110.845 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -92.54 156.24 17.27 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.031 1.332 . . . . 4.17 112.99 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -60.21 -31.36 70.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.702 1.201 . . . . 2.81 113.45 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.45 -42.51 68.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.348 1.059 . . . . 3.03 111.704 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 4.4 p -78.17 -35.26 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.223 0.823 . . . . 2.18 113.223 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.8 -38.95 89.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.668 1.122 . . . . 2.36 111.215 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -49.27 78.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.585 0.754 . . . . 1.97 112.142 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.2 -41.56 79.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.189 1.396 . . . . 3.96 111.546 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 25.4 tpp -64.81 -49.29 71.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.553 1.541 . . . . 1.62 111.811 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.4 t -74.94 -30.53 61.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.885 0.698 . . . . 1.8 112.885 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -58.05 -53.18 61.2 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.477 -1.389 . . . . 2.5 112.629 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -71.31 -29.13 64.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.532 0.733 . . . . 3.78 112.572 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.05 -46.08 89.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.949 0.9 . . . . 4.84 111.595 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -66.93 -29.54 69.44 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.389 1.475 . . . . 4.46 113.625 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 23.5 mttp -65.44 -10.69 36.08 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.482 1.513 . . . . 3.43 113.51 169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.26 29.52 10.18 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.941 1.258 . . . . 1.72 114.409 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -126.63 176.94 6.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.715 1.606 . . . . 6.93 111.043 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 55.2 m -90.79 139.16 31.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.072 1.349 . . . . 1.84 111.328 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -136.86 130.95 32.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.025 0.93 . . . . 1.85 112.514 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 164.58 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.717 1.607 . . . . 0.95 113.423 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.37 168.74 10.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.363 1.465 . . . . 1.03 113.489 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.2 t -137.02 128.56 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.624 1.57 . . . . 2.95 112.101 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.55 150.24 47.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.243 1.417 . . . . 2.07 113.259 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.32 125.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.091 1.756 . . . . 1.33 111.529 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 37.7 53.5 1.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.494 2.318 . . . . 2.74 113.268 -173.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.275 16.3 m-20 58.85 29.29 18.62 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.369 1.989 . . . . 2.05 116.369 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.18 151.7 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.496 1.918 . . . . 3.22 110.091 166.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.55 145.33 34.89 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.833 -1.167 . . . . 1.86 110.124 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -119.5 -40.55 2.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.527 -0.749 . . . . 1.22 112.892 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.27 -172.7 37.67 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 120.11 1.323 . . . . 0.44 116.222 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -138.25 152.62 48.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.264 1.826 . . . . 0.9 112.656 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 11.1 mm -132.29 136.28 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 1.8 110.242 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -109.97 136.9 48.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.311 1.444 . . . . 1.92 110.266 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.36 143.65 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.805 1.642 . . . . 2.56 111.146 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 126.518 1.927 . . . . 2.04 111.956 179.679 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 119.983 -0.056 . . . . 12.89 110.856 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 15.7 t80 -148.86 172.32 14.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.528 1.131 . . . . 14.33 112.5 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 14.6 t -74.44 150.84 39.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.358 1.463 . . . . 8.16 114.141 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.6 32.02 0.16 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.068 1.747 . . . . 6.75 112.374 172.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 49.6 m80 -79.34 -27.3 42.04 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.853 1.427 . . . . 6.23 114.853 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -80.17 71.09 2.83 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 119.959 1.254 . . . . 2.64 112.719 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 90.6 m -72.93 130.52 85.01 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 125.073 1.349 . . . . 3.46 113.359 -169.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.89 149.32 3.94 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.969 3.113 . . . . 1.69 112.923 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 3.9 m -131.52 130.24 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.728 2.011 . . . . 3.81 111.903 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.2 p -74.8 126.44 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.396 -0.815 . . . . 2.2 110.745 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.02 -38.29 3.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.733 1.753 . . . . 3.08 115.733 -165.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -149.09 145.18 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.281 1.401 . . . . 3.13 111.961 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 30.1 m -125.41 143.16 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.088 0.955 . . . . 1.55 112.786 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 71.9 tttt -136.88 142.19 42.78 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.526 1.53 . . . . 2.8 111.385 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 58.0 t -94.38 148.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.131 1.373 . . . . 1.31 111.45 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.91 -39.09 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.35 1.46 . . . . 2.31 113.682 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.4 t -81.12 29.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.82 1.191 . . . . 3.41 113.424 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.34 132.42 39.26 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.859 -1.776 . . . . 4.37 111.634 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 20.8 m 61.65 -8.62 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.763 2.505 . . . . 2.53 117.763 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.84 -30.86 12.91 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.397 1.628 . . . . 3.48 115.397 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -150.04 -66.28 0.21 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.658 1.117 . . . . 6.45 112.579 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 4.4 mt -128.15 140.08 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.577 1.951 . . . . 2.57 110.905 -171.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.5 m -103.15 160.27 14.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.637 1.175 . . . . 2.41 112.746 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.8 p80 -47.13 -41.41 17.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.944 1.698 . . . . 3.23 115.466 -169.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -70.55 -42.22 71.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.071 1.348 . . . . 4.51 111.913 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.53 -33.23 72.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.067 -1.02 . . . . 3.84 112.138 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -58.41 -52.65 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.884 1.22 . . . . 2.03 110.768 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.79 -29.96 68.43 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.402 -0.811 . . . . 2.0 112.181 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.62 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.095 0.558 . . . . 1.31 112.279 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 15.1 pt -70.31 -35.53 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.809 1.186 . . . . 2.05 112.867 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 92.4 t -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.452 1.023 . . . . 1.5 111.006 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.8 -34.74 88.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.451 -0.78 . . . . 0.72 113.51 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.9 p -75.9 -32.61 59.72 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.746 1.273 . . . . 1.42 112.815 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.05 67.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.877 0.762 . . . . 0.97 112.137 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.41 -21.13 62.87 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.313 -0.867 . . . . 1.92 112.439 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.0 t -65.23 -18.51 65.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.93 -1.106 . . . . 1.97 112.566 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -117.69 -9.23 10.77 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.169 1.388 . . . . 2.55 113.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.9 t -85.62 -174.89 5.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.409 1.484 . . . . 1.61 112.32 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -135.82 32.13 3.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.547 1.939 . . . . 4.26 112.703 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1086 ' ' HIS . . . . . 0.426 ' CB ' HN61 ' A' 1232 ' ' ATP . 2.0 m-70 -93.51 162.3 28.09 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 114.199 1.185 . . . . 2.64 114.199 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.68 -21.55 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.052 3.168 . . . . 1.03 114.657 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.4 -52.48 2.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.054 1.341 . . . . 1.61 113.383 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.91 -23.59 65.83 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 114.154 0.422 . . . . 1.06 114.154 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 12.9 p -61.44 -18.45 58.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.929 -1.336 . . . . 2.56 113.988 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.68 81.42 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.885 -1.134 . . . . 1.6 111.719 168.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.64 -32.85 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.299 1.039 . . . . 2.48 111.291 172.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 28.0 m -52.27 -50.81 61.39 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.798 1.181 . . . . 2.5 111.253 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -61.32 -48.04 83.18 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.852 0.751 . . . . 3.6 112.647 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -55.73 -41.63 74.16 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.961 0.904 . . . . 2.76 111.735 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.1 t -67.91 -52.74 32.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.132 1.373 . . . . 2.48 112.371 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -42.31 88.86 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.413 -1.429 . . . . 3.73 112.455 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -67.47 -31.51 71.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.81 1.644 . . . . 3.79 111.901 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -70.25 -50.34 40.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.501 1.046 . . . . 2.66 112.224 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 27.4 mt -72.18 -22.72 61.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.484 1.29 . . . . 1.47 114.484 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.6 t0 56.36 43.9 25.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.87 1.668 . . . . 2.76 113.333 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.7 t -138.88 -30.8 0.74 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.175 2.287 . . . . 3.31 117.175 -169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 61.1 tt0 64.47 -26.41 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.744 2.498 . . . . 4.43 117.744 -171.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 46.9 p -84.57 45.2 1.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.446 1.898 . . . . 3.93 114.828 -169.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.95 151.75 23.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.159 1.383 . . . . 1.33 113.523 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 92.79 122.76 3.23 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.049 0.841 . . . . 1.34 114.611 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 74.4 m -129.3 -172.58 2.77 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.254 2.622 . . . . 2.6 107.653 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -56.42 143.37 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.151 1.908 . . . . 2.06 116.151 -168.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 16.5 tt -135.11 140.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 131.523 3.929 . . . . 3.03 106.368 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.2 t0 -124.53 93.48 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.46 1.104 . . . . 3.21 108.845 172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.341 0.0 OUTLIER -97.43 166.55 11.48 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 117.412 2.375 . . . . 4.41 117.412 -169.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -142.81 105.45 4.49 Favored 'General case' 0 CA--C 1.562 1.414 1 C-N-CA 132.332 4.253 . . . . 2.14 107.625 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 6.3 m -109.62 151.04 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.303 -1.498 . . . . 3.99 114.515 -170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 13.9 t -137.71 138.87 25.16 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.9 1.28 . . . . 1.63 110.599 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.33 132.95 28.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.647 2.231 . . . . 2.34 111.758 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.1 -34.5 0.41 Allowed Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.267 1.889 . . . . 2.16 115.893 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -90.21 2.91 54.88 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.212 1.56 . . . . 2.99 115.212 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 90.98 -176.29 40.67 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.308 0.956 . . . . 1.11 114.598 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.5 pt -136.53 160.01 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.111 0.964 . . . . 3.92 112.59 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 21.7 t -130.27 147.03 51.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.415 1.486 . . . . 1.06 111.565 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.4 p -154.63 173.77 15.9 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.013 -1.055 . . . . 1.26 113.003 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -115.88 111.18 20.07 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 106.409 -1.7 . . . . 1.58 106.409 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 2.6 m -103.05 127.93 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.596 1.158 . . . . 3.42 113.432 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.3 t -109.23 159.1 17.21 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.074 0.95 . . . . 1.67 112.306 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -168.53 -42.44 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.728 2.811 . . . . 2.55 107.786 161.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 15.4 pt -49.03 -37.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.711 2.004 . . . . 2.44 115.845 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -150.24 45.1 0.89 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.98 1.264 . . . . 4.43 111.253 167.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -67.11 -4.68 29.88 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.983 1.278 . . . . 3.23 114.855 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.36 -1.14 5.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.73 2.012 . . . . 3.97 115.087 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.7 tt -86.96 -36.24 18.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.58 1.152 . . . . 5.33 111.914 171.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 12.3 m80 64.58 115.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 127.163 2.185 . . . . 8.42 112.808 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -84.17 155.98 22.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.324 1.972 . . . . 13.54 116.324 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.22 121.97 36.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.85 -1.537 . . . . 14.02 106.85 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -126.42 17.62 7.61 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.507 1.123 . . . . 13.73 113.556 -168.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -78.73 111.58 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 119.726 -1.859 . . . . 18.36 112.651 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 53.98 21.78 3.06 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.072 1.749 . . . . 17.95 113.27 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . 0.305 0.8 OUTLIER -63.85 -15.21 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 117.484 2.401 . . . . 18.16 117.484 -162.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -71.27 -20.31 62.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.369 1.068 . . . . 22.52 112.71 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -108.64 -42.98 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 116.988 -1.482 . . . . 20.97 111.429 168.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -35.5 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.553 1.941 . . . . 20.47 111.08 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -89.89 140.1 29.95 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.775 0.83 . . . . 27.93 111.46 -166.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.73 -37.85 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.721 0.409 . . . . 29.58 111.776 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -169.78 116.73 0.57 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.334 1.454 . . . . 33.44 111.131 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -81.98 36.57 0.46 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.084 1.142 . . . . 31.98 114.084 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -154.04 177.46 11.04 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.456 1.902 . . . . 34.72 112.107 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 40.4 t -66.59 144.81 56.19 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.173 2.189 . . . . 40.03 114.555 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.29 -12.47 0.1 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 118.453 2.761 . . . . 39.99 118.453 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 95.0 t -78.99 -48.63 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.502 1.501 . . . . 43.94 110.222 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -153.52 91.81 1.52 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.078 1.351 . . . . 51.32 110.099 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.65 -38.14 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.046 1.338 . . . . 46.05 110.943 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.44 -22.94 67.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.69 0.996 . . . . 51.35 113.69 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -99.77 -13.02 19.44 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 49.2 113.527 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 66.2 p -142.64 95.02 2.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.13 0.972 . . . . 44.89 112.756 -173.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 51.65 81.0 0.08 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.441 2.296 . . . . 43.11 115.692 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -76.4 68.4 2.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.436 1.094 . . . . 44.13 112.521 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -66.43 -51.99 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.126 -0.984 . . . . 39.86 110.825 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 11.9 t -136.89 172.42 13.04 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.554 1.316 . . . . 37.63 114.554 -168.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 6.5 p -64.41 -37.67 88.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 130.195 3.398 . . . . 38.27 113.973 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 59.5 p 61.61 148.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 128.832 2.853 . . . . 33.16 118.25 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 142.12 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.863 1.265 . . . . 29.44 109.442 167.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.21 0.63 6.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.781 2.141 . . . . 29.03 116.781 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 32.1 t -128.9 -31.16 2.19 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.865 1.802 . . . . 25.53 115.865 165.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 7.8 ptt? -73.53 134.65 43.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.204 1.82 . . . . 22.67 110.527 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 34.6 mt 67.45 -37.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 126.513 1.925 . . . . 16.32 113.912 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.68 138.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.574 1.95 . . . . 21.07 109.324 168.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 14.9 t70 60.78 -20.39 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.853 2.061 . . . . 14.99 116.094 -169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -54.92 -27.05 40.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.81 1.644 . . . . 11.42 114.787 -171.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.36 -25.16 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.294 1.438 . . . . 11.84 113.443 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.56 -50.27 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.768 1.227 . . . . 10.9 109.308 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 38.3 p -66.26 -28.09 68.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.951 0.352 . . . . 8.51 111.951 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.99 -57.92 10.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.858 0.863 . . . . 6.15 110.005 168.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.91 85.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.927 1.455 . . . . 4.4 114.927 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.24 -15.94 61.93 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.66 0.985 . . . . 6.94 113.66 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.18 -46.28 5.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.108 0.867 . . . . 4.78 111.418 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -78.08 57.7 1.85 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.478 1.911 . . . . 4.0 110.472 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . 0.329 28.7 mt-30 -50.95 139.54 17.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.067 1.889 . . . . 4.04 114.915 -166.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -148.8 168.44 22.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 111.557 -2.565 . . . . 2.98 114.635 -159.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 119.25 10.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.898 0.879 . . . . 4.68 112.365 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.29 117.29 18.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.23 . . . . 2.07 110.686 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -135.29 144.07 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 0.94 112.198 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.26 154.59 42.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.895 1.278 . . . . 0.9 112.603 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.0 tt -152.5 145.79 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.279 1.032 . . . . 1.89 110.587 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 121.83 166.58 12.89 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 116.042 1.177 . . . . 1.44 116.042 168.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 48.11 -141.36 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.604 1.962 . . . . 2.46 113.93 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.43 -32.58 0.45 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.499 1.52 . . . . 7.29 114.184 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.59 -37.49 79.86 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.433 1.469 . . . . 3.77 114.275 -174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.3 t90 -68.22 -31.18 70.51 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.657 -1.277 . . . . 4.28 111.819 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 10.4 tpp -60.23 -34.53 73.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.137 0.975 . . . . 2.57 111.752 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.66 -67.01 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.467 1.507 . . . . 2.46 109.043 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -52.96 -24.97 10.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.967 2.107 . . . . 6.34 115.987 -172.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.76 20.23 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.006 1.275 . . . . 1.09 113.811 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.26 13.41 81.4 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.193 -1.567 . . . . 0.93 115.376 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.6 mt -83.96 175.3 9.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.605 1.162 . . . . 0.92 111.388 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 57.8 t -119.41 131.05 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.087 1.355 . . . . 2.43 108.744 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.5 tt -102.71 135.73 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.396 0.679 . . . . 2.07 110.954 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.7 p30 -96.82 159.51 14.88 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.736 1.214 . . . . 4.12 113.099 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.1 p30 -71.99 -15.04 62.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.447 1.277 . . . . 4.38 114.447 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -84.24 -45.22 13.11 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.62 -1.3 . . . . 2.46 113.019 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.2 p -64.45 -34.46 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 118.823 -0.608 . . . . 1.3 110.92 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.67 -42.96 81.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.761 1.164 . . . . 2.58 112.604 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.61 -34.69 77.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.274 1.03 . . . . 1.97 112.405 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 39.9 t80 -71.95 -35.41 69.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.818 1.247 . . . . 3.56 112.718 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.3 tpp -71.21 -58.95 3.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.502 1.921 . . . . 1.69 112.435 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -62.53 -28.2 69.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 1.9 112.297 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -58.31 -47.42 83.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.757 2.023 . . . . 2.71 113.403 171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -64.78 -36.11 83.25 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.213 -0.929 . . . . 3.12 111.842 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.41 -31.96 72.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.514 -0.741 . . . . 3.07 112.36 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 48.9 ttp85 -70.6 -39.9 73.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.558 2.343 . . . . 10.41 111.431 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 13.8 mttp -69.2 -1.38 7.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.728 2.011 . . . . 3.06 112.624 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 75.34 16.58 80.53 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.824 1.202 . . . . 1.35 115.022 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -95.45 178.93 5.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.259 1.424 . . . . 4.43 111.205 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.2 m -93.29 121.08 34.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.16 1.784 . . . . 2.0 109.635 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.41 113.95 15.56 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.754 0.822 . . . . 1.27 111.873 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 26.7 m -140.55 163.13 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.569 1.148 . . . . 1.07 114.06 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.1 160.95 23.97 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.352 1.461 . . . . 1.07 112.982 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 5.0 t -127.49 125.75 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.22 1.808 . . . . 2.75 111.677 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -118.66 154.36 32.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.122 1.369 . . . . 0.95 112.19 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.9 m -146.61 122.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.027 1.731 . . . . 2.11 110.462 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 31.2 t70 44.39 46.79 7.98 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 122.705 1.241 . . . . 3.34 113.368 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.265 4.9 m-20 62.42 28.1 16.66 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.549 1.94 . . . . 1.76 115.838 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.46 149.07 42.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.726 2.811 . . . . 3.27 110.273 168.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.61 114.61 26.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.47 -1.394 . . . . 1.62 110.812 170.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.4 p -89.21 -38.06 14.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.738 1.154 . . . . 1.33 113.32 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . 176.48 -168.69 40.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 119.259 0.936 . . . . 0.64 114.883 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.23 156.08 44.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.349 1.46 . . . . 1.0 113.772 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.37 133.05 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 2.82 111.525 -170.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -105.15 136.59 44.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.978 1.711 . . . . 1.77 110.356 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 67.3 mt -140.97 148.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.759 1.624 . . . . 2.21 109.869 -168.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.25 170.6 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.413 1.085 . . . . 1.57 112.585 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.15 137.76 44.61 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.752 1.621 . . . . 3.44 112.419 -172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 115.22 1.563 . . . . 4.73 115.22 -172.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1232 ' ' ATP . . . . . 0.426 HN61 ' CB ' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 112.575 0.583 . . . . 11.73 112.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 2.2 t80 54.71 16.0 1.26 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.598 2.444 . . . . 13.86 117.598 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 51.7 m -105.46 -11.44 16.42 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.757 2.023 . . . . 8.65 113.036 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 3.4 tpt -144.1 108.48 4.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.851 1.261 . . . . 6.77 110.384 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -98.18 -46.09 5.97 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.876 1.065 . . . . 8.62 113.876 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -75.72 84.55 0.88 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.472 -1.451 . . . . 3.28 109.472 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 1.6 p -96.18 137.6 21.67 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 116.134 1.902 . . . . 2.74 116.134 -166.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.79 132.48 40.16 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.105 2.537 . . . . 2.81 111.955 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.52 129.52 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.662 1.585 . . . . 3.08 110.946 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 128.23 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.781 0.833 . . . . 2.56 111.531 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.35 -35.3 4.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.128 1.158 . . . . 2.76 114.128 -168.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -164.88 152.66 11.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 2.7 111.69 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.4 m -125.07 135.13 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.514 1.126 . . . . 1.02 109.216 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 51.8 tttt -140.96 148.26 40.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.04 0.936 . . . . 2.91 113.026 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.1 t -90.38 151.13 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 1.67 112.532 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.01 -35.5 4.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.395 1.878 . . . . 1.61 111.42 168.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 92.5 m -119.93 97.85 5.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.225 1.012 . . . . 3.02 111.798 -170.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -91.59 140.89 29.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.449 1.5 . . . . 3.88 111.071 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 52.93 29.13 7.36 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.772 2.138 . . . . 3.31 116.772 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -145.55 -14.7 0.49 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.093 1.886 . . . . 3.49 116.093 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -149.65 -97.53 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.271 1.428 . . . . 5.15 109.99 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 54.9 mt -139.68 146.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.106 1.762 . . . . 2.86 109.857 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 3.3 t -123.18 172.73 8.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.852 1.661 . . . . 5.33 114.975 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.0 p80 -38.79 -53.49 1.67 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 117.194 2.294 . . . . 4.07 117.194 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.34 -36.53 84.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.488 1.495 . . . . 3.73 111.897 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.5 -26.03 21.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 117.476 -1.25 . . . . 3.5 113.04 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.75 -52.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.198 1.363 . . . . 2.52 109.37 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.13 -31.93 73.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.91 -0.494 . . . . 1.89 111.348 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.12 -61.13 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.599 -0.715 . . . . 1.31 112.39 171.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.53 -31.38 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.711 1.141 . . . . 1.04 114.022 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 85.0 t -67.18 -42.25 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.224 0.92 . . . . 1.97 110.224 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.46 91.73 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.633 -0.537 . . . . 0.91 113.276 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.2 p -72.46 -28.46 62.95 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.669 1.235 . . . . 1.76 113.144 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -69.36 -60.81 2.09 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.034 0.834 . . . . 2.6 111.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -65.23 -18.32 65.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.883 1.273 . . . . 2.64 112.462 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 39.7 t -51.53 -31.37 23.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.022 1.329 . . . . 1.78 113.032 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -79.49 3.3 19.05 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.804 -1.185 . . . . 3.48 114.185 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 48.0 m -120.74 -178.48 3.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.181 1.792 . . . . 1.98 112.785 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -139.71 29.95 2.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.234 1.414 . . . . 4.48 113.186 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.05 150.23 64.49 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 114.264 1.209 . . . . 2.39 114.264 -170.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.59 -25.05 75.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.151 3.234 . . . . 1.42 115.066 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.74 -41.57 3.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.469 1.508 . . . . 2.31 111.81 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.66 70.05 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 123.634 0.635 . . . . 1.2 113.918 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 4.8 p -58.96 -24.0 62.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.92 1.288 . . . . 2.9 114.455 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -71.18 -36.53 71.99 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.608 -1.308 . . . . 1.56 111.816 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.2 mt -72.03 -41.14 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.139 1.375 . . . . 1.42 110.425 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 76.9 p -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 117.354 -1.307 . . . . 3.64 111.862 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -59.37 -49.87 76.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.784 1.174 . . . . 3.3 112.498 169.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.91 -41.74 74.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.425 0.69 . . . . 3.88 111.424 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 38.1 t -71.26 -56.19 6.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.51 1.124 . . . . 2.36 113.116 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -42.8 -52.0 5.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.912 2.085 . . . . 4.52 112.005 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.741 0.816 . . . . 5.16 112.428 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.59 -40.28 95.24 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.395 -1.44 . . . . 2.26 112.74 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.5 -10.48 59.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.332 1.053 . . . . 2.07 113.048 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 45.0 t0 54.38 34.06 19.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.797 1.639 . . . . 2.41 113.108 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 15.1 t -115.63 162.76 16.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.055 1.342 . . . . 2.68 111.541 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.96 -16.99 25.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.474 1.51 . . . . 3.63 111.453 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.8 t -146.59 135.28 22.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.306 1.443 . . . . 3.98 111.821 -170.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.68 150.32 32.99 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.876 0.871 . . . . 1.84 111.414 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 81.22 167.33 37.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.594 0.998 . . . . 1.11 115.594 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 52.5 m -152.51 -37.43 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.058 2.143 . . . . 1.92 113.144 -173.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1108 ' ' CYS . . . . . 0.423 ' HB3' ' H ' ' A' 1124 ' ' THR . 51.7 t -134.33 142.96 47.41 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 2.97 114.872 -166.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 4.6 tp -150.6 151.31 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.934 1.293 . . . . 3.31 113.131 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.57 -17.26 12.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.492 1.517 . . . . 3.62 114.082 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 57.3 t80 45.26 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.49 2.716 . . . . 3.96 118.068 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.78 112.61 20.64 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.764 2.026 . . . . 2.46 109.132 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.8 t -99.75 136.67 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 2.94 111.377 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.1 t -131.42 108.37 14.71 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 108.645 -0.872 . . . . 1.26 108.645 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.02 141.5 64.43 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.898 2.399 . . . . 2.0 110.265 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 69.1 13.93 67.68 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 118.997 -0.89 . . . . 2.02 114.819 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 m -137.48 -87.77 0.28 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.803 1.241 . . . . 2.55 112.696 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . -175.16 -151.15 8.32 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.851 0.7 . . . . 1.2 114.851 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 146.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.263 1.425 . . . . 3.09 112.08 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.9 t -133.31 150.69 51.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.393 1.877 . . . . 1.32 111.43 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.6 p -163.06 166.43 23.62 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.967 1.469 . . . . 1.33 114.967 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -109.71 140.72 43.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.553 1.941 . . . . 1.53 107.759 166.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 14.7 p -149.4 140.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.806 1.41 . . . . 3.07 114.806 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1124 ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' 1108 ' ' CYS . 4.4 t -124.32 157.04 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.751 1.621 . . . . 2.67 110.87 166.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -175.56 -42.55 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.187 2.195 . . . . 2.71 109.852 160.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -27.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 117.262 2.319 . . . . 4.89 117.262 -171.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.07 8.44 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.735 1.607 . . . . 7.45 112.887 166.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -72.42 9.28 5.98 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.637 2.065 . . . . 4.61 116.994 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -1.04 21.65 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.345 1.572 . . . . 7.14 114.182 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.4 -33.24 53.09 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.797 1.239 . . . . 8.22 114.274 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 11.3 t-80 40.71 73.24 0.13 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.254 2.221 . . . . 10.15 113.682 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.17 129.35 40.38 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.281 -0.887 . . . . 16.06 111.288 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.1 118.55 5.98 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.769 -1.197 . . . . 19.18 107.769 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.73 146.48 31.01 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.095 1.887 . . . . 14.32 116.095 -165.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 21.5 t90 -155.85 -22.64 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.568 1.947 . . . . 20.61 114.316 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -130.14 -4.52 4.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.776 1.23 . . . . 16.23 114.242 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 60.8 mt -80.77 119.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.136 0.974 . . . . 13.42 108.879 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -101.49 -16.76 16.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.102 0.961 . . . . 16.04 113.264 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.25 -14.6 51.22 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.185 -0.947 . . . . 13.54 111.627 167.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -20.88 64.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.37 1.868 . . . . 15.45 112.818 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -112.95 -59.5 2.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.032 2.133 . . . . 19.2 114.022 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.27 117.34 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.972 0.909 . . . . 20.29 111.293 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 27.6 ttpt 45.09 45.83 9.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.504 1.521 . . . . 17.84 111.406 -169.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 51.2 p30 -64.56 -11.37 33.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.527 1.306 . . . . 23.88 114.527 -169.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -137.18 -87.09 0.3 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.635 0.976 . . . . 23.47 113.635 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 20.1 t 68.16 -45.43 0.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.936 2.199 . . . . 23.93 116.936 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 mm? 45.8 -116.34 0.59 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.909 2.084 . . . . 25.98 111.275 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 13.5 p -149.53 159.01 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.228 2.211 . . . . 28.88 108.785 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -71.27 32.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.703 1.372 . . . . 32.35 114.703 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 32.9 mm -143.45 -29.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.815 2.446 . . . . 34.22 112.889 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 21.2 t70 -140.77 164.13 31.03 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.668 -1.27 . . . . 34.53 111.549 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -123.17 9.89 9.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.533 1.133 . . . . 36.24 114.034 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 29.6 t 57.93 136.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.371 2.668 . . . . 34.11 115.707 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.4 -13.49 61.86 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.69 1.196 . . . . 36.39 113.038 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -107.07 172.18 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.855 1.662 . . . . 32.62 111.68 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 155.2 38.06 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.196 . . . . 36.18 111.892 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 1.9 t 52.67 51.71 15.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.954 1.302 . . . . 29.82 113.006 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 78.0 p -121.48 37.78 4.26 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.682 1.734 . . . . 25.94 115.682 -166.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 4.9 t -74.17 151.54 40.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.37 -0.831 . . . . 23.24 111.544 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 38.6 t -75.62 139.69 42.18 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.237 -0.915 . . . . 19.65 112.151 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 11.5 t -65.25 -3.43 3.96 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.855 2.062 . . . . 21.02 113.293 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 18.1 p -72.15 1.21 7.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.351 1.46 . . . . 17.06 113.507 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 8.2 ptt? -51.28 143.39 11.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.874 2.47 . . . . 21.13 113.746 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 4.2 mm 43.81 49.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.776 1.63 . . . . 13.28 111.881 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -42.29 -47.7 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.513 1.525 . . . . 11.05 113.902 -168.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -73.88 -21.32 60.13 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.042 1.127 . . . . 10.39 114.042 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -87.44 -16.22 35.47 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.377 0.671 . . . . 10.73 111.636 168.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -82.97 -41.85 18.29 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.489 1.115 . . . . 11.14 110.472 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.8 -44.26 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.401 1.08 . . . . 7.96 110.632 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 3.2 p -71.4 -14.14 62.07 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.84 1.052 . . . . 9.1 113.84 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -98.32 -8.04 27.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.77 1.628 . . . . 9.0 113.963 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.02 63.37 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.377 1.251 . . . . 6.75 114.377 -169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1173 ' ' LEU . . . . . 0.412 ' H ' ' CD2' ' A' 1173 ' ' LEU . 3.3 mm? -44.64 -34.05 2.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.655 1.582 . . . . 9.44 113.635 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 31.2 m120 -99.83 -3.74 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.159 1.54 . . . . 9.94 115.159 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -133.37 -23.34 1.9 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.461 1.652 . . . . 6.51 115.461 -168.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . 0.279 31.3 mt-30 46.2 129.28 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 130.143 3.377 . . . . 5.48 117.51 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.29 142.54 35.69 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.259 -1.337 . . . . 3.17 111.226 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -129.23 138.68 51.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.073 1.749 . . . . 4.31 110.417 -171.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -105.83 113.75 27.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.717 1.207 . . . . 2.12 108.718 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.9 m -131.39 139.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.376 0.989 . . . . 1.07 113.319 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.77 154.84 44.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.702 1.201 . . . . 1.2 112.93 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.9 tt -155.91 142.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.753 1.621 . . . . 1.81 110.555 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 125.33 147.36 6.99 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.391 1.317 . . . . 2.18 116.391 168.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.64 -159.46 0.1 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.743 1.617 . . . . 2.14 111.801 -169.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -125.68 -40.53 2.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.258 1.577 . . . . 6.09 115.258 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.25 -41.08 67.19 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.085 -1.635 . . . . 4.05 111.639 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 11.8 t90 -57.71 -23.23 50.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.562 0.949 . . . . 4.05 113.562 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 75.5 mmm -75.42 -53.19 9.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.888 1.275 . . . . 3.25 112.148 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 96.9 mt -47.89 -62.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.139 1.775 . . . . 3.72 110.654 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -47.7 -13.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 128.504 2.722 . . . . 7.3 116.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.61 24.88 0.45 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 119.689 1.131 . . . . 1.03 111.859 169.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.17 27.63 73.65 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.385 -1.447 . . . . 0.82 114.772 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 17.3 mt -95.41 159.08 15.17 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.977 1.389 . . . . 0.94 114.253 -169.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 44.2 t -105.32 125.61 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.276 1.43 . . . . 2.54 110.544 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.9 tt -119.11 148.59 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.795 1.638 . . . . 2.08 110.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -127.43 165.41 19.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.383 1.073 . . . . 2.94 113.041 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.71 -30.84 69.58 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.408 -1.433 . . . . 4.03 114.12 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.36 -42.94 98.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.19 1.396 . . . . 5.08 111.565 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.5 p -77.78 -40.51 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.505 1.522 . . . . 1.43 112.113 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -57.69 -41.6 81.98 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.447 1.022 . . . . 3.72 112.125 171.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.6 -34.71 78.86 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.632 0.975 . . . . 2.92 113.632 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -74.93 -39.32 61.45 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 3.72 112.968 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 37.4 tpp -57.84 -58.7 7.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.033 1.333 . . . . 2.11 110.204 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.3 t -63.23 -31.17 72.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.819 0.674 . . . . 2.7 112.819 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -58.38 -50.19 74.54 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.841 -1.162 . . . . 3.01 112.108 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -72.73 -33.22 66.25 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.355 1.242 . . . . 2.71 114.355 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -65.3 -43.66 90.4 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.423 -0.798 . . . . 4.7 111.686 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -69.49 -25.59 64.14 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.599 -1.313 . . . . 5.93 112.661 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.4 mttp -67.07 -12.56 60.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.225 1.41 . . . . 2.98 112.959 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.0 25.35 66.91 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.531 1.062 . . . . 1.88 113.384 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.83 172.4 7.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.642 1.577 . . . . 7.65 110.076 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 87.5 m -83.76 127.66 33.96 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.541 -0.725 . . . . 1.98 111.192 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -134.65 109.54 8.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.438 1.495 . . . . 1.97 110.045 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.2 m -140.51 154.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.595 1.158 . . . . 1.14 112.498 -172.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.44 170.28 8.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.37 0.878 . . . . 1.25 113.37 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 10.3 t -130.66 130.26 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.426 1.89 . . . . 2.76 111.035 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.08 150.03 47.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.421 1.089 . . . . 1.0 112.227 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.5 m -142.94 117.54 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.912 2.085 . . . . 2.45 111.255 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 45.29 53.9 7.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.701 2.0 . . . . 2.85 112.805 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.65 33.47 23.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.387 1.875 . . . . 1.52 114.091 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.33 144.86 36.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 2.79 109.911 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 146.17 41.08 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.923 -1.736 . . . . 1.86 112.296 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 24.9 p -121.84 -44.24 2.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.107 0.963 . . . . 1.3 113.123 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.23 -169.93 34.75 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.325 0.966 . . . . 0.63 114.853 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.58 161.12 39.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.709 1.603 . . . . 1.26 114.296 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 18.1 mm -129.38 135.01 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.008 1.723 . . . . 1.97 110.651 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -110.77 126.5 54.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.273 1.829 . . . . 1.56 110.198 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.09 153.97 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.421 1.488 . . . . 2.94 110.032 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -121.34 122.28 39.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.16 1.384 . . . . 1.74 111.425 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 43.0 t0 -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.811 1.244 . . . . 4.64 113.153 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.256 1.426 0 C-N-CA 125.766 1.626 . . . . 5.56 112.904 179.089 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 51.5 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.419 0.152 . . . . 14.73 110.815 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.96 159.46 42.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.953 . . . . 10.77 112.036 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 51.6 m -128.96 132.14 47.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.454 1.501 . . . . 10.51 110.426 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 20.0 ptm -164.66 147.53 8.71 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 6.4 113.629 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -141.37 -31.83 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.894 1.678 . . . . 7.47 113.139 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -97.61 99.56 2.26 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.666 0.651 . . . . 3.07 113.068 -171.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 18.2 p -113.59 147.64 37.99 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.272 1.029 . . . . 3.47 113.705 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.58 141.55 46.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.026 3.151 . . . . 1.79 112.19 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.11 128.11 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.727 2.011 . . . . 3.08 110.302 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.293 10.3 p -76.04 117.51 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.61 -1.306 . . . . 2.42 113.464 -169.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -100.72 -47.05 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.9 1.28 . . . . 3.06 112.928 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -154.97 153.81 31.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 4.23 112.203 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -131.87 143.53 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.936 1.294 . . . . 1.14 109.868 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.3 tttt -141.38 146.92 37.23 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.081 0.771 . . . . 2.71 113.081 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 61.2 t -89.93 134.51 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 1.95 111.717 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.9 tp -113.25 -22.82 10.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.136 1.774 . . . . 2.79 113.274 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 121.56 25.2 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.015 1.726 . . . . 2.1 109.111 169.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -135.43 137.72 42.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.742 1.016 . . . . 3.53 113.742 -171.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 5.0 m 61.32 -50.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.98 2.912 . . . . 3.43 115.227 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -75.35 133.47 41.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.999 -1.111 . . . . 3.58 107.999 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 64.34 -53.85 0.27 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.363 2.265 . . . . 6.1 115.393 -168.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.74 154.57 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.299 1.44 . . . . 3.82 111.79 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.6 m -121.86 153.42 38.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.013 1.325 . . . . 2.68 113.954 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 31.9 p80 -50.05 -50.53 47.51 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.678 2.103 . . . . 4.37 116.678 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -74.32 -28.78 61.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.483 1.038 . . . . 3.79 111.978 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.98 -37.51 67.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.8 -1.095 . . . . 4.04 112.007 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.13 -56.19 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 119.416 1.007 . . . . 1.97 110.565 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.98 -28.63 69.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.448 -0.783 . . . . 1.82 112.617 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.27 -46.75 63.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.937 0.717 . . . . 1.84 112.937 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 27.6 pt -70.25 -28.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.968 1.258 . . . . 2.03 113.372 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 63.1 t -70.55 -52.02 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.568 0.622 . . . . 1.53 110.944 170.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.39 -30.37 73.34 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.369 -0.832 . . . . 0.74 114.271 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 12.6 p -70.2 -44.1 69.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.761 1.281 . . . . 1.64 112.85 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.66 -49.56 76.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.679 0.792 . . . . 1.1 111.549 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -65.91 -22.68 66.52 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.568 -0.708 . . . . 2.41 112.905 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 68.4 m -67.0 -38.52 86.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.735 1.214 . . . . 3.5 114.116 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.3 t30 -95.42 -15.18 23.19 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.237 1.415 . . . . 2.73 111.934 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 37.8 t -66.21 176.0 1.92 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.544 1.538 . . . . 1.66 109.928 165.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.2 46.87 1.72 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.263 -1.523 . . . . 3.69 113.407 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -93.39 165.1 19.0 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.219 1.408 . . . . 2.45 113.884 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.98 -26.07 0.96 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.593 2.862 . . . . 1.27 114.74 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.9 tt -110.62 -48.83 3.1 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.212 1.405 . . . . 2.16 112.643 -168.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -56.9 -24.16 48.58 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 113.999 0.36 . . . . 0.98 113.999 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 36.7 p -60.67 -17.38 47.31 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.724 1.379 . . . . 2.23 114.724 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.09 86.1 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.418 1.008 . . . . 1.71 111.396 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.6 mt -70.26 -39.52 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.553 1.141 . . . . 1.45 110.192 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 79.8 m -52.58 -48.09 66.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.338 0.655 . . . . 1.75 111.695 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 43.9 tttt -64.16 -49.7 71.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.313 0.645 . . . . 3.16 112.279 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 11.2 t80 -53.89 -42.84 69.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 2.84 111.542 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.5 t -70.39 -53.74 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.213 1.405 . . . . 2.17 112.031 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -58.17 -42.58 86.31 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.772 -1.205 . . . . 4.41 111.816 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.31 -32.3 70.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.618 0.767 . . . . 3.82 112.953 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.31 -48.41 65.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.319 1.048 . . . . 1.89 111.781 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.47 -31.36 67.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.673 0.99 . . . . 2.28 113.673 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 26.4 t0 53.39 29.5 8.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.335 1.854 . . . . 2.65 113.622 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.1 t -98.82 -21.53 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.36 1.615 . . . . 4.03 115.36 -168.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 6.4 tt0 52.62 20.15 1.43 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.824 2.157 . . . . 2.88 116.824 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 56.7 p -137.46 0.15 2.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.15 -1.594 . . . . 4.48 114.844 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 157.69 36.74 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.112 -0.993 . . . . 1.95 113.413 -169.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 84.4 130.76 2.06 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.528 0.971 . . . . 1.19 115.528 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1107 ' ' THR . . . . . 0.417 HG23 ' H ' ' A' 1108 ' ' CYS . 0.5 OUTLIER -144.18 -170.02 3.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.209 2.604 . . . . 2.69 108.603 -175.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1108 ' ' CYS . . . . . 0.417 ' H ' HG23 ' A' 1107 ' ' THR . 48.8 t -60.68 132.41 53.8 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.063 1.875 . . . . 2.09 116.063 -168.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.03 148.74 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.168 2.187 . . . . 4.27 116.057 169.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.5 143.8 26.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.465 -2.05 . . . . 2.96 105.465 161.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.85 132.3 54.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.645 1.578 . . . . 3.94 112.451 -169.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.48 99.12 4.41 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.935 2.094 . . . . 3.16 109.352 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 33.2 m -102.1 148.61 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.245 0.832 . . . . 3.65 113.245 -169.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 24.5 t -133.16 111.08 12.94 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.959 1.303 . . . . 1.64 107.773 168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.66 134.74 62.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.892 2.394 . . . . 2.16 113.519 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 59.93 26.22 62.82 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.465 1.507 . . . . 2.4 115.924 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.0 t -146.52 -47.9 0.19 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.002 1.401 . . . . 2.41 114.257 -172.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.13 169.26 21.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.888 0.756 . . . . 0.88 113.445 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.84 162.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.673 -0.898 . . . . 3.89 112.621 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 34.6 t -122.49 145.37 48.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.716 2.006 . . . . 1.25 109.757 167.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.1 p -150.03 160.91 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.613 0.765 . . . . 1.3 112.42 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -119.99 105.32 10.93 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.551 -0.718 . . . . 2.05 109.135 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.9 p -104.45 138.28 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.052 1.341 . . . . 2.97 112.191 -168.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 171.37 8.14 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.824 1.416 . . . . 2.08 114.824 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.282 18.2 t-20 148.09 59.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 1 C-N-CA 134.088 4.955 . . . . 2.85 108.547 166.561 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.35 -67.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.279 2.631 . . . . 3.15 109.286 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.28 33.7 2.32 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.829 1.048 . . . . 6.17 113.829 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.34 -6.83 22.8 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.737 1.637 . . . . 4.36 115.219 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.39 -7.83 0.67 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.193 1.797 . . . . 4.82 115.003 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -38.11 67.86 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.599 1.56 . . . . 6.41 110.213 167.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 48.0 t60 31.24 64.75 0.18 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.939 3.296 . . . . 6.61 114.945 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -61.75 128.61 37.04 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.463 1.105 . . . . 12.9 111.875 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.64 -1.15 56.85 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.739 1.015 . . . . 12.96 113.739 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 60.7 119.52 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.489 2.716 . . . . 10.71 112.959 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -141.62 -19.1 0.76 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.05 1.13 . . . . 15.87 114.05 -169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -117.44 5.79 12.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.492 1.517 . . . . 14.66 111.097 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 33.6 mt -140.73 125.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 12.52 107.452 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -101.86 -29.56 11.77 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.258 0.935 . . . . 14.53 112.401 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -86.41 -8.68 57.45 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.731 2.123 . . . . 14.2 116.731 -168.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -50.67 -41.92 56.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.926 2.565 . . . . 12.86 117.926 -168.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -159.84 -34.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.002 1.853 . . . . 15.86 116.002 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 12.6 tt -68.87 128.7 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.599 1.09 . . . . 15.76 112.241 -168.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -158.5 167.18 30.33 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.164 1.386 . . . . 15.43 111.874 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -78.19 47.82 0.7 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.311 1.445 . . . . 18.07 114.369 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 47.06 47.21 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.56 1.944 . . . . 19.41 115.835 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.66 5.73 41.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.743 2.417 . . . . 19.01 114.43 -169.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.62 6.1 1.22 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.088 1.755 . . . . 21.06 113.689 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.8 p -152.72 157.47 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.511 1.924 . . . . 25.23 109.438 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.26 23.53 1.27 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.03 1.332 . . . . 27.58 114.587 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.31 150.46 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.535 1.934 . . . . 31.25 112.26 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 40.9 t0 -76.71 132.14 39.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.923 1.689 . . . . 31.12 113.562 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -99.03 -13.12 20.0 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.78 1.632 . . . . 31.57 113.562 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 9.5 t 58.35 -6.11 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.96 2.904 . . . . 33.77 116.824 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -118.64 155.86 30.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.214 1.805 . . . . 31.08 112.915 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.45 141.39 29.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.109 0.963 . . . . 28.39 110.805 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -139.37 -82.14 0.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.149 1.166 . . . . 29.13 114.149 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 13.7 t -156.09 175.65 13.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.382 1.073 . . . . 22.43 112.149 -166.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 68.7 p -150.76 166.06 31.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.933 1.293 . . . . 19.06 113.005 169.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 38.8 p -123.03 21.62 9.74 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.462 1.905 . . . . 19.78 112.498 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 55.5 p -87.12 79.61 8.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.998 2.119 . . . . 16.47 111.542 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 79.8 p -65.62 -0.55 2.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 118.301 2.704 . . . . 16.25 118.301 -167.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 69.3 m -87.81 -3.57 58.93 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.798 1.036 . . . . 15.74 113.798 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 9.9 ptt? -71.48 -179.32 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.855 1.262 . . . . 15.08 112.755 169.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 22.4 mm -69.26 78.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.992 1.717 . . . . 13.16 111.777 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.5 pp -103.13 -18.62 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.428 1.491 . . . . 10.99 113.73 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.06 -24.69 59.45 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.107 -0.996 . . . . 10.07 112.318 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.42 10.35 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.299 1.44 . . . . 8.38 113.533 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -85.57 -35.78 20.83 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.931 1.293 . . . . 8.63 111.09 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.59 -44.69 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.48 1.112 . . . . 8.86 110.373 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 72.9 m -67.79 -17.04 64.4 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.942 1.09 . . . . 8.39 113.942 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -96.36 -6.3 37.94 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.051 1.34 . . . . 7.29 113.333 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -71.0 -23.39 62.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.411 1.263 . . . . 5.43 114.411 -173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 9.2 tt -68.19 -37.78 81.3 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.158 -0.964 . . . . 8.31 111.724 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 7.5 m120 -76.29 -53.84 7.64 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.195 1.398 . . . . 7.68 111.12 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -68.85 -4.09 14.99 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 113.643 0.979 . . . . 4.67 113.643 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 61.83 -14.63 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.625 3.17 . . . . 4.61 116.207 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -9.49 118.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.127 2.971 . . . . 2.54 115.113 166.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 123.94 30.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.848 1.659 . . . . 4.84 111.067 -170.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.28 123.16 26.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.946 0.794 . . . . 2.68 110.615 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -134.67 133.67 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.359 1.064 . . . . 0.97 111.104 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.18 147.51 41.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.605 1.162 . . . . 0.92 113.01 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.7 tt -149.58 141.35 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.895 1.278 . . . . 1.71 110.77 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.82 -155.25 26.05 Favored Glycine 0 CA--C 1.532 1.133 0 N-CA-C 115.411 0.924 . . . . 1.41 115.411 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -71.41 160.42 32.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.621 1.568 . . . . 3.48 111.59 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -59.13 -16.84 21.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.762 1.225 . . . . 7.37 114.066 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -57.74 -36.0 71.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.683 0.793 . . . . 4.78 112.256 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 5.3 m95 -74.35 -47.57 33.46 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.13 0.972 . . . . 5.03 112.156 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -29.06 68.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.478 0.711 . . . . 2.44 112.164 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.33 -66.89 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.156 2.182 . . . . 3.57 108.127 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -23.38 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.536 1.935 . . . . 9.2 115.953 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.66 14.62 31.43 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 120.349 1.431 . . . . 1.05 114.163 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.81 17.88 67.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.249 1.404 . . . . 1.19 116.517 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.16 155.48 28.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.405 1.103 . . . . 1.25 111.533 -170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 92.3 t -91.94 127.95 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.485 0.714 . . . . 2.89 110.189 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 13.8 tt -112.97 152.44 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.003 1.321 . . . . 2.35 111.954 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.46 156.64 20.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.571 1.693 . . . . 2.91 115.571 -168.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.4 t30 -68.66 -37.26 79.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.533 1.133 . . . . 3.51 113.914 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.29 -33.61 69.89 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.93 -1.106 . . . . 2.91 112.305 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -76.27 -37.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.227 -0.921 . . . . 2.6 112.196 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.59 -35.37 77.67 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.125 0.875 . . . . 3.22 112.075 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.03 -40.29 84.6 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.947 1.092 . . . . 2.72 113.947 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.57 -44.99 48.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.073 0.949 . . . . 4.22 112.319 171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 47.8 tpp -59.85 -56.27 23.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.39 1.076 . . . . 1.86 111.681 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.8 t -66.54 -30.65 71.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.522 -0.736 . . . . 2.24 112.52 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -62.4 -45.79 91.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.401 1.08 . . . . 3.52 111.391 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -67.53 -39.09 85.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.081 1.353 . . . . 5.0 112.071 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.11 -45.26 92.83 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.626 -0.671 . . . . 3.87 112.158 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.52 -21.14 62.77 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.936 -1.102 . . . . 5.76 113.309 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.266 14.2 ptpt -85.23 7.62 21.37 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.934 1.457 . . . . 4.4 114.934 167.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 72.2 21.21 79.34 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.785 1.074 . . . . 2.37 115.785 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -110.42 144.08 39.74 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.121 1.461 . . . . 5.57 110.39 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 52.5 m -61.35 124.31 20.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 2.01 112.44 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.06 125.43 37.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.756 1.222 . . . . 1.32 110.174 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.6 m -141.99 159.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.709 1.204 . . . . 2.0 113.536 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.2 mt -111.61 158.3 19.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.634 1.974 . . . . 1.79 111.559 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.7 p -139.47 128.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.076 0.951 . . . . 3.26 112.665 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.6 153.06 48.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.381 2.272 . . . . 0.98 111.008 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 10.5 m -144.09 136.13 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.252 -0.905 . . . . 1.8 112.098 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 33.3 t70 41.74 50.88 4.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.004 1.721 . . . . 2.99 112.207 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.26 6.0 m-20 66.19 21.59 11.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.385 1.994 . . . . 1.54 116.385 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -126.71 151.04 48.68 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.015 2.126 . . . . 2.48 110.147 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.18 143.08 41.32 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.769 -1.832 . . . . 1.88 111.795 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 17.5 p -118.72 -38.84 3.05 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.422 1.267 . . . . 1.39 114.422 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.73 -172.94 37.53 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 119.389 0.995 . . . . 0.65 114.588 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.7 151.59 41.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.716 1.606 . . . . 1.07 112.838 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.34 137.0 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.944 1.697 . . . . 2.21 109.962 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -123.7 135.06 53.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.653 1.581 . . . . 1.71 110.951 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 32.5 mt -140.41 153.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.463 1.905 . . . . 2.82 110.403 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -128.7 173.09 10.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.026 1.33 . . . . 2.5 109.918 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.11 151.02 21.8 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.285 -0.884 . . . . 4.43 113.016 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.293 1.837 . . . . 4.72 111.779 175.654 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.432 0.901 . . . . 15.3 113.432 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 26.3 m-85 54.79 33.54 19.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.34 1.456 . . . . 13.84 114.107 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 18.3 m -77.11 141.61 40.13 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.465 1.506 . . . . 10.45 110.31 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 6.1 ptm -91.54 174.22 7.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.204 1.187 . . . . 7.8 114.204 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -68.93 -87.91 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.763 0.825 . . . . 6.42 112.594 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.34 87.5 1.2 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.688 1.137 . . . . 3.09 111.942 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.28 135.35 84.53 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.884 1.674 . . . . 4.43 115.235 -167.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -84.04 94.51 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.532 2.821 . . . . 2.51 112.008 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 82.2 t -89.96 108.86 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.883 -1.135 . . . . 3.9 109.767 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.1 p -72.38 129.44 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.745 -1.222 . . . . 2.96 111.968 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.14 -50.7 2.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.177 1.547 . . . . 4.03 115.177 -167.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -149.64 149.74 31.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.142 0.883 . . . . 2.77 112.609 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -129.67 145.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.876 1.27 . . . . 1.42 110.904 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.9 tttt -141.66 138.86 32.79 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.155 0.982 . . . . 2.66 113.433 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 94.3 t -82.93 134.5 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.951 0.9 . . . . 1.33 110.71 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 20.0 tp -107.22 -32.31 7.85 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.096 1.358 . . . . 2.55 112.966 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 51.9 m -118.03 99.11 6.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.729 1.212 . . . . 2.76 108.234 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 141.47 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.284 1.034 . . . . 3.49 110.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.7 m 52.52 29.24 6.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.958 1.836 . . . . 2.83 115.958 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -137.91 -17.51 1.24 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.106 1.151 . . . . 3.27 114.106 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.5 -49.3 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.166 1.348 . . . . 5.48 114.41 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.96 142.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.52 1.528 . . . . 2.53 111.25 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 14.5 m -87.53 147.93 25.12 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.335 1.054 . . . . 2.75 112.287 170.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.1 p80 -53.5 -38.89 64.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.45 1.648 . . . . 3.49 115.45 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 23.8 t60 -66.79 -37.19 84.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.609 1.095 . . . . 4.1 111.869 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -65.68 -36.29 83.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 118.228 -0.891 . . . . 4.24 111.259 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.11 -54.35 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 118.947 0.794 . . . . 1.77 111.189 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.51 -33.88 76.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.877 0.762 . . . . 1.66 111.881 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.39 57.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.63 -0.7 . . . . 1.87 112.143 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 6.0 pt -69.48 -27.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 119.642 1.11 . . . . 1.89 113.748 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 77.5 t -70.68 -43.39 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.237 0.926 . . . . 1.42 110.415 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.34 -37.42 93.87 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.127 -0.818 . . . . 0.68 113.282 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.6 p -73.88 -37.62 64.67 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.353 1.576 . . . . 2.19 112.636 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.68 88.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.961 0.801 . . . . 0.91 112.896 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . 0.254 3.4 tp10 -75.75 -20.92 57.95 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.196 0.813 . . . . 3.38 113.196 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 26.3 t -57.7 -47.46 82.32 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.075 -1.64 . . . . 1.86 112.743 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -77.33 -2.94 37.46 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 121.222 -0.924 . . . . 2.14 112.689 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 20.0 m -111.12 -178.6 3.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.584 2.354 . . . . 3.13 111.494 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.03 51.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.135 -0.978 . . . . 4.17 113.55 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1086 ' ' HIS . . . . . 0.412 ' CB ' HN61 ' A' 1232 ' ' ATP . 1.9 m-70 -73.68 147.41 86.77 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.042 . . . . 2.28 113.688 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.83 -36.51 90.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.172 3.248 . . . . 1.55 114.028 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.03 -47.49 4.98 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.787 2.035 . . . . 1.58 110.874 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -33.01 78.98 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 114.583 0.593 . . . . 1.21 114.583 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 3.9 t -66.0 -16.02 63.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.126 1.463 . . . . 4.01 114.458 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -73.63 -27.16 61.13 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.089 -1.007 . . . . 2.65 112.922 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.5 -41.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.878 0.871 . . . . 2.29 109.199 171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.7 m -51.62 -43.97 62.75 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.757 0.708 . . . . 2.4 111.289 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.1 tttt -63.82 -51.78 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.913 0.778 . . . . 3.24 112.936 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.41 -47.2 66.43 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 3.9 111.105 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 98.3 m -69.07 -52.48 28.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.023 1.329 . . . . 2.94 112.369 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -49.49 -48.34 47.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.06 1.344 . . . . 4.74 111.642 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -71.62 -35.91 70.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.844 0.857 . . . . 3.12 112.905 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -70.33 -35.75 73.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.5 -1.375 . . . . 2.18 113.448 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.86 -6.38 37.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.285 1.034 . . . . 1.51 113.751 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.8 t0 54.91 40.07 31.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.239 1.416 . . . . 3.39 112.472 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.6 t -131.38 174.12 10.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.518 1.527 . . . . 2.58 111.508 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -114.87 -3.67 12.71 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.337 1.455 . . . . 2.95 112.4 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 8.1 t -148.76 142.6 25.69 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.337 1.455 . . . . 3.94 111.69 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.69 145.87 20.38 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.974 0.91 . . . . 2.19 112.322 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 83.18 135.75 2.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.074 1.321 . . . . 1.21 114.458 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 54.9 m -105.72 -64.77 1.11 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.041 1.336 . . . . 2.47 111.118 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -137.85 131.67 31.42 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.308 0.575 . . . . 1.7 110.595 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 30.3 mm -143.54 142.29 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.801 4.441 . . . . 4.56 102.797 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.12 106.25 5.47 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 120.895 -1.128 . . . . 4.48 111.442 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -100.62 145.67 28.09 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 118.038 2.607 . . . . 3.59 118.038 -166.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.16 104.65 7.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 130.843 3.657 . . . . 2.78 106.68 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 91.5 t -99.03 139.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.309 1.044 . . . . 3.15 110.932 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 43.4 t -126.48 101.3 27.77 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.021 1.328 . . . . 1.48 109.257 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.01 130.8 32.84 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.039 3.159 . . . . 2.02 114.978 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 75.75 -37.68 1.25 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.031 2.253 . . . . 1.91 114.412 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 60.4 m -82.19 -48.28 11.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.052 1.426 . . . . 2.56 113.938 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 159.43 -178.0 35.73 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.835 0.743 . . . . 0.8 113.387 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.12 157.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.661 0.615 . . . . 3.76 112.661 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -131.68 151.6 51.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.997 1.719 . . . . 0.97 110.871 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -153.8 166.26 33.43 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.842 -1.161 . . . . 1.28 114.003 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -110.71 136.72 49.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.253 -1.017 . . . . 1.6 108.253 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 80.1 t -128.95 139.44 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.458 1.103 . . . . 3.65 111.877 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.8 t -146.6 152.82 39.54 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.789 2.144 . . . . 2.47 116.789 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.305 24.7 t-20 178.71 65.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 1 C-N-CA 132.582 4.353 . . . . 3.92 106.207 158.061 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -149.55 -89.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.791 2.036 . . . . 3.88 107.879 -171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -132.25 9.26 4.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 120.156 1.344 . . . . 5.32 113.896 172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.51 60.4 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.562 -1.336 . . . . 6.61 113.848 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -7.64 2.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.96 1.704 . . . . 5.98 115.58 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.93 -42.05 97.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.592 1.157 . . . . 7.52 110.263 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 95.9 m-70 58.36 -72.46 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.029 2.132 . . . . 9.35 115.726 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -157.04 156.62 33.18 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.702 1.601 . . . . 15.97 112.331 -166.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.92 124.92 27.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 106.248 -1.76 . . . . 18.53 106.248 164.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 9.1 p30 -140.41 155.86 46.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.563 1.32 . . . . 16.02 114.563 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 3.5 p90 -161.93 70.21 0.32 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.084 1.354 . . . . 19.81 111.888 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 5.2 m-80 61.31 18.67 9.45 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.671 1.73 . . . . 17.57 115.671 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.98 123.26 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.137 0.975 . . . . 16.42 110.216 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -85.01 -26.9 26.77 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.41 -0.806 . . . . 18.43 112.344 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.67 -10.43 12.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.087 1.355 . . . . 17.43 113.996 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -65.77 -22.96 66.62 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.84 2.456 . . . . 14.81 114.505 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.265 2.226 . . . . 16.09 112.328 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.49 113.3 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 120.496 -1.378 . . . . 16.14 111.432 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -141.19 165.05 28.6 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.751 2.02 . . . . 21.72 111.617 -168.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -82.69 -19.33 38.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.987 -1.071 . . . . 21.31 112.954 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -129.53 145.24 51.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.715 1.206 . . . . 24.17 110.755 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 50.5 m -137.24 -41.57 0.57 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.573 1.549 . . . . 26.68 111.591 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 13.1 mt 59.73 -176.9 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.33 1.452 . . . . 31.1 114.109 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.2 p -148.61 155.6 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.829 -1.169 . . . . 33.38 112.996 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -149.24 159.78 43.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.059 2.144 . . . . 38.55 110.896 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 12.3 mm 66.06 128.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 128.852 2.861 . . . . 42.11 115.643 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.25 30.02 4.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.893 1.677 . . . . 41.24 114.86 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -78.18 12.05 2.05 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.713 1.746 . . . . 37.48 115.713 -169.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 80.3 p 43.19 -110.67 0.16 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.951 2.5 . . . . 36.49 115.846 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 11.9 p30 -141.36 174.01 10.94 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.247 1.819 . . . . 35.27 111.6 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -134.04 154.7 50.98 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.424 1.639 . . . . 30.43 115.424 -168.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -150.45 145.16 25.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.756 2.422 . . . . 32.38 108.158 167.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 38.0 m 60.29 157.47 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.508 1.923 . . . . 24.58 115.361 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 57.6 p -72.09 -38.41 69.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.048 -1.657 . . . . 20.49 112.611 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.52 128.8 11.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.243 1.817 . . . . 17.64 110.363 175.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 6.4 t -74.27 -27.54 60.79 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.47 0.708 . . . . 16.05 112.802 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 6.0 m -152.05 -68.78 0.17 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.492 1.293 . . . . 14.9 114.492 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 2.0 m -122.54 10.59 9.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 117.359 2.355 . . . . 13.27 117.359 -163.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 60.0 mtt 61.75 129.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.772 2.029 . . . . 14.59 115.543 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . 0.253 1.9 mt 55.77 41.52 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 125.949 1.7 . . . . 12.57 111.865 -173.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.4 pp -117.76 -8.1 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.1 1.36 . . . . 10.11 113.633 168.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -25.18 68.16 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.885 -1.134 . . . . 8.94 113.507 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -73.07 -3.22 24.91 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.601 1.334 . . . . 9.22 114.601 172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -106.71 -25.12 11.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.062 1.345 . . . . 9.42 113.561 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 77.0 mt -51.24 -35.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 126.065 1.746 . . . . 6.92 112.663 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 19.7 p -64.09 -3.99 3.14 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.409 1.633 . . . . 8.25 115.409 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -92.35 -17.16 25.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.997 1.319 . . . . 7.87 113.625 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.79 63.82 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.666 1.728 . . . . 5.34 115.666 -168.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.7 -26.56 68.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.165 0.986 . . . . 8.35 112.974 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -104.23 -44.89 4.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.423 1.489 . . . . 7.08 112.587 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -79.05 63.84 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.533 1.933 . . . . 5.42 110.888 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -49.02 136.08 14.98 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.127 1.371 . . . . 3.21 114.554 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -160.4 156.16 25.69 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.963 1.705 . . . . 2.43 112.37 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.75 143.63 32.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.488 1.515 . . . . 3.88 111.398 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -110.87 115.74 30.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.698 1.599 . . . . 2.92 108.656 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.8 m -133.76 142.35 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 119.979 1.263 . . . . 1.13 112.829 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 150.89 39.7 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.648 0.981 . . . . 0.93 113.648 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.2 tt -141.29 135.24 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.428 1.891 . . . . 1.81 109.799 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.08 -167.9 40.93 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.582 1.393 . . . . 1.49 116.582 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -76.08 166.1 23.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.046 1.738 . . . . 3.02 114.523 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -50.78 -45.32 59.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.904 2.187 . . . . 6.14 116.904 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.27 -31.89 58.51 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.152 1.796 . . . . 3.47 112.003 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -64.0 -35.87 82.13 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.958 -1.089 . . . . 3.92 112.239 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.44 83.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.075 1.139 . . . . 2.94 114.075 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.0 mt -54.94 -60.06 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.506 1.122 . . . . 2.91 109.047 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -49.57 -19.35 0.57 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.59 2.07 . . . . 6.32 116.59 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.82 11.57 4.8 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 121.632 2.014 . . . . 1.05 112.593 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.71 35.59 85.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 119.868 -1.77 . . . . 0.78 113.966 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.18 153.45 19.59 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.535 1.167 . . . . 0.81 111.435 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -84.53 132.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.804 -0.56 . . . . 1.89 109.554 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.67 140.05 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.676 1.19 . . . . 2.08 110.862 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -116.06 167.85 10.61 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.987 1.477 . . . . 2.99 114.987 -167.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.05 -45.98 69.01 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.15 1.537 . . . . 3.49 115.15 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.34 -26.91 64.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.068 -1.02 . . . . 2.39 112.021 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -78.56 -38.62 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 117.748 -1.12 . . . . 1.31 112.481 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.69 -41.56 91.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.902 1.683 . . . . 2.04 110.884 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.18 -40.96 91.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.417 1.487 . . . . 2.39 113.305 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 52.1 t80 -72.11 -40.93 67.79 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.187 0.995 . . . . 3.61 112.523 174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 46.2 tpp -59.96 -57.53 12.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.01 1.724 . . . . 2.22 110.104 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.2 t -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.903 0.881 . . . . 1.79 111.971 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.11 -54.75 42.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.233 1.013 . . . . 2.5 111.776 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.29 -34.19 70.42 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.498 0.925 . . . . 3.64 113.498 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -59.35 -49.92 75.95 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.223 -0.923 . . . . 3.28 110.764 170.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -72.76 -14.86 61.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.936 -1.103 . . . . 5.47 113.957 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 16.7 mttp -75.79 -6.23 49.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.099 1.76 . . . . 3.5 112.367 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 86.2 24.59 39.94 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.231 1.396 . . . . 1.36 114.071 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.74 163.06 13.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.372 1.469 . . . . 5.34 110.302 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 14.0 m -76.2 133.19 40.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 2.28 110.195 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -137.12 116.63 12.84 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.105 1.362 . . . . 1.79 111.138 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 25.9 m -140.22 156.83 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.191 1.396 . . . . 1.99 112.784 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.92 162.88 14.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.901 1.681 . . . . 1.52 112.293 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.6 p -135.65 126.98 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.655 1.582 . . . . 3.57 112.456 172.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.86 157.0 38.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.436 1.894 . . . . 0.85 111.75 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 133.21 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.413 1.485 . . . . 2.23 112.292 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 40.16 45.42 1.71 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.385 2.274 . . . . 2.76 113.428 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 12.3 m-20 64.79 39.79 5.97 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.713 2.405 . . . . 1.56 116.115 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -146.69 146.4 30.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.148 2.179 . . . . 2.29 110.176 169.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.23 147.81 42.13 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 119.498 -2.001 . . . . 2.22 112.964 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.0 p -124.83 -38.52 2.35 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.02 1.489 . . . . 1.13 115.02 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -163.34 179.92 38.18 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 120.7 1.591 . . . . 0.59 115.875 -173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.58 155.62 43.73 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.86 1.664 . . . . 1.06 113.502 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.9 mm -130.93 141.92 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.585 1.954 . . . . 1.96 110.247 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -122.87 131.2 53.64 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.349 1.46 . . . . 1.71 111.59 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 8.4 mt -135.83 145.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.967 1.707 . . . . 2.8 109.789 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -124.42 -173.96 2.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.505 1.522 . . . . 2.0 112.884 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.338 27.4 t70 66.86 -67.65 0.16 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.968 2.907 . . . . 4.89 115.175 -168.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.256 1.429 0 CA-C-O 116.59 -1.672 . . . . 9.12 113.705 169.426 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1232 ' ' ATP . . . . . 0.412 HN61 ' CB ' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 118.473 -0.775 . . . . 14.37 113.009 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -126.88 141.05 51.92 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.114 1.325 . . . . 17.19 112.235 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 78.1 m -80.88 158.87 25.18 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 10.02 113.11 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 7.7 ttp -32.56 134.15 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.252 2.621 . . . . 6.79 113.519 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 64.4 m80 -90.08 -25.01 20.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.719 1.377 . . . . 10.51 114.719 -172.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -69.84 75.83 0.43 Allowed Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.572 1.558 . . . . 4.32 113.784 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 16.5 p -115.2 150.28 44.1 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 125.669 1.588 . . . . 3.45 115.274 -166.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.31 166.69 7.13 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.739 2.293 . . . . 1.89 110.486 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 11.7 p -135.47 130.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.969 -1.082 . . . . 2.99 111.28 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -66.59 135.01 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.14 -0.975 . . . . 2.58 111.507 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.88 -33.67 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.227 0.825 . . . . 2.88 113.227 -172.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -159.2 143.87 15.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.296 0.953 . . . . 3.15 112.113 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -114.66 134.27 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.686 0.795 . . . . 1.27 109.15 167.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.5 tttt -140.71 145.1 36.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.291 0.849 . . . . 4.06 113.291 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.3 t -101.5 129.82 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.386 1.474 . . . . 2.36 111.169 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.05 -25.0 11.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.017 1.727 . . . . 2.52 112.45 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 34.4 m -137.0 130.72 31.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.454 1.501 . . . . 2.44 110.492 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.25 144.52 40.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.009 1.324 . . . . 6.2 110.918 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 61.9 m 54.55 13.13 0.62 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.254 2.221 . . . . 3.7 115.839 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -137.53 13.63 2.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.717 2.407 . . . . 3.1 112.433 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -163.46 -58.42 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.298 1.439 . . . . 5.81 110.679 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.48 159.76 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 129.768 3.227 . . . . 2.87 108.006 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 39.7 m -106.6 155.6 19.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.842 1.257 . . . . 2.29 113.68 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.83 -41.36 57.53 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.706 2.484 . . . . 3.94 117.706 -167.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.97 -28.05 54.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.971 1.26 . . . . 3.36 111.406 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1072 ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' 1072 ' ' LYS . 9.7 mmpt? -70.36 -34.63 72.85 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 116.917 -1.516 . . . . 6.3 111.933 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 63.3 mt -56.81 -53.68 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.662 1.574 . . . . 1.87 110.547 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.53 -30.76 71.15 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.4 -0.812 . . . . 1.94 112.323 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.03 60.84 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 1.17 112.231 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.7 pt -69.98 -35.09 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.508 -1.37 . . . . 0.98 112.682 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.0 t -71.01 -43.52 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.096 0.862 . . . . 1.87 111.71 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.96 -35.7 79.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.849 -1.157 . . . . 0.57 113.492 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 73.8 p -73.96 -25.31 59.87 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.51 -0.994 . . . . 1.66 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.27 -55.49 15.87 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.538 0.735 . . . . 0.89 110.98 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.07 -20.85 63.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.133 0.79 . . . . 2.13 113.133 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 24.8 t -55.39 -33.18 63.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.72 -1.238 . . . . 1.86 112.87 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.73 -8.57 58.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.051 0.941 . . . . 2.25 113.361 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 5.0 t -99.35 -179.64 4.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.797 1.639 . . . . 1.59 113.754 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -137.5 8.86 2.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.353 2.261 . . . . 3.91 113.962 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -87.33 150.01 48.23 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.779 1.232 . . . . 2.24 113.906 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.17 -28.65 40.42 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.466 3.444 . . . . 1.1 115.47 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.11 -46.94 4.12 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.182 0.993 . . . . 1.64 112.576 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.84 -30.11 76.76 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 113.938 0.335 . . . . 0.89 113.938 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 21.3 p -63.69 -17.74 63.27 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.947 -1.325 . . . . 2.38 114.248 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.13 85.8 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.136 -0.978 . . . . 1.75 111.71 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 15.1 mt -73.29 -36.4 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.824 1.65 . . . . 1.51 110.573 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 21.5 m -51.44 -47.34 63.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.904 0.775 . . . . 1.92 111.546 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.68 -49.81 75.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.035 0.934 . . . . 3.06 112.574 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.62 -40.0 74.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.563 0.745 . . . . 2.76 111.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 28.3 t -71.66 -52.53 17.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.38 1.472 . . . . 2.15 112.591 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -51.87 -44.16 63.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.751 1.62 . . . . 4.0 112.588 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -69.84 -34.05 73.12 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.602 0.761 . . . . 4.12 112.591 175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.91 -47.77 67.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.413 1.006 . . . . 2.96 112.977 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.91 -32.54 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.78 0.832 . . . . 2.18 112.48 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 1.7 t70 54.94 54.39 9.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.747 2.019 . . . . 2.76 112.009 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.3 t -148.37 142.99 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.125 -0.984 . . . . 2.76 113.193 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -98.0 21.88 10.11 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.042 1.337 . . . . 3.0 112.707 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 43.1 p -131.23 4.23 4.37 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.024 1.861 . . . . 3.83 116.024 -168.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 139.4 57.75 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.689 1.366 . . . . 1.72 114.689 -167.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 70.38 171.77 10.34 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.42 1.009 . . . . 1.12 115.363 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 4.6 m -157.24 -40.49 0.07 Allowed 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.398 -1.06 . . . . 1.82 112.809 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.11 143.54 48.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.517 1.127 . . . . 1.84 113.125 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.2 129.01 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 127.408 2.283 . . . . 3.51 109.097 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -25.71 32.14 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.983 1.105 . . . . 3.6 113.983 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 34.0 t80 60.7 130.49 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 128.613 2.765 . . . . 5.2 114.864 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -149.69 106.89 3.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.613 1.965 . . . . 2.12 108.318 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 9.8 p -106.43 144.44 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.801 0.728 . . . . 3.9 112.744 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 59.2 t -129.25 102.8 18.46 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.196 -1.409 . . . . 1.6 107.196 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.89 136.54 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.276 2.651 . . . . 2.34 113.512 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.79 20.58 77.62 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.42 1.01 . . . . 2.14 114.17 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 21.5 t -145.02 -50.85 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.777 1.231 . . . . 3.72 112.826 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 137.33 -153.3 21.87 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 119.524 1.056 . . . . 1.35 114.643 174.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.3 mm -120.65 147.79 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.738 1.615 . . . . 3.59 112.175 -172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.5 t -133.63 148.26 51.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.502 1.921 . . . . 1.26 109.303 165.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.0 p -167.34 177.5 6.04 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.428 -1.42 . . . . 1.5 114.072 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 137.64 53.78 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 105.965 -1.865 . . . . 5.2 105.965 165.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 29.6 m -132.48 154.51 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.835 0.854 . . . . 3.46 113.053 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.0 t -161.55 165.39 28.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.264 1.579 . . . . 1.9 115.264 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -164.5 -25.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 1 C-N-CA 132.888 4.475 . . . . 2.42 108.144 162.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 16.9 pt -43.48 -29.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.512 1.525 . . . . 3.24 113.702 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.92 43.85 1.25 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 122.259 1.028 . . . . 4.83 111.015 165.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -71.03 11.94 2.43 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 127.035 2.255 . . . . 4.29 116.145 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.9 -11.34 50.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.993 1.717 . . . . 3.97 114.212 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.0 tt -82.85 -74.67 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.661 0.785 . . . . 5.43 112.313 -168.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 80.5 t60 -160.95 165.05 30.61 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.84 0.856 . . . . 7.89 112.298 -169.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -54.63 157.99 2.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.845 0.831 . . . . 12.63 110.534 167.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -43.6 66.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.347 -0.846 . . . . 15.57 110.147 172.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -150.45 143.27 24.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 13.81 111.475 166.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -148.19 -44.02 0.16 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.449 1.099 . . . . 17.35 111.78 168.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 7.4 m120 -130.5 13.55 5.48 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.872 1.269 . . . . 12.3 113.405 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.99 108.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.838 -1.164 . . . . 13.6 111.184 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -70.87 -5.44 30.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.188 1.395 . . . . 16.98 113.881 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.52 -13.28 26.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.048 1.739 . . . . 18.95 114.094 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . 0.271 6.1 m-20 -89.61 55.91 3.37 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.233 -1.542 . . . . 16.21 114.638 -169.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -118.18 166.66 12.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.169 2.587 . . . . 21.99 109.778 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.79 156.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.854 -1.154 . . . . 24.49 110.15 167.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -126.84 52.59 1.76 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.485 1.114 . . . . 26.43 111.712 -172.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -71.61 62.75 0.4 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.673 1.989 . . . . 27.49 111.85 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -105.65 139.44 40.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.089 1.755 . . . . 30.03 112.108 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 57.9 m 58.64 72.51 0.52 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.504 1.122 . . . . 32.5 112.072 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.85 2.76 4.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.045 1.868 . . . . 33.39 116.045 -167.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 29.3 m -93.21 1.33 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.55 1.14 . . . . 37.52 113.585 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -121.38 79.23 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.511 1.525 . . . . 40.31 109.347 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.23 164.33 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 38.31 112.622 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 131.39 41.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.193 0.812 . . . . 39.55 113.193 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -120.06 7.46 10.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.619 1.568 . . . . 41.8 113.463 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 4.0 t -150.64 143.19 24.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.888 2.075 . . . . 43.22 108.963 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 61.0 t30 -67.21 -39.16 86.24 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.892 1.071 . . . . 41.5 113.892 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . 0.266 39.3 mt-10 61.21 24.18 14.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.089 1.755 . . . . 41.09 115.258 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 61.25 -50.91 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 130.804 3.642 . . . . 45.15 117.843 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 7.9 m -123.68 -37.33 2.64 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 39.02 112.521 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 51.4 p -166.76 149.89 6.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.257 1.027 . . . . 35.7 113.208 165.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 12.9 t -101.94 169.61 8.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.083 1.753 . . . . 32.24 107.659 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1160 ' ' SER . . . . . 0.432 ' HG ' HG12 ' A' 1165 ' ' ILE . 2.0 t -152.13 82.1 1.26 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 115.578 1.696 . . . . 29.9 115.578 167.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 47.3 m -73.59 92.58 1.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 101.095 -3.668 . . . . 26.9 101.095 160.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 82.7 p -50.96 -16.14 0.39 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.63 2.826 . . . . 25.23 118.63 -162.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 14.4 mmt -91.66 -61.01 1.73 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.23 1.012 . . . . 26.44 110.71 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.63 -27.91 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 113.501 0.926 . . . . 25.02 113.501 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1165 ' ' ILE . . . . . 0.432 HG12 ' HG ' ' A' 1160 ' ' SER . 2.5 pp -78.69 -18.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 114.052 1.13 . . . . 19.67 114.052 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.26 -28.24 69.21 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.554 1.07 . . . . 13.93 111.778 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -66.95 -20.58 65.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.606 1.163 . . . . 13.62 113.702 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.24 -80.28 0.57 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.751 1.22 . . . . 15.72 111.139 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.81 -33.87 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.087 1.755 . . . . 14.85 112.869 -167.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.0 m -71.39 -14.22 62.1 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.611 0.967 . . . . 9.21 113.611 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . 0.282 4.8 p30 -104.0 -49.29 3.66 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.194 -0.941 . . . . 9.1 111.563 164.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.1 -13.36 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.414 1.886 . . . . 6.05 116.014 -170.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.56 -47.79 83.06 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.183 0.901 . . . . 9.06 112.172 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -99.83 -42.46 6.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.718 1.207 . . . . 5.25 112.719 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -91.12 55.73 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.574 1.55 . . . . 3.78 111.221 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -42.47 133.05 3.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.382 1.073 . . . . 4.34 113.77 -169.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 168.22 27.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.478 1.288 . . . . 3.67 114.478 -166.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -135.92 126.82 27.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.833 1.653 . . . . 4.56 109.514 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.1 tttt -84.84 120.39 26.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.327 -0.99 . . . . 1.99 108.327 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.8 m -135.26 141.15 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.56 1.073 . . . . 0.98 112.469 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.58 152.88 41.17 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 1.01 112.92 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.1 tt -153.01 136.77 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 1.74 110.991 -171.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 150.4 -141.89 9.15 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.252 1.261 . . . . 1.32 116.252 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.63 152.14 0.23 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.312 2.645 . . . . 2.41 113.509 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -57.49 -28.72 63.66 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.244 -0.91 . . . . 5.55 112.529 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.35 -31.83 70.69 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.815 1.188 . . . . 4.49 113.941 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.1 m95 -63.86 -27.04 68.89 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.281 1.401 . . . . 5.1 112.716 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -71.54 -38.85 70.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.092 0.557 . . . . 2.7 111.161 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.57 -70.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.12 1.368 . . . . 3.45 109.016 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -40.26 -46.91 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.454 2.301 . . . . 6.23 114.495 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.0 t30 -81.71 9.11 8.37 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.965 1.098 . . . . 1.06 113.965 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.74 20.83 79.35 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 120.759 -1.213 . . . . 0.99 114.791 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.1 mt -89.08 166.62 13.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.247 1.019 . . . . 1.28 109.868 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.2 t -124.9 112.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.859 1.264 . . . . 3.74 109.581 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.2 tt -87.57 147.98 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.569 1.548 . . . . 2.69 111.365 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -116.32 177.6 4.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.63 1.172 . . . . 3.58 113.181 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -72.09 -33.42 67.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.282 1.956 . . . . 3.24 116.282 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.08 -31.05 25.53 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.127 1.331 . . . . 3.24 113.445 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.2 p -67.08 -41.14 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 117.991 -1.004 . . . . 1.83 110.428 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.95 -34.5 76.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.384 1.447 . . . . 2.65 112.157 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.6 -42.13 99.39 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.015 0.926 . . . . 2.25 113.3 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -66.73 -40.94 88.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.162 1.385 . . . . 3.46 112.105 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 20.3 ttm -63.61 -56.26 17.24 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.369 1.068 . . . . 2.49 109.983 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.2 t -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.629 0.772 . . . . 2.04 112.673 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.45 -51.73 67.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.836 -1.165 . . . . 3.56 112.297 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -70.97 -31.09 67.54 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.396 0.887 . . . . 4.71 113.396 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -65.07 -34.08 77.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.755 -1.216 . . . . 3.69 111.853 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -70.92 -29.9 66.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.912 1.285 . . . . 4.28 113.268 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 2.2 mttp -71.54 3.17 4.14 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.996 1.318 . . . . 3.98 113.439 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.77 20.52 55.81 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.732 1.158 . . . . 2.07 114.897 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.55 158.29 17.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.337 1.455 . . . . 3.93 111.482 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.0 m -81.41 137.27 35.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.844 2.058 . . . . 1.95 110.285 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -138.69 124.77 20.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.886 0.874 . . . . 1.14 112.686 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 31.1 m -140.99 158.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 125.936 1.694 . . . . 2.06 112.887 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.54 164.26 12.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.86 1.264 . . . . 2.04 113.311 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 14.4 t -136.55 118.1 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.428 1.891 . . . . 2.92 111.124 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -119.14 155.08 32.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.195 1.398 . . . . 1.92 112.018 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.81 132.45 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.309 1.844 . . . . 1.58 112.218 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 71.1 m-20 40.22 47.94 2.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.882 2.073 . . . . 3.47 112.845 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.263 27.9 m-20 60.05 34.74 21.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.484 2.313 . . . . 1.56 116.383 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -145.13 149.17 34.53 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.578 -1.326 . . . . 2.79 112.651 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.43 142.48 58.16 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.319 -1.488 . . . . 1.79 113.512 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.9 p -125.74 -34.03 2.67 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.897 1.444 . . . . 1.19 114.897 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.69 -176.15 38.11 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-N 120.964 1.711 . . . . 0.6 115.876 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.64 153.61 42.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.839 1.656 . . . . 0.93 113.292 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 22.0 mm -123.6 134.39 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.567 1.547 . . . . 2.04 110.058 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -117.23 133.01 56.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.328 1.851 . . . . 1.69 109.549 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -139.31 147.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.006 1.723 . . . . 2.58 111.974 -167.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -117.69 -164.03 0.98 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.621 1.168 . . . . 1.78 112.204 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -119.0 151.16 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.421 1.488 . . . . 4.09 112.538 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 116.64 -1.648 . . . . 4.52 114.492 -179.599 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.293 -0.86 . . . . 16.38 111.653 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -142.44 157.47 44.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.753 1.621 . . . . 18.31 112.705 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 67.8 m -68.93 -44.54 72.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.949 1.462 . . . . 9.49 114.949 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 46.9 ttp -146.63 -32.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.318 1.97 . . . . 9.32 116.318 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.57 -7.31 50.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.792 1.404 . . . . 8.71 114.792 -171.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.11 72.17 2.52 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.955 -1.091 . . . . 3.17 113.038 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 40.8 p -109.99 145.97 33.17 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 113.932 1.086 . . . . 3.39 113.932 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -85.87 153.8 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.09 3.193 . . . . 2.62 113.637 -173.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 4.7 m -139.17 126.52 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 126.113 1.765 . . . . 4.25 110.475 171.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -72.09 142.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.756 -1.215 . . . . 2.56 110.008 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.9 -42.57 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.339 0.866 . . . . 3.36 113.339 -168.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -153.59 147.19 25.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.749 0.704 . . . . 3.41 112.073 172.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 2.5 m -130.69 136.13 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.263 1.025 . . . . 1.2 111.043 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 60.9 tttt -138.23 147.83 44.14 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.776 0.831 . . . . 2.39 112.357 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.2 t -91.18 137.64 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.561 1.145 . . . . 1.84 111.374 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.7 tp -107.04 -22.98 12.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.253 1.821 . . . . 1.38 112.753 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 5.0 t -100.03 27.76 5.32 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.512 1.525 . . . . 3.06 113.782 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.82 125.02 21.78 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.695 -1.253 . . . . 4.18 111.538 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 58.6 m 43.65 41.0 3.25 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.808 2.043 . . . . 4.21 113.931 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -133.04 -29.25 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.028 1.331 . . . . 4.57 113.594 172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -146.0 -55.7 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.661 1.726 . . . . 6.51 115.661 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 19.7 mt -135.53 144.04 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.991 1.316 . . . . 2.47 110.89 -169.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 50.9 m -98.42 158.62 15.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.641 1.576 . . . . 2.95 113.357 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -55.5 -38.0 68.6 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.11 1.522 . . . . 4.3 115.11 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 29.2 t60 -75.03 -37.38 61.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.506 1.048 . . . . 3.27 112.165 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.5 mttt -65.99 -40.78 91.46 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.137 0.881 . . . . 3.6 111.637 169.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.2 mt -57.75 -52.43 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.826 0.739 . . . . 1.61 110.932 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.13 -29.76 69.57 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.198 -0.938 . . . . 1.63 112.373 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.01 19.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.092 0.557 . . . . 1.18 111.959 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.64 -35.25 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 120.235 1.38 . . . . 1.02 113.055 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 46.0 t -70.81 -46.06 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.342 -0.849 . . . . 1.45 111.356 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -71.93 -28.58 68.45 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.97 -1.081 . . . . 0.65 114.335 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 62.8 p -76.42 -32.71 58.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.369 1.067 . . . . 1.42 112.398 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.37 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.053 0.842 . . . . 0.81 112.323 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -66.36 -17.07 64.55 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.56 0.948 . . . . 2.23 113.56 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 16.1 p -67.25 -15.62 63.8 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.126 -1.608 . . . . 2.02 114.463 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -94.76 -18.51 21.18 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.377 1.071 . . . . 1.98 112.565 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 4.4 t -77.48 164.43 25.44 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.526 1.306 . . . . 1.99 114.526 -169.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.12 23.5 4.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.881 2.073 . . . . 3.41 112.259 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -85.68 160.8 52.51 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.738 1.215 . . . . 2.72 113.136 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -81.51 1.52 9.2 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.58 3.52 . . . . 2.61 115.425 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -141.12 -48.09 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.938 1.295 . . . . 1.96 112.055 -167.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.15 -23.2 65.9 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.894 1.117 . . . . 0.97 115.894 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 23.7 p -58.0 -25.68 61.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.16 -1.2 . . . . 2.65 113.324 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.9 85.84 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.316 0.858 . . . . 1.67 113.316 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.53 -41.66 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.243 1.417 . . . . 2.33 110.898 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 8.9 t -64.0 -39.13 93.43 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 118.278 -0.867 . . . . 3.79 112.204 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 23.5 tttp -60.14 -50.55 73.23 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.529 1.059 . . . . 4.04 112.785 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.47 -44.73 55.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.574 1.149 . . . . 3.45 112.184 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 35.6 t -69.68 -52.38 26.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.592 1.157 . . . . 2.17 112.416 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 14.9 tptm -49.96 -39.39 40.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.183 1.793 . . . . 3.35 112.545 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.87 -40.37 65.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.718 1.207 . . . . 3.79 113.99 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -70.53 -34.62 72.5 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.061 -1.649 . . . . 2.07 113.298 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.01 -7.92 54.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.225 1.41 . . . . 1.27 114.421 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 40.3 m-20 53.53 29.99 9.96 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.152 1.381 . . . . 4.61 114.094 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -123.4 176.33 6.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.141 1.776 . . . . 2.72 112.557 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -115.44 -2.97 12.45 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.263 1.425 . . . . 2.67 113.716 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.0 t -143.97 125.08 14.47 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.777 -1.202 . . . . 3.83 112.443 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.24 144.89 29.21 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.38 1.472 . . . . 1.39 110.722 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 68.66 179.38 19.35 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 120.687 -1.258 . . . . 1.08 114.201 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.7 m -158.2 -62.54 0.08 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.15 1.38 . . . . 2.18 112.911 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.2 t -136.06 142.23 44.35 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.835 1.198 . . . . 1.89 112.382 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 6.0 mm -143.17 150.17 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 1 C-N-CA 133.085 4.554 . . . . 3.14 107.533 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -7.81 12.34 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.043 1.868 . . . . 3.05 116.043 -173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 65.9 m-85 43.94 109.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 129.396 3.079 . . . . 4.67 118.773 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.37 94.27 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.879 2.072 . . . . 2.33 106.213 166.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 19.2 m -103.21 146.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.276 1.03 . . . . 3.79 113.302 -168.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.3 t -138.61 124.61 12.53 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.414 1.486 . . . . 1.25 109.231 171.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.35 146.31 39.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.976 3.117 . . . . 2.56 112.994 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 53.27 32.57 44.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.39 0.995 . . . . 1.61 113.396 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 53.9 t -150.01 -81.74 0.11 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.548 1.539 . . . . 2.33 111.655 -168.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 178.12 171.01 41.03 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 121.341 -0.849 . . . . 1.18 112.838 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.36 157.16 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 117.373 0.586 . . . . 3.86 112.124 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 20.1 t -130.89 157.31 43.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.025 1.73 . . . . 1.1 111.077 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 27.6 p -162.8 167.44 22.87 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.424 0.898 . . . . 1.34 113.424 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -112.24 119.85 39.74 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.227 1.011 . . . . 1.55 108.853 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.2 p -111.67 139.08 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.944 0.72 . . . . 3.11 112.944 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -128.47 151.44 49.4 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 122.363 1.078 . . . . 2.1 111.75 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -163.66 50.63 0.14 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 130.171 3.388 . . . . 2.78 104.807 159.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 88.2 mt -128.02 -55.78 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.639 1.976 . . . . 5.76 107.881 -169.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -127.3 20.5 6.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.452 1.901 . . . . 5.3 111.056 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -63.52 -22.2 65.55 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 120.434 -1.416 . . . . 4.87 114.967 -170.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.49 1.56 0.78 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.718 2.007 . . . . 6.31 115.037 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.82 -46.71 29.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.555 1.542 . . . . 7.44 112.651 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 16.6 m80 53.58 149.62 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.192 2.597 . . . . 9.85 117.326 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.16 160.06 42.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.663 -1.898 . . . . 10.49 115.918 168.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.78 175.15 5.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 103.868 -2.641 . . . . 15.3 103.868 159.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 44.8 t30 -57.72 149.59 21.68 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 119.518 -1.989 . . . . 12.89 110.336 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -140.5 -23.19 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 116.576 2.065 . . . . 14.41 116.576 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -151.43 -0.57 0.35 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.272 1.212 . . . . 13.64 114.272 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.27 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 119.645 1.111 . . . . 13.32 108.44 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -68.3 81.88 0.24 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.929 1.692 . . . . 17.53 115.092 -167.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 5.8 t0 66.0 22.36 11.23 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.824 2.45 . . . . 16.24 115.752 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -55.52 152.35 9.11 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.556 1.942 . . . . 16.28 114.046 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -62.95 125.83 25.31 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.176 -0.952 . . . . 16.95 112.427 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 38.5 pt -124.87 4.12 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.555 1.942 . . . . 15.55 112.908 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -65.36 114.17 4.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.742 1.617 . . . . 16.77 112.21 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -64.11 -29.85 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.612 1.338 . . . . 16.33 114.612 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 59.98 127.04 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.139 2.976 . . . . 16.5 115.615 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 32.8 m -96.78 149.44 21.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.96 1.304 . . . . 18.84 111.751 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . 0.282 0.9 OUTLIER 42.27 -142.87 0.09 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.325 2.25 . . . . 21.15 113.902 -176.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 11.5 p -114.32 147.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.258 1.823 . . . . 21.74 110.635 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -132.73 108.51 9.06 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.791 0.836 . . . . 23.31 112.103 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 7.1 tp -77.96 -25.91 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.106 0.963 . . . . 26.48 111.735 171.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -72.69 140.43 47.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.107 0.963 . . . . 27.7 112.359 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -68.97 -26.88 65.27 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.048 -1.033 . . . . 28.36 113.424 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 36.5 t -148.17 123.95 10.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.865 1.266 . . . . 28.96 111.125 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 32.6 t30 -155.56 -33.5 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.968 1.307 . . . . 28.22 112.504 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.85 104.62 17.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.137 0.881 . . . . 25.52 112.349 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -93.37 -169.45 2.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.225 1.41 . . . . 32.43 110.56 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 9.5 t -45.16 127.4 6.82 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.558 1.318 . . . . 27.23 114.558 171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 88.7 p -88.39 3.22 50.67 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.479 1.112 . . . . 26.24 111.574 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 27.2 p 58.59 10.49 1.43 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.705 2.402 . . . . 28.83 115.428 -172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 48.5 t -101.67 159.84 14.97 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.986 1.714 . . . . 25.24 112.176 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 42.8 m -76.23 -22.88 54.69 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.942 -1.099 . . . . 24.79 111.219 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 45.8 m -65.05 -8.08 14.79 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.312 1.445 . . . . 23.73 114.635 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 13.0 ptt? -92.67 -12.47 31.46 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.879 1.066 . . . . 22.78 113.879 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 40.3 pt -126.75 32.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.207 1.803 . . . . 18.89 113.07 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.9 pp -73.23 -20.72 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 120.623 -1.298 . . . . 17.37 113.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.96 -30.0 71.23 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.712 -1.242 . . . . 15.63 112.196 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.01 68.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.813 0.845 . . . . 15.03 112.901 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.99 -35.53 59.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.519 0.599 . . . . 14.63 111.424 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.28 -27.99 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.83 1.252 . . . . 13.69 111.603 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 42.6 m -60.69 -10.08 4.83 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.963 1.098 . . . . 13.32 113.963 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -27.13 65.94 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.767 -1.208 . . . . 10.5 113.768 169.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.38 64.86 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.774 1.398 . . . . 8.61 114.774 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -50.66 -36.58 36.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.049 1.34 . . . . 12.85 112.105 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 19.0 m120 -96.77 -50.22 4.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.073 1.349 . . . . 10.19 112.256 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -90.47 101.81 14.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.717 1.006 . . . . 6.27 113.717 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -45.8 145.35 1.44 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.149 1.907 . . . . 4.74 116.149 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.57 144.05 39.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.942 1.697 . . . . 2.46 114.256 -171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.89 149.87 23.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.635 1.974 . . . . 5.58 110.57 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -104.74 119.04 38.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.779 0.831 . . . . 3.05 111.572 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 11.1 m -133.84 141.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.995 0.739 . . . . 0.94 112.995 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.03 153.54 42.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 2.04 113.457 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 3.4 tt -150.09 143.46 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.101 1.36 . . . . 1.88 108.919 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 161.13 -160.85 32.47 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 117.789 1.876 . . . . 1.52 117.789 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.05 155.97 0.58 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.105 3.362 . . . . 2.56 113.889 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -55.22 -49.93 70.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.308 1.043 . . . . 5.57 113.558 169.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -63.23 -35.38 80.13 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 3.14 112.214 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -67.42 -25.37 65.89 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.581 1.553 . . . . 5.7 113.552 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 23.1 mmt -77.06 -37.63 54.25 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.118 1.155 . . . . 2.19 114.118 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 73.8 mt -53.11 -63.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.382 1.073 . . . . 2.61 108.516 168.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -40.89 -34.43 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.45 2.7 . . . . 7.18 116.348 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.16 9.14 2.7 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 121.458 1.935 . . . . 1.08 112.933 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.72 27.41 73.87 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 119.804 -1.81 . . . . 1.0 113.891 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.4 mt -93.65 160.97 14.54 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.363 1.465 . . . . 0.88 110.894 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 22.0 t -92.67 119.56 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.438 0.695 . . . . 1.78 109.825 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.2 tt -105.81 148.75 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.707 1.603 . . . . 2.46 110.396 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -138.58 163.97 30.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.61 0.966 . . . . 3.64 113.61 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.01 -27.37 69.37 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.97 1.1 . . . . 3.31 113.97 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.62 -30.28 56.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.783 1.174 . . . . 2.84 113.901 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.3 p -76.89 -39.56 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 118.243 -0.884 . . . . 2.64 110.466 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -62.54 -41.0 98.6 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.626 1.103 . . . . 2.49 112.256 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.57 -43.59 80.26 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.039 0.755 . . . . 2.53 113.039 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 18.4 t80 -56.44 -38.98 72.36 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 4.76 111.181 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 17.6 tpp -66.04 -50.55 63.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.933 0.893 . . . . 2.01 111.404 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.6 t -64.98 -38.35 90.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.301 0.955 . . . . 2.16 112.063 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.98 -53.57 55.26 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.218 -0.926 . . . . 4.61 112.334 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -72.33 -32.77 66.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.919 1.081 . . . . 3.89 113.919 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.48 -41.67 85.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.304 0.956 . . . . 3.12 111.121 169.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -74.44 -19.93 60.21 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.088 1.755 . . . . 6.69 114.999 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -69.88 -13.1 62.09 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.39 1.076 . . . . 5.25 112.921 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.53 11.47 59.38 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.327 1.918 . . . . 2.79 113.763 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -91.22 156.53 17.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.621 1.568 . . . . 6.07 109.345 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.6 m -82.92 130.42 35.14 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.639 1.175 . . . . 2.24 108.299 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -117.93 130.23 56.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.19 0.996 . . . . 1.19 110.645 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.7 m -143.0 164.53 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.089 1.356 . . . . 1.08 113.341 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.15 159.77 18.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.508 1.523 . . . . 1.67 111.571 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 7.3 p -138.41 135.08 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.321 1.048 . . . . 3.21 112.597 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -136.74 152.71 50.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.722 1.609 . . . . 0.95 111.685 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.0 m -148.7 136.24 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.123 0.969 . . . . 2.34 112.082 -171.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 38.3 m-20 41.06 45.31 2.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.71 2.004 . . . . 3.67 113.163 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 52.8 m-20 64.89 32.23 10.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.317 2.647 . . . . 1.62 117.414 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -137.57 145.15 42.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.168 -1.582 . . . . 2.39 111.491 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.86 122.84 24.71 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.042 -1.036 . . . . 1.61 111.206 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.7 p -106.3 -32.2 8.28 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 2.11 113.856 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.04 179.44 39.63 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 120.264 1.393 . . . . 0.46 116.489 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.05 144.35 34.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.272 1.829 . . . . 2.29 111.253 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.72 145.53 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.32 1.448 . . . . 2.41 112.028 -166.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -119.79 133.69 55.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.838 1.655 . . . . 1.86 110.878 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.41 150.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.418 1.887 . . . . 2.74 109.896 -171.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.38 -169.73 2.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.894 1.277 . . . . 2.18 111.143 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -125.56 167.64 14.77 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.813 -1.179 . . . . 4.59 112.38 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.919 1.688 . . . . 4.96 114.424 -177.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.651 0.739 . . . . 11.56 112.763 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -80.59 -31.52 36.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.436 1.894 . . . . 13.02 112.742 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 10.2 t -141.33 136.79 31.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.109 1.364 . . . . 8.29 110.951 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.18 -174.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.0 1.32 . . . . 6.95 111.811 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -119.57 -53.13 2.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.254 1.421 . . . . 7.26 110.652 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -113.82 93.81 0.67 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.871 1.224 . . . . 2.74 114.096 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 93.0 m -70.71 141.8 87.85 Favored Pre-proline 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.417 . . . . 3.2 112.438 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.34 155.22 4.54 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.803 3.669 . . . . 1.66 112.529 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 5.9 m -134.75 123.94 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.149 1.779 . . . . 4.02 111.057 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.252 2.7 p -74.52 137.19 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.855 -1.153 . . . . 2.3 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.04 -33.1 3.59 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.197 1.554 . . . . 3.22 115.197 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -153.12 148.45 26.99 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.466 1.106 . . . . 3.5 111.06 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 7.5 m -128.73 130.21 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.762 0.825 . . . . 2.34 111.614 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.1 tttt -135.21 144.15 46.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.392 1.077 . . . . 2.58 113.277 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 27.3 t -90.67 135.59 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.417 1.087 . . . . 1.57 110.674 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.18 -41.78 8.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 1.28 110.772 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 1.5 t -81.97 37.9 0.5 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.675 1.59 . . . . 3.5 113.358 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -57.98 119.23 6.38 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.485 -1.384 . . . . 4.86 111.185 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 34.0 m 55.17 25.72 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.138 2.175 . . . . 3.49 116.081 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -123.95 -21.35 5.12 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 116.454 2.02 . . . . 4.19 116.454 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -152.69 -62.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.355 1.434 . . . . 6.54 113.497 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 63.2 mt -129.12 150.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.817 1.647 . . . . 2.11 109.16 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 7.7 t -108.25 161.91 14.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.739 1.385 . . . . 3.39 114.739 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -43.92 -50.7 8.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.925 2.49 . . . . 4.56 116.652 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -76.36 -32.45 58.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.391 0.996 . . . . 3.86 112.149 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 45.9 mttp -67.12 -41.55 86.0 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.057 . . . . 3.47 112.09 170.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.15 -48.3 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.617 0.644 . . . . 1.95 111.05 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.9 -32.94 73.77 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.288 -0.883 . . . . 1.5 112.452 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.16 81.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 1.24 112.742 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.9 pt -70.23 -38.35 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.362 0.983 . . . . 1.78 112.752 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 99.8 t -65.82 -45.58 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.635 1.107 . . . . 1.82 110.71 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.71 -37.58 92.52 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.636 -0.665 . . . . 0.61 113.823 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 23.2 p -72.97 -40.42 65.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.462 1.131 . . . . 1.77 112.182 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.98 -51.71 63.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.977 0.808 . . . . 0.82 112.626 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.12 -23.91 67.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.316 -0.865 . . . . 2.7 112.485 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 11.9 p -63.85 -18.58 64.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.513 1.301 . . . . 2.43 114.513 171.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.85 5.87 31.08 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.744 1.618 . . . . 2.92 111.87 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.7 t -105.31 -177.54 3.39 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.246 1.818 . . . . 1.63 112.697 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -128.82 17.5 6.26 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.585 1.954 . . . . 3.83 113.703 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -88.16 146.68 38.73 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.127 1.528 . . . . 3.1 115.127 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.95 -44.74 4.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.725 2.283 . . . . 1.43 112.363 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -44.21 74.85 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.64 -0.663 . . . . 2.17 111.533 172.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.37 -44.34 95.23 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.222 0.915 . . . . 1.57 113.949 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 20.8 p -64.56 -33.59 76.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.41 -1.053 . . . . 2.73 112.184 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.84 83.22 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.813 -1.179 . . . . 1.95 112.811 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.06 -40.51 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.076 0.55 . . . . 2.02 110.493 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 95.2 m -54.07 -46.53 72.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.374 1.07 . . . . 2.21 111.057 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.9 tttt -59.89 -48.67 80.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.882 0.765 . . . . 3.15 112.343 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -61.55 -43.17 99.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 2.76 112.719 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 77.8 m -68.74 -45.08 72.4 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.704 1.202 . . . . 3.24 111.827 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.75 -31.16 72.24 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.856 -1.152 . . . . 3.83 111.794 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -66.26 -44.18 84.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.07 0.85 . . . . 3.53 110.819 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -61.55 -47.96 83.17 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.199 0.909 . . . . 2.42 112.753 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.11 -23.53 63.05 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.212 1.19 . . . . 1.46 114.212 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.51 54.77 10.42 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.764 1.269 . . . . 2.24 112.78 -174.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.1 t -127.38 -15.35 5.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.679 1.591 . . . . 3.25 114.449 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 58.29 -50.67 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 129.076 2.95 . . . . 2.88 115.649 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.4 t -111.97 135.01 53.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.27 2.228 . . . . 4.04 110.883 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.43 174.28 15.47 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.251 1.02 . . . . 1.64 112.847 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.31 155.88 4.39 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 123.067 1.371 . . . . 1.0 115.495 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1107 ' ' THR . . . . . 0.434 ' CG2' ' H ' ' A' 1108 ' ' CYS . 97.6 m -150.76 -166.5 2.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.373 2.269 . . . . 2.51 107.312 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1108 ' ' CYS . . . . . 0.434 ' H ' ' CG2' ' A' 1107 ' ' THR . 79.5 m -57.84 142.05 47.09 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.655 1.982 . . . . 3.07 114.829 -169.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 177.94 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 129.273 3.029 . . . . 2.97 110.667 -166.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 1.9 t0 -135.64 171.6 14.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.432 1.493 . . . . 2.79 109.484 167.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.385 1.448 . . . . 4.45 113.818 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.78 99.34 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.344 2.657 . . . . 3.31 105.776 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 42.5 t -99.18 138.61 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.244 1.418 . . . . 3.08 110.389 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 11.4 t -133.6 102.8 12.47 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.971 -1.122 . . . . 1.6 107.971 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.69 130.25 30.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.52 2.147 . . . . 2.16 113.001 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.3 20.36 76.68 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.321 0.962 . . . . 1.59 114.816 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 50.8 t -143.52 -43.72 0.28 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.28 1.54 . . . . 2.25 113.804 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.43 34.96 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.666 1.026 . . . . 0.89 115.666 171.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.5 tt -140.61 154.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.529 1.532 . . . . 2.76 111.747 168.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -132.08 147.05 52.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.717 1.607 . . . . 0.98 113.136 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.1 p -151.8 167.37 28.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.532 1.308 . . . . 1.32 114.532 -175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -114.44 97.14 6.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.029 1.732 . . . . 1.62 109.282 171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.9 p -107.53 130.13 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.727 1.149 . . . . 3.12 113.499 -169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -115.04 168.54 9.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.514 1.126 . . . . 1.64 113.752 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 28.0 t-20 179.19 -47.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.422 3.089 . . . . 2.23 107.87 162.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -10.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.099 1.76 . . . . 3.32 115.538 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -136.47 27.75 3.07 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.508 1.523 . . . . 4.84 110.957 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.32 58.6 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.703 -1.248 . . . . 3.32 115.611 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.14 -6.02 59.33 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.426 1.269 . . . . 4.34 114.426 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.71 -52.73 3.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.919 1.687 . . . . 6.16 111.536 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -149.6 136.14 19.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.454 1.101 . . . . 10.6 111.561 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -93.55 -48.55 6.31 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.553 1.316 . . . . 12.66 114.553 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 1.4 t30 74.04 59.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.918 1.687 . . . . 14.9 109.166 -164.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 52.5 t30 -108.22 134.97 50.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.323 1.849 . . . . 10.34 111.682 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 5.4 m-90 53.5 -172.37 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.529 1.932 . . . . 15.28 112.246 -170.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 9.3 m-80 62.64 34.11 15.2 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 123.493 1.616 . . . . 14.18 112.127 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.96 159.68 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 129.091 2.956 . . . . 14.83 108.982 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -49.71 -41.48 43.57 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.223 1.409 . . . . 21.55 111.506 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.22 126.2 5.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.094 2.958 . . . . 18.04 107.829 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -98.43 -44.76 6.38 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.286 1.403 . . . . 14.89 111.462 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -81.37 163.12 23.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.294 1.438 . . . . 16.9 112.512 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 31.4 pt -60.05 144.28 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.921 0.889 . . . . 21.53 112.833 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -111.66 123.7 50.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.221 1.408 . . . . 20.27 111.263 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.74 10.77 4.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.218 1.407 . . . . 22.94 114.713 -169.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -116.02 52.97 0.88 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.091 1.356 . . . . 22.28 113.165 -170.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 20.1 m 62.5 170.27 0.13 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.24 1.816 . . . . 24.98 114.999 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.27 -24.73 22.0 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.286 1.034 . . . . 23.77 113.071 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.8 t 64.71 108.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 127.13 2.172 . . . . 23.08 113.998 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 61.36 177.07 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.032 2.133 . . . . 24.97 115.147 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.37 -23.42 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.972 1.309 . . . . 28.18 114.114 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.1 -49.29 2.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.394 1.452 . . . . 25.98 112.66 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . 51.42 21.5 1.22 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.217 2.207 . . . . 24.51 116.228 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 39.6 t -123.91 -48.9 1.87 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.783 1.031 . . . . 24.21 113.783 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 56.5 t30 50.74 47.01 25.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.775 1.23 . . . . 26.72 112.228 -170.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 27.4 tt0 48.87 72.61 0.28 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.952 2.101 . . . . 26.73 113.113 -171.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.88 166.61 0.95 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.463 1.282 . . . . 24.05 114.463 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 37.4 m -66.23 159.03 27.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.256 1.422 . . . . 23.22 113.578 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 27.0 p -93.7 3.61 55.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.571 2.063 . . . . 23.36 116.571 -169.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 17.6 p 63.76 151.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.458 1.903 . . . . 19.71 114.829 -169.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 43.2 p -170.27 -28.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.538 . . . . 18.75 115.154 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 8.6 t -68.69 129.77 40.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.44 1.274 . . . . 16.11 114.44 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 4.1 m -103.69 21.2 16.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.082 1.753 . . . . 15.7 113.169 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1163 ' ' MET . . . . . 0.413 ' C ' ' H ' ' A' 1165 ' ' ILE . 26.1 mmt -90.93 133.22 35.44 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.449 1.278 . . . . 17.87 114.449 -167.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 22.0 mm 58.61 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 128.29 2.636 . . . . 12.77 114.166 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1165 ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' 1163 ' ' MET . 2.7 pp -62.77 -25.64 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 120.25 -1.531 . . . . 10.15 112.663 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.96 -24.36 66.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.284 1.034 . . . . 10.18 113.379 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -71.77 -25.93 62.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.369 -0.832 . . . . 9.26 112.046 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.35 -32.81 17.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.023 1.329 . . . . 7.83 110.494 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.11 -39.81 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.773 1.229 . . . . 8.45 109.402 167.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 68.8 m -65.8 -21.0 66.46 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.16 0.8 . . . . 8.39 113.16 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 31.1 t30 -91.31 -11.38 38.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.02 1.328 . . . . 7.31 114.073 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -44.34 -46.06 9.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.692 2.108 . . . . 6.88 116.692 -167.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.63 -26.68 63.98 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 112.949 0.722 . . . . 9.07 112.949 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.57 -37.85 9.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.623 1.569 . . . . 6.07 111.353 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -98.39 68.81 1.91 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.68 1.992 . . . . 5.49 110.832 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.06 -31.57 13.39 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.319 0.859 . . . . 4.5 113.319 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 tm0? 9.5 107.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.515 3.126 . . . . 2.62 112.982 162.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.07 119.88 25.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.364 1.066 . . . . 3.31 113.347 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -81.35 115.08 20.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.056 1.342 . . . . 3.19 109.477 169.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.0 m -136.59 142.83 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.757 0.708 . . . . 1.05 112.871 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.61 153.16 47.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.728 1.211 . . . . 0.99 112.976 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -140.3 137.04 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.764 1.626 . . . . 1.69 108.642 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . -172.42 168.12 41.14 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.281 -0.887 . . . . 1.69 113.26 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.301 12.9 p30 -69.43 -49.33 56.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.021 1.489 . . . . 4.19 115.021 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -173.81 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 115.064 1.505 . . . . 5.58 115.064 169.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.16 -32.13 71.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.282 1.401 . . . . 3.32 113.286 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -67.27 -22.49 65.66 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.699 -1.251 . . . . 3.93 113.022 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -29.24 68.36 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.242 -1.536 . . . . 2.74 111.247 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 55.3 mt -69.39 -66.35 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.847 1.659 . . . . 2.46 108.63 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -48.01 -32.97 7.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.81 1.644 . . . . 5.75 114.9 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.68 5.52 27.84 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.919 1.236 . . . . 1.2 113.991 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 73.25 35.49 56.81 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.823 -1.173 . . . . 0.95 114.572 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.82 158.7 15.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.801 1.241 . . . . 0.73 110.343 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 86.7 t -97.26 123.56 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.362 -0.977 . . . . 1.8 108.362 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.1 tt -110.44 139.89 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.97 0.89 . . . . 2.32 112.675 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -96.55 150.83 20.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.699 1.2 . . . . 2.78 114.182 -168.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -69.2 -26.87 65.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.661 1.184 . . . . 3.82 114.057 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -84.26 -42.77 15.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.525 1.13 . . . . 2.85 112.989 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 13.1 p -65.09 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.117 0.871 . . . . 2.22 111.609 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -62.69 -45.71 91.51 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.639 1.109 . . . . 2.54 111.528 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.87 -33.88 73.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.172 0.989 . . . . 2.61 112.652 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.47 -44.35 64.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.605 1.093 . . . . 3.74 112.518 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.3 tpp -58.89 -48.01 82.93 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.711 1.604 . . . . 1.82 111.799 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 9.7 t -75.5 -38.45 59.46 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.99 -0.528 . . . . 2.63 112.364 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -53.95 -44.76 70.98 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.185 1.357 . . . . 3.48 112.744 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -62.49 -44.77 95.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.59 1.556 . . . . 4.78 112.224 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -71.57 -30.71 66.17 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.817 1.247 . . . . 4.26 112.655 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -70.46 -16.78 62.96 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.936 1.694 . . . . 5.81 113.74 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.369 0.0 OUTLIER -104.01 24.01 12.04 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.84 1.656 . . . . 4.84 114.247 170.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.75 76.02 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 117.755 1.862 . . . . 1.5 117.755 167.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -105.6 148.56 27.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.706 1.753 . . . . 5.48 111.598 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 56.5 m -76.41 128.38 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.094 1.358 . . . . 1.8 112.108 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.46 126.69 44.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.542 1.137 . . . . 1.26 112.108 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 32.7 m -141.17 156.73 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.141 1.376 . . . . 2.08 113.818 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.51 157.22 25.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.037 2.535 . . . . 1.86 112.131 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -131.34 119.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.519 1.527 . . . . 2.86 111.103 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -121.5 147.52 45.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.023 1.329 . . . . 0.82 111.601 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 35.1 m -144.44 121.67 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.32 1.048 . . . . 1.36 112.324 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.255 33.3 t0 41.11 50.97 3.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.582 2.353 . . . . 3.44 113.694 -176.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.289 7.6 m-20 68.51 25.77 6.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.855 2.862 . . . . 2.2 116.714 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.31 143.85 49.29 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.736 1.214 . . . . 2.41 111.141 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.14 136.59 48.24 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.535 -1.353 . . . . 1.63 112.355 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.7 p -113.81 -44.1 3.21 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.898 1.073 . . . . 1.13 113.898 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.3 -172.23 34.24 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 120.055 1.298 . . . . 0.59 115.47 -173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.16 154.0 43.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.914 1.686 . . . . 0.99 112.413 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.0 mm -126.9 137.23 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.28 1.432 . . . . 1.99 109.287 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -114.9 131.52 56.84 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.321 1.849 . . . . 2.22 109.801 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.46 155.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.92 1.688 . . . . 2.63 111.266 -168.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -127.69 173.0 10.28 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.492 1.517 . . . . 1.59 111.881 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -113.65 129.48 56.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.082 1.353 . . . . 4.25 111.623 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.256 1.429 0 N-CA-C 115.284 1.587 . . . . 4.41 115.284 -175.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.349 0.595 . . . . 11.13 111.294 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -129.4 162.74 27.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.949 1.7 . . . . 10.98 111.037 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 92.7 m -82.63 145.15 29.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.138 0.975 . . . . 8.63 110.978 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 10.6 tpt -84.98 -65.83 0.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.677 1.591 . . . . 9.03 110.644 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -116.83 -51.27 2.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.649 1.18 . . . . 8.79 113.948 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -138.62 122.2 2.32 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.094 0.798 . . . . 3.94 115.094 -171.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 12.0 m -80.25 139.3 52.31 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.04 0.92 . . . . 3.82 111.542 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.25 150.01 52.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.269 2.646 . . . . 1.63 112.765 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 6.1 p -134.86 133.56 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.52 1.528 . . . . 4.22 109.459 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 1.9 p -71.93 121.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.539 1.063 . . . . 2.93 108.941 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 17.4 t30 -106.21 -44.75 4.48 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.796 1.036 . . . . 4.0 113.796 -166.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -142.98 148.67 37.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.542 1.537 . . . . 3.02 110.812 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.0 m -129.16 148.45 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.124 0.97 . . . . 1.53 111.432 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -141.38 147.69 38.43 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.151 -0.968 . . . . 4.49 112.841 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 62.9 t -105.23 136.76 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.412 1.085 . . . . 1.48 111.742 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 22.6 tp -108.77 -23.96 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.872 2.469 . . . . 2.1 113.105 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 46.2 m -132.91 110.4 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.01 1.324 . . . . 2.27 110.051 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -118.54 155.69 30.44 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.688 1.195 . . . . 3.36 112.946 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 58.25 3.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.95 2.574 . . . . 2.85 117.95 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -127.49 -11.92 5.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.512 1.525 . . . . 3.29 114.028 -172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -158.27 -48.88 0.06 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.308 1.843 . . . . 4.94 110.312 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 165.41 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 128.471 2.708 . . . . 2.63 108.569 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.0 m -142.31 162.41 35.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.144 1.777 . . . . 2.56 111.49 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.6 t60 -45.83 -51.87 12.21 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.929 1.826 . . . . 6.05 115.929 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -75.21 -28.96 60.16 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.125 -0.985 . . . . 3.73 112.224 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -70.22 -41.98 72.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.016 -1.053 . . . . 3.82 111.706 170.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.01 -52.91 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 1.8 110.647 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.94 -32.62 74.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.073 0.851 . . . . 1.81 112.462 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.22 -51.17 60.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.97 0.508 . . . . 1.24 112.17 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.2 pt -70.43 -30.99 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.009 -1.057 . . . . 1.02 113.099 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 65.1 t -71.01 -48.86 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.167 0.894 . . . . 1.5 111.796 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.78 -34.64 83.48 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.248 -0.907 . . . . 1.19 113.316 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 58.9 p -74.51 -35.41 63.19 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.527 -0.749 . . . . 2.24 112.86 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.66 66.22 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.125 1.157 . . . . 1.19 114.125 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -78.86 -10.51 59.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.439 1.644 . . . . 2.07 115.439 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.2 t -61.29 -52.07 66.25 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.394 -1.442 . . . . 1.82 113.629 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.7 1.24 31.0 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.969 -1.082 . . . . 2.42 113.638 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.3 t -79.53 177.34 8.94 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.447 1.099 . . . . 1.64 113.914 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.99 2.5 9.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.113 2.165 . . . . 5.23 113.267 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -81.04 158.29 70.2 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 114.397 1.258 . . . . 2.45 114.397 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.21 -32.37 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.088 2.525 . . . . 1.0 113.913 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.6 -55.46 2.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.376 0.67 . . . . 1.5 112.318 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.55 -28.63 71.64 Favored Glycine 0 CA--C 1.543 1.805 0 N-CA-C 114.292 0.477 . . . . 0.94 114.292 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.3 p -61.23 -22.78 65.12 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.011 -1.288 . . . . 2.47 113.725 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.49 72.65 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.579 -1.326 . . . . 1.52 112.334 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.81 -34.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.015 1.326 . . . . 1.26 110.76 173.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 75.4 m -53.14 -46.7 68.94 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 118.432 -0.794 . . . . 1.82 111.508 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.46 -47.32 86.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.463 1.029 . . . . 2.7 112.821 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -55.11 -46.28 75.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.217 1.007 . . . . 3.11 112.145 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.2 t -66.49 -52.94 40.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.669 0.788 . . . . 2.4 112.207 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.2 -35.26 73.28 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 3.74 112.607 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 -48.68 65.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.386 1.075 . . . . 3.64 111.865 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -61.37 -37.86 84.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.096 0.958 . . . . 2.01 113.297 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.59 -16.98 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.333 1.605 . . . . 1.26 115.333 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.2 t0 56.47 30.38 17.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.279 1.432 . . . . 2.72 114.558 -170.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 14.2 t -107.72 159.88 16.14 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.273 -1.517 . . . . 3.04 111.48 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.55 -9.57 26.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.447 1.099 . . . . 2.88 111.569 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.0 t -141.92 130.95 23.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.753 2.021 . . . . 4.41 111.14 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -163.24 162.08 25.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.571 1.548 . . . . 1.86 111.091 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 57.82 76.42 0.21 Allowed Glycine 0 N--CA 1.471 1.013 0 CA-C-N 119.175 0.898 . . . . 2.95 113.748 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 23.6 m -68.14 -50.08 56.9 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.637 0.606 . . . . 3.03 112.637 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.1 t -136.85 142.34 42.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.145 0.978 . . . . 1.75 111.424 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.69 147.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 128.202 2.601 . . . . 4.18 107.615 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.92 81.05 1.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.173 1.389 . . . . 2.68 109.543 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -91.13 137.08 32.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.918 1.822 . . . . 3.62 115.918 -168.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -119.05 101.92 8.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.967 3.707 . . . . 2.36 106.267 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 21.7 m -99.65 142.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.432 0.901 . . . . 4.0 113.432 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 25.7 t -133.65 92.86 22.37 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.764 1.226 . . . . 2.19 109.06 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.9 149.37 61.52 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.938 3.092 . . . . 2.97 113.496 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.07 15.38 65.06 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.069 -0.851 . . . . 1.7 114.688 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 t -147.51 -70.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.966 1.383 . . . . 2.43 112.159 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 177.52 179.48 47.76 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.662 1.125 . . . . 1.02 112.72 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.51 160.76 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.372 -1.075 . . . . 3.82 111.432 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 148.93 50.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.378 1.471 . . . . 1.21 111.227 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.8 p -155.81 173.32 16.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.405 1.261 . . . . 1.3 114.405 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -119.14 123.68 44.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.531 1.132 . . . . 1.77 108.745 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.4 t -106.11 148.31 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.797 1.239 . . . . 3.59 110.037 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.8 t -148.71 158.59 44.25 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.153 1.908 . . . . 2.16 116.153 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.259 24.8 t-20 -177.67 56.45 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 132.409 4.283 . . . . 2.99 106.949 156.5 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.7 -31.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.129 1.772 . . . . 2.78 111.964 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.39 21.18 1.53 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.888 1.675 . . . . 7.56 110.889 167.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -52.23 -9.83 0.7 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 127.94 2.686 . . . . 3.68 119.489 -165.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.5 -7.51 32.86 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.101 1.45 . . . . 6.02 113.269 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 57.7 tp -91.75 -37.83 12.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.601 1.96 . . . . 7.35 113.448 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 54.7 t60 -48.57 138.83 10.05 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 118.076 2.621 . . . . 11.48 118.076 -166.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -146.55 151.49 37.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.373 3.069 . . . . 11.47 110.932 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 43.4 t30 -80.67 -45.04 17.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.478 1.511 . . . . 16.33 109.499 167.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -150.19 140.75 22.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.248 2.619 . . . . 14.52 108.267 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 30.9 m95 -99.47 -42.74 6.81 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.389 0.885 . . . . 15.95 113.389 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -144.03 -8.88 0.7 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 116.444 2.016 . . . . 14.87 116.444 -165.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.55 112.56 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.103 1.149 . . . . 15.84 114.103 -162.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.86 -29.06 25.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.6 1.16 . . . . 16.56 112.362 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.2 -13.28 26.03 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.539 1.136 . . . . 18.77 114.042 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -74.38 -9.39 58.55 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.797 2.839 . . . . 17.25 114.566 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -74.52 55.16 0.63 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.35 1.46 . . . . 17.74 114.416 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 45.4 pt -143.76 161.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.848 2.459 . . . . 22.45 111.326 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -75.0 146.26 41.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.803 0.841 . . . . 20.91 111.592 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -83.46 5.57 23.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 120.152 3.39 . . . . 20.59 120.152 -164.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -120.91 175.19 6.17 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 120.206 1.366 . . . . 22.45 113.939 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 8.5 t -143.48 62.41 1.37 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.419 1.488 . . . . 25.22 112.375 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.83 147.58 31.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.353 1.612 . . . . 26.12 115.353 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 50.0 t -114.33 136.06 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.357 1.463 . . . . 27.69 112.348 -169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 61.22 38.21 16.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.178 1.791 . . . . 31.08 114.735 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 40.8 mm -117.95 115.87 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.323 1.449 . . . . 28.09 110.754 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.81 148.69 48.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.27 1.028 . . . . 27.44 113.358 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -74.55 24.67 0.09 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.157 1.783 . . . . 24.59 114.94 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 50.9 m -51.51 -26.59 8.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.446 2.298 . . . . 27.68 115.605 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -140.94 34.95 1.75 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.093 2.157 . . . . 25.37 110.885 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.22 113.12 26.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.999 1.319 . . . . 23.21 108.797 169.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -125.28 162.42 24.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.452 1.501 . . . . 26.14 111.992 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 6.1 t 53.06 -159.79 0.13 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.458 1.903 . . . . 21.56 114.39 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 79.1 p -118.9 126.7 52.4 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.535 1.934 . . . . 18.72 112.11 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 8.8 t -156.25 156.71 34.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.199 1.4 . . . . 17.64 111.478 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 84.9 p -137.51 173.55 11.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.494 1.918 . . . . 15.47 112.07 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 82.6 p -61.02 143.27 55.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.361 -0.837 . . . . 16.3 112.824 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 36.4 m -74.06 -5.94 44.55 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.167 1.543 . . . . 14.44 115.167 -168.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.2 ptm -49.23 -26.34 2.88 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.539 1.311 . . . . 15.41 114.539 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.08 -20.47 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 114.147 1.165 . . . . 12.35 114.147 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.5 pp -81.14 -37.31 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.574 1.533 . . . . 10.71 111.331 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -71.96 -23.52 61.46 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.997 0.919 . . . . 11.48 112.192 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -72.04 -13.44 61.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.443 1.497 . . . . 9.88 114.067 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -112.57 -4.24 14.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.178 1.547 . . . . 8.37 115.178 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.56 -33.19 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.29 1.436 . . . . 8.86 111.079 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 13.7 p -68.21 -6.86 25.84 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.142 1.534 . . . . 7.95 115.142 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -92.24 -5.57 52.19 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 113.968 1.099 . . . . 6.84 113.968 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.46 -31.98 70.96 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.205 1.557 . . . . 6.69 115.205 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.91 -38.79 76.5 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.079 -1.013 . . . . 8.04 112.602 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -83.0 -30.81 27.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.055 1.342 . . . . 6.11 113.444 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.7 127.79 34.98 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.571 0.952 . . . . 6.93 113.571 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.21 -40.63 17.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.125 0.97 . . . . 4.67 108.863 166.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -5.5 122.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 130.231 3.412 . . . . 2.63 117.376 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.23 110.83 16.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.683 1.593 . . . . 4.32 111.554 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.26 117.81 20.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.115 1.366 . . . . 2.01 109.374 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.2 m -136.61 139.81 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 113.044 0.757 . . . . 2.41 113.044 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.1 150.0 43.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.986 1.315 . . . . 2.04 112.772 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -147.79 141.39 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.277 1.431 . . . . 2.01 109.92 -173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 147.83 -147.32 17.9 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.178 0.831 . . . . 1.46 115.178 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -68.98 157.9 35.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.384 1.874 . . . . 2.61 113.896 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -53.49 -28.11 29.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.268 2.227 . . . . 9.76 114.756 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.65 -39.18 87.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.571 1.148 . . . . 4.05 113.415 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.69 -21.16 26.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.678 -0.639 . . . . 4.63 112.547 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 15.9 mmt -61.83 -34.61 76.25 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.245 -0.909 . . . . 2.34 110.592 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 36.2 mt -68.31 -68.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.812 1.245 . . . . 2.65 109.278 168.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -24.5 23.42 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.194 1.924 . . . . 9.67 116.194 -172.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -76.08 11.92 1.31 Allowed 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 120.841 1.655 . . . . 1.17 112.306 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 77.15 15.44 81.59 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 119.966 -1.709 . . . . 1.15 114.731 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.65 -178.1 6.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.836 1.318 . . . . 1.16 111.248 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 59.9 t -123.37 134.09 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.361 1.465 . . . . 1.92 109.744 170.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -105.6 139.08 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.162 0.985 . . . . 2.2 111.631 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -97.61 160.19 14.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.332 1.453 . . . . 4.11 112.705 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.5 -21.22 56.06 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 3.74 113.222 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -73.94 -35.29 64.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.377 -0.827 . . . . 3.05 112.315 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -74.36 -33.84 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 119.109 -0.472 . . . . 1.43 110.736 168.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -60.27 -37.27 79.94 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.902 0.774 . . . . 2.58 111.654 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -64.77 -46.57 81.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.987 1.315 . . . . 2.13 112.281 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -41.02 81.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.096 1.358 . . . . 4.26 110.646 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 14.1 tpp -64.09 -57.2 10.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.083 1.353 . . . . 1.69 111.996 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.6 t -67.27 -30.84 70.82 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.691 0.626 . . . . 2.25 112.691 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -58.78 -45.49 89.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.296 -0.877 . . . . 2.77 111.113 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -70.55 -35.78 73.3 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.442 0.904 . . . . 2.93 113.442 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.24 -36.87 83.33 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.47 1.032 . . . . 2.66 112.388 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -70.94 -30.49 66.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.867 2.067 . . . . 4.03 113.189 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 26.8 mttp -72.3 -4.61 30.7 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.168 1.787 . . . . 3.02 112.578 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.38 3.11 87.12 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.894 1.711 . . . . 1.57 115.736 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -98.19 164.59 12.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.781 1.291 . . . . 4.73 111.482 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 50.5 m -72.8 130.65 40.94 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.313 -0.867 . . . . 1.96 110.845 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.1 41.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.838 1.655 . . . . 1.28 109.642 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -140.33 153.9 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 113.748 1.018 . . . . 2.04 113.748 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.68 162.65 12.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.173 1.389 . . . . 1.24 111.642 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 12.0 t -131.73 129.37 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.562 1.545 . . . . 3.08 110.272 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -127.7 148.33 50.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.554 1.141 . . . . 1.02 111.039 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.7 m -148.14 130.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.683 0.793 . . . . 1.65 111.093 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.56 51.92 2.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.802 1.641 . . . . 3.0 112.879 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 12.6 m-20 60.56 33.27 20.48 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.795 2.038 . . . . 1.79 115.551 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -133.95 137.31 44.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.864 1.665 . . . . 2.49 111.518 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.02 115.87 15.13 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.059 -1.026 . . . . 1.97 110.702 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.3 p -103.99 -30.16 10.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.727 -1.13 . . . . 1.66 113.676 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -177.57 -169.6 38.82 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.753 1.615 . . . . 0.73 115.88 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.69 153.71 43.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.687 1.595 . . . . 0.97 112.54 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.09 133.73 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 1.9 109.896 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.24 133.96 51.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.173 1.389 . . . . 1.78 110.733 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 41.3 mm -102.54 171.73 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 125.433 1.493 . . . . 2.96 110.469 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -149.47 -167.21 2.76 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 2.45 111.912 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -117.61 142.73 46.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.006 2.123 . . . . 5.75 111.692 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 125.069 1.348 . . . . 6.12 113.961 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.216 -0.29 . . . . 10.89 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 89.0 t80 -123.39 124.72 43.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.146 1.378 . . . . 15.86 110.471 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 2.6 m 63.87 131.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.59 2.356 . . . . 9.29 112.531 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 58.2 ttp -79.35 -54.05 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.233 -0.917 . . . . 7.92 112.704 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -78.02 -38.77 43.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.612 0.765 . . . . 6.31 111.988 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -76.5 90.61 0.94 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.167 1.365 . . . . 2.99 112.742 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 108.93 48.42 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.73 1.212 . . . . 3.15 113.272 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.77 143.82 79.07 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.187 2.592 . . . . 3.5 113.091 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 26.9 m -122.04 129.92 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.401 1.081 . . . . 3.71 111.527 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -73.91 128.39 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.212 -0.93 . . . . 2.17 110.968 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -105.88 -45.15 4.44 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.08 1.352 . . . . 3.46 112.443 -169.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -155.31 160.83 41.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.627 1.571 . . . . 3.03 112.485 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.4 m -127.63 142.33 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.008 1.323 . . . . 1.29 111.525 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 28.9 tttt -140.37 146.9 39.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.185 0.994 . . . . 3.0 112.861 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 39.6 t -84.83 154.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.374 1.469 . . . . 1.53 111.106 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.0 tp -120.85 -33.06 3.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.917 1.687 . . . . 1.4 111.968 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1063 ' ' THR . . . . . 0.453 HG21 ' H ' ' A' 1068 ' ' ILE . 5.0 t -87.24 32.9 0.68 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.197 1.399 . . . . 2.95 113.846 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -59.12 122.0 12.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.795 1.238 . . . . 3.93 110.853 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 66.7 m 50.92 32.51 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.816 1.413 . . . . 3.69 114.816 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -132.6 -21.65 2.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.205 1.402 . . . . 4.45 114.514 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -157.49 -56.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.625 1.557 . . . . 5.24 114.973 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1068 ' ' ILE . . . . . 0.453 ' H ' HG21 ' A' 1063 ' ' THR . 31.8 mt -137.61 155.6 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.453 1.901 . . . . 2.27 110.707 -167.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 75.0 m -117.31 166.69 12.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.786 1.634 . . . . 2.42 114.078 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.7 p80 -57.95 -43.21 86.23 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.834 2.161 . . . . 3.57 116.834 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -72.87 -28.3 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.477 1.035 . . . . 3.63 111.626 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -71.1 -48.61 51.41 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.444 -0.785 . . . . 4.19 110.934 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.19 -46.67 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.842 0.857 . . . . 1.84 111.621 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.4 -34.38 77.82 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.04 0.836 . . . . 1.78 112.048 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.13 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.639 -0.696 . . . . 1.53 112.416 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.78 -26.86 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.493 1.042 . . . . 1.14 113.315 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 94.6 t -71.32 -44.18 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.094 0.861 . . . . 1.58 110.521 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.48 96.53 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.555 -0.716 . . . . 0.7 113.778 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 72.7 p -74.06 -37.84 64.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.701 1.25 . . . . 1.79 112.904 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.46 -51.14 69.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.741 0.816 . . . . 0.97 111.949 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.78 -21.88 62.45 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.648 -0.657 . . . . 2.09 112.703 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 67.5 m -62.76 -21.45 65.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.501 -1.374 . . . . 3.24 112.806 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 2.53 50.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.513 1.525 . . . . 2.98 112.969 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 6.4 t -107.37 -179.59 3.97 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 1.71 113.758 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -136.45 32.9 2.78 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.529 2.732 . . . . 4.47 111.714 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -97.01 154.69 38.11 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.051 1.34 . . . . 2.5 113.61 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.21 -27.54 1.83 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.206 2.604 . . . . 1.14 114.939 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.0 tt -100.17 -48.09 4.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.563 0.745 . . . . 1.76 111.709 -167.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -68.53 -30.24 73.05 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 114.55 0.58 . . . . 0.98 114.55 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 61.1 p -67.14 -11.01 56.1 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.649 -1.501 . . . . 2.52 113.956 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.38 78.64 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.97 0.908 . . . . 1.42 111.012 167.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.08 -32.67 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.42 1.088 . . . . 2.59 110.866 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 52.0 m -53.16 -49.41 66.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 119.562 1.074 . . . . 2.45 112.285 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -65.96 -46.29 78.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.086 0.857 . . . . 3.33 112.543 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.14 -44.19 71.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.439 1.096 . . . . 3.0 111.457 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.9 t -70.44 -55.41 9.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.793 1.237 . . . . 2.53 111.832 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -53.65 -47.12 70.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.299 0.954 . . . . 3.8 112.251 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -72.48 -28.76 63.1 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.78 0.659 . . . . 5.41 112.78 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -70.2 -46.1 65.26 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.184 0.902 . . . . 2.6 112.773 172.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -25.67 62.5 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.804 1.039 . . . . 1.99 113.804 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.47 17.98 0.41 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.667 2.387 . . . . 2.44 114.624 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 4.5 t -82.59 -7.79 59.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.417 2.287 . . . . 4.13 113.979 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 17.5 tt0 63.05 -27.11 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 129.27 3.028 . . . . 4.29 116.819 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.7 t -144.51 130.45 19.35 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.914 1.234 . . . . 3.39 112.368 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.88 154.25 41.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.202 1.401 . . . . 2.13 113.091 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.6 171.46 36.57 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.405 1.479 . . . . 1.43 115.214 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 17.9 m -150.23 -70.5 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.873 -1.369 . . . . 2.12 113.978 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 37.6 t -138.3 139.42 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.959 1.254 . . . . 1.93 112.478 -172.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.7 mp -140.89 140.8 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 131.668 3.987 . . . . 3.8 106.086 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.283 0.0 OUTLIER -100.76 -13.11 18.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.943 1.831 . . . . 3.1 115.943 -174.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 5.5 t80 54.54 86.01 0.05 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 129.346 3.059 . . . . 3.81 118.929 166.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.91 102.65 11.82 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.289 1.835 . . . . 2.46 109.067 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 84.8 t -99.83 138.88 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.313 1.045 . . . . 2.9 111.589 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.9 t -131.82 124.45 19.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.651 1.18 . . . . 1.36 110.989 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.3 140.97 34.68 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.884 2.39 . . . . 2.56 112.507 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 63.16 21.19 63.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.323 0.963 . . . . 1.94 114.992 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 99.7 m -139.25 -62.69 0.53 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.969 1.708 . . . . 3.08 111.897 -169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.67 -173.35 34.4 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.397 1.475 . . . . 0.81 112.01 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.64 158.74 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 122.005 -0.703 . . . . 3.65 111.551 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 27.5 t -132.65 151.63 51.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.422 1.489 . . . . 0.97 110.634 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -160.57 172.9 16.35 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.081 -1.012 . . . . 1.26 113.317 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -113.65 124.1 51.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.59 1.156 . . . . 2.28 108.248 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.8 m -122.39 131.74 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 113.602 0.964 . . . . 3.49 113.602 -170.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -118.68 153.37 34.47 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.757 1.021 . . . . 1.72 113.757 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -175.23 -26.03 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.355 3.862 . . . . 2.4 108.343 161.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 33.2 pt -46.62 -26.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.482 1.913 . . . . 2.73 115.286 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -146.92 40.65 1.07 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.796 1.239 . . . . 4.47 110.055 166.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1128 ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' 1130 ' ' LEU . . . -77.98 10.29 27.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.413 1.959 . . . . 4.35 115.313 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 0.07 0.62 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.882 2.073 . . . . 4.65 114.781 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1130 ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' 1128 ' ' GLY . 15.0 tp -86.9 -80.68 0.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.852 1.661 . . . . 7.43 113.422 -167.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 21.8 t-80 60.99 161.93 0.06 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.325 1.85 . . . . 8.38 112.844 -166.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.95 148.0 25.52 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.48 -1.388 . . . . 10.48 110.265 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.54 72.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.422 0.897 . . . . 14.12 113.422 -173.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 59.01 157.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.262 2.625 . . . . 11.94 115.516 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 68.2 m95 -140.68 -163.9 1.62 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.428 1.891 . . . . 15.93 110.81 -171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -51.43 -27.49 10.35 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.346 2.259 . . . . 16.74 115.878 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 72.5 mt 29.79 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 129.897 3.279 . . . . 13.45 114.761 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -72.21 -30.34 64.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.245 1.018 . . . . 15.47 113.62 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.55 -22.66 66.72 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.216 -0.928 . . . . 13.25 112.663 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -83.89 -14.79 50.21 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.793 2.037 . . . . 14.52 114.109 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.77 142.01 55.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.316 1.046 . . . . 16.34 111.352 173.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.09 160.24 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.138 1.162 . . . . 20.67 114.138 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -144.2 145.53 32.13 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.778 1.631 . . . . 18.39 111.707 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -74.69 -23.04 58.56 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.112 0.965 . . . . 22.82 112.716 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . 0.282 . . 63.93 26.49 14.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.557 2.343 . . . . 19.92 116.49 170.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 7.0 t -168.52 156.7 8.28 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.237 0.828 . . . . 23.57 113.237 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.65 21.78 2.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.395 1.878 . . . . 27.23 113.16 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 11.3 m -143.97 160.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.145 1.778 . . . . 28.79 112.099 -171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -131.04 150.11 52.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.316 1.846 . . . . 31.76 109.645 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 1.5 mp 45.07 52.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.343 1.457 . . . . 33.94 111.25 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 18.1 t0 -69.39 154.07 42.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.845 1.658 . . . . 29.8 112.019 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -73.12 21.43 0.07 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.113 1.365 . . . . 31.06 112.923 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 83.7 p 50.54 40.6 23.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.466 1.906 . . . . 29.33 113.02 -168.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -176.98 3.44 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.192 0.997 . . . . 28.76 111.884 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 23.1 tt0 63.74 58.65 1.24 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.79 1.636 . . . . 25.93 112.3 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -69.5 -10.47 58.19 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.578 -1.326 . . . . 28.73 113.22 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 23.3 t -152.11 143.93 23.67 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.125 1.37 . . . . 24.11 111.695 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 89.8 p -147.63 154.84 41.15 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.396 1.079 . . . . 21.22 112.853 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 70.9 p -87.77 171.51 10.35 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.36 1.464 . . . . 20.53 112.166 172.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 4.7 t -144.21 135.0 25.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.27 0.841 . . . . 17.84 113.27 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 8.4 t -53.35 154.31 3.42 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.696 1.998 . . . . 19.25 112.664 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 19.5 m -75.85 -40.82 53.97 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 117.872 -1.061 . . . . 15.56 112.748 -173.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 38.9 mtt 63.0 168.05 0.13 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.963 2.505 . . . . 15.83 116.707 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.14 25.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.307 2.243 . . . . 14.74 114.882 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.62 -9.87 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.98 1.712 . . . . 13.24 113.602 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.46 -9.76 4.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.234 1.414 . . . . 12.49 113.849 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -46.44 -41.15 13.4 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.562 0.745 . . . . 11.53 111.307 165.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -68.64 -24.1 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.462 1.282 . . . . 9.33 114.462 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 57.2 mt -76.43 -39.03 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.256 1.022 . . . . 9.77 109.147 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 3.1 t -64.58 -31.48 72.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.058 0.943 . . . . 10.73 111.517 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 24.2 t30 -68.0 -54.86 15.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.453 0.701 . . . . 9.76 110.864 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.86 62.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.457 1.28 . . . . 6.59 114.457 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 7.8 tt -51.26 -48.5 62.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.84 1.656 . . . . 10.91 112.863 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -104.81 -29.43 10.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.317 1.228 . . . . 6.27 114.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -94.83 74.98 3.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.706 1.202 . . . . 5.16 109.948 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -45.44 146.36 1.03 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.302 1.441 . . . . 4.17 114.42 -170.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.08 128.65 46.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.646 1.35 . . . . 2.17 114.646 -169.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.52 128.68 33.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.644 1.177 . . . . 3.76 108.807 168.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.1 tttt -81.78 126.03 31.36 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 107.48 -1.304 . . . . 2.96 107.48 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -133.31 138.08 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.786 0.835 . . . . 2.27 111.3 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 153.15 46.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.308 1.043 . . . . 2.12 112.7 172.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.9 tt -147.96 139.89 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.32 1.448 . . . . 1.75 109.135 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.45 -172.34 44.85 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.735 1.054 . . . . 1.48 115.735 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 24.8 p30 -81.08 158.97 24.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.441 1.096 . . . . 3.19 113.16 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -45.53 -51.77 11.35 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.006 1.484 . . . . 6.38 115.006 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -74.29 -34.45 63.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.042 1.292 . . . . 4.52 112.671 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 36.7 t90 -68.69 -40.9 79.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.031 -1.043 . . . . 4.18 111.468 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 91.1 mmm -63.82 -32.9 74.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.698 0.799 . . . . 3.52 112.735 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.67 -63.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.504 1.522 . . . . 3.14 109.047 167.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -47.4 -8.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.887 2.075 . . . . 7.59 116.565 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -83.63 13.17 4.85 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 121.459 1.936 . . . . 1.18 112.517 168.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 70.02 37.23 73.51 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 119.755 -1.841 . . . . 0.95 114.675 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.95 167.49 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.88 112.766 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.2 t -105.47 114.49 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.835 1.254 . . . . 2.68 109.71 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.18 146.04 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.841 1.257 . . . . 2.1 110.511 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -117.84 171.3 8.15 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.284 1.034 . . . . 3.12 112.732 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -71.07 -40.26 71.7 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.968 1.47 . . . . 3.6 114.968 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.15 -28.36 54.14 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.912 -1.118 . . . . 2.62 113.563 -170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 7.5 p -72.04 -43.74 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.608 1.163 . . . . 1.36 111.878 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.4 t30 -66.89 -38.92 87.18 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.53 0.567 . . . . 2.32 112.53 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.5 -44.14 84.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.57 0.582 . . . . 2.02 112.57 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 17.1 t80 -68.16 -45.08 74.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.148 0.979 . . . . 3.74 111.684 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.5 ttm -60.81 -46.91 88.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.974 0.91 . . . . 2.32 112.502 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.4 t -74.76 -33.9 62.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.051 0.541 . . . . 1.89 112.446 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.64 -44.85 85.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.22 1.008 . . . . 2.98 111.823 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -69.59 -45.77 67.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.794 1.637 . . . . 4.48 112.326 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.63 -32.77 74.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.955 -1.09 . . . . 3.98 112.017 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -71.26 -22.96 61.9 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.332 1.234 . . . . 4.92 114.332 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 15.6 mttp -76.04 -0.61 22.35 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.387 1.075 . . . . 3.8 112.56 167.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.43 16.54 68.6 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.882 1.706 . . . . 1.4 113.951 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -117.8 132.32 56.46 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.376 1.47 . . . . 5.13 109.619 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 96.4 m -65.42 137.37 57.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.679 0.992 . . . . 2.19 113.679 -167.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -133.16 119.08 19.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.506 1.123 . . . . 1.51 111.475 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.3 m -132.97 157.98 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.339 1.456 . . . . 1.86 113.03 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.16 156.68 21.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.833 1.653 . . . . 1.75 111.53 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.6 p -132.12 133.95 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.401 1.48 . . . . 3.33 111.236 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -135.08 153.34 52.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.962 1.705 . . . . 0.82 111.405 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.56 135.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 1.58 112.541 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 48.8 m-20 42.3 48.82 4.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.754 1.621 . . . . 2.72 112.832 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 57.3 m-20 55.6 33.94 22.18 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.951 2.1 . . . . 2.5 115.497 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.69 141.48 49.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.081 2.552 . . . . 2.08 110.145 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.43 130.9 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 119.85 -1.781 . . . . 1.74 112.444 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 22.3 p -108.22 -35.3 6.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.599 -1.191 . . . . 2.21 114.081 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -173.23 -167.07 32.57 Favored Glycine 0 N--CA 1.475 1.277 0 CA-C-N 120.7 1.591 . . . . 0.63 116.447 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.84 154.7 44.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.475 1.91 . . . . 1.08 112.481 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.4 137.33 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.932 1.693 . . . . 2.03 109.708 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.53 137.49 46.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.873 1.669 . . . . 1.94 110.351 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.18 151.7 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.877 1.671 . . . . 2.6 110.843 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -124.18 -170.0 2.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.268 1.427 . . . . 1.49 112.666 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.283 2.7 t70 68.78 -140.94 0.09 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.965 2.106 . . . . 4.93 111.81 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.255 1.376 0 N-CA-C 116.689 2.107 . . . . 9.38 116.689 -167.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.522 -0.177 . . . . 12.38 110.522 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -117.88 172.33 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.64 1.176 . . . . 11.98 112.645 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 84.3 m -52.95 -50.87 63.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.078 1.751 . . . . 7.77 113.086 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 2.3 ttp 64.05 -8.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 117.32 2.341 . . . . 10.54 117.32 170.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -50.56 -58.2 6.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.652 1.569 . . . . 10.58 114.199 -171.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -94.76 69.53 1.19 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.1 0.857 . . . . 4.63 112.337 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.5 p -117.09 149.06 43.62 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.513 1.525 . . . . 3.78 113.499 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.22 148.6 77.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.324 2.016 . . . . 3.25 113.676 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.5 p -120.33 124.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.039 1.735 . . . . 3.37 110.396 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.251 13.1 p -72.12 130.63 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.309 -0.869 . . . . 2.28 110.296 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.54 -40.81 4.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.446 1.276 . . . . 3.13 114.446 -166.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -157.64 146.3 19.41 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.183 0.593 . . . . 2.94 112.08 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 28.1 m -126.86 144.24 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.549 1.14 . . . . 1.45 112.11 169.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 72.7 tttt -134.77 141.76 46.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.119 1.368 . . . . 2.81 110.962 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 49.7 t -92.03 134.36 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.484 1.114 . . . . 1.38 110.778 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 9.7 tp -99.21 -65.27 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.906 2.082 . . . . 1.33 111.022 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 38.1 m -78.63 75.02 5.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.481 -1.303 . . . . 2.86 107.481 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.63 123.97 29.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.274 1.03 . . . . 3.94 109.016 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 70.7 m 60.71 174.76 0.1 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.0 1.482 . . . . 3.66 115.0 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 64.63 -0.03 1.03 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.612 2.449 . . . . 4.26 117.612 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -147.57 -44.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.803 1.241 . . . . 5.7 112.634 167.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mm -130.09 163.9 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.943 1.697 . . . . 2.69 109.614 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 20.4 m -119.35 145.59 46.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.818 1.647 . . . . 2.98 111.109 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -49.79 -51.35 40.13 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.797 1.777 . . . . 4.72 115.797 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 72.8 m80 -74.25 -14.32 60.9 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.969 1.259 . . . . 6.22 112.804 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.94 -37.97 33.36 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.944 -1.027 . . . . 4.15 111.493 168.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.91 -54.34 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.32 0.964 . . . . 1.71 110.13 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.19 -32.27 72.39 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.643 -0.66 . . . . 1.79 112.332 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.98 83.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.65 0.659 . . . . 2.17 112.576 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.36 -29.42 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.916 -1.115 . . . . 1.07 113.427 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.3 t -69.2 -52.35 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.289 0.949 . . . . 1.33 111.107 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.01 -35.87 91.23 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.791 -0.568 . . . . 0.69 113.17 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 36.2 p -71.66 -36.0 70.52 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.523 1.161 . . . . 1.57 112.693 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.31 -49.36 67.3 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.901 0.773 . . . . 0.88 112.846 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -72.08 -15.17 62.01 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 121.366 -0.834 . . . . 2.63 112.715 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.3 t -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.42 -2.05 . . . . 1.78 112.493 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.98 2.04 55.59 Favored 'General case' 0 CA--C 1.557 1.227 0 O-C-N 121.073 -1.017 . . . . 2.13 113.007 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 57.8 m -103.59 167.24 9.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.621 1.569 . . . . 1.93 114.224 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.26 12.34 7.62 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.084 1.754 . . . . 3.47 112.585 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -71.63 148.25 92.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.602 -1.311 . . . . 2.91 113.141 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.95 -31.35 31.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.226 2.617 . . . . 1.13 114.631 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.4 -51.45 3.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.168 1.387 . . . . 1.54 111.793 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -57.12 -34.68 67.05 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.454 0.55 . . . . 1.1 113.514 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.1 p -61.25 -14.5 26.58 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.869 -1.371 . . . . 2.33 114.477 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.09 82.94 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.758 -1.214 . . . . 1.47 111.713 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.12 -39.27 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.397 1.479 . . . . 1.35 109.774 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 24.3 m -57.44 -44.39 84.68 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 117.934 -1.032 . . . . 1.92 112.552 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.27 -47.38 79.77 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.066 1.303 . . . . 3.27 112.091 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.69 -43.12 76.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.903 0.481 . . . . 2.68 111.433 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 94.7 m -69.16 -49.91 52.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.934 1.293 . . . . 4.11 112.389 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -49.9 -48.7 51.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.375 1.47 . . . . 4.74 111.534 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.93 -38.91 72.93 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.591 0.756 . . . . 3.4 112.388 175.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.3 -36.2 81.04 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.485 1.039 . . . . 2.35 112.756 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 5.4 mt -72.42 -9.21 58.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.83 1.252 . . . . 1.42 114.0 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.04 50.82 18.33 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.029 1.332 . . . . 3.58 111.887 -170.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.9 t -138.45 168.73 19.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.385 1.074 . . . . 2.83 112.502 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -102.62 -17.61 15.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.875 1.67 . . . . 3.83 111.26 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.6 t -136.89 130.64 31.99 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.865 -1.147 . . . . 3.88 113.574 -168.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.86 159.14 32.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.591 1.556 . . . . 1.48 110.169 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 76.44 127.82 0.28 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.931 0.777 . . . . 1.4 114.13 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 53.2 m -123.73 -71.17 0.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 1.69 112.709 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 4.4 t -135.44 143.19 45.78 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.096 1.316 . . . . 2.14 112.509 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 5.1 tp -132.35 163.48 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 1 C-N-CA 132.413 4.285 . . . . 3.37 109.416 -166.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.06 86.4 1.92 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.214 1.806 . . . . 2.69 106.176 166.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -93.63 147.9 22.59 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.699 2.111 . . . . 5.19 116.699 -164.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -137.92 118.47 13.91 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.332 2.253 . . . . 2.13 109.133 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 17.0 t -112.73 140.63 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.391 1.076 . . . . 2.72 113.867 -168.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 92.7 t -139.71 117.0 8.42 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 127.025 2.13 . . . . 1.38 107.472 167.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.22 144.24 50.98 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.66 2.24 . . . . 2.53 112.361 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.06 1.41 12.69 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.099 1.2 . . . . 1.68 116.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 1.3 m -136.8 -30.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.686 1.736 . . . . 2.79 115.686 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.66 168.33 19.2 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 121.337 1.88 . . . . 0.93 116.888 168.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 137.35 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.808 1.243 . . . . 2.77 109.911 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 39.3 t -126.67 144.87 50.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.614 1.565 . . . . 1.03 109.785 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.1 174.55 14.57 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.765 1.024 . . . . 1.22 113.765 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -116.77 123.5 47.29 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.215 -2.143 . . . . 1.87 105.215 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.56 144.73 24.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 118.771 0.714 . . . . 3.05 110.807 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -134.3 155.5 50.11 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.134 1.531 . . . . 1.87 115.134 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.28 15.2 t-20 179.7 57.75 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 1 C-N-CA 132.991 4.516 . . . . 2.75 104.918 158.843 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 2.1 pt -146.28 -72.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.072 2.549 . . . . 3.17 110.292 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -140.69 -11.38 1.02 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.93 1.826 . . . . 4.4 115.93 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -62.3 8.73 0.16 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 117.735 1.854 . . . . 5.68 117.735 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.8 pp -87.63 0.22 55.96 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 128.282 2.633 . . . . 5.73 114.778 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 4.3 tt -58.08 -49.5 76.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.539 1.136 . . . . 6.41 111.809 -170.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 31.2 m170 57.7 172.74 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.756 2.022 . . . . 7.93 115.813 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -89.09 151.27 22.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.128 1.371 . . . . 14.83 109.268 165.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.29 123.69 28.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.035 0.934 . . . . 15.44 109.038 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -81.14 72.6 8.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.81 0.844 . . . . 12.51 113.002 -167.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.13 -40.29 1.32 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.636 1.717 . . . . 20.31 115.636 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -123.47 5.7 8.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.525 1.53 . . . . 15.91 112.918 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.49 114.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.491 1.116 . . . . 13.57 110.981 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.68 -22.64 34.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.404 1.082 . . . . 18.77 111.782 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.87 -15.92 63.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.522 1.129 . . . . 15.54 113.717 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.41 48.41 0.9 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.56 2.344 . . . . 15.02 113.628 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -135.39 158.71 43.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.665 1.986 . . . . 18.1 110.114 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 6.6 pt -79.64 132.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.76 1.392 . . . . 19.84 114.76 -171.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -137.37 146.87 45.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.23 3.012 . . . . 18.16 108.216 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 18.7 t30 -81.25 60.54 4.39 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 118.974 2.953 . . . . 20.33 118.974 -163.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -117.37 123.24 45.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.402 1.081 . . . . 17.27 108.944 166.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 3.3 t 61.47 160.84 0.06 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.272 1.429 . . . . 17.76 114.606 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.9 mm? 45.48 44.1 9.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.355 1.462 . . . . 20.11 110.085 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 57.2 t -59.04 120.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.248 1.419 . . . . 22.14 112.109 -166.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -148.64 148.04 29.63 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.146 1.378 . . . . 24.81 110.802 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.89 -44.13 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.783 1.633 . . . . 28.72 110.853 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -136.53 10.76 3.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.221 1.408 . . . . 31.36 113.509 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -89.06 -25.58 21.86 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.332 1.234 . . . . 30.02 114.332 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 21.5 t 41.33 56.33 3.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.368 1.867 . . . . 31.88 112.621 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -93.65 -38.95 11.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.82 0.848 . . . . 28.99 112.255 -169.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -130.88 155.87 46.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.04 0.936 . . . . 27.16 112.74 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.85 -16.44 11.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.75 2.02 . . . . 33.62 113.641 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 3.6 t -152.75 33.28 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.723 1.379 . . . . 25.85 114.723 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.25 99.4 p -96.51 -119.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.049 -1.032 . . . . 22.02 111.237 171.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 4.2 p 60.51 172.23 0.09 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 126.828 2.051 . . . . 19.61 116.201 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 48.8 m -109.12 20.22 18.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.24 2.216 . . . . 16.47 112.014 168.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 1.3 t -128.22 -8.03 5.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.446 1.276 . . . . 16.17 114.446 -169.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 90.7 p -104.22 -22.57 13.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.609 1.564 . . . . 18.31 114.938 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 9.3 ptt? -76.75 33.92 0.14 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.993 1.849 . . . . 15.72 115.993 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . 0.262 4.0 mt 64.12 28.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 127.45 2.3 . . . . 13.78 112.563 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -17.76 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 116.843 2.164 . . . . 12.23 116.843 -169.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.85 -17.75 2.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.362 1.245 . . . . 9.95 114.362 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -58.62 -19.39 38.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.716 1.207 . . . . 8.55 113.409 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -92.67 -7.73 46.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.471 1.908 . . . . 8.86 115.176 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.33 -40.16 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.047 0.839 . . . . 7.99 111.159 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 94.6 p -54.05 -27.31 31.53 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.008 1.114 . . . . 6.89 114.008 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -87.53 -6.92 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.94 1.696 . . . . 7.51 113.557 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.93 31.47 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.26 1.424 . . . . 4.79 114.528 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 10.4 tt -45.96 -38.4 7.6 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.931 1.292 . . . . 7.59 113.675 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 28.8 m120 -100.02 -34.92 9.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.694 1.597 . . . . 5.83 112.609 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -89.18 50.57 1.96 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.538 1.935 . . . . 4.82 111.768 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -50.15 143.35 8.43 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.906 1.447 . . . . 4.0 114.906 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -138.82 173.91 11.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.398 2.279 . . . . 2.21 111.276 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.46 127.34 53.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.675 1.19 . . . . 3.98 108.577 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -86.64 123.36 31.74 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.751 -0.833 . . . . 2.35 108.751 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -132.77 139.54 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.289 0.495 . . . . 1.2 111.934 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.16 147.51 36.75 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.564 1.146 . . . . 1.08 112.471 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.9 tt -141.59 138.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.302 1.441 . . . . 1.85 108.717 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 171.82 -166.85 39.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 117.142 1.617 . . . . 1.45 117.142 -174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.31 162.76 17.21 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.362 3.065 . . . . 2.49 111.895 -169.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -44.21 -65.09 0.55 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.344 1.609 . . . . 9.07 115.344 -167.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.42 -34.3 70.21 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.863 1.21 . . . . 3.25 113.765 -171.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -68.99 -27.88 66.1 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.005 -1.059 . . . . 4.06 112.443 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 55.2 tpp -70.69 -42.88 70.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.103 0.561 . . . . 2.72 112.292 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 97.4 mt -49.3 -61.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.065 1.346 . . . . 2.9 109.504 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -51.31 -11.57 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.071 2.249 . . . . 6.94 117.071 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.28 15.49 0.44 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 121.988 2.176 . . . . 1.07 111.254 166.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.13 11.71 81.69 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 119.354 -2.091 . . . . 0.76 114.589 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.82 159.68 25.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.902 1.351 . . . . 0.8 111.306 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 74.1 t -94.23 122.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.352 . . . . 2.18 109.612 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.4 tt -96.48 132.25 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.245 1.018 . . . . 2.45 110.277 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -93.21 153.9 18.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.521 1.128 . . . . 4.02 112.879 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.88 -32.9 73.3 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.156 -0.965 . . . . 3.26 112.997 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.91 -44.65 80.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.922 0.889 . . . . 2.68 112.139 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.9 p -73.4 -31.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.347 -0.846 . . . . 1.34 111.72 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -64.15 -38.68 91.93 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.898 1.227 . . . . 2.24 111.624 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.75 -33.69 75.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.955 0.902 . . . . 2.51 112.151 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.75 -44.3 81.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.025 1.73 . . . . 3.96 112.096 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 27.0 tpp -62.59 -50.37 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.26 1.424 . . . . 1.6 110.73 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.0 t -72.23 -30.9 65.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.819 0.674 . . . . 1.76 112.819 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.63 -51.77 67.43 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.042 1.292 . . . . 2.56 112.234 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.52 -30.9 68.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.868 0.692 . . . . 3.32 112.868 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.1 -41.27 90.85 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 121.357 -0.839 . . . . 2.57 111.884 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.37 -22.73 61.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.343 1.857 . . . . 5.08 114.232 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 22.3 mttp -73.13 -5.35 38.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.077 2.151 . . . . 3.37 114.406 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 96.68 9.88 55.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.128 1.347 . . . . 2.12 115.246 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -113.73 -176.94 3.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.332 1.453 . . . . 4.03 111.53 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.6 m -102.53 138.35 39.57 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.091 1.756 . . . . 1.99 111.023 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.56 127.77 35.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.985 1.314 . . . . 1.11 111.431 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.4 m -140.14 159.6 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.358 1.063 . . . . 0.98 112.965 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.44 155.04 21.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.895 1.678 . . . . 1.49 110.942 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.1 p -132.86 130.32 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.48 1.112 . . . . 3.29 112.61 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.46 154.59 46.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.559 1.544 . . . . 0.98 111.944 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.7 m -148.72 130.05 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.462 0.705 . . . . 2.1 112.416 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 9.5 m-20 41.35 43.61 2.15 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 3.2 112.853 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.312 14.8 m-20 68.86 30.63 4.63 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 117.095 2.258 . . . . 2.28 117.095 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.71 141.16 50.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.225 1.81 . . . . 2.56 109.871 165.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.74 109.75 13.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.73 -1.231 . . . . 1.78 111.077 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -94.42 -27.59 15.95 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.027 -1.046 . . . . 1.28 112.771 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.27 -176.29 40.96 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 116.336 1.294 . . . . 0.48 116.336 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.39 154.31 45.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.461 1.904 . . . . 2.11 111.905 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 4.0 mt -136.78 135.61 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.917 1.287 . . . . 2.97 110.62 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.39 137.83 45.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.058 1.343 . . . . 1.95 110.678 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.25 145.65 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.163 1.785 . . . . 2.72 108.925 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -112.01 124.82 53.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.218 1.007 . . . . 1.82 111.618 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 37.1 t0 -73.38 144.05 46.57 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.23 -0.919 . . . . 3.81 111.574 172.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.403 1.481 . . . . 4.42 112.315 175.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.431 0.158 . . . . 12.27 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 43.5 p90 -81.28 155.49 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.299 1.44 . . . . 12.1 113.354 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 29.4 m -130.81 146.88 52.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.621 1.968 . . . . 8.41 109.486 171.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 8.9 tpt -108.58 94.11 4.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.204 1.802 . . . . 7.48 109.617 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -89.43 -43.74 10.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 116.624 2.083 . . . . 8.0 116.624 -167.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -83.04 72.94 2.76 Favored Glycine 0 N--CA 1.47 0.924 0 O-C-N 120.989 -1.069 . . . . 3.18 112.226 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 15.1 p -76.76 148.23 79.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.823 1.649 . . . . 3.35 115.332 -167.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -81.48 158.4 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.773 1 C-N-CA 125.552 4.168 . . . . 2.49 112.73 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 2.4 m -139.76 130.11 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.84 1.656 . . . . 4.06 111.734 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.254 8.7 p -77.07 129.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.048 -1.033 . . . . 2.62 112.342 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.82 -39.84 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.042 0.937 . . . . 3.09 113.42 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -149.09 151.58 34.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.095 1.358 . . . . 3.93 111.314 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 8.6 m -135.41 146.6 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.397 1.079 . . . . 1.31 111.356 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 68.1 tttt -141.53 138.9 33.06 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.47 1.108 . . . . 2.32 112.854 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.9 t -88.82 142.39 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.284 1.033 . . . . 1.97 111.286 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.2 tp -106.21 -39.85 5.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.525 1.53 . . . . 2.16 111.977 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 53.1 m -124.81 97.17 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.682 0.674 . . . . 2.5 112.502 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.82 111.61 5.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.469 1.507 . . . . 5.99 108.26 168.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 8.6 t -178.37 -52.8 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.563 1.945 . . . . 5.04 110.777 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 6.7 m120 -150.24 41.76 0.82 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.748 1.619 . . . . 7.4 112.932 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -146.82 -58.57 0.28 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.507 -1.37 . . . . 5.64 112.876 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.16 155.23 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.524 1.53 . . . . 3.37 110.247 -173.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 15.3 m -110.01 143.12 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.306 1.042 . . . . 3.24 110.767 172.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.03 -42.23 68.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.286 2.328 . . . . 4.67 117.286 -168.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 46.9 m80 -68.59 -29.06 67.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.984 1.265 . . . . 6.18 111.81 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.27 -40.19 77.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 117.93 -1.033 . . . . 4.76 111.315 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 82.3 mt -55.15 -54.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 118.968 0.804 . . . . 2.12 110.536 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.51 -33.16 74.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.683 -0.635 . . . . 1.7 112.152 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.11 81.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.542 0.571 . . . . 1.1 112.542 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.0 pt -69.84 -31.25 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.546 1.066 . . . . 1.0 112.921 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 48.0 t -71.12 -49.88 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.007 0.822 . . . . 1.27 111.635 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.68 -33.86 87.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.376 -0.828 . . . . 0.68 113.903 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 34.9 p -74.27 -37.88 63.59 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.822 0.849 . . . . 1.31 112.581 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.39 82.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.069 0.849 . . . . 0.79 112.772 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -66.62 -18.97 65.65 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.858 -1.151 . . . . 2.24 113.362 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 1.6 t -64.91 -15.52 62.14 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.062 -1.024 . . . . 2.29 112.722 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -128.66 -20.22 3.61 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.075 1.35 . . . . 3.19 114.205 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.9 t -70.44 -44.61 67.49 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.908 -1.12 . . . . 3.97 112.313 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . 0.301 33.1 mt-10 70.74 32.29 2.54 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.423 1.889 . . . . 5.23 115.386 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.98 146.32 63.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.263 1.425 . . . . 2.34 113.468 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.42 -54.15 3.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.985 3.79 . . . . 1.28 114.352 -169.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -68.05 -33.69 75.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.818 1.247 . . . . 1.68 111.459 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.34 -22.31 63.16 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.207 1.384 . . . . 0.91 114.813 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 51.7 p -61.92 -35.9 79.75 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.934 1.367 . . . . 3.37 112.611 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.95 79.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.125 0.97 . . . . 2.38 112.168 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.2 mt -72.64 -43.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.352 0.661 . . . . 1.94 111.278 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 5.3 t -66.27 -40.59 90.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.867 -0.587 . . . . 3.14 112.082 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -62.18 -48.82 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.875 0.761 . . . . 4.0 111.964 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -56.4 -42.95 78.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.033 0.833 . . . . 3.1 112.003 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.8 t -61.31 -54.34 45.24 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.771 -0.581 . . . . 3.35 111.277 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.78 -32.67 67.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.588 1.155 . . . . 3.73 113.096 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -71.59 -48.91 45.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.098 1.759 . . . . 4.47 112.856 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.92 -38.19 76.17 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.389 -1.444 . . . . 2.45 112.583 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 -21.3 60.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.072 0.949 . . . . 1.44 113.323 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.92 28.4 2.83 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.512 1.925 . . . . 3.86 114.057 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -128.81 139.37 52.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.919 -1.113 . . . . 2.72 113.86 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -77.25 -11.29 59.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.765 1.226 . . . . 3.83 112.542 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 65.4 p -80.32 47.93 0.97 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.011 2.125 . . . . 5.69 114.21 -171.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.15 148.08 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.821 1.045 . . . . 2.08 113.821 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 75.83 128.41 0.26 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.79 1.662 . . . . 1.61 114.351 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.27 -154.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.797 2.039 . . . . 3.27 108.273 172.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 142.17 50.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.766 1.765 . . . . 2.07 115.766 -167.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.11 153.33 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 1 C-N-CA 132.472 4.309 . . . . 3.22 107.552 -169.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -140.57 117.88 11.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.256 -1.757 . . . . 2.72 106.256 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 166.77 10.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.496 2.036 . . . . 4.81 116.496 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -132.91 131.51 40.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.295 2.238 . . . . 4.15 108.518 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.26 137.32 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.878 0.871 . . . . 3.55 112.044 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 28.6 t -137.3 114.84 9.82 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.421 1.488 . . . . 2.06 107.532 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.76 147.7 45.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.083 2.522 . . . . 3.6 112.607 -172.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 61.23 17.29 52.06 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.657 1.122 . . . . 1.67 114.026 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 38.9 t -139.94 -63.51 0.5 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.746 1.218 . . . . 2.62 113.015 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.17 -152.47 23.64 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 120.583 1.538 . . . . 1.21 115.946 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.33 150.23 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.735 1.614 . . . . 3.5 113.179 -168.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.2 t -130.16 142.38 50.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.12 1.368 . . . . 1.49 109.41 165.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.45 172.87 17.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.46 1.652 . . . . 1.21 115.46 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -118.83 98.33 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 1.64 109.326 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.2 p -112.17 128.38 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.679 0.792 . . . . 3.19 112.829 -168.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 5.6 t -110.38 -163.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.721 1.209 . . . . 2.54 112.998 -171.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.327 3.5 m120 70.35 41.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.557 2.743 . . . . 5.51 116.842 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 35.9 pt -94.46 -17.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.173 -0.955 . . . . 4.8 112.81 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -123.48 20.48 9.55 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.696 1.999 . . . . 7.74 110.651 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.58 0.33 4.11 Favored Glycine 0 N--CA 1.472 1.083 0 C-N-CA 128.139 2.78 . . . . 6.81 117.803 -169.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.0 -14.4 61.57 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.864 1.332 . . . . 8.96 112.8 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.2 tt -44.51 -51.39 8.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.904 2.082 . . . . 9.91 111.483 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -169.67 153.57 5.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.711 1.605 . . . . 12.09 110.275 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -66.46 137.92 57.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.706 -0.85 . . . . 16.82 108.706 165.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -83.95 61.2 6.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.942 0.497 . . . . 13.84 109.868 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 56.8 t30 -63.71 146.79 53.18 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.794 -0.566 . . . . 14.76 109.911 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 63.4 m95 -137.18 75.77 1.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.9 0.88 . . . . 13.67 110.217 168.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 61.77 19.55 10.65 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.959 2.207 . . . . 17.46 116.959 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 59.6 mt -55.51 138.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.461 1.504 . . . . 19.79 110.116 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.26 -55.82 7.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.426 0.899 . . . . 23.15 113.426 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -110.28 -19.86 12.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.821 . . . . 26.77 112.878 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 8.3 t-20 49.13 43.0 22.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.361 2.264 . . . . 22.78 115.739 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.12 170.92 14.81 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.202 1.801 . . . . 28.86 112.146 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 31.3 mm -70.32 108.24 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.194 0.998 . . . . 29.33 111.376 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -83.47 164.32 19.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.999 1.319 . . . . 28.53 112.851 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -65.09 -12.33 49.55 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.022 1.49 . . . . 31.14 115.022 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 68.54 144.73 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.781 2.432 . . . . 28.55 112.941 -167.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.7 t -62.08 138.94 58.46 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.716 1.006 . . . . 28.55 113.716 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.65 117.59 23.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.847 1.259 . . . . 32.9 110.049 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 33.6 m -133.18 14.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.899 1.074 . . . . 31.19 113.899 -169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.02 171.71 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.629 1.972 . . . . 35.49 113.925 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 4.5 mp -71.41 -38.35 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.92 1.288 . . . . 38.79 110.159 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 6.5 t70 -147.52 72.37 1.24 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.862 0.839 . . . . 35.25 112.977 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -147.43 27.08 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.71 1.204 . . . . 34.87 113.997 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 100.0 p -125.67 152.85 44.69 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.521 1.129 . . . . 31.58 112.7 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.42 -15.84 2.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.081 1.752 . . . . 29.16 113.175 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 58.3 19.01 5.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.972 2.109 . . . . 28.43 115.28 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -74.86 151.61 38.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.993 1.317 . . . . 28.27 112.689 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 67.4 m 48.05 35.65 5.42 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 116.5 2.037 . . . . 23.84 116.5 167.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.06 145.56 36.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.001 0.921 . . . . 22.38 112.413 168.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.8 t -132.75 152.09 51.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.344 1.457 . . . . 20.45 113.257 -173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 60.1 m -111.06 -24.46 10.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.351 1.46 . . . . 21.52 112.508 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 18.8 m -124.3 8.6 8.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.048 1.499 . . . . 20.12 115.048 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 55.5 m -114.65 19.22 16.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.995 1.318 . . . . 17.12 113.53 170.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.0 ptt? -116.86 143.63 45.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.257 1.423 . . . . 20.48 111.925 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 1.7 mt 60.19 12.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.497 1.519 . . . . 15.94 113.514 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -21.67 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 119.488 -2.007 . . . . 13.22 114.749 -169.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -96.68 -20.55 18.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.836 1.254 . . . . 11.53 113.793 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -76.25 -14.37 60.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.469 1.108 . . . . 10.36 113.597 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -110.38 2.78 19.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.496 2.036 . . . . 11.22 116.496 -174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.27 -46.7 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.858 1.263 . . . . 8.78 110.926 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.9 m -63.65 -24.87 67.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.485 0.92 . . . . 8.49 113.485 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -88.51 -27.9 21.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.078 0.853 . . . . 9.16 112.656 168.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -63.11 -43.19 99.15 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.52 -1.363 . . . . 7.87 111.925 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.5 -17.74 63.07 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.707 1.373 . . . . 8.77 114.707 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -81.23 -37.49 28.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.934 0.788 . . . . 5.98 112.078 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -89.18 22.81 2.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.34 1.056 . . . . 7.73 112.199 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 47.15 144.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 130.107 3.363 . . . . 4.11 117.391 -165.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -133.06 151.21 52.06 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.945 1.298 . . . . 2.85 110.624 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 125.02 31.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 4.66 110.152 -173.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.9 tttt -79.6 116.93 20.09 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.533 -0.914 . . . . 2.34 108.533 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.7 m -133.67 145.11 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.847 0.859 . . . . 0.92 112.124 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -146.02 151.66 38.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.704 1.001 . . . . 1.06 113.704 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.86 142.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.163 1.385 . . . . 1.69 110.209 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 132.34 143.85 5.19 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 115.492 0.957 . . . . 1.44 115.492 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 7.7 t-20 43.38 -143.99 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.299 1.84 . . . . 2.43 112.281 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.919 1.688 . . . . 8.55 113.064 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -65.3 -36.43 84.04 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.328 -0.858 . . . . 4.56 112.018 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1187 ' ' TRP . . . . . 0.423 ' CE3' ' HD3' ' A' 1190 ' ' ARG . 4.9 m95 -57.03 -30.0 63.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.144 1.164 . . . . 5.14 114.144 172.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.7 mmt -72.05 -37.72 69.62 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.499 0.666 . . . . 2.39 111.626 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.15 -67.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 126.304 1.842 . . . . 2.71 108.259 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1190 ' ' ARG . . . . . 0.423 ' HD3' ' CE3' ' A' 1187 ' ' TRP . 34.5 ttt85 -36.49 -43.51 0.4 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.292 2.637 . . . . 7.59 114.899 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 13.74 5.73 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.28 1.215 . . . . 1.07 114.28 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 69.88 23.76 76.77 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.095 -1.628 . . . . 0.69 115.542 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.16 171.41 12.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.642 1.177 . . . . 0.81 112.059 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -99.66 133.34 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.006 1.322 . . . . 2.13 109.699 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.7 tt -138.78 147.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.761 1.224 . . . . 2.52 111.11 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.69 151.32 32.0 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.101 1.36 . . . . 2.67 113.258 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.07 -26.36 67.45 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.18 -0.95 . . . . 4.6 112.84 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.54 -36.39 76.32 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.002 -1.061 . . . . 3.39 113.213 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -77.16 -36.93 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.724 0.693 . . . . 1.4 111.438 170.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.1 t30 -62.85 -37.72 87.95 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.746 0.703 . . . . 2.52 111.979 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.84 -39.05 93.17 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.475 1.11 . . . . 2.94 112.971 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.56 -37.64 80.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.996 -1.065 . . . . 3.83 111.75 171.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -66.25 -52.16 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.596 1.158 . . . . 1.84 112.01 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.8 t -68.76 -34.62 75.88 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.376 -0.828 . . . . 2.38 112.263 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.37 -49.05 68.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.048 0.84 . . . . 3.26 111.055 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -66.66 -39.57 88.24 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.388 1.075 . . . . 4.99 112.383 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -63.75 -42.31 97.86 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.305 -0.872 . . . . 2.74 112.804 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -70.59 -28.73 65.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.181 1.792 . . . . 4.91 112.785 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.6 mttp -66.81 -12.61 59.57 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.085 1.754 . . . . 3.96 113.565 169.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.89 15.08 71.04 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.188 1.375 . . . . 1.43 114.73 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -106.98 156.57 18.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.818 1.309 . . . . 4.6 110.561 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 27.3 m -77.35 128.35 34.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.571 1.549 . . . . 2.18 112.945 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.42 118.1 16.03 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.674 0.789 . . . . 2.21 113.122 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 23.6 m -141.15 157.09 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 114.75 1.389 . . . . 1.0 114.75 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.91 165.88 10.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.465 . . . . 1.15 113.539 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.7 t -136.96 134.9 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.597 1.959 . . . . 2.98 110.816 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -137.24 157.98 45.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.28 1.432 . . . . 1.0 111.082 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 17.9 m -144.93 138.03 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.546 -1.346 . . . . 1.79 111.394 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 32.8 t70 41.7 48.71 3.7 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.984 2.113 . . . . 2.77 112.377 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.28 3.4 m-20 65.6 32.7 9.06 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.996 2.118 . . . . 1.73 115.995 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.67 145.51 36.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.596 1.558 . . . . 2.25 111.189 169.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.83 145.68 53.52 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.405 -1.434 . . . . 1.86 111.182 172.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -121.33 -43.3 2.42 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.496 0.924 . . . . 1.94 113.496 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.28 -173.3 38.84 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.17 0.895 . . . . 0.47 115.062 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.26 152.94 42.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.365 1.466 . . . . 0.86 113.399 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.07 135.34 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.463 1.505 . . . . 2.04 111.101 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.38 124.82 45.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.56 2.344 . . . . 1.7 109.601 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.13 159.84 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.269 1.828 . . . . 2.69 111.579 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -131.8 -177.25 4.34 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.627 1.171 . . . . 1.6 112.402 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -115.58 140.7 48.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.61 1.964 . . . . 3.48 112.936 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 115.953 1.834 . . . . 4.4 115.953 -173.417 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 120.199 0.047 . . . . 9.87 110.876 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 39.1 p90 -135.34 158.39 44.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.139 1.376 . . . . 12.72 111.202 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 4.2 t -143.76 154.08 43.08 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.541 0.941 . . . . 8.06 113.541 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 167.83 9.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.391 1.876 . . . . 7.01 110.851 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 37.4 m170 -98.8 -41.33 7.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.565 0.746 . . . . 9.58 111.221 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -92.09 93.65 1.83 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.095 -0.836 . . . . 4.36 112.826 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.8 m -80.76 123.26 82.54 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.433 1.617 . . . . 3.53 110.82 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 148.44 52.52 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.377 2.718 . . . . 1.92 112.19 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.1 p -138.07 125.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.863 1.265 . . . . 3.2 111.754 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.8 p -72.13 133.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.1 -1.0 . . . . 2.0 111.518 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -126.18 -34.92 2.48 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.524 1.675 . . . . 3.08 115.524 -166.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -155.03 151.17 28.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.294 1.438 . . . . 2.99 111.03 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.2 m -130.03 142.35 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.32 1.048 . . . . 1.12 111.284 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 40.1 tttt -139.61 147.14 40.68 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.096 0.958 . . . . 2.86 112.173 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 43.5 t -96.78 136.99 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.123 1.369 . . . . 1.45 111.294 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 34.6 tp -100.32 -25.7 14.15 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.873 1.669 . . . . 1.39 112.931 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.5 t -104.75 24.3 12.03 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.562 1.319 . . . . 3.67 114.562 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -56.07 128.19 34.21 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.714 -1.241 . . . . 3.77 110.49 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 60.48 -1.15 0.23 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.949 1.833 . . . . 3.47 115.949 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.74 -32.35 8.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.071 1.305 . . . . 4.81 113.191 -171.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -155.61 -46.53 0.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.259 1.577 . . . . 5.08 115.259 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.16 146.48 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.092 1.357 . . . . 2.85 111.172 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -98.65 157.42 16.27 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.323 1.449 . . . . 2.38 112.841 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -61.14 -38.5 86.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.976 2.213 . . . . 4.53 116.976 -166.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -71.24 -34.69 71.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.288 1.404 . . . . 4.73 111.099 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 94.7 mttt -61.15 -44.3 97.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.162 0.585 . . . . 5.02 110.804 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.28 -53.51 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.052 0.941 . . . . 1.73 111.198 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.91 -32.06 73.07 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.402 -0.811 . . . . 1.74 112.189 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.42 68.55 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.531 0.732 . . . . 1.29 112.013 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.1 pt -70.25 -32.66 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.005 1.275 . . . . 2.04 113.095 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.9 t -70.4 -48.01 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.804 1.184 . . . . 1.97 111.387 172.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.85 92.42 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.258 -0.901 . . . . 0.56 113.321 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 71.7 p -77.58 -27.0 51.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.821 1.045 . . . . 1.32 113.821 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.63 91.92 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.006 0.821 . . . . 0.8 112.5 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.48 -12.38 60.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.807 1.04 . . . . 1.94 113.807 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 35.4 t -54.51 -43.11 71.58 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.186 1.394 . . . . 1.99 114.543 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -92.14 2.61 56.48 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.051 0.76 . . . . 2.48 113.051 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.9 t -89.19 168.17 12.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.058 1.343 . . . . 1.73 112.761 -173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -133.64 80.09 1.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.211 1.405 . . . . 4.67 109.823 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -141.39 152.0 62.68 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.964 1.705 . . . . 2.82 110.917 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.77 -35.81 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.304 2.669 . . . . 1.81 115.19 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.24 -41.35 9.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.721 1.208 . . . . 2.08 113.456 -166.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -76.99 -34.82 40.91 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 114.541 0.576 . . . . 1.04 114.541 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 59.4 p -64.28 -17.28 63.48 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.87 -1.37 . . . . 2.93 113.142 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.15 82.93 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.866 -1.146 . . . . 2.25 111.965 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 4.8 mp -72.23 -32.72 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.43 0.692 . . . . 2.4 110.728 171.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 94.9 m -56.1 -47.61 77.72 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 117.424 -1.274 . . . . 2.08 111.395 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 46.9 tttt -62.39 -46.17 89.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.301 1.41 . . . . 3.58 112.789 175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 4.0 t80 -55.94 -42.33 76.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.348 1.059 . . . . 3.23 111.476 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.1 t -70.66 -52.55 20.46 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.611 1.564 . . . . 2.72 112.355 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -47.76 -47.63 30.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.874 1.67 . . . . 3.91 111.927 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.82 -30.41 65.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.077 0.951 . . . . 4.31 113.243 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.18 -42.22 72.7 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.636 1.107 . . . . 3.71 112.662 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.01 -33.63 61.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.006 1.323 . . . . 1.77 114.48 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.28 42.64 25.98 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.487 1.915 . . . . 3.18 114.334 -172.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -119.78 -21.7 7.13 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.409 1.633 . . . . 4.12 115.409 -172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.8 tt0 58.8 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.154 2.582 . . . . 3.01 117.403 -171.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 75.2 p -95.54 22.23 7.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.275 2.23 . . . . 3.54 113.917 -170.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.59 147.13 53.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.753 1.221 . . . . 1.4 113.847 -169.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 66.44 -173.35 25.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.272 0.929 . . . . 1.57 114.639 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -160.45 -51.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.066 1.347 . . . . 1.9 111.629 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 31.6 t -138.24 142.53 39.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.405 1.082 . . . . 1.81 113.58 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.12 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 1 C-N-CA 131.728 4.011 . . . . 4.07 109.229 168.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -20.31 12.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.944 1.461 . . . . 3.24 114.944 -169.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 51.3 m-85 60.8 105.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.507 2.723 . . . . 5.75 117.35 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -120.91 107.09 12.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.448 2.299 . . . . 2.59 107.493 168.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.7 m -98.4 145.17 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.41 0.684 . . . . 3.26 111.96 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 18.7 t -136.99 85.15 23.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 106.552 -1.647 . . . . 1.59 106.552 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -53.1 134.27 55.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.825 3.683 . . . . 2.35 114.708 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 65.22 10.05 45.46 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.855 -0.969 . . . . 1.94 114.457 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 22.8 m -127.51 -49.11 1.4 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.09 1.445 . . . . 4.26 111.933 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 173.14 -170.89 44.04 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.499 0.571 . . . . 1.15 114.096 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 4.3 tt -141.71 158.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.4 1.08 . . . . 2.84 111.665 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 18.7 t -139.0 152.92 48.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.618 1.167 . . . . 2.24 111.903 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 9.2 p -164.2 167.96 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.495 1.118 . . . . 2.97 112.648 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -110.08 123.1 49.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.307 1.043 . . . . 1.64 109.258 172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.7 t -105.01 145.21 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 123.92 0.888 . . . . 3.39 111.37 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.88 160.54 41.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.305 1.05 . . . . 2.0 113.542 164.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -168.1 -33.77 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 130.674 3.59 . . . . 2.2 108.24 163.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 4.5 pt -54.71 -62.14 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.608 2.363 . . . . 2.67 115.016 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.02 28.64 0.31 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.978 1.473 . . . . 4.28 114.978 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -70.37 -7.2 60.01 Favored Glycine 0 CA--C 1.539 1.592 0 O-C-N 120.574 -1.329 . . . . 4.78 114.818 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.39 -1.31 0.13 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.691 2.796 . . . . 4.22 115.984 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.7 tt -71.46 -28.86 64.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.298 1.839 . . . . 6.54 112.093 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 51.56 -124.52 2.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.913 1.285 . . . . 7.38 111.465 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -127.59 156.24 42.57 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 127.712 2.405 . . . . 14.26 108.677 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -17.54 58.75 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.934 1.087 . . . . 17.65 113.934 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 23.8 t-20 64.76 165.23 0.15 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.315 1.846 . . . . 14.91 113.789 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 98.4 m95 -134.24 -64.36 0.69 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.807 1.643 . . . . 20.83 110.961 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -144.43 -8.23 0.67 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.577 1.695 . . . . 16.82 115.577 -169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1137 ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' 1137 ' ' ILE . 0.9 OUTLIER -82.8 143.38 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.422 1.889 . . . . 15.05 109.657 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -80.06 -24.09 40.9 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.61 -1.306 . . . . 19.12 112.656 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.66 108.88 14.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.887 1.675 . . . . 15.67 110.06 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -127.73 116.59 20.47 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.896 0.879 . . . . 14.44 111.342 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.39 146.62 52.09 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.453 1.901 . . . . 15.57 112.606 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.2 -19.43 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -126.06 147.59 49.53 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.281 1.4 . . . . 18.93 113.468 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 26.3 p30 -82.03 0.56 39.76 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.754 1.622 . . . . 18.88 114.892 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . 0.26 . . 58.28 40.46 24.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.935 2.094 . . . . 17.55 116.629 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 27.3 m -62.27 150.04 40.26 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.249 1.419 . . . . 18.12 111.436 166.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -152.21 154.26 35.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.256 1.422 . . . . 18.34 112.568 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 29.1 m -130.01 150.2 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.979 1.311 . . . . 19.72 112.295 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -117.96 62.3 0.76 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.665 1.986 . . . . 22.42 108.089 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 7.4 tp -101.43 142.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.326 1.851 . . . . 22.79 114.865 -164.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -155.76 137.72 14.51 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.457 1.503 . . . . 24.6 111.552 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . 49.39 30.15 3.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.257 1.823 . . . . 26.2 115.315 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.52 160.46 43.77 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.695 1.198 . . . . 24.46 111.312 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.3 67.64 0.95 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.298 1.439 . . . . 23.07 111.47 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.39 4.09 50.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.599 1.56 . . . . 25.85 114.602 -171.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -134.6 -19.69 1.84 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 117.736 2.495 . . . . 28.19 117.736 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 17.7 t -159.0 150.91 20.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 122.735 2.516 . . . . 23.4 115.645 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.359 0.1 OUTLIER -87.63 15.48 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.804 1.409 . . . . 19.93 114.804 168.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 7.3 t -59.0 -11.97 4.05 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.329 1.603 . . . . 19.78 115.329 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 5.3 p -84.45 129.8 34.83 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.281 -1.512 . . . . 16.27 112.225 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 75.4 m 49.38 43.82 23.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.124 1.369 . . . . 15.88 113.679 -171.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 89.1 p -78.45 -48.09 16.13 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.351 1.461 . . . . 13.35 111.912 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 17.7 mmt 52.97 -174.76 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 128.126 2.57 . . . . 14.52 115.166 172.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 44.1 pt -75.16 21.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.056 1.742 . . . . 12.97 115.048 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.82 -30.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.992 -1.068 . . . . 9.83 113.155 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . 0.281 12.7 p-10 -77.03 -5.66 49.65 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.416 1.265 . . . . 10.32 114.416 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -86.5 -6.25 58.95 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.861 1.264 . . . . 11.81 112.829 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -109.17 -15.85 14.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.148 1.379 . . . . 10.06 112.98 -171.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 79.5 mt -55.86 -29.12 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.276 1.83 . . . . 7.69 111.27 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 52.8 p -60.29 -11.92 7.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.632 1.345 . . . . 9.61 114.632 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.31 -9.27 58.41 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.146 -0.971 . . . . 8.07 112.933 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.89 -14.39 21.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.135 1.374 . . . . 5.43 114.451 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.39 -39.46 73.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.013 . . . . 8.41 110.695 167.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -101.14 -43.64 5.94 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.37 1.468 . . . . 6.04 111.923 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -87.33 63.5 7.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.281 1.832 . . . . 4.36 111.616 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -49.29 129.46 18.38 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.483 1.66 . . . . 3.47 115.483 -167.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -158.82 162.96 37.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.432 1.493 . . . . 2.33 112.776 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -122.42 128.17 50.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.578 1.551 . . . . 4.51 110.973 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.4 tttt -88.14 126.56 35.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.987 0.915 . . . . 2.12 109.073 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.6 m -134.49 151.89 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 113.748 1.018 . . . . 1.31 113.748 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.49 152.35 30.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.159 1.384 . . . . 1.8 113.005 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 10.7 tt -149.36 139.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.144 1.378 . . . . 1.89 110.31 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.9 -142.38 9.09 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.908 1.123 . . . . 1.45 115.908 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.41 161.48 2.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.64 2.376 . . . . 2.19 114.456 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -24.99 63.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.091 1.356 . . . . 7.14 113.68 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -76.61 -32.14 57.87 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.868 1.213 . . . . 3.05 113.652 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.2 t90 -64.05 -21.17 66.41 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 119.994 -1.692 . . . . 4.0 112.484 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -63.92 -33.9 76.74 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.846 -1.158 . . . . 2.59 111.256 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 24.3 mt -66.83 -64.84 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.844 1.658 . . . . 3.52 109.169 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -52.58 -30.86 33.28 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.277 1.431 . . . . 5.8 114.344 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.1 6.07 23.69 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.302 1.441 . . . . 1.07 113.954 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.99 29.8 72.35 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.95 1.738 . . . . 0.7 115.081 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 4.6 mt -96.24 160.7 14.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.84 1.256 . . . . 0.83 109.647 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 58.5 t -110.74 124.5 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.499 0.719 . . . . 1.87 110.559 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -95.63 149.44 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.018 0.927 . . . . 2.28 111.004 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -124.06 154.38 40.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.828 1.251 . . . . 3.09 111.495 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -56.92 -32.09 65.6 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.813 1.412 . . . . 2.69 114.813 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.54 -53.56 46.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.54 1.136 . . . . 3.99 111.391 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.8 p -73.48 -34.3 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.171 1.388 . . . . 1.46 111.638 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.74 -42.74 97.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.742 0.817 . . . . 2.33 111.593 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.27 -44.4 91.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.622 0.646 . . . . 2.29 112.321 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.87 -36.17 82.68 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.346 1.058 . . . . 3.54 112.22 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 18.1 tpp -62.62 -55.12 30.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.369 1.068 . . . . 1.84 111.687 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.3 t -68.56 -33.68 74.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.644 -0.66 . . . . 1.93 111.938 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.191 1.397 . . . . 4.25 112.271 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.19 -39.66 71.69 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.883 1.068 . . . . 2.71 113.883 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.54 -39.72 84.9 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.602 -0.686 . . . . 3.06 111.662 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -70.74 -18.62 62.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.523 2.329 . . . . 4.9 113.786 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -71.89 -22.01 61.56 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.008 1.276 . . . . 3.89 111.865 166.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.45 18.32 42.39 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.332 1.92 . . . . 1.98 114.303 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -106.03 -160.78 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.019 1.327 . . . . 5.4 110.123 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 69.9 m -108.09 131.51 54.54 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.885 1.22 . . . . 1.83 112.388 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.08 118.28 19.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.836 1.654 . . . . 1.22 111.125 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -138.04 155.33 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.777 1.231 . . . . 1.13 113.122 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.0 mp -113.42 159.95 18.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.971 1.309 . . . . 1.04 112.587 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.7 t -127.74 123.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.919 1.687 . . . . 2.87 110.397 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.62 147.29 48.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.784 1.234 . . . . 0.9 110.634 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.58 134.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.928 0.891 . . . . 1.84 112.061 -172.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 41.09 49.73 3.15 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.047 1.739 . . . . 3.16 112.043 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.272 24.0 m-20 54.2 36.15 24.3 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.907 2.883 . . . . 1.5 116.435 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.93 138.43 48.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.999 1.72 . . . . 2.48 110.68 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.25 133.77 48.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.642 -1.286 . . . . 1.73 110.762 169.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.2 p -115.76 -37.89 3.83 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.661 0.985 . . . . 1.34 113.661 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -174.57 -171.46 38.8 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 119.806 1.185 . . . . 0.54 115.349 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.81 154.09 44.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.739 1.616 . . . . 0.88 113.025 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.12 133.04 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.723 1.609 . . . . 2.16 110.016 -173.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -107.53 132.31 53.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 1.82 110.77 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 24.9 mt -135.02 152.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.438 1.895 . . . . 2.18 110.604 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -120.07 -174.44 2.77 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.967 2.107 . . . . 2.05 111.408 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 6.1 t70 -119.16 138.15 53.13 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.907 1.283 . . . . 3.4 110.74 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 114.466 1.284 . . . . 4.02 114.466 -170.221 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 119.013 -0.518 . . . . 12.0 111.711 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -68.46 163.95 22.21 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.272 1.429 . . . . 12.07 111.927 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 7.7 m -130.31 146.0 51.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.953 1.301 . . . . 8.99 112.36 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 6.9 tpt -67.03 162.11 22.87 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.276 1.431 . . . . 7.59 112.729 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 23.0 m170 -55.49 -48.33 74.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.76 1.224 . . . . 8.82 112.548 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -93.4 103.41 3.04 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.209 -1.156 . . . . 3.11 110.209 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 95.5 m -64.27 127.04 91.62 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 118.15 0.975 . . . . 3.89 110.39 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.38 135.07 16.22 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.823 2.349 . . . . 2.62 111.465 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.7 p -135.25 132.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.478 -0.764 . . . . 3.65 110.215 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 6.3 p -68.52 123.16 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.643 -0.66 . . . . 2.33 110.177 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 30.4 t30 -103.64 -39.44 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.85 1.26 . . . . 4.77 112.136 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.22 146.85 20.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.227 1.011 . . . . 3.3 112.295 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 16.7 m -132.49 131.7 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.788 0.835 . . . . 2.08 112.201 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 53.0 tttt -135.08 144.61 47.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.883 1.273 . . . . 2.33 113.224 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 87.7 t -79.17 147.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.054 1.341 . . . . 2.35 110.659 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.9 tp -122.22 -24.1 5.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.59 1.556 . . . . 1.28 112.707 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 36.0 m -127.46 107.42 9.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.153 1.381 . . . . 2.97 109.431 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.34 130.51 49.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.535 1.134 . . . . 3.64 111.788 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 59.8 m 51.61 31.21 7.45 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.132 1.773 . . . . 2.7 115.528 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -137.98 5.5 2.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.965 1.306 . . . . 2.92 113.514 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -154.37 -79.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 6.87 110.423 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.83 146.85 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 128.203 2.601 . . . . 2.82 109.032 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -97.93 155.64 16.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.245 1.418 . . . . 2.8 113.682 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -44.76 -49.42 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.669 2.47 . . . . 4.12 117.669 -167.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.9 t60 -75.33 -28.18 59.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.433 1.47 . . . . 3.45 111.348 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -65.17 -38.71 91.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.857 -1.152 . . . . 4.71 111.062 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.36 -51.85 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.088 0.955 . . . . 1.68 110.603 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -31.81 73.0 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.124 0.874 . . . . 1.92 112.262 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.78 54.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 1.75 112.152 173.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 14.4 pt -69.14 -34.95 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.193 . . . . 1.09 113.157 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 58.1 t -70.75 -45.07 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.133 0.878 . . . . 2.16 111.361 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.0 -36.18 91.66 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.487 -0.758 . . . . 0.91 113.304 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.0 p -72.76 -34.89 67.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.45 0.907 . . . . 2.14 113.45 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -58.05 -51.79 68.23 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.275 0.943 . . . . 1.24 112.64 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.52 -13.66 61.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.875 1.065 . . . . 2.56 113.875 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 9.1 p -65.16 -20.85 66.64 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.058 -1.651 . . . . 2.45 112.667 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -122.99 16.84 10.06 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.973 1.709 . . . . 2.49 112.636 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.5 t -127.83 -176.93 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.524 1.93 . . . . 1.7 110.197 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -142.94 46.77 1.55 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.294 1.438 . . . . 3.81 112.607 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.16 164.76 22.01 Favored Pre-proline 0 CA--C 1.554 1.123 0 O-C-N 121.274 -0.891 . . . . 2.5 112.441 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.73 -22.61 5.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.193 2.596 . . . . 1.41 115.314 -169.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 10.3 tt -112.8 -48.59 2.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.437 1.095 . . . . 2.45 112.848 -169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -66.04 -21.22 69.61 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.18 0.832 . . . . 1.11 115.18 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 67.4 p -62.98 -16.8 60.89 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.942 1.371 . . . . 2.42 113.979 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.33 78.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.013 -1.054 . . . . 2.0 111.737 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.69 -38.95 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.205 1.402 . . . . 2.04 110.232 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 90.9 m -53.08 -47.86 68.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.527 -0.749 . . . . 1.88 111.704 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -60.45 -51.0 71.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.649 0.78 . . . . 3.59 112.252 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.02 -41.28 78.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.214 0.605 . . . . 4.96 111.95 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.1 t -67.65 -56.9 7.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.478 1.511 . . . . 2.02 112.246 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -50.55 -45.49 56.94 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.014 1.279 . . . . 4.74 110.88 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -70.98 -32.44 69.29 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.222 1.009 . . . . 4.36 113.361 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -72.06 -41.4 67.44 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.73 1.15 . . . . 2.19 113.789 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.33 -16.21 61.88 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.715 1.206 . . . . 1.28 112.388 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.12 46.17 9.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.847 2.459 . . . . 2.74 112.064 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.83 143.34 26.24 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.525 -0.734 . . . . 2.76 111.937 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -99.4 -0.42 40.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.173 0.989 . . . . 3.5 112.518 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 63.3 p -101.21 9.02 42.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.305 1.842 . . . . 4.49 114.701 -168.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -67.55 149.37 50.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.979 1.312 . . . . 2.09 112.78 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.44 168.26 19.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.399 1.476 . . . . 1.32 115.758 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 9.8 m -160.76 -49.97 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.123 -1.222 . . . . 1.87 113.516 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 53.6 t -136.29 142.68 43.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.503 1.521 . . . . 1.84 114.745 -168.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.2 mm -138.71 148.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 130.346 3.458 . . . . 3.34 109.317 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 19.2 t0 -131.93 98.38 4.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.964 1.706 . . . . 2.56 106.798 166.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 60.6 t80 -73.57 124.42 25.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.478 1.911 . . . . 5.49 114.544 -167.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.26 123.47 25.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.443 1.897 . . . . 2.32 108.213 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 7.4 p -129.47 149.06 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.023 1.86 . . . . 4.3 116.023 -166.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 52.8 t -128.41 102.79 20.41 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.098 1.359 . . . . 2.01 107.419 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -57.67 133.79 58.77 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.174 2.582 . . . . 1.94 113.821 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.11 11.38 70.43 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.813 1.197 . . . . 1.58 115.499 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 33.2 t -138.89 -41.73 0.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.655 1.227 . . . . 2.38 114.044 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 174.58 -177.86 46.57 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 115.661 1.024 . . . . 1.03 115.661 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.71 149.05 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 2.73 111.218 170.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.5 t -131.41 142.93 50.12 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.188 2.195 . . . . 1.07 109.137 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.1 p -153.84 165.68 35.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.929 1.085 . . . . 1.32 113.929 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -114.66 122.45 46.5 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.032 -1.099 . . . . 1.71 108.032 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 33.1 m -124.34 136.63 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.224 0.609 . . . . 3.33 112.294 -170.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.6 t -122.95 145.4 48.51 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.884 0.373 . . . . 2.07 111.037 166.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.89 45.21 0.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.71 2.004 . . . . 3.36 107.184 158.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.27 -34.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.957 . . . . 3.06 111.721 -171.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -144.6 37.15 1.2 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.92 0.866 . . . . 4.74 111.905 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -69.42 0.7 16.52 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.436 1.493 . . . . 3.62 115.144 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.3 pp -57.79 -6.27 0.51 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.541 2.336 . . . . 3.74 116.174 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 3.5 tt -86.54 -66.29 0.92 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.506 1.122 . . . . 6.31 112.702 -169.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -168.61 154.44 6.72 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.745 2.418 . . . . 7.79 108.821 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.64 144.33 26.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.466 1.506 . . . . 12.82 111.232 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -88.59 27.13 1.33 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.88 1.272 . . . . 14.71 114.317 173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -68.21 108.55 3.2 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.15 0.98 . . . . 12.68 112.449 -169.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -155.76 -44.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.559 1.543 . . . . 17.99 112.053 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.19 -14.28 61.76 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.182 -0.949 . . . . 19.17 112.482 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1137 ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' 1137 ' ' ILE . 0.7 OUTLIER -86.2 -16.17 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 126.974 2.11 . . . . 17.87 112.583 173.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.4 -44.23 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 1 C-N-CA 132.613 4.365 . . . . 18.22 115.959 178.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.14 -20.09 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.494 1.664 . . . . 18.49 115.494 169.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.38 -25.03 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 119.107 3.003 . . . . 18.77 119.107 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -88.21 -5.35 58.44 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.193 1.797 . . . . 21.15 114.642 -175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1142 ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' 1142 ' ' ILE . 0.2 OUTLIER -79.66 153.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.712 1.605 . . . . 21.28 114.715 -169.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -100.22 6.52 44.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.168 2.187 . . . . 28.13 115.247 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -77.33 7.49 5.23 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.889 1.44 . . . . 23.21 114.889 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 59.13 175.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.936 2.494 . . . . 25.08 115.358 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 73.3 m -139.52 109.44 6.37 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.317 1.447 . . . . 23.73 109.734 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 77.8 mt -110.52 158.62 18.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.598 1.159 . . . . 25.15 111.531 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 14.0 m -115.59 141.59 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.989 1.316 . . . . 25.76 111.071 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 164.55 33.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.786 1.234 . . . . 26.59 112.838 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 8.6 tp -143.7 127.67 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.472 0.709 . . . . 28.08 112.622 171.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -157.55 112.32 2.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.497 1.519 . . . . 27.32 109.667 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -64.87 -21.13 66.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.408 0.892 . . . . 28.22 113.408 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 80.9 p -81.66 -3.93 54.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.849 1.425 . . . . 28.64 114.849 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 51.5 t30 -131.25 157.87 42.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.703 1.601 . . . . 26.24 111.686 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -106.12 -17.49 14.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.924 1.289 . . . . 23.97 113.23 168.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 61.07 -58.55 0.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.462 2.705 . . . . 25.76 114.296 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 21.5 m -170.43 139.71 1.71 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.02 3.328 . . . . 23.81 107.24 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 46.5 p -136.91 154.99 50.32 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.11 1.323 . . . . 20.28 113.045 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.6 t -161.88 145.73 12.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.747 1.017 . . . . 17.81 113.747 -172.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 21.1 t -136.38 141.49 43.67 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.442 1.497 . . . . 15.53 110.069 169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 13.9 m -54.84 123.21 12.66 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.152 1.538 . . . . 14.51 115.152 -167.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 58.2 m -102.03 -8.98 21.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.745 1.618 . . . . 15.45 113.795 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 22.4 ptp -61.39 167.56 3.22 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.254 -0.904 . . . . 14.41 110.386 167.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 35.2 pt -72.93 64.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.707 1.203 . . . . 12.3 112.86 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.98 -27.14 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.588 1.555 . . . . 10.45 114.534 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -22.48 52.13 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.169 1.174 . . . . 9.36 114.169 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -80.71 -14.12 58.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.848 0.859 . . . . 8.87 112.769 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.86 -2.69 15.12 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.993 1.479 . . . . 9.48 114.993 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.07 -42.81 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.199 1.0 . . . . 7.18 110.472 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 66.8 m -62.96 -18.27 62.99 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.824 1.046 . . . . 6.42 113.824 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.89 -38.19 54.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.074 0.852 . . . . 7.6 111.666 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.08 60.9 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.584 0.754 . . . . 5.96 112.513 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.77 -36.79 79.84 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.141 -0.975 . . . . 7.63 111.614 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -77.01 -54.77 6.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.871 0.868 . . . . 5.53 111.18 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -82.89 66.39 8.49 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 4.71 111.344 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -31.73 134.78 0.08 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.847 2.459 . . . . 3.32 117.01 -168.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -134.0 135.22 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.619 1.168 . . . . 2.27 113.78 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -89.92 137.64 32.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.03 1.332 . . . . 4.71 109.457 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.87 119.75 31.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.015 0.926 . . . . 2.4 109.058 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.9 m -133.91 138.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 118.878 0.763 . . . . 0.92 112.342 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -144.92 154.66 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.113 0.965 . . . . 0.92 113.542 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.4 tt -149.49 139.29 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.837 1.655 . . . . 1.85 110.048 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 178.35 173.88 44.12 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.312 0.885 . . . . 1.8 115.312 -172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -57.65 -70.34 0.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.431 1.492 . . . . 3.81 114.68 -169.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 -72.77 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.725 1.379 . . . . 6.3 114.725 -177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.18 -31.48 70.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.527 1.512 . . . . 4.83 113.413 -168.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 15.3 t90 -68.25 -23.39 64.78 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.396 -1.44 . . . . 4.01 113.117 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 80.2 mmm -72.04 -40.65 68.23 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.789 0.836 . . . . 2.92 110.979 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.38 -64.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.252 1.421 . . . . 3.35 109.482 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -51.69 -9.64 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.908 2.483 . . . . 7.61 116.6 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.31 13.56 0.72 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 120.903 1.683 . . . . 1.02 111.106 167.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 71.31 33.66 64.43 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 119.475 -2.016 . . . . 1.07 114.001 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.25 172.91 6.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.947 1.299 . . . . 0.81 110.836 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.3 t -117.27 138.55 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.808 1.243 . . . . 1.56 110.28 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 17.7 tt -114.1 141.81 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.332 1.053 . . . . 1.99 112.148 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 11.0 p30 -103.2 158.7 16.14 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.242 1.417 . . . . 4.24 113.093 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -74.0 -21.96 59.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.248 1.203 . . . . 3.42 114.248 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.18 -39.92 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.714 -1.241 . . . . 2.91 112.161 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.6 p -70.32 -36.7 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.575 -0.703 . . . . 2.09 111.111 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.7 t30 -64.44 -38.37 90.79 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.884 0.765 . . . . 2.3 112.556 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -44.98 86.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.795 0.838 . . . . 2.12 112.864 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 29.5 t80 -71.34 -43.03 67.79 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.54 0.736 . . . . 3.8 112.393 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.3 tpp -56.84 -48.03 78.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.417 1.087 . . . . 1.66 111.58 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -74.15 -34.74 63.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.94 -0.552 . . . . 1.94 112.055 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.65 -45.33 85.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.115 1.325 . . . . 3.33 111.818 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -65.3 -47.2 77.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.143 0.977 . . . . 4.89 111.684 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.12 -34.61 76.68 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.332 -0.855 . . . . 4.15 111.967 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -69.84 -15.26 63.07 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.586 1.554 . . . . 4.42 113.78 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 63.1 mttt -73.58 -14.49 61.2 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 120.431 1.469 . . . . 4.87 112.059 165.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.98 10.36 58.75 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 126.59 2.043 . . . . 1.93 113.556 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -115.69 132.34 56.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.886 1.274 . . . . 5.55 111.343 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 99.6 m -59.61 128.25 36.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.619 1.341 . . . . 2.0 114.619 -168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.87 130.05 49.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.841 1.256 . . . . 1.36 111.777 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.8 m -140.9 154.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.345 1.458 . . . . 1.21 113.247 -174.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.58 159.32 15.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.174 0.989 . . . . 1.41 110.551 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.8 p -130.57 124.84 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.456 1.102 . . . . 3.19 112.54 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.27 152.31 37.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.921 1.688 . . . . 0.84 111.226 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.7 m -146.69 119.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.545 1.938 . . . . 1.41 112.008 -167.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 46.46 47.48 14.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.984 2.114 . . . . 3.37 113.215 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.321 34.0 m-20 63.38 26.77 15.1 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.228 2.611 . . . . 2.09 116.382 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -125.66 153.67 43.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.216 2.206 . . . . 3.19 110.824 167.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.6 mt -75.17 148.77 39.31 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.218 -1.551 . . . . 1.92 112.418 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.7 p -124.55 -36.94 2.56 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.08 0.771 . . . . 1.14 113.08 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.47 -166.07 29.68 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 119.268 0.94 . . . . 0.59 115.418 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.39 153.04 46.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.884 1.674 . . . . 1.01 111.743 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.4 mm -132.19 140.58 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.796 1.638 . . . . 2.44 108.864 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -130.84 132.06 44.97 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.974 0.91 . . . . 2.11 111.025 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.19 155.87 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.975 2.11 . . . . 2.57 110.099 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -120.39 176.31 5.54 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.447 1.899 . . . . 2.43 112.945 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.26 134.88 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.369 1.468 . . . . 3.83 111.034 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.256 1.423 0 N-CA-C 114.713 1.375 . . . . 4.95 114.713 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 113.114 0.783 . . . . 13.81 113.114 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.2 162.3 17.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.624 1.569 . . . . 16.47 111.218 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 68.7 m -141.19 145.69 35.98 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.849 0.86 . . . . 7.57 112.21 -169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 7.5 tpt -55.59 106.59 0.26 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.208 1.403 . . . . 7.74 111.028 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 33.3 m170 -120.26 -36.79 3.16 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 6.22 113.358 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -76.92 71.57 2.16 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.943 0.782 . . . . 3.62 114.524 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 27.8 m -70.44 117.48 55.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.544 1.538 . . . . 4.25 113.079 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.51 87.22 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.856 2.371 . . . . 2.45 110.035 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 47.0 t -65.9 109.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.38 1.072 . . . . 4.16 111.107 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.7 p -71.17 131.42 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.605 -0.685 . . . . 2.73 111.552 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -34.43 2.76 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.281 1.586 . . . . 2.96 115.281 -167.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -155.12 145.93 22.42 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.753 1.161 . . . . 2.92 111.666 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.9 m -127.74 133.78 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.072 0.949 . . . . 1.48 111.175 170.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 43.4 tttt -135.88 145.52 46.43 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.935 1.294 . . . . 2.47 112.539 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 96.4 t -89.52 134.15 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.226 1.81 . . . . 1.45 111.077 173.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.3 tp -95.4 -38.53 10.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.898 1.679 . . . . 1.32 110.984 170.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 52.1 m -121.89 111.96 17.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.272 1.429 . . . . 2.2 110.213 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -109.74 136.26 49.36 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.776 1.23 . . . . 3.63 112.854 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 57.93 -57.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 130.072 3.349 . . . . 4.22 118.82 169.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m120 -70.35 -6.28 34.21 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.603 2.075 . . . . 5.75 116.603 -166.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.05 -26.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.401 1.48 . . . . 9.91 114.304 168.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mt -144.96 142.38 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.589 1.156 . . . . 3.64 107.969 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.3 m -91.76 144.08 25.87 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.425 0.69 . . . . 3.17 111.489 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 27.9 p80 -57.31 -41.36 79.76 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.77 1.396 . . . . 4.41 114.77 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 27.1 t60 -74.18 -29.3 61.7 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.075 -1.016 . . . . 3.48 111.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.79 -37.5 84.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 117.493 -1.241 . . . . 6.47 111.7 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.77 -56.63 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.728 1.149 . . . . 2.07 110.309 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.46 -30.1 69.73 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.606 -0.684 . . . . 1.8 112.184 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.7 76.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.759 -0.639 . . . . 1.28 112.596 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 17.3 pt -68.81 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.676 1.58 . . . . 1.26 112.956 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 61.3 t -70.12 -50.77 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.512 1.051 . . . . 1.38 111.349 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.7 84.8 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.526 -0.733 . . . . 0.96 113.349 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 76.6 p -73.58 -35.62 65.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.692 -0.887 . . . . 1.89 112.041 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -71.21 -39.72 71.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.932 1.086 . . . . 1.53 113.932 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.34 -6.94 53.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.952 1.464 . . . . 3.49 114.952 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 84.7 p -58.68 -27.29 64.68 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.221 1.934 . . . . 3.23 116.221 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -95.58 -6.84 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.212 0.914 . . . . 2.44 113.201 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.1 t -79.77 162.03 25.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.562 1.145 . . . . 1.77 113.728 -174.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -112.64 -3.53 14.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.355 2.262 . . . . 4.35 114.097 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1086 ' ' HIS . . . . . 0.506 ' CB ' HN61 ' A' 1232 ' ' ATP . 2.8 m-70 -59.66 144.14 85.57 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.087 -1.008 . . . . 2.11 112.282 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.29 -40.54 24.93 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.048 2.498 . . . . 1.88 112.286 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.85 -44.47 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.32 -0.862 . . . . 2.49 111.922 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.61 98.26 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.539 0.59 . . . . 2.05 113.162 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.2 p -64.32 -38.31 90.58 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.586 -0.95 . . . . 2.68 112.201 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.54 94.78 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.898 0.879 . . . . 2.37 112.843 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 54.4 mt -68.29 -42.32 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.087 0.555 . . . . 1.42 110.214 173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 96.7 m -54.43 -44.71 72.69 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.664 0.666 . . . . 1.99 111.514 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.4 tttt -60.13 -51.43 69.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.68 0.673 . . . . 3.21 111.955 174.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.37 -42.52 82.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.714 0.806 . . . . 4.1 111.77 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 69.1 m -70.82 -45.65 64.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.147 . . . . 2.99 112.696 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.98 -34.86 78.43 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.346 1.884 . . . . 3.47 111.371 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -65.08 -39.15 92.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.349 1.06 . . . . 4.84 112.941 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.79 -44.57 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.861 -1.15 . . . . 2.82 113.074 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.17 -3.1 18.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.848 1.425 . . . . 1.85 114.848 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 31.4 t70 58.64 26.22 14.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.627 1.171 . . . . 5.02 113.586 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.3 t -122.54 168.44 12.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.31 1.844 . . . . 2.58 112.047 -170.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.27 -15.0 15.6 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.994 1.717 . . . . 4.03 112.134 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.5 t -132.81 133.42 43.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.061 1.744 . . . . 3.32 111.194 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.98 147.61 25.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.246 0.618 . . . . 1.5 112.042 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 63.11 177.41 3.83 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.74 1.162 . . . . 1.59 115.08 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 70.7 m -138.47 -69.44 0.44 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.542 0.737 . . . . 1.97 111.414 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 48.9 t -136.11 141.4 44.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.197 0.599 . . . . 2.87 111.898 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.98 148.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.255 2.622 . . . . 3.96 111.714 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -110.72 124.34 51.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.909 -2.626 . . . . 3.3 103.909 163.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.1 OUTLIER -121.43 138.12 54.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.383 1.447 . . . . 4.49 112.889 -174.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.95 98.03 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.385 2.274 . . . . 3.54 108.329 -169.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.5 t -96.22 126.62 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.555 -0.715 . . . . 2.99 110.692 -168.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 33.1 t -143.32 113.88 5.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.751 1.62 . . . . 1.91 109.448 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.14 140.36 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.251 2.634 . . . . 2.09 113.925 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 55.4 35.68 61.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.6 1.095 . . . . 2.77 114.362 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 93.0 m -143.5 -32.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.784 1.234 . . . . 3.5 113.791 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 122.18 -164.26 15.31 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.075 1.321 . . . . 0.94 112.629 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.33 151.14 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.542 -1.563 . . . . 2.86 111.249 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 14.5 t -129.87 140.5 50.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.732 1.613 . . . . 2.05 109.859 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 13.5 p -143.97 156.93 44.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.469 1.032 . . . . 3.06 113.682 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -116.23 97.75 6.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.509 1.124 . . . . 2.36 108.735 -174.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.1 p -93.96 146.66 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.634 0.73 . . . . 3.27 111.426 -174.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.6 t -142.95 162.02 36.57 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.135 1.532 . . . . 2.69 115.135 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 10.9 t-20 176.55 -24.81 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 1 C-N-CA 132.183 4.193 . . . . 3.13 109.914 162.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 18.0 pt -52.43 -26.36 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 126.337 1.855 . . . . 3.1 114.976 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.59 34.39 4.14 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.785 1.634 . . . . 4.96 110.179 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.83 36.39 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 120.647 -1.283 . . . . 3.65 114.477 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -16.39 63.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.947 1.699 . . . . 5.9 115.519 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . 0.313 3.5 pp -95.19 -3.87 46.97 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.274 1.397 . . . . 5.62 114.759 173.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 45.8 t-80 32.3 87.32 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.992 2.917 . . . . 6.81 115.394 170.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -113.93 140.94 47.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.319 1.229 . . . . 11.77 114.319 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 45.8 t30 -145.73 68.79 1.21 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.442 2.297 . . . . 13.28 107.119 166.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.66 -166.35 0.2 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 126.133 1.773 . . . . 13.83 112.479 -169.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -92.22 -178.14 4.87 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.02 -1.675 . . . . 18.91 111.238 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.85 90.52 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.542 1.537 . . . . 12.91 111.252 166.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 70.0 mt -141.67 125.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.472 1.509 . . . . 13.11 109.008 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.79 -31.95 63.53 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.127 0.971 . . . . 15.63 112.529 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.51 -7.84 52.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.68 -1.262 . . . . 15.05 114.399 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.01 -22.26 62.37 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.914 -1.116 . . . . 12.56 112.324 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.96 146.09 54.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.763 0.825 . . . . 14.42 112.66 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.71 136.28 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 16.23 113.458 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -151.77 111.0 3.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.041 1.736 . . . . 17.33 110.799 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -74.69 -40.22 61.5 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.422 -0.799 . . . . 18.14 112.545 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 49.23 35.64 7.86 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.266 1.427 . . . . 19.37 113.606 -169.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 16.2 t 58.81 131.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 129.111 2.964 . . . . 20.73 115.023 -168.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 17.9 mt -98.1 -171.08 2.08 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.971 1.309 . . . . 20.86 111.44 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 5.8 m -62.06 114.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.067 -1.02 . . . . 22.33 109.86 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.17 108.75 20.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.477 1.111 . . . . 24.92 108.752 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.56 9.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.491 1.916 . . . . 27.11 111.985 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 1.7 t70 -154.28 -154.98 0.54 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.603 2.361 . . . . 28.0 110.02 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -68.3 26.01 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.928 1.691 . . . . 29.89 114.895 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 33.2 t 56.45 56.64 5.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.534 1.534 . . . . 27.64 113.774 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 63.4 t30 -77.13 43.86 0.38 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.82 1.648 . . . . 26.58 112.728 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -63.46 -54.39 37.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.01 1.324 . . . . 24.82 112.41 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 46.89 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.431 2.292 . . . . 27.83 114.142 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 18.5 m -152.33 154.2 35.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.718 2.407 . . . . 23.13 111.535 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 89.2 p -151.39 149.94 29.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.366 1.467 . . . . 19.62 113.822 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 65.5 p -144.51 39.0 1.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.463 1.905 . . . . 18.55 112.188 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 23.0 m -65.29 -11.05 37.6 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 118.877 2.917 . . . . 16.44 118.877 -166.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 4.9 t 51.89 83.1 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.634 2.373 . . . . 14.61 117.018 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 54.4 p -125.02 -25.63 3.83 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.639 0.977 . . . . 14.62 113.639 167.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 40.3 mtt -110.63 152.04 26.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.226 1.41 . . . . 16.2 113.121 -174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 2.3 mm 60.54 13.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 127.182 2.193 . . . . 12.49 112.872 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.7 pp -73.15 -18.79 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 120.162 -1.587 . . . . 10.59 112.761 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.47 -16.74 64.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.583 0.957 . . . . 9.13 113.583 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.79 62.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.05 -1.031 . . . . 8.09 112.549 170.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.31 -45.38 13.85 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.389 1.076 . . . . 8.69 109.788 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 83.1 mt -55.82 -41.04 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.134 1.374 . . . . 7.78 110.822 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.4 m -65.1 -16.49 63.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.303 1.223 . . . . 7.93 114.303 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -98.88 -4.03 33.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.494 1.294 . . . . 7.04 114.494 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.22 64.32 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.808 1.186 . . . . 5.98 113.633 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.79 -28.7 66.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.974 1.71 . . . . 8.06 113.205 172.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -103.77 -39.72 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.034 1.334 . . . . 6.29 112.071 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.96 25.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.67 1.73 . . . . 4.83 115.67 -168.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 57.96 -41.04 0.05 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.584 2.754 . . . . 4.89 118.372 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 25.71 119.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 130.667 3.587 . . . . 2.21 117.837 167.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -71.2 115.92 10.91 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.898 -1.126 . . . . 4.22 110.545 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -88.14 125.24 34.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.333 -1.358 . . . . 2.96 107.333 168.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.6 m -126.69 141.17 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.295 0.638 . . . . 1.36 110.369 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.5 150.76 47.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.988 0.915 . . . . 0.92 112.392 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.33 158.47 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.801 1.24 . . . . 1.71 109.938 -169.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 104.85 159.18 23.58 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.75 0.691 . . . . 1.74 114.783 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 49.53 -159.6 0.06 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.219 1.408 . . . . 2.49 113.617 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -58.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.777 1.399 . . . . 8.6 114.777 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -80.96 -37.76 28.84 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.152 0.887 . . . . 5.43 113.002 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 83.6 t90 -54.73 -36.44 64.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.927 1.291 . . . . 4.05 113.087 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.52 -36.36 80.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.665 1.186 . . . . 3.6 113.244 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.8 mt -62.37 -61.44 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.723 1.609 . . . . 4.26 109.134 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.4 -13.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.544 2.338 . . . . 7.63 116.268 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 6.0 t30 -74.28 22.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 121.694 2.043 . . . . 1.24 113.153 168.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.95 26.44 73.23 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.894 -1.753 . . . . 0.85 114.409 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 8.2 mt -96.44 147.7 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.052 1.426 . . . . 0.95 110.066 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 89.7 t -97.37 126.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.328 1.051 . . . . 2.36 110.385 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.0 148.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.977 0.911 . . . . 2.26 112.629 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.55 152.12 38.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.845 1.258 . . . . 2.77 113.583 -168.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -70.93 -28.02 64.2 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.462 1.282 . . . . 3.24 114.462 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.21 -36.64 69.24 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.761 -1.212 . . . . 2.57 112.494 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -78.0 -36.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.905 0.882 . . . . 1.31 113.286 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -54.0 -42.79 69.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.581 1.152 . . . . 3.12 112.517 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.42 -40.01 96.03 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.045 0.938 . . . . 1.91 113.086 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -39.03 75.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.687 1.195 . . . . 3.44 110.879 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.4 tpp -62.99 -53.29 56.31 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.509 1.124 . . . . 1.61 112.313 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 11.0 t -67.48 -32.07 72.64 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.665 -0.647 . . . . 1.88 112.485 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -57.43 -50.86 71.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.518 1.053 . . . . 3.18 112.023 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -71.72 -33.94 69.17 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.314 0.857 . . . . 2.96 113.314 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -68.21 -35.95 78.77 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.391 -0.818 . . . . 3.94 112.564 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.82 -22.04 61.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.845 1.658 . . . . 4.99 113.524 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 21.5 mttp -76.51 -7.66 55.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.883 1.273 . . . . 3.89 112.135 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.56 88.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.964 1.745 . . . . 2.35 115.094 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . 0.259 16.0 mtt-85 -84.19 -152.36 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 4.12 109.956 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 86.0 m -120.61 120.88 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 121.451 1.932 . . . . 1.82 112.112 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -117.06 127.59 54.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.902 2.081 . . . . 1.77 109.595 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 35.8 m -142.29 154.68 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 119.543 1.065 . . . . 0.95 113.483 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.32 164.0 12.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.185 1.394 . . . . 1.31 111.731 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.9 t -135.83 129.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.695 1.598 . . . . 3.12 111.168 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -134.43 153.01 52.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.166 1.386 . . . . 0.99 111.99 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 23.8 m -149.25 130.45 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.879 . . . . 1.77 112.899 -169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 35.7 m-20 41.89 40.67 1.62 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.262 1.825 . . . . 3.39 111.577 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 62.48 30.62 17.22 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 128.125 2.57 . . . . 2.11 116.787 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.14 135.16 54.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.735 2.014 . . . . 2.56 110.199 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.79 133.78 49.82 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.254 -1.529 . . . . 1.68 111.523 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -116.83 -42.24 2.98 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.725 1.009 . . . . 1.3 113.725 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.13 -176.47 39.74 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 119.215 0.916 . . . . 0.75 114.725 -172.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.03 155.05 44.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.865 1.666 . . . . 0.98 112.852 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.63 134.48 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.535 1.534 . . . . 2.0 110.266 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -112.93 131.86 55.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.246 1.418 . . . . 1.75 110.904 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -128.86 147.61 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.734 2.014 . . . . 2.63 108.789 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -94.86 -30.95 13.93 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.128 1.158 . . . . 4.08 114.128 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 11.4 t70 61.46 123.65 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.606 1.962 . . . . 4.24 115.012 177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 126.711 2.005 . . . . 6.13 115.603 -169.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1232 ' ' ATP . . . . . 0.506 HN61 ' CB ' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.145 0.497 . . . . 15.26 110.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -116.38 -31.46 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.257 1.423 . . . . 12.11 112.694 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 9.2 t 49.34 -165.77 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.853 2.461 . . . . 8.0 114.622 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.2 -64.01 1.19 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.467 -1.395 . . . . 7.48 111.427 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 43.3 m170 -123.01 -67.95 0.91 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.658 1.183 . . . . 8.42 112.27 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -73.21 78.38 0.81 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.111 1.339 . . . . 3.89 115.278 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 26.8 m -66.96 125.12 90.38 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.912 0.885 . . . . 3.75 112.426 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -95.04 156.75 1.74 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.198 3.265 . . . . 1.91 111.969 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 30.8 t -134.93 113.08 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.609 1.164 . . . . 3.44 109.588 173.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 5.8 p -73.06 132.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.777 1.171 . . . . 2.32 110.697 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -125.57 -36.17 2.47 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 117.415 2.376 . . . . 3.02 117.415 -164.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -156.42 150.84 25.55 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.737 1.608 . . . . 2.91 111.529 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -129.67 136.69 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.117 0.967 . . . . 1.49 111.375 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -140.8 147.83 39.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.107 0.963 . . . . 4.28 113.153 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 99.1 t -102.45 129.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.318 1.447 . . . . 1.52 112.233 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.65 -35.81 9.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.024 1.73 . . . . 1.54 112.673 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -111.01 88.66 2.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.634 1.574 . . . . 3.0 108.06 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.64 133.12 41.56 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.948 0.899 . . . . 3.59 111.701 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 13.8 m 59.18 25.68 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.226 2.211 . . . . 2.4 115.097 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.61 -6.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.047 1.499 . . . . 2.97 115.047 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -140.87 -77.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.891 1.277 . . . . 5.3 110.799 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 20.9 mt -137.47 147.57 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.111 2.165 . . . . 2.68 110.075 -174.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.5 m -91.68 152.48 20.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.595 1.558 . . . . 2.3 113.704 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 12.2 p80 -53.81 -42.12 68.05 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.781 2.141 . . . . 3.46 116.781 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -73.99 -23.1 59.41 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.073 -1.017 . . . . 4.03 111.73 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.2 tttt -75.77 -39.17 57.5 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.095 0.958 . . . . 4.97 111.474 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 66.3 mt -56.38 -52.2 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 119.459 1.027 . . . . 1.82 110.656 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.23 -33.34 75.53 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.588 -0.695 . . . . 1.56 112.072 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.02 75.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.722 0.638 . . . . 1.28 112.722 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.67 -34.56 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.763 -1.211 . . . . 1.93 113.381 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 73.5 t -70.64 -46.07 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.89 0.768 . . . . 2.14 110.972 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -63.98 -37.41 94.58 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.662 -0.649 . . . . 0.6 113.372 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 32.6 p -73.07 -37.26 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.917 0.887 . . . . 1.82 113.116 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.99 74.5 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.237 0.926 . . . . 0.81 112.247 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.57 -17.36 64.61 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.131 -0.981 . . . . 2.24 112.771 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 4.2 t -60.51 -35.35 75.75 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.927 -1.108 . . . . 1.92 112.077 170.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.88 -22.17 23.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.649 1.18 . . . . 2.05 113.319 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.6 t -74.33 -179.56 4.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.284 1.034 . . . . 1.64 111.8 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -137.3 19.61 2.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.645 1.578 . . . . 4.29 112.691 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1086 ' ' HIS . . . . . 0.418 ' CB ' HN61 ' A' 1232 ' ' ATP . 26.4 m-70 -75.95 161.21 76.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.854 1.262 . . . . 2.36 112.617 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.02 -33.67 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.05 2.5 . . . . 1.18 114.108 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.81 -49.35 5.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.572 1.549 . . . . 1.73 112.722 -167.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.91 -31.62 81.42 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.003 0.335 . . . . 0.98 113.772 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.5 p -66.31 -16.34 63.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.746 -1.444 . . . . 2.77 113.915 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.39 80.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.73 -1.231 . . . . 1.48 110.737 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.91 -37.11 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.261 1.424 . . . . 1.52 110.417 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 97.7 m -53.82 -48.26 70.08 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.074 0.852 . . . . 1.9 111.863 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -64.0 -45.97 86.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.342 0.974 . . . . 4.67 112.553 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.7 t80 -55.92 -43.92 77.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.919 0.888 . . . . 2.75 111.457 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.7 t -65.85 -52.09 53.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.416 1.487 . . . . 3.47 111.864 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -51.51 -45.34 62.84 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.107 1.363 . . . . 4.14 112.204 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.54 -43.19 77.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.501 0.72 . . . . 3.59 111.559 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -62.19 -42.83 99.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.653 0.982 . . . . 2.69 113.653 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.4 mt -71.39 -13.24 61.79 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.825 0.85 . . . . 1.45 112.66 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 15.7 t70 50.61 54.91 10.35 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.293 1.837 . . . . 2.55 112.161 -169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.7 t -128.91 175.07 8.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.85 1.66 . . . . 3.09 111.841 -174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -115.69 -7.17 12.14 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.404 1.882 . . . . 2.79 112.402 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 10.0 t -140.04 127.26 21.14 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.402 -1.436 . . . . 3.39 113.819 -168.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -161.52 154.13 20.33 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.649 1.58 . . . . 1.42 113.609 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.74 132.03 0.6 Allowed Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.383 1.313 . . . . 1.32 116.383 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 87.9 m -120.07 -72.45 0.69 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.448 1.277 . . . . 1.66 114.448 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 52.6 t -138.99 142.5 38.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.786 1.234 . . . . 1.78 111.208 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.16 169.97 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 130.584 3.554 . . . . 3.05 108.577 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1110 ' ' ASP . . . . . 0.405 ' HB2' ' HZ3' ' A' 1132 ' ' LYS . 24.1 t70 -142.27 150.05 40.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.739 1.616 . . . . 2.66 108.44 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -112.72 147.76 36.15 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.367 1.894 . . . . 5.82 115.468 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.21 95.24 2.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 129.55 3.14 . . . . 2.3 108.02 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 24.4 t -101.12 144.54 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.472 1.509 . . . . 2.83 111.657 -171.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 48.8 t -132.7 118.14 15.5 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.881 1.273 . . . . 1.66 109.381 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.36 133.26 48.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.252 2.635 . . . . 1.81 115.514 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 62.33 19.06 59.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.675 1.607 . . . . 1.97 114.372 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.8 t -136.93 -42.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.083 1.142 . . . . 3.42 114.083 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 154.79 -176.91 32.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.902 0.763 . . . . 0.91 113.756 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.22 146.67 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.001 0.92 . . . . 2.98 111.536 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 30.0 t -125.41 138.7 54.03 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.853 2.061 . . . . 1.05 110.909 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -145.49 165.97 27.05 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 115.176 1.547 . . . . 1.29 115.176 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -111.66 94.43 4.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.758 1.223 . . . . 2.41 108.367 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.8 p -101.96 130.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.215 1.007 . . . . 3.0 113.238 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.5 t -123.21 161.05 25.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.359 1.463 . . . . 1.88 113.607 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 176.87 -37.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.103 2.961 . . . . 2.15 109.931 160.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 18.0 pt -50.07 -21.24 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 127.295 2.238 . . . . 2.93 116.826 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -153.79 39.29 0.48 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.341 1.456 . . . . 4.15 109.824 167.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -74.43 0.64 54.27 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 120.465 -1.397 . . . . 3.41 115.185 -170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.81 -6.49 21.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.247 1.573 . . . . 4.67 115.247 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 24.7 mt -87.32 -26.39 23.43 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.006 0.923 . . . . 6.03 111.737 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1131 ' ' HIS . . . . . 0.528 ' CG ' ' H ' ' A' 1132 ' ' LYS . 37.2 t60 52.4 175.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.952 2.101 . . . . 6.87 114.963 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1132 ' ' LYS . . . . . 0.528 ' H ' ' CG ' ' A' 1131 ' ' HIS . 55.1 mtpt -71.51 170.51 13.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.367 1.867 . . . . 13.05 111.688 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -85.22 48.59 1.6 Allowed 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.407 -0.808 . . . . 13.24 109.339 168.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -79.21 39.17 0.38 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.711 -1.243 . . . . 10.31 112.286 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.92 126.9 55.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.773 2.029 . . . . 13.8 107.832 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.2 m-80 60.99 16.0 6.62 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.492 1.117 . . . . 12.2 113.287 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 59.4 mt -139.15 137.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.509 2.724 . . . . 10.88 106.829 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -83.03 71.25 10.12 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.289 1.042 . . . . 14.3 110.665 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 10.6 t70 77.09 123.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 130.527 3.531 . . . . 14.84 116.401 -169.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.57 119.35 26.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.167 1.787 . . . . 14.67 111.522 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -156.44 -175.09 5.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.582 1.553 . . . . 18.67 111.713 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 15.3 pt -133.68 138.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.455 1.102 . . . . 23.72 110.367 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -127.99 61.62 1.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.857 2.063 . . . . 21.03 108.779 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.34 -6.2 41.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.396 1.258 . . . . 26.33 114.396 -169.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -149.63 129.53 13.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.314 0.857 . . . . 25.46 113.314 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.6 t -60.37 -38.16 83.02 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.314 -0.866 . . . . 23.07 111.254 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.52 14.01 22.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.743 1.217 . . . . 27.95 113.186 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 2.4 t 57.53 20.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.823 1.649 . . . . 28.15 113.508 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -79.47 157.57 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.684 1.194 . . . . 32.53 112.843 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.01 137.35 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.292 1.837 . . . . 34.08 109.932 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -117.9 110.41 17.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.088 0.955 . . . . 33.92 112.743 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -81.67 56.76 3.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.778 1.231 . . . . 38.06 110.759 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 11.6 p -51.97 152.05 3.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.815 2.446 . . . . 35.91 113.63 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 25.9 t30 -61.78 -32.8 73.1 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.47 1.656 . . . . 40.3 115.47 -167.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.97 143.19 50.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.837 -0.539 . . . . 35.76 111.397 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -128.77 173.36 10.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.991 1.316 . . . . 43.38 111.054 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 62.3 m -29.54 116.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.218 2.207 . . . . 37.82 115.005 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 25.3 p -78.72 -36.93 42.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.589 1.555 . . . . 35.93 111.454 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.8 t -161.44 -11.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.705 2.002 . . . . 36.98 112.205 167.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 113.41 26.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.103 1.761 . . . . 31.92 111.603 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 17.0 m -70.02 8.53 0.72 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.679 0.992 . . . . 32.84 113.679 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 36.4 t -72.04 -14.45 61.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 27.13 110.554 165.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 65.7 mmm 50.5 -144.29 0.54 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.837 1.255 . . . . 29.01 110.328 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 17.0 mm -118.18 55.51 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.981 1.712 . . . . 21.5 108.225 167.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.69 -11.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 115.325 1.602 . . . . 21.99 115.325 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -148.87 -8.52 0.36 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.371 1.469 . . . . 16.99 114.732 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -55.42 -28.02 51.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.735 1.607 . . . . 14.31 114.904 -173.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -87.36 -28.31 22.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 14.73 113.008 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.97 -32.66 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.361 2.264 . . . . 10.08 112.271 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 88.3 p -61.61 -9.87 6.99 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.062 1.745 . . . . 8.85 115.485 -169.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.35 -57.7 2.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.728 0.811 . . . . 8.0 110.578 168.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.4 -30.26 66.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.313 1.845 . . . . 4.44 113.996 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -23.93 67.21 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.111 -0.993 . . . . 8.74 113.168 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.43 -47.12 5.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.455 1.102 . . . . 6.06 111.881 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -80.29 54.01 1.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.641 1.576 . . . . 3.89 109.912 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -26.48 123.14 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.509 2.324 . . . . 3.27 115.918 -165.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -147.29 137.93 23.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 112.576 -2.102 . . . . 3.03 112.223 -163.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.78 121.85 44.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.125 0.97 . . . . 3.44 108.961 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.37 103.15 13.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.29 -1.004 . . . . 2.09 108.29 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -121.61 138.59 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.959 0.8 . . . . 2.0 112.006 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.31 152.52 41.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.851 0.86 . . . . 1.1 113.132 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -146.12 140.54 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.437 1.495 . . . . 1.98 109.501 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 169.7 -166.0 39.3 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.255 0.862 . . . . 1.56 115.255 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.268 10.4 p30 -84.7 173.19 10.91 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.86 1.264 . . . . 3.37 112.546 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -59.19 -10.12 2.61 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 117.276 2.324 . . . . 5.76 117.276 -165.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -71.48 -34.15 69.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.017 1.28 . . . . 5.11 111.921 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 50.2 m95 -65.42 -26.22 67.87 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.826 -1.171 . . . . 5.54 113.658 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -34.16 67.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.446 0.699 . . . . 3.17 111.359 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.87 -67.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.137 1.375 . . . . 3.69 107.805 169.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -38.54 -42.96 0.81 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.968 2.507 . . . . 6.45 115.451 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.15 1.75 56.07 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.759 1.763 . . . . 3.93 115.759 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 75.86 32.43 53.51 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.749 -1.22 . . . . 0.78 114.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.69 177.45 6.1 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.073 1.349 . . . . 0.83 110.987 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.8 t -121.54 132.67 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.09 1.356 . . . . 2.54 110.726 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.8 tt -108.29 134.38 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 2.48 110.599 171.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -106.22 162.74 13.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.234 1.014 . . . . 2.99 113.461 -168.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.03 -40.32 93.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 3.06 113.757 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.72 -34.15 66.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.542 0.737 . . . . 2.54 112.508 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 11.3 p -76.9 -32.97 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.338 0.655 . . . . 1.28 111.667 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.89 -46.1 88.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.588 0.755 . . . . 2.0 111.492 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.94 -33.54 74.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.881 1.272 . . . . 2.54 113.867 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.63 -42.16 52.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.799 1.639 . . . . 3.89 112.392 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.1 tpp -64.46 -50.65 66.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.232 1.413 . . . . 1.78 111.867 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 13.9 t -63.62 -33.12 74.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.427 0.691 . . . . 2.02 112.141 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -62.5 -48.99 77.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.98 0.912 . . . . 3.2 112.352 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.66 -0.65 . . . . 2.92 112.686 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.97 -40.14 87.4 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.904 -1.122 . . . . 2.97 112.323 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -71.22 -27.13 63.26 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.43 -1.419 . . . . 5.59 113.804 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 20.8 mttp -70.38 -2.7 14.47 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.648 1.579 . . . . 3.32 113.219 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.66 23.53 69.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.957 1.265 . . . . 1.31 113.593 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -101.17 -166.86 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.032 1.333 . . . . 3.68 111.043 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.8 m -115.22 121.75 43.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.553 1.541 . . . . 2.25 109.928 -176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -127.51 118.77 24.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.05 0.94 . . . . 1.86 110.413 -170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 29.1 m -139.29 153.44 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.114 0.965 . . . . 1.12 112.688 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.35 159.15 18.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.206 1.402 . . . . 2.07 111.509 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -128.73 125.93 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.151 1.38 . . . . 3.1 110.741 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.19 154.24 40.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.769 1.228 . . . . 1.86 111.636 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.8 m -148.09 123.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.732 2.013 . . . . 2.27 110.236 -168.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.263 6.7 m-20 40.23 54.91 2.79 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.547 1.939 . . . . 2.92 113.168 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.271 34.2 m-20 57.76 30.9 19.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.125 2.17 . . . . 1.65 115.954 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -134.88 151.67 51.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.914 1.286 . . . . 2.93 110.586 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.02 151.87 45.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.802 -1.811 . . . . 1.82 111.748 170.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -122.09 -44.81 2.27 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.594 -0.692 . . . . 1.22 111.208 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.64 -162.65 24.26 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.224 0.92 . . . . 0.82 115.0 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -140.74 154.25 46.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.591 1.556 . . . . 2.11 112.592 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 13.3 mm -123.94 127.52 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 1.9 109.096 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -97.22 133.0 42.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.684 1.194 . . . . 1.89 109.758 169.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 44.1 mt -140.11 159.85 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.798 2.039 . . . . 2.21 107.397 -170.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -126.33 168.18 14.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.164 -1.585 . . . . 2.02 111.943 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.87 140.2 50.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.048 1.339 . . . . 3.67 111.094 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.425 1.89 . . . . 4.75 111.324 -179.871 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1232 ' ' ATP . . . . . 0.418 HN61 ' CB ' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 110.658 -0.127 . . . . 10.57 110.658 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.5 137.38 56.77 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.219 0.608 . . . . 17.35 110.683 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 3.7 m 57.7 176.49 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.398 1.479 . . . . 9.52 113.618 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 43.4 ttp -136.1 -51.21 0.71 Allowed 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.587 -1.32 . . . . 8.45 112.344 168.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -84.93 -34.81 22.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.378 1.251 . . . . 6.67 114.378 -175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -55.52 122.74 27.79 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.938 0.78 . . . . 4.24 111.587 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 22.9 m -115.21 117.03 41.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.917 0.887 . . . . 3.46 111.126 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.59 154.75 18.24 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.734 2.956 . . . . 2.8 111.422 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 59.4 t -142.21 105.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.053 -1.092 . . . . 3.96 108.053 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -71.9 128.99 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.96 0.886 . . . . 2.02 111.396 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.66 -47.99 4.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.17 1.788 . . . . 3.05 112.936 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -153.79 146.9 24.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.589 0.756 . . . . 3.44 112.571 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.2 m -120.15 128.87 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.28 1.032 . . . . 2.32 110.179 167.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 48.2 tttt -134.12 144.37 48.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.662 0.785 . . . . 3.58 113.098 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 97.4 t -90.31 144.31 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.245 1.418 . . . . 1.29 112.407 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.9 -29.4 5.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.832 1.653 . . . . 1.98 112.551 169.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -127.59 123.8 36.57 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.006 1.323 . . . . 2.28 110.423 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.52 143.35 51.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.574 1.55 . . . . 3.88 110.151 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 42.2 m 63.49 -30.83 0.1 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.635 2.374 . . . . 3.4 116.803 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.56 -10.79 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.492 1.496 . . . . 3.85 114.76 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -160.5 -38.91 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.237 1.415 . . . . 6.57 112.299 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.96 167.85 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 126.984 2.114 . . . . 2.71 108.569 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.8 m -143.76 161.77 37.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.902 1.681 . . . . 2.44 111.32 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -42.32 -50.78 4.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.859 2.463 . . . . 5.2 115.225 -169.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -62.35 -38.32 89.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.672 0.669 . . . . 6.12 112.778 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 64.4 mttm -74.29 -39.74 62.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.526 0.73 . . . . 3.62 111.008 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.68 -52.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.987 0.915 . . . . 1.57 110.945 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.72 -31.21 70.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.513 -0.742 . . . . 2.14 112.249 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.67 -50.38 63.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.024 0.379 . . . . 1.71 112.024 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.2 pt -69.09 -35.95 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.915 -1.116 . . . . 0.99 113.086 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 64.7 t -71.24 -43.76 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.223 0.92 . . . . 1.79 111.512 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.53 -34.34 78.81 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.185 -0.947 . . . . 0.69 113.807 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 17.2 p -68.24 -43.23 78.35 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.63 -0.924 . . . . 1.35 111.691 171.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.26 76.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.083 0.856 . . . . 1.04 112.445 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -71.08 -17.26 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.99 -1.069 . . . . 2.32 113.605 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.1 p -72.38 -28.54 63.07 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.204 -1.56 . . . . 2.4 112.715 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 22.9 m120 -91.14 -22.71 20.54 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.44 1.496 . . . . 3.48 112.262 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.5 t -76.42 173.64 11.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.396 1.478 . . . . 1.64 113.72 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.38 15.11 5.56 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.85 2.06 . . . . 4.08 112.714 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -69.35 165.94 34.8 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.212 1.805 . . . . 3.07 113.991 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.51 -23.94 0.72 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.07 2.513 . . . . 1.6 114.395 -173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.6 tt -111.76 -48.77 3.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.934 2.094 . . . . 1.68 112.554 -167.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.5 -21.35 48.88 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.489 0.956 . . . . 1.03 115.489 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 63.4 p -66.73 -14.11 62.16 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.518 -1.578 . . . . 2.23 114.343 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.18 82.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.947 0.899 . . . . 1.9 111.285 167.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 12.9 mt -71.99 -36.31 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.243 1.417 . . . . 1.24 110.278 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 11.2 m -54.84 -48.29 73.04 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.907 0.776 . . . . 2.4 111.519 170.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -59.0 -49.22 78.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.819 0.736 . . . . 3.85 111.735 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.74 -44.8 82.03 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.485 1.114 . . . . 3.91 112.166 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.5 t -70.05 -50.6 39.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.988 0.915 . . . . 2.04 111.763 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -56.22 -38.82 71.57 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.782 -1.199 . . . . 3.9 112.378 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -70.05 -35.87 74.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.815 0.846 . . . . 3.34 112.633 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -70.17 -46.38 64.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 2.03 112.693 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.79 -30.0 62.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 1.27 113.473 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.52 45.5 26.86 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.569 1.547 . . . . 2.68 112.062 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.2 t -147.69 146.27 29.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.686 1.365 . . . . 2.61 114.686 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.95 19.81 19.94 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.081 1.352 . . . . 3.39 114.317 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 80.6 p -110.6 -6.2 14.91 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.946 -1.721 . . . . 5.07 114.138 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.3 148.77 48.1 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.02 1.328 . . . . 2.18 113.407 -172.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 72.97 137.23 0.27 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.131 1.824 . . . . 0.98 114.838 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 97.2 m -136.57 -41.16 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.955 1.302 . . . . 1.65 112.474 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 7.5 t -138.97 142.88 38.36 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.239 1.415 . . . . 3.11 114.139 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.9 mm -140.27 134.1 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 129.576 3.15 . . . . 3.25 108.206 168.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.323 0.0 OUTLIER -92.18 -14.7 28.66 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.996 1.48 . . . . 3.4 114.996 176.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 8.1 m-85 54.33 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 129.04 2.936 . . . . 4.33 117.631 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.98 93.08 2.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.456 1.902 . . . . 2.75 106.272 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 4.4 m -98.94 150.14 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.269 0.628 . . . . 4.08 110.965 -170.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 31.0 t -140.36 106.41 6.59 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.102 1.361 . . . . 1.35 109.6 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 149.9 75.8 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.188 2.592 . . . . 2.49 112.406 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.73 -18.31 1.4 Allowed Glycine 0 CA--C 1.538 1.472 0 O-C-N 121.057 -1.027 . . . . 1.53 114.75 -171.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.7 t -115.05 -72.93 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.064 1.345 . . . . 2.74 112.976 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 163.9 -153.15 23.4 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.312 0.96 . . . . 1.3 113.482 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.0 tt -144.06 148.48 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.075 0.95 . . . . 3.32 112.645 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.4 t -117.79 145.17 44.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.135 1.774 . . . . 1.19 109.381 164.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 25.9 p -164.57 164.93 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.535 0.939 . . . . 1.47 113.535 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -109.63 146.45 34.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 1.87 108.629 166.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 32.8 m -123.16 153.8 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.386 1.074 . . . . 3.36 110.808 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -146.08 157.93 43.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.086 0.954 . . . . 1.76 111.903 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -165.98 -33.02 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.953 2.901 . . . . 2.57 107.97 158.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -22.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.751 1.62 . . . . 2.96 114.736 168.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -138.72 40.73 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.483 1.113 . . . . 4.76 110.508 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -54.35 -18.63 10.27 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 116.29 1.276 . . . . 3.36 116.29 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -6.15 26.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.665 1.586 . . . . 5.74 115.083 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.174 1.389 . . . . 7.82 113.329 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 4.8 t-80 63.87 176.6 0.17 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.21 1.804 . . . . 7.5 113.229 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -99.94 10.27 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.581 2.808 . . . . 14.78 118.581 -166.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.85 -62.5 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.461 2.304 . . . . 13.83 114.537 -169.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 35.1 t-20 64.93 156.23 0.08 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.299 3.04 . . . . 11.68 114.782 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 7.5 m-90 63.9 162.37 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.957 3.303 . . . . 15.75 115.416 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 66.88 -5.2 0.69 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.127 1.771 . . . . 16.17 115.206 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.02 -14.26 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.568 1.947 . . . . 16.83 112.492 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 9.8 tt0 72.8 -39.99 0.46 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.43 2.692 . . . . 22.42 111.949 -168.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -98.99 -159.88 0.77 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.899 1.68 . . . . 19.7 109.025 165.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 54.3 19.41 2.22 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.349 2.351 . . . . 16.04 117.349 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -154.37 -64.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.692 1.197 . . . . 14.76 112.114 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.2 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.215 1.806 . . . . 17.99 112.308 -174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -72.7 75.77 1.11 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.005 -1.059 . . . . 21.66 110.988 170.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -82.66 6.5 17.66 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.48 2.312 . . . . 18.17 114.101 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -96.47 142.06 29.02 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.468 1.507 . . . . 20.24 113.187 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 91.1 p -146.8 161.76 40.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.965 1.306 . . . . 22.22 112.484 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -84.88 -3.27 58.62 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.759 1.392 . . . . 26.0 114.759 175.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 19.0 t 46.46 70.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 127.258 2.223 . . . . 26.32 111.17 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.63 24.5 0.47 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.696 1.998 . . . . 29.57 113.804 -171.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 32.7 mm -139.52 151.26 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.722 2.409 . . . . 29.18 109.037 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -125.7 11.49 7.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.174 1.39 . . . . 31.38 113.906 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -96.89 62.57 1.89 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.592 1.557 . . . . 31.33 112.775 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 8.7 t 39.93 46.68 1.77 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.793 2.437 . . . . 30.47 113.492 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -94.08 162.74 13.75 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 116.564 2.061 . . . . 27.7 116.564 -167.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . 0.261 39.6 mt-10 62.68 -3.97 0.27 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.711 2.804 . . . . 25.44 117.734 174.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -60.9 -14.38 21.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.42 1.888 . . . . 29.86 115.398 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 2.0 m -133.52 18.76 3.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.501 1.92 . . . . 26.53 112.027 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 99.3 p -82.51 -13.67 56.26 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.455 1.65 . . . . 23.27 115.455 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 1.7 t -150.86 142.92 24.03 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.224 -0.923 . . . . 20.18 112.327 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 14.2 t -156.43 145.18 20.14 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.35 1.46 . . . . 17.64 111.921 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 55.4 m -89.12 145.78 25.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.788 1.235 . . . . 15.48 113.035 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 22.8 p -126.71 -33.83 2.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.073 1.749 . . . . 14.25 114.599 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 72.3 mtm -105.54 157.08 17.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.949 1.7 . . . . 14.16 111.786 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 19.0 mm 63.37 -18.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 128.456 2.702 . . . . 10.85 114.973 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.46 -16.6 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 115.573 1.694 . . . . 11.06 115.573 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.98 -24.05 10.16 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.421 1.489 . . . . 10.23 113.182 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -66.61 -14.7 62.74 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.642 1.577 . . . . 8.55 114.169 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -90.88 -17.29 26.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 8.99 113.564 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.39 -37.22 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.985 0.914 . . . . 8.16 110.475 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 2.0 p -76.31 -4.64 43.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.759 1.623 . . . . 7.31 114.594 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 17.3 t30 -100.29 -10.21 21.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.036 1.734 . . . . 5.81 114.048 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.82 -30.93 68.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.9 1.815 . . . . 5.93 115.9 -167.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.57 -30.35 60.64 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.11 0.868 . . . . 7.59 112.577 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.98 -40.38 8.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.553 1.141 . . . . 4.8 112.628 168.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -79.09 77.16 5.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.392 0.996 . . . . 5.99 112.843 -171.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -45.28 -39.78 6.91 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.544 1.537 . . . . 4.74 113.824 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 4.12 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 129.525 3.13 . . . . 2.13 117.888 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.59 124.55 27.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.585 1.554 . . . . 4.05 110.92 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -88.75 122.74 32.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.555 1.142 . . . . 2.89 110.733 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -135.22 141.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.254 1.021 . . . . 1.97 112.265 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.27 145.44 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.402 1.081 . . . . 1.86 112.465 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.7 tt -144.43 145.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.859 1.264 . . . . 1.95 109.811 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 124.48 162.04 11.27 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.546 0.978 . . . . 1.66 115.546 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.47 -151.63 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.057 1.743 . . . . 2.42 113.368 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.94 -30.23 2.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 127.922 2.489 . . . . 7.11 112.059 168.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -66.07 -37.93 87.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.908 1.231 . . . . 4.19 112.798 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.1 -19.89 65.71 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.433 -1.417 . . . . 3.96 112.759 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 1.7 tpp -70.07 -30.13 67.3 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.384 -0.823 . . . . 3.16 111.351 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.15 -67.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.681 1.993 . . . . 2.96 108.093 166.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -48.47 -21.5 0.57 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 129.348 3.059 . . . . 6.67 115.786 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -93.22 12.9 22.84 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.63 1.344 . . . . 1.1 114.63 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.35 36.18 83.83 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 120.543 -1.348 . . . . 0.81 114.776 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.9 mt -100.61 172.07 7.32 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.589 1.155 . . . . 0.9 111.503 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 16.2 t -121.41 148.11 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.554 1.941 . . . . 3.02 110.625 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.02 155.1 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.393 1.077 . . . . 3.11 113.807 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -117.63 164.98 14.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.993 2.117 . . . . 2.95 113.567 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 58.6 t30 -66.78 -47.04 73.39 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.926 1.454 . . . . 5.41 114.926 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.35 -43.91 98.07 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.201 0.909 . . . . 3.64 111.34 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.9 p -72.18 -35.47 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.172 0.989 . . . . 2.1 112.647 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -68.25 -43.19 78.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.519 1.509 . . . . 2.44 111.723 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.94 -45.04 91.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.701 0.8 . . . . 1.94 111.325 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 35.8 t80 -64.62 -37.56 87.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.267 1.427 . . . . 3.29 112.777 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 28.8 tpp -66.32 -51.07 61.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.809 1.244 . . . . 1.62 111.303 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 14.9 t -66.52 -34.3 77.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.044 -0.503 . . . . 1.95 111.499 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.65 -47.22 86.47 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.529 1.059 . . . . 4.38 113.126 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -70.86 -35.22 72.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.591 0.96 . . . . 2.9 113.591 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.26 -42.32 96.54 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.367 0.985 . . . . 2.96 112.439 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -70.14 -25.99 63.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.667 1.587 . . . . 5.84 113.583 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -81.22 8.22 9.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.929 1.085 . . . . 3.98 113.929 167.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 91.07 -5.43 81.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.175 2.321 . . . . 1.72 116.153 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.63 162.41 14.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 4.43 111.603 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 18.7 m -76.03 119.24 19.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.792 0.837 . . . . 1.81 110.234 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -119.37 115.86 24.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 1.19 109.638 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.89 157.51 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.323 1.049 . . . . 1.21 113.224 -170.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -112.77 162.77 15.38 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.418 1.087 . . . . 1.99 113.214 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 2.8 p -132.37 122.89 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.367 1.467 . . . . 3.45 112.042 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -113.95 152.61 30.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.54 1.936 . . . . 0.99 110.941 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 21.2 m -149.05 120.24 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.646 1.179 . . . . 2.41 111.118 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 20.4 t70 41.75 52.13 4.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.469 1.508 . . . . 3.3 112.683 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.258 6.6 m-20 65.38 22.87 12.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.88 2.178 . . . . 1.44 116.88 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -129.13 151.5 49.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.455 1.502 . . . . 2.78 110.774 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 145.42 48.4 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.757 -1.215 . . . . 2.02 111.965 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -122.61 -35.4 3.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.829 1.048 . . . . 1.27 113.829 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.82 36.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.114 0.87 . . . . 0.51 115.012 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.71 155.28 44.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.679 1.592 . . . . 1.92 112.943 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.83 136.22 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.388 1.475 . . . . 1.95 109.593 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -106.02 130.5 53.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.922 1.289 . . . . 1.98 109.554 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.85 130.72 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 2.34 108.162 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -97.59 -31.72 12.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.337 1.236 . . . . 3.08 114.337 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER 62.56 162.71 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.559 1.544 . . . . 3.48 114.434 -173.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 C--O 1.253 1.256 0 O-C-N 121.103 -0.998 . . . . 4.48 113.073 -173.15 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.197 -0.298 . . . . 11.04 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.14 134.22 44.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.903 0.881 . . . . 13.18 112.62 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 1.2 m -103.44 139.47 38.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.935 1.294 . . . . 8.8 111.967 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 5.4 tmm? -115.18 169.57 9.02 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.383 1.473 . . . . 8.54 110.964 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 59.65 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.648 2.379 . . . . 8.63 111.546 -168.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.03 70.22 2.8 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.088 -0.805 . . . . 3.74 111.088 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 62.1 m -96.74 139.18 21.47 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 125.602 1.561 . . . . 3.23 109.952 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.39 146.02 73.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.631 2.221 . . . . 1.82 112.02 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.0 p -133.16 126.61 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.471 1.508 . . . . 3.88 108.276 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.4 p -71.0 123.98 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.667 -1.27 . . . . 2.64 109.239 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -96.49 -41.63 8.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.985 1.314 . . . . 4.52 112.547 -167.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -159.28 156.82 29.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.16 1.384 . . . . 2.92 110.99 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 6.5 m -131.23 143.89 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 1.38 110.587 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 50.6 tttt -129.33 140.74 51.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.91 1.284 . . . . 2.83 110.753 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 47.4 t -77.86 142.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.653 -0.869 . . . . 1.58 108.653 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.45 -38.96 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.862 1.265 . . . . 1.74 111.376 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 74.2 m -100.45 92.37 5.12 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 106.447 -1.686 . . . . 2.97 106.447 168.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.26 123.12 33.78 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.636 -0.665 . . . . 4.44 111.901 -170.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 40.6 m 51.54 39.23 24.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.422 1.638 . . . . 2.91 115.422 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -141.53 -8.15 0.98 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.685 1.735 . . . . 3.48 115.685 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -144.97 -65.45 0.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.573 1.533 . . . . 5.26 112.613 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.3 142.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.922 2.089 . . . . 2.48 110.063 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 47.4 m -98.95 152.88 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 2.21 113.283 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -38.49 51.76 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.515 2.043 . . . . 5.07 116.515 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.1 t60 -68.95 -34.07 74.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.52 1.054 . . . . 3.39 111.729 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.75 -36.51 65.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.17 -0.919 . . . . 3.09 112.004 173.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.08 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.27 0.941 . . . . 1.92 110.729 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -69.68 -32.54 71.23 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.3 -0.875 . . . . 1.88 112.209 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -62.29 -50.7 70.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.259 0.624 . . . . 1.18 112.114 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.85 -36.45 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.514 1.052 . . . . 0.99 113.189 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 70.7 t -70.42 -44.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 118.893 0.77 . . . . 1.63 111.057 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.86 95.85 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.29 -0.881 . . . . 0.72 113.431 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.3 p -75.14 -30.01 60.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.0 0.92 . . . . 2.02 113.382 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.53 66.18 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.91 0.777 . . . . 0.85 111.715 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.87 -18.74 65.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.463 0.912 . . . . 2.13 113.463 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 13.6 t -58.12 -22.31 50.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.945 1.298 . . . . 2.23 114.263 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -103.74 -2.3 26.66 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.882 1.273 . . . . 1.9 113.978 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 16.0 t -86.23 171.76 11.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 1.95 113.804 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -3.65 14.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.161 1.784 . . . . 5.95 113.746 170.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 153.09 93.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.694 1.197 . . . . 3.24 113.878 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -39.83 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.197 2.598 . . . . 1.13 113.455 -173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.51 -51.35 5.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.303 0.853 . . . . 1.73 113.303 -166.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -65.93 -28.34 73.57 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 114.555 0.582 . . . . 0.97 114.555 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 27.3 p -66.27 -13.06 59.84 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.856 -1.379 . . . . 2.71 113.933 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.21 67.91 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.93 -1.106 . . . . 1.97 111.032 167.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 16.6 mt -69.85 -35.17 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.622 1.169 . . . . 1.49 109.973 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 88.3 m -54.71 -50.32 68.6 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.705 -0.622 . . . . 1.9 111.677 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 69.8 tttt -61.14 -46.31 91.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.68 -0.676 . . . . 2.61 111.875 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 30.9 t80 -55.33 -45.66 76.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.876 0.87 . . . . 2.96 112.547 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 53.7 t -63.35 -54.63 33.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.465 1.106 . . . . 2.55 111.76 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -40.64 67.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.798 1.239 . . . . 4.41 112.437 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -73.18 -34.9 66.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.717 1.607 . . . . 4.12 113.888 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.97 -43.44 87.84 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.647 -1.283 . . . . 2.36 111.32 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.3 0.23 10.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.013 1.325 . . . . 2.23 113.765 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 29.0 t70 46.89 43.41 13.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.473 1.909 . . . . 2.7 113.17 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.9 t -132.83 -175.21 3.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.086 0.954 . . . . 3.67 113.148 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -123.58 -4.58 8.22 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.721 2.008 . . . . 3.5 112.182 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.1 t -151.47 144.95 24.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.358 1.863 . . . . 3.97 112.373 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.25 167.62 23.68 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.849 2.46 . . . . 2.16 110.761 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 67.25 168.89 3.81 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.839 1.496 . . . . 1.12 116.839 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.2 m -149.09 -54.58 0.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.228 1.411 . . . . 1.97 113.495 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 16.6 t -134.65 143.35 47.22 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.494 1.517 . . . . 2.73 112.15 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 11.2 tp -139.56 149.04 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.261 3.425 . . . . 3.23 107.658 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -141.62 66.29 1.36 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.428 1.091 . . . . 4.3 109.279 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.62 149.4 26.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.132 1.901 . . . . 3.61 116.132 -168.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -114.34 113.35 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.85 2.06 . . . . 2.49 107.717 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 90.1 t -98.19 124.03 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.024 1.33 . . . . 3.16 110.777 -169.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 56.4 t -139.51 98.08 8.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.816 1.647 . . . . 2.77 106.899 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -59.28 130.55 36.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.728 2.286 . . . . 2.66 113.519 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 74.61 26.99 66.16 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.308 -0.718 . . . . 1.84 114.801 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.8 t -135.44 -43.47 0.69 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.811 1.306 . . . . 2.21 113.745 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 151.36 -161.47 29.17 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.893 -1.13 . . . . 1.02 113.919 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 mm -140.14 145.77 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.811 1.644 . . . . 3.61 110.226 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 47.3 t -133.43 136.35 45.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.266 1.026 . . . . 1.16 109.368 165.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.8 p -154.15 168.89 25.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.742 1.016 . . . . 1.38 113.742 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -109.88 141.44 42.59 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.386 -1.709 . . . . 1.66 106.386 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 4.7 p -143.11 138.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.335 0.97 . . . . 3.07 112.827 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.4 157.73 45.65 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.698 0.761 . . . . 2.6 112.542 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -162.66 -36.73 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.678 2.791 . . . . 3.27 108.895 162.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 3.1 pt -38.52 -42.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.087 2.155 . . . . 3.46 115.522 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -132.38 52.31 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.092 1.357 . . . . 5.82 110.236 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -61.83 4.15 0.54 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.816 2.151 . . . . 4.6 115.713 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -7.25 0.47 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.658 1.983 . . . . 4.18 114.958 172.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -87.96 -1.87 58.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.399 1.48 . . . . 8.89 114.734 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -145.56 149.53 34.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 9.39 111.979 -169.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -131.09 136.08 48.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.825 1.65 . . . . 16.97 113.032 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.77 -35.54 44.35 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.758 1.623 . . . . 19.91 112.954 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.52 173.74 0.06 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.275 1.83 . . . . 19.17 114.36 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -160.85 -40.48 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.223 -1.548 . . . . 29.12 113.413 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -79.95 -51.99 8.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.814 1.645 . . . . 26.81 109.821 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 71.8 mt 49.49 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 128.691 2.796 . . . . 21.63 114.965 168.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.99 -21.77 61.52 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.603 0.964 . . . . 23.64 113.603 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.0 t0 -65.96 -24.22 66.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.701 1.2 . . . . 19.61 112.914 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.01 94.07 4.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.381 1.872 . . . . 22.42 113.423 -168.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -147.35 -36.24 0.22 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.466 1.906 . . . . 23.76 110.461 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.7 158.39 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.981 2.112 . . . . 23.74 109.346 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 36.4 mtpt 49.83 47.81 22.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.685 1.594 . . . . 21.14 112.928 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -78.75 -4.92 51.71 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.22 1.563 . . . . 24.9 115.22 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 57.56 164.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.009 2.124 . . . . 22.89 115.411 -170.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 28.8 t -138.13 136.65 36.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.943 1.297 . . . . 25.52 111.927 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . 0.265 1.5 pt? -76.75 27.09 0.13 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.463 1.653 . . . . 27.03 115.463 -175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 16.9 m -129.17 2.24 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.969 2.108 . . . . 28.79 112.253 168.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -68.44 146.09 53.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.947 0.899 . . . . 26.6 111.907 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.71 138.98 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 26.59 111.806 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -131.01 42.53 3.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.772 2.029 . . . . 24.91 111.26 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -89.25 14.4 11.09 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.263 1.825 . . . . 24.75 115.402 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 27.1 t -148.5 134.01 18.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.406 0.891 . . . . 22.9 113.406 170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 3.5 p30 -118.51 24.67 10.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.262 1.425 . . . . 22.13 111.546 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 23.4 tt0 74.66 138.4 0.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.588 2.755 . . . . 21.33 111.419 -167.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.29 143.96 55.02 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.838 -1.164 . . . . 26.9 110.542 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 39.6 m 54.54 37.85 28.7 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.665 0.617 . . . . 24.92 112.665 172.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 5.2 p -69.45 162.8 26.68 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.28 -0.887 . . . . 19.92 112.366 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 72.8 p -70.35 160.22 32.68 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.128 -0.982 . . . . 19.24 111.067 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 58.8 m -62.21 145.01 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.904 -1.123 . . . . 16.2 110.592 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 59.9 m -75.63 52.5 0.66 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.048 1.739 . . . . 14.96 113.551 -169.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 65.0 m -60.84 -14.73 23.77 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.169 1.388 . . . . 12.94 113.227 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 25.9 ptt? -55.8 -26.23 45.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.184 0.993 . . . . 14.59 113.41 166.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.98 14.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.963 1.705 . . . . 14.02 114.737 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -42.66 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.099 -1.625 . . . . 10.83 111.148 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.76 3.8 4.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.403 1.481 . . . . 9.02 114.111 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.58 62.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.275 0.943 . . . . 10.7 111.092 169.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -57.3 -31.5 65.71 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.938 1.088 . . . . 11.24 113.938 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 70.9 mt -80.11 -44.99 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.447 1.099 . . . . 8.3 110.842 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 69.1 p -72.82 -17.51 61.55 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.035 0.754 . . . . 9.45 113.035 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -79.08 -49.56 12.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.898 0.879 . . . . 9.3 110.807 167.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -66.31 -13.58 60.72 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.963 1.838 . . . . 5.32 115.963 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.47 -44.23 96.91 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.019 1.282 . . . . 12.75 111.033 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -103.71 -34.35 8.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.993 1.479 . . . . 8.73 114.993 171.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -104.04 156.81 17.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 117.515 2.413 . . . . 5.51 117.515 -165.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -85.93 151.55 23.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.03 -1.47 . . . . 4.56 107.03 163.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.63 169.86 23.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.473 0.916 . . . . 2.97 113.473 -168.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.57 123.79 12.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.743 1.217 . . . . 4.08 110.55 -168.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.9 116.25 28.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.106 0.962 . . . . 3.19 108.624 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.8 m -135.4 141.6 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.127 0.876 . . . . 0.98 112.823 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.35 152.35 40.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.823 1.045 . . . . 0.95 113.823 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -152.13 135.91 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.967 1.707 . . . . 1.84 110.077 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 162.79 -151.68 21.57 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.962 1.545 . . . . 1.34 116.962 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.42 150.63 3.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.333 2.653 . . . . 2.67 112.912 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -61.6 -33.37 73.78 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.504 0.927 . . . . 5.68 113.504 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.98 -31.44 69.91 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.776 1.171 . . . . 4.23 113.082 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -69.3 -19.79 63.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.382 -1.449 . . . . 4.32 112.935 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.4 mmt -67.66 -30.73 70.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.092 -1.005 . . . . 2.57 111.42 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.7 mt -71.43 -65.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.108 1.763 . . . . 3.17 109.28 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.17 -32.86 4.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.798 2.039 . . . . 5.87 115.702 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.99 12.53 6.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.509 1.05 . . . . 1.16 113.828 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.62 31.6 58.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.377 -1.452 . . . . 1.18 115.289 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.33 -161.73 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.914 1.286 . . . . 1.64 110.891 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 21.8 t -136.8 136.39 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.192 1.797 . . . . 2.63 110.202 170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.1 tt -125.93 138.63 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.764 1.226 . . . . 2.27 111.485 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.39 168.52 12.91 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.825 1.787 . . . . 3.69 115.825 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.27 -25.33 61.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.841 1.656 . . . . 2.98 115.372 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.51 -40.89 41.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.089 1.313 . . . . 2.7 113.302 -176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -73.61 -33.71 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.481 0.582 . . . . 1.41 111.41 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -56.94 -43.35 81.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.001 0.92 . . . . 2.31 112.081 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.48 -49.93 75.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.169 0.987 . . . . 2.6 113.506 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 33.2 t80 -70.25 -36.61 74.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 3.31 112.258 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -61.19 -60.79 3.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.141 1.776 . . . . 1.59 110.792 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.1 t -66.27 -31.47 72.29 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.896 -0.503 . . . . 2.13 112.244 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -59.99 -49.93 75.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.191 0.997 . . . . 2.74 112.052 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -68.73 -30.88 69.61 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.764 -0.585 . . . . 3.32 112.136 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -65.29 -42.29 93.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.308 1.043 . . . . 2.84 112.769 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -66.81 -30.17 70.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 120.855 -1.153 . . . . 3.88 113.567 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 19.2 mttp -70.52 -2.93 15.58 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.556 1.942 . . . . 3.37 113.566 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 90.63 20.73 39.53 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.0 1.285 . . . . 2.25 115.162 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.08 148.58 33.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.749 1.62 . . . . 4.79 110.616 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 94.1 m -78.34 137.64 38.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.049 1.34 . . . . 1.88 111.063 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -139.22 124.79 19.4 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.096 0.776 . . . . 1.34 113.096 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.69 159.11 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.536 1.534 . . . . 1.15 113.18 -171.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.64 160.14 16.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.687 1.195 . . . . 2.0 112.574 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.5 t -130.86 122.95 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.078 1.751 . . . . 2.92 111.608 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.93 151.78 39.29 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.446 1.499 . . . . 1.0 110.621 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.5 m -143.33 118.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.162 1.385 . . . . 1.91 112.254 -170.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 30.7 t0 42.07 50.08 4.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.848 2.459 . . . . 3.21 112.942 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.301 2.2 m-20 62.7 38.44 11.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.637 2.375 . . . . 2.33 116.182 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -143.33 147.86 35.39 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.285 1.434 . . . . 3.83 109.861 167.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.76 151.52 43.47 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.276 -1.515 . . . . 2.26 113.267 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 31.3 p -130.51 -47.82 1.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.412 1.264 . . . . 1.36 114.412 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.97 -175.56 36.5 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 120.662 1.574 . . . . 0.55 115.884 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.47 155.15 44.28 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.36 1.464 . . . . 1.05 113.231 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.91 135.09 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.905 1.682 . . . . 2.2 109.955 -172.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -115.05 133.29 56.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.515 1.526 . . . . 1.78 109.859 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.05 143.17 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.814 2.045 . . . . 2.46 110.285 -169.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -122.83 -167.68 1.63 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.128 1.771 . . . . 2.05 111.343 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.92 141.94 47.27 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.836 1.255 . . . . 4.94 111.267 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.693 1.197 . . . . 6.16 111.809 178.564 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 118.955 -0.545 . . . . 11.08 112.16 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -155.39 143.57 20.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.867 1.267 . . . . 16.33 110.822 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 6.3 m -99.51 146.34 26.49 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.194 1.183 . . . . 8.91 114.194 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1050 ' ' MET . . . . . 0.447 ' CE ' ' H ' ' A' 1052 ' ' GLY . 5.0 ttp -90.84 165.66 13.5 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.506 1.922 . . . . 8.81 112.831 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -59.95 -50.67 72.86 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.559 2.059 . . . . 9.12 116.559 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1052 ' ' GLY . . . . . 0.447 ' H ' ' CE ' ' A' 1050 ' ' MET . . . -116.22 93.29 0.6 Allowed Glycine 0 N--CA 1.466 0.672 0 C-N-CA 124.14 0.876 . . . . 4.1 111.764 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 80.9 p -88.46 147.53 40.05 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 118.213 1.006 . . . . 4.9 112.197 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.47 138.78 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.968 2.445 . . . . 2.05 112.062 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 14.5 p -144.25 123.06 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.002 0.921 . . . . 3.19 111.945 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.6 p -72.53 139.58 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.512 -1.368 . . . . 1.95 111.138 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.36 -41.16 1.91 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.333 1.975 . . . . 3.25 116.333 -165.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -150.64 154.85 38.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.392 1.477 . . . . 3.32 110.967 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.7 m -134.91 136.05 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.185 0.994 . . . . 1.13 111.153 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.9 tttt -141.02 140.12 34.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.331 1.234 . . . . 2.6 114.331 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 41.2 t -85.6 143.66 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.251 1.42 . . . . 1.96 110.224 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 31.1 tp -114.76 -25.07 8.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.04 1.736 . . . . 2.29 113.275 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 93.0 m -126.03 67.22 1.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.474 1.509 . . . . 2.56 111.23 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.19 130.33 38.07 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.733 -1.229 . . . . 3.85 112.438 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 23.2 m 64.03 -18.62 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.608 2.077 . . . . 2.56 116.608 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 30.7 m120 -87.05 -15.99 36.97 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.787 1.176 . . . . 3.69 113.646 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 -95.66 0.14 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.388 1.075 . . . . 6.03 110.48 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.38 133.16 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.474 1.51 . . . . 2.78 111.141 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 66.7 m -98.17 164.24 12.41 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.642 1.577 . . . . 2.49 113.291 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -43.04 -56.01 3.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.513 1.925 . . . . 5.21 116.103 -169.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 47.7 m170 -64.74 -30.82 71.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.969 0.804 . . . . 5.14 112.702 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 44.6 mttp -77.56 -38.14 49.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 118.123 -0.942 . . . . 3.36 111.97 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.05 -52.48 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.488 1.04 . . . . 1.83 110.844 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.76 -28.15 66.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.673 -0.642 . . . . 1.69 112.427 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.2 -47.89 59.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.828 -0.605 . . . . 1.88 112.598 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.6 pt -69.62 -32.62 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.53 1.514 . . . . 1.04 112.901 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.2 t -70.88 -45.58 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.813 0.733 . . . . 2.19 111.376 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -69.17 -36.26 79.41 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.975 -1.078 . . . . 0.71 114.009 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 35.8 p -69.15 -34.38 74.89 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.413 -1.051 . . . . 1.7 111.794 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.2 91.21 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.765 0.711 . . . . 0.89 112.56 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.16 -21.97 62.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.956 1.095 . . . . 3.75 113.956 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.0 t -55.88 -42.13 75.45 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.863 -1.148 . . . . 2.24 112.258 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.54 -23.1 40.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.567 0.951 . . . . 2.19 113.567 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 27.0 m -89.47 160.61 16.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.057 1.132 . . . . 3.54 114.057 -167.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -122.73 18.71 10.29 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.668 1.587 . . . . 5.39 113.225 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 143.29 91.56 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.753 1.221 . . . . 2.05 112.132 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.55 -45.52 1.14 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.316 2.677 . . . . 1.44 114.356 -169.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.37 -34.23 72.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.297 -0.877 . . . . 2.06 111.069 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -61.16 -20.33 58.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.135 1.35 . . . . 1.81 115.545 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 66.7 p -59.49 -37.98 79.68 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.019 1.409 . . . . 3.96 112.184 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.55 -36.39 80.87 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.49 -0.756 . . . . 1.96 112.407 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.8 mt -70.78 -36.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.054 -1.029 . . . . 2.04 111.023 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.3 m -55.14 -51.79 65.34 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.168 0.987 . . . . 2.76 110.438 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.5 tttt -54.44 -55.23 30.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.181 0.992 . . . . 4.46 111.574 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -57.72 -45.85 85.22 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.321 0.648 . . . . 2.92 112.636 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 37.3 t -66.82 -54.15 25.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.243 0.617 . . . . 2.07 111.4 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -43.07 75.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.238 1.015 . . . . 4.23 110.756 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.34 -44.54 87.42 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.972 0.73 . . . . 3.86 112.972 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -67.11 -38.7 86.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.535 1.062 . . . . 2.79 113.303 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.35 -19.87 60.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.621 1.168 . . . . 1.41 113.107 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 8.8 t70 64.47 15.66 9.71 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.593 2.357 . . . . 3.31 114.221 -170.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 2.6 t -130.52 147.1 52.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.816 1.646 . . . . 3.12 115.249 -169.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.11 -12.67 43.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.559 1.144 . . . . 3.51 111.858 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 35.6 p -73.43 26.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.397 1.999 . . . . 5.53 116.397 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.74 29.07 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.532 1.533 . . . . 1.85 114.659 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 78.24 145.07 2.55 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.656 1.598 . . . . 1.11 116.989 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -141.42 -63.34 0.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.964 1.705 . . . . 2.06 113.392 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 41.4 t -136.54 141.51 43.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.181 1.355 . . . . 1.58 112.443 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.1 mm -141.93 140.19 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 132.18 4.192 . . . . 2.98 109.389 -170.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.8 t0 -111.72 104.17 12.5 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.905 -1.887 . . . . 2.57 105.905 165.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 32.9 t80 -88.54 133.15 34.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.931 1.292 . . . . 4.79 114.436 -165.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.34 120.7 14.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.304 1.842 . . . . 2.11 110.993 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 44.3 t -104.34 140.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.97 1.308 . . . . 3.07 111.68 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 51.7 t -126.33 111.94 23.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.029 0.932 . . . . 1.89 109.188 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.19 143.08 93.93 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.313 2.675 . . . . 2.33 113.634 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.38 15.15 65.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.947 1.26 . . . . 2.22 113.696 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 73.4 m -134.34 -87.32 0.39 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.86 1.664 . . . . 2.38 111.39 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 172.99 -151.37 13.78 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.937 0.779 . . . . 1.3 112.455 -172.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.26 146.32 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.265 1.026 . . . . 3.02 111.893 -173.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.8 t -134.24 144.18 48.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.857 1.663 . . . . 1.04 111.259 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.8 p -158.04 172.38 18.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.549 1.685 . . . . 1.22 115.549 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -114.64 120.81 41.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.252 1.421 . . . . 2.23 107.453 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 12.0 p -128.76 134.52 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 115.033 1.494 . . . . 2.89 115.033 -167.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -133.81 161.34 35.01 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 123.242 1.496 . . . . 2.09 114.276 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -159.53 -29.99 0.06 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.233 3.413 . . . . 2.6 108.289 160.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 10.2 pt -43.17 -44.24 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.31 1.844 . . . . 2.89 114.839 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -124.93 39.98 3.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.562 1.172 . . . . 4.75 110.772 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.38 15.78 0.14 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.998 2.237 . . . . 4.86 115.957 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.71 -16.68 28.07 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 126.332 1.853 . . . . 3.99 112.867 169.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.43 -44.69 5.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.635 1.174 . . . . 5.75 112.036 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -122.7 135.58 54.62 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.527 1.131 . . . . 8.7 110.261 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -116.92 171.92 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.573 2.064 . . . . 14.8 116.573 -165.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -61.5 -39.41 90.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.446 2.298 . . . . 17.09 115.004 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 72.5 m-80 60.38 156.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.817 2.447 . . . . 14.28 114.939 -168.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 55.1 m95 -136.3 -170.0 2.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.459 2.303 . . . . 22.68 110.011 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -50.01 -31.01 11.8 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.386 1.074 . . . . 20.47 113.85 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 77.2 mt 54.63 111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 129.959 3.303 . . . . 16.68 114.08 171.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -53.38 -38.95 63.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.197 0.999 . . . . 21.58 112.361 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.41 -24.77 66.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.117 1.767 . . . . 19.49 114.158 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -81.04 165.84 21.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.014 1.726 . . . . 15.74 112.826 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -105.1 140.78 37.77 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.985 1.714 . . . . 17.29 107.65 166.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.35 149.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.557 1.688 . . . . 19.41 115.557 -166.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -139.39 144.15 38.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.027 2.131 . . . . 18.98 111.153 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -75.07 -24.07 58.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.124 1.157 . . . . 19.75 114.124 -170.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -87.74 2.66 50.62 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.645 1.35 . . . . 18.87 114.645 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 59.8 m 61.07 171.61 0.1 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.342 1.457 . . . . 18.46 114.56 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.79 132.36 34.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.266 -0.896 . . . . 21.68 109.861 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 6.1 p -146.54 137.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.011 1.325 . . . . 21.55 111.239 -171.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -136.33 6.92 3.07 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.482 1.66 . . . . 24.79 115.482 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 6.0 tp -153.61 -42.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.717 1.207 . . . . 23.94 114.148 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 46.4 t0 -145.29 109.26 4.79 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 0.876 . . . . 22.43 113.045 -168.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -77.31 37.76 0.21 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.874 1.67 . . . . 23.82 114.355 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 45.4 t -77.97 -31.77 50.96 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.015 2.126 . . . . 22.55 115.519 -168.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -134.68 123.54 23.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 23.18 111.541 -168.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -133.24 160.34 37.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.161 0.984 . . . . 23.82 113.262 -168.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.1 mp0 56.39 -170.91 0.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.646 1.979 . . . . 27.3 112.136 -166.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 9.1 t 61.68 -173.84 0.14 Allowed 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.55 -1.344 . . . . 24.35 114.521 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 7.3 p -73.04 77.54 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.281 2.233 . . . . 21.96 112.488 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 8.9 t -56.33 127.46 31.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.584 0.753 . . . . 19.57 111.159 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 49.4 m -145.07 48.51 1.29 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.89 1.276 . . . . 16.41 112.874 -167.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 64.0 p -74.42 180.0 4.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.257 -0.902 . . . . 15.89 113.285 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 17.5 m -52.79 -33.38 48.51 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.124 1.527 . . . . 12.88 115.124 -172.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.9 ptt? -76.62 -13.33 60.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.705 1.372 . . . . 15.41 114.705 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.5 -30.58 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.098 1.759 . . . . 12.84 111.71 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.8 pp -82.02 -17.19 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 113.694 0.998 . . . . 10.65 113.694 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.99 -31.58 71.96 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.706 1.139 . . . . 9.55 112.838 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -76.56 -9.25 58.52 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.289 1.218 . . . . 9.22 114.289 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.64 -19.3 12.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.224 1.809 . . . . 9.7 115.38 -169.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 61.3 mt -48.48 -47.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.989 1.316 . . . . 8.08 111.748 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 69.8 m -63.28 -25.06 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 6.97 113.191 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 7.9 m120 -78.56 -40.28 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.816 0.847 . . . . 7.31 111.261 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.13 87.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.824 0.85 . . . . 6.41 112.372 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.03 -14.38 62.66 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.314 1.227 . . . . 8.57 114.314 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.33 -31.29 16.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.168 0.987 . . . . 5.18 112.311 169.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -81.03 -1.02 42.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.338 1.455 . . . . 4.68 114.444 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 51.66 84.28 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.726 2.01 . . . . 3.45 114.288 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -102.99 98.09 8.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.23 1.412 . . . . 3.51 109.788 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.54 133.38 53.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.937 1.695 . . . . 3.68 110.781 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.13 116.19 27.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.798 0.726 . . . . 2.4 111.767 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.7 m -137.47 144.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.083 0.953 . . . . 1.05 113.067 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.08 152.54 46.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.844 1.258 . . . . 1.1 113.492 171.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.3 tt -149.18 139.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.432 1.493 . . . . 1.88 110.352 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 131.18 150.16 6.66 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.156 0.884 . . . . 1.64 115.09 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 49.29 -155.98 0.09 Allowed 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 126.103 1.761 . . . . 2.34 113.931 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -140.08 -37.46 0.47 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.47 2.396 . . . . 7.29 117.47 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.33 -30.67 69.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.568 1.531 . . . . 3.99 110.703 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -55.45 -34.32 64.38 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.192 -0.942 . . . . 3.91 113.465 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -35.03 77.78 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.745 1.017 . . . . 2.86 113.745 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.68 -60.39 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.986 -1.116 . . . . 2.97 107.986 168.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.19 -27.04 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.835 2.054 . . . . 7.29 115.687 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.85 16.07 1.25 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.892 1.678 . . . . 1.37 112.498 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.73 16.05 67.42 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 119.797 -1.814 . . . . 1.22 116.07 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.59 174.23 10.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.393 1.597 . . . . 0.94 111.911 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.2 t -115.8 130.98 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.664 1.186 . . . . 1.82 109.309 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.69 127.77 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.867 1.267 . . . . 2.38 110.011 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . 0.253 8.9 p30 -89.41 158.3 17.8 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.99 1.107 . . . . 3.84 113.99 -176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 64.6 t30 -62.6 -23.71 67.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.954 1.302 . . . . 3.42 114.344 -170.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.21 -43.37 42.65 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.708 -1.245 . . . . 3.8 112.907 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 3.3 p -75.6 -31.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 125.303 1.441 . . . . 1.3 110.985 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -52.87 -50.59 63.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.987 1.267 . . . . 3.82 111.213 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.32 -44.93 80.43 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.206 0.447 . . . . 2.17 112.206 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.7 t80 -71.57 -36.01 70.78 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.62 0.97 . . . . 3.56 113.62 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.7 tpp -63.22 -50.92 68.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.201 1.401 . . . . 1.88 111.077 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.2 t -69.93 -33.25 71.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.012 -0.43 . . . . 1.77 111.718 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.66 -46.8 87.96 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.731 -1.231 . . . . 4.12 112.889 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -71.16 -37.03 72.22 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.249 1.203 . . . . 2.77 114.249 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -62.28 -37.46 85.59 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.108 -0.995 . . . . 3.69 112.21 172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -72.73 -24.33 60.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.31 1.844 . . . . 4.41 114.961 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 77.6 mttt -66.39 -6.85 15.83 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.627 1.171 . . . . 4.32 114.128 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.64 19.98 35.93 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.854 1.692 . . . . 1.35 113.092 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -118.67 178.36 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.531 1.532 . . . . 3.99 111.994 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 3.4 m -100.4 120.97 40.78 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.771 1.629 . . . . 2.32 110.246 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -116.84 119.65 36.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.014 1.325 . . . . 1.33 110.098 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.2 m -136.34 153.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.431 0.9 . . . . 1.02 113.431 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.17 166.01 10.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.133 0.973 . . . . 1.07 112.794 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 11.6 t -131.71 125.86 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.003 2.121 . . . . 2.82 110.026 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -130.13 156.64 44.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.612 1.165 . . . . 0.86 111.81 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.3 m -144.74 120.11 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.839 1.655 . . . . 2.67 111.689 -169.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 23.3 t70 44.65 47.28 8.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.109 1.364 . . . . 4.15 113.316 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 60.79 42.15 13.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.039 -1.663 . . . . 1.99 115.023 -174.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.93 141.52 30.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.686 1.595 . . . . 2.19 110.561 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.71 137.44 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.108 -1.62 . . . . 1.78 112.852 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.0 p -115.01 -40.96 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.097 0.959 . . . . 2.12 112.719 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -168.13 -174.02 36.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.656 1.116 . . . . 0.61 115.384 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.37 155.71 43.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.402 1.881 . . . . 1.03 112.702 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.9 mm -129.76 140.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.382 1.473 . . . . 1.96 110.526 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -113.07 130.12 56.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.094 1.758 . . . . 1.67 110.36 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.14 157.7 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.846 2.059 . . . . 2.4 109.598 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -132.5 -174.96 3.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.268 1.827 . . . . 1.74 111.956 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.58 151.52 28.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.029 1.332 . . . . 4.2 111.81 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.247 1.419 . . . . 4.7 113.685 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 119.612 -0.232 . . . . 14.32 111.056 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.23 170.93 10.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 16.14 109.899 169.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 1.9 m 66.45 149.82 0.05 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.709 2.004 . . . . 9.81 115.036 170.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 9.9 tpt -122.72 -79.57 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.682 1.993 . . . . 11.88 109.271 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 31.9 m80 -127.07 -16.43 5.07 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.497 1.295 . . . . 11.0 114.497 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -130.46 129.98 6.03 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.705 1.138 . . . . 3.96 114.423 -169.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.6 p -98.38 149.79 36.09 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 125.653 1.581 . . . . 3.77 112.631 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.92 130.02 24.82 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.691 2.928 . . . . 1.82 112.961 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 96.7 t -105.5 124.22 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.187 1.795 . . . . 3.68 109.648 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.4 121.68 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.046 0.839 . . . . 2.27 110.915 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.26 -47.69 3.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.502 0.721 . . . . 4.49 112.82 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -151.49 149.25 29.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.79 1.636 . . . . 4.0 111.713 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 12.3 m -125.52 139.78 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.178 0.991 . . . . 1.21 110.402 168.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.1 tttt -141.99 148.48 38.62 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.048 0.759 . . . . 3.48 113.048 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 73.9 t -106.61 145.01 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.191 1.397 . . . . 1.8 111.31 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.95 -25.04 10.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.559 1.544 . . . . 1.4 113.44 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 9.9 t -93.94 162.09 14.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.824 2.05 . . . . 3.93 112.813 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -146.46 116.02 7.15 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.619 -1.301 . . . . 5.36 110.32 167.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 63.4 m 51.67 33.75 11.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.525 2.046 . . . . 4.11 116.525 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 28.2 m120 -126.97 -30.89 2.67 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.463 1.283 . . . . 4.68 114.463 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 113.52 2.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.713 1.605 . . . . 6.98 108.649 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.3 mm 66.17 133.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 127.55 2.34 . . . . 3.3 114.725 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 67.0 m -81.5 151.11 27.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.985 1.314 . . . . 3.29 113.099 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 61.9 m80 -53.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.598 1.703 . . . . 8.25 115.598 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 43.3 t60 -74.96 -29.45 60.92 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.726 -1.234 . . . . 3.24 111.695 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.47 -36.69 81.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.84 -1.163 . . . . 3.47 111.804 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 98.0 mt -56.62 -53.86 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.117 . . . . 2.09 109.668 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.7 76.53 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.238 0.926 . . . . 1.66 112.367 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.58 -46.17 76.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.105 0.779 . . . . 1.41 113.105 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.71 -35.39 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.232 1.378 . . . . 1.01 112.815 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 59.8 t -70.52 -46.61 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.754 0.706 . . . . 1.5 111.381 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.53 91.45 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.43 -0.794 . . . . 0.75 113.642 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.3 p -73.95 -34.31 64.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.181 0.808 . . . . 1.62 113.181 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.35 90.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.434 0.901 . . . . 0.92 113.434 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.31 -11.73 60.83 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.673 0.99 . . . . 2.07 113.673 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.5 t -62.47 -19.21 63.32 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.587 -1.321 . . . . 1.84 113.6 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -107.43 0.25 22.76 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.203 1.401 . . . . 1.96 113.379 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 69.4 m -101.28 167.46 10.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.271 1.211 . . . . 2.19 114.271 -169.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.83 54.72 1.21 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.312 1.845 . . . . 3.66 111.572 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.03 69.09 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.52 1.528 . . . . 3.18 112.66 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.33 -17.22 9.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.961 3.107 . . . . 1.0 116.285 -167.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.82 -50.91 2.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.575 0.954 . . . . 1.59 113.575 -166.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.61 67.4 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-O 121.531 0.517 . . . . 1.05 113.557 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 32.0 p -63.68 -22.76 67.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.114 1.366 . . . . 2.76 113.337 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.22 69.1 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.701 -1.25 . . . . 1.48 111.702 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.68 -35.75 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.973 0.909 . . . . 1.89 110.077 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 34.3 m -57.1 -48.08 79.47 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.247 0.93 . . . . 1.95 110.93 168.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -54.81 -51.32 66.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.303 1.041 . . . . 5.13 112.036 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.01 -44.39 91.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.331 1.052 . . . . 2.81 111.496 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 48.9 t -65.93 -49.7 67.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.266 1.026 . . . . 2.47 111.93 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.88 -33.04 74.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 3.76 111.446 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.8 -41.12 72.04 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.784 1.234 . . . . 4.13 113.524 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -69.61 -40.49 76.57 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.944 1.247 . . . . 2.0 113.359 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.07 -20.22 61.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.673 1.189 . . . . 1.39 113.351 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.2 t0 54.14 42.36 31.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.687 1.195 . . . . 2.34 112.498 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.1 t -125.85 165.97 17.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.261 1.824 . . . . 2.63 111.086 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -100.01 -11.13 20.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.942 1.297 . . . . 3.12 113.885 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 9.9 t -148.15 135.12 20.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.843 1.257 . . . . 3.75 111.551 -172.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -158.22 149.48 21.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.764 1.226 . . . . 1.54 112.476 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 69.88 142.94 0.18 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.032 1.301 . . . . 1.03 115.244 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 19.0 m -112.01 -80.03 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.653 1.581 . . . . 2.39 112.125 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 44.5 t -135.39 136.75 41.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.92 1.288 . . . . 2.35 111.279 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.4 mp -141.09 149.78 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.275 3.83 . . . . 4.04 107.056 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 31.5 t70 -137.03 109.01 7.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.896 1.278 . . . . 3.34 109.348 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -97.35 135.07 39.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.198 1.925 . . . . 4.43 116.198 -171.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.1 26.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.637 2.775 . . . . 3.05 107.12 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.4 m -112.49 142.57 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 115.092 1.515 . . . . 3.5 115.092 -167.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.77 131.23 14.63 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.321 1.449 . . . . 2.66 109.39 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.4 130.88 21.96 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.784 2.322 . . . . 2.59 111.862 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.74 -41.53 0.69 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.722 2.106 . . . . 2.2 115.148 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -78.75 10.97 2.85 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.636 2.087 . . . . 2.76 116.636 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 85.98 171.79 48.23 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 119.093 0.86 . . . . 1.28 113.249 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.4 pt -136.12 165.51 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.665 1.186 . . . . 4.18 111.868 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.2 t -127.14 152.37 47.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.333 1.053 . . . . 1.9 112.112 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 23.1 p -144.35 169.68 17.46 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.028 -1.045 . . . . 2.78 113.258 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -118.51 119.94 36.05 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.578 -1.267 . . . . 2.09 107.578 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.1 p -127.09 136.78 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.846 1.054 . . . . 3.01 113.846 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 5.3 t -119.76 150.11 40.93 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.445 0.906 . . . . 1.78 113.445 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -167.48 36.6 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.459 2.704 . . . . 2.68 108.463 158.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 6.1 pt -130.78 -75.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.394 1.878 . . . . 3.33 110.443 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -129.43 -10.37 4.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.216 1.371 . . . . 5.45 113.827 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -60.92 -6.84 7.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.193 1.854 . . . . 4.85 116.96 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.91 -8.64 1.04 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 119.079 1.439 . . . . 4.25 114.483 168.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 4.1 tt -71.53 -53.44 13.81 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.979 2.112 . . . . 5.39 111.423 169.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -153.25 134.42 14.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.742 1.617 . . . . 10.94 111.635 -171.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -140.05 -41.35 0.43 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.615 1.566 . . . . 11.19 114.673 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 6.0 t30 51.17 29.16 4.57 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 125.223 1.409 . . . . 13.24 113.026 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -92.4 51.6 1.79 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.674 -1.267 . . . . 12.9 111.645 -169.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 79.2 m95 -90.48 176.25 6.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.159 1.384 . . . . 14.3 109.967 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 4.8 p30 -39.16 -79.08 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.643 2.377 . . . . 16.26 113.306 172.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 55.5 mt 51.08 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 128.166 2.587 . . . . 13.08 113.161 171.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.76 -20.61 66.33 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.293 -1.505 . . . . 18.03 113.334 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.17 -20.75 64.47 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.14 1.376 . . . . 14.07 112.785 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 9.6 t30 -93.2 -45.18 7.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.095 1.358 . . . . 15.39 112.046 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -73.58 -28.91 62.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 117.095 2.257 . . . . 15.9 117.095 -165.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.2 22.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 113.72 1.007 . . . . 19.02 113.72 -169.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -78.6 -38.99 38.67 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.684 -1.26 . . . . 17.53 112.429 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 73.4 m-80 47.81 41.49 14.32 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.211 1.405 . . . . 19.4 113.969 175.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -147.08 171.36 15.42 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.561 0.949 . . . . 20.45 113.561 -174.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.7 t -134.17 126.34 29.74 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.452 1.101 . . . . 23.01 111.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.22 153.09 38.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.511 1.925 . . . . 25.24 110.877 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 2.4 t 48.4 47.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 126.566 1.946 . . . . 28.75 111.697 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 133.18 45.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.645 0.778 . . . . 29.95 112.941 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 35.3 mm -97.99 -34.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 33.53 111.041 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 19.0 m-20 48.68 53.3 12.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.974 1.71 . . . . 32.04 112.363 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -71.42 -19.75 62.2 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 115.216 1.562 . . . . 33.92 115.216 -169.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 16.2 p 65.57 163.73 0.16 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.844 2.458 . . . . 32.97 115.043 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.56 33.26 23.02 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.231 1.812 . . . . 34.84 114.811 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.64 -39.61 2.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.64 1.576 . . . . 28.68 112.32 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 61.29 166.86 0.09 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.117 2.167 . . . . 31.12 115.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 2.6 t 64.09 174.66 0.18 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.829 2.452 . . . . 23.63 115.933 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.25 49.8 p 64.44 24.9 13.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.612 2.365 . . . . 19.69 116.098 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 52.7 p -75.88 -18.62 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.355 1.062 . . . . 20.56 113.556 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 61.8 p -68.37 -54.0 20.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.811 1.244 . . . . 17.14 111.811 170.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 2.5 t -150.92 135.1 16.82 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.988 2.115 . . . . 15.3 108.753 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 11.7 m -104.76 19.67 20.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.527 1.306 . . . . 13.9 114.527 -168.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1163 ' ' MET . . . . . 0.466 ' C ' ' H ' ' A' 1165 ' ' ILE . 36.7 mmm -122.58 153.26 39.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.75 1.22 . . . . 14.72 111.708 -169.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 14.9 mm 63.56 -27.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 126.174 1.789 . . . . 11.27 113.165 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1165 ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' 1163 ' ' MET . 2.3 pp -59.53 -28.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.245 1.418 . . . . 10.42 113.018 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.58 -18.92 20.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.24 1.2 . . . . 8.64 114.24 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -74.73 -5.63 44.32 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 114.527 1.306 . . . . 8.25 114.527 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -109.89 4.77 21.89 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.452 2.301 . . . . 7.94 114.195 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.12 -36.94 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.542 1.937 . . . . 6.84 112.771 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 89.4 p -64.25 -14.75 57.62 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.866 1.432 . . . . 6.78 114.866 -169.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -104.63 -10.98 17.16 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.193 1.923 . . . . 7.12 116.193 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -46.57 -47.54 19.74 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.06 1.874 . . . . 4.69 116.06 -165.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.29 -17.65 64.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.418 1.266 . . . . 7.42 114.418 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -99.88 -42.98 6.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.898 0.879 . . . . 5.43 110.721 168.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.24 52.95 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.875 1.67 . . . . 4.85 111.745 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -54.35 147.06 14.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.676 2.102 . . . . 5.16 116.676 -166.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.04 174.86 14.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.774 2.829 . . . . 2.11 111.909 -166.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -131.03 129.96 42.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.808 1.643 . . . . 4.33 112.12 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -88.42 123.51 33.04 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.595 -0.891 . . . . 2.32 108.595 167.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.6 m -131.67 154.95 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.232 1.013 . . . . 1.24 111.514 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.45 152.06 32.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.076 0.951 . . . . 1.02 112.807 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.9 tt -153.85 153.07 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.048 1.339 . . . . 2.19 110.673 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 103.03 154.55 24.64 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.98 0.767 . . . . 1.92 114.281 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.9 t-20 54.08 -161.52 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.178 1.791 . . . . 2.4 113.248 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -27.95 3.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.594 1.558 . . . . 6.98 113.516 168.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.7 -48.13 73.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.534 1.061 . . . . 4.56 113.033 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 9.7 t90 -75.92 -37.37 58.8 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.425 . . . . 4.24 112.008 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 76.3 mmm -54.68 -37.51 65.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.472 0.709 . . . . 3.52 111.966 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.36 -66.75 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.197 1.399 . . . . 3.52 108.954 166.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -9.97 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.623 2.369 . . . . 8.04 116.627 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.88 21.01 0.22 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 120.298 1.408 . . . . 1.22 112.131 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 63.88 17.65 61.03 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.27 -1.518 . . . . 1.13 115.249 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.07 164.05 26.07 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.278 1.539 . . . . 0.92 111.338 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 55.9 t -91.51 127.66 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.449 -0.782 . . . . 2.32 109.007 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.68 140.02 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.822 0.849 . . . . 1.85 111.087 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -116.8 155.77 28.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.522 1.129 . . . . 2.7 112.437 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.62 -37.0 85.66 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.717 1.006 . . . . 2.69 113.717 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -73.53 -37.31 65.67 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.026 0.83 . . . . 2.69 112.672 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 -35.28 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.911 -0.566 . . . . 1.3 111.407 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -63.33 -43.6 97.29 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.766 1.166 . . . . 1.91 112.16 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.67 -33.23 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.404 -0.81 . . . . 2.17 113.036 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -74.06 -36.81 64.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.046 . . . . 3.78 113.529 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.2 tpp -64.38 -52.61 57.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.165 1.386 . . . . 1.68 111.139 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 7.0 t -65.23 -28.98 69.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.267 1.027 . . . . 1.92 112.687 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -57.52 -54.45 46.68 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.044 0.937 . . . . 2.66 112.987 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -71.09 -29.92 65.9 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.921 0.341 . . . . 3.5 111.921 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.21 -39.98 93.52 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.339 1.056 . . . . 3.61 112.083 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -68.66 -25.61 64.9 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.705 2.402 . . . . 4.41 113.593 172.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 17.7 mttp -78.56 4.87 12.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.506 1.522 . . . . 3.94 113.09 168.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 71.81 18.4 77.44 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.441 1.496 . . . . 1.9 112.877 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -101.89 -174.76 2.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.411 1.484 . . . . 4.36 110.907 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.5 m -108.2 125.15 51.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.439 1.096 . . . . 2.0 111.741 -169.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.28 127.4 29.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.348 1.059 . . . . 1.32 110.303 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.4 m -140.96 158.11 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.907 1.283 . . . . 1.08 113.23 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.0 163.83 11.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.84 1.256 . . . . 1.23 111.791 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.2 p -139.29 134.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.857 1.263 . . . . 3.42 112.56 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -131.04 153.48 49.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.269 1.828 . . . . 0.81 112.53 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.4 m -146.29 131.09 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.999 2.12 . . . . 1.94 110.316 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.395 0.0 OUTLIER 41.29 46.17 2.72 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.335 1.854 . . . . 3.88 114.596 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 61.03 31.31 19.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.308 2.243 . . . . 1.47 115.874 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.03 158.89 39.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.65 1.98 . . . . 2.59 111.82 168.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 146.5 33.27 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.667 -1.271 . . . . 1.92 112.619 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 7.6 p -118.7 -41.82 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.282 0.633 . . . . 1.25 111.085 167.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.17 -163.24 24.85 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.798 1.181 . . . . 0.44 115.869 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.64 153.22 43.24 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.795 2.038 . . . . 1.02 112.57 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 25.6 mm -124.35 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.383 1.473 . . . . 1.78 109.579 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.24 132.27 54.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.21 1.404 . . . . 1.86 110.898 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 19.1 mt -136.02 158.05 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.71 2.004 . . . . 2.55 110.646 -168.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.17 -169.52 2.15 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.907 1.683 . . . . 2.05 111.573 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.55 134.22 55.03 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.419 -1.425 . . . . 3.74 111.495 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.253 1.278 0 CA-C-O 116.692 -1.623 . . . . 4.9 111.618 170.584 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 111.629 0.233 . . . . 11.82 111.629 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -75.22 -23.31 57.58 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.994 1.479 . . . . 13.97 114.994 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 70.5 m -84.15 142.76 30.12 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.434 0.901 . . . . 9.31 113.434 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 15.8 ptm -156.46 154.31 30.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.667 1.187 . . . . 7.28 114.018 169.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -128.32 -46.63 1.34 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.794 1.638 . . . . 7.31 111.491 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -135.18 145.46 17.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.345 0.974 . . . . 3.27 112.937 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.3 p -115.07 148.6 40.94 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 3.12 111.487 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.01 146.95 66.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.756 2.304 . . . . 1.72 111.441 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 10.9 p -130.59 134.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.347 1.059 . . . . 3.75 110.698 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -72.44 113.63 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.87 0.843 . . . . 2.31 109.642 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -91.52 -40.44 11.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.466 1.106 . . . . 3.96 111.725 -168.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -154.4 152.32 30.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.131 0.972 . . . . 3.19 112.099 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.9 m -125.65 142.62 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.943 1.297 . . . . 1.95 111.422 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -143.45 149.35 37.47 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.925 1.083 . . . . 3.43 113.925 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 46.3 t -96.3 143.65 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.638 1.575 . . . . 1.81 111.614 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.3 tp -107.41 -46.15 3.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.605 1.962 . . . . 1.53 111.5 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.8 m -118.98 126.39 51.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.393 1.477 . . . . 2.57 109.115 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -150.52 138.81 20.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.857 0.463 . . . . 4.49 111.568 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.1 m 63.67 -14.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.956 2.103 . . . . 2.99 116.59 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -95.52 -3.25 46.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.665 1.186 . . . . 2.95 114.145 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -157.88 -44.51 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.146 0.979 . . . . 4.93 112.987 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mm -134.12 157.65 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.61 1.964 . . . . 2.38 110.346 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 71.6 m -113.5 149.84 33.74 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.019 1.727 . . . . 2.13 112.589 172.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 21.1 p80 -55.98 -47.01 78.47 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.634 2.087 . . . . 4.02 116.634 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -70.32 -18.01 63.09 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.531 1.06 . . . . 4.12 111.378 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.29 -30.09 18.71 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.558 1.543 . . . . 4.76 111.784 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 92.7 mt -58.6 -52.22 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.191 0.905 . . . . 1.86 109.528 168.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.21 -34.13 77.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.801 -0.562 . . . . 1.69 111.645 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -59.6 -52.96 63.31 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.535 -0.745 . . . . 1.37 112.548 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 28.3 pt -68.37 -31.01 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.94 1.246 . . . . 1.92 113.836 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.0 t -70.37 -45.27 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.609 1.095 . . . . 1.94 110.416 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -61.37 -41.19 99.46 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.28 -0.733 . . . . 0.76 113.241 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 66.3 p -72.82 -37.42 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.159 0.98 . . . . 1.32 113.541 176.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.13 83.27 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.023 0.829 . . . . 0.96 112.379 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.1 -16.91 63.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.275 -0.89 . . . . 2.26 112.763 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 -23.83 67.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.159 1.17 . . . . 1.8 114.159 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -94.22 -13.12 26.93 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.25 -0.906 . . . . 1.9 112.757 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.7 t -73.84 160.18 31.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.298 1.592 . . . . 1.81 115.298 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.24 12.42 26.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.576 2.35 . . . . 5.31 113.445 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.59 160.1 59.69 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.912 1.078 . . . . 2.06 113.912 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.85 -34.66 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.897 3.065 . . . . 1.17 114.61 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.79 -51.67 4.79 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.853 0.861 . . . . 1.93 113.308 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.4 -30.43 77.55 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.844 -0.217 . . . . 1.12 113.345 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 29.2 p -65.19 -18.91 65.7 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.62 -1.518 . . . . 2.8 113.557 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.66 -32.05 73.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.802 -1.186 . . . . 1.6 111.545 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.19 -41.18 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.488 1.515 . . . . 2.09 110.474 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 99.4 m -52.58 -47.99 66.51 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.892 1.223 . . . . 2.08 111.404 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.2 tttt -59.11 -50.29 74.6 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.243 0.929 . . . . 3.48 112.284 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 76.9 t80 -58.28 -40.51 82.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.683 1.193 . . . . 3.15 112.534 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 83.7 m -72.84 -43.19 62.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.732 1.613 . . . . 4.28 113.032 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.93 -36.81 80.29 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.329 1.422 . . . . 3.71 110.836 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.22 -47.39 79.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.216 1.006 . . . . 4.0 111.127 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -62.67 -44.52 96.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.884 1.22 . . . . 1.95 113.844 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.64 -18.71 62.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.322 0.86 . . . . 1.48 113.322 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 18.3 t70 48.99 32.06 3.65 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.69 1.596 . . . . 2.32 113.59 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -99.85 -12.35 19.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.145 1.778 . . . . 3.44 115.344 -167.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 16.8 tt0 66.84 -19.93 0.11 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.656 2.382 . . . . 4.29 116.677 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.8 t -154.35 138.12 16.17 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.101 1.319 . . . . 3.34 113.507 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -156.62 153.78 29.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.012 1.325 . . . . 1.39 114.449 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 98.4 136.95 9.49 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 125.477 1.513 . . . . 1.04 114.622 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 25.1 m -125.94 -68.07 0.84 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.894 0.878 . . . . 2.06 112.661 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 12.8 t -138.77 142.48 38.8 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.395 1.258 . . . . 1.6 114.395 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.4 mm -143.82 139.44 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 130.997 3.719 . . . . 3.17 109.211 -174.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 17.0 t0 -94.72 -28.06 15.5 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.524 1.53 . . . . 2.74 114.027 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.82 97.1 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.946 2.098 . . . . 3.89 116.222 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.59 114.48 22.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.967 1.707 . . . . 2.55 109.136 169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 92.8 t -113.71 131.33 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.445 1.498 . . . . 2.94 111.453 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 50.7 t -133.9 118.79 14.45 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.201 1.4 . . . . 1.92 107.602 169.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -53.42 136.62 63.82 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.214 2.609 . . . . 1.95 113.677 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.31 -45.22 0.96 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.422 1.963 . . . . 2.17 114.767 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 79.2 m -71.48 -5.34 32.26 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 117.369 2.359 . . . . 3.17 117.369 -167.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 110.46 -167.41 12.63 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.983 1.265 . . . . 0.8 113.819 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 143.39 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.127 1.371 . . . . 2.71 110.204 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.6 t -129.19 151.8 49.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.559 1.144 . . . . 1.09 111.466 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 29.3 p -162.94 172.52 14.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.197 0.999 . . . . 1.55 113.413 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.16 135.91 53.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.447 1.499 . . . . 1.58 107.191 169.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 35.0 m -128.6 148.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.609 0.763 . . . . 3.78 112.35 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.0 t -134.09 145.78 49.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.054 0.942 . . . . 2.19 109.68 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -164.34 44.52 0.1 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.233 1.813 . . . . 2.95 108.371 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.56 -31.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.108 1.763 . . . . 2.4 112.188 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.83 -0.48 1.51 Allowed 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.983 1.105 . . . . 4.6 113.983 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.78 7.03 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 118.421 2.128 . . . . 3.33 118.421 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1129 ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' 1131 ' ' HIS . 2.0 pp -71.31 -4.27 25.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.797 1.406 . . . . 4.66 114.797 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 70.2 mt -72.63 29.31 0.06 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.988 2.115 . . . . 8.2 114.281 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1131 ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' 1129 ' ' LEU . 52.6 t-80 -48.78 137.65 12.11 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.957 2.903 . . . . 8.14 113.41 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.77 126.81 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.675 0.79 . . . . 13.06 111.332 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -57.14 -51.06 70.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.702 1.201 . . . . 18.57 110.476 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -161.7 140.53 9.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.113 1.365 . . . . 15.73 112.662 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 25.9 m95 60.24 -162.41 0.26 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.682 1.993 . . . . 16.18 113.006 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.0 m-80 66.01 21.08 11.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.301 1.44 . . . . 15.1 113.055 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 78.6 mt -110.05 -23.68 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.953 2.101 . . . . 12.08 111.115 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 7.1 tt0 62.71 -31.77 0.1 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.838 3.255 . . . . 17.17 116.577 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.53 11.48 24.86 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.694 2.398 . . . . 12.89 113.29 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -43.37 -28.55 0.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.051 2.54 . . . . 13.51 117.457 -167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.87 56.06 0.41 Allowed 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 119.562 1.074 . . . . 15.15 112.214 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.36 107.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.451 1.1 . . . . 16.36 110.57 -168.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -130.77 69.92 1.46 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.354 1.462 . . . . 18.15 109.619 172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -86.64 -13.31 45.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.391 1.256 . . . . 17.13 114.391 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -63.33 134.62 56.1 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.813 1.042 . . . . 17.6 113.813 -173.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 83.2 p -121.4 154.59 36.31 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.812 1.645 . . . . 18.28 113.25 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.57 42.0 0.74 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.316 1.446 . . . . 20.37 112.832 -172.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 57.6 t -75.71 128.29 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.554 1.142 . . . . 21.95 110.046 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 57.85 146.45 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.988 2.915 . . . . 27.13 115.824 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 41.4 mm 62.08 143.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.562 2.345 . . . . 28.55 114.63 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -119.51 -20.42 7.78 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.354 2.262 . . . . 29.06 111.225 169.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -70.86 6.57 1.46 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.021 1.729 . . . . 31.99 115.158 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 87.9 p -109.43 -1.35 18.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.983 1.313 . . . . 30.73 111.999 166.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 43.4 t30 42.94 44.77 4.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 129.221 3.008 . . . . 32.34 117.799 167.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 65.63 12.92 8.6 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 115.169 1.544 . . . . 27.86 115.169 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -101.85 0.97 36.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.635 1.346 . . . . 34.9 114.635 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 3.9 t -136.52 8.77 3.12 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.198 0.999 . . . . 29.07 113.141 -169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 88.6 p -67.63 138.21 56.21 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.041 1.497 . . . . 25.29 115.041 -169.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 11.7 t -164.95 163.9 20.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.069 2.148 . . . . 24.33 109.537 168.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 54.8 p -157.51 171.4 20.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.282 -0.887 . . . . 20.56 112.938 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 34.3 p -58.82 -22.57 58.95 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.592 1.157 . . . . 19.38 113.343 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 69.3 m -81.41 -1.03 44.13 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.351 1.241 . . . . 17.68 114.351 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 89.0 mmm -73.88 145.93 44.45 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.768 -1.207 . . . . 21.15 110.882 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 70.4 mt 60.06 -14.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 127.167 2.187 . . . . 19.53 114.683 -172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.82 -30.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 119.636 -1.915 . . . . 14.55 115.932 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.5 -28.24 66.84 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.86 1.209 . . . . 14.51 113.098 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.69 76.6 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.669 -0.644 . . . . 14.1 110.968 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.64 -43.77 15.24 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.77 1.228 . . . . 13.63 111.471 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 89.7 mt -68.18 -40.63 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.516 1.126 . . . . 11.23 111.003 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 50.8 m -65.53 -29.16 69.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.172 -0.955 . . . . 10.75 112.512 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1171 ' ' ASN . . . . . . . . . . . . 0.261 4.3 p30 -84.77 -5.29 59.32 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.701 1.371 . . . . 8.26 114.701 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.03 64.18 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.982 1.104 . . . . 6.14 113.982 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.01 -33.39 62.58 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.781 1.233 . . . . 10.2 111.33 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.77 -33.6 12.21 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.821 1.648 . . . . 6.0 112.293 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -107.37 103.42 12.76 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.606 1.706 . . . . 4.6 115.606 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -46.43 143.32 2.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.815 1.783 . . . . 3.85 115.815 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -129.9 161.28 31.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.234 1.813 . . . . 2.17 112.937 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -126.33 134.58 51.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.955 2.502 . . . . 3.7 109.179 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -95.04 105.9 17.85 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.855 1.262 . . . . 2.72 110.786 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -124.11 142.33 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.382 0.673 . . . . 1.31 112.652 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.5 151.87 38.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.536 1.135 . . . . 0.97 112.836 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.47 155.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.767 1.627 . . . . 1.74 109.891 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 107.55 163.66 21.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.111 0.839 . . . . 1.7 114.127 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 4.8 t-20 49.98 -155.23 0.11 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.212 1.805 . . . . 2.62 114.013 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -130.11 -34.69 1.65 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.171 2.589 . . . . 5.77 111.556 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.88 -32.47 51.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.159 1.17 . . . . 3.3 114.159 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.2 t90 -72.39 -28.98 63.34 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.354 -1.466 . . . . 4.04 111.892 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 6.1 tpp -57.38 -34.23 68.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.922 0.889 . . . . 2.69 111.617 171.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.96 -66.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.554 1.942 . . . . 2.58 109.985 168.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -55.8 -18.89 9.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 116.01 1.856 . . . . 6.43 116.01 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.71 9.86 2.55 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 120.15 1.341 . . . . 1.17 112.79 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 72.77 18.63 78.92 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.387 1.47 . . . . 0.99 115.571 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.59 171.23 13.53 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.445 1.098 . . . . 2.03 111.325 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 94.7 t -108.79 120.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.568 1.147 . . . . 1.65 109.989 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.87 125.27 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.158 0.983 . . . . 2.27 110.845 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -92.54 156.24 17.27 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.031 1.332 . . . . 4.17 112.99 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -60.21 -31.36 70.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.702 1.201 . . . . 2.81 113.45 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.45 -42.51 68.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.348 1.059 . . . . 3.03 111.704 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 4.4 p -78.17 -35.26 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.223 0.823 . . . . 2.18 113.223 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.8 -38.95 89.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.668 1.122 . . . . 2.36 111.215 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -49.27 78.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.585 0.754 . . . . 1.97 112.142 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.2 -41.56 79.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.189 1.396 . . . . 3.96 111.546 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 25.4 tpp -64.81 -49.29 71.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.553 1.541 . . . . 1.62 111.811 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.4 t -74.94 -30.53 61.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.885 0.698 . . . . 1.8 112.885 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -58.05 -53.18 61.2 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.477 -1.389 . . . . 2.5 112.629 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -71.31 -29.13 64.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.532 0.733 . . . . 3.78 112.572 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.05 -46.08 89.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.949 0.9 . . . . 4.84 111.595 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -66.93 -29.54 69.44 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.389 1.475 . . . . 4.46 113.625 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 23.5 mttp -65.44 -10.69 36.08 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.482 1.513 . . . . 3.43 113.51 169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.26 29.52 10.18 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.941 1.258 . . . . 1.72 114.409 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -126.63 176.94 6.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.715 1.606 . . . . 6.93 111.043 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 55.2 m -90.79 139.16 31.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.072 1.349 . . . . 1.84 111.328 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -136.86 130.95 32.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.025 0.93 . . . . 1.85 112.514 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 164.58 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.717 1.607 . . . . 0.95 113.423 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.37 168.74 10.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.363 1.465 . . . . 1.03 113.489 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.2 t -137.02 128.56 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.624 1.57 . . . . 2.95 112.101 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.55 150.24 47.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.243 1.417 . . . . 2.07 113.259 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.32 125.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.091 1.756 . . . . 1.33 111.529 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 37.7 53.5 1.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.494 2.318 . . . . 2.74 113.268 -173.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.275 16.3 m-20 58.85 29.29 18.62 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.369 1.989 . . . . 2.05 116.369 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.18 151.7 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.496 1.918 . . . . 3.22 110.091 166.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.55 145.33 34.89 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.833 -1.167 . . . . 1.86 110.124 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -119.5 -40.55 2.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.527 -0.749 . . . . 1.22 112.892 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.27 -172.7 37.67 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 120.11 1.323 . . . . 0.44 116.222 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -138.25 152.62 48.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.264 1.826 . . . . 0.9 112.656 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 11.1 mm -132.29 136.28 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 1.8 110.242 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -109.97 136.9 48.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.311 1.444 . . . . 1.92 110.266 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.36 143.65 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.805 1.642 . . . . 2.56 111.146 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -123.31 -171.79 2.38 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.518 1.927 . . . . 2.04 111.956 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -124.75 133.49 53.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.216 1.807 . . . . 3.22 112.222 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.48 1.512 . . . . 5.32 114.556 -174.7 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.359 0.874 . . . . 2.4100000000000001 113.359 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.89 149.32 3.94 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.969 3.113 . . . . 1.3200000000000001 112.923 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 3.9 m -131.52 130.24 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.728 2.011 . . . . 2.3700000000000001 111.903 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.2 p -74.8 126.44 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.396 -0.815 . . . . 1.1299999999999999 110.745 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.02 -38.29 3.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.733 1.753 . . . . 2.3399999999999999 115.733 -165.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -149.09 145.18 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.281 1.401 . . . . 2.1000000000000001 111.961 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 30.1 m -125.41 143.16 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.088 0.955 . . . . 1.21 112.786 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 71.9 tttt -136.88 142.19 42.78 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.526 1.53 . . . . 1.9299999999999999 111.385 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 58.0 t -94.38 148.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.131 1.373 . . . . 0.93000000000000005 111.45 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.91 -39.09 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.35 1.46 . . . . 1.3600000000000001 113.682 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.4 t -81.12 29.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.82 1.191 . . . . 2.75 113.424 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.34 132.42 39.26 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.859 -1.776 . . . . 4.3700000000000001 111.634 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 20.8 m 61.65 -8.62 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.763 2.505 . . . . 2.5299999999999998 117.763 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.84 -30.86 12.91 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.397 1.628 . . . . 3.48 115.397 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -150.04 -66.28 0.21 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.658 1.117 . . . . 5.2999999999999998 112.579 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.507 HD12 HG21 ' A' 1218 ' ' VAL . 4.4 mt -128.15 140.08 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.577 1.951 . . . . 1.77 110.905 -171.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.5 m -103.15 160.27 14.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.637 1.175 . . . . 1.99 112.746 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.8 p80 -47.13 -41.41 17.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.944 1.698 . . . . 2.9500000000000002 115.466 -169.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -70.55 -42.22 71.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.071 1.348 . . . . 3.23 111.913 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.53 -33.23 72.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.067 -1.02 . . . . 2.9700000000000002 112.138 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1073 ' ' ILE . . . . . 0.431 HG13 HG22 ' A' 1068 ' ' ILE . 97.9 mt -58.41 -52.65 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.884 1.22 . . . . 0.79000000000000004 110.768 172.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.79 -29.96 68.43 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.402 -0.811 . . . . 0.82999999999999996 112.181 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.62 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.095 0.558 . . . . 0.64000000000000001 112.279 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 15.1 pt -70.31 -35.53 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.809 1.186 . . . . 0.72999999999999998 112.867 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 92.4 t -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.452 1.023 . . . . 0.78000000000000003 111.006 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.8 -34.74 88.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.451 -0.78 . . . . 0.68999999999999995 113.51 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.9 p -75.9 -32.61 59.72 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.746 1.273 . . . . 0.65000000000000002 112.815 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.05 67.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.877 0.762 . . . . 0.72999999999999998 112.137 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.41 -21.13 62.87 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.313 -0.867 . . . . 1.9199999999999999 112.439 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.0 t -65.23 -18.51 65.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.93 -1.106 . . . . 1.48 112.566 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -117.69 -9.23 10.77 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.169 1.388 . . . . 2.5499999999999998 113.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.9 t -85.62 -174.89 5.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.409 1.484 . . . . 1.4199999999999999 112.32 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -135.82 32.13 3.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.547 1.939 . . . . 4.2599999999999998 112.703 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -93.51 162.3 28.09 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 114.199 1.185 . . . . 1.6899999999999999 114.199 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.68 -21.55 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.052 3.168 . . . . 0.98999999999999999 114.657 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.4 -52.48 2.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.054 1.341 . . . . 0.69999999999999996 113.383 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.91 -23.59 65.83 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 114.154 0.422 . . . . 0.95999999999999996 114.154 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 12.9 p -61.44 -18.45 58.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.929 -1.336 . . . . 1.45 113.988 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.68 81.42 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.885 -1.134 . . . . 0.83999999999999997 111.719 168.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.64 -32.85 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.299 1.039 . . . . 1.3200000000000001 111.291 172.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 28.0 m -52.27 -50.81 61.39 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.798 1.181 . . . . 1.1399999999999999 111.253 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -61.32 -48.04 83.18 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.852 0.751 . . . . 2.71 112.647 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -55.73 -41.63 74.16 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.961 0.904 . . . . 1.76 111.735 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.1 t -67.91 -52.74 32.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.132 1.373 . . . . 2.0299999999999998 112.371 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -42.31 88.86 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.413 -1.429 . . . . 3.02 112.455 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -67.47 -31.51 71.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.81 1.644 . . . . 2.98 111.901 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -70.25 -50.34 40.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.501 1.046 . . . . 2.6600000000000001 112.224 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 27.4 mt -72.18 -22.72 61.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.484 1.29 . . . . 1.4099999999999999 114.484 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.6 t0 56.36 43.9 25.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.87 1.668 . . . . 2.7599999999999998 113.333 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.7 t -138.88 -30.8 0.74 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.175 2.287 . . . . 3.3100000000000001 117.175 -169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 61.1 tt0 64.47 -26.41 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.744 2.498 . . . . 4.4299999999999997 117.744 -171.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 46.9 p -84.57 45.2 1.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.446 1.898 . . . . 3.0899999999999999 114.828 -169.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.95 151.75 23.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.159 1.383 . . . . 0.92000000000000004 113.523 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 92.79 122.76 3.23 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.049 0.841 . . . . 1.1599999999999999 114.611 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1107 ' ' THR . . . . . 0.632 HG22 ' H ' ' A' 1108 ' ' CYS . 74.4 m -129.3 -172.58 2.77 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.254 2.622 . . . . 2.6000000000000001 107.653 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1108 ' ' CYS . . . . . 0.632 ' H ' HG22 ' A' 1107 ' ' THR . 8.3 t -56.42 143.37 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.151 1.908 . . . . 1.54 116.151 -168.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 16.5 tt -135.11 140.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 131.523 3.929 . . . . 2.1400000000000001 106.368 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.2 t0 -124.53 93.48 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.46 1.104 . . . . 3.21 108.845 172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.341 0.0 OUTLIER -97.43 166.55 11.48 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 117.412 2.375 . . . . 3.1400000000000001 117.412 -169.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -142.81 105.45 4.49 Favored 'General case' 0 CA--C 1.562 1.414 1 C-N-CA 132.332 4.253 . . . . 2.1400000000000001 107.625 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 6.3 m -109.62 151.04 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.303 -1.498 . . . . 3.0299999999999998 114.515 -170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 13.9 t -137.71 138.87 25.16 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.9 1.28 . . . . 1.53 110.599 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.33 132.95 28.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.647 2.231 . . . . 1.47 111.758 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.1 -34.5 0.41 Allowed Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.267 1.889 . . . . 2.1600000000000001 115.893 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -90.21 2.91 54.88 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.212 1.56 . . . . 2.1699999999999999 115.212 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 90.98 -176.29 40.67 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.308 0.956 . . . . 0.75 114.598 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.5 pt -136.53 160.01 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.111 0.964 . . . . 2.6299999999999999 112.59 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 21.7 t -130.27 147.03 51.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.415 1.486 . . . . 0.59999999999999998 111.565 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.4 p -154.63 173.77 15.9 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.013 -1.055 . . . . 0.68000000000000005 113.003 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -115.88 111.18 20.07 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 2.6 m -103.05 127.93 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.596 1.158 . . . . 2.2999999999999998 113.432 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.3 t -109.23 159.1 17.21 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.074 0.95 . . . . 1.01 112.306 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.3 t-20 . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 128.728 2.811 . . . . 2.5499999999999998 107.786 161.281 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 114.635 1.346 . . . . 2.98 114.635 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 119.25 10.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.898 0.879 . . . . 3.3399999999999999 112.365 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.29 117.29 18.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.23 . . . . 1.2 110.686 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -135.29 144.07 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 0.55000000000000004 112.198 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.26 154.59 42.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.895 1.278 . . . . 0.5 112.603 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.0 tt -152.5 145.79 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.279 1.032 . . . . 0.63 110.587 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 121.83 166.58 12.89 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 116.042 1.177 . . . . 1.4399999999999999 116.042 168.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 48.11 -141.36 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.604 1.962 . . . . 2.29 113.93 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.43 -32.58 0.45 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.499 1.52 . . . . 6.0199999999999996 114.184 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.59 -37.49 79.86 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.433 1.469 . . . . 3.77 114.275 -174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.3 t90 -68.22 -31.18 70.51 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.657 -1.277 . . . . 3.27 111.819 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 10.4 tpp -60.23 -34.53 73.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.137 0.975 . . . . 2.2000000000000002 111.752 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.66 -67.01 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.467 1.507 . . . . 1.5900000000000001 109.043 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -52.96 -24.97 10.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.967 2.107 . . . . 5.6799999999999997 115.987 -172.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.76 20.23 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.006 1.275 . . . . 0.79000000000000004 113.811 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.26 13.41 81.4 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.193 -1.567 . . . . 0.93000000000000005 115.376 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.6 mt -83.96 175.3 9.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.605 1.162 . . . . 0.92000000000000004 111.388 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 57.8 t -119.41 131.05 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.087 1.355 . . . . 1.21 108.744 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.5 tt -102.71 135.73 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.396 0.679 . . . . 1.1200000000000001 110.954 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.7 p30 -96.82 159.51 14.88 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.736 1.214 . . . . 4.1200000000000001 113.099 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.1 p30 -71.99 -15.04 62.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.447 1.277 . . . . 4.3799999999999999 114.447 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -84.24 -45.22 13.11 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.62 -1.3 . . . . 2.46 113.019 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.2 p -64.45 -34.46 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 118.823 -0.608 . . . . 0.81000000000000005 110.92 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.67 -42.96 81.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.761 1.164 . . . . 1.95 112.604 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.61 -34.69 77.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.274 1.03 . . . . 1.97 112.405 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 39.9 t80 -71.95 -35.41 69.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.818 1.247 . . . . 2.3100000000000001 112.718 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.3 tpp -71.21 -58.95 3.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.502 1.921 . . . . 0.80000000000000004 112.435 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -62.53 -28.2 69.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 0.89000000000000001 112.297 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -58.31 -47.42 83.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.757 2.023 . . . . 2.71 113.403 171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -64.78 -36.11 83.25 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.213 -0.929 . . . . 2.4900000000000002 111.842 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.41 -31.96 72.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.514 -0.741 . . . . 3.0699999999999998 112.36 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 48.9 ttp85 -70.6 -39.9 73.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.558 2.343 . . . . 9.0 111.431 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 13.8 mttp -69.2 -1.38 7.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.728 2.011 . . . . 2.3199999999999998 112.624 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 75.34 16.58 80.53 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.824 1.202 . . . . 1.2 115.022 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -95.45 178.93 5.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 111.205 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1212 ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 70.2 m -93.29 121.08 34.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.16 1.784 . . . . 0.94999999999999996 109.635 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.41 113.95 15.56 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.754 0.822 . . . . 0.62 111.873 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 26.7 m -140.55 163.13 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.569 1.148 . . . . 0.51000000000000001 114.06 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.1 160.95 23.97 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.352 1.461 . . . . 0.81000000000000005 112.982 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 5.0 t -127.49 125.75 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.22 1.808 . . . . 1.7 111.677 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -118.66 154.36 32.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.122 1.369 . . . . 0.51000000000000001 112.19 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1218 ' ' VAL . . . . . 0.507 HG21 HD12 ' A' 1068 ' ' ILE . 18.9 m -146.61 122.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.027 1.731 . . . . 0.84999999999999998 110.462 -172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 31.2 t70 44.39 46.79 7.98 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 122.705 1.241 . . . . 3.3399999999999999 113.368 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.265 4.9 m-20 62.42 28.1 16.66 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.549 1.94 . . . . 1.76 115.838 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.46 149.07 42.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.726 2.811 . . . . 3.27 110.273 168.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.61 114.61 26.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.47 -1.394 . . . . 1.1599999999999999 110.812 170.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.4 p -89.21 -38.06 14.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.738 1.154 . . . . 0.56000000000000005 113.32 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . 176.48 -168.69 40.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 119.259 0.936 . . . . 0.45000000000000001 114.883 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.23 156.08 44.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.349 1.46 . . . . 0.68999999999999995 113.772 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.37 133.05 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 1.4199999999999999 111.525 -170.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -105.15 136.59 44.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.978 1.711 . . . . 0.70999999999999996 110.356 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1228 ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' 1212 ' ' THR . 67.3 mt -140.97 148.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.759 1.624 . . . . 1.0700000000000001 109.869 -168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 124.413 1.085 . . . . 1.51 112.585 179.634 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 116.134 1.902 . . . . 2.25 116.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.79 132.48 40.16 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.105 2.537 . . . . 1.79 111.955 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.52 129.52 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.662 1.585 . . . . 2.1699999999999999 110.946 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 128.23 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.781 0.833 . . . . 1.46 111.531 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.35 -35.3 4.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.128 1.158 . . . . 2.02 114.128 -168.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -164.88 152.66 11.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 1.8799999999999999 111.69 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.4 m -125.07 135.13 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.514 1.126 . . . . 0.65000000000000002 109.216 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 51.8 tttt -140.96 148.26 40.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.04 0.936 . . . . 2.0 113.026 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.1 t -90.38 151.13 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 1.3100000000000001 112.532 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.01 -35.5 4.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.395 1.878 . . . . 1.04 111.42 168.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 92.5 m -119.93 97.85 5.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.225 1.012 . . . . 2.02 111.798 -170.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -91.59 140.89 29.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.449 1.5 . . . . 3.8799999999999999 111.071 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 52.93 29.13 7.36 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.772 2.138 . . . . 2.8900000000000001 116.772 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -145.55 -14.7 0.49 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.093 1.886 . . . . 3.4199999999999999 116.093 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -149.65 -97.53 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.271 1.428 . . . . 4.4800000000000004 109.99 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 54.9 mt -139.68 146.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.106 1.762 . . . . 2.6499999999999999 109.857 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 3.3 t -123.18 172.73 8.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.852 1.661 . . . . 5.04 114.975 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.0 p80 -38.79 -53.49 1.67 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 117.194 2.294 . . . . 3.6600000000000001 117.194 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.34 -36.53 84.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.488 1.495 . . . . 2.5699999999999998 111.897 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.5 -26.03 21.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 117.476 -1.25 . . . . 2.7999999999999998 113.04 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.75 -52.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.198 1.363 . . . . 1.3100000000000001 109.37 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.13 -31.93 73.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.91 -0.494 . . . . 0.76000000000000001 111.348 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.12 -61.13 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.599 -0.715 . . . . 0.62 112.39 171.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.53 -31.38 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.711 1.141 . . . . 0.52000000000000002 114.022 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 85.0 t -67.18 -42.25 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.224 0.92 . . . . 0.72999999999999998 110.224 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.46 91.73 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.633 -0.537 . . . . 0.91000000000000003 113.276 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.2 p -72.46 -28.46 62.95 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.669 1.235 . . . . 1.22 113.144 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -69.36 -60.81 2.09 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.034 0.834 . . . . 1.1399999999999999 111.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -65.23 -18.32 65.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.883 1.273 . . . . 2.3399999999999999 112.462 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 39.7 t -51.53 -31.37 23.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.022 1.329 . . . . 1.29 113.032 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -79.49 3.3 19.05 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.804 -1.185 . . . . 2.5600000000000001 114.185 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 48.0 m -120.74 -178.48 3.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.181 1.792 . . . . 1.8899999999999999 112.785 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -139.71 29.95 2.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.234 1.414 . . . . 4.4800000000000004 113.186 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.05 150.23 64.49 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 114.264 1.209 . . . . 1.9099999999999999 114.264 -170.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.59 -25.05 75.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.151 3.234 . . . . 1.3 115.066 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.74 -41.57 3.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.469 1.508 . . . . 0.95999999999999996 111.81 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.66 70.05 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 123.634 0.635 . . . . 0.98999999999999999 113.918 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 4.8 p -58.96 -24.0 62.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.92 1.288 . . . . 1.73 114.455 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -71.18 -36.53 71.99 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.608 -1.308 . . . . 0.73999999999999999 111.816 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.2 mt -72.03 -41.14 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.139 1.375 . . . . 0.85999999999999999 110.425 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 76.9 p -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 117.354 -1.307 . . . . 2.52 111.862 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -59.37 -49.87 76.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.784 1.174 . . . . 2.3300000000000001 112.498 169.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.91 -41.74 74.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.425 0.69 . . . . 2.29 111.424 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 38.1 t -71.26 -56.19 6.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.51 1.124 . . . . 1.8400000000000001 113.116 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -42.8 -52.0 5.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.912 2.085 . . . . 3.4300000000000002 112.005 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.741 0.816 . . . . 4.0700000000000003 112.428 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.59 -40.28 95.24 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.395 -1.44 . . . . 2.2599999999999998 112.74 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.5 -10.48 59.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.332 1.053 . . . . 1.27 113.048 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 45.0 t0 54.38 34.06 19.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.797 1.639 . . . . 2.4100000000000001 113.108 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 15.1 t -115.63 162.76 16.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.055 1.342 . . . . 2.6699999999999999 111.541 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.96 -16.99 25.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.474 1.51 . . . . 3.6299999999999999 111.453 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.8 t -146.59 135.28 22.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.306 1.443 . . . . 3.52 111.821 -170.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.68 150.32 32.99 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.876 0.871 . . . . 1.1599999999999999 111.414 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 81.22 167.33 37.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.594 0.998 . . . . 1.1100000000000001 115.594 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 52.5 m -152.51 -37.43 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.058 2.143 . . . . 1.8500000000000001 113.144 -173.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1108 ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' 1124 ' ' THR . 51.7 t -134.33 142.96 47.41 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 2.9700000000000002 114.872 -166.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 4.6 tp -150.6 151.31 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.934 1.293 . . . . 2.6099999999999999 113.131 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1110 ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' 1122 ' ' LYS . 0.0 OUTLIER -112.57 -17.26 12.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.492 1.517 . . . . 3.6200000000000001 114.082 169.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 57.3 t80 45.26 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.49 2.716 . . . . 2.7599999999999998 118.068 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.78 112.61 20.64 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.764 2.026 . . . . 2.46 109.132 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.8 t -99.75 136.67 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 2.25 111.377 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.1 t -131.42 108.37 14.71 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 108.645 -0.872 . . . . 1.0700000000000001 108.645 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.02 141.5 64.43 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.898 2.399 . . . . 1.3100000000000001 110.265 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 69.1 13.93 67.68 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 118.997 -0.89 . . . . 2.02 114.819 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 m -137.48 -87.77 0.28 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.803 1.241 . . . . 2.0699999999999998 112.696 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . -175.16 -151.15 8.32 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.851 0.7 . . . . 1.2 114.851 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 146.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.263 1.425 . . . . 2.2400000000000002 112.08 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.9 t -133.31 150.69 51.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.393 1.877 . . . . 0.90000000000000002 111.43 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.6 p -163.06 166.43 23.62 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.967 1.469 . . . . 0.75 114.967 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1122 ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' 1110 ' ' ASP . 38.1 mmtm -109.71 140.72 43.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.553 1.941 . . . . 1.1599999999999999 107.759 166.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 14.7 p -149.4 140.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.806 1.41 . . . . 2.04 114.806 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1124 ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' 1108 ' ' CYS . 4.4 t -124.32 157.04 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.751 1.621 . . . . 1.6799999999999999 110.87 166.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.3 t30 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 127.187 2.195 . . . . 2.71 109.852 160.837 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.238 0.449 0 CA-C-O 120.841 0.353 . . . . 3.1699999999999999 111.226 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -129.23 138.68 51.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.073 1.749 . . . . 2.8700000000000001 110.417 -171.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -105.83 113.75 27.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.717 1.207 . . . . 1.23 108.718 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.9 m -131.39 139.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.376 0.989 . . . . 0.62 113.319 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.77 154.84 44.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.702 1.201 . . . . 0.58999999999999997 112.93 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.9 tt -155.91 142.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.753 1.621 . . . . 0.52000000000000002 110.555 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 125.33 147.36 6.99 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.391 1.317 . . . . 2.1800000000000002 116.391 168.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.64 -159.46 0.1 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.743 1.617 . . . . 2.1400000000000001 111.801 -169.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -125.68 -40.53 2.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.258 1.577 . . . . 5.3200000000000003 115.258 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.25 -41.08 67.19 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.085 -1.635 . . . . 4.0499999999999998 111.639 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 11.8 t90 -57.71 -23.23 50.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.562 0.949 . . . . 3.0899999999999999 113.562 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 75.5 mmm -75.42 -53.19 9.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.888 1.275 . . . . 2.8199999999999998 112.148 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 96.9 mt -47.89 -62.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.139 1.775 . . . . 2.5299999999999998 110.654 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -47.7 -13.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 128.504 2.722 . . . . 6.5999999999999996 116.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.61 24.88 0.45 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 119.689 1.131 . . . . 0.76000000000000001 111.859 169.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.17 27.63 73.65 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.385 -1.447 . . . . 0.81999999999999995 114.772 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 17.3 mt -95.41 159.08 15.17 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.977 1.389 . . . . 0.93999999999999995 114.253 -169.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 44.2 t -105.32 125.61 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.276 1.43 . . . . 1.78 110.544 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.9 tt -119.11 148.59 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.795 1.638 . . . . 1.46 110.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -127.43 165.41 19.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.383 1.073 . . . . 2.9399999999999999 113.041 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.71 -30.84 69.58 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.408 -1.433 . . . . 3.2200000000000002 114.12 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.36 -42.94 98.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.19 1.396 . . . . 5.0800000000000001 111.565 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.5 p -77.78 -40.51 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.505 1.522 . . . . 1.1000000000000001 112.113 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -57.69 -41.6 81.98 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.447 1.022 . . . . 3.7200000000000002 112.125 171.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.6 -34.71 78.86 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.632 0.975 . . . . 2.9199999999999999 113.632 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -74.93 -39.32 61.45 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 2.4199999999999999 112.968 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 37.4 tpp -57.84 -58.7 7.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.033 1.333 . . . . 1.0900000000000001 110.204 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.3 t -63.23 -31.17 72.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.819 0.674 . . . . 1.48 112.819 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -58.38 -50.19 74.54 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.841 -1.162 . . . . 3.0099999999999998 112.108 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -72.73 -33.22 66.25 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.355 1.242 . . . . 2.1499999999999999 114.355 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -65.3 -43.66 90.4 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.423 -0.798 . . . . 4.7000000000000002 111.686 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -69.49 -25.59 64.14 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.599 -1.313 . . . . 4.8899999999999997 112.661 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.4 mttp -67.07 -12.56 60.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.225 1.41 . . . . 2.1800000000000002 112.959 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.0 25.35 66.91 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.531 1.062 . . . . 1.6100000000000001 113.384 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.83 172.4 7.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.642 1.577 . . . . 6.75 110.076 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 87.5 m -83.76 127.66 33.96 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.541 -0.725 . . . . 0.82999999999999996 111.192 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -134.65 109.54 8.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.438 1.495 . . . . 0.68999999999999995 110.045 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.2 m -140.51 154.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.595 1.158 . . . . 0.68999999999999995 112.498 -172.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.44 170.28 8.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.37 0.878 . . . . 0.72999999999999998 113.37 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 10.3 t -130.66 130.26 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.426 1.89 . . . . 1.6699999999999999 111.035 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.08 150.03 47.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.421 1.089 . . . . 0.52000000000000002 112.227 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.5 m -142.94 117.54 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.912 2.085 . . . . 0.92000000000000004 111.255 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 45.29 53.9 7.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.701 2.0 . . . . 2.8500000000000001 112.805 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.65 33.47 23.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.387 1.875 . . . . 1.52 114.091 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.33 144.86 36.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 2.6899999999999999 109.911 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 146.17 41.08 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.923 -1.736 . . . . 0.78000000000000003 112.296 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 24.9 p -121.84 -44.24 2.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.107 0.963 . . . . 0.75 113.123 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.23 -169.93 34.75 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.325 0.966 . . . . 0.51000000000000001 114.853 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.58 161.12 39.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.709 1.603 . . . . 1.03 114.296 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 18.1 mm -129.38 135.01 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.008 1.723 . . . . 0.70999999999999996 110.651 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -110.77 126.5 54.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.273 1.829 . . . . 0.47999999999999998 110.198 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.09 153.97 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.421 1.488 . . . . 1.5700000000000001 110.032 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.16 1.384 . . . . 1.4199999999999999 111.425 175.167 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 113.705 1.002 . . . . 2.5899999999999999 113.705 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.58 141.55 46.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.026 3.151 . . . . 1.49 112.19 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.11 128.11 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.727 2.011 . . . . 2.1600000000000001 110.302 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.293 10.3 p -76.04 117.51 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.61 -1.306 . . . . 1.3700000000000001 113.464 -169.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -100.72 -47.05 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.9 1.28 . . . . 2.3900000000000001 112.928 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -154.97 153.81 31.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 2.77 112.203 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -131.87 143.53 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.936 1.294 . . . . 0.85999999999999999 109.868 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.3 tttt -141.38 146.92 37.23 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.081 0.771 . . . . 1.95 113.081 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 61.2 t -89.93 134.51 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.81999999999999995 111.717 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.9 tp -113.25 -22.82 10.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.136 1.774 . . . . 1.25 113.274 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 121.56 25.2 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.015 1.726 . . . . 1.8400000000000001 109.111 169.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -135.43 137.72 42.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.742 1.016 . . . . 3.5299999999999998 113.742 -171.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 5.0 m 61.32 -50.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.98 2.912 . . . . 3.4300000000000002 115.227 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -75.35 133.47 41.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.999 -1.111 . . . . 3.5800000000000001 107.999 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 64.34 -53.85 0.27 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.363 2.265 . . . . 5.3799999999999999 115.393 -168.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.74 154.57 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.299 1.44 . . . . 2.4900000000000002 111.79 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.6 m -121.86 153.42 38.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.013 1.325 . . . . 2.0099999999999998 113.954 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 31.9 p80 -50.05 -50.53 47.51 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.678 2.103 . . . . 4.1699999999999999 116.678 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -74.32 -28.78 61.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.483 1.038 . . . . 2.98 111.978 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.98 -37.51 67.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.8 -1.095 . . . . 3.23 112.007 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.13 -56.19 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 119.416 1.007 . . . . 0.90000000000000002 110.565 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.98 -28.63 69.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.448 -0.783 . . . . 0.84999999999999998 112.617 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.27 -46.75 63.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.937 0.717 . . . . 0.69999999999999996 112.937 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 27.6 pt -70.25 -28.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.968 1.258 . . . . 0.83999999999999997 113.372 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 63.1 t -70.55 -52.02 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.568 0.622 . . . . 0.84999999999999998 110.944 170.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.39 -30.37 73.34 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.369 -0.832 . . . . 0.68999999999999995 114.271 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 12.6 p -70.2 -44.1 69.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.761 1.281 . . . . 0.71999999999999997 112.85 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.66 -49.56 76.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.679 0.792 . . . . 0.92000000000000004 111.549 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -65.91 -22.68 66.52 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.568 -0.708 . . . . 2.0699999999999998 112.905 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 68.4 m -67.0 -38.52 86.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.735 1.214 . . . . 2.6299999999999999 114.116 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.3 t30 -95.42 -15.18 23.19 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.237 1.415 . . . . 2.5099999999999998 111.934 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 37.8 t -66.21 176.0 1.92 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.544 1.538 . . . . 1.48 109.928 165.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.2 46.87 1.72 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.263 -1.523 . . . . 3.6899999999999999 113.407 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -93.39 165.1 19.0 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.219 1.408 . . . . 1.6200000000000001 113.884 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.98 -26.07 0.96 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.593 2.862 . . . . 1.2 114.74 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.9 tt -110.62 -48.83 3.1 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.212 1.405 . . . . 0.94999999999999996 112.643 -168.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -56.9 -24.16 48.58 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 113.999 0.36 . . . . 0.96999999999999997 113.999 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 36.7 p -60.67 -17.38 47.31 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.724 1.379 . . . . 1.3799999999999999 114.724 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.09 86.1 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.418 1.008 . . . . 0.93000000000000005 111.396 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.6 mt -70.26 -39.52 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.553 1.141 . . . . 0.89000000000000001 110.192 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 79.8 m -52.58 -48.09 66.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.338 0.655 . . . . 1.1100000000000001 111.695 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 43.9 tttt -64.16 -49.7 71.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.313 0.645 . . . . 2.3199999999999998 112.279 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 11.2 t80 -53.89 -42.84 69.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 1.8 111.542 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.5 t -70.39 -53.74 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.213 1.405 . . . . 1.6599999999999999 112.031 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -58.17 -42.58 86.31 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.772 -1.205 . . . . 3.4399999999999999 111.816 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.31 -32.3 70.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.618 0.767 . . . . 3.6699999999999999 112.953 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.31 -48.41 65.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.319 1.048 . . . . 1.8899999999999999 111.781 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.47 -31.36 67.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 26.4 t0 53.39 29.5 8.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.335 1.854 . . . . 2.6499999999999999 113.622 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1102 ' ' THR . . . . . 0.448 HG23 ' H ' ' A' 1104 ' ' THR . 12.1 t -98.82 -21.53 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.36 1.615 . . . . 4.0300000000000002 115.36 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 6.4 tt0 52.62 20.15 1.43 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.824 2.157 . . . . 2.8799999999999999 116.824 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1104 ' ' THR . . . . . 0.448 ' H ' HG23 ' A' 1102 ' ' THR . 56.7 p -137.46 0.15 2.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.15 -1.594 . . . . 3.5699999999999998 114.844 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 157.69 36.74 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.112 -0.993 . . . . 1.0600000000000001 113.413 -169.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 84.4 130.76 2.06 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.528 0.971 . . . . 1.0900000000000001 115.528 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1107 ' ' THR . . . . . 0.409 HG22 ' H ' ' A' 1108 ' ' CYS . 0.5 OUTLIER -144.18 -170.02 3.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.209 2.604 . . . . 2.5800000000000001 108.603 -175.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1108 ' ' CYS . . . . . 0.409 ' H ' HG22 ' A' 1107 ' ' THR . 48.8 t -60.68 132.41 53.8 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.063 1.875 . . . . 1.72 116.063 -168.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.03 148.74 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.168 2.187 . . . . 2.96 116.057 169.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.5 143.8 26.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.465 -2.05 . . . . 2.96 105.465 161.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.85 132.3 54.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.645 1.578 . . . . 2.7799999999999998 112.451 -169.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.48 99.12 4.41 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.935 2.094 . . . . 3.1600000000000001 109.352 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 33.2 m -102.1 148.61 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.245 0.832 . . . . 2.46 113.245 -169.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 24.5 t -133.16 111.08 12.94 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.959 1.303 . . . . 1.25 107.773 168.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.66 134.74 62.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.892 2.394 . . . . 1.5900000000000001 113.519 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 59.93 26.22 62.82 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.465 1.507 . . . . 2.2400000000000002 115.924 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.0 t -146.52 -47.9 0.19 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.002 1.401 . . . . 1.99 114.257 -172.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.13 169.26 21.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.888 0.756 . . . . 0.88 113.445 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.84 162.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.673 -0.898 . . . . 2.6499999999999999 112.621 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 34.6 t -122.49 145.37 48.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.716 2.006 . . . . 0.55000000000000004 109.757 167.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.1 p -150.03 160.91 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.613 0.765 . . . . 0.73999999999999999 112.42 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -119.99 105.32 10.93 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.551 -0.718 . . . . 1.6000000000000001 109.135 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.9 p -104.45 138.28 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.052 1.341 . . . . 1.9199999999999999 112.191 -168.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 171.37 8.14 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.824 1.416 . . . . 1.3999999999999999 114.824 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.282 18.2 t-20 . . . . . 0 N--CA 1.477 0.893 1 C-N-CA 134.088 4.955 . . . . 2.8500000000000001 108.547 166.561 . . . . . . . . 2 1 . 1 . 003 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 115.113 1.523 . . . . 2.54 115.113 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 123.94 30.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.848 1.659 . . . . 3.4700000000000002 111.067 -170.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.28 123.16 26.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.946 0.794 . . . . 1.6000000000000001 110.615 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -134.67 133.67 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.359 1.064 . . . . 0.56999999999999995 111.104 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.18 147.51 41.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.605 1.162 . . . . 0.40000000000000002 113.01 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.7 tt -149.58 141.35 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.895 1.278 . . . . 0.47999999999999998 110.77 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.82 -155.25 26.05 Favored Glycine 0 CA--C 1.532 1.133 0 N-CA-C 115.411 0.924 . . . . 1.4099999999999999 115.411 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -71.41 160.42 32.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.621 1.568 . . . . 3.48 111.59 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -59.13 -16.84 21.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.762 1.225 . . . . 6.3099999999999996 114.066 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -57.74 -36.0 71.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.683 0.793 . . . . 4.7800000000000002 112.256 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 5.3 m95 -74.35 -47.57 33.46 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.13 0.972 . . . . 3.3999999999999999 112.156 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -29.06 68.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.478 0.711 . . . . 2.1200000000000001 112.164 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.33 -66.89 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.156 2.182 . . . . 2.4199999999999999 108.127 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -23.38 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.536 1.935 . . . . 8.3100000000000005 115.953 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.66 14.62 31.43 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 120.349 1.431 . . . . 0.82999999999999996 114.163 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.81 17.88 67.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.249 1.404 . . . . 1.1899999999999999 116.517 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.16 155.48 28.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.405 1.103 . . . . 1.25 111.533 -170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 92.3 t -91.94 127.95 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.485 0.714 . . . . 1.6000000000000001 110.189 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 13.8 tt -112.97 152.44 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.003 1.321 . . . . 1.55 111.954 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.46 156.64 20.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.571 1.693 . . . . 2.9100000000000001 115.571 -168.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.4 t30 -68.66 -37.26 79.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.533 1.133 . . . . 3.0299999999999998 113.914 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.29 -33.61 69.89 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.93 -1.106 . . . . 2.9100000000000001 112.305 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -76.27 -37.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.227 -0.921 . . . . 1.23 112.196 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.59 -35.37 77.67 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.125 0.875 . . . . 2.75 112.075 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.03 -40.29 84.6 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.947 1.092 . . . . 2.7200000000000002 113.947 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.57 -44.99 48.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.073 0.949 . . . . 2.9100000000000001 112.319 171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 47.8 tpp -59.85 -56.27 23.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.39 1.076 . . . . 0.88 111.681 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.8 t -66.54 -30.65 71.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.522 -0.736 . . . . 1.4299999999999999 112.52 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -62.4 -45.79 91.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.401 1.08 . . . . 3.52 111.391 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -67.53 -39.09 85.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.081 1.353 . . . . 3.9399999999999999 112.071 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.11 -45.26 92.83 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.626 -0.671 . . . . 3.8700000000000001 112.158 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.52 -21.14 62.77 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.936 -1.102 . . . . 5.1799999999999997 113.309 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.266 14.2 ptpt -85.23 7.62 21.37 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.934 1.457 . . . . 3.2599999999999998 114.934 167.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 72.2 21.21 79.34 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.785 1.074 . . . . 2.0099999999999998 115.785 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -110.42 144.08 39.74 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.121 1.461 . . . . 4.7699999999999996 110.39 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 52.5 m -61.35 124.31 20.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.80000000000000004 112.44 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.06 125.43 37.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.756 1.222 . . . . 0.68000000000000005 110.174 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.6 m -141.99 159.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.709 1.204 . . . . 0.52000000000000002 113.536 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.2 mt -111.61 158.3 19.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.634 1.974 . . . . 1.3100000000000001 111.559 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.7 p -139.47 128.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.076 0.951 . . . . 1.95 112.665 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.6 153.06 48.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.381 2.272 . . . . 0.52000000000000002 111.008 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 10.5 m -144.09 136.13 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.252 -0.905 . . . . 0.97999999999999998 112.098 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 33.3 t70 41.74 50.88 4.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.004 1.721 . . . . 2.9900000000000002 112.207 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.26 6.0 m-20 66.19 21.59 11.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.385 1.994 . . . . 1.54 116.385 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -126.71 151.04 48.68 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.015 2.126 . . . . 2.48 110.147 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.18 143.08 41.32 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.769 -1.832 . . . . 0.75 111.795 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 17.5 p -118.72 -38.84 3.05 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.422 1.267 . . . . 0.68000000000000005 114.422 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.73 -172.94 37.53 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 119.389 0.995 . . . . 0.57999999999999996 114.588 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.7 151.59 41.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.716 1.606 . . . . 0.84999999999999998 112.838 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.34 137.0 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.944 1.697 . . . . 0.83999999999999997 109.962 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -123.7 135.06 53.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.653 1.581 . . . . 0.66000000000000003 110.951 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 32.5 mt -140.41 153.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.463 1.905 . . . . 1.5800000000000001 110.403 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 125.026 1.33 . . . . 1.4299999999999999 109.918 168.714 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 115.235 1.569 . . . . 3.3599999999999999 115.235 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -84.04 94.51 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.532 2.821 . . . . 1.8799999999999999 112.008 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 82.2 t -89.96 108.86 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.883 -1.135 . . . . 2.8300000000000001 109.767 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.1 p -72.38 129.44 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.745 -1.222 . . . . 1.71 111.968 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.14 -50.7 2.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.177 1.547 . . . . 2.7000000000000002 115.177 -167.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -149.64 149.74 31.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.142 0.883 . . . . 2.77 112.609 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -129.67 145.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.876 1.27 . . . . 0.96999999999999997 110.904 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.9 tttt -141.66 138.86 32.79 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.155 0.982 . . . . 1.8899999999999999 113.433 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 94.3 t -82.93 134.5 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.951 0.9 . . . . 0.69999999999999996 110.71 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 20.0 tp -107.22 -32.31 7.85 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.096 1.358 . . . . 1.4299999999999999 112.966 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 51.9 m -118.03 99.11 6.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.729 1.212 . . . . 1.8300000000000001 108.234 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 141.47 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.284 1.034 . . . . 3.4900000000000002 110.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.7 m 52.52 29.24 6.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.958 1.836 . . . . 2.6499999999999999 115.958 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -137.91 -17.51 1.24 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.106 1.151 . . . . 2.9199999999999999 114.106 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.5 -49.3 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.166 1.348 . . . . 4.71 114.41 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.96 142.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.52 1.528 . . . . 1.47 111.25 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 14.5 m -87.53 147.93 25.12 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.335 1.054 . . . . 2.1200000000000001 112.287 170.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.1 p80 -53.5 -38.89 64.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.45 1.648 . . . . 3.1600000000000001 115.45 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 23.8 t60 -66.79 -37.19 84.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.609 1.095 . . . . 3.4900000000000002 111.869 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -65.68 -36.29 83.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 118.228 -0.891 . . . . 3.3599999999999999 111.259 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.11 -54.35 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 118.947 0.794 . . . . 0.55000000000000004 111.189 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.51 -33.88 76.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.877 0.762 . . . . 0.55000000000000004 111.881 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.39 57.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.63 -0.7 . . . . 0.58999999999999997 112.143 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 6.0 pt -69.48 -27.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 119.642 1.11 . . . . 0.62 113.748 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 77.5 t -70.68 -43.39 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.237 0.926 . . . . 0.69999999999999996 110.415 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.34 -37.42 93.87 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.127 -0.818 . . . . 0.68000000000000005 113.282 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.6 p -73.88 -37.62 64.67 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.353 1.576 . . . . 0.96999999999999997 112.636 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.68 88.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.961 0.801 . . . . 0.78000000000000003 112.896 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1081 ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' 1084 ' ' SER 0.254 3.4 tp10 -75.75 -20.92 57.95 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.196 0.813 . . . . 3.3799999999999999 113.196 175.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 26.3 t -57.7 -47.46 82.32 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.075 -1.64 . . . . 1.3100000000000001 112.743 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -77.33 -2.94 37.46 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 121.222 -0.924 . . . . 2.1400000000000001 112.689 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1084 ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' 1081 ' ' GLU . 20.0 m -111.12 -178.6 3.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.584 2.354 . . . . 2.4100000000000001 111.494 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.03 51.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.135 -0.978 . . . . 4.1699999999999999 113.55 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.68 147.41 86.77 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.042 . . . . 1.5600000000000001 113.688 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.83 -36.51 90.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.172 3.248 . . . . 1.55 114.028 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.03 -47.49 4.98 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.787 2.035 . . . . 1.25 110.874 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -33.01 78.98 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 114.583 0.593 . . . . 1.1699999999999999 114.583 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 3.9 t -66.0 -16.02 63.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.126 1.463 . . . . 2.9500000000000002 114.458 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -73.63 -27.16 61.13 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.089 -1.007 . . . . 1.4399999999999999 112.922 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.5 -41.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.878 0.871 . . . . 1.1399999999999999 109.199 171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.7 m -51.62 -43.97 62.75 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.757 0.708 . . . . 1.27 111.289 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.1 tttt -63.82 -51.78 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.913 0.778 . . . . 2.4300000000000002 112.936 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.41 -47.2 66.43 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 2.3100000000000001 111.105 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 98.3 m -69.07 -52.48 28.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.023 1.329 . . . . 2.9399999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -49.49 -48.34 47.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.06 1.344 . . . . 3.6600000000000001 111.642 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -71.62 -35.91 70.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.844 0.857 . . . . 2.6499999999999999 112.905 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -70.33 -35.75 73.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.5 -1.375 . . . . 2.1800000000000002 113.448 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.86 -6.38 37.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.285 1.034 . . . . 1.3400000000000001 113.751 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.8 t0 54.91 40.07 31.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.239 1.416 . . . . 3.3900000000000001 112.472 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.6 t -131.38 174.12 10.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.518 1.527 . . . . 2.5800000000000001 111.508 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -114.87 -3.67 12.71 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.337 1.455 . . . . 2.9500000000000002 112.4 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 8.1 t -148.76 142.6 25.69 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.337 1.455 . . . . 2.98 111.69 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.69 145.87 20.38 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.974 0.91 . . . . 0.85999999999999999 112.322 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 83.18 135.75 2.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.074 1.321 . . . . 1.0800000000000001 114.458 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 54.9 m -105.72 -64.77 1.11 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.041 1.336 . . . . 1.6499999999999999 111.118 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -137.85 131.67 31.42 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.308 0.575 . . . . 1.7 110.595 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 30.3 mm -143.54 142.29 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.801 4.441 . . . . 3.4700000000000002 102.797 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.12 106.25 5.47 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 120.895 -1.128 . . . . 4.4800000000000004 111.442 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -100.62 145.67 28.09 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 118.038 2.607 . . . . 2.4399999999999999 118.038 -166.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.16 104.65 7.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 130.843 3.657 . . . . 2.7799999999999998 106.68 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 91.5 t -99.03 139.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.309 1.044 . . . . 2.0600000000000001 110.932 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 43.4 t -126.48 101.3 27.77 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.021 1.328 . . . . 1.1499999999999999 109.257 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.01 130.8 32.84 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.039 3.159 . . . . 1.3999999999999999 114.978 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 75.75 -37.68 1.25 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.031 2.253 . . . . 1.9099999999999999 114.412 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 60.4 m -82.19 -48.28 11.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.052 1.426 . . . . 2.1899999999999999 113.938 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 159.43 -178.0 35.73 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.835 0.743 . . . . 0.78000000000000003 113.387 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.12 157.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.661 0.615 . . . . 2.5499999999999998 112.661 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -131.68 151.6 51.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.997 1.719 . . . . 0.47999999999999998 110.871 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -153.8 166.26 33.43 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.842 -1.161 . . . . 0.67000000000000004 114.003 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -110.71 136.72 49.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.253 -1.017 . . . . 1.1899999999999999 108.253 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 80.1 t -128.95 139.44 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.458 1.103 . . . . 2.2999999999999998 111.877 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.8 t -146.6 152.82 39.54 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.789 2.144 . . . . 1.4399999999999999 116.789 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.305 24.7 t-20 . . . . . 0 CA--C 1.539 0.549 1 C-N-CA 132.582 4.353 . . . . 3.9199999999999999 106.207 158.061 . . . . . . . . 2 1 . 1 . 004 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.298 0.571 . . . . 2.3100000000000001 112.37 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.75 143.63 32.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.488 1.515 . . . . 2.6400000000000001 111.398 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -110.87 115.74 30.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.698 1.599 . . . . 1.6699999999999999 108.656 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.8 m -133.76 142.35 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 119.979 1.263 . . . . 0.69999999999999996 112.829 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 150.89 39.7 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.648 0.981 . . . . 0.39000000000000001 113.648 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.2 tt -141.29 135.24 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.428 1.891 . . . . 0.63 109.799 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.08 -167.9 40.93 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.582 1.393 . . . . 1.4199999999999999 116.582 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -76.08 166.1 23.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.046 1.738 . . . . 3.02 114.523 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -50.78 -45.32 59.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.904 2.187 . . . . 5.4000000000000004 116.904 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.27 -31.89 58.51 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.152 1.796 . . . . 3.4700000000000002 112.003 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -64.0 -35.87 82.13 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.958 -1.089 . . . . 2.98 112.239 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.44 83.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.075 1.139 . . . . 2.0600000000000001 114.075 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.0 mt -54.94 -60.06 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.506 1.122 . . . . 1.72 109.047 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -49.57 -19.35 0.57 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.59 2.07 . . . . 5.7800000000000002 116.59 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.82 11.57 4.8 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 121.632 2.014 . . . . 0.72999999999999998 112.593 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.71 35.59 85.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 119.868 -1.77 . . . . 0.78000000000000003 113.966 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.18 153.45 19.59 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.535 1.167 . . . . 0.81000000000000005 111.435 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -84.53 132.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.804 -0.56 . . . . 0.97999999999999998 109.554 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.67 140.05 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.676 1.19 . . . . 0.97999999999999998 110.862 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -116.06 167.85 10.61 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.987 1.477 . . . . 2.9900000000000002 114.987 -167.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.05 -45.98 69.01 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.15 1.537 . . . . 3.0 115.15 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.34 -26.91 64.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.068 -1.02 . . . . 2.3900000000000001 112.021 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -78.56 -38.62 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 117.748 -1.12 . . . . 0.69999999999999996 112.481 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.69 -41.56 91.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.902 1.683 . . . . 2.04 110.884 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.18 -40.96 91.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.417 1.487 . . . . 2.3900000000000001 113.305 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 52.1 t80 -72.11 -40.93 67.79 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.187 0.995 . . . . 2.2200000000000002 112.523 174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 46.2 tpp -59.96 -57.53 12.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.01 1.724 . . . . 0.81999999999999995 110.104 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.2 t -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.903 0.881 . . . . 1.1200000000000001 111.971 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.11 -54.75 42.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.233 1.013 . . . . 2.5 111.776 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.29 -34.19 70.42 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.498 0.925 . . . . 2.9300000000000002 113.498 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -59.35 -49.92 75.95 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.223 -0.923 . . . . 3.2799999999999998 110.764 170.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -72.76 -14.86 61.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.936 -1.103 . . . . 4.8399999999999999 113.957 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 16.7 mttp -75.79 -6.23 49.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.099 1.76 . . . . 2.7599999999999998 112.367 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 86.2 24.59 39.94 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.231 1.396 . . . . 1.28 114.071 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.74 163.06 13.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.372 1.469 . . . . 4.21 110.302 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 14.0 m -76.2 133.19 40.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.93000000000000005 110.195 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -137.12 116.63 12.84 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.105 1.362 . . . . 0.46000000000000002 111.138 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 25.9 m -140.22 156.83 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.191 1.396 . . . . 0.48999999999999999 112.784 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.92 162.88 14.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.901 1.681 . . . . 0.93000000000000005 112.293 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.6 p -135.65 126.98 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.655 1.582 . . . . 2.4399999999999999 112.456 172.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.86 157.0 38.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.436 1.894 . . . . 0.40999999999999998 111.75 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 133.21 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.413 1.485 . . . . 0.85999999999999999 112.292 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 40.16 45.42 1.71 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.385 2.274 . . . . 2.7599999999999998 113.428 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 12.3 m-20 64.79 39.79 5.97 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.713 2.405 . . . . 1.5600000000000001 116.115 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -146.69 146.4 30.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.148 2.179 . . . . 2.29 110.176 169.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.23 147.81 42.13 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 119.498 -2.001 . . . . 0.81000000000000005 112.964 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.0 p -124.83 -38.52 2.35 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.02 1.489 . . . . 0.52000000000000002 115.02 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -163.34 179.92 38.18 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 120.7 1.591 . . . . 0.46999999999999997 115.875 -173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.58 155.62 43.73 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.86 1.664 . . . . 0.79000000000000004 113.502 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.9 mm -130.93 141.92 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.585 1.954 . . . . 0.92000000000000004 110.247 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -122.87 131.2 53.64 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.349 1.46 . . . . 0.56999999999999995 111.59 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 8.4 mt -135.83 145.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.967 1.707 . . . . 1.53 109.789 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.921 0 C-N-CA 125.505 1.522 . . . . 1.3899999999999999 112.884 -174.242 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 115.274 1.583 . . . . 2.48 115.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.31 166.69 7.13 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.739 2.293 . . . . 1.46 110.486 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 11.7 p -135.47 130.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.969 -1.082 . . . . 2.1600000000000001 111.28 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -66.59 135.01 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.14 -0.975 . . . . 1.4399999999999999 111.507 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.88 -33.67 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.227 0.825 . . . . 2.1899999999999999 113.227 -172.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -159.2 143.87 15.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.296 0.953 . . . . 2.3700000000000001 112.113 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -114.66 134.27 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.686 0.795 . . . . 0.93999999999999995 109.15 167.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.5 tttt -140.71 145.1 36.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.291 0.849 . . . . 2.8500000000000001 113.291 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.3 t -101.5 129.82 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.386 1.474 . . . . 1.0 111.169 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.05 -25.0 11.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.017 1.727 . . . . 1.01 112.45 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 34.4 m -137.0 130.72 31.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.454 1.501 . . . . 1.8999999999999999 110.492 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.25 144.52 40.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.009 1.324 . . . . 6.2000000000000002 110.918 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 61.9 m 54.55 13.13 0.62 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.254 2.221 . . . . 2.9100000000000001 115.839 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -137.53 13.63 2.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.717 2.407 . . . . 2.7200000000000002 112.433 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -163.46 -58.42 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.298 1.439 . . . . 5.0199999999999996 110.679 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.48 159.76 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 129.768 3.227 . . . . 1.8600000000000001 108.006 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 39.7 m -106.6 155.6 19.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.842 1.257 . . . . 1.8200000000000001 113.68 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.83 -41.36 57.53 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.706 2.484 . . . . 3.4399999999999999 117.706 -167.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.97 -28.05 54.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.971 1.26 . . . . 2.5899999999999999 111.406 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1072 ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' 1072 ' ' LYS . 9.7 mmpt? -70.36 -34.63 72.85 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 116.917 -1.516 . . . . 5.3200000000000003 111.933 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 63.3 mt -56.81 -53.68 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.662 1.574 . . . . 0.60999999999999999 110.547 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.53 -30.76 71.15 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.4 -0.812 . . . . 0.59999999999999998 112.323 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.03 60.84 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.52000000000000002 112.231 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.7 pt -69.98 -35.09 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.508 -1.37 . . . . 0.52000000000000002 112.682 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.0 t -71.01 -43.52 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.096 0.862 . . . . 0.56999999999999995 111.71 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.96 -35.7 79.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.849 -1.157 . . . . 0.56999999999999995 113.492 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 73.8 p -73.96 -25.31 59.87 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.51 -0.994 . . . . 0.76000000000000001 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.27 -55.49 15.87 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.538 0.735 . . . . 0.66000000000000003 110.98 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.07 -20.85 63.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.133 0.79 . . . . 2.1299999999999999 113.133 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 24.8 t -55.39 -33.18 63.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.72 -1.238 . . . . 1.3100000000000001 112.87 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -85.73 -8.57 58.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.051 0.941 . . . . 2.25 113.361 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 5.0 t -99.35 -179.64 4.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.797 1.639 . . . . 1.5 113.754 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -137.5 8.86 2.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.353 2.261 . . . . 3.9100000000000001 113.962 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -87.33 150.01 48.23 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.779 1.232 . . . . 1.78 113.906 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.17 -28.65 40.42 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.466 3.444 . . . . 1.1000000000000001 115.47 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.11 -46.94 4.12 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.182 0.993 . . . . 0.87 112.576 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.84 -30.11 76.76 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 113.938 0.335 . . . . 0.87 113.938 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 21.3 p -63.69 -17.74 63.27 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.947 -1.325 . . . . 1.3200000000000001 114.248 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.13 85.8 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.136 -0.978 . . . . 1.01 111.71 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 15.1 mt -73.29 -36.4 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.824 1.65 . . . . 0.93999999999999995 110.573 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 21.5 m -51.44 -47.34 63.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.904 0.775 . . . . 1.1200000000000001 111.546 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.68 -49.81 75.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.035 0.934 . . . . 2.1099999999999999 112.574 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.62 -40.0 74.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.563 0.745 . . . . 1.73 111.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 28.3 t -71.66 -52.53 17.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.38 1.472 . . . . 1.78 112.591 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -51.87 -44.16 63.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.751 1.62 . . . . 3.1000000000000001 112.588 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -69.84 -34.05 73.12 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.602 0.761 . . . . 3.5800000000000001 112.591 175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.91 -47.77 67.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.413 1.006 . . . . 2.96 112.977 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.91 -32.54 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.78 0.832 . . . . 1.1100000000000001 112.48 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 1.7 t70 54.94 54.39 9.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.747 2.019 . . . . 2.7599999999999998 112.009 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.3 t -148.37 142.99 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.125 -0.984 . . . . 2.7599999999999998 113.193 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -98.0 21.88 10.11 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.042 1.337 . . . . 3.0 112.707 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 43.1 p -131.23 4.23 4.37 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.024 1.861 . . . . 2.8900000000000001 116.024 -168.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 139.4 57.75 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.689 1.366 . . . . 0.82999999999999996 114.689 -167.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 70.38 171.77 10.34 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.42 1.009 . . . . 1.1200000000000001 115.363 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 4.6 m -157.24 -40.49 0.07 Allowed 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.398 -1.06 . . . . 1.3999999999999999 112.809 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.11 143.54 48.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.517 1.127 . . . . 1.3400000000000001 113.125 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.2 129.01 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 127.408 2.283 . . . . 2.5800000000000001 109.097 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -25.71 32.14 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.983 1.105 . . . . 3.6000000000000001 113.983 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 34.0 t80 60.7 130.49 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 128.613 2.765 . . . . 3.8100000000000001 114.864 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1112 ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' 1112 ' ' GLN . 1.0 OUTLIER -149.69 106.89 3.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.613 1.965 . . . . 2.1200000000000001 108.318 169.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 9.8 p -106.43 144.44 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.801 0.728 . . . . 2.6899999999999999 112.744 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 59.2 t -129.25 102.8 18.46 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.196 -1.409 . . . . 1.3200000000000001 107.196 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.89 136.54 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.276 2.651 . . . . 1.6599999999999999 113.512 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.79 20.58 77.62 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.42 1.01 . . . . 2.1400000000000001 114.17 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 21.5 t -145.02 -50.85 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.777 1.231 . . . . 2.3300000000000001 112.826 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 137.33 -153.3 21.87 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 119.524 1.056 . . . . 0.83999999999999997 114.643 174.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.3 mm -120.65 147.79 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.738 1.615 . . . . 2.5899999999999999 112.175 -172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.5 t -133.63 148.26 51.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.502 1.921 . . . . 0.71999999999999997 109.303 165.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.0 p -167.34 177.5 6.04 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.428 -1.42 . . . . 0.76000000000000001 114.072 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 137.64 53.78 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 105.965 -1.865 . . . . 3.7999999999999998 105.965 165.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 29.6 m -132.48 154.51 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.835 0.854 . . . . 2.2599999999999998 113.053 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.0 t -161.55 165.39 28.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.264 1.579 . . . . 1.8100000000000001 115.264 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.548 0.878 1 C-N-CA 132.888 4.475 . . . . 2.4199999999999999 108.144 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 114.478 1.288 . . . . 2.8799999999999999 114.478 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -135.92 126.82 27.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.833 1.653 . . . . 3.1099999999999999 109.514 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.1 tttt -84.84 120.39 26.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.327 -0.99 . . . . 1.1399999999999999 108.327 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.8 m -135.26 141.15 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.56 1.073 . . . . 0.57999999999999996 112.469 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.58 152.88 41.17 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 0.45000000000000001 112.92 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.1 tt -153.01 136.77 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.51000000000000001 110.991 -171.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 150.4 -141.89 9.15 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.252 1.261 . . . . 1.3200000000000001 116.252 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.63 152.14 0.23 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.312 2.645 . . . . 2.3300000000000001 113.509 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -57.49 -28.72 63.66 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.244 -0.91 . . . . 4.6100000000000003 112.529 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.35 -31.83 70.69 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.815 1.188 . . . . 4.4900000000000002 113.941 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.1 m95 -63.86 -27.04 68.89 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.281 1.401 . . . . 3.6899999999999999 112.716 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -71.54 -38.85 70.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.092 0.557 . . . . 2.5299999999999998 111.161 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.57 -70.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.12 1.368 . . . . 2.4900000000000002 109.016 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -40.26 -46.91 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.454 2.301 . . . . 5.4900000000000002 114.495 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.0 t30 -81.71 9.11 8.37 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.965 1.098 . . . . 0.97999999999999998 113.965 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.74 20.83 79.35 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 120.759 -1.213 . . . . 0.89000000000000001 114.791 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.1 mt -89.08 166.62 13.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.247 1.019 . . . . 1.28 109.868 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.2 t -124.9 112.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.859 1.264 . . . . 2.21 109.581 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.2 tt -87.57 147.98 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.569 1.548 . . . . 1.52 111.365 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -116.32 177.6 4.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.63 1.172 . . . . 3.5800000000000001 113.181 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -72.09 -33.42 67.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.282 1.956 . . . . 3.02 116.282 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.08 -31.05 25.53 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.127 1.331 . . . . 3.2400000000000002 113.445 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.2 p -67.08 -41.14 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 117.991 -1.004 . . . . 1.1799999999999999 110.428 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.95 -34.5 76.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.384 1.447 . . . . 2.6499999999999999 112.157 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.6 -42.13 99.39 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.015 0.926 . . . . 2.25 113.3 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -66.73 -40.94 88.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.162 1.385 . . . . 2.1899999999999999 112.105 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 20.3 ttm -63.61 -56.26 17.24 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.369 1.068 . . . . 1.1699999999999999 109.983 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.2 t -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.629 0.772 . . . . 1.02 112.673 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.45 -51.73 67.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.836 -1.165 . . . . 3.5600000000000001 112.297 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -70.97 -31.09 67.54 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.396 0.887 . . . . 3.8300000000000001 113.396 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -65.07 -34.08 77.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.755 -1.216 . . . . 3.6899999999999999 111.853 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -70.92 -29.9 66.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.912 1.285 . . . . 3.7400000000000002 113.268 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 2.2 mttp -71.54 3.17 4.14 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.996 1.318 . . . . 3.2400000000000002 113.439 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.77 20.52 55.81 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.732 1.158 . . . . 1.8999999999999999 114.897 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.55 158.29 17.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.337 1.455 . . . . 3.3500000000000001 111.482 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.0 m -81.41 137.27 35.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.844 2.058 . . . . 0.91000000000000003 110.285 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -138.69 124.77 20.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.886 0.874 . . . . 0.45000000000000001 112.686 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 31.1 m -140.99 158.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 125.936 1.694 . . . . 0.54000000000000004 112.887 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.54 164.26 12.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.86 1.264 . . . . 0.70999999999999996 113.311 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 14.4 t -136.55 118.1 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.428 1.891 . . . . 1.8899999999999999 111.124 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -119.14 155.08 32.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.195 1.398 . . . . 0.44 112.018 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.81 132.45 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.309 1.844 . . . . 0.87 112.218 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 71.1 m-20 40.22 47.94 2.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.882 2.073 . . . . 3.4700000000000002 112.845 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.263 27.9 m-20 60.05 34.74 21.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.484 2.313 . . . . 1.5600000000000001 116.383 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -145.13 149.17 34.53 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.578 -1.326 . . . . 2.79 112.651 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.43 142.48 58.16 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.319 -1.488 . . . . 0.66000000000000003 113.512 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.9 p -125.74 -34.03 2.67 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.897 1.444 . . . . 0.56000000000000005 114.897 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.69 -176.15 38.11 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-N 120.964 1.711 . . . . 0.51000000000000001 115.876 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.64 153.61 42.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.839 1.656 . . . . 0.69999999999999996 113.292 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 22.0 mm -123.6 134.39 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.567 1.547 . . . . 0.89000000000000001 110.058 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -117.23 133.01 56.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.328 1.851 . . . . 0.58999999999999997 109.549 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -139.31 147.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.006 1.723 . . . . 1.3700000000000001 111.974 -167.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 124.621 1.168 . . . . 1.3600000000000001 112.204 171.665 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.932 1.086 . . . . 2.79 113.932 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -85.87 153.8 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.09 3.193 . . . . 2.1400000000000001 113.637 -173.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 4.7 m -139.17 126.52 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 126.113 1.765 . . . . 3.0899999999999999 110.475 171.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -72.09 142.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.756 -1.215 . . . . 1.3999999999999999 110.008 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.9 -42.57 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.339 0.866 . . . . 2.52 113.339 -168.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -153.59 147.19 25.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.749 0.704 . . . . 2.3100000000000001 112.073 172.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 2.5 m -130.69 136.13 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.263 1.025 . . . . 0.73999999999999999 111.043 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 60.9 tttt -138.23 147.83 44.14 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.776 0.831 . . . . 1.74 112.357 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.2 t -91.18 137.64 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.561 1.145 . . . . 0.66000000000000003 111.374 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1062 ' ' LEU . . . . . 0.704 HD23 HD22 ' A' 1222 ' ' LEU . 24.7 tp -107.04 -22.98 12.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.253 1.821 . . . . 0.91000000000000003 112.753 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 5.0 t -100.03 27.76 5.32 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.512 1.525 . . . . 2.3100000000000001 113.782 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.82 125.02 21.78 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.695 -1.253 . . . . 4.1799999999999997 111.538 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 58.6 m 43.65 41.0 3.25 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.808 2.043 . . . . 4.21 113.931 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -133.04 -29.25 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.028 1.331 . . . . 4.1200000000000001 113.594 172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -146.0 -55.7 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.661 1.726 . . . . 5.5099999999999998 115.661 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 19.7 mt -135.53 144.04 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.991 1.316 . . . . 1.78 110.89 -169.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 50.9 m -98.42 158.62 15.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.641 1.576 . . . . 2.1699999999999999 113.357 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -55.5 -38.0 68.6 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.11 1.522 . . . . 3.1000000000000001 115.11 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 29.2 t60 -75.03 -37.38 61.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.506 1.048 . . . . 2.5899999999999999 112.165 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.5 mttt -65.99 -40.78 91.46 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.137 0.881 . . . . 3.0 111.637 169.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.2 mt -57.75 -52.43 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.826 0.739 . . . . 0.54000000000000004 110.932 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.13 -29.76 69.57 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.198 -0.938 . . . . 0.47999999999999998 112.373 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.01 19.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.092 0.557 . . . . 0.46999999999999997 111.959 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.64 -35.25 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 120.235 1.38 . . . . 0.57999999999999996 113.055 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 46.0 t -70.81 -46.06 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.342 -0.849 . . . . 0.73999999999999999 111.356 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -71.93 -28.58 68.45 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.97 -1.081 . . . . 0.65000000000000002 114.335 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 62.8 p -76.42 -32.71 58.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.369 1.067 . . . . 0.67000000000000004 112.398 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.37 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.053 0.842 . . . . 0.66000000000000003 112.323 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -66.36 -17.07 64.55 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.56 0.948 . . . . 2.23 113.56 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 16.1 p -67.25 -15.62 63.8 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.126 -1.608 . . . . 1.5800000000000001 114.463 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -94.76 -18.51 21.18 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.377 1.071 . . . . 1.8799999999999999 112.565 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 4.4 t -77.48 164.43 25.44 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.526 1.306 . . . . 1.8700000000000001 114.526 -169.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.12 23.5 4.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.881 2.073 . . . . 3.4100000000000001 112.259 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -85.68 160.8 52.51 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.738 1.215 . . . . 1.8200000000000001 113.136 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -81.51 1.52 9.2 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.58 3.52 . . . . 2.6099999999999999 115.425 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -141.12 -48.09 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.938 1.295 . . . . 0.93000000000000005 112.055 -167.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.15 -23.2 65.9 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.894 1.117 . . . . 0.90000000000000002 115.894 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 23.7 p -58.0 -25.68 61.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.16 -1.2 . . . . 1.5900000000000001 113.324 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.9 85.84 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.316 0.858 . . . . 0.91000000000000003 113.316 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.53 -41.66 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 110.898 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 8.9 t -64.0 -39.13 93.43 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 118.278 -0.867 . . . . 2.1800000000000002 112.204 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 23.5 tttp -60.14 -50.55 73.23 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.529 1.059 . . . . 3.1400000000000001 112.785 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.47 -44.73 55.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.574 1.149 . . . . 2.4300000000000002 112.184 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 35.6 t -69.68 -52.38 26.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.592 1.157 . . . . 1.72 112.416 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 14.9 tptm -49.96 -39.39 40.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.183 1.793 . . . . 2.4500000000000002 112.545 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.87 -40.37 65.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.718 1.207 . . . . 3.0800000000000001 113.99 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -70.53 -34.62 72.5 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.061 -1.649 . . . . 2.0699999999999998 113.298 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.01 -7.92 54.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.225 1.41 . . . . 1.0900000000000001 114.421 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 40.3 m-20 53.53 29.99 9.96 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.152 1.381 . . . . 4.6100000000000003 114.094 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -123.4 176.33 6.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.141 1.776 . . . . 2.7200000000000002 112.557 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -115.44 -2.97 12.45 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.263 1.425 . . . . 2.6699999999999999 113.716 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.0 t -143.97 125.08 14.47 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.777 -1.202 . . . . 3.0699999999999998 112.443 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.24 144.89 29.21 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.38 1.472 . . . . 0.93000000000000005 110.722 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 68.66 179.38 19.35 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 120.687 -1.258 . . . . 1.0800000000000001 114.201 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.7 m -158.2 -62.54 0.08 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.15 1.38 . . . . 1.6299999999999999 112.911 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.2 t -136.06 142.23 44.35 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.835 1.198 . . . . 1.8899999999999999 112.382 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 6.0 mm -143.17 150.17 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 1 C-N-CA 133.085 4.554 . . . . 2.0899999999999999 107.533 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -7.81 12.34 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.043 1.868 . . . . 3.0499999999999998 116.043 -173.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 65.9 m-85 43.94 109.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 129.396 3.079 . . . . 3.5600000000000001 118.773 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.37 94.27 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.879 2.072 . . . . 2.3300000000000001 106.213 166.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 19.2 m -103.21 146.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.276 1.03 . . . . 2.52 113.302 -168.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.3 t -138.61 124.61 12.53 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.414 1.486 . . . . 0.94999999999999996 109.231 171.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.35 146.31 39.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.976 3.117 . . . . 1.6200000000000001 112.994 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 53.27 32.57 44.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.39 0.995 . . . . 1.6100000000000001 113.396 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 53.9 t -150.01 -81.74 0.11 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.548 1.539 . . . . 1.76 111.655 -168.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 178.12 171.01 41.03 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 121.341 -0.849 . . . . 1.0900000000000001 112.838 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.36 157.16 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 117.373 0.586 . . . . 2.6400000000000001 112.124 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 20.1 t -130.89 157.31 43.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.025 1.73 . . . . 0.60999999999999999 111.077 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 27.6 p -162.8 167.44 22.87 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.424 0.898 . . . . 0.56999999999999995 113.424 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -112.24 119.85 39.74 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.227 1.011 . . . . 1.1899999999999999 108.853 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.2 p -111.67 139.08 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.944 0.72 . . . . 2.0 112.944 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -128.47 151.44 49.4 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 122.363 1.078 . . . . 1.53 111.75 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 130.171 3.388 . . . . 2.7799999999999998 104.807 159.609 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 2.46 114.256 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.89 149.87 23.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.635 1.974 . . . . 3.98 110.57 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -104.74 119.04 38.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.779 0.831 . . . . 1.78 111.572 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 11.1 m -133.84 141.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.995 0.739 . . . . 0.56999999999999995 112.995 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.03 153.54 42.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 0.67000000000000004 113.457 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 3.4 tt -150.09 143.46 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.101 1.36 . . . . 0.69999999999999996 108.919 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 161.13 -160.85 32.47 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 117.789 1.876 . . . . 1.3600000000000001 117.789 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.05 155.97 0.58 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.105 3.362 . . . . 2.4399999999999999 113.889 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -55.22 -49.93 70.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.308 1.043 . . . . 4.7199999999999998 113.558 169.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -63.23 -35.38 80.13 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 3.1400000000000001 112.214 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -67.42 -25.37 65.89 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.581 1.553 . . . . 4.1399999999999997 113.552 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 23.1 mmt -77.06 -37.63 54.25 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.118 1.155 . . . . 2.1899999999999999 114.118 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 73.8 mt -53.11 -63.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.382 1.073 . . . . 1.76 108.516 168.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -40.89 -34.43 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.45 2.7 . . . . 6.4500000000000002 116.348 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.16 9.14 2.7 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 121.458 1.935 . . . . 0.93000000000000005 112.933 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.72 27.41 73.87 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 119.804 -1.81 . . . . 1.0 113.891 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.4 mt -93.65 160.97 14.54 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.363 1.465 . . . . 0.88 110.894 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 22.0 t -92.67 119.56 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.438 0.695 . . . . 1.24 109.825 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.2 tt -105.81 148.75 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.707 1.603 . . . . 1.72 110.396 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -138.58 163.97 30.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.61 0.966 . . . . 3.6400000000000001 113.61 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.01 -27.37 69.37 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.97 1.1 . . . . 3.0099999999999998 113.97 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.62 -30.28 56.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.783 1.174 . . . . 2.8399999999999999 113.901 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.3 p -76.89 -39.56 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 118.243 -0.884 . . . . 2.1200000000000001 110.466 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -62.54 -41.0 98.6 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.626 1.103 . . . . 2.4900000000000002 112.256 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.57 -43.59 80.26 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.039 0.755 . . . . 2.5299999999999998 113.039 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 18.4 t80 -56.44 -38.98 72.36 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 3.3399999999999999 111.181 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 17.6 tpp -66.04 -50.55 63.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.933 0.893 . . . . 0.96999999999999997 111.404 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.6 t -64.98 -38.35 90.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.301 0.955 . . . . 1.7 112.063 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.98 -53.57 55.26 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.218 -0.926 . . . . 4.6100000000000003 112.334 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.33 -32.77 66.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.919 1.081 . . . . 3.1400000000000001 113.919 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1207 ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 15.3 mm-40 -58.48 -41.67 85.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.304 0.956 . . . . 3.1200000000000001 111.121 169.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -74.44 -19.93 60.21 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.088 1.755 . . . . 5.79 114.999 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -69.88 -13.1 62.09 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.39 1.076 . . . . 4.3300000000000001 112.921 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.53 11.47 59.38 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.327 1.918 . . . . 2.4900000000000002 113.763 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -91.22 156.53 17.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.621 1.568 . . . . 5.3600000000000003 109.345 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.6 m -82.92 130.42 35.14 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.639 1.175 . . . . 1.0600000000000001 108.299 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.93 130.23 56.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.19 0.996 . . . . 0.44 110.645 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.7 m -143.0 164.53 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.089 1.356 . . . . 0.51000000000000001 113.341 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.15 159.77 18.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.508 1.523 . . . . 1.3200000000000001 111.571 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1216 ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' 1222 ' ' LEU . 7.3 p -138.41 135.08 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.321 1.048 . . . . 1.98 112.597 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -136.74 152.71 50.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.722 1.609 . . . . 0.54000000000000004 111.685 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.0 m -148.7 136.24 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.123 0.969 . . . . 0.89000000000000001 112.082 -171.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 38.3 m-20 41.06 45.31 2.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.71 2.004 . . . . 3.6699999999999999 113.163 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 52.8 m-20 64.89 32.23 10.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.317 2.647 . . . . 1.6200000000000001 117.414 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -137.57 145.15 42.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.168 -1.582 . . . . 2.3900000000000001 111.491 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1222 ' ' LEU . . . . . 0.704 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -75.86 122.84 24.71 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.042 -1.036 . . . . 0.90000000000000002 111.206 176.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.7 p -106.3 -32.2 8.28 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.45000000000000001 113.856 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.04 179.44 39.63 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 120.264 1.393 . . . . 0.46000000000000002 116.489 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.05 144.35 34.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.272 1.829 . . . . 1.74 111.253 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.72 145.53 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.32 1.448 . . . . 1.3 112.028 -166.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -119.79 133.69 55.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.838 1.655 . . . . 0.57999999999999996 110.878 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.41 150.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.418 1.887 . . . . 1.77 109.896 -171.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.758 0 C-N-CA 124.894 1.277 . . . . 2.1400000000000001 111.143 171.493 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.438 0.533 . . . . 2.27 112.438 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.34 155.22 4.54 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.803 3.669 . . . . 1.25 112.529 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 5.9 m -134.75 123.94 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.149 1.779 . . . . 2.6800000000000002 111.057 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.252 2.7 p -74.52 137.19 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.855 -1.153 . . . . 1.21 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.04 -33.1 3.59 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.197 1.554 . . . . 2.4900000000000002 115.197 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -153.12 148.45 26.99 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.466 1.106 . . . . 2.4900000000000002 111.06 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 7.5 m -128.73 130.21 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.762 0.825 . . . . 1.22 111.614 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.1 tttt -135.21 144.15 46.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.392 1.077 . . . . 1.6599999999999999 113.277 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 27.3 t -90.67 135.59 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.417 1.087 . . . . 0.73999999999999999 110.674 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.18 -41.78 8.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.88 110.772 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 1.5 t -81.97 37.9 0.5 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.675 1.59 . . . . 2.0699999999999998 113.358 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -57.98 119.23 6.38 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.485 -1.384 . . . . 4.8600000000000003 111.185 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 34.0 m 55.17 25.72 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.138 2.175 . . . . 3.4900000000000002 116.081 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -123.95 -21.35 5.12 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 116.454 2.02 . . . . 3.8999999999999999 116.454 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -152.69 -62.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.355 1.434 . . . . 5.8200000000000003 113.497 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 63.2 mt -129.12 150.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.817 1.647 . . . . 1.45 109.16 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 7.7 t -108.25 161.91 14.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.739 1.385 . . . . 3.1400000000000001 114.739 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -43.92 -50.7 8.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.925 2.49 . . . . 3.3799999999999999 116.652 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -76.36 -32.45 58.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.391 0.996 . . . . 2.7400000000000002 112.149 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 45.9 mttp -67.12 -41.55 86.0 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.057 . . . . 2.6699999999999999 112.09 170.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.15 -48.3 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.617 0.644 . . . . 0.53000000000000003 111.05 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.9 -32.94 73.77 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.288 -0.883 . . . . 0.5 112.452 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.16 81.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 0.52000000000000002 112.742 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.9 pt -70.23 -38.35 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.362 0.983 . . . . 0.59999999999999998 112.752 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 99.8 t -65.82 -45.58 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.635 1.107 . . . . 0.66000000000000003 110.71 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.71 -37.58 92.52 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.636 -0.665 . . . . 0.60999999999999999 113.823 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1079 ' ' THR . . . . . 0.403 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 23.2 p -72.97 -40.42 65.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.462 1.131 . . . . 0.63 112.182 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.98 -51.71 63.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.977 0.808 . . . . 0.67000000000000004 112.626 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.12 -23.91 67.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.316 -0.865 . . . . 2.7000000000000002 112.485 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 11.9 p -63.85 -18.58 64.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.513 1.301 . . . . 1.6000000000000001 114.513 171.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.85 5.87 31.08 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.744 1.618 . . . . 2.9199999999999999 111.87 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.7 t -105.31 -177.54 3.39 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.246 1.818 . . . . 1.4199999999999999 112.697 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -128.82 17.5 6.26 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.585 1.954 . . . . 3.8300000000000001 113.703 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -88.16 146.68 38.73 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.127 1.528 . . . . 2.2200000000000002 115.127 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.95 -44.74 4.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.725 2.283 . . . . 1.4299999999999999 112.363 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -44.21 74.85 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.64 -0.663 . . . . 1.45 111.533 172.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.37 -44.34 95.23 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.222 0.915 . . . . 1.3200000000000001 113.949 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 20.8 p -64.56 -33.59 76.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.41 -1.053 . . . . 1.5700000000000001 112.184 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.84 83.22 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.813 -1.179 . . . . 1.1299999999999999 112.811 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.06 -40.51 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.076 0.55 . . . . 0.89000000000000001 110.493 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 95.2 m -54.07 -46.53 72.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.374 1.07 . . . . 1.0800000000000001 111.057 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.9 tttt -59.89 -48.67 80.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.882 0.765 . . . . 2.3199999999999998 112.343 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -61.55 -43.17 99.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 1.8200000000000001 112.719 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 77.8 m -68.74 -45.08 72.4 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.704 1.202 . . . . 3.2400000000000002 111.827 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.75 -31.16 72.24 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.856 -1.152 . . . . 3.0099999999999998 111.794 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -66.26 -44.18 84.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.07 0.85 . . . . 3.4399999999999999 110.819 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -61.55 -47.96 83.17 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.199 0.909 . . . . 2.4199999999999999 112.753 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.11 -23.53 63.05 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.212 1.19 . . . . 0.98999999999999999 114.212 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.51 54.77 10.42 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.764 1.269 . . . . 2.2400000000000002 112.78 -174.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.1 t -127.38 -15.35 5.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.679 1.591 . . . . 3.25 114.449 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 58.29 -50.67 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 129.076 2.95 . . . . 2.8799999999999999 115.649 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.4 t -111.97 135.01 53.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.27 2.228 . . . . 3.3799999999999999 110.883 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.43 174.28 15.47 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.251 1.02 . . . . 1.24 112.847 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1106 ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 74.31 155.88 4.39 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 123.067 1.371 . . . . 1.0 115.495 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1107 ' ' THR . . . . . 0.763 HG22 ' H ' ' A' 1108 ' ' CYS . 97.6 m -150.76 -166.5 2.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.373 2.269 . . . . 2.46 107.312 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1108 ' ' CYS . . . . . 0.763 ' H ' HG22 ' A' 1107 ' ' THR . 79.5 m -57.84 142.05 47.09 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.655 1.982 . . . . 3.0600000000000001 114.829 -169.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 177.94 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 129.273 3.029 . . . . 2.1099999999999999 110.667 -166.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 1.9 t0 -135.64 171.6 14.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.432 1.493 . . . . 2.79 109.484 167.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.385 1.448 . . . . 2.9500000000000002 113.818 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.78 99.34 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.344 2.657 . . . . 3.3100000000000001 105.776 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 42.5 t -99.18 138.61 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.244 1.418 . . . . 2.25 110.389 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 11.4 t -133.6 102.8 12.47 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.971 -1.122 . . . . 1.3100000000000001 107.971 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.69 130.25 30.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.52 2.147 . . . . 1.6100000000000001 113.001 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.3 20.36 76.68 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.321 0.962 . . . . 1.5700000000000001 114.816 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 50.8 t -143.52 -43.72 0.28 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.28 1.54 . . . . 1.8999999999999999 113.804 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.43 34.96 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.666 1.026 . . . . 0.89000000000000001 115.666 171.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.5 tt -140.61 154.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.529 1.532 . . . . 1.95 111.747 168.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -132.08 147.05 52.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.717 1.607 . . . . 0.46999999999999997 113.136 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.1 p -151.8 167.37 28.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.532 1.308 . . . . 0.67000000000000004 114.532 -175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1122 ' ' LYS . . . . . 0.419 ' HE3' ' HD3' ' A' 1179 ' ' LYS . 39.5 mmtm -114.44 97.14 6.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.029 1.732 . . . . 1.22 109.282 171.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.9 p -107.53 130.13 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.727 1.149 . . . . 1.96 113.499 -169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -115.04 168.54 9.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.514 1.126 . . . . 1.0800000000000001 113.752 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 129.422 3.089 . . . . 2.23 107.87 162.767 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 tm0? . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 112.982 0.734 . . . . 2.6200000000000001 112.982 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.07 119.88 25.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.364 1.066 . . . . 2.1800000000000002 113.347 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1179 ' ' LYS . . . . . 0.419 ' HD3' ' HE3' ' A' 1122 ' ' LYS . 37.7 ttpt -81.35 115.08 20.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.056 1.342 . . . . 1.8600000000000001 109.477 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.0 m -136.59 142.83 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.757 0.708 . . . . 0.59999999999999998 112.871 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.61 153.16 47.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.728 1.211 . . . . 0.48999999999999999 112.976 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -140.3 137.04 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.764 1.626 . . . . 0.45000000000000001 108.642 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . -172.42 168.12 41.14 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.281 -0.887 . . . . 1.6200000000000001 113.26 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.301 12.9 p30 -69.43 -49.33 56.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.021 1.489 . . . . 3.1200000000000001 115.021 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -173.81 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 115.064 1.505 . . . . 4.7999999999999998 115.064 169.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.16 -32.13 71.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.282 1.401 . . . . 3.3199999999999998 113.286 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -67.27 -22.49 65.66 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.699 -1.251 . . . . 2.9100000000000001 113.022 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -29.24 68.36 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.242 -1.536 . . . . 2.0800000000000001 111.247 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 55.3 mt -69.39 -66.35 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.847 1.659 . . . . 1.6599999999999999 108.63 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -48.01 -32.97 7.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.81 1.644 . . . . 5.2199999999999998 114.9 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.68 5.52 27.84 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.919 1.236 . . . . 0.93000000000000005 113.991 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 73.25 35.49 56.81 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.823 -1.173 . . . . 0.94999999999999996 114.572 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.82 158.7 15.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.801 1.241 . . . . 0.72999999999999998 110.343 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 86.7 t -97.26 123.56 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.362 -0.977 . . . . 1.1399999999999999 108.362 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.1 tt -110.44 139.89 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.97 0.89 . . . . 1.4099999999999999 112.675 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -96.55 150.83 20.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.699 1.2 . . . . 2.7400000000000002 114.182 -168.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -69.2 -26.87 65.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.661 1.184 . . . . 3.7200000000000002 114.057 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -84.26 -42.77 15.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.525 1.13 . . . . 2.8500000000000001 112.989 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 13.1 p -65.09 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.117 0.871 . . . . 0.79000000000000004 111.609 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -62.69 -45.71 91.51 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.639 1.109 . . . . 2.3799999999999999 111.528 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.87 -33.88 73.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.172 0.989 . . . . 2.6099999999999999 112.652 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.47 -44.35 64.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.605 1.093 . . . . 2.3900000000000001 112.518 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.3 tpp -58.89 -48.01 82.93 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.711 1.604 . . . . 1.02 111.799 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 9.7 t -75.5 -38.45 59.46 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.99 -0.528 . . . . 1.54 112.364 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -53.95 -44.76 70.98 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.185 1.357 . . . . 3.48 112.744 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1206 ' ' HIS . . . . . 0.486 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 65.7 t-80 -62.49 -44.77 95.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.59 1.556 . . . . 3.7200000000000002 112.224 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -71.57 -30.71 66.17 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.817 1.247 . . . . 4.2599999999999998 112.655 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -70.46 -16.78 62.96 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.936 1.694 . . . . 4.9299999999999997 113.74 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.369 0.0 OUTLIER -104.01 24.01 12.04 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.84 1.656 . . . . 3.9100000000000001 114.247 170.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.75 76.02 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 117.755 1.862 . . . . 1.3300000000000001 117.755 167.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -105.6 148.56 27.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.706 1.753 . . . . 4.4400000000000004 111.598 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 56.5 m -76.41 128.38 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.094 1.358 . . . . 1.0900000000000001 112.108 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.46 126.69 44.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.542 1.137 . . . . 0.76000000000000001 112.108 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 32.7 m -141.17 156.73 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.141 1.376 . . . . 0.93000000000000005 113.818 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.51 157.22 25.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.037 2.535 . . . . 1.47 112.131 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -131.34 119.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.519 1.527 . . . . 1.6799999999999999 111.103 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -121.5 147.52 45.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.023 1.329 . . . . 0.46000000000000002 111.601 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 35.1 m -144.44 121.67 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.32 1.048 . . . . 0.66000000000000003 112.324 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.255 33.3 t0 41.11 50.97 3.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.582 2.353 . . . . 3.4399999999999999 113.694 -176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.289 7.6 m-20 68.51 25.77 6.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.855 2.862 . . . . 2.2000000000000002 116.714 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.31 143.85 49.29 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.736 1.214 . . . . 2.4100000000000001 111.141 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.14 136.59 48.24 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.535 -1.353 . . . . 0.68999999999999995 112.355 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.7 p -113.81 -44.1 3.21 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.898 1.073 . . . . 0.53000000000000003 113.898 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.3 -172.23 34.24 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 120.055 1.298 . . . . 0.54000000000000004 115.47 -173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.16 154.0 43.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.914 1.686 . . . . 0.81000000000000005 112.413 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.0 mm -126.9 137.23 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.28 1.432 . . . . 0.97999999999999998 109.287 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1227 ' ' ALA . . . . . 0.486 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -114.9 131.52 56.84 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.321 1.849 . . . . 0.95999999999999996 109.801 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.46 155.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.92 1.688 . . . . 1.3700000000000001 111.266 -168.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.492 1.517 . . . . 1.52 111.881 173.346 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 119.637 -0.22 . . . . 2.5499999999999998 111.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.25 150.01 52.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.269 2.646 . . . . 1.27 112.765 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 6.1 p -134.86 133.56 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.52 1.528 . . . . 3.2799999999999998 109.459 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 1.9 p -71.93 121.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.539 1.063 . . . . 1.77 108.941 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 17.4 t30 -106.21 -44.75 4.48 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.796 1.036 . . . . 2.9500000000000002 113.796 -166.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -142.98 148.67 37.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.542 1.537 . . . . 1.97 110.812 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.0 m -129.16 148.45 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.124 0.97 . . . . 1.1100000000000001 111.432 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -141.38 147.69 38.43 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.151 -0.968 . . . . 3.3399999999999999 112.841 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 62.9 t -105.23 136.76 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.412 1.085 . . . . 0.93000000000000005 111.742 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1062 ' ' LEU . . . . . 0.585 HD23 HD22 ' A' 1222 ' ' LEU . 22.6 tp -108.77 -23.96 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.872 2.469 . . . . 1.1499999999999999 113.105 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 46.2 m -132.91 110.4 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.01 1.324 . . . . 1.75 110.051 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -118.54 155.69 30.44 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.688 1.195 . . . . 3.21 112.946 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 58.25 3.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.95 2.574 . . . . 2.8500000000000001 117.95 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -127.49 -11.92 5.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.512 1.525 . . . . 2.9700000000000002 114.028 -172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -158.27 -48.88 0.06 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.308 1.843 . . . . 4.3200000000000003 110.312 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 165.41 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 128.471 2.708 . . . . 1.48 108.569 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.0 m -142.31 162.41 35.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.144 1.777 . . . . 1.8700000000000001 111.49 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.6 t60 -45.83 -51.87 12.21 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.929 1.826 . . . . 4.7400000000000002 115.929 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -75.21 -28.96 60.16 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.125 -0.985 . . . . 2.6800000000000002 112.224 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -70.22 -41.98 72.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.016 -1.053 . . . . 2.8900000000000001 111.706 170.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.01 -52.91 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 0.65000000000000002 110.647 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.94 -32.62 74.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.073 0.851 . . . . 0.72999999999999998 112.462 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.22 -51.17 60.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.97 0.508 . . . . 0.79000000000000004 112.17 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.2 pt -70.43 -30.99 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.009 -1.057 . . . . 0.83999999999999997 113.099 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 65.1 t -71.01 -48.86 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.167 0.894 . . . . 1.01 111.796 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.78 -34.64 83.48 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 113.316 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 58.9 p -74.51 -35.41 63.19 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 112.86 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.66 66.22 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.125 1.157 . . . . 1.1899999999999999 114.125 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -78.86 -10.51 59.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.439 1.644 . . . . 2.0699999999999998 115.439 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.2 t -61.29 -52.07 66.25 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.394 -1.442 . . . . 1.4099999999999999 113.629 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.7 1.24 31.0 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.969 -1.082 . . . . 2.21 113.638 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.3 t -79.53 177.34 8.94 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.447 1.099 . . . . 1.6399999999999999 113.914 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.99 2.5 9.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.113 2.165 . . . . 5.2300000000000004 113.267 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -81.04 158.29 70.2 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 114.397 1.258 . . . . 1.6499999999999999 114.397 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.21 -32.37 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.088 2.525 . . . . 1.0 113.913 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.6 -55.46 2.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.376 0.67 . . . . 0.73999999999999999 112.318 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.55 -28.63 71.64 Favored Glycine 0 CA--C 1.543 1.805 0 N-CA-C 114.292 0.477 . . . . 0.84999999999999998 114.292 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.3 p -61.23 -22.78 65.12 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.011 -1.288 . . . . 1.52 113.725 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.49 72.65 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.579 -1.326 . . . . 0.75 112.334 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.81 -34.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.015 1.326 . . . . 0.71999999999999997 110.76 173.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 75.4 m -53.14 -46.7 68.94 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 118.432 -0.794 . . . . 1.1499999999999999 111.508 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.46 -47.32 86.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.463 1.029 . . . . 2.02 112.821 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -55.11 -46.28 75.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.217 1.007 . . . . 2.0899999999999999 112.145 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.2 t -66.49 -52.94 40.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.669 0.788 . . . . 1.8400000000000001 112.207 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.2 -35.26 73.28 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 3.04 112.607 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 -48.68 65.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.386 1.075 . . . . 2.7799999999999998 111.865 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -61.37 -37.86 84.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.096 0.958 . . . . 2.0099999999999998 113.297 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.59 -16.98 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.333 1.605 . . . . 1.1299999999999999 115.333 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.2 t0 56.47 30.38 17.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.279 1.432 . . . . 2.7200000000000002 114.558 -170.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 14.2 t -107.72 159.88 16.14 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.273 -1.517 . . . . 2.6200000000000001 111.48 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.55 -9.57 26.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.447 1.099 . . . . 2.8799999999999999 111.569 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.0 t -141.92 130.95 23.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.753 2.021 . . . . 3.3700000000000001 111.14 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -163.24 162.08 25.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.571 1.548 . . . . 1.3400000000000001 111.091 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 57.82 76.42 0.21 Allowed Glycine 0 N--CA 1.471 1.013 0 CA-C-N 119.175 0.898 . . . . 2.9500000000000002 113.748 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 23.6 m -68.14 -50.08 56.9 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.637 0.606 . . . . 1.76 112.637 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.1 t -136.85 142.34 42.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.145 0.978 . . . . 1.7 111.424 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.69 147.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 128.202 2.601 . . . . 3.0499999999999998 107.615 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.92 81.05 1.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.173 1.389 . . . . 2.6800000000000002 109.543 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -91.13 137.08 32.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.918 1.822 . . . . 2.4199999999999999 115.918 -168.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -119.05 101.92 8.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.967 3.707 . . . . 2.3599999999999999 106.267 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 21.7 m -99.65 142.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.432 0.901 . . . . 2.6499999999999999 113.432 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 25.7 t -133.65 92.86 22.37 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.764 1.226 . . . . 0.97999999999999998 109.06 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.9 149.37 61.52 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.938 3.092 . . . . 2.27 113.496 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.07 15.38 65.06 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.069 -0.851 . . . . 1.7 114.688 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 t -147.51 -70.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.966 1.383 . . . . 1.9199999999999999 112.159 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 177.52 179.48 47.76 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.662 1.125 . . . . 1.02 112.72 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.51 160.76 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.372 -1.075 . . . . 2.5899999999999999 111.432 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 148.93 50.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.378 1.471 . . . . 0.70999999999999996 111.227 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.8 p -155.81 173.32 16.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.405 1.261 . . . . 0.67000000000000004 114.405 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -119.14 123.68 44.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.531 1.132 . . . . 1.3799999999999999 108.745 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.4 t -106.11 148.31 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.797 1.239 . . . . 2.6299999999999999 110.037 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.8 t -148.71 158.59 44.25 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.153 1.908 . . . . 1.1000000000000001 116.153 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.259 24.8 t-20 . . . . . 0 CA--C 1.542 0.64 1 C-N-CA 132.409 4.283 . . . . 2.9900000000000002 106.949 156.5 . . . . . . . . 2 1 . 1 . 008 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 117.376 2.361 . . . . 2.1899999999999999 117.376 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.23 110.83 16.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.683 1.593 . . . . 3.1299999999999999 111.554 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.26 117.81 20.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.115 1.366 . . . . 1.21 109.374 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.2 m -136.61 139.81 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 113.044 0.757 . . . . 0.87 113.044 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.1 150.0 43.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.986 1.315 . . . . 0.47999999999999998 112.772 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -147.79 141.39 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.277 1.431 . . . . 0.63 109.92 -173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 147.83 -147.32 17.9 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.178 0.831 . . . . 1.46 115.178 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -68.98 157.9 35.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.384 1.874 . . . . 2.6099999999999999 113.896 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -53.49 -28.11 29.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.268 2.227 . . . . 8.5299999999999994 114.756 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.65 -39.18 87.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.571 1.148 . . . . 4.0499999999999998 113.415 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.69 -21.16 26.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.678 -0.639 . . . . 3.6200000000000001 112.547 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 15.9 mmt -61.83 -34.61 76.25 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.245 -0.909 . . . . 2.1600000000000001 110.592 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 36.2 mt -68.31 -68.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.812 1.245 . . . . 1.79 109.278 168.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -24.5 23.42 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.194 1.924 . . . . 8.5199999999999996 116.194 -172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -76.08 11.92 1.31 Allowed 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 120.841 1.655 . . . . 0.92000000000000004 112.306 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 77.15 15.44 81.59 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 119.966 -1.709 . . . . 0.98999999999999999 114.731 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.65 -178.1 6.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.836 1.318 . . . . 1.1599999999999999 111.248 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 59.9 t -123.37 134.09 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.361 1.465 . . . . 1.28 109.744 170.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -105.6 139.08 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.162 0.985 . . . . 1.02 111.631 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -97.61 160.19 14.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.332 1.453 . . . . 4.1100000000000003 112.705 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.5 -21.22 56.06 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 3.2000000000000002 113.222 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -73.94 -35.29 64.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.377 -0.827 . . . . 3.0499999999999998 112.315 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -74.36 -33.84 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 119.109 -0.472 . . . . 1.05 110.736 168.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -60.27 -37.27 79.94 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.902 0.774 . . . . 2.5800000000000001 111.654 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -64.77 -46.57 81.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.987 1.315 . . . . 2.1299999999999999 112.281 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -41.02 81.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.096 1.358 . . . . 2.7599999999999998 110.646 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 14.1 tpp -64.09 -57.2 10.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.083 1.353 . . . . 0.89000000000000001 111.996 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.6 t -67.27 -30.84 70.82 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.691 0.626 . . . . 1.3700000000000001 112.691 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -58.78 -45.49 89.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.296 -0.877 . . . . 2.77 111.113 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -70.55 -35.78 73.3 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.442 0.904 . . . . 2.29 113.442 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.24 -36.87 83.33 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.47 1.032 . . . . 2.6600000000000001 112.388 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -70.94 -30.49 66.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.867 2.067 . . . . 3.4199999999999999 113.189 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 26.8 mttp -72.3 -4.61 30.7 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.168 1.787 . . . . 2.25 112.578 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.38 3.11 87.12 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.894 1.711 . . . . 1.3899999999999999 115.736 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -98.19 164.59 12.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.781 1.291 . . . . 4.0 111.482 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 50.5 m -72.8 130.65 40.94 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.313 -0.867 . . . . 1.1100000000000001 110.845 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.1 41.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.838 1.655 . . . . 0.60999999999999999 109.642 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -140.33 153.9 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 113.748 1.018 . . . . 0.46999999999999997 113.748 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.68 162.65 12.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.173 1.389 . . . . 0.97999999999999998 111.642 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 12.0 t -131.73 129.37 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.562 1.545 . . . . 1.96 110.272 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -127.7 148.33 50.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.554 1.141 . . . . 0.58999999999999997 111.039 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.7 m -148.14 130.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.683 0.793 . . . . 0.82999999999999996 111.093 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.56 51.92 2.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.802 1.641 . . . . 3.0 112.879 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 12.6 m-20 60.56 33.27 20.48 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.795 2.038 . . . . 1.79 115.551 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -133.95 137.31 44.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.864 1.665 . . . . 2.4500000000000002 111.518 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1222 ' ' LEU . . . . . 0.585 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -75.02 115.87 15.13 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.059 -1.026 . . . . 1.3999999999999999 110.702 171.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.3 p -103.99 -30.16 10.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.727 -1.13 . . . . 0.64000000000000001 113.676 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -177.57 -169.6 38.82 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.753 1.615 . . . . 0.64000000000000001 115.88 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.69 153.71 43.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.687 1.595 . . . . 0.72999999999999998 112.54 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.09 133.73 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.77000000000000002 109.896 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.24 133.96 51.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 110.733 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 41.3 mm -102.54 171.73 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 125.433 1.493 . . . . 2.0 110.469 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 1.77 111.912 167.718 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 113.272 0.841 . . . . 2.4900000000000002 113.272 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.77 143.82 79.07 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.187 2.592 . . . . 2.46 113.091 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 26.9 m -122.04 129.92 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.401 1.081 . . . . 2.6299999999999999 111.527 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -73.91 128.39 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.212 -0.93 . . . . 1.1499999999999999 110.968 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -105.88 -45.15 4.44 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.08 1.352 . . . . 2.7999999999999998 112.443 -169.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -155.31 160.83 41.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.627 1.571 . . . . 3.0299999999999998 112.485 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.4 m -127.63 142.33 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.008 1.323 . . . . 0.94999999999999996 111.525 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 28.9 tttt -140.37 146.9 39.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.185 0.994 . . . . 1.8999999999999999 112.861 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 39.6 t -84.83 154.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.374 1.469 . . . . 1.05 111.106 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.0 tp -120.85 -33.06 3.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.917 1.687 . . . . 0.87 111.968 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1063 ' ' THR . . . . . 0.41 HG23 ' H ' ' A' 1068 ' ' ILE . 5.0 t -87.24 32.9 0.68 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.197 1.399 . . . . 2.3500000000000001 113.846 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -59.12 122.0 12.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.795 1.238 . . . . 3.9300000000000002 110.853 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 66.7 m 50.92 32.51 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.816 1.413 . . . . 3.6899999999999999 114.816 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -132.6 -21.65 2.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.205 1.402 . . . . 3.8999999999999999 114.514 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -157.49 -56.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.625 1.557 . . . . 4.3899999999999997 114.973 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1068 ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' 1063 ' ' THR . 31.8 mt -137.61 155.6 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.453 1.901 . . . . 1.51 110.707 -167.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 75.0 m -117.31 166.69 12.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.786 1.634 . . . . 2.3999999999999999 114.078 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.7 p80 -57.95 -43.21 86.23 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.834 2.161 . . . . 2.9900000000000002 116.834 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -72.87 -28.3 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.477 1.035 . . . . 2.5699999999999998 111.626 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -71.1 -48.61 51.41 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.444 -0.785 . . . . 3.4500000000000002 110.934 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.19 -46.67 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.842 0.857 . . . . 0.69999999999999996 111.621 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.4 -34.38 77.82 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.04 0.836 . . . . 0.78000000000000003 112.048 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.13 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.639 -0.696 . . . . 0.83999999999999997 112.416 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.78 -26.86 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.493 1.042 . . . . 0.68999999999999995 113.315 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 94.6 t -71.32 -44.18 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.094 0.861 . . . . 0.92000000000000004 110.521 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.48 96.53 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.555 -0.716 . . . . 0.60999999999999999 113.778 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 72.7 p -74.06 -37.84 64.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.701 1.25 . . . . 0.73999999999999999 112.904 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.46 -51.14 69.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.741 0.816 . . . . 0.75 111.949 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.78 -21.88 62.45 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.648 -0.657 . . . . 2.0899999999999999 112.703 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 67.5 m -62.76 -21.45 65.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.501 -1.374 . . . . 2.25 112.806 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 2.53 50.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.513 1.525 . . . . 2.98 112.969 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 6.4 t -107.37 -179.59 3.97 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 1.5700000000000001 113.758 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -136.45 32.9 2.78 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.529 2.732 . . . . 4.4699999999999998 111.714 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -97.01 154.69 38.11 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.051 1.34 . . . . 1.6000000000000001 113.61 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.21 -27.54 1.83 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.206 2.604 . . . . 1.1399999999999999 114.939 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.0 tt -100.17 -48.09 4.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.563 0.745 . . . . 0.87 111.709 -167.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -68.53 -30.24 73.05 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 114.55 0.58 . . . . 0.85999999999999999 114.55 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 61.1 p -67.14 -11.01 56.1 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.649 -1.501 . . . . 1.5 113.956 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.38 78.64 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.97 0.908 . . . . 0.68000000000000005 111.012 167.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.08 -32.67 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.42 1.088 . . . . 1.4399999999999999 110.866 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 52.0 m -53.16 -49.41 66.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 119.562 1.074 . . . . 1.1899999999999999 112.285 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -65.96 -46.29 78.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.086 0.857 . . . . 2.5600000000000001 112.543 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.14 -44.19 71.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.439 1.096 . . . . 1.9199999999999999 111.457 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.9 t -70.44 -55.41 9.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.793 1.237 . . . . 1.79 111.832 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -53.65 -47.12 70.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.299 0.954 . . . . 2.9900000000000002 112.251 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -72.48 -28.76 63.1 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.78 0.659 . . . . 4.1500000000000004 112.78 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -70.2 -46.1 65.26 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.184 0.902 . . . . 2.6000000000000001 112.773 172.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -25.67 62.5 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.804 1.039 . . . . 1.1499999999999999 113.804 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.47 17.98 0.41 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.667 2.387 . . . . 2.4399999999999999 114.624 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 4.5 t -82.59 -7.79 59.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.417 2.287 . . . . 4.1299999999999999 113.979 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 17.5 tt0 63.05 -27.11 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 129.27 3.028 . . . . 4.29 116.819 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.7 t -144.51 130.45 19.35 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.914 1.234 . . . . 2.7599999999999998 112.368 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.88 154.25 41.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.202 1.401 . . . . 1.0 113.091 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.6 171.46 36.57 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.405 1.479 . . . . 1.4299999999999999 115.214 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 17.9 m -150.23 -70.5 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.873 -1.369 . . . . 1.29 113.978 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1108 ' ' CYS . . . . . 0.423 ' O ' HD12 ' A' 1109 ' ' ILE . 37.6 t -138.3 139.42 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.959 1.254 . . . . 1.3200000000000001 112.478 -172.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1109 ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' 1108 ' ' CYS . 1.7 mp -140.89 140.8 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 131.668 3.987 . . . . 2.6699999999999999 106.086 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.283 0.0 OUTLIER -100.76 -13.11 18.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.943 1.831 . . . . 3.1000000000000001 115.943 -174.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 5.5 t80 54.54 86.01 0.05 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 129.346 3.059 . . . . 2.71 118.929 166.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.91 102.65 11.82 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.289 1.835 . . . . 2.46 109.067 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 84.8 t -99.83 138.88 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.313 1.045 . . . . 1.9399999999999999 111.589 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.9 t -131.82 124.45 19.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.651 1.18 . . . . 1.0900000000000001 110.989 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.3 140.97 34.68 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.884 2.39 . . . . 1.73 112.507 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 63.16 21.19 63.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.323 0.963 . . . . 1.9399999999999999 114.992 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 99.7 m -139.25 -62.69 0.53 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.969 1.708 . . . . 2.2400000000000002 111.897 -169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.67 -173.35 34.4 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.397 1.475 . . . . 0.70999999999999996 112.01 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.64 158.74 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 122.005 -0.703 . . . . 2.54 111.551 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 27.5 t -132.65 151.63 51.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.422 1.489 . . . . 0.46000000000000002 110.634 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -160.57 172.9 16.35 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.081 -1.012 . . . . 0.84999999999999998 113.317 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -113.65 124.1 51.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.59 1.156 . . . . 1.1599999999999999 108.248 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.8 m -122.39 131.74 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 113.602 0.964 . . . . 2.27 113.602 -170.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -118.68 153.37 34.47 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.757 1.021 . . . . 0.97999999999999998 113.757 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 131.355 3.862 . . . . 2.3999999999999999 108.343 161.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 114.646 1.35 . . . . 2.1699999999999999 114.646 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.52 128.68 33.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.644 1.177 . . . . 2.3700000000000001 108.807 168.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.1 tttt -81.78 126.03 31.36 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 107.48 -1.304 . . . . 1.8400000000000001 107.48 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -133.31 138.08 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.786 0.835 . . . . 0.76000000000000001 111.3 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 153.15 46.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.308 1.043 . . . . 0.46999999999999997 112.7 172.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.9 tt -147.96 139.89 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.32 1.448 . . . . 0.51000000000000001 109.135 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.45 -172.34 44.85 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.735 1.054 . . . . 1.3600000000000001 115.735 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 24.8 p30 -81.08 158.97 24.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.441 1.096 . . . . 2.29 113.16 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -45.53 -51.77 11.35 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.006 1.484 . . . . 5.3399999999999999 115.006 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -74.29 -34.45 63.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.042 1.292 . . . . 4.5199999999999996 112.671 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 36.7 t90 -68.69 -40.9 79.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.031 -1.043 . . . . 3.1899999999999999 111.468 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 91.1 mmm -63.82 -32.9 74.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.698 0.799 . . . . 2.8900000000000001 112.735 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.67 -63.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.504 1.522 . . . . 2.3100000000000001 109.047 167.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -47.4 -8.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.887 2.075 . . . . 6.8399999999999999 116.565 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -83.63 13.17 4.85 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 121.459 1.936 . . . . 1.0900000000000001 112.517 168.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 70.02 37.23 73.51 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 119.755 -1.841 . . . . 0.94999999999999996 114.675 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.95 167.49 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.81000000000000005 112.766 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.2 t -105.47 114.49 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.835 1.254 . . . . 1.9399999999999999 109.71 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.18 146.04 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.841 1.257 . . . . 1.3799999999999999 110.511 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -117.84 171.3 8.15 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.284 1.034 . . . . 3.1200000000000001 112.732 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -71.07 -40.26 71.7 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.968 1.47 . . . . 3.1499999999999999 114.968 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.15 -28.36 54.14 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.912 -1.118 . . . . 2.6200000000000001 113.563 -170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 7.5 p -72.04 -43.74 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.608 1.163 . . . . 1.26 111.878 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.4 t30 -66.89 -38.92 87.18 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.53 0.567 . . . . 2.3199999999999998 112.53 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.5 -44.14 84.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.57 0.582 . . . . 2.02 112.57 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 17.1 t80 -68.16 -45.08 74.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.148 0.979 . . . . 2.4500000000000002 111.684 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.5 ttm -60.81 -46.91 88.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.974 0.91 . . . . 1.76 112.502 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.4 t -74.76 -33.9 62.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.051 0.541 . . . . 1.2 112.446 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.64 -44.85 85.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.22 1.008 . . . . 2.98 111.823 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -69.59 -45.77 67.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.794 1.637 . . . . 3.4300000000000002 112.326 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.63 -32.77 74.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.955 -1.09 . . . . 3.98 112.017 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -71.26 -22.96 61.9 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.332 1.234 . . . . 4.25 114.332 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 15.6 mttp -76.04 -0.61 22.35 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.387 1.075 . . . . 2.9900000000000002 112.56 167.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.43 16.54 68.6 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.882 1.706 . . . . 1.21 113.951 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -117.8 132.32 56.46 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.376 1.47 . . . . 4.5 109.619 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 96.4 m -65.42 137.37 57.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -167.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -133.16 119.08 19.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.506 1.123 . . . . 0.75 111.475 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.3 m -132.97 157.98 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.339 1.456 . . . . 0.42999999999999999 113.03 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.16 156.68 21.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.833 1.653 . . . . 1.23 111.53 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.6 p -132.12 133.95 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.401 1.48 . . . . 2.3900000000000001 111.236 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -135.08 153.34 52.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.962 1.705 . . . . 0.48999999999999999 111.405 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.56 135.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.90000000000000002 112.541 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 48.8 m-20 42.3 48.82 4.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.754 1.621 . . . . 2.7200000000000002 112.832 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 57.3 m-20 55.6 33.94 22.18 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.951 2.1 . . . . 2.5 115.497 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.69 141.48 49.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.081 2.552 . . . . 2.0800000000000001 110.145 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.43 130.9 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 119.85 -1.781 . . . . 0.79000000000000004 112.444 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 22.3 p -108.22 -35.3 6.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.599 -1.191 . . . . 0.80000000000000004 114.081 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -173.23 -167.07 32.57 Favored Glycine 0 N--CA 1.475 1.277 0 CA-C-N 120.7 1.591 . . . . 0.58999999999999997 116.447 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.84 154.7 44.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.475 1.91 . . . . 0.81000000000000005 112.481 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.4 137.33 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.932 1.693 . . . . 0.81999999999999995 109.708 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.53 137.49 46.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.873 1.669 . . . . 0.68000000000000005 110.351 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.18 151.7 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.877 1.671 . . . . 1.45 110.843 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 125.268 1.427 . . . . 1.47 112.666 169.699 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.499 0.926 . . . . 3.04 113.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.22 148.6 77.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.324 2.016 . . . . 2.1899999999999999 113.676 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.5 p -120.33 124.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.039 1.735 . . . . 2.4399999999999999 110.396 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.251 13.1 p -72.12 130.63 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.309 -0.869 . . . . 1.1599999999999999 110.296 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.54 -40.81 4.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.446 1.276 . . . . 2.3100000000000001 114.446 -166.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -157.64 146.3 19.41 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.183 0.593 . . . . 1.9399999999999999 112.08 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 28.1 m -126.86 144.24 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.549 1.14 . . . . 1.0800000000000001 112.11 169.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 72.7 tttt -134.77 141.76 46.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.119 1.368 . . . . 1.8200000000000001 110.962 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 49.7 t -92.03 134.36 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.484 1.114 . . . . 0.72999999999999998 110.778 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1062 ' ' LEU . . . . . 0.488 HD23 HD22 ' A' 1222 ' ' LEU . 9.7 tp -99.21 -65.27 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.906 2.082 . . . . 0.89000000000000001 111.022 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 38.1 m -78.63 75.02 5.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.481 -1.303 . . . . 1.72 107.481 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.63 123.97 29.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.274 1.03 . . . . 3.9399999999999999 109.016 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 70.7 m 60.71 174.76 0.1 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.0 1.482 . . . . 3.6600000000000001 115.0 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 64.63 -0.03 1.03 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.612 2.449 . . . . 4.2599999999999998 117.612 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -147.57 -44.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.803 1.241 . . . . 5.0499999999999998 112.634 167.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mm -130.09 163.9 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.943 1.697 . . . . 1.9199999999999999 109.614 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 20.4 m -119.35 145.59 46.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.818 1.647 . . . . 2.3700000000000001 111.109 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -49.79 -51.35 40.13 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.797 1.777 . . . . 4.7199999999999998 115.797 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 72.8 m80 -74.25 -14.32 60.9 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.969 1.259 . . . . 4.71 112.804 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.94 -37.97 33.36 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.944 -1.027 . . . . 3.46 111.493 168.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.91 -54.34 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.32 0.964 . . . . 0.69999999999999996 110.13 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.19 -32.27 72.39 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.643 -0.66 . . . . 0.72999999999999998 112.332 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.98 83.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.65 0.659 . . . . 0.72999999999999998 112.576 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.36 -29.42 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.916 -1.115 . . . . 0.68999999999999995 113.427 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.3 t -69.2 -52.35 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.289 0.949 . . . . 0.70999999999999996 111.107 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.01 -35.87 91.23 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.791 -0.568 . . . . 0.68999999999999995 113.17 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 36.2 p -71.66 -36.0 70.52 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.523 1.161 . . . . 0.70999999999999996 112.693 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.31 -49.36 67.3 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.901 0.773 . . . . 0.69999999999999996 112.846 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -72.08 -15.17 62.01 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 121.366 -0.834 . . . . 2.02 112.715 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.3 t -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.42 -2.05 . . . . 1.28 112.493 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.98 2.04 55.59 Favored 'General case' 0 CA--C 1.557 1.227 0 O-C-N 121.073 -1.017 . . . . 2.1299999999999999 113.007 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 57.8 m -103.59 167.24 9.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.621 1.569 . . . . 1.72 114.224 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.26 12.34 7.62 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.084 1.754 . . . . 3.4700000000000002 112.585 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -71.63 148.25 92.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.602 -1.311 . . . . 2.2000000000000002 113.141 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.95 -31.35 31.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.226 2.617 . . . . 1.1299999999999999 114.631 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.4 -51.45 3.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.168 1.387 . . . . 0.89000000000000001 111.793 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -57.12 -34.68 67.05 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.454 0.55 . . . . 1.1000000000000001 113.514 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.1 p -61.25 -14.5 26.58 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.869 -1.371 . . . . 1.3 114.477 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.09 82.94 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.758 -1.214 . . . . 0.89000000000000001 111.713 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.12 -39.27 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.397 1.479 . . . . 0.81000000000000005 109.774 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 24.3 m -57.44 -44.39 84.68 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 117.934 -1.032 . . . . 1.3400000000000001 112.552 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.27 -47.38 79.77 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.066 1.303 . . . . 2.3799999999999999 112.091 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.69 -43.12 76.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.903 0.481 . . . . 1.6200000000000001 111.433 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 94.7 m -69.16 -49.91 52.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.934 1.293 . . . . 2.9300000000000002 112.389 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -49.9 -48.7 51.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.375 1.47 . . . . 3.5800000000000001 111.534 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.93 -38.91 72.93 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.591 0.756 . . . . 2.7200000000000002 112.388 175.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.3 -36.2 81.04 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.485 1.039 . . . . 2.3500000000000001 112.756 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 5.4 mt -72.42 -9.21 58.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.83 1.252 . . . . 1.1599999999999999 114.0 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.04 50.82 18.33 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.029 1.332 . . . . 3.5800000000000001 111.887 -170.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.9 t -138.45 168.73 19.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.385 1.074 . . . . 2.8300000000000001 112.502 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -102.62 -17.61 15.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.875 1.67 . . . . 3.8300000000000001 111.26 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.6 t -136.89 130.64 31.99 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.865 -1.147 . . . . 2.8700000000000001 113.574 -168.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.86 159.14 32.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.591 1.556 . . . . 1.02 110.169 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 76.44 127.82 0.28 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.931 0.777 . . . . 1.3999999999999999 114.13 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 53.2 m -123.73 -71.17 0.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 1.4199999999999999 112.709 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 4.4 t -135.44 143.19 45.78 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.096 1.316 . . . . 1.5800000000000001 112.509 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1109 ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' 1121 ' ' CYS . 5.1 tp -132.35 163.48 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 1 C-N-CA 132.413 4.285 . . . . 2.6000000000000001 109.416 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.06 86.4 1.92 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.214 1.806 . . . . 2.6899999999999999 106.176 166.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -93.63 147.9 22.59 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.699 2.111 . . . . 3.5699999999999998 116.699 -164.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -137.92 118.47 13.91 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.332 2.253 . . . . 2.1299999999999999 109.133 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 17.0 t -112.73 140.63 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.391 1.076 . . . . 1.8999999999999999 113.867 -168.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 92.7 t -139.71 117.0 8.42 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 127.025 2.13 . . . . 1.0700000000000001 107.472 167.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.22 144.24 50.98 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.66 2.24 . . . . 1.5600000000000001 112.361 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.06 1.41 12.69 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.099 1.2 . . . . 1.6799999999999999 116.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 1.3 m -136.8 -30.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.686 1.736 . . . . 2.6899999999999999 115.686 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.66 168.33 19.2 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 121.337 1.88 . . . . 0.83999999999999997 116.888 168.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 137.35 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.808 1.243 . . . . 1.9299999999999999 109.911 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 39.3 t -126.67 144.87 50.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.614 1.565 . . . . 0.47999999999999998 109.785 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1121 ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' 1109 ' ' ILE . 30.1 p -154.1 174.55 14.57 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.765 1.024 . . . . 0.67000000000000004 113.765 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -116.77 123.5 47.29 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.215 -2.143 . . . . 1.4099999999999999 105.215 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.56 144.73 24.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 118.771 0.714 . . . . 2.0 110.807 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1124 ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.5 t -134.3 155.5 50.11 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.134 1.531 . . . . 1.0 115.134 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.28 15.2 t-20 . . . . . 0 CA--C 1.546 0.793 1 C-N-CA 132.991 4.516 . . . . 2.75 104.918 158.843 . . . . . . . . 2 1 . 1 . 010 nuclear build core ' A' A 1177 ' ' GLN . . . . . 0.467 ' HG2' ' HB ' ' A' 1124 ' ' THR . 54.4 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 122.141 0.972 . . . . 1.9399999999999999 111.276 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.46 127.34 53.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.675 1.19 . . . . 2.79 108.577 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -86.64 123.36 31.74 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.751 -0.833 . . . . 1.53 108.751 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -132.77 139.54 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.289 0.495 . . . . 0.79000000000000004 111.934 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.16 147.51 36.75 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.564 1.146 . . . . 0.57999999999999996 112.471 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.9 tt -141.59 138.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.302 1.441 . . . . 0.48999999999999999 108.717 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 171.82 -166.85 39.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 117.142 1.617 . . . . 1.4099999999999999 117.142 -174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.31 162.76 17.21 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.362 3.065 . . . . 2.4900000000000002 111.895 -169.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -44.21 -65.09 0.55 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.344 1.609 . . . . 7.8200000000000003 115.344 -167.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.42 -34.3 70.21 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.863 1.21 . . . . 3.25 113.765 -171.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -68.99 -27.88 66.1 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.005 -1.059 . . . . 2.8700000000000001 112.443 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 55.2 tpp -70.69 -42.88 70.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.103 0.561 . . . . 2.1400000000000001 112.292 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 97.4 mt -49.3 -61.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 109.504 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -51.31 -11.57 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.071 2.249 . . . . 6.1900000000000004 117.071 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.28 15.49 0.44 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 121.988 2.176 . . . . 0.87 111.254 166.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.13 11.71 81.69 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 119.354 -2.091 . . . . 0.76000000000000001 114.589 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.82 159.68 25.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.902 1.351 . . . . 0.80000000000000004 111.306 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 74.1 t -94.23 122.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.352 . . . . 1.01 109.612 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.4 tt -96.48 132.25 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.245 1.018 . . . . 1.1699999999999999 110.277 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -93.21 153.9 18.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.521 1.128 . . . . 4.0199999999999996 112.879 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.88 -32.9 73.3 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.156 -0.965 . . . . 2.7999999999999998 112.997 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.91 -44.65 80.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.922 0.889 . . . . 2.6800000000000002 112.139 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.9 p -73.4 -31.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.347 -0.846 . . . . 1.03 111.72 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -64.15 -38.68 91.93 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.898 1.227 . . . . 2.2400000000000002 111.624 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.75 -33.69 75.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.955 0.902 . . . . 2.5099999999999998 112.151 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.75 -44.3 81.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.025 1.73 . . . . 2.6099999999999999 112.096 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 27.0 tpp -62.59 -50.37 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.26 1.424 . . . . 0.81999999999999995 110.73 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.0 t -72.23 -30.9 65.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.819 0.674 . . . . 1.02 112.819 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.63 -51.77 67.43 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.042 1.292 . . . . 2.5600000000000001 112.234 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.52 -30.9 68.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.868 0.692 . . . . 2.6299999999999999 112.868 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.1 -41.27 90.85 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 121.357 -0.839 . . . . 2.5699999999999998 111.884 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.37 -22.73 61.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 114.232 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 22.3 mttp -73.13 -5.35 38.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.077 2.151 . . . . 2.52 114.406 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 96.68 9.88 55.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.128 1.347 . . . . 1.79 115.246 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -113.73 -176.94 3.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.332 1.453 . . . . 3.3300000000000001 111.53 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.6 m -102.53 138.35 39.57 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.091 1.756 . . . . 0.93999999999999995 111.023 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.56 127.77 35.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.985 1.314 . . . . 0.55000000000000004 111.431 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.4 m -140.14 159.6 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.358 1.063 . . . . 0.55000000000000004 112.965 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.44 155.04 21.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.895 1.678 . . . . 1.1399999999999999 110.942 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.1 p -132.86 130.32 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.48 1.112 . . . . 2.0099999999999998 112.61 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.46 154.59 46.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.944 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.7 m -148.72 130.05 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.462 0.705 . . . . 0.83999999999999997 112.416 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 9.5 m-20 41.35 43.61 2.15 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 3.2000000000000002 112.853 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.312 14.8 m-20 68.86 30.63 4.63 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 117.095 2.258 . . . . 2.2799999999999998 117.095 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.71 141.16 50.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.225 1.81 . . . . 2.5600000000000001 109.871 165.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1222 ' ' LEU . . . . . 0.488 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -78.74 109.75 13.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.73 -1.231 . . . . 1.5700000000000001 111.077 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -94.42 -27.59 15.95 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.027 -1.046 . . . . 0.51000000000000001 112.771 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.27 -176.29 40.96 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 116.336 1.294 . . . . 0.44 116.336 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.39 154.31 45.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.461 1.904 . . . . 0.69999999999999996 111.905 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 4.0 mt -136.78 135.61 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.917 1.287 . . . . 1.5700000000000001 110.62 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.39 137.83 45.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.058 1.343 . . . . 0.68000000000000005 110.678 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.25 145.65 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.163 1.785 . . . . 1.6399999999999999 108.925 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.519 0 C-N-CA 124.218 1.007 . . . . 1.5700000000000001 111.618 176.645 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 115.332 1.604 . . . . 2.5899999999999999 115.332 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1054 ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' 1091 ' ' ALA . 44.1 Cg_endo -81.48 158.4 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.773 1 C-N-CA 125.552 4.168 . . . . 1.97 112.73 176.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 2.4 m -139.76 130.11 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.84 1.656 . . . . 2.6499999999999999 111.734 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.254 8.7 p -77.07 129.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.048 -1.033 . . . . 1.4299999999999999 112.342 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.82 -39.84 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.042 0.937 . . . . 2.3900000000000001 113.42 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -149.09 151.58 34.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.095 1.358 . . . . 2.8999999999999999 111.314 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 8.6 m -135.41 146.6 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.397 1.079 . . . . 0.89000000000000001 111.356 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 68.1 tttt -141.53 138.9 33.06 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.47 1.108 . . . . 1.6899999999999999 112.854 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.9 t -88.82 142.39 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.284 1.033 . . . . 0.72999999999999998 111.286 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1062 ' ' LEU . . . . . 0.479 HD23 HD22 ' A' 1222 ' ' LEU . 30.2 tp -106.21 -39.85 5.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.525 1.53 . . . . 1.4099999999999999 111.977 170.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 53.1 m -124.81 97.17 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.682 0.674 . . . . 1.8500000000000001 112.502 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.82 111.61 5.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.469 1.507 . . . . 5.9900000000000002 108.26 168.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 8.6 t -178.37 -52.8 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.563 1.945 . . . . 5.04 110.777 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 6.7 m120 -150.24 41.76 0.82 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.748 1.619 . . . . 6.6399999999999997 112.932 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -146.82 -58.57 0.28 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.507 -1.37 . . . . 4.7999999999999998 112.876 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.16 155.23 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.524 1.53 . . . . 2.27 110.247 -173.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 15.3 m -110.01 143.12 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.306 1.042 . . . . 2.8599999999999999 110.767 172.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -54.03 -42.23 68.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.286 2.328 . . . . 4.0999999999999996 117.286 -168.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 46.9 m80 -68.59 -29.06 67.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.984 1.265 . . . . 4.6699999999999999 111.81 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.27 -40.19 77.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 117.93 -1.033 . . . . 3.7000000000000002 111.315 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 82.3 mt -55.15 -54.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 118.968 0.804 . . . . 0.85999999999999999 110.536 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.51 -33.16 74.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.683 -0.635 . . . . 0.77000000000000002 112.152 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.11 81.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.542 0.571 . . . . 0.51000000000000001 112.542 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.0 pt -69.84 -31.25 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.546 1.066 . . . . 0.52000000000000002 112.921 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 48.0 t -71.12 -49.88 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.007 0.822 . . . . 0.57999999999999996 111.635 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.68 -33.86 87.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.376 -0.828 . . . . 0.68000000000000005 113.903 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 34.9 p -74.27 -37.88 63.59 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.822 0.849 . . . . 0.75 112.581 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.39 82.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.069 0.849 . . . . 0.68000000000000005 112.772 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -66.62 -18.97 65.65 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.858 -1.151 . . . . 2.2400000000000002 113.362 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 1.6 t -64.91 -15.52 62.14 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.062 -1.024 . . . . 1.74 112.722 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -128.66 -20.22 3.61 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.075 1.35 . . . . 3.1899999999999999 114.205 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.9 t -70.44 -44.61 67.49 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.908 -1.12 . . . . 3.9700000000000002 112.313 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . 0.301 33.1 mt-10 70.74 32.29 2.54 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.423 1.889 . . . . 5.2300000000000004 115.386 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.98 146.32 63.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.263 1.425 . . . . 1.6499999999999999 113.468 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.42 -54.15 3.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.985 3.79 . . . . 1.28 114.352 -169.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -68.05 -33.69 75.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.818 1.247 . . . . 0.91000000000000003 111.459 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.34 -22.31 63.16 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.207 1.384 . . . . 0.90000000000000002 114.813 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 51.7 p -61.92 -35.9 79.75 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.934 1.367 . . . . 2.23 112.611 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1091 ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' 1054 ' ' PRO . . . -56.97 -41.95 79.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.125 0.97 . . . . 0.94999999999999996 112.168 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.2 mt -72.64 -43.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.352 0.661 . . . . 0.73999999999999999 111.278 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 5.3 t -66.27 -40.59 90.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.867 -0.587 . . . . 2.0 112.082 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -62.18 -48.82 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.875 0.761 . . . . 3.1499999999999999 111.964 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -56.4 -42.95 78.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.033 0.833 . . . . 2.02 112.003 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.8 t -61.31 -54.34 45.24 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.771 -0.581 . . . . 1.78 111.277 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.78 -32.67 67.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.588 1.155 . . . . 2.6299999999999999 113.096 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -71.59 -48.91 45.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.098 1.759 . . . . 4.0099999999999998 112.856 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.92 -38.19 76.17 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.389 -1.444 . . . . 2.4500000000000002 112.583 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 -21.3 60.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.072 0.949 . . . . 1.4199999999999999 113.323 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.92 28.4 2.83 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.512 1.925 . . . . 3.8599999999999999 114.057 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -128.81 139.37 52.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.919 -1.113 . . . . 2.7200000000000002 113.86 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -77.25 -11.29 59.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.765 1.226 . . . . 3.8300000000000001 112.542 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 65.4 p -80.32 47.93 0.97 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.011 2.125 . . . . 4.6799999999999997 114.21 -171.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.15 148.08 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.821 1.045 . . . . 1.1499999999999999 113.821 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 75.83 128.41 0.26 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.79 1.662 . . . . 1.3999999999999999 114.351 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.27 -154.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.797 2.039 . . . . 2.54 108.273 172.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 142.17 50.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.766 1.765 . . . . 1.6399999999999999 115.766 -167.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.11 153.33 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 1 C-N-CA 132.472 4.309 . . . . 2.21 107.552 -169.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -140.57 117.88 11.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.256 -1.757 . . . . 2.7200000000000002 106.256 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 166.77 10.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.496 2.036 . . . . 3.5600000000000001 116.496 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -132.91 131.51 40.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.295 2.238 . . . . 4.1500000000000004 108.518 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.26 137.32 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.878 0.871 . . . . 2.6800000000000002 112.044 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 28.6 t -137.3 114.84 9.82 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.421 1.488 . . . . 1.74 107.532 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.76 147.7 45.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.083 2.522 . . . . 2.6899999999999999 112.607 -172.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 61.23 17.29 52.06 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.657 1.122 . . . . 1.6699999999999999 114.026 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 38.9 t -139.94 -63.51 0.5 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.746 1.218 . . . . 2.52 113.015 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.17 -152.47 23.64 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 120.583 1.538 . . . . 0.81999999999999995 115.946 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.33 150.23 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.735 1.614 . . . . 2.4100000000000001 113.179 -168.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.2 t -130.16 142.38 50.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.12 1.368 . . . . 0.51000000000000001 109.41 165.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.45 172.87 17.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.46 1.652 . . . . 0.54000000000000004 115.46 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -118.83 98.33 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 1.1799999999999999 109.326 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.2 p -112.17 128.38 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.679 0.792 . . . . 2.0699999999999998 112.829 -168.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1124 ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' 1177 ' ' GLN . 5.6 t -110.38 -163.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.721 1.209 . . . . 1.53 112.998 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.327 3.5 m120 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 128.557 2.743 . . . . 5.5099999999999998 116.842 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1177 ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' 1124 ' ' THR . 35.6 tt0 . . . . . 0 C--O 1.238 0.457 0 CA-C-O 120.967 0.413 . . . . 2.0099999999999998 110.624 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 125.02 31.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 3.29 110.152 -173.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.9 tttt -79.6 116.93 20.09 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.533 -0.914 . . . . 1.29 108.533 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.7 m -133.67 145.11 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.847 0.859 . . . . 0.53000000000000003 112.124 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -146.02 151.66 38.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.704 1.001 . . . . 0.54000000000000004 113.704 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.86 142.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.163 1.385 . . . . 0.48999999999999999 110.209 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 132.34 143.85 5.19 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 115.492 0.957 . . . . 1.4399999999999999 115.492 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 7.7 t-20 43.38 -143.99 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.299 1.84 . . . . 2.4300000000000002 112.281 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.919 1.688 . . . . 7.21 113.064 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -65.3 -36.43 84.04 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.328 -0.858 . . . . 4.5599999999999996 112.018 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1187 ' ' TRP . . . . . 0.454 ' CE3' ' HD3' ' A' 1190 ' ' ARG . 4.9 m95 -57.03 -30.0 63.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.144 1.164 . . . . 3.75 114.144 172.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.7 mmt -72.05 -37.72 69.62 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.499 0.666 . . . . 2.3500000000000001 111.626 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.15 -67.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 126.304 1.842 . . . . 1.7 108.259 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1190 ' ' ARG . . . . . 0.454 ' HD3' ' CE3' ' A' 1187 ' ' TRP . 34.5 ttt85 -36.49 -43.51 0.4 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.292 2.637 . . . . 6.6600000000000001 114.899 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 13.74 5.73 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.28 1.215 . . . . 0.82999999999999996 114.28 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 69.88 23.76 76.77 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.095 -1.628 . . . . 0.68999999999999995 115.542 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.16 171.41 12.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.642 1.177 . . . . 0.81000000000000005 112.059 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -99.66 133.34 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.006 1.322 . . . . 1.4399999999999999 109.699 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.7 tt -138.78 147.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.761 1.224 . . . . 1.26 111.11 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.69 151.32 32.0 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.101 1.36 . . . . 2.6699999999999999 113.258 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.07 -26.36 67.45 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.18 -0.95 . . . . 3.8399999999999999 112.84 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.54 -36.39 76.32 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.002 -1.061 . . . . 3.3900000000000001 113.213 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -77.16 -36.93 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.724 0.693 . . . . 1.1000000000000001 111.438 170.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.1 t30 -62.85 -37.72 87.95 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.746 0.703 . . . . 2.52 111.979 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.84 -39.05 93.17 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.475 1.11 . . . . 2.9399999999999999 112.971 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.56 -37.64 80.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.996 -1.065 . . . . 2.5299999999999998 111.75 171.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -66.25 -52.16 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.596 1.158 . . . . 1.1499999999999999 112.01 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.8 t -68.76 -34.62 75.88 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.376 -0.828 . . . . 1.3899999999999999 112.263 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.37 -49.05 68.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.048 0.84 . . . . 3.2599999999999998 111.055 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1206 ' ' HIS . . . . . 0.474 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 57.4 t-80 -66.66 -39.57 88.24 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.388 1.075 . . . . 3.9500000000000002 112.383 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -63.75 -42.31 97.86 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.305 -0.872 . . . . 2.7400000000000002 112.804 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -70.59 -28.73 65.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.181 1.792 . . . . 4.2400000000000002 112.785 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.6 mttp -66.81 -12.61 59.57 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.085 1.754 . . . . 3.1200000000000001 113.565 169.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.89 15.08 71.04 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.188 1.375 . . . . 1.25 114.73 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -106.98 156.57 18.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.818 1.309 . . . . 3.7599999999999998 110.561 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 27.3 m -77.35 128.35 34.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.571 1.549 . . . . 1.55 112.945 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.42 118.1 16.03 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.674 0.789 . . . . 0.67000000000000004 113.122 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 23.6 m -141.15 157.09 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 114.75 1.389 . . . . 0.5 114.75 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.91 165.88 10.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.465 . . . . 0.84999999999999998 113.539 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1216 ' ' VAL . . . . . 0.402 ' O ' HD23 ' A' 1222 ' ' LEU . 3.7 t -136.96 134.9 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.597 1.959 . . . . 1.8999999999999999 110.816 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -137.24 157.98 45.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.28 1.432 . . . . 0.48999999999999999 111.082 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 17.9 m -144.93 138.03 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.546 -1.346 . . . . 0.96999999999999997 111.394 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 32.8 t70 41.7 48.71 3.7 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.984 2.113 . . . . 2.77 112.377 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.28 3.4 m-20 65.6 32.7 9.06 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.996 2.118 . . . . 1.73 115.995 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.67 145.51 36.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.596 1.558 . . . . 2.25 111.189 169.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1222 ' ' LEU . . . . . 0.479 HD22 HD23 ' A' 1062 ' ' LEU . 0.2 OUTLIER -68.83 145.68 53.52 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.405 -1.434 . . . . 0.80000000000000004 111.182 172.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -121.33 -43.3 2.42 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.496 0.924 . . . . 0.56000000000000005 113.496 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.28 -173.3 38.84 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.17 0.895 . . . . 0.41999999999999998 115.062 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.26 152.94 42.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.365 1.466 . . . . 0.64000000000000001 113.399 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.07 135.34 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.463 1.505 . . . . 0.79000000000000004 111.101 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1227 ' ' ALA . . . . . 0.474 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -121.38 124.82 45.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.56 2.344 . . . . 0.65000000000000002 109.601 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.13 159.84 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.269 1.828 . . . . 1.45 111.579 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.627 1.171 . . . . 1.6000000000000001 112.402 169.304 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.732 -0.652 . . . . 2.8500000000000001 110.82 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 148.44 52.52 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.377 2.718 . . . . 1.6399999999999999 112.19 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.1 p -138.07 125.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.863 1.265 . . . . 2.29 111.754 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.8 p -72.13 133.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.1 -1.0 . . . . 1.04 111.518 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -126.18 -34.92 2.48 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.524 1.675 . . . . 2.3599999999999999 115.524 -166.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -155.03 151.17 28.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.294 1.438 . . . . 2.0 111.03 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.2 m -130.03 142.35 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.32 1.048 . . . . 0.76000000000000001 111.284 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 40.1 tttt -139.61 147.14 40.68 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.096 0.958 . . . . 1.76 112.173 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 43.5 t -96.78 136.99 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.123 1.369 . . . . 0.76000000000000001 111.294 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 34.6 tp -100.32 -25.7 14.15 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.873 1.669 . . . . 0.81999999999999995 112.931 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.5 t -104.75 24.3 12.03 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.562 1.319 . . . . 2.3199999999999998 114.562 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -56.07 128.19 34.21 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.714 -1.241 . . . . 3.77 110.49 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 60.48 -1.15 0.23 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.949 1.833 . . . . 3.0800000000000001 115.949 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.74 -32.35 8.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.071 1.305 . . . . 4.3099999999999996 113.191 -171.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -155.61 -46.53 0.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.259 1.577 . . . . 4.2199999999999998 115.259 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.16 146.48 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.092 1.357 . . . . 1.6799999999999999 111.172 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -98.65 157.42 16.27 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.323 1.449 . . . . 1.78 112.841 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -61.14 -38.5 86.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.976 2.213 . . . . 3.4900000000000002 116.976 -166.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -71.24 -34.69 71.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.288 1.404 . . . . 3.5299999999999998 111.099 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 94.7 mttt -61.15 -44.3 97.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.162 0.585 . . . . 3.8500000000000001 110.804 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.28 -53.51 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.052 0.941 . . . . 0.54000000000000004 111.198 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.91 -32.06 73.07 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.402 -0.811 . . . . 0.58999999999999997 112.189 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.42 68.55 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.531 0.732 . . . . 0.58999999999999997 112.013 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.1 pt -70.25 -32.66 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.005 1.275 . . . . 0.56000000000000005 113.095 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.9 t -70.4 -48.01 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.804 1.184 . . . . 0.56999999999999995 111.387 172.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.85 92.42 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.258 -0.901 . . . . 0.56000000000000005 113.321 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 71.7 p -77.58 -27.0 51.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.821 1.045 . . . . 0.70999999999999996 113.821 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.63 91.92 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.006 0.821 . . . . 0.67000000000000004 112.5 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.48 -12.38 60.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.807 1.04 . . . . 1.9399999999999999 113.807 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 35.4 t -54.51 -43.11 71.58 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.186 1.394 . . . . 1.53 114.543 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -92.14 2.61 56.48 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.051 0.76 . . . . 2.0600000000000001 113.051 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.9 t -89.19 168.17 12.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.058 1.343 . . . . 1.6299999999999999 112.761 -173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -133.64 80.09 1.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.211 1.405 . . . . 4.6699999999999999 109.823 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -141.39 152.0 62.68 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.964 1.705 . . . . 2.2000000000000002 110.917 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.77 -35.81 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.304 2.669 . . . . 1.6100000000000001 115.19 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.24 -41.35 9.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.721 1.208 . . . . 1.1299999999999999 113.456 -166.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -76.99 -34.82 40.91 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 114.541 0.576 . . . . 1.04 114.541 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 59.4 p -64.28 -17.28 63.48 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.87 -1.37 . . . . 1.75 113.142 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.15 82.93 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.866 -1.146 . . . . 1.0700000000000001 111.965 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 4.8 mp -72.23 -32.72 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.43 0.692 . . . . 1.3 110.728 171.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 94.9 m -56.1 -47.61 77.72 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 117.424 -1.274 . . . . 1.3300000000000001 111.395 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 46.9 tttt -62.39 -46.17 89.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.301 1.41 . . . . 2.8100000000000001 112.789 175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 4.0 t80 -55.94 -42.33 76.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.348 1.059 . . . . 2.0099999999999998 111.476 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.1 t -70.66 -52.55 20.46 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.611 1.564 . . . . 2.25 112.355 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -47.76 -47.63 30.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.874 1.67 . . . . 2.5499999999999998 111.927 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.82 -30.41 65.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.077 0.951 . . . . 4.1100000000000003 113.243 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.18 -42.22 72.7 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.636 1.107 . . . . 3.71 112.662 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.01 -33.63 61.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.006 1.323 . . . . 1.6299999999999999 114.48 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.28 42.64 25.98 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.487 1.915 . . . . 3.1800000000000002 114.334 -172.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -119.78 -21.7 7.13 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.409 1.633 . . . . 4.1200000000000001 115.409 -172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.8 tt0 58.8 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.154 2.582 . . . . 3.0099999999999998 117.403 -171.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 75.2 p -95.54 22.23 7.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.275 2.23 . . . . 2.9100000000000001 113.917 -170.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.59 147.13 53.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.753 1.221 . . . . 0.88 113.847 -169.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 66.44 -173.35 25.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.272 0.929 . . . . 1.5700000000000001 114.639 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -160.45 -51.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.066 1.347 . . . . 1.45 111.629 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 31.6 t -138.24 142.53 39.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.405 1.082 . . . . 1.3700000000000001 113.58 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.12 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 1 C-N-CA 131.728 4.011 . . . . 2.9199999999999999 109.229 168.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -20.31 12.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.944 1.461 . . . . 3.2400000000000002 114.944 -169.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 51.3 m-85 60.8 105.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.507 2.723 . . . . 4.54 117.35 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -120.91 107.09 12.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.448 2.299 . . . . 2.5899999999999999 107.493 168.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.7 m -98.4 145.17 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.41 0.684 . . . . 2.1699999999999999 111.96 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 18.7 t -136.99 85.15 23.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 106.552 -1.647 . . . . 1.26 106.552 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -53.1 134.27 55.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.825 3.683 . . . . 1.76 114.708 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 65.22 10.05 45.46 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.855 -0.969 . . . . 1.9399999999999999 114.457 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 22.8 m -127.51 -49.11 1.4 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.09 1.445 . . . . 3.2200000000000002 111.933 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 173.14 -170.89 44.04 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.499 0.571 . . . . 1.1499999999999999 114.096 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 4.3 tt -141.71 158.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.4 1.08 . . . . 2.04 111.665 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 18.7 t -139.0 152.92 48.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.618 1.167 . . . . 0.73999999999999999 111.903 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 9.2 p -164.2 167.96 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.495 1.118 . . . . 0.97999999999999998 112.648 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -110.08 123.1 49.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.307 1.043 . . . . 1.1499999999999999 109.258 172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.7 t -105.01 145.21 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 123.92 0.888 . . . . 2.27 111.37 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.88 160.54 41.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.305 1.05 . . . . 0.94999999999999996 113.542 164.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 CA--C 1.55 0.946 0 C-N-CA 130.674 3.59 . . . . 2.2000000000000002 108.24 163.914 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.633 0.73 . . . . 2.3300000000000001 112.776 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -122.42 128.17 50.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.578 1.551 . . . . 3.0600000000000001 110.973 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.4 tttt -88.14 126.56 35.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.987 0.915 . . . . 1.23 109.073 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.6 m -134.49 151.89 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 113.748 1.018 . . . . 0.87 113.748 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.49 152.35 30.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.159 1.384 . . . . 0.44 113.005 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 10.7 tt -149.36 139.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.144 1.378 . . . . 0.54000000000000004 110.31 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.9 -142.38 9.09 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.908 1.123 . . . . 1.45 115.908 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.41 161.48 2.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.64 2.376 . . . . 2.1099999999999999 114.456 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -24.99 63.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.091 1.356 . . . . 6.3300000000000001 113.68 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -76.61 -32.14 57.87 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.868 1.213 . . . . 3.0499999999999998 113.652 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.2 t90 -64.05 -21.17 66.41 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 119.994 -1.692 . . . . 2.96 112.484 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -63.92 -33.9 76.74 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.846 -1.158 . . . . 2.3799999999999999 111.256 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 24.3 mt -66.83 -64.84 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.844 1.658 . . . . 2.3199999999999998 109.169 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -52.58 -30.86 33.28 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.277 1.431 . . . . 5.1600000000000001 114.344 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.1 6.07 23.69 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.302 1.441 . . . . 0.81999999999999995 113.954 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.99 29.8 72.35 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.95 1.738 . . . . 0.69999999999999996 115.081 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 4.6 mt -96.24 160.7 14.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.84 1.256 . . . . 0.82999999999999996 109.647 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 58.5 t -110.74 124.5 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.499 0.719 . . . . 1.27 110.559 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -95.63 149.44 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.018 0.927 . . . . 1.1399999999999999 111.004 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -124.06 154.38 40.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.828 1.251 . . . . 3.0899999999999999 111.495 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -56.92 -32.09 65.6 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.813 1.412 . . . . 2.4199999999999999 114.813 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.54 -53.56 46.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.54 1.136 . . . . 3.9900000000000002 111.391 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1199 ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' 1199 ' ' VAL . 1.8 p -73.48 -34.3 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.171 1.388 . . . . 1.24 111.638 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.74 -42.74 97.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.742 0.817 . . . . 1.8100000000000001 111.593 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.27 -44.4 91.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.622 0.646 . . . . 2.29 112.321 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.87 -36.17 82.68 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.346 1.058 . . . . 2.2200000000000002 112.22 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 18.1 tpp -62.62 -55.12 30.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.369 1.068 . . . . 0.80000000000000004 111.687 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.3 t -68.56 -33.68 74.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.644 -0.66 . . . . 1.1000000000000001 111.938 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.191 1.397 . . . . 4.25 112.271 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.19 -39.66 71.69 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.883 1.068 . . . . 2.25 113.883 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.54 -39.72 84.9 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.602 -0.686 . . . . 3.0600000000000001 111.662 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -70.74 -18.62 62.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.523 2.329 . . . . 4.1600000000000001 113.786 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -71.89 -22.01 61.56 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.008 1.276 . . . . 3.0099999999999998 111.865 166.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.45 18.32 42.39 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.332 1.92 . . . . 1.78 114.303 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -106.03 -160.78 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.019 1.327 . . . . 4.5700000000000003 110.123 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 69.9 m -108.09 131.51 54.54 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.885 1.22 . . . . 0.82999999999999996 112.388 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.08 118.28 19.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.836 1.654 . . . . 0.58999999999999997 111.125 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -138.04 155.33 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.777 1.231 . . . . 0.56000000000000005 113.122 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.0 mp -113.42 159.95 18.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.971 1.309 . . . . 0.79000000000000004 112.587 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.7 t -127.74 123.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.919 1.687 . . . . 1.8400000000000001 110.397 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.62 147.29 48.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.784 1.234 . . . . 0.51000000000000001 110.634 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.58 134.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.928 0.891 . . . . 1.01 112.061 -172.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 41.09 49.73 3.15 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.047 1.739 . . . . 3.1600000000000001 112.043 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.272 24.0 m-20 54.2 36.15 24.3 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.907 2.883 . . . . 1.5 116.435 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.93 138.43 48.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.999 1.72 . . . . 2.3399999999999999 110.68 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.25 133.77 48.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.642 -1.286 . . . . 0.72999999999999998 110.762 169.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.2 p -115.76 -37.89 3.83 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -174.57 -171.46 38.8 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 119.806 1.185 . . . . 0.46999999999999997 115.349 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.81 154.09 44.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.739 1.616 . . . . 0.69999999999999996 113.025 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.12 133.04 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.723 1.609 . . . . 0.84999999999999998 110.016 -173.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -107.53 132.31 53.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.71999999999999997 110.77 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 24.9 mt -135.02 152.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.438 1.895 . . . . 1.1499999999999999 110.604 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 126.967 2.107 . . . . 1.4399999999999999 111.408 171.386 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 118.552 -0.737 . . . . 2.9700000000000002 110.39 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.38 135.07 16.22 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.823 2.349 . . . . 2.0800000000000001 111.465 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.7 p -135.25 132.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.478 -0.764 . . . . 2.6299999999999999 110.215 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 6.3 p -68.52 123.16 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.643 -0.66 . . . . 1.22 110.177 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 30.4 t30 -103.64 -39.44 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.85 1.26 . . . . 3.54 112.136 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.22 146.85 20.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.227 1.011 . . . . 2.3999999999999999 112.295 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 16.7 m -132.49 131.7 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.788 0.835 . . . . 0.68999999999999995 112.201 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 53.0 tttt -135.08 144.61 47.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.883 1.273 . . . . 1.55 113.224 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 87.7 t -79.17 147.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.054 1.341 . . . . 0.95999999999999996 110.659 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.9 tp -122.22 -24.1 5.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.59 1.556 . . . . 0.87 112.707 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 36.0 m -127.46 107.42 9.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.153 1.381 . . . . 1.77 109.431 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.34 130.51 49.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.535 1.134 . . . . 3.6400000000000001 111.788 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 59.8 m 51.61 31.21 7.45 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.132 1.773 . . . . 2.5299999999999998 115.528 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -137.98 5.5 2.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.965 1.306 . . . . 2.71 113.514 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -154.37 -79.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 5.6799999999999997 110.423 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.83 146.85 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 128.203 2.601 . . . . 1.99 109.032 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -97.93 155.64 16.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.245 1.418 . . . . 1.98 113.682 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -44.76 -49.42 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.669 2.47 . . . . 3.6899999999999999 117.669 -167.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.9 t60 -75.33 -28.18 59.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.433 1.47 . . . . 2.8399999999999999 111.348 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -65.17 -38.71 91.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.857 -1.152 . . . . 3.77 111.062 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.36 -51.85 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.088 0.955 . . . . 0.65000000000000002 110.603 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -31.81 73.0 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.124 0.874 . . . . 0.70999999999999996 112.262 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.78 54.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 0.64000000000000001 112.152 173.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 14.4 pt -69.14 -34.95 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.193 . . . . 0.76000000000000001 113.157 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 58.1 t -70.75 -45.07 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.133 0.878 . . . . 0.88 111.361 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.0 -36.18 91.66 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.487 -0.758 . . . . 0.91000000000000003 113.304 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.0 p -72.76 -34.89 67.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.45 0.907 . . . . 0.98999999999999999 113.45 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -58.05 -51.79 68.23 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.275 0.943 . . . . 1.0 112.64 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.52 -13.66 61.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.875 1.065 . . . . 2.5600000000000001 113.875 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 9.1 p -65.16 -20.85 66.64 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.058 -1.651 . . . . 1.6299999999999999 112.667 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -122.99 16.84 10.06 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.973 1.709 . . . . 2.0299999999999998 112.636 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.5 t -127.83 -176.93 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.524 1.93 . . . . 1.5 110.197 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -142.94 46.77 1.55 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.294 1.438 . . . . 3.8100000000000001 112.607 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.16 164.76 22.01 Favored Pre-proline 0 CA--C 1.554 1.123 0 O-C-N 121.274 -0.891 . . . . 1.9199999999999999 112.441 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.73 -22.61 5.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.193 2.596 . . . . 1.3400000000000001 115.314 -169.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 10.3 tt -112.8 -48.59 2.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.437 1.095 . . . . 1.05 112.848 -169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -66.04 -21.22 69.61 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.18 0.832 . . . . 0.89000000000000001 115.18 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 67.4 p -62.98 -16.8 60.89 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.942 1.371 . . . . 1.3999999999999999 113.979 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.33 78.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.013 -1.054 . . . . 0.75 111.737 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.69 -38.95 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.205 1.402 . . . . 0.83999999999999997 110.232 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 90.9 m -53.08 -47.86 68.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 111.704 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -60.45 -51.0 71.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.649 0.78 . . . . 2.6899999999999999 112.252 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.02 -41.28 78.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.214 0.605 . . . . 3.29 111.95 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.1 t -67.65 -56.9 7.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.478 1.511 . . . . 1.71 112.246 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -50.55 -45.49 56.94 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.014 1.279 . . . . 3.8399999999999999 110.88 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -70.98 -32.44 69.29 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.222 1.009 . . . . 3.6000000000000001 113.361 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -72.06 -41.4 67.44 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.73 1.15 . . . . 2.1899999999999999 113.789 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.33 -16.21 61.88 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.715 1.206 . . . . 1.04 112.388 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.12 46.17 9.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.847 2.459 . . . . 2.7400000000000002 112.064 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.83 143.34 26.24 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.525 -0.734 . . . . 2.7599999999999998 111.937 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -99.4 -0.42 40.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.173 0.989 . . . . 3.5 112.518 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 63.3 p -101.21 9.02 42.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.305 1.842 . . . . 3.52 114.701 -168.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -67.55 149.37 50.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.979 1.312 . . . . 1.3 112.78 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.44 168.26 19.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.399 1.476 . . . . 1.3200000000000001 115.758 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 9.8 m -160.76 -49.97 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.123 -1.222 . . . . 1.3 113.516 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 53.6 t -136.29 142.68 43.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.503 1.521 . . . . 1.8200000000000001 114.745 -168.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.2 mm -138.71 148.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 130.346 3.458 . . . . 2.29 109.317 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 19.2 t0 -131.93 98.38 4.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.964 1.706 . . . . 2.5600000000000001 106.798 166.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1111 ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' 1119 ' ' ILE . 60.6 t80 -73.57 124.42 25.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.478 1.911 . . . . 4.1799999999999997 114.544 -167.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.26 123.47 25.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.443 1.897 . . . . 2.3199999999999998 108.213 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 7.4 p -129.47 149.06 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.023 1.86 . . . . 3.1000000000000001 116.023 -166.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 52.8 t -128.41 102.79 20.41 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.098 1.359 . . . . 1.7 107.419 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -57.67 133.79 58.77 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.174 2.582 . . . . 1.47 113.821 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.11 11.38 70.43 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.813 1.197 . . . . 1.5800000000000001 115.499 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 33.2 t -138.89 -41.73 0.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.655 1.227 . . . . 1.9399999999999999 114.044 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 174.58 -177.86 46.57 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 115.661 1.024 . . . . 0.75 115.661 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1119 ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' 1111 ' ' PHE . 0.1 OUTLIER -142.71 149.05 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 1.8300000000000001 111.218 170.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.5 t -131.41 142.93 50.12 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.188 2.195 . . . . 0.48999999999999999 109.137 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.1 p -153.84 165.68 35.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.929 1.085 . . . . 0.66000000000000003 113.929 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -114.66 122.45 46.5 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.032 -1.099 . . . . 1.27 108.032 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 33.1 m -124.34 136.63 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.224 0.609 . . . . 2.25 112.294 -170.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.6 t -122.95 145.4 48.51 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.884 0.373 . . . . 1.01 111.037 166.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 59.8 t30 . . . . . 0 CA--C 1.545 0.778 0 C-N-CA 126.71 2.004 . . . . 3.3599999999999999 107.184 158.912 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 113.78 1.03 . . . . 2.27 113.78 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -89.92 137.64 32.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.03 1.332 . . . . 3.1699999999999999 109.457 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.87 119.75 31.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.015 0.926 . . . . 1.53 109.058 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.9 m -133.91 138.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 118.878 0.763 . . . . 0.48999999999999999 112.342 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -144.92 154.66 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.113 0.965 . . . . 0.37 113.542 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.4 tt -149.49 139.29 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.837 1.655 . . . . 0.81000000000000005 110.048 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 178.35 173.88 44.12 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.312 0.885 . . . . 1.47 115.312 -172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -57.65 -70.34 0.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.431 1.492 . . . . 3.8100000000000001 114.68 -169.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 -72.77 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.725 1.379 . . . . 5.5800000000000001 114.725 -177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.18 -31.48 70.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.527 1.512 . . . . 4.8300000000000001 113.413 -168.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 15.3 t90 -68.25 -23.39 64.78 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.396 -1.44 . . . . 3.04 113.117 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 80.2 mmm -72.04 -40.65 68.23 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.789 0.836 . . . . 2.6499999999999999 110.979 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.38 -64.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.252 1.421 . . . . 2.2400000000000002 109.482 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -51.69 -9.64 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.908 2.483 . . . . 6.8499999999999996 116.6 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.31 13.56 0.72 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 120.903 1.683 . . . . 0.76000000000000001 111.106 167.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 71.31 33.66 64.43 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 119.475 -2.016 . . . . 1.0700000000000001 114.001 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.25 172.91 6.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.947 1.299 . . . . 0.81000000000000005 110.836 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.3 t -117.27 138.55 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.808 1.243 . . . . 1.02 110.28 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 17.7 tt -114.1 141.81 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.332 1.053 . . . . 1.0700000000000001 112.148 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 11.0 p30 -103.2 158.7 16.14 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.242 1.417 . . . . 4.2400000000000002 113.093 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -74.0 -21.96 59.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.248 1.203 . . . . 2.8399999999999999 114.248 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.18 -39.92 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.714 -1.241 . . . . 2.9100000000000001 112.161 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.6 p -70.32 -36.7 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.575 -0.703 . . . . 0.81999999999999995 111.111 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.7 t30 -64.44 -38.37 90.79 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.884 0.765 . . . . 2.2999999999999998 112.556 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -44.98 86.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.795 0.838 . . . . 2.1200000000000001 112.864 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 29.5 t80 -71.34 -43.03 67.79 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.54 0.736 . . . . 2.5600000000000001 112.393 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.3 tpp -56.84 -48.03 78.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.417 1.087 . . . . 0.97999999999999998 111.58 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -74.15 -34.74 63.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.94 -0.552 . . . . 1.3400000000000001 112.055 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.65 -45.33 85.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.115 1.325 . . . . 3.3300000000000001 111.818 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -65.3 -47.2 77.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.143 0.977 . . . . 3.8900000000000001 111.684 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.12 -34.61 76.68 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.332 -0.855 . . . . 4.1500000000000004 111.967 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -69.84 -15.26 63.07 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.586 1.554 . . . . 3.8199999999999998 113.78 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 63.1 mttt -73.58 -14.49 61.2 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 120.431 1.469 . . . . 3.6899999999999999 112.059 165.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.98 10.36 58.75 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 126.59 2.043 . . . . 1.79 113.556 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -115.69 132.34 56.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.886 1.274 . . . . 4.7800000000000002 111.343 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 99.6 m -59.61 128.25 36.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.619 1.341 . . . . 1.1499999999999999 114.619 -168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.87 130.05 49.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.841 1.256 . . . . 0.60999999999999999 111.777 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.8 m -140.9 154.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.345 1.458 . . . . 0.72999999999999998 113.247 -174.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.58 159.32 15.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.174 0.989 . . . . 1.0900000000000001 110.551 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.8 p -130.57 124.84 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.456 1.102 . . . . 2.1600000000000001 112.54 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.27 152.31 37.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.921 1.688 . . . . 0.40000000000000002 111.226 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.7 m -146.69 119.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.545 1.938 . . . . 0.72999999999999998 112.008 -167.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 46.46 47.48 14.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.984 2.114 . . . . 3.3700000000000001 113.215 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.321 34.0 m-20 63.38 26.77 15.1 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.228 2.611 . . . . 2.0899999999999999 116.382 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -125.66 153.67 43.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.216 2.206 . . . . 3.1899999999999999 110.824 167.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.6 mt -75.17 148.77 39.31 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.218 -1.551 . . . . 1.02 112.418 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.7 p -124.55 -36.94 2.56 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.08 0.771 . . . . 0.59999999999999998 113.08 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.47 -166.07 29.68 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 119.268 0.94 . . . . 0.58999999999999997 115.418 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.39 153.04 46.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.884 1.674 . . . . 0.78000000000000003 111.743 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.4 mm -132.19 140.58 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.796 1.638 . . . . 1.01 108.864 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -130.84 132.06 44.97 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.974 0.91 . . . . 1.05 111.025 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.19 155.87 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.975 2.11 . . . . 1.6200000000000001 110.099 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.856 0 C-N-CA 126.447 1.899 . . . . 1.5 112.945 170.612 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 113.079 0.77 . . . . 2.8500000000000001 113.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.51 87.22 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.856 2.371 . . . . 2.3500000000000001 110.035 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 47.0 t -65.9 109.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.38 1.072 . . . . 3.0499999999999998 111.107 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.7 p -71.17 131.42 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.605 -0.685 . . . . 1.3799999999999999 111.552 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -34.43 2.76 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.281 1.586 . . . . 2.2400000000000002 115.281 -167.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -155.12 145.93 22.42 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.753 1.161 . . . . 1.95 111.666 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.9 m -127.74 133.78 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.072 0.949 . . . . 1.1000000000000001 111.175 170.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 43.4 tttt -135.88 145.52 46.43 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.935 1.294 . . . . 1.6799999999999999 112.539 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 96.4 t -89.52 134.15 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.226 1.81 . . . . 1.03 111.077 173.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1062 ' ' LEU . . . . . 0.612 HD23 HD22 ' A' 1222 ' ' LEU . 30.3 tp -95.4 -38.53 10.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.898 1.679 . . . . 1.3 110.984 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 52.1 m -121.89 111.96 17.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.272 1.429 . . . . 1.78 110.213 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -109.74 136.26 49.36 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.776 1.23 . . . . 3.6299999999999999 112.854 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 57.93 -57.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 130.072 3.349 . . . . 4.2199999999999998 118.82 169.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m120 -70.35 -6.28 34.21 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.603 2.075 . . . . 5.1299999999999999 116.603 -166.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.05 -26.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.401 1.48 . . . . 9.0199999999999996 114.304 168.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mt -144.96 142.38 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.589 1.156 . . . . 2.48 107.969 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.3 m -91.76 144.08 25.87 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.425 0.69 . . . . 2.8300000000000001 111.489 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 27.9 p80 -57.31 -41.36 79.76 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.77 1.396 . . . . 3.8900000000000001 114.77 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 27.1 t60 -74.18 -29.3 61.7 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.075 -1.016 . . . . 2.6099999999999999 111.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.79 -37.5 84.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 117.493 -1.241 . . . . 5.3099999999999996 111.7 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.77 -56.63 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.728 1.149 . . . . 0.85999999999999999 110.309 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.46 -30.1 69.73 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.606 -0.684 . . . . 0.77000000000000002 112.184 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.7 76.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.759 -0.639 . . . . 0.87 112.596 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 17.3 pt -68.81 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.676 1.58 . . . . 0.90000000000000002 112.956 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 61.3 t -70.12 -50.77 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.512 1.051 . . . . 0.92000000000000004 111.349 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.7 84.8 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.526 -0.733 . . . . 0.95999999999999996 113.349 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 76.6 p -73.58 -35.62 65.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.692 -0.887 . . . . 1.0700000000000001 112.041 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -71.21 -39.72 71.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.932 1.086 . . . . 1.22 113.932 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.34 -6.94 53.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.952 1.464 . . . . 3.4900000000000002 114.952 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 84.7 p -58.68 -27.29 64.68 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.221 1.934 . . . . 2.6899999999999999 116.221 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -95.58 -6.84 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.212 0.914 . . . . 2.1099999999999999 113.201 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.1 t -79.77 162.03 25.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.562 1.145 . . . . 1.77 113.728 -174.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -112.64 -3.53 14.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.355 2.262 . . . . 4.3499999999999996 114.097 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -59.66 144.14 85.57 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.087 -1.008 . . . . 1.6200000000000001 112.282 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.29 -40.54 24.93 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.048 2.498 . . . . 1.8799999999999999 112.286 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.85 -44.47 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.32 -0.862 . . . . 1.8 111.922 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.61 98.26 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.539 0.59 . . . . 1.6599999999999999 113.162 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.2 p -64.32 -38.31 90.58 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.586 -0.95 . . . . 1.55 112.201 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.54 94.78 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.898 0.879 . . . . 1.0800000000000001 112.843 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 54.4 mt -68.29 -42.32 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.087 0.555 . . . . 0.88 110.214 173.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 96.7 m -54.43 -44.71 72.69 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.664 0.666 . . . . 1.23 111.514 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.4 tttt -60.13 -51.43 69.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.68 0.673 . . . . 2.3599999999999999 111.955 174.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.37 -42.52 82.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.714 0.806 . . . . 2.5099999999999998 111.77 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 69.1 m -70.82 -45.65 64.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.147 . . . . 2.9900000000000002 112.696 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.98 -34.86 78.43 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.346 1.884 . . . . 2.5699999999999998 111.371 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -65.08 -39.15 92.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.349 1.06 . . . . 3.9900000000000002 112.941 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.79 -44.57 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.861 -1.15 . . . . 2.8199999999999998 113.074 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.17 -3.1 18.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.848 1.425 . . . . 1.8500000000000001 114.848 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 31.4 t70 58.64 26.22 14.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.627 1.171 . . . . 5.0199999999999996 113.586 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.3 t -122.54 168.44 12.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.31 1.844 . . . . 2.5800000000000001 112.047 -170.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.27 -15.0 15.6 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.994 1.717 . . . . 4.0300000000000002 112.134 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.5 t -132.81 133.42 43.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.061 1.744 . . . . 2.7200000000000002 111.194 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.98 147.61 25.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.246 0.618 . . . . 1.1799999999999999 112.042 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 63.11 177.41 3.83 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.74 1.162 . . . . 1.55 115.08 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 70.7 m -138.47 -69.44 0.44 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.542 0.737 . . . . 1.45 111.414 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 48.9 t -136.11 141.4 44.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.197 0.599 . . . . 1.8999999999999999 111.898 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.98 148.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.255 2.622 . . . . 2.98 111.714 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -110.72 124.34 51.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.909 -2.626 . . . . 3.2999999999999998 103.909 163.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.1 OUTLIER -121.43 138.12 54.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.383 1.447 . . . . 3.1099999999999999 112.889 -174.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.95 98.03 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.385 2.274 . . . . 3.54 108.329 -169.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.5 t -96.22 126.62 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.555 -0.715 . . . . 2.23 110.692 -168.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 33.1 t -143.32 113.88 5.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.751 1.62 . . . . 1.6699999999999999 109.448 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.14 140.36 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.251 2.634 . . . . 1.47 113.925 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 55.4 35.68 61.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.6 1.095 . . . . 2.77 114.362 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 93.0 m -143.5 -32.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.784 1.234 . . . . 2.8799999999999999 113.791 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 122.18 -164.26 15.31 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.075 1.321 . . . . 0.75 112.629 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.33 151.14 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.542 -1.563 . . . . 1.96 111.249 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 14.5 t -129.87 140.5 50.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.732 1.613 . . . . 0.71999999999999997 109.859 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 13.5 p -143.97 156.93 44.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.469 1.032 . . . . 1.3799999999999999 113.682 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -116.23 97.75 6.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.509 1.124 . . . . 1.9399999999999999 108.735 -174.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.1 p -93.96 146.66 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.634 0.73 . . . . 2.2799999999999998 111.426 -174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.6 t -142.95 162.02 36.57 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.135 1.532 . . . . 1.6000000000000001 115.135 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 10.9 t-20 . . . . . 0 CA--C 1.546 0.811 1 C-N-CA 132.183 4.193 . . . . 3.1299999999999999 109.914 162.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 117.837 2.532 . . . . 2.21 117.837 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -71.2 115.92 10.91 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.898 -1.126 . . . . 2.77 110.545 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -88.14 125.24 34.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.333 -1.358 . . . . 1.8999999999999999 107.333 168.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.6 m -126.69 141.17 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.295 0.638 . . . . 0.95999999999999996 110.369 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.5 150.76 47.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.988 0.915 . . . . 0.52000000000000002 112.392 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.33 158.47 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.801 1.24 . . . . 0.46000000000000002 109.938 -169.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 104.85 159.18 23.58 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.75 0.691 . . . . 1.6299999999999999 114.783 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 49.53 -159.6 0.06 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.219 1.408 . . . . 2.4900000000000002 113.617 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -58.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.777 1.399 . . . . 7.4299999999999997 114.777 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -80.96 -37.76 28.84 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.152 0.887 . . . . 5.4299999999999997 113.002 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 83.6 t90 -54.73 -36.44 64.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.927 1.291 . . . . 3.0299999999999998 113.087 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.52 -36.36 80.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.665 1.186 . . . . 2.8300000000000001 113.244 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.8 mt -62.37 -61.44 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.723 1.609 . . . . 2.96 109.134 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.4 -13.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.544 2.338 . . . . 6.4800000000000004 116.268 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 6.0 t30 -74.28 22.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 121.694 2.043 . . . . 0.92000000000000004 113.153 168.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.95 26.44 73.23 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.894 -1.753 . . . . 0.84999999999999998 114.409 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 8.2 mt -96.44 147.7 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.052 1.426 . . . . 0.94999999999999996 110.066 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 89.7 t -97.37 126.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.328 1.051 . . . . 1.1299999999999999 110.385 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.0 148.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.977 0.911 . . . . 1.04 112.629 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.55 152.12 38.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.845 1.258 . . . . 2.77 113.583 -168.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -70.93 -28.02 64.2 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.462 1.282 . . . . 2.98 114.462 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.21 -36.64 69.24 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.761 -1.212 . . . . 2.5699999999999998 112.494 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -78.0 -36.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.905 0.882 . . . . 0.82999999999999996 113.286 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -54.0 -42.79 69.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.581 1.152 . . . . 3.1200000000000001 112.517 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.42 -40.01 96.03 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.045 0.938 . . . . 1.9099999999999999 113.086 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -39.03 75.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.687 1.195 . . . . 2.0499999999999998 110.879 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.4 tpp -62.99 -53.29 56.31 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.509 1.124 . . . . 0.77000000000000002 112.313 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 11.0 t -67.48 -32.07 72.64 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.665 -0.647 . . . . 1.03 112.485 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -57.43 -50.86 71.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.518 1.053 . . . . 3.1800000000000002 112.023 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -71.72 -33.94 69.17 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.314 0.857 . . . . 2.5 113.314 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1207 ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 51.0 mm-40 -68.21 -35.95 78.77 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.391 -0.818 . . . . 3.9399999999999999 112.564 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.82 -22.04 61.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.845 1.658 . . . . 4.25 113.524 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 21.5 mttp -76.51 -7.66 55.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.883 1.273 . . . . 3.1099999999999999 112.135 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.56 88.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.964 1.745 . . . . 2.3500000000000001 115.094 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . 0.259 16.0 mtt-85 -84.19 -152.36 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 3.3199999999999998 109.956 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 86.0 m -120.61 120.88 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 121.451 1.932 . . . . 0.77000000000000002 112.112 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.06 127.59 54.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.902 2.081 . . . . 0.48999999999999999 109.595 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 35.8 m -142.29 154.68 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 119.543 1.065 . . . . 0.45000000000000001 113.483 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.32 164.0 12.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.185 1.394 . . . . 1.0 111.731 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.9 t -135.83 129.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.695 1.598 . . . . 2.0699999999999998 111.168 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -134.43 153.01 52.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.166 1.386 . . . . 0.51000000000000001 111.99 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 23.8 m -149.25 130.45 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.879 . . . . 0.92000000000000004 112.899 -169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 35.7 m-20 41.89 40.67 1.62 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.262 1.825 . . . . 3.3900000000000001 111.577 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 62.48 30.62 17.22 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 128.125 2.57 . . . . 2.1099999999999999 116.787 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.14 135.16 54.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.735 2.014 . . . . 2.5600000000000001 110.199 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1222 ' ' LEU . . . . . 0.612 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -67.79 133.78 49.82 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.254 -1.529 . . . . 0.81999999999999995 111.523 172.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -116.83 -42.24 2.98 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.725 1.009 . . . . 0.63 113.725 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.13 -176.47 39.74 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 119.215 0.916 . . . . 0.64000000000000001 114.725 -172.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.03 155.05 44.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.865 1.666 . . . . 0.69999999999999996 112.852 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.63 134.48 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.535 1.534 . . . . 0.92000000000000004 110.266 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -112.93 131.86 55.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.246 1.418 . . . . 0.68000000000000005 110.904 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -128.86 147.61 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.734 2.014 . . . . 1.47 108.789 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 114.128 1.158 . . . . 4.0800000000000001 114.128 178.481 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 112.426 0.528 . . . . 2.73 112.426 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -95.04 156.75 1.74 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.198 3.265 . . . . 1.4099999999999999 111.969 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 30.8 t -134.93 113.08 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.609 1.164 . . . . 2.1899999999999999 109.588 173.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 5.8 p -73.06 132.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.777 1.171 . . . . 1.1699999999999999 110.697 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -125.57 -36.17 2.47 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 117.415 2.376 . . . . 2.23 117.415 -164.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -156.42 150.84 25.55 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.737 1.608 . . . . 1.9199999999999999 111.529 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -129.67 136.69 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.117 0.967 . . . . 1.1000000000000001 111.375 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -140.8 147.83 39.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.107 0.963 . . . . 3.1200000000000001 113.153 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 99.1 t -102.45 129.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.318 1.447 . . . . 1.1100000000000001 112.233 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.65 -35.81 9.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.024 1.73 . . . . 1.1100000000000001 112.673 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -111.01 88.66 2.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.634 1.574 . . . . 1.95 108.06 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.64 133.12 41.56 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.948 0.899 . . . . 3.5899999999999999 111.701 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 13.8 m 59.18 25.68 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.226 2.211 . . . . 2.25 115.097 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.61 -6.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.047 1.499 . . . . 2.7200000000000002 115.047 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -140.87 -77.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.891 1.277 . . . . 4.4900000000000002 110.799 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 20.9 mt -137.47 147.57 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.111 2.165 . . . . 1.74 110.075 -174.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.5 m -91.68 152.48 20.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.595 1.558 . . . . 1.8 113.704 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 12.2 p80 -53.81 -42.12 68.05 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.781 2.141 . . . . 3.0299999999999998 116.781 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -73.99 -23.1 59.41 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.073 -1.017 . . . . 2.8799999999999999 111.73 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.2 tttt -75.77 -39.17 57.5 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.095 0.958 . . . . 4.04 111.474 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 66.3 mt -56.38 -52.2 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 119.459 1.027 . . . . 0.73999999999999999 110.656 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.23 -33.34 75.53 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.588 -0.695 . . . . 0.62 112.072 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.02 75.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.722 0.638 . . . . 0.52000000000000002 112.722 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.67 -34.56 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.763 -1.211 . . . . 0.51000000000000001 113.381 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 73.5 t -70.64 -46.07 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.89 0.768 . . . . 0.60999999999999999 110.972 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -63.98 -37.41 94.58 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.662 -0.649 . . . . 0.59999999999999998 113.372 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 32.6 p -73.07 -37.26 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.917 0.887 . . . . 0.62 113.116 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.99 74.5 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.237 0.926 . . . . 0.63 112.247 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.57 -17.36 64.61 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.131 -0.981 . . . . 2.2400000000000002 112.771 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 4.2 t -60.51 -35.35 75.75 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.927 -1.108 . . . . 1.3999999999999999 112.077 170.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.88 -22.17 23.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.649 1.18 . . . . 2.0499999999999998 113.319 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.6 t -74.33 -179.56 4.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.284 1.034 . . . . 1.45 111.8 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -137.3 19.61 2.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.645 1.578 . . . . 4.29 112.691 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -75.95 161.21 76.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.854 1.262 . . . . 1.6599999999999999 112.617 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.02 -33.67 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.05 2.5 . . . . 1.1799999999999999 114.108 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.81 -49.35 5.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.572 1.549 . . . . 0.78000000000000003 112.722 -167.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.91 -31.62 81.42 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.003 0.335 . . . . 0.96999999999999997 113.772 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.5 p -66.31 -16.34 63.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.746 -1.444 . . . . 1.72 113.915 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.39 80.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.73 -1.231 . . . . 0.78000000000000003 110.737 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.91 -37.11 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.261 1.424 . . . . 0.92000000000000004 110.417 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 97.7 m -53.82 -48.26 70.08 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.074 0.852 . . . . 1.1599999999999999 111.863 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -64.0 -45.97 86.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.342 0.974 . . . . 3.6800000000000002 112.553 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.7 t80 -55.92 -43.92 77.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.919 0.888 . . . . 1.71 111.457 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.7 t -65.85 -52.09 53.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.416 1.487 . . . . 1.9199999999999999 111.864 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -51.51 -45.34 62.84 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.107 1.363 . . . . 3.0699999999999998 112.204 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.54 -43.19 77.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.501 0.72 . . . . 3.3100000000000001 111.559 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -62.19 -42.83 99.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.653 0.982 . . . . 2.6899999999999999 113.653 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.4 mt -71.39 -13.24 61.79 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.825 0.85 . . . . 1.04 112.66 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 15.7 t70 50.61 54.91 10.35 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.293 1.837 . . . . 2.5499999999999998 112.161 -169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.7 t -128.91 175.07 8.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.85 1.66 . . . . 3.0899999999999999 111.841 -174.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -115.69 -7.17 12.14 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.404 1.882 . . . . 2.79 112.402 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 10.0 t -140.04 127.26 21.14 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.402 -1.436 . . . . 2.71 113.819 -168.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -161.52 154.13 20.33 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.649 1.58 . . . . 0.98999999999999999 113.609 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.74 132.03 0.6 Allowed Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.383 1.313 . . . . 1.3200000000000001 116.383 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 87.9 m -120.07 -72.45 0.69 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.448 1.277 . . . . 1.45 114.448 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 52.6 t -138.99 142.5 38.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.786 1.234 . . . . 1.4399999999999999 111.208 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.16 169.97 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 130.584 3.554 . . . . 2.1800000000000002 108.577 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.27 150.05 40.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.739 1.616 . . . . 2.6600000000000001 108.44 166.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -112.72 147.76 36.15 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.367 1.894 . . . . 4.2300000000000004 115.468 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -146.21 95.24 2.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 129.55 3.14 . . . . 2.2999999999999998 108.02 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 24.4 t -101.12 144.54 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.472 1.509 . . . . 1.9099999999999999 111.657 -171.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 48.8 t -132.7 118.14 15.5 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.881 1.273 . . . . 1.27 109.381 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.36 133.26 48.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.252 2.635 . . . . 1.29 115.514 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 62.33 19.06 59.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.675 1.607 . . . . 1.97 114.372 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.8 t -136.93 -42.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.083 1.142 . . . . 2.0099999999999998 114.083 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 154.79 -176.91 32.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.902 0.763 . . . . 0.79000000000000004 113.756 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.22 146.67 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.001 0.92 . . . . 1.8700000000000001 111.536 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 30.0 t -125.41 138.7 54.03 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.853 2.061 . . . . 0.48999999999999999 110.909 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -145.49 165.97 27.05 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 115.176 1.547 . . . . 0.63 115.176 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -111.66 94.43 4.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.758 1.223 . . . . 1.2 108.367 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.8 p -101.96 130.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.215 1.007 . . . . 1.8899999999999999 113.238 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.5 t -123.21 161.05 25.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.359 1.463 . . . . 1.1599999999999999 113.607 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 129.103 2.961 . . . . 2.1299999999999999 109.931 160.541 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 112.223 0.453 . . . . 3.0299999999999998 112.223 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.78 121.85 44.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.125 0.97 . . . . 2.29 108.961 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.37 103.15 13.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.29 -1.004 . . . . 1.21 108.29 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -121.61 138.59 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.959 0.8 . . . . 0.68000000000000005 112.006 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.31 152.52 41.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.851 0.86 . . . . 0.55000000000000004 113.132 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -146.12 140.54 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.437 1.495 . . . . 0.62 109.501 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 169.7 -166.0 39.3 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.255 0.862 . . . . 1.5600000000000001 115.255 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.268 10.4 p30 -84.7 173.19 10.91 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.86 1.264 . . . . 2.2599999999999998 112.546 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -59.19 -10.12 2.61 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 117.276 2.324 . . . . 4.9199999999999999 117.276 -165.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -71.48 -34.15 69.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.017 1.28 . . . . 5.1100000000000003 111.921 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 50.2 m95 -65.42 -26.22 67.87 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.826 -1.171 . . . . 4.0800000000000001 113.658 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -34.16 67.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.446 0.699 . . . . 2.4199999999999999 111.359 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.87 -67.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.137 1.375 . . . . 2.75 107.805 169.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -38.54 -42.96 0.81 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.968 2.507 . . . . 5.6699999999999999 115.451 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.15 1.75 56.07 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.759 1.763 . . . . 2.02 115.759 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 75.86 32.43 53.51 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.749 -1.22 . . . . 0.75 114.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.69 177.45 6.1 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.073 1.349 . . . . 0.81999999999999995 110.987 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.8 t -121.54 132.67 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.09 1.356 . . . . 1.3200000000000001 110.726 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.8 tt -108.29 134.38 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 1.22 110.599 171.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -106.22 162.74 13.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.234 1.014 . . . . 2.9900000000000002 113.461 -168.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.03 -40.32 93.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 2.4300000000000002 113.757 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.72 -34.15 66.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.542 0.737 . . . . 2.54 112.508 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 11.3 p -76.9 -32.97 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.338 0.655 . . . . 0.68999999999999995 111.667 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.89 -46.1 88.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.588 0.755 . . . . 2.0 111.492 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.94 -33.54 74.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.881 1.272 . . . . 2.54 113.867 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.63 -42.16 52.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.799 1.639 . . . . 2.4900000000000002 112.392 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.1 tpp -64.46 -50.65 66.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.232 1.413 . . . . 0.68000000000000005 111.867 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 13.9 t -63.62 -33.12 74.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.427 0.691 . . . . 1.1000000000000001 112.141 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -62.5 -48.99 77.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.98 0.912 . . . . 3.2000000000000002 112.352 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.66 -0.65 . . . . 2.29 112.686 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.97 -40.14 87.4 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.904 -1.122 . . . . 2.9700000000000002 112.323 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -71.22 -27.13 63.26 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.43 -1.419 . . . . 4.5899999999999999 113.804 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 20.8 mttp -70.38 -2.7 14.47 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.648 1.579 . . . . 2.2999999999999998 113.219 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.66 23.53 69.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.957 1.265 . . . . 1.22 113.593 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -101.17 -166.86 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.032 1.333 . . . . 2.98 111.043 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1212 ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 90.8 m -115.22 121.75 43.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.553 1.541 . . . . 1.2 109.928 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -127.51 118.77 24.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.05 0.94 . . . . 0.54000000000000004 110.413 -170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 29.1 m -139.29 153.44 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.114 0.965 . . . . 0.68999999999999995 112.688 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.35 159.15 18.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.206 1.402 . . . . 0.76000000000000001 111.509 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -128.73 125.93 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.151 1.38 . . . . 1.8 110.741 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.19 154.24 40.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.769 1.228 . . . . 0.47999999999999998 111.636 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.8 m -148.09 123.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.732 2.013 . . . . 0.80000000000000004 110.236 -168.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.263 6.7 m-20 40.23 54.91 2.79 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.547 1.939 . . . . 2.9199999999999999 113.168 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.271 34.2 m-20 57.76 30.9 19.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.125 2.17 . . . . 1.6499999999999999 115.954 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -134.88 151.67 51.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.914 1.286 . . . . 2.9300000000000002 110.586 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.02 151.87 45.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.802 -1.811 . . . . 0.81000000000000005 111.748 170.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -122.09 -44.81 2.27 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.594 -0.692 . . . . 0.72999999999999998 111.208 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.64 -162.65 24.26 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.224 0.92 . . . . 0.59999999999999998 115.0 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -140.74 154.25 46.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.591 1.556 . . . . 0.65000000000000002 112.592 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 13.3 mm -123.94 127.52 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.93000000000000005 109.096 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -97.22 133.0 42.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.684 1.194 . . . . 0.81999999999999995 109.758 169.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1228 ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' 1212 ' ' THR . 44.1 mt -140.11 159.85 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.798 2.039 . . . . 1.22 107.397 -170.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.531 0 O-C-N 120.164 -1.585 . . . . 1.49 111.943 174.043 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 119.345 -0.359 . . . . 2.3799999999999999 111.126 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.59 154.75 18.24 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.734 2.956 . . . . 2.0699999999999998 111.422 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 59.4 t -142.21 105.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.053 -1.092 . . . . 2.7400000000000002 108.053 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -71.9 128.99 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.96 0.886 . . . . 1.0900000000000001 111.396 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.66 -47.99 4.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.17 1.788 . . . . 2.8399999999999999 112.936 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -153.79 146.9 24.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.589 0.756 . . . . 2.4900000000000002 112.571 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.2 m -120.15 128.87 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.28 1.032 . . . . 0.95999999999999996 110.179 167.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 48.2 tttt -134.12 144.37 48.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.662 0.785 . . . . 2.4900000000000002 113.098 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 97.4 t -90.31 144.31 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.245 1.418 . . . . 0.80000000000000004 112.407 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.9 -29.4 5.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.832 1.653 . . . . 0.81999999999999995 112.551 169.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -127.59 123.8 36.57 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.006 1.323 . . . . 1.75 110.423 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.52 143.35 51.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.574 1.55 . . . . 3.8799999999999999 110.151 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 42.2 m 63.49 -30.83 0.1 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.635 2.374 . . . . 3.3999999999999999 116.803 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.56 -10.79 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.492 1.496 . . . . 3.1299999999999999 114.76 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -160.5 -38.91 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.237 1.415 . . . . 5.5499999999999998 112.299 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.96 167.85 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 126.984 2.114 . . . . 1.54 108.569 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.8 m -143.76 161.77 37.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.902 1.681 . . . . 2.1499999999999999 111.32 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -42.32 -50.78 4.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.859 2.463 . . . . 5.2000000000000002 115.225 -169.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -62.35 -38.32 89.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.672 0.669 . . . . 5.6900000000000004 112.778 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 64.4 mttm -74.29 -39.74 62.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.526 0.73 . . . . 2.5699999999999998 111.008 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.68 -52.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.987 0.915 . . . . 0.55000000000000004 110.945 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.72 -31.21 70.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.513 -0.742 . . . . 0.73999999999999999 112.249 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.67 -50.38 63.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.024 0.379 . . . . 0.51000000000000001 112.024 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.2 pt -69.09 -35.95 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.915 -1.116 . . . . 0.56000000000000005 113.086 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 64.7 t -71.24 -43.76 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.223 0.92 . . . . 0.67000000000000004 111.512 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.53 -34.34 78.81 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.185 -0.947 . . . . 0.68999999999999995 113.807 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 17.2 p -68.24 -43.23 78.35 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.63 -0.924 . . . . 0.88 111.691 171.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.26 76.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.083 0.856 . . . . 0.91000000000000003 112.445 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -71.08 -17.26 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.99 -1.069 . . . . 2.3199999999999998 113.605 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.1 p -72.38 -28.54 63.07 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.204 -1.56 . . . . 1.6200000000000001 112.715 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 22.9 m120 -91.14 -22.71 20.54 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.44 1.496 . . . . 3.48 112.262 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.5 t -76.42 173.64 11.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.396 1.478 . . . . 1.4399999999999999 113.72 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.38 15.11 5.56 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.85 2.06 . . . . 4.0800000000000001 112.714 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -69.35 165.94 34.8 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.212 1.805 . . . . 2.23 113.991 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.51 -23.94 0.72 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.07 2.513 . . . . 1.45 114.395 -173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.6 tt -111.76 -48.77 3.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.934 2.094 . . . . 1.02 112.554 -167.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.5 -21.35 48.88 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.489 0.956 . . . . 0.93000000000000005 115.489 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 63.4 p -66.73 -14.11 62.16 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.518 -1.578 . . . . 1.28 114.343 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.18 82.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.947 0.899 . . . . 0.78000000000000003 111.285 167.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 12.9 mt -71.99 -36.31 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.243 1.417 . . . . 0.70999999999999996 110.278 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 11.2 m -54.84 -48.29 73.04 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.907 0.776 . . . . 1.24 111.519 170.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -59.0 -49.22 78.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.819 0.736 . . . . 2.8500000000000001 111.735 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.74 -44.8 82.03 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.485 1.114 . . . . 2.3999999999999999 112.166 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.5 t -70.05 -50.6 39.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.988 0.915 . . . . 1.6699999999999999 111.763 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -56.22 -38.82 71.57 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.782 -1.199 . . . . 2.7999999999999998 112.378 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -70.05 -35.87 74.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.815 0.846 . . . . 3.0800000000000001 112.633 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -70.17 -46.38 64.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 2.0299999999999998 112.693 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.79 -30.0 62.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 1.05 113.473 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.52 45.5 26.86 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.569 1.547 . . . . 2.6800000000000002 112.062 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.2 t -147.69 146.27 29.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.686 1.365 . . . . 2.6099999999999999 114.686 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.95 19.81 19.94 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.081 1.352 . . . . 3.3900000000000001 114.317 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 80.6 p -110.6 -6.2 14.91 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.946 -1.721 . . . . 3.9900000000000002 114.138 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.3 148.77 48.1 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.02 1.328 . . . . 1.4199999999999999 113.407 -172.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 72.97 137.23 0.27 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.131 1.824 . . . . 0.97999999999999998 114.838 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 97.2 m -136.57 -41.16 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.955 1.302 . . . . 1.3999999999999999 112.474 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 7.5 t -138.97 142.88 38.36 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.239 1.415 . . . . 2.4700000000000002 114.139 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.9 mm -140.27 134.1 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 129.576 3.15 . . . . 2.25 108.206 168.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.323 0.0 OUTLIER -92.18 -14.7 28.66 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.996 1.48 . . . . 3.3999999999999999 114.996 176.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 8.1 m-85 54.33 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 129.04 2.936 . . . . 3.1400000000000001 117.631 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.98 93.08 2.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.456 1.902 . . . . 2.6800000000000002 106.272 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 4.4 m -98.94 150.14 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.269 0.628 . . . . 2.77 110.965 -170.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 31.0 t -140.36 106.41 6.59 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.102 1.361 . . . . 1.1299999999999999 109.6 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 149.9 75.8 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.188 2.592 . . . . 1.8899999999999999 112.406 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.73 -18.31 1.4 Allowed Glycine 0 CA--C 1.538 1.472 0 O-C-N 121.057 -1.027 . . . . 1.53 114.75 -171.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.7 t -115.05 -72.93 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.064 1.345 . . . . 2.2999999999999998 112.976 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 163.9 -153.15 23.4 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.312 0.96 . . . . 1.1000000000000001 113.482 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.0 tt -144.06 148.48 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.075 0.95 . . . . 1.9399999999999999 112.645 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.4 t -117.79 145.17 44.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.135 1.774 . . . . 0.56000000000000005 109.381 164.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 25.9 p -164.57 164.93 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.535 0.939 . . . . 0.72999999999999998 113.535 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -109.63 146.45 34.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 1.3200000000000001 108.629 166.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 32.8 m -123.16 153.8 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.386 1.074 . . . . 2.23 110.808 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -146.08 157.93 43.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.086 0.954 . . . . 1.05 111.903 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 128.953 2.901 . . . . 2.5699999999999998 107.97 158.392 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 117.888 2.551 . . . . 2.1299999999999999 117.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.59 124.55 27.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.585 1.554 . . . . 2.6499999999999999 110.92 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -88.75 122.74 32.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.555 1.142 . . . . 1.6399999999999999 110.733 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -135.22 141.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.254 1.021 . . . . 0.52000000000000002 112.265 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.27 145.44 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.402 1.081 . . . . 0.60999999999999999 112.465 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.7 tt -144.43 145.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.859 1.264 . . . . 0.52000000000000002 109.811 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 124.48 162.04 11.27 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.546 0.978 . . . . 1.6599999999999999 115.546 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.47 -151.63 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.057 1.743 . . . . 2.3900000000000001 113.368 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.94 -30.23 2.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 127.922 2.489 . . . . 6.1799999999999997 112.059 168.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -66.07 -37.93 87.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.908 1.231 . . . . 4.1900000000000004 112.798 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.1 -19.89 65.71 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.433 -1.417 . . . . 2.9900000000000002 112.759 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 1.7 tpp -70.07 -30.13 67.3 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.384 -0.823 . . . . 2.52 111.351 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.15 -67.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.681 1.993 . . . . 2.0600000000000001 108.093 166.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -48.47 -21.5 0.57 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 129.348 3.059 . . . . 5.5599999999999996 115.786 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -93.22 12.9 22.84 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.63 1.344 . . . . 0.93000000000000005 114.63 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.35 36.18 83.83 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 120.543 -1.348 . . . . 0.73999999999999999 114.776 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.9 mt -100.61 172.07 7.32 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.589 1.155 . . . . 0.90000000000000002 111.503 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 16.2 t -121.41 148.11 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.554 1.941 . . . . 1.6799999999999999 110.625 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.02 155.1 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.393 1.077 . . . . 1.6000000000000001 113.807 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -117.63 164.98 14.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.993 2.117 . . . . 2.9500000000000002 113.567 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 58.6 t30 -66.78 -47.04 73.39 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.926 1.454 . . . . 4.54 114.926 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.35 -43.91 98.07 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.201 0.909 . . . . 3.6400000000000001 111.34 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.9 p -72.18 -35.47 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.172 0.989 . . . . 1.23 112.647 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -68.25 -43.19 78.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.519 1.509 . . . . 1.8999999999999999 111.723 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.94 -45.04 91.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.701 0.8 . . . . 1.9399999999999999 111.325 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 35.8 t80 -64.62 -37.56 87.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.267 1.427 . . . . 2.0299999999999998 112.777 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 28.8 tpp -66.32 -51.07 61.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.809 1.244 . . . . 0.83999999999999997 111.303 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 14.9 t -66.52 -34.3 77.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.044 -0.503 . . . . 1.25 111.499 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.65 -47.22 86.47 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.529 1.059 . . . . 4.3799999999999999 113.126 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -70.86 -35.22 72.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.591 0.96 . . . . 2.3199999999999998 113.591 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.26 -42.32 96.54 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.367 0.985 . . . . 2.96 112.439 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -70.14 -25.99 63.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.667 1.587 . . . . 4.7999999999999998 113.583 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -81.22 8.22 9.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.929 1.085 . . . . 2.8700000000000001 113.929 167.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 91.07 -5.43 81.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.175 2.321 . . . . 1.72 116.153 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.63 162.41 14.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 3.6600000000000001 111.603 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 18.7 m -76.03 119.24 19.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.792 0.837 . . . . 1.1100000000000001 110.234 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -119.37 115.86 24.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 0.75 109.638 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.89 157.51 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.323 1.049 . . . . 0.84999999999999998 113.224 -170.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -112.77 162.77 15.38 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.418 1.087 . . . . 0.81000000000000005 113.214 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 2.8 p -132.37 122.89 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.367 1.467 . . . . 2.1899999999999999 112.042 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -113.95 152.61 30.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.54 1.936 . . . . 0.64000000000000001 110.941 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 21.2 m -149.05 120.24 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.646 1.179 . . . . 0.89000000000000001 111.118 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 20.4 t70 41.75 52.13 4.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.469 1.508 . . . . 3.2999999999999998 112.683 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.258 6.6 m-20 65.38 22.87 12.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.88 2.178 . . . . 1.4399999999999999 116.88 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -129.13 151.5 49.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.455 1.502 . . . . 2.7799999999999998 110.774 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 145.42 48.4 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.757 -1.215 . . . . 0.67000000000000004 111.965 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -122.61 -35.4 3.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.829 1.048 . . . . 0.44 113.829 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.82 36.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.114 0.87 . . . . 0.44 115.012 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.71 155.28 44.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.679 1.592 . . . . 0.70999999999999996 112.943 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.83 136.22 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.388 1.475 . . . . 0.71999999999999997 109.593 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -106.02 130.5 53.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.922 1.289 . . . . 0.81999999999999995 109.554 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.85 130.72 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 1.3200000000000001 108.162 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 114.337 1.236 . . . . 3.0800000000000001 114.337 -175.385 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.008 -0.52 . . . . 2.5800000000000001 109.952 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.39 146.02 73.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.631 2.221 . . . . 1.4199999999999999 112.02 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.0 p -133.16 126.61 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.471 1.508 . . . . 2.9199999999999999 108.276 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.4 p -71.0 123.98 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.667 -1.27 . . . . 1.5 109.239 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -96.49 -41.63 8.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.985 1.314 . . . . 3.2400000000000002 112.547 -167.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -159.28 156.82 29.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.16 1.384 . . . . 1.96 110.99 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 6.5 m -131.23 143.89 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 1.02 110.587 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 50.6 tttt -129.33 140.74 51.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.91 1.284 . . . . 1.8899999999999999 110.753 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 47.4 t -77.86 142.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.653 -0.869 . . . . 0.83999999999999997 108.653 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.45 -38.96 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.862 1.265 . . . . 1.3600000000000001 111.376 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 74.2 m -100.45 92.37 5.12 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 106.447 -1.686 . . . . 1.9399999999999999 106.447 168.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.26 123.12 33.78 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.636 -0.665 . . . . 4.4400000000000004 111.901 -170.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 40.6 m 51.54 39.23 24.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.422 1.638 . . . . 2.9100000000000001 115.422 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -141.53 -8.15 0.98 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.685 1.735 . . . . 2.96 115.685 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -144.97 -65.45 0.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.573 1.533 . . . . 4.2400000000000002 112.613 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.3 142.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.922 2.089 . . . . 1.48 110.063 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 47.4 m -98.95 152.88 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 1.8200000000000001 113.283 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -38.49 51.76 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.515 2.043 . . . . 4.0 116.515 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.1 t60 -68.95 -34.07 74.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.52 1.054 . . . . 2.5499999999999998 111.729 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.75 -36.51 65.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.17 -0.919 . . . . 2.5299999999999998 112.004 173.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.08 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.27 0.941 . . . . 0.75 110.729 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -69.68 -32.54 71.23 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.3 -0.875 . . . . 0.82999999999999996 112.209 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -62.29 -50.7 70.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.259 0.624 . . . . 0.59999999999999998 112.114 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.85 -36.45 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.514 1.052 . . . . 0.58999999999999997 113.189 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 70.7 t -70.42 -44.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 118.893 0.77 . . . . 0.82999999999999996 111.057 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.86 95.85 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.29 -0.881 . . . . 0.71999999999999997 113.431 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.3 p -75.14 -30.01 60.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.0 0.92 . . . . 0.64000000000000001 113.382 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.53 66.18 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.91 0.777 . . . . 0.69999999999999996 111.715 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.87 -18.74 65.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.463 0.912 . . . . 2.1299999999999999 113.463 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 13.6 t -58.12 -22.31 50.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.945 1.298 . . . . 1.3899999999999999 114.263 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -103.74 -2.3 26.66 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.882 1.273 . . . . 1.8999999999999999 113.978 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 16.0 t -86.23 171.76 11.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 1.8300000000000001 113.804 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -3.65 14.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.161 1.784 . . . . 5.9500000000000002 113.746 170.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 153.09 93.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.694 1.197 . . . . 2.0600000000000001 113.878 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -39.83 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.197 2.598 . . . . 1.1299999999999999 113.455 -173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.51 -51.35 5.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.303 0.853 . . . . 0.76000000000000001 113.303 -166.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -65.93 -28.34 73.57 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 114.555 0.582 . . . . 0.92000000000000004 114.555 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 27.3 p -66.27 -13.06 59.84 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.856 -1.379 . . . . 1.73 113.933 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.21 67.91 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.93 -1.106 . . . . 0.84999999999999998 111.032 167.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 16.6 mt -69.85 -35.17 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.622 1.169 . . . . 0.88 109.973 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 88.3 m -54.71 -50.32 68.6 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.705 -0.622 . . . . 1.1699999999999999 111.677 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 69.8 tttt -61.14 -46.31 91.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.68 -0.676 . . . . 1.97 111.875 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 30.9 t80 -55.33 -45.66 76.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.876 0.87 . . . . 1.98 112.547 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 53.7 t -63.35 -54.63 33.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.465 1.106 . . . . 1.97 111.76 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -40.64 67.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.798 1.239 . . . . 3.5499999999999998 112.437 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -73.18 -34.9 66.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.717 1.607 . . . . 3.0600000000000001 113.888 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.97 -43.44 87.84 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.647 -1.283 . . . . 2.3599999999999999 111.32 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.3 0.23 10.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.013 1.325 . . . . 1.21 113.765 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 29.0 t70 46.89 43.41 13.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.473 1.909 . . . . 2.7000000000000002 113.17 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.9 t -132.83 -175.21 3.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.086 0.954 . . . . 3.6699999999999999 113.148 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -123.58 -4.58 8.22 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.721 2.008 . . . . 3.5 112.182 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.1 t -151.47 144.95 24.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.358 1.863 . . . . 2.9399999999999999 112.373 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.25 167.62 23.68 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.849 2.46 . . . . 1.1599999999999999 110.761 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 67.25 168.89 3.81 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.839 1.496 . . . . 1.1200000000000001 116.839 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.2 m -149.09 -54.58 0.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.228 1.411 . . . . 1.4199999999999999 113.495 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 16.6 t -134.65 143.35 47.22 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.494 1.517 . . . . 1.3500000000000001 112.15 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 11.2 tp -139.56 149.04 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.261 3.425 . . . . 2.5 107.658 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -141.62 66.29 1.36 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.428 1.091 . . . . 4.2999999999999998 109.279 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.62 149.4 26.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.132 1.901 . . . . 2.4199999999999999 116.132 -168.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -114.34 113.35 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.85 2.06 . . . . 2.4900000000000002 107.717 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 90.1 t -98.19 124.03 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.024 1.33 . . . . 2.3500000000000001 110.777 -169.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 56.4 t -139.51 98.08 8.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.816 1.647 . . . . 1.72 106.899 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -59.28 130.55 36.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.728 2.286 . . . . 1.8899999999999999 113.519 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 74.61 26.99 66.16 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.308 -0.718 . . . . 1.8400000000000001 114.801 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.8 t -135.44 -43.47 0.69 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.811 1.306 . . . . 2.1899999999999999 113.745 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 151.36 -161.47 29.17 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.893 -1.13 . . . . 1.02 113.919 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1119 ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' 1119 ' ' ILE . 1.7 mm -140.14 145.77 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.811 1.644 . . . . 2.5099999999999998 110.226 169.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 47.3 t -133.43 136.35 45.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.266 1.026 . . . . 0.63 109.368 165.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.8 p -154.15 168.89 25.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.742 1.016 . . . . 0.60999999999999999 113.742 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -109.88 141.44 42.59 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 4.7 p -143.11 138.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.335 0.97 . . . . 1.8999999999999999 112.827 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.4 157.73 45.65 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.698 0.761 . . . . 1.5600000000000001 112.542 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 128.678 2.791 . . . . 3.27 108.895 162.694 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 113.473 0.916 . . . . 2.9700000000000002 113.473 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.57 123.79 12.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.743 1.217 . . . . 2.8399999999999999 110.55 -168.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.9 116.25 28.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.106 0.962 . . . . 2.0 108.624 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.8 m -135.4 141.6 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.127 0.876 . . . . 0.53000000000000003 112.823 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.35 152.35 40.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.823 1.045 . . . . 0.46999999999999997 113.823 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -152.13 135.91 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.967 1.707 . . . . 0.65000000000000002 110.077 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 162.79 -151.68 21.57 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.962 1.545 . . . . 1.23 116.962 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.42 150.63 3.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.333 2.653 . . . . 2.6600000000000001 112.912 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -61.6 -33.37 73.78 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.504 0.927 . . . . 4.9800000000000004 113.504 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.98 -31.44 69.91 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.776 1.171 . . . . 4.2300000000000004 113.082 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -69.3 -19.79 63.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.382 -1.449 . . . . 3.2200000000000002 112.935 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.4 mmt -67.66 -30.73 70.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.092 -1.005 . . . . 2.5699999999999998 111.42 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.7 mt -71.43 -65.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.108 1.763 . . . . 2.27 109.28 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.17 -32.86 4.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.798 2.039 . . . . 4.6799999999999997 115.702 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.99 12.53 6.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.509 1.05 . . . . 0.88 113.828 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.62 31.6 58.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.377 -1.452 . . . . 1.1799999999999999 115.289 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.33 -161.73 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.914 1.286 . . . . 1.6399999999999999 110.891 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 21.8 t -136.8 136.39 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.192 1.797 . . . . 1.22 110.202 170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.1 tt -125.93 138.63 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.764 1.226 . . . . 1.3100000000000001 111.485 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.39 168.52 12.91 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.825 1.787 . . . . 3.6899999999999999 115.825 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.27 -25.33 61.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.841 1.656 . . . . 2.5699999999999998 115.372 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.51 -40.89 41.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.089 1.313 . . . . 2.7000000000000002 113.302 -176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -73.61 -33.71 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.481 0.582 . . . . 0.94999999999999996 111.41 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -56.94 -43.35 81.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.001 0.92 . . . . 2.3100000000000001 112.081 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.48 -49.93 75.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.169 0.987 . . . . 2.6000000000000001 113.506 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 33.2 t80 -70.25 -36.61 74.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 2.0099999999999998 112.258 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -61.19 -60.79 3.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.141 1.776 . . . . 1.1399999999999999 110.792 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.1 t -66.27 -31.47 72.29 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.896 -0.503 . . . . 1.1899999999999999 112.244 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -59.99 -49.93 75.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.191 0.997 . . . . 2.7400000000000002 112.052 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -68.73 -30.88 69.61 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.764 -0.585 . . . . 3.0600000000000001 112.136 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -65.29 -42.29 93.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.308 1.043 . . . . 2.8399999999999999 112.769 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -66.81 -30.17 70.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 120.855 -1.153 . . . . 3.3399999999999999 113.567 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 19.2 mttp -70.52 -2.93 15.58 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.556 1.942 . . . . 2.5099999999999998 113.566 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 90.63 20.73 39.53 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.0 1.285 . . . . 2.0699999999999998 115.162 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.08 148.58 33.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.749 1.62 . . . . 4.0999999999999996 110.616 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 94.1 m -78.34 137.64 38.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.049 1.34 . . . . 0.79000000000000004 111.063 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -139.22 124.79 19.4 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.096 0.776 . . . . 0.66000000000000003 113.096 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.69 159.11 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.536 1.534 . . . . 0.66000000000000003 113.18 -171.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.64 160.14 16.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.687 1.195 . . . . 0.78000000000000003 112.574 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.5 t -130.86 122.95 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.078 1.751 . . . . 1.6399999999999999 111.608 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.93 151.78 39.29 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.446 1.499 . . . . 0.63 110.621 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.5 m -143.33 118.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.162 1.385 . . . . 0.73999999999999999 112.254 -170.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 30.7 t0 42.07 50.08 4.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.848 2.459 . . . . 3.21 112.942 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.301 2.2 m-20 62.7 38.44 11.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.637 2.375 . . . . 2.3300000000000001 116.182 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -143.33 147.86 35.39 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.285 1.434 . . . . 3.8300000000000001 109.861 167.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.76 151.52 43.47 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.276 -1.515 . . . . 1.3400000000000001 113.267 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 31.3 p -130.51 -47.82 1.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.412 1.264 . . . . 0.63 114.412 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.97 -175.56 36.5 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 120.662 1.574 . . . . 0.48999999999999999 115.884 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.47 155.15 44.28 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.231 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.91 135.09 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.905 1.682 . . . . 0.93000000000000005 109.955 -172.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -115.05 133.29 56.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.515 1.526 . . . . 0.65000000000000002 109.859 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.05 143.17 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.814 2.045 . . . . 1.53 110.285 -169.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 126.128 1.771 . . . . 1.75 111.343 177.476 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 112.197 0.443 . . . . 3.3700000000000001 112.197 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.47 138.78 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.968 2.445 . . . . 1.6399999999999999 112.062 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 14.5 p -144.25 123.06 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.002 0.921 . . . . 2.2599999999999998 111.945 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.6 p -72.53 139.58 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.512 -1.368 . . . . 1.05 111.138 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.36 -41.16 1.91 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.333 1.975 . . . . 2.4399999999999999 116.333 -165.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -150.64 154.85 38.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.392 1.477 . . . . 2.3900000000000001 110.967 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.7 m -134.91 136.05 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.185 0.994 . . . . 0.82999999999999996 111.153 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.9 tttt -141.02 140.12 34.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.331 1.234 . . . . 1.6599999999999999 114.331 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 41.2 t -85.6 143.66 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.251 1.42 . . . . 0.73999999999999999 110.224 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 31.1 tp -114.76 -25.07 8.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.04 1.736 . . . . 0.85999999999999999 113.275 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 93.0 m -126.03 67.22 1.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.474 1.509 . . . . 1.6899999999999999 111.23 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.19 130.33 38.07 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.733 -1.229 . . . . 3.8500000000000001 112.438 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 23.2 m 64.03 -18.62 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.608 2.077 . . . . 2.5600000000000001 116.608 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 30.7 m120 -87.05 -15.99 36.97 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.787 1.176 . . . . 3.2799999999999998 113.646 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 -95.66 0.14 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.388 1.075 . . . . 5.1399999999999997 110.48 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.38 133.16 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.474 1.51 . . . . 1.75 111.141 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 66.7 m -98.17 164.24 12.41 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.642 1.577 . . . . 2.04 113.291 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -43.04 -56.01 3.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.513 1.925 . . . . 5.21 116.103 -169.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 47.7 m170 -64.74 -30.82 71.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.969 0.804 . . . . 3.8999999999999999 112.702 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 44.6 mttp -77.56 -38.14 49.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 118.123 -0.942 . . . . 2.6000000000000001 111.97 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.05 -52.48 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.488 1.04 . . . . 0.68000000000000005 110.844 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.76 -28.15 66.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.673 -0.642 . . . . 0.56000000000000005 112.427 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.2 -47.89 59.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.828 -0.605 . . . . 0.60999999999999999 112.598 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.6 pt -69.62 -32.62 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.53 1.514 . . . . 0.57999999999999996 112.901 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.2 t -70.88 -45.58 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.813 0.733 . . . . 0.69999999999999996 111.376 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -69.17 -36.26 79.41 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.975 -1.078 . . . . 0.70999999999999996 114.009 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 35.8 p -69.15 -34.38 74.89 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.413 -1.051 . . . . 0.76000000000000001 111.794 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.2 91.21 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.765 0.711 . . . . 0.76000000000000001 112.56 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.16 -21.97 62.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.956 1.095 . . . . 3.75 113.956 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.0 t -55.88 -42.13 75.45 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.863 -1.148 . . . . 1.6599999999999999 112.258 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.54 -23.1 40.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.567 0.951 . . . . 2.1899999999999999 113.567 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 27.0 m -89.47 160.61 16.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.057 1.132 . . . . 2.5600000000000001 114.057 -167.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -122.73 18.71 10.29 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.668 1.587 . . . . 5.3899999999999997 113.225 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 143.29 91.56 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.753 1.221 . . . . 1.51 112.132 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.55 -45.52 1.14 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.316 2.677 . . . . 1.28 114.356 -169.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.37 -34.23 72.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.297 -0.877 . . . . 0.93999999999999995 111.069 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -61.16 -20.33 58.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.135 1.35 . . . . 1.8100000000000001 115.545 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 66.7 p -59.49 -37.98 79.68 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.019 1.409 . . . . 2.8199999999999998 112.184 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.55 -36.39 80.87 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.49 -0.756 . . . . 1.2 112.407 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.8 mt -70.78 -36.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.054 -1.029 . . . . 1.5 111.023 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.3 m -55.14 -51.79 65.34 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.168 0.987 . . . . 1.9299999999999999 110.438 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.5 tttt -54.44 -55.23 30.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.181 0.992 . . . . 3.5699999999999998 111.574 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -57.72 -45.85 85.22 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.321 0.648 . . . . 1.8999999999999999 112.636 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 37.3 t -66.82 -54.15 25.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.243 0.617 . . . . 1.6699999999999999 111.4 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -43.07 75.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.238 1.015 . . . . 2.8500000000000001 110.756 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.34 -44.54 87.42 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.972 0.73 . . . . 3.0499999999999998 112.972 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -67.11 -38.7 86.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.535 1.062 . . . . 2.79 113.303 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.35 -19.87 60.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.621 1.168 . . . . 1.3500000000000001 113.107 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 8.8 t70 64.47 15.66 9.71 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.593 2.357 . . . . 3.3100000000000001 114.221 -170.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 2.6 t -130.52 147.1 52.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.816 1.646 . . . . 3.1200000000000001 115.249 -169.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.11 -12.67 43.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.559 1.144 . . . . 3.5099999999999998 111.858 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 35.6 p -73.43 26.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.397 1.999 . . . . 4.7000000000000002 116.397 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.74 29.07 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.532 1.533 . . . . 1.55 114.659 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 78.24 145.07 2.55 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.656 1.598 . . . . 1.1100000000000001 116.989 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -141.42 -63.34 0.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.964 1.705 . . . . 1.4099999999999999 113.392 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 41.4 t -136.54 141.51 43.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.181 1.355 . . . . 1.5 112.443 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.1 mm -141.93 140.19 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 132.18 4.192 . . . . 2.0699999999999998 109.389 -170.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.8 t0 -111.72 104.17 12.5 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.905 -1.887 . . . . 2.5699999999999998 105.905 165.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1111 ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' 1119 ' ' ILE . 32.9 t80 -88.54 133.15 34.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.931 1.292 . . . . 3.2599999999999998 114.436 -165.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -139.34 120.7 14.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.304 1.842 . . . . 2.1099999999999999 110.993 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 44.3 t -104.34 140.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.97 1.308 . . . . 2.3199999999999998 111.68 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 51.7 t -126.33 111.94 23.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.029 0.932 . . . . 1.51 109.188 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.19 143.08 93.93 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.313 2.675 . . . . 1.79 113.634 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.38 15.15 65.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.947 1.26 . . . . 2.0600000000000001 113.696 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 73.4 m -134.34 -87.32 0.39 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.86 1.664 . . . . 1.9099999999999999 111.39 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 172.99 -151.37 13.78 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.937 0.779 . . . . 0.90000000000000002 112.455 -172.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1119 ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' 1111 ' ' PHE . 0.1 OUTLIER -134.26 146.32 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.265 1.026 . . . . 2.2000000000000002 111.893 -173.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.8 t -134.24 144.18 48.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.857 1.663 . . . . 0.72999999999999998 111.259 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.8 p -158.04 172.38 18.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.549 1.685 . . . . 0.62 115.549 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -114.64 120.81 41.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.252 1.421 . . . . 1.1200000000000001 107.453 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 12.0 p -128.76 134.52 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 115.033 1.494 . . . . 1.8600000000000001 115.033 -167.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1124 ' ' THR . . . . . 0.427 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.4 t -133.81 161.34 35.01 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 123.242 1.496 . . . . 1.73 114.276 169.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 130.233 3.413 . . . . 2.6000000000000001 108.289 160.354 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1177 ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' 1124 ' ' THR . 28.1 mt-30 . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.459 0.647 . . . . 3.5099999999999998 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.54 133.38 53.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.937 1.695 . . . . 2.5499999999999998 110.781 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.13 116.19 27.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.798 0.726 . . . . 1.55 111.767 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.7 m -137.47 144.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.083 0.953 . . . . 0.59999999999999998 113.067 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.08 152.54 46.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.844 1.258 . . . . 0.59999999999999998 113.492 171.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.3 tt -149.18 139.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.432 1.493 . . . . 0.79000000000000004 110.352 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 131.18 150.16 6.66 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.156 0.884 . . . . 1.6399999999999999 115.09 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 49.29 -155.98 0.09 Allowed 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 126.103 1.761 . . . . 2.3399999999999999 113.931 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -140.08 -37.46 0.47 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.47 2.396 . . . . 6.4199999999999999 117.47 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.33 -30.67 69.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.568 1.531 . . . . 3.9900000000000002 110.703 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -55.45 -34.32 64.38 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.192 -0.942 . . . . 2.8399999999999999 113.465 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -35.03 77.78 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.745 1.017 . . . . 2.0299999999999998 113.745 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.68 -60.39 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.986 -1.116 . . . . 1.8700000000000001 107.986 168.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.19 -27.04 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.835 2.054 . . . . 6.4199999999999999 115.687 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.85 16.07 1.25 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.892 1.678 . . . . 1.0700000000000001 112.498 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.73 16.05 67.42 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 119.797 -1.814 . . . . 1.22 116.07 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.59 174.23 10.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.393 1.597 . . . . 0.93999999999999995 111.911 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.2 t -115.8 130.98 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.664 1.186 . . . . 1.3600000000000001 109.309 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.69 127.77 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.867 1.267 . . . . 1.21 110.011 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . 0.253 6.1 p-10 -89.41 158.3 17.8 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.99 1.107 . . . . 3.8399999999999999 113.99 -176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 64.6 t30 -62.6 -23.71 67.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.954 1.302 . . . . 2.71 114.344 -170.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.21 -43.37 42.65 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.708 -1.245 . . . . 3.7999999999999998 112.907 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 3.3 p -75.6 -31.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 125.303 1.441 . . . . 0.97999999999999998 110.985 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -52.87 -50.59 63.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.987 1.267 . . . . 3.8199999999999998 111.213 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.32 -44.93 80.43 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.206 0.447 . . . . 2.1699999999999999 112.206 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.7 t80 -71.57 -36.01 70.78 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.62 0.97 . . . . 2.2400000000000002 113.62 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.7 tpp -63.22 -50.92 68.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.201 1.401 . . . . 0.83999999999999997 111.077 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.2 t -69.93 -33.25 71.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.012 -0.43 . . . . 0.91000000000000003 111.718 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.66 -46.8 87.96 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.731 -1.231 . . . . 4.1200000000000001 112.889 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -71.16 -37.03 72.22 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.249 1.203 . . . . 2.1899999999999999 114.249 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1207 ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 43.3 mm-40 -62.28 -37.46 85.59 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.108 -0.995 . . . . 3.6899999999999999 112.21 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -72.73 -24.33 60.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.31 1.844 . . . . 3.77 114.961 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 77.6 mttt -66.39 -6.85 15.83 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.627 1.171 . . . . 3.4300000000000002 114.128 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.64 19.98 35.93 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.854 1.692 . . . . 1.1699999999999999 113.092 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -118.67 178.36 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.531 1.532 . . . . 3.29 111.994 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 3.4 m -100.4 120.97 40.78 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.771 1.629 . . . . 1.1599999999999999 110.246 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1213 ' ' ALA . . . . . 0.59 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -116.84 119.65 36.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.014 1.325 . . . . 0.65000000000000002 110.098 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.2 m -136.34 153.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.431 0.9 . . . . 0.45000000000000001 113.431 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.17 166.01 10.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.133 0.973 . . . . 0.81999999999999995 112.794 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 11.6 t -131.71 125.86 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.003 2.121 . . . . 1.6000000000000001 110.026 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -130.13 156.64 44.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.612 1.165 . . . . 0.5 111.81 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.3 m -144.74 120.11 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.839 1.655 . . . . 1.1699999999999999 111.689 -169.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 23.3 t70 44.65 47.28 8.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.109 1.364 . . . . 4.1500000000000004 113.316 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 60.79 42.15 13.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.039 -1.663 . . . . 1.99 115.023 -174.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.93 141.52 30.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.686 1.595 . . . . 2.1899999999999999 110.561 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.71 137.44 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.108 -1.62 . . . . 0.76000000000000001 112.852 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.0 p -115.01 -40.96 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.097 0.959 . . . . 0.62 112.719 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -168.13 -174.02 36.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.656 1.116 . . . . 0.55000000000000004 115.384 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.37 155.71 43.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.402 1.881 . . . . 0.79000000000000004 112.702 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.9 mm -129.76 140.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.382 1.473 . . . . 0.81000000000000005 110.526 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -113.07 130.12 56.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.094 1.758 . . . . 0.56999999999999995 110.36 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.14 157.7 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.846 2.059 . . . . 1.4099999999999999 109.598 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 126.268 1.827 . . . . 1.5600000000000001 111.956 177.034 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 112.631 0.604 . . . . 2.8999999999999999 112.631 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.92 130.02 24.82 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.691 2.928 . . . . 1.51 112.961 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 96.7 t -105.5 124.22 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.187 1.795 . . . . 2.46 109.648 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.4 121.68 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.046 0.839 . . . . 1.29 110.915 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.26 -47.69 3.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.502 0.721 . . . . 3.3799999999999999 112.82 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -151.49 149.25 29.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.79 1.636 . . . . 2.6099999999999999 111.713 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 12.3 m -125.52 139.78 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.178 0.991 . . . . 0.87 110.402 168.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.1 tttt -141.99 148.48 38.62 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.048 0.759 . . . . 2.3199999999999998 113.048 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 73.9 t -106.61 145.01 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.191 1.397 . . . . 1.1200000000000001 111.31 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.95 -25.04 10.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.559 1.544 . . . . 0.83999999999999997 113.44 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 9.9 t -93.94 162.09 14.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.824 2.05 . . . . 3.0600000000000001 112.813 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -146.46 116.02 7.15 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.619 -1.301 . . . . 5.3600000000000003 110.32 167.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 63.4 m 51.67 33.75 11.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.525 2.046 . . . . 2.9900000000000002 116.525 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 28.2 m120 -126.97 -30.89 2.67 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.463 1.283 . . . . 3.6099999999999999 114.463 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 113.52 2.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.713 1.605 . . . . 5.9800000000000004 108.649 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.3 mm 66.17 133.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 127.55 2.34 . . . . 2.02 114.725 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 67.0 m -81.5 151.11 27.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.985 1.314 . . . . 2.6699999999999999 113.099 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 61.9 m80 -53.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.598 1.703 . . . . 6.6100000000000003 115.598 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 43.3 t60 -74.96 -29.45 60.92 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.726 -1.234 . . . . 2.5299999999999998 111.695 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.47 -36.69 81.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.84 -1.163 . . . . 2.7999999999999998 111.804 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 98.0 mt -56.62 -53.86 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.117 . . . . 0.88 109.668 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.7 76.53 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.238 0.926 . . . . 0.71999999999999997 112.367 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.58 -46.17 76.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.105 0.779 . . . . 0.66000000000000003 113.105 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.71 -35.39 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.232 1.378 . . . . 0.66000000000000003 112.815 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 59.8 t -70.52 -46.61 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.754 0.706 . . . . 0.83999999999999997 111.381 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.53 91.45 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.43 -0.794 . . . . 0.75 113.642 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.3 p -73.95 -34.31 64.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.181 0.808 . . . . 0.87 113.181 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.35 90.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.434 0.901 . . . . 0.76000000000000001 113.434 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.31 -11.73 60.83 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.673 0.99 . . . . 2.0699999999999998 113.673 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.5 t -62.47 -19.21 63.32 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.587 -1.321 . . . . 1.3 113.6 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -107.43 0.25 22.76 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.203 1.401 . . . . 1.96 113.379 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 69.4 m -101.28 167.46 10.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.271 1.211 . . . . 2.1299999999999999 114.271 -169.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.83 54.72 1.21 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.312 1.845 . . . . 3.6600000000000001 111.572 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.03 69.09 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.52 1.528 . . . . 2.0099999999999998 112.66 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.33 -17.22 9.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.961 3.107 . . . . 1.0 116.285 -167.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.82 -50.91 2.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.575 0.954 . . . . 0.82999999999999996 113.575 -166.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.61 67.4 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-O 121.531 0.517 . . . . 0.98999999999999999 113.557 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 32.0 p -63.68 -22.76 67.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.114 1.366 . . . . 1.77 113.337 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.22 69.1 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.701 -1.25 . . . . 0.85999999999999999 111.702 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.68 -35.75 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.973 0.909 . . . . 0.95999999999999996 110.077 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 34.3 m -57.1 -48.08 79.47 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.247 0.93 . . . . 1.3100000000000001 110.93 168.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -54.81 -51.32 66.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.303 1.041 . . . . 3.9199999999999999 112.036 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.01 -44.39 91.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.331 1.052 . . . . 1.77 111.496 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 48.9 t -65.93 -49.7 67.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.266 1.026 . . . . 1.8500000000000001 111.93 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.88 -33.04 74.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 2.9199999999999999 111.446 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.8 -41.12 72.04 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.784 1.234 . . . . 3.1699999999999999 113.524 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -69.61 -40.49 76.57 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.944 1.247 . . . . 2.0 113.359 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.07 -20.22 61.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.673 1.189 . . . . 1.1599999999999999 113.351 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.2 t0 54.14 42.36 31.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.687 1.195 . . . . 2.3399999999999999 112.498 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.1 t -125.85 165.97 17.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.261 1.824 . . . . 2.6299999999999999 111.086 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -100.01 -11.13 20.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.942 1.297 . . . . 3.1200000000000001 113.885 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 9.9 t -148.15 135.12 20.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.843 1.257 . . . . 2.8799999999999999 111.551 -172.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -158.22 149.48 21.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.764 1.226 . . . . 0.84999999999999998 112.476 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 69.88 142.94 0.18 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.032 1.301 . . . . 1.03 115.244 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 19.0 m -112.01 -80.03 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.653 1.581 . . . . 1.45 112.125 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 44.5 t -135.39 136.75 41.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.92 1.288 . . . . 1.3500000000000001 111.279 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.4 mp -141.09 149.78 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.275 3.83 . . . . 3.1400000000000001 107.056 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 31.5 t70 -137.03 109.01 7.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.896 1.278 . . . . 3.3399999999999999 109.348 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -97.35 135.07 39.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.198 1.925 . . . . 2.8799999999999999 116.198 -171.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.1 26.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.637 2.775 . . . . 3.0499999999999998 107.12 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.4 m -112.49 142.57 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 115.092 1.515 . . . . 2.46 115.092 -167.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.77 131.23 14.63 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.321 1.449 . . . . 1.1499999999999999 109.39 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.4 130.88 21.96 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.784 2.322 . . . . 1.71 111.862 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.74 -41.53 0.69 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.722 2.106 . . . . 2.2000000000000002 115.148 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -78.75 10.97 2.85 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.636 2.087 . . . . 2.5699999999999998 116.636 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 85.98 171.79 48.23 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 119.093 0.86 . . . . 1.24 113.249 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.4 pt -136.12 165.51 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.665 1.186 . . . . 2.98 111.868 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.2 t -127.14 152.37 47.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.333 1.053 . . . . 0.56000000000000005 112.112 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 23.1 p -144.35 169.68 17.46 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.028 -1.045 . . . . 0.68999999999999995 113.258 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -118.51 119.94 36.05 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.578 -1.267 . . . . 1.7 107.578 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.1 p -127.09 136.78 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.846 1.054 . . . . 1.8999999999999999 113.846 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1124 ' ' THR . . . . . 0.495 ' HB ' HE21 ' A' 1177 ' ' GLN . 5.3 t -119.76 150.11 40.93 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.445 0.906 . . . . 1.0600000000000001 113.445 168.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 CA--C 1.551 1.011 0 C-N-CA 128.459 2.704 . . . . 2.6800000000000002 108.463 158.601 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1177 ' ' GLN . . . . . 0.495 HE21 ' HB ' ' A' 1124 ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 111.909 0.337 . . . . 2.0299999999999998 111.909 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -131.03 129.96 42.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.808 1.643 . . . . 3.0800000000000001 112.12 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -88.42 123.51 33.04 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.595 -0.891 . . . . 1.3200000000000001 108.595 167.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.6 m -131.67 154.95 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.232 1.013 . . . . 1.0600000000000001 111.514 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.45 152.06 32.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.076 0.951 . . . . 0.56999999999999995 112.807 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.9 tt -153.85 153.07 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.048 1.339 . . . . 0.81999999999999995 110.673 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 103.03 154.55 24.64 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.98 0.767 . . . . 1.9199999999999999 114.281 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.9 t-20 54.08 -161.52 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.178 1.791 . . . . 2.1299999999999999 113.248 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -27.95 3.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.594 1.558 . . . . 6.0499999999999998 113.516 168.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.7 -48.13 73.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.534 1.061 . . . . 4.5599999999999996 113.033 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 9.7 t90 -75.92 -37.37 58.8 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.425 . . . . 3.21 112.008 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 76.3 mmm -54.68 -37.51 65.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.472 0.709 . . . . 2.8399999999999999 111.966 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.36 -66.75 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.197 1.399 . . . . 2.4199999999999999 108.954 166.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -9.97 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.623 2.369 . . . . 6.9299999999999997 116.627 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.88 21.01 0.22 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 120.298 1.408 . . . . 0.95999999999999996 112.131 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 63.88 17.65 61.03 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.27 -1.518 . . . . 1.1299999999999999 115.249 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.07 164.05 26.07 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.278 1.539 . . . . 0.92000000000000004 111.338 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 55.9 t -91.51 127.66 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.449 -0.782 . . . . 1.5600000000000001 109.007 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.68 140.02 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.822 0.849 . . . . 0.89000000000000001 111.087 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -116.8 155.77 28.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.522 1.129 . . . . 2.7000000000000002 112.437 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.62 -37.0 85.66 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.717 1.006 . . . . 2.3700000000000001 113.717 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -73.53 -37.31 65.67 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.026 0.83 . . . . 2.6899999999999999 112.672 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 -35.28 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.911 -0.566 . . . . 0.82999999999999996 111.407 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -63.33 -43.6 97.29 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.766 1.166 . . . . 1.9099999999999999 112.16 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.67 -33.23 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.404 -0.81 . . . . 2.1699999999999999 113.036 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -74.06 -36.81 64.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.046 . . . . 2.4300000000000002 113.529 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.2 tpp -64.38 -52.61 57.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.165 1.386 . . . . 0.89000000000000001 111.139 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 7.0 t -65.23 -28.98 69.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.267 1.027 . . . . 0.89000000000000001 112.687 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -57.52 -54.45 46.68 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.044 0.937 . . . . 2.6600000000000001 112.987 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -71.09 -29.92 65.9 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.921 0.341 . . . . 2.7400000000000002 111.921 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.21 -39.98 93.52 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.339 1.056 . . . . 3.6099999999999999 112.083 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -68.66 -25.61 64.9 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.705 2.402 . . . . 3.77 113.593 172.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 17.7 mttp -78.56 4.87 12.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.506 1.522 . . . . 3.02 113.09 168.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 71.81 18.4 77.44 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.441 1.496 . . . . 1.6100000000000001 112.877 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -101.89 -174.76 2.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.411 1.484 . . . . 3.6299999999999999 110.907 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.5 m -108.2 125.15 51.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.439 1.096 . . . . 0.88 111.741 -169.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.28 127.4 29.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.348 1.059 . . . . 0.58999999999999997 110.303 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.4 m -140.96 158.11 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.907 1.283 . . . . 0.47999999999999998 113.23 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.0 163.83 11.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.84 1.256 . . . . 0.93999999999999995 111.791 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.2 p -139.29 134.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.857 1.263 . . . . 2.1800000000000002 112.56 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -131.04 153.48 49.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.269 1.828 . . . . 0.40000000000000002 112.53 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.4 m -146.29 131.09 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.999 2.12 . . . . 0.69999999999999996 110.316 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.395 0.0 OUTLIER 41.29 46.17 2.72 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.335 1.854 . . . . 3.8799999999999999 114.596 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 61.03 31.31 19.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.308 2.243 . . . . 1.47 115.874 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.03 158.89 39.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.65 1.98 . . . . 2.3799999999999999 111.82 168.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 146.5 33.27 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.667 -1.271 . . . . 0.91000000000000003 112.619 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 7.6 p -118.7 -41.82 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.282 0.633 . . . . 0.53000000000000003 111.085 167.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.17 -163.24 24.85 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.798 1.181 . . . . 0.41999999999999998 115.869 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.64 153.22 43.24 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.795 2.038 . . . . 0.79000000000000004 112.57 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 25.6 mm -124.35 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.383 1.473 . . . . 0.73999999999999999 109.579 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.24 132.27 54.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.21 1.404 . . . . 0.62 110.898 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 19.1 mt -136.02 158.05 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.71 2.004 . . . . 1.3100000000000001 110.646 -168.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 C-N-CA 125.907 1.683 . . . . 1.3899999999999999 111.573 174.464 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.487 0.18 . . . . 2.2999999999999998 111.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.01 146.95 66.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.756 2.304 . . . . 1.3200000000000001 111.441 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 10.9 p -130.59 134.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.347 1.059 . . . . 2.5499999999999998 110.698 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -72.44 113.63 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.87 0.843 . . . . 1.1899999999999999 109.642 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -91.52 -40.44 11.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.466 1.106 . . . . 2.7799999999999998 111.725 -168.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -154.4 152.32 30.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.131 0.972 . . . . 1.97 112.099 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.9 m -125.65 142.62 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.943 1.297 . . . . 0.72999999999999998 111.422 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -143.45 149.35 37.47 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.925 1.083 . . . . 2.3799999999999999 113.925 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 46.3 t -96.3 143.65 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.638 1.575 . . . . 0.68000000000000005 111.614 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.3 tp -107.41 -46.15 3.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.605 1.962 . . . . 1.05 111.5 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.8 m -118.98 126.39 51.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.393 1.477 . . . . 1.73 109.115 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -150.52 138.81 20.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.857 0.463 . . . . 4.4900000000000002 111.568 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.1 m 63.67 -14.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.956 2.103 . . . . 2.9900000000000002 116.59 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -95.52 -3.25 46.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.665 1.186 . . . . 2.8799999999999999 114.145 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -157.88 -44.51 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.146 0.979 . . . . 4.21 112.987 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mm -134.12 157.65 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.61 1.964 . . . . 1.5800000000000001 110.346 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 71.6 m -113.5 149.84 33.74 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.019 1.727 . . . . 2.1099999999999999 112.589 172.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 21.1 p80 -55.98 -47.01 78.47 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.634 2.087 . . . . 3.5299999999999998 116.634 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -70.32 -18.01 63.09 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.531 1.06 . . . . 2.9100000000000001 111.378 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.29 -30.09 18.71 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.558 1.543 . . . . 3.7599999999999998 111.784 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 92.7 mt -58.6 -52.22 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.191 0.905 . . . . 0.68999999999999995 109.528 168.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.21 -34.13 77.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.801 -0.562 . . . . 0.63 111.645 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -59.6 -52.96 63.31 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.535 -0.745 . . . . 0.67000000000000004 112.548 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 28.3 pt -68.37 -31.01 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.94 1.246 . . . . 0.64000000000000001 113.836 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.0 t -70.37 -45.27 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.609 1.095 . . . . 0.77000000000000002 110.416 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -61.37 -41.19 99.46 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.28 -0.733 . . . . 0.65000000000000002 113.241 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1079 ' ' THR . . . . . 0.4 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 66.3 p -72.82 -37.42 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.159 0.98 . . . . 0.66000000000000003 113.541 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.13 83.27 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.023 0.829 . . . . 0.77000000000000002 112.379 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.1 -16.91 63.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.275 -0.89 . . . . 2.2599999999999998 112.763 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 -23.83 67.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.159 1.17 . . . . 1.3200000000000001 114.159 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -94.22 -13.12 26.93 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.25 -0.906 . . . . 1.8999999999999999 112.757 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.7 t -73.84 160.18 31.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.298 1.592 . . . . 1.6599999999999999 115.298 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.24 12.42 26.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.576 2.35 . . . . 5.3099999999999996 113.445 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.59 160.1 59.69 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.912 1.078 . . . . 1.54 113.912 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.85 -34.66 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.897 3.065 . . . . 1.1699999999999999 114.61 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.79 -51.67 4.79 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.853 0.861 . . . . 0.69999999999999996 113.308 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.4 -30.43 77.55 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.844 -0.217 . . . . 0.92000000000000004 113.345 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 29.2 p -65.19 -18.91 65.7 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.62 -1.518 . . . . 1.8600000000000001 113.557 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.66 -32.05 73.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.802 -1.186 . . . . 0.81000000000000005 111.545 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.19 -41.18 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.488 1.515 . . . . 0.84999999999999998 110.474 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 99.4 m -52.58 -47.99 66.51 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.892 1.223 . . . . 1.26 111.404 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.2 tttt -59.11 -50.29 74.6 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.243 0.929 . . . . 2.5800000000000001 112.284 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 76.9 t80 -58.28 -40.51 82.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.683 1.193 . . . . 2.1899999999999999 112.534 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 83.7 m -72.84 -43.19 62.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.732 1.613 . . . . 3.2599999999999998 113.032 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.93 -36.81 80.29 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.329 1.422 . . . . 2.8399999999999999 110.836 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.22 -47.39 79.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.216 1.006 . . . . 4.0 111.127 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -62.67 -44.52 96.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.884 1.22 . . . . 1.95 113.844 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.64 -18.71 62.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.322 0.86 . . . . 1.1499999999999999 113.322 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 18.3 t70 48.99 32.06 3.65 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.69 1.596 . . . . 2.3199999999999998 113.59 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -99.85 -12.35 19.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.145 1.778 . . . . 3.4399999999999999 115.344 -167.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 16.8 tt0 66.84 -19.93 0.11 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.656 2.382 . . . . 4.29 116.677 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.8 t -154.35 138.12 16.17 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.101 1.319 . . . . 3.25 113.507 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -156.62 153.78 29.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.012 1.325 . . . . 1.0600000000000001 114.449 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1106 ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 98.4 136.95 9.49 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 125.477 1.513 . . . . 1.04 114.622 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 25.1 m -125.94 -68.07 0.84 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.894 0.878 . . . . 1.3500000000000001 112.661 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 12.8 t -138.77 142.48 38.8 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.395 1.258 . . . . 1.4299999999999999 114.395 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.4 mm -143.82 139.44 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 130.997 3.719 . . . . 2.25 109.211 -174.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1110 ' ' ASP . . . . . 0.513 ' HB3' ' H ' ' A' 1122 ' ' LYS . 17.0 t0 -94.72 -28.06 15.5 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.524 1.53 . . . . 2.7400000000000002 114.027 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.82 97.1 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.946 2.098 . . . . 2.75 116.222 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.59 114.48 22.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.967 1.707 . . . . 2.5499999999999998 109.136 169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 92.8 t -113.71 131.33 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.445 1.498 . . . . 2.0899999999999999 111.453 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 50.7 t -133.9 118.79 14.45 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.201 1.4 . . . . 1.6200000000000001 107.602 169.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -53.42 136.62 63.82 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.214 2.609 . . . . 1.3400000000000001 113.677 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.31 -45.22 0.96 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.422 1.963 . . . . 2.1699999999999999 114.767 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 79.2 m -71.48 -5.34 32.26 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 117.369 2.359 . . . . 2.54 117.369 -167.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 110.46 -167.41 12.63 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.983 1.265 . . . . 0.67000000000000004 113.819 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 143.39 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.127 1.371 . . . . 1.8700000000000001 110.204 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.6 t -129.19 151.8 49.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.559 1.144 . . . . 0.53000000000000003 111.466 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 29.3 p -162.94 172.52 14.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.197 0.999 . . . . 0.80000000000000004 113.413 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1122 ' ' LYS . . . . . 0.513 ' H ' ' HB3' ' A' 1110 ' ' ASP . 43.0 mmtm -114.16 135.91 53.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.447 1.499 . . . . 1.22 107.191 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 35.0 m -128.6 148.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.609 0.763 . . . . 2.71 112.35 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.0 t -134.09 145.78 49.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.054 0.942 . . . . 1.23 109.68 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 126.233 1.813 . . . . 2.9500000000000002 108.371 159.973 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 122.144 0.973 . . . . 2.0800000000000001 112.937 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -126.33 134.58 51.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.955 2.502 . . . . 2.6000000000000001 109.179 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -95.04 105.9 17.85 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.855 1.262 . . . . 1.52 110.786 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -124.11 142.33 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.382 0.673 . . . . 0.90000000000000002 112.652 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.5 151.87 38.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.536 1.135 . . . . 0.51000000000000001 112.836 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.47 155.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.767 1.627 . . . . 0.67000000000000004 109.891 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 107.55 163.66 21.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.111 0.839 . . . . 1.6299999999999999 114.127 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 4.8 t-20 49.98 -155.23 0.11 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.212 1.805 . . . . 2.3999999999999999 114.013 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -130.11 -34.69 1.65 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.171 2.589 . . . . 5.0099999999999998 111.556 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.88 -32.47 51.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.159 1.17 . . . . 3.2999999999999998 114.159 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.2 t90 -72.39 -28.98 63.34 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.354 -1.466 . . . . 3.0600000000000001 111.892 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 6.1 tpp -57.38 -34.23 68.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.922 0.889 . . . . 2.3100000000000001 111.617 171.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.96 -66.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.554 1.942 . . . . 1.6399999999999999 109.985 168.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -55.8 -18.89 9.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 116.01 1.856 . . . . 5.5999999999999996 116.01 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.71 9.86 2.55 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 120.15 1.341 . . . . 0.81000000000000005 112.79 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 72.77 18.63 78.92 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.387 1.47 . . . . 0.98999999999999999 115.571 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.59 171.23 13.53 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.445 1.098 . . . . 0.80000000000000004 111.325 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 94.7 t -108.79 120.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.568 1.147 . . . . 1.0600000000000001 109.989 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.87 125.27 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.158 0.983 . . . . 1.1299999999999999 110.845 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -92.54 156.24 17.27 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.031 1.332 . . . . 4.1699999999999999 112.99 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -60.21 -31.36 70.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.702 1.201 . . . . 2.6299999999999999 113.45 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.45 -42.51 68.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.348 1.059 . . . . 3.0299999999999998 111.704 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 4.4 p -78.17 -35.26 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.223 0.823 . . . . 0.79000000000000004 113.223 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.8 -38.95 89.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.668 1.122 . . . . 2.3599999999999999 111.215 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -49.27 78.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.585 0.754 . . . . 1.97 112.142 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.2 -41.56 79.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.189 1.396 . . . . 2.5899999999999999 111.546 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 25.4 tpp -64.81 -49.29 71.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.553 1.541 . . . . 0.73999999999999999 111.811 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.4 t -74.94 -30.53 61.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.885 0.698 . . . . 0.90000000000000002 112.885 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -58.05 -53.18 61.2 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.477 -1.389 . . . . 2.5 112.629 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -71.31 -29.13 64.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.532 0.733 . . . . 3.02 112.572 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.05 -46.08 89.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.949 0.9 . . . . 4.8399999999999999 111.595 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -66.93 -29.54 69.44 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.389 1.475 . . . . 3.7999999999999998 113.625 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 23.5 mttp -65.44 -10.69 36.08 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.482 1.513 . . . . 2.6400000000000001 113.51 169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.26 29.52 10.18 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.941 1.258 . . . . 1.72 114.409 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -126.63 176.94 6.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.715 1.606 . . . . 5.5999999999999996 111.043 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 55.2 m -90.79 139.16 31.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.072 1.349 . . . . 0.81999999999999995 111.328 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -136.86 130.95 32.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.025 0.93 . . . . 0.47999999999999998 112.514 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 164.58 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.717 1.607 . . . . 0.45000000000000001 113.423 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.37 168.74 10.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.363 1.465 . . . . 0.78000000000000003 113.489 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.2 t -137.02 128.56 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.624 1.57 . . . . 1.6799999999999999 112.101 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.55 150.24 47.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.243 1.417 . . . . 0.5 113.259 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.32 125.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.091 1.756 . . . . 0.63 111.529 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 37.7 53.5 1.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.494 2.318 . . . . 2.7400000000000002 113.268 -173.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.275 16.3 m-20 58.85 29.29 18.62 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.369 1.989 . . . . 2.0499999999999998 116.369 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.18 151.7 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.496 1.918 . . . . 3.2200000000000002 110.091 166.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.55 145.33 34.89 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.833 -1.167 . . . . 0.70999999999999996 110.124 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -119.5 -40.55 2.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.527 -0.749 . . . . 0.44 112.892 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.27 -172.7 37.67 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 120.11 1.323 . . . . 0.38 116.222 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -138.25 152.62 48.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.264 1.826 . . . . 0.69999999999999996 112.656 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 11.1 mm -132.29 136.28 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.72999999999999998 110.242 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -109.97 136.9 48.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.311 1.444 . . . . 0.64000000000000001 110.266 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.36 143.65 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.805 1.642 . . . . 1.47 111.146 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 126.518 1.927 . . . . 1.54 111.956 179.679 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 119.983 -0.056 . . . . 11.94 110.856 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 15.7 t80 -148.86 172.32 14.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.528 1.131 . . . . 13.0 112.5 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 14.6 t -74.44 150.84 39.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.358 1.463 . . . . 7.4500000000000002 114.141 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.6 32.02 0.16 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.068 1.747 . . . . 6.1500000000000004 112.374 172.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 49.6 m80 -79.34 -27.3 42.04 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.853 1.427 . . . . 5.4699999999999998 114.853 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -80.17 71.09 2.83 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 119.959 1.254 . . . . 2.4500000000000002 112.719 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 90.6 m -72.93 130.52 85.01 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 125.073 1.349 . . . . 2.4100000000000001 113.359 -169.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.89 149.32 3.94 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.969 3.113 . . . . 1.3200000000000001 112.923 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 3.9 m -131.52 130.24 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.728 2.011 . . . . 2.3700000000000001 111.903 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.2 p -74.8 126.44 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.396 -0.815 . . . . 1.1299999999999999 110.745 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.02 -38.29 3.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.733 1.753 . . . . 2.3399999999999999 115.733 -165.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -149.09 145.18 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.281 1.401 . . . . 2.1000000000000001 111.961 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 30.1 m -125.41 143.16 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.088 0.955 . . . . 1.21 112.786 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 71.9 tttt -136.88 142.19 42.78 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.526 1.53 . . . . 1.9299999999999999 111.385 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 58.0 t -94.38 148.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.131 1.373 . . . . 0.93000000000000005 111.45 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.91 -39.09 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.35 1.46 . . . . 1.3600000000000001 113.682 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.4 t -81.12 29.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.82 1.191 . . . . 2.75 113.424 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.34 132.42 39.26 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.859 -1.776 . . . . 4.3700000000000001 111.634 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 20.8 m 61.65 -8.62 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.763 2.505 . . . . 2.5299999999999998 117.763 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.84 -30.86 12.91 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.397 1.628 . . . . 3.48 115.397 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -150.04 -66.28 0.21 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.658 1.117 . . . . 5.2999999999999998 112.579 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.507 HD12 HG21 ' A' 1218 ' ' VAL . 4.4 mt -128.15 140.08 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.577 1.951 . . . . 1.77 110.905 -171.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.5 m -103.15 160.27 14.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.637 1.175 . . . . 1.99 112.746 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.8 p80 -47.13 -41.41 17.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.944 1.698 . . . . 2.9500000000000002 115.466 -169.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -70.55 -42.22 71.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.071 1.348 . . . . 3.23 111.913 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.53 -33.23 72.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.067 -1.02 . . . . 2.9700000000000002 112.138 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1073 ' ' ILE . . . . . 0.431 HG13 HG22 ' A' 1068 ' ' ILE . 97.9 mt -58.41 -52.65 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.884 1.22 . . . . 0.79000000000000004 110.768 172.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.79 -29.96 68.43 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.402 -0.811 . . . . 0.82999999999999996 112.181 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.62 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.095 0.558 . . . . 0.64000000000000001 112.279 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 15.1 pt -70.31 -35.53 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.809 1.186 . . . . 0.72999999999999998 112.867 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 92.4 t -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.452 1.023 . . . . 0.78000000000000003 111.006 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.8 -34.74 88.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.451 -0.78 . . . . 0.68999999999999995 113.51 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.9 p -75.9 -32.61 59.72 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.746 1.273 . . . . 0.65000000000000002 112.815 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.05 67.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.877 0.762 . . . . 0.72999999999999998 112.137 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.41 -21.13 62.87 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.313 -0.867 . . . . 1.9199999999999999 112.439 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.0 t -65.23 -18.51 65.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.93 -1.106 . . . . 1.48 112.566 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -117.69 -9.23 10.77 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.169 1.388 . . . . 2.5499999999999998 113.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.9 t -85.62 -174.89 5.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.409 1.484 . . . . 1.4199999999999999 112.32 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -135.82 32.13 3.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.547 1.939 . . . . 4.2599999999999998 112.703 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1086 ' ' HIS . . . . . 0.463 ' HB3' HN61 ' A' 1232 ' ' ATP . 2.0 m-70 -93.51 162.3 28.09 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 114.199 1.185 . . . . 1.6899999999999999 114.199 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.68 -21.55 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.052 3.168 . . . . 0.98999999999999999 114.657 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.4 -52.48 2.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.054 1.341 . . . . 0.69999999999999996 113.383 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.91 -23.59 65.83 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 114.154 0.422 . . . . 0.95999999999999996 114.154 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 12.9 p -61.44 -18.45 58.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.929 -1.336 . . . . 1.45 113.988 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.68 81.42 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.885 -1.134 . . . . 0.83999999999999997 111.719 168.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.64 -32.85 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.299 1.039 . . . . 1.3200000000000001 111.291 172.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 28.0 m -52.27 -50.81 61.39 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.798 1.181 . . . . 1.1399999999999999 111.253 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -61.32 -48.04 83.18 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.852 0.751 . . . . 2.71 112.647 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -55.73 -41.63 74.16 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.961 0.904 . . . . 1.76 111.735 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.1 t -67.91 -52.74 32.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.132 1.373 . . . . 2.0299999999999998 112.371 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -42.31 88.86 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.413 -1.429 . . . . 3.02 112.455 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -67.47 -31.51 71.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.81 1.644 . . . . 2.98 111.901 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -70.25 -50.34 40.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.501 1.046 . . . . 2.6600000000000001 112.224 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 27.4 mt -72.18 -22.72 61.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.484 1.29 . . . . 1.4099999999999999 114.484 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.6 t0 56.36 43.9 25.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.87 1.668 . . . . 2.7599999999999998 113.333 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.7 t -138.88 -30.8 0.74 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.175 2.287 . . . . 3.3100000000000001 117.175 -169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 61.1 tt0 64.47 -26.41 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.744 2.498 . . . . 4.4299999999999997 117.744 -171.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 46.9 p -84.57 45.2 1.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.446 1.898 . . . . 3.0899999999999999 114.828 -169.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.95 151.75 23.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.159 1.383 . . . . 0.92000000000000004 113.523 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 92.79 122.76 3.23 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.049 0.841 . . . . 1.1599999999999999 114.611 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1107 ' ' THR . . . . . 0.632 HG22 ' H ' ' A' 1108 ' ' CYS . 74.4 m -129.3 -172.58 2.77 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.254 2.622 . . . . 2.6000000000000001 107.653 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1108 ' ' CYS . . . . . 0.632 ' H ' HG22 ' A' 1107 ' ' THR . 8.3 t -56.42 143.37 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.151 1.908 . . . . 1.54 116.151 -168.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 16.5 tt -135.11 140.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 131.523 3.929 . . . . 2.1400000000000001 106.368 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.2 t0 -124.53 93.48 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.46 1.104 . . . . 3.21 108.845 172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.341 0.0 OUTLIER -97.43 166.55 11.48 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 117.412 2.375 . . . . 3.1400000000000001 117.412 -169.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -142.81 105.45 4.49 Favored 'General case' 0 CA--C 1.562 1.414 1 C-N-CA 132.332 4.253 . . . . 2.1400000000000001 107.625 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 6.3 m -109.62 151.04 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.303 -1.498 . . . . 3.0299999999999998 114.515 -170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 13.9 t -137.71 138.87 25.16 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.9 1.28 . . . . 1.53 110.599 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.33 132.95 28.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.647 2.231 . . . . 1.47 111.758 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.1 -34.5 0.41 Allowed Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.267 1.889 . . . . 2.1600000000000001 115.893 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -90.21 2.91 54.88 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.212 1.56 . . . . 2.1699999999999999 115.212 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 90.98 -176.29 40.67 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.308 0.956 . . . . 0.75 114.598 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.5 pt -136.53 160.01 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.111 0.964 . . . . 2.6299999999999999 112.59 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 21.7 t -130.27 147.03 51.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.415 1.486 . . . . 0.59999999999999998 111.565 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.4 p -154.63 173.77 15.9 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.013 -1.055 . . . . 0.68000000000000005 113.003 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -115.88 111.18 20.07 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 2.6 m -103.05 127.93 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.596 1.158 . . . . 2.2999999999999998 113.432 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.3 t -109.23 159.1 17.21 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.074 0.95 . . . . 1.01 112.306 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -168.53 -42.44 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.728 2.811 . . . . 2.5499999999999998 107.786 161.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 15.4 pt -49.03 -37.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.711 2.004 . . . . 2.1699999999999999 115.845 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -150.24 45.1 0.89 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.98 1.264 . . . . 4.4299999999999997 111.253 167.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -67.11 -4.68 29.88 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.983 1.278 . . . . 3.23 114.855 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.36 -1.14 5.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.73 2.012 . . . . 3.4500000000000002 115.087 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.7 tt -86.96 -36.24 18.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.58 1.152 . . . . 4.6699999999999999 111.914 171.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 12.3 m80 64.58 115.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 127.163 2.185 . . . . 7.04 112.808 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -84.17 155.98 22.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.324 1.972 . . . . 12.81 116.324 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.22 121.97 36.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.85 -1.537 . . . . 13.07 106.85 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -126.42 17.62 7.61 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.507 1.123 . . . . 13.73 113.556 -168.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -78.73 111.58 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 119.726 -1.859 . . . . 17.219999999999999 112.651 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 53.98 21.78 3.06 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.072 1.749 . . . . 17.449999999999999 113.27 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . 0.305 0.8 OUTLIER -63.85 -15.21 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 117.484 2.401 . . . . 18.16 117.484 -162.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -71.27 -20.31 62.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.369 1.068 . . . . 21.620000000000001 112.71 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -108.64 -42.98 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 116.988 -1.482 . . . . 20.969999999999999 111.429 168.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -35.5 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.553 1.941 . . . . 20.469999999999999 111.08 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -89.89 140.1 29.95 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.775 0.83 . . . . 26.780000000000001 111.46 -166.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.73 -37.85 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.721 0.409 . . . . 28.600000000000001 111.776 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -169.78 116.73 0.57 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.334 1.454 . . . . 32.659999999999997 111.131 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -81.98 36.57 0.46 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.084 1.142 . . . . 31.98 114.084 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -154.04 177.46 11.04 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.456 1.902 . . . . 34.43 112.107 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 40.4 t -66.59 144.81 56.19 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.173 2.189 . . . . 39.310000000000002 114.555 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.29 -12.47 0.1 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 118.453 2.761 . . . . 39.990000000000002 118.453 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 95.0 t -78.99 -48.63 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.502 1.501 . . . . 43.939999999999998 110.222 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -153.52 91.81 1.52 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.078 1.351 . . . . 50.350000000000001 110.099 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1150 ' ' ILE . . . . . 0.623 HD12 ' H ' ' A' 1150 ' ' ILE . 4.2 mp -63.65 -38.14 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.046 1.338 . . . . 46.049999999999997 110.943 -173.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.44 -22.94 67.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.69 0.996 . . . . 51.350000000000001 113.69 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -99.77 -13.02 19.44 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 48.210000000000001 113.527 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 66.2 p -142.64 95.02 2.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.13 0.972 . . . . 44.740000000000002 112.756 -173.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 51.65 81.0 0.08 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.441 2.296 . . . . 42.43 115.692 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -76.4 68.4 2.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.436 1.094 . . . . 44.130000000000003 112.521 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -66.43 -51.99 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.126 -0.984 . . . . 39.469999999999999 110.825 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 11.9 t -136.89 172.42 13.04 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.554 1.316 . . . . 37.630000000000003 114.554 -168.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 6.5 p -64.41 -37.67 88.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 130.195 3.398 . . . . 36.780000000000001 113.973 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 59.5 p 61.61 148.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 128.832 2.853 . . . . 33.020000000000003 118.25 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 142.12 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.863 1.265 . . . . 28.949999999999999 109.442 167.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.21 0.63 6.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.781 2.141 . . . . 28.100000000000001 116.781 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 32.1 t -128.9 -31.16 2.19 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.865 1.802 . . . . 25.050000000000001 115.865 165.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 7.8 ptt? -73.53 134.65 43.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.204 1.82 . . . . 22.050000000000001 110.527 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 34.6 mt 67.45 -37.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 126.513 1.925 . . . . 16.0 113.912 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1165 ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' 1166 ' ' ASP . 0.0 OUTLIER -62.68 138.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.574 1.95 . . . . 19.609999999999999 109.324 168.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1166 ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' 1165 ' ' ILE . 14.9 t70 60.78 -20.39 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.853 2.061 . . . . 14.99 116.094 -169.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -54.92 -27.05 40.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.81 1.644 . . . . 10.380000000000001 114.787 -171.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.36 -25.16 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.294 1.438 . . . . 11.01 113.443 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.56 -50.27 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.768 1.227 . . . . 9.7200000000000006 109.308 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 38.3 p -66.26 -28.09 68.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.951 0.352 . . . . 7.8200000000000003 111.951 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.99 -57.92 10.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.858 0.863 . . . . 5.6200000000000001 110.005 168.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.91 85.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.927 1.455 . . . . 4.1600000000000001 114.927 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.24 -15.94 61.93 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.66 0.985 . . . . 6.2699999999999996 113.66 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.18 -46.28 5.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.108 0.867 . . . . 4.7800000000000002 111.418 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -78.08 57.7 1.85 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.478 1.911 . . . . 3.4100000000000001 110.472 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . 0.329 28.7 mt-30 -50.95 139.54 17.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.067 1.889 . . . . 3.7400000000000002 114.915 -166.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -148.8 168.44 22.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 111.557 -2.565 . . . . 2.98 114.635 -159.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 119.25 10.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.898 0.879 . . . . 3.3399999999999999 112.365 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.29 117.29 18.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.23 . . . . 1.2 110.686 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -135.29 144.07 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 0.55000000000000004 112.198 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.26 154.59 42.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.895 1.278 . . . . 0.5 112.603 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.0 tt -152.5 145.79 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.279 1.032 . . . . 0.63 110.587 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 121.83 166.58 12.89 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 116.042 1.177 . . . . 1.4399999999999999 116.042 168.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 48.11 -141.36 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.604 1.962 . . . . 2.29 113.93 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.43 -32.58 0.45 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.499 1.52 . . . . 6.0199999999999996 114.184 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.59 -37.49 79.86 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.433 1.469 . . . . 3.77 114.275 -174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.3 t90 -68.22 -31.18 70.51 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.657 -1.277 . . . . 3.27 111.819 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 10.4 tpp -60.23 -34.53 73.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.137 0.975 . . . . 2.2000000000000002 111.752 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.66 -67.01 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.467 1.507 . . . . 1.5900000000000001 109.043 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -52.96 -24.97 10.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.967 2.107 . . . . 5.6799999999999997 115.987 -172.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.76 20.23 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.006 1.275 . . . . 0.79000000000000004 113.811 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.26 13.41 81.4 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.193 -1.567 . . . . 0.93000000000000005 115.376 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.6 mt -83.96 175.3 9.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.605 1.162 . . . . 0.92000000000000004 111.388 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 57.8 t -119.41 131.05 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.087 1.355 . . . . 1.21 108.744 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.5 tt -102.71 135.73 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.396 0.679 . . . . 1.1200000000000001 110.954 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.7 p30 -96.82 159.51 14.88 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.736 1.214 . . . . 4.1200000000000001 113.099 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.1 p30 -71.99 -15.04 62.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.447 1.277 . . . . 4.3799999999999999 114.447 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -84.24 -45.22 13.11 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.62 -1.3 . . . . 2.46 113.019 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.2 p -64.45 -34.46 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 118.823 -0.608 . . . . 0.81000000000000005 110.92 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.67 -42.96 81.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.761 1.164 . . . . 1.95 112.604 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.61 -34.69 77.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.274 1.03 . . . . 1.97 112.405 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 39.9 t80 -71.95 -35.41 69.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.818 1.247 . . . . 2.3100000000000001 112.718 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.3 tpp -71.21 -58.95 3.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.502 1.921 . . . . 0.80000000000000004 112.435 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -62.53 -28.2 69.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 0.89000000000000001 112.297 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -58.31 -47.42 83.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.757 2.023 . . . . 2.71 113.403 171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -64.78 -36.11 83.25 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.213 -0.929 . . . . 2.4900000000000002 111.842 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.41 -31.96 72.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.514 -0.741 . . . . 3.0699999999999998 112.36 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 48.9 ttp85 -70.6 -39.9 73.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.558 2.343 . . . . 9.0 111.431 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 13.8 mttp -69.2 -1.38 7.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.728 2.011 . . . . 2.3199999999999998 112.624 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 75.34 16.58 80.53 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.824 1.202 . . . . 1.2 115.022 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -95.45 178.93 5.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 111.205 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1212 ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 70.2 m -93.29 121.08 34.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.16 1.784 . . . . 0.94999999999999996 109.635 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.41 113.95 15.56 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.754 0.822 . . . . 0.62 111.873 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 26.7 m -140.55 163.13 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.569 1.148 . . . . 0.51000000000000001 114.06 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.1 160.95 23.97 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.352 1.461 . . . . 0.81000000000000005 112.982 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 5.0 t -127.49 125.75 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.22 1.808 . . . . 1.7 111.677 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -118.66 154.36 32.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.122 1.369 . . . . 0.51000000000000001 112.19 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1218 ' ' VAL . . . . . 0.507 HG21 HD12 ' A' 1068 ' ' ILE . 18.9 m -146.61 122.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.027 1.731 . . . . 0.84999999999999998 110.462 -172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 31.2 t70 44.39 46.79 7.98 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 122.705 1.241 . . . . 3.3399999999999999 113.368 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.265 4.9 m-20 62.42 28.1 16.66 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.549 1.94 . . . . 1.76 115.838 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.46 149.07 42.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.726 2.811 . . . . 3.27 110.273 168.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.61 114.61 26.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.47 -1.394 . . . . 1.1599999999999999 110.812 170.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.4 p -89.21 -38.06 14.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.738 1.154 . . . . 0.56000000000000005 113.32 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . 176.48 -168.69 40.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 119.259 0.936 . . . . 0.45000000000000001 114.883 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.23 156.08 44.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.349 1.46 . . . . 0.68999999999999995 113.772 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.37 133.05 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 1.4199999999999999 111.525 -170.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -105.15 136.59 44.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.978 1.711 . . . . 0.70999999999999996 110.356 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1228 ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' 1212 ' ' THR . 67.3 mt -140.97 148.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.759 1.624 . . . . 1.0700000000000001 109.869 -168.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.25 170.6 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.413 1.085 . . . . 1.51 112.585 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.15 137.76 44.61 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.752 1.621 . . . . 3.4399999999999999 112.419 -172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 115.22 1.563 . . . . 4.71 115.22 -172.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1232 ' ' ATP . . . . . 0.463 HN61 ' HB3' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 112.575 0.583 . . . . 11.09 112.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 2.2 t80 54.71 16.0 1.26 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.598 2.444 . . . . 12.640000000000001 117.598 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 51.7 m -105.46 -11.44 16.42 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.757 2.023 . . . . 8.0899999999999999 113.036 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 3.4 tpt -144.1 108.48 4.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.851 1.261 . . . . 6.5899999999999999 110.384 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -98.18 -46.09 5.97 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.876 1.065 . . . . 7.5800000000000001 113.876 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -75.72 84.55 0.88 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.472 -1.451 . . . . 3.1000000000000001 109.472 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 1.6 p -96.18 137.6 21.67 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 116.134 1.902 . . . . 2.25 116.134 -166.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.79 132.48 40.16 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.105 2.537 . . . . 1.79 111.955 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.52 129.52 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.662 1.585 . . . . 2.1699999999999999 110.946 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 128.23 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.781 0.833 . . . . 1.46 111.531 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.35 -35.3 4.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.128 1.158 . . . . 2.02 114.128 -168.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -164.88 152.66 11.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 1.8799999999999999 111.69 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.4 m -125.07 135.13 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.514 1.126 . . . . 0.65000000000000002 109.216 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 51.8 tttt -140.96 148.26 40.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.04 0.936 . . . . 2.0 113.026 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.1 t -90.38 151.13 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 1.3100000000000001 112.532 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.01 -35.5 4.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.395 1.878 . . . . 1.04 111.42 168.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 92.5 m -119.93 97.85 5.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.225 1.012 . . . . 2.02 111.798 -170.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -91.59 140.89 29.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.449 1.5 . . . . 3.8799999999999999 111.071 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 52.93 29.13 7.36 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.772 2.138 . . . . 2.8900000000000001 116.772 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -145.55 -14.7 0.49 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.093 1.886 . . . . 3.4199999999999999 116.093 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -149.65 -97.53 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.271 1.428 . . . . 4.4800000000000004 109.99 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 54.9 mt -139.68 146.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.106 1.762 . . . . 2.6499999999999999 109.857 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 3.3 t -123.18 172.73 8.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.852 1.661 . . . . 5.04 114.975 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.0 p80 -38.79 -53.49 1.67 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 117.194 2.294 . . . . 3.6600000000000001 117.194 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.34 -36.53 84.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.488 1.495 . . . . 2.5699999999999998 111.897 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.5 -26.03 21.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 117.476 -1.25 . . . . 2.7999999999999998 113.04 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.75 -52.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.198 1.363 . . . . 1.3100000000000001 109.37 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.13 -31.93 73.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.91 -0.494 . . . . 0.76000000000000001 111.348 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.12 -61.13 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.599 -0.715 . . . . 0.62 112.39 171.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.53 -31.38 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.711 1.141 . . . . 0.52000000000000002 114.022 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 85.0 t -67.18 -42.25 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.224 0.92 . . . . 0.72999999999999998 110.224 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.46 91.73 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.633 -0.537 . . . . 0.91000000000000003 113.276 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.2 p -72.46 -28.46 62.95 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.669 1.235 . . . . 1.22 113.144 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -69.36 -60.81 2.09 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.034 0.834 . . . . 1.1399999999999999 111.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -65.23 -18.32 65.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.883 1.273 . . . . 2.3399999999999999 112.462 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 39.7 t -51.53 -31.37 23.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.022 1.329 . . . . 1.29 113.032 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -79.49 3.3 19.05 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.804 -1.185 . . . . 2.5600000000000001 114.185 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 48.0 m -120.74 -178.48 3.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.181 1.792 . . . . 1.8899999999999999 112.785 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -139.71 29.95 2.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.234 1.414 . . . . 4.4800000000000004 113.186 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.05 150.23 64.49 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 114.264 1.209 . . . . 1.9099999999999999 114.264 -170.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.59 -25.05 75.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.151 3.234 . . . . 1.3 115.066 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.74 -41.57 3.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.469 1.508 . . . . 0.95999999999999996 111.81 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.66 70.05 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 123.634 0.635 . . . . 0.98999999999999999 113.918 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 4.8 p -58.96 -24.0 62.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.92 1.288 . . . . 1.73 114.455 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -71.18 -36.53 71.99 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.608 -1.308 . . . . 0.73999999999999999 111.816 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.2 mt -72.03 -41.14 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.139 1.375 . . . . 0.85999999999999999 110.425 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 76.9 p -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 117.354 -1.307 . . . . 2.52 111.862 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -59.37 -49.87 76.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.784 1.174 . . . . 2.3300000000000001 112.498 169.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.91 -41.74 74.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.425 0.69 . . . . 2.29 111.424 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 38.1 t -71.26 -56.19 6.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.51 1.124 . . . . 1.8400000000000001 113.116 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -42.8 -52.0 5.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.912 2.085 . . . . 3.4300000000000002 112.005 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.741 0.816 . . . . 4.0700000000000003 112.428 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.59 -40.28 95.24 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.395 -1.44 . . . . 2.2599999999999998 112.74 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.5 -10.48 59.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.332 1.053 . . . . 1.27 113.048 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 45.0 t0 54.38 34.06 19.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.797 1.639 . . . . 2.4100000000000001 113.108 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 15.1 t -115.63 162.76 16.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.055 1.342 . . . . 2.6699999999999999 111.541 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.96 -16.99 25.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.474 1.51 . . . . 3.6299999999999999 111.453 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.8 t -146.59 135.28 22.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.306 1.443 . . . . 3.52 111.821 -170.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.68 150.32 32.99 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.876 0.871 . . . . 1.1599999999999999 111.414 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 81.22 167.33 37.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.594 0.998 . . . . 1.1100000000000001 115.594 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 52.5 m -152.51 -37.43 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.058 2.143 . . . . 1.8500000000000001 113.144 -173.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1108 ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' 1124 ' ' THR . 51.7 t -134.33 142.96 47.41 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 2.9700000000000002 114.872 -166.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 4.6 tp -150.6 151.31 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.934 1.293 . . . . 2.6099999999999999 113.131 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1110 ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' 1122 ' ' LYS . 0.0 OUTLIER -112.57 -17.26 12.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.492 1.517 . . . . 3.6200000000000001 114.082 169.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 57.3 t80 45.26 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.49 2.716 . . . . 2.7599999999999998 118.068 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.78 112.61 20.64 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.764 2.026 . . . . 2.46 109.132 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.8 t -99.75 136.67 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 2.25 111.377 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.1 t -131.42 108.37 14.71 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 108.645 -0.872 . . . . 1.0700000000000001 108.645 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.02 141.5 64.43 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.898 2.399 . . . . 1.3100000000000001 110.265 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 69.1 13.93 67.68 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 118.997 -0.89 . . . . 2.02 114.819 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 m -137.48 -87.77 0.28 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.803 1.241 . . . . 2.0699999999999998 112.696 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . -175.16 -151.15 8.32 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.851 0.7 . . . . 1.2 114.851 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 146.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.263 1.425 . . . . 2.2400000000000002 112.08 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.9 t -133.31 150.69 51.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.393 1.877 . . . . 0.90000000000000002 111.43 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.6 p -163.06 166.43 23.62 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.967 1.469 . . . . 0.75 114.967 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1122 ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' 1110 ' ' ASP . 38.1 mmtm -109.71 140.72 43.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.553 1.941 . . . . 1.1599999999999999 107.759 166.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 14.7 p -149.4 140.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.806 1.41 . . . . 2.04 114.806 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1124 ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' 1108 ' ' CYS . 4.4 t -124.32 157.04 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.751 1.621 . . . . 1.6799999999999999 110.87 166.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.3 t30 -175.56 -42.55 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.187 2.195 . . . . 2.71 109.852 160.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -27.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 117.262 2.319 . . . . 4.5199999999999996 117.262 -171.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.07 8.44 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.735 1.607 . . . . 7.4500000000000002 112.887 166.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -72.42 9.28 5.98 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.637 2.065 . . . . 4.6100000000000003 116.994 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -1.04 21.65 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.345 1.572 . . . . 6.4299999999999997 114.182 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.4 -33.24 53.09 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.797 1.239 . . . . 8.2200000000000006 114.274 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 11.3 t-80 40.71 73.24 0.13 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.254 2.221 . . . . 9.5700000000000003 113.682 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.17 129.35 40.38 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.281 -0.887 . . . . 15.16 111.288 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.1 118.55 5.98 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.769 -1.197 . . . . 18.149999999999999 107.769 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.73 146.48 31.01 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.095 1.887 . . . . 14.32 116.095 -165.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 21.5 t90 -155.85 -22.64 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.568 1.947 . . . . 19.530000000000001 114.316 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -130.14 -4.52 4.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.776 1.23 . . . . 15.890000000000001 114.242 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 60.8 mt -80.77 119.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.136 0.974 . . . . 13.42 108.879 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -101.49 -16.76 16.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.102 0.961 . . . . 16.039999999999999 113.264 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.25 -14.6 51.22 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.185 -0.947 . . . . 13.539999999999999 111.627 167.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -20.88 64.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.37 1.868 . . . . 15.449999999999999 112.818 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -112.95 -59.5 2.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.032 2.133 . . . . 18.350000000000001 114.022 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.27 117.34 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.972 0.909 . . . . 19.379999999999999 111.293 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 27.6 ttpt 45.09 45.83 9.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.504 1.521 . . . . 17.84 111.406 -169.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 51.2 p30 -64.56 -11.37 33.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.527 1.306 . . . . 23.329999999999998 114.527 -169.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -137.18 -87.09 0.3 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.635 0.976 . . . . 22.920000000000002 113.635 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 20.1 t 68.16 -45.43 0.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.936 2.199 . . . . 23.93 116.936 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 mm? 45.8 -116.34 0.59 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.909 2.084 . . . . 25.16 111.275 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 13.5 p -149.53 159.01 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.228 2.211 . . . . 28.879999999999999 108.785 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -71.27 32.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.703 1.372 . . . . 31.789999999999999 114.703 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 32.9 mm -143.45 -29.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.815 2.446 . . . . 34.219999999999999 112.889 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 21.2 t70 -140.77 164.13 31.03 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.668 -1.27 . . . . 34.530000000000001 111.549 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -123.17 9.89 9.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.533 1.133 . . . . 35.799999999999997 114.034 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 29.6 t 57.93 136.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.371 2.668 . . . . 34.109999999999999 115.707 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.4 -13.49 61.86 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.69 1.196 . . . . 36.390000000000001 113.038 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -107.07 172.18 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.855 1.662 . . . . 32.619999999999997 111.68 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 155.2 38.06 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.196 . . . . 35.609999999999999 111.892 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 1.9 t 52.67 51.71 15.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.954 1.302 . . . . 28.969999999999999 113.006 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 78.0 p -121.48 37.78 4.26 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.682 1.734 . . . . 25.510000000000002 115.682 -166.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 4.9 t -74.17 151.54 40.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.37 -0.831 . . . . 22.579999999999998 111.544 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 38.6 t -75.62 139.69 42.18 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.237 -0.915 . . . . 19.420000000000002 112.151 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 11.5 t -65.25 -3.43 3.96 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.855 2.062 . . . . 20.309999999999999 113.293 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 18.1 p -72.15 1.21 7.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.351 1.46 . . . . 16.5 113.507 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 8.2 ptt? -51.28 143.39 11.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.874 2.47 . . . . 20.25 113.746 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 4.2 mm 43.81 49.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.776 1.63 . . . . 12.6 111.881 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -42.29 -47.7 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.513 1.525 . . . . 10.460000000000001 113.902 -168.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -73.88 -21.32 60.13 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.042 1.127 . . . . 10.390000000000001 114.042 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -87.44 -16.22 35.47 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.377 0.671 . . . . 10.01 111.636 168.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -82.97 -41.85 18.29 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.489 1.115 . . . . 10.859999999999999 110.472 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.8 -44.26 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.401 1.08 . . . . 7.2999999999999998 110.632 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 3.2 p -71.4 -14.14 62.07 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.84 1.052 . . . . 8.2400000000000002 113.84 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -98.32 -8.04 27.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.77 1.628 . . . . 8.7599999999999998 113.963 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.02 63.37 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.377 1.251 . . . . 6.5599999999999996 114.377 -169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1173 ' ' LEU . . . . . 0.484 ' H ' HD22 ' A' 1173 ' ' LEU . 3.3 mm? -44.64 -34.05 2.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.655 1.582 . . . . 8.75 113.635 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 31.2 m120 -99.83 -3.74 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.159 1.54 . . . . 9.1500000000000004 115.159 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -133.37 -23.34 1.9 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.461 1.652 . . . . 5.9100000000000001 115.461 -168.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . 0.279 31.3 mt-30 46.2 129.28 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 130.143 3.377 . . . . 5.0899999999999999 117.51 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.29 142.54 35.69 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.259 -1.337 . . . . 3.1699999999999999 111.226 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -129.23 138.68 51.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.073 1.749 . . . . 2.8700000000000001 110.417 -171.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -105.83 113.75 27.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.717 1.207 . . . . 1.23 108.718 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.9 m -131.39 139.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.376 0.989 . . . . 0.62 113.319 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.77 154.84 44.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.702 1.201 . . . . 0.58999999999999997 112.93 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.9 tt -155.91 142.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.753 1.621 . . . . 0.52000000000000002 110.555 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 125.33 147.36 6.99 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.391 1.317 . . . . 2.1800000000000002 116.391 168.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.64 -159.46 0.1 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.743 1.617 . . . . 2.1400000000000001 111.801 -169.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -125.68 -40.53 2.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.258 1.577 . . . . 5.3200000000000003 115.258 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.25 -41.08 67.19 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.085 -1.635 . . . . 4.0499999999999998 111.639 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 11.8 t90 -57.71 -23.23 50.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.562 0.949 . . . . 3.0899999999999999 113.562 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 75.5 mmm -75.42 -53.19 9.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.888 1.275 . . . . 2.8199999999999998 112.148 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 96.9 mt -47.89 -62.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.139 1.775 . . . . 2.5299999999999998 110.654 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -47.7 -13.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 128.504 2.722 . . . . 6.5999999999999996 116.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.61 24.88 0.45 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 119.689 1.131 . . . . 0.76000000000000001 111.859 169.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.17 27.63 73.65 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.385 -1.447 . . . . 0.81999999999999995 114.772 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 17.3 mt -95.41 159.08 15.17 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.977 1.389 . . . . 0.93999999999999995 114.253 -169.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 44.2 t -105.32 125.61 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.276 1.43 . . . . 1.78 110.544 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.9 tt -119.11 148.59 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.795 1.638 . . . . 1.46 110.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -127.43 165.41 19.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.383 1.073 . . . . 2.9399999999999999 113.041 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.71 -30.84 69.58 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.408 -1.433 . . . . 3.2200000000000002 114.12 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.36 -42.94 98.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.19 1.396 . . . . 5.0800000000000001 111.565 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.5 p -77.78 -40.51 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.505 1.522 . . . . 1.1000000000000001 112.113 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -57.69 -41.6 81.98 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.447 1.022 . . . . 3.7200000000000002 112.125 171.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.6 -34.71 78.86 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.632 0.975 . . . . 2.9199999999999999 113.632 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -74.93 -39.32 61.45 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 2.4199999999999999 112.968 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 37.4 tpp -57.84 -58.7 7.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.033 1.333 . . . . 1.0900000000000001 110.204 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.3 t -63.23 -31.17 72.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.819 0.674 . . . . 1.48 112.819 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -58.38 -50.19 74.54 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.841 -1.162 . . . . 3.0099999999999998 112.108 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -72.73 -33.22 66.25 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.355 1.242 . . . . 2.1499999999999999 114.355 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -65.3 -43.66 90.4 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.423 -0.798 . . . . 4.7000000000000002 111.686 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -69.49 -25.59 64.14 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.599 -1.313 . . . . 4.8899999999999997 112.661 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.4 mttp -67.07 -12.56 60.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.225 1.41 . . . . 2.1800000000000002 112.959 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.0 25.35 66.91 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.531 1.062 . . . . 1.6100000000000001 113.384 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.83 172.4 7.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.642 1.577 . . . . 6.75 110.076 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 87.5 m -83.76 127.66 33.96 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.541 -0.725 . . . . 0.82999999999999996 111.192 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -134.65 109.54 8.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.438 1.495 . . . . 0.68999999999999995 110.045 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.2 m -140.51 154.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.595 1.158 . . . . 0.68999999999999995 112.498 -172.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.44 170.28 8.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.37 0.878 . . . . 0.72999999999999998 113.37 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 10.3 t -130.66 130.26 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.426 1.89 . . . . 1.6699999999999999 111.035 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.08 150.03 47.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.421 1.089 . . . . 0.52000000000000002 112.227 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.5 m -142.94 117.54 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.912 2.085 . . . . 0.92000000000000004 111.255 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 45.29 53.9 7.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.701 2.0 . . . . 2.8500000000000001 112.805 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.65 33.47 23.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.387 1.875 . . . . 1.52 114.091 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.33 144.86 36.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 2.6899999999999999 109.911 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 146.17 41.08 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.923 -1.736 . . . . 0.78000000000000003 112.296 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 24.9 p -121.84 -44.24 2.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.107 0.963 . . . . 0.75 113.123 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.23 -169.93 34.75 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.325 0.966 . . . . 0.51000000000000001 114.853 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.58 161.12 39.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.709 1.603 . . . . 1.03 114.296 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 18.1 mm -129.38 135.01 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.008 1.723 . . . . 0.70999999999999996 110.651 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -110.77 126.5 54.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.273 1.829 . . . . 0.47999999999999998 110.198 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.09 153.97 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.421 1.488 . . . . 1.5700000000000001 110.032 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -121.34 122.28 39.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.16 1.384 . . . . 1.4199999999999999 111.425 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 43.0 t0 -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.811 1.244 . . . . 4.6399999999999997 113.153 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.256 1.426 0 C-N-CA 125.766 1.626 . . . . 5.3499999999999996 112.904 179.089 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 51.5 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.419 0.152 . . . . 13.85 110.815 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.96 159.46 42.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.953 . . . . 9.8599999999999994 112.036 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 51.6 m -128.96 132.14 47.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.454 1.501 . . . . 9.7400000000000002 110.426 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 20.0 ptm -164.66 147.53 8.71 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 5.54 113.629 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -141.37 -31.83 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.894 1.678 . . . . 6.5700000000000003 113.139 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -97.61 99.56 2.26 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.666 0.651 . . . . 2.8500000000000001 113.068 -171.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 18.2 p -113.59 147.64 37.99 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.272 1.029 . . . . 2.5899999999999999 113.705 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.58 141.55 46.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.026 3.151 . . . . 1.49 112.19 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.11 128.11 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.727 2.011 . . . . 2.1600000000000001 110.302 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.293 10.3 p -76.04 117.51 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.61 -1.306 . . . . 1.3700000000000001 113.464 -169.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -100.72 -47.05 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.9 1.28 . . . . 2.3900000000000001 112.928 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -154.97 153.81 31.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 2.77 112.203 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -131.87 143.53 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.936 1.294 . . . . 0.85999999999999999 109.868 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.3 tttt -141.38 146.92 37.23 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.081 0.771 . . . . 1.95 113.081 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 61.2 t -89.93 134.51 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.81999999999999995 111.717 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.9 tp -113.25 -22.82 10.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.136 1.774 . . . . 1.25 113.274 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 121.56 25.2 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.015 1.726 . . . . 1.8400000000000001 109.111 169.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -135.43 137.72 42.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.742 1.016 . . . . 3.5299999999999998 113.742 -171.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 5.0 m 61.32 -50.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.98 2.912 . . . . 3.4300000000000002 115.227 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -75.35 133.47 41.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.999 -1.111 . . . . 3.5800000000000001 107.999 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 64.34 -53.85 0.27 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.363 2.265 . . . . 5.3799999999999999 115.393 -168.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.74 154.57 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.299 1.44 . . . . 2.4900000000000002 111.79 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.6 m -121.86 153.42 38.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.013 1.325 . . . . 2.0099999999999998 113.954 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 31.9 p80 -50.05 -50.53 47.51 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.678 2.103 . . . . 4.1699999999999999 116.678 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -74.32 -28.78 61.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.483 1.038 . . . . 2.98 111.978 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.98 -37.51 67.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.8 -1.095 . . . . 3.23 112.007 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.13 -56.19 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 119.416 1.007 . . . . 0.90000000000000002 110.565 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.98 -28.63 69.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.448 -0.783 . . . . 0.84999999999999998 112.617 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.27 -46.75 63.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.937 0.717 . . . . 0.69999999999999996 112.937 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 27.6 pt -70.25 -28.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.968 1.258 . . . . 0.83999999999999997 113.372 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 63.1 t -70.55 -52.02 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.568 0.622 . . . . 0.84999999999999998 110.944 170.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.39 -30.37 73.34 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.369 -0.832 . . . . 0.68999999999999995 114.271 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 12.6 p -70.2 -44.1 69.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.761 1.281 . . . . 0.71999999999999997 112.85 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.66 -49.56 76.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.679 0.792 . . . . 0.92000000000000004 111.549 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -65.91 -22.68 66.52 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.568 -0.708 . . . . 2.0699999999999998 112.905 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 68.4 m -67.0 -38.52 86.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.735 1.214 . . . . 2.6299999999999999 114.116 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.3 t30 -95.42 -15.18 23.19 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.237 1.415 . . . . 2.5099999999999998 111.934 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 37.8 t -66.21 176.0 1.92 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.544 1.538 . . . . 1.48 109.928 165.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.2 46.87 1.72 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.263 -1.523 . . . . 3.6899999999999999 113.407 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -93.39 165.1 19.0 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.219 1.408 . . . . 1.6200000000000001 113.884 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.98 -26.07 0.96 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.593 2.862 . . . . 1.2 114.74 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.9 tt -110.62 -48.83 3.1 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.212 1.405 . . . . 0.94999999999999996 112.643 -168.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -56.9 -24.16 48.58 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 113.999 0.36 . . . . 0.96999999999999997 113.999 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 36.7 p -60.67 -17.38 47.31 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.724 1.379 . . . . 1.3799999999999999 114.724 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.09 86.1 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.418 1.008 . . . . 0.93000000000000005 111.396 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.6 mt -70.26 -39.52 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.553 1.141 . . . . 0.89000000000000001 110.192 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 79.8 m -52.58 -48.09 66.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.338 0.655 . . . . 1.1100000000000001 111.695 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 43.9 tttt -64.16 -49.7 71.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.313 0.645 . . . . 2.3199999999999998 112.279 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 11.2 t80 -53.89 -42.84 69.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 1.8 111.542 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.5 t -70.39 -53.74 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.213 1.405 . . . . 1.6599999999999999 112.031 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -58.17 -42.58 86.31 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.772 -1.205 . . . . 3.4399999999999999 111.816 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.31 -32.3 70.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.618 0.767 . . . . 3.6699999999999999 112.953 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.31 -48.41 65.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.319 1.048 . . . . 1.8899999999999999 111.781 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.47 -31.36 67.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 26.4 t0 53.39 29.5 8.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.335 1.854 . . . . 2.6499999999999999 113.622 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1102 ' ' THR . . . . . 0.448 HG23 ' H ' ' A' 1104 ' ' THR . 12.1 t -98.82 -21.53 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.36 1.615 . . . . 4.0300000000000002 115.36 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 6.4 tt0 52.62 20.15 1.43 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.824 2.157 . . . . 2.8799999999999999 116.824 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1104 ' ' THR . . . . . 0.448 ' H ' HG23 ' A' 1102 ' ' THR . 56.7 p -137.46 0.15 2.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.15 -1.594 . . . . 3.5699999999999998 114.844 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 157.69 36.74 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.112 -0.993 . . . . 1.0600000000000001 113.413 -169.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 84.4 130.76 2.06 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.528 0.971 . . . . 1.0900000000000001 115.528 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1107 ' ' THR . . . . . 0.409 HG22 ' H ' ' A' 1108 ' ' CYS . 0.5 OUTLIER -144.18 -170.02 3.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.209 2.604 . . . . 2.5800000000000001 108.603 -175.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1108 ' ' CYS . . . . . 0.409 ' H ' HG22 ' A' 1107 ' ' THR . 48.8 t -60.68 132.41 53.8 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.063 1.875 . . . . 1.72 116.063 -168.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.03 148.74 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.168 2.187 . . . . 2.96 116.057 169.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.5 143.8 26.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.465 -2.05 . . . . 2.96 105.465 161.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.85 132.3 54.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.645 1.578 . . . . 2.7799999999999998 112.451 -169.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.48 99.12 4.41 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.935 2.094 . . . . 3.1600000000000001 109.352 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 33.2 m -102.1 148.61 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.245 0.832 . . . . 2.46 113.245 -169.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 24.5 t -133.16 111.08 12.94 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.959 1.303 . . . . 1.25 107.773 168.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.66 134.74 62.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.892 2.394 . . . . 1.5900000000000001 113.519 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 59.93 26.22 62.82 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.465 1.507 . . . . 2.2400000000000002 115.924 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.0 t -146.52 -47.9 0.19 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.002 1.401 . . . . 1.99 114.257 -172.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.13 169.26 21.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.888 0.756 . . . . 0.88 113.445 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.84 162.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.673 -0.898 . . . . 2.6499999999999999 112.621 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 34.6 t -122.49 145.37 48.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.716 2.006 . . . . 0.55000000000000004 109.757 167.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.1 p -150.03 160.91 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.613 0.765 . . . . 0.73999999999999999 112.42 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -119.99 105.32 10.93 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.551 -0.718 . . . . 1.6000000000000001 109.135 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.9 p -104.45 138.28 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.052 1.341 . . . . 1.9199999999999999 112.191 -168.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 171.37 8.14 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.824 1.416 . . . . 1.3999999999999999 114.824 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.282 18.2 t-20 148.09 59.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 1 C-N-CA 134.088 4.955 . . . . 2.8500000000000001 108.547 166.561 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.35 -67.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.279 2.631 . . . . 2.98 109.286 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.28 33.7 2.32 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.829 1.048 . . . . 6.1699999999999999 113.829 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.34 -6.83 22.8 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.737 1.637 . . . . 4.3600000000000003 115.219 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.39 -7.83 0.67 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.193 1.797 . . . . 4.6600000000000001 115.003 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -38.11 67.86 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.599 1.56 . . . . 5.9800000000000004 110.213 167.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 48.0 t60 31.24 64.75 0.18 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.939 3.296 . . . . 6.6100000000000003 114.945 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -61.75 128.61 37.04 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.463 1.105 . . . . 12.289999999999999 111.875 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.64 -1.15 56.85 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.739 1.015 . . . . 12.609999999999999 113.739 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 60.7 119.52 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.489 2.716 . . . . 10.710000000000001 112.959 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -141.62 -19.1 0.76 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.05 1.13 . . . . 14.76 114.05 -169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -117.44 5.79 12.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.492 1.517 . . . . 13.970000000000001 111.097 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 33.6 mt -140.73 125.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 12.0 107.452 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -101.86 -29.56 11.77 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.258 0.935 . . . . 14.529999999999999 112.401 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -86.41 -8.68 57.45 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.731 2.123 . . . . 14.199999999999999 116.731 -168.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -50.67 -41.92 56.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.926 2.565 . . . . 12.859999999999999 117.926 -168.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -159.84 -34.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.002 1.853 . . . . 15.050000000000001 116.002 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 12.6 tt -68.87 128.7 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.599 1.09 . . . . 15.25 112.241 -168.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -158.5 167.18 30.33 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.164 1.386 . . . . 15.43 111.874 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -78.19 47.82 0.7 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.311 1.445 . . . . 18.02 114.369 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 47.06 47.21 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.56 1.944 . . . . 18.859999999999999 115.835 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.66 5.73 41.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.743 2.417 . . . . 19.010000000000002 114.43 -169.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.62 6.1 1.22 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.088 1.755 . . . . 21.059999999999999 113.689 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.8 p -152.72 157.47 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.511 1.924 . . . . 24.550000000000001 109.438 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.26 23.53 1.27 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.03 1.332 . . . . 26.899999999999999 114.587 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.31 150.46 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.535 1.934 . . . . 30.609999999999999 112.26 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 40.9 t0 -76.71 132.14 39.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.923 1.689 . . . . 31.120000000000001 113.562 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -99.03 -13.12 20.0 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.78 1.632 . . . . 31.57 113.562 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 9.5 t 58.35 -6.11 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.96 2.904 . . . . 33.210000000000001 116.824 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -118.64 155.86 30.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.214 1.805 . . . . 30.32 112.915 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.45 141.39 29.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.109 0.963 . . . . 27.579999999999998 110.805 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -139.37 -82.14 0.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.149 1.166 . . . . 28.57 114.149 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 13.7 t -156.09 175.65 13.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.382 1.073 . . . . 22.149999999999999 112.149 -166.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 68.7 p -150.76 166.06 31.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.933 1.293 . . . . 19.059999999999999 113.005 169.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 38.8 p -123.03 21.62 9.74 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.462 1.905 . . . . 18.960000000000001 112.498 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 55.5 p -87.12 79.61 8.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.998 2.119 . . . . 16.0 111.542 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 79.8 p -65.62 -0.55 2.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 118.301 2.704 . . . . 15.98 118.301 -167.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 69.3 m -87.81 -3.57 58.93 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.798 1.036 . . . . 15.199999999999999 113.798 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 9.9 ptt? -71.48 -179.32 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.855 1.262 . . . . 14.550000000000001 112.755 169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 22.4 mm -69.26 78.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.992 1.717 . . . . 12.56 111.777 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.5 pp -103.13 -18.62 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.428 1.491 . . . . 10.52 113.73 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.06 -24.69 59.45 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.107 -0.996 . . . . 10.07 112.318 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.42 10.35 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.299 1.44 . . . . 7.9199999999999999 113.533 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -85.57 -35.78 20.83 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.931 1.293 . . . . 8.3699999999999992 111.09 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.59 -44.69 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.48 1.112 . . . . 8.0500000000000007 110.373 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 72.9 m -67.79 -17.04 64.4 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.942 1.09 . . . . 8.3399999999999999 113.942 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -96.36 -6.3 37.94 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.051 1.34 . . . . 6.6699999999999999 113.333 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -71.0 -23.39 62.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.411 1.263 . . . . 5.1100000000000003 114.411 -173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 9.2 tt -68.19 -37.78 81.3 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.158 -0.964 . . . . 7.4800000000000004 111.724 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 7.5 m120 -76.29 -53.84 7.64 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.195 1.398 . . . . 7.6799999999999997 111.12 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -68.85 -4.09 14.99 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 113.643 0.979 . . . . 3.7599999999999998 113.643 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 61.83 -14.63 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.625 3.17 . . . . 3.9199999999999999 116.207 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -9.49 118.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.127 2.971 . . . . 2.54 115.113 166.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 123.94 30.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.848 1.659 . . . . 3.4700000000000002 111.067 -170.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.28 123.16 26.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.946 0.794 . . . . 1.6000000000000001 110.615 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -134.67 133.67 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.359 1.064 . . . . 0.56999999999999995 111.104 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.18 147.51 41.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.605 1.162 . . . . 0.40000000000000002 113.01 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.7 tt -149.58 141.35 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.895 1.278 . . . . 0.47999999999999998 110.77 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.82 -155.25 26.05 Favored Glycine 0 CA--C 1.532 1.133 0 N-CA-C 115.411 0.924 . . . . 1.4099999999999999 115.411 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -71.41 160.42 32.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.621 1.568 . . . . 3.48 111.59 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -59.13 -16.84 21.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.762 1.225 . . . . 6.3099999999999996 114.066 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -57.74 -36.0 71.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.683 0.793 . . . . 4.7800000000000002 112.256 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 5.3 m95 -74.35 -47.57 33.46 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.13 0.972 . . . . 3.3999999999999999 112.156 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -29.06 68.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.478 0.711 . . . . 2.1200000000000001 112.164 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.33 -66.89 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.156 2.182 . . . . 2.4199999999999999 108.127 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -23.38 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.536 1.935 . . . . 8.3100000000000005 115.953 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.66 14.62 31.43 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 120.349 1.431 . . . . 0.82999999999999996 114.163 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.81 17.88 67.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.249 1.404 . . . . 1.1899999999999999 116.517 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.16 155.48 28.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.405 1.103 . . . . 1.25 111.533 -170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 92.3 t -91.94 127.95 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.485 0.714 . . . . 1.6000000000000001 110.189 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 13.8 tt -112.97 152.44 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.003 1.321 . . . . 1.55 111.954 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.46 156.64 20.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.571 1.693 . . . . 2.9100000000000001 115.571 -168.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.4 t30 -68.66 -37.26 79.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.533 1.133 . . . . 3.0299999999999998 113.914 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.29 -33.61 69.89 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.93 -1.106 . . . . 2.9100000000000001 112.305 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -76.27 -37.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.227 -0.921 . . . . 1.23 112.196 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.59 -35.37 77.67 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.125 0.875 . . . . 2.75 112.075 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.03 -40.29 84.6 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.947 1.092 . . . . 2.7200000000000002 113.947 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.57 -44.99 48.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.073 0.949 . . . . 2.9100000000000001 112.319 171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 47.8 tpp -59.85 -56.27 23.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.39 1.076 . . . . 0.88 111.681 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.8 t -66.54 -30.65 71.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.522 -0.736 . . . . 1.4299999999999999 112.52 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -62.4 -45.79 91.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.401 1.08 . . . . 3.52 111.391 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -67.53 -39.09 85.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.081 1.353 . . . . 3.9399999999999999 112.071 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.11 -45.26 92.83 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.626 -0.671 . . . . 3.8700000000000001 112.158 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.52 -21.14 62.77 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.936 -1.102 . . . . 5.1799999999999997 113.309 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.266 14.2 ptpt -85.23 7.62 21.37 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.934 1.457 . . . . 3.2599999999999998 114.934 167.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 72.2 21.21 79.34 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.785 1.074 . . . . 2.0099999999999998 115.785 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -110.42 144.08 39.74 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.121 1.461 . . . . 4.7699999999999996 110.39 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 52.5 m -61.35 124.31 20.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.80000000000000004 112.44 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.06 125.43 37.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.756 1.222 . . . . 0.68000000000000005 110.174 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.6 m -141.99 159.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.709 1.204 . . . . 0.52000000000000002 113.536 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.2 mt -111.61 158.3 19.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.634 1.974 . . . . 1.3100000000000001 111.559 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.7 p -139.47 128.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.076 0.951 . . . . 1.95 112.665 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.6 153.06 48.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.381 2.272 . . . . 0.52000000000000002 111.008 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 10.5 m -144.09 136.13 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.252 -0.905 . . . . 0.97999999999999998 112.098 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 33.3 t70 41.74 50.88 4.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.004 1.721 . . . . 2.9900000000000002 112.207 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.26 6.0 m-20 66.19 21.59 11.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.385 1.994 . . . . 1.54 116.385 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -126.71 151.04 48.68 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.015 2.126 . . . . 2.48 110.147 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.18 143.08 41.32 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.769 -1.832 . . . . 0.75 111.795 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 17.5 p -118.72 -38.84 3.05 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.422 1.267 . . . . 0.68000000000000005 114.422 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.73 -172.94 37.53 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 119.389 0.995 . . . . 0.57999999999999996 114.588 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.7 151.59 41.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.716 1.606 . . . . 0.84999999999999998 112.838 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.34 137.0 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.944 1.697 . . . . 0.83999999999999997 109.962 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -123.7 135.06 53.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.653 1.581 . . . . 0.66000000000000003 110.951 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 32.5 mt -140.41 153.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.463 1.905 . . . . 1.5800000000000001 110.403 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -128.7 173.09 10.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.026 1.33 . . . . 1.4299999999999999 109.918 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.11 151.02 21.8 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.285 -0.884 . . . . 4.4299999999999997 113.016 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.293 1.837 . . . . 4.6100000000000003 111.779 175.654 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.432 0.901 . . . . 14.630000000000001 113.432 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 26.3 m-85 54.79 33.54 19.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.34 1.456 . . . . 12.68 114.107 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 18.3 m -77.11 141.61 40.13 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.465 1.506 . . . . 9.9700000000000006 110.31 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 6.1 ptm -91.54 174.22 7.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.204 1.187 . . . . 7.0700000000000003 114.204 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -68.93 -87.91 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.763 0.825 . . . . 6.1399999999999997 112.594 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.34 87.5 1.2 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.688 1.137 . . . . 2.8500000000000001 111.942 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.28 135.35 84.53 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.884 1.674 . . . . 3.3599999999999999 115.235 -167.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -84.04 94.51 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.532 2.821 . . . . 1.8799999999999999 112.008 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 82.2 t -89.96 108.86 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.883 -1.135 . . . . 2.8300000000000001 109.767 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.1 p -72.38 129.44 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.745 -1.222 . . . . 1.71 111.968 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.14 -50.7 2.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.177 1.547 . . . . 2.7000000000000002 115.177 -167.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -149.64 149.74 31.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.142 0.883 . . . . 2.77 112.609 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -129.67 145.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.876 1.27 . . . . 0.96999999999999997 110.904 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.9 tttt -141.66 138.86 32.79 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.155 0.982 . . . . 1.8899999999999999 113.433 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 94.3 t -82.93 134.5 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.951 0.9 . . . . 0.69999999999999996 110.71 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 20.0 tp -107.22 -32.31 7.85 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.096 1.358 . . . . 1.4299999999999999 112.966 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 51.9 m -118.03 99.11 6.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.729 1.212 . . . . 1.8300000000000001 108.234 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 141.47 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.284 1.034 . . . . 3.4900000000000002 110.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.7 m 52.52 29.24 6.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.958 1.836 . . . . 2.6499999999999999 115.958 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -137.91 -17.51 1.24 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.106 1.151 . . . . 2.9199999999999999 114.106 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.5 -49.3 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.166 1.348 . . . . 4.71 114.41 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.96 142.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.52 1.528 . . . . 1.47 111.25 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 14.5 m -87.53 147.93 25.12 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.335 1.054 . . . . 2.1200000000000001 112.287 170.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.1 p80 -53.5 -38.89 64.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.45 1.648 . . . . 3.1600000000000001 115.45 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 23.8 t60 -66.79 -37.19 84.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.609 1.095 . . . . 3.4900000000000002 111.869 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -65.68 -36.29 83.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 118.228 -0.891 . . . . 3.3599999999999999 111.259 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.11 -54.35 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 118.947 0.794 . . . . 0.55000000000000004 111.189 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.51 -33.88 76.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.877 0.762 . . . . 0.55000000000000004 111.881 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.39 57.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.63 -0.7 . . . . 0.58999999999999997 112.143 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 6.0 pt -69.48 -27.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 119.642 1.11 . . . . 0.62 113.748 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 77.5 t -70.68 -43.39 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.237 0.926 . . . . 0.69999999999999996 110.415 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.34 -37.42 93.87 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.127 -0.818 . . . . 0.68000000000000005 113.282 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.6 p -73.88 -37.62 64.67 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.353 1.576 . . . . 0.96999999999999997 112.636 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.68 88.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.961 0.801 . . . . 0.78000000000000003 112.896 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1081 ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' 1084 ' ' SER 0.254 3.4 tp10 -75.75 -20.92 57.95 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.196 0.813 . . . . 3.3799999999999999 113.196 175.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 26.3 t -57.7 -47.46 82.32 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.075 -1.64 . . . . 1.3100000000000001 112.743 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -77.33 -2.94 37.46 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 121.222 -0.924 . . . . 2.1400000000000001 112.689 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1084 ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' 1081 ' ' GLU . 20.0 m -111.12 -178.6 3.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.584 2.354 . . . . 2.4100000000000001 111.494 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.03 51.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.135 -0.978 . . . . 4.1699999999999999 113.55 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.68 147.41 86.77 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.042 . . . . 1.5600000000000001 113.688 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.83 -36.51 90.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.172 3.248 . . . . 1.55 114.028 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.03 -47.49 4.98 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.787 2.035 . . . . 1.25 110.874 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -33.01 78.98 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 114.583 0.593 . . . . 1.1699999999999999 114.583 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 3.9 t -66.0 -16.02 63.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.126 1.463 . . . . 2.9500000000000002 114.458 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -73.63 -27.16 61.13 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.089 -1.007 . . . . 1.4399999999999999 112.922 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.5 -41.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.878 0.871 . . . . 1.1399999999999999 109.199 171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.7 m -51.62 -43.97 62.75 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.757 0.708 . . . . 1.27 111.289 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.1 tttt -63.82 -51.78 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.913 0.778 . . . . 2.4300000000000002 112.936 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.41 -47.2 66.43 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 2.3100000000000001 111.105 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 98.3 m -69.07 -52.48 28.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.023 1.329 . . . . 2.9399999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -49.49 -48.34 47.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.06 1.344 . . . . 3.6600000000000001 111.642 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -71.62 -35.91 70.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.844 0.857 . . . . 2.6499999999999999 112.905 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -70.33 -35.75 73.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.5 -1.375 . . . . 2.1800000000000002 113.448 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.86 -6.38 37.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.285 1.034 . . . . 1.3400000000000001 113.751 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.8 t0 54.91 40.07 31.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.239 1.416 . . . . 3.3900000000000001 112.472 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.6 t -131.38 174.12 10.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.518 1.527 . . . . 2.5800000000000001 111.508 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -114.87 -3.67 12.71 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.337 1.455 . . . . 2.9500000000000002 112.4 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 8.1 t -148.76 142.6 25.69 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.337 1.455 . . . . 2.98 111.69 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.69 145.87 20.38 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.974 0.91 . . . . 0.85999999999999999 112.322 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 83.18 135.75 2.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.074 1.321 . . . . 1.0800000000000001 114.458 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 54.9 m -105.72 -64.77 1.11 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.041 1.336 . . . . 1.6499999999999999 111.118 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -137.85 131.67 31.42 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.308 0.575 . . . . 1.7 110.595 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 30.3 mm -143.54 142.29 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.801 4.441 . . . . 3.4700000000000002 102.797 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.12 106.25 5.47 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 120.895 -1.128 . . . . 4.4800000000000004 111.442 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -100.62 145.67 28.09 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 118.038 2.607 . . . . 2.4399999999999999 118.038 -166.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.16 104.65 7.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 130.843 3.657 . . . . 2.7799999999999998 106.68 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 91.5 t -99.03 139.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.309 1.044 . . . . 2.0600000000000001 110.932 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 43.4 t -126.48 101.3 27.77 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.021 1.328 . . . . 1.1499999999999999 109.257 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.01 130.8 32.84 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.039 3.159 . . . . 1.3999999999999999 114.978 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 75.75 -37.68 1.25 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.031 2.253 . . . . 1.9099999999999999 114.412 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 60.4 m -82.19 -48.28 11.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.052 1.426 . . . . 2.1899999999999999 113.938 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 159.43 -178.0 35.73 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.835 0.743 . . . . 0.78000000000000003 113.387 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.12 157.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.661 0.615 . . . . 2.5499999999999998 112.661 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -131.68 151.6 51.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.997 1.719 . . . . 0.47999999999999998 110.871 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -153.8 166.26 33.43 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.842 -1.161 . . . . 0.67000000000000004 114.003 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -110.71 136.72 49.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.253 -1.017 . . . . 1.1899999999999999 108.253 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 80.1 t -128.95 139.44 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.458 1.103 . . . . 2.2999999999999998 111.877 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.8 t -146.6 152.82 39.54 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.789 2.144 . . . . 1.4399999999999999 116.789 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.305 24.7 t-20 178.71 65.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 1 C-N-CA 132.582 4.353 . . . . 3.9199999999999999 106.207 158.061 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -149.55 -89.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.791 2.036 . . . . 3.4700000000000002 107.879 -171.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -132.25 9.26 4.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 120.156 1.344 . . . . 5.3200000000000003 113.896 172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.51 60.4 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.562 -1.336 . . . . 6.6100000000000003 113.848 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -7.64 2.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.96 1.704 . . . . 5.4000000000000004 115.58 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.93 -42.05 97.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.592 1.157 . . . . 6.2300000000000004 110.263 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 95.9 m-70 58.36 -72.46 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.029 2.132 . . . . 9.3499999999999996 115.726 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -157.04 156.62 33.18 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.702 1.601 . . . . 15.140000000000001 112.331 -166.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.92 124.92 27.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 106.248 -1.76 . . . . 17.719999999999999 106.248 164.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 9.1 p30 -140.41 155.86 46.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.563 1.32 . . . . 16.02 114.563 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 3.5 p90 -161.93 70.21 0.32 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.084 1.354 . . . . 19.010000000000002 111.888 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 5.2 m-80 61.31 18.67 9.45 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.671 1.73 . . . . 17.199999999999999 115.671 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.98 123.26 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.137 0.975 . . . . 15.69 110.216 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -85.01 -26.9 26.77 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.41 -0.806 . . . . 18.43 112.344 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.67 -10.43 12.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.087 1.355 . . . . 16.949999999999999 113.996 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -65.77 -22.96 66.62 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.84 2.456 . . . . 14.58 114.505 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.265 2.226 . . . . 15.67 112.328 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.49 113.3 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 120.496 -1.378 . . . . 16.140000000000001 111.432 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -141.19 165.05 28.6 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.751 2.02 . . . . 21.140000000000001 111.617 -168.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -82.69 -19.33 38.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.987 -1.071 . . . . 21.109999999999999 112.954 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -129.53 145.24 51.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.715 1.206 . . . . 23.579999999999998 110.755 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 50.5 m -137.24 -41.57 0.57 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.573 1.549 . . . . 26.68 111.591 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 13.1 mt 59.73 -176.9 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.33 1.452 . . . . 30.379999999999999 114.109 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.2 p -148.61 155.6 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.829 -1.169 . . . . 33.380000000000003 112.996 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -149.24 159.78 43.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.059 2.144 . . . . 38.549999999999997 110.896 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 12.3 mm 66.06 128.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 128.852 2.861 . . . . 41.460000000000001 115.643 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.25 30.02 4.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.893 1.677 . . . . 41.240000000000002 114.86 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -78.18 12.05 2.05 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.713 1.746 . . . . 37.039999999999999 115.713 -169.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 80.3 p 43.19 -110.67 0.16 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.951 2.5 . . . . 35.710000000000001 115.846 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 11.9 p30 -141.36 174.01 10.94 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.247 1.819 . . . . 34.609999999999999 111.6 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -134.04 154.7 50.98 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.424 1.639 . . . . 29.77 115.424 -168.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -150.45 145.16 25.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.756 2.422 . . . . 31.649999999999999 108.158 167.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 38.0 m 60.29 157.47 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.508 1.923 . . . . 23.890000000000001 115.361 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 57.6 p -72.09 -38.41 69.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.048 -1.657 . . . . 20.43 112.611 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.52 128.8 11.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.243 1.817 . . . . 17.43 110.363 175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 6.4 t -74.27 -27.54 60.79 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.47 0.708 . . . . 15.81 112.802 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 6.0 m -152.05 -68.78 0.17 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.492 1.293 . . . . 14.41 114.492 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 2.0 m -122.54 10.59 9.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 117.359 2.355 . . . . 13.130000000000001 117.359 -163.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 60.0 mtt 61.75 129.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.772 2.029 . . . . 14.23 115.543 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . 0.253 1.9 mt 55.77 41.52 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 125.949 1.7 . . . . 11.74 111.865 -173.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.4 pp -117.76 -8.1 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.1 1.36 . . . . 9.6099999999999994 113.633 168.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -25.18 68.16 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.885 -1.134 . . . . 8.9399999999999995 113.507 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -73.07 -3.22 24.91 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.601 1.334 . . . . 8.6799999999999997 114.601 172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -106.71 -25.12 11.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.062 1.345 . . . . 8.9800000000000004 113.561 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 77.0 mt -51.24 -35.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 126.065 1.746 . . . . 6.4000000000000004 112.663 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 19.7 p -64.09 -3.99 3.14 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.409 1.633 . . . . 7.4000000000000004 115.409 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -92.35 -17.16 25.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.997 1.319 . . . . 7.5300000000000002 113.625 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.79 63.82 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.666 1.728 . . . . 5.1900000000000004 115.666 -168.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.7 -26.56 68.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.165 0.986 . . . . 7.5999999999999996 112.974 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -104.23 -44.89 4.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.423 1.489 . . . . 6.5599999999999996 112.587 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -79.05 63.84 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.533 1.933 . . . . 4.7400000000000002 110.888 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -49.02 136.08 14.98 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.127 1.371 . . . . 3.21 114.554 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -160.4 156.16 25.69 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.963 1.705 . . . . 2.3100000000000001 112.37 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.75 143.63 32.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.488 1.515 . . . . 2.6400000000000001 111.398 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -110.87 115.74 30.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.698 1.599 . . . . 1.6699999999999999 108.656 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.8 m -133.76 142.35 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 119.979 1.263 . . . . 0.69999999999999996 112.829 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 150.89 39.7 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.648 0.981 . . . . 0.39000000000000001 113.648 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.2 tt -141.29 135.24 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.428 1.891 . . . . 0.63 109.799 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.08 -167.9 40.93 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.582 1.393 . . . . 1.4199999999999999 116.582 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -76.08 166.1 23.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.046 1.738 . . . . 3.02 114.523 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -50.78 -45.32 59.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.904 2.187 . . . . 5.4000000000000004 116.904 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.27 -31.89 58.51 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.152 1.796 . . . . 3.4700000000000002 112.003 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -64.0 -35.87 82.13 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.958 -1.089 . . . . 2.98 112.239 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.44 83.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.075 1.139 . . . . 2.0600000000000001 114.075 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.0 mt -54.94 -60.06 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.506 1.122 . . . . 1.72 109.047 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -49.57 -19.35 0.57 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.59 2.07 . . . . 5.7800000000000002 116.59 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.82 11.57 4.8 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 121.632 2.014 . . . . 0.72999999999999998 112.593 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.71 35.59 85.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 119.868 -1.77 . . . . 0.78000000000000003 113.966 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.18 153.45 19.59 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.535 1.167 . . . . 0.81000000000000005 111.435 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -84.53 132.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.804 -0.56 . . . . 0.97999999999999998 109.554 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.67 140.05 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.676 1.19 . . . . 0.97999999999999998 110.862 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -116.06 167.85 10.61 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.987 1.477 . . . . 2.9900000000000002 114.987 -167.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.05 -45.98 69.01 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.15 1.537 . . . . 3.0 115.15 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.34 -26.91 64.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.068 -1.02 . . . . 2.3900000000000001 112.021 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -78.56 -38.62 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 117.748 -1.12 . . . . 0.69999999999999996 112.481 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.69 -41.56 91.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.902 1.683 . . . . 2.04 110.884 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.18 -40.96 91.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.417 1.487 . . . . 2.3900000000000001 113.305 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 52.1 t80 -72.11 -40.93 67.79 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.187 0.995 . . . . 2.2200000000000002 112.523 174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 46.2 tpp -59.96 -57.53 12.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.01 1.724 . . . . 0.81999999999999995 110.104 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.2 t -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.903 0.881 . . . . 1.1200000000000001 111.971 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.11 -54.75 42.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.233 1.013 . . . . 2.5 111.776 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.29 -34.19 70.42 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.498 0.925 . . . . 2.9300000000000002 113.498 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -59.35 -49.92 75.95 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.223 -0.923 . . . . 3.2799999999999998 110.764 170.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -72.76 -14.86 61.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.936 -1.103 . . . . 4.8399999999999999 113.957 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 16.7 mttp -75.79 -6.23 49.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.099 1.76 . . . . 2.7599999999999998 112.367 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 86.2 24.59 39.94 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.231 1.396 . . . . 1.28 114.071 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.74 163.06 13.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.372 1.469 . . . . 4.21 110.302 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 14.0 m -76.2 133.19 40.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.93000000000000005 110.195 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -137.12 116.63 12.84 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.105 1.362 . . . . 0.46000000000000002 111.138 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 25.9 m -140.22 156.83 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.191 1.396 . . . . 0.48999999999999999 112.784 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.92 162.88 14.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.901 1.681 . . . . 0.93000000000000005 112.293 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.6 p -135.65 126.98 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.655 1.582 . . . . 2.4399999999999999 112.456 172.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.86 157.0 38.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.436 1.894 . . . . 0.40999999999999998 111.75 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 133.21 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.413 1.485 . . . . 0.85999999999999999 112.292 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 40.16 45.42 1.71 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.385 2.274 . . . . 2.7599999999999998 113.428 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 12.3 m-20 64.79 39.79 5.97 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.713 2.405 . . . . 1.5600000000000001 116.115 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -146.69 146.4 30.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.148 2.179 . . . . 2.29 110.176 169.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.23 147.81 42.13 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 119.498 -2.001 . . . . 0.81000000000000005 112.964 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.0 p -124.83 -38.52 2.35 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.02 1.489 . . . . 0.52000000000000002 115.02 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -163.34 179.92 38.18 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 120.7 1.591 . . . . 0.46999999999999997 115.875 -173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.58 155.62 43.73 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.86 1.664 . . . . 0.79000000000000004 113.502 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.9 mm -130.93 141.92 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.585 1.954 . . . . 0.92000000000000004 110.247 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -122.87 131.2 53.64 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.349 1.46 . . . . 0.56999999999999995 111.59 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 8.4 mt -135.83 145.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.967 1.707 . . . . 1.53 109.789 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -124.42 -173.96 2.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.505 1.522 . . . . 1.3899999999999999 112.884 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.338 27.4 t70 66.86 -67.65 0.16 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.968 2.907 . . . . 4.8899999999999997 115.175 -168.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.256 1.429 0 CA-C-O 116.59 -1.672 . . . . 9.1199999999999992 113.705 169.426 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 118.473 -0.775 . . . . 13.48 113.009 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -126.88 141.05 51.92 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.114 1.325 . . . . 15.91 112.235 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 78.1 m -80.88 158.87 25.18 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 9.5099999999999998 113.11 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 7.7 ttp -32.56 134.15 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.252 2.621 . . . . 5.96 113.519 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 64.4 m80 -90.08 -25.01 20.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.719 1.377 . . . . 10.51 114.719 -172.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -69.84 75.83 0.43 Allowed Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.572 1.558 . . . . 3.8199999999999998 113.784 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 16.5 p -115.2 150.28 44.1 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 125.669 1.588 . . . . 2.48 115.274 -166.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.31 166.69 7.13 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.739 2.293 . . . . 1.46 110.486 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 11.7 p -135.47 130.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.969 -1.082 . . . . 2.1600000000000001 111.28 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -66.59 135.01 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.14 -0.975 . . . . 1.4399999999999999 111.507 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.88 -33.67 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.227 0.825 . . . . 2.1899999999999999 113.227 -172.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -159.2 143.87 15.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.296 0.953 . . . . 2.3700000000000001 112.113 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -114.66 134.27 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.686 0.795 . . . . 0.93999999999999995 109.15 167.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.5 tttt -140.71 145.1 36.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.291 0.849 . . . . 2.8500000000000001 113.291 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.3 t -101.5 129.82 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.386 1.474 . . . . 1.0 111.169 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.05 -25.0 11.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.017 1.727 . . . . 1.01 112.45 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 34.4 m -137.0 130.72 31.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.454 1.501 . . . . 1.8999999999999999 110.492 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.25 144.52 40.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.009 1.324 . . . . 6.2000000000000002 110.918 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 61.9 m 54.55 13.13 0.62 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.254 2.221 . . . . 2.9100000000000001 115.839 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -137.53 13.63 2.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.717 2.407 . . . . 2.7200000000000002 112.433 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -163.46 -58.42 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.298 1.439 . . . . 5.0199999999999996 110.679 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.48 159.76 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 129.768 3.227 . . . . 1.8600000000000001 108.006 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 39.7 m -106.6 155.6 19.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.842 1.257 . . . . 1.8200000000000001 113.68 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.83 -41.36 57.53 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.706 2.484 . . . . 3.4399999999999999 117.706 -167.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.97 -28.05 54.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.971 1.26 . . . . 2.5899999999999999 111.406 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1072 ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' 1072 ' ' LYS . 9.7 mmpt? -70.36 -34.63 72.85 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 116.917 -1.516 . . . . 5.3200000000000003 111.933 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 63.3 mt -56.81 -53.68 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.662 1.574 . . . . 0.60999999999999999 110.547 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.53 -30.76 71.15 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.4 -0.812 . . . . 0.59999999999999998 112.323 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.03 60.84 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.52000000000000002 112.231 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.7 pt -69.98 -35.09 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.508 -1.37 . . . . 0.52000000000000002 112.682 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.0 t -71.01 -43.52 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.096 0.862 . . . . 0.56999999999999995 111.71 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.96 -35.7 79.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.849 -1.157 . . . . 0.56999999999999995 113.492 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 73.8 p -73.96 -25.31 59.87 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.51 -0.994 . . . . 0.76000000000000001 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.27 -55.49 15.87 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.538 0.735 . . . . 0.66000000000000003 110.98 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.07 -20.85 63.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.133 0.79 . . . . 2.1299999999999999 113.133 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 24.8 t -55.39 -33.18 63.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.72 -1.238 . . . . 1.3100000000000001 112.87 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -85.73 -8.57 58.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.051 0.941 . . . . 2.25 113.361 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 5.0 t -99.35 -179.64 4.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.797 1.639 . . . . 1.5 113.754 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -137.5 8.86 2.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.353 2.261 . . . . 3.9100000000000001 113.962 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -87.33 150.01 48.23 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.779 1.232 . . . . 1.78 113.906 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.17 -28.65 40.42 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.466 3.444 . . . . 1.1000000000000001 115.47 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1088 ' ' LEU . . . . . 0.454 HD13 " H2'" ' A' 1232 ' ' ATP . 2.0 tt -105.11 -46.94 4.12 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.182 0.993 . . . . 0.87 112.576 -166.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.84 -30.11 76.76 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 113.938 0.335 . . . . 0.87 113.938 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 21.3 p -63.69 -17.74 63.27 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.947 -1.325 . . . . 1.3200000000000001 114.248 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.13 85.8 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.136 -0.978 . . . . 1.01 111.71 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 15.1 mt -73.29 -36.4 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.824 1.65 . . . . 0.93999999999999995 110.573 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 21.5 m -51.44 -47.34 63.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.904 0.775 . . . . 1.1200000000000001 111.546 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.68 -49.81 75.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.035 0.934 . . . . 2.1099999999999999 112.574 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.62 -40.0 74.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.563 0.745 . . . . 1.73 111.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 28.3 t -71.66 -52.53 17.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.38 1.472 . . . . 1.78 112.591 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -51.87 -44.16 63.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.751 1.62 . . . . 3.1000000000000001 112.588 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -69.84 -34.05 73.12 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.602 0.761 . . . . 3.5800000000000001 112.591 175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.91 -47.77 67.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.413 1.006 . . . . 2.96 112.977 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.91 -32.54 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.78 0.832 . . . . 1.1100000000000001 112.48 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 1.7 t70 54.94 54.39 9.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.747 2.019 . . . . 2.7599999999999998 112.009 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.3 t -148.37 142.99 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.125 -0.984 . . . . 2.7599999999999998 113.193 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -98.0 21.88 10.11 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.042 1.337 . . . . 3.0 112.707 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 43.1 p -131.23 4.23 4.37 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.024 1.861 . . . . 2.8900000000000001 116.024 -168.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 139.4 57.75 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.689 1.366 . . . . 0.82999999999999996 114.689 -167.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 70.38 171.77 10.34 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.42 1.009 . . . . 1.1200000000000001 115.363 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 4.6 m -157.24 -40.49 0.07 Allowed 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.398 -1.06 . . . . 1.3999999999999999 112.809 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.11 143.54 48.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.517 1.127 . . . . 1.3400000000000001 113.125 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.2 129.01 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 127.408 2.283 . . . . 2.5800000000000001 109.097 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -25.71 32.14 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.983 1.105 . . . . 3.6000000000000001 113.983 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 34.0 t80 60.7 130.49 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 128.613 2.765 . . . . 3.8100000000000001 114.864 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -149.69 106.89 3.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.613 1.965 . . . . 2.1200000000000001 108.318 169.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 9.8 p -106.43 144.44 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.801 0.728 . . . . 2.6899999999999999 112.744 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 59.2 t -129.25 102.8 18.46 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.196 -1.409 . . . . 1.3200000000000001 107.196 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.89 136.54 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.276 2.651 . . . . 1.6599999999999999 113.512 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.79 20.58 77.62 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.42 1.01 . . . . 2.1400000000000001 114.17 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 21.5 t -145.02 -50.85 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.777 1.231 . . . . 2.3300000000000001 112.826 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 137.33 -153.3 21.87 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 119.524 1.056 . . . . 0.83999999999999997 114.643 174.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.3 mm -120.65 147.79 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.738 1.615 . . . . 2.5899999999999999 112.175 -172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.5 t -133.63 148.26 51.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.502 1.921 . . . . 0.71999999999999997 109.303 165.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.0 p -167.34 177.5 6.04 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.428 -1.42 . . . . 0.76000000000000001 114.072 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 137.64 53.78 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 105.965 -1.865 . . . . 3.7999999999999998 105.965 165.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 29.6 m -132.48 154.51 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.835 0.854 . . . . 2.2599999999999998 113.053 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.0 t -161.55 165.39 28.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.264 1.579 . . . . 1.8100000000000001 115.264 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -164.5 -25.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 1 C-N-CA 132.888 4.475 . . . . 2.4199999999999999 108.144 162.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 16.9 pt -43.48 -29.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.512 1.525 . . . . 2.4100000000000001 113.702 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.92 43.85 1.25 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 122.259 1.028 . . . . 4.8300000000000001 111.015 165.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -71.03 11.94 2.43 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 127.035 2.255 . . . . 4.29 116.145 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.9 -11.34 50.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.993 1.717 . . . . 3.9700000000000002 114.212 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.0 tt -82.85 -74.67 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.661 0.785 . . . . 4.6500000000000004 112.313 -168.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 80.5 t60 -160.95 165.05 30.61 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.84 0.856 . . . . 7.54 112.298 -169.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -54.63 157.99 2.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.845 0.831 . . . . 11.859999999999999 110.534 167.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -43.6 66.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.347 -0.846 . . . . 14.65 110.147 172.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -150.45 143.27 24.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 13.130000000000001 111.475 166.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -148.19 -44.02 0.16 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.449 1.099 . . . . 16.050000000000001 111.78 168.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 7.4 m120 -130.5 13.55 5.48 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.872 1.269 . . . . 11.99 113.405 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.99 108.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.838 -1.164 . . . . 13.6 111.184 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -70.87 -5.44 30.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.188 1.395 . . . . 16.98 113.881 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.52 -13.28 26.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.048 1.739 . . . . 18.949999999999999 114.094 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . 0.271 6.1 m-20 -89.61 55.91 3.37 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.233 -1.542 . . . . 16.210000000000001 114.638 -169.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -118.18 166.66 12.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.169 2.587 . . . . 21.239999999999998 109.778 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.79 156.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.854 -1.154 . . . . 23.350000000000001 110.15 167.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -126.84 52.59 1.76 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.485 1.114 . . . . 26.43 111.712 -172.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -71.61 62.75 0.4 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.673 1.989 . . . . 26.920000000000002 111.85 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -105.65 139.44 40.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.089 1.755 . . . . 30.030000000000001 112.108 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 57.9 m 58.64 72.51 0.52 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.504 1.122 . . . . 32.43 112.072 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.85 2.76 4.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.045 1.868 . . . . 33.390000000000001 116.045 -167.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 29.3 m -93.21 1.33 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.55 1.14 . . . . 37.520000000000003 113.585 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -121.38 79.23 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.511 1.525 . . . . 39.960000000000001 109.347 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.23 164.33 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 38.310000000000002 112.622 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 131.39 41.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.193 0.812 . . . . 38.619999999999997 113.193 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -120.06 7.46 10.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.619 1.568 . . . . 41.43 113.463 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 4.0 t -150.64 143.19 24.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.888 2.075 . . . . 42.850000000000001 108.963 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 61.0 t30 -67.21 -39.16 86.24 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.892 1.071 . . . . 40.670000000000002 113.892 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . 0.266 39.3 mt-10 61.21 24.18 14.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.089 1.755 . . . . 40.68 115.258 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 61.25 -50.91 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 130.804 3.642 . . . . 44.68 117.843 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 7.9 m -123.68 -37.33 2.64 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 38.210000000000001 112.521 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 51.4 p -166.76 149.89 6.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.257 1.027 . . . . 34.990000000000002 113.208 165.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 12.9 t -101.94 169.61 8.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.083 1.753 . . . . 31.91 107.659 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 2.0 t -152.13 82.1 1.26 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 115.578 1.696 . . . . 29.289999999999999 115.578 167.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 47.3 m -73.59 92.58 1.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 101.095 -3.668 . . . . 26.09 101.095 160.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 82.7 p -50.96 -16.14 0.39 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.63 2.826 . . . . 24.079999999999998 118.63 -162.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 14.4 mmt -91.66 -61.01 1.73 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.23 1.012 . . . . 25.809999999999999 110.71 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.63 -27.91 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 113.501 0.926 . . . . 24.09 113.501 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.69 -18.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 114.052 1.13 . . . . 18.75 114.052 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.26 -28.24 69.21 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.554 1.07 . . . . 13.02 111.778 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -66.95 -20.58 65.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.606 1.163 . . . . 12.57 113.702 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.24 -80.28 0.57 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.751 1.22 . . . . 14.640000000000001 111.139 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.81 -33.87 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.087 1.755 . . . . 13.44 112.869 -167.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.0 m -71.39 -14.22 62.1 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.611 0.967 . . . . 9.1400000000000006 113.611 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . 0.282 4.8 p30 -104.0 -49.29 3.66 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.194 -0.941 . . . . 8.1799999999999997 111.563 164.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.1 -13.36 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.414 1.886 . . . . 5.71 116.014 -170.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.56 -47.79 83.06 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.183 0.901 . . . . 8.0500000000000007 112.172 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -99.83 -42.46 6.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.718 1.207 . . . . 5.1500000000000004 112.719 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -91.12 55.73 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.574 1.55 . . . . 3.25 111.221 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -42.47 133.05 3.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.382 1.073 . . . . 4.3399999999999999 113.77 -169.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 168.22 27.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.478 1.288 . . . . 2.8799999999999999 114.478 -166.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -135.92 126.82 27.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.833 1.653 . . . . 3.1099999999999999 109.514 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.1 tttt -84.84 120.39 26.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.327 -0.99 . . . . 1.1399999999999999 108.327 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.8 m -135.26 141.15 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.56 1.073 . . . . 0.57999999999999996 112.469 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.58 152.88 41.17 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 0.45000000000000001 112.92 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.1 tt -153.01 136.77 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.51000000000000001 110.991 -171.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 150.4 -141.89 9.15 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.252 1.261 . . . . 1.3200000000000001 116.252 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.63 152.14 0.23 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.312 2.645 . . . . 2.3300000000000001 113.509 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -57.49 -28.72 63.66 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.244 -0.91 . . . . 4.6100000000000003 112.529 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.35 -31.83 70.69 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.815 1.188 . . . . 4.4900000000000002 113.941 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.1 m95 -63.86 -27.04 68.89 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.281 1.401 . . . . 3.6899999999999999 112.716 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -71.54 -38.85 70.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.092 0.557 . . . . 2.5299999999999998 111.161 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.57 -70.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.12 1.368 . . . . 2.4900000000000002 109.016 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -40.26 -46.91 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.454 2.301 . . . . 5.4900000000000002 114.495 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.0 t30 -81.71 9.11 8.37 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.965 1.098 . . . . 0.97999999999999998 113.965 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.74 20.83 79.35 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 120.759 -1.213 . . . . 0.89000000000000001 114.791 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.1 mt -89.08 166.62 13.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.247 1.019 . . . . 1.28 109.868 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.2 t -124.9 112.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.859 1.264 . . . . 2.21 109.581 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.2 tt -87.57 147.98 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.569 1.548 . . . . 1.52 111.365 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -116.32 177.6 4.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.63 1.172 . . . . 3.5800000000000001 113.181 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -72.09 -33.42 67.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.282 1.956 . . . . 3.02 116.282 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.08 -31.05 25.53 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.127 1.331 . . . . 3.2400000000000002 113.445 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.2 p -67.08 -41.14 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 117.991 -1.004 . . . . 1.1799999999999999 110.428 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.95 -34.5 76.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.384 1.447 . . . . 2.6499999999999999 112.157 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.6 -42.13 99.39 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.015 0.926 . . . . 2.25 113.3 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -66.73 -40.94 88.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.162 1.385 . . . . 2.1899999999999999 112.105 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 20.3 ttm -63.61 -56.26 17.24 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.369 1.068 . . . . 1.1699999999999999 109.983 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.2 t -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.629 0.772 . . . . 1.02 112.673 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.45 -51.73 67.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.836 -1.165 . . . . 3.5600000000000001 112.297 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -70.97 -31.09 67.54 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.396 0.887 . . . . 3.8300000000000001 113.396 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -65.07 -34.08 77.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.755 -1.216 . . . . 3.6899999999999999 111.853 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -70.92 -29.9 66.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.912 1.285 . . . . 3.7400000000000002 113.268 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 2.2 mttp -71.54 3.17 4.14 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.996 1.318 . . . . 3.2400000000000002 113.439 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.77 20.52 55.81 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.732 1.158 . . . . 1.8999999999999999 114.897 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.55 158.29 17.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.337 1.455 . . . . 3.3500000000000001 111.482 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.0 m -81.41 137.27 35.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.844 2.058 . . . . 0.91000000000000003 110.285 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -138.69 124.77 20.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.886 0.874 . . . . 0.45000000000000001 112.686 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 31.1 m -140.99 158.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 125.936 1.694 . . . . 0.54000000000000004 112.887 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.54 164.26 12.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.86 1.264 . . . . 0.70999999999999996 113.311 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 14.4 t -136.55 118.1 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.428 1.891 . . . . 1.8899999999999999 111.124 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -119.14 155.08 32.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.195 1.398 . . . . 0.44 112.018 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.81 132.45 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.309 1.844 . . . . 0.87 112.218 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 71.1 m-20 40.22 47.94 2.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.882 2.073 . . . . 3.4700000000000002 112.845 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.263 27.9 m-20 60.05 34.74 21.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.484 2.313 . . . . 1.5600000000000001 116.383 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -145.13 149.17 34.53 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.578 -1.326 . . . . 2.79 112.651 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.43 142.48 58.16 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.319 -1.488 . . . . 0.66000000000000003 113.512 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.9 p -125.74 -34.03 2.67 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.897 1.444 . . . . 0.56000000000000005 114.897 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.69 -176.15 38.11 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-N 120.964 1.711 . . . . 0.51000000000000001 115.876 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.64 153.61 42.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.839 1.656 . . . . 0.69999999999999996 113.292 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 22.0 mm -123.6 134.39 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.567 1.547 . . . . 0.89000000000000001 110.058 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -117.23 133.01 56.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.328 1.851 . . . . 0.58999999999999997 109.549 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -139.31 147.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.006 1.723 . . . . 1.3700000000000001 111.974 -167.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -117.69 -164.03 0.98 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.621 1.168 . . . . 1.3600000000000001 112.204 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -119.0 151.16 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.421 1.488 . . . . 4.0899999999999999 112.538 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 116.64 -1.648 . . . . 4.5199999999999996 114.492 -179.599 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1232 ' ' ATP . . . . . 0.454 " H2'" HD13 ' A' 1088 ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.293 -0.86 . . . . 15.25 111.653 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -142.44 157.47 44.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.753 1.621 . . . . 16.780000000000001 112.705 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 67.8 m -68.93 -44.54 72.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.949 1.462 . . . . 8.8300000000000001 114.949 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 46.9 ttp -146.63 -32.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.318 1.97 . . . . 8.3599999999999994 116.318 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.57 -7.31 50.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.792 1.404 . . . . 7.6399999999999997 114.792 -171.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.11 72.17 2.52 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.955 -1.091 . . . . 2.8300000000000001 113.038 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 40.8 p -109.99 145.97 33.17 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 113.932 1.086 . . . . 2.79 113.932 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -85.87 153.8 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.09 3.193 . . . . 2.1400000000000001 113.637 -173.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 4.7 m -139.17 126.52 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 126.113 1.765 . . . . 3.0899999999999999 110.475 171.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -72.09 142.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.756 -1.215 . . . . 1.3999999999999999 110.008 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.9 -42.57 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.339 0.866 . . . . 2.52 113.339 -168.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -153.59 147.19 25.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.749 0.704 . . . . 2.3100000000000001 112.073 172.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 2.5 m -130.69 136.13 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.263 1.025 . . . . 0.73999999999999999 111.043 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 60.9 tttt -138.23 147.83 44.14 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.776 0.831 . . . . 1.74 112.357 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.2 t -91.18 137.64 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.561 1.145 . . . . 0.66000000000000003 111.374 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1062 ' ' LEU . . . . . 0.704 HD23 HD22 ' A' 1222 ' ' LEU . 24.7 tp -107.04 -22.98 12.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.253 1.821 . . . . 0.91000000000000003 112.753 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 5.0 t -100.03 27.76 5.32 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.512 1.525 . . . . 2.3100000000000001 113.782 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.82 125.02 21.78 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.695 -1.253 . . . . 4.1799999999999997 111.538 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 58.6 m 43.65 41.0 3.25 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.808 2.043 . . . . 4.21 113.931 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -133.04 -29.25 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.028 1.331 . . . . 4.1200000000000001 113.594 172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -146.0 -55.7 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.661 1.726 . . . . 5.5099999999999998 115.661 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 19.7 mt -135.53 144.04 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.991 1.316 . . . . 1.78 110.89 -169.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 50.9 m -98.42 158.62 15.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.641 1.576 . . . . 2.1699999999999999 113.357 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -55.5 -38.0 68.6 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.11 1.522 . . . . 3.1000000000000001 115.11 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 29.2 t60 -75.03 -37.38 61.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.506 1.048 . . . . 2.5899999999999999 112.165 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.5 mttt -65.99 -40.78 91.46 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.137 0.881 . . . . 3.0 111.637 169.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.2 mt -57.75 -52.43 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.826 0.739 . . . . 0.54000000000000004 110.932 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.13 -29.76 69.57 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.198 -0.938 . . . . 0.47999999999999998 112.373 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.01 19.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.092 0.557 . . . . 0.46999999999999997 111.959 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.64 -35.25 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 120.235 1.38 . . . . 0.57999999999999996 113.055 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 46.0 t -70.81 -46.06 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.342 -0.849 . . . . 0.73999999999999999 111.356 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -71.93 -28.58 68.45 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.97 -1.081 . . . . 0.65000000000000002 114.335 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 62.8 p -76.42 -32.71 58.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.369 1.067 . . . . 0.67000000000000004 112.398 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.37 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.053 0.842 . . . . 0.66000000000000003 112.323 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -66.36 -17.07 64.55 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.56 0.948 . . . . 2.23 113.56 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 16.1 p -67.25 -15.62 63.8 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.126 -1.608 . . . . 1.5800000000000001 114.463 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -94.76 -18.51 21.18 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.377 1.071 . . . . 1.8799999999999999 112.565 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 4.4 t -77.48 164.43 25.44 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.526 1.306 . . . . 1.8700000000000001 114.526 -169.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.12 23.5 4.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.881 2.073 . . . . 3.4100000000000001 112.259 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -85.68 160.8 52.51 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.738 1.215 . . . . 1.8200000000000001 113.136 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -81.51 1.52 9.2 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.58 3.52 . . . . 2.6099999999999999 115.425 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1088 ' ' LEU . . . . . 0.473 HD13 " H2'" ' A' 1232 ' ' ATP . 5.9 tt -141.12 -48.09 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.938 1.295 . . . . 0.93000000000000005 112.055 -167.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.15 -23.2 65.9 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.894 1.117 . . . . 0.90000000000000002 115.894 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 23.7 p -58.0 -25.68 61.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.16 -1.2 . . . . 1.5900000000000001 113.324 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.9 85.84 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.316 0.858 . . . . 0.91000000000000003 113.316 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.53 -41.66 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 110.898 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 8.9 t -64.0 -39.13 93.43 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 118.278 -0.867 . . . . 2.1800000000000002 112.204 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 23.5 tttp -60.14 -50.55 73.23 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.529 1.059 . . . . 3.1400000000000001 112.785 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.47 -44.73 55.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.574 1.149 . . . . 2.4300000000000002 112.184 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 35.6 t -69.68 -52.38 26.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.592 1.157 . . . . 1.72 112.416 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 14.9 tptm -49.96 -39.39 40.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.183 1.793 . . . . 2.4500000000000002 112.545 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.87 -40.37 65.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.718 1.207 . . . . 3.0800000000000001 113.99 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -70.53 -34.62 72.5 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.061 -1.649 . . . . 2.0699999999999998 113.298 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.01 -7.92 54.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.225 1.41 . . . . 1.0900000000000001 114.421 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 40.3 m-20 53.53 29.99 9.96 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.152 1.381 . . . . 4.6100000000000003 114.094 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -123.4 176.33 6.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.141 1.776 . . . . 2.7200000000000002 112.557 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -115.44 -2.97 12.45 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.263 1.425 . . . . 2.6699999999999999 113.716 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.0 t -143.97 125.08 14.47 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.777 -1.202 . . . . 3.0699999999999998 112.443 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.24 144.89 29.21 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.38 1.472 . . . . 0.93000000000000005 110.722 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 68.66 179.38 19.35 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 120.687 -1.258 . . . . 1.0800000000000001 114.201 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.7 m -158.2 -62.54 0.08 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.15 1.38 . . . . 1.6299999999999999 112.911 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.2 t -136.06 142.23 44.35 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.835 1.198 . . . . 1.8899999999999999 112.382 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 6.0 mm -143.17 150.17 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 1 C-N-CA 133.085 4.554 . . . . 2.0899999999999999 107.533 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -7.81 12.34 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.043 1.868 . . . . 3.0499999999999998 116.043 -173.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 65.9 m-85 43.94 109.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 129.396 3.079 . . . . 3.5600000000000001 118.773 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.37 94.27 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.879 2.072 . . . . 2.3300000000000001 106.213 166.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 19.2 m -103.21 146.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.276 1.03 . . . . 2.52 113.302 -168.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.3 t -138.61 124.61 12.53 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.414 1.486 . . . . 0.94999999999999996 109.231 171.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.35 146.31 39.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.976 3.117 . . . . 1.6200000000000001 112.994 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 53.27 32.57 44.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.39 0.995 . . . . 1.6100000000000001 113.396 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 53.9 t -150.01 -81.74 0.11 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.548 1.539 . . . . 1.76 111.655 -168.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 178.12 171.01 41.03 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 121.341 -0.849 . . . . 1.0900000000000001 112.838 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.36 157.16 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 117.373 0.586 . . . . 2.6400000000000001 112.124 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 20.1 t -130.89 157.31 43.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.025 1.73 . . . . 0.60999999999999999 111.077 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 27.6 p -162.8 167.44 22.87 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.424 0.898 . . . . 0.56999999999999995 113.424 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -112.24 119.85 39.74 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.227 1.011 . . . . 1.1899999999999999 108.853 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.2 p -111.67 139.08 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.944 0.72 . . . . 2.0 112.944 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -128.47 151.44 49.4 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 122.363 1.078 . . . . 1.53 111.75 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -163.66 50.63 0.14 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 130.171 3.388 . . . . 2.7799999999999998 104.807 159.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 88.2 mt -128.02 -55.78 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.639 1.976 . . . . 4.2999999999999998 107.881 -169.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -127.3 20.5 6.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.452 1.901 . . . . 5.2999999999999998 111.056 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -63.52 -22.2 65.55 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 120.434 -1.416 . . . . 4.8700000000000001 114.967 -170.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.49 1.56 0.78 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.718 2.007 . . . . 5.9100000000000001 115.037 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.82 -46.71 29.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.555 1.542 . . . . 6.54 112.651 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 16.6 m80 53.58 149.62 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.192 2.597 . . . . 8.7400000000000002 117.326 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.16 160.06 42.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.663 -1.898 . . . . 9.8499999999999996 115.918 168.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.78 175.15 5.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 103.868 -2.641 . . . . 14.42 103.868 159.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 44.8 t30 -57.72 149.59 21.68 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 119.518 -1.989 . . . . 12.140000000000001 110.336 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -140.5 -23.19 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 116.576 2.065 . . . . 13.43 116.576 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -151.43 -0.57 0.35 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.272 1.212 . . . . 13.52 114.272 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.27 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 119.645 1.111 . . . . 12.82 108.44 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -68.3 81.88 0.24 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.929 1.692 . . . . 17.530000000000001 115.092 -167.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 5.8 t0 66.0 22.36 11.23 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.824 2.45 . . . . 16.239999999999998 115.752 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -55.52 152.35 9.11 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.556 1.942 . . . . 15.51 114.046 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -62.95 125.83 25.31 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.176 -0.952 . . . . 16.350000000000001 112.427 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 38.5 pt -124.87 4.12 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.555 1.942 . . . . 14.98 112.908 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -65.36 114.17 4.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.742 1.617 . . . . 16.25 112.21 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -64.11 -29.85 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.612 1.338 . . . . 15.949999999999999 114.612 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 59.98 127.04 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.139 2.976 . . . . 16.129999999999999 115.615 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 32.8 m -96.78 149.44 21.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.96 1.304 . . . . 18.449999999999999 111.751 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . 0.282 0.9 OUTLIER 42.27 -142.87 0.09 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.325 2.25 . . . . 20.690000000000001 113.902 -176.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 11.5 p -114.32 147.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.258 1.823 . . . . 21.670000000000002 110.635 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -132.73 108.51 9.06 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.791 0.836 . . . . 23.010000000000002 112.103 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 7.1 tp -77.96 -25.91 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.106 0.963 . . . . 25.870000000000001 111.735 171.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -72.69 140.43 47.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.107 0.963 . . . . 27.699999999999999 112.359 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -68.97 -26.88 65.27 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.048 -1.033 . . . . 27.690000000000001 113.424 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 36.5 t -148.17 123.95 10.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.865 1.266 . . . . 28.41 111.125 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 32.6 t30 -155.56 -33.5 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.968 1.307 . . . . 28.219999999999999 112.504 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.85 104.62 17.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.137 0.881 . . . . 25.27 112.349 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -93.37 -169.45 2.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.225 1.41 . . . . 31.370000000000001 110.56 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 9.5 t -45.16 127.4 6.82 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.558 1.318 . . . . 26.719999999999999 114.558 171.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 88.7 p -88.39 3.22 50.67 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.479 1.112 . . . . 26.239999999999998 111.574 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 27.2 p 58.59 10.49 1.43 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.705 2.402 . . . . 28.239999999999998 115.428 -172.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 48.5 t -101.67 159.84 14.97 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.986 1.714 . . . . 24.82 112.176 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 42.8 m -76.23 -22.88 54.69 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.942 -1.099 . . . . 24.199999999999999 111.219 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 45.8 m -65.05 -8.08 14.79 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.312 1.445 . . . . 23.25 114.635 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1163 ' ' MET . . . . . 0.443 ' HG3' HG23 ' A' 1164 ' ' ILE . 13.0 ptt? -92.67 -12.47 31.46 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.879 1.066 . . . . 21.670000000000002 113.879 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1164 ' ' ILE . . . . . 0.443 HG23 ' HG3' ' A' 1163 ' ' MET . 40.3 pt -126.75 32.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.207 1.803 . . . . 17.91 113.07 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.9 pp -73.23 -20.72 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 120.623 -1.298 . . . . 16.91 113.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.96 -30.0 71.23 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.712 -1.242 . . . . 14.75 112.196 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.01 68.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.813 0.845 . . . . 14.140000000000001 112.901 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.99 -35.53 59.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.519 0.599 . . . . 14.07 111.424 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.28 -27.99 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.83 1.252 . . . . 12.949999999999999 111.603 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 42.6 m -60.69 -10.08 4.83 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.963 1.098 . . . . 12.449999999999999 113.963 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -27.13 65.94 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.767 -1.208 . . . . 10.23 113.768 169.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.38 64.86 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.774 1.398 . . . . 8.0600000000000005 114.774 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -50.66 -36.58 36.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.049 1.34 . . . . 11.91 112.105 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 19.0 m120 -96.77 -50.22 4.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.073 1.349 . . . . 10.19 112.256 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -90.47 101.81 14.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.717 1.006 . . . . 5.4400000000000004 113.717 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -45.8 145.35 1.44 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.149 1.907 . . . . 4.7400000000000002 116.149 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.57 144.05 39.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.942 1.697 . . . . 2.46 114.256 -171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.89 149.87 23.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.635 1.974 . . . . 3.98 110.57 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -104.74 119.04 38.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.779 0.831 . . . . 1.78 111.572 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 11.1 m -133.84 141.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.995 0.739 . . . . 0.56999999999999995 112.995 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.03 153.54 42.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 0.67000000000000004 113.457 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 3.4 tt -150.09 143.46 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.101 1.36 . . . . 0.69999999999999996 108.919 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 161.13 -160.85 32.47 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 117.789 1.876 . . . . 1.3600000000000001 117.789 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.05 155.97 0.58 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.105 3.362 . . . . 2.4399999999999999 113.889 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -55.22 -49.93 70.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.308 1.043 . . . . 4.7199999999999998 113.558 169.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -63.23 -35.38 80.13 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 3.1400000000000001 112.214 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -67.42 -25.37 65.89 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.581 1.553 . . . . 4.1399999999999997 113.552 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 23.1 mmt -77.06 -37.63 54.25 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.118 1.155 . . . . 2.1899999999999999 114.118 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 73.8 mt -53.11 -63.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.382 1.073 . . . . 1.76 108.516 168.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -40.89 -34.43 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.45 2.7 . . . . 6.4500000000000002 116.348 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.16 9.14 2.7 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 121.458 1.935 . . . . 0.93000000000000005 112.933 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.72 27.41 73.87 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 119.804 -1.81 . . . . 1.0 113.891 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.4 mt -93.65 160.97 14.54 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.363 1.465 . . . . 0.88 110.894 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 22.0 t -92.67 119.56 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.438 0.695 . . . . 1.24 109.825 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.2 tt -105.81 148.75 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.707 1.603 . . . . 1.72 110.396 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -138.58 163.97 30.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.61 0.966 . . . . 3.6400000000000001 113.61 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.01 -27.37 69.37 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.97 1.1 . . . . 3.0099999999999998 113.97 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.62 -30.28 56.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.783 1.174 . . . . 2.8399999999999999 113.901 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.3 p -76.89 -39.56 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 118.243 -0.884 . . . . 2.1200000000000001 110.466 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -62.54 -41.0 98.6 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.626 1.103 . . . . 2.4900000000000002 112.256 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.57 -43.59 80.26 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.039 0.755 . . . . 2.5299999999999998 113.039 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 18.4 t80 -56.44 -38.98 72.36 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 3.3399999999999999 111.181 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 17.6 tpp -66.04 -50.55 63.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.933 0.893 . . . . 0.96999999999999997 111.404 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.6 t -64.98 -38.35 90.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.301 0.955 . . . . 1.7 112.063 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.98 -53.57 55.26 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.218 -0.926 . . . . 4.6100000000000003 112.334 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.33 -32.77 66.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.919 1.081 . . . . 3.1400000000000001 113.919 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1207 ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 15.3 mm-40 -58.48 -41.67 85.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.304 0.956 . . . . 3.1200000000000001 111.121 169.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -74.44 -19.93 60.21 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.088 1.755 . . . . 5.79 114.999 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -69.88 -13.1 62.09 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.39 1.076 . . . . 4.3300000000000001 112.921 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.53 11.47 59.38 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.327 1.918 . . . . 2.4900000000000002 113.763 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -91.22 156.53 17.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.621 1.568 . . . . 5.3600000000000003 109.345 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.6 m -82.92 130.42 35.14 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.639 1.175 . . . . 1.0600000000000001 108.299 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.93 130.23 56.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.19 0.996 . . . . 0.44 110.645 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.7 m -143.0 164.53 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.089 1.356 . . . . 0.51000000000000001 113.341 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.15 159.77 18.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.508 1.523 . . . . 1.3200000000000001 111.571 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1216 ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' 1222 ' ' LEU . 7.3 p -138.41 135.08 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.321 1.048 . . . . 1.98 112.597 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -136.74 152.71 50.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.722 1.609 . . . . 0.54000000000000004 111.685 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.0 m -148.7 136.24 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.123 0.969 . . . . 0.89000000000000001 112.082 -171.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 38.3 m-20 41.06 45.31 2.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.71 2.004 . . . . 3.6699999999999999 113.163 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 52.8 m-20 64.89 32.23 10.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.317 2.647 . . . . 1.6200000000000001 117.414 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -137.57 145.15 42.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.168 -1.582 . . . . 2.3900000000000001 111.491 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1222 ' ' LEU . . . . . 0.704 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -75.86 122.84 24.71 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.042 -1.036 . . . . 0.90000000000000002 111.206 176.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.7 p -106.3 -32.2 8.28 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.45000000000000001 113.856 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.04 179.44 39.63 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 120.264 1.393 . . . . 0.46000000000000002 116.489 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.05 144.35 34.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.272 1.829 . . . . 1.74 111.253 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.72 145.53 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.32 1.448 . . . . 1.3 112.028 -166.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -119.79 133.69 55.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.838 1.655 . . . . 0.57999999999999996 110.878 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.41 150.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.418 1.887 . . . . 1.77 109.896 -171.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.38 -169.73 2.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.894 1.277 . . . . 2.1400000000000001 111.143 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -125.56 167.64 14.77 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.813 -1.179 . . . . 4.5899999999999999 112.38 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.919 1.688 . . . . 4.5 114.424 -177.724 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1232 ' ' ATP . . . . . 0.473 " H2'" HD13 ' A' 1088 ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.651 0.739 . . . . 10.949999999999999 112.763 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -80.59 -31.52 36.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.436 1.894 . . . . 11.869999999999999 112.742 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 10.2 t -141.33 136.79 31.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.109 1.364 . . . . 7.4299999999999997 110.951 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.18 -174.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.0 1.32 . . . . 6.0999999999999996 111.811 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -119.57 -53.13 2.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.254 1.421 . . . . 6.9900000000000002 110.652 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -113.82 93.81 0.67 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.871 1.224 . . . . 2.52 114.096 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 93.0 m -70.71 141.8 87.85 Favored Pre-proline 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.417 . . . . 2.27 112.438 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.34 155.22 4.54 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.803 3.669 . . . . 1.25 112.529 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 5.9 m -134.75 123.94 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.149 1.779 . . . . 2.6800000000000002 111.057 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.252 2.7 p -74.52 137.19 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.855 -1.153 . . . . 1.21 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.04 -33.1 3.59 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.197 1.554 . . . . 2.4900000000000002 115.197 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -153.12 148.45 26.99 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.466 1.106 . . . . 2.4900000000000002 111.06 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 7.5 m -128.73 130.21 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.762 0.825 . . . . 1.22 111.614 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.1 tttt -135.21 144.15 46.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.392 1.077 . . . . 1.6599999999999999 113.277 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 27.3 t -90.67 135.59 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.417 1.087 . . . . 0.73999999999999999 110.674 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.18 -41.78 8.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.88 110.772 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 1.5 t -81.97 37.9 0.5 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.675 1.59 . . . . 2.0699999999999998 113.358 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -57.98 119.23 6.38 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.485 -1.384 . . . . 4.8600000000000003 111.185 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 34.0 m 55.17 25.72 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.138 2.175 . . . . 3.4900000000000002 116.081 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -123.95 -21.35 5.12 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 116.454 2.02 . . . . 3.8999999999999999 116.454 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -152.69 -62.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.355 1.434 . . . . 5.8200000000000003 113.497 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 63.2 mt -129.12 150.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.817 1.647 . . . . 1.45 109.16 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 7.7 t -108.25 161.91 14.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.739 1.385 . . . . 3.1400000000000001 114.739 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -43.92 -50.7 8.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.925 2.49 . . . . 3.3799999999999999 116.652 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -76.36 -32.45 58.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.391 0.996 . . . . 2.7400000000000002 112.149 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 45.9 mttp -67.12 -41.55 86.0 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.057 . . . . 2.6699999999999999 112.09 170.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.15 -48.3 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.617 0.644 . . . . 0.53000000000000003 111.05 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.9 -32.94 73.77 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.288 -0.883 . . . . 0.5 112.452 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.16 81.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 0.52000000000000002 112.742 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.9 pt -70.23 -38.35 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.362 0.983 . . . . 0.59999999999999998 112.752 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 99.8 t -65.82 -45.58 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.635 1.107 . . . . 0.66000000000000003 110.71 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.71 -37.58 92.52 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.636 -0.665 . . . . 0.60999999999999999 113.823 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1079 ' ' THR . . . . . 0.403 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 23.2 p -72.97 -40.42 65.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.462 1.131 . . . . 0.63 112.182 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.98 -51.71 63.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.977 0.808 . . . . 0.67000000000000004 112.626 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.12 -23.91 67.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.316 -0.865 . . . . 2.7000000000000002 112.485 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 11.9 p -63.85 -18.58 64.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.513 1.301 . . . . 1.6000000000000001 114.513 171.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.85 5.87 31.08 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.744 1.618 . . . . 2.9199999999999999 111.87 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.7 t -105.31 -177.54 3.39 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.246 1.818 . . . . 1.4199999999999999 112.697 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -128.82 17.5 6.26 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.585 1.954 . . . . 3.8300000000000001 113.703 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -88.16 146.68 38.73 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.127 1.528 . . . . 2.2200000000000002 115.127 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.95 -44.74 4.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.725 2.283 . . . . 1.4299999999999999 112.363 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -44.21 74.85 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.64 -0.663 . . . . 1.45 111.533 172.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.37 -44.34 95.23 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.222 0.915 . . . . 1.3200000000000001 113.949 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 20.8 p -64.56 -33.59 76.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.41 -1.053 . . . . 1.5700000000000001 112.184 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.84 83.22 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.813 -1.179 . . . . 1.1299999999999999 112.811 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.06 -40.51 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.076 0.55 . . . . 0.89000000000000001 110.493 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 95.2 m -54.07 -46.53 72.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.374 1.07 . . . . 1.0800000000000001 111.057 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.9 tttt -59.89 -48.67 80.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.882 0.765 . . . . 2.3199999999999998 112.343 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -61.55 -43.17 99.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 1.8200000000000001 112.719 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 77.8 m -68.74 -45.08 72.4 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.704 1.202 . . . . 3.2400000000000002 111.827 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.75 -31.16 72.24 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.856 -1.152 . . . . 3.0099999999999998 111.794 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -66.26 -44.18 84.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.07 0.85 . . . . 3.4399999999999999 110.819 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -61.55 -47.96 83.17 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.199 0.909 . . . . 2.4199999999999999 112.753 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.11 -23.53 63.05 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.212 1.19 . . . . 0.98999999999999999 114.212 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.51 54.77 10.42 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.764 1.269 . . . . 2.2400000000000002 112.78 -174.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.1 t -127.38 -15.35 5.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.679 1.591 . . . . 3.25 114.449 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 58.29 -50.67 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 129.076 2.95 . . . . 2.8799999999999999 115.649 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.4 t -111.97 135.01 53.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.27 2.228 . . . . 3.3799999999999999 110.883 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.43 174.28 15.47 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.251 1.02 . . . . 1.24 112.847 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1106 ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 74.31 155.88 4.39 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 123.067 1.371 . . . . 1.0 115.495 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1107 ' ' THR . . . . . 0.763 HG22 ' H ' ' A' 1108 ' ' CYS . 97.6 m -150.76 -166.5 2.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.373 2.269 . . . . 2.46 107.312 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1108 ' ' CYS . . . . . 0.763 ' H ' HG22 ' A' 1107 ' ' THR . 79.5 m -57.84 142.05 47.09 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.655 1.982 . . . . 3.0600000000000001 114.829 -169.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 177.94 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 129.273 3.029 . . . . 2.1099999999999999 110.667 -166.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 1.9 t0 -135.64 171.6 14.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.432 1.493 . . . . 2.79 109.484 167.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.385 1.448 . . . . 2.9500000000000002 113.818 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.78 99.34 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.344 2.657 . . . . 3.3100000000000001 105.776 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 42.5 t -99.18 138.61 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.244 1.418 . . . . 2.25 110.389 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 11.4 t -133.6 102.8 12.47 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.971 -1.122 . . . . 1.3100000000000001 107.971 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.69 130.25 30.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.52 2.147 . . . . 1.6100000000000001 113.001 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.3 20.36 76.68 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.321 0.962 . . . . 1.5700000000000001 114.816 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 50.8 t -143.52 -43.72 0.28 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.28 1.54 . . . . 1.8999999999999999 113.804 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.43 34.96 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.666 1.026 . . . . 0.89000000000000001 115.666 171.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.5 tt -140.61 154.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.529 1.532 . . . . 1.95 111.747 168.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -132.08 147.05 52.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.717 1.607 . . . . 0.46999999999999997 113.136 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.1 p -151.8 167.37 28.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.532 1.308 . . . . 0.67000000000000004 114.532 -175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1122 ' ' LYS . . . . . 0.419 ' HE3' ' HD3' ' A' 1179 ' ' LYS . 39.5 mmtm -114.44 97.14 6.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.029 1.732 . . . . 1.22 109.282 171.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.9 p -107.53 130.13 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.727 1.149 . . . . 1.96 113.499 -169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -115.04 168.54 9.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.514 1.126 . . . . 1.0800000000000001 113.752 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 28.0 t-20 179.19 -47.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.422 3.089 . . . . 2.23 107.87 162.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -10.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.099 1.76 . . . . 2.46 115.538 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -136.47 27.75 3.07 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.508 1.523 . . . . 4.8399999999999999 110.957 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.32 58.6 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.703 -1.248 . . . . 3.3199999999999998 115.611 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.14 -6.02 59.33 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.426 1.269 . . . . 4.3399999999999999 114.426 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.71 -52.73 3.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.919 1.687 . . . . 5.4100000000000001 111.536 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -149.6 136.14 19.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.454 1.101 . . . . 9.5800000000000001 111.561 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -93.55 -48.55 6.31 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.553 1.316 . . . . 11.65 114.553 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 1.4 t30 74.04 59.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.918 1.687 . . . . 13.960000000000001 109.166 -164.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 52.5 t30 -108.22 134.97 50.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.323 1.849 . . . . 10.34 111.682 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 5.4 m-90 53.5 -172.37 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.529 1.932 . . . . 14.27 112.246 -170.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 9.3 m-80 62.64 34.11 15.2 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 123.493 1.616 . . . . 14.18 112.127 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.96 159.68 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 129.091 2.956 . . . . 14.58 108.982 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -49.71 -41.48 43.57 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.223 1.409 . . . . 21.550000000000001 111.506 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.22 126.2 5.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.094 2.958 . . . . 18.039999999999999 107.829 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -98.43 -44.76 6.38 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.286 1.403 . . . . 14.890000000000001 111.462 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -81.37 163.12 23.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.294 1.438 . . . . 16.449999999999999 112.512 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 31.4 pt -60.05 144.28 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.921 0.889 . . . . 20.960000000000001 112.833 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -111.66 123.7 50.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.221 1.408 . . . . 20.27 111.263 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.74 10.77 4.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.218 1.407 . . . . 22.539999999999999 114.713 -169.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -116.02 52.97 0.88 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.091 1.356 . . . . 21.489999999999998 113.165 -170.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 20.1 m 62.5 170.27 0.13 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.24 1.816 . . . . 24.48 114.999 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.27 -24.73 22.0 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.286 1.034 . . . . 23.030000000000001 113.071 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.8 t 64.71 108.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 127.13 2.172 . . . . 22.699999999999999 113.998 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 61.36 177.07 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.032 2.133 . . . . 24.969999999999999 115.147 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.37 -23.42 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.972 1.309 . . . . 27.390000000000001 114.114 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.1 -49.29 2.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.394 1.452 . . . . 25.170000000000002 112.66 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . 51.42 21.5 1.22 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.217 2.207 . . . . 23.940000000000001 116.228 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 39.6 t -123.91 -48.9 1.87 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.783 1.031 . . . . 23.59 113.783 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 56.5 t30 50.74 47.01 25.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.775 1.23 . . . . 26.059999999999999 112.228 -170.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 27.4 tt0 48.87 72.61 0.28 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.952 2.101 . . . . 26.73 113.113 -171.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.88 166.61 0.95 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.463 1.282 . . . . 23.640000000000001 114.463 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 37.4 m -66.23 159.03 27.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.256 1.422 . . . . 22.690000000000001 113.578 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 27.0 p -93.7 3.61 55.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.571 2.063 . . . . 22.670000000000002 116.571 -169.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 17.6 p 63.76 151.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.458 1.903 . . . . 19.710000000000001 114.829 -169.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 43.2 p -170.27 -28.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.538 . . . . 18.190000000000001 115.154 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 8.6 t -68.69 129.77 40.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.44 1.274 . . . . 16.0 114.44 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 4.1 m -103.69 21.2 16.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.082 1.753 . . . . 15.699999999999999 113.169 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.1 mmt -90.93 133.22 35.44 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.449 1.278 . . . . 17.050000000000001 114.449 -167.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 22.0 mm 58.61 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 128.29 2.636 . . . . 12.08 114.166 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.77 -25.64 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 120.25 -1.531 . . . . 9.8000000000000007 112.663 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.96 -24.36 66.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.284 1.034 . . . . 10.18 113.379 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -71.77 -25.93 62.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.369 -0.832 . . . . 8.7599999999999998 112.046 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.35 -32.81 17.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.023 1.329 . . . . 7.5199999999999996 110.494 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.11 -39.81 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.773 1.229 . . . . 7.6399999999999997 109.402 167.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 68.8 m -65.8 -21.0 66.46 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.16 0.8 . . . . 8.3900000000000006 113.16 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 31.1 t30 -91.31 -11.38 38.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.02 1.328 . . . . 7.3099999999999996 114.073 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -44.34 -46.06 9.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.692 2.108 . . . . 6.5899999999999999 116.692 -167.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.63 -26.68 63.98 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 112.949 0.722 . . . . 8.4299999999999997 112.949 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.57 -37.85 9.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.623 1.569 . . . . 6.0700000000000003 111.353 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -98.39 68.81 1.91 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.68 1.992 . . . . 4.7199999999999998 110.832 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.06 -31.57 13.39 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.319 0.859 . . . . 4.5 113.319 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 tm0? 9.5 107.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.515 3.126 . . . . 2.6200000000000001 112.982 162.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.07 119.88 25.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.364 1.066 . . . . 2.1800000000000002 113.347 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1179 ' ' LYS . . . . . 0.419 ' HD3' ' HE3' ' A' 1122 ' ' LYS . 37.7 ttpt -81.35 115.08 20.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.056 1.342 . . . . 1.8600000000000001 109.477 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.0 m -136.59 142.83 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.757 0.708 . . . . 0.59999999999999998 112.871 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.61 153.16 47.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.728 1.211 . . . . 0.48999999999999999 112.976 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -140.3 137.04 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.764 1.626 . . . . 0.45000000000000001 108.642 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . -172.42 168.12 41.14 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.281 -0.887 . . . . 1.6200000000000001 113.26 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.301 12.9 p30 -69.43 -49.33 56.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.021 1.489 . . . . 3.1200000000000001 115.021 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -173.81 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 115.064 1.505 . . . . 4.7999999999999998 115.064 169.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.16 -32.13 71.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.282 1.401 . . . . 3.3199999999999998 113.286 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -67.27 -22.49 65.66 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.699 -1.251 . . . . 2.9100000000000001 113.022 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -29.24 68.36 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.242 -1.536 . . . . 2.0800000000000001 111.247 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 55.3 mt -69.39 -66.35 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.847 1.659 . . . . 1.6599999999999999 108.63 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -48.01 -32.97 7.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.81 1.644 . . . . 5.2199999999999998 114.9 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.68 5.52 27.84 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.919 1.236 . . . . 0.93000000000000005 113.991 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 73.25 35.49 56.81 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.823 -1.173 . . . . 0.94999999999999996 114.572 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.82 158.7 15.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.801 1.241 . . . . 0.72999999999999998 110.343 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 86.7 t -97.26 123.56 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.362 -0.977 . . . . 1.1399999999999999 108.362 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.1 tt -110.44 139.89 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.97 0.89 . . . . 1.4099999999999999 112.675 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -96.55 150.83 20.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.699 1.2 . . . . 2.7400000000000002 114.182 -168.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -69.2 -26.87 65.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.661 1.184 . . . . 3.7200000000000002 114.057 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -84.26 -42.77 15.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.525 1.13 . . . . 2.8500000000000001 112.989 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 13.1 p -65.09 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.117 0.871 . . . . 0.79000000000000004 111.609 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -62.69 -45.71 91.51 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.639 1.109 . . . . 2.3799999999999999 111.528 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.87 -33.88 73.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.172 0.989 . . . . 2.6099999999999999 112.652 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.47 -44.35 64.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.605 1.093 . . . . 2.3900000000000001 112.518 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.3 tpp -58.89 -48.01 82.93 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.711 1.604 . . . . 1.02 111.799 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 9.7 t -75.5 -38.45 59.46 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.99 -0.528 . . . . 1.54 112.364 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -53.95 -44.76 70.98 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.185 1.357 . . . . 3.48 112.744 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1206 ' ' HIS . . . . . 0.486 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 65.7 t-80 -62.49 -44.77 95.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.59 1.556 . . . . 3.7200000000000002 112.224 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -71.57 -30.71 66.17 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.817 1.247 . . . . 4.2599999999999998 112.655 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -70.46 -16.78 62.96 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.936 1.694 . . . . 4.9299999999999997 113.74 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.369 0.0 OUTLIER -104.01 24.01 12.04 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.84 1.656 . . . . 3.9100000000000001 114.247 170.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.75 76.02 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 117.755 1.862 . . . . 1.3300000000000001 117.755 167.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -105.6 148.56 27.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.706 1.753 . . . . 4.4400000000000004 111.598 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 56.5 m -76.41 128.38 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.094 1.358 . . . . 1.0900000000000001 112.108 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.46 126.69 44.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.542 1.137 . . . . 0.76000000000000001 112.108 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 32.7 m -141.17 156.73 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.141 1.376 . . . . 0.93000000000000005 113.818 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.51 157.22 25.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.037 2.535 . . . . 1.47 112.131 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -131.34 119.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.519 1.527 . . . . 1.6799999999999999 111.103 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -121.5 147.52 45.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.023 1.329 . . . . 0.46000000000000002 111.601 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 35.1 m -144.44 121.67 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.32 1.048 . . . . 0.66000000000000003 112.324 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.255 33.3 t0 41.11 50.97 3.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.582 2.353 . . . . 3.4399999999999999 113.694 -176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.289 7.6 m-20 68.51 25.77 6.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.855 2.862 . . . . 2.2000000000000002 116.714 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.31 143.85 49.29 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.736 1.214 . . . . 2.4100000000000001 111.141 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.14 136.59 48.24 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.535 -1.353 . . . . 0.68999999999999995 112.355 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.7 p -113.81 -44.1 3.21 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.898 1.073 . . . . 0.53000000000000003 113.898 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.3 -172.23 34.24 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 120.055 1.298 . . . . 0.54000000000000004 115.47 -173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.16 154.0 43.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.914 1.686 . . . . 0.81000000000000005 112.413 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.0 mm -126.9 137.23 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.28 1.432 . . . . 0.97999999999999998 109.287 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1227 ' ' ALA . . . . . 0.486 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -114.9 131.52 56.84 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.321 1.849 . . . . 0.95999999999999996 109.801 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.46 155.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.92 1.688 . . . . 1.3700000000000001 111.266 -168.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -127.69 173.0 10.28 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.492 1.517 . . . . 1.52 111.881 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -113.65 129.48 56.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.082 1.353 . . . . 4.25 111.623 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.256 1.429 0 N-CA-C 115.284 1.587 . . . . 4.3499999999999996 115.284 -175.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.349 0.595 . . . . 10.4 111.294 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -129.4 162.74 27.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.949 1.7 . . . . 9.8300000000000001 111.037 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 92.7 m -82.63 145.15 29.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.138 0.975 . . . . 7.79 110.978 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 10.6 tpt -84.98 -65.83 0.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.677 1.591 . . . . 8.3900000000000006 110.644 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -116.83 -51.27 2.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.649 1.18 . . . . 8.25 113.948 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -138.62 122.2 2.32 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.094 0.798 . . . . 3.0299999999999998 115.094 -171.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 12.0 m -80.25 139.3 52.31 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.04 0.92 . . . . 2.5499999999999998 111.542 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.25 150.01 52.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.269 2.646 . . . . 1.27 112.765 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 6.1 p -134.86 133.56 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.52 1.528 . . . . 3.2799999999999998 109.459 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 1.9 p -71.93 121.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.539 1.063 . . . . 1.77 108.941 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 17.4 t30 -106.21 -44.75 4.48 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.796 1.036 . . . . 2.9500000000000002 113.796 -166.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -142.98 148.67 37.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.542 1.537 . . . . 1.97 110.812 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.0 m -129.16 148.45 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.124 0.97 . . . . 1.1100000000000001 111.432 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -141.38 147.69 38.43 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.151 -0.968 . . . . 3.3399999999999999 112.841 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 62.9 t -105.23 136.76 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.412 1.085 . . . . 0.93000000000000005 111.742 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1062 ' ' LEU . . . . . 0.585 HD23 HD22 ' A' 1222 ' ' LEU . 22.6 tp -108.77 -23.96 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.872 2.469 . . . . 1.1499999999999999 113.105 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 46.2 m -132.91 110.4 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.01 1.324 . . . . 1.75 110.051 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -118.54 155.69 30.44 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.688 1.195 . . . . 3.21 112.946 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 58.25 3.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.95 2.574 . . . . 2.8500000000000001 117.95 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -127.49 -11.92 5.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.512 1.525 . . . . 2.9700000000000002 114.028 -172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -158.27 -48.88 0.06 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.308 1.843 . . . . 4.3200000000000003 110.312 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 165.41 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 128.471 2.708 . . . . 1.48 108.569 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.0 m -142.31 162.41 35.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.144 1.777 . . . . 1.8700000000000001 111.49 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.6 t60 -45.83 -51.87 12.21 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.929 1.826 . . . . 4.7400000000000002 115.929 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -75.21 -28.96 60.16 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.125 -0.985 . . . . 2.6800000000000002 112.224 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -70.22 -41.98 72.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.016 -1.053 . . . . 2.8900000000000001 111.706 170.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.01 -52.91 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 0.65000000000000002 110.647 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.94 -32.62 74.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.073 0.851 . . . . 0.72999999999999998 112.462 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.22 -51.17 60.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.97 0.508 . . . . 0.79000000000000004 112.17 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.2 pt -70.43 -30.99 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.009 -1.057 . . . . 0.83999999999999997 113.099 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 65.1 t -71.01 -48.86 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.167 0.894 . . . . 1.01 111.796 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.78 -34.64 83.48 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 113.316 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 58.9 p -74.51 -35.41 63.19 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 112.86 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.66 66.22 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.125 1.157 . . . . 1.1899999999999999 114.125 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -78.86 -10.51 59.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.439 1.644 . . . . 2.0699999999999998 115.439 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.2 t -61.29 -52.07 66.25 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.394 -1.442 . . . . 1.4099999999999999 113.629 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.7 1.24 31.0 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.969 -1.082 . . . . 2.21 113.638 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.3 t -79.53 177.34 8.94 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.447 1.099 . . . . 1.6399999999999999 113.914 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.99 2.5 9.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.113 2.165 . . . . 5.2300000000000004 113.267 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -81.04 158.29 70.2 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 114.397 1.258 . . . . 1.6499999999999999 114.397 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.21 -32.37 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.088 2.525 . . . . 1.0 113.913 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.6 -55.46 2.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.376 0.67 . . . . 0.73999999999999999 112.318 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.55 -28.63 71.64 Favored Glycine 0 CA--C 1.543 1.805 0 N-CA-C 114.292 0.477 . . . . 0.84999999999999998 114.292 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.3 p -61.23 -22.78 65.12 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.011 -1.288 . . . . 1.52 113.725 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.49 72.65 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.579 -1.326 . . . . 0.75 112.334 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.81 -34.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.015 1.326 . . . . 0.71999999999999997 110.76 173.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 75.4 m -53.14 -46.7 68.94 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 118.432 -0.794 . . . . 1.1499999999999999 111.508 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.46 -47.32 86.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.463 1.029 . . . . 2.02 112.821 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -55.11 -46.28 75.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.217 1.007 . . . . 2.0899999999999999 112.145 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.2 t -66.49 -52.94 40.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.669 0.788 . . . . 1.8400000000000001 112.207 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.2 -35.26 73.28 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 3.04 112.607 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 -48.68 65.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.386 1.075 . . . . 2.7799999999999998 111.865 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -61.37 -37.86 84.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.096 0.958 . . . . 2.0099999999999998 113.297 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.59 -16.98 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.333 1.605 . . . . 1.1299999999999999 115.333 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.2 t0 56.47 30.38 17.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.279 1.432 . . . . 2.7200000000000002 114.558 -170.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 14.2 t -107.72 159.88 16.14 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.273 -1.517 . . . . 2.6200000000000001 111.48 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.55 -9.57 26.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.447 1.099 . . . . 2.8799999999999999 111.569 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.0 t -141.92 130.95 23.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.753 2.021 . . . . 3.3700000000000001 111.14 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -163.24 162.08 25.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.571 1.548 . . . . 1.3400000000000001 111.091 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 57.82 76.42 0.21 Allowed Glycine 0 N--CA 1.471 1.013 0 CA-C-N 119.175 0.898 . . . . 2.9500000000000002 113.748 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 23.6 m -68.14 -50.08 56.9 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.637 0.606 . . . . 1.76 112.637 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.1 t -136.85 142.34 42.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.145 0.978 . . . . 1.7 111.424 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.69 147.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 128.202 2.601 . . . . 3.0499999999999998 107.615 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.92 81.05 1.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.173 1.389 . . . . 2.6800000000000002 109.543 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -91.13 137.08 32.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.918 1.822 . . . . 2.4199999999999999 115.918 -168.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -119.05 101.92 8.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.967 3.707 . . . . 2.3599999999999999 106.267 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 21.7 m -99.65 142.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.432 0.901 . . . . 2.6499999999999999 113.432 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 25.7 t -133.65 92.86 22.37 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.764 1.226 . . . . 0.97999999999999998 109.06 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.9 149.37 61.52 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.938 3.092 . . . . 2.27 113.496 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.07 15.38 65.06 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.069 -0.851 . . . . 1.7 114.688 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 t -147.51 -70.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.966 1.383 . . . . 1.9199999999999999 112.159 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 177.52 179.48 47.76 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.662 1.125 . . . . 1.02 112.72 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.51 160.76 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.372 -1.075 . . . . 2.5899999999999999 111.432 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 148.93 50.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.378 1.471 . . . . 0.70999999999999996 111.227 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.8 p -155.81 173.32 16.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.405 1.261 . . . . 0.67000000000000004 114.405 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -119.14 123.68 44.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.531 1.132 . . . . 1.3799999999999999 108.745 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.4 t -106.11 148.31 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.797 1.239 . . . . 2.6299999999999999 110.037 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.8 t -148.71 158.59 44.25 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.153 1.908 . . . . 1.1000000000000001 116.153 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.259 24.8 t-20 -177.67 56.45 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 132.409 4.283 . . . . 2.9900000000000002 106.949 156.5 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.7 -31.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.129 1.772 . . . . 2.5099999999999998 111.964 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.39 21.18 1.53 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.888 1.675 . . . . 7.5599999999999996 110.889 167.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -52.23 -9.83 0.7 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 127.94 2.686 . . . . 3.6800000000000002 119.489 -165.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.5 -7.51 32.86 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.101 1.45 . . . . 5.21 113.269 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 57.7 tp -91.75 -37.83 12.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.601 1.96 . . . . 6.3799999999999999 113.448 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 54.7 t60 -48.57 138.83 10.05 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 118.076 2.621 . . . . 10.220000000000001 118.076 -166.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -146.55 151.49 37.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.373 3.069 . . . . 10.73 110.932 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 43.4 t30 -80.67 -45.04 17.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.478 1.511 . . . . 15.27 109.499 167.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -150.19 140.75 22.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.248 2.619 . . . . 13.9 108.267 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 30.9 m95 -99.47 -42.74 6.81 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.389 0.885 . . . . 15.08 113.389 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -144.03 -8.88 0.7 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 116.444 2.016 . . . . 14.369999999999999 116.444 -165.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.55 112.56 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.103 1.149 . . . . 14.970000000000001 114.103 -162.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.86 -29.06 25.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.6 1.16 . . . . 16.559999999999999 112.362 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.2 -13.28 26.03 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.539 1.136 . . . . 18.77 114.042 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -74.38 -9.39 58.55 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.797 2.839 . . . . 17.25 114.566 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -74.52 55.16 0.63 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.35 1.46 . . . . 17.739999999999998 114.416 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 45.4 pt -143.76 161.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.848 2.459 . . . . 21.75 111.326 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -75.0 146.26 41.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.803 0.841 . . . . 20.23 111.592 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -83.46 5.57 23.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 120.152 3.39 . . . . 20.48 120.152 -164.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1145 ' ' ALA . . . . . 0.423 ' HB1' HD22 ' A' 1147 ' ' LEU . . . -120.91 175.19 6.17 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 120.206 1.366 . . . . 21.850000000000001 113.939 -172.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 8.5 t -143.48 62.41 1.37 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.419 1.488 . . . . 25.219999999999999 112.375 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1147 ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' 1145 ' ' ALA . 1.1 pt? -145.83 147.58 31.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.353 1.612 . . . . 25.239999999999998 115.353 -174.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 50.0 t -114.33 136.06 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.357 1.463 . . . . 27.109999999999999 112.348 -169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 61.22 38.21 16.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.178 1.791 . . . . 30.68 114.735 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 40.8 mm -117.95 115.87 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.323 1.449 . . . . 27.469999999999999 110.754 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.81 148.69 48.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.27 1.028 . . . . 27.440000000000001 113.358 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -74.55 24.67 0.09 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.157 1.783 . . . . 24.5 114.94 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 50.9 m -51.51 -26.59 8.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.446 2.298 . . . . 26.829999999999998 115.605 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -140.94 34.95 1.75 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.093 2.157 . . . . 25.120000000000001 110.885 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.22 113.12 26.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.999 1.319 . . . . 22.890000000000001 108.797 169.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -125.28 162.42 24.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.452 1.501 . . . . 25.59 111.992 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 6.1 t 53.06 -159.79 0.13 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.458 1.903 . . . . 20.989999999999998 114.39 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 79.1 p -118.9 126.7 52.4 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.535 1.934 . . . . 18.710000000000001 112.11 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 8.8 t -156.25 156.71 34.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.199 1.4 . . . . 17.170000000000002 111.478 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 84.9 p -137.51 173.55 11.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.494 1.918 . . . . 14.83 112.07 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 82.6 p -61.02 143.27 55.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.361 -0.837 . . . . 15.539999999999999 112.824 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 36.4 m -74.06 -5.94 44.55 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.167 1.543 . . . . 13.84 115.167 -168.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.2 ptm -49.23 -26.34 2.88 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.539 1.311 . . . . 14.77 114.539 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.08 -20.47 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 114.147 1.165 . . . . 11.73 114.147 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.5 pp -81.14 -37.31 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.574 1.533 . . . . 10.24 111.331 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -71.96 -23.52 61.46 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.997 0.919 . . . . 11.48 112.192 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -72.04 -13.44 61.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.443 1.497 . . . . 9.2200000000000006 114.067 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -112.57 -4.24 14.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.178 1.547 . . . . 7.8499999999999996 115.178 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.56 -33.19 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.29 1.436 . . . . 8.1999999999999993 111.079 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 13.7 p -68.21 -6.86 25.84 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.142 1.534 . . . . 7.3099999999999996 115.142 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -92.24 -5.57 52.19 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 113.968 1.099 . . . . 6.8399999999999999 113.968 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.46 -31.98 70.96 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.205 1.557 . . . . 6.4500000000000002 115.205 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.91 -38.79 76.5 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.079 -1.013 . . . . 7.4100000000000001 112.602 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -83.0 -30.81 27.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.055 1.342 . . . . 5.25 113.444 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.7 127.79 34.98 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.571 0.952 . . . . 5.5 113.571 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.21 -40.63 17.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.125 0.97 . . . . 4.3600000000000003 108.863 166.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -5.5 122.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 130.231 3.412 . . . . 2.1899999999999999 117.376 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.23 110.83 16.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.683 1.593 . . . . 3.1299999999999999 111.554 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.26 117.81 20.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.115 1.366 . . . . 1.21 109.374 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.2 m -136.61 139.81 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 113.044 0.757 . . . . 0.87 113.044 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.1 150.0 43.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.986 1.315 . . . . 0.47999999999999998 112.772 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -147.79 141.39 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.277 1.431 . . . . 0.63 109.92 -173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 147.83 -147.32 17.9 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.178 0.831 . . . . 1.46 115.178 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -68.98 157.9 35.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.384 1.874 . . . . 2.6099999999999999 113.896 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -53.49 -28.11 29.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.268 2.227 . . . . 8.5299999999999994 114.756 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.65 -39.18 87.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.571 1.148 . . . . 4.0499999999999998 113.415 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.69 -21.16 26.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.678 -0.639 . . . . 3.6200000000000001 112.547 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 15.9 mmt -61.83 -34.61 76.25 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.245 -0.909 . . . . 2.1600000000000001 110.592 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 36.2 mt -68.31 -68.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.812 1.245 . . . . 1.79 109.278 168.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -24.5 23.42 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.194 1.924 . . . . 8.5199999999999996 116.194 -172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -76.08 11.92 1.31 Allowed 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 120.841 1.655 . . . . 0.92000000000000004 112.306 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 77.15 15.44 81.59 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 119.966 -1.709 . . . . 0.98999999999999999 114.731 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.65 -178.1 6.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.836 1.318 . . . . 1.1599999999999999 111.248 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 59.9 t -123.37 134.09 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.361 1.465 . . . . 1.28 109.744 170.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -105.6 139.08 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.162 0.985 . . . . 1.02 111.631 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -97.61 160.19 14.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.332 1.453 . . . . 4.1100000000000003 112.705 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.5 -21.22 56.06 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 3.2000000000000002 113.222 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -73.94 -35.29 64.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.377 -0.827 . . . . 3.0499999999999998 112.315 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -74.36 -33.84 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 119.109 -0.472 . . . . 1.05 110.736 168.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -60.27 -37.27 79.94 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.902 0.774 . . . . 2.5800000000000001 111.654 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -64.77 -46.57 81.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.987 1.315 . . . . 2.1299999999999999 112.281 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -41.02 81.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.096 1.358 . . . . 2.7599999999999998 110.646 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 14.1 tpp -64.09 -57.2 10.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.083 1.353 . . . . 0.89000000000000001 111.996 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.6 t -67.27 -30.84 70.82 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.691 0.626 . . . . 1.3700000000000001 112.691 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -58.78 -45.49 89.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.296 -0.877 . . . . 2.77 111.113 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -70.55 -35.78 73.3 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.442 0.904 . . . . 2.29 113.442 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.24 -36.87 83.33 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.47 1.032 . . . . 2.6600000000000001 112.388 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -70.94 -30.49 66.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.867 2.067 . . . . 3.4199999999999999 113.189 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 26.8 mttp -72.3 -4.61 30.7 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.168 1.787 . . . . 2.25 112.578 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.38 3.11 87.12 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.894 1.711 . . . . 1.3899999999999999 115.736 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -98.19 164.59 12.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.781 1.291 . . . . 4.0 111.482 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 50.5 m -72.8 130.65 40.94 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.313 -0.867 . . . . 1.1100000000000001 110.845 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.1 41.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.838 1.655 . . . . 0.60999999999999999 109.642 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -140.33 153.9 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 113.748 1.018 . . . . 0.46999999999999997 113.748 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.68 162.65 12.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.173 1.389 . . . . 0.97999999999999998 111.642 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 12.0 t -131.73 129.37 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.562 1.545 . . . . 1.96 110.272 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -127.7 148.33 50.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.554 1.141 . . . . 0.58999999999999997 111.039 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.7 m -148.14 130.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.683 0.793 . . . . 0.82999999999999996 111.093 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.56 51.92 2.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.802 1.641 . . . . 3.0 112.879 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 12.6 m-20 60.56 33.27 20.48 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.795 2.038 . . . . 1.79 115.551 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -133.95 137.31 44.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.864 1.665 . . . . 2.4500000000000002 111.518 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1222 ' ' LEU . . . . . 0.585 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -75.02 115.87 15.13 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.059 -1.026 . . . . 1.3999999999999999 110.702 171.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.3 p -103.99 -30.16 10.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.727 -1.13 . . . . 0.64000000000000001 113.676 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -177.57 -169.6 38.82 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.753 1.615 . . . . 0.64000000000000001 115.88 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.69 153.71 43.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.687 1.595 . . . . 0.72999999999999998 112.54 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.09 133.73 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.77000000000000002 109.896 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.24 133.96 51.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 110.733 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 41.3 mm -102.54 171.73 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 125.433 1.493 . . . . 2.0 110.469 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -149.47 -167.21 2.76 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 1.77 111.912 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -117.61 142.73 46.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.006 2.123 . . . . 5.75 111.692 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 125.069 1.348 . . . . 6.1200000000000001 113.961 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.216 -0.29 . . . . 10.449999999999999 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 89.0 t80 -123.39 124.72 43.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.146 1.378 . . . . 14.52 110.471 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 2.6 m 63.87 131.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.59 2.356 . . . . 8.9199999999999999 112.531 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 58.2 ttp -79.35 -54.05 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.233 -0.917 . . . . 7.4400000000000004 112.704 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 29.9 m80 -78.02 -38.77 43.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.612 0.765 . . . . 5.5099999999999998 111.988 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -76.5 90.61 0.94 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.167 1.365 . . . . 2.54 112.742 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 108.93 48.42 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.73 1.212 . . . . 2.4900000000000002 113.272 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.77 143.82 79.07 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.187 2.592 . . . . 2.46 113.091 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 26.9 m -122.04 129.92 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.401 1.081 . . . . 2.6299999999999999 111.527 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -73.91 128.39 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.212 -0.93 . . . . 1.1499999999999999 110.968 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -105.88 -45.15 4.44 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.08 1.352 . . . . 2.7999999999999998 112.443 -169.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -155.31 160.83 41.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.627 1.571 . . . . 3.0299999999999998 112.485 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.4 m -127.63 142.33 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.008 1.323 . . . . 0.94999999999999996 111.525 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 28.9 tttt -140.37 146.9 39.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.185 0.994 . . . . 1.8999999999999999 112.861 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 39.6 t -84.83 154.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.374 1.469 . . . . 1.05 111.106 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.0 tp -120.85 -33.06 3.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.917 1.687 . . . . 0.87 111.968 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1063 ' ' THR . . . . . 0.41 HG23 ' H ' ' A' 1068 ' ' ILE . 5.0 t -87.24 32.9 0.68 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.197 1.399 . . . . 2.3500000000000001 113.846 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -59.12 122.0 12.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.795 1.238 . . . . 3.9300000000000002 110.853 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 66.7 m 50.92 32.51 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.816 1.413 . . . . 3.6899999999999999 114.816 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -132.6 -21.65 2.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.205 1.402 . . . . 3.8999999999999999 114.514 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -157.49 -56.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.625 1.557 . . . . 4.3899999999999997 114.973 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1068 ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' 1063 ' ' THR . 31.8 mt -137.61 155.6 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.453 1.901 . . . . 1.51 110.707 -167.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 75.0 m -117.31 166.69 12.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.786 1.634 . . . . 2.3999999999999999 114.078 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.7 p80 -57.95 -43.21 86.23 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.834 2.161 . . . . 2.9900000000000002 116.834 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -72.87 -28.3 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.477 1.035 . . . . 2.5699999999999998 111.626 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -71.1 -48.61 51.41 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.444 -0.785 . . . . 3.4500000000000002 110.934 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.19 -46.67 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.842 0.857 . . . . 0.69999999999999996 111.621 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.4 -34.38 77.82 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.04 0.836 . . . . 0.78000000000000003 112.048 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.13 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.639 -0.696 . . . . 0.83999999999999997 112.416 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.78 -26.86 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.493 1.042 . . . . 0.68999999999999995 113.315 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 94.6 t -71.32 -44.18 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.094 0.861 . . . . 0.92000000000000004 110.521 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.48 96.53 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.555 -0.716 . . . . 0.60999999999999999 113.778 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 72.7 p -74.06 -37.84 64.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.701 1.25 . . . . 0.73999999999999999 112.904 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.46 -51.14 69.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.741 0.816 . . . . 0.75 111.949 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.78 -21.88 62.45 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.648 -0.657 . . . . 2.0899999999999999 112.703 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 67.5 m -62.76 -21.45 65.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.501 -1.374 . . . . 2.25 112.806 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 2.53 50.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.513 1.525 . . . . 2.98 112.969 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 6.4 t -107.37 -179.59 3.97 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 1.5700000000000001 113.758 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -136.45 32.9 2.78 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.529 2.732 . . . . 4.4699999999999998 111.714 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -97.01 154.69 38.11 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.051 1.34 . . . . 1.6000000000000001 113.61 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.21 -27.54 1.83 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.206 2.604 . . . . 1.1399999999999999 114.939 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.0 tt -100.17 -48.09 4.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.563 0.745 . . . . 0.87 111.709 -167.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -68.53 -30.24 73.05 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 114.55 0.58 . . . . 0.85999999999999999 114.55 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 61.1 p -67.14 -11.01 56.1 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.649 -1.501 . . . . 1.5 113.956 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.38 78.64 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.97 0.908 . . . . 0.68000000000000005 111.012 167.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.08 -32.67 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.42 1.088 . . . . 1.4399999999999999 110.866 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 52.0 m -53.16 -49.41 66.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 119.562 1.074 . . . . 1.1899999999999999 112.285 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -65.96 -46.29 78.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.086 0.857 . . . . 2.5600000000000001 112.543 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.14 -44.19 71.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.439 1.096 . . . . 1.9199999999999999 111.457 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.9 t -70.44 -55.41 9.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.793 1.237 . . . . 1.79 111.832 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -53.65 -47.12 70.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.299 0.954 . . . . 2.9900000000000002 112.251 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -72.48 -28.76 63.1 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.78 0.659 . . . . 4.1500000000000004 112.78 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -70.2 -46.1 65.26 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.184 0.902 . . . . 2.6000000000000001 112.773 172.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -25.67 62.5 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.804 1.039 . . . . 1.1499999999999999 113.804 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.47 17.98 0.41 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.667 2.387 . . . . 2.4399999999999999 114.624 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 4.5 t -82.59 -7.79 59.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.417 2.287 . . . . 4.1299999999999999 113.979 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 17.5 tt0 63.05 -27.11 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 129.27 3.028 . . . . 4.29 116.819 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.7 t -144.51 130.45 19.35 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.914 1.234 . . . . 2.7599999999999998 112.368 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.88 154.25 41.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.202 1.401 . . . . 1.0 113.091 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.6 171.46 36.57 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.405 1.479 . . . . 1.4299999999999999 115.214 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 17.9 m -150.23 -70.5 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.873 -1.369 . . . . 1.29 113.978 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1108 ' ' CYS . . . . . 0.423 ' O ' HD12 ' A' 1109 ' ' ILE . 37.6 t -138.3 139.42 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.959 1.254 . . . . 1.3200000000000001 112.478 -172.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1109 ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' 1108 ' ' CYS . 1.7 mp -140.89 140.8 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 131.668 3.987 . . . . 2.6699999999999999 106.086 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.283 0.0 OUTLIER -100.76 -13.11 18.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.943 1.831 . . . . 3.1000000000000001 115.943 -174.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 5.5 t80 54.54 86.01 0.05 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 129.346 3.059 . . . . 2.71 118.929 166.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.91 102.65 11.82 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.289 1.835 . . . . 2.46 109.067 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 84.8 t -99.83 138.88 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.313 1.045 . . . . 1.9399999999999999 111.589 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.9 t -131.82 124.45 19.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.651 1.18 . . . . 1.0900000000000001 110.989 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.3 140.97 34.68 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.884 2.39 . . . . 1.73 112.507 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 63.16 21.19 63.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.323 0.963 . . . . 1.9399999999999999 114.992 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 99.7 m -139.25 -62.69 0.53 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.969 1.708 . . . . 2.2400000000000002 111.897 -169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.67 -173.35 34.4 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.397 1.475 . . . . 0.70999999999999996 112.01 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.64 158.74 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 122.005 -0.703 . . . . 2.54 111.551 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 27.5 t -132.65 151.63 51.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.422 1.489 . . . . 0.46000000000000002 110.634 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -160.57 172.9 16.35 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.081 -1.012 . . . . 0.84999999999999998 113.317 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -113.65 124.1 51.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.59 1.156 . . . . 1.1599999999999999 108.248 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.8 m -122.39 131.74 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 113.602 0.964 . . . . 2.27 113.602 -170.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -118.68 153.37 34.47 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.757 1.021 . . . . 0.97999999999999998 113.757 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -175.23 -26.03 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.355 3.862 . . . . 2.3999999999999999 108.343 161.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 33.2 pt -46.62 -26.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.482 1.913 . . . . 2.5 115.286 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -146.92 40.65 1.07 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.796 1.239 . . . . 4.4699999999999998 110.055 166.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -77.98 10.29 27.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.413 1.959 . . . . 4.3499999999999996 115.313 -170.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 0.07 0.62 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.882 2.073 . . . . 4.6500000000000004 114.781 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 15.0 tp -86.9 -80.68 0.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.852 1.661 . . . . 6.3499999999999996 113.422 -167.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 21.8 t-80 60.99 161.93 0.06 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.325 1.85 . . . . 7.71 112.844 -166.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.95 148.0 25.52 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.48 -1.388 . . . . 9.8499999999999996 110.265 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.54 72.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.422 0.897 . . . . 13.59 113.422 -173.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 59.01 157.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.262 2.625 . . . . 11.94 115.516 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 68.2 m95 -140.68 -163.9 1.62 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.428 1.891 . . . . 14.970000000000001 110.81 -171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -51.43 -27.49 10.35 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.346 2.259 . . . . 15.85 115.878 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 72.5 mt 29.79 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 129.897 3.279 . . . . 13.449999999999999 114.761 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -72.21 -30.34 64.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.245 1.018 . . . . 15.25 113.62 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.55 -22.66 66.72 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.216 -0.928 . . . . 13.25 112.663 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -83.89 -14.79 50.21 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.793 2.037 . . . . 14.52 114.109 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.77 142.01 55.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.316 1.046 . . . . 16.050000000000001 111.352 173.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.09 160.24 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.138 1.162 . . . . 19.949999999999999 114.138 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -144.2 145.53 32.13 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.778 1.631 . . . . 18.390000000000001 111.707 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -74.69 -23.04 58.56 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.112 0.965 . . . . 22.379999999999999 112.716 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . 0.282 . . 63.93 26.49 14.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.557 2.343 . . . . 19.920000000000002 116.49 170.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 7.0 t -168.52 156.7 8.28 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.237 0.828 . . . . 23.57 113.237 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.65 21.78 2.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.395 1.878 . . . . 27.23 113.16 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 11.3 m -143.97 160.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.145 1.778 . . . . 27.829999999999998 112.099 -171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -131.04 150.11 52.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.316 1.846 . . . . 31.629999999999999 109.645 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 1.5 mp 45.07 52.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.343 1.457 . . . . 33.469999999999999 111.25 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 18.1 t0 -69.39 154.07 42.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.845 1.658 . . . . 29.800000000000001 112.019 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -73.12 21.43 0.07 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.113 1.365 . . . . 30.280000000000001 112.923 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 83.7 p 50.54 40.6 23.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.466 1.906 . . . . 28.609999999999999 113.02 -168.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -176.98 3.44 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.192 0.997 . . . . 28.43 111.884 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 23.1 tt0 63.74 58.65 1.24 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.79 1.636 . . . . 25.640000000000001 112.3 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -69.5 -10.47 58.19 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.578 -1.326 . . . . 28.440000000000001 113.22 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 23.3 t -152.11 143.93 23.67 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.125 1.37 . . . . 23.469999999999999 111.695 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 89.8 p -147.63 154.84 41.15 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.396 1.079 . . . . 21.050000000000001 112.853 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 70.9 p -87.77 171.51 10.35 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.36 1.464 . . . . 20.109999999999999 112.166 172.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 4.7 t -144.21 135.0 25.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.27 0.841 . . . . 17.129999999999999 113.27 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 8.4 t -53.35 154.31 3.42 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.696 1.998 . . . . 18.57 112.664 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 19.5 m -75.85 -40.82 53.97 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 117.872 -1.061 . . . . 14.94 112.748 -173.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 38.9 mtt 63.0 168.05 0.13 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.963 2.505 . . . . 15.17 116.707 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.14 25.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.307 2.243 . . . . 14.039999999999999 114.882 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.62 -9.87 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.98 1.712 . . . . 12.880000000000001 113.602 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.46 -9.76 4.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.234 1.414 . . . . 12.49 113.849 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -46.44 -41.15 13.4 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.562 0.745 . . . . 11.0 111.307 165.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -68.64 -24.1 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.462 1.282 . . . . 8.7799999999999994 114.462 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 57.2 mt -76.43 -39.03 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.256 1.022 . . . . 8.8800000000000008 109.147 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 3.1 t -64.58 -31.48 72.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.058 0.943 . . . . 10.51 111.517 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 24.2 t30 -68.0 -54.86 15.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.453 0.701 . . . . 8.9600000000000009 110.864 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.86 62.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.457 1.28 . . . . 6.0999999999999996 114.457 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 7.8 tt -51.26 -48.5 62.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.84 1.656 . . . . 10.16 112.863 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -104.81 -29.43 10.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.317 1.228 . . . . 5.8799999999999999 114.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -94.83 74.98 3.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.706 1.202 . . . . 4.4500000000000002 109.948 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -45.44 146.36 1.03 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.302 1.441 . . . . 3.75 114.42 -170.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.08 128.65 46.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.646 1.35 . . . . 2.1699999999999999 114.646 -169.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.52 128.68 33.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.644 1.177 . . . . 2.3700000000000001 108.807 168.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.1 tttt -81.78 126.03 31.36 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 107.48 -1.304 . . . . 1.8400000000000001 107.48 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -133.31 138.08 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.786 0.835 . . . . 0.76000000000000001 111.3 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 153.15 46.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.308 1.043 . . . . 0.46999999999999997 112.7 172.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.9 tt -147.96 139.89 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.32 1.448 . . . . 0.51000000000000001 109.135 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.45 -172.34 44.85 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.735 1.054 . . . . 1.3600000000000001 115.735 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 24.8 p30 -81.08 158.97 24.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.441 1.096 . . . . 2.29 113.16 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -45.53 -51.77 11.35 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.006 1.484 . . . . 5.3399999999999999 115.006 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -74.29 -34.45 63.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.042 1.292 . . . . 4.5199999999999996 112.671 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 36.7 t90 -68.69 -40.9 79.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.031 -1.043 . . . . 3.1899999999999999 111.468 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 91.1 mmm -63.82 -32.9 74.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.698 0.799 . . . . 2.8900000000000001 112.735 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.67 -63.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.504 1.522 . . . . 2.3100000000000001 109.047 167.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -47.4 -8.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.887 2.075 . . . . 6.8399999999999999 116.565 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -83.63 13.17 4.85 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 121.459 1.936 . . . . 1.0900000000000001 112.517 168.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 70.02 37.23 73.51 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 119.755 -1.841 . . . . 0.94999999999999996 114.675 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.95 167.49 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.81000000000000005 112.766 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.2 t -105.47 114.49 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.835 1.254 . . . . 1.9399999999999999 109.71 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.18 146.04 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.841 1.257 . . . . 1.3799999999999999 110.511 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -117.84 171.3 8.15 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.284 1.034 . . . . 3.1200000000000001 112.732 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -71.07 -40.26 71.7 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.968 1.47 . . . . 3.1499999999999999 114.968 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.15 -28.36 54.14 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.912 -1.118 . . . . 2.6200000000000001 113.563 -170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 7.5 p -72.04 -43.74 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.608 1.163 . . . . 1.26 111.878 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.4 t30 -66.89 -38.92 87.18 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.53 0.567 . . . . 2.3199999999999998 112.53 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.5 -44.14 84.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.57 0.582 . . . . 2.02 112.57 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 17.1 t80 -68.16 -45.08 74.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.148 0.979 . . . . 2.4500000000000002 111.684 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.5 ttm -60.81 -46.91 88.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.974 0.91 . . . . 1.76 112.502 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.4 t -74.76 -33.9 62.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.051 0.541 . . . . 1.2 112.446 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.64 -44.85 85.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.22 1.008 . . . . 2.98 111.823 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -69.59 -45.77 67.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.794 1.637 . . . . 3.4300000000000002 112.326 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.63 -32.77 74.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.955 -1.09 . . . . 3.98 112.017 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -71.26 -22.96 61.9 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.332 1.234 . . . . 4.25 114.332 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 15.6 mttp -76.04 -0.61 22.35 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.387 1.075 . . . . 2.9900000000000002 112.56 167.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.43 16.54 68.6 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.882 1.706 . . . . 1.21 113.951 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -117.8 132.32 56.46 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.376 1.47 . . . . 4.5 109.619 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 96.4 m -65.42 137.37 57.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -167.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -133.16 119.08 19.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.506 1.123 . . . . 0.75 111.475 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.3 m -132.97 157.98 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.339 1.456 . . . . 0.42999999999999999 113.03 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.16 156.68 21.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.833 1.653 . . . . 1.23 111.53 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.6 p -132.12 133.95 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.401 1.48 . . . . 2.3900000000000001 111.236 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -135.08 153.34 52.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.962 1.705 . . . . 0.48999999999999999 111.405 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.56 135.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.90000000000000002 112.541 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 48.8 m-20 42.3 48.82 4.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.754 1.621 . . . . 2.7200000000000002 112.832 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 57.3 m-20 55.6 33.94 22.18 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.951 2.1 . . . . 2.5 115.497 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.69 141.48 49.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.081 2.552 . . . . 2.0800000000000001 110.145 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.43 130.9 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 119.85 -1.781 . . . . 0.79000000000000004 112.444 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 22.3 p -108.22 -35.3 6.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.599 -1.191 . . . . 0.80000000000000004 114.081 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -173.23 -167.07 32.57 Favored Glycine 0 N--CA 1.475 1.277 0 CA-C-N 120.7 1.591 . . . . 0.58999999999999997 116.447 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.84 154.7 44.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.475 1.91 . . . . 0.81000000000000005 112.481 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.4 137.33 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.932 1.693 . . . . 0.81999999999999995 109.708 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.53 137.49 46.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.873 1.669 . . . . 0.68000000000000005 110.351 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.18 151.7 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.877 1.671 . . . . 1.45 110.843 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -124.18 -170.0 2.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.268 1.427 . . . . 1.47 112.666 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.283 2.7 t70 68.78 -140.94 0.09 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.965 2.106 . . . . 4.9299999999999997 111.81 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.255 1.376 0 N-CA-C 116.689 2.107 . . . . 9.3800000000000008 116.689 -167.898 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.522 -0.177 . . . . 11.56 110.522 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -117.88 172.33 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.64 1.176 . . . . 10.77 112.645 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 84.3 m -52.95 -50.87 63.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.078 1.751 . . . . 7.3899999999999997 113.086 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 2.3 ttp 64.05 -8.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 117.32 2.341 . . . . 10.08 117.32 170.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -50.56 -58.2 6.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.652 1.569 . . . . 9.5099999999999998 114.199 -171.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -94.76 69.53 1.19 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.1 0.857 . . . . 4.21 112.337 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.5 p -117.09 149.06 43.62 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.513 1.525 . . . . 3.04 113.499 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.22 148.6 77.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.324 2.016 . . . . 2.1899999999999999 113.676 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.5 p -120.33 124.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.039 1.735 . . . . 2.4399999999999999 110.396 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.251 13.1 p -72.12 130.63 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.309 -0.869 . . . . 1.1599999999999999 110.296 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.54 -40.81 4.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.446 1.276 . . . . 2.3100000000000001 114.446 -166.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -157.64 146.3 19.41 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.183 0.593 . . . . 1.9399999999999999 112.08 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 28.1 m -126.86 144.24 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.549 1.14 . . . . 1.0800000000000001 112.11 169.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 72.7 tttt -134.77 141.76 46.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.119 1.368 . . . . 1.8200000000000001 110.962 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 49.7 t -92.03 134.36 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.484 1.114 . . . . 0.72999999999999998 110.778 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1062 ' ' LEU . . . . . 0.488 HD23 HD22 ' A' 1222 ' ' LEU . 9.7 tp -99.21 -65.27 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.906 2.082 . . . . 0.89000000000000001 111.022 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 38.1 m -78.63 75.02 5.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.481 -1.303 . . . . 1.72 107.481 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.63 123.97 29.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.274 1.03 . . . . 3.9399999999999999 109.016 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 70.7 m 60.71 174.76 0.1 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.0 1.482 . . . . 3.6600000000000001 115.0 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 64.63 -0.03 1.03 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.612 2.449 . . . . 4.2599999999999998 117.612 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -147.57 -44.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.803 1.241 . . . . 5.0499999999999998 112.634 167.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mm -130.09 163.9 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.943 1.697 . . . . 1.9199999999999999 109.614 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 20.4 m -119.35 145.59 46.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.818 1.647 . . . . 2.3700000000000001 111.109 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -49.79 -51.35 40.13 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.797 1.777 . . . . 4.7199999999999998 115.797 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 72.8 m80 -74.25 -14.32 60.9 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.969 1.259 . . . . 4.71 112.804 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.94 -37.97 33.36 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.944 -1.027 . . . . 3.46 111.493 168.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.91 -54.34 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.32 0.964 . . . . 0.69999999999999996 110.13 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.19 -32.27 72.39 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.643 -0.66 . . . . 0.72999999999999998 112.332 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.98 83.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.65 0.659 . . . . 0.72999999999999998 112.576 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.36 -29.42 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.916 -1.115 . . . . 0.68999999999999995 113.427 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.3 t -69.2 -52.35 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.289 0.949 . . . . 0.70999999999999996 111.107 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.01 -35.87 91.23 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.791 -0.568 . . . . 0.68999999999999995 113.17 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 36.2 p -71.66 -36.0 70.52 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.523 1.161 . . . . 0.70999999999999996 112.693 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.31 -49.36 67.3 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.901 0.773 . . . . 0.69999999999999996 112.846 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -72.08 -15.17 62.01 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 121.366 -0.834 . . . . 2.02 112.715 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.3 t -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.42 -2.05 . . . . 1.28 112.493 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.98 2.04 55.59 Favored 'General case' 0 CA--C 1.557 1.227 0 O-C-N 121.073 -1.017 . . . . 2.1299999999999999 113.007 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 57.8 m -103.59 167.24 9.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.621 1.569 . . . . 1.72 114.224 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.26 12.34 7.62 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.084 1.754 . . . . 3.4700000000000002 112.585 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -71.63 148.25 92.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.602 -1.311 . . . . 2.2000000000000002 113.141 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.95 -31.35 31.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.226 2.617 . . . . 1.1299999999999999 114.631 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.4 -51.45 3.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.168 1.387 . . . . 0.89000000000000001 111.793 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -57.12 -34.68 67.05 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.454 0.55 . . . . 1.1000000000000001 113.514 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.1 p -61.25 -14.5 26.58 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.869 -1.371 . . . . 1.3 114.477 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.09 82.94 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.758 -1.214 . . . . 0.89000000000000001 111.713 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.12 -39.27 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.397 1.479 . . . . 0.81000000000000005 109.774 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 24.3 m -57.44 -44.39 84.68 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 117.934 -1.032 . . . . 1.3400000000000001 112.552 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.27 -47.38 79.77 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.066 1.303 . . . . 2.3799999999999999 112.091 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.69 -43.12 76.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.903 0.481 . . . . 1.6200000000000001 111.433 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 94.7 m -69.16 -49.91 52.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.934 1.293 . . . . 2.9300000000000002 112.389 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -49.9 -48.7 51.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.375 1.47 . . . . 3.5800000000000001 111.534 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.93 -38.91 72.93 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.591 0.756 . . . . 2.7200000000000002 112.388 175.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.3 -36.2 81.04 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.485 1.039 . . . . 2.3500000000000001 112.756 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 5.4 mt -72.42 -9.21 58.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.83 1.252 . . . . 1.1599999999999999 114.0 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.04 50.82 18.33 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.029 1.332 . . . . 3.5800000000000001 111.887 -170.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.9 t -138.45 168.73 19.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.385 1.074 . . . . 2.8300000000000001 112.502 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -102.62 -17.61 15.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.875 1.67 . . . . 3.8300000000000001 111.26 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.6 t -136.89 130.64 31.99 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.865 -1.147 . . . . 2.8700000000000001 113.574 -168.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.86 159.14 32.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.591 1.556 . . . . 1.02 110.169 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 76.44 127.82 0.28 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.931 0.777 . . . . 1.3999999999999999 114.13 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 53.2 m -123.73 -71.17 0.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 1.4199999999999999 112.709 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 4.4 t -135.44 143.19 45.78 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.096 1.316 . . . . 1.5800000000000001 112.509 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1109 ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' 1121 ' ' CYS . 5.1 tp -132.35 163.48 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 1 C-N-CA 132.413 4.285 . . . . 2.6000000000000001 109.416 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.06 86.4 1.92 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.214 1.806 . . . . 2.6899999999999999 106.176 166.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -93.63 147.9 22.59 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.699 2.111 . . . . 3.5699999999999998 116.699 -164.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -137.92 118.47 13.91 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.332 2.253 . . . . 2.1299999999999999 109.133 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 17.0 t -112.73 140.63 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.391 1.076 . . . . 1.8999999999999999 113.867 -168.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 92.7 t -139.71 117.0 8.42 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 127.025 2.13 . . . . 1.0700000000000001 107.472 167.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.22 144.24 50.98 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.66 2.24 . . . . 1.5600000000000001 112.361 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.06 1.41 12.69 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.099 1.2 . . . . 1.6799999999999999 116.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 1.3 m -136.8 -30.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.686 1.736 . . . . 2.6899999999999999 115.686 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.66 168.33 19.2 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 121.337 1.88 . . . . 0.83999999999999997 116.888 168.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 137.35 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.808 1.243 . . . . 1.9299999999999999 109.911 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 39.3 t -126.67 144.87 50.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.614 1.565 . . . . 0.47999999999999998 109.785 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1121 ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' 1109 ' ' ILE . 30.1 p -154.1 174.55 14.57 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.765 1.024 . . . . 0.67000000000000004 113.765 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -116.77 123.5 47.29 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.215 -2.143 . . . . 1.4099999999999999 105.215 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.56 144.73 24.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 118.771 0.714 . . . . 2.0 110.807 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1124 ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.5 t -134.3 155.5 50.11 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.134 1.531 . . . . 1.0 115.134 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.28 15.2 t-20 179.7 57.75 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 1 C-N-CA 132.991 4.516 . . . . 2.75 104.918 158.843 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 2.1 pt -146.28 -72.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.072 2.549 . . . . 3.1200000000000001 110.292 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -140.69 -11.38 1.02 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.93 1.826 . . . . 4.4000000000000004 115.93 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -62.3 8.73 0.16 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 117.735 1.854 . . . . 5.6799999999999997 117.735 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.8 pp -87.63 0.22 55.96 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 128.282 2.633 . . . . 5.1100000000000003 114.778 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 4.3 tt -58.08 -49.5 76.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.539 1.136 . . . . 5.4000000000000004 111.809 -170.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 31.2 m170 57.7 172.74 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.756 2.022 . . . . 7.9299999999999997 115.813 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -89.09 151.27 22.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.128 1.371 . . . . 14.27 109.268 165.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.29 123.69 28.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.035 0.934 . . . . 15.06 109.038 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -81.14 72.6 8.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.81 0.844 . . . . 12.51 113.002 -167.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.13 -40.29 1.32 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.636 1.717 . . . . 19.079999999999998 115.636 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -123.47 5.7 8.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.525 1.53 . . . . 15.91 112.918 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.49 114.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.491 1.116 . . . . 13.57 110.981 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.68 -22.64 34.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.404 1.082 . . . . 18.77 111.782 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.87 -15.92 63.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.522 1.129 . . . . 15.539999999999999 113.717 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.41 48.41 0.9 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.56 2.344 . . . . 15.02 113.628 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -135.39 158.71 43.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.665 1.986 . . . . 17.84 110.114 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 6.6 pt -79.64 132.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.76 1.392 . . . . 18.800000000000001 114.76 -171.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -137.37 146.87 45.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.23 3.012 . . . . 17.300000000000001 108.216 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 18.7 t30 -81.25 60.54 4.39 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 118.974 2.953 . . . . 19.719999999999999 118.974 -163.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -117.37 123.24 45.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.402 1.081 . . . . 16.530000000000001 108.944 166.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 3.3 t 61.47 160.84 0.06 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.272 1.429 . . . . 17.760000000000002 114.606 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.9 mm? 45.48 44.1 9.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.355 1.462 . . . . 20.109999999999999 110.085 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 57.2 t -59.04 120.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.248 1.419 . . . . 22.140000000000001 112.109 -166.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -148.64 148.04 29.63 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.146 1.378 . . . . 24.809999999999999 110.802 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.89 -44.13 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.783 1.633 . . . . 27.93 110.853 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -136.53 10.76 3.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.221 1.408 . . . . 31.359999999999999 113.509 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -89.06 -25.58 21.86 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.332 1.234 . . . . 30.02 114.332 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 21.5 t 41.33 56.33 3.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.368 1.867 . . . . 30.989999999999998 112.621 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -93.65 -38.95 11.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.82 0.848 . . . . 28.949999999999999 112.255 -169.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -130.88 155.87 46.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.04 0.936 . . . . 26.809999999999999 112.74 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.85 -16.44 11.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.75 2.02 . . . . 32.469999999999999 113.641 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 3.6 t -152.75 33.28 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.723 1.379 . . . . 24.93 114.723 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.25 99.4 p -96.51 -119.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.049 -1.032 . . . . 21.850000000000001 111.237 171.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 4.2 p 60.51 172.23 0.09 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 126.828 2.051 . . . . 19.140000000000001 116.201 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 48.8 m -109.12 20.22 18.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.24 2.216 . . . . 16.469999999999999 112.014 168.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 1.3 t -128.22 -8.03 5.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.446 1.276 . . . . 15.52 114.446 -169.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 90.7 p -104.22 -22.57 13.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.609 1.564 . . . . 17.579999999999998 114.938 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 9.3 ptt? -76.75 33.92 0.14 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.993 1.849 . . . . 15.130000000000001 115.993 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . 0.262 4.0 mt 64.12 28.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 127.45 2.3 . . . . 13.25 112.563 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -17.76 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 116.843 2.164 . . . . 11.609999999999999 116.843 -169.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.85 -17.75 2.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.362 1.245 . . . . 9.9499999999999993 114.362 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -58.62 -19.39 38.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.716 1.207 . . . . 8.1099999999999994 113.409 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -92.67 -7.73 46.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.471 1.908 . . . . 8.2300000000000004 115.176 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.33 -40.16 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.047 0.839 . . . . 7.3200000000000003 111.159 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 94.6 p -54.05 -27.31 31.53 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.008 1.114 . . . . 6.2999999999999998 114.008 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -87.53 -6.92 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.94 1.696 . . . . 6.7199999999999998 113.557 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.93 31.47 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.26 1.424 . . . . 4.5300000000000002 114.528 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 10.4 tt -45.96 -38.4 7.6 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.931 1.292 . . . . 6.9800000000000004 113.675 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 28.8 m120 -100.02 -34.92 9.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.694 1.597 . . . . 5.46 112.609 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -89.18 50.57 1.96 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.538 1.935 . . . . 4.0300000000000002 111.768 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -50.15 143.35 8.43 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.906 1.447 . . . . 3.5499999999999998 114.906 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1177 ' ' GLN . . . . . 0.467 ' HG2' ' HB ' ' A' 1124 ' ' THR . 54.4 mt-30 -138.82 173.91 11.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.398 2.279 . . . . 1.9399999999999999 111.276 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.46 127.34 53.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.675 1.19 . . . . 2.79 108.577 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -86.64 123.36 31.74 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.751 -0.833 . . . . 1.53 108.751 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -132.77 139.54 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.289 0.495 . . . . 0.79000000000000004 111.934 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.16 147.51 36.75 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.564 1.146 . . . . 0.57999999999999996 112.471 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.9 tt -141.59 138.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.302 1.441 . . . . 0.48999999999999999 108.717 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 171.82 -166.85 39.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 117.142 1.617 . . . . 1.4099999999999999 117.142 -174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.31 162.76 17.21 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.362 3.065 . . . . 2.4900000000000002 111.895 -169.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -44.21 -65.09 0.55 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.344 1.609 . . . . 7.8200000000000003 115.344 -167.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.42 -34.3 70.21 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.863 1.21 . . . . 3.25 113.765 -171.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -68.99 -27.88 66.1 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.005 -1.059 . . . . 2.8700000000000001 112.443 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 55.2 tpp -70.69 -42.88 70.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.103 0.561 . . . . 2.1400000000000001 112.292 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 97.4 mt -49.3 -61.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 109.504 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -51.31 -11.57 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.071 2.249 . . . . 6.1900000000000004 117.071 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.28 15.49 0.44 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 121.988 2.176 . . . . 0.87 111.254 166.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.13 11.71 81.69 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 119.354 -2.091 . . . . 0.76000000000000001 114.589 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.82 159.68 25.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.902 1.351 . . . . 0.80000000000000004 111.306 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 74.1 t -94.23 122.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.352 . . . . 1.01 109.612 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.4 tt -96.48 132.25 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.245 1.018 . . . . 1.1699999999999999 110.277 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -93.21 153.9 18.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.521 1.128 . . . . 4.0199999999999996 112.879 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.88 -32.9 73.3 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.156 -0.965 . . . . 2.7999999999999998 112.997 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.91 -44.65 80.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.922 0.889 . . . . 2.6800000000000002 112.139 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.9 p -73.4 -31.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.347 -0.846 . . . . 1.03 111.72 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -64.15 -38.68 91.93 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.898 1.227 . . . . 2.2400000000000002 111.624 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.75 -33.69 75.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.955 0.902 . . . . 2.5099999999999998 112.151 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.75 -44.3 81.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.025 1.73 . . . . 2.6099999999999999 112.096 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 27.0 tpp -62.59 -50.37 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.26 1.424 . . . . 0.81999999999999995 110.73 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.0 t -72.23 -30.9 65.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.819 0.674 . . . . 1.02 112.819 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.63 -51.77 67.43 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.042 1.292 . . . . 2.5600000000000001 112.234 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.52 -30.9 68.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.868 0.692 . . . . 2.6299999999999999 112.868 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.1 -41.27 90.85 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 121.357 -0.839 . . . . 2.5699999999999998 111.884 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.37 -22.73 61.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 114.232 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 22.3 mttp -73.13 -5.35 38.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.077 2.151 . . . . 2.52 114.406 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 96.68 9.88 55.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.128 1.347 . . . . 1.79 115.246 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -113.73 -176.94 3.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.332 1.453 . . . . 3.3300000000000001 111.53 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.6 m -102.53 138.35 39.57 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.091 1.756 . . . . 0.93999999999999995 111.023 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.56 127.77 35.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.985 1.314 . . . . 0.55000000000000004 111.431 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.4 m -140.14 159.6 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.358 1.063 . . . . 0.55000000000000004 112.965 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.44 155.04 21.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.895 1.678 . . . . 1.1399999999999999 110.942 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.1 p -132.86 130.32 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.48 1.112 . . . . 2.0099999999999998 112.61 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.46 154.59 46.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.944 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.7 m -148.72 130.05 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.462 0.705 . . . . 0.83999999999999997 112.416 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 9.5 m-20 41.35 43.61 2.15 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 3.2000000000000002 112.853 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.312 14.8 m-20 68.86 30.63 4.63 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 117.095 2.258 . . . . 2.2799999999999998 117.095 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.71 141.16 50.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.225 1.81 . . . . 2.5600000000000001 109.871 165.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1222 ' ' LEU . . . . . 0.488 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -78.74 109.75 13.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.73 -1.231 . . . . 1.5700000000000001 111.077 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -94.42 -27.59 15.95 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.027 -1.046 . . . . 0.51000000000000001 112.771 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.27 -176.29 40.96 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 116.336 1.294 . . . . 0.44 116.336 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.39 154.31 45.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.461 1.904 . . . . 0.69999999999999996 111.905 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 4.0 mt -136.78 135.61 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.917 1.287 . . . . 1.5700000000000001 110.62 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.39 137.83 45.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.058 1.343 . . . . 0.68000000000000005 110.678 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.25 145.65 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.163 1.785 . . . . 1.6399999999999999 108.925 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -112.01 124.82 53.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.218 1.007 . . . . 1.5700000000000001 111.618 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 37.1 t0 -73.38 144.05 46.57 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.23 -0.919 . . . . 3.8100000000000001 111.574 172.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.403 1.481 . . . . 4.1600000000000001 112.315 175.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.431 0.158 . . . . 11.6 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 43.5 p90 -81.28 155.49 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.299 1.44 . . . . 11.01 113.354 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 29.4 m -130.81 146.88 52.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.621 1.968 . . . . 8.0800000000000001 109.486 171.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 8.9 tpt -108.58 94.11 4.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.204 1.802 . . . . 6.6799999999999997 109.617 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -89.43 -43.74 10.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 116.624 2.083 . . . . 7.0899999999999999 116.624 -167.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -83.04 72.94 2.76 Favored Glycine 0 N--CA 1.47 0.924 0 O-C-N 120.989 -1.069 . . . . 3.0699999999999998 112.226 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 15.1 p -76.76 148.23 79.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.823 1.649 . . . . 2.5899999999999999 115.332 -167.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1054 ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' 1091 ' ' ALA . 44.1 Cg_endo -81.48 158.4 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.773 1 C-N-CA 125.552 4.168 . . . . 1.97 112.73 176.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 2.4 m -139.76 130.11 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.84 1.656 . . . . 2.6499999999999999 111.734 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.254 8.7 p -77.07 129.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.048 -1.033 . . . . 1.4299999999999999 112.342 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.82 -39.84 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.042 0.937 . . . . 2.3900000000000001 113.42 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -149.09 151.58 34.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.095 1.358 . . . . 2.8999999999999999 111.314 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 8.6 m -135.41 146.6 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.397 1.079 . . . . 0.89000000000000001 111.356 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 68.1 tttt -141.53 138.9 33.06 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.47 1.108 . . . . 1.6899999999999999 112.854 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.9 t -88.82 142.39 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.284 1.033 . . . . 0.72999999999999998 111.286 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1062 ' ' LEU . . . . . 0.479 HD23 HD22 ' A' 1222 ' ' LEU . 30.2 tp -106.21 -39.85 5.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.525 1.53 . . . . 1.4099999999999999 111.977 170.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 53.1 m -124.81 97.17 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.682 0.674 . . . . 1.8500000000000001 112.502 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.82 111.61 5.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.469 1.507 . . . . 5.9900000000000002 108.26 168.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 8.6 t -178.37 -52.8 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.563 1.945 . . . . 5.04 110.777 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 6.7 m120 -150.24 41.76 0.82 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.748 1.619 . . . . 6.6399999999999997 112.932 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -146.82 -58.57 0.28 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.507 -1.37 . . . . 4.7999999999999998 112.876 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.16 155.23 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.524 1.53 . . . . 2.27 110.247 -173.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 15.3 m -110.01 143.12 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.306 1.042 . . . . 2.8599999999999999 110.767 172.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -54.03 -42.23 68.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.286 2.328 . . . . 4.0999999999999996 117.286 -168.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 46.9 m80 -68.59 -29.06 67.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.984 1.265 . . . . 4.6699999999999999 111.81 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.27 -40.19 77.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 117.93 -1.033 . . . . 3.7000000000000002 111.315 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 82.3 mt -55.15 -54.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 118.968 0.804 . . . . 0.85999999999999999 110.536 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.51 -33.16 74.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.683 -0.635 . . . . 0.77000000000000002 112.152 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.11 81.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.542 0.571 . . . . 0.51000000000000001 112.542 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.0 pt -69.84 -31.25 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.546 1.066 . . . . 0.52000000000000002 112.921 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 48.0 t -71.12 -49.88 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.007 0.822 . . . . 0.57999999999999996 111.635 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.68 -33.86 87.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.376 -0.828 . . . . 0.68000000000000005 113.903 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 34.9 p -74.27 -37.88 63.59 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.822 0.849 . . . . 0.75 112.581 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.39 82.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.069 0.849 . . . . 0.68000000000000005 112.772 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -66.62 -18.97 65.65 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.858 -1.151 . . . . 2.2400000000000002 113.362 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 1.6 t -64.91 -15.52 62.14 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.062 -1.024 . . . . 1.74 112.722 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -128.66 -20.22 3.61 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.075 1.35 . . . . 3.1899999999999999 114.205 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.9 t -70.44 -44.61 67.49 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.908 -1.12 . . . . 3.9700000000000002 112.313 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . 0.301 33.1 mt-10 70.74 32.29 2.54 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.423 1.889 . . . . 5.2300000000000004 115.386 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.98 146.32 63.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.263 1.425 . . . . 1.6499999999999999 113.468 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.42 -54.15 3.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.985 3.79 . . . . 1.28 114.352 -169.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1088 ' ' LEU . . . . . 0.533 HD13 " H2'" ' A' 1232 ' ' ATP . 5.9 tt -68.05 -33.69 75.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.818 1.247 . . . . 0.91000000000000003 111.459 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.34 -22.31 63.16 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.207 1.384 . . . . 0.90000000000000002 114.813 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 51.7 p -61.92 -35.9 79.75 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.934 1.367 . . . . 2.23 112.611 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1091 ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' 1054 ' ' PRO . . . -56.97 -41.95 79.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.125 0.97 . . . . 0.94999999999999996 112.168 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.2 mt -72.64 -43.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.352 0.661 . . . . 0.73999999999999999 111.278 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 5.3 t -66.27 -40.59 90.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.867 -0.587 . . . . 2.0 112.082 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -62.18 -48.82 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.875 0.761 . . . . 3.1499999999999999 111.964 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -56.4 -42.95 78.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.033 0.833 . . . . 2.02 112.003 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.8 t -61.31 -54.34 45.24 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.771 -0.581 . . . . 1.78 111.277 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.78 -32.67 67.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.588 1.155 . . . . 2.6299999999999999 113.096 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -71.59 -48.91 45.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.098 1.759 . . . . 4.0099999999999998 112.856 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.92 -38.19 76.17 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.389 -1.444 . . . . 2.4500000000000002 112.583 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 -21.3 60.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.072 0.949 . . . . 1.4199999999999999 113.323 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.92 28.4 2.83 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.512 1.925 . . . . 3.8599999999999999 114.057 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -128.81 139.37 52.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.919 -1.113 . . . . 2.7200000000000002 113.86 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -77.25 -11.29 59.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.765 1.226 . . . . 3.8300000000000001 112.542 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 65.4 p -80.32 47.93 0.97 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.011 2.125 . . . . 4.6799999999999997 114.21 -171.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.15 148.08 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.821 1.045 . . . . 1.1499999999999999 113.821 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 75.83 128.41 0.26 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.79 1.662 . . . . 1.3999999999999999 114.351 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.27 -154.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.797 2.039 . . . . 2.54 108.273 172.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 142.17 50.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.766 1.765 . . . . 1.6399999999999999 115.766 -167.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.11 153.33 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 1 C-N-CA 132.472 4.309 . . . . 2.21 107.552 -169.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -140.57 117.88 11.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.256 -1.757 . . . . 2.7200000000000002 106.256 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 166.77 10.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.496 2.036 . . . . 3.5600000000000001 116.496 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -132.91 131.51 40.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.295 2.238 . . . . 4.1500000000000004 108.518 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.26 137.32 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.878 0.871 . . . . 2.6800000000000002 112.044 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 28.6 t -137.3 114.84 9.82 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.421 1.488 . . . . 1.74 107.532 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.76 147.7 45.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.083 2.522 . . . . 2.6899999999999999 112.607 -172.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 61.23 17.29 52.06 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.657 1.122 . . . . 1.6699999999999999 114.026 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 38.9 t -139.94 -63.51 0.5 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.746 1.218 . . . . 2.52 113.015 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.17 -152.47 23.64 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 120.583 1.538 . . . . 0.81999999999999995 115.946 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.33 150.23 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.735 1.614 . . . . 2.4100000000000001 113.179 -168.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.2 t -130.16 142.38 50.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.12 1.368 . . . . 0.51000000000000001 109.41 165.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.45 172.87 17.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.46 1.652 . . . . 0.54000000000000004 115.46 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -118.83 98.33 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 1.1799999999999999 109.326 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.2 p -112.17 128.38 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.679 0.792 . . . . 2.0699999999999998 112.829 -168.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1124 ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' 1177 ' ' GLN . 5.6 t -110.38 -163.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.721 1.209 . . . . 1.53 112.998 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.327 3.5 m120 70.35 41.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.557 2.743 . . . . 5.5099999999999998 116.842 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 35.9 pt -94.46 -17.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.173 -0.955 . . . . 4.7999999999999998 112.81 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -123.48 20.48 9.55 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.696 1.999 . . . . 7.7400000000000002 110.651 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.58 0.33 4.11 Favored Glycine 0 N--CA 1.472 1.083 0 C-N-CA 128.139 2.78 . . . . 6.8099999999999996 117.803 -169.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.0 -14.4 61.57 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.864 1.332 . . . . 8.5999999999999996 112.8 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.2 tt -44.51 -51.39 8.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.904 2.082 . . . . 9.9100000000000001 111.483 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -169.67 153.57 5.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.711 1.605 . . . . 12.09 110.275 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -66.46 137.92 57.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.706 -0.85 . . . . 16.0 108.706 165.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -83.95 61.2 6.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.942 0.497 . . . . 13.17 109.868 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 56.8 t30 -63.71 146.79 53.18 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.794 -0.566 . . . . 14.19 109.911 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 63.4 m95 -137.18 75.77 1.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.9 0.88 . . . . 13.58 110.217 168.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 61.77 19.55 10.65 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.959 2.207 . . . . 17.460000000000001 116.959 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 59.6 mt -55.51 138.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.461 1.504 . . . . 19.149999999999999 110.116 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.26 -55.82 7.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.426 0.899 . . . . 23.149999999999999 113.426 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -110.28 -19.86 12.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.821 . . . . 26.77 112.878 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 8.3 t-20 49.13 43.0 22.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.361 2.264 . . . . 22.780000000000001 115.739 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.12 170.92 14.81 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.202 1.801 . . . . 28.120000000000001 112.146 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 31.3 mm -70.32 108.24 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.194 0.998 . . . . 28.379999999999999 111.376 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -83.47 164.32 19.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.999 1.319 . . . . 28.530000000000001 112.851 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -65.09 -12.33 49.55 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.022 1.49 . . . . 30.199999999999999 115.022 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 68.54 144.73 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.781 2.432 . . . . 28.5 112.941 -167.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.7 t -62.08 138.94 58.46 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.716 1.006 . . . . 28.550000000000001 113.716 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.65 117.59 23.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.847 1.259 . . . . 31.879999999999999 110.049 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 33.6 m -133.18 14.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.899 1.074 . . . . 31.190000000000001 113.899 -169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.02 171.71 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.629 1.972 . . . . 35.490000000000002 113.925 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 4.5 mp -71.41 -38.35 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.92 1.288 . . . . 38.140000000000001 110.159 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 6.5 t70 -147.52 72.37 1.24 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.862 0.839 . . . . 34.520000000000003 112.977 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -147.43 27.08 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.71 1.204 . . . . 33.920000000000002 113.997 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 100.0 p -125.67 152.85 44.69 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.521 1.129 . . . . 31.260000000000002 112.7 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.42 -15.84 2.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.081 1.752 . . . . 28.57 113.175 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 58.3 19.01 5.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.972 2.109 . . . . 28.43 115.28 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -74.86 151.61 38.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.993 1.317 . . . . 27.66 112.689 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 67.4 m 48.05 35.65 5.42 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 116.5 2.037 . . . . 23.050000000000001 116.5 167.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.06 145.56 36.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.001 0.921 . . . . 22.199999999999999 112.413 168.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.8 t -132.75 152.09 51.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.344 1.457 . . . . 20.449999999999999 113.257 -173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 60.1 m -111.06 -24.46 10.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.351 1.46 . . . . 21.190000000000001 112.508 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 18.8 m -124.3 8.6 8.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.048 1.499 . . . . 19.66 115.048 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 55.5 m -114.65 19.22 16.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.995 1.318 . . . . 16.34 113.53 170.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.0 ptt? -116.86 143.63 45.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.257 1.423 . . . . 19.850000000000001 111.925 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 1.7 mt 60.19 12.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.497 1.519 . . . . 15.369999999999999 113.514 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -21.67 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 119.488 -2.007 . . . . 12.220000000000001 114.749 -169.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -96.68 -20.55 18.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.836 1.254 . . . . 11.529999999999999 113.793 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -76.25 -14.37 60.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.469 1.108 . . . . 10.01 113.597 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -110.38 2.78 19.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.496 2.036 . . . . 10.57 116.496 -174.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.27 -46.7 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.858 1.263 . . . . 8.1799999999999997 110.926 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.9 m -63.65 -24.87 67.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.485 0.92 . . . . 7.7300000000000004 113.485 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -88.51 -27.9 21.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.078 0.853 . . . . 8.5500000000000007 112.656 168.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -63.11 -43.19 99.15 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.52 -1.363 . . . . 7.3600000000000003 111.925 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.5 -17.74 63.07 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.707 1.373 . . . . 8.0700000000000003 114.707 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -81.23 -37.49 28.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.934 0.788 . . . . 5.5899999999999999 112.078 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -89.18 22.81 2.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.34 1.056 . . . . 6.5700000000000003 112.199 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 47.15 144.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 130.107 3.363 . . . . 3.8799999999999999 117.391 -165.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1177 ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' 1124 ' ' THR . 35.6 tt0 -133.06 151.21 52.06 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.945 1.298 . . . . 2.0099999999999998 110.624 171.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 125.02 31.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 3.29 110.152 -173.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.9 tttt -79.6 116.93 20.09 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.533 -0.914 . . . . 1.29 108.533 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.7 m -133.67 145.11 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.847 0.859 . . . . 0.53000000000000003 112.124 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -146.02 151.66 38.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.704 1.001 . . . . 0.54000000000000004 113.704 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.86 142.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.163 1.385 . . . . 0.48999999999999999 110.209 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 132.34 143.85 5.19 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 115.492 0.957 . . . . 1.4399999999999999 115.492 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 7.7 t-20 43.38 -143.99 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.299 1.84 . . . . 2.4300000000000002 112.281 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.919 1.688 . . . . 7.21 113.064 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -65.3 -36.43 84.04 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.328 -0.858 . . . . 4.5599999999999996 112.018 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1187 ' ' TRP . . . . . 0.454 ' CE3' ' HD3' ' A' 1190 ' ' ARG . 4.9 m95 -57.03 -30.0 63.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.144 1.164 . . . . 3.75 114.144 172.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.7 mmt -72.05 -37.72 69.62 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.499 0.666 . . . . 2.3500000000000001 111.626 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.15 -67.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 126.304 1.842 . . . . 1.7 108.259 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1190 ' ' ARG . . . . . 0.454 ' HD3' ' CE3' ' A' 1187 ' ' TRP . 34.5 ttt85 -36.49 -43.51 0.4 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.292 2.637 . . . . 6.6600000000000001 114.899 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 13.74 5.73 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.28 1.215 . . . . 0.82999999999999996 114.28 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 69.88 23.76 76.77 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.095 -1.628 . . . . 0.68999999999999995 115.542 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.16 171.41 12.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.642 1.177 . . . . 0.81000000000000005 112.059 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -99.66 133.34 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.006 1.322 . . . . 1.4399999999999999 109.699 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.7 tt -138.78 147.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.761 1.224 . . . . 1.26 111.11 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.69 151.32 32.0 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.101 1.36 . . . . 2.6699999999999999 113.258 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.07 -26.36 67.45 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.18 -0.95 . . . . 3.8399999999999999 112.84 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.54 -36.39 76.32 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.002 -1.061 . . . . 3.3900000000000001 113.213 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -77.16 -36.93 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.724 0.693 . . . . 1.1000000000000001 111.438 170.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.1 t30 -62.85 -37.72 87.95 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.746 0.703 . . . . 2.52 111.979 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.84 -39.05 93.17 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.475 1.11 . . . . 2.9399999999999999 112.971 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.56 -37.64 80.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.996 -1.065 . . . . 2.5299999999999998 111.75 171.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -66.25 -52.16 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.596 1.158 . . . . 1.1499999999999999 112.01 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.8 t -68.76 -34.62 75.88 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.376 -0.828 . . . . 1.3899999999999999 112.263 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.37 -49.05 68.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.048 0.84 . . . . 3.2599999999999998 111.055 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1206 ' ' HIS . . . . . 0.474 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 57.4 t-80 -66.66 -39.57 88.24 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.388 1.075 . . . . 3.9500000000000002 112.383 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -63.75 -42.31 97.86 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.305 -0.872 . . . . 2.7400000000000002 112.804 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -70.59 -28.73 65.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.181 1.792 . . . . 4.2400000000000002 112.785 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.6 mttp -66.81 -12.61 59.57 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.085 1.754 . . . . 3.1200000000000001 113.565 169.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.89 15.08 71.04 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.188 1.375 . . . . 1.25 114.73 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -106.98 156.57 18.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.818 1.309 . . . . 3.7599999999999998 110.561 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 27.3 m -77.35 128.35 34.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.571 1.549 . . . . 1.55 112.945 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.42 118.1 16.03 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.674 0.789 . . . . 0.67000000000000004 113.122 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 23.6 m -141.15 157.09 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 114.75 1.389 . . . . 0.5 114.75 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.91 165.88 10.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.465 . . . . 0.84999999999999998 113.539 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1216 ' ' VAL . . . . . 0.402 ' O ' HD23 ' A' 1222 ' ' LEU . 3.7 t -136.96 134.9 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.597 1.959 . . . . 1.8999999999999999 110.816 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -137.24 157.98 45.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.28 1.432 . . . . 0.48999999999999999 111.082 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 17.9 m -144.93 138.03 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.546 -1.346 . . . . 0.96999999999999997 111.394 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 32.8 t70 41.7 48.71 3.7 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.984 2.113 . . . . 2.77 112.377 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.28 3.4 m-20 65.6 32.7 9.06 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.996 2.118 . . . . 1.73 115.995 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.67 145.51 36.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.596 1.558 . . . . 2.25 111.189 169.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1222 ' ' LEU . . . . . 0.479 HD22 HD23 ' A' 1062 ' ' LEU . 0.2 OUTLIER -68.83 145.68 53.52 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.405 -1.434 . . . . 0.80000000000000004 111.182 172.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -121.33 -43.3 2.42 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.496 0.924 . . . . 0.56000000000000005 113.496 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.28 -173.3 38.84 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.17 0.895 . . . . 0.41999999999999998 115.062 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.26 152.94 42.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.365 1.466 . . . . 0.64000000000000001 113.399 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.07 135.34 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.463 1.505 . . . . 0.79000000000000004 111.101 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1227 ' ' ALA . . . . . 0.474 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -121.38 124.82 45.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.56 2.344 . . . . 0.65000000000000002 109.601 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.13 159.84 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.269 1.828 . . . . 1.45 111.579 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -131.8 -177.25 4.34 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.627 1.171 . . . . 1.6000000000000001 112.402 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -115.58 140.7 48.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.61 1.964 . . . . 3.48 112.936 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 115.953 1.834 . . . . 4.2199999999999998 115.953 -173.417 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1232 ' ' ATP . . . . . 0.533 " H2'" HD13 ' A' 1088 ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 120.199 0.047 . . . . 9.5600000000000005 110.876 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 39.1 p90 -135.34 158.39 44.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.139 1.376 . . . . 11.57 111.202 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 4.2 t -143.76 154.08 43.08 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.541 0.941 . . . . 7.3600000000000003 113.541 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 167.83 9.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.391 1.876 . . . . 6.3899999999999997 110.851 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 37.4 m170 -98.8 -41.33 7.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.565 0.746 . . . . 8.3599999999999994 111.221 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -92.09 93.65 1.83 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.095 -0.836 . . . . 4.04 112.826 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.8 m -80.76 123.26 82.54 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.433 1.617 . . . . 2.8500000000000001 110.82 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 148.44 52.52 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.377 2.718 . . . . 1.6399999999999999 112.19 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.1 p -138.07 125.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.863 1.265 . . . . 2.29 111.754 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.8 p -72.13 133.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.1 -1.0 . . . . 1.04 111.518 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -126.18 -34.92 2.48 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.524 1.675 . . . . 2.3599999999999999 115.524 -166.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -155.03 151.17 28.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.294 1.438 . . . . 2.0 111.03 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.2 m -130.03 142.35 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.32 1.048 . . . . 0.76000000000000001 111.284 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 40.1 tttt -139.61 147.14 40.68 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.096 0.958 . . . . 1.76 112.173 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 43.5 t -96.78 136.99 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.123 1.369 . . . . 0.76000000000000001 111.294 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 34.6 tp -100.32 -25.7 14.15 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.873 1.669 . . . . 0.81999999999999995 112.931 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.5 t -104.75 24.3 12.03 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.562 1.319 . . . . 2.3199999999999998 114.562 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -56.07 128.19 34.21 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.714 -1.241 . . . . 3.77 110.49 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 60.48 -1.15 0.23 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.949 1.833 . . . . 3.0800000000000001 115.949 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.74 -32.35 8.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.071 1.305 . . . . 4.3099999999999996 113.191 -171.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -155.61 -46.53 0.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.259 1.577 . . . . 4.2199999999999998 115.259 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.16 146.48 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.092 1.357 . . . . 1.6799999999999999 111.172 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -98.65 157.42 16.27 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.323 1.449 . . . . 1.78 112.841 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -61.14 -38.5 86.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.976 2.213 . . . . 3.4900000000000002 116.976 -166.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -71.24 -34.69 71.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.288 1.404 . . . . 3.5299999999999998 111.099 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 94.7 mttt -61.15 -44.3 97.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.162 0.585 . . . . 3.8500000000000001 110.804 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.28 -53.51 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.052 0.941 . . . . 0.54000000000000004 111.198 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.91 -32.06 73.07 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.402 -0.811 . . . . 0.58999999999999997 112.189 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.42 68.55 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.531 0.732 . . . . 0.58999999999999997 112.013 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.1 pt -70.25 -32.66 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.005 1.275 . . . . 0.56000000000000005 113.095 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.9 t -70.4 -48.01 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.804 1.184 . . . . 0.56999999999999995 111.387 172.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.85 92.42 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.258 -0.901 . . . . 0.56000000000000005 113.321 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 71.7 p -77.58 -27.0 51.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.821 1.045 . . . . 0.70999999999999996 113.821 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.63 91.92 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.006 0.821 . . . . 0.67000000000000004 112.5 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.48 -12.38 60.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.807 1.04 . . . . 1.9399999999999999 113.807 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 35.4 t -54.51 -43.11 71.58 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.186 1.394 . . . . 1.53 114.543 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -92.14 2.61 56.48 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.051 0.76 . . . . 2.0600000000000001 113.051 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.9 t -89.19 168.17 12.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.058 1.343 . . . . 1.6299999999999999 112.761 -173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -133.64 80.09 1.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.211 1.405 . . . . 4.6699999999999999 109.823 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -141.39 152.0 62.68 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.964 1.705 . . . . 2.2000000000000002 110.917 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.77 -35.81 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.304 2.669 . . . . 1.6100000000000001 115.19 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.24 -41.35 9.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.721 1.208 . . . . 1.1299999999999999 113.456 -166.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -76.99 -34.82 40.91 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 114.541 0.576 . . . . 1.04 114.541 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 59.4 p -64.28 -17.28 63.48 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.87 -1.37 . . . . 1.75 113.142 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.15 82.93 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.866 -1.146 . . . . 1.0700000000000001 111.965 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 4.8 mp -72.23 -32.72 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.43 0.692 . . . . 1.3 110.728 171.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 94.9 m -56.1 -47.61 77.72 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 117.424 -1.274 . . . . 1.3300000000000001 111.395 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 46.9 tttt -62.39 -46.17 89.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.301 1.41 . . . . 2.8100000000000001 112.789 175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 4.0 t80 -55.94 -42.33 76.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.348 1.059 . . . . 2.0099999999999998 111.476 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.1 t -70.66 -52.55 20.46 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.611 1.564 . . . . 2.25 112.355 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -47.76 -47.63 30.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.874 1.67 . . . . 2.5499999999999998 111.927 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.82 -30.41 65.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.077 0.951 . . . . 4.1100000000000003 113.243 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.18 -42.22 72.7 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.636 1.107 . . . . 3.71 112.662 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.01 -33.63 61.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.006 1.323 . . . . 1.6299999999999999 114.48 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.28 42.64 25.98 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.487 1.915 . . . . 3.1800000000000002 114.334 -172.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -119.78 -21.7 7.13 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.409 1.633 . . . . 4.1200000000000001 115.409 -172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.8 tt0 58.8 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.154 2.582 . . . . 3.0099999999999998 117.403 -171.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 75.2 p -95.54 22.23 7.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.275 2.23 . . . . 2.9100000000000001 113.917 -170.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.59 147.13 53.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.753 1.221 . . . . 0.88 113.847 -169.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 66.44 -173.35 25.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.272 0.929 . . . . 1.5700000000000001 114.639 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -160.45 -51.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.066 1.347 . . . . 1.45 111.629 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 31.6 t -138.24 142.53 39.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.405 1.082 . . . . 1.3700000000000001 113.58 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.12 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 1 C-N-CA 131.728 4.011 . . . . 2.9199999999999999 109.229 168.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -20.31 12.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.944 1.461 . . . . 3.2400000000000002 114.944 -169.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 51.3 m-85 60.8 105.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.507 2.723 . . . . 4.54 117.35 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -120.91 107.09 12.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.448 2.299 . . . . 2.5899999999999999 107.493 168.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.7 m -98.4 145.17 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.41 0.684 . . . . 2.1699999999999999 111.96 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 18.7 t -136.99 85.15 23.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 106.552 -1.647 . . . . 1.26 106.552 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -53.1 134.27 55.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.825 3.683 . . . . 1.76 114.708 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 65.22 10.05 45.46 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.855 -0.969 . . . . 1.9399999999999999 114.457 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 22.8 m -127.51 -49.11 1.4 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.09 1.445 . . . . 3.2200000000000002 111.933 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 173.14 -170.89 44.04 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.499 0.571 . . . . 1.1499999999999999 114.096 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 4.3 tt -141.71 158.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.4 1.08 . . . . 2.04 111.665 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 18.7 t -139.0 152.92 48.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.618 1.167 . . . . 0.73999999999999999 111.903 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 9.2 p -164.2 167.96 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.495 1.118 . . . . 0.97999999999999998 112.648 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -110.08 123.1 49.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.307 1.043 . . . . 1.1499999999999999 109.258 172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.7 t -105.01 145.21 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 123.92 0.888 . . . . 2.27 111.37 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.88 160.54 41.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.305 1.05 . . . . 0.94999999999999996 113.542 164.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -168.1 -33.77 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 130.674 3.59 . . . . 2.2000000000000002 108.24 163.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 4.5 pt -54.71 -62.14 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.608 2.363 . . . . 2.2999999999999998 115.016 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.02 28.64 0.31 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.978 1.473 . . . . 4.2800000000000002 114.978 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -70.37 -7.2 60.01 Favored Glycine 0 CA--C 1.539 1.592 0 O-C-N 120.574 -1.329 . . . . 4.7800000000000002 114.818 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.39 -1.31 0.13 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.691 2.796 . . . . 4.0899999999999999 115.984 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.7 tt -71.46 -28.86 64.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.298 1.839 . . . . 5.3200000000000003 112.093 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 51.56 -124.52 2.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.913 1.285 . . . . 7.3799999999999999 111.465 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -127.59 156.24 42.57 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 127.712 2.405 . . . . 13.42 108.677 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -17.54 58.75 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.934 1.087 . . . . 16.66 113.934 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 23.8 t-20 64.76 165.23 0.15 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.315 1.846 . . . . 14.91 113.789 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 98.4 m95 -134.24 -64.36 0.69 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.807 1.643 . . . . 19.649999999999999 110.961 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -144.43 -8.23 0.67 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.577 1.695 . . . . 15.9 115.577 -169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1137 ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' 1137 ' ' ILE . 0.9 OUTLIER -82.8 143.38 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.422 1.889 . . . . 15.050000000000001 109.657 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -80.06 -24.09 40.9 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.61 -1.306 . . . . 19.120000000000001 112.656 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.66 108.88 14.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.887 1.675 . . . . 15.67 110.06 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -127.73 116.59 20.47 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.896 0.879 . . . . 14.44 111.342 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.39 146.62 52.09 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.453 1.901 . . . . 15.4 112.606 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.2 -19.43 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.215 1.561 . . . . 20.370000000000001 115.215 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -126.06 147.59 49.53 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.281 1.4 . . . . 18.210000000000001 113.468 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 26.3 p30 -82.03 0.56 39.76 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.754 1.622 . . . . 18.079999999999998 114.892 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . 0.26 . . 58.28 40.46 24.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.935 2.094 . . . . 16.719999999999999 116.629 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 27.3 m -62.27 150.04 40.26 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.249 1.419 . . . . 17.75 111.436 166.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -152.21 154.26 35.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.256 1.422 . . . . 18.050000000000001 112.568 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 29.1 m -130.01 150.2 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.979 1.311 . . . . 19.719999999999999 112.295 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -117.96 62.3 0.76 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.665 1.986 . . . . 22.329999999999998 108.089 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1150 ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' 1153 ' ' SER . 7.4 tp -101.43 142.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.326 1.851 . . . . 22.440000000000001 114.865 -164.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -155.76 137.72 14.51 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.457 1.503 . . . . 24.600000000000001 111.552 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . 49.39 30.15 3.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.257 1.823 . . . . 25.620000000000001 115.315 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1153 ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' 1150 ' ' ILE . 0.6 OUTLIER -150.52 160.46 43.77 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.695 1.198 . . . . 23.73 111.312 -176.115 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.3 67.64 0.95 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.298 1.439 . . . . 22.719999999999999 111.47 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.39 4.09 50.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.599 1.56 . . . . 25.850000000000001 114.602 -171.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -134.6 -19.69 1.84 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 117.736 2.495 . . . . 27.640000000000001 117.736 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 17.7 t -159.0 150.91 20.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 122.735 2.516 . . . . 22.329999999999998 115.645 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.359 0.1 OUTLIER -87.63 15.48 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.804 1.409 . . . . 19.649999999999999 114.804 168.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 7.3 t -59.0 -11.97 4.05 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.329 1.603 . . . . 19.02 115.329 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 5.3 p -84.45 129.8 34.83 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.281 -1.512 . . . . 15.93 112.225 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 75.4 m 49.38 43.82 23.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.124 1.369 . . . . 15.31 113.679 -171.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 89.1 p -78.45 -48.09 16.13 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.351 1.461 . . . . 13.08 111.912 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 17.7 mmt 52.97 -174.76 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 128.126 2.57 . . . . 13.81 115.166 172.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 44.1 pt -75.16 21.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.056 1.742 . . . . 12.42 115.048 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.82 -30.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.992 -1.068 . . . . 9.4399999999999995 113.155 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . 0.281 12.7 p-10 -77.03 -5.66 49.65 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.416 1.265 . . . . 10.32 114.416 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -86.5 -6.25 58.95 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.861 1.264 . . . . 10.869999999999999 112.829 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -109.17 -15.85 14.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.148 1.379 . . . . 9.7699999999999996 112.98 -171.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 79.5 mt -55.86 -29.12 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.276 1.83 . . . . 6.7000000000000002 111.27 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 52.8 p -60.29 -11.92 7.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.632 1.345 . . . . 8.5600000000000005 114.632 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.31 -9.27 58.41 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.146 -0.971 . . . . 7.71 112.933 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.89 -14.39 21.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.135 1.374 . . . . 5.1200000000000001 114.451 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.39 -39.46 73.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.013 . . . . 7.7999999999999998 110.695 167.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -101.14 -43.64 5.94 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.37 1.468 . . . . 5.9900000000000002 111.923 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -87.33 63.5 7.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.281 1.832 . . . . 3.7200000000000002 111.616 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -49.29 129.46 18.38 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.483 1.66 . . . . 3.4500000000000002 115.483 -167.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -158.82 162.96 37.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.432 1.493 . . . . 2.3300000000000001 112.776 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -122.42 128.17 50.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.578 1.551 . . . . 3.0600000000000001 110.973 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.4 tttt -88.14 126.56 35.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.987 0.915 . . . . 1.23 109.073 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.6 m -134.49 151.89 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 113.748 1.018 . . . . 0.87 113.748 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.49 152.35 30.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.159 1.384 . . . . 0.44 113.005 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 10.7 tt -149.36 139.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.144 1.378 . . . . 0.54000000000000004 110.31 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.9 -142.38 9.09 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.908 1.123 . . . . 1.45 115.908 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.41 161.48 2.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.64 2.376 . . . . 2.1099999999999999 114.456 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -24.99 63.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.091 1.356 . . . . 6.3300000000000001 113.68 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -76.61 -32.14 57.87 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.868 1.213 . . . . 3.0499999999999998 113.652 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.2 t90 -64.05 -21.17 66.41 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 119.994 -1.692 . . . . 2.96 112.484 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -63.92 -33.9 76.74 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.846 -1.158 . . . . 2.3799999999999999 111.256 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 24.3 mt -66.83 -64.84 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.844 1.658 . . . . 2.3199999999999998 109.169 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -52.58 -30.86 33.28 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.277 1.431 . . . . 5.1600000000000001 114.344 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.1 6.07 23.69 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.302 1.441 . . . . 0.81999999999999995 113.954 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.99 29.8 72.35 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.95 1.738 . . . . 0.69999999999999996 115.081 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 4.6 mt -96.24 160.7 14.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.84 1.256 . . . . 0.82999999999999996 109.647 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 58.5 t -110.74 124.5 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.499 0.719 . . . . 1.27 110.559 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -95.63 149.44 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.018 0.927 . . . . 1.1399999999999999 111.004 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -124.06 154.38 40.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.828 1.251 . . . . 3.0899999999999999 111.495 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -56.92 -32.09 65.6 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.813 1.412 . . . . 2.4199999999999999 114.813 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.54 -53.56 46.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.54 1.136 . . . . 3.9900000000000002 111.391 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1199 ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' 1199 ' ' VAL . 1.8 p -73.48 -34.3 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.171 1.388 . . . . 1.24 111.638 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.74 -42.74 97.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.742 0.817 . . . . 1.8100000000000001 111.593 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.27 -44.4 91.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.622 0.646 . . . . 2.29 112.321 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.87 -36.17 82.68 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.346 1.058 . . . . 2.2200000000000002 112.22 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 18.1 tpp -62.62 -55.12 30.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.369 1.068 . . . . 0.80000000000000004 111.687 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.3 t -68.56 -33.68 74.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.644 -0.66 . . . . 1.1000000000000001 111.938 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.191 1.397 . . . . 4.25 112.271 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.19 -39.66 71.69 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.883 1.068 . . . . 2.25 113.883 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.54 -39.72 84.9 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.602 -0.686 . . . . 3.0600000000000001 111.662 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -70.74 -18.62 62.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.523 2.329 . . . . 4.1600000000000001 113.786 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -71.89 -22.01 61.56 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.008 1.276 . . . . 3.0099999999999998 111.865 166.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.45 18.32 42.39 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.332 1.92 . . . . 1.78 114.303 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -106.03 -160.78 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.019 1.327 . . . . 4.5700000000000003 110.123 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 69.9 m -108.09 131.51 54.54 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.885 1.22 . . . . 0.82999999999999996 112.388 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.08 118.28 19.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.836 1.654 . . . . 0.58999999999999997 111.125 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -138.04 155.33 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.777 1.231 . . . . 0.56000000000000005 113.122 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.0 mp -113.42 159.95 18.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.971 1.309 . . . . 0.79000000000000004 112.587 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.7 t -127.74 123.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.919 1.687 . . . . 1.8400000000000001 110.397 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.62 147.29 48.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.784 1.234 . . . . 0.51000000000000001 110.634 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.58 134.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.928 0.891 . . . . 1.01 112.061 -172.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 41.09 49.73 3.15 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.047 1.739 . . . . 3.1600000000000001 112.043 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.272 24.0 m-20 54.2 36.15 24.3 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.907 2.883 . . . . 1.5 116.435 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.93 138.43 48.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.999 1.72 . . . . 2.3399999999999999 110.68 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.25 133.77 48.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.642 -1.286 . . . . 0.72999999999999998 110.762 169.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.2 p -115.76 -37.89 3.83 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -174.57 -171.46 38.8 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 119.806 1.185 . . . . 0.46999999999999997 115.349 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.81 154.09 44.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.739 1.616 . . . . 0.69999999999999996 113.025 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.12 133.04 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.723 1.609 . . . . 0.84999999999999998 110.016 -173.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -107.53 132.31 53.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.71999999999999997 110.77 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 24.9 mt -135.02 152.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.438 1.895 . . . . 1.1499999999999999 110.604 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -120.07 -174.44 2.77 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.967 2.107 . . . . 1.4399999999999999 111.408 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 6.1 t70 -119.16 138.15 53.13 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.907 1.283 . . . . 3.3999999999999999 110.74 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 114.466 1.284 . . . . 3.9900000000000002 114.466 -170.221 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 119.013 -0.518 . . . . 11.07 111.711 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -68.46 163.95 22.21 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.272 1.429 . . . . 10.91 111.927 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 7.7 m -130.31 146.0 51.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.953 1.301 . . . . 8.8300000000000001 112.36 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 6.9 tpt -67.03 162.11 22.87 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.276 1.431 . . . . 7.3499999999999996 112.729 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 23.0 m170 -55.49 -48.33 74.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.76 1.224 . . . . 7.5300000000000002 112.548 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -93.4 103.41 3.04 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.209 -1.156 . . . . 2.71 110.209 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 95.5 m -64.27 127.04 91.62 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 118.15 0.975 . . . . 2.9700000000000002 110.39 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.38 135.07 16.22 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.823 2.349 . . . . 2.0800000000000001 111.465 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.7 p -135.25 132.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.478 -0.764 . . . . 2.6299999999999999 110.215 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 6.3 p -68.52 123.16 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.643 -0.66 . . . . 1.22 110.177 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 30.4 t30 -103.64 -39.44 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.85 1.26 . . . . 3.54 112.136 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.22 146.85 20.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.227 1.011 . . . . 2.3999999999999999 112.295 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 16.7 m -132.49 131.7 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.788 0.835 . . . . 0.68999999999999995 112.201 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 53.0 tttt -135.08 144.61 47.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.883 1.273 . . . . 1.55 113.224 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 87.7 t -79.17 147.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.054 1.341 . . . . 0.95999999999999996 110.659 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.9 tp -122.22 -24.1 5.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.59 1.556 . . . . 0.87 112.707 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 36.0 m -127.46 107.42 9.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.153 1.381 . . . . 1.77 109.431 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.34 130.51 49.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.535 1.134 . . . . 3.6400000000000001 111.788 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 59.8 m 51.61 31.21 7.45 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.132 1.773 . . . . 2.5299999999999998 115.528 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -137.98 5.5 2.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.965 1.306 . . . . 2.71 113.514 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -154.37 -79.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 5.6799999999999997 110.423 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.83 146.85 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 128.203 2.601 . . . . 1.99 109.032 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -97.93 155.64 16.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.245 1.418 . . . . 1.98 113.682 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -44.76 -49.42 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.669 2.47 . . . . 3.6899999999999999 117.669 -167.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.9 t60 -75.33 -28.18 59.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.433 1.47 . . . . 2.8399999999999999 111.348 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -65.17 -38.71 91.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.857 -1.152 . . . . 3.77 111.062 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.36 -51.85 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.088 0.955 . . . . 0.65000000000000002 110.603 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -31.81 73.0 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.124 0.874 . . . . 0.70999999999999996 112.262 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.78 54.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 0.64000000000000001 112.152 173.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 14.4 pt -69.14 -34.95 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.193 . . . . 0.76000000000000001 113.157 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 58.1 t -70.75 -45.07 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.133 0.878 . . . . 0.88 111.361 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.0 -36.18 91.66 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.487 -0.758 . . . . 0.91000000000000003 113.304 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.0 p -72.76 -34.89 67.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.45 0.907 . . . . 0.98999999999999999 113.45 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -58.05 -51.79 68.23 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.275 0.943 . . . . 1.0 112.64 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.52 -13.66 61.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.875 1.065 . . . . 2.5600000000000001 113.875 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 9.1 p -65.16 -20.85 66.64 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.058 -1.651 . . . . 1.6299999999999999 112.667 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -122.99 16.84 10.06 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.973 1.709 . . . . 2.0299999999999998 112.636 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.5 t -127.83 -176.93 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.524 1.93 . . . . 1.5 110.197 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -142.94 46.77 1.55 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.294 1.438 . . . . 3.8100000000000001 112.607 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.16 164.76 22.01 Favored Pre-proline 0 CA--C 1.554 1.123 0 O-C-N 121.274 -0.891 . . . . 1.9199999999999999 112.441 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.73 -22.61 5.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.193 2.596 . . . . 1.3400000000000001 115.314 -169.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 10.3 tt -112.8 -48.59 2.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.437 1.095 . . . . 1.05 112.848 -169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -66.04 -21.22 69.61 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.18 0.832 . . . . 0.89000000000000001 115.18 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 67.4 p -62.98 -16.8 60.89 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.942 1.371 . . . . 1.3999999999999999 113.979 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.33 78.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.013 -1.054 . . . . 0.75 111.737 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.69 -38.95 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.205 1.402 . . . . 0.83999999999999997 110.232 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 90.9 m -53.08 -47.86 68.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 111.704 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -60.45 -51.0 71.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.649 0.78 . . . . 2.6899999999999999 112.252 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.02 -41.28 78.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.214 0.605 . . . . 3.29 111.95 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.1 t -67.65 -56.9 7.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.478 1.511 . . . . 1.71 112.246 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -50.55 -45.49 56.94 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.014 1.279 . . . . 3.8399999999999999 110.88 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -70.98 -32.44 69.29 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.222 1.009 . . . . 3.6000000000000001 113.361 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -72.06 -41.4 67.44 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.73 1.15 . . . . 2.1899999999999999 113.789 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.33 -16.21 61.88 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.715 1.206 . . . . 1.04 112.388 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.12 46.17 9.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.847 2.459 . . . . 2.7400000000000002 112.064 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.83 143.34 26.24 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.525 -0.734 . . . . 2.7599999999999998 111.937 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -99.4 -0.42 40.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.173 0.989 . . . . 3.5 112.518 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 63.3 p -101.21 9.02 42.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.305 1.842 . . . . 3.52 114.701 -168.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -67.55 149.37 50.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.979 1.312 . . . . 1.3 112.78 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.44 168.26 19.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.399 1.476 . . . . 1.3200000000000001 115.758 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 9.8 m -160.76 -49.97 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.123 -1.222 . . . . 1.3 113.516 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 53.6 t -136.29 142.68 43.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.503 1.521 . . . . 1.8200000000000001 114.745 -168.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.2 mm -138.71 148.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 130.346 3.458 . . . . 2.29 109.317 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 19.2 t0 -131.93 98.38 4.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.964 1.706 . . . . 2.5600000000000001 106.798 166.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1111 ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' 1119 ' ' ILE . 60.6 t80 -73.57 124.42 25.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.478 1.911 . . . . 4.1799999999999997 114.544 -167.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.26 123.47 25.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.443 1.897 . . . . 2.3199999999999998 108.213 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 7.4 p -129.47 149.06 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.023 1.86 . . . . 3.1000000000000001 116.023 -166.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 52.8 t -128.41 102.79 20.41 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.098 1.359 . . . . 1.7 107.419 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -57.67 133.79 58.77 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.174 2.582 . . . . 1.47 113.821 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.11 11.38 70.43 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.813 1.197 . . . . 1.5800000000000001 115.499 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 33.2 t -138.89 -41.73 0.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.655 1.227 . . . . 1.9399999999999999 114.044 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 174.58 -177.86 46.57 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 115.661 1.024 . . . . 0.75 115.661 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1119 ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' 1111 ' ' PHE . 0.1 OUTLIER -142.71 149.05 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 1.8300000000000001 111.218 170.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.5 t -131.41 142.93 50.12 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.188 2.195 . . . . 0.48999999999999999 109.137 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.1 p -153.84 165.68 35.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.929 1.085 . . . . 0.66000000000000003 113.929 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -114.66 122.45 46.5 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.032 -1.099 . . . . 1.27 108.032 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 33.1 m -124.34 136.63 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.224 0.609 . . . . 2.25 112.294 -170.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.6 t -122.95 145.4 48.51 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.884 0.373 . . . . 1.01 111.037 166.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 59.8 t30 -160.89 45.21 0.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.71 2.004 . . . . 3.3599999999999999 107.184 158.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.27 -34.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.957 . . . . 2.1600000000000001 111.721 -171.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -144.6 37.15 1.2 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.92 0.866 . . . . 4.7400000000000002 111.905 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -69.42 0.7 16.52 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.436 1.493 . . . . 3.6200000000000001 115.144 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.3 pp -57.79 -6.27 0.51 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.541 2.336 . . . . 3.7400000000000002 116.174 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 3.5 tt -86.54 -66.29 0.92 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.506 1.122 . . . . 5.4900000000000002 112.702 -169.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -168.61 154.44 6.72 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.745 2.418 . . . . 7.2599999999999998 108.821 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.64 144.33 26.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.466 1.506 . . . . 12.050000000000001 111.232 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -88.59 27.13 1.33 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.88 1.272 . . . . 13.550000000000001 114.317 173.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -68.21 108.55 3.2 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.15 0.98 . . . . 12.07 112.449 -169.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -155.76 -44.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.559 1.543 . . . . 16.850000000000001 112.053 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.19 -14.28 61.76 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.182 -0.949 . . . . 18.670000000000002 112.482 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1137 ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' 1137 ' ' ILE . 0.7 OUTLIER -86.2 -16.17 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 126.974 2.11 . . . . 17.219999999999999 112.583 173.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.4 -44.23 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 1 C-N-CA 132.613 4.365 . . . . 18.219999999999999 115.959 178.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.14 -20.09 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.494 1.664 . . . . 17.640000000000001 115.494 169.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.38 -25.03 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 119.107 3.003 . . . . 18.77 119.107 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -88.21 -5.35 58.44 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.193 1.797 . . . . 21.149999999999999 114.642 -175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1142 ' ' ILE . . . . . 0.657 HD13 ' H ' ' A' 1142 ' ' ILE . 0.2 OUTLIER -79.66 153.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.712 1.605 . . . . 21.280000000000001 114.715 -169.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -100.22 6.52 44.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.168 2.187 . . . . 27.07 115.247 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -77.33 7.49 5.23 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.889 1.44 . . . . 22.550000000000001 114.889 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 59.13 175.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.936 2.494 . . . . 24.329999999999998 115.358 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 73.3 m -139.52 109.44 6.37 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.317 1.447 . . . . 23.73 109.734 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 77.8 mt -110.52 158.62 18.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.598 1.159 . . . . 24.73 111.531 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 14.0 m -115.59 141.59 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.989 1.316 . . . . 25.760000000000002 111.071 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 164.55 33.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.786 1.234 . . . . 26.16 112.838 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 8.6 tp -143.7 127.67 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.472 0.709 . . . . 27.52 112.622 171.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -157.55 112.32 2.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.497 1.519 . . . . 27.32 109.667 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -64.87 -21.13 66.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.408 0.892 . . . . 27.559999999999999 113.408 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 80.9 p -81.66 -3.93 54.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.849 1.425 . . . . 28.260000000000002 114.849 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 51.5 t30 -131.25 157.87 42.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.703 1.601 . . . . 25.940000000000001 111.686 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -106.12 -17.49 14.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.924 1.289 . . . . 23.809999999999999 113.23 168.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 61.07 -58.55 0.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.462 2.705 . . . . 25.469999999999999 114.296 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 21.5 m -170.43 139.71 1.71 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.02 3.328 . . . . 23.149999999999999 107.24 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 46.5 p -136.91 154.99 50.32 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.11 1.323 . . . . 20.109999999999999 113.045 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.6 t -161.88 145.73 12.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.747 1.017 . . . . 17.620000000000001 113.747 -172.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 21.1 t -136.38 141.49 43.67 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.442 1.497 . . . . 15.5 110.069 169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 13.9 m -54.84 123.21 12.66 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.152 1.538 . . . . 13.94 115.152 -167.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 58.2 m -102.03 -8.98 21.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.745 1.618 . . . . 15.050000000000001 113.795 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 22.4 ptp -61.39 167.56 3.22 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.254 -0.904 . . . . 13.67 110.386 167.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 35.2 pt -72.93 64.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.707 1.203 . . . . 11.82 112.86 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.98 -27.14 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.588 1.555 . . . . 10.01 114.534 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -22.48 52.13 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.169 1.174 . . . . 9.3599999999999994 114.169 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -80.71 -14.12 58.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.848 0.859 . . . . 8.4199999999999999 112.769 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.86 -2.69 15.12 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.993 1.479 . . . . 9.0399999999999991 114.993 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.07 -42.81 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.199 1.0 . . . . 6.6500000000000004 110.472 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 66.8 m -62.96 -18.27 62.99 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.824 1.046 . . . . 5.9299999999999997 113.824 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.89 -38.19 54.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.074 0.852 . . . . 6.9500000000000002 111.666 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.08 60.9 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.584 0.754 . . . . 5.6200000000000001 112.513 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.77 -36.79 79.84 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.141 -0.975 . . . . 6.8099999999999996 111.614 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -77.01 -54.77 6.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.871 0.868 . . . . 5.2400000000000002 111.18 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -82.89 66.39 8.49 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 4.1600000000000001 111.344 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -31.73 134.78 0.08 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.847 2.459 . . . . 3.2999999999999998 117.01 -168.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -134.0 135.22 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.619 1.168 . . . . 2.27 113.78 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -89.92 137.64 32.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.03 1.332 . . . . 3.1699999999999999 109.457 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.87 119.75 31.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.015 0.926 . . . . 1.53 109.058 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.9 m -133.91 138.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 118.878 0.763 . . . . 0.48999999999999999 112.342 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -144.92 154.66 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.113 0.965 . . . . 0.37 113.542 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.4 tt -149.49 139.29 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.837 1.655 . . . . 0.81000000000000005 110.048 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 178.35 173.88 44.12 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.312 0.885 . . . . 1.47 115.312 -172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -57.65 -70.34 0.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.431 1.492 . . . . 3.8100000000000001 114.68 -169.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 -72.77 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.725 1.379 . . . . 5.5800000000000001 114.725 -177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.18 -31.48 70.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.527 1.512 . . . . 4.8300000000000001 113.413 -168.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 15.3 t90 -68.25 -23.39 64.78 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.396 -1.44 . . . . 3.04 113.117 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 80.2 mmm -72.04 -40.65 68.23 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.789 0.836 . . . . 2.6499999999999999 110.979 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.38 -64.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.252 1.421 . . . . 2.2400000000000002 109.482 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -51.69 -9.64 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.908 2.483 . . . . 6.8499999999999996 116.6 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.31 13.56 0.72 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 120.903 1.683 . . . . 0.76000000000000001 111.106 167.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 71.31 33.66 64.43 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 119.475 -2.016 . . . . 1.0700000000000001 114.001 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.25 172.91 6.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.947 1.299 . . . . 0.81000000000000005 110.836 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.3 t -117.27 138.55 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.808 1.243 . . . . 1.02 110.28 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 17.7 tt -114.1 141.81 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.332 1.053 . . . . 1.0700000000000001 112.148 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 11.0 p30 -103.2 158.7 16.14 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.242 1.417 . . . . 4.2400000000000002 113.093 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -74.0 -21.96 59.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.248 1.203 . . . . 2.8399999999999999 114.248 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.18 -39.92 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.714 -1.241 . . . . 2.9100000000000001 112.161 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.6 p -70.32 -36.7 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.575 -0.703 . . . . 0.81999999999999995 111.111 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.7 t30 -64.44 -38.37 90.79 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.884 0.765 . . . . 2.2999999999999998 112.556 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -44.98 86.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.795 0.838 . . . . 2.1200000000000001 112.864 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 29.5 t80 -71.34 -43.03 67.79 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.54 0.736 . . . . 2.5600000000000001 112.393 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.3 tpp -56.84 -48.03 78.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.417 1.087 . . . . 0.97999999999999998 111.58 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -74.15 -34.74 63.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.94 -0.552 . . . . 1.3400000000000001 112.055 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.65 -45.33 85.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.115 1.325 . . . . 3.3300000000000001 111.818 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -65.3 -47.2 77.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.143 0.977 . . . . 3.8900000000000001 111.684 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.12 -34.61 76.68 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.332 -0.855 . . . . 4.1500000000000004 111.967 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -69.84 -15.26 63.07 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.586 1.554 . . . . 3.8199999999999998 113.78 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 63.1 mttt -73.58 -14.49 61.2 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 120.431 1.469 . . . . 3.6899999999999999 112.059 165.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.98 10.36 58.75 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 126.59 2.043 . . . . 1.79 113.556 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -115.69 132.34 56.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.886 1.274 . . . . 4.7800000000000002 111.343 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 99.6 m -59.61 128.25 36.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.619 1.341 . . . . 1.1499999999999999 114.619 -168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.87 130.05 49.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.841 1.256 . . . . 0.60999999999999999 111.777 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.8 m -140.9 154.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.345 1.458 . . . . 0.72999999999999998 113.247 -174.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.58 159.32 15.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.174 0.989 . . . . 1.0900000000000001 110.551 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.8 p -130.57 124.84 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.456 1.102 . . . . 2.1600000000000001 112.54 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.27 152.31 37.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.921 1.688 . . . . 0.40000000000000002 111.226 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.7 m -146.69 119.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.545 1.938 . . . . 0.72999999999999998 112.008 -167.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 46.46 47.48 14.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.984 2.114 . . . . 3.3700000000000001 113.215 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.321 34.0 m-20 63.38 26.77 15.1 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.228 2.611 . . . . 2.0899999999999999 116.382 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -125.66 153.67 43.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.216 2.206 . . . . 3.1899999999999999 110.824 167.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.6 mt -75.17 148.77 39.31 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.218 -1.551 . . . . 1.02 112.418 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.7 p -124.55 -36.94 2.56 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.08 0.771 . . . . 0.59999999999999998 113.08 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.47 -166.07 29.68 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 119.268 0.94 . . . . 0.58999999999999997 115.418 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.39 153.04 46.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.884 1.674 . . . . 0.78000000000000003 111.743 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.4 mm -132.19 140.58 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.796 1.638 . . . . 1.01 108.864 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -130.84 132.06 44.97 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.974 0.91 . . . . 1.05 111.025 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.19 155.87 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.975 2.11 . . . . 1.6200000000000001 110.099 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -120.39 176.31 5.54 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.447 1.899 . . . . 1.5 112.945 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.26 134.88 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.369 1.468 . . . . 3.8300000000000001 111.034 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.256 1.423 0 N-CA-C 114.713 1.375 . . . . 4.9500000000000002 114.713 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 113.114 0.783 . . . . 13.140000000000001 113.114 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.2 162.3 17.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.624 1.569 . . . . 15.029999999999999 111.218 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 68.7 m -141.19 145.69 35.98 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.849 0.86 . . . . 7.4000000000000004 112.21 -169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 7.5 tpt -55.59 106.59 0.26 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.208 1.403 . . . . 6.79 111.028 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 33.3 m170 -120.26 -36.79 3.16 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 5.4199999999999999 113.358 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -76.92 71.57 2.16 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.943 0.782 . . . . 3.04 114.524 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 27.8 m -70.44 117.48 55.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.544 1.538 . . . . 2.8500000000000001 113.079 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.51 87.22 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.856 2.371 . . . . 2.3500000000000001 110.035 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 47.0 t -65.9 109.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.38 1.072 . . . . 3.0499999999999998 111.107 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.7 p -71.17 131.42 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.605 -0.685 . . . . 1.3799999999999999 111.552 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -34.43 2.76 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.281 1.586 . . . . 2.2400000000000002 115.281 -167.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -155.12 145.93 22.42 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.753 1.161 . . . . 1.95 111.666 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.9 m -127.74 133.78 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.072 0.949 . . . . 1.1000000000000001 111.175 170.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 43.4 tttt -135.88 145.52 46.43 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.935 1.294 . . . . 1.6799999999999999 112.539 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 96.4 t -89.52 134.15 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.226 1.81 . . . . 1.03 111.077 173.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1062 ' ' LEU . . . . . 0.612 HD23 HD22 ' A' 1222 ' ' LEU . 30.3 tp -95.4 -38.53 10.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.898 1.679 . . . . 1.3 110.984 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 52.1 m -121.89 111.96 17.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.272 1.429 . . . . 1.78 110.213 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -109.74 136.26 49.36 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.776 1.23 . . . . 3.6299999999999999 112.854 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 57.93 -57.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 130.072 3.349 . . . . 4.2199999999999998 118.82 169.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m120 -70.35 -6.28 34.21 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.603 2.075 . . . . 5.1299999999999999 116.603 -166.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.05 -26.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.401 1.48 . . . . 9.0199999999999996 114.304 168.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mt -144.96 142.38 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.589 1.156 . . . . 2.48 107.969 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.3 m -91.76 144.08 25.87 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.425 0.69 . . . . 2.8300000000000001 111.489 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 27.9 p80 -57.31 -41.36 79.76 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.77 1.396 . . . . 3.8900000000000001 114.77 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 27.1 t60 -74.18 -29.3 61.7 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.075 -1.016 . . . . 2.6099999999999999 111.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.79 -37.5 84.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 117.493 -1.241 . . . . 5.3099999999999996 111.7 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.77 -56.63 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.728 1.149 . . . . 0.85999999999999999 110.309 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.46 -30.1 69.73 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.606 -0.684 . . . . 0.77000000000000002 112.184 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.7 76.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.759 -0.639 . . . . 0.87 112.596 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 17.3 pt -68.81 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.676 1.58 . . . . 0.90000000000000002 112.956 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 61.3 t -70.12 -50.77 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.512 1.051 . . . . 0.92000000000000004 111.349 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.7 84.8 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.526 -0.733 . . . . 0.95999999999999996 113.349 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 76.6 p -73.58 -35.62 65.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.692 -0.887 . . . . 1.0700000000000001 112.041 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -71.21 -39.72 71.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.932 1.086 . . . . 1.22 113.932 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.34 -6.94 53.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.952 1.464 . . . . 3.4900000000000002 114.952 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 84.7 p -58.68 -27.29 64.68 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.221 1.934 . . . . 2.6899999999999999 116.221 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -95.58 -6.84 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.212 0.914 . . . . 2.1099999999999999 113.201 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.1 t -79.77 162.03 25.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.562 1.145 . . . . 1.77 113.728 -174.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -112.64 -3.53 14.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.355 2.262 . . . . 4.3499999999999996 114.097 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1086 ' ' HIS . . . . . 0.474 ' HB3' HN61 ' A' 1232 ' ' ATP . 2.8 m-70 -59.66 144.14 85.57 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.087 -1.008 . . . . 1.6200000000000001 112.282 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.29 -40.54 24.93 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.048 2.498 . . . . 1.8799999999999999 112.286 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.85 -44.47 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.32 -0.862 . . . . 1.8 111.922 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.61 98.26 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.539 0.59 . . . . 1.6599999999999999 113.162 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.2 p -64.32 -38.31 90.58 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.586 -0.95 . . . . 1.55 112.201 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.54 94.78 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.898 0.879 . . . . 1.0800000000000001 112.843 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 54.4 mt -68.29 -42.32 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.087 0.555 . . . . 0.88 110.214 173.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 96.7 m -54.43 -44.71 72.69 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.664 0.666 . . . . 1.23 111.514 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.4 tttt -60.13 -51.43 69.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.68 0.673 . . . . 2.3599999999999999 111.955 174.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.37 -42.52 82.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.714 0.806 . . . . 2.5099999999999998 111.77 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 69.1 m -70.82 -45.65 64.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.147 . . . . 2.9900000000000002 112.696 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.98 -34.86 78.43 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.346 1.884 . . . . 2.5699999999999998 111.371 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -65.08 -39.15 92.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.349 1.06 . . . . 3.9900000000000002 112.941 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.79 -44.57 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.861 -1.15 . . . . 2.8199999999999998 113.074 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.17 -3.1 18.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.848 1.425 . . . . 1.8500000000000001 114.848 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 31.4 t70 58.64 26.22 14.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.627 1.171 . . . . 5.0199999999999996 113.586 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.3 t -122.54 168.44 12.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.31 1.844 . . . . 2.5800000000000001 112.047 -170.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.27 -15.0 15.6 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.994 1.717 . . . . 4.0300000000000002 112.134 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.5 t -132.81 133.42 43.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.061 1.744 . . . . 2.7200000000000002 111.194 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.98 147.61 25.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.246 0.618 . . . . 1.1799999999999999 112.042 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 63.11 177.41 3.83 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.74 1.162 . . . . 1.55 115.08 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 70.7 m -138.47 -69.44 0.44 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.542 0.737 . . . . 1.45 111.414 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 48.9 t -136.11 141.4 44.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.197 0.599 . . . . 1.8999999999999999 111.898 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.98 148.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.255 2.622 . . . . 2.98 111.714 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -110.72 124.34 51.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.909 -2.626 . . . . 3.2999999999999998 103.909 163.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.1 OUTLIER -121.43 138.12 54.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.383 1.447 . . . . 3.1099999999999999 112.889 -174.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.95 98.03 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.385 2.274 . . . . 3.54 108.329 -169.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.5 t -96.22 126.62 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.555 -0.715 . . . . 2.23 110.692 -168.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 33.1 t -143.32 113.88 5.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.751 1.62 . . . . 1.6699999999999999 109.448 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.14 140.36 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.251 2.634 . . . . 1.47 113.925 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 55.4 35.68 61.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.6 1.095 . . . . 2.77 114.362 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 93.0 m -143.5 -32.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.784 1.234 . . . . 2.8799999999999999 113.791 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 122.18 -164.26 15.31 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.075 1.321 . . . . 0.75 112.629 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.33 151.14 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.542 -1.563 . . . . 1.96 111.249 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 14.5 t -129.87 140.5 50.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.732 1.613 . . . . 0.71999999999999997 109.859 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 13.5 p -143.97 156.93 44.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.469 1.032 . . . . 1.3799999999999999 113.682 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -116.23 97.75 6.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.509 1.124 . . . . 1.9399999999999999 108.735 -174.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.1 p -93.96 146.66 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.634 0.73 . . . . 2.2799999999999998 111.426 -174.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.6 t -142.95 162.02 36.57 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.135 1.532 . . . . 1.6000000000000001 115.135 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 10.9 t-20 176.55 -24.81 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 1 C-N-CA 132.183 4.193 . . . . 3.1299999999999999 109.914 162.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 18.0 pt -52.43 -26.36 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 126.337 1.855 . . . . 3.1000000000000001 114.976 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.59 34.39 4.14 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.785 1.634 . . . . 4.6799999999999997 110.179 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.83 36.39 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 120.647 -1.283 . . . . 3.6499999999999999 114.477 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -16.39 63.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.947 1.699 . . . . 4.9000000000000004 115.519 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . 0.313 3.5 pp -95.19 -3.87 46.97 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.274 1.397 . . . . 4.9100000000000001 114.759 173.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 45.8 t-80 32.3 87.32 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.992 2.917 . . . . 6.0499999999999998 115.394 170.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -113.93 140.94 47.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.319 1.229 . . . . 10.93 114.319 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 45.8 t30 -145.73 68.79 1.21 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.442 2.297 . . . . 12.32 107.119 166.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.66 -166.35 0.2 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 126.133 1.773 . . . . 12.960000000000001 112.479 -169.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -92.22 -178.14 4.87 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.02 -1.675 . . . . 17.640000000000001 111.238 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.85 90.52 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.542 1.537 . . . . 12.75 111.252 166.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 70.0 mt -141.67 125.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.472 1.509 . . . . 12.470000000000001 109.008 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.79 -31.95 63.53 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.127 0.971 . . . . 15.630000000000001 112.529 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.51 -7.84 52.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.68 -1.262 . . . . 15.050000000000001 114.399 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.01 -22.26 62.37 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.914 -1.116 . . . . 12.56 112.324 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.96 146.09 54.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.763 0.825 . . . . 14.42 112.66 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.71 136.28 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 15.85 113.458 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -151.77 111.0 3.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.041 1.736 . . . . 16.879999999999999 110.799 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -74.69 -40.22 61.5 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.422 -0.799 . . . . 17.530000000000001 112.545 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 49.23 35.64 7.86 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.266 1.427 . . . . 19.239999999999998 113.606 -169.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 16.2 t 58.81 131.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 129.111 2.964 . . . . 20.73 115.023 -168.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 17.9 mt -98.1 -171.08 2.08 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.971 1.309 . . . . 20.859999999999999 111.44 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 5.8 m -62.06 114.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.067 -1.02 . . . . 22.329999999999998 109.86 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.17 108.75 20.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.477 1.111 . . . . 24.920000000000002 108.752 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.56 9.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.491 1.916 . . . . 27.109999999999999 111.985 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 1.7 t70 -154.28 -154.98 0.54 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.603 2.361 . . . . 27.949999999999999 110.02 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -68.3 26.01 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.928 1.691 . . . . 29.120000000000001 114.895 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 33.2 t 56.45 56.64 5.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.534 1.534 . . . . 26.920000000000002 113.774 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 63.4 t30 -77.13 43.86 0.38 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.82 1.648 . . . . 26.350000000000001 112.728 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -63.46 -54.39 37.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.01 1.324 . . . . 24.399999999999999 112.41 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 46.89 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.431 2.292 . . . . 27.300000000000001 114.142 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 18.5 m -152.33 154.2 35.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.718 2.407 . . . . 22.800000000000001 111.535 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 89.2 p -151.39 149.94 29.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.366 1.467 . . . . 19.620000000000001 113.822 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 65.5 p -144.51 39.0 1.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.463 1.905 . . . . 18.059999999999999 112.188 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 23.0 m -65.29 -11.05 37.6 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 118.877 2.917 . . . . 16.440000000000001 118.877 -166.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 4.9 t 51.89 83.1 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.634 2.373 . . . . 14.390000000000001 117.018 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 54.4 p -125.02 -25.63 3.83 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.639 0.977 . . . . 14.039999999999999 113.639 167.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 40.3 mtt -110.63 152.04 26.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.226 1.41 . . . . 15.75 113.121 -174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 2.3 mm 60.54 13.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 127.182 2.193 . . . . 11.970000000000001 112.872 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.7 pp -73.15 -18.79 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 120.162 -1.587 . . . . 10.0 112.761 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.47 -16.74 64.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.583 0.957 . . . . 9.1300000000000008 113.583 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.79 62.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.05 -1.031 . . . . 7.6299999999999999 112.549 170.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.31 -45.38 13.85 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.389 1.076 . . . . 8.1899999999999995 109.788 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 83.1 mt -55.82 -41.04 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.134 1.374 . . . . 7.2199999999999998 110.822 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.4 m -65.1 -16.49 63.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.303 1.223 . . . . 7.6100000000000003 114.303 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -98.88 -4.03 33.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.494 1.294 . . . . 6.4800000000000004 114.494 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.22 64.32 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.808 1.186 . . . . 5.0999999999999996 113.633 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1173 ' ' LEU . . . . . 0.581 ' H ' HD22 ' A' 1173 ' ' LEU . 2.4 mm? -58.79 -28.7 66.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.974 1.71 . . . . 7.2400000000000002 113.205 172.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -103.77 -39.72 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.034 1.334 . . . . 5.79 112.071 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.96 25.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.67 1.73 . . . . 4.25 115.67 -168.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 57.96 -41.04 0.05 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.584 2.754 . . . . 4.8899999999999997 118.372 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 25.71 119.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 130.667 3.587 . . . . 2.21 117.837 167.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -71.2 115.92 10.91 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.898 -1.126 . . . . 2.77 110.545 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -88.14 125.24 34.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.333 -1.358 . . . . 1.8999999999999999 107.333 168.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.6 m -126.69 141.17 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.295 0.638 . . . . 0.95999999999999996 110.369 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.5 150.76 47.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.988 0.915 . . . . 0.52000000000000002 112.392 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.33 158.47 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.801 1.24 . . . . 0.46000000000000002 109.938 -169.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 104.85 159.18 23.58 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.75 0.691 . . . . 1.6299999999999999 114.783 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 49.53 -159.6 0.06 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.219 1.408 . . . . 2.4900000000000002 113.617 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -58.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.777 1.399 . . . . 7.4299999999999997 114.777 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -80.96 -37.76 28.84 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.152 0.887 . . . . 5.4299999999999997 113.002 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 83.6 t90 -54.73 -36.44 64.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.927 1.291 . . . . 3.0299999999999998 113.087 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.52 -36.36 80.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.665 1.186 . . . . 2.8300000000000001 113.244 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.8 mt -62.37 -61.44 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.723 1.609 . . . . 2.96 109.134 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.4 -13.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.544 2.338 . . . . 6.4800000000000004 116.268 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 6.0 t30 -74.28 22.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 121.694 2.043 . . . . 0.92000000000000004 113.153 168.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.95 26.44 73.23 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.894 -1.753 . . . . 0.84999999999999998 114.409 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 8.2 mt -96.44 147.7 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.052 1.426 . . . . 0.94999999999999996 110.066 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 89.7 t -97.37 126.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.328 1.051 . . . . 1.1299999999999999 110.385 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.0 148.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.977 0.911 . . . . 1.04 112.629 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.55 152.12 38.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.845 1.258 . . . . 2.77 113.583 -168.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -70.93 -28.02 64.2 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.462 1.282 . . . . 2.98 114.462 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.21 -36.64 69.24 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.761 -1.212 . . . . 2.5699999999999998 112.494 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -78.0 -36.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.905 0.882 . . . . 0.82999999999999996 113.286 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -54.0 -42.79 69.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.581 1.152 . . . . 3.1200000000000001 112.517 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.42 -40.01 96.03 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.045 0.938 . . . . 1.9099999999999999 113.086 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -39.03 75.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.687 1.195 . . . . 2.0499999999999998 110.879 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.4 tpp -62.99 -53.29 56.31 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.509 1.124 . . . . 0.77000000000000002 112.313 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 11.0 t -67.48 -32.07 72.64 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.665 -0.647 . . . . 1.03 112.485 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -57.43 -50.86 71.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.518 1.053 . . . . 3.1800000000000002 112.023 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -71.72 -33.94 69.17 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.314 0.857 . . . . 2.5 113.314 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1207 ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 51.0 mm-40 -68.21 -35.95 78.77 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.391 -0.818 . . . . 3.9399999999999999 112.564 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.82 -22.04 61.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.845 1.658 . . . . 4.25 113.524 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 21.5 mttp -76.51 -7.66 55.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.883 1.273 . . . . 3.1099999999999999 112.135 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.56 88.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.964 1.745 . . . . 2.3500000000000001 115.094 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . 0.259 16.0 mtt-85 -84.19 -152.36 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 3.3199999999999998 109.956 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 86.0 m -120.61 120.88 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 121.451 1.932 . . . . 0.77000000000000002 112.112 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.06 127.59 54.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.902 2.081 . . . . 0.48999999999999999 109.595 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 35.8 m -142.29 154.68 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 119.543 1.065 . . . . 0.45000000000000001 113.483 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.32 164.0 12.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.185 1.394 . . . . 1.0 111.731 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.9 t -135.83 129.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.695 1.598 . . . . 2.0699999999999998 111.168 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -134.43 153.01 52.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.166 1.386 . . . . 0.51000000000000001 111.99 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 23.8 m -149.25 130.45 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.879 . . . . 0.92000000000000004 112.899 -169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 35.7 m-20 41.89 40.67 1.62 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.262 1.825 . . . . 3.3900000000000001 111.577 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 62.48 30.62 17.22 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 128.125 2.57 . . . . 2.1099999999999999 116.787 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.14 135.16 54.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.735 2.014 . . . . 2.5600000000000001 110.199 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1222 ' ' LEU . . . . . 0.612 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -67.79 133.78 49.82 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.254 -1.529 . . . . 0.81999999999999995 111.523 172.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -116.83 -42.24 2.98 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.725 1.009 . . . . 0.63 113.725 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.13 -176.47 39.74 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 119.215 0.916 . . . . 0.64000000000000001 114.725 -172.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.03 155.05 44.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.865 1.666 . . . . 0.69999999999999996 112.852 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.63 134.48 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.535 1.534 . . . . 0.92000000000000004 110.266 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -112.93 131.86 55.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.246 1.418 . . . . 0.68000000000000005 110.904 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -128.86 147.61 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.734 2.014 . . . . 1.47 108.789 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -94.86 -30.95 13.93 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.128 1.158 . . . . 4.0800000000000001 114.128 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 11.4 t70 61.46 123.65 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.606 1.962 . . . . 4.2400000000000002 115.012 177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 126.711 2.005 . . . . 5.2199999999999998 115.603 -169.899 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1232 ' ' ATP . . . . . 0.474 HN61 ' HB3' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.145 0.497 . . . . 14.73 110.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -116.38 -31.46 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.257 1.423 . . . . 11.31 112.694 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 9.2 t 49.34 -165.77 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.853 2.461 . . . . 7.6100000000000003 114.622 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.2 -64.01 1.19 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.467 -1.395 . . . . 7.0099999999999998 111.427 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 43.3 m170 -123.01 -67.95 0.91 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.658 1.183 . . . . 7.2999999999999998 112.27 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -73.21 78.38 0.81 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.111 1.339 . . . . 3.52 115.278 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 26.8 m -66.96 125.12 90.38 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.912 0.885 . . . . 2.73 112.426 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -95.04 156.75 1.74 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.198 3.265 . . . . 1.4099999999999999 111.969 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 30.8 t -134.93 113.08 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.609 1.164 . . . . 2.1899999999999999 109.588 173.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 5.8 p -73.06 132.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.777 1.171 . . . . 1.1699999999999999 110.697 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -125.57 -36.17 2.47 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 117.415 2.376 . . . . 2.23 117.415 -164.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -156.42 150.84 25.55 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.737 1.608 . . . . 1.9199999999999999 111.529 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -129.67 136.69 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.117 0.967 . . . . 1.1000000000000001 111.375 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -140.8 147.83 39.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.107 0.963 . . . . 3.1200000000000001 113.153 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 99.1 t -102.45 129.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.318 1.447 . . . . 1.1100000000000001 112.233 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.65 -35.81 9.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.024 1.73 . . . . 1.1100000000000001 112.673 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -111.01 88.66 2.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.634 1.574 . . . . 1.95 108.06 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.64 133.12 41.56 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.948 0.899 . . . . 3.5899999999999999 111.701 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 13.8 m 59.18 25.68 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.226 2.211 . . . . 2.25 115.097 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.61 -6.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.047 1.499 . . . . 2.7200000000000002 115.047 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -140.87 -77.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.891 1.277 . . . . 4.4900000000000002 110.799 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 20.9 mt -137.47 147.57 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.111 2.165 . . . . 1.74 110.075 -174.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.5 m -91.68 152.48 20.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.595 1.558 . . . . 1.8 113.704 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 12.2 p80 -53.81 -42.12 68.05 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.781 2.141 . . . . 3.0299999999999998 116.781 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -73.99 -23.1 59.41 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.073 -1.017 . . . . 2.8799999999999999 111.73 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.2 tttt -75.77 -39.17 57.5 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.095 0.958 . . . . 4.04 111.474 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 66.3 mt -56.38 -52.2 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 119.459 1.027 . . . . 0.73999999999999999 110.656 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.23 -33.34 75.53 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.588 -0.695 . . . . 0.62 112.072 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.02 75.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.722 0.638 . . . . 0.52000000000000002 112.722 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.67 -34.56 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.763 -1.211 . . . . 0.51000000000000001 113.381 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 73.5 t -70.64 -46.07 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.89 0.768 . . . . 0.60999999999999999 110.972 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -63.98 -37.41 94.58 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.662 -0.649 . . . . 0.59999999999999998 113.372 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 32.6 p -73.07 -37.26 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.917 0.887 . . . . 0.62 113.116 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.99 74.5 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.237 0.926 . . . . 0.63 112.247 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.57 -17.36 64.61 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.131 -0.981 . . . . 2.2400000000000002 112.771 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 4.2 t -60.51 -35.35 75.75 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.927 -1.108 . . . . 1.3999999999999999 112.077 170.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.88 -22.17 23.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.649 1.18 . . . . 2.0499999999999998 113.319 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.6 t -74.33 -179.56 4.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.284 1.034 . . . . 1.45 111.8 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -137.3 19.61 2.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.645 1.578 . . . . 4.29 112.691 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1086 ' ' HIS . . . . . 0.417 ' CB ' HN61 ' A' 1232 ' ' ATP . 26.4 m-70 -75.95 161.21 76.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.854 1.262 . . . . 1.6599999999999999 112.617 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.02 -33.67 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.05 2.5 . . . . 1.1799999999999999 114.108 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.81 -49.35 5.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.572 1.549 . . . . 0.78000000000000003 112.722 -167.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.91 -31.62 81.42 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.003 0.335 . . . . 0.96999999999999997 113.772 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.5 p -66.31 -16.34 63.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.746 -1.444 . . . . 1.72 113.915 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.39 80.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.73 -1.231 . . . . 0.78000000000000003 110.737 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.91 -37.11 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.261 1.424 . . . . 0.92000000000000004 110.417 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 97.7 m -53.82 -48.26 70.08 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.074 0.852 . . . . 1.1599999999999999 111.863 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -64.0 -45.97 86.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.342 0.974 . . . . 3.6800000000000002 112.553 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.7 t80 -55.92 -43.92 77.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.919 0.888 . . . . 1.71 111.457 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.7 t -65.85 -52.09 53.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.416 1.487 . . . . 1.9199999999999999 111.864 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -51.51 -45.34 62.84 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.107 1.363 . . . . 3.0699999999999998 112.204 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.54 -43.19 77.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.501 0.72 . . . . 3.3100000000000001 111.559 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -62.19 -42.83 99.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.653 0.982 . . . . 2.6899999999999999 113.653 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.4 mt -71.39 -13.24 61.79 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.825 0.85 . . . . 1.04 112.66 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 15.7 t70 50.61 54.91 10.35 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.293 1.837 . . . . 2.5499999999999998 112.161 -169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.7 t -128.91 175.07 8.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.85 1.66 . . . . 3.0899999999999999 111.841 -174.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -115.69 -7.17 12.14 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.404 1.882 . . . . 2.79 112.402 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 10.0 t -140.04 127.26 21.14 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.402 -1.436 . . . . 2.71 113.819 -168.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -161.52 154.13 20.33 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.649 1.58 . . . . 0.98999999999999999 113.609 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.74 132.03 0.6 Allowed Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.383 1.313 . . . . 1.3200000000000001 116.383 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 87.9 m -120.07 -72.45 0.69 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.448 1.277 . . . . 1.45 114.448 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 52.6 t -138.99 142.5 38.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.786 1.234 . . . . 1.4399999999999999 111.208 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.16 169.97 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 130.584 3.554 . . . . 2.1800000000000002 108.577 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.27 150.05 40.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.739 1.616 . . . . 2.6600000000000001 108.44 166.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -112.72 147.76 36.15 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.367 1.894 . . . . 4.2300000000000004 115.468 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -146.21 95.24 2.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 129.55 3.14 . . . . 2.2999999999999998 108.02 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 24.4 t -101.12 144.54 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.472 1.509 . . . . 1.9099999999999999 111.657 -171.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 48.8 t -132.7 118.14 15.5 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.881 1.273 . . . . 1.27 109.381 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.36 133.26 48.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.252 2.635 . . . . 1.29 115.514 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 62.33 19.06 59.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.675 1.607 . . . . 1.97 114.372 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.8 t -136.93 -42.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.083 1.142 . . . . 2.0099999999999998 114.083 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 154.79 -176.91 32.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.902 0.763 . . . . 0.79000000000000004 113.756 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.22 146.67 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.001 0.92 . . . . 1.8700000000000001 111.536 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 30.0 t -125.41 138.7 54.03 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.853 2.061 . . . . 0.48999999999999999 110.909 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -145.49 165.97 27.05 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 115.176 1.547 . . . . 0.63 115.176 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -111.66 94.43 4.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.758 1.223 . . . . 1.2 108.367 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.8 p -101.96 130.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.215 1.007 . . . . 1.8899999999999999 113.238 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.5 t -123.21 161.05 25.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.359 1.463 . . . . 1.1599999999999999 113.607 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 176.87 -37.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.103 2.961 . . . . 2.1299999999999999 109.931 160.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 18.0 pt -50.07 -21.24 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 127.295 2.238 . . . . 2.52 116.826 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -153.79 39.29 0.48 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.341 1.456 . . . . 4.1500000000000004 109.824 167.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -74.43 0.64 54.27 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 120.465 -1.397 . . . . 3.4100000000000001 115.185 -170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.81 -6.49 21.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.247 1.573 . . . . 3.8700000000000001 115.247 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 24.7 mt -87.32 -26.39 23.43 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.006 0.923 . . . . 5.1299999999999999 111.737 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1131 ' ' HIS . . . . . 0.401 ' CG ' ' H ' ' A' 1132 ' ' LYS . 37.2 t60 52.4 175.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.952 2.101 . . . . 6.1500000000000004 114.963 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1132 ' ' LYS . . . . . 0.401 ' H ' ' CG ' ' A' 1131 ' ' HIS . 55.1 mtpt -71.51 170.51 13.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.367 1.867 . . . . 12.390000000000001 111.688 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -85.22 48.59 1.6 Allowed 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.407 -0.808 . . . . 12.369999999999999 109.339 168.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -79.21 39.17 0.38 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.711 -1.243 . . . . 9.5899999999999999 112.286 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.92 126.9 55.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.773 2.029 . . . . 12.83 107.832 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.2 m-80 60.99 16.0 6.62 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.492 1.117 . . . . 11.789999999999999 113.287 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 59.4 mt -139.15 137.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.509 2.724 . . . . 10.539999999999999 106.829 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -83.03 71.25 10.12 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.289 1.042 . . . . 14.300000000000001 110.665 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 10.6 t70 77.09 123.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 130.527 3.531 . . . . 14.84 116.401 -169.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.57 119.35 26.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.167 1.787 . . . . 14.67 111.522 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -156.44 -175.09 5.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.582 1.553 . . . . 18.120000000000001 111.713 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 15.3 pt -133.68 138.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.455 1.102 . . . . 23.050000000000001 110.367 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -127.99 61.62 1.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.857 2.063 . . . . 20.969999999999999 108.779 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.34 -6.2 41.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.396 1.258 . . . . 25.449999999999999 114.396 -169.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -149.63 129.53 13.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.314 0.857 . . . . 24.84 113.314 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.6 t -60.37 -38.16 83.02 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.314 -0.866 . . . . 23.07 111.254 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.52 14.01 22.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.743 1.217 . . . . 26.960000000000001 113.186 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 2.4 t 57.53 20.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.823 1.649 . . . . 28.149999999999999 113.508 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -79.47 157.57 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.684 1.194 . . . . 31.84 112.843 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.01 137.35 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.292 1.837 . . . . 33.450000000000003 109.932 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -117.9 110.41 17.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.088 0.955 . . . . 33.920000000000002 112.743 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -81.67 56.76 3.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.778 1.231 . . . . 36.979999999999997 110.759 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 11.6 p -51.97 152.05 3.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.815 2.446 . . . . 35.909999999999997 113.63 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 25.9 t30 -61.78 -32.8 73.1 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.47 1.656 . . . . 39.200000000000003 115.47 -167.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.97 143.19 50.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.837 -0.539 . . . . 35.109999999999999 111.397 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -128.77 173.36 10.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.991 1.316 . . . . 42.350000000000001 111.054 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 62.3 m -29.54 116.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.218 2.207 . . . . 36.789999999999999 115.005 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 25.3 p -78.72 -36.93 42.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.589 1.555 . . . . 35.93 111.454 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.8 t -161.44 -11.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.705 2.002 . . . . 36.039999999999999 112.205 167.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 113.41 26.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.103 1.761 . . . . 31.879999999999999 111.603 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 17.0 m -70.02 8.53 0.72 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.679 0.992 . . . . 31.82 113.679 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 36.4 t -72.04 -14.45 61.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 26.52 110.554 165.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 65.7 mmm 50.5 -144.29 0.54 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.837 1.255 . . . . 28.370000000000001 110.328 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 17.0 mm -118.18 55.51 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.981 1.712 . . . . 20.59 108.225 167.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.69 -11.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 115.325 1.602 . . . . 20.920000000000002 115.325 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -148.87 -8.52 0.36 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.371 1.469 . . . . 16.989999999999998 114.732 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -55.42 -28.02 51.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.735 1.607 . . . . 13.119999999999999 114.904 -173.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -87.36 -28.31 22.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 13.76 113.008 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.97 -32.66 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.361 2.264 . . . . 9.5700000000000003 112.271 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 88.3 p -61.61 -9.87 6.99 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.062 1.745 . . . . 8.1099999999999994 115.485 -169.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.35 -57.7 2.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.728 0.811 . . . . 7.0800000000000001 110.578 168.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.4 -30.26 66.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.313 1.845 . . . . 4.2300000000000004 113.996 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -23.93 67.21 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.111 -0.993 . . . . 7.6600000000000001 113.168 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.43 -47.12 5.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.455 1.102 . . . . 5.8700000000000001 111.881 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -80.29 54.01 1.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.641 1.576 . . . . 3.27 109.912 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -26.48 123.14 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.509 2.324 . . . . 2.9900000000000002 115.918 -165.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -147.29 137.93 23.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 112.576 -2.102 . . . . 3.0299999999999998 112.223 -163.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.78 121.85 44.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.125 0.97 . . . . 2.29 108.961 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.37 103.15 13.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.29 -1.004 . . . . 1.21 108.29 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -121.61 138.59 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.959 0.8 . . . . 0.68000000000000005 112.006 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.31 152.52 41.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.851 0.86 . . . . 0.55000000000000004 113.132 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -146.12 140.54 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.437 1.495 . . . . 0.62 109.501 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 169.7 -166.0 39.3 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.255 0.862 . . . . 1.5600000000000001 115.255 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.268 10.4 p30 -84.7 173.19 10.91 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.86 1.264 . . . . 2.2599999999999998 112.546 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -59.19 -10.12 2.61 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 117.276 2.324 . . . . 4.9199999999999999 117.276 -165.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -71.48 -34.15 69.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.017 1.28 . . . . 5.1100000000000003 111.921 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 50.2 m95 -65.42 -26.22 67.87 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.826 -1.171 . . . . 4.0800000000000001 113.658 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -34.16 67.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.446 0.699 . . . . 2.4199999999999999 111.359 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.87 -67.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.137 1.375 . . . . 2.75 107.805 169.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -38.54 -42.96 0.81 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.968 2.507 . . . . 5.6699999999999999 115.451 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.15 1.75 56.07 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.759 1.763 . . . . 2.02 115.759 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 75.86 32.43 53.51 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.749 -1.22 . . . . 0.75 114.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.69 177.45 6.1 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.073 1.349 . . . . 0.81999999999999995 110.987 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.8 t -121.54 132.67 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.09 1.356 . . . . 1.3200000000000001 110.726 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.8 tt -108.29 134.38 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 1.22 110.599 171.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -106.22 162.74 13.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.234 1.014 . . . . 2.9900000000000002 113.461 -168.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.03 -40.32 93.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 2.4300000000000002 113.757 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.72 -34.15 66.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.542 0.737 . . . . 2.54 112.508 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 11.3 p -76.9 -32.97 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.338 0.655 . . . . 0.68999999999999995 111.667 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.89 -46.1 88.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.588 0.755 . . . . 2.0 111.492 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.94 -33.54 74.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.881 1.272 . . . . 2.54 113.867 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.63 -42.16 52.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.799 1.639 . . . . 2.4900000000000002 112.392 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.1 tpp -64.46 -50.65 66.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.232 1.413 . . . . 0.68000000000000005 111.867 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 13.9 t -63.62 -33.12 74.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.427 0.691 . . . . 1.1000000000000001 112.141 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -62.5 -48.99 77.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.98 0.912 . . . . 3.2000000000000002 112.352 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.66 -0.65 . . . . 2.29 112.686 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.97 -40.14 87.4 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.904 -1.122 . . . . 2.9700000000000002 112.323 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -71.22 -27.13 63.26 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.43 -1.419 . . . . 4.5899999999999999 113.804 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 20.8 mttp -70.38 -2.7 14.47 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.648 1.579 . . . . 2.2999999999999998 113.219 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.66 23.53 69.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.957 1.265 . . . . 1.22 113.593 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -101.17 -166.86 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.032 1.333 . . . . 2.98 111.043 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1212 ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 90.8 m -115.22 121.75 43.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.553 1.541 . . . . 1.2 109.928 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -127.51 118.77 24.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.05 0.94 . . . . 0.54000000000000004 110.413 -170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 29.1 m -139.29 153.44 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.114 0.965 . . . . 0.68999999999999995 112.688 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.35 159.15 18.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.206 1.402 . . . . 0.76000000000000001 111.509 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -128.73 125.93 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.151 1.38 . . . . 1.8 110.741 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.19 154.24 40.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.769 1.228 . . . . 0.47999999999999998 111.636 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.8 m -148.09 123.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.732 2.013 . . . . 0.80000000000000004 110.236 -168.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.263 6.7 m-20 40.23 54.91 2.79 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.547 1.939 . . . . 2.9199999999999999 113.168 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.271 34.2 m-20 57.76 30.9 19.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.125 2.17 . . . . 1.6499999999999999 115.954 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -134.88 151.67 51.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.914 1.286 . . . . 2.9300000000000002 110.586 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.02 151.87 45.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.802 -1.811 . . . . 0.81000000000000005 111.748 170.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -122.09 -44.81 2.27 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.594 -0.692 . . . . 0.72999999999999998 111.208 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.64 -162.65 24.26 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.224 0.92 . . . . 0.59999999999999998 115.0 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -140.74 154.25 46.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.591 1.556 . . . . 0.65000000000000002 112.592 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 13.3 mm -123.94 127.52 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.93000000000000005 109.096 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -97.22 133.0 42.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.684 1.194 . . . . 0.81999999999999995 109.758 169.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1228 ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' 1212 ' ' THR . 44.1 mt -140.11 159.85 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.798 2.039 . . . . 1.22 107.397 -170.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -126.33 168.18 14.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.164 -1.585 . . . . 1.49 111.943 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.87 140.2 50.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.048 1.339 . . . . 3.6699999999999999 111.094 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.425 1.89 . . . . 4.75 111.324 -179.871 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1232 ' ' ATP . . . . . 0.417 HN61 ' CB ' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 110.658 -0.127 . . . . 10.06 110.658 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.5 137.38 56.77 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.219 0.608 . . . . 15.93 110.683 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1049 ' ' THR . . . . . 0.433 HG22 ' H ' ' A' 1050 ' ' MET . 3.7 m 57.7 176.49 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.398 1.479 . . . . 9.1199999999999992 113.618 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1050 ' ' MET . . . . . 0.433 ' H ' HG22 ' A' 1049 ' ' THR . 43.4 ttp -136.1 -51.21 0.71 Allowed 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.587 -1.32 . . . . 8.0800000000000001 112.344 168.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -84.93 -34.81 22.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.378 1.251 . . . . 5.9900000000000002 114.378 -175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -55.52 122.74 27.79 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.938 0.78 . . . . 3.71 111.587 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 22.9 m -115.21 117.03 41.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.917 0.887 . . . . 2.3799999999999999 111.126 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.59 154.75 18.24 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.734 2.956 . . . . 2.0699999999999998 111.422 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 59.4 t -142.21 105.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.053 -1.092 . . . . 2.7400000000000002 108.053 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -71.9 128.99 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.96 0.886 . . . . 1.0900000000000001 111.396 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.66 -47.99 4.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.17 1.788 . . . . 2.8399999999999999 112.936 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -153.79 146.9 24.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.589 0.756 . . . . 2.4900000000000002 112.571 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.2 m -120.15 128.87 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.28 1.032 . . . . 0.95999999999999996 110.179 167.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 48.2 tttt -134.12 144.37 48.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.662 0.785 . . . . 2.4900000000000002 113.098 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 97.4 t -90.31 144.31 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.245 1.418 . . . . 0.80000000000000004 112.407 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.9 -29.4 5.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.832 1.653 . . . . 0.81999999999999995 112.551 169.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -127.59 123.8 36.57 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.006 1.323 . . . . 1.75 110.423 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.52 143.35 51.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.574 1.55 . . . . 3.8799999999999999 110.151 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 42.2 m 63.49 -30.83 0.1 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.635 2.374 . . . . 3.3999999999999999 116.803 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.56 -10.79 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.492 1.496 . . . . 3.1299999999999999 114.76 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -160.5 -38.91 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.237 1.415 . . . . 5.5499999999999998 112.299 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.96 167.85 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 126.984 2.114 . . . . 1.54 108.569 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.8 m -143.76 161.77 37.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.902 1.681 . . . . 2.1499999999999999 111.32 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -42.32 -50.78 4.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.859 2.463 . . . . 5.2000000000000002 115.225 -169.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -62.35 -38.32 89.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.672 0.669 . . . . 5.6900000000000004 112.778 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 64.4 mttm -74.29 -39.74 62.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.526 0.73 . . . . 2.5699999999999998 111.008 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.68 -52.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.987 0.915 . . . . 0.55000000000000004 110.945 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.72 -31.21 70.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.513 -0.742 . . . . 0.73999999999999999 112.249 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.67 -50.38 63.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.024 0.379 . . . . 0.51000000000000001 112.024 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.2 pt -69.09 -35.95 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.915 -1.116 . . . . 0.56000000000000005 113.086 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 64.7 t -71.24 -43.76 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.223 0.92 . . . . 0.67000000000000004 111.512 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.53 -34.34 78.81 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.185 -0.947 . . . . 0.68999999999999995 113.807 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 17.2 p -68.24 -43.23 78.35 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.63 -0.924 . . . . 0.88 111.691 171.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.26 76.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.083 0.856 . . . . 0.91000000000000003 112.445 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -71.08 -17.26 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.99 -1.069 . . . . 2.3199999999999998 113.605 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.1 p -72.38 -28.54 63.07 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.204 -1.56 . . . . 1.6200000000000001 112.715 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 22.9 m120 -91.14 -22.71 20.54 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.44 1.496 . . . . 3.48 112.262 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.5 t -76.42 173.64 11.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.396 1.478 . . . . 1.4399999999999999 113.72 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.38 15.11 5.56 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.85 2.06 . . . . 4.0800000000000001 112.714 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -69.35 165.94 34.8 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.212 1.805 . . . . 2.23 113.991 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.51 -23.94 0.72 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.07 2.513 . . . . 1.45 114.395 -173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.6 tt -111.76 -48.77 3.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.934 2.094 . . . . 1.02 112.554 -167.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.5 -21.35 48.88 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.489 0.956 . . . . 0.93000000000000005 115.489 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 63.4 p -66.73 -14.11 62.16 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.518 -1.578 . . . . 1.28 114.343 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.18 82.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.947 0.899 . . . . 0.78000000000000003 111.285 167.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 12.9 mt -71.99 -36.31 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.243 1.417 . . . . 0.70999999999999996 110.278 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 11.2 m -54.84 -48.29 73.04 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.907 0.776 . . . . 1.24 111.519 170.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -59.0 -49.22 78.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.819 0.736 . . . . 2.8500000000000001 111.735 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.74 -44.8 82.03 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.485 1.114 . . . . 2.3999999999999999 112.166 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.5 t -70.05 -50.6 39.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.988 0.915 . . . . 1.6699999999999999 111.763 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -56.22 -38.82 71.57 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.782 -1.199 . . . . 2.7999999999999998 112.378 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -70.05 -35.87 74.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.815 0.846 . . . . 3.0800000000000001 112.633 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -70.17 -46.38 64.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 2.0299999999999998 112.693 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.79 -30.0 62.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 1.05 113.473 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.52 45.5 26.86 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.569 1.547 . . . . 2.6800000000000002 112.062 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.2 t -147.69 146.27 29.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.686 1.365 . . . . 2.6099999999999999 114.686 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.95 19.81 19.94 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.081 1.352 . . . . 3.3900000000000001 114.317 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 80.6 p -110.6 -6.2 14.91 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.946 -1.721 . . . . 3.9900000000000002 114.138 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.3 148.77 48.1 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.02 1.328 . . . . 1.4199999999999999 113.407 -172.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 72.97 137.23 0.27 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.131 1.824 . . . . 0.97999999999999998 114.838 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 97.2 m -136.57 -41.16 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.955 1.302 . . . . 1.3999999999999999 112.474 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 7.5 t -138.97 142.88 38.36 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.239 1.415 . . . . 2.4700000000000002 114.139 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.9 mm -140.27 134.1 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 129.576 3.15 . . . . 2.25 108.206 168.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.323 0.0 OUTLIER -92.18 -14.7 28.66 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.996 1.48 . . . . 3.3999999999999999 114.996 176.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 8.1 m-85 54.33 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 129.04 2.936 . . . . 3.1400000000000001 117.631 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.98 93.08 2.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.456 1.902 . . . . 2.6800000000000002 106.272 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 4.4 m -98.94 150.14 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.269 0.628 . . . . 2.77 110.965 -170.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 31.0 t -140.36 106.41 6.59 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.102 1.361 . . . . 1.1299999999999999 109.6 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 149.9 75.8 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.188 2.592 . . . . 1.8899999999999999 112.406 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.73 -18.31 1.4 Allowed Glycine 0 CA--C 1.538 1.472 0 O-C-N 121.057 -1.027 . . . . 1.53 114.75 -171.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.7 t -115.05 -72.93 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.064 1.345 . . . . 2.2999999999999998 112.976 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 163.9 -153.15 23.4 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.312 0.96 . . . . 1.1000000000000001 113.482 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.0 tt -144.06 148.48 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.075 0.95 . . . . 1.9399999999999999 112.645 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.4 t -117.79 145.17 44.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.135 1.774 . . . . 0.56000000000000005 109.381 164.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 25.9 p -164.57 164.93 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.535 0.939 . . . . 0.72999999999999998 113.535 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -109.63 146.45 34.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 1.3200000000000001 108.629 166.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 32.8 m -123.16 153.8 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.386 1.074 . . . . 2.23 110.808 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -146.08 157.93 43.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.086 0.954 . . . . 1.05 111.903 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -165.98 -33.02 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.953 2.901 . . . . 2.5699999999999998 107.97 158.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1126 ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' 1126 ' ' ILE . 0.2 OUTLIER -52.2 -22.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.751 1.62 . . . . 2.6800000000000002 114.736 168.038 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -138.72 40.73 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.483 1.113 . . . . 4.4000000000000004 110.508 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -54.35 -18.63 10.27 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 116.29 1.276 . . . . 3.3599999999999999 116.29 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -6.15 26.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.665 1.586 . . . . 4.9199999999999999 115.083 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.174 1.389 . . . . 6.71 113.329 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 4.8 t-80 63.87 176.6 0.17 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.21 1.804 . . . . 6.7000000000000002 113.229 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -99.94 10.27 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.581 2.808 . . . . 14.02 118.581 -166.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.85 -62.5 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.461 2.304 . . . . 12.960000000000001 114.537 -169.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 35.1 t-20 64.93 156.23 0.08 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.299 3.04 . . . . 11.68 114.782 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 7.5 m-90 63.9 162.37 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.957 3.303 . . . . 14.869999999999999 115.416 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 66.88 -5.2 0.69 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.127 1.771 . . . . 16.010000000000002 115.206 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.02 -14.26 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.568 1.947 . . . . 16.829999999999998 112.492 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 9.8 tt0 72.8 -39.99 0.46 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.43 2.692 . . . . 22.420000000000002 111.949 -168.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -98.99 -159.88 0.77 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.899 1.68 . . . . 19.699999999999999 109.025 165.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 54.3 19.41 2.22 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.349 2.351 . . . . 15.140000000000001 117.349 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -154.37 -64.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.692 1.197 . . . . 14.75 112.114 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.2 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.215 1.806 . . . . 17.289999999999999 112.308 -174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -72.7 75.77 1.11 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.005 -1.059 . . . . 20.98 110.988 170.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -82.66 6.5 17.66 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.48 2.312 . . . . 18.170000000000002 114.101 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -96.47 142.06 29.02 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.468 1.507 . . . . 19.469999999999999 113.187 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 91.1 p -146.8 161.76 40.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.965 1.306 . . . . 22.219999999999999 112.484 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1147 ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' 1147 ' ' LEU . 2.4 pt? -84.88 -3.27 58.62 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.759 1.392 . . . . 25.420000000000002 114.759 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 19.0 t 46.46 70.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 127.258 2.223 . . . . 26.32 111.17 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.63 24.5 0.47 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.696 1.998 . . . . 29.210000000000001 113.804 -171.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 32.7 mm -139.52 151.26 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.722 2.409 . . . . 28.5 109.037 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -125.7 11.49 7.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.174 1.39 . . . . 30.91 113.906 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -96.89 62.57 1.89 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.592 1.557 . . . . 30.739999999999998 112.775 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 8.7 t 39.93 46.68 1.77 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.793 2.437 . . . . 29.780000000000001 113.492 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -94.08 162.74 13.75 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 116.564 2.061 . . . . 27.399999999999999 116.564 -167.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . 0.261 39.6 mt-10 62.68 -3.97 0.27 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.711 2.804 . . . . 25.27 117.734 174.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -60.9 -14.38 21.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.42 1.888 . . . . 29.07 115.398 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 2.0 m -133.52 18.76 3.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.501 1.92 . . . . 25.68 112.027 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 99.3 p -82.51 -13.67 56.26 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.455 1.65 . . . . 22.579999999999998 115.455 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 1.7 t -150.86 142.92 24.03 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.224 -0.923 . . . . 20.0 112.327 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 14.2 t -156.43 145.18 20.14 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.35 1.46 . . . . 17.199999999999999 111.921 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 55.4 m -89.12 145.78 25.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.788 1.235 . . . . 15.07 113.035 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 22.8 p -126.71 -33.83 2.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.073 1.749 . . . . 13.720000000000001 114.599 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 72.3 mtm -105.54 157.08 17.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.949 1.7 . . . . 13.57 111.786 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 19.0 mm 63.37 -18.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 128.456 2.702 . . . . 10.49 114.973 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.46 -16.6 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 115.573 1.694 . . . . 10.49 115.573 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.98 -24.05 10.16 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.421 1.489 . . . . 10.23 113.182 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -66.61 -14.7 62.74 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.642 1.577 . . . . 7.9900000000000002 114.169 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -90.88 -17.29 26.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 8.5899999999999999 113.564 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.39 -37.22 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.985 0.914 . . . . 7.5499999999999998 110.475 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 2.0 p -76.31 -4.64 43.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.759 1.623 . . . . 6.7599999999999998 114.594 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 17.3 t30 -100.29 -10.21 21.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.036 1.734 . . . . 5.6399999999999997 114.048 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.82 -30.93 68.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.9 1.815 . . . . 5.6900000000000004 115.9 -167.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.57 -30.35 60.64 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.11 0.868 . . . . 6.9000000000000004 112.577 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.98 -40.38 8.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.553 1.141 . . . . 4.4400000000000004 112.628 168.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -79.09 77.16 5.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.392 0.996 . . . . 4.8399999999999999 112.843 -171.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -45.28 -39.78 6.91 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.544 1.537 . . . . 4.0199999999999996 113.824 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 4.12 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 129.525 3.13 . . . . 2.1299999999999999 117.888 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.59 124.55 27.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.585 1.554 . . . . 2.6499999999999999 110.92 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -88.75 122.74 32.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.555 1.142 . . . . 1.6399999999999999 110.733 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -135.22 141.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.254 1.021 . . . . 0.52000000000000002 112.265 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.27 145.44 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.402 1.081 . . . . 0.60999999999999999 112.465 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.7 tt -144.43 145.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.859 1.264 . . . . 0.52000000000000002 109.811 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 124.48 162.04 11.27 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.546 0.978 . . . . 1.6599999999999999 115.546 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.47 -151.63 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.057 1.743 . . . . 2.3900000000000001 113.368 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.94 -30.23 2.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 127.922 2.489 . . . . 6.1799999999999997 112.059 168.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -66.07 -37.93 87.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.908 1.231 . . . . 4.1900000000000004 112.798 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.1 -19.89 65.71 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.433 -1.417 . . . . 2.9900000000000002 112.759 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 1.7 tpp -70.07 -30.13 67.3 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.384 -0.823 . . . . 2.52 111.351 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.15 -67.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.681 1.993 . . . . 2.0600000000000001 108.093 166.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -48.47 -21.5 0.57 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 129.348 3.059 . . . . 5.5599999999999996 115.786 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -93.22 12.9 22.84 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.63 1.344 . . . . 0.93000000000000005 114.63 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.35 36.18 83.83 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 120.543 -1.348 . . . . 0.73999999999999999 114.776 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.9 mt -100.61 172.07 7.32 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.589 1.155 . . . . 0.90000000000000002 111.503 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 16.2 t -121.41 148.11 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.554 1.941 . . . . 1.6799999999999999 110.625 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.02 155.1 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.393 1.077 . . . . 1.6000000000000001 113.807 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -117.63 164.98 14.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.993 2.117 . . . . 2.9500000000000002 113.567 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 58.6 t30 -66.78 -47.04 73.39 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.926 1.454 . . . . 4.54 114.926 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.35 -43.91 98.07 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.201 0.909 . . . . 3.6400000000000001 111.34 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.9 p -72.18 -35.47 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.172 0.989 . . . . 1.23 112.647 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -68.25 -43.19 78.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.519 1.509 . . . . 1.8999999999999999 111.723 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.94 -45.04 91.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.701 0.8 . . . . 1.9399999999999999 111.325 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 35.8 t80 -64.62 -37.56 87.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.267 1.427 . . . . 2.0299999999999998 112.777 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 28.8 tpp -66.32 -51.07 61.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.809 1.244 . . . . 0.83999999999999997 111.303 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 14.9 t -66.52 -34.3 77.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.044 -0.503 . . . . 1.25 111.499 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.65 -47.22 86.47 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.529 1.059 . . . . 4.3799999999999999 113.126 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -70.86 -35.22 72.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.591 0.96 . . . . 2.3199999999999998 113.591 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.26 -42.32 96.54 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.367 0.985 . . . . 2.96 112.439 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -70.14 -25.99 63.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.667 1.587 . . . . 4.7999999999999998 113.583 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -81.22 8.22 9.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.929 1.085 . . . . 2.8700000000000001 113.929 167.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 91.07 -5.43 81.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.175 2.321 . . . . 1.72 116.153 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.63 162.41 14.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 3.6600000000000001 111.603 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 18.7 m -76.03 119.24 19.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.792 0.837 . . . . 1.1100000000000001 110.234 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -119.37 115.86 24.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 0.75 109.638 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.89 157.51 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.323 1.049 . . . . 0.84999999999999998 113.224 -170.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -112.77 162.77 15.38 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.418 1.087 . . . . 0.81000000000000005 113.214 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 2.8 p -132.37 122.89 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.367 1.467 . . . . 2.1899999999999999 112.042 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -113.95 152.61 30.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.54 1.936 . . . . 0.64000000000000001 110.941 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 21.2 m -149.05 120.24 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.646 1.179 . . . . 0.89000000000000001 111.118 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 20.4 t70 41.75 52.13 4.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.469 1.508 . . . . 3.2999999999999998 112.683 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.258 6.6 m-20 65.38 22.87 12.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.88 2.178 . . . . 1.4399999999999999 116.88 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -129.13 151.5 49.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.455 1.502 . . . . 2.7799999999999998 110.774 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 145.42 48.4 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.757 -1.215 . . . . 0.67000000000000004 111.965 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -122.61 -35.4 3.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.829 1.048 . . . . 0.44 113.829 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.82 36.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.114 0.87 . . . . 0.44 115.012 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.71 155.28 44.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.679 1.592 . . . . 0.70999999999999996 112.943 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.83 136.22 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.388 1.475 . . . . 0.71999999999999997 109.593 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -106.02 130.5 53.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.922 1.289 . . . . 0.81999999999999995 109.554 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.85 130.72 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 1.3200000000000001 108.162 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -97.59 -31.72 12.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.337 1.236 . . . . 3.0800000000000001 114.337 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER 62.56 162.71 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.559 1.544 . . . . 3.0699999999999998 114.434 -173.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 C--O 1.253 1.256 0 O-C-N 121.103 -0.998 . . . . 4.4800000000000004 113.073 -173.15 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.197 -0.298 . . . . 10.52 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.14 134.22 44.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.903 0.881 . . . . 11.890000000000001 112.62 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 1.2 m -103.44 139.47 38.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.935 1.294 . . . . 7.9699999999999998 111.967 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 5.4 tmm? -115.18 169.57 9.02 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.383 1.473 . . . . 8.5399999999999991 110.964 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 37.7 m80 59.65 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.648 2.379 . . . . 7.5499999999999998 111.546 -168.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.03 70.22 2.8 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.088 -0.805 . . . . 3.46 111.088 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 62.1 m -96.74 139.18 21.47 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 125.602 1.561 . . . . 2.5800000000000001 109.952 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.39 146.02 73.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.631 2.221 . . . . 1.4199999999999999 112.02 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.0 p -133.16 126.61 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.471 1.508 . . . . 2.9199999999999999 108.276 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.4 p -71.0 123.98 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.667 -1.27 . . . . 1.5 109.239 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -96.49 -41.63 8.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.985 1.314 . . . . 3.2400000000000002 112.547 -167.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -159.28 156.82 29.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.16 1.384 . . . . 1.96 110.99 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 6.5 m -131.23 143.89 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 1.02 110.587 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 50.6 tttt -129.33 140.74 51.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.91 1.284 . . . . 1.8899999999999999 110.753 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 47.4 t -77.86 142.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.653 -0.869 . . . . 0.83999999999999997 108.653 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.45 -38.96 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.862 1.265 . . . . 1.3600000000000001 111.376 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 74.2 m -100.45 92.37 5.12 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 106.447 -1.686 . . . . 1.9399999999999999 106.447 168.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.26 123.12 33.78 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.636 -0.665 . . . . 4.4400000000000004 111.901 -170.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 40.6 m 51.54 39.23 24.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.422 1.638 . . . . 2.9100000000000001 115.422 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -141.53 -8.15 0.98 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.685 1.735 . . . . 2.96 115.685 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -144.97 -65.45 0.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.573 1.533 . . . . 4.2400000000000002 112.613 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.3 142.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.922 2.089 . . . . 1.48 110.063 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 47.4 m -98.95 152.88 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 1.8200000000000001 113.283 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -38.49 51.76 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.515 2.043 . . . . 4.0 116.515 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.1 t60 -68.95 -34.07 74.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.52 1.054 . . . . 2.5499999999999998 111.729 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.75 -36.51 65.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.17 -0.919 . . . . 2.5299999999999998 112.004 173.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.08 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.27 0.941 . . . . 0.75 110.729 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -69.68 -32.54 71.23 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.3 -0.875 . . . . 0.82999999999999996 112.209 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -62.29 -50.7 70.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.259 0.624 . . . . 0.59999999999999998 112.114 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.85 -36.45 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.514 1.052 . . . . 0.58999999999999997 113.189 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 70.7 t -70.42 -44.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 118.893 0.77 . . . . 0.82999999999999996 111.057 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.86 95.85 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.29 -0.881 . . . . 0.71999999999999997 113.431 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.3 p -75.14 -30.01 60.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.0 0.92 . . . . 0.64000000000000001 113.382 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.53 66.18 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.91 0.777 . . . . 0.69999999999999996 111.715 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.87 -18.74 65.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.463 0.912 . . . . 2.1299999999999999 113.463 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 13.6 t -58.12 -22.31 50.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.945 1.298 . . . . 1.3899999999999999 114.263 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -103.74 -2.3 26.66 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.882 1.273 . . . . 1.8999999999999999 113.978 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 16.0 t -86.23 171.76 11.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 1.8300000000000001 113.804 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -3.65 14.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.161 1.784 . . . . 5.9500000000000002 113.746 170.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 153.09 93.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.694 1.197 . . . . 2.0600000000000001 113.878 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -39.83 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.197 2.598 . . . . 1.1299999999999999 113.455 -173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.51 -51.35 5.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.303 0.853 . . . . 0.76000000000000001 113.303 -166.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -65.93 -28.34 73.57 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 114.555 0.582 . . . . 0.92000000000000004 114.555 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 27.3 p -66.27 -13.06 59.84 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.856 -1.379 . . . . 1.73 113.933 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.21 67.91 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.93 -1.106 . . . . 0.84999999999999998 111.032 167.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 16.6 mt -69.85 -35.17 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.622 1.169 . . . . 0.88 109.973 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 88.3 m -54.71 -50.32 68.6 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.705 -0.622 . . . . 1.1699999999999999 111.677 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 69.8 tttt -61.14 -46.31 91.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.68 -0.676 . . . . 1.97 111.875 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 30.9 t80 -55.33 -45.66 76.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.876 0.87 . . . . 1.98 112.547 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 53.7 t -63.35 -54.63 33.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.465 1.106 . . . . 1.97 111.76 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -40.64 67.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.798 1.239 . . . . 3.5499999999999998 112.437 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -73.18 -34.9 66.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.717 1.607 . . . . 3.0600000000000001 113.888 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.97 -43.44 87.84 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.647 -1.283 . . . . 2.3599999999999999 111.32 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.3 0.23 10.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.013 1.325 . . . . 1.21 113.765 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 29.0 t70 46.89 43.41 13.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.473 1.909 . . . . 2.7000000000000002 113.17 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.9 t -132.83 -175.21 3.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.086 0.954 . . . . 3.6699999999999999 113.148 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -123.58 -4.58 8.22 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.721 2.008 . . . . 3.5 112.182 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.1 t -151.47 144.95 24.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.358 1.863 . . . . 2.9399999999999999 112.373 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.25 167.62 23.68 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.849 2.46 . . . . 1.1599999999999999 110.761 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 67.25 168.89 3.81 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.839 1.496 . . . . 1.1200000000000001 116.839 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.2 m -149.09 -54.58 0.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.228 1.411 . . . . 1.4199999999999999 113.495 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 16.6 t -134.65 143.35 47.22 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.494 1.517 . . . . 1.3500000000000001 112.15 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 11.2 tp -139.56 149.04 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.261 3.425 . . . . 2.5 107.658 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -141.62 66.29 1.36 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.428 1.091 . . . . 4.2999999999999998 109.279 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.62 149.4 26.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.132 1.901 . . . . 2.4199999999999999 116.132 -168.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -114.34 113.35 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.85 2.06 . . . . 2.4900000000000002 107.717 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 90.1 t -98.19 124.03 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.024 1.33 . . . . 2.3500000000000001 110.777 -169.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 56.4 t -139.51 98.08 8.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.816 1.647 . . . . 1.72 106.899 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -59.28 130.55 36.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.728 2.286 . . . . 1.8899999999999999 113.519 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 74.61 26.99 66.16 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.308 -0.718 . . . . 1.8400000000000001 114.801 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.8 t -135.44 -43.47 0.69 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.811 1.306 . . . . 2.1899999999999999 113.745 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 151.36 -161.47 29.17 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.893 -1.13 . . . . 1.02 113.919 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1119 ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' 1119 ' ' ILE . 1.7 mm -140.14 145.77 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.811 1.644 . . . . 2.5099999999999998 110.226 169.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 47.3 t -133.43 136.35 45.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.266 1.026 . . . . 0.63 109.368 165.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.8 p -154.15 168.89 25.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.742 1.016 . . . . 0.60999999999999999 113.742 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -109.88 141.44 42.59 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 4.7 p -143.11 138.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.335 0.97 . . . . 1.8999999999999999 112.827 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.4 157.73 45.65 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.698 0.761 . . . . 1.5600000000000001 112.542 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -162.66 -36.73 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.678 2.791 . . . . 3.27 108.895 162.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 3.1 pt -38.52 -42.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.087 2.155 . . . . 3.46 115.522 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -132.38 52.31 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.092 1.357 . . . . 5.8200000000000003 110.236 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -61.83 4.15 0.54 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.816 2.151 . . . . 4.5999999999999996 115.713 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -7.25 0.47 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.658 1.983 . . . . 4.0099999999999998 114.958 172.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -87.96 -1.87 58.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.399 1.48 . . . . 7.8799999999999999 114.734 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -145.56 149.53 34.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 9.3900000000000006 111.979 -169.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -131.09 136.08 48.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.825 1.65 . . . . 15.970000000000001 113.032 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.77 -35.54 44.35 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.758 1.623 . . . . 19.800000000000001 112.954 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.52 173.74 0.06 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.275 1.83 . . . . 19.170000000000002 114.36 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -160.85 -40.48 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.223 -1.548 . . . . 27.920000000000002 113.413 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -79.95 -51.99 8.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.814 1.645 . . . . 26.809999999999999 109.821 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 71.8 mt 49.49 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 128.691 2.796 . . . . 21.629999999999999 114.965 168.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.99 -21.77 61.52 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.603 0.964 . . . . 23.640000000000001 113.603 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.0 t0 -65.96 -24.22 66.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.701 1.2 . . . . 19.609999999999999 112.914 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.01 94.07 4.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.381 1.872 . . . . 21.829999999999998 113.423 -168.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -147.35 -36.24 0.22 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.466 1.906 . . . . 23.760000000000002 110.461 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.7 158.39 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.981 2.112 . . . . 23.27 109.346 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 36.4 mtpt 49.83 47.81 22.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.685 1.594 . . . . 20.559999999999999 112.928 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -78.75 -4.92 51.71 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.22 1.563 . . . . 24.370000000000001 115.22 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 57.56 164.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.009 2.124 . . . . 22.890000000000001 115.411 -170.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 28.8 t -138.13 136.65 36.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.943 1.297 . . . . 25.120000000000001 111.927 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . 0.265 1.5 pt? -76.75 27.09 0.13 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.463 1.653 . . . . 26.23 115.463 -175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 16.9 m -129.17 2.24 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.969 2.108 . . . . 28.039999999999999 112.253 168.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -68.44 146.09 53.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.947 0.899 . . . . 26.379999999999999 111.907 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.71 138.98 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 25.98 111.806 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -131.01 42.53 3.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.772 2.029 . . . . 24.91 111.26 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -89.25 14.4 11.09 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.263 1.825 . . . . 24.329999999999998 115.402 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 27.1 t -148.5 134.01 18.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.406 0.891 . . . . 22.559999999999999 113.406 170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 3.5 p30 -118.51 24.67 10.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.262 1.425 . . . . 21.75 111.546 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 23.4 tt0 74.66 138.4 0.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.588 2.755 . . . . 21.050000000000001 111.419 -167.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.29 143.96 55.02 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.838 -1.164 . . . . 26.140000000000001 110.542 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 39.6 m 54.54 37.85 28.7 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.665 0.617 . . . . 24.149999999999999 112.665 172.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 5.2 p -69.45 162.8 26.68 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.28 -0.887 . . . . 19.920000000000002 112.366 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 72.8 p -70.35 160.22 32.68 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.128 -0.982 . . . . 18.690000000000001 111.067 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 58.8 m -62.21 145.01 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.904 -1.123 . . . . 16.030000000000001 110.592 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 59.9 m -75.63 52.5 0.66 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.048 1.739 . . . . 14.5 113.551 -169.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 65.0 m -60.84 -14.73 23.77 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.169 1.388 . . . . 12.710000000000001 113.227 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 25.9 ptt? -55.8 -26.23 45.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.184 0.993 . . . . 13.91 113.41 166.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.98 14.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.963 1.705 . . . . 13.140000000000001 114.737 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -42.66 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.099 -1.625 . . . . 10.0 111.148 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.76 3.8 4.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.403 1.481 . . . . 9.0199999999999996 114.111 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.58 62.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.275 0.943 . . . . 9.8599999999999994 111.092 169.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -57.3 -31.5 65.71 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.938 1.088 . . . . 10.34 113.938 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 70.9 mt -80.11 -44.99 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.447 1.099 . . . . 7.4800000000000004 110.842 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 69.1 p -72.82 -17.51 61.55 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.035 0.754 . . . . 9.1899999999999995 113.035 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -79.08 -49.56 12.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.898 0.879 . . . . 9.3000000000000007 110.807 167.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -66.31 -13.58 60.72 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.963 1.838 . . . . 4.79 115.963 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.47 -44.23 96.91 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.019 1.282 . . . . 11.56 111.033 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -103.71 -34.35 8.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.993 1.479 . . . . 8.4399999999999995 114.993 171.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -104.04 156.81 17.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 117.515 2.413 . . . . 4.4199999999999999 117.515 -165.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -85.93 151.55 23.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.03 -1.47 . . . . 4.5599999999999996 107.03 163.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.63 169.86 23.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.473 0.916 . . . . 2.9700000000000002 113.473 -168.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.57 123.79 12.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.743 1.217 . . . . 2.8399999999999999 110.55 -168.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.9 116.25 28.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.106 0.962 . . . . 2.0 108.624 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.8 m -135.4 141.6 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.127 0.876 . . . . 0.53000000000000003 112.823 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.35 152.35 40.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.823 1.045 . . . . 0.46999999999999997 113.823 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -152.13 135.91 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.967 1.707 . . . . 0.65000000000000002 110.077 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 162.79 -151.68 21.57 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.962 1.545 . . . . 1.23 116.962 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.42 150.63 3.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.333 2.653 . . . . 2.6600000000000001 112.912 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -61.6 -33.37 73.78 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.504 0.927 . . . . 4.9800000000000004 113.504 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.98 -31.44 69.91 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.776 1.171 . . . . 4.2300000000000004 113.082 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -69.3 -19.79 63.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.382 -1.449 . . . . 3.2200000000000002 112.935 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.4 mmt -67.66 -30.73 70.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.092 -1.005 . . . . 2.5699999999999998 111.42 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.7 mt -71.43 -65.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.108 1.763 . . . . 2.27 109.28 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.17 -32.86 4.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.798 2.039 . . . . 4.6799999999999997 115.702 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.99 12.53 6.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.509 1.05 . . . . 0.88 113.828 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.62 31.6 58.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.377 -1.452 . . . . 1.1799999999999999 115.289 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.33 -161.73 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.914 1.286 . . . . 1.6399999999999999 110.891 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 21.8 t -136.8 136.39 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.192 1.797 . . . . 1.22 110.202 170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.1 tt -125.93 138.63 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.764 1.226 . . . . 1.3100000000000001 111.485 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.39 168.52 12.91 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.825 1.787 . . . . 3.6899999999999999 115.825 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.27 -25.33 61.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.841 1.656 . . . . 2.5699999999999998 115.372 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.51 -40.89 41.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.089 1.313 . . . . 2.7000000000000002 113.302 -176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -73.61 -33.71 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.481 0.582 . . . . 0.94999999999999996 111.41 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -56.94 -43.35 81.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.001 0.92 . . . . 2.3100000000000001 112.081 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.48 -49.93 75.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.169 0.987 . . . . 2.6000000000000001 113.506 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 33.2 t80 -70.25 -36.61 74.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 2.0099999999999998 112.258 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -61.19 -60.79 3.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.141 1.776 . . . . 1.1399999999999999 110.792 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.1 t -66.27 -31.47 72.29 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.896 -0.503 . . . . 1.1899999999999999 112.244 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -59.99 -49.93 75.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.191 0.997 . . . . 2.7400000000000002 112.052 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -68.73 -30.88 69.61 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.764 -0.585 . . . . 3.0600000000000001 112.136 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -65.29 -42.29 93.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.308 1.043 . . . . 2.8399999999999999 112.769 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -66.81 -30.17 70.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 120.855 -1.153 . . . . 3.3399999999999999 113.567 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 19.2 mttp -70.52 -2.93 15.58 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.556 1.942 . . . . 2.5099999999999998 113.566 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 90.63 20.73 39.53 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.0 1.285 . . . . 2.0699999999999998 115.162 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.08 148.58 33.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.749 1.62 . . . . 4.0999999999999996 110.616 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 94.1 m -78.34 137.64 38.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.049 1.34 . . . . 0.79000000000000004 111.063 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -139.22 124.79 19.4 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.096 0.776 . . . . 0.66000000000000003 113.096 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.69 159.11 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.536 1.534 . . . . 0.66000000000000003 113.18 -171.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.64 160.14 16.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.687 1.195 . . . . 0.78000000000000003 112.574 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.5 t -130.86 122.95 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.078 1.751 . . . . 1.6399999999999999 111.608 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.93 151.78 39.29 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.446 1.499 . . . . 0.63 110.621 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.5 m -143.33 118.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.162 1.385 . . . . 0.73999999999999999 112.254 -170.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 30.7 t0 42.07 50.08 4.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.848 2.459 . . . . 3.21 112.942 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.301 2.2 m-20 62.7 38.44 11.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.637 2.375 . . . . 2.3300000000000001 116.182 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -143.33 147.86 35.39 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.285 1.434 . . . . 3.8300000000000001 109.861 167.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.76 151.52 43.47 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.276 -1.515 . . . . 1.3400000000000001 113.267 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 31.3 p -130.51 -47.82 1.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.412 1.264 . . . . 0.63 114.412 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.97 -175.56 36.5 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 120.662 1.574 . . . . 0.48999999999999999 115.884 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.47 155.15 44.28 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.231 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.91 135.09 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.905 1.682 . . . . 0.93000000000000005 109.955 -172.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -115.05 133.29 56.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.515 1.526 . . . . 0.65000000000000002 109.859 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.05 143.17 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.814 2.045 . . . . 1.53 110.285 -169.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -122.83 -167.68 1.63 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.128 1.771 . . . . 1.75 111.343 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.92 141.94 47.27 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.836 1.255 . . . . 4.9400000000000004 111.267 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.693 1.197 . . . . 6.1600000000000001 111.809 178.564 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 118.955 -0.545 . . . . 11.08 112.16 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -155.39 143.57 20.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.867 1.267 . . . . 14.94 110.822 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 6.3 m -99.51 146.34 26.49 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.194 1.183 . . . . 8.2300000000000004 114.194 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1050 ' ' MET . . . . . 0.467 ' CE ' ' H ' ' A' 1052 ' ' GLY . 5.0 ttp -90.84 165.66 13.5 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.506 1.922 . . . . 8.1699999999999999 112.831 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -59.95 -50.67 72.86 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.559 2.059 . . . . 8.3699999999999992 116.559 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1052 ' ' GLY . . . . . 0.467 ' H ' ' CE ' ' A' 1050 ' ' MET . . . -116.22 93.29 0.6 Allowed Glycine 0 N--CA 1.466 0.672 0 C-N-CA 124.14 0.876 . . . . 4.0099999999999998 111.764 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 80.9 p -88.46 147.53 40.05 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 118.213 1.006 . . . . 3.3700000000000001 112.197 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.47 138.78 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.968 2.445 . . . . 1.6399999999999999 112.062 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 14.5 p -144.25 123.06 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.002 0.921 . . . . 2.2599999999999998 111.945 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.6 p -72.53 139.58 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.512 -1.368 . . . . 1.05 111.138 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.36 -41.16 1.91 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.333 1.975 . . . . 2.4399999999999999 116.333 -165.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -150.64 154.85 38.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.392 1.477 . . . . 2.3900000000000001 110.967 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.7 m -134.91 136.05 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.185 0.994 . . . . 0.82999999999999996 111.153 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.9 tttt -141.02 140.12 34.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.331 1.234 . . . . 1.6599999999999999 114.331 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 41.2 t -85.6 143.66 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.251 1.42 . . . . 0.73999999999999999 110.224 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 31.1 tp -114.76 -25.07 8.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.04 1.736 . . . . 0.85999999999999999 113.275 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 93.0 m -126.03 67.22 1.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.474 1.509 . . . . 1.6899999999999999 111.23 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.19 130.33 38.07 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.733 -1.229 . . . . 3.8500000000000001 112.438 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 23.2 m 64.03 -18.62 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.608 2.077 . . . . 2.5600000000000001 116.608 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 30.7 m120 -87.05 -15.99 36.97 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.787 1.176 . . . . 3.2799999999999998 113.646 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 -95.66 0.14 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.388 1.075 . . . . 5.1399999999999997 110.48 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.38 133.16 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.474 1.51 . . . . 1.75 111.141 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 66.7 m -98.17 164.24 12.41 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.642 1.577 . . . . 2.04 113.291 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -43.04 -56.01 3.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.513 1.925 . . . . 5.21 116.103 -169.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 47.7 m170 -64.74 -30.82 71.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.969 0.804 . . . . 3.8999999999999999 112.702 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 44.6 mttp -77.56 -38.14 49.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 118.123 -0.942 . . . . 2.6000000000000001 111.97 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.05 -52.48 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.488 1.04 . . . . 0.68000000000000005 110.844 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.76 -28.15 66.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.673 -0.642 . . . . 0.56000000000000005 112.427 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.2 -47.89 59.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.828 -0.605 . . . . 0.60999999999999999 112.598 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.6 pt -69.62 -32.62 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.53 1.514 . . . . 0.57999999999999996 112.901 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.2 t -70.88 -45.58 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.813 0.733 . . . . 0.69999999999999996 111.376 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -69.17 -36.26 79.41 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.975 -1.078 . . . . 0.70999999999999996 114.009 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 35.8 p -69.15 -34.38 74.89 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.413 -1.051 . . . . 0.76000000000000001 111.794 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.2 91.21 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.765 0.711 . . . . 0.76000000000000001 112.56 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.16 -21.97 62.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.956 1.095 . . . . 3.75 113.956 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.0 t -55.88 -42.13 75.45 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.863 -1.148 . . . . 1.6599999999999999 112.258 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.54 -23.1 40.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.567 0.951 . . . . 2.1899999999999999 113.567 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 27.0 m -89.47 160.61 16.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.057 1.132 . . . . 2.5600000000000001 114.057 -167.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -122.73 18.71 10.29 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.668 1.587 . . . . 5.3899999999999997 113.225 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 143.29 91.56 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.753 1.221 . . . . 1.51 112.132 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.55 -45.52 1.14 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.316 2.677 . . . . 1.28 114.356 -169.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.37 -34.23 72.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.297 -0.877 . . . . 0.93999999999999995 111.069 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -61.16 -20.33 58.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.135 1.35 . . . . 1.8100000000000001 115.545 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 66.7 p -59.49 -37.98 79.68 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.019 1.409 . . . . 2.8199999999999998 112.184 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.55 -36.39 80.87 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.49 -0.756 . . . . 1.2 112.407 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.8 mt -70.78 -36.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.054 -1.029 . . . . 1.5 111.023 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.3 m -55.14 -51.79 65.34 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.168 0.987 . . . . 1.9299999999999999 110.438 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.5 tttt -54.44 -55.23 30.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.181 0.992 . . . . 3.5699999999999998 111.574 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -57.72 -45.85 85.22 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.321 0.648 . . . . 1.8999999999999999 112.636 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 37.3 t -66.82 -54.15 25.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.243 0.617 . . . . 1.6699999999999999 111.4 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -43.07 75.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.238 1.015 . . . . 2.8500000000000001 110.756 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.34 -44.54 87.42 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.972 0.73 . . . . 3.0499999999999998 112.972 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -67.11 -38.7 86.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.535 1.062 . . . . 2.79 113.303 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.35 -19.87 60.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.621 1.168 . . . . 1.3500000000000001 113.107 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 8.8 t70 64.47 15.66 9.71 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.593 2.357 . . . . 3.3100000000000001 114.221 -170.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 2.6 t -130.52 147.1 52.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.816 1.646 . . . . 3.1200000000000001 115.249 -169.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.11 -12.67 43.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.559 1.144 . . . . 3.5099999999999998 111.858 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 35.6 p -73.43 26.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.397 1.999 . . . . 4.7000000000000002 116.397 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.74 29.07 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.532 1.533 . . . . 1.55 114.659 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 78.24 145.07 2.55 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.656 1.598 . . . . 1.1100000000000001 116.989 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -141.42 -63.34 0.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.964 1.705 . . . . 1.4099999999999999 113.392 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 41.4 t -136.54 141.51 43.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.181 1.355 . . . . 1.5 112.443 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.1 mm -141.93 140.19 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 132.18 4.192 . . . . 2.0699999999999998 109.389 -170.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.8 t0 -111.72 104.17 12.5 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.905 -1.887 . . . . 2.5699999999999998 105.905 165.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1111 ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' 1119 ' ' ILE . 32.9 t80 -88.54 133.15 34.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.931 1.292 . . . . 3.2599999999999998 114.436 -165.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -139.34 120.7 14.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.304 1.842 . . . . 2.1099999999999999 110.993 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 44.3 t -104.34 140.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.97 1.308 . . . . 2.3199999999999998 111.68 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 51.7 t -126.33 111.94 23.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.029 0.932 . . . . 1.51 109.188 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.19 143.08 93.93 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.313 2.675 . . . . 1.79 113.634 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.38 15.15 65.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.947 1.26 . . . . 2.0600000000000001 113.696 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 73.4 m -134.34 -87.32 0.39 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.86 1.664 . . . . 1.9099999999999999 111.39 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 172.99 -151.37 13.78 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.937 0.779 . . . . 0.90000000000000002 112.455 -172.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1119 ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' 1111 ' ' PHE . 0.1 OUTLIER -134.26 146.32 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.265 1.026 . . . . 2.2000000000000002 111.893 -173.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.8 t -134.24 144.18 48.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.857 1.663 . . . . 0.72999999999999998 111.259 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.8 p -158.04 172.38 18.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.549 1.685 . . . . 0.62 115.549 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -114.64 120.81 41.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.252 1.421 . . . . 1.1200000000000001 107.453 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 12.0 p -128.76 134.52 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 115.033 1.494 . . . . 1.8600000000000001 115.033 -167.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1124 ' ' THR . . . . . 0.427 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.4 t -133.81 161.34 35.01 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 123.242 1.496 . . . . 1.73 114.276 169.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -159.53 -29.99 0.06 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.233 3.413 . . . . 2.6000000000000001 108.289 160.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 10.2 pt -43.17 -44.24 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.31 1.844 . . . . 2.71 114.839 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -124.93 39.98 3.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.562 1.172 . . . . 4.75 110.772 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.38 15.78 0.14 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.998 2.237 . . . . 4.8600000000000003 115.957 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.71 -16.68 28.07 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 126.332 1.853 . . . . 3.8100000000000001 112.867 169.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.43 -44.69 5.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.635 1.174 . . . . 4.9199999999999999 112.036 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -122.7 135.58 54.62 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.527 1.131 . . . . 7.5700000000000003 110.261 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -116.92 171.92 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.573 2.064 . . . . 13.630000000000001 116.573 -165.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -61.5 -39.41 90.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.446 2.298 . . . . 16.420000000000002 115.004 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 72.5 m-80 60.38 156.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.817 2.447 . . . . 14.279999999999999 114.939 -168.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 55.1 m95 -136.3 -170.0 2.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.459 2.303 . . . . 21.52 110.011 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -50.01 -31.01 11.8 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.386 1.074 . . . . 20.300000000000001 113.85 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 77.2 mt 54.63 111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 129.959 3.303 . . . . 15.83 114.08 171.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -53.38 -38.95 63.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.197 0.999 . . . . 21.579999999999998 112.361 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.41 -24.77 66.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.117 1.767 . . . . 19.489999999999998 114.158 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -81.04 165.84 21.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.014 1.726 . . . . 15.74 112.826 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -105.1 140.78 37.77 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.985 1.714 . . . . 16.920000000000002 107.65 166.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.35 149.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.557 1.688 . . . . 18.559999999999999 115.557 -166.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -139.39 144.15 38.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.027 2.131 . . . . 18.190000000000001 111.153 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -75.07 -24.07 58.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.124 1.157 . . . . 19.359999999999999 114.124 -170.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -87.74 2.66 50.62 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.645 1.35 . . . . 18.120000000000001 114.645 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 59.8 m 61.07 171.61 0.1 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.342 1.457 . . . . 18.460000000000001 114.56 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.79 132.36 34.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.266 -0.896 . . . . 20.899999999999999 109.861 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 6.1 p -146.54 137.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.011 1.325 . . . . 21.550000000000001 111.239 -171.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -136.33 6.92 3.07 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.482 1.66 . . . . 24.34 115.482 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 6.0 tp -153.61 -42.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.717 1.207 . . . . 23.329999999999998 114.148 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 46.4 t0 -145.29 109.26 4.79 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 0.876 . . . . 22.260000000000002 113.045 -168.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -77.31 37.76 0.21 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.874 1.67 . . . . 23.390000000000001 114.355 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 45.4 t -77.97 -31.77 50.96 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.015 2.126 . . . . 22.550000000000001 115.519 -168.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -134.68 123.54 23.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 23.170000000000002 111.541 -168.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -133.24 160.34 37.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.161 0.984 . . . . 23.82 113.262 -168.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.1 mp0 56.39 -170.91 0.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.646 1.979 . . . . 27.010000000000002 112.136 -166.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 9.1 t 61.68 -173.84 0.14 Allowed 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.55 -1.344 . . . . 23.629999999999999 114.521 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 7.3 p -73.04 77.54 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.281 2.233 . . . . 21.59 112.488 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 8.9 t -56.33 127.46 31.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.584 0.753 . . . . 19.129999999999999 111.159 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 49.4 m -145.07 48.51 1.29 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.89 1.276 . . . . 16.370000000000001 112.874 -167.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 64.0 p -74.42 180.0 4.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.257 -0.902 . . . . 15.220000000000001 113.285 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 17.5 m -52.79 -33.38 48.51 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.124 1.527 . . . . 12.42 115.124 -172.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.9 ptt? -76.62 -13.33 60.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.705 1.372 . . . . 14.5 114.705 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.5 -30.58 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.098 1.759 . . . . 12.27 111.71 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.8 pp -82.02 -17.19 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 113.694 0.998 . . . . 10.289999999999999 113.694 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.99 -31.58 71.96 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.706 1.139 . . . . 9.4700000000000006 112.838 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -76.56 -9.25 58.52 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.289 1.218 . . . . 8.7699999999999996 114.289 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.64 -19.3 12.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.224 1.809 . . . . 9.4800000000000004 115.38 -169.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 61.3 mt -48.48 -47.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.989 1.316 . . . . 7.2999999999999998 111.748 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 69.8 m -63.28 -25.06 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 6.3799999999999999 113.191 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 7.9 m120 -78.56 -40.28 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.816 0.847 . . . . 7.1799999999999997 111.261 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.13 87.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.824 0.85 . . . . 6.04 112.372 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.03 -14.38 62.66 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.314 1.227 . . . . 7.79 114.314 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.33 -31.29 16.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.168 0.987 . . . . 4.8700000000000001 112.311 169.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -81.03 -1.02 42.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.338 1.455 . . . . 4.2400000000000002 114.444 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 51.66 84.28 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.726 2.01 . . . . 2.9300000000000002 114.288 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1177 ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' 1124 ' ' THR . 28.1 mt-30 -102.99 98.09 8.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.23 1.412 . . . . 3.5099999999999998 109.788 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.54 133.38 53.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.937 1.695 . . . . 2.5499999999999998 110.781 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.13 116.19 27.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.798 0.726 . . . . 1.55 111.767 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.7 m -137.47 144.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.083 0.953 . . . . 0.59999999999999998 113.067 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.08 152.54 46.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.844 1.258 . . . . 0.59999999999999998 113.492 171.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.3 tt -149.18 139.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.432 1.493 . . . . 0.79000000000000004 110.352 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 131.18 150.16 6.66 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.156 0.884 . . . . 1.6399999999999999 115.09 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 49.29 -155.98 0.09 Allowed 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 126.103 1.761 . . . . 2.3399999999999999 113.931 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -140.08 -37.46 0.47 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.47 2.396 . . . . 6.4199999999999999 117.47 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.33 -30.67 69.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.568 1.531 . . . . 3.9900000000000002 110.703 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -55.45 -34.32 64.38 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.192 -0.942 . . . . 2.8399999999999999 113.465 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -35.03 77.78 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.745 1.017 . . . . 2.0299999999999998 113.745 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.68 -60.39 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.986 -1.116 . . . . 1.8700000000000001 107.986 168.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.19 -27.04 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.835 2.054 . . . . 6.4199999999999999 115.687 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.85 16.07 1.25 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.892 1.678 . . . . 1.0700000000000001 112.498 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.73 16.05 67.42 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 119.797 -1.814 . . . . 1.22 116.07 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.59 174.23 10.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.393 1.597 . . . . 0.93999999999999995 111.911 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.2 t -115.8 130.98 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.664 1.186 . . . . 1.3600000000000001 109.309 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.69 127.77 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.867 1.267 . . . . 1.21 110.011 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . 0.253 6.1 p-10 -89.41 158.3 17.8 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.99 1.107 . . . . 3.8399999999999999 113.99 -176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 64.6 t30 -62.6 -23.71 67.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.954 1.302 . . . . 2.71 114.344 -170.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.21 -43.37 42.65 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.708 -1.245 . . . . 3.7999999999999998 112.907 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 3.3 p -75.6 -31.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 125.303 1.441 . . . . 0.97999999999999998 110.985 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -52.87 -50.59 63.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.987 1.267 . . . . 3.8199999999999998 111.213 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.32 -44.93 80.43 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.206 0.447 . . . . 2.1699999999999999 112.206 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.7 t80 -71.57 -36.01 70.78 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.62 0.97 . . . . 2.2400000000000002 113.62 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.7 tpp -63.22 -50.92 68.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.201 1.401 . . . . 0.83999999999999997 111.077 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.2 t -69.93 -33.25 71.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.012 -0.43 . . . . 0.91000000000000003 111.718 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.66 -46.8 87.96 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.731 -1.231 . . . . 4.1200000000000001 112.889 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -71.16 -37.03 72.22 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.249 1.203 . . . . 2.1899999999999999 114.249 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1207 ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 43.3 mm-40 -62.28 -37.46 85.59 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.108 -0.995 . . . . 3.6899999999999999 112.21 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -72.73 -24.33 60.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.31 1.844 . . . . 3.77 114.961 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 77.6 mttt -66.39 -6.85 15.83 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.627 1.171 . . . . 3.4300000000000002 114.128 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.64 19.98 35.93 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.854 1.692 . . . . 1.1699999999999999 113.092 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -118.67 178.36 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.531 1.532 . . . . 3.29 111.994 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 3.4 m -100.4 120.97 40.78 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.771 1.629 . . . . 1.1599999999999999 110.246 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1213 ' ' ALA . . . . . 0.59 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -116.84 119.65 36.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.014 1.325 . . . . 0.65000000000000002 110.098 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.2 m -136.34 153.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.431 0.9 . . . . 0.45000000000000001 113.431 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.17 166.01 10.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.133 0.973 . . . . 0.81999999999999995 112.794 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 11.6 t -131.71 125.86 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.003 2.121 . . . . 1.6000000000000001 110.026 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -130.13 156.64 44.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.612 1.165 . . . . 0.5 111.81 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.3 m -144.74 120.11 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.839 1.655 . . . . 1.1699999999999999 111.689 -169.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 23.3 t70 44.65 47.28 8.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.109 1.364 . . . . 4.1500000000000004 113.316 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 60.79 42.15 13.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.039 -1.663 . . . . 1.99 115.023 -174.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.93 141.52 30.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.686 1.595 . . . . 2.1899999999999999 110.561 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.71 137.44 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.108 -1.62 . . . . 0.76000000000000001 112.852 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.0 p -115.01 -40.96 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.097 0.959 . . . . 0.62 112.719 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -168.13 -174.02 36.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.656 1.116 . . . . 0.55000000000000004 115.384 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.37 155.71 43.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.402 1.881 . . . . 0.79000000000000004 112.702 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.9 mm -129.76 140.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.382 1.473 . . . . 0.81000000000000005 110.526 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -113.07 130.12 56.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.094 1.758 . . . . 0.56999999999999995 110.36 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.14 157.7 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.846 2.059 . . . . 1.4099999999999999 109.598 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -132.5 -174.96 3.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.268 1.827 . . . . 1.5600000000000001 111.956 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.58 151.52 28.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.029 1.332 . . . . 4.2000000000000002 111.81 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.247 1.419 . . . . 4.5899999999999999 113.685 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 119.612 -0.232 . . . . 13.289999999999999 111.056 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.23 170.93 10.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 14.800000000000001 109.899 169.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 1.9 m 66.45 149.82 0.05 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.709 2.004 . . . . 8.9700000000000006 115.036 170.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 9.9 tpt -122.72 -79.57 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.682 1.993 . . . . 11.609999999999999 109.271 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 31.9 m80 -127.07 -16.43 5.07 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.497 1.295 . . . . 9.5199999999999996 114.497 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -130.46 129.98 6.03 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.705 1.138 . . . . 3.5499999999999998 114.423 -169.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.6 p -98.38 149.79 36.09 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 125.653 1.581 . . . . 2.8999999999999999 112.631 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.92 130.02 24.82 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.691 2.928 . . . . 1.51 112.961 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 96.7 t -105.5 124.22 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.187 1.795 . . . . 2.46 109.648 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.4 121.68 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.046 0.839 . . . . 1.29 110.915 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.26 -47.69 3.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.502 0.721 . . . . 3.3799999999999999 112.82 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -151.49 149.25 29.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.79 1.636 . . . . 2.6099999999999999 111.713 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 12.3 m -125.52 139.78 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.178 0.991 . . . . 0.87 110.402 168.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.1 tttt -141.99 148.48 38.62 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.048 0.759 . . . . 2.3199999999999998 113.048 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 73.9 t -106.61 145.01 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.191 1.397 . . . . 1.1200000000000001 111.31 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.95 -25.04 10.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.559 1.544 . . . . 0.83999999999999997 113.44 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 9.9 t -93.94 162.09 14.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.824 2.05 . . . . 3.0600000000000001 112.813 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -146.46 116.02 7.15 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.619 -1.301 . . . . 5.3600000000000003 110.32 167.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 63.4 m 51.67 33.75 11.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.525 2.046 . . . . 2.9900000000000002 116.525 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 28.2 m120 -126.97 -30.89 2.67 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.463 1.283 . . . . 3.6099999999999999 114.463 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 113.52 2.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.713 1.605 . . . . 5.9800000000000004 108.649 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.3 mm 66.17 133.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 127.55 2.34 . . . . 2.02 114.725 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 67.0 m -81.5 151.11 27.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.985 1.314 . . . . 2.6699999999999999 113.099 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 61.9 m80 -53.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.598 1.703 . . . . 6.6100000000000003 115.598 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 43.3 t60 -74.96 -29.45 60.92 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.726 -1.234 . . . . 2.5299999999999998 111.695 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.47 -36.69 81.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.84 -1.163 . . . . 2.7999999999999998 111.804 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 98.0 mt -56.62 -53.86 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.117 . . . . 0.88 109.668 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.7 76.53 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.238 0.926 . . . . 0.71999999999999997 112.367 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.58 -46.17 76.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.105 0.779 . . . . 0.66000000000000003 113.105 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.71 -35.39 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.232 1.378 . . . . 0.66000000000000003 112.815 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 59.8 t -70.52 -46.61 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.754 0.706 . . . . 0.83999999999999997 111.381 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.53 91.45 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.43 -0.794 . . . . 0.75 113.642 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.3 p -73.95 -34.31 64.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.181 0.808 . . . . 0.87 113.181 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.35 90.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.434 0.901 . . . . 0.76000000000000001 113.434 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.31 -11.73 60.83 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.673 0.99 . . . . 2.0699999999999998 113.673 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.5 t -62.47 -19.21 63.32 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.587 -1.321 . . . . 1.3 113.6 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -107.43 0.25 22.76 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.203 1.401 . . . . 1.96 113.379 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 69.4 m -101.28 167.46 10.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.271 1.211 . . . . 2.1299999999999999 114.271 -169.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.83 54.72 1.21 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.312 1.845 . . . . 3.6600000000000001 111.572 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.03 69.09 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.52 1.528 . . . . 2.0099999999999998 112.66 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.33 -17.22 9.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.961 3.107 . . . . 1.0 116.285 -167.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.82 -50.91 2.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.575 0.954 . . . . 0.82999999999999996 113.575 -166.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.61 67.4 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-O 121.531 0.517 . . . . 0.98999999999999999 113.557 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 32.0 p -63.68 -22.76 67.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.114 1.366 . . . . 1.77 113.337 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.22 69.1 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.701 -1.25 . . . . 0.85999999999999999 111.702 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.68 -35.75 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.973 0.909 . . . . 0.95999999999999996 110.077 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 34.3 m -57.1 -48.08 79.47 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.247 0.93 . . . . 1.3100000000000001 110.93 168.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -54.81 -51.32 66.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.303 1.041 . . . . 3.9199999999999999 112.036 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.01 -44.39 91.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.331 1.052 . . . . 1.77 111.496 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 48.9 t -65.93 -49.7 67.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.266 1.026 . . . . 1.8500000000000001 111.93 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.88 -33.04 74.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 2.9199999999999999 111.446 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.8 -41.12 72.04 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.784 1.234 . . . . 3.1699999999999999 113.524 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -69.61 -40.49 76.57 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.944 1.247 . . . . 2.0 113.359 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.07 -20.22 61.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.673 1.189 . . . . 1.1599999999999999 113.351 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.2 t0 54.14 42.36 31.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.687 1.195 . . . . 2.3399999999999999 112.498 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.1 t -125.85 165.97 17.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.261 1.824 . . . . 2.6299999999999999 111.086 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -100.01 -11.13 20.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.942 1.297 . . . . 3.1200000000000001 113.885 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 9.9 t -148.15 135.12 20.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.843 1.257 . . . . 2.8799999999999999 111.551 -172.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -158.22 149.48 21.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.764 1.226 . . . . 0.84999999999999998 112.476 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 69.88 142.94 0.18 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.032 1.301 . . . . 1.03 115.244 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 19.0 m -112.01 -80.03 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.653 1.581 . . . . 1.45 112.125 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 44.5 t -135.39 136.75 41.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.92 1.288 . . . . 1.3500000000000001 111.279 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.4 mp -141.09 149.78 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.275 3.83 . . . . 3.1400000000000001 107.056 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 31.5 t70 -137.03 109.01 7.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.896 1.278 . . . . 3.3399999999999999 109.348 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -97.35 135.07 39.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.198 1.925 . . . . 2.8799999999999999 116.198 -171.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.1 26.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.637 2.775 . . . . 3.0499999999999998 107.12 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.4 m -112.49 142.57 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 115.092 1.515 . . . . 2.46 115.092 -167.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.77 131.23 14.63 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.321 1.449 . . . . 1.1499999999999999 109.39 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.4 130.88 21.96 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.784 2.322 . . . . 1.71 111.862 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.74 -41.53 0.69 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.722 2.106 . . . . 2.2000000000000002 115.148 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -78.75 10.97 2.85 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.636 2.087 . . . . 2.5699999999999998 116.636 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 85.98 171.79 48.23 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 119.093 0.86 . . . . 1.24 113.249 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.4 pt -136.12 165.51 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.665 1.186 . . . . 2.98 111.868 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.2 t -127.14 152.37 47.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.333 1.053 . . . . 0.56000000000000005 112.112 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 23.1 p -144.35 169.68 17.46 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.028 -1.045 . . . . 0.68999999999999995 113.258 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -118.51 119.94 36.05 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.578 -1.267 . . . . 1.7 107.578 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.1 p -127.09 136.78 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.846 1.054 . . . . 1.8999999999999999 113.846 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1124 ' ' THR . . . . . 0.495 ' HB ' HE21 ' A' 1177 ' ' GLN . 5.3 t -119.76 150.11 40.93 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.445 0.906 . . . . 1.0600000000000001 113.445 168.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 51.3 t30 -167.48 36.6 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.459 2.704 . . . . 2.6800000000000002 108.463 158.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 6.1 pt -130.78 -75.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.394 1.878 . . . . 2.3799999999999999 110.443 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -129.43 -10.37 4.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.216 1.371 . . . . 5.4500000000000002 113.827 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -60.92 -6.84 7.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.193 1.854 . . . . 4.5999999999999996 116.96 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.91 -8.64 1.04 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 119.079 1.439 . . . . 3.7599999999999998 114.483 168.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 4.1 tt -71.53 -53.44 13.81 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.979 2.112 . . . . 4.8200000000000003 111.423 169.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -153.25 134.42 14.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.742 1.617 . . . . 10.26 111.635 -171.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -140.05 -41.35 0.43 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.615 1.566 . . . . 10.56 114.673 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 6.0 t30 51.17 29.16 4.57 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 125.223 1.409 . . . . 12.390000000000001 113.026 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -92.4 51.6 1.79 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.674 -1.267 . . . . 12.01 111.645 -169.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 79.2 m95 -90.48 176.25 6.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.159 1.384 . . . . 13.460000000000001 109.967 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 4.8 p30 -39.16 -79.08 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.643 2.377 . . . . 15.35 113.306 172.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 55.5 mt 51.08 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 128.166 2.587 . . . . 13.08 113.161 171.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.76 -20.61 66.33 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.293 -1.505 . . . . 18.030000000000001 113.334 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.17 -20.75 64.47 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.14 1.376 . . . . 14.050000000000001 112.785 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 9.6 t30 -93.2 -45.18 7.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.095 1.358 . . . . 15.390000000000001 112.046 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -73.58 -28.91 62.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 117.095 2.257 . . . . 15.9 117.095 -165.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.2 22.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 113.72 1.007 . . . . 18.390000000000001 113.72 -169.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -78.6 -38.99 38.67 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.684 -1.26 . . . . 17.469999999999999 112.429 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 73.4 m-80 47.81 41.49 14.32 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.211 1.405 . . . . 19.0 113.969 175.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -147.08 171.36 15.42 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.561 0.949 . . . . 19.59 113.561 -174.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.7 t -134.17 126.34 29.74 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.452 1.101 . . . . 22.719999999999999 111.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.22 153.09 38.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.511 1.925 . . . . 24.670000000000002 110.877 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 2.4 t 48.4 47.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 126.566 1.946 . . . . 28.32 111.697 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 133.18 45.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.645 0.778 . . . . 29.949999999999999 112.941 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 35.3 mm -97.99 -34.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 32.960000000000001 111.041 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 19.0 m-20 48.68 53.3 12.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.974 1.71 . . . . 32.039999999999999 112.363 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -71.42 -19.75 62.2 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 115.216 1.562 . . . . 33.310000000000002 115.216 -169.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 16.2 p 65.57 163.73 0.16 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.844 2.458 . . . . 32.93 115.043 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.56 33.26 23.02 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.231 1.812 . . . . 34.340000000000003 114.811 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.64 -39.61 2.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.64 1.576 . . . . 28.68 112.32 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 61.29 166.86 0.09 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.117 2.167 . . . . 30.149999999999999 115.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 2.6 t 64.09 174.66 0.18 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.829 2.452 . . . . 23.18 115.933 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.25 49.8 p 64.44 24.9 13.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.612 2.365 . . . . 19.690000000000001 116.098 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 52.7 p -75.88 -18.62 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.355 1.062 . . . . 20.010000000000002 113.556 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 61.8 p -68.37 -54.0 20.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.811 1.244 . . . . 16.57 111.811 170.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 2.5 t -150.92 135.1 16.82 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.988 2.115 . . . . 15.24 108.753 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 11.7 m -104.76 19.67 20.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.527 1.306 . . . . 13.9 114.527 -168.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1163 ' ' MET . . . . . 0.405 ' C ' ' H ' ' A' 1165 ' ' ILE . 36.7 mmm -122.58 153.26 39.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.75 1.22 . . . . 13.99 111.708 -169.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 14.9 mm 63.56 -27.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 126.174 1.789 . . . . 10.84 113.165 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1165 ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' 1163 ' ' MET . 2.3 pp -59.53 -28.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.245 1.418 . . . . 9.9199999999999999 113.018 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.58 -18.92 20.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.24 1.2 . . . . 8.6400000000000006 114.24 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -74.73 -5.63 44.32 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 114.527 1.306 . . . . 7.5700000000000003 114.527 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -109.89 4.77 21.89 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.452 2.301 . . . . 7.5199999999999996 114.195 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.12 -36.94 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.542 1.937 . . . . 6.3200000000000003 112.771 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 89.4 p -64.25 -14.75 57.62 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.866 1.432 . . . . 6.21 114.866 -169.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -104.63 -10.98 17.16 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.193 1.923 . . . . 6.6299999999999999 116.193 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -46.57 -47.54 19.74 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.06 1.874 . . . . 4.46 116.06 -165.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.29 -17.65 64.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.418 1.266 . . . . 6.6500000000000004 114.418 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -99.88 -42.98 6.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.898 0.879 . . . . 5.25 110.721 168.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.24 52.95 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.875 1.67 . . . . 3.9100000000000001 111.745 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -54.35 147.06 14.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.676 2.102 . . . . 5.1600000000000001 116.676 -166.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1177 ' ' GLN . . . . . 0.495 HE21 ' HB ' ' A' 1124 ' ' THR . 0.3 OUTLIER -154.04 174.86 14.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.774 2.829 . . . . 2.0299999999999998 111.909 -166.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -131.03 129.96 42.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.808 1.643 . . . . 3.0800000000000001 112.12 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -88.42 123.51 33.04 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.595 -0.891 . . . . 1.3200000000000001 108.595 167.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.6 m -131.67 154.95 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.232 1.013 . . . . 1.0600000000000001 111.514 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.45 152.06 32.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.076 0.951 . . . . 0.56999999999999995 112.807 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.9 tt -153.85 153.07 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.048 1.339 . . . . 0.81999999999999995 110.673 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 103.03 154.55 24.64 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.98 0.767 . . . . 1.9199999999999999 114.281 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.9 t-20 54.08 -161.52 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.178 1.791 . . . . 2.1299999999999999 113.248 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -27.95 3.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.594 1.558 . . . . 6.0499999999999998 113.516 168.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.7 -48.13 73.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.534 1.061 . . . . 4.5599999999999996 113.033 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 9.7 t90 -75.92 -37.37 58.8 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.425 . . . . 3.21 112.008 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 76.3 mmm -54.68 -37.51 65.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.472 0.709 . . . . 2.8399999999999999 111.966 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.36 -66.75 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.197 1.399 . . . . 2.4199999999999999 108.954 166.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -9.97 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.623 2.369 . . . . 6.9299999999999997 116.627 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.88 21.01 0.22 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 120.298 1.408 . . . . 0.95999999999999996 112.131 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 63.88 17.65 61.03 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.27 -1.518 . . . . 1.1299999999999999 115.249 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.07 164.05 26.07 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.278 1.539 . . . . 0.92000000000000004 111.338 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 55.9 t -91.51 127.66 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.449 -0.782 . . . . 1.5600000000000001 109.007 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.68 140.02 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.822 0.849 . . . . 0.89000000000000001 111.087 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -116.8 155.77 28.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.522 1.129 . . . . 2.7000000000000002 112.437 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.62 -37.0 85.66 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.717 1.006 . . . . 2.3700000000000001 113.717 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -73.53 -37.31 65.67 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.026 0.83 . . . . 2.6899999999999999 112.672 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 -35.28 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.911 -0.566 . . . . 0.82999999999999996 111.407 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -63.33 -43.6 97.29 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.766 1.166 . . . . 1.9099999999999999 112.16 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.67 -33.23 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.404 -0.81 . . . . 2.1699999999999999 113.036 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -74.06 -36.81 64.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.046 . . . . 2.4300000000000002 113.529 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.2 tpp -64.38 -52.61 57.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.165 1.386 . . . . 0.89000000000000001 111.139 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 7.0 t -65.23 -28.98 69.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.267 1.027 . . . . 0.89000000000000001 112.687 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -57.52 -54.45 46.68 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.044 0.937 . . . . 2.6600000000000001 112.987 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -71.09 -29.92 65.9 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.921 0.341 . . . . 2.7400000000000002 111.921 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.21 -39.98 93.52 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.339 1.056 . . . . 3.6099999999999999 112.083 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -68.66 -25.61 64.9 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.705 2.402 . . . . 3.77 113.593 172.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 17.7 mttp -78.56 4.87 12.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.506 1.522 . . . . 3.02 113.09 168.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 71.81 18.4 77.44 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.441 1.496 . . . . 1.6100000000000001 112.877 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -101.89 -174.76 2.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.411 1.484 . . . . 3.6299999999999999 110.907 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.5 m -108.2 125.15 51.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.439 1.096 . . . . 0.88 111.741 -169.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.28 127.4 29.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.348 1.059 . . . . 0.58999999999999997 110.303 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.4 m -140.96 158.11 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.907 1.283 . . . . 0.47999999999999998 113.23 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.0 163.83 11.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.84 1.256 . . . . 0.93999999999999995 111.791 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.2 p -139.29 134.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.857 1.263 . . . . 2.1800000000000002 112.56 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -131.04 153.48 49.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.269 1.828 . . . . 0.40000000000000002 112.53 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.4 m -146.29 131.09 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.999 2.12 . . . . 0.69999999999999996 110.316 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.395 0.0 OUTLIER 41.29 46.17 2.72 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.335 1.854 . . . . 3.8799999999999999 114.596 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 61.03 31.31 19.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.308 2.243 . . . . 1.47 115.874 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.03 158.89 39.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.65 1.98 . . . . 2.3799999999999999 111.82 168.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 146.5 33.27 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.667 -1.271 . . . . 0.91000000000000003 112.619 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 7.6 p -118.7 -41.82 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.282 0.633 . . . . 0.53000000000000003 111.085 167.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.17 -163.24 24.85 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.798 1.181 . . . . 0.41999999999999998 115.869 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.64 153.22 43.24 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.795 2.038 . . . . 0.79000000000000004 112.57 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 25.6 mm -124.35 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.383 1.473 . . . . 0.73999999999999999 109.579 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.24 132.27 54.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.21 1.404 . . . . 0.62 110.898 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 19.1 mt -136.02 158.05 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.71 2.004 . . . . 1.3100000000000001 110.646 -168.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.17 -169.52 2.15 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.907 1.683 . . . . 1.3899999999999999 111.573 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.55 134.22 55.03 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.419 -1.425 . . . . 3.7400000000000002 111.495 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.253 1.278 0 CA-C-O 116.692 -1.623 . . . . 4.2999999999999998 111.618 170.584 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 111.629 0.233 . . . . 10.99 111.629 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -75.22 -23.31 57.58 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.994 1.479 . . . . 12.869999999999999 114.994 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 70.5 m -84.15 142.76 30.12 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.434 0.901 . . . . 9.1300000000000008 113.434 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 15.8 ptm -156.46 154.31 30.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.667 1.187 . . . . 6.6500000000000004 114.018 169.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -128.32 -46.63 1.34 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.794 1.638 . . . . 6.3300000000000001 111.491 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -135.18 145.46 17.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.345 0.974 . . . . 2.9100000000000001 112.937 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.3 p -115.07 148.6 40.94 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 2.2999999999999998 111.487 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.01 146.95 66.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.756 2.304 . . . . 1.3200000000000001 111.441 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 10.9 p -130.59 134.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.347 1.059 . . . . 2.5499999999999998 110.698 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -72.44 113.63 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.87 0.843 . . . . 1.1899999999999999 109.642 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -91.52 -40.44 11.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.466 1.106 . . . . 2.7799999999999998 111.725 -168.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -154.4 152.32 30.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.131 0.972 . . . . 1.97 112.099 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.9 m -125.65 142.62 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.943 1.297 . . . . 0.72999999999999998 111.422 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -143.45 149.35 37.47 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.925 1.083 . . . . 2.3799999999999999 113.925 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 46.3 t -96.3 143.65 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.638 1.575 . . . . 0.68000000000000005 111.614 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.3 tp -107.41 -46.15 3.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.605 1.962 . . . . 1.05 111.5 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.8 m -118.98 126.39 51.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.393 1.477 . . . . 1.73 109.115 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -150.52 138.81 20.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.857 0.463 . . . . 4.4900000000000002 111.568 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.1 m 63.67 -14.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.956 2.103 . . . . 2.9900000000000002 116.59 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -95.52 -3.25 46.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.665 1.186 . . . . 2.8799999999999999 114.145 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -157.88 -44.51 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.146 0.979 . . . . 4.21 112.987 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mm -134.12 157.65 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.61 1.964 . . . . 1.5800000000000001 110.346 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 71.6 m -113.5 149.84 33.74 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.019 1.727 . . . . 2.1099999999999999 112.589 172.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 21.1 p80 -55.98 -47.01 78.47 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.634 2.087 . . . . 3.5299999999999998 116.634 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -70.32 -18.01 63.09 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.531 1.06 . . . . 2.9100000000000001 111.378 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.29 -30.09 18.71 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.558 1.543 . . . . 3.7599999999999998 111.784 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 92.7 mt -58.6 -52.22 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.191 0.905 . . . . 0.68999999999999995 109.528 168.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.21 -34.13 77.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.801 -0.562 . . . . 0.63 111.645 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -59.6 -52.96 63.31 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.535 -0.745 . . . . 0.67000000000000004 112.548 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 28.3 pt -68.37 -31.01 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.94 1.246 . . . . 0.64000000000000001 113.836 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.0 t -70.37 -45.27 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.609 1.095 . . . . 0.77000000000000002 110.416 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -61.37 -41.19 99.46 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.28 -0.733 . . . . 0.65000000000000002 113.241 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1079 ' ' THR . . . . . 0.4 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 66.3 p -72.82 -37.42 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.159 0.98 . . . . 0.66000000000000003 113.541 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.13 83.27 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.023 0.829 . . . . 0.77000000000000002 112.379 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.1 -16.91 63.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.275 -0.89 . . . . 2.2599999999999998 112.763 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 -23.83 67.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.159 1.17 . . . . 1.3200000000000001 114.159 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -94.22 -13.12 26.93 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.25 -0.906 . . . . 1.8999999999999999 112.757 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.7 t -73.84 160.18 31.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.298 1.592 . . . . 1.6599999999999999 115.298 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.24 12.42 26.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.576 2.35 . . . . 5.3099999999999996 113.445 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.59 160.1 59.69 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.912 1.078 . . . . 1.54 113.912 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.85 -34.66 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.897 3.065 . . . . 1.1699999999999999 114.61 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.79 -51.67 4.79 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.853 0.861 . . . . 0.69999999999999996 113.308 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.4 -30.43 77.55 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.844 -0.217 . . . . 0.92000000000000004 113.345 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 29.2 p -65.19 -18.91 65.7 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.62 -1.518 . . . . 1.8600000000000001 113.557 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.66 -32.05 73.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.802 -1.186 . . . . 0.81000000000000005 111.545 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.19 -41.18 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.488 1.515 . . . . 0.84999999999999998 110.474 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 99.4 m -52.58 -47.99 66.51 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.892 1.223 . . . . 1.26 111.404 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.2 tttt -59.11 -50.29 74.6 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.243 0.929 . . . . 2.5800000000000001 112.284 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 76.9 t80 -58.28 -40.51 82.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.683 1.193 . . . . 2.1899999999999999 112.534 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 83.7 m -72.84 -43.19 62.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.732 1.613 . . . . 3.2599999999999998 113.032 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.93 -36.81 80.29 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.329 1.422 . . . . 2.8399999999999999 110.836 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.22 -47.39 79.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.216 1.006 . . . . 4.0 111.127 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -62.67 -44.52 96.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.884 1.22 . . . . 1.95 113.844 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.64 -18.71 62.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.322 0.86 . . . . 1.1499999999999999 113.322 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 18.3 t70 48.99 32.06 3.65 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.69 1.596 . . . . 2.3199999999999998 113.59 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -99.85 -12.35 19.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.145 1.778 . . . . 3.4399999999999999 115.344 -167.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 16.8 tt0 66.84 -19.93 0.11 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.656 2.382 . . . . 4.29 116.677 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.8 t -154.35 138.12 16.17 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.101 1.319 . . . . 3.25 113.507 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -156.62 153.78 29.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.012 1.325 . . . . 1.0600000000000001 114.449 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1106 ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 98.4 136.95 9.49 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 125.477 1.513 . . . . 1.04 114.622 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 25.1 m -125.94 -68.07 0.84 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.894 0.878 . . . . 1.3500000000000001 112.661 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 12.8 t -138.77 142.48 38.8 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.395 1.258 . . . . 1.4299999999999999 114.395 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.4 mm -143.82 139.44 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 130.997 3.719 . . . . 2.25 109.211 -174.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1110 ' ' ASP . . . . . 0.513 ' HB3' ' H ' ' A' 1122 ' ' LYS . 17.0 t0 -94.72 -28.06 15.5 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.524 1.53 . . . . 2.7400000000000002 114.027 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.82 97.1 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.946 2.098 . . . . 2.75 116.222 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.59 114.48 22.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.967 1.707 . . . . 2.5499999999999998 109.136 169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 92.8 t -113.71 131.33 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.445 1.498 . . . . 2.0899999999999999 111.453 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 50.7 t -133.9 118.79 14.45 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.201 1.4 . . . . 1.6200000000000001 107.602 169.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -53.42 136.62 63.82 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.214 2.609 . . . . 1.3400000000000001 113.677 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.31 -45.22 0.96 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.422 1.963 . . . . 2.1699999999999999 114.767 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 79.2 m -71.48 -5.34 32.26 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 117.369 2.359 . . . . 2.54 117.369 -167.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 110.46 -167.41 12.63 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.983 1.265 . . . . 0.67000000000000004 113.819 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 143.39 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.127 1.371 . . . . 1.8700000000000001 110.204 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.6 t -129.19 151.8 49.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.559 1.144 . . . . 0.53000000000000003 111.466 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 29.3 p -162.94 172.52 14.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.197 0.999 . . . . 0.80000000000000004 113.413 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1122 ' ' LYS . . . . . 0.513 ' H ' ' HB3' ' A' 1110 ' ' ASP . 43.0 mmtm -114.16 135.91 53.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.447 1.499 . . . . 1.22 107.191 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 35.0 m -128.6 148.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.609 0.763 . . . . 2.71 112.35 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.0 t -134.09 145.78 49.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.054 0.942 . . . . 1.23 109.68 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 57.5 t30 -164.34 44.52 0.1 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.233 1.813 . . . . 2.9500000000000002 108.371 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.56 -31.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.108 1.763 . . . . 2.2999999999999998 112.188 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.83 -0.48 1.51 Allowed 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.983 1.105 . . . . 4.5999999999999996 113.983 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.78 7.03 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 118.421 2.128 . . . . 3.3300000000000001 118.421 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.31 -4.27 25.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.797 1.406 . . . . 4.2199999999999998 114.797 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 70.2 mt -72.63 29.31 0.06 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.988 2.115 . . . . 7.1399999999999997 114.281 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -48.78 137.65 12.11 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.957 2.903 . . . . 8.1400000000000006 113.41 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.77 126.81 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.675 0.79 . . . . 12.17 111.332 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -57.14 -51.06 70.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.702 1.201 . . . . 17.460000000000001 110.476 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -161.7 140.53 9.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.113 1.365 . . . . 15.01 112.662 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 25.9 m95 60.24 -162.41 0.26 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.682 1.993 . . . . 15.07 113.006 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.0 m-80 66.01 21.08 11.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.301 1.44 . . . . 14.94 113.055 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 78.6 mt -110.05 -23.68 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.953 2.101 . . . . 12.08 111.115 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 7.1 tt0 62.71 -31.77 0.1 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.838 3.255 . . . . 17.170000000000002 116.577 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.53 11.48 24.86 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.694 2.398 . . . . 12.890000000000001 113.29 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -43.37 -28.55 0.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.051 2.54 . . . . 13.51 117.457 -167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.87 56.06 0.41 Allowed 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 119.562 1.074 . . . . 14.6 112.214 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.36 107.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.451 1.1 . . . . 15.94 110.57 -168.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -130.77 69.92 1.46 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.354 1.462 . . . . 17.48 109.619 172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -86.64 -13.31 45.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.391 1.256 . . . . 16.600000000000001 114.391 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -63.33 134.62 56.1 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.813 1.042 . . . . 17.149999999999999 113.813 -173.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 83.2 p -121.4 154.59 36.31 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.812 1.645 . . . . 18.280000000000001 113.25 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.57 42.0 0.74 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.316 1.446 . . . . 19.98 112.832 -172.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 57.6 t -75.71 128.29 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.554 1.142 . . . . 21.949999999999999 110.046 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 57.85 146.45 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.988 2.915 . . . . 26.079999999999998 115.824 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 41.4 mm 62.08 143.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.562 2.345 . . . . 27.800000000000001 114.63 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -119.51 -20.42 7.78 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.354 2.262 . . . . 29.059999999999999 111.225 169.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -70.86 6.57 1.46 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.021 1.729 . . . . 31.699999999999999 115.158 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 87.9 p -109.43 -1.35 18.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.983 1.313 . . . . 29.890000000000001 111.999 166.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 43.4 t30 42.94 44.77 4.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 129.221 3.008 . . . . 31.75 117.799 167.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 65.63 12.92 8.6 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 115.169 1.544 . . . . 27.859999999999999 115.169 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -101.85 0.97 36.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.635 1.346 . . . . 33.899999999999999 114.635 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 3.9 t -136.52 8.77 3.12 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.198 0.999 . . . . 28.59 113.141 -169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 88.6 p -67.63 138.21 56.21 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.041 1.497 . . . . 25.059999999999999 115.041 -169.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 11.7 t -164.95 163.9 20.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.069 2.148 . . . . 23.84 109.537 168.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 54.8 p -157.51 171.4 20.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.282 -0.887 . . . . 20.530000000000001 112.938 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 34.3 p -58.82 -22.57 58.95 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.592 1.157 . . . . 18.949999999999999 113.343 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 69.3 m -81.41 -1.03 44.13 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.351 1.241 . . . . 17.18 114.351 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 89.0 mmm -73.88 145.93 44.45 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.768 -1.207 . . . . 20.120000000000001 110.882 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 70.4 mt 60.06 -14.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 127.167 2.187 . . . . 18.920000000000002 114.683 -172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.82 -30.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 119.636 -1.915 . . . . 13.800000000000001 115.932 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.5 -28.24 66.84 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.86 1.209 . . . . 14.0 113.098 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.69 76.6 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.669 -0.644 . . . . 13.25 110.968 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.64 -43.77 15.24 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.77 1.228 . . . . 13.029999999999999 111.471 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 89.7 mt -68.18 -40.63 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.516 1.126 . . . . 10.300000000000001 111.003 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 50.8 m -65.53 -29.16 69.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.172 -0.955 . . . . 9.9000000000000004 112.512 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1171 ' ' ASN . . . . . . . . . . . . 0.261 4.3 p30 -84.77 -5.29 59.32 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.701 1.371 . . . . 8.0 114.701 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.03 64.18 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.982 1.104 . . . . 5.6100000000000003 113.982 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.01 -33.39 62.58 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.781 1.233 . . . . 8.9000000000000004 111.33 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.77 -33.6 12.21 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.821 1.648 . . . . 6.0 112.293 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -107.37 103.42 12.76 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.606 1.706 . . . . 3.79 115.606 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -46.43 143.32 2.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.815 1.783 . . . . 3.3799999999999999 115.815 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -129.9 161.28 31.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.234 1.813 . . . . 2.0800000000000001 112.937 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -126.33 134.58 51.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.955 2.502 . . . . 2.6000000000000001 109.179 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -95.04 105.9 17.85 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.855 1.262 . . . . 1.52 110.786 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -124.11 142.33 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.382 0.673 . . . . 0.90000000000000002 112.652 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.5 151.87 38.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.536 1.135 . . . . 0.51000000000000001 112.836 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.47 155.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.767 1.627 . . . . 0.67000000000000004 109.891 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 107.55 163.66 21.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.111 0.839 . . . . 1.6299999999999999 114.127 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 4.8 t-20 49.98 -155.23 0.11 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.212 1.805 . . . . 2.3999999999999999 114.013 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -130.11 -34.69 1.65 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.171 2.589 . . . . 5.0099999999999998 111.556 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.88 -32.47 51.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.159 1.17 . . . . 3.2999999999999998 114.159 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.2 t90 -72.39 -28.98 63.34 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.354 -1.466 . . . . 3.0600000000000001 111.892 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 6.1 tpp -57.38 -34.23 68.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.922 0.889 . . . . 2.3100000000000001 111.617 171.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.96 -66.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.554 1.942 . . . . 1.6399999999999999 109.985 168.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -55.8 -18.89 9.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 116.01 1.856 . . . . 5.5999999999999996 116.01 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.71 9.86 2.55 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 120.15 1.341 . . . . 0.81000000000000005 112.79 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 72.77 18.63 78.92 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.387 1.47 . . . . 0.98999999999999999 115.571 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.59 171.23 13.53 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.445 1.098 . . . . 0.80000000000000004 111.325 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 94.7 t -108.79 120.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.568 1.147 . . . . 1.0600000000000001 109.989 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.87 125.27 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.158 0.983 . . . . 1.1299999999999999 110.845 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -92.54 156.24 17.27 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.031 1.332 . . . . 4.1699999999999999 112.99 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -60.21 -31.36 70.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.702 1.201 . . . . 2.6299999999999999 113.45 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.45 -42.51 68.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.348 1.059 . . . . 3.0299999999999998 111.704 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 4.4 p -78.17 -35.26 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.223 0.823 . . . . 0.79000000000000004 113.223 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.8 -38.95 89.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.668 1.122 . . . . 2.3599999999999999 111.215 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -49.27 78.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.585 0.754 . . . . 1.97 112.142 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.2 -41.56 79.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.189 1.396 . . . . 2.5899999999999999 111.546 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 25.4 tpp -64.81 -49.29 71.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.553 1.541 . . . . 0.73999999999999999 111.811 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.4 t -74.94 -30.53 61.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.885 0.698 . . . . 0.90000000000000002 112.885 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -58.05 -53.18 61.2 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.477 -1.389 . . . . 2.5 112.629 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -71.31 -29.13 64.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.532 0.733 . . . . 3.02 112.572 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.05 -46.08 89.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.949 0.9 . . . . 4.8399999999999999 111.595 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -66.93 -29.54 69.44 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.389 1.475 . . . . 3.7999999999999998 113.625 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 23.5 mttp -65.44 -10.69 36.08 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.482 1.513 . . . . 2.6400000000000001 113.51 169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.26 29.52 10.18 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.941 1.258 . . . . 1.72 114.409 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -126.63 176.94 6.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.715 1.606 . . . . 5.5999999999999996 111.043 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 55.2 m -90.79 139.16 31.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.072 1.349 . . . . 0.81999999999999995 111.328 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -136.86 130.95 32.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.025 0.93 . . . . 0.47999999999999998 112.514 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 164.58 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.717 1.607 . . . . 0.45000000000000001 113.423 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.37 168.74 10.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.363 1.465 . . . . 0.78000000000000003 113.489 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.2 t -137.02 128.56 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.624 1.57 . . . . 1.6799999999999999 112.101 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.55 150.24 47.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.243 1.417 . . . . 0.5 113.259 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.32 125.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.091 1.756 . . . . 0.63 111.529 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 37.7 53.5 1.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.494 2.318 . . . . 2.7400000000000002 113.268 -173.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.275 16.3 m-20 58.85 29.29 18.62 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.369 1.989 . . . . 2.0499999999999998 116.369 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.18 151.7 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.496 1.918 . . . . 3.2200000000000002 110.091 166.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.55 145.33 34.89 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.833 -1.167 . . . . 0.70999999999999996 110.124 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -119.5 -40.55 2.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.527 -0.749 . . . . 0.44 112.892 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.27 -172.7 37.67 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 120.11 1.323 . . . . 0.38 116.222 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -138.25 152.62 48.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.264 1.826 . . . . 0.69999999999999996 112.656 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 11.1 mm -132.29 136.28 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.72999999999999998 110.242 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -109.97 136.9 48.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.311 1.444 . . . . 0.64000000000000001 110.266 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.36 143.65 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.805 1.642 . . . . 1.47 111.146 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -123.31 -171.79 2.38 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.518 1.927 . . . . 1.54 111.956 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -124.75 133.49 53.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.216 1.807 . . . . 3.2200000000000002 112.222 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.48 1.512 . . . . 5.3200000000000003 114.556 -174.7 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.359 0.874 . . . . 2.4100000000000001 113.359 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.89 149.32 3.94 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.969 3.113 . . . . 1.3200000000000001 112.923 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 3.9 m -131.52 130.24 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.728 2.011 . . . . 2.3700000000000001 111.903 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.2 p -74.8 126.44 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.396 -0.815 . . . . 1.1299999999999999 110.745 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.02 -38.29 3.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.733 1.753 . . . . 2.3399999999999999 115.733 -165.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -149.09 145.18 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.281 1.401 . . . . 2.1000000000000001 111.961 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 30.1 m -125.41 143.16 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.088 0.955 . . . . 1.21 112.786 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 71.9 tttt -136.88 142.19 42.78 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.526 1.53 . . . . 1.9299999999999999 111.385 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 58.0 t -94.38 148.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.131 1.373 . . . . 0.93000000000000005 111.45 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.91 -39.09 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.35 1.46 . . . . 1.3600000000000001 113.682 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.4 t -81.12 29.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.82 1.191 . . . . 2.75 113.424 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.34 132.42 39.26 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.859 -1.776 . . . . 4.3700000000000001 111.634 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 20.8 m 61.65 -8.62 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.763 2.505 . . . . 2.5299999999999998 117.763 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.84 -30.86 12.91 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.397 1.628 . . . . 3.48 115.397 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -150.04 -66.28 0.21 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.658 1.117 . . . . 5.2999999999999998 112.579 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.507 HD12 HG21 ' A' 1218 ' ' VAL . 4.4 mt -128.15 140.08 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.577 1.951 . . . . 1.77 110.905 -171.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.5 m -103.15 160.27 14.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.637 1.175 . . . . 1.99 112.746 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.8 p80 -47.13 -41.41 17.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.944 1.698 . . . . 2.9500000000000002 115.466 -169.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -70.55 -42.22 71.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.071 1.348 . . . . 3.23 111.913 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.53 -33.23 72.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.067 -1.02 . . . . 2.9700000000000002 112.138 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . 0.431 HG13 HG22 ' A' 1068 ' ' ILE . 97.9 mt -58.41 -52.65 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.884 1.22 . . . . 0.79000000000000004 110.768 172.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.79 -29.96 68.43 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.402 -0.811 . . . . 0.82999999999999996 112.181 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.62 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.095 0.558 . . . . 0.64000000000000001 112.279 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 15.1 pt -70.31 -35.53 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.809 1.186 . . . . 0.72999999999999998 112.867 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 92.4 t -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.452 1.023 . . . . 0.78000000000000003 111.006 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.8 -34.74 88.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.451 -0.78 . . . . 0.68999999999999995 113.51 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.9 p -75.9 -32.61 59.72 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.746 1.273 . . . . 0.65000000000000002 112.815 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.05 67.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.877 0.762 . . . . 0.72999999999999998 112.137 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.41 -21.13 62.87 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.313 -0.867 . . . . 1.9199999999999999 112.439 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.0 t -65.23 -18.51 65.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.93 -1.106 . . . . 1.48 112.566 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -117.69 -9.23 10.77 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.169 1.388 . . . . 2.5499999999999998 113.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.9 t -85.62 -174.89 5.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.409 1.484 . . . . 1.4199999999999999 112.32 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -135.82 32.13 3.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.547 1.939 . . . . 4.2599999999999998 112.703 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -93.51 162.3 28.09 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 114.199 1.185 . . . . 1.6899999999999999 114.199 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.68 -21.55 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.052 3.168 . . . . 0.98999999999999999 114.657 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.4 -52.48 2.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.054 1.341 . . . . 0.69999999999999996 113.383 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.91 -23.59 65.83 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 114.154 0.422 . . . . 0.95999999999999996 114.154 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 12.9 p -61.44 -18.45 58.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.929 -1.336 . . . . 1.45 113.988 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.68 81.42 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.885 -1.134 . . . . 0.83999999999999997 111.719 168.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.64 -32.85 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.299 1.039 . . . . 1.3200000000000001 111.291 172.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 28.0 m -52.27 -50.81 61.39 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.798 1.181 . . . . 1.1399999999999999 111.253 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -61.32 -48.04 83.18 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.852 0.751 . . . . 2.71 112.647 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -55.73 -41.63 74.16 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.961 0.904 . . . . 1.76 111.735 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.1 t -67.91 -52.74 32.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.132 1.373 . . . . 2.0299999999999998 112.371 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -42.31 88.86 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.413 -1.429 . . . . 3.02 112.455 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -67.47 -31.51 71.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.81 1.644 . . . . 2.98 111.901 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -70.25 -50.34 40.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.501 1.046 . . . . 2.6600000000000001 112.224 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 27.4 mt -72.18 -22.72 61.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.484 1.29 . . . . 1.4099999999999999 114.484 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.6 t0 56.36 43.9 25.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.87 1.668 . . . . 2.7599999999999998 113.333 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.7 t -138.88 -30.8 0.74 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.175 2.287 . . . . 3.3100000000000001 117.175 -169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 61.1 tt0 64.47 -26.41 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.744 2.498 . . . . 4.4299999999999997 117.744 -171.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 46.9 p -84.57 45.2 1.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.446 1.898 . . . . 3.0899999999999999 114.828 -169.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.95 151.75 23.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.159 1.383 . . . . 0.92000000000000004 113.523 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 92.79 122.76 3.23 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.049 0.841 . . . . 1.1599999999999999 114.611 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . 0.632 HG22 ' H ' ' A' 1108 ' ' CYS . 74.4 m -129.3 -172.58 2.77 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.254 2.622 . . . . 2.6000000000000001 107.653 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . 0.632 ' H ' HG22 ' A' 1107 ' ' THR . 8.3 t -56.42 143.37 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.151 1.908 . . . . 1.54 116.151 -168.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 16.5 tt -135.11 140.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 131.523 3.929 . . . . 2.1400000000000001 106.368 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.2 t0 -124.53 93.48 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.46 1.104 . . . . 3.21 108.845 172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.341 0.0 OUTLIER -97.43 166.55 11.48 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 117.412 2.375 . . . . 3.1400000000000001 117.412 -169.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -142.81 105.45 4.49 Favored 'General case' 0 CA--C 1.562 1.414 1 C-N-CA 132.332 4.253 . . . . 2.1400000000000001 107.625 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 6.3 m -109.62 151.04 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.303 -1.498 . . . . 3.0299999999999998 114.515 -170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 13.9 t -137.71 138.87 25.16 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.9 1.28 . . . . 1.53 110.599 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.33 132.95 28.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.647 2.231 . . . . 1.47 111.758 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.1 -34.5 0.41 Allowed Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.267 1.889 . . . . 2.1600000000000001 115.893 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -90.21 2.91 54.88 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.212 1.56 . . . . 2.1699999999999999 115.212 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 90.98 -176.29 40.67 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.308 0.956 . . . . 0.75 114.598 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.5 pt -136.53 160.01 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.111 0.964 . . . . 2.6299999999999999 112.59 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 21.7 t -130.27 147.03 51.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.415 1.486 . . . . 0.59999999999999998 111.565 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.4 p -154.63 173.77 15.9 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.013 -1.055 . . . . 0.68000000000000005 113.003 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -115.88 111.18 20.07 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 2.6 m -103.05 127.93 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.596 1.158 . . . . 2.2999999999999998 113.432 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.3 t -109.23 159.1 17.21 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.074 0.95 . . . . 1.01 112.306 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.3 t-20 . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 128.728 2.811 . . . . 2.5499999999999998 107.786 161.281 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 114.635 1.346 . . . . 2.98 114.635 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 119.25 10.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.898 0.879 . . . . 3.3399999999999999 112.365 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.29 117.29 18.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.23 . . . . 1.2 110.686 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -135.29 144.07 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 0.55000000000000004 112.198 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.26 154.59 42.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.895 1.278 . . . . 0.5 112.603 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.0 tt -152.5 145.79 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.279 1.032 . . . . 0.63 110.587 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 121.83 166.58 12.89 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 116.042 1.177 . . . . 1.4399999999999999 116.042 168.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 48.11 -141.36 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.604 1.962 . . . . 2.29 113.93 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.43 -32.58 0.45 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.499 1.52 . . . . 6.0199999999999996 114.184 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.59 -37.49 79.86 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.433 1.469 . . . . 3.77 114.275 -174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.3 t90 -68.22 -31.18 70.51 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.657 -1.277 . . . . 3.27 111.819 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 10.4 tpp -60.23 -34.53 73.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.137 0.975 . . . . 2.2000000000000002 111.752 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.66 -67.01 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.467 1.507 . . . . 1.5900000000000001 109.043 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -52.96 -24.97 10.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.967 2.107 . . . . 5.6799999999999997 115.987 -172.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.76 20.23 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.006 1.275 . . . . 0.79000000000000004 113.811 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.26 13.41 81.4 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.193 -1.567 . . . . 0.93000000000000005 115.376 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.6 mt -83.96 175.3 9.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.605 1.162 . . . . 0.92000000000000004 111.388 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 57.8 t -119.41 131.05 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.087 1.355 . . . . 1.21 108.744 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.5 tt -102.71 135.73 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.396 0.679 . . . . 1.1200000000000001 110.954 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.7 p30 -96.82 159.51 14.88 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.736 1.214 . . . . 4.1200000000000001 113.099 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.1 p30 -71.99 -15.04 62.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.447 1.277 . . . . 4.3799999999999999 114.447 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -84.24 -45.22 13.11 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.62 -1.3 . . . . 2.46 113.019 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.2 p -64.45 -34.46 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 118.823 -0.608 . . . . 0.81000000000000005 110.92 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.67 -42.96 81.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.761 1.164 . . . . 1.95 112.604 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.61 -34.69 77.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.274 1.03 . . . . 1.97 112.405 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 39.9 t80 -71.95 -35.41 69.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.818 1.247 . . . . 2.3100000000000001 112.718 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.3 tpp -71.21 -58.95 3.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.502 1.921 . . . . 0.80000000000000004 112.435 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -62.53 -28.2 69.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 0.89000000000000001 112.297 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -58.31 -47.42 83.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.757 2.023 . . . . 2.71 113.403 171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -64.78 -36.11 83.25 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.213 -0.929 . . . . 2.4900000000000002 111.842 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.41 -31.96 72.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.514 -0.741 . . . . 3.0699999999999998 112.36 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 48.9 ttp85 -70.6 -39.9 73.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.558 2.343 . . . . 9.0 111.431 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 13.8 mttp -69.2 -1.38 7.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.728 2.011 . . . . 2.3199999999999998 112.624 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 75.34 16.58 80.53 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.824 1.202 . . . . 1.2 115.022 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -95.45 178.93 5.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 111.205 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 70.2 m -93.29 121.08 34.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.16 1.784 . . . . 0.94999999999999996 109.635 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.41 113.95 15.56 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.754 0.822 . . . . 0.62 111.873 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 26.7 m -140.55 163.13 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.569 1.148 . . . . 0.51000000000000001 114.06 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.1 160.95 23.97 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.352 1.461 . . . . 0.81000000000000005 112.982 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 5.0 t -127.49 125.75 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.22 1.808 . . . . 1.7 111.677 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -118.66 154.36 32.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.122 1.369 . . . . 0.51000000000000001 112.19 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . 0.507 HG21 HD12 ' A' 1068 ' ' ILE . 18.9 m -146.61 122.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.027 1.731 . . . . 0.84999999999999998 110.462 -172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 31.2 t70 44.39 46.79 7.98 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 122.705 1.241 . . . . 3.3399999999999999 113.368 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.265 4.9 m-20 62.42 28.1 16.66 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.549 1.94 . . . . 1.76 115.838 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.46 149.07 42.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.726 2.811 . . . . 3.27 110.273 168.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.61 114.61 26.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.47 -1.394 . . . . 1.1599999999999999 110.812 170.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.4 p -89.21 -38.06 14.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.738 1.154 . . . . 0.56000000000000005 113.32 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . 176.48 -168.69 40.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 119.259 0.936 . . . . 0.45000000000000001 114.883 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.23 156.08 44.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.349 1.46 . . . . 0.68999999999999995 113.772 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.37 133.05 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 1.4199999999999999 111.525 -170.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -105.15 136.59 44.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.978 1.711 . . . . 0.70999999999999996 110.356 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' 1212 ' ' THR . 67.3 mt -140.97 148.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.759 1.624 . . . . 1.0700000000000001 109.869 -168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 124.413 1.085 . . . . 1.51 112.585 179.634 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 116.134 1.902 . . . . 2.25 116.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.79 132.48 40.16 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.105 2.537 . . . . 1.79 111.955 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.52 129.52 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.662 1.585 . . . . 2.1699999999999999 110.946 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 128.23 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.781 0.833 . . . . 1.46 111.531 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.35 -35.3 4.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.128 1.158 . . . . 2.02 114.128 -168.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -164.88 152.66 11.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 1.8799999999999999 111.69 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.4 m -125.07 135.13 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.514 1.126 . . . . 0.65000000000000002 109.216 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 51.8 tttt -140.96 148.26 40.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.04 0.936 . . . . 2.0 113.026 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.1 t -90.38 151.13 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 1.3100000000000001 112.532 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.01 -35.5 4.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.395 1.878 . . . . 1.04 111.42 168.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 92.5 m -119.93 97.85 5.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.225 1.012 . . . . 2.02 111.798 -170.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -91.59 140.89 29.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.449 1.5 . . . . 3.8799999999999999 111.071 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 52.93 29.13 7.36 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.772 2.138 . . . . 2.8900000000000001 116.772 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -145.55 -14.7 0.49 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.093 1.886 . . . . 3.4199999999999999 116.093 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -149.65 -97.53 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.271 1.428 . . . . 4.4800000000000004 109.99 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 54.9 mt -139.68 146.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.106 1.762 . . . . 2.6499999999999999 109.857 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 3.3 t -123.18 172.73 8.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.852 1.661 . . . . 5.04 114.975 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.0 p80 -38.79 -53.49 1.67 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 117.194 2.294 . . . . 3.6600000000000001 117.194 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.34 -36.53 84.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.488 1.495 . . . . 2.5699999999999998 111.897 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.5 -26.03 21.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 117.476 -1.25 . . . . 2.7999999999999998 113.04 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.75 -52.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.198 1.363 . . . . 1.3100000000000001 109.37 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.13 -31.93 73.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.91 -0.494 . . . . 0.76000000000000001 111.348 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.12 -61.13 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.599 -0.715 . . . . 0.62 112.39 171.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.53 -31.38 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.711 1.141 . . . . 0.52000000000000002 114.022 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 85.0 t -67.18 -42.25 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.224 0.92 . . . . 0.72999999999999998 110.224 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.46 91.73 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.633 -0.537 . . . . 0.91000000000000003 113.276 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.2 p -72.46 -28.46 62.95 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.669 1.235 . . . . 1.22 113.144 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -69.36 -60.81 2.09 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.034 0.834 . . . . 1.1399999999999999 111.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -65.23 -18.32 65.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.883 1.273 . . . . 2.3399999999999999 112.462 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 39.7 t -51.53 -31.37 23.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.022 1.329 . . . . 1.29 113.032 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -79.49 3.3 19.05 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.804 -1.185 . . . . 2.5600000000000001 114.185 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 48.0 m -120.74 -178.48 3.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.181 1.792 . . . . 1.8899999999999999 112.785 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -139.71 29.95 2.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.234 1.414 . . . . 4.4800000000000004 113.186 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.05 150.23 64.49 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 114.264 1.209 . . . . 1.9099999999999999 114.264 -170.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.59 -25.05 75.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.151 3.234 . . . . 1.3 115.066 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.74 -41.57 3.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.469 1.508 . . . . 0.95999999999999996 111.81 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.66 70.05 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 123.634 0.635 . . . . 0.98999999999999999 113.918 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 4.8 p -58.96 -24.0 62.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.92 1.288 . . . . 1.73 114.455 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -71.18 -36.53 71.99 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.608 -1.308 . . . . 0.73999999999999999 111.816 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.2 mt -72.03 -41.14 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.139 1.375 . . . . 0.85999999999999999 110.425 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 76.9 p -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 117.354 -1.307 . . . . 2.52 111.862 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -59.37 -49.87 76.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.784 1.174 . . . . 2.3300000000000001 112.498 169.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.91 -41.74 74.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.425 0.69 . . . . 2.29 111.424 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 38.1 t -71.26 -56.19 6.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.51 1.124 . . . . 1.8400000000000001 113.116 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -42.8 -52.0 5.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.912 2.085 . . . . 3.4300000000000002 112.005 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.741 0.816 . . . . 4.0700000000000003 112.428 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.59 -40.28 95.24 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.395 -1.44 . . . . 2.2599999999999998 112.74 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.5 -10.48 59.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.332 1.053 . . . . 1.27 113.048 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 45.0 t0 54.38 34.06 19.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.797 1.639 . . . . 2.4100000000000001 113.108 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 15.1 t -115.63 162.76 16.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.055 1.342 . . . . 2.6699999999999999 111.541 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.96 -16.99 25.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.474 1.51 . . . . 3.6299999999999999 111.453 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.8 t -146.59 135.28 22.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.306 1.443 . . . . 3.52 111.821 -170.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.68 150.32 32.99 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.876 0.871 . . . . 1.1599999999999999 111.414 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 81.22 167.33 37.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.594 0.998 . . . . 1.1100000000000001 115.594 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 52.5 m -152.51 -37.43 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.058 2.143 . . . . 1.8500000000000001 113.144 -173.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' 1124 ' ' THR . 51.7 t -134.33 142.96 47.41 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 2.9700000000000002 114.872 -166.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 4.6 tp -150.6 151.31 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.934 1.293 . . . . 2.6099999999999999 113.131 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' 1122 ' ' LYS . 0.0 OUTLIER -112.57 -17.26 12.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.492 1.517 . . . . 3.6200000000000001 114.082 169.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 57.3 t80 45.26 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.49 2.716 . . . . 2.7599999999999998 118.068 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.78 112.61 20.64 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.764 2.026 . . . . 2.46 109.132 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.8 t -99.75 136.67 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 2.25 111.377 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.1 t -131.42 108.37 14.71 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 108.645 -0.872 . . . . 1.0700000000000001 108.645 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.02 141.5 64.43 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.898 2.399 . . . . 1.3100000000000001 110.265 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 69.1 13.93 67.68 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 118.997 -0.89 . . . . 2.02 114.819 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 m -137.48 -87.77 0.28 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.803 1.241 . . . . 2.0699999999999998 112.696 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . -175.16 -151.15 8.32 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.851 0.7 . . . . 1.2 114.851 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 146.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.263 1.425 . . . . 2.2400000000000002 112.08 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.9 t -133.31 150.69 51.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.393 1.877 . . . . 0.90000000000000002 111.43 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.6 p -163.06 166.43 23.62 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.967 1.469 . . . . 0.75 114.967 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' 1110 ' ' ASP . 38.1 mmtm -109.71 140.72 43.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.553 1.941 . . . . 1.1599999999999999 107.759 166.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 14.7 p -149.4 140.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.806 1.41 . . . . 2.04 114.806 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' 1108 ' ' CYS . 4.4 t -124.32 157.04 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.751 1.621 . . . . 1.6799999999999999 110.87 166.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 127.187 2.195 . . . . 2.71 109.852 160.837 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.238 0.449 0 CA-C-O 120.841 0.353 . . . . 3.1699999999999999 111.226 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -129.23 138.68 51.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.073 1.749 . . . . 2.8700000000000001 110.417 -171.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -105.83 113.75 27.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.717 1.207 . . . . 1.23 108.718 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.9 m -131.39 139.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.376 0.989 . . . . 0.62 113.319 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.77 154.84 44.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.702 1.201 . . . . 0.58999999999999997 112.93 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.9 tt -155.91 142.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.753 1.621 . . . . 0.52000000000000002 110.555 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 125.33 147.36 6.99 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.391 1.317 . . . . 2.1800000000000002 116.391 168.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.64 -159.46 0.1 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.743 1.617 . . . . 2.1400000000000001 111.801 -169.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -125.68 -40.53 2.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.258 1.577 . . . . 5.3200000000000003 115.258 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.25 -41.08 67.19 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.085 -1.635 . . . . 4.0499999999999998 111.639 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 11.8 t90 -57.71 -23.23 50.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.562 0.949 . . . . 3.0899999999999999 113.562 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 75.5 mmm -75.42 -53.19 9.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.888 1.275 . . . . 2.8199999999999998 112.148 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 96.9 mt -47.89 -62.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.139 1.775 . . . . 2.5299999999999998 110.654 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -47.7 -13.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 128.504 2.722 . . . . 6.5999999999999996 116.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.61 24.88 0.45 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 119.689 1.131 . . . . 0.76000000000000001 111.859 169.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.17 27.63 73.65 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.385 -1.447 . . . . 0.81999999999999995 114.772 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 17.3 mt -95.41 159.08 15.17 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.977 1.389 . . . . 0.93999999999999995 114.253 -169.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 44.2 t -105.32 125.61 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.276 1.43 . . . . 1.78 110.544 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.9 tt -119.11 148.59 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.795 1.638 . . . . 1.46 110.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -127.43 165.41 19.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.383 1.073 . . . . 2.9399999999999999 113.041 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.71 -30.84 69.58 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.408 -1.433 . . . . 3.2200000000000002 114.12 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.36 -42.94 98.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.19 1.396 . . . . 5.0800000000000001 111.565 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.5 p -77.78 -40.51 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.505 1.522 . . . . 1.1000000000000001 112.113 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -57.69 -41.6 81.98 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.447 1.022 . . . . 3.7200000000000002 112.125 171.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.6 -34.71 78.86 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.632 0.975 . . . . 2.9199999999999999 113.632 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -74.93 -39.32 61.45 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 2.4199999999999999 112.968 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 37.4 tpp -57.84 -58.7 7.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.033 1.333 . . . . 1.0900000000000001 110.204 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.3 t -63.23 -31.17 72.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.819 0.674 . . . . 1.48 112.819 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -58.38 -50.19 74.54 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.841 -1.162 . . . . 3.0099999999999998 112.108 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -72.73 -33.22 66.25 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.355 1.242 . . . . 2.1499999999999999 114.355 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -65.3 -43.66 90.4 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.423 -0.798 . . . . 4.7000000000000002 111.686 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -69.49 -25.59 64.14 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.599 -1.313 . . . . 4.8899999999999997 112.661 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.4 mttp -67.07 -12.56 60.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.225 1.41 . . . . 2.1800000000000002 112.959 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.0 25.35 66.91 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.531 1.062 . . . . 1.6100000000000001 113.384 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.83 172.4 7.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.642 1.577 . . . . 6.75 110.076 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 87.5 m -83.76 127.66 33.96 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.541 -0.725 . . . . 0.82999999999999996 111.192 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -134.65 109.54 8.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.438 1.495 . . . . 0.68999999999999995 110.045 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.2 m -140.51 154.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.595 1.158 . . . . 0.68999999999999995 112.498 -172.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.44 170.28 8.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.37 0.878 . . . . 0.72999999999999998 113.37 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 10.3 t -130.66 130.26 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.426 1.89 . . . . 1.6699999999999999 111.035 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.08 150.03 47.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.421 1.089 . . . . 0.52000000000000002 112.227 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.5 m -142.94 117.54 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.912 2.085 . . . . 0.92000000000000004 111.255 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 45.29 53.9 7.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.701 2.0 . . . . 2.8500000000000001 112.805 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.65 33.47 23.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.387 1.875 . . . . 1.52 114.091 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.33 144.86 36.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 2.6899999999999999 109.911 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 146.17 41.08 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.923 -1.736 . . . . 0.78000000000000003 112.296 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 24.9 p -121.84 -44.24 2.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.107 0.963 . . . . 0.75 113.123 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.23 -169.93 34.75 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.325 0.966 . . . . 0.51000000000000001 114.853 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.58 161.12 39.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.709 1.603 . . . . 1.03 114.296 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 18.1 mm -129.38 135.01 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.008 1.723 . . . . 0.70999999999999996 110.651 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -110.77 126.5 54.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.273 1.829 . . . . 0.47999999999999998 110.198 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.09 153.97 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.421 1.488 . . . . 1.5700000000000001 110.032 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.16 1.384 . . . . 1.4199999999999999 111.425 175.167 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 113.705 1.002 . . . . 2.5899999999999999 113.705 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.58 141.55 46.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.026 3.151 . . . . 1.49 112.19 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.11 128.11 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.727 2.011 . . . . 2.1600000000000001 110.302 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.293 10.3 p -76.04 117.51 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.61 -1.306 . . . . 1.3700000000000001 113.464 -169.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -100.72 -47.05 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.9 1.28 . . . . 2.3900000000000001 112.928 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -154.97 153.81 31.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 2.77 112.203 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -131.87 143.53 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.936 1.294 . . . . 0.85999999999999999 109.868 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.3 tttt -141.38 146.92 37.23 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.081 0.771 . . . . 1.95 113.081 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 61.2 t -89.93 134.51 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.81999999999999995 111.717 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.9 tp -113.25 -22.82 10.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.136 1.774 . . . . 1.25 113.274 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 121.56 25.2 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.015 1.726 . . . . 1.8400000000000001 109.111 169.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -135.43 137.72 42.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.742 1.016 . . . . 3.5299999999999998 113.742 -171.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 5.0 m 61.32 -50.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.98 2.912 . . . . 3.4300000000000002 115.227 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -75.35 133.47 41.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.999 -1.111 . . . . 3.5800000000000001 107.999 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 64.34 -53.85 0.27 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.363 2.265 . . . . 5.3799999999999999 115.393 -168.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.74 154.57 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.299 1.44 . . . . 2.4900000000000002 111.79 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.6 m -121.86 153.42 38.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.013 1.325 . . . . 2.0099999999999998 113.954 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 31.9 p80 -50.05 -50.53 47.51 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.678 2.103 . . . . 4.1699999999999999 116.678 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -74.32 -28.78 61.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.483 1.038 . . . . 2.98 111.978 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.98 -37.51 67.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.8 -1.095 . . . . 3.23 112.007 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.13 -56.19 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 119.416 1.007 . . . . 0.90000000000000002 110.565 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.98 -28.63 69.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.448 -0.783 . . . . 0.84999999999999998 112.617 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.27 -46.75 63.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.937 0.717 . . . . 0.69999999999999996 112.937 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 27.6 pt -70.25 -28.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.968 1.258 . . . . 0.83999999999999997 113.372 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 63.1 t -70.55 -52.02 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.568 0.622 . . . . 0.84999999999999998 110.944 170.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.39 -30.37 73.34 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.369 -0.832 . . . . 0.68999999999999995 114.271 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 12.6 p -70.2 -44.1 69.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.761 1.281 . . . . 0.71999999999999997 112.85 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.66 -49.56 76.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.679 0.792 . . . . 0.92000000000000004 111.549 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -65.91 -22.68 66.52 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.568 -0.708 . . . . 2.0699999999999998 112.905 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 68.4 m -67.0 -38.52 86.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.735 1.214 . . . . 2.6299999999999999 114.116 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.3 t30 -95.42 -15.18 23.19 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.237 1.415 . . . . 2.5099999999999998 111.934 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 37.8 t -66.21 176.0 1.92 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.544 1.538 . . . . 1.48 109.928 165.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.2 46.87 1.72 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.263 -1.523 . . . . 3.6899999999999999 113.407 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -93.39 165.1 19.0 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.219 1.408 . . . . 1.6200000000000001 113.884 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.98 -26.07 0.96 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.593 2.862 . . . . 1.2 114.74 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.9 tt -110.62 -48.83 3.1 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.212 1.405 . . . . 0.94999999999999996 112.643 -168.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -56.9 -24.16 48.58 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 113.999 0.36 . . . . 0.96999999999999997 113.999 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 36.7 p -60.67 -17.38 47.31 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.724 1.379 . . . . 1.3799999999999999 114.724 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.09 86.1 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.418 1.008 . . . . 0.93000000000000005 111.396 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.6 mt -70.26 -39.52 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.553 1.141 . . . . 0.89000000000000001 110.192 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 79.8 m -52.58 -48.09 66.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.338 0.655 . . . . 1.1100000000000001 111.695 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 43.9 tttt -64.16 -49.7 71.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.313 0.645 . . . . 2.3199999999999998 112.279 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 11.2 t80 -53.89 -42.84 69.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 1.8 111.542 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.5 t -70.39 -53.74 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.213 1.405 . . . . 1.6599999999999999 112.031 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -58.17 -42.58 86.31 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.772 -1.205 . . . . 3.4399999999999999 111.816 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.31 -32.3 70.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.618 0.767 . . . . 3.6699999999999999 112.953 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.31 -48.41 65.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.319 1.048 . . . . 1.8899999999999999 111.781 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.47 -31.36 67.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 26.4 t0 53.39 29.5 8.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.335 1.854 . . . . 2.6499999999999999 113.622 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . 0.448 HG23 ' H ' ' A' 1104 ' ' THR . 12.1 t -98.82 -21.53 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.36 1.615 . . . . 4.0300000000000002 115.36 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 6.4 tt0 52.62 20.15 1.43 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.824 2.157 . . . . 2.8799999999999999 116.824 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . 0.448 ' H ' HG23 ' A' 1102 ' ' THR . 56.7 p -137.46 0.15 2.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.15 -1.594 . . . . 3.5699999999999998 114.844 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 157.69 36.74 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.112 -0.993 . . . . 1.0600000000000001 113.413 -169.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 84.4 130.76 2.06 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.528 0.971 . . . . 1.0900000000000001 115.528 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . 0.409 HG22 ' H ' ' A' 1108 ' ' CYS . 0.5 OUTLIER -144.18 -170.02 3.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.209 2.604 . . . . 2.5800000000000001 108.603 -175.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . 0.409 ' H ' HG22 ' A' 1107 ' ' THR . 48.8 t -60.68 132.41 53.8 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.063 1.875 . . . . 1.72 116.063 -168.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.03 148.74 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.168 2.187 . . . . 2.96 116.057 169.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.5 143.8 26.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.465 -2.05 . . . . 2.96 105.465 161.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.85 132.3 54.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.645 1.578 . . . . 2.7799999999999998 112.451 -169.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.48 99.12 4.41 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.935 2.094 . . . . 3.1600000000000001 109.352 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 33.2 m -102.1 148.61 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.245 0.832 . . . . 2.46 113.245 -169.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 24.5 t -133.16 111.08 12.94 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.959 1.303 . . . . 1.25 107.773 168.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.66 134.74 62.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.892 2.394 . . . . 1.5900000000000001 113.519 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 59.93 26.22 62.82 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.465 1.507 . . . . 2.2400000000000002 115.924 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.0 t -146.52 -47.9 0.19 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.002 1.401 . . . . 1.99 114.257 -172.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.13 169.26 21.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.888 0.756 . . . . 0.88 113.445 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.84 162.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.673 -0.898 . . . . 2.6499999999999999 112.621 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 34.6 t -122.49 145.37 48.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.716 2.006 . . . . 0.55000000000000004 109.757 167.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.1 p -150.03 160.91 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.613 0.765 . . . . 0.73999999999999999 112.42 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -119.99 105.32 10.93 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.551 -0.718 . . . . 1.6000000000000001 109.135 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.9 p -104.45 138.28 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.052 1.341 . . . . 1.9199999999999999 112.191 -168.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 171.37 8.14 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.824 1.416 . . . . 1.3999999999999999 114.824 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.282 18.2 t-20 . . . . . 0 N--CA 1.477 0.893 1 C-N-CA 134.088 4.955 . . . . 2.8500000000000001 108.547 166.561 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 115.113 1.523 . . . . 2.54 115.113 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 123.94 30.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.848 1.659 . . . . 3.4700000000000002 111.067 -170.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.28 123.16 26.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.946 0.794 . . . . 1.6000000000000001 110.615 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -134.67 133.67 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.359 1.064 . . . . 0.56999999999999995 111.104 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.18 147.51 41.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.605 1.162 . . . . 0.40000000000000002 113.01 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.7 tt -149.58 141.35 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.895 1.278 . . . . 0.47999999999999998 110.77 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.82 -155.25 26.05 Favored Glycine 0 CA--C 1.532 1.133 0 N-CA-C 115.411 0.924 . . . . 1.4099999999999999 115.411 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -71.41 160.42 32.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.621 1.568 . . . . 3.48 111.59 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -59.13 -16.84 21.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.762 1.225 . . . . 6.3099999999999996 114.066 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -57.74 -36.0 71.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.683 0.793 . . . . 4.7800000000000002 112.256 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 5.3 m95 -74.35 -47.57 33.46 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.13 0.972 . . . . 3.3999999999999999 112.156 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -29.06 68.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.478 0.711 . . . . 2.1200000000000001 112.164 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.33 -66.89 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.156 2.182 . . . . 2.4199999999999999 108.127 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -23.38 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.536 1.935 . . . . 8.3100000000000005 115.953 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.66 14.62 31.43 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 120.349 1.431 . . . . 0.82999999999999996 114.163 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.81 17.88 67.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.249 1.404 . . . . 1.1899999999999999 116.517 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.16 155.48 28.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.405 1.103 . . . . 1.25 111.533 -170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 92.3 t -91.94 127.95 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.485 0.714 . . . . 1.6000000000000001 110.189 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 13.8 tt -112.97 152.44 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.003 1.321 . . . . 1.55 111.954 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.46 156.64 20.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.571 1.693 . . . . 2.9100000000000001 115.571 -168.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.4 t30 -68.66 -37.26 79.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.533 1.133 . . . . 3.0299999999999998 113.914 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.29 -33.61 69.89 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.93 -1.106 . . . . 2.9100000000000001 112.305 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -76.27 -37.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.227 -0.921 . . . . 1.23 112.196 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.59 -35.37 77.67 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.125 0.875 . . . . 2.75 112.075 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.03 -40.29 84.6 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.947 1.092 . . . . 2.7200000000000002 113.947 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.57 -44.99 48.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.073 0.949 . . . . 2.9100000000000001 112.319 171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 47.8 tpp -59.85 -56.27 23.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.39 1.076 . . . . 0.88 111.681 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.8 t -66.54 -30.65 71.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.522 -0.736 . . . . 1.4299999999999999 112.52 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -62.4 -45.79 91.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.401 1.08 . . . . 3.52 111.391 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -67.53 -39.09 85.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.081 1.353 . . . . 3.9399999999999999 112.071 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.11 -45.26 92.83 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.626 -0.671 . . . . 3.8700000000000001 112.158 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.52 -21.14 62.77 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.936 -1.102 . . . . 5.1799999999999997 113.309 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.266 14.2 ptpt -85.23 7.62 21.37 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.934 1.457 . . . . 3.2599999999999998 114.934 167.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 72.2 21.21 79.34 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.785 1.074 . . . . 2.0099999999999998 115.785 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -110.42 144.08 39.74 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.121 1.461 . . . . 4.7699999999999996 110.39 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 52.5 m -61.35 124.31 20.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.80000000000000004 112.44 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.06 125.43 37.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.756 1.222 . . . . 0.68000000000000005 110.174 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.6 m -141.99 159.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.709 1.204 . . . . 0.52000000000000002 113.536 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.2 mt -111.61 158.3 19.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.634 1.974 . . . . 1.3100000000000001 111.559 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.7 p -139.47 128.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.076 0.951 . . . . 1.95 112.665 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.6 153.06 48.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.381 2.272 . . . . 0.52000000000000002 111.008 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 10.5 m -144.09 136.13 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.252 -0.905 . . . . 0.97999999999999998 112.098 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 33.3 t70 41.74 50.88 4.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.004 1.721 . . . . 2.9900000000000002 112.207 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.26 6.0 m-20 66.19 21.59 11.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.385 1.994 . . . . 1.54 116.385 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -126.71 151.04 48.68 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.015 2.126 . . . . 2.48 110.147 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.18 143.08 41.32 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.769 -1.832 . . . . 0.75 111.795 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 17.5 p -118.72 -38.84 3.05 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.422 1.267 . . . . 0.68000000000000005 114.422 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.73 -172.94 37.53 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 119.389 0.995 . . . . 0.57999999999999996 114.588 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.7 151.59 41.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.716 1.606 . . . . 0.84999999999999998 112.838 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.34 137.0 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.944 1.697 . . . . 0.83999999999999997 109.962 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -123.7 135.06 53.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.653 1.581 . . . . 0.66000000000000003 110.951 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 32.5 mt -140.41 153.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.463 1.905 . . . . 1.5800000000000001 110.403 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 125.026 1.33 . . . . 1.4299999999999999 109.918 168.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 115.235 1.569 . . . . 3.3599999999999999 115.235 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -84.04 94.51 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.532 2.821 . . . . 1.8799999999999999 112.008 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 82.2 t -89.96 108.86 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.883 -1.135 . . . . 2.8300000000000001 109.767 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.1 p -72.38 129.44 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.745 -1.222 . . . . 1.71 111.968 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.14 -50.7 2.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.177 1.547 . . . . 2.7000000000000002 115.177 -167.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -149.64 149.74 31.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.142 0.883 . . . . 2.77 112.609 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -129.67 145.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.876 1.27 . . . . 0.96999999999999997 110.904 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.9 tttt -141.66 138.86 32.79 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.155 0.982 . . . . 1.8899999999999999 113.433 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 94.3 t -82.93 134.5 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.951 0.9 . . . . 0.69999999999999996 110.71 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 20.0 tp -107.22 -32.31 7.85 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.096 1.358 . . . . 1.4299999999999999 112.966 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 51.9 m -118.03 99.11 6.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.729 1.212 . . . . 1.8300000000000001 108.234 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 141.47 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.284 1.034 . . . . 3.4900000000000002 110.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.7 m 52.52 29.24 6.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.958 1.836 . . . . 2.6499999999999999 115.958 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -137.91 -17.51 1.24 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.106 1.151 . . . . 2.9199999999999999 114.106 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.5 -49.3 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.166 1.348 . . . . 4.71 114.41 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.96 142.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.52 1.528 . . . . 1.47 111.25 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 14.5 m -87.53 147.93 25.12 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.335 1.054 . . . . 2.1200000000000001 112.287 170.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.1 p80 -53.5 -38.89 64.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.45 1.648 . . . . 3.1600000000000001 115.45 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 23.8 t60 -66.79 -37.19 84.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.609 1.095 . . . . 3.4900000000000002 111.869 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -65.68 -36.29 83.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 118.228 -0.891 . . . . 3.3599999999999999 111.259 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.11 -54.35 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 118.947 0.794 . . . . 0.55000000000000004 111.189 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.51 -33.88 76.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.877 0.762 . . . . 0.55000000000000004 111.881 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.39 57.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.63 -0.7 . . . . 0.58999999999999997 112.143 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 6.0 pt -69.48 -27.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 119.642 1.11 . . . . 0.62 113.748 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 77.5 t -70.68 -43.39 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.237 0.926 . . . . 0.69999999999999996 110.415 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.34 -37.42 93.87 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.127 -0.818 . . . . 0.68000000000000005 113.282 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.6 p -73.88 -37.62 64.67 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.353 1.576 . . . . 0.96999999999999997 112.636 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.68 88.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.961 0.801 . . . . 0.78000000000000003 112.896 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' 1084 ' ' SER 0.254 3.4 tp10 -75.75 -20.92 57.95 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.196 0.813 . . . . 3.3799999999999999 113.196 175.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 26.3 t -57.7 -47.46 82.32 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.075 -1.64 . . . . 1.3100000000000001 112.743 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -77.33 -2.94 37.46 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 121.222 -0.924 . . . . 2.1400000000000001 112.689 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' 1081 ' ' GLU . 20.0 m -111.12 -178.6 3.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.584 2.354 . . . . 2.4100000000000001 111.494 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.03 51.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.135 -0.978 . . . . 4.1699999999999999 113.55 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.68 147.41 86.77 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.042 . . . . 1.5600000000000001 113.688 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.83 -36.51 90.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.172 3.248 . . . . 1.55 114.028 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.03 -47.49 4.98 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.787 2.035 . . . . 1.25 110.874 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -33.01 78.98 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 114.583 0.593 . . . . 1.1699999999999999 114.583 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 3.9 t -66.0 -16.02 63.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.126 1.463 . . . . 2.9500000000000002 114.458 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -73.63 -27.16 61.13 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.089 -1.007 . . . . 1.4399999999999999 112.922 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.5 -41.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.878 0.871 . . . . 1.1399999999999999 109.199 171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.7 m -51.62 -43.97 62.75 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.757 0.708 . . . . 1.27 111.289 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.1 tttt -63.82 -51.78 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.913 0.778 . . . . 2.4300000000000002 112.936 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.41 -47.2 66.43 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 2.3100000000000001 111.105 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 98.3 m -69.07 -52.48 28.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.023 1.329 . . . . 2.9399999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -49.49 -48.34 47.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.06 1.344 . . . . 3.6600000000000001 111.642 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -71.62 -35.91 70.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.844 0.857 . . . . 2.6499999999999999 112.905 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -70.33 -35.75 73.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.5 -1.375 . . . . 2.1800000000000002 113.448 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.86 -6.38 37.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.285 1.034 . . . . 1.3400000000000001 113.751 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.8 t0 54.91 40.07 31.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.239 1.416 . . . . 3.3900000000000001 112.472 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.6 t -131.38 174.12 10.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.518 1.527 . . . . 2.5800000000000001 111.508 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -114.87 -3.67 12.71 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.337 1.455 . . . . 2.9500000000000002 112.4 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 8.1 t -148.76 142.6 25.69 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.337 1.455 . . . . 2.98 111.69 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.69 145.87 20.38 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.974 0.91 . . . . 0.85999999999999999 112.322 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 83.18 135.75 2.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.074 1.321 . . . . 1.0800000000000001 114.458 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 54.9 m -105.72 -64.77 1.11 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.041 1.336 . . . . 1.6499999999999999 111.118 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -137.85 131.67 31.42 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.308 0.575 . . . . 1.7 110.595 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 30.3 mm -143.54 142.29 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.801 4.441 . . . . 3.4700000000000002 102.797 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.12 106.25 5.47 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 120.895 -1.128 . . . . 4.4800000000000004 111.442 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -100.62 145.67 28.09 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 118.038 2.607 . . . . 2.4399999999999999 118.038 -166.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.16 104.65 7.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 130.843 3.657 . . . . 2.7799999999999998 106.68 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 91.5 t -99.03 139.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.309 1.044 . . . . 2.0600000000000001 110.932 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 43.4 t -126.48 101.3 27.77 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.021 1.328 . . . . 1.1499999999999999 109.257 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.01 130.8 32.84 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.039 3.159 . . . . 1.3999999999999999 114.978 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 75.75 -37.68 1.25 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.031 2.253 . . . . 1.9099999999999999 114.412 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 60.4 m -82.19 -48.28 11.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.052 1.426 . . . . 2.1899999999999999 113.938 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 159.43 -178.0 35.73 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.835 0.743 . . . . 0.78000000000000003 113.387 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.12 157.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.661 0.615 . . . . 2.5499999999999998 112.661 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -131.68 151.6 51.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.997 1.719 . . . . 0.47999999999999998 110.871 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -153.8 166.26 33.43 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.842 -1.161 . . . . 0.67000000000000004 114.003 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -110.71 136.72 49.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.253 -1.017 . . . . 1.1899999999999999 108.253 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 80.1 t -128.95 139.44 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.458 1.103 . . . . 2.2999999999999998 111.877 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.8 t -146.6 152.82 39.54 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.789 2.144 . . . . 1.4399999999999999 116.789 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.305 24.7 t-20 . . . . . 0 CA--C 1.539 0.549 1 C-N-CA 132.582 4.353 . . . . 3.9199999999999999 106.207 158.061 . . . . . . . . 2 1 . 1 . 004 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.298 0.571 . . . . 2.3100000000000001 112.37 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.75 143.63 32.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.488 1.515 . . . . 2.6400000000000001 111.398 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -110.87 115.74 30.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.698 1.599 . . . . 1.6699999999999999 108.656 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.8 m -133.76 142.35 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 119.979 1.263 . . . . 0.69999999999999996 112.829 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 150.89 39.7 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.648 0.981 . . . . 0.39000000000000001 113.648 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.2 tt -141.29 135.24 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.428 1.891 . . . . 0.63 109.799 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.08 -167.9 40.93 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.582 1.393 . . . . 1.4199999999999999 116.582 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -76.08 166.1 23.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.046 1.738 . . . . 3.02 114.523 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -50.78 -45.32 59.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.904 2.187 . . . . 5.4000000000000004 116.904 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.27 -31.89 58.51 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.152 1.796 . . . . 3.4700000000000002 112.003 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -64.0 -35.87 82.13 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.958 -1.089 . . . . 2.98 112.239 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.44 83.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.075 1.139 . . . . 2.0600000000000001 114.075 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.0 mt -54.94 -60.06 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.506 1.122 . . . . 1.72 109.047 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -49.57 -19.35 0.57 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.59 2.07 . . . . 5.7800000000000002 116.59 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.82 11.57 4.8 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 121.632 2.014 . . . . 0.72999999999999998 112.593 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.71 35.59 85.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 119.868 -1.77 . . . . 0.78000000000000003 113.966 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.18 153.45 19.59 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.535 1.167 . . . . 0.81000000000000005 111.435 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -84.53 132.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.804 -0.56 . . . . 0.97999999999999998 109.554 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.67 140.05 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.676 1.19 . . . . 0.97999999999999998 110.862 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -116.06 167.85 10.61 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.987 1.477 . . . . 2.9900000000000002 114.987 -167.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.05 -45.98 69.01 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.15 1.537 . . . . 3.0 115.15 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.34 -26.91 64.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.068 -1.02 . . . . 2.3900000000000001 112.021 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -78.56 -38.62 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 117.748 -1.12 . . . . 0.69999999999999996 112.481 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.69 -41.56 91.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.902 1.683 . . . . 2.04 110.884 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.18 -40.96 91.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.417 1.487 . . . . 2.3900000000000001 113.305 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 52.1 t80 -72.11 -40.93 67.79 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.187 0.995 . . . . 2.2200000000000002 112.523 174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 46.2 tpp -59.96 -57.53 12.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.01 1.724 . . . . 0.81999999999999995 110.104 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.2 t -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.903 0.881 . . . . 1.1200000000000001 111.971 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.11 -54.75 42.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.233 1.013 . . . . 2.5 111.776 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.29 -34.19 70.42 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.498 0.925 . . . . 2.9300000000000002 113.498 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -59.35 -49.92 75.95 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.223 -0.923 . . . . 3.2799999999999998 110.764 170.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -72.76 -14.86 61.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.936 -1.103 . . . . 4.8399999999999999 113.957 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 16.7 mttp -75.79 -6.23 49.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.099 1.76 . . . . 2.7599999999999998 112.367 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 86.2 24.59 39.94 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.231 1.396 . . . . 1.28 114.071 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.74 163.06 13.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.372 1.469 . . . . 4.21 110.302 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 14.0 m -76.2 133.19 40.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.93000000000000005 110.195 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -137.12 116.63 12.84 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.105 1.362 . . . . 0.46000000000000002 111.138 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 25.9 m -140.22 156.83 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.191 1.396 . . . . 0.48999999999999999 112.784 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.92 162.88 14.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.901 1.681 . . . . 0.93000000000000005 112.293 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.6 p -135.65 126.98 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.655 1.582 . . . . 2.4399999999999999 112.456 172.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.86 157.0 38.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.436 1.894 . . . . 0.40999999999999998 111.75 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 133.21 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.413 1.485 . . . . 0.85999999999999999 112.292 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 40.16 45.42 1.71 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.385 2.274 . . . . 2.7599999999999998 113.428 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 12.3 m-20 64.79 39.79 5.97 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.713 2.405 . . . . 1.5600000000000001 116.115 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -146.69 146.4 30.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.148 2.179 . . . . 2.29 110.176 169.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.23 147.81 42.13 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 119.498 -2.001 . . . . 0.81000000000000005 112.964 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.0 p -124.83 -38.52 2.35 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.02 1.489 . . . . 0.52000000000000002 115.02 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -163.34 179.92 38.18 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 120.7 1.591 . . . . 0.46999999999999997 115.875 -173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.58 155.62 43.73 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.86 1.664 . . . . 0.79000000000000004 113.502 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.9 mm -130.93 141.92 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.585 1.954 . . . . 0.92000000000000004 110.247 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -122.87 131.2 53.64 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.349 1.46 . . . . 0.56999999999999995 111.59 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 8.4 mt -135.83 145.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.967 1.707 . . . . 1.53 109.789 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.921 0 C-N-CA 125.505 1.522 . . . . 1.3899999999999999 112.884 -174.242 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 115.274 1.583 . . . . 2.48 115.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.31 166.69 7.13 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.739 2.293 . . . . 1.46 110.486 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 11.7 p -135.47 130.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.969 -1.082 . . . . 2.1600000000000001 111.28 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -66.59 135.01 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.14 -0.975 . . . . 1.4399999999999999 111.507 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.88 -33.67 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.227 0.825 . . . . 2.1899999999999999 113.227 -172.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -159.2 143.87 15.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.296 0.953 . . . . 2.3700000000000001 112.113 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -114.66 134.27 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.686 0.795 . . . . 0.93999999999999995 109.15 167.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.5 tttt -140.71 145.1 36.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.291 0.849 . . . . 2.8500000000000001 113.291 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.3 t -101.5 129.82 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.386 1.474 . . . . 1.0 111.169 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.05 -25.0 11.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.017 1.727 . . . . 1.01 112.45 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 34.4 m -137.0 130.72 31.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.454 1.501 . . . . 1.8999999999999999 110.492 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.25 144.52 40.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.009 1.324 . . . . 6.2000000000000002 110.918 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 61.9 m 54.55 13.13 0.62 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.254 2.221 . . . . 2.9100000000000001 115.839 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -137.53 13.63 2.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.717 2.407 . . . . 2.7200000000000002 112.433 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -163.46 -58.42 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.298 1.439 . . . . 5.0199999999999996 110.679 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.48 159.76 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 129.768 3.227 . . . . 1.8600000000000001 108.006 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 39.7 m -106.6 155.6 19.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.842 1.257 . . . . 1.8200000000000001 113.68 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.83 -41.36 57.53 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.706 2.484 . . . . 3.4399999999999999 117.706 -167.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.97 -28.05 54.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.971 1.26 . . . . 2.5899999999999999 111.406 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' 1072 ' ' LYS . 9.7 mmpt? -70.36 -34.63 72.85 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 116.917 -1.516 . . . . 5.3200000000000003 111.933 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 63.3 mt -56.81 -53.68 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.662 1.574 . . . . 0.60999999999999999 110.547 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.53 -30.76 71.15 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.4 -0.812 . . . . 0.59999999999999998 112.323 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.03 60.84 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.52000000000000002 112.231 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.7 pt -69.98 -35.09 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.508 -1.37 . . . . 0.52000000000000002 112.682 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.0 t -71.01 -43.52 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.096 0.862 . . . . 0.56999999999999995 111.71 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.96 -35.7 79.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.849 -1.157 . . . . 0.56999999999999995 113.492 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 73.8 p -73.96 -25.31 59.87 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.51 -0.994 . . . . 0.76000000000000001 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.27 -55.49 15.87 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.538 0.735 . . . . 0.66000000000000003 110.98 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.07 -20.85 63.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.133 0.79 . . . . 2.1299999999999999 113.133 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 24.8 t -55.39 -33.18 63.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.72 -1.238 . . . . 1.3100000000000001 112.87 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.73 -8.57 58.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.051 0.941 . . . . 2.25 113.361 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 5.0 t -99.35 -179.64 4.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.797 1.639 . . . . 1.5 113.754 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -137.5 8.86 2.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.353 2.261 . . . . 3.9100000000000001 113.962 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -87.33 150.01 48.23 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.779 1.232 . . . . 1.78 113.906 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.17 -28.65 40.42 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.466 3.444 . . . . 1.1000000000000001 115.47 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.11 -46.94 4.12 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.182 0.993 . . . . 0.87 112.576 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.84 -30.11 76.76 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 113.938 0.335 . . . . 0.87 113.938 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 21.3 p -63.69 -17.74 63.27 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.947 -1.325 . . . . 1.3200000000000001 114.248 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.13 85.8 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.136 -0.978 . . . . 1.01 111.71 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 15.1 mt -73.29 -36.4 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.824 1.65 . . . . 0.93999999999999995 110.573 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 21.5 m -51.44 -47.34 63.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.904 0.775 . . . . 1.1200000000000001 111.546 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.68 -49.81 75.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.035 0.934 . . . . 2.1099999999999999 112.574 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.62 -40.0 74.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.563 0.745 . . . . 1.73 111.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 28.3 t -71.66 -52.53 17.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.38 1.472 . . . . 1.78 112.591 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -51.87 -44.16 63.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.751 1.62 . . . . 3.1000000000000001 112.588 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -69.84 -34.05 73.12 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.602 0.761 . . . . 3.5800000000000001 112.591 175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.91 -47.77 67.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.413 1.006 . . . . 2.96 112.977 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.91 -32.54 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.78 0.832 . . . . 1.1100000000000001 112.48 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 1.7 t70 54.94 54.39 9.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.747 2.019 . . . . 2.7599999999999998 112.009 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.3 t -148.37 142.99 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.125 -0.984 . . . . 2.7599999999999998 113.193 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -98.0 21.88 10.11 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.042 1.337 . . . . 3.0 112.707 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 43.1 p -131.23 4.23 4.37 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.024 1.861 . . . . 2.8900000000000001 116.024 -168.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 139.4 57.75 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.689 1.366 . . . . 0.82999999999999996 114.689 -167.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 70.38 171.77 10.34 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.42 1.009 . . . . 1.1200000000000001 115.363 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 4.6 m -157.24 -40.49 0.07 Allowed 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.398 -1.06 . . . . 1.3999999999999999 112.809 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.11 143.54 48.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.517 1.127 . . . . 1.3400000000000001 113.125 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.2 129.01 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 127.408 2.283 . . . . 2.5800000000000001 109.097 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -25.71 32.14 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.983 1.105 . . . . 3.6000000000000001 113.983 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 34.0 t80 60.7 130.49 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 128.613 2.765 . . . . 3.8100000000000001 114.864 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' 1112 ' ' GLN . 1.0 OUTLIER -149.69 106.89 3.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.613 1.965 . . . . 2.1200000000000001 108.318 169.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 9.8 p -106.43 144.44 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.801 0.728 . . . . 2.6899999999999999 112.744 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 59.2 t -129.25 102.8 18.46 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.196 -1.409 . . . . 1.3200000000000001 107.196 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.89 136.54 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.276 2.651 . . . . 1.6599999999999999 113.512 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.79 20.58 77.62 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.42 1.01 . . . . 2.1400000000000001 114.17 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 21.5 t -145.02 -50.85 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.777 1.231 . . . . 2.3300000000000001 112.826 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 137.33 -153.3 21.87 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 119.524 1.056 . . . . 0.83999999999999997 114.643 174.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.3 mm -120.65 147.79 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.738 1.615 . . . . 2.5899999999999999 112.175 -172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.5 t -133.63 148.26 51.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.502 1.921 . . . . 0.71999999999999997 109.303 165.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.0 p -167.34 177.5 6.04 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.428 -1.42 . . . . 0.76000000000000001 114.072 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 137.64 53.78 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 105.965 -1.865 . . . . 3.7999999999999998 105.965 165.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 29.6 m -132.48 154.51 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.835 0.854 . . . . 2.2599999999999998 113.053 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.0 t -161.55 165.39 28.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.264 1.579 . . . . 1.8100000000000001 115.264 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.548 0.878 1 C-N-CA 132.888 4.475 . . . . 2.4199999999999999 108.144 162.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 114.478 1.288 . . . . 2.8799999999999999 114.478 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -135.92 126.82 27.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.833 1.653 . . . . 3.1099999999999999 109.514 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.1 tttt -84.84 120.39 26.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.327 -0.99 . . . . 1.1399999999999999 108.327 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.8 m -135.26 141.15 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.56 1.073 . . . . 0.57999999999999996 112.469 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.58 152.88 41.17 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 0.45000000000000001 112.92 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.1 tt -153.01 136.77 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.51000000000000001 110.991 -171.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 150.4 -141.89 9.15 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.252 1.261 . . . . 1.3200000000000001 116.252 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.63 152.14 0.23 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.312 2.645 . . . . 2.3300000000000001 113.509 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -57.49 -28.72 63.66 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.244 -0.91 . . . . 4.6100000000000003 112.529 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.35 -31.83 70.69 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.815 1.188 . . . . 4.4900000000000002 113.941 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.1 m95 -63.86 -27.04 68.89 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.281 1.401 . . . . 3.6899999999999999 112.716 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -71.54 -38.85 70.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.092 0.557 . . . . 2.5299999999999998 111.161 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.57 -70.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.12 1.368 . . . . 2.4900000000000002 109.016 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -40.26 -46.91 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.454 2.301 . . . . 5.4900000000000002 114.495 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.0 t30 -81.71 9.11 8.37 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.965 1.098 . . . . 0.97999999999999998 113.965 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.74 20.83 79.35 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 120.759 -1.213 . . . . 0.89000000000000001 114.791 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.1 mt -89.08 166.62 13.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.247 1.019 . . . . 1.28 109.868 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.2 t -124.9 112.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.859 1.264 . . . . 2.21 109.581 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.2 tt -87.57 147.98 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.569 1.548 . . . . 1.52 111.365 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -116.32 177.6 4.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.63 1.172 . . . . 3.5800000000000001 113.181 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -72.09 -33.42 67.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.282 1.956 . . . . 3.02 116.282 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.08 -31.05 25.53 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.127 1.331 . . . . 3.2400000000000002 113.445 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.2 p -67.08 -41.14 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 117.991 -1.004 . . . . 1.1799999999999999 110.428 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.95 -34.5 76.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.384 1.447 . . . . 2.6499999999999999 112.157 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.6 -42.13 99.39 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.015 0.926 . . . . 2.25 113.3 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -66.73 -40.94 88.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.162 1.385 . . . . 2.1899999999999999 112.105 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 20.3 ttm -63.61 -56.26 17.24 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.369 1.068 . . . . 1.1699999999999999 109.983 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.2 t -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.629 0.772 . . . . 1.02 112.673 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.45 -51.73 67.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.836 -1.165 . . . . 3.5600000000000001 112.297 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -70.97 -31.09 67.54 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.396 0.887 . . . . 3.8300000000000001 113.396 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -65.07 -34.08 77.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.755 -1.216 . . . . 3.6899999999999999 111.853 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -70.92 -29.9 66.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.912 1.285 . . . . 3.7400000000000002 113.268 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 2.2 mttp -71.54 3.17 4.14 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.996 1.318 . . . . 3.2400000000000002 113.439 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.77 20.52 55.81 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.732 1.158 . . . . 1.8999999999999999 114.897 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.55 158.29 17.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.337 1.455 . . . . 3.3500000000000001 111.482 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.0 m -81.41 137.27 35.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.844 2.058 . . . . 0.91000000000000003 110.285 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -138.69 124.77 20.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.886 0.874 . . . . 0.45000000000000001 112.686 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 31.1 m -140.99 158.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 125.936 1.694 . . . . 0.54000000000000004 112.887 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.54 164.26 12.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.86 1.264 . . . . 0.70999999999999996 113.311 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 14.4 t -136.55 118.1 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.428 1.891 . . . . 1.8899999999999999 111.124 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -119.14 155.08 32.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.195 1.398 . . . . 0.44 112.018 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.81 132.45 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.309 1.844 . . . . 0.87 112.218 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 71.1 m-20 40.22 47.94 2.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.882 2.073 . . . . 3.4700000000000002 112.845 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.263 27.9 m-20 60.05 34.74 21.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.484 2.313 . . . . 1.5600000000000001 116.383 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -145.13 149.17 34.53 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.578 -1.326 . . . . 2.79 112.651 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.43 142.48 58.16 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.319 -1.488 . . . . 0.66000000000000003 113.512 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.9 p -125.74 -34.03 2.67 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.897 1.444 . . . . 0.56000000000000005 114.897 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.69 -176.15 38.11 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-N 120.964 1.711 . . . . 0.51000000000000001 115.876 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.64 153.61 42.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.839 1.656 . . . . 0.69999999999999996 113.292 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 22.0 mm -123.6 134.39 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.567 1.547 . . . . 0.89000000000000001 110.058 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -117.23 133.01 56.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.328 1.851 . . . . 0.58999999999999997 109.549 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -139.31 147.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.006 1.723 . . . . 1.3700000000000001 111.974 -167.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 124.621 1.168 . . . . 1.3600000000000001 112.204 171.665 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.932 1.086 . . . . 2.79 113.932 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -85.87 153.8 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.09 3.193 . . . . 2.1400000000000001 113.637 -173.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 4.7 m -139.17 126.52 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 126.113 1.765 . . . . 3.0899999999999999 110.475 171.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -72.09 142.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.756 -1.215 . . . . 1.3999999999999999 110.008 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.9 -42.57 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.339 0.866 . . . . 2.52 113.339 -168.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -153.59 147.19 25.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.749 0.704 . . . . 2.3100000000000001 112.073 172.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 2.5 m -130.69 136.13 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.263 1.025 . . . . 0.73999999999999999 111.043 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 60.9 tttt -138.23 147.83 44.14 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.776 0.831 . . . . 1.74 112.357 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.2 t -91.18 137.64 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.561 1.145 . . . . 0.66000000000000003 111.374 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . 0.704 HD23 HD22 ' A' 1222 ' ' LEU . 24.7 tp -107.04 -22.98 12.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.253 1.821 . . . . 0.91000000000000003 112.753 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 5.0 t -100.03 27.76 5.32 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.512 1.525 . . . . 2.3100000000000001 113.782 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.82 125.02 21.78 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.695 -1.253 . . . . 4.1799999999999997 111.538 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 58.6 m 43.65 41.0 3.25 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.808 2.043 . . . . 4.21 113.931 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -133.04 -29.25 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.028 1.331 . . . . 4.1200000000000001 113.594 172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -146.0 -55.7 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.661 1.726 . . . . 5.5099999999999998 115.661 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 19.7 mt -135.53 144.04 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.991 1.316 . . . . 1.78 110.89 -169.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 50.9 m -98.42 158.62 15.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.641 1.576 . . . . 2.1699999999999999 113.357 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -55.5 -38.0 68.6 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.11 1.522 . . . . 3.1000000000000001 115.11 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 29.2 t60 -75.03 -37.38 61.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.506 1.048 . . . . 2.5899999999999999 112.165 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.5 mttt -65.99 -40.78 91.46 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.137 0.881 . . . . 3.0 111.637 169.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.2 mt -57.75 -52.43 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.826 0.739 . . . . 0.54000000000000004 110.932 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.13 -29.76 69.57 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.198 -0.938 . . . . 0.47999999999999998 112.373 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.01 19.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.092 0.557 . . . . 0.46999999999999997 111.959 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.64 -35.25 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 120.235 1.38 . . . . 0.57999999999999996 113.055 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 46.0 t -70.81 -46.06 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.342 -0.849 . . . . 0.73999999999999999 111.356 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -71.93 -28.58 68.45 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.97 -1.081 . . . . 0.65000000000000002 114.335 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 62.8 p -76.42 -32.71 58.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.369 1.067 . . . . 0.67000000000000004 112.398 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.37 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.053 0.842 . . . . 0.66000000000000003 112.323 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -66.36 -17.07 64.55 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.56 0.948 . . . . 2.23 113.56 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 16.1 p -67.25 -15.62 63.8 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.126 -1.608 . . . . 1.5800000000000001 114.463 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -94.76 -18.51 21.18 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.377 1.071 . . . . 1.8799999999999999 112.565 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 4.4 t -77.48 164.43 25.44 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.526 1.306 . . . . 1.8700000000000001 114.526 -169.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.12 23.5 4.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.881 2.073 . . . . 3.4100000000000001 112.259 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -85.68 160.8 52.51 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.738 1.215 . . . . 1.8200000000000001 113.136 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -81.51 1.52 9.2 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.58 3.52 . . . . 2.6099999999999999 115.425 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -141.12 -48.09 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.938 1.295 . . . . 0.93000000000000005 112.055 -167.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.15 -23.2 65.9 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.894 1.117 . . . . 0.90000000000000002 115.894 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 23.7 p -58.0 -25.68 61.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.16 -1.2 . . . . 1.5900000000000001 113.324 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.9 85.84 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.316 0.858 . . . . 0.91000000000000003 113.316 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.53 -41.66 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 110.898 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 8.9 t -64.0 -39.13 93.43 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 118.278 -0.867 . . . . 2.1800000000000002 112.204 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 23.5 tttp -60.14 -50.55 73.23 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.529 1.059 . . . . 3.1400000000000001 112.785 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.47 -44.73 55.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.574 1.149 . . . . 2.4300000000000002 112.184 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 35.6 t -69.68 -52.38 26.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.592 1.157 . . . . 1.72 112.416 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 14.9 tptm -49.96 -39.39 40.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.183 1.793 . . . . 2.4500000000000002 112.545 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.87 -40.37 65.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.718 1.207 . . . . 3.0800000000000001 113.99 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -70.53 -34.62 72.5 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.061 -1.649 . . . . 2.0699999999999998 113.298 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.01 -7.92 54.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.225 1.41 . . . . 1.0900000000000001 114.421 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 40.3 m-20 53.53 29.99 9.96 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.152 1.381 . . . . 4.6100000000000003 114.094 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -123.4 176.33 6.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.141 1.776 . . . . 2.7200000000000002 112.557 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -115.44 -2.97 12.45 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.263 1.425 . . . . 2.6699999999999999 113.716 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.0 t -143.97 125.08 14.47 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.777 -1.202 . . . . 3.0699999999999998 112.443 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.24 144.89 29.21 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.38 1.472 . . . . 0.93000000000000005 110.722 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 68.66 179.38 19.35 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 120.687 -1.258 . . . . 1.0800000000000001 114.201 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.7 m -158.2 -62.54 0.08 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.15 1.38 . . . . 1.6299999999999999 112.911 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.2 t -136.06 142.23 44.35 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.835 1.198 . . . . 1.8899999999999999 112.382 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 6.0 mm -143.17 150.17 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 1 C-N-CA 133.085 4.554 . . . . 2.0899999999999999 107.533 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -7.81 12.34 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.043 1.868 . . . . 3.0499999999999998 116.043 -173.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 65.9 m-85 43.94 109.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 129.396 3.079 . . . . 3.5600000000000001 118.773 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.37 94.27 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.879 2.072 . . . . 2.3300000000000001 106.213 166.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 19.2 m -103.21 146.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.276 1.03 . . . . 2.52 113.302 -168.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.3 t -138.61 124.61 12.53 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.414 1.486 . . . . 0.94999999999999996 109.231 171.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.35 146.31 39.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.976 3.117 . . . . 1.6200000000000001 112.994 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 53.27 32.57 44.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.39 0.995 . . . . 1.6100000000000001 113.396 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 53.9 t -150.01 -81.74 0.11 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.548 1.539 . . . . 1.76 111.655 -168.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 178.12 171.01 41.03 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 121.341 -0.849 . . . . 1.0900000000000001 112.838 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.36 157.16 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 117.373 0.586 . . . . 2.6400000000000001 112.124 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 20.1 t -130.89 157.31 43.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.025 1.73 . . . . 0.60999999999999999 111.077 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 27.6 p -162.8 167.44 22.87 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.424 0.898 . . . . 0.56999999999999995 113.424 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -112.24 119.85 39.74 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.227 1.011 . . . . 1.1899999999999999 108.853 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.2 p -111.67 139.08 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.944 0.72 . . . . 2.0 112.944 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -128.47 151.44 49.4 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 122.363 1.078 . . . . 1.53 111.75 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 130.171 3.388 . . . . 2.7799999999999998 104.807 159.609 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 114.256 1.206 . . . . 2.46 114.256 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.89 149.87 23.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.635 1.974 . . . . 3.98 110.57 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -104.74 119.04 38.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.779 0.831 . . . . 1.78 111.572 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 11.1 m -133.84 141.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.995 0.739 . . . . 0.56999999999999995 112.995 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.03 153.54 42.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 0.67000000000000004 113.457 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 3.4 tt -150.09 143.46 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.101 1.36 . . . . 0.69999999999999996 108.919 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 161.13 -160.85 32.47 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 117.789 1.876 . . . . 1.3600000000000001 117.789 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.05 155.97 0.58 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.105 3.362 . . . . 2.4399999999999999 113.889 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -55.22 -49.93 70.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.308 1.043 . . . . 4.7199999999999998 113.558 169.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -63.23 -35.38 80.13 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 3.1400000000000001 112.214 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -67.42 -25.37 65.89 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.581 1.553 . . . . 4.1399999999999997 113.552 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 23.1 mmt -77.06 -37.63 54.25 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.118 1.155 . . . . 2.1899999999999999 114.118 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 73.8 mt -53.11 -63.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.382 1.073 . . . . 1.76 108.516 168.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -40.89 -34.43 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.45 2.7 . . . . 6.4500000000000002 116.348 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.16 9.14 2.7 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 121.458 1.935 . . . . 0.93000000000000005 112.933 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.72 27.41 73.87 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 119.804 -1.81 . . . . 1.0 113.891 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.4 mt -93.65 160.97 14.54 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.363 1.465 . . . . 0.88 110.894 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 22.0 t -92.67 119.56 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.438 0.695 . . . . 1.24 109.825 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.2 tt -105.81 148.75 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.707 1.603 . . . . 1.72 110.396 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -138.58 163.97 30.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.61 0.966 . . . . 3.6400000000000001 113.61 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.01 -27.37 69.37 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.97 1.1 . . . . 3.0099999999999998 113.97 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.62 -30.28 56.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.783 1.174 . . . . 2.8399999999999999 113.901 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.3 p -76.89 -39.56 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 118.243 -0.884 . . . . 2.1200000000000001 110.466 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -62.54 -41.0 98.6 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.626 1.103 . . . . 2.4900000000000002 112.256 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.57 -43.59 80.26 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.039 0.755 . . . . 2.5299999999999998 113.039 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 18.4 t80 -56.44 -38.98 72.36 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 3.3399999999999999 111.181 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 17.6 tpp -66.04 -50.55 63.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.933 0.893 . . . . 0.96999999999999997 111.404 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.6 t -64.98 -38.35 90.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.301 0.955 . . . . 1.7 112.063 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.98 -53.57 55.26 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.218 -0.926 . . . . 4.6100000000000003 112.334 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -72.33 -32.77 66.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.919 1.081 . . . . 3.1400000000000001 113.919 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 15.3 mm-40 -58.48 -41.67 85.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.304 0.956 . . . . 3.1200000000000001 111.121 169.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -74.44 -19.93 60.21 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.088 1.755 . . . . 5.79 114.999 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -69.88 -13.1 62.09 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.39 1.076 . . . . 4.3300000000000001 112.921 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.53 11.47 59.38 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.327 1.918 . . . . 2.4900000000000002 113.763 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -91.22 156.53 17.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.621 1.568 . . . . 5.3600000000000003 109.345 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.6 m -82.92 130.42 35.14 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.639 1.175 . . . . 1.0600000000000001 108.299 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.93 130.23 56.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.19 0.996 . . . . 0.44 110.645 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.7 m -143.0 164.53 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.089 1.356 . . . . 0.51000000000000001 113.341 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.15 159.77 18.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.508 1.523 . . . . 1.3200000000000001 111.571 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' 1222 ' ' LEU . 7.3 p -138.41 135.08 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.321 1.048 . . . . 1.98 112.597 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -136.74 152.71 50.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.722 1.609 . . . . 0.54000000000000004 111.685 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.0 m -148.7 136.24 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.123 0.969 . . . . 0.89000000000000001 112.082 -171.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 38.3 m-20 41.06 45.31 2.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.71 2.004 . . . . 3.6699999999999999 113.163 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 52.8 m-20 64.89 32.23 10.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.317 2.647 . . . . 1.6200000000000001 117.414 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -137.57 145.15 42.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.168 -1.582 . . . . 2.3900000000000001 111.491 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . 0.704 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -75.86 122.84 24.71 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.042 -1.036 . . . . 0.90000000000000002 111.206 176.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.7 p -106.3 -32.2 8.28 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.45000000000000001 113.856 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.04 179.44 39.63 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 120.264 1.393 . . . . 0.46000000000000002 116.489 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.05 144.35 34.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.272 1.829 . . . . 1.74 111.253 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.72 145.53 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.32 1.448 . . . . 1.3 112.028 -166.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -119.79 133.69 55.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.838 1.655 . . . . 0.57999999999999996 110.878 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.41 150.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.418 1.887 . . . . 1.77 109.896 -171.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.758 0 C-N-CA 124.894 1.277 . . . . 2.1400000000000001 111.143 171.493 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.438 0.533 . . . . 2.27 112.438 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.34 155.22 4.54 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.803 3.669 . . . . 1.25 112.529 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 5.9 m -134.75 123.94 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.149 1.779 . . . . 2.6800000000000002 111.057 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.252 2.7 p -74.52 137.19 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.855 -1.153 . . . . 1.21 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.04 -33.1 3.59 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.197 1.554 . . . . 2.4900000000000002 115.197 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -153.12 148.45 26.99 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.466 1.106 . . . . 2.4900000000000002 111.06 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 7.5 m -128.73 130.21 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.762 0.825 . . . . 1.22 111.614 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.1 tttt -135.21 144.15 46.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.392 1.077 . . . . 1.6599999999999999 113.277 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 27.3 t -90.67 135.59 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.417 1.087 . . . . 0.73999999999999999 110.674 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.18 -41.78 8.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.88 110.772 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 1.5 t -81.97 37.9 0.5 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.675 1.59 . . . . 2.0699999999999998 113.358 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -57.98 119.23 6.38 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.485 -1.384 . . . . 4.8600000000000003 111.185 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 34.0 m 55.17 25.72 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.138 2.175 . . . . 3.4900000000000002 116.081 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -123.95 -21.35 5.12 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 116.454 2.02 . . . . 3.8999999999999999 116.454 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -152.69 -62.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.355 1.434 . . . . 5.8200000000000003 113.497 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 63.2 mt -129.12 150.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.817 1.647 . . . . 1.45 109.16 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 7.7 t -108.25 161.91 14.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.739 1.385 . . . . 3.1400000000000001 114.739 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -43.92 -50.7 8.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.925 2.49 . . . . 3.3799999999999999 116.652 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -76.36 -32.45 58.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.391 0.996 . . . . 2.7400000000000002 112.149 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 45.9 mttp -67.12 -41.55 86.0 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.057 . . . . 2.6699999999999999 112.09 170.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.15 -48.3 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.617 0.644 . . . . 0.53000000000000003 111.05 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.9 -32.94 73.77 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.288 -0.883 . . . . 0.5 112.452 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.16 81.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 0.52000000000000002 112.742 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.9 pt -70.23 -38.35 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.362 0.983 . . . . 0.59999999999999998 112.752 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 99.8 t -65.82 -45.58 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.635 1.107 . . . . 0.66000000000000003 110.71 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.71 -37.58 92.52 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.636 -0.665 . . . . 0.60999999999999999 113.823 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . 0.403 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 23.2 p -72.97 -40.42 65.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.462 1.131 . . . . 0.63 112.182 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.98 -51.71 63.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.977 0.808 . . . . 0.67000000000000004 112.626 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.12 -23.91 67.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.316 -0.865 . . . . 2.7000000000000002 112.485 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 11.9 p -63.85 -18.58 64.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.513 1.301 . . . . 1.6000000000000001 114.513 171.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.85 5.87 31.08 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.744 1.618 . . . . 2.9199999999999999 111.87 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.7 t -105.31 -177.54 3.39 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.246 1.818 . . . . 1.4199999999999999 112.697 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -128.82 17.5 6.26 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.585 1.954 . . . . 3.8300000000000001 113.703 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -88.16 146.68 38.73 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.127 1.528 . . . . 2.2200000000000002 115.127 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.95 -44.74 4.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.725 2.283 . . . . 1.4299999999999999 112.363 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -44.21 74.85 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.64 -0.663 . . . . 1.45 111.533 172.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.37 -44.34 95.23 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.222 0.915 . . . . 1.3200000000000001 113.949 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 20.8 p -64.56 -33.59 76.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.41 -1.053 . . . . 1.5700000000000001 112.184 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.84 83.22 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.813 -1.179 . . . . 1.1299999999999999 112.811 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.06 -40.51 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.076 0.55 . . . . 0.89000000000000001 110.493 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 95.2 m -54.07 -46.53 72.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.374 1.07 . . . . 1.0800000000000001 111.057 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.9 tttt -59.89 -48.67 80.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.882 0.765 . . . . 2.3199999999999998 112.343 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -61.55 -43.17 99.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 1.8200000000000001 112.719 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 77.8 m -68.74 -45.08 72.4 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.704 1.202 . . . . 3.2400000000000002 111.827 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.75 -31.16 72.24 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.856 -1.152 . . . . 3.0099999999999998 111.794 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -66.26 -44.18 84.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.07 0.85 . . . . 3.4399999999999999 110.819 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -61.55 -47.96 83.17 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.199 0.909 . . . . 2.4199999999999999 112.753 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.11 -23.53 63.05 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.212 1.19 . . . . 0.98999999999999999 114.212 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.51 54.77 10.42 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.764 1.269 . . . . 2.2400000000000002 112.78 -174.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.1 t -127.38 -15.35 5.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.679 1.591 . . . . 3.25 114.449 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 58.29 -50.67 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 129.076 2.95 . . . . 2.8799999999999999 115.649 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.4 t -111.97 135.01 53.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.27 2.228 . . . . 3.3799999999999999 110.883 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.43 174.28 15.47 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.251 1.02 . . . . 1.24 112.847 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 74.31 155.88 4.39 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 123.067 1.371 . . . . 1.0 115.495 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . 0.763 HG22 ' H ' ' A' 1108 ' ' CYS . 97.6 m -150.76 -166.5 2.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.373 2.269 . . . . 2.46 107.312 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . 0.763 ' H ' HG22 ' A' 1107 ' ' THR . 79.5 m -57.84 142.05 47.09 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.655 1.982 . . . . 3.0600000000000001 114.829 -169.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 177.94 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 129.273 3.029 . . . . 2.1099999999999999 110.667 -166.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 1.9 t0 -135.64 171.6 14.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.432 1.493 . . . . 2.79 109.484 167.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.385 1.448 . . . . 2.9500000000000002 113.818 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.78 99.34 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.344 2.657 . . . . 3.3100000000000001 105.776 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 42.5 t -99.18 138.61 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.244 1.418 . . . . 2.25 110.389 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 11.4 t -133.6 102.8 12.47 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.971 -1.122 . . . . 1.3100000000000001 107.971 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.69 130.25 30.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.52 2.147 . . . . 1.6100000000000001 113.001 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.3 20.36 76.68 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.321 0.962 . . . . 1.5700000000000001 114.816 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 50.8 t -143.52 -43.72 0.28 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.28 1.54 . . . . 1.8999999999999999 113.804 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.43 34.96 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.666 1.026 . . . . 0.89000000000000001 115.666 171.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.5 tt -140.61 154.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.529 1.532 . . . . 1.95 111.747 168.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -132.08 147.05 52.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.717 1.607 . . . . 0.46999999999999997 113.136 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.1 p -151.8 167.37 28.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.532 1.308 . . . . 0.67000000000000004 114.532 -175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . 0.419 ' HE3' ' HD3' ' A' 1179 ' ' LYS . 39.5 mmtm -114.44 97.14 6.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.029 1.732 . . . . 1.22 109.282 171.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.9 p -107.53 130.13 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.727 1.149 . . . . 1.96 113.499 -169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -115.04 168.54 9.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.514 1.126 . . . . 1.0800000000000001 113.752 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 129.422 3.089 . . . . 2.23 107.87 162.767 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 tm0? . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 112.982 0.734 . . . . 2.6200000000000001 112.982 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.07 119.88 25.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.364 1.066 . . . . 2.1800000000000002 113.347 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . 0.419 ' HD3' ' HE3' ' A' 1122 ' ' LYS . 37.7 ttpt -81.35 115.08 20.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.056 1.342 . . . . 1.8600000000000001 109.477 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.0 m -136.59 142.83 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.757 0.708 . . . . 0.59999999999999998 112.871 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.61 153.16 47.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.728 1.211 . . . . 0.48999999999999999 112.976 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -140.3 137.04 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.764 1.626 . . . . 0.45000000000000001 108.642 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . -172.42 168.12 41.14 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.281 -0.887 . . . . 1.6200000000000001 113.26 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.301 12.9 p30 -69.43 -49.33 56.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.021 1.489 . . . . 3.1200000000000001 115.021 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -173.81 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 115.064 1.505 . . . . 4.7999999999999998 115.064 169.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.16 -32.13 71.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.282 1.401 . . . . 3.3199999999999998 113.286 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -67.27 -22.49 65.66 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.699 -1.251 . . . . 2.9100000000000001 113.022 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -29.24 68.36 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.242 -1.536 . . . . 2.0800000000000001 111.247 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 55.3 mt -69.39 -66.35 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.847 1.659 . . . . 1.6599999999999999 108.63 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -48.01 -32.97 7.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.81 1.644 . . . . 5.2199999999999998 114.9 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.68 5.52 27.84 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.919 1.236 . . . . 0.93000000000000005 113.991 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 73.25 35.49 56.81 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.823 -1.173 . . . . 0.94999999999999996 114.572 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.82 158.7 15.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.801 1.241 . . . . 0.72999999999999998 110.343 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 86.7 t -97.26 123.56 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.362 -0.977 . . . . 1.1399999999999999 108.362 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.1 tt -110.44 139.89 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.97 0.89 . . . . 1.4099999999999999 112.675 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -96.55 150.83 20.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.699 1.2 . . . . 2.7400000000000002 114.182 -168.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -69.2 -26.87 65.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.661 1.184 . . . . 3.7200000000000002 114.057 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -84.26 -42.77 15.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.525 1.13 . . . . 2.8500000000000001 112.989 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 13.1 p -65.09 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.117 0.871 . . . . 0.79000000000000004 111.609 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -62.69 -45.71 91.51 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.639 1.109 . . . . 2.3799999999999999 111.528 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.87 -33.88 73.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.172 0.989 . . . . 2.6099999999999999 112.652 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.47 -44.35 64.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.605 1.093 . . . . 2.3900000000000001 112.518 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.3 tpp -58.89 -48.01 82.93 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.711 1.604 . . . . 1.02 111.799 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 9.7 t -75.5 -38.45 59.46 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.99 -0.528 . . . . 1.54 112.364 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -53.95 -44.76 70.98 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.185 1.357 . . . . 3.48 112.744 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . 0.486 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 65.7 t-80 -62.49 -44.77 95.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.59 1.556 . . . . 3.7200000000000002 112.224 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -71.57 -30.71 66.17 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.817 1.247 . . . . 4.2599999999999998 112.655 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -70.46 -16.78 62.96 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.936 1.694 . . . . 4.9299999999999997 113.74 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.369 0.0 OUTLIER -104.01 24.01 12.04 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.84 1.656 . . . . 3.9100000000000001 114.247 170.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.75 76.02 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 117.755 1.862 . . . . 1.3300000000000001 117.755 167.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -105.6 148.56 27.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.706 1.753 . . . . 4.4400000000000004 111.598 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 56.5 m -76.41 128.38 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.094 1.358 . . . . 1.0900000000000001 112.108 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.46 126.69 44.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.542 1.137 . . . . 0.76000000000000001 112.108 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 32.7 m -141.17 156.73 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.141 1.376 . . . . 0.93000000000000005 113.818 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.51 157.22 25.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.037 2.535 . . . . 1.47 112.131 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -131.34 119.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.519 1.527 . . . . 1.6799999999999999 111.103 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -121.5 147.52 45.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.023 1.329 . . . . 0.46000000000000002 111.601 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 35.1 m -144.44 121.67 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.32 1.048 . . . . 0.66000000000000003 112.324 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.255 33.3 t0 41.11 50.97 3.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.582 2.353 . . . . 3.4399999999999999 113.694 -176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.289 7.6 m-20 68.51 25.77 6.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.855 2.862 . . . . 2.2000000000000002 116.714 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.31 143.85 49.29 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.736 1.214 . . . . 2.4100000000000001 111.141 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.14 136.59 48.24 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.535 -1.353 . . . . 0.68999999999999995 112.355 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.7 p -113.81 -44.1 3.21 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.898 1.073 . . . . 0.53000000000000003 113.898 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.3 -172.23 34.24 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 120.055 1.298 . . . . 0.54000000000000004 115.47 -173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.16 154.0 43.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.914 1.686 . . . . 0.81000000000000005 112.413 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.0 mm -126.9 137.23 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.28 1.432 . . . . 0.97999999999999998 109.287 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . 0.486 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -114.9 131.52 56.84 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.321 1.849 . . . . 0.95999999999999996 109.801 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.46 155.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.92 1.688 . . . . 1.3700000000000001 111.266 -168.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.492 1.517 . . . . 1.52 111.881 173.346 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 119.637 -0.22 . . . . 2.5499999999999998 111.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.25 150.01 52.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.269 2.646 . . . . 1.27 112.765 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 6.1 p -134.86 133.56 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.52 1.528 . . . . 3.2799999999999998 109.459 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 1.9 p -71.93 121.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.539 1.063 . . . . 1.77 108.941 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 17.4 t30 -106.21 -44.75 4.48 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.796 1.036 . . . . 2.9500000000000002 113.796 -166.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -142.98 148.67 37.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.542 1.537 . . . . 1.97 110.812 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.0 m -129.16 148.45 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.124 0.97 . . . . 1.1100000000000001 111.432 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -141.38 147.69 38.43 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.151 -0.968 . . . . 3.3399999999999999 112.841 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 62.9 t -105.23 136.76 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.412 1.085 . . . . 0.93000000000000005 111.742 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . 0.585 HD23 HD22 ' A' 1222 ' ' LEU . 22.6 tp -108.77 -23.96 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.872 2.469 . . . . 1.1499999999999999 113.105 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 46.2 m -132.91 110.4 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.01 1.324 . . . . 1.75 110.051 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -118.54 155.69 30.44 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.688 1.195 . . . . 3.21 112.946 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 58.25 3.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.95 2.574 . . . . 2.8500000000000001 117.95 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -127.49 -11.92 5.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.512 1.525 . . . . 2.9700000000000002 114.028 -172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -158.27 -48.88 0.06 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.308 1.843 . . . . 4.3200000000000003 110.312 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 165.41 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 128.471 2.708 . . . . 1.48 108.569 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.0 m -142.31 162.41 35.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.144 1.777 . . . . 1.8700000000000001 111.49 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.6 t60 -45.83 -51.87 12.21 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.929 1.826 . . . . 4.7400000000000002 115.929 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -75.21 -28.96 60.16 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.125 -0.985 . . . . 2.6800000000000002 112.224 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -70.22 -41.98 72.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.016 -1.053 . . . . 2.8900000000000001 111.706 170.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.01 -52.91 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 0.65000000000000002 110.647 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.94 -32.62 74.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.073 0.851 . . . . 0.72999999999999998 112.462 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.22 -51.17 60.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.97 0.508 . . . . 0.79000000000000004 112.17 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.2 pt -70.43 -30.99 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.009 -1.057 . . . . 0.83999999999999997 113.099 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 65.1 t -71.01 -48.86 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.167 0.894 . . . . 1.01 111.796 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.78 -34.64 83.48 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 113.316 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 58.9 p -74.51 -35.41 63.19 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 112.86 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.66 66.22 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.125 1.157 . . . . 1.1899999999999999 114.125 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -78.86 -10.51 59.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.439 1.644 . . . . 2.0699999999999998 115.439 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.2 t -61.29 -52.07 66.25 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.394 -1.442 . . . . 1.4099999999999999 113.629 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.7 1.24 31.0 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.969 -1.082 . . . . 2.21 113.638 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.3 t -79.53 177.34 8.94 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.447 1.099 . . . . 1.6399999999999999 113.914 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.99 2.5 9.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.113 2.165 . . . . 5.2300000000000004 113.267 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -81.04 158.29 70.2 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 114.397 1.258 . . . . 1.6499999999999999 114.397 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.21 -32.37 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.088 2.525 . . . . 1.0 113.913 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.6 -55.46 2.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.376 0.67 . . . . 0.73999999999999999 112.318 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.55 -28.63 71.64 Favored Glycine 0 CA--C 1.543 1.805 0 N-CA-C 114.292 0.477 . . . . 0.84999999999999998 114.292 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.3 p -61.23 -22.78 65.12 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.011 -1.288 . . . . 1.52 113.725 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.49 72.65 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.579 -1.326 . . . . 0.75 112.334 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.81 -34.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.015 1.326 . . . . 0.71999999999999997 110.76 173.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 75.4 m -53.14 -46.7 68.94 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 118.432 -0.794 . . . . 1.1499999999999999 111.508 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.46 -47.32 86.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.463 1.029 . . . . 2.02 112.821 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -55.11 -46.28 75.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.217 1.007 . . . . 2.0899999999999999 112.145 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.2 t -66.49 -52.94 40.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.669 0.788 . . . . 1.8400000000000001 112.207 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.2 -35.26 73.28 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 3.04 112.607 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 -48.68 65.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.386 1.075 . . . . 2.7799999999999998 111.865 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -61.37 -37.86 84.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.096 0.958 . . . . 2.0099999999999998 113.297 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.59 -16.98 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.333 1.605 . . . . 1.1299999999999999 115.333 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.2 t0 56.47 30.38 17.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.279 1.432 . . . . 2.7200000000000002 114.558 -170.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 14.2 t -107.72 159.88 16.14 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.273 -1.517 . . . . 2.6200000000000001 111.48 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.55 -9.57 26.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.447 1.099 . . . . 2.8799999999999999 111.569 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.0 t -141.92 130.95 23.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.753 2.021 . . . . 3.3700000000000001 111.14 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -163.24 162.08 25.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.571 1.548 . . . . 1.3400000000000001 111.091 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 57.82 76.42 0.21 Allowed Glycine 0 N--CA 1.471 1.013 0 CA-C-N 119.175 0.898 . . . . 2.9500000000000002 113.748 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 23.6 m -68.14 -50.08 56.9 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.637 0.606 . . . . 1.76 112.637 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.1 t -136.85 142.34 42.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.145 0.978 . . . . 1.7 111.424 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.69 147.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 128.202 2.601 . . . . 3.0499999999999998 107.615 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.92 81.05 1.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.173 1.389 . . . . 2.6800000000000002 109.543 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -91.13 137.08 32.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.918 1.822 . . . . 2.4199999999999999 115.918 -168.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -119.05 101.92 8.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.967 3.707 . . . . 2.3599999999999999 106.267 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 21.7 m -99.65 142.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.432 0.901 . . . . 2.6499999999999999 113.432 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 25.7 t -133.65 92.86 22.37 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.764 1.226 . . . . 0.97999999999999998 109.06 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.9 149.37 61.52 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.938 3.092 . . . . 2.27 113.496 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.07 15.38 65.06 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.069 -0.851 . . . . 1.7 114.688 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 t -147.51 -70.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.966 1.383 . . . . 1.9199999999999999 112.159 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 177.52 179.48 47.76 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.662 1.125 . . . . 1.02 112.72 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.51 160.76 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.372 -1.075 . . . . 2.5899999999999999 111.432 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 148.93 50.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.378 1.471 . . . . 0.70999999999999996 111.227 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.8 p -155.81 173.32 16.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.405 1.261 . . . . 0.67000000000000004 114.405 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -119.14 123.68 44.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.531 1.132 . . . . 1.3799999999999999 108.745 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.4 t -106.11 148.31 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.797 1.239 . . . . 2.6299999999999999 110.037 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.8 t -148.71 158.59 44.25 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.153 1.908 . . . . 1.1000000000000001 116.153 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.259 24.8 t-20 . . . . . 0 CA--C 1.542 0.64 1 C-N-CA 132.409 4.283 . . . . 2.9900000000000002 106.949 156.5 . . . . . . . . 2 1 . 1 . 008 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 117.376 2.361 . . . . 2.1899999999999999 117.376 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.23 110.83 16.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.683 1.593 . . . . 3.1299999999999999 111.554 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.26 117.81 20.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.115 1.366 . . . . 1.21 109.374 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.2 m -136.61 139.81 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 113.044 0.757 . . . . 0.87 113.044 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.1 150.0 43.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.986 1.315 . . . . 0.47999999999999998 112.772 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -147.79 141.39 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.277 1.431 . . . . 0.63 109.92 -173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 147.83 -147.32 17.9 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.178 0.831 . . . . 1.46 115.178 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -68.98 157.9 35.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.384 1.874 . . . . 2.6099999999999999 113.896 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -53.49 -28.11 29.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.268 2.227 . . . . 8.5299999999999994 114.756 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.65 -39.18 87.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.571 1.148 . . . . 4.0499999999999998 113.415 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.69 -21.16 26.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.678 -0.639 . . . . 3.6200000000000001 112.547 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 15.9 mmt -61.83 -34.61 76.25 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.245 -0.909 . . . . 2.1600000000000001 110.592 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 36.2 mt -68.31 -68.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.812 1.245 . . . . 1.79 109.278 168.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -24.5 23.42 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.194 1.924 . . . . 8.5199999999999996 116.194 -172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -76.08 11.92 1.31 Allowed 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 120.841 1.655 . . . . 0.92000000000000004 112.306 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 77.15 15.44 81.59 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 119.966 -1.709 . . . . 0.98999999999999999 114.731 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.65 -178.1 6.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.836 1.318 . . . . 1.1599999999999999 111.248 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 59.9 t -123.37 134.09 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.361 1.465 . . . . 1.28 109.744 170.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -105.6 139.08 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.162 0.985 . . . . 1.02 111.631 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -97.61 160.19 14.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.332 1.453 . . . . 4.1100000000000003 112.705 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.5 -21.22 56.06 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 3.2000000000000002 113.222 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -73.94 -35.29 64.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.377 -0.827 . . . . 3.0499999999999998 112.315 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -74.36 -33.84 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 119.109 -0.472 . . . . 1.05 110.736 168.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -60.27 -37.27 79.94 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.902 0.774 . . . . 2.5800000000000001 111.654 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -64.77 -46.57 81.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.987 1.315 . . . . 2.1299999999999999 112.281 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -41.02 81.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.096 1.358 . . . . 2.7599999999999998 110.646 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 14.1 tpp -64.09 -57.2 10.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.083 1.353 . . . . 0.89000000000000001 111.996 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.6 t -67.27 -30.84 70.82 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.691 0.626 . . . . 1.3700000000000001 112.691 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -58.78 -45.49 89.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.296 -0.877 . . . . 2.77 111.113 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -70.55 -35.78 73.3 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.442 0.904 . . . . 2.29 113.442 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.24 -36.87 83.33 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.47 1.032 . . . . 2.6600000000000001 112.388 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -70.94 -30.49 66.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.867 2.067 . . . . 3.4199999999999999 113.189 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 26.8 mttp -72.3 -4.61 30.7 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.168 1.787 . . . . 2.25 112.578 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.38 3.11 87.12 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.894 1.711 . . . . 1.3899999999999999 115.736 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -98.19 164.59 12.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.781 1.291 . . . . 4.0 111.482 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 50.5 m -72.8 130.65 40.94 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.313 -0.867 . . . . 1.1100000000000001 110.845 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.1 41.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.838 1.655 . . . . 0.60999999999999999 109.642 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -140.33 153.9 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 113.748 1.018 . . . . 0.46999999999999997 113.748 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.68 162.65 12.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.173 1.389 . . . . 0.97999999999999998 111.642 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 12.0 t -131.73 129.37 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.562 1.545 . . . . 1.96 110.272 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -127.7 148.33 50.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.554 1.141 . . . . 0.58999999999999997 111.039 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.7 m -148.14 130.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.683 0.793 . . . . 0.82999999999999996 111.093 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.56 51.92 2.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.802 1.641 . . . . 3.0 112.879 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 12.6 m-20 60.56 33.27 20.48 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.795 2.038 . . . . 1.79 115.551 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -133.95 137.31 44.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.864 1.665 . . . . 2.4500000000000002 111.518 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . 0.585 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -75.02 115.87 15.13 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.059 -1.026 . . . . 1.3999999999999999 110.702 171.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.3 p -103.99 -30.16 10.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.727 -1.13 . . . . 0.64000000000000001 113.676 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -177.57 -169.6 38.82 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.753 1.615 . . . . 0.64000000000000001 115.88 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.69 153.71 43.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.687 1.595 . . . . 0.72999999999999998 112.54 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.09 133.73 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.77000000000000002 109.896 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.24 133.96 51.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 110.733 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 41.3 mm -102.54 171.73 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 125.433 1.493 . . . . 2.0 110.469 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 1.77 111.912 167.718 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 113.272 0.841 . . . . 2.4900000000000002 113.272 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.77 143.82 79.07 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.187 2.592 . . . . 2.46 113.091 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 26.9 m -122.04 129.92 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.401 1.081 . . . . 2.6299999999999999 111.527 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -73.91 128.39 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.212 -0.93 . . . . 1.1499999999999999 110.968 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -105.88 -45.15 4.44 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.08 1.352 . . . . 2.7999999999999998 112.443 -169.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -155.31 160.83 41.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.627 1.571 . . . . 3.0299999999999998 112.485 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.4 m -127.63 142.33 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.008 1.323 . . . . 0.94999999999999996 111.525 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 28.9 tttt -140.37 146.9 39.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.185 0.994 . . . . 1.8999999999999999 112.861 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 39.6 t -84.83 154.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.374 1.469 . . . . 1.05 111.106 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.0 tp -120.85 -33.06 3.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.917 1.687 . . . . 0.87 111.968 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . 0.41 HG23 ' H ' ' A' 1068 ' ' ILE . 5.0 t -87.24 32.9 0.68 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.197 1.399 . . . . 2.3500000000000001 113.846 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -59.12 122.0 12.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.795 1.238 . . . . 3.9300000000000002 110.853 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 66.7 m 50.92 32.51 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.816 1.413 . . . . 3.6899999999999999 114.816 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -132.6 -21.65 2.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.205 1.402 . . . . 3.8999999999999999 114.514 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -157.49 -56.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.625 1.557 . . . . 4.3899999999999997 114.973 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' 1063 ' ' THR . 31.8 mt -137.61 155.6 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.453 1.901 . . . . 1.51 110.707 -167.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 75.0 m -117.31 166.69 12.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.786 1.634 . . . . 2.3999999999999999 114.078 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.7 p80 -57.95 -43.21 86.23 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.834 2.161 . . . . 2.9900000000000002 116.834 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -72.87 -28.3 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.477 1.035 . . . . 2.5699999999999998 111.626 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -71.1 -48.61 51.41 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.444 -0.785 . . . . 3.4500000000000002 110.934 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.19 -46.67 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.842 0.857 . . . . 0.69999999999999996 111.621 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.4 -34.38 77.82 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.04 0.836 . . . . 0.78000000000000003 112.048 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.13 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.639 -0.696 . . . . 0.83999999999999997 112.416 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.78 -26.86 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.493 1.042 . . . . 0.68999999999999995 113.315 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 94.6 t -71.32 -44.18 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.094 0.861 . . . . 0.92000000000000004 110.521 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.48 96.53 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.555 -0.716 . . . . 0.60999999999999999 113.778 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 72.7 p -74.06 -37.84 64.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.701 1.25 . . . . 0.73999999999999999 112.904 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.46 -51.14 69.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.741 0.816 . . . . 0.75 111.949 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.78 -21.88 62.45 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.648 -0.657 . . . . 2.0899999999999999 112.703 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 67.5 m -62.76 -21.45 65.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.501 -1.374 . . . . 2.25 112.806 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 2.53 50.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.513 1.525 . . . . 2.98 112.969 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 6.4 t -107.37 -179.59 3.97 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 1.5700000000000001 113.758 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -136.45 32.9 2.78 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.529 2.732 . . . . 4.4699999999999998 111.714 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -97.01 154.69 38.11 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.051 1.34 . . . . 1.6000000000000001 113.61 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.21 -27.54 1.83 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.206 2.604 . . . . 1.1399999999999999 114.939 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.0 tt -100.17 -48.09 4.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.563 0.745 . . . . 0.87 111.709 -167.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -68.53 -30.24 73.05 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 114.55 0.58 . . . . 0.85999999999999999 114.55 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 61.1 p -67.14 -11.01 56.1 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.649 -1.501 . . . . 1.5 113.956 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.38 78.64 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.97 0.908 . . . . 0.68000000000000005 111.012 167.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.08 -32.67 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.42 1.088 . . . . 1.4399999999999999 110.866 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 52.0 m -53.16 -49.41 66.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 119.562 1.074 . . . . 1.1899999999999999 112.285 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -65.96 -46.29 78.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.086 0.857 . . . . 2.5600000000000001 112.543 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.14 -44.19 71.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.439 1.096 . . . . 1.9199999999999999 111.457 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.9 t -70.44 -55.41 9.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.793 1.237 . . . . 1.79 111.832 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -53.65 -47.12 70.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.299 0.954 . . . . 2.9900000000000002 112.251 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -72.48 -28.76 63.1 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.78 0.659 . . . . 4.1500000000000004 112.78 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -70.2 -46.1 65.26 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.184 0.902 . . . . 2.6000000000000001 112.773 172.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -25.67 62.5 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.804 1.039 . . . . 1.1499999999999999 113.804 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.47 17.98 0.41 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.667 2.387 . . . . 2.4399999999999999 114.624 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 4.5 t -82.59 -7.79 59.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.417 2.287 . . . . 4.1299999999999999 113.979 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 17.5 tt0 63.05 -27.11 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 129.27 3.028 . . . . 4.29 116.819 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.7 t -144.51 130.45 19.35 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.914 1.234 . . . . 2.7599999999999998 112.368 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.88 154.25 41.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.202 1.401 . . . . 1.0 113.091 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.6 171.46 36.57 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.405 1.479 . . . . 1.4299999999999999 115.214 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 17.9 m -150.23 -70.5 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.873 -1.369 . . . . 1.29 113.978 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . 0.423 ' O ' HD12 ' A' 1109 ' ' ILE . 37.6 t -138.3 139.42 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.959 1.254 . . . . 1.3200000000000001 112.478 -172.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' 1108 ' ' CYS . 1.7 mp -140.89 140.8 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 131.668 3.987 . . . . 2.6699999999999999 106.086 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.283 0.0 OUTLIER -100.76 -13.11 18.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.943 1.831 . . . . 3.1000000000000001 115.943 -174.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 5.5 t80 54.54 86.01 0.05 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 129.346 3.059 . . . . 2.71 118.929 166.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.91 102.65 11.82 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.289 1.835 . . . . 2.46 109.067 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 84.8 t -99.83 138.88 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.313 1.045 . . . . 1.9399999999999999 111.589 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.9 t -131.82 124.45 19.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.651 1.18 . . . . 1.0900000000000001 110.989 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.3 140.97 34.68 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.884 2.39 . . . . 1.73 112.507 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 63.16 21.19 63.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.323 0.963 . . . . 1.9399999999999999 114.992 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 99.7 m -139.25 -62.69 0.53 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.969 1.708 . . . . 2.2400000000000002 111.897 -169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.67 -173.35 34.4 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.397 1.475 . . . . 0.70999999999999996 112.01 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.64 158.74 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 122.005 -0.703 . . . . 2.54 111.551 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 27.5 t -132.65 151.63 51.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.422 1.489 . . . . 0.46000000000000002 110.634 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -160.57 172.9 16.35 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.081 -1.012 . . . . 0.84999999999999998 113.317 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -113.65 124.1 51.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.59 1.156 . . . . 1.1599999999999999 108.248 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.8 m -122.39 131.74 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 113.602 0.964 . . . . 2.27 113.602 -170.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -118.68 153.37 34.47 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.757 1.021 . . . . 0.97999999999999998 113.757 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 CA--C 1.551 1.001 0 C-N-CA 131.355 3.862 . . . . 2.3999999999999999 108.343 161.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 . . . . . 0 CA--C 1.533 0.306 0 N-CA-C 114.646 1.35 . . . . 2.1699999999999999 114.646 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.52 128.68 33.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.644 1.177 . . . . 2.3700000000000001 108.807 168.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.1 tttt -81.78 126.03 31.36 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 107.48 -1.304 . . . . 1.8400000000000001 107.48 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -133.31 138.08 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.786 0.835 . . . . 0.76000000000000001 111.3 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 153.15 46.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.308 1.043 . . . . 0.46999999999999997 112.7 172.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.9 tt -147.96 139.89 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.32 1.448 . . . . 0.51000000000000001 109.135 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.45 -172.34 44.85 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.735 1.054 . . . . 1.3600000000000001 115.735 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 24.8 p30 -81.08 158.97 24.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.441 1.096 . . . . 2.29 113.16 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -45.53 -51.77 11.35 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.006 1.484 . . . . 5.3399999999999999 115.006 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -74.29 -34.45 63.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.042 1.292 . . . . 4.5199999999999996 112.671 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 36.7 t90 -68.69 -40.9 79.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.031 -1.043 . . . . 3.1899999999999999 111.468 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 91.1 mmm -63.82 -32.9 74.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.698 0.799 . . . . 2.8900000000000001 112.735 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.67 -63.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.504 1.522 . . . . 2.3100000000000001 109.047 167.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -47.4 -8.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.887 2.075 . . . . 6.8399999999999999 116.565 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -83.63 13.17 4.85 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 121.459 1.936 . . . . 1.0900000000000001 112.517 168.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 70.02 37.23 73.51 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 119.755 -1.841 . . . . 0.94999999999999996 114.675 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.95 167.49 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.81000000000000005 112.766 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.2 t -105.47 114.49 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.835 1.254 . . . . 1.9399999999999999 109.71 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.18 146.04 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.841 1.257 . . . . 1.3799999999999999 110.511 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -117.84 171.3 8.15 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.284 1.034 . . . . 3.1200000000000001 112.732 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -71.07 -40.26 71.7 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.968 1.47 . . . . 3.1499999999999999 114.968 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.15 -28.36 54.14 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.912 -1.118 . . . . 2.6200000000000001 113.563 -170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 7.5 p -72.04 -43.74 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.608 1.163 . . . . 1.26 111.878 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.4 t30 -66.89 -38.92 87.18 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.53 0.567 . . . . 2.3199999999999998 112.53 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.5 -44.14 84.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.57 0.582 . . . . 2.02 112.57 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 17.1 t80 -68.16 -45.08 74.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.148 0.979 . . . . 2.4500000000000002 111.684 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.5 ttm -60.81 -46.91 88.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.974 0.91 . . . . 1.76 112.502 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.4 t -74.76 -33.9 62.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.051 0.541 . . . . 1.2 112.446 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.64 -44.85 85.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.22 1.008 . . . . 2.98 111.823 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -69.59 -45.77 67.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.794 1.637 . . . . 3.4300000000000002 112.326 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.63 -32.77 74.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.955 -1.09 . . . . 3.98 112.017 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -71.26 -22.96 61.9 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.332 1.234 . . . . 4.25 114.332 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 15.6 mttp -76.04 -0.61 22.35 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.387 1.075 . . . . 2.9900000000000002 112.56 167.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.43 16.54 68.6 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.882 1.706 . . . . 1.21 113.951 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -117.8 132.32 56.46 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.376 1.47 . . . . 4.5 109.619 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 96.4 m -65.42 137.37 57.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -167.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -133.16 119.08 19.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.506 1.123 . . . . 0.75 111.475 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.3 m -132.97 157.98 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.339 1.456 . . . . 0.42999999999999999 113.03 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.16 156.68 21.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.833 1.653 . . . . 1.23 111.53 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.6 p -132.12 133.95 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.401 1.48 . . . . 2.3900000000000001 111.236 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -135.08 153.34 52.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.962 1.705 . . . . 0.48999999999999999 111.405 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.56 135.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.90000000000000002 112.541 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 48.8 m-20 42.3 48.82 4.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.754 1.621 . . . . 2.7200000000000002 112.832 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 57.3 m-20 55.6 33.94 22.18 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.951 2.1 . . . . 2.5 115.497 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.69 141.48 49.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.081 2.552 . . . . 2.0800000000000001 110.145 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.43 130.9 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 119.85 -1.781 . . . . 0.79000000000000004 112.444 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 22.3 p -108.22 -35.3 6.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.599 -1.191 . . . . 0.80000000000000004 114.081 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -173.23 -167.07 32.57 Favored Glycine 0 N--CA 1.475 1.277 0 CA-C-N 120.7 1.591 . . . . 0.58999999999999997 116.447 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.84 154.7 44.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.475 1.91 . . . . 0.81000000000000005 112.481 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.4 137.33 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.932 1.693 . . . . 0.81999999999999995 109.708 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.53 137.49 46.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.873 1.669 . . . . 0.68000000000000005 110.351 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.18 151.7 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.877 1.671 . . . . 1.45 110.843 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 125.268 1.427 . . . . 1.47 112.666 169.699 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.499 0.926 . . . . 3.04 113.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.22 148.6 77.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.324 2.016 . . . . 2.1899999999999999 113.676 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.5 p -120.33 124.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.039 1.735 . . . . 2.4399999999999999 110.396 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.251 13.1 p -72.12 130.63 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.309 -0.869 . . . . 1.1599999999999999 110.296 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.54 -40.81 4.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.446 1.276 . . . . 2.3100000000000001 114.446 -166.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -157.64 146.3 19.41 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.183 0.593 . . . . 1.9399999999999999 112.08 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 28.1 m -126.86 144.24 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.549 1.14 . . . . 1.0800000000000001 112.11 169.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 72.7 tttt -134.77 141.76 46.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.119 1.368 . . . . 1.8200000000000001 110.962 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 49.7 t -92.03 134.36 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.484 1.114 . . . . 0.72999999999999998 110.778 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . 0.488 HD23 HD22 ' A' 1222 ' ' LEU . 9.7 tp -99.21 -65.27 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.906 2.082 . . . . 0.89000000000000001 111.022 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 38.1 m -78.63 75.02 5.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.481 -1.303 . . . . 1.72 107.481 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.63 123.97 29.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.274 1.03 . . . . 3.9399999999999999 109.016 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 70.7 m 60.71 174.76 0.1 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.0 1.482 . . . . 3.6600000000000001 115.0 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 64.63 -0.03 1.03 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.612 2.449 . . . . 4.2599999999999998 117.612 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -147.57 -44.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.803 1.241 . . . . 5.0499999999999998 112.634 167.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mm -130.09 163.9 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.943 1.697 . . . . 1.9199999999999999 109.614 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 20.4 m -119.35 145.59 46.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.818 1.647 . . . . 2.3700000000000001 111.109 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -49.79 -51.35 40.13 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.797 1.777 . . . . 4.7199999999999998 115.797 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 72.8 m80 -74.25 -14.32 60.9 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.969 1.259 . . . . 4.71 112.804 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.94 -37.97 33.36 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.944 -1.027 . . . . 3.46 111.493 168.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.91 -54.34 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.32 0.964 . . . . 0.69999999999999996 110.13 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.19 -32.27 72.39 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.643 -0.66 . . . . 0.72999999999999998 112.332 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.98 83.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.65 0.659 . . . . 0.72999999999999998 112.576 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.36 -29.42 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.916 -1.115 . . . . 0.68999999999999995 113.427 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.3 t -69.2 -52.35 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.289 0.949 . . . . 0.70999999999999996 111.107 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.01 -35.87 91.23 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.791 -0.568 . . . . 0.68999999999999995 113.17 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 36.2 p -71.66 -36.0 70.52 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.523 1.161 . . . . 0.70999999999999996 112.693 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.31 -49.36 67.3 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.901 0.773 . . . . 0.69999999999999996 112.846 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -72.08 -15.17 62.01 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 121.366 -0.834 . . . . 2.02 112.715 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.3 t -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.42 -2.05 . . . . 1.28 112.493 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.98 2.04 55.59 Favored 'General case' 0 CA--C 1.557 1.227 0 O-C-N 121.073 -1.017 . . . . 2.1299999999999999 113.007 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 57.8 m -103.59 167.24 9.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.621 1.569 . . . . 1.72 114.224 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.26 12.34 7.62 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.084 1.754 . . . . 3.4700000000000002 112.585 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -71.63 148.25 92.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.602 -1.311 . . . . 2.2000000000000002 113.141 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.95 -31.35 31.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.226 2.617 . . . . 1.1299999999999999 114.631 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.4 -51.45 3.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.168 1.387 . . . . 0.89000000000000001 111.793 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -57.12 -34.68 67.05 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.454 0.55 . . . . 1.1000000000000001 113.514 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.1 p -61.25 -14.5 26.58 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.869 -1.371 . . . . 1.3 114.477 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.09 82.94 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.758 -1.214 . . . . 0.89000000000000001 111.713 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.12 -39.27 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.397 1.479 . . . . 0.81000000000000005 109.774 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 24.3 m -57.44 -44.39 84.68 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 117.934 -1.032 . . . . 1.3400000000000001 112.552 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.27 -47.38 79.77 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.066 1.303 . . . . 2.3799999999999999 112.091 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.69 -43.12 76.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.903 0.481 . . . . 1.6200000000000001 111.433 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 94.7 m -69.16 -49.91 52.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.934 1.293 . . . . 2.9300000000000002 112.389 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -49.9 -48.7 51.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.375 1.47 . . . . 3.5800000000000001 111.534 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.93 -38.91 72.93 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.591 0.756 . . . . 2.7200000000000002 112.388 175.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.3 -36.2 81.04 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.485 1.039 . . . . 2.3500000000000001 112.756 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 5.4 mt -72.42 -9.21 58.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.83 1.252 . . . . 1.1599999999999999 114.0 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.04 50.82 18.33 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.029 1.332 . . . . 3.5800000000000001 111.887 -170.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.9 t -138.45 168.73 19.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.385 1.074 . . . . 2.8300000000000001 112.502 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -102.62 -17.61 15.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.875 1.67 . . . . 3.8300000000000001 111.26 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.6 t -136.89 130.64 31.99 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.865 -1.147 . . . . 2.8700000000000001 113.574 -168.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.86 159.14 32.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.591 1.556 . . . . 1.02 110.169 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 76.44 127.82 0.28 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.931 0.777 . . . . 1.3999999999999999 114.13 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 53.2 m -123.73 -71.17 0.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 1.4199999999999999 112.709 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 4.4 t -135.44 143.19 45.78 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.096 1.316 . . . . 1.5800000000000001 112.509 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' 1121 ' ' CYS . 5.1 tp -132.35 163.48 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 1 C-N-CA 132.413 4.285 . . . . 2.6000000000000001 109.416 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.06 86.4 1.92 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.214 1.806 . . . . 2.6899999999999999 106.176 166.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -93.63 147.9 22.59 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.699 2.111 . . . . 3.5699999999999998 116.699 -164.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -137.92 118.47 13.91 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.332 2.253 . . . . 2.1299999999999999 109.133 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 17.0 t -112.73 140.63 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.391 1.076 . . . . 1.8999999999999999 113.867 -168.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 92.7 t -139.71 117.0 8.42 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 127.025 2.13 . . . . 1.0700000000000001 107.472 167.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.22 144.24 50.98 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.66 2.24 . . . . 1.5600000000000001 112.361 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.06 1.41 12.69 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.099 1.2 . . . . 1.6799999999999999 116.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 1.3 m -136.8 -30.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.686 1.736 . . . . 2.6899999999999999 115.686 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.66 168.33 19.2 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 121.337 1.88 . . . . 0.83999999999999997 116.888 168.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 137.35 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.808 1.243 . . . . 1.9299999999999999 109.911 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 39.3 t -126.67 144.87 50.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.614 1.565 . . . . 0.47999999999999998 109.785 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' 1109 ' ' ILE . 30.1 p -154.1 174.55 14.57 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.765 1.024 . . . . 0.67000000000000004 113.765 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -116.77 123.5 47.29 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.215 -2.143 . . . . 1.4099999999999999 105.215 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.56 144.73 24.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 118.771 0.714 . . . . 2.0 110.807 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.5 t -134.3 155.5 50.11 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.134 1.531 . . . . 1.0 115.134 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.28 15.2 t-20 . . . . . 0 CA--C 1.546 0.793 1 C-N-CA 132.991 4.516 . . . . 2.75 104.918 158.843 . . . . . . . . 2 1 . 1 . 010 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . 0.467 ' HG2' ' HB ' ' A' 1124 ' ' THR . 54.4 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 122.141 0.972 . . . . 1.9399999999999999 111.276 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.46 127.34 53.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.675 1.19 . . . . 2.79 108.577 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -86.64 123.36 31.74 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.751 -0.833 . . . . 1.53 108.751 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -132.77 139.54 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.289 0.495 . . . . 0.79000000000000004 111.934 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.16 147.51 36.75 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.564 1.146 . . . . 0.57999999999999996 112.471 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.9 tt -141.59 138.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.302 1.441 . . . . 0.48999999999999999 108.717 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 171.82 -166.85 39.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 117.142 1.617 . . . . 1.4099999999999999 117.142 -174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.31 162.76 17.21 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.362 3.065 . . . . 2.4900000000000002 111.895 -169.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -44.21 -65.09 0.55 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.344 1.609 . . . . 7.8200000000000003 115.344 -167.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.42 -34.3 70.21 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.863 1.21 . . . . 3.25 113.765 -171.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -68.99 -27.88 66.1 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.005 -1.059 . . . . 2.8700000000000001 112.443 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 55.2 tpp -70.69 -42.88 70.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.103 0.561 . . . . 2.1400000000000001 112.292 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 97.4 mt -49.3 -61.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 109.504 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -51.31 -11.57 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.071 2.249 . . . . 6.1900000000000004 117.071 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.28 15.49 0.44 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 121.988 2.176 . . . . 0.87 111.254 166.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.13 11.71 81.69 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 119.354 -2.091 . . . . 0.76000000000000001 114.589 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.82 159.68 25.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.902 1.351 . . . . 0.80000000000000004 111.306 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 74.1 t -94.23 122.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.352 . . . . 1.01 109.612 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.4 tt -96.48 132.25 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.245 1.018 . . . . 1.1699999999999999 110.277 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -93.21 153.9 18.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.521 1.128 . . . . 4.0199999999999996 112.879 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.88 -32.9 73.3 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.156 -0.965 . . . . 2.7999999999999998 112.997 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.91 -44.65 80.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.922 0.889 . . . . 2.6800000000000002 112.139 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.9 p -73.4 -31.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.347 -0.846 . . . . 1.03 111.72 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -64.15 -38.68 91.93 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.898 1.227 . . . . 2.2400000000000002 111.624 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.75 -33.69 75.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.955 0.902 . . . . 2.5099999999999998 112.151 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.75 -44.3 81.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.025 1.73 . . . . 2.6099999999999999 112.096 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 27.0 tpp -62.59 -50.37 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.26 1.424 . . . . 0.81999999999999995 110.73 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.0 t -72.23 -30.9 65.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.819 0.674 . . . . 1.02 112.819 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.63 -51.77 67.43 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.042 1.292 . . . . 2.5600000000000001 112.234 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.52 -30.9 68.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.868 0.692 . . . . 2.6299999999999999 112.868 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.1 -41.27 90.85 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 121.357 -0.839 . . . . 2.5699999999999998 111.884 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.37 -22.73 61.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 114.232 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 22.3 mttp -73.13 -5.35 38.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.077 2.151 . . . . 2.52 114.406 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 96.68 9.88 55.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.128 1.347 . . . . 1.79 115.246 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -113.73 -176.94 3.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.332 1.453 . . . . 3.3300000000000001 111.53 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.6 m -102.53 138.35 39.57 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.091 1.756 . . . . 0.93999999999999995 111.023 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.56 127.77 35.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.985 1.314 . . . . 0.55000000000000004 111.431 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.4 m -140.14 159.6 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.358 1.063 . . . . 0.55000000000000004 112.965 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.44 155.04 21.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.895 1.678 . . . . 1.1399999999999999 110.942 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.1 p -132.86 130.32 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.48 1.112 . . . . 2.0099999999999998 112.61 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.46 154.59 46.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.944 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.7 m -148.72 130.05 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.462 0.705 . . . . 0.83999999999999997 112.416 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 9.5 m-20 41.35 43.61 2.15 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 3.2000000000000002 112.853 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.312 14.8 m-20 68.86 30.63 4.63 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 117.095 2.258 . . . . 2.2799999999999998 117.095 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.71 141.16 50.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.225 1.81 . . . . 2.5600000000000001 109.871 165.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . 0.488 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -78.74 109.75 13.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.73 -1.231 . . . . 1.5700000000000001 111.077 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -94.42 -27.59 15.95 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.027 -1.046 . . . . 0.51000000000000001 112.771 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.27 -176.29 40.96 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 116.336 1.294 . . . . 0.44 116.336 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.39 154.31 45.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.461 1.904 . . . . 0.69999999999999996 111.905 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 4.0 mt -136.78 135.61 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.917 1.287 . . . . 1.5700000000000001 110.62 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.39 137.83 45.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.058 1.343 . . . . 0.68000000000000005 110.678 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.25 145.65 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.163 1.785 . . . . 1.6399999999999999 108.925 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.519 0 C-N-CA 124.218 1.007 . . . . 1.5700000000000001 111.618 176.645 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 115.332 1.604 . . . . 2.5899999999999999 115.332 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' 1091 ' ' ALA . 44.1 Cg_endo -81.48 158.4 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.773 1 C-N-CA 125.552 4.168 . . . . 1.97 112.73 176.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 2.4 m -139.76 130.11 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.84 1.656 . . . . 2.6499999999999999 111.734 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.254 8.7 p -77.07 129.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.048 -1.033 . . . . 1.4299999999999999 112.342 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.82 -39.84 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.042 0.937 . . . . 2.3900000000000001 113.42 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -149.09 151.58 34.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.095 1.358 . . . . 2.8999999999999999 111.314 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 8.6 m -135.41 146.6 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.397 1.079 . . . . 0.89000000000000001 111.356 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 68.1 tttt -141.53 138.9 33.06 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.47 1.108 . . . . 1.6899999999999999 112.854 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.9 t -88.82 142.39 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.284 1.033 . . . . 0.72999999999999998 111.286 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . 0.479 HD23 HD22 ' A' 1222 ' ' LEU . 30.2 tp -106.21 -39.85 5.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.525 1.53 . . . . 1.4099999999999999 111.977 170.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 53.1 m -124.81 97.17 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.682 0.674 . . . . 1.8500000000000001 112.502 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.82 111.61 5.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.469 1.507 . . . . 5.9900000000000002 108.26 168.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 8.6 t -178.37 -52.8 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.563 1.945 . . . . 5.04 110.777 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 6.7 m120 -150.24 41.76 0.82 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.748 1.619 . . . . 6.6399999999999997 112.932 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -146.82 -58.57 0.28 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.507 -1.37 . . . . 4.7999999999999998 112.876 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.16 155.23 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.524 1.53 . . . . 2.27 110.247 -173.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 15.3 m -110.01 143.12 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.306 1.042 . . . . 2.8599999999999999 110.767 172.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.03 -42.23 68.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.286 2.328 . . . . 4.0999999999999996 117.286 -168.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 46.9 m80 -68.59 -29.06 67.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.984 1.265 . . . . 4.6699999999999999 111.81 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.27 -40.19 77.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 117.93 -1.033 . . . . 3.7000000000000002 111.315 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 82.3 mt -55.15 -54.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 118.968 0.804 . . . . 0.85999999999999999 110.536 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.51 -33.16 74.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.683 -0.635 . . . . 0.77000000000000002 112.152 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.11 81.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.542 0.571 . . . . 0.51000000000000001 112.542 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.0 pt -69.84 -31.25 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.546 1.066 . . . . 0.52000000000000002 112.921 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 48.0 t -71.12 -49.88 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.007 0.822 . . . . 0.57999999999999996 111.635 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.68 -33.86 87.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.376 -0.828 . . . . 0.68000000000000005 113.903 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 34.9 p -74.27 -37.88 63.59 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.822 0.849 . . . . 0.75 112.581 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.39 82.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.069 0.849 . . . . 0.68000000000000005 112.772 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -66.62 -18.97 65.65 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.858 -1.151 . . . . 2.2400000000000002 113.362 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 1.6 t -64.91 -15.52 62.14 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.062 -1.024 . . . . 1.74 112.722 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -128.66 -20.22 3.61 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.075 1.35 . . . . 3.1899999999999999 114.205 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.9 t -70.44 -44.61 67.49 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.908 -1.12 . . . . 3.9700000000000002 112.313 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . 0.301 33.1 mt-10 70.74 32.29 2.54 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.423 1.889 . . . . 5.2300000000000004 115.386 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.98 146.32 63.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.263 1.425 . . . . 1.6499999999999999 113.468 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.42 -54.15 3.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.985 3.79 . . . . 1.28 114.352 -169.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.9 tt -68.05 -33.69 75.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.818 1.247 . . . . 0.91000000000000003 111.459 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.34 -22.31 63.16 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.207 1.384 . . . . 0.90000000000000002 114.813 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 51.7 p -61.92 -35.9 79.75 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.934 1.367 . . . . 2.23 112.611 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' 1054 ' ' PRO . . . -56.97 -41.95 79.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.125 0.97 . . . . 0.94999999999999996 112.168 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.2 mt -72.64 -43.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.352 0.661 . . . . 0.73999999999999999 111.278 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 5.3 t -66.27 -40.59 90.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.867 -0.587 . . . . 2.0 112.082 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -62.18 -48.82 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.875 0.761 . . . . 3.1499999999999999 111.964 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -56.4 -42.95 78.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.033 0.833 . . . . 2.02 112.003 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.8 t -61.31 -54.34 45.24 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.771 -0.581 . . . . 1.78 111.277 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.78 -32.67 67.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.588 1.155 . . . . 2.6299999999999999 113.096 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -71.59 -48.91 45.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.098 1.759 . . . . 4.0099999999999998 112.856 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.92 -38.19 76.17 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.389 -1.444 . . . . 2.4500000000000002 112.583 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 -21.3 60.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.072 0.949 . . . . 1.4199999999999999 113.323 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.92 28.4 2.83 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.512 1.925 . . . . 3.8599999999999999 114.057 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -128.81 139.37 52.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.919 -1.113 . . . . 2.7200000000000002 113.86 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -77.25 -11.29 59.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.765 1.226 . . . . 3.8300000000000001 112.542 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 65.4 p -80.32 47.93 0.97 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.011 2.125 . . . . 4.6799999999999997 114.21 -171.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.15 148.08 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.821 1.045 . . . . 1.1499999999999999 113.821 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 75.83 128.41 0.26 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.79 1.662 . . . . 1.3999999999999999 114.351 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.27 -154.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.797 2.039 . . . . 2.54 108.273 172.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 142.17 50.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.766 1.765 . . . . 1.6399999999999999 115.766 -167.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.11 153.33 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 1 C-N-CA 132.472 4.309 . . . . 2.21 107.552 -169.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -140.57 117.88 11.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.256 -1.757 . . . . 2.7200000000000002 106.256 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 166.77 10.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.496 2.036 . . . . 3.5600000000000001 116.496 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -132.91 131.51 40.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.295 2.238 . . . . 4.1500000000000004 108.518 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.26 137.32 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.878 0.871 . . . . 2.6800000000000002 112.044 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 28.6 t -137.3 114.84 9.82 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.421 1.488 . . . . 1.74 107.532 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.76 147.7 45.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.083 2.522 . . . . 2.6899999999999999 112.607 -172.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 61.23 17.29 52.06 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.657 1.122 . . . . 1.6699999999999999 114.026 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 38.9 t -139.94 -63.51 0.5 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.746 1.218 . . . . 2.52 113.015 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.17 -152.47 23.64 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 120.583 1.538 . . . . 0.81999999999999995 115.946 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.33 150.23 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.735 1.614 . . . . 2.4100000000000001 113.179 -168.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.2 t -130.16 142.38 50.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.12 1.368 . . . . 0.51000000000000001 109.41 165.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.45 172.87 17.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.46 1.652 . . . . 0.54000000000000004 115.46 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -118.83 98.33 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 1.1799999999999999 109.326 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.2 p -112.17 128.38 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.679 0.792 . . . . 2.0699999999999998 112.829 -168.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' 1177 ' ' GLN . 5.6 t -110.38 -163.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.721 1.209 . . . . 1.53 112.998 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.327 3.5 m120 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 128.557 2.743 . . . . 5.5099999999999998 116.842 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' 1124 ' ' THR . 35.6 tt0 . . . . . 0 C--O 1.238 0.457 0 CA-C-O 120.967 0.413 . . . . 2.0099999999999998 110.624 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 125.02 31.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 3.29 110.152 -173.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.9 tttt -79.6 116.93 20.09 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.533 -0.914 . . . . 1.29 108.533 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.7 m -133.67 145.11 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.847 0.859 . . . . 0.53000000000000003 112.124 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -146.02 151.66 38.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.704 1.001 . . . . 0.54000000000000004 113.704 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.86 142.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.163 1.385 . . . . 0.48999999999999999 110.209 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 132.34 143.85 5.19 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 115.492 0.957 . . . . 1.4399999999999999 115.492 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 7.7 t-20 43.38 -143.99 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.299 1.84 . . . . 2.4300000000000002 112.281 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.919 1.688 . . . . 7.21 113.064 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -65.3 -36.43 84.04 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.328 -0.858 . . . . 4.5599999999999996 112.018 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . 0.454 ' CE3' ' HD3' ' A' 1190 ' ' ARG . 4.9 m95 -57.03 -30.0 63.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.144 1.164 . . . . 3.75 114.144 172.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.7 mmt -72.05 -37.72 69.62 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.499 0.666 . . . . 2.3500000000000001 111.626 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.15 -67.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 126.304 1.842 . . . . 1.7 108.259 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . 0.454 ' HD3' ' CE3' ' A' 1187 ' ' TRP . 34.5 ttt85 -36.49 -43.51 0.4 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.292 2.637 . . . . 6.6600000000000001 114.899 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 13.74 5.73 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.28 1.215 . . . . 0.82999999999999996 114.28 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 69.88 23.76 76.77 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.095 -1.628 . . . . 0.68999999999999995 115.542 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.16 171.41 12.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.642 1.177 . . . . 0.81000000000000005 112.059 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -99.66 133.34 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.006 1.322 . . . . 1.4399999999999999 109.699 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.7 tt -138.78 147.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.761 1.224 . . . . 1.26 111.11 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.69 151.32 32.0 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.101 1.36 . . . . 2.6699999999999999 113.258 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.07 -26.36 67.45 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.18 -0.95 . . . . 3.8399999999999999 112.84 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.54 -36.39 76.32 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.002 -1.061 . . . . 3.3900000000000001 113.213 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -77.16 -36.93 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.724 0.693 . . . . 1.1000000000000001 111.438 170.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.1 t30 -62.85 -37.72 87.95 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.746 0.703 . . . . 2.52 111.979 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.84 -39.05 93.17 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.475 1.11 . . . . 2.9399999999999999 112.971 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.56 -37.64 80.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.996 -1.065 . . . . 2.5299999999999998 111.75 171.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -66.25 -52.16 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.596 1.158 . . . . 1.1499999999999999 112.01 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.8 t -68.76 -34.62 75.88 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.376 -0.828 . . . . 1.3899999999999999 112.263 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.37 -49.05 68.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.048 0.84 . . . . 3.2599999999999998 111.055 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . 0.474 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 57.4 t-80 -66.66 -39.57 88.24 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.388 1.075 . . . . 3.9500000000000002 112.383 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -63.75 -42.31 97.86 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.305 -0.872 . . . . 2.7400000000000002 112.804 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -70.59 -28.73 65.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.181 1.792 . . . . 4.2400000000000002 112.785 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.6 mttp -66.81 -12.61 59.57 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.085 1.754 . . . . 3.1200000000000001 113.565 169.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.89 15.08 71.04 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.188 1.375 . . . . 1.25 114.73 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -106.98 156.57 18.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.818 1.309 . . . . 3.7599999999999998 110.561 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 27.3 m -77.35 128.35 34.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.571 1.549 . . . . 1.55 112.945 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.42 118.1 16.03 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.674 0.789 . . . . 0.67000000000000004 113.122 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 23.6 m -141.15 157.09 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 114.75 1.389 . . . . 0.5 114.75 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.91 165.88 10.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.465 . . . . 0.84999999999999998 113.539 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . 0.402 ' O ' HD23 ' A' 1222 ' ' LEU . 3.7 t -136.96 134.9 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.597 1.959 . . . . 1.8999999999999999 110.816 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -137.24 157.98 45.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.28 1.432 . . . . 0.48999999999999999 111.082 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 17.9 m -144.93 138.03 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.546 -1.346 . . . . 0.96999999999999997 111.394 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 32.8 t70 41.7 48.71 3.7 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.984 2.113 . . . . 2.77 112.377 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.28 3.4 m-20 65.6 32.7 9.06 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.996 2.118 . . . . 1.73 115.995 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.67 145.51 36.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.596 1.558 . . . . 2.25 111.189 169.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . 0.479 HD22 HD23 ' A' 1062 ' ' LEU . 0.2 OUTLIER -68.83 145.68 53.52 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.405 -1.434 . . . . 0.80000000000000004 111.182 172.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -121.33 -43.3 2.42 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.496 0.924 . . . . 0.56000000000000005 113.496 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.28 -173.3 38.84 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.17 0.895 . . . . 0.41999999999999998 115.062 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.26 152.94 42.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.365 1.466 . . . . 0.64000000000000001 113.399 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.07 135.34 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.463 1.505 . . . . 0.79000000000000004 111.101 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . 0.474 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -121.38 124.82 45.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.56 2.344 . . . . 0.65000000000000002 109.601 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.13 159.84 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.269 1.828 . . . . 1.45 111.579 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.627 1.171 . . . . 1.6000000000000001 112.402 169.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 118.732 -0.652 . . . . 2.8500000000000001 110.82 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 148.44 52.52 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.377 2.718 . . . . 1.6399999999999999 112.19 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.1 p -138.07 125.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.863 1.265 . . . . 2.29 111.754 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.8 p -72.13 133.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.1 -1.0 . . . . 1.04 111.518 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -126.18 -34.92 2.48 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.524 1.675 . . . . 2.3599999999999999 115.524 -166.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -155.03 151.17 28.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.294 1.438 . . . . 2.0 111.03 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.2 m -130.03 142.35 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.32 1.048 . . . . 0.76000000000000001 111.284 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 40.1 tttt -139.61 147.14 40.68 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.096 0.958 . . . . 1.76 112.173 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 43.5 t -96.78 136.99 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.123 1.369 . . . . 0.76000000000000001 111.294 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 34.6 tp -100.32 -25.7 14.15 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.873 1.669 . . . . 0.81999999999999995 112.931 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.5 t -104.75 24.3 12.03 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.562 1.319 . . . . 2.3199999999999998 114.562 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -56.07 128.19 34.21 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.714 -1.241 . . . . 3.77 110.49 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 60.48 -1.15 0.23 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.949 1.833 . . . . 3.0800000000000001 115.949 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.74 -32.35 8.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.071 1.305 . . . . 4.3099999999999996 113.191 -171.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -155.61 -46.53 0.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.259 1.577 . . . . 4.2199999999999998 115.259 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.16 146.48 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.092 1.357 . . . . 1.6799999999999999 111.172 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -98.65 157.42 16.27 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.323 1.449 . . . . 1.78 112.841 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -61.14 -38.5 86.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.976 2.213 . . . . 3.4900000000000002 116.976 -166.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -71.24 -34.69 71.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.288 1.404 . . . . 3.5299999999999998 111.099 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 94.7 mttt -61.15 -44.3 97.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.162 0.585 . . . . 3.8500000000000001 110.804 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.28 -53.51 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.052 0.941 . . . . 0.54000000000000004 111.198 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.91 -32.06 73.07 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.402 -0.811 . . . . 0.58999999999999997 112.189 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.42 68.55 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.531 0.732 . . . . 0.58999999999999997 112.013 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.1 pt -70.25 -32.66 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.005 1.275 . . . . 0.56000000000000005 113.095 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.9 t -70.4 -48.01 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.804 1.184 . . . . 0.56999999999999995 111.387 172.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.85 92.42 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.258 -0.901 . . . . 0.56000000000000005 113.321 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 71.7 p -77.58 -27.0 51.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.821 1.045 . . . . 0.70999999999999996 113.821 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.63 91.92 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.006 0.821 . . . . 0.67000000000000004 112.5 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.48 -12.38 60.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.807 1.04 . . . . 1.9399999999999999 113.807 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 35.4 t -54.51 -43.11 71.58 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.186 1.394 . . . . 1.53 114.543 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -92.14 2.61 56.48 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.051 0.76 . . . . 2.0600000000000001 113.051 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.9 t -89.19 168.17 12.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.058 1.343 . . . . 1.6299999999999999 112.761 -173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -133.64 80.09 1.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.211 1.405 . . . . 4.6699999999999999 109.823 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -141.39 152.0 62.68 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.964 1.705 . . . . 2.2000000000000002 110.917 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.77 -35.81 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.304 2.669 . . . . 1.6100000000000001 115.19 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.24 -41.35 9.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.721 1.208 . . . . 1.1299999999999999 113.456 -166.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -76.99 -34.82 40.91 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 114.541 0.576 . . . . 1.04 114.541 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 59.4 p -64.28 -17.28 63.48 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.87 -1.37 . . . . 1.75 113.142 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.15 82.93 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.866 -1.146 . . . . 1.0700000000000001 111.965 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 4.8 mp -72.23 -32.72 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.43 0.692 . . . . 1.3 110.728 171.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 94.9 m -56.1 -47.61 77.72 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 117.424 -1.274 . . . . 1.3300000000000001 111.395 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 46.9 tttt -62.39 -46.17 89.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.301 1.41 . . . . 2.8100000000000001 112.789 175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 4.0 t80 -55.94 -42.33 76.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.348 1.059 . . . . 2.0099999999999998 111.476 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.1 t -70.66 -52.55 20.46 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.611 1.564 . . . . 2.25 112.355 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -47.76 -47.63 30.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.874 1.67 . . . . 2.5499999999999998 111.927 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.82 -30.41 65.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.077 0.951 . . . . 4.1100000000000003 113.243 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.18 -42.22 72.7 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.636 1.107 . . . . 3.71 112.662 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.01 -33.63 61.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.006 1.323 . . . . 1.6299999999999999 114.48 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.28 42.64 25.98 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.487 1.915 . . . . 3.1800000000000002 114.334 -172.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -119.78 -21.7 7.13 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.409 1.633 . . . . 4.1200000000000001 115.409 -172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.8 tt0 58.8 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.154 2.582 . . . . 3.0099999999999998 117.403 -171.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 75.2 p -95.54 22.23 7.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.275 2.23 . . . . 2.9100000000000001 113.917 -170.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.59 147.13 53.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.753 1.221 . . . . 0.88 113.847 -169.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 66.44 -173.35 25.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.272 0.929 . . . . 1.5700000000000001 114.639 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -160.45 -51.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.066 1.347 . . . . 1.45 111.629 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 31.6 t -138.24 142.53 39.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.405 1.082 . . . . 1.3700000000000001 113.58 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.12 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 1 C-N-CA 131.728 4.011 . . . . 2.9199999999999999 109.229 168.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -20.31 12.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.944 1.461 . . . . 3.2400000000000002 114.944 -169.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 51.3 m-85 60.8 105.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.507 2.723 . . . . 4.54 117.35 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -120.91 107.09 12.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.448 2.299 . . . . 2.5899999999999999 107.493 168.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.7 m -98.4 145.17 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.41 0.684 . . . . 2.1699999999999999 111.96 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 18.7 t -136.99 85.15 23.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 106.552 -1.647 . . . . 1.26 106.552 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -53.1 134.27 55.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.825 3.683 . . . . 1.76 114.708 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 65.22 10.05 45.46 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.855 -0.969 . . . . 1.9399999999999999 114.457 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 22.8 m -127.51 -49.11 1.4 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.09 1.445 . . . . 3.2200000000000002 111.933 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 173.14 -170.89 44.04 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.499 0.571 . . . . 1.1499999999999999 114.096 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 4.3 tt -141.71 158.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.4 1.08 . . . . 2.04 111.665 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 18.7 t -139.0 152.92 48.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.618 1.167 . . . . 0.73999999999999999 111.903 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 9.2 p -164.2 167.96 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.495 1.118 . . . . 0.97999999999999998 112.648 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -110.08 123.1 49.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.307 1.043 . . . . 1.1499999999999999 109.258 172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.7 t -105.01 145.21 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 123.92 0.888 . . . . 2.27 111.37 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.88 160.54 41.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.305 1.05 . . . . 0.94999999999999996 113.542 164.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 CA--C 1.55 0.946 0 C-N-CA 130.674 3.59 . . . . 2.2000000000000002 108.24 163.914 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.633 0.73 . . . . 2.3300000000000001 112.776 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -122.42 128.17 50.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.578 1.551 . . . . 3.0600000000000001 110.973 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.4 tttt -88.14 126.56 35.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.987 0.915 . . . . 1.23 109.073 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.6 m -134.49 151.89 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 113.748 1.018 . . . . 0.87 113.748 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.49 152.35 30.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.159 1.384 . . . . 0.44 113.005 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 10.7 tt -149.36 139.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.144 1.378 . . . . 0.54000000000000004 110.31 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.9 -142.38 9.09 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.908 1.123 . . . . 1.45 115.908 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.41 161.48 2.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.64 2.376 . . . . 2.1099999999999999 114.456 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -24.99 63.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.091 1.356 . . . . 6.3300000000000001 113.68 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -76.61 -32.14 57.87 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.868 1.213 . . . . 3.0499999999999998 113.652 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.2 t90 -64.05 -21.17 66.41 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 119.994 -1.692 . . . . 2.96 112.484 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -63.92 -33.9 76.74 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.846 -1.158 . . . . 2.3799999999999999 111.256 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 24.3 mt -66.83 -64.84 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.844 1.658 . . . . 2.3199999999999998 109.169 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -52.58 -30.86 33.28 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.277 1.431 . . . . 5.1600000000000001 114.344 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.1 6.07 23.69 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.302 1.441 . . . . 0.81999999999999995 113.954 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.99 29.8 72.35 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.95 1.738 . . . . 0.69999999999999996 115.081 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 4.6 mt -96.24 160.7 14.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.84 1.256 . . . . 0.82999999999999996 109.647 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 58.5 t -110.74 124.5 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.499 0.719 . . . . 1.27 110.559 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -95.63 149.44 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.018 0.927 . . . . 1.1399999999999999 111.004 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -124.06 154.38 40.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.828 1.251 . . . . 3.0899999999999999 111.495 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -56.92 -32.09 65.6 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.813 1.412 . . . . 2.4199999999999999 114.813 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.54 -53.56 46.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.54 1.136 . . . . 3.9900000000000002 111.391 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' 1199 ' ' VAL . 1.8 p -73.48 -34.3 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.171 1.388 . . . . 1.24 111.638 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.74 -42.74 97.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.742 0.817 . . . . 1.8100000000000001 111.593 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.27 -44.4 91.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.622 0.646 . . . . 2.29 112.321 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.87 -36.17 82.68 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.346 1.058 . . . . 2.2200000000000002 112.22 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 18.1 tpp -62.62 -55.12 30.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.369 1.068 . . . . 0.80000000000000004 111.687 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.3 t -68.56 -33.68 74.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.644 -0.66 . . . . 1.1000000000000001 111.938 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.191 1.397 . . . . 4.25 112.271 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.19 -39.66 71.69 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.883 1.068 . . . . 2.25 113.883 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.54 -39.72 84.9 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.602 -0.686 . . . . 3.0600000000000001 111.662 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -70.74 -18.62 62.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.523 2.329 . . . . 4.1600000000000001 113.786 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -71.89 -22.01 61.56 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.008 1.276 . . . . 3.0099999999999998 111.865 166.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.45 18.32 42.39 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.332 1.92 . . . . 1.78 114.303 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -106.03 -160.78 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.019 1.327 . . . . 4.5700000000000003 110.123 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 69.9 m -108.09 131.51 54.54 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.885 1.22 . . . . 0.82999999999999996 112.388 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.08 118.28 19.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.836 1.654 . . . . 0.58999999999999997 111.125 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -138.04 155.33 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.777 1.231 . . . . 0.56000000000000005 113.122 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.0 mp -113.42 159.95 18.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.971 1.309 . . . . 0.79000000000000004 112.587 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.7 t -127.74 123.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.919 1.687 . . . . 1.8400000000000001 110.397 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.62 147.29 48.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.784 1.234 . . . . 0.51000000000000001 110.634 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.58 134.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.928 0.891 . . . . 1.01 112.061 -172.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 41.09 49.73 3.15 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.047 1.739 . . . . 3.1600000000000001 112.043 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.272 24.0 m-20 54.2 36.15 24.3 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.907 2.883 . . . . 1.5 116.435 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.93 138.43 48.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.999 1.72 . . . . 2.3399999999999999 110.68 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.25 133.77 48.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.642 -1.286 . . . . 0.72999999999999998 110.762 169.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.2 p -115.76 -37.89 3.83 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -174.57 -171.46 38.8 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 119.806 1.185 . . . . 0.46999999999999997 115.349 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.81 154.09 44.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.739 1.616 . . . . 0.69999999999999996 113.025 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.12 133.04 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.723 1.609 . . . . 0.84999999999999998 110.016 -173.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -107.53 132.31 53.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.71999999999999997 110.77 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 24.9 mt -135.02 152.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.438 1.895 . . . . 1.1499999999999999 110.604 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 126.967 2.107 . . . . 1.4399999999999999 111.408 171.386 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 118.552 -0.737 . . . . 2.9700000000000002 110.39 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.38 135.07 16.22 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.823 2.349 . . . . 2.0800000000000001 111.465 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.7 p -135.25 132.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.478 -0.764 . . . . 2.6299999999999999 110.215 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 6.3 p -68.52 123.16 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.643 -0.66 . . . . 1.22 110.177 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 30.4 t30 -103.64 -39.44 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.85 1.26 . . . . 3.54 112.136 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.22 146.85 20.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.227 1.011 . . . . 2.3999999999999999 112.295 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 16.7 m -132.49 131.7 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.788 0.835 . . . . 0.68999999999999995 112.201 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 53.0 tttt -135.08 144.61 47.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.883 1.273 . . . . 1.55 113.224 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 87.7 t -79.17 147.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.054 1.341 . . . . 0.95999999999999996 110.659 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.9 tp -122.22 -24.1 5.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.59 1.556 . . . . 0.87 112.707 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 36.0 m -127.46 107.42 9.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.153 1.381 . . . . 1.77 109.431 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.34 130.51 49.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.535 1.134 . . . . 3.6400000000000001 111.788 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 59.8 m 51.61 31.21 7.45 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.132 1.773 . . . . 2.5299999999999998 115.528 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -137.98 5.5 2.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.965 1.306 . . . . 2.71 113.514 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -154.37 -79.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 5.6799999999999997 110.423 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.83 146.85 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 128.203 2.601 . . . . 1.99 109.032 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -97.93 155.64 16.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.245 1.418 . . . . 1.98 113.682 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -44.76 -49.42 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.669 2.47 . . . . 3.6899999999999999 117.669 -167.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.9 t60 -75.33 -28.18 59.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.433 1.47 . . . . 2.8399999999999999 111.348 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -65.17 -38.71 91.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.857 -1.152 . . . . 3.77 111.062 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.36 -51.85 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.088 0.955 . . . . 0.65000000000000002 110.603 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -31.81 73.0 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.124 0.874 . . . . 0.70999999999999996 112.262 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.78 54.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 0.64000000000000001 112.152 173.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 14.4 pt -69.14 -34.95 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.193 . . . . 0.76000000000000001 113.157 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 58.1 t -70.75 -45.07 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.133 0.878 . . . . 0.88 111.361 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.0 -36.18 91.66 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.487 -0.758 . . . . 0.91000000000000003 113.304 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.0 p -72.76 -34.89 67.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.45 0.907 . . . . 0.98999999999999999 113.45 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -58.05 -51.79 68.23 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.275 0.943 . . . . 1.0 112.64 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.52 -13.66 61.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.875 1.065 . . . . 2.5600000000000001 113.875 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 9.1 p -65.16 -20.85 66.64 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.058 -1.651 . . . . 1.6299999999999999 112.667 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -122.99 16.84 10.06 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.973 1.709 . . . . 2.0299999999999998 112.636 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.5 t -127.83 -176.93 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.524 1.93 . . . . 1.5 110.197 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -142.94 46.77 1.55 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.294 1.438 . . . . 3.8100000000000001 112.607 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.16 164.76 22.01 Favored Pre-proline 0 CA--C 1.554 1.123 0 O-C-N 121.274 -0.891 . . . . 1.9199999999999999 112.441 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.73 -22.61 5.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.193 2.596 . . . . 1.3400000000000001 115.314 -169.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 10.3 tt -112.8 -48.59 2.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.437 1.095 . . . . 1.05 112.848 -169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -66.04 -21.22 69.61 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.18 0.832 . . . . 0.89000000000000001 115.18 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 67.4 p -62.98 -16.8 60.89 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.942 1.371 . . . . 1.3999999999999999 113.979 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.33 78.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.013 -1.054 . . . . 0.75 111.737 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.69 -38.95 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.205 1.402 . . . . 0.83999999999999997 110.232 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 90.9 m -53.08 -47.86 68.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 111.704 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -60.45 -51.0 71.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.649 0.78 . . . . 2.6899999999999999 112.252 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.02 -41.28 78.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.214 0.605 . . . . 3.29 111.95 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.1 t -67.65 -56.9 7.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.478 1.511 . . . . 1.71 112.246 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -50.55 -45.49 56.94 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.014 1.279 . . . . 3.8399999999999999 110.88 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -70.98 -32.44 69.29 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.222 1.009 . . . . 3.6000000000000001 113.361 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -72.06 -41.4 67.44 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.73 1.15 . . . . 2.1899999999999999 113.789 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.33 -16.21 61.88 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.715 1.206 . . . . 1.04 112.388 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.12 46.17 9.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.847 2.459 . . . . 2.7400000000000002 112.064 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.83 143.34 26.24 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.525 -0.734 . . . . 2.7599999999999998 111.937 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -99.4 -0.42 40.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.173 0.989 . . . . 3.5 112.518 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 63.3 p -101.21 9.02 42.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.305 1.842 . . . . 3.52 114.701 -168.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -67.55 149.37 50.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.979 1.312 . . . . 1.3 112.78 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.44 168.26 19.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.399 1.476 . . . . 1.3200000000000001 115.758 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 9.8 m -160.76 -49.97 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.123 -1.222 . . . . 1.3 113.516 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 53.6 t -136.29 142.68 43.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.503 1.521 . . . . 1.8200000000000001 114.745 -168.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.2 mm -138.71 148.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 130.346 3.458 . . . . 2.29 109.317 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 19.2 t0 -131.93 98.38 4.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.964 1.706 . . . . 2.5600000000000001 106.798 166.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' 1119 ' ' ILE . 60.6 t80 -73.57 124.42 25.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.478 1.911 . . . . 4.1799999999999997 114.544 -167.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.26 123.47 25.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.443 1.897 . . . . 2.3199999999999998 108.213 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 7.4 p -129.47 149.06 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.023 1.86 . . . . 3.1000000000000001 116.023 -166.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 52.8 t -128.41 102.79 20.41 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.098 1.359 . . . . 1.7 107.419 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -57.67 133.79 58.77 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.174 2.582 . . . . 1.47 113.821 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.11 11.38 70.43 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.813 1.197 . . . . 1.5800000000000001 115.499 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 33.2 t -138.89 -41.73 0.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.655 1.227 . . . . 1.9399999999999999 114.044 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 174.58 -177.86 46.57 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 115.661 1.024 . . . . 0.75 115.661 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' 1111 ' ' PHE . 0.1 OUTLIER -142.71 149.05 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 1.8300000000000001 111.218 170.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.5 t -131.41 142.93 50.12 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.188 2.195 . . . . 0.48999999999999999 109.137 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.1 p -153.84 165.68 35.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.929 1.085 . . . . 0.66000000000000003 113.929 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -114.66 122.45 46.5 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.032 -1.099 . . . . 1.27 108.032 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 33.1 m -124.34 136.63 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.224 0.609 . . . . 2.25 112.294 -170.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.6 t -122.95 145.4 48.51 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.884 0.373 . . . . 1.01 111.037 166.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.545 0.778 0 C-N-CA 126.71 2.004 . . . . 3.3599999999999999 107.184 158.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 113.78 1.03 . . . . 2.27 113.78 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -89.92 137.64 32.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.03 1.332 . . . . 3.1699999999999999 109.457 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.87 119.75 31.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.015 0.926 . . . . 1.53 109.058 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.9 m -133.91 138.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 118.878 0.763 . . . . 0.48999999999999999 112.342 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -144.92 154.66 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.113 0.965 . . . . 0.37 113.542 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.4 tt -149.49 139.29 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.837 1.655 . . . . 0.81000000000000005 110.048 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 178.35 173.88 44.12 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.312 0.885 . . . . 1.47 115.312 -172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -57.65 -70.34 0.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.431 1.492 . . . . 3.8100000000000001 114.68 -169.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 -72.77 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.725 1.379 . . . . 5.5800000000000001 114.725 -177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.18 -31.48 70.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.527 1.512 . . . . 4.8300000000000001 113.413 -168.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 15.3 t90 -68.25 -23.39 64.78 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.396 -1.44 . . . . 3.04 113.117 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 80.2 mmm -72.04 -40.65 68.23 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.789 0.836 . . . . 2.6499999999999999 110.979 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.38 -64.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.252 1.421 . . . . 2.2400000000000002 109.482 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -51.69 -9.64 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.908 2.483 . . . . 6.8499999999999996 116.6 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.31 13.56 0.72 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 120.903 1.683 . . . . 0.76000000000000001 111.106 167.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 71.31 33.66 64.43 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 119.475 -2.016 . . . . 1.0700000000000001 114.001 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.25 172.91 6.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.947 1.299 . . . . 0.81000000000000005 110.836 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.3 t -117.27 138.55 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.808 1.243 . . . . 1.02 110.28 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 17.7 tt -114.1 141.81 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.332 1.053 . . . . 1.0700000000000001 112.148 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 11.0 p30 -103.2 158.7 16.14 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.242 1.417 . . . . 4.2400000000000002 113.093 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -74.0 -21.96 59.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.248 1.203 . . . . 2.8399999999999999 114.248 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.18 -39.92 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.714 -1.241 . . . . 2.9100000000000001 112.161 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.6 p -70.32 -36.7 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.575 -0.703 . . . . 0.81999999999999995 111.111 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.7 t30 -64.44 -38.37 90.79 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.884 0.765 . . . . 2.2999999999999998 112.556 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -44.98 86.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.795 0.838 . . . . 2.1200000000000001 112.864 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 29.5 t80 -71.34 -43.03 67.79 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.54 0.736 . . . . 2.5600000000000001 112.393 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.3 tpp -56.84 -48.03 78.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.417 1.087 . . . . 0.97999999999999998 111.58 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -74.15 -34.74 63.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.94 -0.552 . . . . 1.3400000000000001 112.055 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.65 -45.33 85.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.115 1.325 . . . . 3.3300000000000001 111.818 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -65.3 -47.2 77.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.143 0.977 . . . . 3.8900000000000001 111.684 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.12 -34.61 76.68 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.332 -0.855 . . . . 4.1500000000000004 111.967 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -69.84 -15.26 63.07 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.586 1.554 . . . . 3.8199999999999998 113.78 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 63.1 mttt -73.58 -14.49 61.2 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 120.431 1.469 . . . . 3.6899999999999999 112.059 165.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.98 10.36 58.75 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 126.59 2.043 . . . . 1.79 113.556 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -115.69 132.34 56.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.886 1.274 . . . . 4.7800000000000002 111.343 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 99.6 m -59.61 128.25 36.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.619 1.341 . . . . 1.1499999999999999 114.619 -168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.87 130.05 49.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.841 1.256 . . . . 0.60999999999999999 111.777 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.8 m -140.9 154.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.345 1.458 . . . . 0.72999999999999998 113.247 -174.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.58 159.32 15.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.174 0.989 . . . . 1.0900000000000001 110.551 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.8 p -130.57 124.84 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.456 1.102 . . . . 2.1600000000000001 112.54 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.27 152.31 37.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.921 1.688 . . . . 0.40000000000000002 111.226 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.7 m -146.69 119.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.545 1.938 . . . . 0.72999999999999998 112.008 -167.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 46.46 47.48 14.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.984 2.114 . . . . 3.3700000000000001 113.215 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.321 34.0 m-20 63.38 26.77 15.1 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.228 2.611 . . . . 2.0899999999999999 116.382 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -125.66 153.67 43.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.216 2.206 . . . . 3.1899999999999999 110.824 167.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.6 mt -75.17 148.77 39.31 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.218 -1.551 . . . . 1.02 112.418 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.7 p -124.55 -36.94 2.56 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.08 0.771 . . . . 0.59999999999999998 113.08 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.47 -166.07 29.68 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 119.268 0.94 . . . . 0.58999999999999997 115.418 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.39 153.04 46.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.884 1.674 . . . . 0.78000000000000003 111.743 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.4 mm -132.19 140.58 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.796 1.638 . . . . 1.01 108.864 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -130.84 132.06 44.97 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.974 0.91 . . . . 1.05 111.025 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.19 155.87 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.975 2.11 . . . . 1.6200000000000001 110.099 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.856 0 C-N-CA 126.447 1.899 . . . . 1.5 112.945 170.612 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 113.079 0.77 . . . . 2.8500000000000001 113.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.51 87.22 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.856 2.371 . . . . 2.3500000000000001 110.035 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 47.0 t -65.9 109.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.38 1.072 . . . . 3.0499999999999998 111.107 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.7 p -71.17 131.42 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.605 -0.685 . . . . 1.3799999999999999 111.552 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -34.43 2.76 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.281 1.586 . . . . 2.2400000000000002 115.281 -167.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -155.12 145.93 22.42 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.753 1.161 . . . . 1.95 111.666 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.9 m -127.74 133.78 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.072 0.949 . . . . 1.1000000000000001 111.175 170.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 43.4 tttt -135.88 145.52 46.43 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.935 1.294 . . . . 1.6799999999999999 112.539 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 96.4 t -89.52 134.15 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.226 1.81 . . . . 1.03 111.077 173.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . 0.612 HD23 HD22 ' A' 1222 ' ' LEU . 30.3 tp -95.4 -38.53 10.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.898 1.679 . . . . 1.3 110.984 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 52.1 m -121.89 111.96 17.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.272 1.429 . . . . 1.78 110.213 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -109.74 136.26 49.36 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.776 1.23 . . . . 3.6299999999999999 112.854 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 57.93 -57.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 130.072 3.349 . . . . 4.2199999999999998 118.82 169.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m120 -70.35 -6.28 34.21 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.603 2.075 . . . . 5.1299999999999999 116.603 -166.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.05 -26.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.401 1.48 . . . . 9.0199999999999996 114.304 168.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mt -144.96 142.38 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.589 1.156 . . . . 2.48 107.969 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.3 m -91.76 144.08 25.87 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.425 0.69 . . . . 2.8300000000000001 111.489 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 27.9 p80 -57.31 -41.36 79.76 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.77 1.396 . . . . 3.8900000000000001 114.77 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 27.1 t60 -74.18 -29.3 61.7 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.075 -1.016 . . . . 2.6099999999999999 111.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.79 -37.5 84.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 117.493 -1.241 . . . . 5.3099999999999996 111.7 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.77 -56.63 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.728 1.149 . . . . 0.85999999999999999 110.309 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.46 -30.1 69.73 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.606 -0.684 . . . . 0.77000000000000002 112.184 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.7 76.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.759 -0.639 . . . . 0.87 112.596 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 17.3 pt -68.81 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.676 1.58 . . . . 0.90000000000000002 112.956 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 61.3 t -70.12 -50.77 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.512 1.051 . . . . 0.92000000000000004 111.349 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.7 84.8 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.526 -0.733 . . . . 0.95999999999999996 113.349 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 76.6 p -73.58 -35.62 65.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.692 -0.887 . . . . 1.0700000000000001 112.041 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -71.21 -39.72 71.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.932 1.086 . . . . 1.22 113.932 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.34 -6.94 53.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.952 1.464 . . . . 3.4900000000000002 114.952 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 84.7 p -58.68 -27.29 64.68 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.221 1.934 . . . . 2.6899999999999999 116.221 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -95.58 -6.84 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.212 0.914 . . . . 2.1099999999999999 113.201 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.1 t -79.77 162.03 25.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.562 1.145 . . . . 1.77 113.728 -174.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -112.64 -3.53 14.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.355 2.262 . . . . 4.3499999999999996 114.097 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -59.66 144.14 85.57 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.087 -1.008 . . . . 1.6200000000000001 112.282 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.29 -40.54 24.93 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.048 2.498 . . . . 1.8799999999999999 112.286 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.85 -44.47 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.32 -0.862 . . . . 1.8 111.922 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.61 98.26 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.539 0.59 . . . . 1.6599999999999999 113.162 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.2 p -64.32 -38.31 90.58 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.586 -0.95 . . . . 1.55 112.201 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.54 94.78 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.898 0.879 . . . . 1.0800000000000001 112.843 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 54.4 mt -68.29 -42.32 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.087 0.555 . . . . 0.88 110.214 173.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 96.7 m -54.43 -44.71 72.69 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.664 0.666 . . . . 1.23 111.514 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.4 tttt -60.13 -51.43 69.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.68 0.673 . . . . 2.3599999999999999 111.955 174.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.37 -42.52 82.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.714 0.806 . . . . 2.5099999999999998 111.77 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 69.1 m -70.82 -45.65 64.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.147 . . . . 2.9900000000000002 112.696 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.98 -34.86 78.43 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.346 1.884 . . . . 2.5699999999999998 111.371 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -65.08 -39.15 92.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.349 1.06 . . . . 3.9900000000000002 112.941 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.79 -44.57 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.861 -1.15 . . . . 2.8199999999999998 113.074 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.17 -3.1 18.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.848 1.425 . . . . 1.8500000000000001 114.848 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 31.4 t70 58.64 26.22 14.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.627 1.171 . . . . 5.0199999999999996 113.586 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.3 t -122.54 168.44 12.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.31 1.844 . . . . 2.5800000000000001 112.047 -170.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.27 -15.0 15.6 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.994 1.717 . . . . 4.0300000000000002 112.134 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.5 t -132.81 133.42 43.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.061 1.744 . . . . 2.7200000000000002 111.194 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.98 147.61 25.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.246 0.618 . . . . 1.1799999999999999 112.042 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 63.11 177.41 3.83 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.74 1.162 . . . . 1.55 115.08 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 70.7 m -138.47 -69.44 0.44 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.542 0.737 . . . . 1.45 111.414 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 48.9 t -136.11 141.4 44.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.197 0.599 . . . . 1.8999999999999999 111.898 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.98 148.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.255 2.622 . . . . 2.98 111.714 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -110.72 124.34 51.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.909 -2.626 . . . . 3.2999999999999998 103.909 163.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.1 OUTLIER -121.43 138.12 54.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.383 1.447 . . . . 3.1099999999999999 112.889 -174.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.95 98.03 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.385 2.274 . . . . 3.54 108.329 -169.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.5 t -96.22 126.62 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.555 -0.715 . . . . 2.23 110.692 -168.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 33.1 t -143.32 113.88 5.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.751 1.62 . . . . 1.6699999999999999 109.448 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.14 140.36 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.251 2.634 . . . . 1.47 113.925 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 55.4 35.68 61.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.6 1.095 . . . . 2.77 114.362 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 93.0 m -143.5 -32.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.784 1.234 . . . . 2.8799999999999999 113.791 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 122.18 -164.26 15.31 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.075 1.321 . . . . 0.75 112.629 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.33 151.14 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.542 -1.563 . . . . 1.96 111.249 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 14.5 t -129.87 140.5 50.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.732 1.613 . . . . 0.71999999999999997 109.859 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 13.5 p -143.97 156.93 44.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.469 1.032 . . . . 1.3799999999999999 113.682 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -116.23 97.75 6.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.509 1.124 . . . . 1.9399999999999999 108.735 -174.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.1 p -93.96 146.66 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.634 0.73 . . . . 2.2799999999999998 111.426 -174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.6 t -142.95 162.02 36.57 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.135 1.532 . . . . 1.6000000000000001 115.135 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 10.9 t-20 . . . . . 0 CA--C 1.546 0.811 1 C-N-CA 132.183 4.193 . . . . 3.1299999999999999 109.914 162.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 117.837 2.532 . . . . 2.21 117.837 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -71.2 115.92 10.91 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.898 -1.126 . . . . 2.77 110.545 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -88.14 125.24 34.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.333 -1.358 . . . . 1.8999999999999999 107.333 168.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.6 m -126.69 141.17 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.295 0.638 . . . . 0.95999999999999996 110.369 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.5 150.76 47.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.988 0.915 . . . . 0.52000000000000002 112.392 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.33 158.47 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.801 1.24 . . . . 0.46000000000000002 109.938 -169.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 104.85 159.18 23.58 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.75 0.691 . . . . 1.6299999999999999 114.783 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 49.53 -159.6 0.06 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.219 1.408 . . . . 2.4900000000000002 113.617 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -58.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.777 1.399 . . . . 7.4299999999999997 114.777 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -80.96 -37.76 28.84 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.152 0.887 . . . . 5.4299999999999997 113.002 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 83.6 t90 -54.73 -36.44 64.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.927 1.291 . . . . 3.0299999999999998 113.087 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.52 -36.36 80.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.665 1.186 . . . . 2.8300000000000001 113.244 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.8 mt -62.37 -61.44 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.723 1.609 . . . . 2.96 109.134 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.4 -13.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.544 2.338 . . . . 6.4800000000000004 116.268 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 6.0 t30 -74.28 22.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 121.694 2.043 . . . . 0.92000000000000004 113.153 168.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.95 26.44 73.23 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.894 -1.753 . . . . 0.84999999999999998 114.409 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 8.2 mt -96.44 147.7 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.052 1.426 . . . . 0.94999999999999996 110.066 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 89.7 t -97.37 126.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.328 1.051 . . . . 1.1299999999999999 110.385 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.0 148.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.977 0.911 . . . . 1.04 112.629 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.55 152.12 38.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.845 1.258 . . . . 2.77 113.583 -168.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -70.93 -28.02 64.2 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.462 1.282 . . . . 2.98 114.462 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.21 -36.64 69.24 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.761 -1.212 . . . . 2.5699999999999998 112.494 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -78.0 -36.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.905 0.882 . . . . 0.82999999999999996 113.286 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -54.0 -42.79 69.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.581 1.152 . . . . 3.1200000000000001 112.517 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.42 -40.01 96.03 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.045 0.938 . . . . 1.9099999999999999 113.086 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -39.03 75.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.687 1.195 . . . . 2.0499999999999998 110.879 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.4 tpp -62.99 -53.29 56.31 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.509 1.124 . . . . 0.77000000000000002 112.313 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 11.0 t -67.48 -32.07 72.64 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.665 -0.647 . . . . 1.03 112.485 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -57.43 -50.86 71.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.518 1.053 . . . . 3.1800000000000002 112.023 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -71.72 -33.94 69.17 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.314 0.857 . . . . 2.5 113.314 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 51.0 mm-40 -68.21 -35.95 78.77 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.391 -0.818 . . . . 3.9399999999999999 112.564 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.82 -22.04 61.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.845 1.658 . . . . 4.25 113.524 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 21.5 mttp -76.51 -7.66 55.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.883 1.273 . . . . 3.1099999999999999 112.135 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.56 88.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.964 1.745 . . . . 2.3500000000000001 115.094 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . 0.259 16.0 mtt-85 -84.19 -152.36 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 3.3199999999999998 109.956 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 86.0 m -120.61 120.88 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 121.451 1.932 . . . . 0.77000000000000002 112.112 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.06 127.59 54.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.902 2.081 . . . . 0.48999999999999999 109.595 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 35.8 m -142.29 154.68 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 119.543 1.065 . . . . 0.45000000000000001 113.483 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.32 164.0 12.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.185 1.394 . . . . 1.0 111.731 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.9 t -135.83 129.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.695 1.598 . . . . 2.0699999999999998 111.168 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -134.43 153.01 52.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.166 1.386 . . . . 0.51000000000000001 111.99 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 23.8 m -149.25 130.45 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.879 . . . . 0.92000000000000004 112.899 -169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 35.7 m-20 41.89 40.67 1.62 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.262 1.825 . . . . 3.3900000000000001 111.577 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 62.48 30.62 17.22 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 128.125 2.57 . . . . 2.1099999999999999 116.787 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.14 135.16 54.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.735 2.014 . . . . 2.5600000000000001 110.199 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . 0.612 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -67.79 133.78 49.82 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.254 -1.529 . . . . 0.81999999999999995 111.523 172.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -116.83 -42.24 2.98 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.725 1.009 . . . . 0.63 113.725 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.13 -176.47 39.74 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 119.215 0.916 . . . . 0.64000000000000001 114.725 -172.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.03 155.05 44.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.865 1.666 . . . . 0.69999999999999996 112.852 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.63 134.48 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.535 1.534 . . . . 0.92000000000000004 110.266 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -112.93 131.86 55.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.246 1.418 . . . . 0.68000000000000005 110.904 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -128.86 147.61 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.734 2.014 . . . . 1.47 108.789 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 114.128 1.158 . . . . 4.0800000000000001 114.128 178.481 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 112.426 0.528 . . . . 2.73 112.426 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -95.04 156.75 1.74 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.198 3.265 . . . . 1.4099999999999999 111.969 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 30.8 t -134.93 113.08 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.609 1.164 . . . . 2.1899999999999999 109.588 173.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 5.8 p -73.06 132.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.777 1.171 . . . . 1.1699999999999999 110.697 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -125.57 -36.17 2.47 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 117.415 2.376 . . . . 2.23 117.415 -164.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -156.42 150.84 25.55 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.737 1.608 . . . . 1.9199999999999999 111.529 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -129.67 136.69 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.117 0.967 . . . . 1.1000000000000001 111.375 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -140.8 147.83 39.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.107 0.963 . . . . 3.1200000000000001 113.153 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 99.1 t -102.45 129.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.318 1.447 . . . . 1.1100000000000001 112.233 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.65 -35.81 9.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.024 1.73 . . . . 1.1100000000000001 112.673 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -111.01 88.66 2.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.634 1.574 . . . . 1.95 108.06 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.64 133.12 41.56 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.948 0.899 . . . . 3.5899999999999999 111.701 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 13.8 m 59.18 25.68 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.226 2.211 . . . . 2.25 115.097 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.61 -6.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.047 1.499 . . . . 2.7200000000000002 115.047 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -140.87 -77.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.891 1.277 . . . . 4.4900000000000002 110.799 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 20.9 mt -137.47 147.57 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.111 2.165 . . . . 1.74 110.075 -174.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.5 m -91.68 152.48 20.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.595 1.558 . . . . 1.8 113.704 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 12.2 p80 -53.81 -42.12 68.05 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.781 2.141 . . . . 3.0299999999999998 116.781 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -73.99 -23.1 59.41 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.073 -1.017 . . . . 2.8799999999999999 111.73 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.2 tttt -75.77 -39.17 57.5 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.095 0.958 . . . . 4.04 111.474 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 66.3 mt -56.38 -52.2 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 119.459 1.027 . . . . 0.73999999999999999 110.656 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.23 -33.34 75.53 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.588 -0.695 . . . . 0.62 112.072 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.02 75.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.722 0.638 . . . . 0.52000000000000002 112.722 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.67 -34.56 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.763 -1.211 . . . . 0.51000000000000001 113.381 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 73.5 t -70.64 -46.07 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.89 0.768 . . . . 0.60999999999999999 110.972 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -63.98 -37.41 94.58 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.662 -0.649 . . . . 0.59999999999999998 113.372 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 32.6 p -73.07 -37.26 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.917 0.887 . . . . 0.62 113.116 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.99 74.5 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.237 0.926 . . . . 0.63 112.247 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.57 -17.36 64.61 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.131 -0.981 . . . . 2.2400000000000002 112.771 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 4.2 t -60.51 -35.35 75.75 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.927 -1.108 . . . . 1.3999999999999999 112.077 170.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.88 -22.17 23.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.649 1.18 . . . . 2.0499999999999998 113.319 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.6 t -74.33 -179.56 4.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.284 1.034 . . . . 1.45 111.8 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -137.3 19.61 2.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.645 1.578 . . . . 4.29 112.691 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -75.95 161.21 76.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.854 1.262 . . . . 1.6599999999999999 112.617 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.02 -33.67 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.05 2.5 . . . . 1.1799999999999999 114.108 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.81 -49.35 5.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.572 1.549 . . . . 0.78000000000000003 112.722 -167.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.91 -31.62 81.42 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.003 0.335 . . . . 0.96999999999999997 113.772 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.5 p -66.31 -16.34 63.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.746 -1.444 . . . . 1.72 113.915 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.39 80.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.73 -1.231 . . . . 0.78000000000000003 110.737 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.91 -37.11 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.261 1.424 . . . . 0.92000000000000004 110.417 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 97.7 m -53.82 -48.26 70.08 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.074 0.852 . . . . 1.1599999999999999 111.863 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -64.0 -45.97 86.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.342 0.974 . . . . 3.6800000000000002 112.553 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.7 t80 -55.92 -43.92 77.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.919 0.888 . . . . 1.71 111.457 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.7 t -65.85 -52.09 53.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.416 1.487 . . . . 1.9199999999999999 111.864 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -51.51 -45.34 62.84 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.107 1.363 . . . . 3.0699999999999998 112.204 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.54 -43.19 77.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.501 0.72 . . . . 3.3100000000000001 111.559 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -62.19 -42.83 99.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.653 0.982 . . . . 2.6899999999999999 113.653 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.4 mt -71.39 -13.24 61.79 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.825 0.85 . . . . 1.04 112.66 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 15.7 t70 50.61 54.91 10.35 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.293 1.837 . . . . 2.5499999999999998 112.161 -169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.7 t -128.91 175.07 8.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.85 1.66 . . . . 3.0899999999999999 111.841 -174.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -115.69 -7.17 12.14 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.404 1.882 . . . . 2.79 112.402 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 10.0 t -140.04 127.26 21.14 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.402 -1.436 . . . . 2.71 113.819 -168.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -161.52 154.13 20.33 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.649 1.58 . . . . 0.98999999999999999 113.609 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.74 132.03 0.6 Allowed Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.383 1.313 . . . . 1.3200000000000001 116.383 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 87.9 m -120.07 -72.45 0.69 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.448 1.277 . . . . 1.45 114.448 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 52.6 t -138.99 142.5 38.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.786 1.234 . . . . 1.4399999999999999 111.208 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.16 169.97 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 130.584 3.554 . . . . 2.1800000000000002 108.577 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.27 150.05 40.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.739 1.616 . . . . 2.6600000000000001 108.44 166.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -112.72 147.76 36.15 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.367 1.894 . . . . 4.2300000000000004 115.468 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.21 95.24 2.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 129.55 3.14 . . . . 2.2999999999999998 108.02 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 24.4 t -101.12 144.54 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.472 1.509 . . . . 1.9099999999999999 111.657 -171.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 48.8 t -132.7 118.14 15.5 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.881 1.273 . . . . 1.27 109.381 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.36 133.26 48.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.252 2.635 . . . . 1.29 115.514 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 62.33 19.06 59.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.675 1.607 . . . . 1.97 114.372 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.8 t -136.93 -42.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.083 1.142 . . . . 2.0099999999999998 114.083 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 154.79 -176.91 32.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.902 0.763 . . . . 0.79000000000000004 113.756 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.22 146.67 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.001 0.92 . . . . 1.8700000000000001 111.536 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 30.0 t -125.41 138.7 54.03 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.853 2.061 . . . . 0.48999999999999999 110.909 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -145.49 165.97 27.05 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 115.176 1.547 . . . . 0.63 115.176 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -111.66 94.43 4.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.758 1.223 . . . . 1.2 108.367 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.8 p -101.96 130.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.215 1.007 . . . . 1.8899999999999999 113.238 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.5 t -123.21 161.05 25.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.359 1.463 . . . . 1.1599999999999999 113.607 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 129.103 2.961 . . . . 2.1299999999999999 109.931 160.541 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 112.223 0.453 . . . . 3.0299999999999998 112.223 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.78 121.85 44.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.125 0.97 . . . . 2.29 108.961 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.37 103.15 13.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.29 -1.004 . . . . 1.21 108.29 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -121.61 138.59 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.959 0.8 . . . . 0.68000000000000005 112.006 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.31 152.52 41.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.851 0.86 . . . . 0.55000000000000004 113.132 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -146.12 140.54 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.437 1.495 . . . . 0.62 109.501 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 169.7 -166.0 39.3 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.255 0.862 . . . . 1.5600000000000001 115.255 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.268 10.4 p30 -84.7 173.19 10.91 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.86 1.264 . . . . 2.2599999999999998 112.546 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -59.19 -10.12 2.61 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 117.276 2.324 . . . . 4.9199999999999999 117.276 -165.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -71.48 -34.15 69.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.017 1.28 . . . . 5.1100000000000003 111.921 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 50.2 m95 -65.42 -26.22 67.87 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.826 -1.171 . . . . 4.0800000000000001 113.658 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -34.16 67.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.446 0.699 . . . . 2.4199999999999999 111.359 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.87 -67.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.137 1.375 . . . . 2.75 107.805 169.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -38.54 -42.96 0.81 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.968 2.507 . . . . 5.6699999999999999 115.451 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.15 1.75 56.07 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.759 1.763 . . . . 2.02 115.759 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 75.86 32.43 53.51 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.749 -1.22 . . . . 0.75 114.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.69 177.45 6.1 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.073 1.349 . . . . 0.81999999999999995 110.987 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.8 t -121.54 132.67 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.09 1.356 . . . . 1.3200000000000001 110.726 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.8 tt -108.29 134.38 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 1.22 110.599 171.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -106.22 162.74 13.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.234 1.014 . . . . 2.9900000000000002 113.461 -168.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.03 -40.32 93.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 2.4300000000000002 113.757 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.72 -34.15 66.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.542 0.737 . . . . 2.54 112.508 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 11.3 p -76.9 -32.97 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.338 0.655 . . . . 0.68999999999999995 111.667 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.89 -46.1 88.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.588 0.755 . . . . 2.0 111.492 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.94 -33.54 74.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.881 1.272 . . . . 2.54 113.867 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.63 -42.16 52.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.799 1.639 . . . . 2.4900000000000002 112.392 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.1 tpp -64.46 -50.65 66.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.232 1.413 . . . . 0.68000000000000005 111.867 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 13.9 t -63.62 -33.12 74.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.427 0.691 . . . . 1.1000000000000001 112.141 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -62.5 -48.99 77.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.98 0.912 . . . . 3.2000000000000002 112.352 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.66 -0.65 . . . . 2.29 112.686 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.97 -40.14 87.4 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.904 -1.122 . . . . 2.9700000000000002 112.323 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -71.22 -27.13 63.26 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.43 -1.419 . . . . 4.5899999999999999 113.804 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 20.8 mttp -70.38 -2.7 14.47 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.648 1.579 . . . . 2.2999999999999998 113.219 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.66 23.53 69.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.957 1.265 . . . . 1.22 113.593 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -101.17 -166.86 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.032 1.333 . . . . 2.98 111.043 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 90.8 m -115.22 121.75 43.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.553 1.541 . . . . 1.2 109.928 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -127.51 118.77 24.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.05 0.94 . . . . 0.54000000000000004 110.413 -170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 29.1 m -139.29 153.44 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.114 0.965 . . . . 0.68999999999999995 112.688 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.35 159.15 18.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.206 1.402 . . . . 0.76000000000000001 111.509 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -128.73 125.93 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.151 1.38 . . . . 1.8 110.741 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.19 154.24 40.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.769 1.228 . . . . 0.47999999999999998 111.636 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.8 m -148.09 123.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.732 2.013 . . . . 0.80000000000000004 110.236 -168.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.263 6.7 m-20 40.23 54.91 2.79 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.547 1.939 . . . . 2.9199999999999999 113.168 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.271 34.2 m-20 57.76 30.9 19.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.125 2.17 . . . . 1.6499999999999999 115.954 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -134.88 151.67 51.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.914 1.286 . . . . 2.9300000000000002 110.586 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.02 151.87 45.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.802 -1.811 . . . . 0.81000000000000005 111.748 170.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -122.09 -44.81 2.27 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.594 -0.692 . . . . 0.72999999999999998 111.208 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.64 -162.65 24.26 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.224 0.92 . . . . 0.59999999999999998 115.0 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -140.74 154.25 46.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.591 1.556 . . . . 0.65000000000000002 112.592 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 13.3 mm -123.94 127.52 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.93000000000000005 109.096 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -97.22 133.0 42.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.684 1.194 . . . . 0.81999999999999995 109.758 169.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' 1212 ' ' THR . 44.1 mt -140.11 159.85 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.798 2.039 . . . . 1.22 107.397 -170.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.531 0 O-C-N 120.164 -1.585 . . . . 1.49 111.943 174.043 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 119.345 -0.359 . . . . 2.3799999999999999 111.126 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.59 154.75 18.24 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.734 2.956 . . . . 2.0699999999999998 111.422 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 59.4 t -142.21 105.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.053 -1.092 . . . . 2.7400000000000002 108.053 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -71.9 128.99 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.96 0.886 . . . . 1.0900000000000001 111.396 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.66 -47.99 4.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.17 1.788 . . . . 2.8399999999999999 112.936 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -153.79 146.9 24.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.589 0.756 . . . . 2.4900000000000002 112.571 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.2 m -120.15 128.87 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.28 1.032 . . . . 0.95999999999999996 110.179 167.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 48.2 tttt -134.12 144.37 48.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.662 0.785 . . . . 2.4900000000000002 113.098 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 97.4 t -90.31 144.31 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.245 1.418 . . . . 0.80000000000000004 112.407 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.9 -29.4 5.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.832 1.653 . . . . 0.81999999999999995 112.551 169.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -127.59 123.8 36.57 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.006 1.323 . . . . 1.75 110.423 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.52 143.35 51.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.574 1.55 . . . . 3.8799999999999999 110.151 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 42.2 m 63.49 -30.83 0.1 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.635 2.374 . . . . 3.3999999999999999 116.803 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.56 -10.79 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.492 1.496 . . . . 3.1299999999999999 114.76 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -160.5 -38.91 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.237 1.415 . . . . 5.5499999999999998 112.299 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.96 167.85 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 126.984 2.114 . . . . 1.54 108.569 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.8 m -143.76 161.77 37.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.902 1.681 . . . . 2.1499999999999999 111.32 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -42.32 -50.78 4.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.859 2.463 . . . . 5.2000000000000002 115.225 -169.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -62.35 -38.32 89.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.672 0.669 . . . . 5.6900000000000004 112.778 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 64.4 mttm -74.29 -39.74 62.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.526 0.73 . . . . 2.5699999999999998 111.008 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.68 -52.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.987 0.915 . . . . 0.55000000000000004 110.945 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.72 -31.21 70.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.513 -0.742 . . . . 0.73999999999999999 112.249 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.67 -50.38 63.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.024 0.379 . . . . 0.51000000000000001 112.024 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.2 pt -69.09 -35.95 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.915 -1.116 . . . . 0.56000000000000005 113.086 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 64.7 t -71.24 -43.76 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.223 0.92 . . . . 0.67000000000000004 111.512 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.53 -34.34 78.81 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.185 -0.947 . . . . 0.68999999999999995 113.807 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 17.2 p -68.24 -43.23 78.35 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.63 -0.924 . . . . 0.88 111.691 171.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.26 76.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.083 0.856 . . . . 0.91000000000000003 112.445 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -71.08 -17.26 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.99 -1.069 . . . . 2.3199999999999998 113.605 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.1 p -72.38 -28.54 63.07 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.204 -1.56 . . . . 1.6200000000000001 112.715 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 22.9 m120 -91.14 -22.71 20.54 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.44 1.496 . . . . 3.48 112.262 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.5 t -76.42 173.64 11.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.396 1.478 . . . . 1.4399999999999999 113.72 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.38 15.11 5.56 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.85 2.06 . . . . 4.0800000000000001 112.714 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -69.35 165.94 34.8 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.212 1.805 . . . . 2.23 113.991 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.51 -23.94 0.72 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.07 2.513 . . . . 1.45 114.395 -173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.6 tt -111.76 -48.77 3.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.934 2.094 . . . . 1.02 112.554 -167.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.5 -21.35 48.88 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.489 0.956 . . . . 0.93000000000000005 115.489 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 63.4 p -66.73 -14.11 62.16 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.518 -1.578 . . . . 1.28 114.343 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.18 82.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.947 0.899 . . . . 0.78000000000000003 111.285 167.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 12.9 mt -71.99 -36.31 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.243 1.417 . . . . 0.70999999999999996 110.278 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 11.2 m -54.84 -48.29 73.04 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.907 0.776 . . . . 1.24 111.519 170.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -59.0 -49.22 78.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.819 0.736 . . . . 2.8500000000000001 111.735 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.74 -44.8 82.03 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.485 1.114 . . . . 2.3999999999999999 112.166 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.5 t -70.05 -50.6 39.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.988 0.915 . . . . 1.6699999999999999 111.763 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -56.22 -38.82 71.57 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.782 -1.199 . . . . 2.7999999999999998 112.378 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -70.05 -35.87 74.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.815 0.846 . . . . 3.0800000000000001 112.633 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -70.17 -46.38 64.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 2.0299999999999998 112.693 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.79 -30.0 62.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 1.05 113.473 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.52 45.5 26.86 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.569 1.547 . . . . 2.6800000000000002 112.062 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.2 t -147.69 146.27 29.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.686 1.365 . . . . 2.6099999999999999 114.686 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.95 19.81 19.94 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.081 1.352 . . . . 3.3900000000000001 114.317 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 80.6 p -110.6 -6.2 14.91 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.946 -1.721 . . . . 3.9900000000000002 114.138 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.3 148.77 48.1 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.02 1.328 . . . . 1.4199999999999999 113.407 -172.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 72.97 137.23 0.27 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.131 1.824 . . . . 0.97999999999999998 114.838 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 97.2 m -136.57 -41.16 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.955 1.302 . . . . 1.3999999999999999 112.474 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 7.5 t -138.97 142.88 38.36 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.239 1.415 . . . . 2.4700000000000002 114.139 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.9 mm -140.27 134.1 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 129.576 3.15 . . . . 2.25 108.206 168.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.323 0.0 OUTLIER -92.18 -14.7 28.66 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.996 1.48 . . . . 3.3999999999999999 114.996 176.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 8.1 m-85 54.33 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 129.04 2.936 . . . . 3.1400000000000001 117.631 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.98 93.08 2.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.456 1.902 . . . . 2.6800000000000002 106.272 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 4.4 m -98.94 150.14 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.269 0.628 . . . . 2.77 110.965 -170.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 31.0 t -140.36 106.41 6.59 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.102 1.361 . . . . 1.1299999999999999 109.6 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 149.9 75.8 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.188 2.592 . . . . 1.8899999999999999 112.406 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.73 -18.31 1.4 Allowed Glycine 0 CA--C 1.538 1.472 0 O-C-N 121.057 -1.027 . . . . 1.53 114.75 -171.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.7 t -115.05 -72.93 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.064 1.345 . . . . 2.2999999999999998 112.976 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 163.9 -153.15 23.4 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.312 0.96 . . . . 1.1000000000000001 113.482 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.0 tt -144.06 148.48 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.075 0.95 . . . . 1.9399999999999999 112.645 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.4 t -117.79 145.17 44.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.135 1.774 . . . . 0.56000000000000005 109.381 164.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 25.9 p -164.57 164.93 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.535 0.939 . . . . 0.72999999999999998 113.535 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -109.63 146.45 34.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 1.3200000000000001 108.629 166.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 32.8 m -123.16 153.8 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.386 1.074 . . . . 2.23 110.808 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -146.08 157.93 43.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.086 0.954 . . . . 1.05 111.903 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 128.953 2.901 . . . . 2.5699999999999998 107.97 158.392 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 117.888 2.551 . . . . 2.1299999999999999 117.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.59 124.55 27.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.585 1.554 . . . . 2.6499999999999999 110.92 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -88.75 122.74 32.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.555 1.142 . . . . 1.6399999999999999 110.733 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -135.22 141.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.254 1.021 . . . . 0.52000000000000002 112.265 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.27 145.44 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.402 1.081 . . . . 0.60999999999999999 112.465 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.7 tt -144.43 145.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.859 1.264 . . . . 0.52000000000000002 109.811 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 124.48 162.04 11.27 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.546 0.978 . . . . 1.6599999999999999 115.546 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.47 -151.63 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.057 1.743 . . . . 2.3900000000000001 113.368 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.94 -30.23 2.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 127.922 2.489 . . . . 6.1799999999999997 112.059 168.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -66.07 -37.93 87.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.908 1.231 . . . . 4.1900000000000004 112.798 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.1 -19.89 65.71 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.433 -1.417 . . . . 2.9900000000000002 112.759 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 1.7 tpp -70.07 -30.13 67.3 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.384 -0.823 . . . . 2.52 111.351 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.15 -67.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.681 1.993 . . . . 2.0600000000000001 108.093 166.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -48.47 -21.5 0.57 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 129.348 3.059 . . . . 5.5599999999999996 115.786 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -93.22 12.9 22.84 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.63 1.344 . . . . 0.93000000000000005 114.63 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.35 36.18 83.83 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 120.543 -1.348 . . . . 0.73999999999999999 114.776 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.9 mt -100.61 172.07 7.32 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.589 1.155 . . . . 0.90000000000000002 111.503 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 16.2 t -121.41 148.11 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.554 1.941 . . . . 1.6799999999999999 110.625 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.02 155.1 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.393 1.077 . . . . 1.6000000000000001 113.807 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -117.63 164.98 14.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.993 2.117 . . . . 2.9500000000000002 113.567 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 58.6 t30 -66.78 -47.04 73.39 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.926 1.454 . . . . 4.54 114.926 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.35 -43.91 98.07 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.201 0.909 . . . . 3.6400000000000001 111.34 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.9 p -72.18 -35.47 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.172 0.989 . . . . 1.23 112.647 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -68.25 -43.19 78.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.519 1.509 . . . . 1.8999999999999999 111.723 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.94 -45.04 91.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.701 0.8 . . . . 1.9399999999999999 111.325 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 35.8 t80 -64.62 -37.56 87.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.267 1.427 . . . . 2.0299999999999998 112.777 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 28.8 tpp -66.32 -51.07 61.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.809 1.244 . . . . 0.83999999999999997 111.303 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 14.9 t -66.52 -34.3 77.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.044 -0.503 . . . . 1.25 111.499 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.65 -47.22 86.47 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.529 1.059 . . . . 4.3799999999999999 113.126 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -70.86 -35.22 72.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.591 0.96 . . . . 2.3199999999999998 113.591 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.26 -42.32 96.54 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.367 0.985 . . . . 2.96 112.439 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -70.14 -25.99 63.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.667 1.587 . . . . 4.7999999999999998 113.583 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -81.22 8.22 9.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.929 1.085 . . . . 2.8700000000000001 113.929 167.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 91.07 -5.43 81.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.175 2.321 . . . . 1.72 116.153 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.63 162.41 14.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 3.6600000000000001 111.603 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 18.7 m -76.03 119.24 19.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.792 0.837 . . . . 1.1100000000000001 110.234 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -119.37 115.86 24.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 0.75 109.638 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.89 157.51 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.323 1.049 . . . . 0.84999999999999998 113.224 -170.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -112.77 162.77 15.38 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.418 1.087 . . . . 0.81000000000000005 113.214 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 2.8 p -132.37 122.89 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.367 1.467 . . . . 2.1899999999999999 112.042 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -113.95 152.61 30.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.54 1.936 . . . . 0.64000000000000001 110.941 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 21.2 m -149.05 120.24 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.646 1.179 . . . . 0.89000000000000001 111.118 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 20.4 t70 41.75 52.13 4.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.469 1.508 . . . . 3.2999999999999998 112.683 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.258 6.6 m-20 65.38 22.87 12.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.88 2.178 . . . . 1.4399999999999999 116.88 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -129.13 151.5 49.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.455 1.502 . . . . 2.7799999999999998 110.774 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 145.42 48.4 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.757 -1.215 . . . . 0.67000000000000004 111.965 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -122.61 -35.4 3.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.829 1.048 . . . . 0.44 113.829 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.82 36.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.114 0.87 . . . . 0.44 115.012 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.71 155.28 44.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.679 1.592 . . . . 0.70999999999999996 112.943 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.83 136.22 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.388 1.475 . . . . 0.71999999999999997 109.593 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -106.02 130.5 53.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.922 1.289 . . . . 0.81999999999999995 109.554 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.85 130.72 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 1.3200000000000001 108.162 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 114.337 1.236 . . . . 3.0800000000000001 114.337 -175.385 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.008 -0.52 . . . . 2.5800000000000001 109.952 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.39 146.02 73.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.631 2.221 . . . . 1.4199999999999999 112.02 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.0 p -133.16 126.61 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.471 1.508 . . . . 2.9199999999999999 108.276 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.4 p -71.0 123.98 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.667 -1.27 . . . . 1.5 109.239 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -96.49 -41.63 8.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.985 1.314 . . . . 3.2400000000000002 112.547 -167.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -159.28 156.82 29.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.16 1.384 . . . . 1.96 110.99 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 6.5 m -131.23 143.89 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 1.02 110.587 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 50.6 tttt -129.33 140.74 51.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.91 1.284 . . . . 1.8899999999999999 110.753 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 47.4 t -77.86 142.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.653 -0.869 . . . . 0.83999999999999997 108.653 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.45 -38.96 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.862 1.265 . . . . 1.3600000000000001 111.376 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 74.2 m -100.45 92.37 5.12 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 106.447 -1.686 . . . . 1.9399999999999999 106.447 168.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.26 123.12 33.78 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.636 -0.665 . . . . 4.4400000000000004 111.901 -170.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 40.6 m 51.54 39.23 24.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.422 1.638 . . . . 2.9100000000000001 115.422 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -141.53 -8.15 0.98 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.685 1.735 . . . . 2.96 115.685 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -144.97 -65.45 0.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.573 1.533 . . . . 4.2400000000000002 112.613 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.3 142.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.922 2.089 . . . . 1.48 110.063 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 47.4 m -98.95 152.88 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 1.8200000000000001 113.283 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -38.49 51.76 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.515 2.043 . . . . 4.0 116.515 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.1 t60 -68.95 -34.07 74.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.52 1.054 . . . . 2.5499999999999998 111.729 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.75 -36.51 65.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.17 -0.919 . . . . 2.5299999999999998 112.004 173.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.08 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.27 0.941 . . . . 0.75 110.729 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -69.68 -32.54 71.23 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.3 -0.875 . . . . 0.82999999999999996 112.209 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -62.29 -50.7 70.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.259 0.624 . . . . 0.59999999999999998 112.114 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.85 -36.45 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.514 1.052 . . . . 0.58999999999999997 113.189 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 70.7 t -70.42 -44.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 118.893 0.77 . . . . 0.82999999999999996 111.057 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.86 95.85 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.29 -0.881 . . . . 0.71999999999999997 113.431 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.3 p -75.14 -30.01 60.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.0 0.92 . . . . 0.64000000000000001 113.382 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.53 66.18 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.91 0.777 . . . . 0.69999999999999996 111.715 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.87 -18.74 65.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.463 0.912 . . . . 2.1299999999999999 113.463 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 13.6 t -58.12 -22.31 50.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.945 1.298 . . . . 1.3899999999999999 114.263 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -103.74 -2.3 26.66 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.882 1.273 . . . . 1.8999999999999999 113.978 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 16.0 t -86.23 171.76 11.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 1.8300000000000001 113.804 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -3.65 14.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.161 1.784 . . . . 5.9500000000000002 113.746 170.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 153.09 93.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.694 1.197 . . . . 2.0600000000000001 113.878 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -39.83 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.197 2.598 . . . . 1.1299999999999999 113.455 -173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.51 -51.35 5.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.303 0.853 . . . . 0.76000000000000001 113.303 -166.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -65.93 -28.34 73.57 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 114.555 0.582 . . . . 0.92000000000000004 114.555 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 27.3 p -66.27 -13.06 59.84 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.856 -1.379 . . . . 1.73 113.933 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.21 67.91 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.93 -1.106 . . . . 0.84999999999999998 111.032 167.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 16.6 mt -69.85 -35.17 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.622 1.169 . . . . 0.88 109.973 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 88.3 m -54.71 -50.32 68.6 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.705 -0.622 . . . . 1.1699999999999999 111.677 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 69.8 tttt -61.14 -46.31 91.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.68 -0.676 . . . . 1.97 111.875 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 30.9 t80 -55.33 -45.66 76.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.876 0.87 . . . . 1.98 112.547 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 53.7 t -63.35 -54.63 33.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.465 1.106 . . . . 1.97 111.76 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -40.64 67.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.798 1.239 . . . . 3.5499999999999998 112.437 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -73.18 -34.9 66.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.717 1.607 . . . . 3.0600000000000001 113.888 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.97 -43.44 87.84 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.647 -1.283 . . . . 2.3599999999999999 111.32 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.3 0.23 10.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.013 1.325 . . . . 1.21 113.765 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 29.0 t70 46.89 43.41 13.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.473 1.909 . . . . 2.7000000000000002 113.17 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.9 t -132.83 -175.21 3.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.086 0.954 . . . . 3.6699999999999999 113.148 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -123.58 -4.58 8.22 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.721 2.008 . . . . 3.5 112.182 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.1 t -151.47 144.95 24.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.358 1.863 . . . . 2.9399999999999999 112.373 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.25 167.62 23.68 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.849 2.46 . . . . 1.1599999999999999 110.761 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 67.25 168.89 3.81 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.839 1.496 . . . . 1.1200000000000001 116.839 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.2 m -149.09 -54.58 0.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.228 1.411 . . . . 1.4199999999999999 113.495 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 16.6 t -134.65 143.35 47.22 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.494 1.517 . . . . 1.3500000000000001 112.15 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 11.2 tp -139.56 149.04 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.261 3.425 . . . . 2.5 107.658 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -141.62 66.29 1.36 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.428 1.091 . . . . 4.2999999999999998 109.279 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.62 149.4 26.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.132 1.901 . . . . 2.4199999999999999 116.132 -168.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -114.34 113.35 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.85 2.06 . . . . 2.4900000000000002 107.717 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 90.1 t -98.19 124.03 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.024 1.33 . . . . 2.3500000000000001 110.777 -169.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 56.4 t -139.51 98.08 8.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.816 1.647 . . . . 1.72 106.899 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -59.28 130.55 36.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.728 2.286 . . . . 1.8899999999999999 113.519 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 74.61 26.99 66.16 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.308 -0.718 . . . . 1.8400000000000001 114.801 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.8 t -135.44 -43.47 0.69 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.811 1.306 . . . . 2.1899999999999999 113.745 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 151.36 -161.47 29.17 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.893 -1.13 . . . . 1.02 113.919 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' 1119 ' ' ILE . 1.7 mm -140.14 145.77 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.811 1.644 . . . . 2.5099999999999998 110.226 169.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 47.3 t -133.43 136.35 45.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.266 1.026 . . . . 0.63 109.368 165.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.8 p -154.15 168.89 25.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.742 1.016 . . . . 0.60999999999999999 113.742 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -109.88 141.44 42.59 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 4.7 p -143.11 138.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.335 0.97 . . . . 1.8999999999999999 112.827 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.4 157.73 45.65 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.698 0.761 . . . . 1.5600000000000001 112.542 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 128.678 2.791 . . . . 3.27 108.895 162.694 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 113.473 0.916 . . . . 2.9700000000000002 113.473 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.57 123.79 12.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.743 1.217 . . . . 2.8399999999999999 110.55 -168.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.9 116.25 28.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.106 0.962 . . . . 2.0 108.624 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.8 m -135.4 141.6 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.127 0.876 . . . . 0.53000000000000003 112.823 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.35 152.35 40.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.823 1.045 . . . . 0.46999999999999997 113.823 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -152.13 135.91 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.967 1.707 . . . . 0.65000000000000002 110.077 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 162.79 -151.68 21.57 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.962 1.545 . . . . 1.23 116.962 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.42 150.63 3.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.333 2.653 . . . . 2.6600000000000001 112.912 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -61.6 -33.37 73.78 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.504 0.927 . . . . 4.9800000000000004 113.504 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.98 -31.44 69.91 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.776 1.171 . . . . 4.2300000000000004 113.082 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -69.3 -19.79 63.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.382 -1.449 . . . . 3.2200000000000002 112.935 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.4 mmt -67.66 -30.73 70.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.092 -1.005 . . . . 2.5699999999999998 111.42 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.7 mt -71.43 -65.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.108 1.763 . . . . 2.27 109.28 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.17 -32.86 4.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.798 2.039 . . . . 4.6799999999999997 115.702 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.99 12.53 6.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.509 1.05 . . . . 0.88 113.828 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.62 31.6 58.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.377 -1.452 . . . . 1.1799999999999999 115.289 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.33 -161.73 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.914 1.286 . . . . 1.6399999999999999 110.891 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 21.8 t -136.8 136.39 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.192 1.797 . . . . 1.22 110.202 170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.1 tt -125.93 138.63 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.764 1.226 . . . . 1.3100000000000001 111.485 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.39 168.52 12.91 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.825 1.787 . . . . 3.6899999999999999 115.825 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.27 -25.33 61.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.841 1.656 . . . . 2.5699999999999998 115.372 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.51 -40.89 41.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.089 1.313 . . . . 2.7000000000000002 113.302 -176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -73.61 -33.71 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.481 0.582 . . . . 0.94999999999999996 111.41 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -56.94 -43.35 81.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.001 0.92 . . . . 2.3100000000000001 112.081 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.48 -49.93 75.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.169 0.987 . . . . 2.6000000000000001 113.506 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 33.2 t80 -70.25 -36.61 74.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 2.0099999999999998 112.258 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -61.19 -60.79 3.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.141 1.776 . . . . 1.1399999999999999 110.792 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.1 t -66.27 -31.47 72.29 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.896 -0.503 . . . . 1.1899999999999999 112.244 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -59.99 -49.93 75.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.191 0.997 . . . . 2.7400000000000002 112.052 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -68.73 -30.88 69.61 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.764 -0.585 . . . . 3.0600000000000001 112.136 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -65.29 -42.29 93.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.308 1.043 . . . . 2.8399999999999999 112.769 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -66.81 -30.17 70.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 120.855 -1.153 . . . . 3.3399999999999999 113.567 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 19.2 mttp -70.52 -2.93 15.58 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.556 1.942 . . . . 2.5099999999999998 113.566 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 90.63 20.73 39.53 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.0 1.285 . . . . 2.0699999999999998 115.162 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.08 148.58 33.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.749 1.62 . . . . 4.0999999999999996 110.616 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 94.1 m -78.34 137.64 38.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.049 1.34 . . . . 0.79000000000000004 111.063 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -139.22 124.79 19.4 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.096 0.776 . . . . 0.66000000000000003 113.096 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.69 159.11 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.536 1.534 . . . . 0.66000000000000003 113.18 -171.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.64 160.14 16.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.687 1.195 . . . . 0.78000000000000003 112.574 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.5 t -130.86 122.95 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.078 1.751 . . . . 1.6399999999999999 111.608 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.93 151.78 39.29 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.446 1.499 . . . . 0.63 110.621 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.5 m -143.33 118.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.162 1.385 . . . . 0.73999999999999999 112.254 -170.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 30.7 t0 42.07 50.08 4.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.848 2.459 . . . . 3.21 112.942 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.301 2.2 m-20 62.7 38.44 11.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.637 2.375 . . . . 2.3300000000000001 116.182 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -143.33 147.86 35.39 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.285 1.434 . . . . 3.8300000000000001 109.861 167.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.76 151.52 43.47 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.276 -1.515 . . . . 1.3400000000000001 113.267 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 31.3 p -130.51 -47.82 1.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.412 1.264 . . . . 0.63 114.412 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.97 -175.56 36.5 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 120.662 1.574 . . . . 0.48999999999999999 115.884 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.47 155.15 44.28 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.231 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.91 135.09 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.905 1.682 . . . . 0.93000000000000005 109.955 -172.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -115.05 133.29 56.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.515 1.526 . . . . 0.65000000000000002 109.859 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.05 143.17 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.814 2.045 . . . . 1.53 110.285 -169.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 126.128 1.771 . . . . 1.75 111.343 177.476 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 112.197 0.443 . . . . 3.3700000000000001 112.197 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.47 138.78 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.968 2.445 . . . . 1.6399999999999999 112.062 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 14.5 p -144.25 123.06 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.002 0.921 . . . . 2.2599999999999998 111.945 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.6 p -72.53 139.58 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.512 -1.368 . . . . 1.05 111.138 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.36 -41.16 1.91 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.333 1.975 . . . . 2.4399999999999999 116.333 -165.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -150.64 154.85 38.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.392 1.477 . . . . 2.3900000000000001 110.967 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.7 m -134.91 136.05 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.185 0.994 . . . . 0.82999999999999996 111.153 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.9 tttt -141.02 140.12 34.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.331 1.234 . . . . 1.6599999999999999 114.331 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 41.2 t -85.6 143.66 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.251 1.42 . . . . 0.73999999999999999 110.224 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . 0.402 HD11 HD21 ' A' 1196 ' ' ASN . 31.1 tp -114.76 -25.07 8.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.04 1.736 . . . . 0.85999999999999999 113.275 173.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 93.0 m -126.03 67.22 1.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.474 1.509 . . . . 1.6899999999999999 111.23 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.19 130.33 38.07 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.733 -1.229 . . . . 3.8500000000000001 112.438 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 23.2 m 64.03 -18.62 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.608 2.077 . . . . 2.5600000000000001 116.608 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 30.7 m120 -87.05 -15.99 36.97 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.787 1.176 . . . . 3.2799999999999998 113.646 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 -95.66 0.14 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.388 1.075 . . . . 5.1399999999999997 110.48 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.38 133.16 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.474 1.51 . . . . 1.75 111.141 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 66.7 m -98.17 164.24 12.41 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.642 1.577 . . . . 2.04 113.291 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -43.04 -56.01 3.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.513 1.925 . . . . 5.21 116.103 -169.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 47.7 m170 -64.74 -30.82 71.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.969 0.804 . . . . 3.8999999999999999 112.702 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 44.6 mttp -77.56 -38.14 49.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 118.123 -0.942 . . . . 2.6000000000000001 111.97 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.05 -52.48 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.488 1.04 . . . . 0.68000000000000005 110.844 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.76 -28.15 66.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.673 -0.642 . . . . 0.56000000000000005 112.427 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.2 -47.89 59.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.828 -0.605 . . . . 0.60999999999999999 112.598 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.6 pt -69.62 -32.62 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.53 1.514 . . . . 0.57999999999999996 112.901 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.2 t -70.88 -45.58 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.813 0.733 . . . . 0.69999999999999996 111.376 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -69.17 -36.26 79.41 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.975 -1.078 . . . . 0.70999999999999996 114.009 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 35.8 p -69.15 -34.38 74.89 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.413 -1.051 . . . . 0.76000000000000001 111.794 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.2 91.21 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.765 0.711 . . . . 0.76000000000000001 112.56 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.16 -21.97 62.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.956 1.095 . . . . 3.75 113.956 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.0 t -55.88 -42.13 75.45 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.863 -1.148 . . . . 1.6599999999999999 112.258 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.54 -23.1 40.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.567 0.951 . . . . 2.1899999999999999 113.567 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 27.0 m -89.47 160.61 16.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.057 1.132 . . . . 2.5600000000000001 114.057 -167.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -122.73 18.71 10.29 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.668 1.587 . . . . 5.3899999999999997 113.225 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 143.29 91.56 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.753 1.221 . . . . 1.51 112.132 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.55 -45.52 1.14 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.316 2.677 . . . . 1.28 114.356 -169.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.37 -34.23 72.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.297 -0.877 . . . . 0.93999999999999995 111.069 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -61.16 -20.33 58.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.135 1.35 . . . . 1.8100000000000001 115.545 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 66.7 p -59.49 -37.98 79.68 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.019 1.409 . . . . 2.8199999999999998 112.184 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.55 -36.39 80.87 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.49 -0.756 . . . . 1.2 112.407 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.8 mt -70.78 -36.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.054 -1.029 . . . . 1.5 111.023 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.3 m -55.14 -51.79 65.34 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.168 0.987 . . . . 1.9299999999999999 110.438 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.5 tttt -54.44 -55.23 30.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.181 0.992 . . . . 3.5699999999999998 111.574 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -57.72 -45.85 85.22 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.321 0.648 . . . . 1.8999999999999999 112.636 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 37.3 t -66.82 -54.15 25.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.243 0.617 . . . . 1.6699999999999999 111.4 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -43.07 75.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.238 1.015 . . . . 2.8500000000000001 110.756 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.34 -44.54 87.42 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.972 0.73 . . . . 3.0499999999999998 112.972 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -67.11 -38.7 86.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.535 1.062 . . . . 2.79 113.303 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.35 -19.87 60.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.621 1.168 . . . . 1.3500000000000001 113.107 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 8.8 t70 64.47 15.66 9.71 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.593 2.357 . . . . 3.3100000000000001 114.221 -170.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 2.6 t -130.52 147.1 52.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.816 1.646 . . . . 3.1200000000000001 115.249 -169.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.11 -12.67 43.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.559 1.144 . . . . 3.5099999999999998 111.858 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 35.6 p -73.43 26.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.397 1.999 . . . . 4.7000000000000002 116.397 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.74 29.07 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.532 1.533 . . . . 1.55 114.659 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 78.24 145.07 2.55 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.656 1.598 . . . . 1.1100000000000001 116.989 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -141.42 -63.34 0.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.964 1.705 . . . . 1.4099999999999999 113.392 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 41.4 t -136.54 141.51 43.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.181 1.355 . . . . 1.5 112.443 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.1 mm -141.93 140.19 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 132.18 4.192 . . . . 2.0699999999999998 109.389 -170.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.8 t0 -111.72 104.17 12.5 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.905 -1.887 . . . . 2.5699999999999998 105.905 165.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' 1119 ' ' ILE . 32.9 t80 -88.54 133.15 34.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.931 1.292 . . . . 3.2599999999999998 114.436 -165.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . 0.458 HE21 ' HB2' ' A' 1112 ' ' GLN . 0.7 OUTLIER -139.34 120.7 14.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.304 1.842 . . . . 2.1099999999999999 110.993 175.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 44.3 t -104.34 140.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.97 1.308 . . . . 2.3199999999999998 111.68 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 51.7 t -126.33 111.94 23.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.029 0.932 . . . . 1.51 109.188 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.19 143.08 93.93 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.313 2.675 . . . . 1.79 113.634 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.38 15.15 65.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.947 1.26 . . . . 2.0600000000000001 113.696 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 73.4 m -134.34 -87.32 0.39 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.86 1.664 . . . . 1.9099999999999999 111.39 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 172.99 -151.37 13.78 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.937 0.779 . . . . 0.90000000000000002 112.455 -172.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' 1111 ' ' PHE . 0.1 OUTLIER -134.26 146.32 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.265 1.026 . . . . 2.2000000000000002 111.893 -173.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.8 t -134.24 144.18 48.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.857 1.663 . . . . 0.72999999999999998 111.259 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.8 p -158.04 172.38 18.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.549 1.685 . . . . 0.62 115.549 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -114.64 120.81 41.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.252 1.421 . . . . 1.1200000000000001 107.453 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 12.0 p -128.76 134.52 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 115.033 1.494 . . . . 1.8600000000000001 115.033 -167.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . 0.427 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.4 t -133.81 161.34 35.01 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 123.242 1.496 . . . . 1.73 114.276 169.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 130.233 3.413 . . . . 2.6000000000000001 108.289 160.354 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' 1124 ' ' THR . 28.1 mt-30 . . . . . 0 CA--C 1.536 0.406 0 CA-C-O 121.459 0.647 . . . . 3.5099999999999998 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.54 133.38 53.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.937 1.695 . . . . 2.5499999999999998 110.781 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.13 116.19 27.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.798 0.726 . . . . 1.55 111.767 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.7 m -137.47 144.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.083 0.953 . . . . 0.59999999999999998 113.067 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.08 152.54 46.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.844 1.258 . . . . 0.59999999999999998 113.492 171.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.3 tt -149.18 139.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.432 1.493 . . . . 0.79000000000000004 110.352 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 131.18 150.16 6.66 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.156 0.884 . . . . 1.6399999999999999 115.09 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 49.29 -155.98 0.09 Allowed 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 126.103 1.761 . . . . 2.3399999999999999 113.931 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -140.08 -37.46 0.47 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.47 2.396 . . . . 6.4199999999999999 117.47 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.33 -30.67 69.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.568 1.531 . . . . 3.9900000000000002 110.703 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -55.45 -34.32 64.38 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.192 -0.942 . . . . 2.8399999999999999 113.465 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -35.03 77.78 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.745 1.017 . . . . 2.0299999999999998 113.745 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.68 -60.39 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.986 -1.116 . . . . 1.8700000000000001 107.986 168.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.19 -27.04 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.835 2.054 . . . . 6.4199999999999999 115.687 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.85 16.07 1.25 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.892 1.678 . . . . 1.0700000000000001 112.498 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.73 16.05 67.42 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 119.797 -1.814 . . . . 1.22 116.07 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.59 174.23 10.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.393 1.597 . . . . 0.93999999999999995 111.911 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.2 t -115.8 130.98 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.664 1.186 . . . . 1.3600000000000001 109.309 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.69 127.77 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.867 1.267 . . . . 1.21 110.011 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . 0.402 HD21 HD11 ' A' 1062 ' ' LEU 0.253 8.9 p30 -89.41 158.3 17.8 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.99 1.107 . . . . 3.8399999999999999 113.99 -176.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 64.6 t30 -62.6 -23.71 67.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.954 1.302 . . . . 2.71 114.344 -170.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.21 -43.37 42.65 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.708 -1.245 . . . . 3.7999999999999998 112.907 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 3.3 p -75.6 -31.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 125.303 1.441 . . . . 0.97999999999999998 110.985 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -52.87 -50.59 63.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.987 1.267 . . . . 3.8199999999999998 111.213 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.32 -44.93 80.43 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.206 0.447 . . . . 2.1699999999999999 112.206 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.7 t80 -71.57 -36.01 70.78 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.62 0.97 . . . . 2.2400000000000002 113.62 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.7 tpp -63.22 -50.92 68.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.201 1.401 . . . . 0.83999999999999997 111.077 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.2 t -69.93 -33.25 71.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.012 -0.43 . . . . 0.91000000000000003 111.718 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.66 -46.8 87.96 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.731 -1.231 . . . . 4.1200000000000001 112.889 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -71.16 -37.03 72.22 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.249 1.203 . . . . 2.1899999999999999 114.249 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 43.3 mm-40 -62.28 -37.46 85.59 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.108 -0.995 . . . . 3.6899999999999999 112.21 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -72.73 -24.33 60.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.31 1.844 . . . . 3.77 114.961 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 77.6 mttt -66.39 -6.85 15.83 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.627 1.171 . . . . 3.4300000000000002 114.128 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.64 19.98 35.93 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.854 1.692 . . . . 1.1699999999999999 113.092 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -118.67 178.36 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.531 1.532 . . . . 3.29 111.994 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 3.4 m -100.4 120.97 40.78 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.771 1.629 . . . . 1.1599999999999999 110.246 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . 0.59 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -116.84 119.65 36.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.014 1.325 . . . . 0.65000000000000002 110.098 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.2 m -136.34 153.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.431 0.9 . . . . 0.45000000000000001 113.431 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.17 166.01 10.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.133 0.973 . . . . 0.81999999999999995 112.794 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 11.6 t -131.71 125.86 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.003 2.121 . . . . 1.6000000000000001 110.026 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -130.13 156.64 44.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.612 1.165 . . . . 0.5 111.81 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.3 m -144.74 120.11 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.839 1.655 . . . . 1.1699999999999999 111.689 -169.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 23.3 t70 44.65 47.28 8.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.109 1.364 . . . . 4.1500000000000004 113.316 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 60.79 42.15 13.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.039 -1.663 . . . . 1.99 115.023 -174.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.93 141.52 30.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.686 1.595 . . . . 2.1899999999999999 110.561 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.71 137.44 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.108 -1.62 . . . . 0.76000000000000001 112.852 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.0 p -115.01 -40.96 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.097 0.959 . . . . 0.62 112.719 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -168.13 -174.02 36.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.656 1.116 . . . . 0.55000000000000004 115.384 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.37 155.71 43.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.402 1.881 . . . . 0.79000000000000004 112.702 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.9 mm -129.76 140.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.382 1.473 . . . . 0.81000000000000005 110.526 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -113.07 130.12 56.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.094 1.758 . . . . 0.56999999999999995 110.36 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.14 157.7 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.846 2.059 . . . . 1.4099999999999999 109.598 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 126.268 1.827 . . . . 1.5600000000000001 111.956 177.034 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 112.631 0.604 . . . . 2.8999999999999999 112.631 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.92 130.02 24.82 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.691 2.928 . . . . 1.51 112.961 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 96.7 t -105.5 124.22 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.187 1.795 . . . . 2.46 109.648 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.4 121.68 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.046 0.839 . . . . 1.29 110.915 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.26 -47.69 3.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.502 0.721 . . . . 3.3799999999999999 112.82 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -151.49 149.25 29.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.79 1.636 . . . . 2.6099999999999999 111.713 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 12.3 m -125.52 139.78 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.178 0.991 . . . . 0.87 110.402 168.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.1 tttt -141.99 148.48 38.62 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.048 0.759 . . . . 2.3199999999999998 113.048 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 73.9 t -106.61 145.01 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.191 1.397 . . . . 1.1200000000000001 111.31 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.95 -25.04 10.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.559 1.544 . . . . 0.83999999999999997 113.44 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 9.9 t -93.94 162.09 14.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.824 2.05 . . . . 3.0600000000000001 112.813 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -146.46 116.02 7.15 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.619 -1.301 . . . . 5.3600000000000003 110.32 167.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 63.4 m 51.67 33.75 11.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.525 2.046 . . . . 2.9900000000000002 116.525 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 28.2 m120 -126.97 -30.89 2.67 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.463 1.283 . . . . 3.6099999999999999 114.463 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 113.52 2.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.713 1.605 . . . . 5.9800000000000004 108.649 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.3 mm 66.17 133.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 127.55 2.34 . . . . 2.02 114.725 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 67.0 m -81.5 151.11 27.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.985 1.314 . . . . 2.6699999999999999 113.099 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 61.9 m80 -53.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.598 1.703 . . . . 6.6100000000000003 115.598 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 43.3 t60 -74.96 -29.45 60.92 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.726 -1.234 . . . . 2.5299999999999998 111.695 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.47 -36.69 81.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.84 -1.163 . . . . 2.7999999999999998 111.804 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 98.0 mt -56.62 -53.86 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.117 . . . . 0.88 109.668 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.7 76.53 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.238 0.926 . . . . 0.71999999999999997 112.367 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.58 -46.17 76.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.105 0.779 . . . . 0.66000000000000003 113.105 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.71 -35.39 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.232 1.378 . . . . 0.66000000000000003 112.815 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 59.8 t -70.52 -46.61 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.754 0.706 . . . . 0.83999999999999997 111.381 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.53 91.45 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.43 -0.794 . . . . 0.75 113.642 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.3 p -73.95 -34.31 64.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.181 0.808 . . . . 0.87 113.181 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.35 90.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.434 0.901 . . . . 0.76000000000000001 113.434 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.31 -11.73 60.83 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.673 0.99 . . . . 2.0699999999999998 113.673 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.5 t -62.47 -19.21 63.32 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.587 -1.321 . . . . 1.3 113.6 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -107.43 0.25 22.76 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.203 1.401 . . . . 1.96 113.379 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 69.4 m -101.28 167.46 10.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.271 1.211 . . . . 2.1299999999999999 114.271 -169.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.83 54.72 1.21 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.312 1.845 . . . . 3.6600000000000001 111.572 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.03 69.09 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.52 1.528 . . . . 2.0099999999999998 112.66 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.33 -17.22 9.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.961 3.107 . . . . 1.0 116.285 -167.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.82 -50.91 2.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.575 0.954 . . . . 0.82999999999999996 113.575 -166.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.61 67.4 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-O 121.531 0.517 . . . . 0.98999999999999999 113.557 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 32.0 p -63.68 -22.76 67.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.114 1.366 . . . . 1.77 113.337 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.22 69.1 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.701 -1.25 . . . . 0.85999999999999999 111.702 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.68 -35.75 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.973 0.909 . . . . 0.95999999999999996 110.077 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 34.3 m -57.1 -48.08 79.47 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.247 0.93 . . . . 1.3100000000000001 110.93 168.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -54.81 -51.32 66.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.303 1.041 . . . . 3.9199999999999999 112.036 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.01 -44.39 91.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.331 1.052 . . . . 1.77 111.496 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 48.9 t -65.93 -49.7 67.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.266 1.026 . . . . 1.8500000000000001 111.93 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.88 -33.04 74.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 2.9199999999999999 111.446 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.8 -41.12 72.04 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.784 1.234 . . . . 3.1699999999999999 113.524 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -69.61 -40.49 76.57 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.944 1.247 . . . . 2.0 113.359 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.07 -20.22 61.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.673 1.189 . . . . 1.1599999999999999 113.351 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.2 t0 54.14 42.36 31.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.687 1.195 . . . . 2.3399999999999999 112.498 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.1 t -125.85 165.97 17.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.261 1.824 . . . . 2.6299999999999999 111.086 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -100.01 -11.13 20.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.942 1.297 . . . . 3.1200000000000001 113.885 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 9.9 t -148.15 135.12 20.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.843 1.257 . . . . 2.8799999999999999 111.551 -172.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -158.22 149.48 21.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.764 1.226 . . . . 0.84999999999999998 112.476 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 69.88 142.94 0.18 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.032 1.301 . . . . 1.03 115.244 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 19.0 m -112.01 -80.03 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.653 1.581 . . . . 1.45 112.125 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 44.5 t -135.39 136.75 41.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.92 1.288 . . . . 1.3500000000000001 111.279 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.4 mp -141.09 149.78 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.275 3.83 . . . . 3.1400000000000001 107.056 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 31.5 t70 -137.03 109.01 7.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.896 1.278 . . . . 3.3399999999999999 109.348 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -97.35 135.07 39.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.198 1.925 . . . . 2.8799999999999999 116.198 -171.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.1 26.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.637 2.775 . . . . 3.0499999999999998 107.12 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.4 m -112.49 142.57 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 115.092 1.515 . . . . 2.46 115.092 -167.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.77 131.23 14.63 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.321 1.449 . . . . 1.1499999999999999 109.39 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.4 130.88 21.96 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.784 2.322 . . . . 1.71 111.862 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.74 -41.53 0.69 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.722 2.106 . . . . 2.2000000000000002 115.148 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -78.75 10.97 2.85 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.636 2.087 . . . . 2.5699999999999998 116.636 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 85.98 171.79 48.23 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 119.093 0.86 . . . . 1.24 113.249 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.4 pt -136.12 165.51 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.665 1.186 . . . . 2.98 111.868 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.2 t -127.14 152.37 47.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.333 1.053 . . . . 0.56000000000000005 112.112 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 23.1 p -144.35 169.68 17.46 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.028 -1.045 . . . . 0.68999999999999995 113.258 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -118.51 119.94 36.05 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.578 -1.267 . . . . 1.7 107.578 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.1 p -127.09 136.78 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.846 1.054 . . . . 1.8999999999999999 113.846 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . 0.495 ' HB ' HE21 ' A' 1177 ' ' GLN . 5.3 t -119.76 150.11 40.93 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.445 0.906 . . . . 1.0600000000000001 113.445 168.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 . . . . . 0 CA--C 1.551 1.011 0 C-N-CA 128.459 2.704 . . . . 2.6800000000000002 108.463 158.601 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . 0.495 HE21 ' HB ' ' A' 1124 ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 111.909 0.337 . . . . 2.0299999999999998 111.909 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -131.03 129.96 42.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.808 1.643 . . . . 3.0800000000000001 112.12 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -88.42 123.51 33.04 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.595 -0.891 . . . . 1.3200000000000001 108.595 167.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.6 m -131.67 154.95 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.232 1.013 . . . . 1.0600000000000001 111.514 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.45 152.06 32.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.076 0.951 . . . . 0.56999999999999995 112.807 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.9 tt -153.85 153.07 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.048 1.339 . . . . 0.81999999999999995 110.673 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 103.03 154.55 24.64 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.98 0.767 . . . . 1.9199999999999999 114.281 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.9 t-20 54.08 -161.52 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.178 1.791 . . . . 2.1299999999999999 113.248 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -27.95 3.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.594 1.558 . . . . 6.0499999999999998 113.516 168.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.7 -48.13 73.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.534 1.061 . . . . 4.5599999999999996 113.033 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 9.7 t90 -75.92 -37.37 58.8 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.425 . . . . 3.21 112.008 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 76.3 mmm -54.68 -37.51 65.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.472 0.709 . . . . 2.8399999999999999 111.966 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.36 -66.75 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.197 1.399 . . . . 2.4199999999999999 108.954 166.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -9.97 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.623 2.369 . . . . 6.9299999999999997 116.627 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.88 21.01 0.22 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 120.298 1.408 . . . . 0.95999999999999996 112.131 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 63.88 17.65 61.03 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.27 -1.518 . . . . 1.1299999999999999 115.249 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.07 164.05 26.07 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.278 1.539 . . . . 0.92000000000000004 111.338 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 55.9 t -91.51 127.66 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.449 -0.782 . . . . 1.5600000000000001 109.007 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.68 140.02 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.822 0.849 . . . . 0.89000000000000001 111.087 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -116.8 155.77 28.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.522 1.129 . . . . 2.7000000000000002 112.437 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.62 -37.0 85.66 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.717 1.006 . . . . 2.3700000000000001 113.717 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -73.53 -37.31 65.67 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.026 0.83 . . . . 2.6899999999999999 112.672 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 -35.28 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.911 -0.566 . . . . 0.82999999999999996 111.407 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -63.33 -43.6 97.29 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.766 1.166 . . . . 1.9099999999999999 112.16 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.67 -33.23 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.404 -0.81 . . . . 2.1699999999999999 113.036 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -74.06 -36.81 64.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.046 . . . . 2.4300000000000002 113.529 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.2 tpp -64.38 -52.61 57.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.165 1.386 . . . . 0.89000000000000001 111.139 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 7.0 t -65.23 -28.98 69.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.267 1.027 . . . . 0.89000000000000001 112.687 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -57.52 -54.45 46.68 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.044 0.937 . . . . 2.6600000000000001 112.987 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -71.09 -29.92 65.9 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.921 0.341 . . . . 2.7400000000000002 111.921 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.21 -39.98 93.52 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.339 1.056 . . . . 3.6099999999999999 112.083 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -68.66 -25.61 64.9 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.705 2.402 . . . . 3.77 113.593 172.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 17.7 mttp -78.56 4.87 12.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.506 1.522 . . . . 3.02 113.09 168.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 71.81 18.4 77.44 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.441 1.496 . . . . 1.6100000000000001 112.877 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -101.89 -174.76 2.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.411 1.484 . . . . 3.6299999999999999 110.907 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.5 m -108.2 125.15 51.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.439 1.096 . . . . 0.88 111.741 -169.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.28 127.4 29.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.348 1.059 . . . . 0.58999999999999997 110.303 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.4 m -140.96 158.11 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.907 1.283 . . . . 0.47999999999999998 113.23 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.0 163.83 11.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.84 1.256 . . . . 0.93999999999999995 111.791 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.2 p -139.29 134.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.857 1.263 . . . . 2.1800000000000002 112.56 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -131.04 153.48 49.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.269 1.828 . . . . 0.40000000000000002 112.53 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.4 m -146.29 131.09 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.999 2.12 . . . . 0.69999999999999996 110.316 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.395 0.0 OUTLIER 41.29 46.17 2.72 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.335 1.854 . . . . 3.8799999999999999 114.596 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 61.03 31.31 19.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.308 2.243 . . . . 1.47 115.874 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.03 158.89 39.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.65 1.98 . . . . 2.3799999999999999 111.82 168.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 146.5 33.27 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.667 -1.271 . . . . 0.91000000000000003 112.619 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 7.6 p -118.7 -41.82 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.282 0.633 . . . . 0.53000000000000003 111.085 167.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.17 -163.24 24.85 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.798 1.181 . . . . 0.41999999999999998 115.869 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.64 153.22 43.24 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.795 2.038 . . . . 0.79000000000000004 112.57 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 25.6 mm -124.35 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.383 1.473 . . . . 0.73999999999999999 109.579 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.24 132.27 54.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.21 1.404 . . . . 0.62 110.898 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 19.1 mt -136.02 158.05 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.71 2.004 . . . . 1.3100000000000001 110.646 -168.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 C-N-CA 125.907 1.683 . . . . 1.3899999999999999 111.573 174.464 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.487 0.18 . . . . 2.2999999999999998 111.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.01 146.95 66.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.756 2.304 . . . . 1.3200000000000001 111.441 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 10.9 p -130.59 134.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.347 1.059 . . . . 2.5499999999999998 110.698 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -72.44 113.63 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.87 0.843 . . . . 1.1899999999999999 109.642 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -91.52 -40.44 11.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.466 1.106 . . . . 2.7799999999999998 111.725 -168.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -154.4 152.32 30.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.131 0.972 . . . . 1.97 112.099 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.9 m -125.65 142.62 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.943 1.297 . . . . 0.72999999999999998 111.422 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -143.45 149.35 37.47 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.925 1.083 . . . . 2.3799999999999999 113.925 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 46.3 t -96.3 143.65 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.638 1.575 . . . . 0.68000000000000005 111.614 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.3 tp -107.41 -46.15 3.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.605 1.962 . . . . 1.05 111.5 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.8 m -118.98 126.39 51.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.393 1.477 . . . . 1.73 109.115 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -150.52 138.81 20.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.857 0.463 . . . . 4.4900000000000002 111.568 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.1 m 63.67 -14.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.956 2.103 . . . . 2.9900000000000002 116.59 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -95.52 -3.25 46.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.665 1.186 . . . . 2.8799999999999999 114.145 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -157.88 -44.51 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.146 0.979 . . . . 4.21 112.987 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mm -134.12 157.65 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.61 1.964 . . . . 1.5800000000000001 110.346 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1069 ' ' SER . . . . . . . . . . . . . 71.6 m -113.5 149.84 33.74 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.019 1.727 . . . . 2.1099999999999999 112.589 172.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 21.1 p80 -55.98 -47.01 78.47 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.634 2.087 . . . . 3.5299999999999998 116.634 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -70.32 -18.01 63.09 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.531 1.06 . . . . 2.9100000000000001 111.378 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.29 -30.09 18.71 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.558 1.543 . . . . 3.7599999999999998 111.784 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 92.7 mt -58.6 -52.22 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.191 0.905 . . . . 0.68999999999999995 109.528 168.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.21 -34.13 77.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.801 -0.562 . . . . 0.63 111.645 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -59.6 -52.96 63.31 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.535 -0.745 . . . . 0.67000000000000004 112.548 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 28.3 pt -68.37 -31.01 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.94 1.246 . . . . 0.64000000000000001 113.836 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.0 t -70.37 -45.27 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.609 1.095 . . . . 0.77000000000000002 110.416 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -61.37 -41.19 99.46 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.28 -0.733 . . . . 0.65000000000000002 113.241 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1079 ' ' THR . . . . . 0.4 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 66.3 p -72.82 -37.42 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.159 0.98 . . . . 0.66000000000000003 113.541 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.13 83.27 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.023 0.829 . . . . 0.77000000000000002 112.379 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.1 -16.91 63.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.275 -0.89 . . . . 2.2599999999999998 112.763 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 -23.83 67.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.159 1.17 . . . . 1.3200000000000001 114.159 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -94.22 -13.12 26.93 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.25 -0.906 . . . . 1.8999999999999999 112.757 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.7 t -73.84 160.18 31.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.298 1.592 . . . . 1.6599999999999999 115.298 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.24 12.42 26.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.576 2.35 . . . . 5.3099999999999996 113.445 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.59 160.1 59.69 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.912 1.078 . . . . 1.54 113.912 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.85 -34.66 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.897 3.065 . . . . 1.1699999999999999 114.61 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.79 -51.67 4.79 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.853 0.861 . . . . 0.69999999999999996 113.308 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.4 -30.43 77.55 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.844 -0.217 . . . . 0.92000000000000004 113.345 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1090 ' ' THR . . . . . . . . . . . . . 29.2 p -65.19 -18.91 65.7 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.62 -1.518 . . . . 1.8600000000000001 113.557 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.66 -32.05 73.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.802 -1.186 . . . . 0.81000000000000005 111.545 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.19 -41.18 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.488 1.515 . . . . 0.84999999999999998 110.474 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1093 ' ' THR . . . . . . . . . . . . . 99.4 m -52.58 -47.99 66.51 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.892 1.223 . . . . 1.26 111.404 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.2 tttt -59.11 -50.29 74.6 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.243 0.929 . . . . 2.5800000000000001 112.284 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 76.9 t80 -58.28 -40.51 82.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.683 1.193 . . . . 2.1899999999999999 112.534 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 83.7 m -72.84 -43.19 62.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.732 1.613 . . . . 3.2599999999999998 113.032 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.93 -36.81 80.29 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.329 1.422 . . . . 2.8399999999999999 110.836 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.22 -47.39 79.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.216 1.006 . . . . 4.0 111.127 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -62.67 -44.52 96.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.884 1.22 . . . . 1.95 113.844 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.64 -18.71 62.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.322 0.86 . . . . 1.1499999999999999 113.322 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 18.3 t70 48.99 32.06 3.65 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.69 1.596 . . . . 2.3199999999999998 113.59 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -99.85 -12.35 19.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.145 1.778 . . . . 3.4399999999999999 115.344 -167.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 16.8 tt0 66.84 -19.93 0.11 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.656 2.382 . . . . 4.29 116.677 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.8 t -154.35 138.12 16.17 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.101 1.319 . . . . 3.25 113.507 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -156.62 153.78 29.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.012 1.325 . . . . 1.0600000000000001 114.449 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1106 ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 98.4 136.95 9.49 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 125.477 1.513 . . . . 1.04 114.622 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1107 ' ' THR . . . . . . . . . . . . . 25.1 m -125.94 -68.07 0.84 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.894 0.878 . . . . 1.3500000000000001 112.661 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 12.8 t -138.77 142.48 38.8 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.395 1.258 . . . . 1.4299999999999999 114.395 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.4 mm -143.82 139.44 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 130.997 3.719 . . . . 2.25 109.211 -174.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1110 ' ' ASP . . . . . 0.513 ' HB3' ' H ' ' A' 1122 ' ' LYS . 17.0 t0 -94.72 -28.06 15.5 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.524 1.53 . . . . 2.7400000000000002 114.027 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.82 97.1 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.946 2.098 . . . . 2.75 116.222 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.59 114.48 22.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.967 1.707 . . . . 2.5499999999999998 109.136 169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 92.8 t -113.71 131.33 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.445 1.498 . . . . 2.0899999999999999 111.453 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 50.7 t -133.9 118.79 14.45 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.201 1.4 . . . . 1.6200000000000001 107.602 169.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -53.42 136.62 63.82 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.214 2.609 . . . . 1.3400000000000001 113.677 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.31 -45.22 0.96 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.422 1.963 . . . . 2.1699999999999999 114.767 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 79.2 m -71.48 -5.34 32.26 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 117.369 2.359 . . . . 2.54 117.369 -167.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 110.46 -167.41 12.63 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.983 1.265 . . . . 0.67000000000000004 113.819 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 143.39 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.127 1.371 . . . . 1.8700000000000001 110.204 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.6 t -129.19 151.8 49.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.559 1.144 . . . . 0.53000000000000003 111.466 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 29.3 p -162.94 172.52 14.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.197 0.999 . . . . 0.80000000000000004 113.413 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1122 ' ' LYS . . . . . 0.513 ' H ' ' HB3' ' A' 1110 ' ' ASP . 43.0 mmtm -114.16 135.91 53.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.447 1.499 . . . . 1.22 107.191 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 35.0 m -128.6 148.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.609 0.763 . . . . 2.71 112.35 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.0 t -134.09 145.78 49.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.054 0.942 . . . . 1.23 109.68 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 CA--C 1.542 0.635 0 C-N-CA 126.233 1.813 . . . . 2.9500000000000002 108.371 159.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 122.144 0.973 . . . . 2.0800000000000001 112.937 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -126.33 134.58 51.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.955 2.502 . . . . 2.6000000000000001 109.179 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -95.04 105.9 17.85 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.855 1.262 . . . . 1.52 110.786 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -124.11 142.33 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.382 0.673 . . . . 0.90000000000000002 112.652 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.5 151.87 38.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.536 1.135 . . . . 0.51000000000000001 112.836 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.47 155.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.767 1.627 . . . . 0.67000000000000004 109.891 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 107.55 163.66 21.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.111 0.839 . . . . 1.6299999999999999 114.127 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 4.8 t-20 49.98 -155.23 0.11 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.212 1.805 . . . . 2.3999999999999999 114.013 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -130.11 -34.69 1.65 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.171 2.589 . . . . 5.0099999999999998 111.556 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.88 -32.47 51.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.159 1.17 . . . . 3.2999999999999998 114.159 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.2 t90 -72.39 -28.98 63.34 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.354 -1.466 . . . . 3.0600000000000001 111.892 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1188 ' ' MET . . . . . . . . . . . . . 6.1 tpp -57.38 -34.23 68.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.922 0.889 . . . . 2.3100000000000001 111.617 171.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.96 -66.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.554 1.942 . . . . 1.6399999999999999 109.985 168.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -55.8 -18.89 9.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 116.01 1.856 . . . . 5.5999999999999996 116.01 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.71 9.86 2.55 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 120.15 1.341 . . . . 0.81000000000000005 112.79 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 72.77 18.63 78.92 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.387 1.47 . . . . 0.98999999999999999 115.571 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.59 171.23 13.53 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.445 1.098 . . . . 0.80000000000000004 111.325 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 94.7 t -108.79 120.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.568 1.147 . . . . 1.0600000000000001 109.989 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.87 125.27 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.158 0.983 . . . . 1.1299999999999999 110.845 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -92.54 156.24 17.27 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.031 1.332 . . . . 4.1699999999999999 112.99 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -60.21 -31.36 70.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.702 1.201 . . . . 2.6299999999999999 113.45 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.45 -42.51 68.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.348 1.059 . . . . 3.0299999999999998 111.704 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 4.4 p -78.17 -35.26 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.223 0.823 . . . . 0.79000000000000004 113.223 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.8 -38.95 89.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.668 1.122 . . . . 2.3599999999999999 111.215 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -49.27 78.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.585 0.754 . . . . 1.97 112.142 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.2 -41.56 79.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.189 1.396 . . . . 2.5899999999999999 111.546 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1203 ' ' MET . . . . . . . . . . . . . 25.4 tpp -64.81 -49.29 71.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.553 1.541 . . . . 0.73999999999999999 111.811 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.4 t -74.94 -30.53 61.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.885 0.698 . . . . 0.90000000000000002 112.885 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -58.05 -53.18 61.2 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.477 -1.389 . . . . 2.5 112.629 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -71.31 -29.13 64.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.532 0.733 . . . . 3.02 112.572 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.05 -46.08 89.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.949 0.9 . . . . 4.8399999999999999 111.595 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -66.93 -29.54 69.44 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.389 1.475 . . . . 3.7999999999999998 113.625 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 23.5 mttp -65.44 -10.69 36.08 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.482 1.513 . . . . 2.6400000000000001 113.51 169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.26 29.52 10.18 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.941 1.258 . . . . 1.72 114.409 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -126.63 176.94 6.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.715 1.606 . . . . 5.5999999999999996 111.043 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1212 ' ' THR . . . . . . . . . . . . . 55.2 m -90.79 139.16 31.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.072 1.349 . . . . 0.81999999999999995 111.328 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -136.86 130.95 32.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.025 0.93 . . . . 0.47999999999999998 112.514 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 164.58 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.717 1.607 . . . . 0.45000000000000001 113.423 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.37 168.74 10.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.363 1.465 . . . . 0.78000000000000003 113.489 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.2 t -137.02 128.56 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.624 1.57 . . . . 1.6799999999999999 112.101 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.55 150.24 47.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.243 1.417 . . . . 0.5 113.259 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.32 125.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.091 1.756 . . . . 0.63 111.529 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 37.7 53.5 1.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.494 2.318 . . . . 2.7400000000000002 113.268 -173.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.275 16.3 m-20 58.85 29.29 18.62 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.369 1.989 . . . . 2.0499999999999998 116.369 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.18 151.7 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.496 1.918 . . . . 3.2200000000000002 110.091 166.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.55 145.33 34.89 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.833 -1.167 . . . . 0.70999999999999996 110.124 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -119.5 -40.55 2.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.527 -0.749 . . . . 0.44 112.892 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.27 -172.7 37.67 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 120.11 1.323 . . . . 0.38 116.222 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -138.25 152.62 48.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.264 1.826 . . . . 0.69999999999999996 112.656 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 11.1 mm -132.29 136.28 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.72999999999999998 110.242 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -109.97 136.9 48.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.311 1.444 . . . . 0.64000000000000001 110.266 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.36 143.65 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.805 1.642 . . . . 1.47 111.146 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.976 0 C-N-CA 126.518 1.927 . . . . 1.54 111.956 179.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 119.983 -0.056 . . . . 11.94 110.856 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 15.7 t80 -148.86 172.32 14.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.528 1.131 . . . . 13.0 112.5 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 14.6 t -74.44 150.84 39.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.358 1.463 . . . . 7.4500000000000002 114.141 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.6 32.02 0.16 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.068 1.747 . . . . 6.1500000000000004 112.374 172.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 49.6 m80 -79.34 -27.3 42.04 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.853 1.427 . . . . 5.4699999999999998 114.853 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -80.17 71.09 2.83 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 119.959 1.254 . . . . 2.4500000000000002 112.719 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 90.6 m -72.93 130.52 85.01 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 125.073 1.349 . . . . 2.4100000000000001 113.359 -169.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.89 149.32 3.94 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.969 3.113 . . . . 1.3200000000000001 112.923 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 3.9 m -131.52 130.24 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.728 2.011 . . . . 2.3700000000000001 111.903 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.2 p -74.8 126.44 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 O-C-N 121.396 -0.815 . . . . 1.1299999999999999 110.745 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.02 -38.29 3.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.733 1.753 . . . . 2.3399999999999999 115.733 -165.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -149.09 145.18 27.11 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.281 1.401 . . . . 2.1000000000000001 111.961 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 30.1 m -125.41 143.16 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.088 0.955 . . . . 1.21 112.786 171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 71.9 tttt -136.88 142.19 42.78 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.526 1.53 . . . . 1.9299999999999999 111.385 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 58.0 t -94.38 148.37 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.131 1.373 . . . . 0.93000000000000005 111.45 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.91 -39.09 2.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.35 1.46 . . . . 1.3600000000000001 113.682 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.4 t -81.12 29.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 119.82 1.191 . . . . 2.75 113.424 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.34 132.42 39.26 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 119.859 -1.776 . . . . 4.3700000000000001 111.634 -170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 20.8 m 61.65 -8.62 0.09 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 117.763 2.505 . . . . 2.5299999999999998 117.763 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.84 -30.86 12.91 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.397 1.628 . . . . 3.48 115.397 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 13.0 tpt85 -150.04 -66.28 0.21 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 119.658 1.117 . . . . 5.2999999999999998 112.579 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.507 HD12 HG21 ' A' 1218 ' ' VAL . 4.4 mt -128.15 140.08 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.577 1.951 . . . . 1.77 110.905 -171.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.5 m -103.15 160.27 14.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.637 1.175 . . . . 1.99 112.746 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.8 p80 -47.13 -41.41 17.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.944 1.698 . . . . 2.9500000000000002 115.466 -169.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -70.55 -42.22 71.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.071 1.348 . . . . 3.23 111.913 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -69.53 -33.23 72.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.067 -1.02 . . . . 2.9700000000000002 112.138 170.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . 0.431 HG13 HG22 ' A' 1068 ' ' ILE . 97.9 mt -58.41 -52.65 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.884 1.22 . . . . 0.79000000000000004 110.768 172.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.79 -29.96 68.43 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.402 -0.811 . . . . 0.82999999999999996 112.181 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.62 70.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.095 0.558 . . . . 0.64000000000000001 112.279 173.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 15.1 pt -70.31 -35.53 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.809 1.186 . . . . 0.72999999999999998 112.867 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 92.4 t -69.06 -45.14 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.452 1.023 . . . . 0.78000000000000003 111.006 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.8 -34.74 88.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.451 -0.78 . . . . 0.68999999999999995 113.51 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.9 p -75.9 -32.61 59.72 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.746 1.273 . . . . 0.65000000000000002 112.815 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.05 67.96 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.877 0.762 . . . . 0.72999999999999998 112.137 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.41 -21.13 62.87 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.313 -0.867 . . . . 1.9199999999999999 112.439 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.0 t -65.23 -18.51 65.37 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 120.93 -1.106 . . . . 1.48 112.566 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -117.69 -9.23 10.77 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.169 1.388 . . . . 2.5499999999999998 113.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.9 t -85.62 -174.89 5.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.409 1.484 . . . . 1.4199999999999999 112.32 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -135.82 32.13 3.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.547 1.939 . . . . 4.2599999999999998 112.703 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . 0.463 ' HB3' HN61 ' A' 1232 ' ' ATP . 2.0 m-70 -93.51 162.3 28.09 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 114.199 1.185 . . . . 1.6899999999999999 114.199 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.68 -21.55 1.36 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.052 3.168 . . . . 0.98999999999999999 114.657 -174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.6 tt -108.4 -52.48 2.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.054 1.341 . . . . 0.69999999999999996 113.383 -166.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.91 -23.59 65.83 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 114.154 0.422 . . . . 0.95999999999999996 114.154 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 12.9 p -61.44 -18.45 58.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.929 -1.336 . . . . 1.45 113.988 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.82 -35.68 81.42 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.885 -1.134 . . . . 0.83999999999999997 111.719 168.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.0 mp -72.64 -32.85 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.299 1.039 . . . . 1.3200000000000001 111.291 172.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 28.0 m -52.27 -50.81 61.39 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.798 1.181 . . . . 1.1399999999999999 111.253 170.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -61.32 -48.04 83.18 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.852 0.751 . . . . 2.71 112.647 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -55.73 -41.63 74.16 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.961 0.904 . . . . 1.76 111.735 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.1 t -67.91 -52.74 32.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.132 1.373 . . . . 2.0299999999999998 112.371 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -42.31 88.86 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.413 -1.429 . . . . 3.02 112.455 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -67.47 -31.51 71.71 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.81 1.644 . . . . 2.98 111.901 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -70.25 -50.34 40.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.501 1.046 . . . . 2.6600000000000001 112.224 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 27.4 mt -72.18 -22.72 61.25 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.484 1.29 . . . . 1.4099999999999999 114.484 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.6 t0 56.36 43.9 25.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.87 1.668 . . . . 2.7599999999999998 113.333 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.7 t -138.88 -30.8 0.74 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.175 2.287 . . . . 3.3100000000000001 117.175 -169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 61.1 tt0 64.47 -26.41 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 117.744 2.498 . . . . 4.4299999999999997 117.744 -171.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 46.9 p -84.57 45.2 1.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.446 1.898 . . . . 3.0899999999999999 114.828 -169.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.95 151.75 23.52 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.159 1.383 . . . . 0.92000000000000004 113.523 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 92.79 122.76 3.23 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 119.049 0.841 . . . . 1.1599999999999999 114.611 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . 0.632 HG22 ' H ' ' A' 1108 ' ' CYS . 74.4 m -129.3 -172.58 2.77 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.254 2.622 . . . . 2.6000000000000001 107.653 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . 0.632 ' H ' HG22 ' A' 1107 ' ' THR . 8.3 t -56.42 143.37 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 116.151 1.908 . . . . 1.54 116.151 -168.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 16.5 tt -135.11 140.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 131.523 3.929 . . . . 2.1400000000000001 106.368 -169.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.2 t0 -124.53 93.48 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.46 1.104 . . . . 3.21 108.845 172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.341 0.0 OUTLIER -97.43 166.55 11.48 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 117.412 2.375 . . . . 3.1400000000000001 117.412 -169.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -142.81 105.45 4.49 Favored 'General case' 0 CA--C 1.562 1.414 1 C-N-CA 132.332 4.253 . . . . 2.1400000000000001 107.625 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 6.3 m -109.62 151.04 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.303 -1.498 . . . . 3.0299999999999998 114.515 -170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 13.9 t -137.71 138.87 25.16 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 124.9 1.28 . . . . 1.53 110.599 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.33 132.95 28.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.647 2.231 . . . . 1.47 111.758 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.1 -34.5 0.41 Allowed Glycine 0 CA--C 1.538 1.521 0 C-N-CA 126.267 1.889 . . . . 2.1600000000000001 115.893 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -90.21 2.91 54.88 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 115.212 1.56 . . . . 2.1699999999999999 115.212 -171.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 90.98 -176.29 40.67 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.308 0.956 . . . . 0.75 114.598 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.5 pt -136.53 160.01 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.111 0.964 . . . . 2.6299999999999999 112.59 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 21.7 t -130.27 147.03 51.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.415 1.486 . . . . 0.59999999999999998 111.565 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.4 p -154.63 173.77 15.9 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.013 -1.055 . . . . 0.68000000000000005 113.003 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -115.88 111.18 20.07 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 2.6 m -103.05 127.93 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.596 1.158 . . . . 2.2999999999999998 113.432 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.3 t -109.23 159.1 17.21 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.074 0.95 . . . . 1.01 112.306 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -168.53 -42.44 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.728 2.811 . . . . 2.5499999999999998 107.786 161.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 15.4 pt -49.03 -37.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.711 2.004 . . . . 2.1699999999999999 115.845 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -150.24 45.1 0.89 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.98 1.264 . . . . 4.4299999999999997 111.253 167.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -67.11 -4.68 29.88 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.983 1.278 . . . . 3.23 114.855 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.36 -1.14 5.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.73 2.012 . . . . 3.4500000000000002 115.087 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.7 tt -86.96 -36.24 18.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.58 1.152 . . . . 4.6699999999999999 111.914 171.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 12.3 m80 64.58 115.02 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 127.163 2.185 . . . . 7.04 112.808 -173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -84.17 155.98 22.3 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.324 1.972 . . . . 12.81 116.324 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.22 121.97 36.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 106.85 -1.537 . . . . 13.07 106.85 164.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -126.42 17.62 7.61 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.507 1.123 . . . . 13.73 113.556 -168.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -78.73 111.58 14.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 119.726 -1.859 . . . . 17.219999999999999 112.651 -166.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 53.98 21.78 3.06 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 126.072 1.749 . . . . 17.449999999999999 113.27 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . 0.305 0.8 OUTLIER -63.85 -15.21 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 117.484 2.401 . . . . 18.16 117.484 -162.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -71.27 -20.31 62.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.369 1.068 . . . . 21.620000000000001 112.71 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 11.3 t0 -108.64 -42.98 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 116.988 -1.482 . . . . 20.969999999999999 111.429 168.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -35.5 98.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.553 1.941 . . . . 20.469999999999999 111.08 -170.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -89.89 140.1 29.95 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.775 0.83 . . . . 26.780000000000001 111.46 -166.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.73 -37.85 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.721 0.409 . . . . 28.600000000000001 111.776 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -169.78 116.73 0.57 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.334 1.454 . . . . 32.659999999999997 111.131 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -81.98 36.57 0.46 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.084 1.142 . . . . 31.98 114.084 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -154.04 177.46 11.04 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.456 1.902 . . . . 34.43 112.107 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 40.4 t -66.59 144.81 56.19 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.173 2.189 . . . . 39.310000000000002 114.555 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.29 -12.47 0.1 Allowed 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 118.453 2.761 . . . . 39.990000000000002 118.453 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 95.0 t -78.99 -48.63 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.502 1.501 . . . . 43.939999999999998 110.222 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -153.52 91.81 1.52 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.078 1.351 . . . . 50.350000000000001 110.099 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . 0.623 HD12 ' H ' ' A' 1150 ' ' ILE . 4.2 mp -63.65 -38.14 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.046 1.338 . . . . 46.049999999999997 110.943 -173.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.44 -22.94 67.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.69 0.996 . . . . 51.350000000000001 113.69 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -99.77 -13.02 19.44 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.599 1.559 . . . . 48.210000000000001 113.527 174.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 66.2 p -142.64 95.02 2.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.13 0.972 . . . . 44.740000000000002 112.756 -173.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 51.65 81.0 0.08 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.441 2.296 . . . . 42.43 115.692 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -76.4 68.4 2.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.436 1.094 . . . . 44.130000000000003 112.521 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -66.43 -51.99 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.126 -0.984 . . . . 39.469999999999999 110.825 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 11.9 t -136.89 172.42 13.04 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.554 1.316 . . . . 37.630000000000003 114.554 -168.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 6.5 p -64.41 -37.67 88.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 130.195 3.398 . . . . 36.780000000000001 113.973 168.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 59.5 p 61.61 148.98 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 128.832 2.853 . . . . 33.020000000000003 118.25 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 142.12 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.863 1.265 . . . . 28.949999999999999 109.442 167.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.21 0.63 6.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.781 2.141 . . . . 28.100000000000001 116.781 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 32.1 t -128.9 -31.16 2.19 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.865 1.802 . . . . 25.050000000000001 115.865 165.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 7.8 ptt? -73.53 134.65 43.86 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.204 1.82 . . . . 22.050000000000001 110.527 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 34.6 mt 67.45 -37.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 126.513 1.925 . . . . 16.0 113.912 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' 1166 ' ' ASP . 0.0 OUTLIER -62.68 138.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.574 1.95 . . . . 19.609999999999999 109.324 168.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' 1165 ' ' ILE . 14.9 t70 60.78 -20.39 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.853 2.061 . . . . 14.99 116.094 -169.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -54.92 -27.05 40.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.81 1.644 . . . . 10.380000000000001 114.787 -171.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.36 -25.16 14.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.294 1.438 . . . . 11.01 113.443 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 63.4 mt -80.56 -50.27 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.768 1.227 . . . . 9.7200000000000006 109.308 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 38.3 p -66.26 -28.09 68.45 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.951 0.352 . . . . 7.8200000000000003 111.951 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -60.99 -57.92 10.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.858 0.863 . . . . 5.6200000000000001 110.005 168.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.91 85.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.927 1.455 . . . . 4.1600000000000001 114.927 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.24 -15.94 61.93 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.66 0.985 . . . . 6.2699999999999996 113.66 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.18 -46.28 5.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.108 0.867 . . . . 4.7800000000000002 111.418 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -78.08 57.7 1.85 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.478 1.911 . . . . 3.4100000000000001 110.472 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . 0.329 28.7 mt-30 -50.95 139.54 17.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 124.067 1.889 . . . . 3.7400000000000002 114.915 -166.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -148.8 168.44 22.94 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 111.557 -2.565 . . . . 2.98 114.635 -159.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 119.25 10.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.898 0.879 . . . . 3.3399999999999999 112.365 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.29 117.29 18.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.23 . . . . 1.2 110.686 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -135.29 144.07 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 0.55000000000000004 112.198 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.26 154.59 42.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.895 1.278 . . . . 0.5 112.603 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.0 tt -152.5 145.79 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.279 1.032 . . . . 0.63 110.587 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 121.83 166.58 12.89 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 116.042 1.177 . . . . 1.4399999999999999 116.042 168.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 48.11 -141.36 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.604 1.962 . . . . 2.29 113.93 169.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -143.43 -32.58 0.45 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.499 1.52 . . . . 6.0199999999999996 114.184 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -68.59 -37.49 79.86 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.433 1.469 . . . . 3.77 114.275 -174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.3 t90 -68.22 -31.18 70.51 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.657 -1.277 . . . . 3.27 111.819 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 10.4 tpp -60.23 -34.53 73.8 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.137 0.975 . . . . 2.2000000000000002 111.752 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 65.5 mt -67.66 -67.01 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.467 1.507 . . . . 1.5900000000000001 109.043 168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -52.96 -24.97 10.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.967 2.107 . . . . 5.6799999999999997 115.987 -172.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.76 20.23 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 120.006 1.275 . . . . 0.79000000000000004 113.811 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.26 13.41 81.4 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.193 -1.567 . . . . 0.93000000000000005 115.376 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.6 mt -83.96 175.3 9.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.605 1.162 . . . . 0.92000000000000004 111.388 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 57.8 t -119.41 131.05 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.087 1.355 . . . . 1.21 108.744 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.5 tt -102.71 135.73 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.396 0.679 . . . . 1.1200000000000001 110.954 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.7 p30 -96.82 159.51 14.88 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.736 1.214 . . . . 4.1200000000000001 113.099 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.1 p30 -71.99 -15.04 62.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.447 1.277 . . . . 4.3799999999999999 114.447 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -84.24 -45.22 13.11 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.62 -1.3 . . . . 2.46 113.019 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.2 p -64.45 -34.46 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 118.823 -0.608 . . . . 0.81000000000000005 110.92 172.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 21.0 t30 -67.67 -42.96 81.31 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.761 1.164 . . . . 1.95 112.604 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.61 -34.69 77.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.274 1.03 . . . . 1.97 112.405 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 39.9 t80 -71.95 -35.41 69.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.818 1.247 . . . . 2.3100000000000001 112.718 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.3 tpp -71.21 -58.95 3.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.502 1.921 . . . . 0.80000000000000004 112.435 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -62.53 -28.2 69.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.599 0.76 . . . . 0.89000000000000001 112.297 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -58.31 -47.42 83.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.757 2.023 . . . . 2.71 113.403 171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -64.78 -36.11 83.25 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.213 -0.929 . . . . 2.4900000000000002 111.842 172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.41 -31.96 72.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 121.514 -0.741 . . . . 3.0699999999999998 112.36 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 48.9 ttp85 -70.6 -39.9 73.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.558 2.343 . . . . 9.0 111.431 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 13.8 mttp -69.2 -1.38 7.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.728 2.011 . . . . 2.3199999999999998 112.624 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 75.34 16.58 80.53 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.824 1.202 . . . . 1.2 115.022 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -95.45 178.93 5.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 111.205 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 70.2 m -93.29 121.08 34.3 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.16 1.784 . . . . 0.94999999999999996 109.635 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.41 113.95 15.56 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.754 0.822 . . . . 0.62 111.873 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 26.7 m -140.55 163.13 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.569 1.148 . . . . 0.51000000000000001 114.06 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.4 mp -122.1 160.95 23.97 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.352 1.461 . . . . 0.81000000000000005 112.982 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 5.0 t -127.49 125.75 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.22 1.808 . . . . 1.7 111.677 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -118.66 154.36 32.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.122 1.369 . . . . 0.51000000000000001 112.19 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . 0.507 HG21 HD12 ' A' 1068 ' ' ILE . 18.9 m -146.61 122.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.027 1.731 . . . . 0.84999999999999998 110.462 -172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 31.2 t70 44.39 46.79 7.98 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 122.705 1.241 . . . . 3.3399999999999999 113.368 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.265 4.9 m-20 62.42 28.1 16.66 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.549 1.94 . . . . 1.76 115.838 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.46 149.07 42.96 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.726 2.811 . . . . 3.27 110.273 168.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.61 114.61 26.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.47 -1.394 . . . . 1.1599999999999999 110.812 170.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.4 p -89.21 -38.06 14.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.738 1.154 . . . . 0.56000000000000005 113.32 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . 176.48 -168.69 40.9 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 119.259 0.936 . . . . 0.45000000000000001 114.883 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.23 156.08 44.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.349 1.46 . . . . 0.68999999999999995 113.772 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 2.1 mt -135.37 133.05 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 1.4199999999999999 111.525 -170.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -105.15 136.59 44.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.978 1.711 . . . . 0.70999999999999996 110.356 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' 1212 ' ' THR . 67.3 mt -140.97 148.14 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.759 1.624 . . . . 1.0700000000000001 109.869 -168.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.25 170.6 13.89 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.413 1.085 . . . . 1.51 112.585 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.15 137.76 44.61 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.752 1.621 . . . . 3.4399999999999999 112.419 -172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 115.22 1.563 . . . . 4.71 115.22 -172.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . 0.463 HN61 ' HB3' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 112.575 0.583 . . . . 11.09 112.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 2.2 t80 54.71 16.0 1.26 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.598 2.444 . . . . 12.640000000000001 117.598 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 51.7 m -105.46 -11.44 16.42 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.757 2.023 . . . . 8.0899999999999999 113.036 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 3.4 tpt -144.1 108.48 4.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.851 1.261 . . . . 6.5899999999999999 110.384 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -98.18 -46.09 5.97 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.876 1.065 . . . . 7.5800000000000001 113.876 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -75.72 84.55 0.88 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 109.472 -1.451 . . . . 3.1000000000000001 109.472 171.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 1.6 p -96.18 137.6 21.67 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 116.134 1.902 . . . . 2.25 116.134 -166.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.79 132.48 40.16 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.105 2.537 . . . . 1.79 111.955 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.52 129.52 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.662 1.585 . . . . 2.1699999999999999 110.946 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 128.23 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.781 0.833 . . . . 1.46 111.531 -173.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.35 -35.3 4.67 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.128 1.158 . . . . 2.02 114.128 -168.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -164.88 152.66 11.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 1.8799999999999999 111.69 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.4 m -125.07 135.13 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.514 1.126 . . . . 0.65000000000000002 109.216 168.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 51.8 tttt -140.96 148.26 40.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.04 0.936 . . . . 2.0 113.026 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.1 t -90.38 151.13 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 1.3100000000000001 112.532 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.4 tp -116.01 -35.5 4.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.395 1.878 . . . . 1.04 111.42 168.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 92.5 m -119.93 97.85 5.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.225 1.012 . . . . 2.02 111.798 -170.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -91.59 140.89 29.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.449 1.5 . . . . 3.8799999999999999 111.071 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 52.93 29.13 7.36 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.772 2.138 . . . . 2.8900000000000001 116.772 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -145.55 -14.7 0.49 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.093 1.886 . . . . 3.4199999999999999 116.093 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -149.65 -97.53 0.07 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.271 1.428 . . . . 4.4800000000000004 109.99 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 54.9 mt -139.68 146.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 126.106 1.762 . . . . 2.6499999999999999 109.857 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 3.3 t -123.18 172.73 8.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.852 1.661 . . . . 5.04 114.975 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.0 p80 -38.79 -53.49 1.67 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 117.194 2.294 . . . . 3.6600000000000001 117.194 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.34 -36.53 84.02 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.488 1.495 . . . . 2.5699999999999998 111.897 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.5 -26.03 21.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 117.476 -1.25 . . . . 2.7999999999999998 113.04 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.2 mt -59.75 -52.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 120.198 1.363 . . . . 1.3100000000000001 109.37 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.13 -31.93 73.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.91 -0.494 . . . . 0.76000000000000001 111.348 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.12 -61.13 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.599 -0.715 . . . . 0.62 112.39 171.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.53 -31.38 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.711 1.141 . . . . 0.52000000000000002 114.022 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 85.0 t -67.18 -42.25 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.224 0.92 . . . . 0.72999999999999998 110.224 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.46 91.73 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.633 -0.537 . . . . 0.91000000000000003 113.276 177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.2 p -72.46 -28.46 62.95 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.669 1.235 . . . . 1.22 113.144 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -69.36 -60.81 2.09 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.034 0.834 . . . . 1.1399999999999999 111.639 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -65.23 -18.32 65.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.883 1.273 . . . . 2.3399999999999999 112.462 -172.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 39.7 t -51.53 -31.37 23.93 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.022 1.329 . . . . 1.29 113.032 169.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -79.49 3.3 19.05 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 120.804 -1.185 . . . . 2.5600000000000001 114.185 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 48.0 m -120.74 -178.48 3.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.181 1.792 . . . . 1.8899999999999999 112.785 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -139.71 29.95 2.1 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.234 1.414 . . . . 4.4800000000000004 113.186 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -82.05 150.23 64.49 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 114.264 1.209 . . . . 1.9099999999999999 114.264 -170.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -62.59 -25.05 75.33 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.151 3.234 . . . . 1.3 115.066 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.74 -41.57 3.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.469 1.508 . . . . 0.95999999999999996 111.81 -169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.66 70.05 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 123.634 0.635 . . . . 0.98999999999999999 113.918 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 4.8 p -58.96 -24.0 62.16 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.92 1.288 . . . . 1.73 114.455 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -71.18 -36.53 71.99 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.608 -1.308 . . . . 0.73999999999999999 111.816 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.2 mt -72.03 -41.14 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.139 1.375 . . . . 0.85999999999999999 110.425 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 76.9 p -62.38 -40.81 97.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 117.354 -1.307 . . . . 2.52 111.862 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -59.37 -49.87 76.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.784 1.174 . . . . 2.3300000000000001 112.498 169.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.91 -41.74 74.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.425 0.69 . . . . 2.29 111.424 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 38.1 t -71.26 -56.19 6.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.51 1.124 . . . . 1.8400000000000001 113.116 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -42.8 -52.0 5.2 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.912 2.085 . . . . 3.4300000000000002 112.005 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -73.3 -33.22 65.06 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.741 0.816 . . . . 4.0700000000000003 112.428 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -64.59 -40.28 95.24 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.395 -1.44 . . . . 2.2599999999999998 112.74 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.5 -10.48 59.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.332 1.053 . . . . 1.27 113.048 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 45.0 t0 54.38 34.06 19.91 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.797 1.639 . . . . 2.4100000000000001 113.108 -174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 15.1 t -115.63 162.76 16.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.055 1.342 . . . . 2.6699999999999999 111.541 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -91.96 -16.99 25.79 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.474 1.51 . . . . 3.6299999999999999 111.453 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.8 t -146.59 135.28 22.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.306 1.443 . . . . 3.52 111.821 -170.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -148.68 150.32 32.99 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.876 0.871 . . . . 1.1599999999999999 111.414 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 81.22 167.33 37.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 115.594 0.998 . . . . 1.1100000000000001 115.594 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 52.5 m -152.51 -37.43 0.11 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.058 2.143 . . . . 1.8500000000000001 113.144 -173.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . 0.431 ' HB3' ' H ' ' A' 1124 ' ' THR . 51.7 t -134.33 142.96 47.41 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.872 1.434 . . . . 2.9700000000000002 114.872 -166.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 4.6 tp -150.6 151.31 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.934 1.293 . . . . 2.6099999999999999 113.131 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' 1122 ' ' LYS . 0.0 OUTLIER -112.57 -17.26 12.67 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.492 1.517 . . . . 3.6200000000000001 114.082 169.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 57.3 t80 45.26 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 128.49 2.716 . . . . 2.7599999999999998 118.068 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -117.78 112.61 20.64 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.764 2.026 . . . . 2.46 109.132 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.8 t -99.75 136.67 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.231 1.013 . . . . 2.25 111.377 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.1 t -131.42 108.37 14.71 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 108.645 -0.872 . . . . 1.0700000000000001 108.645 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.02 141.5 64.43 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.898 2.399 . . . . 1.3100000000000001 110.265 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 69.1 13.93 67.68 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 118.997 -0.89 . . . . 2.02 114.819 -169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 m -137.48 -87.77 0.28 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.803 1.241 . . . . 2.0699999999999998 112.696 172.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . -175.16 -151.15 8.32 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.851 0.7 . . . . 1.2 114.851 -169.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 146.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.263 1.425 . . . . 2.2400000000000002 112.08 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.9 t -133.31 150.69 51.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.393 1.877 . . . . 0.90000000000000002 111.43 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.6 p -163.06 166.43 23.62 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.967 1.469 . . . . 0.75 114.967 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' 1110 ' ' ASP . 38.1 mmtm -109.71 140.72 43.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.553 1.941 . . . . 1.1599999999999999 107.759 166.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 14.7 p -149.4 140.8 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.806 1.41 . . . . 2.04 114.806 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' 1108 ' ' CYS . 4.4 t -124.32 157.04 35.93 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.751 1.621 . . . . 1.6799999999999999 110.87 166.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -175.56 -42.55 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.187 2.195 . . . . 2.71 109.852 160.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -27.53 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 117.262 2.319 . . . . 4.5199999999999996 117.262 -171.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -137.07 8.44 2.96 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.735 1.607 . . . . 7.4500000000000002 112.887 166.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -72.42 9.28 5.98 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.637 2.065 . . . . 4.6100000000000003 116.994 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.26 -1.04 21.65 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.345 1.572 . . . . 6.4299999999999997 114.182 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.4 -33.24 53.09 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.797 1.239 . . . . 8.2200000000000006 114.274 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 11.3 t-80 40.71 73.24 0.13 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.254 2.221 . . . . 9.5700000000000003 113.682 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -62.17 129.35 40.38 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.281 -0.887 . . . . 15.16 111.288 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.1 118.55 5.98 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.769 -1.197 . . . . 18.149999999999999 107.769 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.73 146.48 31.01 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.095 1.887 . . . . 14.32 116.095 -165.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 21.5 t90 -155.85 -22.64 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.568 1.947 . . . . 19.530000000000001 114.316 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -130.14 -4.52 4.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.776 1.23 . . . . 15.890000000000001 114.242 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 60.8 mt -80.77 119.24 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.136 0.974 . . . . 13.42 108.879 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -101.49 -16.76 16.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.102 0.961 . . . . 16.039999999999999 113.264 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.25 -14.6 51.22 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.185 -0.947 . . . . 13.539999999999999 111.627 167.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -20.88 64.49 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.37 1.868 . . . . 15.449999999999999 112.818 168.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -112.95 -59.5 2.01 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.032 2.133 . . . . 18.350000000000001 114.022 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 46.3 mm -81.27 117.34 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.972 0.909 . . . . 19.379999999999999 111.293 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 27.6 ttpt 45.09 45.83 9.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.504 1.521 . . . . 17.84 111.406 -169.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 51.2 p30 -64.56 -11.37 33.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.527 1.306 . . . . 23.329999999999998 114.527 -169.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -137.18 -87.09 0.3 Allowed 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 113.635 0.976 . . . . 22.920000000000002 113.635 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 20.1 t 68.16 -45.43 0.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.936 2.199 . . . . 23.93 116.936 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 mm? 45.8 -116.34 0.59 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.909 2.084 . . . . 25.16 111.275 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 13.5 p -149.53 159.01 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.228 2.211 . . . . 28.879999999999999 108.785 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -71.27 32.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 114.703 1.372 . . . . 31.789999999999999 114.703 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 32.9 mm -143.45 -29.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 127.815 2.446 . . . . 34.219999999999999 112.889 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 21.2 t70 -140.77 164.13 31.03 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.668 -1.27 . . . . 34.530000000000001 111.549 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -123.17 9.89 9.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.533 1.133 . . . . 35.799999999999997 114.034 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 29.6 t 57.93 136.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.371 2.668 . . . . 34.109999999999999 115.707 -173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.4 -13.49 61.86 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.69 1.196 . . . . 36.390000000000001 113.038 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -107.07 172.18 6.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.855 1.662 . . . . 32.619999999999997 111.68 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 155.2 38.06 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.689 1.196 . . . . 35.609999999999999 111.892 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 1.9 t 52.67 51.71 15.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.954 1.302 . . . . 28.969999999999999 113.006 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 78.0 p -121.48 37.78 4.26 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.682 1.734 . . . . 25.510000000000002 115.682 -166.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 4.9 t -74.17 151.54 40.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.37 -0.831 . . . . 22.579999999999998 111.544 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 38.6 t -75.62 139.69 42.18 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.237 -0.915 . . . . 19.420000000000002 112.151 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 11.5 t -65.25 -3.43 3.96 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.855 2.062 . . . . 20.309999999999999 113.293 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 18.1 p -72.15 1.21 7.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.351 1.46 . . . . 16.5 113.507 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 8.2 ptt? -51.28 143.39 11.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.874 2.47 . . . . 20.25 113.746 169.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 4.2 mm 43.81 49.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.776 1.63 . . . . 12.6 111.881 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -42.29 -47.7 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.513 1.525 . . . . 10.460000000000001 113.902 -168.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -73.88 -21.32 60.13 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.042 1.127 . . . . 10.390000000000001 114.042 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -87.44 -16.22 35.47 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.377 0.671 . . . . 10.01 111.636 168.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -82.97 -41.85 18.29 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.489 1.115 . . . . 10.859999999999999 110.472 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.8 -44.26 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.401 1.08 . . . . 7.2999999999999998 110.632 172.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 3.2 p -71.4 -14.14 62.07 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.84 1.052 . . . . 8.2400000000000002 113.84 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -98.32 -8.04 27.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.77 1.628 . . . . 8.7599999999999998 113.963 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.02 63.37 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.377 1.251 . . . . 6.5599999999999996 114.377 -169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . 0.484 ' H ' HD22 ' A' 1173 ' ' LEU . 3.3 mm? -44.64 -34.05 2.04 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.655 1.582 . . . . 8.75 113.635 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 31.2 m120 -99.83 -3.74 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.159 1.54 . . . . 9.1500000000000004 115.159 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -133.37 -23.34 1.9 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.461 1.652 . . . . 5.9100000000000001 115.461 -168.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . 0.279 31.3 mt-30 46.2 129.28 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 130.143 3.377 . . . . 5.0899999999999999 117.51 -167.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.29 142.54 35.69 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.259 -1.337 . . . . 3.1699999999999999 111.226 -175.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -129.23 138.68 51.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.073 1.749 . . . . 2.8700000000000001 110.417 -171.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -105.83 113.75 27.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.717 1.207 . . . . 1.23 108.718 173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.9 m -131.39 139.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.376 0.989 . . . . 0.62 113.319 -171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.77 154.84 44.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.702 1.201 . . . . 0.58999999999999997 112.93 177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.9 tt -155.91 142.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.753 1.621 . . . . 0.52000000000000002 110.555 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 125.33 147.36 6.99 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.391 1.317 . . . . 2.1800000000000002 116.391 168.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.64 -159.46 0.1 Allowed 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 125.743 1.617 . . . . 2.1400000000000001 111.801 -169.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -125.68 -40.53 2.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.258 1.577 . . . . 5.3200000000000003 115.258 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -72.25 -41.08 67.19 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.085 -1.635 . . . . 4.0499999999999998 111.639 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 11.8 t90 -57.71 -23.23 50.74 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.562 0.949 . . . . 3.0899999999999999 113.562 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 75.5 mmm -75.42 -53.19 9.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.888 1.275 . . . . 2.8199999999999998 112.148 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 96.9 mt -47.89 -62.61 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.139 1.775 . . . . 2.5299999999999998 110.654 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -47.7 -13.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 128.504 2.722 . . . . 6.5999999999999996 116.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.61 24.88 0.45 Allowed 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 119.689 1.131 . . . . 0.76000000000000001 111.859 169.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.17 27.63 73.65 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.385 -1.447 . . . . 0.81999999999999995 114.772 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 17.3 mt -95.41 159.08 15.17 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.977 1.389 . . . . 0.93999999999999995 114.253 -169.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 44.2 t -105.32 125.61 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.276 1.43 . . . . 1.78 110.544 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.9 tt -119.11 148.59 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.795 1.638 . . . . 1.46 110.615 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -127.43 165.41 19.85 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.383 1.073 . . . . 2.9399999999999999 113.041 -168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.71 -30.84 69.58 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.408 -1.433 . . . . 3.2200000000000002 114.12 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.36 -42.94 98.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.19 1.396 . . . . 5.0800000000000001 111.565 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.5 p -77.78 -40.51 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 125.505 1.522 . . . . 1.1000000000000001 112.113 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -57.69 -41.6 81.98 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.447 1.022 . . . . 3.7200000000000002 112.125 171.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.6 -34.71 78.86 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.632 0.975 . . . . 2.9199999999999999 113.632 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -74.93 -39.32 61.45 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 2.4199999999999999 112.968 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 37.4 tpp -57.84 -58.7 7.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.033 1.333 . . . . 1.0900000000000001 110.204 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.3 t -63.23 -31.17 72.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.819 0.674 . . . . 1.48 112.819 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -58.38 -50.19 74.54 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.841 -1.162 . . . . 3.0099999999999998 112.108 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -72.73 -33.22 66.25 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.355 1.242 . . . . 2.1499999999999999 114.355 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -65.3 -43.66 90.4 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.423 -0.798 . . . . 4.7000000000000002 111.686 172.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -69.49 -25.59 64.14 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 120.599 -1.313 . . . . 4.8899999999999997 112.661 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.4 mttp -67.07 -12.56 60.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.225 1.41 . . . . 2.1800000000000002 112.959 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.0 25.35 66.91 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.531 1.062 . . . . 1.6100000000000001 113.384 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.83 172.4 7.06 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.642 1.577 . . . . 6.75 110.076 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 87.5 m -83.76 127.66 33.96 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.541 -0.725 . . . . 0.82999999999999996 111.192 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -134.65 109.54 8.69 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.438 1.495 . . . . 0.68999999999999995 110.045 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.2 m -140.51 154.79 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.595 1.158 . . . . 0.68999999999999995 112.498 -172.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.3 mp -106.44 170.28 8.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.37 0.878 . . . . 0.72999999999999998 113.37 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 10.3 t -130.66 130.26 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.426 1.89 . . . . 1.6699999999999999 111.035 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.08 150.03 47.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.421 1.089 . . . . 0.52000000000000002 112.227 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.5 m -142.94 117.54 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.912 2.085 . . . . 0.92000000000000004 111.255 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 2.9 m-20 45.29 53.9 7.7 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.701 2.0 . . . . 2.8500000000000001 112.805 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 58.65 33.47 23.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.387 1.875 . . . . 1.52 114.091 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.33 144.86 36.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.9 1.68 . . . . 2.6899999999999999 109.911 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 146.17 41.08 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.923 -1.736 . . . . 0.78000000000000003 112.296 176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 24.9 p -121.84 -44.24 2.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.107 0.963 . . . . 0.75 113.123 170.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.23 -169.93 34.75 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.325 0.966 . . . . 0.51000000000000001 114.853 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.58 161.12 39.31 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.709 1.603 . . . . 1.03 114.296 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 18.1 mm -129.38 135.01 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.008 1.723 . . . . 0.70999999999999996 110.651 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -110.77 126.5 54.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.273 1.829 . . . . 0.47999999999999998 110.198 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mt -135.09 153.97 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 125.421 1.488 . . . . 1.5700000000000001 110.032 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -121.34 122.28 39.5 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.16 1.384 . . . . 1.4199999999999999 111.425 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 43.0 t0 -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.811 1.244 . . . . 4.6399999999999997 113.153 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.256 1.426 0 C-N-CA 125.766 1.626 . . . . 5.3499999999999996 112.904 179.089 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 51.5 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.419 0.152 . . . . 13.85 110.815 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.96 159.46 42.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.084 0.953 . . . . 9.8599999999999994 112.036 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 51.6 m -128.96 132.14 47.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.454 1.501 . . . . 9.7400000000000002 110.426 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 20.0 ptm -164.66 147.53 8.71 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.267 1.427 . . . . 5.54 113.629 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -141.37 -31.83 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.894 1.678 . . . . 6.5700000000000003 113.139 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -97.61 99.56 2.26 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 123.666 0.651 . . . . 2.8500000000000001 113.068 -171.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 18.2 p -113.59 147.64 37.99 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.272 1.029 . . . . 2.5899999999999999 113.705 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.58 141.55 46.26 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.026 3.151 . . . . 1.49 112.19 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.11 128.11 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.727 2.011 . . . . 2.1600000000000001 110.302 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.293 10.3 p -76.04 117.51 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 120.61 -1.306 . . . . 1.3700000000000001 113.464 -169.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -100.72 -47.05 4.96 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.9 1.28 . . . . 2.3900000000000001 112.928 -169.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -154.97 153.81 31.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.978 1.311 . . . . 2.77 112.203 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -131.87 143.53 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.936 1.294 . . . . 0.85999999999999999 109.868 167.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.3 tttt -141.38 146.92 37.23 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.081 0.771 . . . . 1.95 113.081 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 61.2 t -89.93 134.51 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.81999999999999995 111.717 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 24.9 tp -113.25 -22.82 10.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.136 1.774 . . . . 1.25 113.274 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 121.56 25.2 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.015 1.726 . . . . 1.8400000000000001 109.111 169.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -135.43 137.72 42.53 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.742 1.016 . . . . 3.5299999999999998 113.742 -171.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 5.0 m 61.32 -50.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.98 2.912 . . . . 3.4300000000000002 115.227 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -75.35 133.47 41.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.999 -1.111 . . . . 3.5800000000000001 107.999 169.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 64.34 -53.85 0.27 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 127.363 2.265 . . . . 5.3799999999999999 115.393 -168.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.74 154.57 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.299 1.44 . . . . 2.4900000000000002 111.79 -171.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 58.6 m -121.86 153.42 38.42 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.013 1.325 . . . . 2.0099999999999998 113.954 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 31.9 p80 -50.05 -50.53 47.51 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.678 2.103 . . . . 4.1699999999999999 116.678 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 58.1 t60 -74.32 -28.78 61.32 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.483 1.038 . . . . 2.98 111.978 -178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.98 -37.51 67.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 117.8 -1.095 . . . . 3.23 112.007 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 79.3 mt -55.13 -56.19 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 119.416 1.007 . . . . 0.90000000000000002 110.565 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.98 -28.63 69.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.448 -0.783 . . . . 0.84999999999999998 112.617 -174.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.27 -46.75 63.72 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.937 0.717 . . . . 0.69999999999999996 112.937 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 27.6 pt -70.25 -28.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.968 1.258 . . . . 0.83999999999999997 113.372 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 63.1 t -70.55 -52.02 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 118.568 0.622 . . . . 0.84999999999999998 110.944 170.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.39 -30.37 73.34 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.369 -0.832 . . . . 0.68999999999999995 114.271 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 12.6 p -70.2 -44.1 69.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.761 1.281 . . . . 0.71999999999999997 112.85 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.66 -49.56 76.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.679 0.792 . . . . 0.92000000000000004 111.549 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -65.91 -22.68 66.52 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.568 -0.708 . . . . 2.0699999999999998 112.905 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 68.4 m -67.0 -38.52 86.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.735 1.214 . . . . 2.6299999999999999 114.116 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.3 t30 -95.42 -15.18 23.19 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.237 1.415 . . . . 2.5099999999999998 111.934 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 37.8 t -66.21 176.0 1.92 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.544 1.538 . . . . 1.48 109.928 165.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -141.2 46.87 1.72 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.263 -1.523 . . . . 3.6899999999999999 113.407 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -93.39 165.1 19.0 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.219 1.408 . . . . 1.6200000000000001 113.884 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.98 -26.07 0.96 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.593 2.862 . . . . 1.2 114.74 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.9 tt -110.62 -48.83 3.1 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.212 1.405 . . . . 0.94999999999999996 112.643 -168.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -56.9 -24.16 48.58 Favored Glycine 0 CA--C 1.539 1.533 0 N-CA-C 113.999 0.36 . . . . 0.96999999999999997 113.999 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 36.7 p -60.67 -17.38 47.31 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.724 1.379 . . . . 1.3799999999999999 114.724 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.09 86.1 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.418 1.008 . . . . 0.93000000000000005 111.396 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 17.6 mt -70.26 -39.52 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.553 1.141 . . . . 0.89000000000000001 110.192 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 79.8 m -52.58 -48.09 66.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.338 0.655 . . . . 1.1100000000000001 111.695 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 43.9 tttt -64.16 -49.7 71.08 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.313 0.645 . . . . 2.3199999999999998 112.279 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 11.2 t80 -53.89 -42.84 69.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 1.8 111.542 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 49.5 t -70.39 -53.74 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.213 1.405 . . . . 1.6599999999999999 112.031 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -58.17 -42.58 86.31 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.772 -1.205 . . . . 3.4399999999999999 111.816 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.31 -32.3 70.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.618 0.767 . . . . 3.6699999999999999 112.953 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.31 -48.41 65.01 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.319 1.048 . . . . 1.8899999999999999 111.781 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.47 -31.36 67.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.673 0.99 . . . . 1.01 113.673 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 26.4 t0 53.39 29.5 8.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.335 1.854 . . . . 2.6499999999999999 113.622 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . 0.448 HG23 ' H ' ' A' 1104 ' ' THR . 12.1 t -98.82 -21.53 16.29 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.36 1.615 . . . . 4.0300000000000002 115.36 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 6.4 tt0 52.62 20.15 1.43 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 116.824 2.157 . . . . 2.8799999999999999 116.824 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . 0.448 ' H ' HG23 ' A' 1102 ' ' THR . 56.7 p -137.46 0.15 2.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.15 -1.594 . . . . 3.5699999999999998 114.844 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.61 157.69 36.74 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.112 -0.993 . . . . 1.0600000000000001 113.413 -169.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 84.4 130.76 2.06 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 115.528 0.971 . . . . 1.0900000000000001 115.528 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . 0.409 HG22 ' H ' ' A' 1108 ' ' CYS . 0.5 OUTLIER -144.18 -170.02 3.25 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.209 2.604 . . . . 2.5800000000000001 108.603 -175.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . 0.409 ' H ' HG22 ' A' 1107 ' ' THR . 48.8 t -60.68 132.41 53.8 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.063 1.875 . . . . 1.72 116.063 -168.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.03 148.74 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.168 2.187 . . . . 2.96 116.057 169.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.5 143.8 26.22 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 105.465 -2.05 . . . . 2.96 105.465 161.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.85 132.3 54.5 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.645 1.578 . . . . 2.7799999999999998 112.451 -169.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.48 99.12 4.41 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.935 2.094 . . . . 3.1600000000000001 109.352 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 33.2 m -102.1 148.61 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.245 0.832 . . . . 2.46 113.245 -169.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 24.5 t -133.16 111.08 12.94 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 124.959 1.303 . . . . 1.25 107.773 168.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -58.66 134.74 62.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.892 2.394 . . . . 1.5900000000000001 113.519 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 59.93 26.22 62.82 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.465 1.507 . . . . 2.2400000000000002 115.924 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.0 t -146.52 -47.9 0.19 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.002 1.401 . . . . 1.99 114.257 -172.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.13 169.26 21.5 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.888 0.756 . . . . 0.88 113.445 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.84 162.65 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.673 -0.898 . . . . 2.6499999999999999 112.621 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 34.6 t -122.49 145.37 48.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.716 2.006 . . . . 0.55000000000000004 109.757 167.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.1 p -150.03 160.91 43.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.613 0.765 . . . . 0.73999999999999999 112.42 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -119.99 105.32 10.93 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.551 -0.718 . . . . 1.6000000000000001 109.135 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.9 p -104.45 138.28 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.052 1.341 . . . . 1.9199999999999999 112.191 -168.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 171.37 8.14 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.824 1.416 . . . . 1.3999999999999999 114.824 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.282 18.2 t-20 148.09 59.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.893 1 C-N-CA 134.088 4.955 . . . . 2.8500000000000001 108.547 166.561 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.35 -67.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.279 2.631 . . . . 2.98 109.286 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.28 33.7 2.32 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.829 1.048 . . . . 6.1699999999999999 113.829 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.34 -6.83 22.8 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.737 1.637 . . . . 4.3600000000000003 115.219 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.39 -7.83 0.67 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.193 1.797 . . . . 4.6600000000000001 115.003 174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -38.11 67.86 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.599 1.56 . . . . 5.9800000000000004 110.213 167.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 48.0 t60 31.24 64.75 0.18 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.939 3.296 . . . . 6.6100000000000003 114.945 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -61.75 128.61 37.04 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.463 1.105 . . . . 12.289999999999999 111.875 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.64 -1.15 56.85 Favored 'General case' 0 CA--C 1.55 0.942 0 N-CA-C 113.739 1.015 . . . . 12.609999999999999 113.739 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 60.7 119.52 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.489 2.716 . . . . 10.710000000000001 112.959 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -141.62 -19.1 0.76 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.05 1.13 . . . . 14.76 114.05 -169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.8 m120 -117.44 5.79 12.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.492 1.517 . . . . 13.970000000000001 111.097 174.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 33.6 mt -140.73 125.79 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 126.487 1.915 . . . . 12.0 107.452 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -101.86 -29.56 11.77 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.258 0.935 . . . . 14.529999999999999 112.401 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -86.41 -8.68 57.45 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.731 2.123 . . . . 14.199999999999999 116.731 -168.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -50.67 -41.92 56.16 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 117.926 2.565 . . . . 12.859999999999999 117.926 -168.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -159.84 -34.38 0.06 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.002 1.853 . . . . 15.050000000000001 116.002 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 12.6 tt -68.87 128.7 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.599 1.09 . . . . 15.25 112.241 -168.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -158.5 167.18 30.33 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.164 1.386 . . . . 15.43 111.874 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -78.19 47.82 0.7 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.311 1.445 . . . . 18.02 114.369 -169.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 47.06 47.21 16.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.56 1.944 . . . . 18.859999999999999 115.835 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.66 5.73 41.76 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.743 2.417 . . . . 19.010000000000002 114.43 -169.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.62 6.1 1.22 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.088 1.755 . . . . 21.059999999999999 113.689 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.8 p -152.72 157.47 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.511 1.924 . . . . 24.550000000000001 109.438 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -85.26 23.53 1.27 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.03 1.332 . . . . 26.899999999999999 114.587 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.31 150.46 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.535 1.934 . . . . 30.609999999999999 112.26 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 40.9 t0 -76.71 132.14 39.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.923 1.689 . . . . 31.120000000000001 113.562 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -99.03 -13.12 20.0 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.78 1.632 . . . . 31.57 113.562 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 9.5 t 58.35 -6.11 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.96 2.904 . . . . 33.210000000000001 116.824 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -118.64 155.86 30.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.214 1.805 . . . . 30.32 112.915 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.45 141.39 29.98 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.109 0.963 . . . . 27.579999999999998 110.805 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -139.37 -82.14 0.28 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.149 1.166 . . . . 28.57 114.149 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 13.7 t -156.09 175.65 13.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.382 1.073 . . . . 22.149999999999999 112.149 -166.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 68.7 p -150.76 166.06 31.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.933 1.293 . . . . 19.059999999999999 113.005 169.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 38.8 p -123.03 21.62 9.74 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.462 1.905 . . . . 18.960000000000001 112.498 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 55.5 p -87.12 79.61 8.59 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.998 2.119 . . . . 16.0 111.542 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 79.8 p -65.62 -0.55 2.12 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 118.301 2.704 . . . . 15.98 118.301 -167.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 69.3 m -87.81 -3.57 58.93 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.798 1.036 . . . . 15.199999999999999 113.798 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 9.9 ptt? -71.48 -179.32 2.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.855 1.262 . . . . 14.550000000000001 112.755 169.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 22.4 mm -69.26 78.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.992 1.717 . . . . 12.56 111.777 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.5 pp -103.13 -18.62 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.428 1.491 . . . . 10.52 113.73 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.06 -24.69 59.45 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.107 -0.996 . . . . 10.07 112.318 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.42 10.35 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.299 1.44 . . . . 7.9199999999999999 113.533 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -85.57 -35.78 20.83 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.931 1.293 . . . . 8.3699999999999992 111.09 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.59 -44.69 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.48 1.112 . . . . 8.0500000000000007 110.373 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 72.9 m -67.79 -17.04 64.4 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.942 1.09 . . . . 8.3399999999999999 113.942 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -96.36 -6.3 37.94 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.051 1.34 . . . . 6.6699999999999999 113.333 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -71.0 -23.39 62.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.411 1.263 . . . . 5.1100000000000003 114.411 -173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 9.2 tt -68.19 -37.78 81.3 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.158 -0.964 . . . . 7.4800000000000004 111.724 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 7.5 m120 -76.29 -53.84 7.64 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.195 1.398 . . . . 7.6799999999999997 111.12 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -68.85 -4.09 14.99 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 113.643 0.979 . . . . 3.7599999999999998 113.643 171.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 61.83 -14.63 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 129.625 3.17 . . . . 3.9199999999999999 116.207 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -9.49 118.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 129.127 2.971 . . . . 2.54 115.113 166.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 123.94 30.97 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.848 1.659 . . . . 3.4700000000000002 111.067 -170.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.1 tttt -77.28 123.16 26.09 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.946 0.794 . . . . 1.6000000000000001 110.615 171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -134.67 133.67 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.359 1.064 . . . . 0.56999999999999995 111.104 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.18 147.51 41.92 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.605 1.162 . . . . 0.40000000000000002 113.01 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.7 tt -149.58 141.35 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.895 1.278 . . . . 0.47999999999999998 110.77 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.82 -155.25 26.05 Favored Glycine 0 CA--C 1.532 1.133 0 N-CA-C 115.411 0.924 . . . . 1.4099999999999999 115.411 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -71.41 160.42 32.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.621 1.568 . . . . 3.48 111.59 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -59.13 -16.84 21.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.762 1.225 . . . . 6.3099999999999996 114.066 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -57.74 -36.0 71.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.683 0.793 . . . . 4.7800000000000002 112.256 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 5.3 m95 -74.35 -47.57 33.46 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.13 0.972 . . . . 3.3999999999999999 112.156 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -29.06 68.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.478 0.711 . . . . 2.1200000000000001 112.164 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 68.0 mt -66.33 -66.89 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.156 2.182 . . . . 2.4199999999999999 108.127 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -23.38 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.536 1.935 . . . . 8.3100000000000005 115.953 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.66 14.62 31.43 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 120.349 1.431 . . . . 0.82999999999999996 114.163 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.81 17.88 67.79 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.249 1.404 . . . . 1.1899999999999999 116.517 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.16 155.48 28.66 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.405 1.103 . . . . 1.25 111.533 -170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 92.3 t -91.94 127.95 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.485 0.714 . . . . 1.6000000000000001 110.189 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 13.8 tt -112.97 152.44 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.003 1.321 . . . . 1.55 111.954 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.46 156.64 20.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.571 1.693 . . . . 2.9100000000000001 115.571 -168.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.4 t30 -68.66 -37.26 79.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.533 1.133 . . . . 3.0299999999999998 113.914 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.29 -33.61 69.89 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.93 -1.106 . . . . 2.9100000000000001 112.305 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -76.27 -37.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.227 -0.921 . . . . 1.23 112.196 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -61.59 -35.37 77.67 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.125 0.875 . . . . 2.75 112.075 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.03 -40.29 84.6 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.947 1.092 . . . . 2.7200000000000002 113.947 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -74.57 -44.99 48.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.073 0.949 . . . . 2.9100000000000001 112.319 171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 47.8 tpp -59.85 -56.27 23.84 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.39 1.076 . . . . 0.88 111.681 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.8 t -66.54 -30.65 71.01 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.522 -0.736 . . . . 1.4299999999999999 112.52 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -62.4 -45.79 91.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.401 1.08 . . . . 3.52 111.391 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -67.53 -39.09 85.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.081 1.353 . . . . 3.9399999999999999 112.071 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -63.11 -45.26 92.83 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.626 -0.671 . . . . 3.8700000000000001 112.158 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -70.52 -21.14 62.77 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.936 -1.102 . . . . 5.1799999999999997 113.309 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.266 14.2 ptpt -85.23 7.62 21.37 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.934 1.457 . . . . 3.2599999999999998 114.934 167.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 72.2 21.21 79.34 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.785 1.074 . . . . 2.0099999999999998 115.785 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -110.42 144.08 39.74 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.121 1.461 . . . . 4.7699999999999996 110.39 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 52.5 m -61.35 124.31 20.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.904 1.281 . . . . 0.80000000000000004 112.44 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -129.06 125.43 37.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.756 1.222 . . . . 0.68000000000000005 110.174 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.6 m -141.99 159.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.709 1.204 . . . . 0.52000000000000002 113.536 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.2 mt -111.61 158.3 19.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.634 1.974 . . . . 1.3100000000000001 111.559 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.7 p -139.47 128.54 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.076 0.951 . . . . 1.95 112.665 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.6 153.06 48.45 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.381 2.272 . . . . 0.52000000000000002 111.008 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 10.5 m -144.09 136.13 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.252 -0.905 . . . . 0.97999999999999998 112.098 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 33.3 t70 41.74 50.88 4.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.004 1.721 . . . . 2.9900000000000002 112.207 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.26 6.0 m-20 66.19 21.59 11.08 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.385 1.994 . . . . 1.54 116.385 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -126.71 151.04 48.68 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.015 2.126 . . . . 2.48 110.147 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.18 143.08 41.32 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.769 -1.832 . . . . 0.75 111.795 173.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 17.5 p -118.72 -38.84 3.05 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.422 1.267 . . . . 0.68000000000000005 114.422 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.73 -172.94 37.53 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 119.389 0.995 . . . . 0.57999999999999996 114.588 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.7 151.59 41.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.716 1.606 . . . . 0.84999999999999998 112.838 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.34 137.0 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.944 1.697 . . . . 0.83999999999999997 109.962 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -123.7 135.06 53.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.653 1.581 . . . . 0.66000000000000003 110.951 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 32.5 mt -140.41 153.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 126.463 1.905 . . . . 1.5800000000000001 110.403 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -128.7 173.09 10.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.026 1.33 . . . . 1.4299999999999999 109.918 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.11 151.02 21.8 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.285 -0.884 . . . . 4.4299999999999997 113.016 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.293 1.837 . . . . 4.6100000000000003 111.779 175.654 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.432 0.901 . . . . 14.630000000000001 113.432 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 26.3 m-85 54.79 33.54 19.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.34 1.456 . . . . 12.68 114.107 -175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 18.3 m -77.11 141.61 40.13 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.465 1.506 . . . . 9.9700000000000006 110.31 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 6.1 ptm -91.54 174.22 7.48 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.204 1.187 . . . . 7.0700000000000003 114.204 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -68.93 -87.91 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.763 0.825 . . . . 6.1399999999999997 112.594 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.34 87.5 1.2 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.688 1.137 . . . . 2.8500000000000001 111.942 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.28 135.35 84.53 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.884 1.674 . . . . 3.3599999999999999 115.235 -167.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -84.04 94.51 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.532 2.821 . . . . 1.8799999999999999 112.008 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 82.2 t -89.96 108.86 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.883 -1.135 . . . . 2.8300000000000001 109.767 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.1 p -72.38 129.44 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.745 -1.222 . . . . 1.71 111.968 -172.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.14 -50.7 2.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.177 1.547 . . . . 2.7000000000000002 115.177 -167.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -149.64 149.74 31.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.142 0.883 . . . . 2.77 112.609 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -129.67 145.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.876 1.27 . . . . 0.96999999999999997 110.904 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.9 tttt -141.66 138.86 32.79 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.155 0.982 . . . . 1.8899999999999999 113.433 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 94.3 t -82.93 134.5 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.951 0.9 . . . . 0.69999999999999996 110.71 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 20.0 tp -107.22 -32.31 7.85 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.096 1.358 . . . . 1.4299999999999999 112.966 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 51.9 m -118.03 99.11 6.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.729 1.212 . . . . 1.8300000000000001 108.234 172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -95.77 141.47 29.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.284 1.034 . . . . 3.4900000000000002 110.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.7 m 52.52 29.24 6.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.958 1.836 . . . . 2.6499999999999999 115.958 172.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -137.91 -17.51 1.24 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.106 1.151 . . . . 2.9199999999999999 114.106 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.5 -49.3 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 120.166 1.348 . . . . 4.71 114.41 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.96 142.76 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 125.52 1.528 . . . . 1.47 111.25 -169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 14.5 m -87.53 147.93 25.12 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.335 1.054 . . . . 2.1200000000000001 112.287 170.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.1 p80 -53.5 -38.89 64.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.45 1.648 . . . . 3.1600000000000001 115.45 -172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 23.8 t60 -66.79 -37.19 84.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.609 1.095 . . . . 3.4900000000000002 111.869 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -65.68 -36.29 83.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 118.228 -0.891 . . . . 3.3599999999999999 111.259 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 65.1 mt -61.11 -54.35 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 118.947 0.794 . . . . 0.55000000000000004 111.189 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.51 -33.88 76.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.877 0.762 . . . . 0.55000000000000004 111.881 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.39 57.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.63 -0.7 . . . . 0.58999999999999997 112.143 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 6.0 pt -69.48 -27.55 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 119.642 1.11 . . . . 0.62 113.748 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 77.5 t -70.68 -43.39 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.237 0.926 . . . . 0.69999999999999996 110.415 169.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.34 -37.42 93.87 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.127 -0.818 . . . . 0.68000000000000005 113.282 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 70.6 p -73.88 -37.62 64.67 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.353 1.576 . . . . 0.96999999999999997 112.636 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.68 88.29 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.961 0.801 . . . . 0.78000000000000003 112.896 173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' 1084 ' ' SER 0.254 3.4 tp10 -75.75 -20.92 57.95 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.196 0.813 . . . . 3.3799999999999999 113.196 175.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 26.3 t -57.7 -47.46 82.32 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.075 -1.64 . . . . 1.3100000000000001 112.743 174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -77.33 -2.94 37.46 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 121.222 -0.924 . . . . 2.1400000000000001 112.689 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' 1081 ' ' GLU . 20.0 m -111.12 -178.6 3.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.584 2.354 . . . . 2.4100000000000001 111.494 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.03 51.39 0.79 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.135 -0.978 . . . . 4.1699999999999999 113.55 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -73.68 147.41 86.77 Favored Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.042 . . . . 1.5600000000000001 113.688 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.83 -36.51 90.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.172 3.248 . . . . 1.55 114.028 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.1 tt -100.03 -47.49 4.98 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.787 2.035 . . . . 1.25 110.874 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -33.01 78.98 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 114.583 0.593 . . . . 1.1699999999999999 114.583 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 3.9 t -66.0 -16.02 63.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.126 1.463 . . . . 2.9500000000000002 114.458 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -73.63 -27.16 61.13 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.089 -1.007 . . . . 1.4399999999999999 112.922 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.5 -41.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.878 0.871 . . . . 1.1399999999999999 109.199 171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.7 m -51.62 -43.97 62.75 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.757 0.708 . . . . 1.27 111.289 171.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.1 tttt -63.82 -51.78 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.913 0.778 . . . . 2.4300000000000002 112.936 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.41 -47.2 66.43 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.858 0.863 . . . . 2.3100000000000001 111.105 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 98.3 m -69.07 -52.48 28.08 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.023 1.329 . . . . 2.9399999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -49.49 -48.34 47.93 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.06 1.344 . . . . 3.6600000000000001 111.642 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -71.62 -35.91 70.59 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.844 0.857 . . . . 2.6499999999999999 112.905 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -70.33 -35.75 73.82 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.5 -1.375 . . . . 2.1800000000000002 113.448 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.86 -6.38 37.68 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.285 1.034 . . . . 1.3400000000000001 113.751 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 39.8 t0 54.91 40.07 31.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.239 1.416 . . . . 3.3900000000000001 112.472 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.6 t -131.38 174.12 10.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.518 1.527 . . . . 2.5800000000000001 111.508 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -114.87 -3.67 12.71 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.337 1.455 . . . . 2.9500000000000002 112.4 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 8.1 t -148.76 142.6 25.69 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.337 1.455 . . . . 2.98 111.69 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.69 145.87 20.38 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.974 0.91 . . . . 0.85999999999999999 112.322 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 83.18 135.75 2.59 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.074 1.321 . . . . 1.0800000000000001 114.458 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 54.9 m -105.72 -64.77 1.11 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.041 1.336 . . . . 1.6499999999999999 111.118 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.3 t -137.85 131.67 31.42 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.308 0.575 . . . . 1.7 110.595 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 30.3 mm -143.54 142.29 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 1 C-N-CA 132.801 4.441 . . . . 3.4700000000000002 102.797 -170.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.12 106.25 5.47 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 120.895 -1.128 . . . . 4.4800000000000004 111.442 174.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -100.62 145.67 28.09 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 118.038 2.607 . . . . 2.4399999999999999 118.038 -166.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -129.16 104.65 7.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 130.843 3.657 . . . . 2.7799999999999998 106.68 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 91.5 t -99.03 139.8 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.309 1.044 . . . . 2.0600000000000001 110.932 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 43.4 t -126.48 101.3 27.77 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.021 1.328 . . . . 1.1499999999999999 109.257 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -51.01 130.8 32.84 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.039 3.159 . . . . 1.3999999999999999 114.978 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 75.75 -37.68 1.25 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 127.031 2.253 . . . . 1.9099999999999999 114.412 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 60.4 m -82.19 -48.28 11.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.052 1.426 . . . . 2.1899999999999999 113.938 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 159.43 -178.0 35.73 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 118.835 0.743 . . . . 0.78000000000000003 113.387 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.12 157.2 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 112.661 0.615 . . . . 2.5499999999999998 112.661 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -131.68 151.6 51.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.997 1.719 . . . . 0.47999999999999998 110.871 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -153.8 166.26 33.43 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.842 -1.161 . . . . 0.67000000000000004 114.003 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -110.71 136.72 49.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.253 -1.017 . . . . 1.1899999999999999 108.253 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 80.1 t -128.95 139.44 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.458 1.103 . . . . 2.2999999999999998 111.877 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.8 t -146.6 152.82 39.54 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.789 2.144 . . . . 1.4399999999999999 116.789 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.305 24.7 t-20 178.71 65.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 1 C-N-CA 132.582 4.353 . . . . 3.9199999999999999 106.207 158.061 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -149.55 -89.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.791 2.036 . . . . 3.4700000000000002 107.879 -171.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -132.25 9.26 4.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 120.156 1.344 . . . . 5.3200000000000003 113.896 172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -58.24 -27.51 60.4 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.562 -1.336 . . . . 6.6100000000000003 113.848 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -7.64 2.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.96 1.704 . . . . 5.4000000000000004 115.58 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.93 -42.05 97.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.592 1.157 . . . . 6.2300000000000004 110.263 169.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 95.9 m-70 58.36 -72.46 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.029 2.132 . . . . 9.3499999999999996 115.726 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -157.04 156.62 33.18 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.702 1.601 . . . . 15.140000000000001 112.331 -166.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.92 124.92 27.09 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 106.248 -1.76 . . . . 17.719999999999999 106.248 164.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 9.1 p30 -140.41 155.86 46.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.563 1.32 . . . . 16.02 114.563 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 3.5 p90 -161.93 70.21 0.32 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.084 1.354 . . . . 19.010000000000002 111.888 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 5.2 m-80 61.31 18.67 9.45 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.671 1.73 . . . . 17.199999999999999 115.671 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.98 123.26 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.137 0.975 . . . . 15.69 110.216 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -85.01 -26.9 26.77 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.41 -0.806 . . . . 18.43 112.344 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.67 -10.43 12.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.087 1.355 . . . . 16.949999999999999 113.996 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -65.77 -22.96 66.62 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.84 2.456 . . . . 14.58 114.505 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -60.81 165.63 3.88 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.265 2.226 . . . . 15.67 112.328 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.49 113.3 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 120.496 -1.378 . . . . 16.140000000000001 111.432 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -141.19 165.05 28.6 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.751 2.02 . . . . 21.140000000000001 111.617 -168.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -82.69 -19.33 38.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.987 -1.071 . . . . 21.109999999999999 112.954 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -129.53 145.24 51.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.715 1.206 . . . . 23.579999999999998 110.755 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 50.5 m -137.24 -41.57 0.57 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.573 1.549 . . . . 26.68 111.591 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 13.1 mt 59.73 -176.9 0.1 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.33 1.452 . . . . 30.379999999999999 114.109 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.2 p -148.61 155.6 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.829 -1.169 . . . . 33.380000000000003 112.996 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -149.24 159.78 43.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.059 2.144 . . . . 38.549999999999997 110.896 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 12.3 mm 66.06 128.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 128.852 2.861 . . . . 41.460000000000001 115.643 169.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 28.1 t70 50.25 30.02 4.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.893 1.677 . . . . 41.240000000000002 114.86 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -78.18 12.05 2.05 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.713 1.746 . . . . 37.039999999999999 115.713 -169.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 80.3 p 43.19 -110.67 0.16 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.951 2.5 . . . . 35.710000000000001 115.846 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 11.9 p30 -141.36 174.01 10.94 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.247 1.819 . . . . 34.609999999999999 111.6 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -134.04 154.7 50.98 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.424 1.639 . . . . 29.77 115.424 -168.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -150.45 145.16 25.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.756 2.422 . . . . 31.649999999999999 108.158 167.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 38.0 m 60.29 157.47 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.508 1.923 . . . . 23.890000000000001 115.361 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 57.6 p -72.09 -38.41 69.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.048 -1.657 . . . . 20.43 112.611 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.52 128.8 11.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.243 1.817 . . . . 17.43 110.363 175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 6.4 t -74.27 -27.54 60.79 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.47 0.708 . . . . 15.81 112.802 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 6.0 m -152.05 -68.78 0.17 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.492 1.293 . . . . 14.41 114.492 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 2.0 m -122.54 10.59 9.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 117.359 2.355 . . . . 13.130000000000001 117.359 -163.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 60.0 mtt 61.75 129.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.772 2.029 . . . . 14.23 115.543 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . 0.253 1.9 mt 55.77 41.52 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 125.949 1.7 . . . . 11.74 111.865 -173.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.4 pp -117.76 -8.1 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.1 1.36 . . . . 9.6099999999999994 113.633 168.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -25.18 68.16 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.885 -1.134 . . . . 8.9399999999999995 113.507 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -73.07 -3.22 24.91 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 114.601 1.334 . . . . 8.6799999999999997 114.601 172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -106.71 -25.12 11.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.062 1.345 . . . . 8.9800000000000004 113.561 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 77.0 mt -51.24 -35.4 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 126.065 1.746 . . . . 6.4000000000000004 112.663 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 19.7 p -64.09 -3.99 3.14 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.409 1.633 . . . . 7.4000000000000004 115.409 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -92.35 -17.16 25.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.997 1.319 . . . . 7.5300000000000002 113.625 171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.79 63.82 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.666 1.728 . . . . 5.1900000000000004 115.666 -168.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.7 -26.56 68.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.165 0.986 . . . . 7.5999999999999996 112.974 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -104.23 -44.89 4.85 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.423 1.489 . . . . 6.5599999999999996 112.587 169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -79.05 63.84 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.533 1.933 . . . . 4.7400000000000002 110.888 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -49.02 136.08 14.98 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.127 1.371 . . . . 3.21 114.554 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -160.4 156.16 25.69 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.963 1.705 . . . . 2.3100000000000001 112.37 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.75 143.63 32.55 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.488 1.515 . . . . 2.6400000000000001 111.398 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -110.87 115.74 30.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.698 1.599 . . . . 1.6699999999999999 108.656 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.8 m -133.76 142.35 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 119.979 1.263 . . . . 0.69999999999999996 112.829 -172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 150.89 39.7 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.648 0.981 . . . . 0.39000000000000001 113.648 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 6.2 tt -141.29 135.24 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.428 1.891 . . . . 0.63 109.799 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.08 -167.9 40.93 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 116.582 1.393 . . . . 1.4199999999999999 116.582 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -76.08 166.1 23.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.046 1.738 . . . . 3.02 114.523 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -50.78 -45.32 59.02 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.904 2.187 . . . . 5.4000000000000004 116.904 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.27 -31.89 58.51 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 121.152 1.796 . . . . 3.4700000000000002 112.003 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.3 t90 -64.0 -35.87 82.13 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.958 -1.089 . . . . 2.98 112.239 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.44 83.75 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.075 1.139 . . . . 2.0600000000000001 114.075 169.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.0 mt -54.94 -60.06 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.506 1.122 . . . . 1.72 109.047 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -49.57 -19.35 0.57 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.59 2.07 . . . . 5.7800000000000002 116.59 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.82 11.57 4.8 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 121.632 2.014 . . . . 0.72999999999999998 112.593 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.71 35.59 85.92 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 119.868 -1.77 . . . . 0.78000000000000003 113.966 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.18 153.45 19.59 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.535 1.167 . . . . 0.81000000000000005 111.435 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -84.53 132.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.804 -0.56 . . . . 0.97999999999999998 109.554 169.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.67 140.05 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.676 1.19 . . . . 0.97999999999999998 110.862 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -116.06 167.85 10.61 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.987 1.477 . . . . 2.9900000000000002 114.987 -167.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 50.2 t30 -69.05 -45.98 69.01 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.15 1.537 . . . . 3.0 115.15 -169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.34 -26.91 64.93 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.068 -1.02 . . . . 2.3900000000000001 112.021 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -78.56 -38.62 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 117.748 -1.12 . . . . 0.69999999999999996 112.481 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -59.69 -41.56 91.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.902 1.683 . . . . 2.04 110.884 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.18 -40.96 91.82 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.417 1.487 . . . . 2.3900000000000001 113.305 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 52.1 t80 -72.11 -40.93 67.79 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.187 0.995 . . . . 2.2200000000000002 112.523 174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 46.2 tpp -59.96 -57.53 12.46 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.01 1.724 . . . . 0.81999999999999995 110.104 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.2 t -64.57 -33.47 76.0 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.903 0.881 . . . . 1.1200000000000001 111.971 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.11 -54.75 42.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.233 1.013 . . . . 2.5 111.776 172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -71.29 -34.19 70.42 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.498 0.925 . . . . 2.9300000000000002 113.498 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -59.35 -49.92 75.95 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.223 -0.923 . . . . 3.2799999999999998 110.764 170.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -72.76 -14.86 61.63 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 120.936 -1.103 . . . . 4.8399999999999999 113.957 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 16.7 mttp -75.79 -6.23 49.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.099 1.76 . . . . 2.7599999999999998 112.367 166.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 86.2 24.59 39.94 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 125.231 1.396 . . . . 1.28 114.071 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -107.74 163.06 13.42 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.372 1.469 . . . . 4.21 110.302 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 14.0 m -76.2 133.19 40.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.843 1.257 . . . . 0.93000000000000005 110.195 169.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -137.12 116.63 12.84 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.105 1.362 . . . . 0.46000000000000002 111.138 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 25.9 m -140.22 156.83 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.191 1.396 . . . . 0.48999999999999999 112.784 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.92 162.88 14.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.901 1.681 . . . . 0.93000000000000005 112.293 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.6 p -135.65 126.98 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.655 1.582 . . . . 2.4399999999999999 112.456 172.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.86 157.0 38.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.436 1.894 . . . . 0.40999999999999998 111.75 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.0 m -145.84 133.21 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.413 1.485 . . . . 0.85999999999999999 112.292 -171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 40.16 45.42 1.71 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.385 2.274 . . . . 2.7599999999999998 113.428 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 12.3 m-20 64.79 39.79 5.97 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.713 2.405 . . . . 1.5600000000000001 116.115 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -146.69 146.4 30.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.148 2.179 . . . . 2.29 110.176 169.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.5 mt -74.23 147.81 42.13 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 119.498 -2.001 . . . . 0.81000000000000005 112.964 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.0 p -124.83 -38.52 2.35 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.02 1.489 . . . . 0.52000000000000002 115.02 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -163.34 179.92 38.18 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 120.7 1.591 . . . . 0.46999999999999997 115.875 -173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.58 155.62 43.73 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.86 1.664 . . . . 0.79000000000000004 113.502 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.9 mm -130.93 141.92 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.585 1.954 . . . . 0.92000000000000004 110.247 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -122.87 131.2 53.64 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.349 1.46 . . . . 0.56999999999999995 111.59 175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 8.4 mt -135.83 145.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.967 1.707 . . . . 1.53 109.789 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -124.42 -173.96 2.9 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.505 1.522 . . . . 1.3899999999999999 112.884 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.338 27.4 t70 66.86 -67.65 0.16 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.968 2.907 . . . . 4.8899999999999997 115.175 -168.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.256 1.429 0 CA-C-O 116.59 -1.672 . . . . 9.1199999999999992 113.705 169.426 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 118.473 -0.775 . . . . 13.48 113.009 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -126.88 141.05 51.92 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.114 1.325 . . . . 15.91 112.235 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 78.1 m -80.88 158.87 25.18 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.793 1.237 . . . . 9.5099999999999998 113.11 -169.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 7.7 ttp -32.56 134.15 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.252 2.621 . . . . 5.96 113.519 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 64.4 m80 -90.08 -25.01 20.98 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.719 1.377 . . . . 10.51 114.719 -172.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -69.84 75.83 0.43 Allowed Glycine 0 N--CA 1.479 1.556 0 C-N-CA 125.572 1.558 . . . . 3.8199999999999998 113.784 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 16.5 p -115.2 150.28 44.1 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 125.669 1.588 . . . . 2.48 115.274 -166.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.31 166.69 7.13 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.739 2.293 . . . . 1.46 110.486 166.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 11.7 p -135.47 130.03 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.969 -1.082 . . . . 2.1600000000000001 111.28 172.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -66.59 135.01 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.14 -0.975 . . . . 1.4399999999999999 111.507 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.88 -33.67 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.227 0.825 . . . . 2.1899999999999999 113.227 -172.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -159.2 143.87 15.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.296 0.953 . . . . 2.3700000000000001 112.113 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.5 m -114.66 134.27 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.686 0.795 . . . . 0.93999999999999995 109.15 167.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 59.5 tttt -140.71 145.1 36.05 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.291 0.849 . . . . 2.8500000000000001 113.291 -169.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.3 t -101.5 129.82 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.386 1.474 . . . . 1.0 111.169 -172.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.05 -25.0 11.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.017 1.727 . . . . 1.01 112.45 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 34.4 m -137.0 130.72 31.88 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.454 1.501 . . . . 1.8999999999999999 110.492 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -138.25 144.52 40.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.009 1.324 . . . . 6.2000000000000002 110.918 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 61.9 m 54.55 13.13 0.62 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.254 2.221 . . . . 2.9100000000000001 115.839 173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -137.53 13.63 2.97 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.717 2.407 . . . . 2.7200000000000002 112.433 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -163.46 -58.42 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.298 1.439 . . . . 5.0199999999999996 110.679 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.8 mt -145.48 159.76 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 129.768 3.227 . . . . 1.8600000000000001 108.006 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 39.7 m -106.6 155.6 19.46 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.842 1.257 . . . . 1.8200000000000001 113.68 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.0 p80 -50.83 -41.36 57.53 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.706 2.484 . . . . 3.4399999999999999 117.706 -167.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 11.3 t60 -76.97 -28.05 54.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.971 1.26 . . . . 2.5899999999999999 111.406 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' 1072 ' ' LYS . 9.7 mmpt? -70.36 -34.63 72.85 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 116.917 -1.516 . . . . 5.3200000000000003 111.933 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 63.3 mt -56.81 -53.68 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.662 1.574 . . . . 0.60999999999999999 110.547 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.53 -30.76 71.15 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.4 -0.812 . . . . 0.59999999999999998 112.323 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.03 60.84 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.52000000000000002 112.231 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 7.7 pt -69.98 -35.09 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.508 -1.37 . . . . 0.52000000000000002 112.682 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.0 t -71.01 -43.52 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.096 0.862 . . . . 0.56999999999999995 111.71 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.96 -35.7 79.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.849 -1.157 . . . . 0.56999999999999995 113.492 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 73.8 p -73.96 -25.31 59.87 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.51 -0.994 . . . . 0.76000000000000001 112.851 174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.27 -55.49 15.87 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.538 0.735 . . . . 0.66000000000000003 110.98 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.07 -20.85 63.2 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.133 0.79 . . . . 2.1299999999999999 113.133 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 24.8 t -55.39 -33.18 63.24 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.72 -1.238 . . . . 1.3100000000000001 112.87 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -85.73 -8.57 58.09 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.051 0.941 . . . . 2.25 113.361 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 5.0 t -99.35 -179.64 4.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.797 1.639 . . . . 1.5 113.754 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -137.5 8.86 2.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.353 2.261 . . . . 3.9100000000000001 113.962 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -87.33 150.01 48.23 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.779 1.232 . . . . 1.78 113.906 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.17 -28.65 40.42 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.466 3.444 . . . . 1.1000000000000001 115.47 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . 0.454 HD13 " H2'" ' A' 1232 ' ' ATP . 2.0 tt -105.11 -46.94 4.12 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.182 0.993 . . . . 0.87 112.576 -166.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.84 -30.11 76.76 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 113.938 0.335 . . . . 0.87 113.938 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 21.3 p -63.69 -17.74 63.27 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.947 -1.325 . . . . 1.3200000000000001 114.248 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.13 85.8 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.136 -0.978 . . . . 1.01 111.71 169.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 15.1 mt -73.29 -36.4 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.824 1.65 . . . . 0.93999999999999995 110.573 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 21.5 m -51.44 -47.34 63.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.904 0.775 . . . . 1.1200000000000001 111.546 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.68 -49.81 75.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.035 0.934 . . . . 2.1099999999999999 112.574 175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.62 -40.0 74.6 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.563 0.745 . . . . 1.73 111.869 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 28.3 t -71.66 -52.53 17.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.38 1.472 . . . . 1.78 112.591 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -51.87 -44.16 63.58 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.751 1.62 . . . . 3.1000000000000001 112.588 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -69.84 -34.05 73.12 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.602 0.761 . . . . 3.5800000000000001 112.591 175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.91 -47.77 67.85 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.413 1.006 . . . . 2.96 112.977 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 19.4 mt -71.91 -32.54 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.78 0.832 . . . . 1.1100000000000001 112.48 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 1.7 t70 54.94 54.39 9.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.747 2.019 . . . . 2.7599999999999998 112.009 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.3 t -148.37 142.99 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.125 -0.984 . . . . 2.7599999999999998 113.193 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -98.0 21.88 10.11 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.042 1.337 . . . . 3.0 112.707 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 43.1 p -131.23 4.23 4.37 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 116.024 1.861 . . . . 2.8900000000000001 116.024 -168.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.86 139.4 57.75 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.689 1.366 . . . . 0.82999999999999996 114.689 -167.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 70.38 171.77 10.34 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.42 1.009 . . . . 1.1200000000000001 115.363 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 4.6 m -157.24 -40.49 0.07 Allowed 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.398 -1.06 . . . . 1.3999999999999999 112.809 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.11 143.54 48.03 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.517 1.127 . . . . 1.3400000000000001 113.125 -175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.2 129.01 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 127.408 2.283 . . . . 2.5800000000000001 109.097 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -25.71 32.14 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.983 1.105 . . . . 3.6000000000000001 113.983 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 34.0 t80 60.7 130.49 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 128.613 2.765 . . . . 3.8100000000000001 114.864 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' 1112 ' ' GLN . 1.0 OUTLIER -149.69 106.89 3.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.613 1.965 . . . . 2.1200000000000001 108.318 169.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 9.8 p -106.43 144.44 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.801 0.728 . . . . 2.6899999999999999 112.744 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 59.2 t -129.25 102.8 18.46 Favored Pre-proline 0 N--CA 1.469 0.517 0 N-CA-C 107.196 -1.409 . . . . 1.3200000000000001 107.196 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.89 136.54 74.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.276 2.651 . . . . 1.6599999999999999 113.512 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.79 20.58 77.62 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.42 1.01 . . . . 2.1400000000000001 114.17 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 21.5 t -145.02 -50.85 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.777 1.231 . . . . 2.3300000000000001 112.826 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 137.33 -153.3 21.87 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 119.524 1.056 . . . . 0.83999999999999997 114.643 174.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.3 mm -120.65 147.79 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.738 1.615 . . . . 2.5899999999999999 112.175 -172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.5 t -133.63 148.26 51.52 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.502 1.921 . . . . 0.71999999999999997 109.303 165.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.0 p -167.34 177.5 6.04 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.428 -1.42 . . . . 0.76000000000000001 114.072 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 137.64 53.78 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 105.965 -1.865 . . . . 3.7999999999999998 105.965 165.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 29.6 m -132.48 154.51 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.835 0.854 . . . . 2.2599999999999998 113.053 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.0 t -161.55 165.39 28.58 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.264 1.579 . . . . 1.8100000000000001 115.264 172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -164.5 -25.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 1 C-N-CA 132.888 4.475 . . . . 2.4199999999999999 108.144 162.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 16.9 pt -43.48 -29.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.512 1.525 . . . . 2.4100000000000001 113.702 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.92 43.85 1.25 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 122.259 1.028 . . . . 4.8300000000000001 111.015 165.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -71.03 11.94 2.43 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 127.035 2.255 . . . . 4.29 116.145 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.9 -11.34 50.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.993 1.717 . . . . 3.9700000000000002 114.212 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.0 tt -82.85 -74.67 0.35 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.661 0.785 . . . . 4.6500000000000004 112.313 -168.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 80.5 t60 -160.95 165.05 30.61 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.84 0.856 . . . . 7.54 112.298 -169.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -54.63 157.99 2.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.845 0.831 . . . . 11.859999999999999 110.534 167.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -43.6 66.75 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.347 -0.846 . . . . 14.65 110.147 172.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -150.45 143.27 24.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 13.130000000000001 111.475 166.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -148.19 -44.02 0.16 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.449 1.099 . . . . 16.050000000000001 111.78 168.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 7.4 m120 -130.5 13.55 5.48 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.872 1.269 . . . . 11.99 113.405 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 68.6 mt -113.99 108.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.838 -1.164 . . . . 13.6 111.184 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -70.87 -5.44 30.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.188 1.395 . . . . 16.98 113.881 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.52 -13.28 26.24 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.048 1.739 . . . . 18.949999999999999 114.094 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . 0.271 6.1 m-20 -89.61 55.91 3.37 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.233 -1.542 . . . . 16.210000000000001 114.638 -169.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 52.9 t30 -118.18 166.66 12.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.169 2.587 . . . . 21.239999999999998 109.778 168.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.79 156.51 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.854 -1.154 . . . . 23.350000000000001 110.15 167.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -126.84 52.59 1.76 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.485 1.114 . . . . 26.43 111.712 -172.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -71.61 62.75 0.4 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.673 1.989 . . . . 26.920000000000002 111.85 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -105.65 139.44 40.24 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.089 1.755 . . . . 30.030000000000001 112.108 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 57.9 m 58.64 72.51 0.52 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.504 1.122 . . . . 32.43 112.072 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.85 2.76 4.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.045 1.868 . . . . 33.390000000000001 116.045 -167.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 29.3 m -93.21 1.33 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.55 1.14 . . . . 37.520000000000003 113.585 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -121.38 79.23 1.51 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.511 1.525 . . . . 39.960000000000001 109.347 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.23 164.33 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 126.621 1.969 . . . . 38.310000000000002 112.622 -168.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.58 131.39 41.66 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.193 0.812 . . . . 38.619999999999997 113.193 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -120.06 7.46 10.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.619 1.568 . . . . 41.43 113.463 172.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 4.0 t -150.64 143.19 24.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.888 2.075 . . . . 42.850000000000001 108.963 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 61.0 t30 -67.21 -39.16 86.24 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.892 1.071 . . . . 40.670000000000002 113.892 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . 0.266 39.3 mt-10 61.21 24.18 14.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.089 1.755 . . . . 40.68 115.258 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 1.3 mp0 61.25 -50.91 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 130.804 3.642 . . . . 44.68 117.843 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 7.9 m -123.68 -37.33 2.64 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 38.210000000000001 112.521 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 51.4 p -166.76 149.89 6.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.257 1.027 . . . . 34.990000000000002 113.208 165.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 12.9 t -101.94 169.61 8.66 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.083 1.753 . . . . 31.91 107.659 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 2.0 t -152.13 82.1 1.26 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 115.578 1.696 . . . . 29.289999999999999 115.578 167.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 47.3 m -73.59 92.58 1.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 101.095 -3.668 . . . . 26.09 101.095 160.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 82.7 p -50.96 -16.14 0.39 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.63 2.826 . . . . 24.079999999999998 118.63 -162.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 14.4 mmt -91.66 -61.01 1.73 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.23 1.012 . . . . 25.809999999999999 110.71 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.63 -27.91 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 113.501 0.926 . . . . 24.09 113.501 -175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.69 -18.27 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 114.052 1.13 . . . . 18.75 114.052 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.26 -28.24 69.21 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.554 1.07 . . . . 13.02 111.778 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -66.95 -20.58 65.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.606 1.163 . . . . 12.57 113.702 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.24 -80.28 0.57 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.751 1.22 . . . . 14.640000000000001 111.139 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.81 -33.87 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.087 1.755 . . . . 13.44 112.869 -167.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.0 m -71.39 -14.22 62.1 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.611 0.967 . . . . 9.1400000000000006 113.611 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . 0.282 4.8 p30 -104.0 -49.29 3.66 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.194 -0.941 . . . . 8.1799999999999997 111.563 164.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.1 -13.36 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.414 1.886 . . . . 5.71 116.014 -170.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -58.56 -47.79 83.06 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.183 0.901 . . . . 8.0500000000000007 112.172 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -99.83 -42.46 6.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.718 1.207 . . . . 5.1500000000000004 112.719 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -91.12 55.73 2.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.574 1.55 . . . . 3.25 111.221 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -42.47 133.05 3.42 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.382 1.073 . . . . 4.3399999999999999 113.77 -169.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 168.22 27.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.478 1.288 . . . . 2.8799999999999999 114.478 -166.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -135.92 126.82 27.6 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.833 1.653 . . . . 3.1099999999999999 109.514 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.1 tttt -84.84 120.39 26.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.327 -0.99 . . . . 1.1399999999999999 108.327 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.8 m -135.26 141.15 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.56 1.073 . . . . 0.57999999999999996 112.469 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.58 152.88 41.17 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 0.45000000000000001 112.92 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.1 tt -153.01 136.77 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.655 1.182 . . . . 0.51000000000000001 110.991 -171.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 150.4 -141.89 9.15 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.252 1.261 . . . . 1.3200000000000001 116.252 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.63 152.14 0.23 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.312 2.645 . . . . 2.3300000000000001 113.509 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -57.49 -28.72 63.66 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 121.244 -0.91 . . . . 4.6100000000000003 112.529 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.35 -31.83 70.69 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.815 1.188 . . . . 4.4900000000000002 113.941 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.1 m95 -63.86 -27.04 68.89 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.281 1.401 . . . . 3.6899999999999999 112.716 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -71.54 -38.85 70.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.092 0.557 . . . . 2.5299999999999998 111.161 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.57 -70.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.12 1.368 . . . . 2.4900000000000002 109.016 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -40.26 -46.91 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 127.454 2.301 . . . . 5.4900000000000002 114.495 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.0 t30 -81.71 9.11 8.37 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.965 1.098 . . . . 0.97999999999999998 113.965 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.74 20.83 79.35 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 120.759 -1.213 . . . . 0.89000000000000001 114.791 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.1 mt -89.08 166.62 13.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.247 1.019 . . . . 1.28 109.868 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.2 t -124.9 112.62 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.859 1.264 . . . . 2.21 109.581 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.2 tt -87.57 147.98 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.569 1.548 . . . . 1.52 111.365 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -116.32 177.6 4.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.63 1.172 . . . . 3.5800000000000001 113.181 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -72.09 -33.42 67.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.282 1.956 . . . . 3.02 116.282 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -84.08 -31.05 25.53 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.127 1.331 . . . . 3.2400000000000002 113.445 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 2.2 p -67.08 -41.14 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 117.991 -1.004 . . . . 1.1799999999999999 110.428 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 59.9 t30 -67.95 -34.5 76.7 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.384 1.447 . . . . 2.6499999999999999 112.157 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.6 -42.13 99.39 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.015 0.926 . . . . 2.25 113.3 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 53.2 t80 -66.73 -40.94 88.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.162 1.385 . . . . 2.1899999999999999 112.105 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 20.3 ttm -63.61 -56.26 17.24 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.369 1.068 . . . . 1.1699999999999999 109.983 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 4.2 t -64.38 -31.5 72.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.629 0.772 . . . . 1.02 112.673 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.45 -51.73 67.49 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.836 -1.165 . . . . 3.5600000000000001 112.297 172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -70.97 -31.09 67.54 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.396 0.887 . . . . 3.8300000000000001 113.396 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -65.07 -34.08 77.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.755 -1.216 . . . . 3.6899999999999999 111.853 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -70.92 -29.9 66.07 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.912 1.285 . . . . 3.7400000000000002 113.268 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 2.2 mttp -71.54 3.17 4.14 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.996 1.318 . . . . 3.2400000000000002 113.439 168.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.77 20.52 55.81 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.732 1.158 . . . . 1.8999999999999999 114.897 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -108.55 158.29 17.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.337 1.455 . . . . 3.3500000000000001 111.482 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.0 m -81.41 137.27 35.69 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.844 2.058 . . . . 0.91000000000000003 110.285 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -138.69 124.77 20.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.886 0.874 . . . . 0.45000000000000001 112.686 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 31.1 m -140.99 158.83 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 125.936 1.694 . . . . 0.54000000000000004 112.887 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mp -108.54 164.26 12.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.86 1.264 . . . . 0.70999999999999996 113.311 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 14.4 t -136.55 118.1 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.428 1.891 . . . . 1.8899999999999999 111.124 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -119.14 155.08 32.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.195 1.398 . . . . 0.44 112.018 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.81 132.45 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.309 1.844 . . . . 0.87 112.218 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 71.1 m-20 40.22 47.94 2.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.882 2.073 . . . . 3.4700000000000002 112.845 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.263 27.9 m-20 60.05 34.74 21.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.484 2.313 . . . . 1.5600000000000001 116.383 -176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -145.13 149.17 34.53 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.578 -1.326 . . . . 2.79 112.651 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.43 142.48 58.16 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 120.319 -1.488 . . . . 0.66000000000000003 113.512 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 25.9 p -125.74 -34.03 2.67 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.897 1.444 . . . . 0.56000000000000005 114.897 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.69 -176.15 38.11 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-N 120.964 1.711 . . . . 0.51000000000000001 115.876 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.64 153.61 42.69 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.839 1.656 . . . . 0.69999999999999996 113.292 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 22.0 mm -123.6 134.39 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.567 1.547 . . . . 0.89000000000000001 110.058 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -117.23 133.01 56.5 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.328 1.851 . . . . 0.58999999999999997 109.549 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -139.31 147.89 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.006 1.723 . . . . 1.3700000000000001 111.974 -167.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -117.69 -164.03 0.98 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.621 1.168 . . . . 1.3600000000000001 112.204 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -119.0 151.16 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.421 1.488 . . . . 4.0899999999999999 112.538 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 116.64 -1.648 . . . . 4.5199999999999996 114.492 -179.599 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . 0.454 " H2'" HD13 ' A' 1088 ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.293 -0.86 . . . . 15.25 111.653 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -142.44 157.47 44.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.753 1.621 . . . . 16.780000000000001 112.705 -173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 67.8 m -68.93 -44.54 72.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.949 1.462 . . . . 8.8300000000000001 114.949 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 46.9 ttp -146.63 -32.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.318 1.97 . . . . 8.3599999999999994 116.318 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.57 -7.31 50.59 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.792 1.404 . . . . 7.6399999999999997 114.792 -171.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.11 72.17 2.52 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.955 -1.091 . . . . 2.8300000000000001 113.038 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 40.8 p -109.99 145.97 33.17 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 113.932 1.086 . . . . 2.79 113.932 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -85.87 153.8 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.09 3.193 . . . . 2.1400000000000001 113.637 -173.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 4.7 m -139.17 126.52 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 126.113 1.765 . . . . 3.0899999999999999 110.475 171.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -72.09 142.43 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 120.756 -1.215 . . . . 1.3999999999999999 110.008 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.9 -42.57 2.6 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.339 0.866 . . . . 2.52 113.339 -168.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -153.59 147.19 25.1 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.749 0.704 . . . . 2.3100000000000001 112.073 172.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 2.5 m -130.69 136.13 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.263 1.025 . . . . 0.73999999999999999 111.043 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 60.9 tttt -138.23 147.83 44.14 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.776 0.831 . . . . 1.74 112.357 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 25.2 t -91.18 137.64 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.561 1.145 . . . . 0.66000000000000003 111.374 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . 0.704 HD23 HD22 ' A' 1222 ' ' LEU . 24.7 tp -107.04 -22.98 12.47 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.253 1.821 . . . . 0.91000000000000003 112.753 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 5.0 t -100.03 27.76 5.32 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.512 1.525 . . . . 2.3100000000000001 113.782 172.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -58.82 125.02 21.78 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.695 -1.253 . . . . 4.1799999999999997 111.538 -170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 58.6 m 43.65 41.0 3.25 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.808 2.043 . . . . 4.21 113.931 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -133.04 -29.25 1.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.028 1.331 . . . . 4.1200000000000001 113.594 172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -146.0 -55.7 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.661 1.726 . . . . 5.5099999999999998 115.661 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 19.7 mt -135.53 144.04 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.991 1.316 . . . . 1.78 110.89 -169.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 50.9 m -98.42 158.62 15.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.641 1.576 . . . . 2.1699999999999999 113.357 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -55.5 -38.0 68.6 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.11 1.522 . . . . 3.1000000000000001 115.11 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 29.2 t60 -75.03 -37.38 61.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.506 1.048 . . . . 2.5899999999999999 112.165 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.5 mttt -65.99 -40.78 91.46 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.137 0.881 . . . . 3.0 111.637 169.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.2 mt -57.75 -52.43 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.826 0.739 . . . . 0.54000000000000004 110.932 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.13 -29.76 69.57 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.198 -0.938 . . . . 0.47999999999999998 112.373 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.01 19.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.092 0.557 . . . . 0.46999999999999997 111.959 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.5 pt -67.64 -35.25 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 120.235 1.38 . . . . 0.57999999999999996 113.055 -176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 46.0 t -70.81 -46.06 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.342 -0.849 . . . . 0.73999999999999999 111.356 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -71.93 -28.58 68.45 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.97 -1.081 . . . . 0.65000000000000002 114.335 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 62.8 p -76.42 -32.71 58.65 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.369 1.067 . . . . 0.67000000000000004 112.398 171.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.37 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.053 0.842 . . . . 0.66000000000000003 112.323 169.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -66.36 -17.07 64.55 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.56 0.948 . . . . 2.23 113.56 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 16.1 p -67.25 -15.62 63.8 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.126 -1.608 . . . . 1.5800000000000001 114.463 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -94.76 -18.51 21.18 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.377 1.071 . . . . 1.8799999999999999 112.565 169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 4.4 t -77.48 164.43 25.44 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.526 1.306 . . . . 1.8700000000000001 114.526 -169.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.12 23.5 4.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.881 2.073 . . . . 3.4100000000000001 112.259 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -85.68 160.8 52.51 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.738 1.215 . . . . 1.8200000000000001 113.136 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -81.51 1.52 9.2 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.58 3.52 . . . . 2.6099999999999999 115.425 -169.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . 0.473 HD13 " H2'" ' A' 1232 ' ' ATP . 5.9 tt -141.12 -48.09 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.938 1.295 . . . . 0.93000000000000005 112.055 -167.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.15 -23.2 65.9 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 115.894 1.117 . . . . 0.90000000000000002 115.894 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 23.7 p -58.0 -25.68 61.41 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.16 -1.2 . . . . 1.5900000000000001 113.324 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.9 85.84 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.316 0.858 . . . . 0.91000000000000003 113.316 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.7 mt -73.53 -41.66 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.243 1.417 . . . . 0.94999999999999996 110.898 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 8.9 t -64.0 -39.13 93.43 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 118.278 -0.867 . . . . 2.1800000000000002 112.204 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 23.5 tttp -60.14 -50.55 73.23 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.529 1.059 . . . . 3.1400000000000001 112.785 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.47 -44.73 55.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.574 1.149 . . . . 2.4300000000000002 112.184 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 35.6 t -69.68 -52.38 26.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.592 1.157 . . . . 1.72 112.416 176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 14.9 tptm -49.96 -39.39 40.46 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.183 1.793 . . . . 2.4500000000000002 112.545 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -72.87 -40.37 65.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.718 1.207 . . . . 3.0800000000000001 113.99 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -70.53 -34.62 72.5 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.061 -1.649 . . . . 2.0699999999999998 113.298 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.01 -7.92 54.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.225 1.41 . . . . 1.0900000000000001 114.421 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 40.3 m-20 53.53 29.99 9.96 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.152 1.381 . . . . 4.6100000000000003 114.094 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -123.4 176.33 6.22 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.141 1.776 . . . . 2.7200000000000002 112.557 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -115.44 -2.97 12.45 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.263 1.425 . . . . 2.6699999999999999 113.716 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.0 t -143.97 125.08 14.47 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.777 -1.202 . . . . 3.0699999999999998 112.443 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.24 144.89 29.21 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.38 1.472 . . . . 0.93000000000000005 110.722 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 68.66 179.38 19.35 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 120.687 -1.258 . . . . 1.0800000000000001 114.201 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.7 m -158.2 -62.54 0.08 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.15 1.38 . . . . 1.6299999999999999 112.911 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.2 t -136.06 142.23 44.35 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.835 1.198 . . . . 1.8899999999999999 112.382 -177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 6.0 mm -143.17 150.17 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 1 C-N-CA 133.085 4.554 . . . . 2.0899999999999999 107.533 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -7.81 12.34 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.043 1.868 . . . . 3.0499999999999998 116.043 -173.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 65.9 m-85 43.94 109.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 129.396 3.079 . . . . 3.5600000000000001 118.773 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.37 94.27 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.879 2.072 . . . . 2.3300000000000001 106.213 166.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 19.2 m -103.21 146.65 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.276 1.03 . . . . 2.52 113.302 -168.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.3 t -138.61 124.61 12.53 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.414 1.486 . . . . 0.94999999999999996 109.231 171.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.35 146.31 39.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.976 3.117 . . . . 1.6200000000000001 112.994 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 53.27 32.57 44.35 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.39 0.995 . . . . 1.6100000000000001 113.396 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 53.9 t -150.01 -81.74 0.11 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.548 1.539 . . . . 1.76 111.655 -168.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 178.12 171.01 41.03 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 121.341 -0.849 . . . . 1.0900000000000001 112.838 -175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.36 157.16 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 117.373 0.586 . . . . 2.6400000000000001 112.124 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 20.1 t -130.89 157.31 43.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.025 1.73 . . . . 0.60999999999999999 111.077 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 27.6 p -162.8 167.44 22.87 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.424 0.898 . . . . 0.56999999999999995 113.424 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -112.24 119.85 39.74 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.227 1.011 . . . . 1.1899999999999999 108.853 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.2 p -111.67 139.08 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 112.944 0.72 . . . . 2.0 112.944 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -128.47 151.44 49.4 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 122.363 1.078 . . . . 1.53 111.75 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -163.66 50.63 0.14 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 130.171 3.388 . . . . 2.7799999999999998 104.807 159.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 88.2 mt -128.02 -55.78 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.639 1.976 . . . . 4.2999999999999998 107.881 -169.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -127.3 20.5 6.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.452 1.901 . . . . 5.2999999999999998 111.056 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -63.52 -22.2 65.55 Favored Glycine 0 CA--C 1.532 1.143 0 O-C-N 120.434 -1.416 . . . . 4.8700000000000001 114.967 -170.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.49 1.56 0.78 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.718 2.007 . . . . 5.9100000000000001 115.037 171.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.82 -46.71 29.02 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.555 1.542 . . . . 6.54 112.651 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 16.6 m80 53.58 149.62 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 128.192 2.597 . . . . 8.7400000000000002 117.326 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.16 160.06 42.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 119.663 -1.898 . . . . 9.8499999999999996 115.918 168.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.78 175.15 5.58 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 103.868 -2.641 . . . . 14.42 103.868 159.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 44.8 t30 -57.72 149.59 21.68 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 119.518 -1.989 . . . . 12.140000000000001 110.336 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -140.5 -23.19 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 116.576 2.065 . . . . 13.43 116.576 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -151.43 -0.57 0.35 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.272 1.212 . . . . 13.52 114.272 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.27 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 119.645 1.111 . . . . 12.82 108.44 -171.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -68.3 81.88 0.24 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.929 1.692 . . . . 17.530000000000001 115.092 -167.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 5.8 t0 66.0 22.36 11.23 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.824 2.45 . . . . 16.239999999999998 115.752 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -55.52 152.35 9.11 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.556 1.942 . . . . 15.51 114.046 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -62.95 125.83 25.31 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.176 -0.952 . . . . 16.350000000000001 112.427 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 38.5 pt -124.87 4.12 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 126.555 1.942 . . . . 14.98 112.908 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -65.36 114.17 4.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.742 1.617 . . . . 16.25 112.21 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -64.11 -29.85 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.612 1.338 . . . . 15.949999999999999 114.612 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 59.98 127.04 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 129.139 2.976 . . . . 16.129999999999999 115.615 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 32.8 m -96.78 149.44 21.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.96 1.304 . . . . 18.449999999999999 111.751 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . 0.282 0.9 OUTLIER 42.27 -142.87 0.09 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.325 2.25 . . . . 20.690000000000001 113.902 -176.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 11.5 p -114.32 147.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.258 1.823 . . . . 21.670000000000002 110.635 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -132.73 108.51 9.06 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.791 0.836 . . . . 23.010000000000002 112.103 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 7.1 tp -77.96 -25.91 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.106 0.963 . . . . 25.870000000000001 111.735 171.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -72.69 140.43 47.88 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.107 0.963 . . . . 27.699999999999999 112.359 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -68.97 -26.88 65.27 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.048 -1.033 . . . . 27.690000000000001 113.424 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 36.5 t -148.17 123.95 10.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.865 1.266 . . . . 28.41 111.125 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 32.6 t30 -155.56 -33.5 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.968 1.307 . . . . 28.219999999999999 112.504 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -90.85 104.62 17.19 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.137 0.881 . . . . 25.27 112.349 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -93.37 -169.45 2.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.225 1.41 . . . . 31.370000000000001 110.56 168.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 9.5 t -45.16 127.4 6.82 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.558 1.318 . . . . 26.719999999999999 114.558 171.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 88.7 p -88.39 3.22 50.67 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.479 1.112 . . . . 26.239999999999998 111.574 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 27.2 p 58.59 10.49 1.43 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.705 2.402 . . . . 28.239999999999998 115.428 -172.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 48.5 t -101.67 159.84 14.97 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.986 1.714 . . . . 24.82 112.176 -172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 42.8 m -76.23 -22.88 54.69 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.942 -1.099 . . . . 24.199999999999999 111.219 168.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 45.8 m -65.05 -8.08 14.79 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.312 1.445 . . . . 23.25 114.635 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . 0.443 ' HG3' HG23 ' A' 1164 ' ' ILE . 13.0 ptt? -92.67 -12.47 31.46 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.879 1.066 . . . . 21.670000000000002 113.879 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . 0.443 HG23 ' HG3' ' A' 1163 ' ' MET . 40.3 pt -126.75 32.08 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.207 1.803 . . . . 17.91 113.07 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.9 pp -73.23 -20.72 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 120.623 -1.298 . . . . 16.91 113.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.96 -30.0 71.23 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.712 -1.242 . . . . 14.75 112.196 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.01 68.24 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.813 0.845 . . . . 14.140000000000001 112.901 172.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.99 -35.53 59.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.519 0.599 . . . . 14.07 111.424 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 61.7 mt -52.28 -27.99 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.83 1.252 . . . . 12.949999999999999 111.603 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 42.6 m -60.69 -10.08 4.83 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.963 1.098 . . . . 12.449999999999999 113.963 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -27.13 65.94 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.767 -1.208 . . . . 10.23 113.768 169.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.38 64.86 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.774 1.398 . . . . 8.0600000000000005 114.774 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -50.66 -36.58 36.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.049 1.34 . . . . 11.91 112.105 169.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 19.0 m120 -96.77 -50.22 4.76 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.073 1.349 . . . . 10.19 112.256 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -90.47 101.81 14.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.717 1.006 . . . . 5.4400000000000004 113.717 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -45.8 145.35 1.44 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.149 1.907 . . . . 4.7400000000000002 116.149 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.57 144.05 39.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.942 1.697 . . . . 2.46 114.256 -171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.89 149.87 23.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.635 1.974 . . . . 3.98 110.57 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -104.74 119.04 38.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.779 0.831 . . . . 1.78 111.572 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 11.1 m -133.84 141.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.995 0.739 . . . . 0.56999999999999995 112.995 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.03 153.54 42.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 0.67000000000000004 113.457 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 3.4 tt -150.09 143.46 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.101 1.36 . . . . 0.69999999999999996 108.919 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 161.13 -160.85 32.47 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 117.789 1.876 . . . . 1.3600000000000001 117.789 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.05 155.97 0.58 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 130.105 3.362 . . . . 2.4399999999999999 113.889 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -55.22 -49.93 70.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.308 1.043 . . . . 4.7199999999999998 113.558 169.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -63.23 -35.38 80.13 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 3.1400000000000001 112.214 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -67.42 -25.37 65.89 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.581 1.553 . . . . 4.1399999999999997 113.552 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 23.1 mmt -77.06 -37.63 54.25 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.118 1.155 . . . . 2.1899999999999999 114.118 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 73.8 mt -53.11 -63.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.382 1.073 . . . . 1.76 108.516 168.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -40.89 -34.43 0.4 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.45 2.7 . . . . 6.4500000000000002 116.348 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.16 9.14 2.7 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 121.458 1.935 . . . . 0.93000000000000005 112.933 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.72 27.41 73.87 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 119.804 -1.81 . . . . 1.0 113.891 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.4 mt -93.65 160.97 14.54 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.363 1.465 . . . . 0.88 110.894 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 22.0 t -92.67 119.56 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.438 0.695 . . . . 1.24 109.825 173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.2 tt -105.81 148.75 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.707 1.603 . . . . 1.72 110.396 172.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -138.58 163.97 30.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.61 0.966 . . . . 3.6400000000000001 113.61 -168.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.01 -27.37 69.37 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.97 1.1 . . . . 3.0099999999999998 113.97 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.62 -30.28 56.83 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.783 1.174 . . . . 2.8399999999999999 113.901 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 1.3 p -76.89 -39.56 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 118.243 -0.884 . . . . 2.1200000000000001 110.466 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -62.54 -41.0 98.6 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.626 1.103 . . . . 2.4900000000000002 112.256 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -67.57 -43.59 80.26 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.039 0.755 . . . . 2.5299999999999998 113.039 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 18.4 t80 -56.44 -38.98 72.36 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.636 0.774 . . . . 3.3399999999999999 111.181 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 17.6 tpp -66.04 -50.55 63.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.933 0.893 . . . . 0.96999999999999997 111.404 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.6 t -64.98 -38.35 90.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.301 0.955 . . . . 1.7 112.063 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -55.98 -53.57 55.26 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.218 -0.926 . . . . 4.6100000000000003 112.334 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -72.33 -32.77 66.81 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.919 1.081 . . . . 3.1400000000000001 113.919 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 15.3 mm-40 -58.48 -41.67 85.82 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.304 0.956 . . . . 3.1200000000000001 111.121 169.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -74.44 -19.93 60.21 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.088 1.755 . . . . 5.79 114.999 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 78.5 mttt -69.88 -13.1 62.09 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.39 1.076 . . . . 4.3300000000000001 112.921 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.53 11.47 59.38 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.327 1.918 . . . . 2.4900000000000002 113.763 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -91.22 156.53 17.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.621 1.568 . . . . 5.3600000000000003 109.345 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 98.6 m -82.92 130.42 35.14 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.639 1.175 . . . . 1.0600000000000001 108.299 168.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.525 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.93 130.23 56.1 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.19 0.996 . . . . 0.44 110.645 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.7 m -143.0 164.53 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 125.089 1.356 . . . . 0.51000000000000001 113.341 -173.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.15 159.77 18.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.508 1.523 . . . . 1.3200000000000001 111.571 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' 1222 ' ' LEU . 7.3 p -138.41 135.08 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.321 1.048 . . . . 1.98 112.597 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -136.74 152.71 50.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.722 1.609 . . . . 0.54000000000000004 111.685 -175.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.0 m -148.7 136.24 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.123 0.969 . . . . 0.89000000000000001 112.082 -171.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 38.3 m-20 41.06 45.31 2.27 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.71 2.004 . . . . 3.6699999999999999 113.163 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.291 52.8 m-20 64.89 32.23 10.9 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.317 2.647 . . . . 1.6200000000000001 117.414 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -137.57 145.15 42.51 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.168 -1.582 . . . . 2.3900000000000001 111.491 168.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . 0.704 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -75.86 122.84 24.71 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.042 -1.036 . . . . 0.90000000000000002 111.206 176.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.7 p -106.3 -32.2 8.28 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.45000000000000001 113.856 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.04 179.44 39.63 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 120.264 1.393 . . . . 0.46000000000000002 116.489 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.05 144.35 34.91 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.272 1.829 . . . . 1.74 111.253 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.72 145.53 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.32 1.448 . . . . 1.3 112.028 -166.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -119.79 133.69 55.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.838 1.655 . . . . 0.57999999999999996 110.878 169.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.41 150.66 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.418 1.887 . . . . 1.77 109.896 -171.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.38 -169.73 2.2 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.894 1.277 . . . . 2.1400000000000001 111.143 171.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -125.56 167.64 14.77 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.813 -1.179 . . . . 4.5899999999999999 112.38 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.919 1.688 . . . . 4.5 114.424 -177.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . 0.473 " H2'" HD13 ' A' 1088 ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.651 0.739 . . . . 10.949999999999999 112.763 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -80.59 -31.52 36.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.436 1.894 . . . . 11.869999999999999 112.742 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 10.2 t -141.33 136.79 31.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.109 1.364 . . . . 7.4299999999999997 110.951 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.18 -174.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.0 1.32 . . . . 6.0999999999999996 111.811 -172.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -119.57 -53.13 2.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.254 1.421 . . . . 6.9900000000000002 110.652 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -113.82 93.81 0.67 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.871 1.224 . . . . 2.52 114.096 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 93.0 m -70.71 141.8 87.85 Favored Pre-proline 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.417 . . . . 2.27 112.438 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.34 155.22 4.54 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.803 3.669 . . . . 1.25 112.529 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 5.9 m -134.75 123.94 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.149 1.779 . . . . 2.6800000000000002 111.057 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.252 2.7 p -74.52 137.19 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.855 -1.153 . . . . 1.21 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.04 -33.1 3.59 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.197 1.554 . . . . 2.4900000000000002 115.197 -164.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -153.12 148.45 26.99 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.466 1.106 . . . . 2.4900000000000002 111.06 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 7.5 m -128.73 130.21 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.762 0.825 . . . . 1.22 111.614 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 69.1 tttt -135.21 144.15 46.78 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.392 1.077 . . . . 1.6599999999999999 113.277 -169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 27.3 t -90.67 135.59 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.417 1.087 . . . . 0.73999999999999999 110.674 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.18 -41.78 8.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.792 1.237 . . . . 0.88 110.772 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 1.5 t -81.97 37.9 0.5 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.675 1.59 . . . . 2.0699999999999998 113.358 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -57.98 119.23 6.38 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.485 -1.384 . . . . 4.8600000000000003 111.185 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 34.0 m 55.17 25.72 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.138 2.175 . . . . 3.4900000000000002 116.081 -171.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -123.95 -21.35 5.12 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 116.454 2.02 . . . . 3.8999999999999999 116.454 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -152.69 -62.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 120.355 1.434 . . . . 5.8200000000000003 113.497 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 63.2 mt -129.12 150.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.817 1.647 . . . . 1.45 109.16 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 7.7 t -108.25 161.91 14.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.739 1.385 . . . . 3.1400000000000001 114.739 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -43.92 -50.7 8.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.925 2.49 . . . . 3.3799999999999999 116.652 -172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -76.36 -32.45 58.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.391 0.996 . . . . 2.7400000000000002 112.149 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 45.9 mttp -67.12 -41.55 86.0 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.008 -1.057 . . . . 2.6699999999999999 112.09 170.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.15 -48.3 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.617 0.644 . . . . 0.53000000000000003 111.05 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.9 -32.94 73.77 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.288 -0.883 . . . . 0.5 112.452 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.16 81.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.742 0.645 . . . . 0.52000000000000002 112.742 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.9 pt -70.23 -38.35 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.362 0.983 . . . . 0.59999999999999998 112.752 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 99.8 t -65.82 -45.58 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.635 1.107 . . . . 0.66000000000000003 110.71 174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.71 -37.58 92.52 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.636 -0.665 . . . . 0.60999999999999999 113.823 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . 0.403 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 23.2 p -72.97 -40.42 65.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.462 1.131 . . . . 0.63 112.182 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.98 -51.71 63.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.977 0.808 . . . . 0.67000000000000004 112.626 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.12 -23.91 67.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.316 -0.865 . . . . 2.7000000000000002 112.485 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 11.9 p -63.85 -18.58 64.3 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.513 1.301 . . . . 1.6000000000000001 114.513 171.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -105.85 5.87 31.08 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.744 1.618 . . . . 2.9199999999999999 111.87 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.7 t -105.31 -177.54 3.39 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.246 1.818 . . . . 1.4199999999999999 112.697 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -128.82 17.5 6.26 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.585 1.954 . . . . 3.8300000000000001 113.703 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -88.16 146.68 38.73 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.127 1.528 . . . . 2.2200000000000002 115.127 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.95 -44.74 4.91 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.725 2.283 . . . . 1.4299999999999999 112.363 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -44.21 74.85 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.64 -0.663 . . . . 1.45 111.533 172.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.37 -44.34 95.23 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.222 0.915 . . . . 1.3200000000000001 113.949 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 20.8 p -64.56 -33.59 76.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.41 -1.053 . . . . 1.5700000000000001 112.184 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.64 -41.84 83.22 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.813 -1.179 . . . . 1.1299999999999999 112.811 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.06 -40.51 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.076 0.55 . . . . 0.89000000000000001 110.493 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 95.2 m -54.07 -46.53 72.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.374 1.07 . . . . 1.0800000000000001 111.057 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.9 tttt -59.89 -48.67 80.73 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.882 0.765 . . . . 2.3199999999999998 112.343 175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -61.55 -43.17 99.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.372 1.069 . . . . 1.8200000000000001 112.719 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 77.8 m -68.74 -45.08 72.4 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.704 1.202 . . . . 3.2400000000000002 111.827 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -63.75 -31.16 72.24 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.856 -1.152 . . . . 3.0099999999999998 111.794 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -66.26 -44.18 84.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.07 0.85 . . . . 3.4399999999999999 110.819 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -61.55 -47.96 83.17 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.199 0.909 . . . . 2.4199999999999999 112.753 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.11 -23.53 63.05 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.212 1.19 . . . . 0.98999999999999999 114.212 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.51 54.77 10.42 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-O 122.764 1.269 . . . . 2.2400000000000002 112.78 -174.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.1 t -127.38 -15.35 5.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.679 1.591 . . . . 3.25 114.449 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 26.8 tt0 58.29 -50.67 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 129.076 2.95 . . . . 2.8799999999999999 115.649 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 4.4 t -111.97 135.01 53.16 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.27 2.228 . . . . 3.3799999999999999 110.883 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.43 174.28 15.47 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.251 1.02 . . . . 1.24 112.847 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 74.31 155.88 4.39 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 123.067 1.371 . . . . 1.0 115.495 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . 0.763 HG22 ' H ' ' A' 1108 ' ' CYS . 97.6 m -150.76 -166.5 2.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.373 2.269 . . . . 2.46 107.312 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . 0.763 ' H ' HG22 ' A' 1107 ' ' THR . 79.5 m -57.84 142.05 47.09 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.655 1.982 . . . . 3.0600000000000001 114.829 -169.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 177.94 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 129.273 3.029 . . . . 2.1099999999999999 110.667 -166.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 1.9 t0 -135.64 171.6 14.22 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.432 1.493 . . . . 2.79 109.484 167.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.385 1.448 . . . . 2.9500000000000002 113.818 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.78 99.34 3.39 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.344 2.657 . . . . 3.3100000000000001 105.776 166.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 42.5 t -99.18 138.61 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.244 1.418 . . . . 2.25 110.389 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 11.4 t -133.6 102.8 12.47 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.971 -1.122 . . . . 1.3100000000000001 107.971 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -61.69 130.25 30.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.52 2.147 . . . . 1.6100000000000001 113.001 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 70.3 20.36 76.68 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.321 0.962 . . . . 1.5700000000000001 114.816 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 50.8 t -143.52 -43.72 0.28 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.28 1.54 . . . . 1.8999999999999999 113.804 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 161.31 -164.43 34.96 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.666 1.026 . . . . 0.89000000000000001 115.666 171.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.5 tt -140.61 154.01 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.529 1.532 . . . . 1.95 111.747 168.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.1 t -132.08 147.05 52.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.717 1.607 . . . . 0.46999999999999997 113.136 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.1 p -151.8 167.37 28.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.532 1.308 . . . . 0.67000000000000004 114.532 -175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . 0.419 ' HE3' ' HD3' ' A' 1179 ' ' LYS . 39.5 mmtm -114.44 97.14 6.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.029 1.732 . . . . 1.22 109.282 171.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.9 p -107.53 130.13 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.727 1.149 . . . . 1.96 113.499 -169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.5 t -115.04 168.54 9.83 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.514 1.126 . . . . 1.0800000000000001 113.752 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 28.0 t-20 179.19 -47.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.422 3.089 . . . . 2.23 107.87 162.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -10.15 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 126.099 1.76 . . . . 2.46 115.538 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -136.47 27.75 3.07 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.508 1.523 . . . . 4.8399999999999999 110.957 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.32 58.6 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.703 -1.248 . . . . 3.3199999999999998 115.611 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.14 -6.02 59.33 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.426 1.269 . . . . 4.3399999999999999 114.426 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.71 -52.73 3.38 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.919 1.687 . . . . 5.4100000000000001 111.536 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -149.6 136.14 19.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.454 1.101 . . . . 9.5800000000000001 111.561 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -93.55 -48.55 6.31 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.553 1.316 . . . . 11.65 114.553 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 1.4 t30 74.04 59.44 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.918 1.687 . . . . 13.960000000000001 109.166 -164.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 52.5 t30 -108.22 134.97 50.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.323 1.849 . . . . 10.34 111.682 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 5.4 m-90 53.5 -172.37 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.529 1.932 . . . . 14.27 112.246 -170.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 9.3 m-80 62.64 34.11 15.2 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 123.493 1.616 . . . . 14.18 112.127 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.96 159.68 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 129.091 2.956 . . . . 14.58 108.982 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -49.71 -41.48 43.57 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.223 1.409 . . . . 21.550000000000001 111.506 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -157.22 126.2 5.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 129.094 2.958 . . . . 18.039999999999999 107.829 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -98.43 -44.76 6.38 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.286 1.403 . . . . 14.890000000000001 111.462 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -81.37 163.12 23.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.294 1.438 . . . . 16.449999999999999 112.512 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 31.4 pt -60.05 144.28 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.921 0.889 . . . . 20.960000000000001 112.833 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -111.66 123.7 50.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.221 1.408 . . . . 20.27 111.263 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 19.0 m120 -132.74 10.77 4.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.218 1.407 . . . . 22.539999999999999 114.713 -169.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -116.02 52.97 0.88 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.091 1.356 . . . . 21.489999999999998 113.165 -170.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 20.1 m 62.5 170.27 0.13 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.24 1.816 . . . . 24.48 114.999 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.27 -24.73 22.0 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.286 1.034 . . . . 23.030000000000001 113.071 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 8.8 t 64.71 108.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 127.13 2.172 . . . . 22.699999999999999 113.998 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 61.36 177.07 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.032 2.133 . . . . 24.969999999999999 115.147 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.37 -23.42 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.972 1.309 . . . . 27.390000000000001 114.114 -168.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -113.1 -49.29 2.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.394 1.452 . . . . 25.170000000000002 112.66 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . 51.42 21.5 1.22 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.217 2.207 . . . . 23.940000000000001 116.228 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 39.6 t -123.91 -48.9 1.87 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.783 1.031 . . . . 23.59 113.783 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 56.5 t30 50.74 47.01 25.19 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.775 1.23 . . . . 26.059999999999999 112.228 -170.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 27.4 tt0 48.87 72.61 0.28 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.952 2.101 . . . . 26.73 113.113 -171.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -56.88 166.61 0.95 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.463 1.282 . . . . 23.640000000000001 114.463 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 37.4 m -66.23 159.03 27.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.256 1.422 . . . . 22.690000000000001 113.578 173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 27.0 p -93.7 3.61 55.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.571 2.063 . . . . 22.670000000000002 116.571 -169.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 17.6 p 63.76 151.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.458 1.903 . . . . 19.710000000000001 114.829 -169.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 43.2 p -170.27 -28.27 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.538 . . . . 18.190000000000001 115.154 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 8.6 t -68.69 129.77 40.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.44 1.274 . . . . 16.0 114.44 -167.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 4.1 m -103.69 21.2 16.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.082 1.753 . . . . 15.699999999999999 113.169 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.1 mmt -90.93 133.22 35.44 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.449 1.278 . . . . 17.050000000000001 114.449 -167.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 22.0 mm 58.61 -24.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 128.29 2.636 . . . . 12.08 114.166 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.7 pp -62.77 -25.64 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 120.25 -1.531 . . . . 9.8000000000000007 112.663 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.96 -24.36 66.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.284 1.034 . . . . 10.18 113.379 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -71.77 -25.93 62.23 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.369 -0.832 . . . . 8.7599999999999998 112.046 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -89.35 -32.81 17.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.023 1.329 . . . . 7.5199999999999996 110.494 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.11 -39.81 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.773 1.229 . . . . 7.6399999999999997 109.402 167.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 68.8 m -65.8 -21.0 66.46 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.16 0.8 . . . . 8.3900000000000006 113.16 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 31.1 t30 -91.31 -11.38 38.18 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.02 1.328 . . . . 7.3099999999999996 114.073 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -44.34 -46.06 9.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.692 2.108 . . . . 6.5899999999999999 116.692 -167.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.63 -26.68 63.98 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 112.949 0.722 . . . . 8.4299999999999997 112.949 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.57 -37.85 9.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.623 1.569 . . . . 6.0700000000000003 111.353 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -98.39 68.81 1.91 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.68 1.992 . . . . 4.7199999999999998 110.832 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -50.06 -31.57 13.39 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.319 0.859 . . . . 4.5 113.319 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 2.7 tm0? 9.5 107.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 129.515 3.126 . . . . 2.6200000000000001 112.982 162.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.07 119.88 25.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.364 1.066 . . . . 2.1800000000000002 113.347 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . 0.419 ' HD3' ' HE3' ' A' 1122 ' ' LYS . 37.7 ttpt -81.35 115.08 20.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.056 1.342 . . . . 1.8600000000000001 109.477 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.0 m -136.59 142.83 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 118.757 0.708 . . . . 0.59999999999999998 112.871 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.61 153.16 47.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.728 1.211 . . . . 0.48999999999999999 112.976 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -140.3 137.04 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.764 1.626 . . . . 0.45000000000000001 108.642 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . -172.42 168.12 41.14 Favored Glycine 0 CA--C 1.528 0.86 0 O-C-N 121.281 -0.887 . . . . 1.6200000000000001 113.26 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.301 12.9 p30 -69.43 -49.33 56.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.021 1.489 . . . . 3.1200000000000001 115.021 -171.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -173.81 -35.69 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 115.064 1.505 . . . . 4.7999999999999998 115.064 169.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.16 -32.13 71.87 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.282 1.401 . . . . 3.3199999999999998 113.286 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.7 t90 -67.27 -22.49 65.66 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.699 -1.251 . . . . 2.9100000000000001 113.022 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -29.24 68.36 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.242 -1.536 . . . . 2.0800000000000001 111.247 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 55.3 mt -69.39 -66.35 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.847 1.659 . . . . 1.6599999999999999 108.63 168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 81.7 mtt-85 -48.01 -32.97 7.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.81 1.644 . . . . 5.2199999999999998 114.9 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.68 5.52 27.84 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 119.919 1.236 . . . . 0.93000000000000005 113.991 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 73.25 35.49 56.81 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.823 -1.173 . . . . 0.94999999999999996 114.572 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.82 158.7 15.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.801 1.241 . . . . 0.72999999999999998 110.343 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 86.7 t -97.26 123.56 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.362 -0.977 . . . . 1.1399999999999999 108.362 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.1 tt -110.44 139.89 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.97 0.89 . . . . 1.4099999999999999 112.675 177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -96.55 150.83 20.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.699 1.2 . . . . 2.7400000000000002 114.182 -168.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -69.2 -26.87 65.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.661 1.184 . . . . 3.7200000000000002 114.057 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -84.26 -42.77 15.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.525 1.13 . . . . 2.8500000000000001 112.989 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 13.1 p -65.09 -35.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 119.117 0.871 . . . . 0.79000000000000004 111.609 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -62.69 -45.71 91.51 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.639 1.109 . . . . 2.3799999999999999 111.528 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.87 -33.88 73.76 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.172 0.989 . . . . 2.6099999999999999 112.652 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.47 -44.35 64.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.605 1.093 . . . . 2.3900000000000001 112.518 172.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.3 tpp -58.89 -48.01 82.93 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.711 1.604 . . . . 1.02 111.799 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 9.7 t -75.5 -38.45 59.46 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.99 -0.528 . . . . 1.54 112.364 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -53.95 -44.76 70.98 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.185 1.357 . . . . 3.48 112.744 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . 0.486 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 65.7 t-80 -62.49 -44.77 95.58 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.59 1.556 . . . . 3.7200000000000002 112.224 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -71.57 -30.71 66.17 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.817 1.247 . . . . 4.2599999999999998 112.655 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -70.46 -16.78 62.96 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.936 1.694 . . . . 4.9299999999999997 113.74 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . 0.369 0.0 OUTLIER -104.01 24.01 12.04 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.84 1.656 . . . . 3.9100000000000001 114.247 170.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 79.58 -1.75 76.02 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 117.755 1.862 . . . . 1.3300000000000001 117.755 167.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -105.6 148.56 27.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 119.706 1.753 . . . . 4.4400000000000004 111.598 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 56.5 m -76.41 128.38 34.7 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.094 1.358 . . . . 1.0900000000000001 112.108 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.46 126.69 44.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.542 1.137 . . . . 0.76000000000000001 112.108 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 32.7 m -141.17 156.73 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 125.141 1.376 . . . . 0.93000000000000005 113.818 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.51 157.22 25.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 128.037 2.535 . . . . 1.47 112.131 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -131.34 119.18 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.519 1.527 . . . . 1.6799999999999999 111.103 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -121.5 147.52 45.66 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.023 1.329 . . . . 0.46000000000000002 111.601 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 35.1 m -144.44 121.67 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.32 1.048 . . . . 0.66000000000000003 112.324 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.255 33.3 t0 41.11 50.97 3.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.582 2.353 . . . . 3.4399999999999999 113.694 -176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.289 7.6 m-20 68.51 25.77 6.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.855 2.862 . . . . 2.2000000000000002 116.714 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.31 143.85 49.29 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.736 1.214 . . . . 2.4100000000000001 111.141 168.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.14 136.59 48.24 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.535 -1.353 . . . . 0.68999999999999995 112.355 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.7 p -113.81 -44.1 3.21 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.898 1.073 . . . . 0.53000000000000003 113.898 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -167.3 -172.23 34.24 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 120.055 1.298 . . . . 0.54000000000000004 115.47 -173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.16 154.0 43.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.914 1.686 . . . . 0.81000000000000005 112.413 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 15.0 mm -126.9 137.23 58.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.28 1.432 . . . . 0.97999999999999998 109.287 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . 0.486 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -114.9 131.52 56.84 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.321 1.849 . . . . 0.95999999999999996 109.801 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.46 155.01 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.92 1.688 . . . . 1.3700000000000001 111.266 -168.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -127.69 173.0 10.28 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.492 1.517 . . . . 1.52 111.881 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -113.65 129.48 56.56 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.082 1.353 . . . . 4.25 111.623 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.256 1.429 0 N-CA-C 115.284 1.587 . . . . 4.3499999999999996 115.284 -175.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.349 0.595 . . . . 10.4 111.294 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -129.4 162.74 27.35 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.949 1.7 . . . . 9.8300000000000001 111.037 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 92.7 m -82.63 145.15 29.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.138 0.975 . . . . 7.79 110.978 171.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 10.6 tpt -84.98 -65.83 0.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.677 1.591 . . . . 8.3900000000000006 110.644 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -116.83 -51.27 2.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.649 1.18 . . . . 8.25 113.948 -174.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -138.62 122.2 2.32 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.094 0.798 . . . . 3.0299999999999998 115.094 -171.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 12.0 m -80.25 139.3 52.31 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 118.04 0.92 . . . . 2.5499999999999998 111.542 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.25 150.01 52.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.269 2.646 . . . . 1.27 112.765 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 6.1 p -134.86 133.56 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.52 1.528 . . . . 3.2799999999999998 109.459 172.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 1.9 p -71.93 121.14 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.539 1.063 . . . . 1.77 108.941 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 17.4 t30 -106.21 -44.75 4.48 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.796 1.036 . . . . 2.9500000000000002 113.796 -166.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -142.98 148.67 37.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.542 1.537 . . . . 1.97 110.812 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 5.0 m -129.16 148.45 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.124 0.97 . . . . 1.1100000000000001 111.432 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -141.38 147.69 38.43 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.151 -0.968 . . . . 3.3399999999999999 112.841 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 62.9 t -105.23 136.76 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.412 1.085 . . . . 0.93000000000000005 111.742 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . 0.585 HD23 HD22 ' A' 1222 ' ' LEU . 22.6 tp -108.77 -23.96 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.872 2.469 . . . . 1.1499999999999999 113.105 178.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 46.2 m -132.91 110.4 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.01 1.324 . . . . 1.75 110.051 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -118.54 155.69 30.44 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.688 1.195 . . . . 3.21 112.946 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 58.25 3.72 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.95 2.574 . . . . 2.8500000000000001 117.95 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -127.49 -11.92 5.6 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.512 1.525 . . . . 2.9700000000000002 114.028 -172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -158.27 -48.88 0.06 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.308 1.843 . . . . 4.3200000000000003 110.312 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 165.41 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 128.471 2.708 . . . . 1.48 108.569 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.0 m -142.31 162.41 35.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.144 1.777 . . . . 1.8700000000000001 111.49 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 10.6 t60 -45.83 -51.87 12.21 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.929 1.826 . . . . 4.7400000000000002 115.929 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -75.21 -28.96 60.16 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.125 -0.985 . . . . 2.6800000000000002 112.224 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 57.3 mttp -70.22 -41.98 72.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.016 -1.053 . . . . 2.8900000000000001 111.706 170.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.01 -52.91 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 0.65000000000000002 110.647 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.94 -32.62 74.42 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.073 0.851 . . . . 0.72999999999999998 112.462 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.22 -51.17 60.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.97 0.508 . . . . 0.79000000000000004 112.17 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.2 pt -70.43 -30.99 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.009 -1.057 . . . . 0.83999999999999997 113.099 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 65.1 t -71.01 -48.86 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.167 0.894 . . . . 1.01 111.796 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.78 -34.64 83.48 Favored Glycine 0 CA--C 1.533 1.191 0 O-C-N 121.248 -0.907 . . . . 1.1899999999999999 113.316 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 58.9 p -74.51 -35.41 63.19 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 112.86 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -56.94 -32.66 66.22 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.125 1.157 . . . . 1.1899999999999999 114.125 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -78.86 -10.51 59.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.439 1.644 . . . . 2.0699999999999998 115.439 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 23.2 t -61.29 -52.07 66.25 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.394 -1.442 . . . . 1.4099999999999999 113.629 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.7 1.24 31.0 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.969 -1.082 . . . . 2.21 113.638 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.3 t -79.53 177.34 8.94 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.447 1.099 . . . . 1.6399999999999999 113.914 -172.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.99 2.5 9.34 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.113 2.165 . . . . 5.2300000000000004 113.267 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -81.04 158.29 70.2 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 114.397 1.258 . . . . 1.6499999999999999 114.397 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.21 -32.37 0.41 Allowed 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.088 2.525 . . . . 1.0 113.913 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.5 tt -97.6 -55.46 2.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.376 0.67 . . . . 0.73999999999999999 112.318 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.55 -28.63 71.64 Favored Glycine 0 CA--C 1.543 1.805 0 N-CA-C 114.292 0.477 . . . . 0.84999999999999998 114.292 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.3 p -61.23 -22.78 65.12 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.011 -1.288 . . . . 1.52 113.725 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.49 72.65 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 120.579 -1.326 . . . . 0.75 112.334 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.81 -34.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.015 1.326 . . . . 0.71999999999999997 110.76 173.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 75.4 m -53.14 -46.7 68.94 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 118.432 -0.794 . . . . 1.1499999999999999 111.508 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.46 -47.32 86.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.463 1.029 . . . . 2.02 112.821 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -55.11 -46.28 75.55 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.217 1.007 . . . . 2.0899999999999999 112.145 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.2 t -66.49 -52.94 40.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.669 0.788 . . . . 1.8400000000000001 112.207 174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.2 -35.26 73.28 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 3.04 112.607 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -67.72 -48.68 65.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.386 1.075 . . . . 2.7799999999999998 111.865 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -61.37 -37.86 84.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.096 0.958 . . . . 2.0099999999999998 113.297 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.59 -16.98 60.78 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.333 1.605 . . . . 1.1299999999999999 115.333 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.2 t0 56.47 30.38 17.0 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.279 1.432 . . . . 2.7200000000000002 114.558 -170.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 14.2 t -107.72 159.88 16.14 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.273 -1.517 . . . . 2.6200000000000001 111.48 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.55 -9.57 26.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.447 1.099 . . . . 2.8799999999999999 111.569 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.0 t -141.92 130.95 23.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.753 2.021 . . . . 3.3700000000000001 111.14 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -163.24 162.08 25.16 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.571 1.548 . . . . 1.3400000000000001 111.091 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 57.82 76.42 0.21 Allowed Glycine 0 N--CA 1.471 1.013 0 CA-C-N 119.175 0.898 . . . . 2.9500000000000002 113.748 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 23.6 m -68.14 -50.08 56.9 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.637 0.606 . . . . 1.76 112.637 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 8.1 t -136.85 142.34 42.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.145 0.978 . . . . 1.7 111.424 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.69 147.77 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 128.202 2.601 . . . . 3.0499999999999998 107.615 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.92 81.05 1.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.173 1.389 . . . . 2.6800000000000002 109.543 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.0 OUTLIER -91.13 137.08 32.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.918 1.822 . . . . 2.4199999999999999 115.918 -168.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -119.05 101.92 8.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.967 3.707 . . . . 2.3599999999999999 106.267 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 21.7 m -99.65 142.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 113.432 0.901 . . . . 2.6499999999999999 113.432 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 25.7 t -133.65 92.86 22.37 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.764 1.226 . . . . 0.97999999999999998 109.06 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.9 149.37 61.52 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.938 3.092 . . . . 2.27 113.496 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.07 15.38 65.06 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.069 -0.851 . . . . 1.7 114.688 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 51.9 t -147.51 -70.72 0.23 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.966 1.383 . . . . 1.9199999999999999 112.159 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 177.52 179.48 47.76 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.662 1.125 . . . . 1.02 112.72 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.51 160.76 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.372 -1.075 . . . . 2.5899999999999999 111.432 175.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 148.93 50.29 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.378 1.471 . . . . 0.70999999999999996 111.227 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 26.8 p -155.81 173.32 16.93 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.405 1.261 . . . . 0.67000000000000004 114.405 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -119.14 123.68 44.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.531 1.132 . . . . 1.3799999999999999 108.745 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.4 t -106.11 148.31 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.797 1.239 . . . . 2.6299999999999999 110.037 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 2.8 t -148.71 158.59 44.25 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.153 1.908 . . . . 1.1000000000000001 116.153 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.259 24.8 t-20 -177.67 56.45 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 132.409 4.283 . . . . 2.9900000000000002 106.949 156.5 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.7 -31.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.129 1.772 . . . . 2.5099999999999998 111.964 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.39 21.18 1.53 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.888 1.675 . . . . 7.5599999999999996 110.889 167.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -52.23 -9.83 0.7 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 127.94 2.686 . . . . 3.6800000000000002 119.489 -165.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.5 -7.51 32.86 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 119.101 1.45 . . . . 5.21 113.269 169.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 57.7 tp -91.75 -37.83 12.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.601 1.96 . . . . 6.3799999999999999 113.448 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 54.7 t60 -48.57 138.83 10.05 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 118.076 2.621 . . . . 10.220000000000001 118.076 -166.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -146.55 151.49 37.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.373 3.069 . . . . 10.73 110.932 171.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 43.4 t30 -80.67 -45.04 17.83 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.478 1.511 . . . . 15.27 109.499 167.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -150.19 140.75 22.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.248 2.619 . . . . 13.9 108.267 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 30.9 m95 -99.47 -42.74 6.81 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.389 0.885 . . . . 15.08 113.389 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -144.03 -8.88 0.7 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 116.444 2.016 . . . . 14.369999999999999 116.444 -165.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.55 112.56 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.103 1.149 . . . . 14.970000000000001 114.103 -162.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.86 -29.06 25.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.6 1.16 . . . . 16.559999999999999 112.362 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.2 -13.28 26.03 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.539 1.136 . . . . 18.77 114.042 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -74.38 -9.39 58.55 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.797 2.839 . . . . 17.25 114.566 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -74.52 55.16 0.63 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.35 1.46 . . . . 17.739999999999998 114.416 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 45.4 pt -143.76 161.31 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.848 2.459 . . . . 21.75 111.326 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -75.0 146.26 41.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.803 0.841 . . . . 20.23 111.592 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -83.46 5.57 23.32 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 120.152 3.39 . . . . 20.48 120.152 -164.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . 0.423 ' HB1' HD22 ' A' 1147 ' ' LEU . . . -120.91 175.19 6.17 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 120.206 1.366 . . . . 21.850000000000001 113.939 -172.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 8.5 t -143.48 62.41 1.37 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.419 1.488 . . . . 25.219999999999999 112.375 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . 0.423 HD22 ' HB1' ' A' 1145 ' ' ALA . 1.1 pt? -145.83 147.58 31.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.353 1.612 . . . . 25.239999999999998 115.353 -174.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 50.0 t -114.33 136.06 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.357 1.463 . . . . 27.109999999999999 112.348 -169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 9.5 tt0 61.22 38.21 16.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.178 1.791 . . . . 30.68 114.735 174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 40.8 mm -117.95 115.87 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.323 1.449 . . . . 27.469999999999999 110.754 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.81 148.69 48.67 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.27 1.028 . . . . 27.440000000000001 113.358 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -74.55 24.67 0.09 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.157 1.783 . . . . 24.5 114.94 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 50.9 m -51.51 -26.59 8.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.446 2.298 . . . . 26.829999999999998 115.605 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -140.94 34.95 1.75 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.093 2.157 . . . . 25.120000000000001 110.885 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.22 113.12 26.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.999 1.319 . . . . 22.890000000000001 108.797 169.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -125.28 162.42 24.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.452 1.501 . . . . 25.59 111.992 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 6.1 t 53.06 -159.79 0.13 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.458 1.903 . . . . 20.989999999999998 114.39 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 79.1 p -118.9 126.7 52.4 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.535 1.934 . . . . 18.710000000000001 112.11 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 8.8 t -156.25 156.71 34.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.199 1.4 . . . . 17.170000000000002 111.478 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 84.9 p -137.51 173.55 11.55 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.494 1.918 . . . . 14.83 112.07 -172.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 82.6 p -61.02 143.27 55.67 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.361 -0.837 . . . . 15.539999999999999 112.824 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 36.4 m -74.06 -5.94 44.55 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.167 1.543 . . . . 13.84 115.167 -168.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.2 ptm -49.23 -26.34 2.88 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.539 1.311 . . . . 14.77 114.539 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 31.9 pt -78.08 -20.47 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 114.147 1.165 . . . . 11.73 114.147 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.5 pp -81.14 -37.31 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.574 1.533 . . . . 10.24 111.331 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -71.96 -23.52 61.46 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.997 0.919 . . . . 11.48 112.192 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -72.04 -13.44 61.6 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.443 1.497 . . . . 9.2200000000000006 114.067 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -112.57 -4.24 14.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.178 1.547 . . . . 7.8499999999999996 115.178 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.56 -33.19 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.29 1.436 . . . . 8.1999999999999993 111.079 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 13.7 p -68.21 -6.86 25.84 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.142 1.534 . . . . 7.3099999999999996 115.142 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -92.24 -5.57 52.19 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 113.968 1.099 . . . . 6.8399999999999999 113.968 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.46 -31.98 70.96 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.205 1.557 . . . . 6.4500000000000002 115.205 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.91 -38.79 76.5 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.079 -1.013 . . . . 7.4100000000000001 112.602 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -83.0 -30.81 27.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.055 1.342 . . . . 5.25 113.444 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.7 127.79 34.98 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.571 0.952 . . . . 5.5 113.571 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.21 -40.63 17.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.125 0.97 . . . . 4.3600000000000003 108.863 166.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -5.5 122.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 130.231 3.412 . . . . 2.1899999999999999 117.376 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.23 110.83 16.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.683 1.593 . . . . 3.1299999999999999 111.554 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 81.3 tttt -79.26 117.81 20.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.115 1.366 . . . . 1.21 109.374 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.2 m -136.61 139.81 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 113.044 0.757 . . . . 0.87 113.044 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.1 150.0 43.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.986 1.315 . . . . 0.47999999999999998 112.772 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 13.2 tt -147.79 141.39 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.277 1.431 . . . . 0.63 109.92 -173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 147.83 -147.32 17.9 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.178 0.831 . . . . 1.46 115.178 175.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -68.98 157.9 35.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.384 1.874 . . . . 2.6099999999999999 113.896 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -53.49 -28.11 29.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.268 2.227 . . . . 8.5299999999999994 114.756 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.65 -39.18 87.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.571 1.148 . . . . 4.0499999999999998 113.415 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.69 -21.16 26.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.678 -0.639 . . . . 3.6200000000000001 112.547 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 15.9 mmt -61.83 -34.61 76.25 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.245 -0.909 . . . . 2.1600000000000001 110.592 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 36.2 mt -68.31 -68.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.812 1.245 . . . . 1.79 109.278 168.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -24.5 23.42 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.194 1.924 . . . . 8.5199999999999996 116.194 -172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -76.08 11.92 1.31 Allowed 'General case' 0 CA--C 1.557 1.24 0 CA-C-N 120.841 1.655 . . . . 0.92000000000000004 112.306 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 77.15 15.44 81.59 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 119.966 -1.709 . . . . 0.98999999999999999 114.731 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.65 -178.1 6.01 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.836 1.318 . . . . 1.1599999999999999 111.248 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 59.9 t -123.37 134.09 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.361 1.465 . . . . 1.28 109.744 170.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -105.6 139.08 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.162 0.985 . . . . 1.02 111.631 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -97.61 160.19 14.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.332 1.453 . . . . 4.1100000000000003 112.705 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.5 -21.22 56.06 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 3.2000000000000002 113.222 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -73.94 -35.29 64.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.377 -0.827 . . . . 3.0499999999999998 112.315 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -74.36 -33.84 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 119.109 -0.472 . . . . 1.05 110.736 168.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -60.27 -37.27 79.94 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.902 0.774 . . . . 2.5800000000000001 111.654 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -64.77 -46.57 81.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.987 1.315 . . . . 2.1299999999999999 112.281 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -41.02 81.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.096 1.358 . . . . 2.7599999999999998 110.646 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 14.1 tpp -64.09 -57.2 10.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.083 1.353 . . . . 0.89000000000000001 111.996 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.6 t -67.27 -30.84 70.82 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.691 0.626 . . . . 1.3700000000000001 112.691 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -58.78 -45.49 89.72 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.296 -0.877 . . . . 2.77 111.113 175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -70.55 -35.78 73.3 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.442 0.904 . . . . 2.29 113.442 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.24 -36.87 83.33 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.47 1.032 . . . . 2.6600000000000001 112.388 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -70.94 -30.49 66.81 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.867 2.067 . . . . 3.4199999999999999 113.189 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 26.8 mttp -72.3 -4.61 30.7 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.168 1.787 . . . . 2.25 112.578 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.38 3.11 87.12 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.894 1.711 . . . . 1.3899999999999999 115.736 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -98.19 164.59 12.26 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.781 1.291 . . . . 4.0 111.482 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 50.5 m -72.8 130.65 40.94 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.313 -0.867 . . . . 1.1100000000000001 110.845 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.1 41.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.838 1.655 . . . . 0.60999999999999999 109.642 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -140.33 153.9 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 113.748 1.018 . . . . 0.46999999999999997 113.748 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.68 162.65 12.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.173 1.389 . . . . 0.97999999999999998 111.642 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 12.0 t -131.73 129.37 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.562 1.545 . . . . 1.96 110.272 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -127.7 148.33 50.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.554 1.141 . . . . 0.58999999999999997 111.039 174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 27.7 m -148.14 130.68 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.683 0.793 . . . . 0.82999999999999996 111.093 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.56 51.92 2.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.802 1.641 . . . . 3.0 112.879 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 12.6 m-20 60.56 33.27 20.48 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.795 2.038 . . . . 1.79 115.551 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -133.95 137.31 44.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.864 1.665 . . . . 2.4500000000000002 111.518 170.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . 0.585 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -75.02 115.87 15.13 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.059 -1.026 . . . . 1.3999999999999999 110.702 171.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 30.3 p -103.99 -30.16 10.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 117.727 -1.13 . . . . 0.64000000000000001 113.676 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -177.57 -169.6 38.82 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.753 1.615 . . . . 0.64000000000000001 115.88 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.69 153.71 43.63 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.687 1.595 . . . . 0.72999999999999998 112.54 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.09 133.73 68.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.775 1.63 . . . . 0.77000000000000002 109.896 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.24 133.96 51.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.173 1.389 . . . . 0.55000000000000004 110.733 170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 41.3 mm -102.54 171.73 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 125.433 1.493 . . . . 2.0 110.469 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -149.47 -167.21 2.76 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.557 1.543 . . . . 1.77 111.912 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -117.61 142.73 46.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.006 2.123 . . . . 5.75 111.692 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 125.069 1.348 . . . . 6.1200000000000001 113.961 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.216 -0.29 . . . . 10.449999999999999 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 89.0 t80 -123.39 124.72 43.55 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.146 1.378 . . . . 14.52 110.471 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 2.6 m 63.87 131.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.59 2.356 . . . . 8.9199999999999999 112.531 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 58.2 ttp -79.35 -54.05 6.32 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.233 -0.917 . . . . 7.4400000000000004 112.704 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -78.02 -38.77 43.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.612 0.765 . . . . 5.5099999999999998 111.988 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -76.5 90.61 0.94 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.167 1.365 . . . . 2.54 112.742 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 108.93 48.42 Favored Pre-proline 0 N--CA 1.472 0.675 0 C-N-CA 124.73 1.212 . . . . 2.4900000000000002 113.272 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.77 143.82 79.07 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.187 2.592 . . . . 2.46 113.091 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 26.9 m -122.04 129.92 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.401 1.081 . . . . 2.6299999999999999 111.527 178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.6 p -73.91 128.39 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.212 -0.93 . . . . 1.1499999999999999 110.968 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -105.88 -45.15 4.44 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.08 1.352 . . . . 2.7999999999999998 112.443 -169.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -155.31 160.83 41.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.627 1.571 . . . . 3.0299999999999998 112.485 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.4 m -127.63 142.33 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.008 1.323 . . . . 0.94999999999999996 111.525 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 28.9 tttt -140.37 146.9 39.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.185 0.994 . . . . 1.8999999999999999 112.861 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 39.6 t -84.83 154.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.374 1.469 . . . . 1.05 111.106 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.0 tp -120.85 -33.06 3.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.917 1.687 . . . . 0.87 111.968 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . 0.41 HG23 ' H ' ' A' 1068 ' ' ILE . 5.0 t -87.24 32.9 0.68 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.197 1.399 . . . . 2.3500000000000001 113.846 176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -59.12 122.0 12.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.795 1.238 . . . . 3.9300000000000002 110.853 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 66.7 m 50.92 32.51 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.816 1.413 . . . . 3.6899999999999999 114.816 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -132.6 -21.65 2.22 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.205 1.402 . . . . 3.8999999999999999 114.514 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -157.49 -56.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.625 1.557 . . . . 4.3899999999999997 114.973 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' 1063 ' ' THR . 31.8 mt -137.61 155.6 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 126.453 1.901 . . . . 1.51 110.707 -167.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 75.0 m -117.31 166.69 12.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.786 1.634 . . . . 2.3999999999999999 114.078 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 3.7 p80 -57.95 -43.21 86.23 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 116.834 2.161 . . . . 2.9900000000000002 116.834 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -72.87 -28.3 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.477 1.035 . . . . 2.5699999999999998 111.626 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -71.1 -48.61 51.41 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.444 -0.785 . . . . 3.4500000000000002 110.934 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.19 -46.67 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.842 0.857 . . . . 0.69999999999999996 111.621 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.4 -34.38 77.82 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.04 0.836 . . . . 0.78000000000000003 112.048 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.13 70.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.639 -0.696 . . . . 0.83999999999999997 112.416 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 20.7 pt -66.78 -26.86 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.493 1.042 . . . . 0.68999999999999995 113.315 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 94.6 t -71.32 -44.18 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.094 0.861 . . . . 0.92000000000000004 110.521 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.48 96.53 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 121.555 -0.716 . . . . 0.60999999999999999 113.778 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 72.7 p -74.06 -37.84 64.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.701 1.25 . . . . 0.73999999999999999 112.904 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -61.46 -51.14 69.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.741 0.816 . . . . 0.75 111.949 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.78 -21.88 62.45 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.648 -0.657 . . . . 2.0899999999999999 112.703 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 67.5 m -62.76 -21.45 65.85 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.501 -1.374 . . . . 2.25 112.806 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 2.53 50.24 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.513 1.525 . . . . 2.98 112.969 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 6.4 t -107.37 -179.59 3.97 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 1.5700000000000001 113.758 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -136.45 32.9 2.78 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.529 2.732 . . . . 4.4699999999999998 111.714 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -97.01 154.69 38.11 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.051 1.34 . . . . 1.6000000000000001 113.61 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.21 -27.54 1.83 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.206 2.604 . . . . 1.1399999999999999 114.939 -174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 4.0 tt -100.17 -48.09 4.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.563 0.745 . . . . 0.87 111.709 -167.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -68.53 -30.24 73.05 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 114.55 0.58 . . . . 0.85999999999999999 114.55 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 61.1 p -67.14 -11.01 56.1 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.649 -1.501 . . . . 1.5 113.956 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.38 78.64 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.97 0.908 . . . . 0.68000000000000005 111.012 167.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.1 mp -71.08 -32.67 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.42 1.088 . . . . 1.4399999999999999 110.866 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 52.0 m -53.16 -49.41 66.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 119.562 1.074 . . . . 1.1899999999999999 112.285 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -65.96 -46.29 78.65 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.086 0.857 . . . . 2.5600000000000001 112.543 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.14 -44.19 71.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.439 1.096 . . . . 1.9199999999999999 111.457 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.9 t -70.44 -55.41 9.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.793 1.237 . . . . 1.79 111.832 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -53.65 -47.12 70.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.299 0.954 . . . . 2.9900000000000002 112.251 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -72.48 -28.76 63.1 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.78 0.659 . . . . 4.1500000000000004 112.78 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -70.2 -46.1 65.26 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.184 0.902 . . . . 2.6000000000000001 112.773 172.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -25.67 62.5 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.804 1.039 . . . . 1.1499999999999999 113.804 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 19.5 t0 50.47 17.98 0.41 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.667 2.387 . . . . 2.4399999999999999 114.624 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 4.5 t -82.59 -7.79 59.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.417 2.287 . . . . 4.1299999999999999 113.979 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 17.5 tt0 63.05 -27.11 0.07 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 129.27 3.028 . . . . 4.29 116.819 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.7 t -144.51 130.45 19.35 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.914 1.234 . . . . 2.7599999999999998 112.368 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.88 154.25 41.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.202 1.401 . . . . 1.0 113.091 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.6 171.46 36.57 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.405 1.479 . . . . 1.4299999999999999 115.214 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 17.9 m -150.23 -70.5 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.873 -1.369 . . . . 1.29 113.978 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . 0.423 ' O ' HD12 ' A' 1109 ' ' ILE . 37.6 t -138.3 139.42 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.959 1.254 . . . . 1.3200000000000001 112.478 -172.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' 1108 ' ' CYS . 1.7 mp -140.89 140.8 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 131.668 3.987 . . . . 2.6699999999999999 106.086 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.283 0.0 OUTLIER -100.76 -13.11 18.59 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.943 1.831 . . . . 3.1000000000000001 115.943 -174.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 5.5 t80 54.54 86.01 0.05 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 129.346 3.059 . . . . 2.71 118.929 166.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.91 102.65 11.82 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.289 1.835 . . . . 2.46 109.067 168.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 84.8 t -99.83 138.88 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.313 1.045 . . . . 1.9399999999999999 111.589 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 16.9 t -131.82 124.45 19.78 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.651 1.18 . . . . 1.0900000000000001 110.989 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.3 140.97 34.68 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.884 2.39 . . . . 1.73 112.507 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 63.16 21.19 63.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.323 0.963 . . . . 1.9399999999999999 114.992 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 99.7 m -139.25 -62.69 0.53 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.969 1.708 . . . . 2.2400000000000002 111.897 -169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.67 -173.35 34.4 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.397 1.475 . . . . 0.70999999999999996 112.01 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.64 158.74 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 122.005 -0.703 . . . . 2.54 111.551 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 27.5 t -132.65 151.63 51.9 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.422 1.489 . . . . 0.46000000000000002 110.634 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.1 p -160.57 172.9 16.35 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.081 -1.012 . . . . 0.84999999999999998 113.317 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -113.65 124.1 51.52 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.59 1.156 . . . . 1.1599999999999999 108.248 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.8 m -122.39 131.74 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 113.602 0.964 . . . . 2.27 113.602 -170.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.4 t -118.68 153.37 34.47 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.757 1.021 . . . . 0.97999999999999998 113.757 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -175.23 -26.03 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.355 3.862 . . . . 2.3999999999999999 108.343 161.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 33.2 pt -46.62 -26.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 126.482 1.913 . . . . 2.5 115.286 169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -146.92 40.65 1.07 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.796 1.239 . . . . 4.4699999999999998 110.055 166.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -77.98 10.29 27.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.413 1.959 . . . . 4.3499999999999996 115.313 -170.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 0.07 0.62 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.882 2.073 . . . . 4.6500000000000004 114.781 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 15.0 tp -86.9 -80.68 0.24 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.852 1.661 . . . . 6.3499999999999996 113.422 -167.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 21.8 t-80 60.99 161.93 0.06 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.325 1.85 . . . . 7.71 112.844 -166.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.95 148.0 25.52 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.48 -1.388 . . . . 9.8499999999999996 110.265 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.54 72.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.422 0.897 . . . . 13.59 113.422 -173.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 95.0 m-20 59.01 157.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.262 2.625 . . . . 11.94 115.516 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 68.2 m95 -140.68 -163.9 1.62 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.428 1.891 . . . . 14.970000000000001 110.81 -171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -51.43 -27.49 10.35 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.346 2.259 . . . . 15.85 115.878 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 72.5 mt 29.79 94.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 129.897 3.279 . . . . 13.449999999999999 114.761 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -72.21 -30.34 64.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.245 1.018 . . . . 15.25 113.62 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.55 -22.66 66.72 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.216 -0.928 . . . . 13.25 112.663 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -83.89 -14.79 50.21 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.793 2.037 . . . . 14.52 114.109 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -68.77 142.01 55.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.316 1.046 . . . . 16.050000000000001 111.352 173.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 1.3 pp -72.09 160.24 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 114.138 1.162 . . . . 19.949999999999999 114.138 -175.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -144.2 145.53 32.13 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.778 1.631 . . . . 18.390000000000001 111.707 -174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -74.69 -23.04 58.56 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.112 0.965 . . . . 22.379999999999999 112.716 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . 0.282 . . 63.93 26.49 14.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.557 2.343 . . . . 19.920000000000002 116.49 170.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 7.0 t -168.52 156.7 8.28 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.237 0.828 . . . . 23.57 113.237 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.65 21.78 2.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.395 1.878 . . . . 27.23 113.16 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 11.3 m -143.97 160.41 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.145 1.778 . . . . 27.829999999999998 112.099 -171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -131.04 150.11 52.3 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.316 1.846 . . . . 31.629999999999999 109.645 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 1.5 mp 45.07 52.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.343 1.457 . . . . 33.469999999999999 111.25 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 18.1 t0 -69.39 154.07 42.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.845 1.658 . . . . 29.800000000000001 112.019 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -73.12 21.43 0.07 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.113 1.365 . . . . 30.280000000000001 112.923 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 83.7 p 50.54 40.6 23.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.466 1.906 . . . . 28.609999999999999 113.02 -168.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -176.98 3.44 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.192 0.997 . . . . 28.43 111.884 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 23.1 tt0 63.74 58.65 1.24 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.79 1.636 . . . . 25.640000000000001 112.3 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -69.5 -10.47 58.19 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.578 -1.326 . . . . 28.440000000000001 113.22 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 23.3 t -152.11 143.93 23.67 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.125 1.37 . . . . 23.469999999999999 111.695 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 89.8 p -147.63 154.84 41.15 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.396 1.079 . . . . 21.050000000000001 112.853 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 70.9 p -87.77 171.51 10.35 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.36 1.464 . . . . 20.109999999999999 112.166 172.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 4.7 t -144.21 135.0 25.06 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.27 0.841 . . . . 17.129999999999999 113.27 173.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 8.4 t -53.35 154.31 3.42 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.696 1.998 . . . . 18.57 112.664 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 19.5 m -75.85 -40.82 53.97 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 117.872 -1.061 . . . . 14.94 112.748 -173.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 38.9 mtt 63.0 168.05 0.13 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.963 2.505 . . . . 15.17 116.707 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.14 25.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.307 2.243 . . . . 14.039999999999999 114.882 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.62 -9.87 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.98 1.712 . . . . 12.880000000000001 113.602 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.46 -9.76 4.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.234 1.414 . . . . 12.49 113.849 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -46.44 -41.15 13.4 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.562 0.745 . . . . 11.0 111.307 165.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -68.64 -24.1 64.51 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.462 1.282 . . . . 8.7799999999999994 114.462 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 57.2 mt -76.43 -39.03 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.256 1.022 . . . . 8.8800000000000008 109.147 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 3.1 t -64.58 -31.48 72.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.058 0.943 . . . . 10.51 111.517 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 24.2 t30 -68.0 -54.86 15.28 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.453 0.701 . . . . 8.9600000000000009 110.864 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.86 62.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.457 1.28 . . . . 6.0999999999999996 114.457 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 7.8 tt -51.26 -48.5 62.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.84 1.656 . . . . 10.16 112.863 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -104.81 -29.43 10.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.317 1.228 . . . . 5.8799999999999999 114.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -94.83 74.98 3.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.706 1.202 . . . . 4.4500000000000002 109.948 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -45.44 146.36 1.03 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.302 1.441 . . . . 3.75 114.42 -170.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.08 128.65 46.58 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.646 1.35 . . . . 2.1699999999999999 114.646 -169.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -80.52 128.68 33.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.644 1.177 . . . . 2.3700000000000001 108.807 168.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.1 tttt -81.78 126.03 31.36 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 107.48 -1.304 . . . . 1.8400000000000001 107.48 167.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.2 m -133.31 138.08 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.786 0.835 . . . . 0.76000000000000001 111.3 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 153.15 46.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.308 1.043 . . . . 0.46999999999999997 112.7 172.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.9 tt -147.96 139.89 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.32 1.448 . . . . 0.51000000000000001 109.135 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 172.45 -172.34 44.85 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 115.735 1.054 . . . . 1.3600000000000001 115.735 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 24.8 p30 -81.08 158.97 24.86 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.441 1.096 . . . . 2.29 113.16 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -45.53 -51.77 11.35 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.006 1.484 . . . . 5.3399999999999999 115.006 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -74.29 -34.45 63.53 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.042 1.292 . . . . 4.5199999999999996 112.671 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 36.7 t90 -68.69 -40.9 79.84 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.031 -1.043 . . . . 3.1899999999999999 111.468 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 91.1 mmm -63.82 -32.9 74.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.698 0.799 . . . . 2.8900000000000001 112.735 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 58.2 mt -59.67 -63.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.504 1.522 . . . . 2.3100000000000001 109.047 167.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -47.4 -8.65 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.887 2.075 . . . . 6.8399999999999999 116.565 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -83.63 13.17 4.85 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 121.459 1.936 . . . . 1.0900000000000001 112.517 168.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 70.02 37.23 73.51 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 119.755 -1.841 . . . . 0.94999999999999996 114.675 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.95 167.49 10.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.234 1.014 . . . . 0.81000000000000005 112.766 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.2 t -105.47 114.49 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.835 1.254 . . . . 1.9399999999999999 109.71 174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.2 tt -107.18 146.04 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.841 1.257 . . . . 1.3799999999999999 110.511 173.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -117.84 171.3 8.15 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.284 1.034 . . . . 3.1200000000000001 112.732 -168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -71.07 -40.26 71.7 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.968 1.47 . . . . 3.1499999999999999 114.968 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.15 -28.36 54.14 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.912 -1.118 . . . . 2.6200000000000001 113.563 -170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 7.5 p -72.04 -43.74 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.608 1.163 . . . . 1.26 111.878 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.4 t30 -66.89 -38.92 87.18 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.53 0.567 . . . . 2.3199999999999998 112.53 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.5 -44.14 84.75 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.57 0.582 . . . . 2.02 112.57 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 17.1 t80 -68.16 -45.08 74.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.148 0.979 . . . . 2.4500000000000002 111.684 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.5 ttm -60.81 -46.91 88.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.974 0.91 . . . . 1.76 112.502 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.4 t -74.76 -33.9 62.38 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.051 0.541 . . . . 1.2 112.446 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.64 -44.85 85.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.22 1.008 . . . . 2.98 111.823 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -69.59 -45.77 67.85 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.794 1.637 . . . . 3.4300000000000002 112.326 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -63.63 -32.77 74.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.955 -1.09 . . . . 3.98 112.017 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -71.26 -22.96 61.9 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.332 1.234 . . . . 4.25 114.332 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 15.6 mttp -76.04 -0.61 22.35 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.387 1.075 . . . . 2.9900000000000002 112.56 167.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.43 16.54 68.6 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.882 1.706 . . . . 1.21 113.951 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -117.8 132.32 56.46 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.376 1.47 . . . . 4.5 109.619 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 96.4 m -65.42 137.37 57.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -167.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -133.16 119.08 19.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.506 1.123 . . . . 0.75 111.475 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.3 m -132.97 157.98 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.339 1.456 . . . . 0.42999999999999999 113.03 -170.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.6 mt -111.16 156.68 21.03 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.833 1.653 . . . . 1.23 111.53 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.6 p -132.12 133.95 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.401 1.48 . . . . 2.3900000000000001 111.236 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -135.08 153.34 52.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.962 1.705 . . . . 0.48999999999999999 111.405 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.56 135.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.90000000000000002 112.541 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 48.8 m-20 42.3 48.82 4.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.754 1.621 . . . . 2.7200000000000002 112.832 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.266 57.3 m-20 55.6 33.94 22.18 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.951 2.1 . . . . 2.5 115.497 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.69 141.48 49.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.081 2.552 . . . . 2.0800000000000001 110.145 171.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.43 130.9 40.5 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 119.85 -1.781 . . . . 0.79000000000000004 112.444 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 22.3 p -108.22 -35.3 6.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.599 -1.191 . . . . 0.80000000000000004 114.081 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -173.23 -167.07 32.57 Favored Glycine 0 N--CA 1.475 1.277 0 CA-C-N 120.7 1.591 . . . . 0.58999999999999997 116.447 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.84 154.7 44.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.475 1.91 . . . . 0.81000000000000005 112.481 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.0 mm -124.4 137.33 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.932 1.693 . . . . 0.81999999999999995 109.708 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.53 137.49 46.39 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.873 1.669 . . . . 0.68000000000000005 110.351 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.18 151.7 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.877 1.671 . . . . 1.45 110.843 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -124.18 -170.0 2.06 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.268 1.427 . . . . 1.47 112.666 169.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.283 2.7 t70 68.78 -140.94 0.09 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.965 2.106 . . . . 4.9299999999999997 111.81 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.255 1.376 0 N-CA-C 116.689 2.107 . . . . 9.3800000000000008 116.689 -167.898 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.522 -0.177 . . . . 11.56 110.522 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -117.88 172.33 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.64 1.176 . . . . 10.77 112.645 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 84.3 m -52.95 -50.87 63.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.078 1.751 . . . . 7.3899999999999997 113.086 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 2.3 ttp 64.05 -8.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 117.32 2.341 . . . . 10.08 117.32 170.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -50.56 -58.2 6.36 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.652 1.569 . . . . 9.5099999999999998 114.199 -171.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -94.76 69.53 1.19 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.1 0.857 . . . . 4.21 112.337 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.5 p -117.09 149.06 43.62 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.513 1.525 . . . . 3.04 113.499 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.22 148.6 77.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.324 2.016 . . . . 2.1899999999999999 113.676 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.5 p -120.33 124.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.039 1.735 . . . . 2.4399999999999999 110.396 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.251 13.1 p -72.12 130.63 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.309 -0.869 . . . . 1.1599999999999999 110.296 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.54 -40.81 4.5 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.446 1.276 . . . . 2.3100000000000001 114.446 -166.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -157.64 146.3 19.41 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.183 0.593 . . . . 1.9399999999999999 112.08 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 28.1 m -126.86 144.24 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.549 1.14 . . . . 1.0800000000000001 112.11 169.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 72.7 tttt -134.77 141.76 46.53 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.119 1.368 . . . . 1.8200000000000001 110.962 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 49.7 t -92.03 134.36 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.484 1.114 . . . . 0.72999999999999998 110.778 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . 0.488 HD23 HD22 ' A' 1222 ' ' LEU . 9.7 tp -99.21 -65.27 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.906 2.082 . . . . 0.89000000000000001 111.022 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 38.1 m -78.63 75.02 5.16 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.481 -1.303 . . . . 1.72 107.481 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.63 123.97 29.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.274 1.03 . . . . 3.9399999999999999 109.016 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 70.7 m 60.71 174.76 0.1 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.0 1.482 . . . . 3.6600000000000001 115.0 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 64.63 -0.03 1.03 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 117.612 2.449 . . . . 4.2599999999999998 117.612 171.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -147.57 -44.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.803 1.241 . . . . 5.0499999999999998 112.634 167.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.4 mm -130.09 163.9 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 125.943 1.697 . . . . 1.9199999999999999 109.614 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 20.4 m -119.35 145.59 46.04 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.818 1.647 . . . . 2.3700000000000001 111.109 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -49.79 -51.35 40.13 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.797 1.777 . . . . 4.7199999999999998 115.797 -170.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 72.8 m80 -74.25 -14.32 60.9 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.969 1.259 . . . . 4.71 112.804 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.94 -37.97 33.36 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.944 -1.027 . . . . 3.46 111.493 168.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.91 -54.34 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 119.32 0.964 . . . . 0.69999999999999996 110.13 171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.19 -32.27 72.39 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.643 -0.66 . . . . 0.72999999999999998 112.332 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -63.65 -46.98 83.17 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.65 0.659 . . . . 0.72999999999999998 112.576 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.6 pt -71.36 -29.42 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.916 -1.115 . . . . 0.68999999999999995 113.427 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.3 t -69.2 -52.35 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.289 0.949 . . . . 0.70999999999999996 111.107 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.01 -35.87 91.23 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.791 -0.568 . . . . 0.68999999999999995 113.17 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 36.2 p -71.66 -36.0 70.52 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.523 1.161 . . . . 0.70999999999999996 112.693 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -66.31 -49.36 67.3 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.901 0.773 . . . . 0.69999999999999996 112.846 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -72.08 -15.17 62.01 Favored 'General case' 0 CA--C 1.552 1.032 0 O-C-N 121.366 -0.834 . . . . 2.02 112.715 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.3 t -66.35 -21.9 66.25 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 119.42 -2.05 . . . . 1.28 112.493 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -89.98 2.04 55.59 Favored 'General case' 0 CA--C 1.557 1.227 0 O-C-N 121.073 -1.017 . . . . 2.1299999999999999 113.007 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 57.8 m -103.59 167.24 9.93 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.621 1.569 . . . . 1.72 114.224 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.26 12.34 7.62 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.084 1.754 . . . . 3.4700000000000002 112.585 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -71.63 148.25 92.68 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.602 -1.311 . . . . 2.2000000000000002 113.141 -170.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.95 -31.35 31.17 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.226 2.617 . . . . 1.1299999999999999 114.631 -168.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.4 -51.45 3.22 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.168 1.387 . . . . 0.89000000000000001 111.793 -168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -57.12 -34.68 67.05 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.454 0.55 . . . . 1.1000000000000001 113.514 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 18.1 p -61.25 -14.5 26.58 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.869 -1.371 . . . . 1.3 114.477 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.09 82.94 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.758 -1.214 . . . . 0.89000000000000001 111.713 168.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.12 -39.27 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 125.397 1.479 . . . . 0.81000000000000005 109.774 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 24.3 m -57.44 -44.39 84.68 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 117.934 -1.032 . . . . 1.3400000000000001 112.552 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.27 -47.38 79.77 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.066 1.303 . . . . 2.3799999999999999 112.091 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -55.69 -43.12 76.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.903 0.481 . . . . 1.6200000000000001 111.433 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 94.7 m -69.16 -49.91 52.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.934 1.293 . . . . 2.9300000000000002 112.389 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -49.9 -48.7 51.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.375 1.47 . . . . 3.5800000000000001 111.534 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.93 -38.91 72.93 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.591 0.756 . . . . 2.7200000000000002 112.388 175.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.3 -36.2 81.04 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.485 1.039 . . . . 2.3500000000000001 112.756 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 5.4 mt -72.42 -9.21 58.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.83 1.252 . . . . 1.1599999999999999 114.0 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.04 50.82 18.33 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.029 1.332 . . . . 3.5800000000000001 111.887 -170.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 10.9 t -138.45 168.73 19.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.385 1.074 . . . . 2.8300000000000001 112.502 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -102.62 -17.61 15.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.875 1.67 . . . . 3.8300000000000001 111.26 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.6 t -136.89 130.64 31.99 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.865 -1.147 . . . . 2.8700000000000001 113.574 -168.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.86 159.14 32.14 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.591 1.556 . . . . 1.02 110.169 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 76.44 127.82 0.28 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.931 0.777 . . . . 1.3999999999999999 114.13 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 53.2 m -123.73 -71.17 0.73 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.67 1.188 . . . . 1.4199999999999999 112.709 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 4.4 t -135.44 143.19 45.78 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.096 1.316 . . . . 1.5800000000000001 112.509 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' 1121 ' ' CYS . 5.1 tp -132.35 163.48 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 1 C-N-CA 132.413 4.285 . . . . 2.6000000000000001 109.416 -166.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -143.06 86.4 1.92 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.214 1.806 . . . . 2.6899999999999999 106.176 166.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -93.63 147.9 22.59 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.699 2.111 . . . . 3.5699999999999998 116.699 -164.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -137.92 118.47 13.91 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.332 2.253 . . . . 2.1299999999999999 109.133 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 17.0 t -112.73 140.63 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.391 1.076 . . . . 1.8999999999999999 113.867 -168.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 92.7 t -139.71 117.0 8.42 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 127.025 2.13 . . . . 1.0700000000000001 107.472 167.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.22 144.24 50.98 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.66 2.24 . . . . 1.5600000000000001 112.361 -173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.06 1.41 12.69 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.099 1.2 . . . . 1.6799999999999999 116.099 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 1.3 m -136.8 -30.62 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.686 1.736 . . . . 2.6899999999999999 115.686 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 156.66 168.33 19.2 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 121.337 1.88 . . . . 0.83999999999999997 116.888 168.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 137.35 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.808 1.243 . . . . 1.9299999999999999 109.911 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 39.3 t -126.67 144.87 50.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.614 1.565 . . . . 0.47999999999999998 109.785 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' 1109 ' ' ILE . 30.1 p -154.1 174.55 14.57 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.765 1.024 . . . . 0.67000000000000004 113.765 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -116.77 123.5 47.29 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.215 -2.143 . . . . 1.4099999999999999 105.215 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 9.2 p -117.56 144.73 24.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 118.771 0.714 . . . . 2.0 110.807 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.5 t -134.3 155.5 50.11 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.134 1.531 . . . . 1.0 115.134 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.28 15.2 t-20 179.7 57.75 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 1 C-N-CA 132.991 4.516 . . . . 2.75 104.918 158.843 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 2.1 pt -146.28 -72.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 128.072 2.549 . . . . 3.1200000000000001 110.292 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -140.69 -11.38 1.02 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.93 1.826 . . . . 4.4000000000000004 115.93 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -62.3 8.73 0.16 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 117.735 1.854 . . . . 5.6799999999999997 117.735 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.8 pp -87.63 0.22 55.96 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 128.282 2.633 . . . . 5.1100000000000003 114.778 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 4.3 tt -58.08 -49.5 76.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.539 1.136 . . . . 5.4000000000000004 111.809 -170.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 31.2 m170 57.7 172.74 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.756 2.022 . . . . 7.9299999999999997 115.813 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -89.09 151.27 22.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.128 1.371 . . . . 14.27 109.268 165.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -80.29 123.69 28.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.035 0.934 . . . . 15.06 109.038 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -81.14 72.6 8.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.81 0.844 . . . . 12.51 113.002 -167.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.13 -40.29 1.32 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.636 1.717 . . . . 19.079999999999998 115.636 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -123.47 5.7 8.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.525 1.53 . . . . 15.91 112.918 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.49 114.13 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.491 1.116 . . . . 13.57 110.981 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -82.68 -22.64 34.5 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.404 1.082 . . . . 18.77 111.782 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.87 -15.92 63.95 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.522 1.129 . . . . 15.539999999999999 113.717 173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.41 48.41 0.9 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.56 2.344 . . . . 15.02 113.628 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -135.39 158.71 43.67 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.665 1.986 . . . . 17.84 110.114 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 6.6 pt -79.64 132.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 114.76 1.392 . . . . 18.800000000000001 114.76 -171.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -137.37 146.87 45.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 129.23 3.012 . . . . 17.300000000000001 108.216 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 18.7 t30 -81.25 60.54 4.39 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 118.974 2.953 . . . . 19.719999999999999 118.974 -163.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -117.37 123.24 45.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.402 1.081 . . . . 16.530000000000001 108.944 166.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 3.3 t 61.47 160.84 0.06 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.272 1.429 . . . . 17.760000000000002 114.606 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.9 mm? 45.48 44.1 9.42 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.355 1.462 . . . . 20.109999999999999 110.085 -168.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 57.2 t -59.04 120.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.248 1.419 . . . . 22.140000000000001 112.109 -166.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -148.64 148.04 29.63 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.146 1.378 . . . . 24.809999999999999 110.802 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.89 -44.13 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.783 1.633 . . . . 27.93 110.853 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -136.53 10.76 3.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.221 1.408 . . . . 31.359999999999999 113.509 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -89.06 -25.58 21.86 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.332 1.234 . . . . 30.02 114.332 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 21.5 t 41.33 56.33 3.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.368 1.867 . . . . 30.989999999999998 112.621 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -93.65 -38.95 11.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.82 0.848 . . . . 28.949999999999999 112.255 -169.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -130.88 155.87 46.02 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.04 0.936 . . . . 26.809999999999999 112.74 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.85 -16.44 11.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.75 2.02 . . . . 32.469999999999999 113.641 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 3.6 t -152.75 33.28 0.49 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.723 1.379 . . . . 24.93 114.723 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.25 99.4 p -96.51 -119.11 0.12 Allowed 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.049 -1.032 . . . . 21.850000000000001 111.237 171.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 4.2 p 60.51 172.23 0.09 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 126.828 2.051 . . . . 19.140000000000001 116.201 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 48.8 m -109.12 20.22 18.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.24 2.216 . . . . 16.469999999999999 112.014 168.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 1.3 t -128.22 -8.03 5.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.446 1.276 . . . . 15.52 114.446 -169.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 90.7 p -104.22 -22.57 13.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.609 1.564 . . . . 17.579999999999998 114.938 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 9.3 ptt? -76.75 33.92 0.14 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.993 1.849 . . . . 15.130000000000001 115.993 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . 0.262 4.0 mt 64.12 28.78 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 127.45 2.3 . . . . 13.25 112.563 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -17.76 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 116.843 2.164 . . . . 11.609999999999999 116.843 -169.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -131.85 -17.75 2.78 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.362 1.245 . . . . 9.9499999999999993 114.362 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -58.62 -19.39 38.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.716 1.207 . . . . 8.1099999999999994 113.409 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -92.67 -7.73 46.02 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.471 1.908 . . . . 8.2300000000000004 115.176 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.33 -40.16 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.047 0.839 . . . . 7.3200000000000003 111.159 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 94.6 p -54.05 -27.31 31.53 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.008 1.114 . . . . 6.2999999999999998 114.008 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -87.53 -6.92 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.94 1.696 . . . . 6.7199999999999998 113.557 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.93 31.47 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.26 1.424 . . . . 4.5300000000000002 114.528 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 10.4 tt -45.96 -38.4 7.6 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.931 1.292 . . . . 6.9800000000000004 113.675 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 28.8 m120 -100.02 -34.92 9.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.694 1.597 . . . . 5.46 112.609 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -89.18 50.57 1.96 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.538 1.935 . . . . 4.0300000000000002 111.768 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -50.15 143.35 8.43 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.906 1.447 . . . . 3.5499999999999998 114.906 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . 0.467 ' HG2' ' HB ' ' A' 1124 ' ' THR . 54.4 mt-30 -138.82 173.91 11.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.398 2.279 . . . . 1.9399999999999999 111.276 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.46 127.34 53.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.675 1.19 . . . . 2.79 108.577 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 83.6 tttt -86.64 123.36 31.74 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.751 -0.833 . . . . 1.53 108.751 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -132.77 139.54 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.289 0.495 . . . . 0.79000000000000004 111.934 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.16 147.51 36.75 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.564 1.146 . . . . 0.57999999999999996 112.471 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 8.9 tt -141.59 138.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.302 1.441 . . . . 0.48999999999999999 108.717 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 171.82 -166.85 39.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 117.142 1.617 . . . . 1.4099999999999999 117.142 -174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -87.31 162.76 17.21 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.362 3.065 . . . . 2.4900000000000002 111.895 -169.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -44.21 -65.09 0.55 Allowed 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.344 1.609 . . . . 7.8200000000000003 115.344 -167.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -71.42 -34.3 70.21 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.863 1.21 . . . . 3.25 113.765 -171.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -68.99 -27.88 66.1 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.005 -1.059 . . . . 2.8700000000000001 112.443 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 55.2 tpp -70.69 -42.88 70.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.103 0.561 . . . . 2.1400000000000001 112.292 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 97.4 mt -49.3 -61.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.065 1.346 . . . . 1.8100000000000001 109.504 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -51.31 -11.57 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.071 2.249 . . . . 6.1900000000000004 117.071 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.28 15.49 0.44 Allowed 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 121.988 2.176 . . . . 0.87 111.254 166.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.13 11.71 81.69 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 119.354 -2.091 . . . . 0.76000000000000001 114.589 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.82 159.68 25.03 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.902 1.351 . . . . 0.80000000000000004 111.306 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 74.1 t -94.23 122.45 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.079 1.352 . . . . 1.01 109.612 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 16.4 tt -96.48 132.25 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.245 1.018 . . . . 1.1699999999999999 110.277 169.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 10.6 p30 -93.21 153.9 18.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.521 1.128 . . . . 4.0199999999999996 112.879 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -61.88 -32.9 73.3 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.156 -0.965 . . . . 2.7999999999999998 112.997 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.91 -44.65 80.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.922 0.889 . . . . 2.6800000000000002 112.139 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.9 p -73.4 -31.34 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.347 -0.846 . . . . 1.03 111.72 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -64.15 -38.68 91.93 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.898 1.227 . . . . 2.2400000000000002 111.624 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.75 -33.69 75.37 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.955 0.902 . . . . 2.5099999999999998 112.151 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.75 -44.3 81.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.025 1.73 . . . . 2.6099999999999999 112.096 170.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 27.0 tpp -62.59 -50.37 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.26 1.424 . . . . 0.81999999999999995 110.73 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 2.0 t -72.23 -30.9 65.34 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.819 0.674 . . . . 1.02 112.819 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.63 -51.77 67.43 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.042 1.292 . . . . 2.5600000000000001 112.234 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -69.52 -30.9 68.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.868 0.692 . . . . 2.6299999999999999 112.868 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.1 -41.27 90.85 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 121.357 -0.839 . . . . 2.5699999999999998 111.884 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.37 -22.73 61.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 114.232 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 22.3 mttp -73.13 -5.35 38.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.077 2.151 . . . . 2.52 114.406 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 96.68 9.88 55.98 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.128 1.347 . . . . 1.79 115.246 172.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -113.73 -176.94 3.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.332 1.453 . . . . 3.3300000000000001 111.53 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 90.6 m -102.53 138.35 39.57 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.091 1.756 . . . . 0.93999999999999995 111.023 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.56 127.77 35.78 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.985 1.314 . . . . 0.55000000000000004 111.431 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 34.4 m -140.14 159.6 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.358 1.063 . . . . 0.55000000000000004 112.965 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.44 155.04 21.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.895 1.678 . . . . 1.1399999999999999 110.942 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.1 p -132.86 130.32 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.48 1.112 . . . . 2.0099999999999998 112.61 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -129.46 154.59 46.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.559 1.544 . . . . 0.54000000000000004 111.944 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 31.7 m -148.72 130.05 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.462 0.705 . . . . 0.83999999999999997 112.416 -170.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 9.5 m-20 41.35 43.61 2.15 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 3.2000000000000002 112.853 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.312 14.8 m-20 68.86 30.63 4.63 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 117.095 2.258 . . . . 2.2799999999999998 117.095 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.71 141.16 50.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.225 1.81 . . . . 2.5600000000000001 109.871 165.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . 0.488 HD22 HD23 ' A' 1062 ' ' LEU . 0.4 OUTLIER -78.74 109.75 13.27 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.73 -1.231 . . . . 1.5700000000000001 111.077 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -94.42 -27.59 15.95 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.027 -1.046 . . . . 0.51000000000000001 112.771 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.27 -176.29 40.96 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 116.336 1.294 . . . . 0.44 116.336 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.39 154.31 45.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.461 1.904 . . . . 0.69999999999999996 111.905 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 4.0 mt -136.78 135.61 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.917 1.287 . . . . 1.5700000000000001 110.62 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -108.39 137.83 45.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.058 1.343 . . . . 0.68000000000000005 110.678 170.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 4.1 mp -141.25 145.65 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.163 1.785 . . . . 1.6399999999999999 108.925 -173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -112.01 124.82 53.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.218 1.007 . . . . 1.5700000000000001 111.618 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 37.1 t0 -73.38 144.05 46.57 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.23 -0.919 . . . . 3.8100000000000001 111.574 172.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.403 1.481 . . . . 4.1600000000000001 112.315 175.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 120.431 0.158 . . . . 11.6 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 43.5 p90 -81.28 155.49 26.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.299 1.44 . . . . 11.01 113.354 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 29.4 m -130.81 146.88 52.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.621 1.968 . . . . 8.0800000000000001 109.486 171.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 8.9 tpt -108.58 94.11 4.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.204 1.802 . . . . 6.6799999999999997 109.617 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -89.43 -43.74 10.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 116.624 2.083 . . . . 7.0899999999999999 116.624 -167.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -83.04 72.94 2.76 Favored Glycine 0 N--CA 1.47 0.924 0 O-C-N 120.989 -1.069 . . . . 3.0699999999999998 112.226 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 15.1 p -76.76 148.23 79.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.823 1.649 . . . . 2.5899999999999999 115.332 -167.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' 1091 ' ' ALA . 44.1 Cg_endo -81.48 158.4 19.47 Favored 'Trans proline' 0 CA--C 1.539 0.773 1 C-N-CA 125.552 4.168 . . . . 1.97 112.73 176.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 2.4 m -139.76 130.11 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.84 1.656 . . . . 2.6499999999999999 111.734 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . 0.254 8.7 p -77.07 129.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.048 -1.033 . . . . 1.4299999999999999 112.342 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -114.82 -39.84 3.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.042 0.937 . . . . 2.3900000000000001 113.42 -167.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -149.09 151.58 34.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.095 1.358 . . . . 2.8999999999999999 111.314 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 8.6 m -135.41 146.6 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.397 1.079 . . . . 0.89000000000000001 111.356 171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 68.1 tttt -141.53 138.9 33.06 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.47 1.108 . . . . 1.6899999999999999 112.854 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 98.9 t -88.82 142.39 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.284 1.033 . . . . 0.72999999999999998 111.286 172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . 0.479 HD23 HD22 ' A' 1222 ' ' LEU . 30.2 tp -106.21 -39.85 5.81 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.525 1.53 . . . . 1.4099999999999999 111.977 170.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 53.1 m -124.81 97.17 5.16 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.682 0.674 . . . . 1.8500000000000001 112.502 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -144.82 111.61 5.82 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.469 1.507 . . . . 5.9900000000000002 108.26 168.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 8.6 t -178.37 -52.8 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.563 1.945 . . . . 5.04 110.777 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 6.7 m120 -150.24 41.76 0.82 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.748 1.619 . . . . 6.6399999999999997 112.932 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -146.82 -58.57 0.28 Allowed 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.507 -1.37 . . . . 4.7999999999999998 112.876 171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 1.9 mt -135.16 155.23 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.524 1.53 . . . . 2.27 110.247 -173.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 15.3 m -110.01 143.12 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.306 1.042 . . . . 2.8599999999999999 110.767 172.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 1.6 p80 -54.03 -42.23 68.92 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.286 2.328 . . . . 4.0999999999999996 117.286 -168.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 46.9 m80 -68.59 -29.06 67.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.984 1.265 . . . . 4.6699999999999999 111.81 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -69.27 -40.19 77.92 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 117.93 -1.033 . . . . 3.7000000000000002 111.315 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 82.3 mt -55.15 -54.74 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 118.968 0.804 . . . . 0.85999999999999999 110.536 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.51 -33.16 74.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.683 -0.635 . . . . 0.77000000000000002 112.152 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.11 81.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.542 0.571 . . . . 0.51000000000000001 112.542 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.0 pt -69.84 -31.25 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.546 1.066 . . . . 0.52000000000000002 112.921 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 48.0 t -71.12 -49.88 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.007 0.822 . . . . 0.57999999999999996 111.635 170.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.68 -33.86 87.27 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.376 -0.828 . . . . 0.68000000000000005 113.903 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 34.9 p -74.27 -37.88 63.59 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.822 0.849 . . . . 0.75 112.581 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.39 82.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.069 0.849 . . . . 0.68000000000000005 112.772 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -66.62 -18.97 65.65 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.858 -1.151 . . . . 2.2400000000000002 113.362 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 1.6 t -64.91 -15.52 62.14 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.062 -1.024 . . . . 1.74 112.722 171.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -128.66 -20.22 3.61 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.075 1.35 . . . . 3.1899999999999999 114.205 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.9 t -70.44 -44.61 67.49 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.908 -1.12 . . . . 3.9700000000000002 112.313 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . 0.301 33.1 mt-10 70.74 32.29 2.54 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.423 1.889 . . . . 5.2300000000000004 115.386 170.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -79.98 146.32 63.31 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 125.263 1.425 . . . . 1.6499999999999999 113.468 169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.42 -54.15 3.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.985 3.79 . . . . 1.28 114.352 -169.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . 0.533 HD13 " H2'" ' A' 1232 ' ' ATP . 5.9 tt -68.05 -33.69 75.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.818 1.247 . . . . 0.91000000000000003 111.459 -177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -62.34 -22.31 63.16 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.207 1.384 . . . . 0.90000000000000002 114.813 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 51.7 p -61.92 -35.9 79.75 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.934 1.367 . . . . 2.23 112.611 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' 1054 ' ' PRO . . . -56.97 -41.95 79.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.125 0.97 . . . . 0.94999999999999996 112.168 172.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 18.2 mt -72.64 -43.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.352 0.661 . . . . 0.73999999999999999 111.278 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 5.3 t -66.27 -40.59 90.22 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 118.867 -0.587 . . . . 2.0 112.082 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -62.18 -48.82 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.875 0.761 . . . . 3.1499999999999999 111.964 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 13.5 t80 -56.4 -42.95 78.78 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.033 0.833 . . . . 2.02 112.003 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 45.8 t -61.31 -54.34 45.24 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.771 -0.581 . . . . 1.78 111.277 173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.78 -32.67 67.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.588 1.155 . . . . 2.6299999999999999 113.096 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -71.59 -48.91 45.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.098 1.759 . . . . 4.0099999999999998 112.856 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.92 -38.19 76.17 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.389 -1.444 . . . . 2.4500000000000002 112.583 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.02 -21.3 60.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.072 0.949 . . . . 1.4199999999999999 113.323 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.92 28.4 2.83 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.512 1.925 . . . . 3.8599999999999999 114.057 -169.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -128.81 139.37 52.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.919 -1.113 . . . . 2.7200000000000002 113.86 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -77.25 -11.29 59.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.765 1.226 . . . . 3.8300000000000001 112.542 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 65.4 p -80.32 47.93 0.97 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.011 2.125 . . . . 4.6799999999999997 114.21 -171.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.15 148.08 50.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.821 1.045 . . . . 1.1499999999999999 113.821 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 75.83 128.41 0.26 Allowed Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.79 1.662 . . . . 1.3999999999999999 114.351 175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.27 -154.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.797 2.039 . . . . 2.54 108.273 172.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 142.17 50.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.766 1.765 . . . . 1.6399999999999999 115.766 -167.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.11 153.33 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 1 C-N-CA 132.472 4.309 . . . . 2.21 107.552 -169.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -140.57 117.88 11.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.256 -1.757 . . . . 2.7200000000000002 106.256 169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 166.77 10.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 116.496 2.036 . . . . 3.5600000000000001 116.496 -167.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -132.91 131.51 40.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.295 2.238 . . . . 4.1500000000000004 108.518 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 45.4 t -108.26 137.32 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.878 0.871 . . . . 2.6800000000000002 112.044 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 28.6 t -137.3 114.84 9.82 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.421 1.488 . . . . 1.74 107.532 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.76 147.7 45.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.083 2.522 . . . . 2.6899999999999999 112.607 -172.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 61.23 17.29 52.06 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.657 1.122 . . . . 1.6699999999999999 114.026 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 38.9 t -139.94 -63.51 0.5 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.746 1.218 . . . . 2.52 113.015 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 158.17 -152.47 23.64 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 120.583 1.538 . . . . 0.81999999999999995 115.946 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.33 150.23 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.735 1.614 . . . . 2.4100000000000001 113.179 -168.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 12.2 t -130.16 142.38 50.59 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.12 1.368 . . . . 0.51000000000000001 109.41 165.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.45 172.87 17.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.46 1.652 . . . . 0.54000000000000004 115.46 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -118.83 98.33 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.585 1.954 . . . . 1.1799999999999999 109.326 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.2 p -112.17 128.38 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.679 0.792 . . . . 2.0699999999999998 112.829 -168.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' 1177 ' ' GLN . 5.6 t -110.38 -163.62 0.87 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.721 1.209 . . . . 1.53 112.998 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . 0.327 3.5 m120 70.35 41.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.557 2.743 . . . . 5.5099999999999998 116.842 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 35.9 pt -94.46 -17.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.173 -0.955 . . . . 4.7999999999999998 112.81 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -123.48 20.48 9.55 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.696 1.999 . . . . 7.7400000000000002 110.651 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.58 0.33 4.11 Favored Glycine 0 N--CA 1.472 1.083 0 C-N-CA 128.139 2.78 . . . . 6.8099999999999996 117.803 -169.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.0 -14.4 61.57 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.864 1.332 . . . . 8.5999999999999996 112.8 168.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.2 tt -44.51 -51.39 8.9 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.904 2.082 . . . . 9.9100000000000001 111.483 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -169.67 153.57 5.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.711 1.605 . . . . 12.09 110.275 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -66.46 137.92 57.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.706 -0.85 . . . . 16.0 108.706 165.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -83.95 61.2 6.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.942 0.497 . . . . 13.17 109.868 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 56.8 t30 -63.71 146.79 53.18 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.794 -0.566 . . . . 14.19 109.911 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 63.4 m95 -137.18 75.77 1.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.9 0.88 . . . . 13.58 110.217 168.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 18.0 m-80 61.77 19.55 10.65 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.959 2.207 . . . . 17.460000000000001 116.959 166.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 59.6 mt -55.51 138.96 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.461 1.504 . . . . 19.149999999999999 110.116 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.26 -55.82 7.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.426 0.899 . . . . 23.149999999999999 113.426 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -110.28 -19.86 12.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.751 0.821 . . . . 26.77 112.878 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 8.3 t-20 49.13 43.0 22.21 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.361 2.264 . . . . 22.780000000000001 115.739 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.12 170.92 14.81 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.202 1.801 . . . . 28.120000000000001 112.146 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 31.3 mm -70.32 108.24 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.194 0.998 . . . . 28.379999999999999 111.376 -171.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -83.47 164.32 19.95 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.999 1.319 . . . . 28.530000000000001 112.851 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -65.09 -12.33 49.55 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.022 1.49 . . . . 30.199999999999999 115.022 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 68.54 144.73 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.781 2.432 . . . . 28.5 112.941 -167.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.7 t -62.08 138.94 58.46 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.716 1.006 . . . . 28.550000000000001 113.716 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.65 117.59 23.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.847 1.259 . . . . 31.879999999999999 110.049 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 33.6 m -133.18 14.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.899 1.074 . . . . 31.190000000000001 113.899 -169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.02 171.71 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.629 1.972 . . . . 35.490000000000002 113.925 -176.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 4.5 mp -71.41 -38.35 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.92 1.288 . . . . 38.140000000000001 110.159 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 6.5 t70 -147.52 72.37 1.24 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.862 0.839 . . . . 34.520000000000003 112.977 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -147.43 27.08 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.71 1.204 . . . . 33.920000000000002 113.997 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 100.0 p -125.67 152.85 44.69 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.521 1.129 . . . . 31.260000000000002 112.7 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 18.5 p30 -133.42 -15.84 2.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.081 1.752 . . . . 28.57 113.175 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 58.3 19.01 5.9 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.972 2.109 . . . . 28.43 115.28 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -74.86 151.61 38.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.993 1.317 . . . . 27.66 112.689 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 67.4 m 48.05 35.65 5.42 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 116.5 2.037 . . . . 23.050000000000001 116.5 167.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.06 145.56 36.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.001 0.921 . . . . 22.199999999999999 112.413 168.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.8 t -132.75 152.09 51.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.344 1.457 . . . . 20.449999999999999 113.257 -173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 60.1 m -111.06 -24.46 10.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.351 1.46 . . . . 21.190000000000001 112.508 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 18.8 m -124.3 8.6 8.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.048 1.499 . . . . 19.66 115.048 -168.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 55.5 m -114.65 19.22 16.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.995 1.318 . . . . 16.34 113.53 170.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.0 ptt? -116.86 143.63 45.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.257 1.423 . . . . 19.850000000000001 111.925 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 1.7 mt 60.19 12.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.497 1.519 . . . . 15.369999999999999 113.514 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -21.67 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 119.488 -2.007 . . . . 12.220000000000001 114.749 -169.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -96.68 -20.55 18.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.836 1.254 . . . . 11.529999999999999 113.793 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -76.25 -14.37 60.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.469 1.108 . . . . 10.01 113.597 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -110.38 2.78 19.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.496 2.036 . . . . 10.57 116.496 -174.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.27 -46.7 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.858 1.263 . . . . 8.1799999999999997 110.926 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.9 m -63.65 -24.87 67.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.485 0.92 . . . . 7.7300000000000004 113.485 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -88.51 -27.9 21.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.078 0.853 . . . . 8.5500000000000007 112.656 168.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -63.11 -43.19 99.15 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.52 -1.363 . . . . 7.3600000000000003 111.925 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.5 -17.74 63.07 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.707 1.373 . . . . 8.0700000000000003 114.707 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -81.23 -37.49 28.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.934 0.788 . . . . 5.5899999999999999 112.078 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -89.18 22.81 2.67 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.34 1.056 . . . . 6.5700000000000003 112.199 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 47.15 144.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 130.107 3.363 . . . . 3.8799999999999999 117.391 -165.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' A' 1124 ' ' THR . 35.6 tt0 -133.06 151.21 52.06 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.945 1.298 . . . . 2.0099999999999998 110.624 171.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 125.02 31.15 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.655 1.582 . . . . 3.29 110.152 -173.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.9 tttt -79.6 116.93 20.09 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.533 -0.914 . . . . 1.29 108.533 169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.7 m -133.67 145.11 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.847 0.859 . . . . 0.53000000000000003 112.124 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -146.02 151.66 38.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.704 1.001 . . . . 0.54000000000000004 113.704 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.86 142.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.163 1.385 . . . . 0.48999999999999999 110.209 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 132.34 143.85 5.19 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 115.492 0.957 . . . . 1.4399999999999999 115.492 168.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 7.7 t-20 43.38 -143.99 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.299 1.84 . . . . 2.4300000000000002 112.281 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 5.6 ptm85 -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.919 1.688 . . . . 7.21 113.064 167.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -65.3 -36.43 84.04 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.328 -0.858 . . . . 4.5599999999999996 112.018 -171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . 0.454 ' CE3' ' HD3' ' A' 1190 ' ' ARG . 4.9 m95 -57.03 -30.0 63.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.144 1.164 . . . . 3.75 114.144 172.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.7 mmt -72.05 -37.72 69.62 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.499 0.666 . . . . 2.3500000000000001 111.626 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.15 -67.2 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 126.304 1.842 . . . . 1.7 108.259 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . 0.454 ' HD3' ' CE3' ' A' 1187 ' ' TRP . 34.5 ttt85 -36.49 -43.51 0.4 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 128.292 2.637 . . . . 6.6600000000000001 114.899 175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 13.74 5.73 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.28 1.215 . . . . 0.82999999999999996 114.28 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 69.88 23.76 76.77 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.095 -1.628 . . . . 0.68999999999999995 115.542 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.16 171.41 12.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.642 1.177 . . . . 0.81000000000000005 112.059 -174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 61.8 t -99.66 133.34 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.006 1.322 . . . . 1.4399999999999999 109.699 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.7 tt -138.78 147.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.761 1.224 . . . . 1.26 111.11 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -113.69 151.32 32.0 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.101 1.36 . . . . 2.6699999999999999 113.258 -169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -66.07 -26.36 67.45 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.18 -0.95 . . . . 3.8399999999999999 112.84 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.54 -36.39 76.32 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.002 -1.061 . . . . 3.3900000000000001 113.213 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.5 p -77.16 -36.93 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.724 0.693 . . . . 1.1000000000000001 111.438 170.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.1 t30 -62.85 -37.72 87.95 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.746 0.703 . . . . 2.52 111.979 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.84 -39.05 93.17 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.475 1.11 . . . . 2.9399999999999999 112.971 173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.0 t80 -68.56 -37.64 80.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.996 -1.065 . . . . 2.5299999999999998 111.75 171.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -66.25 -52.16 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.596 1.158 . . . . 1.1499999999999999 112.01 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.8 t -68.76 -34.62 75.88 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.376 -0.828 . . . . 1.3899999999999999 112.263 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -53.37 -49.05 68.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.048 0.84 . . . . 3.2599999999999998 111.055 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . 0.474 ' NE2' ' HB1' ' A' 1227 ' ' ALA . 57.4 t-80 -66.66 -39.57 88.24 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.388 1.075 . . . . 3.9500000000000002 112.383 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -63.75 -42.31 97.86 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.305 -0.872 . . . . 2.7400000000000002 112.804 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -70.59 -28.73 65.1 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.181 1.792 . . . . 4.2400000000000002 112.785 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 18.6 mttp -66.81 -12.61 59.57 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.085 1.754 . . . . 3.1200000000000001 113.565 169.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 83.89 15.08 71.04 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.188 1.375 . . . . 1.25 114.73 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -106.98 156.57 18.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.818 1.309 . . . . 3.7599999999999998 110.561 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 27.3 m -77.35 128.35 34.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.571 1.549 . . . . 1.55 112.945 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.42 118.1 16.03 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.674 0.789 . . . . 0.67000000000000004 113.122 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 23.6 m -141.15 157.09 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 114.75 1.389 . . . . 0.5 114.75 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.91 165.88 10.77 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.361 1.465 . . . . 0.84999999999999998 113.539 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . 0.402 ' O ' HD23 ' A' 1222 ' ' LEU . 3.7 t -136.96 134.9 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.597 1.959 . . . . 1.8999999999999999 110.816 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -137.24 157.98 45.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.28 1.432 . . . . 0.48999999999999999 111.082 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 17.9 m -144.93 138.03 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 120.546 -1.346 . . . . 0.96999999999999997 111.394 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 32.8 t70 41.7 48.71 3.7 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.984 2.113 . . . . 2.77 112.377 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.28 3.4 m-20 65.6 32.7 9.06 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.996 2.118 . . . . 1.73 115.995 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -140.67 145.51 36.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.596 1.558 . . . . 2.25 111.189 169.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . 0.479 HD22 HD23 ' A' 1062 ' ' LEU . 0.2 OUTLIER -68.83 145.68 53.52 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.405 -1.434 . . . . 0.80000000000000004 111.182 172.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -121.33 -43.3 2.42 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.496 0.924 . . . . 0.56000000000000005 113.496 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -172.28 -173.3 38.84 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.17 0.895 . . . . 0.41999999999999998 115.062 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.26 152.94 42.27 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.365 1.466 . . . . 0.64000000000000001 113.399 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.07 135.34 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.463 1.505 . . . . 0.79000000000000004 111.101 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . 0.474 ' HB1' ' NE2' ' A' 1206 ' ' HIS . . . -121.38 124.82 45.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.56 2.344 . . . . 0.65000000000000002 109.601 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 20.2 mt -135.13 159.84 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.269 1.828 . . . . 1.45 111.579 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -131.8 -177.25 4.34 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.627 1.171 . . . . 1.6000000000000001 112.402 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 6.3 t70 -115.58 140.7 48.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.61 1.964 . . . . 3.48 112.936 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 115.953 1.834 . . . . 4.2199999999999998 115.953 -173.417 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . 0.533 " H2'" HD13 ' A' 1088 ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 120.199 0.047 . . . . 9.5600000000000005 110.876 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 39.1 p90 -135.34 158.39 44.5 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.139 1.376 . . . . 11.57 111.202 171.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 4.2 t -143.76 154.08 43.08 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.541 0.941 . . . . 7.3600000000000003 113.541 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.81 167.83 9.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.391 1.876 . . . . 6.3899999999999997 110.851 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 37.4 m170 -98.8 -41.33 7.7 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.565 0.746 . . . . 8.3599999999999994 111.221 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -92.09 93.65 1.83 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.095 -0.836 . . . . 4.04 112.826 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 32.8 m -80.76 123.26 82.54 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.433 1.617 . . . . 2.8500000000000001 110.82 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 148.44 52.52 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.377 2.718 . . . . 1.6399999999999999 112.19 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.1 p -138.07 125.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.863 1.265 . . . . 2.29 111.754 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.8 p -72.13 133.01 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 121.1 -1.0 . . . . 1.04 111.518 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -126.18 -34.92 2.48 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 115.524 1.675 . . . . 2.3599999999999999 115.524 -166.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -155.03 151.17 28.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.294 1.438 . . . . 2.0 111.03 171.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.2 m -130.03 142.35 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.32 1.048 . . . . 0.76000000000000001 111.284 171.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 40.1 tttt -139.61 147.14 40.68 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.096 0.958 . . . . 1.76 112.173 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 43.5 t -96.78 136.99 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.123 1.369 . . . . 0.76000000000000001 111.294 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 34.6 tp -100.32 -25.7 14.15 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.873 1.669 . . . . 0.81999999999999995 112.931 176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 2.5 t -104.75 24.3 12.03 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.562 1.319 . . . . 2.3199999999999998 114.562 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -56.07 128.19 34.21 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.714 -1.241 . . . . 3.77 110.49 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 15.0 m 60.48 -1.15 0.23 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.949 1.833 . . . . 3.0800000000000001 115.949 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.74 -32.35 8.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.071 1.305 . . . . 4.3099999999999996 113.191 -171.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -155.61 -46.53 0.08 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 115.259 1.577 . . . . 4.2199999999999998 115.259 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 15.2 mt -131.16 146.48 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.092 1.357 . . . . 1.6799999999999999 111.172 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -98.65 157.42 16.27 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.323 1.449 . . . . 1.78 112.841 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -61.14 -38.5 86.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.976 2.213 . . . . 3.4900000000000002 116.976 -166.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -71.24 -34.69 71.0 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.288 1.404 . . . . 3.5299999999999998 111.099 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 94.7 mttt -61.15 -44.3 97.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.162 0.585 . . . . 3.8500000000000001 110.804 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.28 -53.51 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.052 0.941 . . . . 0.54000000000000004 111.198 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.91 -32.06 73.07 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.402 -0.811 . . . . 0.58999999999999997 112.189 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.02 -50.42 68.55 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.531 0.732 . . . . 0.58999999999999997 112.013 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 11.1 pt -70.25 -32.66 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 120.005 1.275 . . . . 0.56000000000000005 113.095 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.9 t -70.4 -48.01 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.804 1.184 . . . . 0.56999999999999995 111.387 172.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.85 92.42 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.258 -0.901 . . . . 0.56000000000000005 113.321 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 71.7 p -77.58 -27.0 51.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.821 1.045 . . . . 0.70999999999999996 113.821 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -65.5 -42.63 91.92 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.006 0.821 . . . . 0.67000000000000004 112.5 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -74.48 -12.38 60.47 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.807 1.04 . . . . 1.9399999999999999 113.807 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 35.4 t -54.51 -43.11 71.58 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.186 1.394 . . . . 1.53 114.543 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -92.14 2.61 56.48 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.051 0.76 . . . . 2.0600000000000001 113.051 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 1.9 t -89.19 168.17 12.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.058 1.343 . . . . 1.6299999999999999 112.761 -173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -133.64 80.09 1.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.211 1.405 . . . . 4.6699999999999999 109.823 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -141.39 152.0 62.68 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.964 1.705 . . . . 2.2000000000000002 110.917 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.77 -35.81 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.304 2.669 . . . . 1.6100000000000001 115.19 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.24 -41.35 9.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.721 1.208 . . . . 1.1299999999999999 113.456 -166.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -76.99 -34.82 40.91 Favored Glycine 0 CA--C 1.54 1.629 0 N-CA-C 114.541 0.576 . . . . 1.04 114.541 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 59.4 p -64.28 -17.28 63.48 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.87 -1.37 . . . . 1.75 113.142 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.15 82.93 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.866 -1.146 . . . . 1.0700000000000001 111.965 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 4.8 mp -72.23 -32.72 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.43 0.692 . . . . 1.3 110.728 171.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 94.9 m -56.1 -47.61 77.72 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 117.424 -1.274 . . . . 1.3300000000000001 111.395 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 46.9 tttt -62.39 -46.17 89.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.301 1.41 . . . . 2.8100000000000001 112.789 175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 4.0 t80 -55.94 -42.33 76.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.348 1.059 . . . . 2.0099999999999998 111.476 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.1 t -70.66 -52.55 20.46 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.611 1.564 . . . . 2.25 112.355 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 13.5 tptm -47.76 -47.63 30.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.874 1.67 . . . . 2.5499999999999998 111.927 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.82 -30.41 65.47 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.077 0.951 . . . . 4.1100000000000003 113.243 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.18 -42.22 72.7 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.636 1.107 . . . . 3.71 112.662 169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.01 -33.63 61.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.006 1.323 . . . . 1.6299999999999999 114.48 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 25.6 t0 50.28 42.64 25.98 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.487 1.915 . . . . 3.1800000000000002 114.334 -172.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.9 t -119.78 -21.7 7.13 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 115.409 1.633 . . . . 4.1200000000000001 115.409 -172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.8 tt0 58.8 -26.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.154 2.582 . . . . 3.0099999999999998 117.403 -171.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 75.2 p -95.54 22.23 7.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.275 2.23 . . . . 2.9100000000000001 113.917 -170.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.59 147.13 53.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.753 1.221 . . . . 0.88 113.847 -169.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 66.44 -173.35 25.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.272 0.929 . . . . 1.5700000000000001 114.639 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -160.45 -51.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.066 1.347 . . . . 1.45 111.629 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 31.6 t -138.24 142.53 39.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.405 1.082 . . . . 1.3700000000000001 113.58 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 156.12 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 1 C-N-CA 131.728 4.011 . . . . 2.9199999999999999 109.229 168.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -20.31 12.01 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.944 1.461 . . . . 3.2400000000000002 114.944 -169.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 51.3 m-85 60.8 105.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.507 2.723 . . . . 4.54 117.35 172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -120.91 107.09 12.27 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.448 2.299 . . . . 2.5899999999999999 107.493 168.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.7 m -98.4 145.17 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.41 0.684 . . . . 2.1699999999999999 111.96 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 18.7 t -136.99 85.15 23.36 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 106.552 -1.647 . . . . 1.26 106.552 173.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -53.1 134.27 55.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.825 3.683 . . . . 1.76 114.708 -167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 65.22 10.05 45.46 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.855 -0.969 . . . . 1.9399999999999999 114.457 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 22.8 m -127.51 -49.11 1.4 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.09 1.445 . . . . 3.2200000000000002 111.933 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 173.14 -170.89 44.04 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.499 0.571 . . . . 1.1499999999999999 114.096 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 4.3 tt -141.71 158.32 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.4 1.08 . . . . 2.04 111.665 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 18.7 t -139.0 152.92 48.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.618 1.167 . . . . 0.73999999999999999 111.903 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 9.2 p -164.2 167.96 19.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.495 1.118 . . . . 0.97999999999999998 112.648 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -110.08 123.1 49.1 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.307 1.043 . . . . 1.1499999999999999 109.258 172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 1.7 t -105.01 145.21 13.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 123.92 0.888 . . . . 2.27 111.37 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.88 160.54 41.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.305 1.05 . . . . 0.94999999999999996 113.542 164.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -168.1 -33.77 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 130.674 3.59 . . . . 2.2000000000000002 108.24 163.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 4.5 pt -54.71 -62.14 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.608 2.363 . . . . 2.2999999999999998 115.016 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -157.02 28.64 0.31 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.978 1.473 . . . . 4.2800000000000002 114.978 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -70.37 -7.2 60.01 Favored Glycine 0 CA--C 1.539 1.592 0 O-C-N 120.574 -1.329 . . . . 4.7800000000000002 114.818 175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.39 -1.31 0.13 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.691 2.796 . . . . 4.0899999999999999 115.984 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 7.7 tt -71.46 -28.86 64.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.298 1.839 . . . . 5.3200000000000003 112.093 170.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 51.56 -124.52 2.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.913 1.285 . . . . 7.3799999999999999 111.465 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -127.59 156.24 42.57 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 127.712 2.405 . . . . 13.42 108.677 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 39.1 t30 -77.02 -17.54 58.75 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.934 1.087 . . . . 16.66 113.934 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 23.8 t-20 64.76 165.23 0.15 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.315 1.846 . . . . 14.91 113.789 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 98.4 m95 -134.24 -64.36 0.69 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.807 1.643 . . . . 19.649999999999999 110.961 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -144.43 -8.23 0.67 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.577 1.695 . . . . 15.9 115.577 -169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' 1137 ' ' ILE . 0.9 OUTLIER -82.8 143.38 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.422 1.889 . . . . 15.050000000000001 109.657 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -80.06 -24.09 40.9 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.61 -1.306 . . . . 19.120000000000001 112.656 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.66 108.88 14.99 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.887 1.675 . . . . 15.67 110.06 173.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -127.73 116.59 20.47 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.896 0.879 . . . . 14.44 111.342 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -132.39 146.62 52.09 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.453 1.901 . . . . 15.4 112.606 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.2 -19.43 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 115.215 1.561 . . . . 20.370000000000001 115.215 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -126.06 147.59 49.53 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.281 1.4 . . . . 18.210000000000001 113.468 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 26.3 p30 -82.03 0.56 39.76 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.754 1.622 . . . . 18.079999999999998 114.892 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . 0.26 . . 58.28 40.46 24.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.935 2.094 . . . . 16.719999999999999 116.629 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 27.3 m -62.27 150.04 40.26 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.249 1.419 . . . . 17.75 111.436 166.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -152.21 154.26 35.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.256 1.422 . . . . 18.050000000000001 112.568 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 29.1 m -130.01 150.2 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.979 1.311 . . . . 19.719999999999999 112.295 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -117.96 62.3 0.76 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.665 1.986 . . . . 22.329999999999998 108.089 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' 1153 ' ' SER . 7.4 tp -101.43 142.67 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.326 1.851 . . . . 22.440000000000001 114.865 -164.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -155.76 137.72 14.51 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.457 1.503 . . . . 24.600000000000001 111.552 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . 49.39 30.15 3.16 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.257 1.823 . . . . 25.620000000000001 115.315 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' 1150 ' ' ILE . 0.6 OUTLIER -150.52 160.46 43.77 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.695 1.198 . . . . 23.73 111.312 -176.115 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 1.3 t30 57.3 67.64 0.95 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.298 1.439 . . . . 22.719999999999999 111.47 -170.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -97.39 4.09 50.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.599 1.56 . . . . 25.850000000000001 114.602 -171.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -134.6 -19.69 1.84 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 117.736 2.495 . . . . 27.640000000000001 117.736 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 17.7 t -159.0 150.91 20.9 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 122.735 2.516 . . . . 22.329999999999998 115.645 -169.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.359 0.1 OUTLIER -87.63 15.48 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.804 1.409 . . . . 19.649999999999999 114.804 168.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 7.3 t -59.0 -11.97 4.05 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.329 1.603 . . . . 19.02 115.329 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 5.3 p -84.45 129.8 34.83 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.281 -1.512 . . . . 15.93 112.225 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 75.4 m 49.38 43.82 23.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.124 1.369 . . . . 15.31 113.679 -171.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 89.1 p -78.45 -48.09 16.13 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.351 1.461 . . . . 13.08 111.912 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 17.7 mmt 52.97 -174.76 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 128.126 2.57 . . . . 13.81 115.166 172.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 44.1 pt -75.16 21.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.056 1.742 . . . . 12.42 115.048 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.82 -30.66 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 120.992 -1.068 . . . . 9.4399999999999995 113.155 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . 0.281 12.7 p-10 -77.03 -5.66 49.65 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.416 1.265 . . . . 10.32 114.416 -173.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -86.5 -6.25 58.95 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.861 1.264 . . . . 10.869999999999999 112.829 167.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -109.17 -15.85 14.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.148 1.379 . . . . 9.7699999999999996 112.98 -171.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 79.5 mt -55.86 -29.12 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.276 1.83 . . . . 6.7000000000000002 111.27 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 52.8 p -60.29 -11.92 7.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 114.632 1.345 . . . . 8.5600000000000005 114.632 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.31 -9.27 58.41 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.146 -0.971 . . . . 7.71 112.933 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -60.89 -14.39 21.94 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.135 1.374 . . . . 5.1200000000000001 114.451 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.39 -39.46 73.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.013 . . . . 7.7999999999999998 110.695 167.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -101.14 -43.64 5.94 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.37 1.468 . . . . 5.9900000000000002 111.923 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -87.33 63.5 7.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.281 1.832 . . . . 3.7200000000000002 111.616 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -49.29 129.46 18.38 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.483 1.66 . . . . 3.4500000000000002 115.483 -167.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -158.82 162.96 37.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.432 1.493 . . . . 2.3300000000000001 112.776 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -122.42 128.17 50.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.578 1.551 . . . . 3.0600000000000001 110.973 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 84.4 tttt -88.14 126.56 35.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.987 0.915 . . . . 1.23 109.073 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 12.6 m -134.49 151.89 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 113.748 1.018 . . . . 0.87 113.748 -176.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -153.49 152.35 30.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.159 1.384 . . . . 0.44 113.005 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 10.7 tt -149.36 139.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.144 1.378 . . . . 0.54000000000000004 110.31 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 153.9 -142.38 9.09 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.908 1.123 . . . . 1.45 115.908 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.41 161.48 2.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.64 2.376 . . . . 2.1099999999999999 114.456 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -24.99 63.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.091 1.356 . . . . 6.3300000000000001 113.68 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -76.61 -32.14 57.87 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.868 1.213 . . . . 3.0499999999999998 113.652 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.2 t90 -64.05 -21.17 66.41 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 119.994 -1.692 . . . . 2.96 112.484 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 31.1 mmt -63.92 -33.9 76.74 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.846 -1.158 . . . . 2.3799999999999999 111.256 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 24.3 mt -66.83 -64.84 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.844 1.658 . . . . 2.3199999999999998 109.169 168.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -52.58 -30.86 33.28 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.277 1.431 . . . . 5.1600000000000001 114.344 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.1 6.07 23.69 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.302 1.441 . . . . 0.81999999999999995 113.954 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.99 29.8 72.35 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.95 1.738 . . . . 0.69999999999999996 115.081 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 4.6 mt -96.24 160.7 14.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.84 1.256 . . . . 0.82999999999999996 109.647 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 58.5 t -110.74 124.5 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.499 0.719 . . . . 1.27 110.559 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 15.7 tt -95.63 149.44 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.018 0.927 . . . . 1.1399999999999999 111.004 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -124.06 154.38 40.01 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.828 1.251 . . . . 3.0899999999999999 111.495 -170.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -56.92 -32.09 65.6 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.813 1.412 . . . . 2.4199999999999999 114.813 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.54 -53.56 46.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.54 1.136 . . . . 3.9900000000000002 111.391 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' 1199 ' ' VAL . 1.8 p -73.48 -34.3 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.171 1.388 . . . . 1.24 111.638 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -60.74 -42.74 97.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.742 0.817 . . . . 1.8100000000000001 111.593 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.27 -44.4 91.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.622 0.646 . . . . 2.29 112.321 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.8 t80 -65.87 -36.17 82.68 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.346 1.058 . . . . 2.2200000000000002 112.22 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 18.1 tpp -62.62 -55.12 30.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.369 1.068 . . . . 0.80000000000000004 111.687 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 10.3 t -68.56 -33.68 74.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.644 -0.66 . . . . 1.1000000000000001 111.938 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.191 1.397 . . . . 4.25 112.271 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.19 -39.66 71.69 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.883 1.068 . . . . 2.25 113.883 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.54 -39.72 84.9 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.602 -0.686 . . . . 3.0600000000000001 111.662 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -70.74 -18.62 62.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.523 2.329 . . . . 4.1600000000000001 113.786 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -71.89 -22.01 61.56 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 120.008 1.276 . . . . 3.0099999999999998 111.865 166.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.45 18.32 42.39 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.332 1.92 . . . . 1.78 114.303 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -106.03 -160.78 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.019 1.327 . . . . 4.5700000000000003 110.123 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 69.9 m -108.09 131.51 54.54 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.885 1.22 . . . . 0.82999999999999996 112.388 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -132.08 118.28 19.44 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.836 1.654 . . . . 0.58999999999999997 111.125 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 20.1 m -138.04 155.33 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.777 1.231 . . . . 0.56000000000000005 113.122 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.0 mp -113.42 159.95 18.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.971 1.309 . . . . 0.79000000000000004 112.587 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.7 t -127.74 123.35 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.919 1.687 . . . . 1.8400000000000001 110.397 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.62 147.29 48.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.784 1.234 . . . . 0.51000000000000001 110.634 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 29.7 m -149.58 134.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.928 0.891 . . . . 1.01 112.061 -172.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 4.3 m-20 41.09 49.73 3.15 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 126.047 1.739 . . . . 3.1600000000000001 112.043 -174.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.272 24.0 m-20 54.2 36.15 24.3 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.907 2.883 . . . . 1.5 116.435 -176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.93 138.43 48.36 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.999 1.72 . . . . 2.3399999999999999 110.68 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.25 133.77 48.34 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.642 -1.286 . . . . 0.72999999999999998 110.762 169.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.2 p -115.76 -37.89 3.83 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -174.57 -171.46 38.8 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 119.806 1.185 . . . . 0.46999999999999997 115.349 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.81 154.09 44.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.739 1.616 . . . . 0.69999999999999996 113.025 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.12 133.04 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.723 1.609 . . . . 0.84999999999999998 110.016 -173.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -107.53 132.31 53.39 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.71999999999999997 110.77 172.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 24.9 mt -135.02 152.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.438 1.895 . . . . 1.1499999999999999 110.604 -171.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -120.07 -174.44 2.77 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.967 2.107 . . . . 1.4399999999999999 111.408 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 6.1 t70 -119.16 138.15 53.13 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.907 1.283 . . . . 3.3999999999999999 110.74 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 65.4 p . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 114.466 1.284 . . . . 3.9900000000000002 114.466 -170.221 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 119.013 -0.518 . . . . 11.07 111.711 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -68.46 163.95 22.21 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.272 1.429 . . . . 10.91 111.927 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 7.7 m -130.31 146.0 51.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.953 1.301 . . . . 8.8300000000000001 112.36 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 6.9 tpt -67.03 162.11 22.87 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.276 1.431 . . . . 7.3499999999999996 112.729 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 23.0 m170 -55.49 -48.33 74.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.76 1.224 . . . . 7.5300000000000002 112.548 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -93.4 103.41 3.04 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.209 -1.156 . . . . 2.71 110.209 169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 95.5 m -64.27 127.04 91.62 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 118.15 0.975 . . . . 2.9700000000000002 110.39 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.38 135.07 16.22 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.823 2.349 . . . . 2.0800000000000001 111.465 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 12.7 p -135.25 132.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.478 -0.764 . . . . 2.6299999999999999 110.215 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 6.3 p -68.52 123.16 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.643 -0.66 . . . . 1.22 110.177 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 30.4 t30 -103.64 -39.44 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.85 1.26 . . . . 3.54 112.136 -169.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.22 146.85 20.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.227 1.011 . . . . 2.3999999999999999 112.295 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 16.7 m -132.49 131.7 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.788 0.835 . . . . 0.68999999999999995 112.201 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 53.0 tttt -135.08 144.61 47.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.883 1.273 . . . . 1.55 113.224 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 87.7 t -79.17 147.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.054 1.341 . . . . 0.95999999999999996 110.659 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.9 tp -122.22 -24.1 5.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.59 1.556 . . . . 0.87 112.707 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 36.0 m -127.46 107.42 9.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.153 1.381 . . . . 1.77 109.431 172.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.34 130.51 49.09 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.535 1.134 . . . . 3.6400000000000001 111.788 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 59.8 m 51.61 31.21 7.45 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.132 1.773 . . . . 2.5299999999999998 115.528 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -137.98 5.5 2.58 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.965 1.306 . . . . 2.71 113.514 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -154.37 -79.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 5.6799999999999997 110.423 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 40.2 mt -134.83 146.85 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 128.203 2.601 . . . . 1.99 109.032 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 19.3 m -97.93 155.64 16.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.245 1.418 . . . . 1.98 113.682 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 6.7 p80 -44.76 -49.42 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.669 2.47 . . . . 3.6899999999999999 117.669 -167.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.9 t60 -75.33 -28.18 59.53 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.433 1.47 . . . . 2.8399999999999999 111.348 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -65.17 -38.71 91.38 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.857 -1.152 . . . . 3.77 111.062 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.36 -51.85 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.088 0.955 . . . . 0.65000000000000002 110.603 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -31.81 73.0 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.124 0.874 . . . . 0.70999999999999996 112.262 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.78 54.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 0.64000000000000001 112.152 173.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 14.4 pt -69.14 -34.95 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.791 -1.193 . . . . 0.76000000000000001 113.157 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 58.1 t -70.75 -45.07 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.133 0.878 . . . . 0.88 111.361 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.0 -36.18 91.66 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 121.487 -0.758 . . . . 0.91000000000000003 113.304 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.0 p -72.76 -34.89 67.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.45 0.907 . . . . 0.98999999999999999 113.45 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -58.05 -51.79 68.23 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.275 0.943 . . . . 1.0 112.64 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.52 -13.66 61.47 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.875 1.065 . . . . 2.5600000000000001 113.875 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 9.1 p -65.16 -20.85 66.64 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.058 -1.651 . . . . 1.6299999999999999 112.667 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 41.4 t30 -122.99 16.84 10.06 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.973 1.709 . . . . 2.0299999999999998 112.636 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 8.5 t -127.83 -176.93 3.92 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.524 1.93 . . . . 1.5 110.197 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -142.94 46.77 1.55 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.294 1.438 . . . . 3.8100000000000001 112.607 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.16 164.76 22.01 Favored Pre-proline 0 CA--C 1.554 1.123 0 O-C-N 121.274 -0.891 . . . . 1.9199999999999999 112.441 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.73 -22.61 5.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.193 2.596 . . . . 1.3400000000000001 115.314 -169.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 10.3 tt -112.8 -48.59 2.98 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.437 1.095 . . . . 1.05 112.848 -169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -66.04 -21.22 69.61 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 115.18 0.832 . . . . 0.89000000000000001 115.18 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 67.4 p -62.98 -16.8 60.89 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.942 1.371 . . . . 1.3999999999999999 113.979 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.33 78.14 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.013 -1.054 . . . . 0.75 111.737 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 13.7 mt -72.69 -38.95 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.205 1.402 . . . . 0.83999999999999997 110.232 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 90.9 m -53.08 -47.86 68.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.527 -0.749 . . . . 1.0900000000000001 111.704 169.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -60.45 -51.0 71.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.649 0.78 . . . . 2.6899999999999999 112.252 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.02 -41.28 78.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.214 0.605 . . . . 3.29 111.95 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.1 t -67.65 -56.9 7.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.478 1.511 . . . . 1.71 112.246 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -50.55 -45.49 56.94 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.014 1.279 . . . . 3.8399999999999999 110.88 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -70.98 -32.44 69.29 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.222 1.009 . . . . 3.6000000000000001 113.361 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -72.06 -41.4 67.44 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.73 1.15 . . . . 2.1899999999999999 113.789 171.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.33 -16.21 61.88 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.715 1.206 . . . . 1.04 112.388 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 27.9 t70 45.12 46.17 9.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.847 2.459 . . . . 2.7400000000000002 112.064 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.83 143.34 26.24 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.525 -0.734 . . . . 2.7599999999999998 111.937 -172.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -99.4 -0.42 40.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.173 0.989 . . . . 3.5 112.518 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 63.3 p -101.21 9.02 42.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.305 1.842 . . . . 3.52 114.701 -168.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -67.55 149.37 50.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.979 1.312 . . . . 1.3 112.78 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 74.44 168.26 19.35 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.399 1.476 . . . . 1.3200000000000001 115.758 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 9.8 m -160.76 -49.97 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.123 -1.222 . . . . 1.3 113.516 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 53.6 t -136.29 142.68 43.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.503 1.521 . . . . 1.8200000000000001 114.745 -168.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.2 mm -138.71 148.91 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 130.346 3.458 . . . . 2.29 109.317 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 19.2 t0 -131.93 98.38 4.43 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.964 1.706 . . . . 2.5600000000000001 106.798 166.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' 1119 ' ' ILE . 60.6 t80 -73.57 124.42 25.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.478 1.911 . . . . 4.1799999999999997 114.544 -167.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.26 123.47 25.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.443 1.897 . . . . 2.3199999999999998 108.213 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 7.4 p -129.47 149.06 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 116.023 1.86 . . . . 3.1000000000000001 116.023 -166.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 52.8 t -128.41 102.79 20.41 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.098 1.359 . . . . 1.7 107.419 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -57.67 133.79 58.77 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.174 2.582 . . . . 1.47 113.821 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.11 11.38 70.43 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.813 1.197 . . . . 1.5800000000000001 115.499 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 33.2 t -138.89 -41.73 0.48 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.655 1.227 . . . . 1.9399999999999999 114.044 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 174.58 -177.86 46.57 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 115.661 1.024 . . . . 0.75 115.661 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' 1111 ' ' PHE . 0.1 OUTLIER -142.71 149.05 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 1.8300000000000001 111.218 170.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.5 t -131.41 142.93 50.12 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.188 2.195 . . . . 0.48999999999999999 109.137 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.1 p -153.84 165.68 35.29 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.929 1.085 . . . . 0.66000000000000003 113.929 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -114.66 122.45 46.5 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.032 -1.099 . . . . 1.27 108.032 174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 33.1 m -124.34 136.63 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.224 0.609 . . . . 2.25 112.294 -170.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.6 t -122.95 145.4 48.51 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.884 0.373 . . . . 1.01 111.037 166.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.89 45.21 0.19 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.71 2.004 . . . . 3.3599999999999999 107.184 158.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.27 -34.2 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.957 . . . . 2.1600000000000001 111.721 -171.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -144.6 37.15 1.2 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.92 0.866 . . . . 4.7400000000000002 111.905 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -69.42 0.7 16.52 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.436 1.493 . . . . 3.6200000000000001 115.144 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.3 pp -57.79 -6.27 0.51 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.541 2.336 . . . . 3.7400000000000002 116.174 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 3.5 tt -86.54 -66.29 0.92 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.506 1.122 . . . . 5.4900000000000002 112.702 -169.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -168.61 154.44 6.72 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.745 2.418 . . . . 7.2599999999999998 108.821 -173.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.64 144.33 26.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.466 1.506 . . . . 12.050000000000001 111.232 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -88.59 27.13 1.33 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.88 1.272 . . . . 13.550000000000001 114.317 173.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -68.21 108.55 3.2 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.15 0.98 . . . . 12.07 112.449 -169.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -155.76 -44.6 0.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.559 1.543 . . . . 16.850000000000001 112.053 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -72.19 -14.28 61.76 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.182 -0.949 . . . . 18.670000000000002 112.482 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' 1137 ' ' ILE . 0.7 OUTLIER -86.2 -16.17 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 126.974 2.11 . . . . 17.219999999999999 112.583 173.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.4 -44.23 0.08 Allowed 'General case' 0 N--CA 1.473 0.719 1 C-N-CA 132.613 4.365 . . . . 18.219999999999999 115.959 178.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.14 -20.09 0.29 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.494 1.664 . . . . 17.640000000000001 115.494 169.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 58.38 -25.03 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 119.107 3.003 . . . . 18.77 119.107 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -88.21 -5.35 58.44 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.193 1.797 . . . . 21.149999999999999 114.642 -175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . 0.657 HD13 ' H ' ' A' 1142 ' ' ILE . 0.2 OUTLIER -79.66 153.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.712 1.605 . . . . 21.280000000000001 114.715 -169.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -100.22 6.52 44.75 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.168 2.187 . . . . 27.07 115.247 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -77.33 7.49 5.23 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.889 1.44 . . . . 22.550000000000001 114.889 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 59.13 175.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.936 2.494 . . . . 24.329999999999998 115.358 -178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 73.3 m -139.52 109.44 6.37 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.317 1.447 . . . . 23.73 109.734 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 77.8 mt -110.52 158.62 18.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.598 1.159 . . . . 24.73 111.531 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 14.0 m -115.59 141.59 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.989 1.316 . . . . 25.760000000000002 111.071 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 164.55 33.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.786 1.234 . . . . 26.16 112.838 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 8.6 tp -143.7 127.67 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.472 0.709 . . . . 27.52 112.622 171.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 19.7 t0 -157.55 112.32 2.7 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.497 1.519 . . . . 27.32 109.667 168.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -64.87 -21.13 66.74 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.408 0.892 . . . . 27.559999999999999 113.408 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 80.9 p -81.66 -3.93 54.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.849 1.425 . . . . 28.260000000000002 114.849 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 51.5 t30 -131.25 157.87 42.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.703 1.601 . . . . 25.940000000000001 111.686 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -106.12 -17.49 14.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.924 1.289 . . . . 23.809999999999999 113.23 168.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 1.1 mp0 61.07 -58.55 0.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.462 2.705 . . . . 25.469999999999999 114.296 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 21.5 m -170.43 139.71 1.71 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 130.02 3.328 . . . . 23.149999999999999 107.24 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 46.5 p -136.91 154.99 50.32 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 120.11 1.323 . . . . 20.109999999999999 113.045 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.6 t -161.88 145.73 12.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.747 1.017 . . . . 17.620000000000001 113.747 -172.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 21.1 t -136.38 141.49 43.67 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.442 1.497 . . . . 15.5 110.069 169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 13.9 m -54.84 123.21 12.66 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.152 1.538 . . . . 13.94 115.152 -167.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 58.2 m -102.03 -8.98 21.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.745 1.618 . . . . 15.050000000000001 113.795 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 22.4 ptp -61.39 167.56 3.22 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.254 -0.904 . . . . 13.67 110.386 167.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 35.2 pt -72.93 64.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.707 1.203 . . . . 11.82 112.86 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 1.6 pp -55.98 -27.14 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.588 1.555 . . . . 10.01 114.534 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -22.48 52.13 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.169 1.174 . . . . 9.3599999999999994 114.169 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -80.71 -14.12 58.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.848 0.859 . . . . 8.4199999999999999 112.769 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -111.86 -2.69 15.12 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.993 1.479 . . . . 9.0399999999999991 114.993 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.07 -42.81 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.199 1.0 . . . . 6.6500000000000004 110.472 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 66.8 m -62.96 -18.27 62.99 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.824 1.046 . . . . 5.9299999999999997 113.824 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.89 -38.19 54.06 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.074 0.852 . . . . 6.9500000000000002 111.666 172.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -72.95 -25.08 60.9 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.584 0.754 . . . . 5.6200000000000001 112.513 172.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 7.5 tt -60.77 -36.79 79.84 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.141 -0.975 . . . . 6.8099999999999996 111.614 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -77.01 -54.77 6.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.871 0.868 . . . . 5.2400000000000002 111.18 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -82.89 66.39 8.49 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 4.1600000000000001 111.344 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -31.73 134.78 0.08 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.847 2.459 . . . . 3.2999999999999998 117.01 -168.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -134.0 135.22 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.619 1.168 . . . . 2.27 113.78 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -89.92 137.64 32.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.03 1.332 . . . . 3.1699999999999999 109.457 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -91.87 119.75 31.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.015 0.926 . . . . 1.53 109.058 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.9 m -133.91 138.74 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 118.878 0.763 . . . . 0.48999999999999999 112.342 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -144.92 154.66 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.113 0.965 . . . . 0.37 113.542 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.4 tt -149.49 139.29 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.837 1.655 . . . . 0.81000000000000005 110.048 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 178.35 173.88 44.12 Favored Glycine 0 CA--C 1.538 1.48 0 N-CA-C 115.312 0.885 . . . . 1.47 115.312 -172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -57.65 -70.34 0.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.431 1.492 . . . . 3.8100000000000001 114.68 -169.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 -72.77 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.725 1.379 . . . . 5.5800000000000001 114.725 -177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -69.18 -31.48 70.13 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.527 1.512 . . . . 4.8300000000000001 113.413 -168.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 15.3 t90 -68.25 -23.39 64.78 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.396 -1.44 . . . . 3.04 113.117 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 80.2 mmm -72.04 -40.65 68.23 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.789 0.836 . . . . 2.6499999999999999 110.979 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.38 -64.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.252 1.421 . . . . 2.2400000000000002 109.482 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -51.69 -9.64 0.09 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.908 2.483 . . . . 6.8499999999999996 116.6 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.31 13.56 0.72 Allowed 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 120.903 1.683 . . . . 0.76000000000000001 111.106 167.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 71.31 33.66 64.43 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 119.475 -2.016 . . . . 1.0700000000000001 114.001 -174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.25 172.91 6.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.947 1.299 . . . . 0.81000000000000005 110.836 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.3 t -117.27 138.55 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.808 1.243 . . . . 1.02 110.28 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 17.7 tt -114.1 141.81 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.332 1.053 . . . . 1.0700000000000001 112.148 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 11.0 p30 -103.2 158.7 16.14 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.242 1.417 . . . . 4.2400000000000002 113.093 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -74.0 -21.96 59.79 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.248 1.203 . . . . 2.8399999999999999 114.248 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.18 -39.92 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.714 -1.241 . . . . 2.9100000000000001 112.161 -175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 9.6 p -70.32 -36.7 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.575 -0.703 . . . . 0.81999999999999995 111.111 171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 55.7 t30 -64.44 -38.37 90.79 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.884 0.765 . . . . 2.2999999999999998 112.556 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -44.98 86.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.795 0.838 . . . . 2.1200000000000001 112.864 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 29.5 t80 -71.34 -43.03 67.79 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.54 0.736 . . . . 2.5600000000000001 112.393 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.3 tpp -56.84 -48.03 78.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.417 1.087 . . . . 0.97999999999999998 111.58 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 1.8 t -74.15 -34.74 63.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.94 -0.552 . . . . 1.3400000000000001 112.055 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.65 -45.33 85.63 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.115 1.325 . . . . 3.3300000000000001 111.818 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -65.3 -47.2 77.41 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.143 0.977 . . . . 3.8900000000000001 111.684 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.12 -34.61 76.68 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.332 -0.855 . . . . 4.1500000000000004 111.967 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -69.84 -15.26 63.07 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.586 1.554 . . . . 3.8199999999999998 113.78 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 63.1 mttt -73.58 -14.49 61.2 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 120.431 1.469 . . . . 3.6899999999999999 112.059 165.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.98 10.36 58.75 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 126.59 2.043 . . . . 1.79 113.556 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -115.69 132.34 56.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.886 1.274 . . . . 4.7800000000000002 111.343 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 99.6 m -59.61 128.25 36.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.619 1.341 . . . . 1.1499999999999999 114.619 -168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -126.87 130.05 49.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.841 1.256 . . . . 0.60999999999999999 111.777 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 28.8 m -140.9 154.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.345 1.458 . . . . 0.72999999999999998 113.247 -174.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.58 159.32 15.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.174 0.989 . . . . 1.0900000000000001 110.551 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.8 p -130.57 124.84 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.456 1.102 . . . . 2.1600000000000001 112.54 175.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.27 152.31 37.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.921 1.688 . . . . 0.40000000000000002 111.226 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 18.7 m -146.69 119.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.545 1.938 . . . . 0.72999999999999998 112.008 -167.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 5.2 m-20 46.46 47.48 14.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.984 2.114 . . . . 3.3700000000000001 113.215 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.321 34.0 m-20 63.38 26.77 15.1 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.228 2.611 . . . . 2.0899999999999999 116.382 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -125.66 153.67 43.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.216 2.206 . . . . 3.1899999999999999 110.824 167.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 2.6 mt -75.17 148.77 39.31 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.218 -1.551 . . . . 1.02 112.418 168.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 29.7 p -124.55 -36.94 2.56 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.08 0.771 . . . . 0.59999999999999998 113.08 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.47 -166.07 29.68 Favored Glycine 0 N--CA 1.466 0.686 0 CA-C-N 119.268 0.94 . . . . 0.58999999999999997 115.418 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -140.39 153.04 46.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.884 1.674 . . . . 0.78000000000000003 111.743 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.4 mm -132.19 140.58 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.796 1.638 . . . . 1.01 108.864 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -130.84 132.06 44.97 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.974 0.91 . . . . 1.05 111.025 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.19 155.87 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.975 2.11 . . . . 1.6200000000000001 110.099 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -120.39 176.31 5.54 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.447 1.899 . . . . 1.5 112.945 170.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.26 134.88 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.369 1.468 . . . . 3.8300000000000001 111.034 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.256 1.423 0 N-CA-C 114.713 1.375 . . . . 4.9500000000000002 114.713 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 113.114 0.783 . . . . 13.140000000000001 113.114 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -116.2 162.3 17.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.624 1.569 . . . . 15.029999999999999 111.218 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 68.7 m -141.19 145.69 35.98 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.849 0.86 . . . . 7.4000000000000004 112.21 -169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 7.5 tpt -55.59 106.59 0.26 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.208 1.403 . . . . 6.79 111.028 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 33.3 m170 -120.26 -36.79 3.16 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.336 1.054 . . . . 5.4199999999999999 113.358 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -76.92 71.57 2.16 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.943 0.782 . . . . 3.04 114.524 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 27.8 m -70.44 117.48 55.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 125.544 1.538 . . . . 2.8500000000000001 113.079 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.51 87.22 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.856 2.371 . . . . 2.3500000000000001 110.035 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 47.0 t -65.9 109.71 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.38 1.072 . . . . 3.0499999999999998 111.107 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.7 p -71.17 131.42 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.605 -0.685 . . . . 1.3799999999999999 111.552 -176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.11 -34.43 2.76 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.281 1.586 . . . . 2.2400000000000002 115.281 -167.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -155.12 145.93 22.42 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.753 1.161 . . . . 1.95 111.666 171.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.9 m -127.74 133.78 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.072 0.949 . . . . 1.1000000000000001 111.175 170.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 43.4 tttt -135.88 145.52 46.43 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.935 1.294 . . . . 1.6799999999999999 112.539 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 96.4 t -89.52 134.15 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 126.226 1.81 . . . . 1.03 111.077 173.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . 0.612 HD23 HD22 ' A' 1222 ' ' LEU . 30.3 tp -95.4 -38.53 10.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.898 1.679 . . . . 1.3 110.984 170.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 52.1 m -121.89 111.96 17.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.272 1.429 . . . . 1.78 110.213 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -109.74 136.26 49.36 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.776 1.23 . . . . 3.6299999999999999 112.854 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.7 m 57.93 -57.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 130.072 3.349 . . . . 4.2199999999999998 118.82 169.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 22.8 m120 -70.35 -6.28 34.21 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.603 2.075 . . . . 5.1299999999999999 116.603 -166.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.05 -26.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.401 1.48 . . . . 9.0199999999999996 114.304 168.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mt -144.96 142.38 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.589 1.156 . . . . 2.48 107.969 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.3 m -91.76 144.08 25.87 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.425 0.69 . . . . 2.8300000000000001 111.489 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 27.9 p80 -57.31 -41.36 79.76 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.77 1.396 . . . . 3.8900000000000001 114.77 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 27.1 t60 -74.18 -29.3 61.7 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.075 -1.016 . . . . 2.6099999999999999 111.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 49.1 tptt -66.79 -37.5 84.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 117.493 -1.241 . . . . 5.3099999999999996 111.7 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.77 -56.63 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.728 1.149 . . . . 0.85999999999999999 110.309 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.46 -30.1 69.73 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.606 -0.684 . . . . 0.77000000000000002 112.184 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.7 76.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.759 -0.639 . . . . 0.87 112.596 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 17.3 pt -68.81 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.676 1.58 . . . . 0.90000000000000002 112.956 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 61.3 t -70.12 -50.77 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.512 1.051 . . . . 0.92000000000000004 111.349 170.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -67.56 -34.7 84.8 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 121.526 -0.733 . . . . 0.95999999999999996 113.349 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 76.6 p -73.58 -35.62 65.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.692 -0.887 . . . . 1.0700000000000001 112.041 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -71.21 -39.72 71.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.932 1.086 . . . . 1.22 113.932 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -76.34 -6.94 53.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.952 1.464 . . . . 3.4900000000000002 114.952 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 84.7 p -58.68 -27.29 64.68 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.221 1.934 . . . . 2.6899999999999999 116.221 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -95.58 -6.84 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 119.212 0.914 . . . . 2.1099999999999999 113.201 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.1 t -79.77 162.03 25.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.562 1.145 . . . . 1.77 113.728 -174.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -112.64 -3.53 14.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.355 2.262 . . . . 4.3499999999999996 114.097 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . 0.474 ' HB3' HN61 ' A' 1232 ' ' ATP . 2.8 m-70 -59.66 144.14 85.57 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.087 -1.008 . . . . 1.6200000000000001 112.282 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.29 -40.54 24.93 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.048 2.498 . . . . 1.8799999999999999 112.286 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.85 -44.47 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.32 -0.862 . . . . 1.8 111.922 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -64.21 -41.61 98.26 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.539 0.59 . . . . 1.6599999999999999 113.162 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.2 p -64.32 -38.31 90.58 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.586 -0.95 . . . . 1.55 112.201 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.54 94.78 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.898 0.879 . . . . 1.0800000000000001 112.843 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 54.4 mt -68.29 -42.32 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.087 0.555 . . . . 0.88 110.214 173.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 96.7 m -54.43 -44.71 72.69 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.664 0.666 . . . . 1.23 111.514 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 31.4 tttt -60.13 -51.43 69.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.68 0.673 . . . . 2.3599999999999999 111.955 174.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.37 -42.52 82.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.714 0.806 . . . . 2.5099999999999998 111.77 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 69.1 m -70.82 -45.65 64.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.147 . . . . 2.9900000000000002 112.696 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.98 -34.86 78.43 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 121.346 1.884 . . . . 2.5699999999999998 111.371 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -65.08 -39.15 92.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.349 1.06 . . . . 3.9900000000000002 112.941 169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.79 -44.57 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.861 -1.15 . . . . 2.8199999999999998 113.074 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.17 -3.1 18.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.848 1.425 . . . . 1.8500000000000001 114.848 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 31.4 t70 58.64 26.22 14.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.627 1.171 . . . . 5.0199999999999996 113.586 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.3 t -122.54 168.44 12.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.31 1.844 . . . . 2.5800000000000001 112.047 -170.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -104.27 -15.0 15.6 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.994 1.717 . . . . 4.0300000000000002 112.134 170.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 1.5 t -132.81 133.42 43.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.061 1.744 . . . . 2.7200000000000002 111.194 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.98 147.61 25.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.246 0.618 . . . . 1.1799999999999999 112.042 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 63.11 177.41 3.83 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.74 1.162 . . . . 1.55 115.08 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 70.7 m -138.47 -69.44 0.44 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.542 0.737 . . . . 1.45 111.414 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 48.9 t -136.11 141.4 44.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.197 0.599 . . . . 1.8999999999999999 111.898 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.98 148.85 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.255 2.622 . . . . 2.98 111.714 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -110.72 124.34 51.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.909 -2.626 . . . . 3.2999999999999998 103.909 163.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.299 0.1 OUTLIER -121.43 138.12 54.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.383 1.447 . . . . 3.1099999999999999 112.889 -174.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.95 98.03 7.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.385 2.274 . . . . 3.54 108.329 -169.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 57.5 t -96.22 126.62 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.555 -0.715 . . . . 2.23 110.692 -168.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 33.1 t -143.32 113.88 5.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.751 1.62 . . . . 1.6699999999999999 109.448 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.14 140.36 92.52 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.251 2.634 . . . . 1.47 113.925 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 55.4 35.68 61.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.6 1.095 . . . . 2.77 114.362 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 93.0 m -143.5 -32.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.784 1.234 . . . . 2.8799999999999999 113.791 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 122.18 -164.26 15.31 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.075 1.321 . . . . 0.75 112.629 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.33 151.14 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.542 -1.563 . . . . 1.96 111.249 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 14.5 t -129.87 140.5 50.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.732 1.613 . . . . 0.71999999999999997 109.859 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 13.5 p -143.97 156.93 44.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.469 1.032 . . . . 1.3799999999999999 113.682 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -116.23 97.75 6.23 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.509 1.124 . . . . 1.9399999999999999 108.735 -174.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 8.1 p -93.96 146.66 6.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.634 0.73 . . . . 2.2799999999999998 111.426 -174.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 3.6 t -142.95 162.02 36.57 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.135 1.532 . . . . 1.6000000000000001 115.135 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 10.9 t-20 176.55 -24.81 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 1 C-N-CA 132.183 4.193 . . . . 3.1299999999999999 109.914 162.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 18.0 pt -52.43 -26.36 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 126.337 1.855 . . . . 3.1000000000000001 114.976 169.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.59 34.39 4.14 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.785 1.634 . . . . 4.6799999999999997 110.179 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.83 36.39 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 120.647 -1.283 . . . . 3.6499999999999999 114.477 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.89 -16.39 63.17 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.947 1.699 . . . . 4.9000000000000004 115.519 177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . 0.313 3.5 pp -95.19 -3.87 46.97 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.274 1.397 . . . . 4.9100000000000001 114.759 173.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 45.8 t-80 32.3 87.32 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.992 2.917 . . . . 6.0499999999999998 115.394 170.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -113.93 140.94 47.97 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.319 1.229 . . . . 10.93 114.319 -174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 45.8 t30 -145.73 68.79 1.21 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.442 2.297 . . . . 12.32 107.119 166.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 2.4 t-20 60.66 -166.35 0.2 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 126.133 1.773 . . . . 12.960000000000001 112.479 -169.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -92.22 -178.14 4.87 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.02 -1.675 . . . . 17.640000000000001 111.238 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.85 90.52 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.542 1.537 . . . . 12.75 111.252 166.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 70.0 mt -141.67 125.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.472 1.509 . . . . 12.470000000000001 109.008 -175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.79 -31.95 63.53 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.127 0.971 . . . . 15.630000000000001 112.529 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -72.51 -7.84 52.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.68 -1.262 . . . . 15.050000000000001 114.399 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -60.01 -22.26 62.37 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.914 -1.116 . . . . 12.56 112.324 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.96 146.09 54.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.763 0.825 . . . . 14.42 112.66 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 19.0 tt -55.71 136.28 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 15.85 113.458 -173.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -151.77 111.0 3.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.041 1.736 . . . . 16.879999999999999 110.799 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -74.69 -40.22 61.5 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.422 -0.799 . . . . 17.530000000000001 112.545 172.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 49.23 35.64 7.86 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.266 1.427 . . . . 19.239999999999998 113.606 -169.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 16.2 t 58.81 131.41 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 129.111 2.964 . . . . 20.73 115.023 -168.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 17.9 mt -98.1 -171.08 2.08 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.971 1.309 . . . . 20.859999999999999 111.44 -171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 5.8 m -62.06 114.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.067 -1.02 . . . . 22.329999999999998 109.86 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -105.17 108.75 20.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.477 1.111 . . . . 24.920000000000002 108.752 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.56 9.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.491 1.916 . . . . 27.109999999999999 111.985 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 1.7 t70 -154.28 -154.98 0.54 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.603 2.361 . . . . 27.949999999999999 110.02 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -68.3 26.01 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.928 1.691 . . . . 29.120000000000001 114.895 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 33.2 t 56.45 56.64 5.5 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.534 1.534 . . . . 26.920000000000002 113.774 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 63.4 t30 -77.13 43.86 0.38 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.82 1.648 . . . . 26.350000000000001 112.728 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -63.46 -54.39 37.26 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.01 1.324 . . . . 24.399999999999999 112.41 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 46.89 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.431 2.292 . . . . 27.300000000000001 114.142 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 18.5 m -152.33 154.2 35.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.718 2.407 . . . . 22.800000000000001 111.535 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 89.2 p -151.39 149.94 29.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.366 1.467 . . . . 19.620000000000001 113.822 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 65.5 p -144.51 39.0 1.26 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.463 1.905 . . . . 18.059999999999999 112.188 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 23.0 m -65.29 -11.05 37.6 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 118.877 2.917 . . . . 16.440000000000001 118.877 -166.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 4.9 t 51.89 83.1 0.06 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.634 2.373 . . . . 14.390000000000001 117.018 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 54.4 p -125.02 -25.63 3.83 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.639 0.977 . . . . 14.039999999999999 113.639 167.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 40.3 mtt -110.63 152.04 26.95 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.226 1.41 . . . . 15.75 113.121 -174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 2.3 mm 60.54 13.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 127.182 2.193 . . . . 11.970000000000001 112.872 -172.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.7 pp -73.15 -18.79 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 120.162 -1.587 . . . . 10.0 112.761 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.47 -16.74 64.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.583 0.957 . . . . 9.1300000000000008 113.583 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.79 62.79 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.05 -1.031 . . . . 7.6299999999999999 112.549 170.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -83.31 -45.38 13.85 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.389 1.076 . . . . 8.1899999999999995 109.788 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 83.1 mt -55.82 -41.04 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.134 1.374 . . . . 7.2199999999999998 110.822 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 15.4 m -65.1 -16.49 63.54 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.303 1.223 . . . . 7.6100000000000003 114.303 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -98.88 -4.03 33.91 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.494 1.294 . . . . 6.4800000000000004 114.494 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.22 64.32 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.808 1.186 . . . . 5.0999999999999996 113.633 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . 0.581 ' H ' HD22 ' A' 1173 ' ' LEU . 2.4 mm? -58.79 -28.7 66.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.974 1.71 . . . . 7.2400000000000002 113.205 172.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -103.77 -39.72 6.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.034 1.334 . . . . 5.79 112.071 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.96 25.27 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.67 1.73 . . . . 4.25 115.67 -168.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 57.96 -41.04 0.05 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 128.584 2.754 . . . . 4.8899999999999997 118.372 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 25.71 119.85 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 130.667 3.587 . . . . 2.21 117.837 167.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -71.2 115.92 10.91 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.898 -1.126 . . . . 2.77 110.545 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 77.2 tttt -88.14 125.24 34.5 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.333 -1.358 . . . . 1.8999999999999999 107.333 168.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 8.6 m -126.69 141.17 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.295 0.638 . . . . 0.95999999999999996 110.369 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.5 150.76 47.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.988 0.915 . . . . 0.52000000000000002 112.392 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.3 tt -159.33 158.47 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.801 1.24 . . . . 0.46000000000000002 109.938 -169.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 104.85 159.18 23.58 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.75 0.691 . . . . 1.6299999999999999 114.783 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.2 t-20 49.53 -159.6 0.06 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.219 1.408 . . . . 2.4900000000000002 113.617 -175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.7 -58.52 1.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.777 1.399 . . . . 7.4299999999999997 114.777 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -80.96 -37.76 28.84 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.152 0.887 . . . . 5.4299999999999997 113.002 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 83.6 t90 -54.73 -36.44 64.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.927 1.291 . . . . 3.0299999999999998 113.087 172.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 92.8 mmm -61.52 -36.36 80.31 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.665 1.186 . . . . 2.8300000000000001 113.244 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.8 mt -62.37 -61.44 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.723 1.609 . . . . 2.96 109.134 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.4 -13.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.544 2.338 . . . . 6.4800000000000004 116.268 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 6.0 t30 -74.28 22.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 121.694 2.043 . . . . 0.92000000000000004 113.153 168.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 66.95 26.44 73.23 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 119.894 -1.753 . . . . 0.84999999999999998 114.409 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 8.2 mt -96.44 147.7 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.052 1.426 . . . . 0.94999999999999996 110.066 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 89.7 t -97.37 126.73 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.328 1.051 . . . . 1.1299999999999999 110.385 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 12.5 tt -107.0 148.26 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.977 0.911 . . . . 1.04 112.629 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.55 152.12 38.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.845 1.258 . . . . 2.77 113.583 -168.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -70.93 -28.02 64.2 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.462 1.282 . . . . 2.98 114.462 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.21 -36.64 69.24 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.761 -1.212 . . . . 2.5699999999999998 112.494 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.5 p -78.0 -36.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.905 0.882 . . . . 0.82999999999999996 113.286 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -54.0 -42.79 69.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.581 1.152 . . . . 3.1200000000000001 112.517 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.42 -40.01 96.03 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.045 0.938 . . . . 1.9099999999999999 113.086 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.31 -39.03 75.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.687 1.195 . . . . 2.0499999999999998 110.879 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 33.4 tpp -62.99 -53.29 56.31 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.509 1.124 . . . . 0.77000000000000002 112.313 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 11.0 t -67.48 -32.07 72.64 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.665 -0.647 . . . . 1.03 112.485 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -57.43 -50.86 71.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.518 1.053 . . . . 3.1800000000000002 112.023 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -71.72 -33.94 69.17 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.314 0.857 . . . . 2.5 113.314 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 51.0 mm-40 -68.21 -35.95 78.77 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.391 -0.818 . . . . 3.9399999999999999 112.564 171.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -71.82 -22.04 61.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.845 1.658 . . . . 4.25 113.524 172.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 21.5 mttp -76.51 -7.66 55.59 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.883 1.273 . . . . 3.1099999999999999 112.135 167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.56 88.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.964 1.745 . . . . 2.3500000000000001 115.094 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . 0.259 16.0 mtt-85 -84.19 -152.36 0.13 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 3.3199999999999998 109.956 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 86.0 m -120.61 120.88 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 121.451 1.932 . . . . 0.77000000000000002 112.112 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -117.06 127.59 54.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.902 2.081 . . . . 0.48999999999999999 109.595 176.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 35.8 m -142.29 154.68 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 119.543 1.065 . . . . 0.45000000000000001 113.483 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.32 164.0 12.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.185 1.394 . . . . 1.0 111.731 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 3.9 t -135.83 129.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.695 1.598 . . . . 2.0699999999999998 111.168 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -134.43 153.01 52.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.166 1.386 . . . . 0.51000000000000001 111.99 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 23.8 m -149.25 130.45 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.879 . . . . 0.92000000000000004 112.899 -169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 35.7 m-20 41.89 40.67 1.62 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.262 1.825 . . . . 3.3900000000000001 111.577 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 62.48 30.62 17.22 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 128.125 2.57 . . . . 2.1099999999999999 116.787 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -119.14 135.16 54.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.735 2.014 . . . . 2.5600000000000001 110.199 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . 0.612 HD22 HD23 ' A' 1062 ' ' LEU . 0.3 OUTLIER -67.79 133.78 49.82 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.254 -1.529 . . . . 0.81999999999999995 111.523 172.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -116.83 -42.24 2.98 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.725 1.009 . . . . 0.63 113.725 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -170.13 -176.47 39.74 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 119.215 0.916 . . . . 0.64000000000000001 114.725 -172.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.03 155.05 44.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.865 1.666 . . . . 0.69999999999999996 112.852 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 23.7 mm -125.63 134.48 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.535 1.534 . . . . 0.92000000000000004 110.266 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -112.93 131.86 55.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.246 1.418 . . . . 0.68000000000000005 110.904 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 10.6 mt -128.86 147.61 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.734 2.014 . . . . 1.47 108.789 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -94.86 -30.95 13.93 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.128 1.158 . . . . 4.0800000000000001 114.128 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 11.4 t70 61.46 123.65 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.606 1.962 . . . . 4.2400000000000002 115.012 177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 126.711 2.005 . . . . 5.2199999999999998 115.603 -169.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . 0.474 HN61 ' HB3' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 121.145 0.497 . . . . 14.73 110.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -116.38 -31.46 5.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.257 1.423 . . . . 11.31 112.694 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 9.2 t 49.34 -165.77 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.853 2.461 . . . . 7.6100000000000003 114.622 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 4.2 tpt -76.2 -64.01 1.19 Allowed 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.467 -1.395 . . . . 7.0099999999999998 111.427 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 43.3 m170 -123.01 -67.95 0.91 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.658 1.183 . . . . 7.2999999999999998 112.27 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -73.21 78.38 0.81 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.111 1.339 . . . . 3.52 115.278 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 26.8 m -66.96 125.12 90.38 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.912 0.885 . . . . 2.73 112.426 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -95.04 156.75 1.74 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.198 3.265 . . . . 1.4099999999999999 111.969 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 30.8 t -134.93 113.08 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.609 1.164 . . . . 2.1899999999999999 109.588 173.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 5.8 p -73.06 132.69 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.777 1.171 . . . . 1.1699999999999999 110.697 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -125.57 -36.17 2.47 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 117.415 2.376 . . . . 2.23 117.415 -164.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -156.42 150.84 25.55 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.737 1.608 . . . . 1.9199999999999999 111.529 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.0 m -129.67 136.69 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.117 0.967 . . . . 1.1000000000000001 111.375 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -140.8 147.83 39.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.107 0.963 . . . . 3.1200000000000001 113.153 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 99.1 t -102.45 129.95 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.318 1.447 . . . . 1.1100000000000001 112.233 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.7 tp -99.65 -35.81 9.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.024 1.73 . . . . 1.1100000000000001 112.673 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -111.01 88.66 2.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.634 1.574 . . . . 1.95 108.06 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.64 133.12 41.56 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.948 0.899 . . . . 3.5899999999999999 111.701 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 13.8 m 59.18 25.68 14.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.226 2.211 . . . . 2.25 115.097 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -140.61 -6.08 1.17 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.047 1.499 . . . . 2.7200000000000002 115.047 -172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -140.87 -77.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.891 1.277 . . . . 4.4900000000000002 110.799 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 20.9 mt -137.47 147.57 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 127.111 2.165 . . . . 1.74 110.075 -174.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 49.5 m -91.68 152.48 20.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.595 1.558 . . . . 1.8 113.704 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 12.2 p80 -53.81 -42.12 68.05 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.781 2.141 . . . . 3.0299999999999998 116.781 -168.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -73.99 -23.1 59.41 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.073 -1.017 . . . . 2.8799999999999999 111.73 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.2 tttt -75.77 -39.17 57.5 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.095 0.958 . . . . 4.04 111.474 169.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 66.3 mt -56.38 -52.2 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 119.459 1.027 . . . . 0.73999999999999999 110.656 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.23 -33.34 75.53 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.588 -0.695 . . . . 0.62 112.072 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.02 75.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.722 0.638 . . . . 0.52000000000000002 112.722 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 12.4 pt -70.67 -34.56 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 120.763 -1.211 . . . . 0.51000000000000001 113.381 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 73.5 t -70.64 -46.07 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 118.89 0.768 . . . . 0.60999999999999999 110.972 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -63.98 -37.41 94.58 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.662 -0.649 . . . . 0.59999999999999998 113.372 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 32.6 p -73.07 -37.26 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.917 0.887 . . . . 0.62 113.116 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.99 74.5 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.237 0.926 . . . . 0.63 112.247 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -67.57 -17.36 64.61 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.131 -0.981 . . . . 2.2400000000000002 112.771 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 4.2 t -60.51 -35.35 75.75 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.927 -1.108 . . . . 1.3999999999999999 112.077 170.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.88 -22.17 23.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.649 1.18 . . . . 2.0499999999999998 113.319 177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 3.6 t -74.33 -179.56 4.0 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.284 1.034 . . . . 1.45 111.8 173.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -137.3 19.61 2.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.645 1.578 . . . . 4.29 112.691 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . 0.417 ' CB ' HN61 ' A' 1232 ' ' ATP . 26.4 m-70 -75.95 161.21 76.49 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.854 1.262 . . . . 1.6599999999999999 112.617 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.02 -33.67 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.05 2.5 . . . . 1.1799999999999999 114.108 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.81 -49.35 5.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.572 1.549 . . . . 0.78000000000000003 112.722 -167.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.91 -31.62 81.42 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.003 0.335 . . . . 0.96999999999999997 113.772 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 28.5 p -66.31 -16.34 63.96 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.746 -1.444 . . . . 1.72 113.915 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.39 80.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.73 -1.231 . . . . 0.78000000000000003 110.737 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.91 -37.11 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.261 1.424 . . . . 0.92000000000000004 110.417 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 97.7 m -53.82 -48.26 70.08 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.074 0.852 . . . . 1.1599999999999999 111.863 168.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -64.0 -45.97 86.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.342 0.974 . . . . 3.6800000000000002 112.553 174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 53.7 t80 -55.92 -43.92 77.83 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.919 0.888 . . . . 1.71 111.457 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 42.7 t -65.85 -52.09 53.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.416 1.487 . . . . 1.9199999999999999 111.864 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -51.51 -45.34 62.84 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.107 1.363 . . . . 3.0699999999999998 112.204 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.54 -43.19 77.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.501 0.72 . . . . 3.3100000000000001 111.559 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -62.19 -42.83 99.65 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.653 0.982 . . . . 2.6899999999999999 113.653 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.4 mt -71.39 -13.24 61.79 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.825 0.85 . . . . 1.04 112.66 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 15.7 t70 50.61 54.91 10.35 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.293 1.837 . . . . 2.5499999999999998 112.161 -169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 12.7 t -128.91 175.07 8.94 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.85 1.66 . . . . 3.0899999999999999 111.841 -174.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -115.69 -7.17 12.14 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.404 1.882 . . . . 2.79 112.402 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 10.0 t -140.04 127.26 21.14 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.402 -1.436 . . . . 2.71 113.819 -168.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -161.52 154.13 20.33 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 125.649 1.58 . . . . 0.98999999999999999 113.609 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 77.74 132.03 0.6 Allowed Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.383 1.313 . . . . 1.3200000000000001 116.383 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 87.9 m -120.07 -72.45 0.69 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.448 1.277 . . . . 1.45 114.448 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 52.6 t -138.99 142.5 38.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.786 1.234 . . . . 1.4399999999999999 111.208 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.16 169.97 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 130.584 3.554 . . . . 2.1800000000000002 108.577 -167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -142.27 150.05 40.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.739 1.616 . . . . 2.6600000000000001 108.44 166.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -112.72 147.76 36.15 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 121.367 1.894 . . . . 4.2300000000000004 115.468 -169.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.21 95.24 2.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 129.55 3.14 . . . . 2.2999999999999998 108.02 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 24.4 t -101.12 144.54 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.472 1.509 . . . . 1.9099999999999999 111.657 -171.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 48.8 t -132.7 118.14 15.5 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.881 1.273 . . . . 1.27 109.381 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.36 133.26 48.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.252 2.635 . . . . 1.29 115.514 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 62.33 19.06 59.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.675 1.607 . . . . 1.97 114.372 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.8 t -136.93 -42.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.083 1.142 . . . . 2.0099999999999998 114.083 -168.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 154.79 -176.91 32.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.902 0.763 . . . . 0.79000000000000004 113.756 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.22 146.67 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 124.001 0.92 . . . . 1.8700000000000001 111.536 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 30.0 t -125.41 138.7 54.03 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.853 2.061 . . . . 0.48999999999999999 110.909 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.7 p -145.49 165.97 27.05 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 115.176 1.547 . . . . 0.63 115.176 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -111.66 94.43 4.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.758 1.223 . . . . 1.2 108.367 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 7.8 p -101.96 130.05 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.215 1.007 . . . . 1.8899999999999999 113.238 -173.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.5 t -123.21 161.05 25.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.359 1.463 . . . . 1.1599999999999999 113.607 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 176.87 -37.56 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.103 2.961 . . . . 2.1299999999999999 109.931 160.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 18.0 pt -50.07 -21.24 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 127.295 2.238 . . . . 2.52 116.826 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -153.79 39.29 0.48 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.341 1.456 . . . . 4.1500000000000004 109.824 167.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -74.43 0.64 54.27 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 120.465 -1.397 . . . . 3.4100000000000001 115.185 -170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.81 -6.49 21.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.247 1.573 . . . . 3.8700000000000001 115.247 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 24.7 mt -87.32 -26.39 23.43 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.006 0.923 . . . . 5.1299999999999999 111.737 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . 0.401 ' CG ' ' H ' ' A' 1132 ' ' LYS . 37.2 t60 52.4 175.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.952 2.101 . . . . 6.1500000000000004 114.963 -172.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . 0.401 ' H ' ' CG ' ' A' 1131 ' ' HIS . 55.1 mtpt -71.51 170.51 13.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.367 1.867 . . . . 12.390000000000001 111.688 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -85.22 48.59 1.6 Allowed 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.407 -0.808 . . . . 12.369999999999999 109.339 168.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -79.21 39.17 0.38 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.711 -1.243 . . . . 9.5899999999999999 112.286 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -114.92 126.9 55.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.773 2.029 . . . . 12.83 107.832 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.2 m-80 60.99 16.0 6.62 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.492 1.117 . . . . 11.789999999999999 113.287 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 59.4 mt -139.15 137.28 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.509 2.724 . . . . 10.539999999999999 106.829 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -83.03 71.25 10.12 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.289 1.042 . . . . 14.300000000000001 110.665 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 10.6 t70 77.09 123.66 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 130.527 3.531 . . . . 14.84 116.401 -169.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.57 119.35 26.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.167 1.787 . . . . 14.67 111.522 175.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -156.44 -175.09 5.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.582 1.553 . . . . 18.120000000000001 111.713 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 15.3 pt -133.68 138.06 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.455 1.102 . . . . 23.050000000000001 110.367 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -127.99 61.62 1.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.857 2.063 . . . . 20.969999999999999 108.779 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.34 -6.2 41.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.396 1.258 . . . . 25.449999999999999 114.396 -169.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -149.63 129.53 13.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.314 0.857 . . . . 24.84 113.314 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.6 t -60.37 -38.16 83.02 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.314 -0.866 . . . . 23.07 111.254 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.52 14.01 22.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.743 1.217 . . . . 26.960000000000001 113.186 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 2.4 t 57.53 20.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.823 1.649 . . . . 28.149999999999999 113.508 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -79.47 157.57 27.46 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.684 1.194 . . . . 31.84 112.843 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.01 137.35 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.292 1.837 . . . . 33.450000000000003 109.932 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -117.9 110.41 17.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.088 0.955 . . . . 33.920000000000002 112.743 -171.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -81.67 56.76 3.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.778 1.231 . . . . 36.979999999999997 110.759 169.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 11.6 p -51.97 152.05 3.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.815 2.446 . . . . 35.909999999999997 113.63 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 25.9 t30 -61.78 -32.8 73.1 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.47 1.656 . . . . 39.200000000000003 115.47 -167.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.97 143.19 50.94 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.837 -0.539 . . . . 35.109999999999999 111.397 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -128.77 173.36 10.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.991 1.316 . . . . 42.350000000000001 111.054 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 62.3 m -29.54 116.11 0.11 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.218 2.207 . . . . 36.789999999999999 115.005 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 25.3 p -78.72 -36.93 42.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.589 1.555 . . . . 35.93 111.454 171.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 14.8 t -161.44 -11.23 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.705 2.002 . . . . 36.039999999999999 112.205 167.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 113.41 26.96 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.103 1.761 . . . . 31.879999999999999 111.603 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 17.0 m -70.02 8.53 0.72 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.679 0.992 . . . . 31.82 113.679 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 36.4 t -72.04 -14.45 61.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 26.52 110.554 165.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 65.7 mmm 50.5 -144.29 0.54 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.837 1.255 . . . . 28.370000000000001 110.328 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 17.0 mm -118.18 55.51 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 125.981 1.712 . . . . 20.59 108.225 167.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.69 -11.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 115.325 1.602 . . . . 20.920000000000002 115.325 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -148.87 -8.52 0.36 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.371 1.469 . . . . 16.989999999999998 114.732 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -55.42 -28.02 51.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.735 1.607 . . . . 13.119999999999999 114.904 -173.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -87.36 -28.31 22.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.222 1.009 . . . . 13.76 113.008 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.97 -32.66 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.361 2.264 . . . . 9.5700000000000003 112.271 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 88.3 p -61.61 -9.87 6.99 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.062 1.745 . . . . 8.1099999999999994 115.485 -169.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.35 -57.7 2.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.728 0.811 . . . . 7.0800000000000001 110.578 168.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.4 -30.26 66.71 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.313 1.845 . . . . 4.2300000000000004 113.996 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -23.93 67.21 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.111 -0.993 . . . . 7.6600000000000001 113.168 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.43 -47.12 5.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.455 1.102 . . . . 5.8700000000000001 111.881 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -80.29 54.01 1.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.641 1.576 . . . . 3.27 109.912 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -26.48 123.14 0.08 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.509 2.324 . . . . 2.9900000000000002 115.918 -165.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -147.29 137.93 23.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 112.576 -2.102 . . . . 3.0299999999999998 112.223 -163.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.78 121.85 44.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.125 0.97 . . . . 2.29 108.961 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.37 103.15 13.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.29 -1.004 . . . . 1.21 108.29 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -121.61 138.59 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.959 0.8 . . . . 0.68000000000000005 112.006 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.31 152.52 41.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.851 0.86 . . . . 0.55000000000000004 113.132 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -146.12 140.54 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.437 1.495 . . . . 0.62 109.501 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 169.7 -166.0 39.3 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.255 0.862 . . . . 1.5600000000000001 115.255 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . 0.268 10.4 p30 -84.7 173.19 10.91 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.86 1.264 . . . . 2.2599999999999998 112.546 173.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -59.19 -10.12 2.61 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 117.276 2.324 . . . . 4.9199999999999999 117.276 -165.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -71.48 -34.15 69.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.017 1.28 . . . . 5.1100000000000003 111.921 171.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 50.2 m95 -65.42 -26.22 67.87 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.826 -1.171 . . . . 4.0800000000000001 113.658 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -34.16 67.53 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.446 0.699 . . . . 2.4199999999999999 111.359 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 56.5 mt -66.87 -67.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.137 1.375 . . . . 2.75 107.805 169.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -38.54 -42.96 0.81 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.968 2.507 . . . . 5.6699999999999999 115.451 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.15 1.75 56.07 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 115.759 1.763 . . . . 2.02 115.759 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 75.86 32.43 53.51 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 120.749 -1.22 . . . . 0.75 114.586 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.69 177.45 6.1 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.073 1.349 . . . . 0.81999999999999995 110.987 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 48.8 t -121.54 132.67 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.09 1.356 . . . . 1.3200000000000001 110.726 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.8 tt -108.29 134.38 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.9 0.88 . . . . 1.22 110.599 171.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -106.22 162.74 13.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.234 1.014 . . . . 2.9900000000000002 113.461 -168.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.03 -40.32 93.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.423 1.089 . . . . 2.4300000000000002 113.757 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.72 -34.15 66.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.542 0.737 . . . . 2.54 112.508 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 11.3 p -76.9 -32.97 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.338 0.655 . . . . 0.68999999999999995 111.667 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -58.89 -46.1 88.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.588 0.755 . . . . 2.0 111.492 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.94 -33.54 74.45 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.881 1.272 . . . . 2.54 113.867 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.63 -42.16 52.33 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.799 1.639 . . . . 2.4900000000000002 112.392 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 24.1 tpp -64.46 -50.65 66.68 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.232 1.413 . . . . 0.68000000000000005 111.867 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 13.9 t -63.62 -33.12 74.91 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.427 0.691 . . . . 1.1000000000000001 112.141 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -62.5 -48.99 77.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.98 0.912 . . . . 3.2000000000000002 112.352 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.66 -0.65 . . . . 2.29 112.686 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -66.97 -40.14 87.4 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.904 -1.122 . . . . 2.9700000000000002 112.323 171.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -71.22 -27.13 63.26 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.43 -1.419 . . . . 4.5899999999999999 113.804 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 20.8 mttp -70.38 -2.7 14.47 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.648 1.579 . . . . 2.2999999999999998 113.219 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 76.66 23.53 69.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.957 1.265 . . . . 1.22 113.593 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -101.17 -166.86 1.35 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.032 1.333 . . . . 2.98 111.043 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' 1228 ' ' ILE . 90.8 m -115.22 121.75 43.9 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.553 1.541 . . . . 1.2 109.928 -176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -127.51 118.77 24.63 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.05 0.94 . . . . 0.54000000000000004 110.413 -170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 29.1 m -139.29 153.44 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.114 0.965 . . . . 0.68999999999999995 112.688 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.35 159.15 18.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.206 1.402 . . . . 0.76000000000000001 111.509 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 13.0 t -128.73 125.93 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.151 1.38 . . . . 1.8 110.741 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -124.19 154.24 40.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.769 1.228 . . . . 0.47999999999999998 111.636 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.8 m -148.09 123.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.732 2.013 . . . . 0.80000000000000004 110.236 -168.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.263 6.7 m-20 40.23 54.91 2.79 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.547 1.939 . . . . 2.9199999999999999 113.168 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.271 34.2 m-20 57.76 30.9 19.68 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.125 2.17 . . . . 1.6499999999999999 115.954 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -134.88 151.67 51.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.914 1.286 . . . . 2.9300000000000002 110.586 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.02 151.87 45.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 119.802 -1.811 . . . . 0.81000000000000005 111.748 170.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 27.1 p -122.09 -44.81 2.27 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.594 -0.692 . . . . 0.72999999999999998 111.208 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.64 -162.65 24.26 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.224 0.92 . . . . 0.59999999999999998 115.0 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.1 pt? -140.74 154.25 46.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.591 1.556 . . . . 0.65000000000000002 112.592 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 13.3 mm -123.94 127.52 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.93000000000000005 109.096 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -97.22 133.0 42.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.684 1.194 . . . . 0.81999999999999995 109.758 169.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' 1212 ' ' THR . 44.1 mt -140.11 159.85 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.798 2.039 . . . . 1.22 107.397 -170.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -126.33 168.18 14.5 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.164 -1.585 . . . . 1.49 111.943 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.4 t70 -118.87 140.2 50.37 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.048 1.339 . . . . 3.6699999999999999 111.094 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.253 1.278 0 C-N-CA 126.425 1.89 . . . . 4.75 111.324 -179.871 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . 0.417 HN61 ' CB ' ' A' 1086 ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 110.658 -0.127 . . . . 10.06 110.658 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.5 137.38 56.77 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.219 0.608 . . . . 15.93 110.683 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . 0.433 HG22 ' H ' ' A' 1050 ' ' MET . 3.7 m 57.7 176.49 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.398 1.479 . . . . 9.1199999999999992 113.618 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . 0.433 ' H ' HG22 ' A' 1049 ' ' THR . 43.4 ttp -136.1 -51.21 0.71 Allowed 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.587 -1.32 . . . . 8.0800000000000001 112.344 168.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -84.93 -34.81 22.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.378 1.251 . . . . 5.9900000000000002 114.378 -175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -55.52 122.74 27.79 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.938 0.78 . . . . 3.71 111.587 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 22.9 m -115.21 117.03 41.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.917 0.887 . . . . 2.3799999999999999 111.126 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.59 154.75 18.24 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.734 2.956 . . . . 2.0699999999999998 111.422 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 59.4 t -142.21 105.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.053 -1.092 . . . . 2.7400000000000002 108.053 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 8.1 p -71.9 128.99 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.96 0.886 . . . . 1.0900000000000001 111.396 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -102.66 -47.99 4.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.17 1.788 . . . . 2.8399999999999999 112.936 -169.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -153.79 146.9 24.6 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.589 0.756 . . . . 2.4900000000000002 112.571 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.2 m -120.15 128.87 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.28 1.032 . . . . 0.95999999999999996 110.179 167.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 48.2 tttt -134.12 144.37 48.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.662 0.785 . . . . 2.4900000000000002 113.098 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 97.4 t -90.31 144.31 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.245 1.418 . . . . 0.80000000000000004 112.407 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.9 -29.4 5.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.832 1.653 . . . . 0.81999999999999995 112.551 169.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.9 m -127.59 123.8 36.57 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.006 1.323 . . . . 1.75 110.423 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.52 143.35 51.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.574 1.55 . . . . 3.8799999999999999 110.151 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 42.2 m 63.49 -30.83 0.1 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.635 2.374 . . . . 3.3999999999999999 116.803 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.56 -10.79 58.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.492 1.496 . . . . 3.1299999999999999 114.76 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -160.5 -38.91 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.237 1.415 . . . . 5.5499999999999998 112.299 175.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.96 167.85 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 126.984 2.114 . . . . 1.54 108.569 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 62.8 m -143.76 161.77 37.75 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.902 1.681 . . . . 2.1499999999999999 111.32 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -42.32 -50.78 4.99 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.859 2.463 . . . . 5.2000000000000002 115.225 -169.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -62.35 -38.32 89.08 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.672 0.669 . . . . 5.6900000000000004 112.778 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 64.4 mttm -74.29 -39.74 62.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.526 0.73 . . . . 2.5699999999999998 111.008 175.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 97.9 mt -57.68 -52.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.987 0.915 . . . . 0.55000000000000004 110.945 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.72 -31.21 70.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.513 -0.742 . . . . 0.73999999999999999 112.249 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.67 -50.38 63.09 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.024 0.379 . . . . 0.51000000000000001 112.024 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 16.2 pt -69.09 -35.95 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.915 -1.116 . . . . 0.56000000000000005 113.086 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 64.7 t -71.24 -43.76 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.223 0.92 . . . . 0.67000000000000004 111.512 175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -68.53 -34.34 78.81 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.185 -0.947 . . . . 0.68999999999999995 113.807 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 17.2 p -68.24 -43.23 78.35 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.63 -0.924 . . . . 0.88 111.691 171.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.26 76.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.083 0.856 . . . . 0.91000000000000003 112.445 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -71.08 -17.26 62.6 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.99 -1.069 . . . . 2.3199999999999998 113.605 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.1 p -72.38 -28.54 63.07 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 120.204 -1.56 . . . . 1.6200000000000001 112.715 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 22.9 m120 -91.14 -22.71 20.54 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.44 1.496 . . . . 3.48 112.262 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 7.5 t -76.42 173.64 11.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.396 1.478 . . . . 1.4399999999999999 113.72 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -130.38 15.11 5.56 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.85 2.06 . . . . 4.0800000000000001 112.714 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -69.35 165.94 34.8 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.212 1.805 . . . . 2.23 113.991 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.51 -23.94 0.72 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.07 2.513 . . . . 1.45 114.395 -173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 6.6 tt -111.76 -48.77 3.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.934 2.094 . . . . 1.02 112.554 -167.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -58.5 -21.35 48.88 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.489 0.956 . . . . 0.93000000000000005 115.489 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 63.4 p -66.73 -14.11 62.16 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.518 -1.578 . . . . 1.28 114.343 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.18 82.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.947 0.899 . . . . 0.78000000000000003 111.285 167.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 12.9 mt -71.99 -36.31 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.243 1.417 . . . . 0.70999999999999996 110.278 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 11.2 m -54.84 -48.29 73.04 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.907 0.776 . . . . 1.24 111.519 170.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -59.0 -49.22 78.74 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.819 0.736 . . . . 2.8500000000000001 111.735 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 27.4 t80 -56.74 -44.8 82.03 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.485 1.114 . . . . 2.3999999999999999 112.166 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 43.5 t -70.05 -50.6 39.57 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.988 0.915 . . . . 1.6699999999999999 111.763 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -56.22 -38.82 71.57 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.782 -1.199 . . . . 2.7999999999999998 112.378 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -70.05 -35.87 74.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.815 0.846 . . . . 3.0800000000000001 112.633 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -70.17 -46.38 64.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 2.0299999999999998 112.693 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.79 -30.0 62.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.851 1.26 . . . . 1.05 113.473 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 21.1 t70 54.52 45.5 26.86 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.569 1.547 . . . . 2.6800000000000002 112.062 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 1.2 t -147.69 146.27 29.21 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.686 1.365 . . . . 2.6099999999999999 114.686 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -105.95 19.81 19.94 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.081 1.352 . . . . 3.3900000000000001 114.317 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 80.6 p -110.6 -6.2 14.91 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.946 -1.721 . . . . 3.9900000000000002 114.138 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.3 148.77 48.1 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.02 1.328 . . . . 1.4199999999999999 113.407 -172.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 72.97 137.23 0.27 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.131 1.824 . . . . 0.97999999999999998 114.838 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 97.2 m -136.57 -41.16 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.955 1.302 . . . . 1.3999999999999999 112.474 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 7.5 t -138.97 142.88 38.36 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.239 1.415 . . . . 2.4700000000000002 114.139 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.9 mm -140.27 134.1 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 129.576 3.15 . . . . 2.25 108.206 168.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . 0.323 0.0 OUTLIER -92.18 -14.7 28.66 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.996 1.48 . . . . 3.3999999999999999 114.996 176.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 8.1 m-85 54.33 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 129.04 2.936 . . . . 3.1400000000000001 117.631 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.98 93.08 2.6 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.456 1.902 . . . . 2.6800000000000002 106.272 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 4.4 m -98.94 150.14 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.269 0.628 . . . . 2.77 110.965 -170.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 31.0 t -140.36 106.41 6.59 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.102 1.361 . . . . 1.1299999999999999 109.6 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 149.9 75.8 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.188 2.592 . . . . 1.8899999999999999 112.406 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.73 -18.31 1.4 Allowed Glycine 0 CA--C 1.538 1.472 0 O-C-N 121.057 -1.027 . . . . 1.53 114.75 -171.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 45.7 t -115.05 -72.93 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.064 1.345 . . . . 2.2999999999999998 112.976 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 163.9 -153.15 23.4 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.312 0.96 . . . . 1.1000000000000001 113.482 -171.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.0 tt -144.06 148.48 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.075 0.95 . . . . 1.9399999999999999 112.645 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 41.4 t -117.79 145.17 44.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.135 1.774 . . . . 0.56000000000000005 109.381 164.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 25.9 p -164.57 164.93 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.535 0.939 . . . . 0.72999999999999998 113.535 -174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -109.63 146.45 34.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.629 -0.878 . . . . 1.3200000000000001 108.629 166.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 32.8 m -123.16 153.8 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.386 1.074 . . . . 2.23 110.808 172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 1.2 t -146.08 157.93 43.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.086 0.954 . . . . 1.05 111.903 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -165.98 -33.02 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 128.953 2.901 . . . . 2.5699999999999998 107.97 158.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . 0.409 ' H ' HD13 ' A' 1126 ' ' ILE . 0.2 OUTLIER -52.2 -22.5 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 125.751 1.62 . . . . 2.6800000000000002 114.736 168.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -138.72 40.73 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.483 1.113 . . . . 4.4000000000000004 110.508 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -54.35 -18.63 10.27 Favored Glycine 0 N--CA 1.474 1.203 0 N-CA-C 116.29 1.276 . . . . 3.3599999999999999 116.29 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -6.15 26.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.665 1.586 . . . . 4.9199999999999999 115.083 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.44 -26.94 62.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.174 1.389 . . . . 6.71 113.329 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 4.8 t-80 63.87 176.6 0.17 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 126.21 1.804 . . . . 6.7000000000000002 113.229 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -99.94 10.27 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 118.581 2.808 . . . . 14.02 118.581 -166.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.85 -62.5 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.461 2.304 . . . . 12.960000000000001 114.537 -169.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 35.1 t-20 64.93 156.23 0.08 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.299 3.04 . . . . 11.68 114.782 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 7.5 m-90 63.9 162.37 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 129.957 3.303 . . . . 14.869999999999999 115.416 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 66.88 -5.2 0.69 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.127 1.771 . . . . 16.010000000000002 115.206 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.02 -14.26 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.568 1.947 . . . . 16.829999999999998 112.492 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 9.8 tt0 72.8 -39.99 0.46 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.43 2.692 . . . . 22.420000000000002 111.949 -168.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -98.99 -159.88 0.77 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.899 1.68 . . . . 19.699999999999999 109.025 165.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 54.3 19.41 2.22 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 117.349 2.351 . . . . 15.140000000000001 117.349 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -154.37 -64.87 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.692 1.197 . . . . 14.75 112.114 175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.2 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.215 1.806 . . . . 17.289999999999999 112.308 -174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -72.7 75.77 1.11 Allowed 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.005 -1.059 . . . . 20.98 110.988 170.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -82.66 6.5 17.66 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.48 2.312 . . . . 18.170000000000002 114.101 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -96.47 142.06 29.02 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.468 1.507 . . . . 19.469999999999999 113.187 -173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 91.1 p -146.8 161.76 40.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.965 1.306 . . . . 22.219999999999999 112.484 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . 0.422 ' H ' HD23 ' A' 1147 ' ' LEU . 2.4 pt? -84.88 -3.27 58.62 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.759 1.392 . . . . 25.420000000000002 114.759 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 19.0 t 46.46 70.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 127.258 2.223 . . . . 26.32 111.17 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.63 24.5 0.47 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.696 1.998 . . . . 29.210000000000001 113.804 -171.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 32.7 mm -139.52 151.26 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.722 2.409 . . . . 28.5 109.037 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -125.7 11.49 7.87 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.174 1.39 . . . . 30.91 113.906 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -96.89 62.57 1.89 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.592 1.557 . . . . 30.739999999999998 112.775 -176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 8.7 t 39.93 46.68 1.77 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.793 2.437 . . . . 29.780000000000001 113.492 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -94.08 162.74 13.75 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 116.564 2.061 . . . . 27.399999999999999 116.564 -167.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . 0.261 39.6 mt-10 62.68 -3.97 0.27 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 128.711 2.804 . . . . 25.27 117.734 174.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -60.9 -14.38 21.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.42 1.888 . . . . 29.07 115.398 -175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 2.0 m -133.52 18.76 3.94 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.501 1.92 . . . . 25.68 112.027 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 99.3 p -82.51 -13.67 56.26 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.455 1.65 . . . . 22.579999999999998 115.455 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 1.7 t -150.86 142.92 24.03 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.224 -0.923 . . . . 20.0 112.327 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 14.2 t -156.43 145.18 20.14 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.35 1.46 . . . . 17.199999999999999 111.921 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 55.4 m -89.12 145.78 25.23 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.788 1.235 . . . . 15.07 113.035 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 22.8 p -126.71 -33.83 2.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.073 1.749 . . . . 13.720000000000001 114.599 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 72.3 mtm -105.54 157.08 17.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.949 1.7 . . . . 13.57 111.786 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 19.0 mm 63.37 -18.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 128.456 2.702 . . . . 10.49 114.973 -171.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.9 pp -74.46 -16.6 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 115.573 1.694 . . . . 10.49 115.573 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.98 -24.05 10.16 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.421 1.489 . . . . 10.23 113.182 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -66.61 -14.7 62.74 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.642 1.577 . . . . 7.9900000000000002 114.169 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -90.88 -17.29 26.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.742 1.217 . . . . 8.5899999999999999 113.564 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.39 -37.22 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.985 0.914 . . . . 7.5499999999999998 110.475 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 2.0 p -76.31 -4.64 43.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.759 1.623 . . . . 6.7599999999999998 114.594 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 17.3 t30 -100.29 -10.21 21.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.036 1.734 . . . . 5.6399999999999997 114.048 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.82 -30.93 68.03 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.9 1.815 . . . . 5.6900000000000004 115.9 -167.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.57 -30.35 60.64 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.11 0.868 . . . . 6.9000000000000004 112.577 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -96.98 -40.38 8.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.553 1.141 . . . . 4.4400000000000004 112.628 168.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -79.09 77.16 5.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.392 0.996 . . . . 4.8399999999999999 112.843 -171.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -45.28 -39.78 6.91 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.544 1.537 . . . . 4.0199999999999996 113.824 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 4.12 118.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 129.525 3.13 . . . . 2.1299999999999999 117.888 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.59 124.55 27.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.585 1.554 . . . . 2.6499999999999999 110.92 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -88.75 122.74 32.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.555 1.142 . . . . 1.6399999999999999 110.733 170.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 5.3 m -135.22 141.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.254 1.021 . . . . 0.52000000000000002 112.265 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -141.27 145.44 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.402 1.081 . . . . 0.60999999999999999 112.465 172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 11.7 tt -144.43 145.96 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.859 1.264 . . . . 0.52000000000000002 109.811 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 124.48 162.04 11.27 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.546 0.978 . . . . 1.6599999999999999 115.546 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.47 -151.63 0.2 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.057 1.743 . . . . 2.3900000000000001 113.368 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.94 -30.23 2.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 127.922 2.489 . . . . 6.1799999999999997 112.059 168.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -66.07 -37.93 87.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.908 1.231 . . . . 4.1900000000000004 112.798 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.1 -19.89 65.71 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.433 -1.417 . . . . 2.9900000000000002 112.759 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 1.7 tpp -70.07 -30.13 67.3 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.384 -0.823 . . . . 2.52 111.351 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.15 -67.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.681 1.993 . . . . 2.0600000000000001 108.093 166.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -48.47 -21.5 0.57 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 129.348 3.059 . . . . 5.5599999999999996 115.786 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 2.5 t30 -93.22 12.9 22.84 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 114.63 1.344 . . . . 0.93000000000000005 114.63 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 68.35 36.18 83.83 Favored Glycine 0 CA--C 1.536 1.367 0 O-C-N 120.543 -1.348 . . . . 0.73999999999999999 114.776 175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.9 mt -100.61 172.07 7.32 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.589 1.155 . . . . 0.90000000000000002 111.503 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 16.2 t -121.41 148.11 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.554 1.941 . . . . 1.6799999999999999 110.625 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.02 155.1 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.393 1.077 . . . . 1.6000000000000001 113.807 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -117.63 164.98 14.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.993 2.117 . . . . 2.9500000000000002 113.567 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 58.6 t30 -66.78 -47.04 73.39 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.926 1.454 . . . . 4.54 114.926 -169.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.35 -43.91 98.07 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.201 0.909 . . . . 3.6400000000000001 111.34 -175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 10.9 p -72.18 -35.47 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.172 0.989 . . . . 1.23 112.647 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -68.25 -43.19 78.41 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.519 1.509 . . . . 1.8999999999999999 111.723 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.94 -45.04 91.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.701 0.8 . . . . 1.9399999999999999 111.325 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 35.8 t80 -64.62 -37.56 87.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.267 1.427 . . . . 2.0299999999999998 112.777 174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 28.8 tpp -66.32 -51.07 61.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.809 1.244 . . . . 0.83999999999999997 111.303 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 14.9 t -66.52 -34.3 77.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.044 -0.503 . . . . 1.25 111.499 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.65 -47.22 86.47 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.529 1.059 . . . . 4.3799999999999999 113.126 176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -70.86 -35.22 72.29 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.591 0.96 . . . . 2.3199999999999998 113.591 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.26 -42.32 96.54 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.367 0.985 . . . . 2.96 112.439 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -70.14 -25.99 63.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.667 1.587 . . . . 4.7999999999999998 113.583 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -81.22 8.22 9.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.929 1.085 . . . . 2.8700000000000001 113.929 167.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 91.07 -5.43 81.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 127.175 2.321 . . . . 1.72 116.153 169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -92.63 162.41 14.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 3.6600000000000001 111.603 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 18.7 m -76.03 119.24 19.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.792 0.837 . . . . 1.1100000000000001 110.234 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -119.37 115.86 24.98 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.736 1.214 . . . . 0.75 109.638 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.89 157.51 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.323 1.049 . . . . 0.84999999999999998 113.224 -170.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -112.77 162.77 15.38 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.418 1.087 . . . . 0.81000000000000005 113.214 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 2.8 p -132.37 122.89 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.367 1.467 . . . . 2.1899999999999999 112.042 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -113.95 152.61 30.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.54 1.936 . . . . 0.64000000000000001 110.941 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 21.2 m -149.05 120.24 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.646 1.179 . . . . 0.89000000000000001 111.118 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 20.4 t70 41.75 52.13 4.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.469 1.508 . . . . 3.2999999999999998 112.683 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.258 6.6 m-20 65.38 22.87 12.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.88 2.178 . . . . 1.4399999999999999 116.88 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -129.13 151.5 49.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.455 1.502 . . . . 2.7799999999999998 110.774 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 145.42 48.4 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.757 -1.215 . . . . 0.67000000000000004 111.965 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 32.0 p -122.61 -35.4 3.08 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.829 1.048 . . . . 0.44 113.829 169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.82 36.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.114 0.87 . . . . 0.44 115.012 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.71 155.28 44.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.679 1.592 . . . . 0.70999999999999996 112.943 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.83 136.22 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.388 1.475 . . . . 0.71999999999999997 109.593 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -106.02 130.5 53.93 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.922 1.289 . . . . 0.81999999999999995 109.554 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.1 mp -123.85 130.72 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.206 1.402 . . . . 1.3200000000000001 108.162 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -97.59 -31.72 12.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 114.337 1.236 . . . . 3.0800000000000001 114.337 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . 0.285 0.0 OUTLIER 62.56 162.71 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.559 1.544 . . . . 3.0699999999999998 114.434 -173.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 C--O 1.253 1.256 0 O-C-N 121.103 -0.998 . . . . 4.4800000000000004 113.073 -173.15 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.197 -0.298 . . . . 10.52 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.14 134.22 44.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.903 0.881 . . . . 11.890000000000001 112.62 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 1.2 m -103.44 139.47 38.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.935 1.294 . . . . 7.9699999999999998 111.967 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 5.4 tmm? -115.18 169.57 9.02 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.383 1.473 . . . . 8.5399999999999991 110.964 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 59.65 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.648 2.379 . . . . 7.5499999999999998 111.546 -168.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -79.03 70.22 2.8 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.088 -0.805 . . . . 3.46 111.088 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 62.1 m -96.74 139.18 21.47 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 125.602 1.561 . . . . 2.5800000000000001 109.952 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.39 146.02 73.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.631 2.221 . . . . 1.4199999999999999 112.02 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 7.0 p -133.16 126.61 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.471 1.508 . . . . 2.9199999999999999 108.276 173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 12.4 p -71.0 123.98 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 120.667 -1.27 . . . . 1.5 109.239 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -96.49 -41.63 8.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.985 1.314 . . . . 3.2400000000000002 112.547 -167.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -159.28 156.82 29.41 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.16 1.384 . . . . 1.96 110.99 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 6.5 m -131.23 143.89 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.815 0.846 . . . . 1.02 110.587 168.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 50.6 tttt -129.33 140.74 51.28 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.91 1.284 . . . . 1.8899999999999999 110.753 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 47.4 t -77.86 142.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.653 -0.869 . . . . 0.83999999999999997 108.653 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.45 -38.96 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.862 1.265 . . . . 1.3600000000000001 111.376 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 74.2 m -100.45 92.37 5.12 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 106.447 -1.686 . . . . 1.9399999999999999 106.447 168.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -90.26 123.12 33.78 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.636 -0.665 . . . . 4.4400000000000004 111.901 -170.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 40.6 m 51.54 39.23 24.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 115.422 1.638 . . . . 2.9100000000000001 115.422 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -141.53 -8.15 0.98 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.685 1.735 . . . . 2.96 115.685 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -144.97 -65.45 0.33 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.573 1.533 . . . . 4.2400000000000002 112.613 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.3 142.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 126.922 2.089 . . . . 1.48 110.063 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 47.4 m -98.95 152.88 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 1.8200000000000001 113.283 -172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -38.49 51.76 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.515 2.043 . . . . 4.0 116.515 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 56.1 t60 -68.95 -34.07 74.75 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.52 1.054 . . . . 2.5499999999999998 111.729 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.75 -36.51 65.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.17 -0.919 . . . . 2.5299999999999998 112.004 173.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.08 -49.63 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.27 0.941 . . . . 0.75 110.729 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -69.68 -32.54 71.23 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.3 -0.875 . . . . 0.82999999999999996 112.209 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -62.29 -50.7 70.62 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.259 0.624 . . . . 0.59999999999999998 112.114 174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 9.0 pt -69.85 -36.45 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 119.514 1.052 . . . . 0.58999999999999997 113.189 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 70.7 t -70.42 -44.23 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 118.893 0.77 . . . . 0.82999999999999996 111.057 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -65.08 -38.86 95.85 Favored Glycine 0 CA--C 1.534 1.269 0 O-C-N 121.29 -0.881 . . . . 0.71999999999999997 113.431 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 31.3 p -75.14 -30.01 60.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.0 0.92 . . . . 0.64000000000000001 113.382 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.53 66.18 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.91 0.777 . . . . 0.69999999999999996 111.715 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -66.87 -18.74 65.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.463 0.912 . . . . 2.1299999999999999 113.463 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 13.6 t -58.12 -22.31 50.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.945 1.298 . . . . 1.3899999999999999 114.263 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -103.74 -2.3 26.66 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.882 1.273 . . . . 1.8999999999999999 113.978 174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 16.0 t -86.23 171.76 11.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.214 1.405 . . . . 1.8300000000000001 113.804 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -3.65 14.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.161 1.784 . . . . 5.9500000000000002 113.746 170.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.51 153.09 93.86 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.694 1.197 . . . . 2.0600000000000001 113.878 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -39.83 0.85 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.197 2.598 . . . . 1.1299999999999999 113.455 -173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.51 -51.35 5.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.303 0.853 . . . . 0.76000000000000001 113.303 -166.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -65.93 -28.34 73.57 Favored Glycine 0 CA--C 1.541 1.714 0 N-CA-C 114.555 0.582 . . . . 0.92000000000000004 114.555 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 27.3 p -66.27 -13.06 59.84 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.856 -1.379 . . . . 1.73 113.933 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.21 67.91 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.93 -1.106 . . . . 0.84999999999999998 111.032 167.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 16.6 mt -69.85 -35.17 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.622 1.169 . . . . 0.88 109.973 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 88.3 m -54.71 -50.32 68.6 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.705 -0.622 . . . . 1.1699999999999999 111.677 168.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 69.8 tttt -61.14 -46.31 91.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.68 -0.676 . . . . 1.97 111.875 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 30.9 t80 -55.33 -45.66 76.38 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.876 0.87 . . . . 1.98 112.547 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 53.7 t -63.35 -54.63 33.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.465 1.106 . . . . 1.97 111.76 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -40.64 67.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.798 1.239 . . . . 3.5499999999999998 112.437 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -73.18 -34.9 66.26 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.717 1.607 . . . . 3.0600000000000001 113.888 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -65.97 -43.44 87.84 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.647 -1.283 . . . . 2.3599999999999999 111.32 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.3 0.23 10.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.013 1.325 . . . . 1.21 113.765 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 29.0 t70 46.89 43.41 13.43 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.473 1.909 . . . . 2.7000000000000002 113.17 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.9 t -132.83 -175.21 3.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.086 0.954 . . . . 3.6699999999999999 113.148 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -123.58 -4.58 8.22 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.721 2.008 . . . . 3.5 112.182 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 2.1 t -151.47 144.95 24.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.358 1.863 . . . . 2.9399999999999999 112.373 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.25 167.62 23.68 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.849 2.46 . . . . 1.1599999999999999 110.761 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 67.25 168.89 3.81 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.839 1.496 . . . . 1.1200000000000001 116.839 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 3.2 m -149.09 -54.58 0.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.228 1.411 . . . . 1.4199999999999999 113.495 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 16.6 t -134.65 143.35 47.22 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.494 1.517 . . . . 1.3500000000000001 112.15 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 11.2 tp -139.56 149.04 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.261 3.425 . . . . 2.5 107.658 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -141.62 66.29 1.36 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.428 1.091 . . . . 4.2999999999999998 109.279 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.62 149.4 26.57 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 116.132 1.901 . . . . 2.4199999999999999 116.132 -168.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -114.34 113.35 24.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.85 2.06 . . . . 2.4900000000000002 107.717 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 90.1 t -98.19 124.03 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.024 1.33 . . . . 2.3500000000000001 110.777 -169.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 56.4 t -139.51 98.08 8.16 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.816 1.647 . . . . 1.72 106.899 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -59.28 130.55 36.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.728 2.286 . . . . 1.8899999999999999 113.519 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 74.61 26.99 66.16 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.308 -0.718 . . . . 1.8400000000000001 114.801 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 42.8 t -135.44 -43.47 0.69 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.811 1.306 . . . . 2.1899999999999999 113.745 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 151.36 -161.47 29.17 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 120.893 -1.13 . . . . 1.02 113.919 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' 1119 ' ' ILE . 1.7 mm -140.14 145.77 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.811 1.644 . . . . 2.5099999999999998 110.226 169.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 47.3 t -133.43 136.35 45.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.266 1.026 . . . . 0.63 109.368 165.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 31.8 p -154.15 168.89 25.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.742 1.016 . . . . 0.60999999999999999 113.742 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -109.88 141.44 42.59 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 168.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 4.7 p -143.11 138.21 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.335 0.97 . . . . 1.8999999999999999 112.827 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.4 157.73 45.65 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.698 0.761 . . . . 1.5600000000000001 112.542 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -162.66 -36.73 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.678 2.791 . . . . 3.27 108.895 162.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 3.1 pt -38.52 -42.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.087 2.155 . . . . 3.46 115.522 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -132.38 52.31 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.092 1.357 . . . . 5.8200000000000003 110.236 170.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -61.83 4.15 0.54 Allowed Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.816 2.151 . . . . 4.5999999999999996 115.713 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.09 -7.25 0.47 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.658 1.983 . . . . 4.0099999999999998 114.958 172.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 1.2 pt? -87.96 -1.87 58.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.399 1.48 . . . . 7.8799999999999999 114.734 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -145.56 149.53 34.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 9.3900000000000006 111.979 -169.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -131.09 136.08 48.09 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.825 1.65 . . . . 15.970000000000001 113.032 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -78.77 -35.54 44.35 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.758 1.623 . . . . 19.800000000000001 112.954 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.52 173.74 0.06 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.275 1.83 . . . . 19.170000000000002 114.36 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -160.85 -40.48 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.223 -1.548 . . . . 27.920000000000002 113.413 -169.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -79.95 -51.99 8.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.814 1.645 . . . . 26.809999999999999 109.821 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 71.8 mt 49.49 103.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 128.691 2.796 . . . . 21.629999999999999 114.965 168.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.99 -21.77 61.52 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.603 0.964 . . . . 23.640000000000001 113.603 170.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.0 t0 -65.96 -24.22 66.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.701 1.2 . . . . 19.609999999999999 112.914 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.01 94.07 4.97 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.381 1.872 . . . . 21.829999999999998 113.423 -168.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -147.35 -36.24 0.22 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.466 1.906 . . . . 23.760000000000002 110.461 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 45.4 pt -120.7 158.39 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.981 2.112 . . . . 23.27 109.346 168.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 36.4 mtpt 49.83 47.81 22.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.685 1.594 . . . . 20.559999999999999 112.928 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -78.75 -4.92 51.71 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.22 1.563 . . . . 24.370000000000001 115.22 -168.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . 57.56 164.58 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.009 2.124 . . . . 22.890000000000001 115.411 -170.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 28.8 t -138.13 136.65 36.92 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.943 1.297 . . . . 25.120000000000001 111.927 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . 0.265 1.5 pt? -76.75 27.09 0.13 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.463 1.653 . . . . 26.23 115.463 -175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 16.9 m -129.17 2.24 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.969 2.108 . . . . 28.039999999999999 112.253 168.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -68.44 146.09 53.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.947 0.899 . . . . 26.379999999999999 111.907 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.71 138.98 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.321 1.449 . . . . 25.98 111.806 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -131.01 42.53 3.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.772 2.029 . . . . 24.91 111.26 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -89.25 14.4 11.09 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.263 1.825 . . . . 24.329999999999998 115.402 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 27.1 t -148.5 134.01 18.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.406 0.891 . . . . 22.559999999999999 113.406 170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 3.5 p30 -118.51 24.67 10.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.262 1.425 . . . . 21.75 111.546 168.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 23.4 tt0 74.66 138.4 0.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 128.588 2.755 . . . . 21.050000000000001 111.419 -167.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -68.29 143.96 55.02 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.838 -1.164 . . . . 26.140000000000001 110.542 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 39.6 m 54.54 37.85 28.7 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.665 0.617 . . . . 24.149999999999999 112.665 172.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 5.2 p -69.45 162.8 26.68 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.28 -0.887 . . . . 19.920000000000002 112.366 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 72.8 p -70.35 160.22 32.68 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.128 -0.982 . . . . 18.690000000000001 111.067 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 58.8 m -62.21 145.01 54.74 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.904 -1.123 . . . . 16.030000000000001 110.592 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 59.9 m -75.63 52.5 0.66 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.048 1.739 . . . . 14.5 113.551 -169.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 65.0 m -60.84 -14.73 23.77 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.169 1.388 . . . . 12.710000000000001 113.227 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 25.9 ptt? -55.8 -26.23 45.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.184 0.993 . . . . 13.91 113.41 166.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.98 14.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.963 1.705 . . . . 13.140000000000001 114.737 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -42.66 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.099 -1.625 . . . . 10.0 111.148 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.76 3.8 4.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.403 1.481 . . . . 9.0199999999999996 114.111 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.58 62.97 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.275 0.943 . . . . 9.8599999999999994 111.092 169.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -57.3 -31.5 65.71 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.938 1.088 . . . . 10.34 113.938 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 70.9 mt -80.11 -44.99 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.447 1.099 . . . . 7.4800000000000004 110.842 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 69.1 p -72.82 -17.51 61.55 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.035 0.754 . . . . 9.1899999999999995 113.035 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -79.08 -49.56 12.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.898 0.879 . . . . 9.3000000000000007 110.807 167.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -66.31 -13.58 60.72 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.963 1.838 . . . . 4.79 115.963 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.47 -44.23 96.91 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.019 1.282 . . . . 11.56 111.033 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -103.71 -34.35 8.62 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.993 1.479 . . . . 8.4399999999999995 114.993 171.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -104.04 156.81 17.57 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 117.515 2.413 . . . . 4.4199999999999999 117.515 -165.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -85.93 151.55 23.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.03 -1.47 . . . . 4.5599999999999996 107.03 163.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.63 169.86 23.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.473 0.916 . . . . 2.9700000000000002 113.473 -168.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.57 123.79 12.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.743 1.217 . . . . 2.8399999999999999 110.55 -168.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.9 116.25 28.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.106 0.962 . . . . 2.0 108.624 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.8 m -135.4 141.6 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 119.127 0.876 . . . . 0.53000000000000003 112.823 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.35 152.35 40.6 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.823 1.045 . . . . 0.46999999999999997 113.823 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 9.3 tt -152.13 135.91 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.967 1.707 . . . . 0.65000000000000002 110.077 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 162.79 -151.68 21.57 Favored Glycine 0 CA--C 1.537 1.465 0 N-CA-C 116.962 1.545 . . . . 1.23 116.962 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.42 150.63 3.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 128.333 2.653 . . . . 2.6600000000000001 112.912 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -61.6 -33.37 73.78 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.504 0.927 . . . . 4.9800000000000004 113.504 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -59.98 -31.44 69.91 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.776 1.171 . . . . 4.2300000000000004 113.082 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 1.4 t90 -69.3 -19.79 63.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.382 -1.449 . . . . 3.2200000000000002 112.935 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 29.4 mmt -67.66 -30.73 70.35 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.092 -1.005 . . . . 2.5699999999999998 111.42 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 30.7 mt -71.43 -65.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.108 1.763 . . . . 2.27 109.28 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.17 -32.86 4.68 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.798 2.039 . . . . 4.6799999999999997 115.702 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.99 12.53 6.13 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 119.509 1.05 . . . . 0.88 113.828 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 74.62 31.6 58.43 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.377 -1.452 . . . . 1.1799999999999999 115.289 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 3.5 mt -105.33 -161.73 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.914 1.286 . . . . 1.6399999999999999 110.891 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 21.8 t -136.8 136.39 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 126.192 1.797 . . . . 1.22 110.202 170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.1 tt -125.93 138.63 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.764 1.226 . . . . 1.3100000000000001 111.485 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.39 168.52 12.91 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.825 1.787 . . . . 3.6899999999999999 115.825 -167.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -58.27 -25.33 61.65 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.841 1.656 . . . . 2.5699999999999998 115.372 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.51 -40.89 41.26 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.089 1.313 . . . . 2.7000000000000002 113.302 -176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.8 p -73.61 -33.71 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 118.481 0.582 . . . . 0.94999999999999996 111.41 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -56.94 -43.35 81.42 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.001 0.92 . . . . 2.3100000000000001 112.081 174.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.48 -49.93 75.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.169 0.987 . . . . 2.6000000000000001 113.506 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 33.2 t80 -70.25 -36.61 74.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.8 1.24 . . . . 2.0099999999999998 112.258 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 31.7 tpp -61.19 -60.79 3.2 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.141 1.776 . . . . 1.1399999999999999 110.792 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 3.1 t -66.27 -31.47 72.29 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.896 -0.503 . . . . 1.1899999999999999 112.244 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -59.99 -49.93 75.74 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.191 0.997 . . . . 2.7400000000000002 112.052 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -68.73 -30.88 69.61 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.764 -0.585 . . . . 3.0600000000000001 112.136 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -65.29 -42.29 93.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.308 1.043 . . . . 2.8399999999999999 112.769 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -66.81 -30.17 70.3 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 120.855 -1.153 . . . . 3.3399999999999999 113.567 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 19.2 mttp -70.52 -2.93 15.58 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.556 1.942 . . . . 2.5099999999999998 113.566 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 90.63 20.73 39.53 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.0 1.285 . . . . 2.0699999999999998 115.162 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -112.08 148.58 33.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.749 1.62 . . . . 4.0999999999999996 110.616 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 94.1 m -78.34 137.64 38.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.049 1.34 . . . . 0.79000000000000004 111.063 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -139.22 124.79 19.4 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.096 0.776 . . . . 0.66000000000000003 113.096 -170.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -140.69 159.11 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.536 1.534 . . . . 0.66000000000000003 113.18 -171.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.64 160.14 16.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.687 1.195 . . . . 0.78000000000000003 112.574 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.5 t -130.86 122.95 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.078 1.751 . . . . 1.6399999999999999 111.608 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -120.93 151.78 39.29 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.446 1.499 . . . . 0.63 110.621 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 19.5 m -143.33 118.65 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.162 1.385 . . . . 0.73999999999999999 112.254 -170.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 30.7 t0 42.07 50.08 4.29 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.848 2.459 . . . . 3.21 112.942 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.301 2.2 m-20 62.7 38.44 11.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.637 2.375 . . . . 2.3300000000000001 116.182 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -143.33 147.86 35.39 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.285 1.434 . . . . 3.8300000000000001 109.861 167.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.76 151.52 43.47 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.276 -1.515 . . . . 1.3400000000000001 113.267 174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 31.3 p -130.51 -47.82 1.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.412 1.264 . . . . 0.63 114.412 169.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -165.97 -175.56 36.5 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 120.662 1.574 . . . . 0.48999999999999999 115.884 -170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.47 155.15 44.28 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.36 1.464 . . . . 0.70999999999999996 113.231 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.91 135.09 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.905 1.682 . . . . 0.93000000000000005 109.955 -172.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -115.05 133.29 56.17 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.515 1.526 . . . . 0.65000000000000002 109.859 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 5.3 mp -132.05 143.17 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.814 2.045 . . . . 1.53 110.285 -169.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -122.83 -167.68 1.63 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.128 1.771 . . . . 1.75 111.343 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -114.92 141.94 47.27 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.836 1.255 . . . . 4.9400000000000004 111.267 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.324 0 C-N-CA 124.693 1.197 . . . . 6.1600000000000001 111.809 178.564 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 118.955 -0.545 . . . . 11.08 112.16 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -155.39 143.57 20.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.867 1.267 . . . . 14.94 110.822 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 6.3 m -99.51 146.34 26.49 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.194 1.183 . . . . 8.2300000000000004 114.194 -169.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . 0.467 ' CE ' ' H ' ' A' 1052 ' ' GLY . 5.0 ttp -90.84 165.66 13.5 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.506 1.922 . . . . 8.1699999999999999 112.831 177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -59.95 -50.67 72.86 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.559 2.059 . . . . 8.3699999999999992 116.559 -172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . 0.467 ' H ' ' CE ' ' A' 1050 ' ' MET . . . -116.22 93.29 0.6 Allowed Glycine 0 N--CA 1.466 0.672 0 C-N-CA 124.14 0.876 . . . . 4.0099999999999998 111.764 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 80.9 p -88.46 147.53 40.05 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 118.213 1.006 . . . . 3.3700000000000001 112.197 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.47 138.78 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.968 2.445 . . . . 1.6399999999999999 112.062 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 14.5 p -144.25 123.06 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.002 0.921 . . . . 2.2599999999999998 111.945 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 10.6 p -72.53 139.58 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 120.512 -1.368 . . . . 1.05 111.138 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.36 -41.16 1.91 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.333 1.975 . . . . 2.4399999999999999 116.333 -165.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -150.64 154.85 38.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.392 1.477 . . . . 2.3900000000000001 110.967 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 4.7 m -134.91 136.05 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.185 0.994 . . . . 0.82999999999999996 111.153 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.9 tttt -141.02 140.12 34.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.331 1.234 . . . . 1.6599999999999999 114.331 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 41.2 t -85.6 143.66 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.251 1.42 . . . . 0.73999999999999999 110.224 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . 0.402 HD11 HD21 ' A' 1196 ' ' ASN . 31.1 tp -114.76 -25.07 8.4 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.04 1.736 . . . . 0.85999999999999999 113.275 173.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 93.0 m -126.03 67.22 1.19 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.474 1.509 . . . . 1.6899999999999999 111.23 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.19 130.33 38.07 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.733 -1.229 . . . . 3.8500000000000001 112.438 -174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 23.2 m 64.03 -18.62 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.608 2.077 . . . . 2.5600000000000001 116.608 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 30.7 m120 -87.05 -15.99 36.97 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.787 1.176 . . . . 3.2799999999999998 113.646 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 -95.66 0.14 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.388 1.075 . . . . 5.1399999999999997 110.48 169.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.38 133.16 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.474 1.51 . . . . 1.75 111.141 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 66.7 m -98.17 164.24 12.41 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.642 1.577 . . . . 2.04 113.291 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -43.04 -56.01 3.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.513 1.925 . . . . 5.21 116.103 -169.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 47.7 m170 -64.74 -30.82 71.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.969 0.804 . . . . 3.8999999999999999 112.702 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 44.6 mttp -77.56 -38.14 49.13 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 118.123 -0.942 . . . . 2.6000000000000001 111.97 175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.05 -52.48 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.488 1.04 . . . . 0.68000000000000005 110.844 173.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.76 -28.15 66.54 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.673 -0.642 . . . . 0.56000000000000005 112.427 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -70.2 -47.89 59.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.828 -0.605 . . . . 0.60999999999999999 112.598 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 10.6 pt -69.62 -32.62 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 120.53 1.514 . . . . 0.57999999999999996 112.901 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 57.2 t -70.88 -45.58 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.813 0.733 . . . . 0.69999999999999996 111.376 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -69.17 -36.26 79.41 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.975 -1.078 . . . . 0.70999999999999996 114.009 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 35.8 p -69.15 -34.38 74.89 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.413 -1.051 . . . . 0.76000000000000001 111.794 174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.2 91.21 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.765 0.711 . . . . 0.76000000000000001 112.56 170.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -71.16 -21.97 62.11 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.956 1.095 . . . . 3.75 113.956 176.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 20.0 t -55.88 -42.13 75.45 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.863 -1.148 . . . . 1.6599999999999999 112.258 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.54 -23.1 40.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.567 0.951 . . . . 2.1899999999999999 113.567 174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 27.0 m -89.47 160.61 16.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.057 1.132 . . . . 2.5600000000000001 114.057 -167.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -122.73 18.71 10.29 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.668 1.587 . . . . 5.3899999999999997 113.225 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 143.29 91.56 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.753 1.221 . . . . 1.51 112.132 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.55 -45.52 1.14 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.316 2.677 . . . . 1.28 114.356 -169.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 3.8 tt -70.37 -34.23 72.34 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.297 -0.877 . . . . 0.93999999999999995 111.069 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -61.16 -20.33 58.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.135 1.35 . . . . 1.8100000000000001 115.545 174.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 66.7 p -59.49 -37.98 79.68 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.019 1.409 . . . . 2.8199999999999998 112.184 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -67.55 -36.39 80.87 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.49 -0.756 . . . . 1.2 112.407 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 5.8 mt -70.78 -36.61 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.054 -1.029 . . . . 1.5 111.023 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 26.3 m -55.14 -51.79 65.34 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.168 0.987 . . . . 1.9299999999999999 110.438 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 77.5 tttt -54.44 -55.23 30.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.181 0.992 . . . . 3.5699999999999998 111.574 169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -57.72 -45.85 85.22 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.321 0.648 . . . . 1.8999999999999999 112.636 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 37.3 t -66.82 -54.15 25.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.243 0.617 . . . . 1.6699999999999999 111.4 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -43.07 75.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.238 1.015 . . . . 2.8500000000000001 110.756 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -65.34 -44.54 87.42 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.972 0.73 . . . . 3.0499999999999998 112.972 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -67.11 -38.7 86.11 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.535 1.062 . . . . 2.79 113.303 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.35 -19.87 60.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.621 1.168 . . . . 1.3500000000000001 113.107 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 8.8 t70 64.47 15.66 9.71 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.593 2.357 . . . . 3.3100000000000001 114.221 -170.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 2.6 t -130.52 147.1 52.17 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.816 1.646 . . . . 3.1200000000000001 115.249 -169.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.11 -12.67 43.45 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.559 1.144 . . . . 3.5099999999999998 111.858 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 35.6 p -73.43 26.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.397 1.999 . . . . 4.7000000000000002 116.397 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.41 146.74 29.07 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.532 1.533 . . . . 1.55 114.659 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 78.24 145.07 2.55 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.656 1.598 . . . . 1.1100000000000001 116.989 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 1.5 m -141.42 -63.34 0.46 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.964 1.705 . . . . 1.4099999999999999 113.392 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 41.4 t -136.54 141.51 43.39 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.181 1.355 . . . . 1.5 112.443 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 3.1 mm -141.93 140.19 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 132.18 4.192 . . . . 2.0699999999999998 109.389 -170.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 48.8 t0 -111.72 104.17 12.5 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.905 -1.887 . . . . 2.5699999999999998 105.905 165.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' 1119 ' ' ILE . 32.9 t80 -88.54 133.15 34.24 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.931 1.292 . . . . 3.2599999999999998 114.436 -165.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . 0.458 HE21 ' HB2' ' A' 1112 ' ' GLN . 0.7 OUTLIER -139.34 120.7 14.94 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.304 1.842 . . . . 2.1099999999999999 110.993 175.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 44.3 t -104.34 140.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.97 1.308 . . . . 2.3199999999999998 111.68 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 51.7 t -126.33 111.94 23.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.029 0.932 . . . . 1.51 109.188 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -62.19 143.08 93.93 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.313 2.675 . . . . 1.79 113.634 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 67.38 15.15 65.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.947 1.26 . . . . 2.0600000000000001 113.696 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 73.4 m -134.34 -87.32 0.39 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.86 1.664 . . . . 1.9099999999999999 111.39 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 172.99 -151.37 13.78 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.937 0.779 . . . . 0.90000000000000002 112.455 -172.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' 1111 ' ' PHE . 0.1 OUTLIER -134.26 146.32 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.265 1.026 . . . . 2.2000000000000002 111.893 -173.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.8 t -134.24 144.18 48.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.857 1.663 . . . . 0.72999999999999998 111.259 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 28.8 p -158.04 172.38 18.53 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.549 1.685 . . . . 0.62 115.549 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -114.64 120.81 41.43 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.252 1.421 . . . . 1.1200000000000001 107.453 169.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 12.0 p -128.76 134.52 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 115.033 1.494 . . . . 1.8600000000000001 115.033 -167.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . 0.427 ' HB ' ' HG2' ' A' 1177 ' ' GLN . 1.4 t -133.81 161.34 35.01 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 123.242 1.496 . . . . 1.73 114.276 169.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -159.53 -29.99 0.06 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.233 3.413 . . . . 2.6000000000000001 108.289 160.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 10.2 pt -43.17 -44.24 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.31 1.844 . . . . 2.71 114.839 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -124.93 39.98 3.85 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.562 1.172 . . . . 4.75 110.772 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -64.38 15.78 0.14 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.998 2.237 . . . . 4.8600000000000003 115.957 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.71 -16.68 28.07 Favored 'General case' 0 CA--C 1.543 0.712 0 C-N-CA 126.332 1.853 . . . . 3.8100000000000001 112.867 169.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.43 -44.69 5.07 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.635 1.174 . . . . 4.9199999999999999 112.036 -174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -122.7 135.58 54.62 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.527 1.131 . . . . 7.5700000000000003 110.261 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -116.92 171.92 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 116.573 2.064 . . . . 13.630000000000001 116.573 -165.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -61.5 -39.41 90.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.446 2.298 . . . . 16.420000000000002 115.004 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 72.5 m-80 60.38 156.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.817 2.447 . . . . 14.279999999999999 114.939 -168.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 55.1 m95 -136.3 -170.0 2.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.459 2.303 . . . . 21.52 110.011 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -50.01 -31.01 11.8 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.386 1.074 . . . . 20.300000000000001 113.85 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 77.2 mt 54.63 111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 129.959 3.303 . . . . 15.83 114.08 171.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -53.38 -38.95 63.83 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.197 0.999 . . . . 21.579999999999998 112.361 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.41 -24.77 66.52 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.117 1.767 . . . . 19.489999999999998 114.158 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -81.04 165.84 21.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.014 1.726 . . . . 15.74 112.826 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -105.1 140.78 37.77 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.985 1.714 . . . . 16.920000000000002 107.65 166.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 37.8 pt -132.35 149.96 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.557 1.688 . . . . 18.559999999999999 115.557 -166.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -139.39 144.15 38.02 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.027 2.131 . . . . 18.190000000000001 111.153 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -75.07 -24.07 58.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.124 1.157 . . . . 19.359999999999999 114.124 -170.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -87.74 2.66 50.62 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.645 1.35 . . . . 18.120000000000001 114.645 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 59.8 m 61.07 171.61 0.1 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.342 1.457 . . . . 18.460000000000001 114.56 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.79 132.36 34.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.266 -0.896 . . . . 20.899999999999999 109.861 172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 6.1 p -146.54 137.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.011 1.325 . . . . 21.550000000000001 111.239 -171.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -136.33 6.92 3.07 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.482 1.66 . . . . 24.34 115.482 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 6.0 tp -153.61 -42.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.717 1.207 . . . . 23.329999999999998 114.148 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 46.4 t0 -145.29 109.26 4.79 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.127 0.876 . . . . 22.260000000000002 113.045 -168.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -77.31 37.76 0.21 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.874 1.67 . . . . 23.390000000000001 114.355 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 45.4 t -77.97 -31.77 50.96 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.015 2.126 . . . . 22.550000000000001 115.519 -168.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 48.9 t30 -134.68 123.54 23.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.636 0.774 . . . . 23.170000000000002 111.541 -168.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -133.24 160.34 37.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.161 0.984 . . . . 23.82 113.262 -168.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 4.1 mp0 56.39 -170.91 0.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.646 1.979 . . . . 27.010000000000002 112.136 -166.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 9.1 t 61.68 -173.84 0.14 Allowed 'General case' 0 N--CA 1.479 0.976 0 O-C-N 120.55 -1.344 . . . . 23.629999999999999 114.521 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 7.3 p -73.04 77.54 1.21 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.281 2.233 . . . . 21.59 112.488 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 8.9 t -56.33 127.46 31.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.584 0.753 . . . . 19.129999999999999 111.159 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 49.4 m -145.07 48.51 1.29 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.89 1.276 . . . . 16.370000000000001 112.874 -167.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 64.0 p -74.42 180.0 4.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.257 -0.902 . . . . 15.220000000000001 113.285 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 17.5 m -52.79 -33.38 48.51 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.124 1.527 . . . . 12.42 115.124 -172.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 26.9 ptt? -76.62 -13.33 60.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.705 1.372 . . . . 14.5 114.705 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.5 -30.58 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 126.098 1.759 . . . . 12.27 111.71 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.8 pp -82.02 -17.19 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 113.694 0.998 . . . . 10.289999999999999 113.694 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.99 -31.58 71.96 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.706 1.139 . . . . 9.4700000000000006 112.838 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -76.56 -9.25 58.52 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.289 1.218 . . . . 8.7699999999999996 114.289 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.64 -19.3 12.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.224 1.809 . . . . 9.4800000000000004 115.38 -169.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 61.3 mt -48.48 -47.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 124.989 1.316 . . . . 7.2999999999999998 111.748 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 69.8 m -63.28 -25.06 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.191 0.812 . . . . 6.3799999999999999 113.191 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 7.9 m120 -78.56 -40.28 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.816 0.847 . . . . 7.1799999999999997 111.261 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.13 87.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.824 0.85 . . . . 6.04 112.372 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.03 -14.38 62.66 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.314 1.227 . . . . 7.79 114.314 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -90.33 -31.29 16.98 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.168 0.987 . . . . 4.8700000000000001 112.311 169.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -81.03 -1.02 42.32 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.338 1.455 . . . . 4.2400000000000002 114.444 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 51.66 84.28 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.726 2.01 . . . . 2.9300000000000002 114.288 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' 1124 ' ' THR . 28.1 mt-30 -102.99 98.09 8.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.23 1.412 . . . . 3.5099999999999998 109.788 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -63.54 133.38 53.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.937 1.695 . . . . 2.5499999999999998 110.781 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 88.0 tttt -90.13 116.19 27.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.798 0.726 . . . . 1.55 111.767 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 4.7 m -137.47 144.81 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.083 0.953 . . . . 0.59999999999999998 113.067 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.08 152.54 46.24 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.844 1.258 . . . . 0.59999999999999998 113.492 171.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 4.3 tt -149.18 139.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.432 1.493 . . . . 0.79000000000000004 110.352 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 131.18 150.16 6.66 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.156 0.884 . . . . 1.6399999999999999 115.09 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 49.29 -155.98 0.09 Allowed 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 126.103 1.761 . . . . 2.3399999999999999 113.931 -177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 -140.08 -37.46 0.47 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.47 2.396 . . . . 6.4199999999999999 117.47 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.33 -30.67 69.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.568 1.531 . . . . 3.9900000000000002 110.703 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 2.9 t90 -55.45 -34.32 64.38 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.192 -0.942 . . . . 2.8399999999999999 113.465 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -35.03 77.78 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.745 1.017 . . . . 2.0299999999999998 113.745 170.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.68 -60.39 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 107.986 -1.116 . . . . 1.8700000000000001 107.986 168.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.19 -27.04 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.835 2.054 . . . . 6.4199999999999999 115.687 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.9 t30 -79.85 16.07 1.25 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 120.892 1.678 . . . . 1.0700000000000001 112.498 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 67.73 16.05 67.42 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 119.797 -1.814 . . . . 1.22 116.07 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.59 174.23 10.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.393 1.597 . . . . 0.93999999999999995 111.911 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 95.2 t -115.8 130.98 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.664 1.186 . . . . 1.3600000000000001 109.309 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 19.6 tt -108.69 127.77 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.867 1.267 . . . . 1.21 110.011 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . 0.402 HD21 HD11 ' A' 1062 ' ' LEU 0.253 8.9 p30 -89.41 158.3 17.8 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.99 1.107 . . . . 3.8399999999999999 113.99 -176.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 64.6 t30 -62.6 -23.71 67.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.954 1.302 . . . . 2.71 114.344 -170.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.21 -43.37 42.65 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.708 -1.245 . . . . 3.7999999999999998 112.907 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 3.3 p -75.6 -31.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 125.303 1.441 . . . . 0.97999999999999998 110.985 174.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -52.87 -50.59 63.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.987 1.267 . . . . 3.8199999999999998 111.213 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.32 -44.93 80.43 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.206 0.447 . . . . 2.1699999999999999 112.206 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 50.7 t80 -71.57 -36.01 70.78 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.62 0.97 . . . . 2.2400000000000002 113.62 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 29.7 tpp -63.22 -50.92 68.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.201 1.401 . . . . 0.83999999999999997 111.077 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 6.2 t -69.93 -33.25 71.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.012 -0.43 . . . . 0.91000000000000003 111.718 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.66 -46.8 87.96 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.731 -1.231 . . . . 4.1200000000000001 112.889 175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -71.16 -37.03 72.22 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.249 1.203 . . . . 2.1899999999999999 114.249 173.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' 1213 ' ' ALA . 43.3 mm-40 -62.28 -37.46 85.59 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.108 -0.995 . . . . 3.6899999999999999 112.21 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -72.73 -24.33 60.96 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.31 1.844 . . . . 3.77 114.961 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 77.6 mttt -66.39 -6.85 15.83 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.627 1.171 . . . . 3.4300000000000002 114.128 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 92.64 19.98 35.93 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.854 1.692 . . . . 1.1699999999999999 113.092 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -118.67 178.36 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.531 1.532 . . . . 3.29 111.994 -168.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 3.4 m -100.4 120.97 40.78 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.771 1.629 . . . . 1.1599999999999999 110.246 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . 0.59 ' HB3' ' HG2' ' A' 1207 ' ' GLU . . . -116.84 119.65 36.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.014 1.325 . . . . 0.65000000000000002 110.098 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.2 m -136.34 153.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.431 0.9 . . . . 0.45000000000000001 113.431 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.17 166.01 10.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.133 0.973 . . . . 0.81999999999999995 112.794 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 11.6 t -131.71 125.86 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.003 2.121 . . . . 1.6000000000000001 110.026 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -130.13 156.64 44.21 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.612 1.165 . . . . 0.5 111.81 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.3 m -144.74 120.11 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.839 1.655 . . . . 1.1699999999999999 111.689 -169.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 23.3 t70 44.65 47.28 8.65 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.109 1.364 . . . . 4.1500000000000004 113.316 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 60.79 42.15 13.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.039 -1.663 . . . . 1.99 115.023 -174.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.93 141.52 30.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.686 1.595 . . . . 2.1899999999999999 110.561 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.71 137.44 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.108 -1.62 . . . . 0.76000000000000001 112.852 172.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.0 p -115.01 -40.96 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.097 0.959 . . . . 0.62 112.719 170.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -168.13 -174.02 36.6 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.656 1.116 . . . . 0.55000000000000004 115.384 -175.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.37 155.71 43.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.402 1.881 . . . . 0.79000000000000004 112.702 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 17.9 mm -129.76 140.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.382 1.473 . . . . 0.81000000000000005 110.526 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -113.07 130.12 56.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.094 1.758 . . . . 0.56999999999999995 110.36 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.14 157.7 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.846 2.059 . . . . 1.4099999999999999 109.598 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -132.5 -174.96 3.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.268 1.827 . . . . 1.5600000000000001 111.956 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.58 151.52 28.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.029 1.332 . . . . 4.2000000000000002 111.81 171.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.247 1.419 . . . . 4.5899999999999999 113.685 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 119.612 -0.232 . . . . 13.289999999999999 111.056 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.23 170.93 10.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 14.800000000000001 109.899 169.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 1.9 m 66.45 149.82 0.05 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.709 2.004 . . . . 8.9700000000000006 115.036 170.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 9.9 tpt -122.72 -79.57 0.61 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.682 1.993 . . . . 11.609999999999999 109.271 175.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 31.9 m80 -127.07 -16.43 5.07 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.497 1.295 . . . . 9.5199999999999996 114.497 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -130.46 129.98 6.03 Favored Glycine 0 N--CA 1.47 0.944 0 CA-C-N 119.705 1.138 . . . . 3.5499999999999998 114.423 -169.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.6 p -98.38 149.79 36.09 Favored Pre-proline 0 N--CA 1.469 0.525 0 C-N-CA 125.653 1.581 . . . . 2.8999999999999999 112.631 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.92 130.02 24.82 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.691 2.928 . . . . 1.51 112.961 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 96.7 t -105.5 124.22 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.187 1.795 . . . . 2.46 109.648 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 14.9 p -70.4 121.68 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.046 0.839 . . . . 1.29 110.915 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 8.6 t30 -111.26 -47.69 3.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.502 0.721 . . . . 3.3799999999999999 112.82 -168.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -151.49 149.25 29.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.79 1.636 . . . . 2.6099999999999999 111.713 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 12.3 m -125.52 139.78 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.178 0.991 . . . . 0.87 110.402 168.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 52.1 tttt -141.99 148.48 38.62 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.048 0.759 . . . . 2.3199999999999998 113.048 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 73.9 t -106.61 145.01 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.191 1.397 . . . . 1.1200000000000001 111.31 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 44.1 tp -108.95 -25.04 10.94 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.559 1.544 . . . . 0.83999999999999997 113.44 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 9.9 t -93.94 162.09 14.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.824 2.05 . . . . 3.0600000000000001 112.813 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -146.46 116.02 7.15 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.619 -1.301 . . . . 5.3600000000000003 110.32 167.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 63.4 m 51.67 33.75 11.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.525 2.046 . . . . 2.9900000000000002 116.525 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 28.2 m120 -126.97 -30.89 2.67 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.463 1.283 . . . . 3.6099999999999999 114.463 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 113.52 2.46 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.713 1.605 . . . . 5.9800000000000004 108.649 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 3.3 mm 66.17 133.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 127.55 2.34 . . . . 2.02 114.725 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 67.0 m -81.5 151.11 27.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.985 1.314 . . . . 2.6699999999999999 113.099 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 61.9 m80 -53.03 -46.26 68.37 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.598 1.703 . . . . 6.6100000000000003 115.598 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 43.3 t60 -74.96 -29.45 60.92 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.726 -1.234 . . . . 2.5299999999999998 111.695 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.47 -36.69 81.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.84 -1.163 . . . . 2.7999999999999998 111.804 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 98.0 mt -56.62 -53.86 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.494 1.117 . . . . 0.88 109.668 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.7 76.53 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.238 0.926 . . . . 0.71999999999999997 112.367 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -66.58 -46.17 76.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.105 0.779 . . . . 0.66000000000000003 113.105 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 19.0 pt -68.71 -35.39 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 120.232 1.378 . . . . 0.66000000000000003 112.815 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 59.8 t -70.52 -46.61 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 118.754 0.706 . . . . 0.83999999999999997 111.381 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.53 91.45 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.43 -0.794 . . . . 0.75 113.642 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . . . . . . . . . 41.3 p -73.95 -34.31 64.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.181 0.808 . . . . 0.87 113.181 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.35 90.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.434 0.901 . . . . 0.76000000000000001 113.434 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -72.31 -11.73 60.83 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.673 0.99 . . . . 2.0699999999999998 113.673 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.5 t -62.47 -19.21 63.32 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.587 -1.321 . . . . 1.3 113.6 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -107.43 0.25 22.76 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.203 1.401 . . . . 1.96 113.379 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 69.4 m -101.28 167.46 10.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.271 1.211 . . . . 2.1299999999999999 114.271 -169.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -122.83 54.72 1.21 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.312 1.845 . . . . 3.6600000000000001 111.572 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.34 155.03 69.09 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.52 1.528 . . . . 2.0099999999999998 112.66 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.33 -17.22 9.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.961 3.107 . . . . 1.0 116.285 -167.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 7.9 tt -121.82 -50.91 2.05 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.575 0.954 . . . . 0.82999999999999996 113.575 -166.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.61 67.4 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-O 121.531 0.517 . . . . 0.98999999999999999 113.557 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 32.0 p -63.68 -22.76 67.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.114 1.366 . . . . 1.77 113.337 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -66.8 -29.22 69.1 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.701 -1.25 . . . . 0.85999999999999999 111.702 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.68 -35.75 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.973 0.909 . . . . 0.95999999999999996 110.077 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 34.3 m -57.1 -48.08 79.47 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.247 0.93 . . . . 1.3100000000000001 110.93 168.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -54.81 -51.32 66.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.303 1.041 . . . . 3.9199999999999999 112.036 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.01 -44.39 91.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.331 1.052 . . . . 1.77 111.496 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 48.9 t -65.93 -49.7 67.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.266 1.026 . . . . 1.8500000000000001 111.93 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -62.88 -33.04 74.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.111 1.323 . . . . 2.9199999999999999 111.446 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -70.8 -41.12 72.04 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.784 1.234 . . . . 3.1699999999999999 113.524 170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -69.61 -40.49 76.57 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.944 1.247 . . . . 2.0 113.359 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 16.1 mt -73.07 -20.22 61.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.673 1.189 . . . . 1.1599999999999999 113.351 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 28.2 t0 54.14 42.36 31.6 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.687 1.195 . . . . 2.3399999999999999 112.498 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 11.1 t -125.85 165.97 17.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.261 1.824 . . . . 2.6299999999999999 111.086 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -100.01 -11.13 20.85 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.942 1.297 . . . . 3.1200000000000001 113.885 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 9.9 t -148.15 135.12 20.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.843 1.257 . . . . 2.8799999999999999 111.551 -172.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -158.22 149.48 21.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.764 1.226 . . . . 0.84999999999999998 112.476 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . . . . . . . . . . . 69.88 142.94 0.18 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.032 1.301 . . . . 1.03 115.244 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 19.0 m -112.01 -80.03 0.58 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.653 1.581 . . . . 1.45 112.125 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 44.5 t -135.39 136.75 41.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.92 1.288 . . . . 1.3500000000000001 111.279 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 1.4 mp -141.09 149.78 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.275 3.83 . . . . 3.1400000000000001 107.056 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . . . . . . . . . 31.5 t70 -137.03 109.01 7.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.896 1.278 . . . . 3.3399999999999999 109.348 170.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -97.35 135.07 39.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 116.198 1.925 . . . . 2.8799999999999999 116.198 -171.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.24 113.1 26.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.637 2.775 . . . . 3.0499999999999998 107.12 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 27.4 m -112.49 142.57 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 115.092 1.515 . . . . 2.46 115.092 -167.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.77 131.23 14.63 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 125.321 1.449 . . . . 1.1499999999999999 109.39 172.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.4 130.88 21.96 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.784 2.322 . . . . 1.71 111.862 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 71.74 -41.53 0.69 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.722 2.106 . . . . 2.2000000000000002 115.148 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 5.7 t -78.75 10.97 2.85 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.636 2.087 . . . . 2.5699999999999998 116.636 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 85.98 171.79 48.23 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 119.093 0.86 . . . . 1.24 113.249 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 3.4 pt -136.12 165.51 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.665 1.186 . . . . 2.98 111.868 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 48.2 t -127.14 152.37 47.42 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.333 1.053 . . . . 0.56000000000000005 112.112 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 23.1 p -144.35 169.68 17.46 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.028 -1.045 . . . . 0.68999999999999995 113.258 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -118.51 119.94 36.05 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.578 -1.267 . . . . 1.7 107.578 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 13.1 p -127.09 136.78 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 113.846 1.054 . . . . 1.8999999999999999 113.846 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . 0.495 ' HB ' HE21 ' A' 1177 ' ' GLN . 5.3 t -119.76 150.11 40.93 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.445 0.906 . . . . 1.0600000000000001 113.445 168.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -167.48 36.6 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.459 2.704 . . . . 2.6800000000000002 108.463 158.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 6.1 pt -130.78 -75.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.394 1.878 . . . . 2.3799999999999999 110.443 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -129.43 -10.37 4.6 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 120.216 1.371 . . . . 5.4500000000000002 113.827 178.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -60.92 -6.84 7.29 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 126.193 1.854 . . . . 4.5999999999999996 116.96 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.91 -8.64 1.04 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 119.079 1.439 . . . . 3.7599999999999998 114.483 168.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 4.1 tt -71.53 -53.44 13.81 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.979 2.112 . . . . 4.8200000000000003 111.423 169.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 62.1 t60 -153.25 134.42 14.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.742 1.617 . . . . 10.26 111.635 -171.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -140.05 -41.35 0.43 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.615 1.566 . . . . 10.56 114.673 -173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 6.0 t30 51.17 29.16 4.57 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 125.223 1.409 . . . . 12.390000000000001 113.026 -169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -92.4 51.6 1.79 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 120.674 -1.267 . . . . 12.01 111.645 -169.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 79.2 m95 -90.48 176.25 6.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.159 1.384 . . . . 13.460000000000001 109.967 173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 4.8 p30 -39.16 -79.08 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.643 2.377 . . . . 15.35 113.306 172.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 55.5 mt 51.08 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 128.166 2.587 . . . . 13.08 113.161 171.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.76 -20.61 66.33 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.293 -1.505 . . . . 18.030000000000001 113.334 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.17 -20.75 64.47 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.14 1.376 . . . . 14.050000000000001 112.785 169.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 9.6 t30 -93.2 -45.18 7.98 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.095 1.358 . . . . 15.390000000000001 112.046 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -73.58 -28.91 62.09 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 117.095 2.257 . . . . 15.9 117.095 -165.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.2 22.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 113.72 1.007 . . . . 18.390000000000001 113.72 -169.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -78.6 -38.99 38.67 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.684 -1.26 . . . . 17.469999999999999 112.429 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 73.4 m-80 47.81 41.49 14.32 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.211 1.405 . . . . 19.0 113.969 175.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -147.08 171.36 15.42 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.561 0.949 . . . . 19.59 113.561 -174.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 22.7 t -134.17 126.34 29.74 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.452 1.101 . . . . 22.719999999999999 111.466 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.22 153.09 38.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.511 1.925 . . . . 24.670000000000002 110.877 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 2.4 t 48.4 47.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 126.566 1.946 . . . . 28.32 111.697 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.11 133.18 45.05 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.645 0.778 . . . . 29.949999999999999 112.941 -168.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 35.3 mm -97.99 -34.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 32.960000000000001 111.041 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 19.0 m-20 48.68 53.3 12.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.974 1.71 . . . . 32.039999999999999 112.363 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -71.42 -19.75 62.2 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 115.216 1.562 . . . . 33.310000000000002 115.216 -169.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 16.2 p 65.57 163.73 0.16 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.844 2.458 . . . . 32.93 115.043 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.56 33.26 23.02 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.231 1.812 . . . . 34.340000000000003 114.811 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -118.64 -39.61 2.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.64 1.576 . . . . 28.68 112.32 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 3.2 mp0 61.29 166.86 0.09 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.117 2.167 . . . . 30.149999999999999 115.67 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 2.6 t 64.09 174.66 0.18 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.829 2.452 . . . . 23.18 115.933 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . 0.25 49.8 p 64.44 24.9 13.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.612 2.365 . . . . 19.690000000000001 116.098 -173.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 52.7 p -75.88 -18.62 59.35 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.355 1.062 . . . . 20.010000000000002 113.556 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 61.8 p -68.37 -54.0 20.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.811 1.244 . . . . 16.57 111.811 170.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 2.5 t -150.92 135.1 16.82 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.988 2.115 . . . . 15.24 108.753 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 11.7 m -104.76 19.67 20.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.527 1.306 . . . . 13.9 114.527 -168.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . 0.405 ' C ' ' H ' ' A' 1165 ' ' ILE . 36.7 mmm -122.58 153.26 39.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.75 1.22 . . . . 13.99 111.708 -169.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 14.9 mm 63.56 -27.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 126.174 1.789 . . . . 10.84 113.165 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' 1163 ' ' MET . 2.3 pp -59.53 -28.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.245 1.418 . . . . 9.9199999999999999 113.018 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.58 -18.92 20.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.24 1.2 . . . . 8.6400000000000006 114.24 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -74.73 -5.63 44.32 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 114.527 1.306 . . . . 7.5700000000000003 114.527 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -109.89 4.77 21.89 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.452 2.301 . . . . 7.5199999999999996 114.195 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 83.9 mt -83.12 -36.94 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 126.542 1.937 . . . . 6.3200000000000003 112.771 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 89.4 p -64.25 -14.75 57.62 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.866 1.432 . . . . 6.21 114.866 -169.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -104.63 -10.98 17.16 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.193 1.923 . . . . 6.6299999999999999 116.193 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -46.57 -47.54 19.74 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.06 1.874 . . . . 4.46 116.06 -165.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.29 -17.65 64.88 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.418 1.266 . . . . 6.6500000000000004 114.418 -175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -99.88 -42.98 6.57 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.898 0.879 . . . . 5.25 110.721 168.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -86.24 52.95 2.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.875 1.67 . . . . 3.9100000000000001 111.745 176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -54.35 147.06 14.28 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 116.676 2.102 . . . . 5.1600000000000001 116.676 -166.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . 0.495 HE21 ' HB ' ' A' 1124 ' ' THR . 0.3 OUTLIER -154.04 174.86 14.11 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.774 2.829 . . . . 2.0299999999999998 111.909 -166.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -131.03 129.96 42.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.808 1.643 . . . . 3.0800000000000001 112.12 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -88.42 123.51 33.04 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.595 -0.891 . . . . 1.3200000000000001 108.595 167.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.6 m -131.67 154.95 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.232 1.013 . . . . 1.0600000000000001 111.514 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -151.45 152.06 32.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.076 0.951 . . . . 0.56999999999999995 112.807 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 16.9 tt -153.85 153.07 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.048 1.339 . . . . 0.81999999999999995 110.673 -172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 103.03 154.55 24.64 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 121.98 0.767 . . . . 1.9199999999999999 114.281 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 3.9 t-20 54.08 -161.52 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.178 1.791 . . . . 2.1299999999999999 113.248 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -27.95 3.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.594 1.558 . . . . 6.0499999999999998 113.516 168.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.7 -48.13 73.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.534 1.061 . . . . 4.5599999999999996 113.033 -171.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 9.7 t90 -75.92 -37.37 58.8 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.134 0.425 . . . . 3.21 112.008 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 76.3 mmm -54.68 -37.51 65.85 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.472 0.709 . . . . 2.8399999999999999 111.966 175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.36 -66.75 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.197 1.399 . . . . 2.4199999999999999 108.954 166.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -9.97 0.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.623 2.369 . . . . 6.9299999999999997 116.627 -175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.88 21.01 0.22 Allowed 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 120.298 1.408 . . . . 0.95999999999999996 112.131 168.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 63.88 17.65 61.03 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.27 -1.518 . . . . 1.1299999999999999 115.249 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.07 164.05 26.07 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.278 1.539 . . . . 0.92000000000000004 111.338 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 55.9 t -91.51 127.66 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.449 -0.782 . . . . 1.5600000000000001 109.007 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.68 140.02 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.822 0.849 . . . . 0.89000000000000001 111.087 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -116.8 155.77 28.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.522 1.129 . . . . 2.7000000000000002 112.437 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.62 -37.0 85.66 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.717 1.006 . . . . 2.3700000000000001 113.717 -173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -73.53 -37.31 65.67 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.026 0.83 . . . . 2.6899999999999999 112.672 -174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 14.2 p -71.71 -35.28 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.911 -0.566 . . . . 0.82999999999999996 111.407 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -63.33 -43.6 97.29 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.766 1.166 . . . . 1.9099999999999999 112.16 175.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.67 -33.23 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.404 -0.81 . . . . 2.1699999999999999 113.036 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -74.06 -36.81 64.36 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.316 1.046 . . . . 2.4300000000000002 113.529 170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 35.2 tpp -64.38 -52.61 57.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.165 1.386 . . . . 0.89000000000000001 111.139 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 7.0 t -65.23 -28.98 69.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.267 1.027 . . . . 0.89000000000000001 112.687 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -57.52 -54.45 46.68 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.044 0.937 . . . . 2.6600000000000001 112.987 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -71.09 -29.92 65.9 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.921 0.341 . . . . 2.7400000000000002 111.921 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.21 -39.98 93.52 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.339 1.056 . . . . 3.6099999999999999 112.083 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -68.66 -25.61 64.9 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.705 2.402 . . . . 3.77 113.593 172.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 17.7 mttp -78.56 4.87 12.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.506 1.522 . . . . 3.02 113.09 168.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 71.81 18.4 77.44 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.441 1.496 . . . . 1.6100000000000001 112.877 177.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 28.7 mmt-85 -101.89 -174.76 2.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.411 1.484 . . . . 3.6299999999999999 110.907 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 70.5 m -108.2 125.15 51.3 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.439 1.096 . . . . 0.88 111.741 -169.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -135.28 127.4 29.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.348 1.059 . . . . 0.58999999999999997 110.303 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 33.4 m -140.96 158.11 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.907 1.283 . . . . 0.47999999999999998 113.23 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.0 163.83 11.98 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.84 1.256 . . . . 0.93999999999999995 111.791 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 6.2 p -139.29 134.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.857 1.263 . . . . 2.1800000000000002 112.56 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -131.04 153.48 49.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.269 1.828 . . . . 0.40000000000000002 112.53 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 30.4 m -146.29 131.09 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.999 2.12 . . . . 0.69999999999999996 110.316 -171.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . 0.395 0.0 OUTLIER 41.29 46.17 2.72 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 126.335 1.854 . . . . 3.8799999999999999 114.596 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 61.03 31.31 19.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.308 2.243 . . . . 1.47 115.874 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.03 158.89 39.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.65 1.98 . . . . 2.3799999999999999 111.82 168.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 146.5 33.27 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.667 -1.271 . . . . 0.91000000000000003 112.619 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 7.6 p -118.7 -41.82 2.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.282 0.633 . . . . 0.53000000000000003 111.085 167.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.17 -163.24 24.85 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.798 1.181 . . . . 0.41999999999999998 115.869 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -142.64 153.22 43.24 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.795 2.038 . . . . 0.79000000000000004 112.57 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 25.6 mm -124.35 135.46 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.383 1.473 . . . . 0.73999999999999999 109.579 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -121.24 132.27 54.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.21 1.404 . . . . 0.62 110.898 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 19.1 mt -136.02 158.05 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.71 2.004 . . . . 1.3100000000000001 110.646 -168.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -130.17 -169.52 2.15 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.907 1.683 . . . . 1.3899999999999999 111.573 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 8.2 t70 -121.55 134.22 55.03 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.419 -1.425 . . . . 3.7400000000000002 111.495 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.253 1.278 0 CA-C-O 116.692 -1.623 . . . . 4.2999999999999998 111.618 170.584 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1047 ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 111.629 0.233 . . . . 10.99 111.629 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1048 ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -75.22 -23.31 57.58 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.994 1.479 . . . . 12.869999999999999 114.994 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1049 ' ' THR . . . . . . . . . . . . . 70.5 m -84.15 142.76 30.12 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.434 0.901 . . . . 9.1300000000000008 113.434 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1050 ' ' MET . . . . . . . . . . . . . 15.8 ptm -156.46 154.31 30.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.667 1.187 . . . . 6.6500000000000004 114.018 169.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1051 ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -128.32 -46.63 1.34 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.794 1.638 . . . . 6.3300000000000001 111.491 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1052 ' ' GLY . . . . . . . . . . . . . . . -135.18 145.46 17.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.345 0.974 . . . . 2.9100000000000001 112.937 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1053 ' ' THR . . . . . . . . . . . . . 5.3 p -115.07 148.6 40.94 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 2.2999999999999998 111.487 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1054 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.01 146.95 66.56 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.756 2.304 . . . . 1.3200000000000001 111.441 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1055 ' ' VAL . . . . . . . . . . . . . 10.9 p -130.59 134.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.347 1.059 . . . . 2.5499999999999998 110.698 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1056 ' ' VAL . . . . . . . . . . . . . 7.4 p -72.44 113.63 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.87 0.843 . . . . 1.1899999999999999 109.642 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1057 ' ' ASN . . . . . . . . . . . . . 2.1 t30 -91.52 -40.44 11.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.466 1.106 . . . . 2.7799999999999998 111.725 -168.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1058 ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -154.4 152.32 30.05 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.131 0.972 . . . . 1.97 112.099 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1059 ' ' VAL . . . . . . . . . . . . . 3.9 m -125.65 142.62 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.943 1.297 . . . . 0.72999999999999998 111.422 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1060 ' ' LYS . . . . . . . . . . . . . 56.2 tttt -143.45 149.35 37.47 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.925 1.083 . . . . 2.3799999999999999 113.925 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1061 ' ' VAL . . . . . . . . . . . . . 46.3 t -96.3 143.65 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.638 1.575 . . . . 0.68000000000000005 111.614 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1062 ' ' LEU . . . . . . . . . . . . . 29.3 tp -107.41 -46.15 3.92 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.605 1.962 . . . . 1.05 111.5 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1063 ' ' THR . . . . . . . . . . . . . 89.8 m -118.98 126.39 51.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.393 1.477 . . . . 1.73 109.115 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1064 ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -150.52 138.81 20.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.857 0.463 . . . . 4.4900000000000002 111.568 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1065 ' ' SER . . . . . . . . . . . . . 68.1 m 63.67 -14.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.956 2.103 . . . . 2.9900000000000002 116.59 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1066 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -95.52 -3.25 46.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.665 1.186 . . . . 2.8799999999999999 114.145 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1067 ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -157.88 -44.51 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.146 0.979 . . . . 4.21 112.987 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1068 ' ' ILE . . . . . . . . . . . . . 2.5 mm -134.12 157.65 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.61 1.964 . . . . 1.5800000000000001 110.346 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1069 ' ' SER . . . . . . . . . . . . . 71.6 m -113.5 149.84 33.74 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.019 1.727 . . . . 2.1099999999999999 112.589 172.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1070 ' ' HIS . . . . . . . . . . . . . 21.1 p80 -55.98 -47.01 78.47 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 116.634 2.087 . . . . 3.5299999999999998 116.634 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1071 ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -70.32 -18.01 63.09 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.531 1.06 . . . . 2.9100000000000001 111.378 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1072 ' ' LYS . . . . . . . . . . . . . 93.9 mttt -89.29 -30.09 18.71 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.558 1.543 . . . . 3.7599999999999998 111.784 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1073 ' ' ILE . . . . . . . . . . . . . 92.7 mt -58.6 -52.22 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 119.191 0.905 . . . . 0.68999999999999995 109.528 168.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1074 ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.21 -34.13 77.65 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.801 -0.562 . . . . 0.63 111.645 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1075 ' ' ALA . . . . . . . . . . . . . . . -59.6 -52.96 63.31 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 118.535 -0.745 . . . . 0.67000000000000004 112.548 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1076 ' ' ILE . . . . . . . . . . . . . 28.3 pt -68.37 -31.01 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.94 1.246 . . . . 0.64000000000000001 113.836 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1077 ' ' VAL . . . . . . . . . . . . . 84.0 t -70.37 -45.27 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.609 1.095 . . . . 0.77000000000000002 110.416 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1078 ' ' GLY . . . . . . . . . . . . . . . -61.37 -41.19 99.46 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.28 -0.733 . . . . 0.65000000000000002 113.241 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1079 ' ' THR . . . . . 0.4 ' HB ' ' HA2' ' A' 1106 ' ' GLY . 66.3 p -72.82 -37.42 67.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.159 0.98 . . . . 0.66000000000000003 113.541 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1080 ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.13 83.27 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.023 0.829 . . . . 0.77000000000000002 112.379 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1081 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.1 -16.91 63.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.275 -0.89 . . . . 2.2599999999999998 112.763 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1082 ' ' SER . . . . . . . . . . . . . 7.0 t -62.55 -23.83 67.2 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.159 1.17 . . . . 1.3200000000000001 114.159 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1083 ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -94.22 -13.12 26.93 Favored 'General case' 0 CA--C 1.551 1.005 0 O-C-N 121.25 -0.906 . . . . 1.8999999999999999 112.757 173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1084 ' ' SER . . . . . . . . . . . . . 10.7 t -73.84 160.18 31.8 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 115.298 1.592 . . . . 1.6599999999999999 115.298 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1085 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.24 12.42 26.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.576 2.35 . . . . 5.3099999999999996 113.445 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1086 ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -83.59 160.1 59.69 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.912 1.078 . . . . 1.54 113.912 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1087 ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -87.85 -34.66 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.897 3.065 . . . . 1.1699999999999999 114.61 -172.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1088 ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.79 -51.67 4.79 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.853 0.861 . . . . 0.69999999999999996 113.308 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1089 ' ' GLY . . . . . . . . . . . . . . . -63.4 -30.43 77.55 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.844 -0.217 . . . . 0.92000000000000004 113.345 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1090 ' ' THR . . . . . . . . . . . . . 29.2 p -65.19 -18.91 65.7 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.62 -1.518 . . . . 1.8600000000000001 113.557 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1091 ' ' ALA . . . . . . . . . . . . . . . -65.66 -32.05 73.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.802 -1.186 . . . . 0.81000000000000005 111.545 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1092 ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.19 -41.18 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.488 1.515 . . . . 0.84999999999999998 110.474 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1093 ' ' THR . . . . . . . . . . . . . 99.4 m -52.58 -47.99 66.51 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.892 1.223 . . . . 1.26 111.404 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1094 ' ' LYS . . . . . . . . . . . . . 33.2 tttt -59.11 -50.29 74.6 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.243 0.929 . . . . 2.5800000000000001 112.284 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1095 ' ' TYR . . . . . . . . . . . . . 76.9 t80 -58.28 -40.51 82.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.683 1.193 . . . . 2.1899999999999999 112.534 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1096 ' ' CYS . . . . . . . . . . . . . 83.7 m -72.84 -43.19 62.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.732 1.613 . . . . 3.2599999999999998 113.032 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1097 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.93 -36.81 80.29 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.329 1.422 . . . . 2.8399999999999999 110.836 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1098 ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.22 -47.39 79.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.216 1.006 . . . . 4.0 111.127 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1099 ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -62.67 -44.52 96.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.884 1.22 . . . . 1.95 113.844 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1100 ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.64 -18.71 62.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.322 0.86 . . . . 1.1499999999999999 113.322 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1101 ' ' ASP . . . . . . . . . . . . . 18.3 t70 48.99 32.06 3.65 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.69 1.596 . . . . 2.3199999999999998 113.59 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1102 ' ' THR . . . . . . . . . . . . . 6.8 t -99.85 -12.35 19.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.145 1.778 . . . . 3.4399999999999999 115.344 -167.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1103 ' ' GLU . . . . . . . . . . . . . 16.8 tt0 66.84 -19.93 0.11 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.656 2.382 . . . . 4.29 116.677 -178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1104 ' ' THR . . . . . . . . . . . . . 14.8 t -154.35 138.12 16.17 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.101 1.319 . . . . 3.25 113.507 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1105 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -156.62 153.78 29.12 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.012 1.325 . . . . 1.0600000000000001 114.449 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1106 ' ' GLY . . . . . 0.4 ' HA2' ' HB ' ' A' 1079 ' ' THR . . . 98.4 136.95 9.49 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 125.477 1.513 . . . . 1.04 114.622 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1107 ' ' THR . . . . . . . . . . . . . 25.1 m -125.94 -68.07 0.84 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.894 0.878 . . . . 1.3500000000000001 112.661 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1108 ' ' CYS . . . . . . . . . . . . . 12.8 t -138.77 142.48 38.8 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.395 1.258 . . . . 1.4299999999999999 114.395 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1109 ' ' ILE . . . . . . . . . . . . . 2.4 mm -143.82 139.44 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 130.997 3.719 . . . . 2.25 109.211 -174.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1110 ' ' ASP . . . . . 0.513 ' HB3' ' H ' ' A' 1122 ' ' LYS . 17.0 t0 -94.72 -28.06 15.5 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.524 1.53 . . . . 2.7400000000000002 114.027 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1111 ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.82 97.1 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.946 2.098 . . . . 2.75 116.222 169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1112 ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -119.59 114.48 22.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.967 1.707 . . . . 2.5499999999999998 109.136 169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1113 ' ' VAL . . . . . . . . . . . . . 92.8 t -113.71 131.33 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.445 1.498 . . . . 2.0899999999999999 111.453 -171.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1114 ' ' VAL . . . . . . . . . . . . . 50.7 t -133.9 118.79 14.45 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.201 1.4 . . . . 1.6200000000000001 107.602 169.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1115 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -53.42 136.62 63.82 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.214 2.609 . . . . 1.3400000000000001 113.677 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1116 ' ' GLY . . . . . . . . . . . . . . . 72.31 -45.22 0.96 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.422 1.963 . . . . 2.1699999999999999 114.767 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1117 ' ' CYS . . . . . . . . . . . . . 79.2 m -71.48 -5.34 32.26 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 117.369 2.359 . . . . 2.54 117.369 -167.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1118 ' ' GLY . . . . . . . . . . . . . . . 110.46 -167.41 12.63 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-N 119.983 1.265 . . . . 0.67000000000000004 113.819 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1119 ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 143.39 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.127 1.371 . . . . 1.8700000000000001 110.204 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1120 ' ' SER . . . . . . . . . . . . . 33.6 t -129.19 151.8 49.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.559 1.144 . . . . 0.53000000000000003 111.466 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1121 ' ' CYS . . . . . . . . . . . . . 29.3 p -162.94 172.52 14.96 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.197 0.999 . . . . 0.80000000000000004 113.413 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1122 ' ' LYS . . . . . 0.513 ' H ' ' HB3' ' A' 1110 ' ' ASP . 43.0 mmtm -114.16 135.91 53.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.447 1.499 . . . . 1.22 107.191 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1123 ' ' VAL . . . . . . . . . . . . . 35.0 m -128.6 148.18 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.609 0.763 . . . . 2.71 112.35 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1124 ' ' THR . . . . . . . . . . . . . 4.0 t -134.09 145.78 49.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.054 0.942 . . . . 1.23 109.68 165.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1125 ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -164.34 44.52 0.1 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.233 1.813 . . . . 2.9500000000000002 108.371 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1126 ' ' ILE . . . . . . . . . . . . . 9.3 pt -136.56 -31.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.108 1.763 . . . . 2.2999999999999998 112.188 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1127 ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -140.83 -0.48 1.51 Allowed 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.983 1.105 . . . . 4.5999999999999996 113.983 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1128 ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.78 7.03 Favored Glycine 0 N--CA 1.48 1.606 0 N-CA-C 118.421 2.128 . . . . 3.3300000000000001 118.421 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1129 ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.31 -4.27 25.05 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.797 1.406 . . . . 4.2199999999999998 114.797 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1130 ' ' LEU . . . . . . . . . . . . . 70.2 mt -72.63 29.31 0.06 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.988 2.115 . . . . 7.1399999999999997 114.281 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1131 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -48.78 137.65 12.11 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.957 2.903 . . . . 8.1400000000000006 113.41 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1132 ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.77 126.81 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.675 0.79 . . . . 12.17 111.332 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1133 ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -57.14 -51.06 70.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.702 1.201 . . . . 17.460000000000001 110.476 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1134 ' ' ASN . . . . . . . . . . . . . 64.3 t30 -161.7 140.53 9.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.113 1.365 . . . . 15.01 112.662 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1135 ' ' TRP . . . . . . . . . . . . . 25.9 m95 60.24 -162.41 0.26 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.682 1.993 . . . . 15.07 113.006 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1136 ' ' ASN . . . . . . . . . . . . . 6.0 m-80 66.01 21.08 11.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.301 1.44 . . . . 14.94 113.055 -169.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1137 ' ' ILE . . . . . . . . . . . . . 78.6 mt -110.05 -23.68 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 126.953 2.101 . . . . 12.08 111.115 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1138 ' ' GLU . . . . . . . . . . . . . 7.1 tt0 62.71 -31.77 0.1 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 129.838 3.255 . . . . 17.170000000000002 116.577 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1139 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.53 11.48 24.86 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.694 2.398 . . . . 12.890000000000001 113.29 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1140 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -43.37 -28.55 0.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.051 2.54 . . . . 13.51 117.457 -167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1141 ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.87 56.06 0.41 Allowed 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 119.562 1.074 . . . . 14.6 112.214 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1142 ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.36 107.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.451 1.1 . . . . 15.94 110.57 -168.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1143 ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -130.77 69.92 1.46 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.354 1.462 . . . . 17.48 109.619 172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1144 ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -86.64 -13.31 45.94 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.391 1.256 . . . . 16.600000000000001 114.391 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1145 ' ' ALA . . . . . . . . . . . . . . . -63.33 134.62 56.1 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.813 1.042 . . . . 17.149999999999999 113.813 -173.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1146 ' ' SER . . . . . . . . . . . . . 83.2 p -121.4 154.59 36.31 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.812 1.645 . . . . 18.280000000000001 113.25 -173.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1147 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.57 42.0 0.74 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.316 1.446 . . . . 19.98 112.832 -172.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1148 ' ' VAL . . . . . . . . . . . . . 57.6 t -75.71 128.29 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.554 1.142 . . . . 21.949999999999999 110.046 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1149 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 57.85 146.45 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.988 2.915 . . . . 26.079999999999998 115.824 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1150 ' ' ILE . . . . . . . . . . . . . 41.4 mm 62.08 143.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.562 2.345 . . . . 27.800000000000001 114.63 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1151 ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -119.51 -20.42 7.78 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.354 2.262 . . . . 29.059999999999999 111.225 169.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1152 ' ' ALA . . . . . . . . . . . . . . . -70.86 6.57 1.46 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.021 1.729 . . . . 31.699999999999999 115.158 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1153 ' ' SER . . . . . . . . . . . . . 87.9 p -109.43 -1.35 18.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.983 1.313 . . . . 29.890000000000001 111.999 166.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1154 ' ' ASN . . . . . . . . . . . . . 43.4 t30 42.94 44.77 4.12 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 129.221 3.008 . . . . 31.75 117.799 167.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1155 ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 65.63 12.92 8.6 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 115.169 1.544 . . . . 27.859999999999999 115.169 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1156 ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -101.85 0.97 36.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.635 1.346 . . . . 33.899999999999999 114.635 -175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1157 ' ' SER . . . . . . . . . . . . . 3.9 t -136.52 8.77 3.12 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.198 0.999 . . . . 28.59 113.141 -169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1158 ' ' SER . . . . . . . . . . . . . 88.6 p -67.63 138.21 56.21 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.041 1.497 . . . . 25.059999999999999 115.041 -169.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1159 ' ' THR . . . . . . . . . . . . . 11.7 t -164.95 163.9 20.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.069 2.148 . . . . 23.84 109.537 168.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1160 ' ' SER . . . . . . . . . . . . . 54.8 p -157.51 171.4 20.43 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.282 -0.887 . . . . 20.530000000000001 112.938 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1161 ' ' SER . . . . . . . . . . . . . 34.3 p -58.82 -22.57 58.95 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.592 1.157 . . . . 18.949999999999999 113.343 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1162 ' ' SER . . . . . . . . . . . . . 69.3 m -81.41 -1.03 44.13 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.351 1.241 . . . . 17.18 114.351 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1163 ' ' MET . . . . . . . . . . . . . 89.0 mmm -73.88 145.93 44.45 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.768 -1.207 . . . . 20.120000000000001 110.882 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1164 ' ' ILE . . . . . . . . . . . . . 70.4 mt 60.06 -14.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 127.167 2.187 . . . . 18.920000000000002 114.683 -172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1165 ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.82 -30.36 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 119.636 -1.915 . . . . 13.800000000000001 115.932 -168.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1166 ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -68.5 -28.24 66.84 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.86 1.209 . . . . 14.0 113.098 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1167 ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.69 76.6 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.669 -0.644 . . . . 13.25 110.968 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1168 ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.64 -43.77 15.24 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.77 1.228 . . . . 13.029999999999999 111.471 -169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1169 ' ' ILE . . . . . . . . . . . . . 89.7 mt -68.18 -40.63 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.516 1.126 . . . . 10.300000000000001 111.003 172.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1170 ' ' SER . . . . . . . . . . . . . 50.8 m -65.53 -29.16 69.76 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.172 -0.955 . . . . 9.9000000000000004 112.512 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1171 ' ' ASN . . . . . . . . . . . . 0.261 4.3 p30 -84.77 -5.29 59.32 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.701 1.371 . . . . 8.0 114.701 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1172 ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.03 64.18 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.982 1.104 . . . . 5.6100000000000003 113.982 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1173 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.01 -33.39 62.58 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.781 1.233 . . . . 8.9000000000000004 111.33 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1174 ' ' ASN . . . . . . . . . . . . . 16.8 m120 -95.77 -33.6 12.21 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.821 1.648 . . . . 6.0 112.293 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1175 ' ' ALA . . . . . . . . . . . . . . . -107.37 103.42 12.76 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.606 1.706 . . . . 3.79 115.606 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1176 ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -46.43 143.32 2.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.815 1.783 . . . . 3.3799999999999999 115.815 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1177 ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -129.9 161.28 31.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.234 1.813 . . . . 2.0800000000000001 112.937 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1178 ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -126.33 134.58 51.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.955 2.502 . . . . 2.6000000000000001 109.179 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1179 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -95.04 105.9 17.85 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.855 1.262 . . . . 1.52 110.786 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1180 ' ' VAL . . . . . . . . . . . . . 6.5 m -124.11 142.33 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.382 0.673 . . . . 0.90000000000000002 112.652 -169.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1181 ' ' LEU . . . . . . . . . . . . . 1.8 pt? -145.5 151.87 38.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.536 1.135 . . . . 0.51000000000000001 112.836 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1182 ' ' ILE . . . . . . . . . . . . . 12.4 tt -146.47 155.47 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.767 1.627 . . . . 0.67000000000000004 109.891 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1183 ' ' GLY . . . . . . . . . . . . . . . 107.55 163.66 21.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.111 0.839 . . . . 1.6299999999999999 114.127 168.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1184 ' ' ASN . . . . . . . . . . . . . 4.8 t-20 49.98 -155.23 0.11 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.212 1.805 . . . . 2.3999999999999999 114.013 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1185 ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -130.11 -34.69 1.65 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 128.171 2.589 . . . . 5.0099999999999998 111.556 174.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1186 ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.88 -32.47 51.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.159 1.17 . . . . 3.2999999999999998 114.159 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1187 ' ' TRP . . . . . . . . . . . . . 4.2 t90 -72.39 -28.98 63.34 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.354 -1.466 . . . . 3.0600000000000001 111.892 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1188 ' ' MET . . . . . . . . . . . . . 6.1 tpp -57.38 -34.23 68.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.922 0.889 . . . . 2.3100000000000001 111.617 171.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1189 ' ' ILE . . . . . . . . . . . . . 69.5 mt -68.96 -66.0 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.554 1.942 . . . . 1.6399999999999999 109.985 168.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1190 ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -55.8 -18.89 9.57 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 116.01 1.856 . . . . 5.5999999999999996 116.01 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1191 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.71 9.86 2.55 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 120.15 1.341 . . . . 0.81000000000000005 112.79 169.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1192 ' ' GLY . . . . . . . . . . . . . . . 72.77 18.63 78.92 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.387 1.47 . . . . 0.98999999999999999 115.571 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1193 ' ' LEU . . . . . . . . . . . . . 9.6 mt -83.59 171.23 13.53 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.445 1.098 . . . . 0.80000000000000004 111.325 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1194 ' ' VAL . . . . . . . . . . . . . 94.7 t -108.79 120.12 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.568 1.147 . . . . 1.0600000000000001 109.989 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1195 ' ' ILE . . . . . . . . . . . . . 20.5 tt -99.87 125.27 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.158 0.983 . . . . 1.1299999999999999 110.845 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1196 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -92.54 156.24 17.27 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.031 1.332 . . . . 4.1699999999999999 112.99 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1197 ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -60.21 -31.36 70.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.702 1.201 . . . . 2.6299999999999999 113.45 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1198 ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.45 -42.51 68.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.348 1.059 . . . . 3.0299999999999998 111.704 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1199 ' ' VAL . . . . . . . . . . . . . 4.4 p -78.17 -35.26 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.223 0.823 . . . . 0.79000000000000004 113.223 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1200 ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.8 -38.95 89.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.668 1.122 . . . . 2.3599999999999999 111.215 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1201 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.06 -49.27 78.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.585 0.754 . . . . 1.97 112.142 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1202 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -57.2 -41.56 79.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.189 1.396 . . . . 2.5899999999999999 111.546 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1203 ' ' MET . . . . . . . . . . . . . 25.4 tpp -64.81 -49.29 71.25 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.553 1.541 . . . . 0.73999999999999999 111.811 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1204 ' ' THR . . . . . . . . . . . . . 5.4 t -74.94 -30.53 61.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.885 0.698 . . . . 0.90000000000000002 112.885 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1205 ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -58.05 -53.18 61.2 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.477 -1.389 . . . . 2.5 112.629 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1206 ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -71.31 -29.13 64.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.532 0.733 . . . . 3.02 112.572 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1207 ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.05 -46.08 89.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.949 0.9 . . . . 4.8399999999999999 111.595 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1208 ' ' ARG . . . . . . . . . . . . . 28.2 mtt180 -66.93 -29.54 69.44 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.389 1.475 . . . . 3.7999999999999998 113.625 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1209 ' ' LYS . . . . . . . . . . . . . 23.5 mttp -65.44 -10.69 36.08 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.482 1.513 . . . . 2.6400000000000001 113.51 169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1210 ' ' GLY . . . . . . . . . . . . . . . 93.26 29.52 10.18 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.941 1.258 . . . . 1.72 114.409 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1211 ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -126.63 176.94 6.84 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.715 1.606 . . . . 5.5999999999999996 111.043 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1212 ' ' THR . . . . . . . . . . . . . 55.2 m -90.79 139.16 31.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.072 1.349 . . . . 0.81999999999999995 111.328 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1213 ' ' ALA . . . . . . . . . . . . . . . -136.86 130.95 32.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.025 0.93 . . . . 0.47999999999999998 112.514 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1214 ' ' VAL . . . . . . . . . . . . . 27.5 m -142.57 164.58 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 125.717 1.607 . . . . 0.45000000000000001 113.423 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1215 ' ' LEU . . . . . . . . . . . . . 2.7 mp -118.37 168.74 10.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.363 1.465 . . . . 0.78000000000000003 113.489 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1216 ' ' VAL . . . . . . . . . . . . . 9.2 t -137.02 128.56 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.624 1.57 . . . . 1.6799999999999999 112.101 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1217 ' ' ALA . . . . . . . . . . . . . . . -125.55 150.24 47.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.243 1.417 . . . . 0.5 113.259 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1218 ' ' VAL . . . . . . . . . . . . . 34.3 m -146.32 125.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.091 1.756 . . . . 0.63 111.529 -173.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1219 ' ' ASP . . . . . . . . . . . . . 29.0 m-20 37.7 53.5 1.47 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.494 2.318 . . . . 2.7400000000000002 113.268 -173.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1220 ' ' ASP . . . . . . . . . . . . 0.275 16.3 m-20 58.85 29.29 18.62 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.369 1.989 . . . . 2.0499999999999998 116.369 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1221 ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -125.18 151.7 45.48 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.496 1.918 . . . . 3.2200000000000002 110.091 166.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1222 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.55 145.33 34.89 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.833 -1.167 . . . . 0.70999999999999996 110.124 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1223 ' ' CYS . . . . . . . . . . . . . 26.8 p -119.5 -40.55 2.77 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.527 -0.749 . . . . 0.44 112.892 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1224 ' ' GLY . . . . . . . . . . . . . . . -171.27 -172.7 37.67 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 120.11 1.323 . . . . 0.38 116.222 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1225 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -138.25 152.62 48.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.264 1.826 . . . . 0.69999999999999996 112.656 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1226 ' ' ILE . . . . . . . . . . . . . 11.1 mm -132.29 136.28 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.032 1.333 . . . . 0.72999999999999998 110.242 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1227 ' ' ALA . . . . . . . . . . . . . . . -109.97 136.9 48.51 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.311 1.444 . . . . 0.64000000000000001 110.266 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1228 ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.36 143.65 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.805 1.642 . . . . 1.47 111.146 -170.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1229 ' ' ALA . . . . . . . . . . . . . . . -123.31 -171.79 2.38 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.518 1.927 . . . . 1.54 111.956 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1230 ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -124.75 133.49 53.14 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.216 1.807 . . . . 3.2200000000000002 112.222 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1231 ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.48 1.512 . . . . 5.3200000000000003 114.556 -174.7 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1232 ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_